{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 14,
   "id": "3e011884-3f4b-4439-ab84-00d06fc0c9e5",
   "metadata": {
    "collapsed": true,
    "jupyter": {
     "outputs_hidden": true
    },
    "scrolled": true
   },
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "C:\\Users\\dagri\\anaconda3\\envs\\WIKIbench\\Lib\\site-packages\\lxml\\html\\__init__.py:710: RuntimeWarning: coroutine 'WikiEval.get_section' was never awaited\n",
      "  def lookup(self, node_type, document, namespace, name):\n",
      "RuntimeWarning: Enable tracemalloc to get the object allocation traceback\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "2023 год\n",
      "2024 год\n",
      "Atomic Heart\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "C:\\Users\\dagri\\anaconda3\\envs\\WIKIbench\\Lib\\site-packages\\dateutil\\parser\\_parser.py:1207: UnknownTimezoneWarning: tzname PST identified but not understood.  Pass `tzinfos` argument in order to correctly return a timezone-aware datetime.  In a future version, this will raise an exception.\n",
      "  warnings.warn(\"tzname {tzname} identified but not understood.  \"\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "BTS\n",
      "ChatGPT\n",
      "F-35\n",
      "General Dynamics F-16 Fighting Falcon\n",
      "Grand Theft Auto V\n",
      "Instagram\n",
      "Linkin Park\n",
      "Minecraft\n",
      "Ozon\n",
      "Rutube\n",
      "Shaman\n",
      "Telegram\n",
      "WhatsApp\n",
      "Wildberries\n",
      "YouTube\n",
      "Аватар: Путь воды\n",
      "Азербайджан\n",
      "Американская история ужасов\n",
      "Арабо-израильский конфликт\n",
      "Армения\n",
      "Асад, Башар\n",
      "Аутизм\n",
      "Афганистан\n",
      "Афганская война (1979—1989)\n",
      "БРИКС\n",
      "Байден, Джо\n",
      "Басаев, Шамиль Салманович\n",
      "Баста (музыкант)\n",
      "Биткойн\n",
      "Блиновская, Елена Олеговна\n",
      "Блокада Ленинграда\n",
      "Бондарчук, Фёдор Сергеевич\n",
      "Боярский, Михаил Сергеевич\n",
      "Братья Менендес\n",
      "ВКонтакте\n",
      "Валиева, Камила Валерьевна\n",
      "Великобритания\n",
      "Википедия\n",
      "Владивосток\n",
      "Властелин колец: Кольца власти\n",
      "Во все тяжкие\n",
      "Волгоград\n",
      "Вооружённые силы Российской Федерации\n",
      "Вооружённые силы Украины\n",
      "Вызов (фильм, 2023)\n",
      "Гагарин, Юрий Алексеевич\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Some characters could not be decoded, and were replaced with REPLACEMENT CHARACTER.\n",
      "Some characters could not be decoded, and were replaced with REPLACEMENT CHARACTER.\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Германия\n",
      "Гибель тургруппы Дятлова\n",
      "Голикова, Татьяна Алексеевна\n",
      "Горбачёв, Михаил Сергеевич\n",
      "Государство Палестина\n",
      "Гражданская война в Сирии\n",
      "Де Армас, Ана\n",
      "Джексон, Майкл\n",
      "Джобс, Стив\n",
      "Джокер: Безумие на двоих\n",
      "Джонсон, Дуэйн\n",
      "Дзюба, Артём Сергеевич\n",
      "Ди Каприо, Леонардо\n",
      "Дом Дракона\n",
      "Дуров, Павел Валерьевич\n",
      "Дэдпул и Росомаха\n",
      "Дюмин, Алексей Геннадьевич\n",
      "Дюна (фильм, 2021)\n",
      "Евромайдан\n",
      "Единая Россия\n",
      "Екатеринбург\n",
      "Елизавета II\n",
      "Ефремов, Михаил Олегович\n",
      "Жириновский, Владимир Вольфович\n",
      "Зеленский, Владимир Александрович\n",
      "Землетрясение в Турции и Сирии (2023)\n",
      "Зендея\n",
      "Зенит (футбольный клуб, Санкт-Петербург)\n",
      "Ибрагимович, Златан\n",
      "Иванов, Тимур Вадимович\n",
      "Игра в кальмара\n",
      "Игра престолов (телесериал)\n",
      "Израиль\n",
      "Искандер (ракетный комплекс)\n",
      "Искусственный интеллект\n",
      "Исламское государство\n",
      "Италия\n",
      "Йеллоустон (телесериал)\n",
      "Йоханссон, Скарлетт\n",
      "Кабаева, Алина Маратовна\n",
      "Каддафи, Муаммар\n",
      "Кадыров, Рамзан Ахматович\n",
      "Казань\n",
      "Казахстан\n",
      "Калашников, Михаил Тимофеевич\n",
      "Калининград\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Some characters could not be decoded, and were replaced with REPLACEMENT CHARACTER.\n",
      "Some characters could not be decoded, and were replaced with REPLACEMENT CHARACTER.\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Канада\n",
      "Карлсон, Такер\n",
      "Кинематографическая вселенная Marvel\n",
      "Кирилл (патриарх Московский)\n",
      "Киркоров, Филипп Бедросович\n",
      "Китай\n",
      "Кобейн, Курт\n",
      "Комбс, Шон\n",
      "Корейская Народно-Демократическая Республика\n",
      "Король и Шут\n",
      "Кошка\n",
      "Краснодар\n",
      "Красноярск\n",
      "Криштиану Роналду\n",
      "Крымский мост\n",
      "Крёстный отец (фильм)\n",
      "Лавров, Сергей Викторович\n",
      "Леди Гага\n",
      "Ленин, Владимир Ильич\n",
      "Лукашенко, Александр Григорьевич\n",
      "Магическая битва\n",
      "Макконахи, Мэттью\n",
      "Манчестер Сити\n",
      "Манчестер Юнайтед\n",
      "Марцинкевич, Максим Сергеевич\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "C:\\Users\\dagri\\anaconda3\\envs\\WIKIbench\\Lib\\site-packages\\dateutil\\parser\\_parser.py:1207: UnknownTimezoneWarning: tzname EST identified but not understood.  Pass `tzinfos` argument in order to correctly return a timezone-aware datetime.  In a future version, this will raise an exception.\n",
      "  warnings.warn(\"tzname {tzname} identified but not understood.  \"\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Маск, Илон\n",
      "Матвиенко, Валентина Ивановна\n",
      "Машков, Владимир Львович\n",
      "Мбаппе, Килиан\n",
      "Медведев, Дмитрий Анатольевич\n",
      "Месси, Лионель\n",
      "Мизулина, Елена Борисовна\n",
      "Мишустин, Михаил Владимирович\n",
      "Миядзаки, Хаяо\n",
      "Моргенштерн\n",
      "Москва\n",
      "Московский метрополитен\n",
      "Мэрилин Монро\n",
      "Мятеж ЧВК «Вагнер»\n",
      "НАТО\n",
      "Набиуллина, Эльвира Сахипзадовна\n",
      "Навальный, Алексей Анатольевич\n",
      "Настоящий детектив\n",
      "Нижний Новгород\n",
      "Новосибирск\n",
      "Нурмагомедов, Хабиб Абдулманапович\n",
      "Обама, Барак\n",
      "Овечкин, Александр Михайлович\n",
      "Одни из нас (телесериал)\n",
      "Октябрьская революция\n",
      "Оппенгеймер (фильм)\n",
      "Очень странные дела\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Some characters could not be decoded, and were replaced with REPLACEMENT CHARACTER.\n",
      "Some characters could not be decoded, and were replaced with REPLACEMENT CHARACTER.\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Пандемия COVID-19\n",
      "Пасха\n",
      "Пацаны (4-й сезон)\n",
      "Пацаны (телесериал)\n",
      "Пелевин, Виктор Олегович\n",
      "Перельман, Григорий Яковлевич\n",
      "Пермь\n",
      "Пожар в торговом центре «Зимняя вишня»\n",
      "Православие\n",
      "Президентские выборы в России (2018)\n",
      "Президентские выборы в России (2024)\n",
      "Президентские выборы в США (2020)\n",
      "Президентские выборы в США (2024)\n",
      "Пригожин, Евгений Викторович\n",
      "Приднестровская Молдавская Республика\n",
      "Прилепин, Захар\n",
      "Пугачёва, Алла Борисовна\n",
      "Путин, Владимир Владимирович\n",
      "Пушкин, Александр Сергеевич\n",
      "Российская империя\n",
      "Россия\n",
      "Русский язык\n",
      "Самара\n",
      "Санкт-Петербург\n",
      "Сармат (ракетный комплекс)\n",
      "Сбербанк России\n",
      "Сверхъестественное (телесериал)\n",
      "Свифт, Тейлор\n",
      "Севастополь\n",
      "Синдром Аспергера\n",
      "Сирия\n",
      "Слово пацана. Кровь на асфальте\n",
      "Слуцкий, Леонид Эдуардович\n",
      "Собчак, Ксения Анатольевна\n",
      "События сентября — октября 1993 года в Москве\n",
      "Солнечная система\n",
      "Соловьёв, Владимир Рудольфович\n",
      "Сочи\n",
      "Союз Советских Социалистических Республик\n",
      "Спартак (футбольный клуб, Москва)\n",
      "Список фильмов кинематографической вселенной Marvel\n",
      "Сталин, Иосиф Виссарионович\n",
      "Стоун, Эмма\n",
      "Стрелков, Игорь Иванович\n",
      "Су-34\n",
      "Су-57\n",
      "Сёгун (телесериал, 2024)\n",
      "Талибан\n",
      "Тарантино, Квентин\n",
      "Теракт на Дубровке\n",
      "Террористические акты 11 сентября 2001 года\n",
      "Террористический акт в Беслане\n",
      "Тиньков, Олег Юрьевич\n",
      "Титаник\n",
      "Толстой, Лев Николаевич\n",
      "Трамп, Дональд\n",
      "Ту-160\n",
      "Тюмень\n",
      "Уильямс, Робин\n",
      "Усама бен Ладен\n",
      "Уткин, Василий Вячеславович\n",
      "Флаг России\n",
      "Фрейндлих, Алиса Бруновна\n",
      "Фриске, Жанна Владимировна\n",
      "ХАМАС\n",
      "Хабенский, Константин Юрьевич\n",
      "Харрис, Камала\n",
      "Хинштейн, Александр Евсеевич\n",
      "Хрущёв, Никита Сергеевич\n",
      "Цой, Виктор Робертович\n",
      "ЧВК «Вагнер»\n",
      "Человек разумный\n",
      "Шаламе, Тимоти\n",
      "Шизофрения\n",
      "Шойгу, Сергей Кужугетович\n",
      "Экономика России\n",
      "Эминем\n",
      "Эпштейн, Джеффри\n",
      "Яндекс\n",
      "Янковский, Олег Иванович\n",
      "Янукович, Виктор Фёдорович\n",
      "Яшин, Илья Валерьевич\n"
     ]
    }
   ],
   "source": [
    "import shutil\n",
    "import os\n",
    "\n",
    "source_path = r'Articles\\Sources'\n",
    "err = []\n",
    "succ = []\n",
    "for name in names:\n",
    "    try:\n",
    "        page = wiki_bench.get_article(name=name, retrieve_sources=True, verbose=False, html=False, needs_saving=True)\n",
    "        if len(page.downloaded_links) >= 25:\n",
    "            succ.append(name)\n",
    "            print(page.name)\n",
    "        else:\n",
    "            article_dir = os.path.join(source_path, page.cleared_name)\n",
    "            if os.path.exists(article_dir) and os.path.isdir(article_dir):\n",
    "                shutil.rmtree(article_dir)\n",
    "    except:\n",
    "        err.append(name)\n",
    "        continue"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1,
   "id": "0b8632f9-b953-47c5-8045-542c52621be8",
   "metadata": {
    "scrolled": true
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Requirement already satisfied: numpy==2.0.2 in c:\\users\\dagri\\anaconda3\\envs\\wikibench\\lib\\site-packages (from -r requirements.txt (line 1)) (2.0.2)\n",
      "Requirement already satisfied: pandas in c:\\users\\dagri\\anaconda3\\envs\\wikibench\\lib\\site-packages (from -r requirements.txt (line 2)) (2.2.3)\n",
      "Requirement already satisfied: scipy==1.14.1 in c:\\users\\dagri\\anaconda3\\envs\\wikibench\\lib\\site-packages (from -r requirements.txt (line 3)) (1.14.1)\n",
      "Requirement already satisfied: scikit-learn==1.6.1 in c:\\users\\dagri\\anaconda3\\envs\\wikibench\\lib\\site-packages (from -r requirements.txt (line 4)) (1.6.1)\n",
      "Requirement already satisfied: requests==2.32.3 in c:\\users\\dagri\\anaconda3\\envs\\wikibench\\lib\\site-packages (from -r requirements.txt (line 5)) (2.32.3)\n",
      "Requirement already satisfied: BeautifulSoup4==4.11.1 in c:\\users\\dagri\\anaconda3\\envs\\wikibench\\lib\\site-packages (from -r requirements.txt (line 6)) (4.11.1)\n",
      "Requirement already satisfied: lxml_html_clean==0.4.1 in c:\\users\\dagri\\anaconda3\\envs\\wikibench\\lib\\site-packages (from -r requirements.txt (line 7)) (0.4.1)\n",
      "Requirement already satisfied: newspaper3k==0.2.8 in c:\\users\\dagri\\anaconda3\\envs\\wikibench\\lib\\site-packages (from -r requirements.txt (line 8)) (0.2.8)\n",
      "Requirement already satisfied: openai==1.55.3 in c:\\users\\dagri\\anaconda3\\envs\\wikibench\\lib\\site-packages (from -r requirements.txt (line 10)) (1.55.3)\n",
      "Requirement already satisfied: httpx==0.27.2 in c:\\users\\dagri\\anaconda3\\envs\\wikibench\\lib\\site-packages (from -r requirements.txt (line 11)) (0.27.2)\n",
      "Requirement already satisfied: asyncio==3.4.3 in c:\\users\\dagri\\anaconda3\\envs\\wikibench\\lib\\site-packages (from -r requirements.txt (line 12)) (3.4.3)\n",
      "Requirement already satisfied: nltk in c:\\users\\dagri\\anaconda3\\envs\\wikibench\\lib\\site-packages (from -r requirements.txt (line 13)) (3.9.1)\n",
      "Requirement already satisfied: PyStemmer==2.2.0.3 in c:\\users\\dagri\\anaconda3\\envs\\wikibench\\lib\\site-packages (from -r requirements.txt (line 14)) (2.2.0.3)\n",
      "Requirement already satisfied: datasets in c:\\users\\dagri\\anaconda3\\envs\\wikibench\\lib\\site-packages (from -r requirements.txt (line 16)) (3.5.0)\n",
      "Requirement already satisfied: jax==0.5.2 in c:\\users\\dagri\\anaconda3\\envs\\wikibench\\lib\\site-packages (from jax[cpu]==0.5.2->-r requirements.txt (line 17)) (0.5.2)\n",
      "Requirement already satisfied: tqdm in c:\\users\\dagri\\anaconda3\\envs\\wikibench\\lib\\site-packages (from -r requirements.txt (line 18)) (4.67.1)\n",
      "Requirement already satisfied: sentence-transformers in c:\\users\\dagri\\anaconda3\\envs\\wikibench\\lib\\site-packages (from -r requirements.txt (line 19)) (4.0.2)\n",
      "Requirement already satisfied: accelerate in c:\\users\\dagri\\anaconda3\\envs\\wikibench\\lib\\site-packages (from -r requirements.txt (line 20)) (1.6.0)\n",
      "Requirement already satisfied: transformers in c:\\users\\dagri\\anaconda3\\envs\\wikibench\\lib\\site-packages (from -r requirements.txt (line 21)) (4.51.0)\n",
      "Requirement already satisfied: matplotlib in c:\\users\\dagri\\anaconda3\\envs\\wikibench\\lib\\site-packages (from -r requirements.txt (line 22)) (3.10.1)\n",
      "Requirement already satisfied: pymorphy3 in c:\\users\\dagri\\anaconda3\\envs\\wikibench\\lib\\site-packages (from -r requirements.txt (line 23)) (2.0.3)\n",
      "Requirement already satisfied: razdel in c:\\users\\dagri\\anaconda3\\envs\\wikibench\\lib\\site-packages (from -r requirements.txt (line 24)) (0.5.0)\n",
      "Requirement already satisfied: goose3[all] in c:\\users\\dagri\\anaconda3\\envs\\wikibench\\lib\\site-packages (from -r requirements.txt (line 9)) (3.1.19)\n",
      "Requirement already satisfied: bm25s[full] in c:\\users\\dagri\\anaconda3\\envs\\wikibench\\lib\\site-packages (from -r requirements.txt (line 15)) (0.2.10)\n",
      "Requirement already satisfied: joblib>=1.2.0 in c:\\users\\dagri\\anaconda3\\envs\\wikibench\\lib\\site-packages (from scikit-learn==1.6.1->-r requirements.txt (line 4)) (1.4.2)\n",
      "Requirement already satisfied: threadpoolctl>=3.1.0 in c:\\users\\dagri\\anaconda3\\envs\\wikibench\\lib\\site-packages (from scikit-learn==1.6.1->-r requirements.txt (line 4)) (3.6.0)\n",
      "Requirement already satisfied: charset-normalizer<4,>=2 in c:\\users\\dagri\\anaconda3\\envs\\wikibench\\lib\\site-packages (from requests==2.32.3->-r requirements.txt (line 5)) (2.0.12)\n",
      "Requirement already satisfied: idna<4,>=2.5 in c:\\users\\dagri\\anaconda3\\envs\\wikibench\\lib\\site-packages (from requests==2.32.3->-r requirements.txt (line 5)) (3.10)\n",
      "Requirement already satisfied: urllib3<3,>=1.21.1 in c:\\users\\dagri\\anaconda3\\envs\\wikibench\\lib\\site-packages (from requests==2.32.3->-r requirements.txt (line 5)) (1.26.20)\n",
      "Requirement already satisfied: certifi>=2017.4.17 in c:\\users\\dagri\\anaconda3\\envs\\wikibench\\lib\\site-packages (from requests==2.32.3->-r requirements.txt (line 5)) (2025.1.31)\n",
      "Requirement already satisfied: soupsieve>1.2 in c:\\users\\dagri\\anaconda3\\envs\\wikibench\\lib\\site-packages (from BeautifulSoup4==4.11.1->-r requirements.txt (line 6)) (2.5)\n",
      "Requirement already satisfied: lxml in c:\\users\\dagri\\anaconda3\\envs\\wikibench\\lib\\site-packages (from lxml_html_clean==0.4.1->-r requirements.txt (line 7)) (5.3.1)\n",
      "Requirement already satisfied: Pillow>=3.3.0 in c:\\users\\dagri\\anaconda3\\envs\\wikibench\\lib\\site-packages (from newspaper3k==0.2.8->-r requirements.txt (line 8)) (11.1.0)\n",
      "Requirement already satisfied: PyYAML>=3.11 in c:\\users\\dagri\\anaconda3\\envs\\wikibench\\lib\\site-packages (from newspaper3k==0.2.8->-r requirements.txt (line 8)) (6.0.2)\n",
      "Requirement already satisfied: cssselect>=0.9.2 in c:\\users\\dagri\\anaconda3\\envs\\wikibench\\lib\\site-packages (from newspaper3k==0.2.8->-r requirements.txt (line 8)) (1.2.0)\n",
      "Requirement already satisfied: feedparser>=5.2.1 in c:\\users\\dagri\\anaconda3\\envs\\wikibench\\lib\\site-packages (from newspaper3k==0.2.8->-r requirements.txt (line 8)) (6.0.11)\n",
      "Requirement already satisfied: tldextract>=2.0.1 in c:\\users\\dagri\\anaconda3\\envs\\wikibench\\lib\\site-packages (from newspaper3k==0.2.8->-r requirements.txt (line 8)) (5.1.3)\n",
      "Requirement already satisfied: feedfinder2>=0.0.4 in c:\\users\\dagri\\anaconda3\\envs\\wikibench\\lib\\site-packages (from newspaper3k==0.2.8->-r requirements.txt (line 8)) (0.0.4)\n",
      "Requirement already satisfied: jieba3k>=0.35.1 in c:\\users\\dagri\\anaconda3\\envs\\wikibench\\lib\\site-packages (from newspaper3k==0.2.8->-r requirements.txt (line 8)) (0.35.1)\n",
      "Requirement already satisfied: python-dateutil>=2.5.3 in c:\\users\\dagri\\anaconda3\\envs\\wikibench\\lib\\site-packages (from newspaper3k==0.2.8->-r requirements.txt (line 8)) (2.9.0.post0)\n",
      "Requirement already satisfied: tinysegmenter==0.3 in c:\\users\\dagri\\anaconda3\\envs\\wikibench\\lib\\site-packages (from newspaper3k==0.2.8->-r requirements.txt (line 8)) (0.3)\n",
      "Requirement already satisfied: anyio<5,>=3.5.0 in c:\\users\\dagri\\anaconda3\\envs\\wikibench\\lib\\site-packages (from openai==1.55.3->-r requirements.txt (line 10)) (4.9.0)\n",
      "Requirement already satisfied: distro<2,>=1.7.0 in c:\\users\\dagri\\anaconda3\\envs\\wikibench\\lib\\site-packages (from openai==1.55.3->-r requirements.txt (line 10)) (1.9.0)\n",
      "Requirement already satisfied: jiter<1,>=0.4.0 in c:\\users\\dagri\\anaconda3\\envs\\wikibench\\lib\\site-packages (from openai==1.55.3->-r requirements.txt (line 10)) (0.9.0)\n",
      "Requirement already satisfied: pydantic<3,>=1.9.0 in c:\\users\\dagri\\anaconda3\\envs\\wikibench\\lib\\site-packages (from openai==1.55.3->-r requirements.txt (line 10)) (2.10.6)\n",
      "Requirement already satisfied: sniffio in c:\\users\\dagri\\anaconda3\\envs\\wikibench\\lib\\site-packages (from openai==1.55.3->-r requirements.txt (line 10)) (1.3.1)\n",
      "Requirement already satisfied: typing-extensions<5,>=4.11 in c:\\users\\dagri\\anaconda3\\envs\\wikibench\\lib\\site-packages (from openai==1.55.3->-r requirements.txt (line 10)) (4.13.0)\n",
      "Requirement already satisfied: httpcore==1.* in c:\\users\\dagri\\anaconda3\\envs\\wikibench\\lib\\site-packages (from httpx==0.27.2->-r requirements.txt (line 11)) (1.0.7)\n",
      "Requirement already satisfied: jaxlib<=0.5.2,>=0.5.1 in c:\\users\\dagri\\anaconda3\\envs\\wikibench\\lib\\site-packages (from jax==0.5.2->jax[cpu]==0.5.2->-r requirements.txt (line 17)) (0.5.1)\n",
      "Requirement already satisfied: ml_dtypes>=0.4.0 in c:\\users\\dagri\\anaconda3\\envs\\wikibench\\lib\\site-packages (from jax==0.5.2->jax[cpu]==0.5.2->-r requirements.txt (line 17)) (0.5.1)\n",
      "Requirement already satisfied: opt_einsum in c:\\users\\dagri\\anaconda3\\envs\\wikibench\\lib\\site-packages (from jax==0.5.2->jax[cpu]==0.5.2->-r requirements.txt (line 17)) (3.4.0)\n",
      "Requirement already satisfied: h11<0.15,>=0.13 in c:\\users\\dagri\\anaconda3\\envs\\wikibench\\lib\\site-packages (from httpcore==1.*->httpx==0.27.2->-r requirements.txt (line 11)) (0.14.0)\n",
      "Requirement already satisfied: pytz>=2020.1 in c:\\users\\dagri\\anaconda3\\envs\\wikibench\\lib\\site-packages (from pandas->-r requirements.txt (line 2)) (2025.2)\n",
      "Requirement already satisfied: tzdata>=2022.7 in c:\\users\\dagri\\anaconda3\\envs\\wikibench\\lib\\site-packages (from pandas->-r requirements.txt (line 2)) (2025.1)\n",
      "Requirement already satisfied: langdetect in c:\\users\\dagri\\anaconda3\\envs\\wikibench\\lib\\site-packages (from goose3[all]->-r requirements.txt (line 9)) (1.0.9)\n",
      "Requirement already satisfied: pyahocorasick in c:\\users\\dagri\\anaconda3\\envs\\wikibench\\lib\\site-packages (from goose3[all]->-r requirements.txt (line 9)) (2.1.0)\n",
      "Requirement already satisfied: jieba in c:\\users\\dagri\\anaconda3\\envs\\wikibench\\lib\\site-packages (from goose3[all]->-r requirements.txt (line 9)) (0.42.1)\n",
      "Requirement already satisfied: click in c:\\users\\dagri\\anaconda3\\envs\\wikibench\\lib\\site-packages (from nltk->-r requirements.txt (line 13)) (8.1.8)\n",
      "Requirement already satisfied: regex>=2021.8.3 in c:\\users\\dagri\\anaconda3\\envs\\wikibench\\lib\\site-packages (from nltk->-r requirements.txt (line 13)) (2024.11.6)\n",
      "Requirement already satisfied: orjson in c:\\users\\dagri\\anaconda3\\envs\\wikibench\\lib\\site-packages (from bm25s[full]->-r requirements.txt (line 15)) (3.10.16)\n",
      "Requirement already satisfied: numba in c:\\users\\dagri\\anaconda3\\envs\\wikibench\\lib\\site-packages (from bm25s[full]->-r requirements.txt (line 15)) (0.61.0)\n",
      "Requirement already satisfied: huggingface-hub in c:\\users\\dagri\\anaconda3\\envs\\wikibench\\lib\\site-packages (from bm25s[full]->-r requirements.txt (line 15)) (0.30.1)\n",
      "Requirement already satisfied: black in c:\\users\\dagri\\anaconda3\\envs\\wikibench\\lib\\site-packages (from bm25s[full]->-r requirements.txt (line 15)) (25.1.0)\n",
      "Requirement already satisfied: pytrec-eval in c:\\users\\dagri\\anaconda3\\envs\\wikibench\\lib\\site-packages (from bm25s[full]->-r requirements.txt (line 15)) (0.5)\n",
      "Requirement already satisfied: filelock in c:\\users\\dagri\\anaconda3\\envs\\wikibench\\lib\\site-packages (from datasets->-r requirements.txt (line 16)) (3.17.0)\n",
      "Requirement already satisfied: pyarrow>=15.0.0 in c:\\users\\dagri\\anaconda3\\envs\\wikibench\\lib\\site-packages (from datasets->-r requirements.txt (line 16)) (19.0.1)\n",
      "Requirement already satisfied: dill<0.3.9,>=0.3.0 in c:\\users\\dagri\\anaconda3\\envs\\wikibench\\lib\\site-packages (from datasets->-r requirements.txt (line 16)) (0.3.8)\n",
      "Requirement already satisfied: xxhash in c:\\users\\dagri\\anaconda3\\envs\\wikibench\\lib\\site-packages (from datasets->-r requirements.txt (line 16)) (3.5.0)\n",
      "Requirement already satisfied: multiprocess<0.70.17 in c:\\users\\dagri\\anaconda3\\envs\\wikibench\\lib\\site-packages (from datasets->-r requirements.txt (line 16)) (0.70.16)\n",
      "Requirement already satisfied: fsspec<=2024.12.0,>=2023.1.0 in c:\\users\\dagri\\anaconda3\\envs\\wikibench\\lib\\site-packages (from fsspec[http]<=2024.12.0,>=2023.1.0->datasets->-r requirements.txt (line 16)) (2024.12.0)\n",
      "Requirement already satisfied: aiohttp in c:\\users\\dagri\\anaconda3\\envs\\wikibench\\lib\\site-packages (from datasets->-r requirements.txt (line 16)) (3.11.16)\n",
      "Requirement already satisfied: packaging in c:\\users\\dagri\\anaconda3\\envs\\wikibench\\lib\\site-packages (from datasets->-r requirements.txt (line 16)) (24.2)\n",
      "Requirement already satisfied: colorama in c:\\users\\dagri\\anaconda3\\envs\\wikibench\\lib\\site-packages (from tqdm->-r requirements.txt (line 18)) (0.4.6)\n",
      "Requirement already satisfied: torch>=1.11.0 in c:\\users\\dagri\\anaconda3\\envs\\wikibench\\lib\\site-packages (from sentence-transformers->-r requirements.txt (line 19)) (2.6.0)\n",
      "Requirement already satisfied: psutil in c:\\users\\dagri\\anaconda3\\envs\\wikibench\\lib\\site-packages (from accelerate->-r requirements.txt (line 20)) (7.0.0)\n",
      "Requirement already satisfied: safetensors>=0.4.3 in c:\\users\\dagri\\anaconda3\\envs\\wikibench\\lib\\site-packages (from accelerate->-r requirements.txt (line 20)) (0.5.3)\n",
      "Requirement already satisfied: tokenizers<0.22,>=0.21 in c:\\users\\dagri\\anaconda3\\envs\\wikibench\\lib\\site-packages (from transformers->-r requirements.txt (line 21)) (0.21.1)\n",
      "Requirement already satisfied: contourpy>=1.0.1 in c:\\users\\dagri\\anaconda3\\envs\\wikibench\\lib\\site-packages (from matplotlib->-r requirements.txt (line 22)) (1.3.1)\n",
      "Requirement already satisfied: cycler>=0.10 in c:\\users\\dagri\\anaconda3\\envs\\wikibench\\lib\\site-packages (from matplotlib->-r requirements.txt (line 22)) (0.12.1)\n",
      "Requirement already satisfied: fonttools>=4.22.0 in c:\\users\\dagri\\anaconda3\\envs\\wikibench\\lib\\site-packages (from matplotlib->-r requirements.txt (line 22)) (4.57.0)\n",
      "Requirement already satisfied: kiwisolver>=1.3.1 in c:\\users\\dagri\\anaconda3\\envs\\wikibench\\lib\\site-packages (from matplotlib->-r requirements.txt (line 22)) (1.4.8)\n",
      "Requirement already satisfied: pyparsing>=2.3.1 in c:\\users\\dagri\\anaconda3\\envs\\wikibench\\lib\\site-packages (from matplotlib->-r requirements.txt (line 22)) (3.2.3)\n",
      "Requirement already satisfied: dawg2-python>=0.8.0 in c:\\users\\dagri\\anaconda3\\envs\\wikibench\\lib\\site-packages (from pymorphy3->-r requirements.txt (line 23)) (0.9.0)\n",
      "Requirement already satisfied: pymorphy3-dicts-ru in c:\\users\\dagri\\anaconda3\\envs\\wikibench\\lib\\site-packages (from pymorphy3->-r requirements.txt (line 23)) (2.4.417150.4580142)\n",
      "Requirement already satisfied: setuptools>=68.2.2 in c:\\users\\dagri\\anaconda3\\envs\\wikibench\\lib\\site-packages (from pymorphy3->-r requirements.txt (line 23)) (78.1.0)\n",
      "Requirement already satisfied: six in c:\\users\\dagri\\anaconda3\\envs\\wikibench\\lib\\site-packages (from feedfinder2>=0.0.4->newspaper3k==0.2.8->-r requirements.txt (line 8)) (1.17.0)\n",
      "Requirement already satisfied: sgmllib3k in c:\\users\\dagri\\anaconda3\\envs\\wikibench\\lib\\site-packages (from feedparser>=5.2.1->newspaper3k==0.2.8->-r requirements.txt (line 8)) (1.0.0)\n",
      "Requirement already satisfied: aiohappyeyeballs>=2.3.0 in c:\\users\\dagri\\anaconda3\\envs\\wikibench\\lib\\site-packages (from aiohttp->datasets->-r requirements.txt (line 16)) (2.6.1)\n",
      "Requirement already satisfied: aiosignal>=1.1.2 in c:\\users\\dagri\\anaconda3\\envs\\wikibench\\lib\\site-packages (from aiohttp->datasets->-r requirements.txt (line 16)) (1.3.2)\n",
      "Requirement already satisfied: attrs>=17.3.0 in c:\\users\\dagri\\anaconda3\\envs\\wikibench\\lib\\site-packages (from aiohttp->datasets->-r requirements.txt (line 16)) (25.3.0)\n",
      "Requirement already satisfied: frozenlist>=1.1.1 in c:\\users\\dagri\\anaconda3\\envs\\wikibench\\lib\\site-packages (from aiohttp->datasets->-r requirements.txt (line 16)) (1.5.0)\n",
      "Requirement already satisfied: multidict<7.0,>=4.5 in c:\\users\\dagri\\anaconda3\\envs\\wikibench\\lib\\site-packages (from aiohttp->datasets->-r requirements.txt (line 16)) (6.2.0)\n",
      "Requirement already satisfied: propcache>=0.2.0 in c:\\users\\dagri\\anaconda3\\envs\\wikibench\\lib\\site-packages (from aiohttp->datasets->-r requirements.txt (line 16)) (0.3.1)\n",
      "Requirement already satisfied: yarl<2.0,>=1.17.0 in c:\\users\\dagri\\anaconda3\\envs\\wikibench\\lib\\site-packages (from aiohttp->datasets->-r requirements.txt (line 16)) (1.18.3)\n",
      "Requirement already satisfied: annotated-types>=0.6.0 in c:\\users\\dagri\\anaconda3\\envs\\wikibench\\lib\\site-packages (from pydantic<3,>=1.9.0->openai==1.55.3->-r requirements.txt (line 10)) (0.7.0)\n",
      "Requirement already satisfied: pydantic-core==2.27.2 in c:\\users\\dagri\\anaconda3\\envs\\wikibench\\lib\\site-packages (from pydantic<3,>=1.9.0->openai==1.55.3->-r requirements.txt (line 10)) (2.27.2)\n",
      "Requirement already satisfied: requests-file>=1.4 in c:\\users\\dagri\\anaconda3\\envs\\wikibench\\lib\\site-packages (from tldextract>=2.0.1->newspaper3k==0.2.8->-r requirements.txt (line 8)) (2.1.0)\n",
      "Requirement already satisfied: networkx in c:\\users\\dagri\\anaconda3\\envs\\wikibench\\lib\\site-packages (from torch>=1.11.0->sentence-transformers->-r requirements.txt (line 19)) (3.4.2)\n",
      "Requirement already satisfied: jinja2 in c:\\users\\dagri\\anaconda3\\envs\\wikibench\\lib\\site-packages (from torch>=1.11.0->sentence-transformers->-r requirements.txt (line 19)) (3.1.6)\n",
      "Requirement already satisfied: sympy==1.13.1 in c:\\users\\dagri\\anaconda3\\envs\\wikibench\\lib\\site-packages (from torch>=1.11.0->sentence-transformers->-r requirements.txt (line 19)) (1.13.1)\n",
      "Requirement already satisfied: mpmath<1.4,>=1.1.0 in c:\\users\\dagri\\anaconda3\\envs\\wikibench\\lib\\site-packages (from sympy==1.13.1->torch>=1.11.0->sentence-transformers->-r requirements.txt (line 19)) (1.3.0)\n",
      "Requirement already satisfied: mypy-extensions>=0.4.3 in c:\\users\\dagri\\anaconda3\\envs\\wikibench\\lib\\site-packages (from black->bm25s[full]->-r requirements.txt (line 15)) (1.0.0)\n",
      "Requirement already satisfied: pathspec>=0.9.0 in c:\\users\\dagri\\anaconda3\\envs\\wikibench\\lib\\site-packages (from black->bm25s[full]->-r requirements.txt (line 15)) (0.12.1)\n",
      "Requirement already satisfied: platformdirs>=2 in c:\\users\\dagri\\anaconda3\\envs\\wikibench\\lib\\site-packages (from black->bm25s[full]->-r requirements.txt (line 15)) (4.3.7)\n",
      "Requirement already satisfied: llvmlite<0.45,>=0.44.0dev0 in c:\\users\\dagri\\anaconda3\\envs\\wikibench\\lib\\site-packages (from numba->bm25s[full]->-r requirements.txt (line 15)) (0.44.0)\n",
      "Requirement already satisfied: MarkupSafe>=2.0 in c:\\users\\dagri\\anaconda3\\envs\\wikibench\\lib\\site-packages (from jinja2->torch>=1.11.0->sentence-transformers->-r requirements.txt (line 19)) (3.0.2)\n"
     ]
    }
   ],
   "source": [
    "!pip install -r requirements.txt"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "id": "10a4b5ec-3805-4a98-9942-d5b12d1bb298",
   "metadata": {},
   "outputs": [],
   "source": [
    "%load_ext autoreload\n",
    "%autoreload 2"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "id": "6664a03f-3846-48ae-8bcc-6377651f84c2",
   "metadata": {
    "scrolled": true
   },
   "outputs": [],
   "source": [
    "%reload_ext autoreload"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "id": "954571ad-a45a-494c-a0ab-dbf20f1a0781",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "resource module not available on Windows\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Default prompt name is set to 'Classification'. This prompt will be applied to all `encode()` calls, except if `encode()` is called with `prompt` or `prompt_name` parameters.\n"
     ]
    }
   ],
   "source": [
    "import sys\n",
    "\n",
    "sys.path.append(\"src\")\n",
    "from wiki_bench import WikiBench\n",
    "with open('Access_key.txt', 'r', encoding='utf-8') as file:\n",
    "    url, key = file.read().split()\n",
    "wiki_bench = WikiBench(url, key, model_name='RefalMachine/RuadaptQwen2.5-7B-Lite-Beta', pre_load=True)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "id": "8a090083-df20-400e-8ce9-a7ec407f6c2f",
   "metadata": {},
   "outputs": [],
   "source": [
    "import json"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "id": "e56dae49-6551-40d7-bdb6-f7b4b03a233f",
   "metadata": {
    "scrolled": true
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Atomic Heart\n"
     ]
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "ec003bb1cb744f558b30ef7cb07a1c73",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Split strings:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "a98a55d8cca84906968e0827b70cf54d",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Stem Tokens:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "7cd4e5d1ce984097a7e0f62cf0bb3a9e",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "BM25S Retrieve:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "BTS\n"
     ]
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "bcdf5794d5ea48dc84f2bab07219131b",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Split strings:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "7c34cde80971440ab7037f94169dc936",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Stem Tokens:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "56ca214655cb4f8fac3e96c13d1d5a42",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "BM25S Retrieve:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "C++\n"
     ]
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "3458f61a844b4660a938db43fcbab1ea",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Split strings:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "5e4d53f5e739449e82968d40151ef4ad",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Stem Tokens:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "57df09871fab4039aa797b9c427400d1",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "BM25S Retrieve:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "ChatGPT\n"
     ]
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "2e93bcfc4f5c4f93a973b6ef054e97aa",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Split strings:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "1800a599bc6244d3aa31d70b9b0bf960",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Stem Tokens:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "45191daf5ab64e03893237efb0a6b394",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "BM25S Retrieve:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "COVID-19\n"
     ]
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "4ba589ab949544efa408ce2997778715",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Split strings:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "c73e7a656df249fca7218695727acf60",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Stem Tokens:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "1001d28eb4874c029b8cea3842971760",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "BM25S Retrieve:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Dota 2\n"
     ]
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "95447a8655954ad8aff76360ba047643",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Split strings:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "698d600b735f4e1bae2c555b132f36c2",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Stem Tokens:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "3eabfeb2b5524b8c9cd454f14f91510c",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "BM25S Retrieve:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "F-35\n"
     ]
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "0e22cceb1aa9403ea1a7ebbc463fd2dd",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Split strings:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "d3634fd708b24261abc2729d9ffb67b4",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Stem Tokens:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "877265e6775b47fda9ebf4d5acf01c7e",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "BM25S Retrieve:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Google (компания)\n"
     ]
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "8d0cfa96cccf456fadab8db9d66ae322",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Split strings:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "8e09a33b2cf04b1c86a8e7266c4acc69",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Stem Tokens:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "cd17cbb999c94c42bab4df67ad291dac",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "BM25S Retrieve:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Linkin Park\n"
     ]
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "acb890ca06f2423993b875c7a8ea0a6f",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Split strings:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "68547e3365aa4f07b2c991dc6bbb5af9",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Stem Tokens:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "8a3e2e1639914b4689788300fc87e24e",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "BM25S Retrieve:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Minecraft\n"
     ]
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "4483c8e96ad4475a90da3a83852bf142",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Split strings:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "065190cf57634dd1b2779b5f4e325042",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Stem Tokens:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "56586562a7624ed6a1db047957bd627f",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "BM25S Retrieve:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Ozon\n"
     ]
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "645310313eeb487386a3609ff35f4e0b",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Split strings:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "2051594ed4b54e4b99758c52055c6b58",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Stem Tokens:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "91796c9a58984c39a513078c7a4a96ab",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "BM25S Retrieve:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Portal 2\n"
     ]
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "8072d9ea8dfb4db8a6bfebc33f720f41",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Split strings:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "22b1c91a3934491d9c4c738b427c6a0e",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Stem Tokens:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "4fbdcc8e53174a7d9ee7e50dd87af7ea",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "BM25S Retrieve:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Python\n"
     ]
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "13056b573f9246b8b366f82cfc906740",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Split strings:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "e50e940960784fdbb57cdb9773bc7e56",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Stem Tokens:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "b17a34431585442ebe8b7eb16c5f2eed",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "BM25S Retrieve:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Rutube\n"
     ]
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "4c77eb52be0e4accb2be7335871c6375",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Split strings:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "8b1881c647d9429ab0941ca19b40cf24",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Stem Tokens:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "8ee133d94a764497ba213064a8f223ec",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "BM25S Retrieve:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Telegram\n"
     ]
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "af05fc4bd6db418b9190cea5947575be",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Split strings:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "162b125d7ca144a29bff57fa47f61810",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Stem Tokens:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "fa3ed9886ae84180bdfb825d50f8fb2d",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "BM25S Retrieve:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "TikTok\n"
     ]
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "40385411e26440daa49534050d8da2e8",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Split strings:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "f00c709afcb14382b43a2f9bcb8f06d9",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Stem Tokens:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "5d15e94b6aaf4439bbb20cef3b16b7c2",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "BM25S Retrieve:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Tomb Raider (игра, 2013)\n"
     ]
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "36640ae4e794417fb64e21d0645aa92a",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Split strings:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "aead1307c9d249c2863e8264fcbd0c81",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Stem Tokens:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "d0c2bb3704f8462b8d2c8327853c0a27",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "BM25S Retrieve:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Uncharted 4 A Thief’s End\n"
     ]
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "80fcca33e4cd48bcb1c085749ee9ad93",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Split strings:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "e18aea9398f745498b3908c2f7e420df",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Stem Tokens:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "e4c9235f514b44ebabdb3db0f334f8c9",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "BM25S Retrieve:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "WhatsApp\n"
     ]
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "a0ec1455d0dd4150853ad4a41eb940bb",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Split strings:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "3782d27106534ff9a023fea1eca7d000",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Stem Tokens:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "763f15d0ad7b442f9548f139a76112ee",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "BM25S Retrieve:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Wildberries\n"
     ]
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "3d6b204bfcdc482eac80df0e077aa40b",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Split strings:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "3132720e380c46e5835adac7fcc6bfbb",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Stem Tokens:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "bf8c70ade70440c28ab320863c65ea47",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "BM25S Retrieve:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "YouTube\n"
     ]
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "0f947d21510d4e3dbb2ae23bf5d0688e",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Split strings:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "e3b7d1ac613242c6a7df4a5874573c43",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Stem Tokens:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "2c2bb2581f3c4a46a9457418e0b9be90",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "BM25S Retrieve:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Аватар Путь воды\n"
     ]
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "727308c27aa446528ef47a0c5a1034da",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Split strings:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "73e155b3719f453abf40644e1d8f509e",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Stem Tokens:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "ae919cad505241f692924539497cc21b",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "BM25S Retrieve:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Азербайджан\n"
     ]
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "6a613ee6ea9345fdba5c1bbcb224fb40",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Split strings:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "b040d20c1ba2459c8ded6893d921fcff",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Stem Tokens:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "913e2f3d1a66435ea5e9401fb942d9a9",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "BM25S Retrieve:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Арабо-израильский конфликт\n"
     ]
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "3aa66ff40d3a421e92b6e1b0f6dcc99d",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Split strings:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "9781e22192304618871e646c7152021e",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Stem Tokens:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "686d5b795f9a4ed7a1d7bd03cc22c303",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "BM25S Retrieve:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Армения\n"
     ]
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "8fa3b22a2a3a4c10bdb5af02bd5cd61c",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Split strings:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "2cded8baa28549dda29be1fd18e36de6",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Stem Tokens:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "4fc24acd3270409d8dd0e5f59e081f8d",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "BM25S Retrieve:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Аутизм\n"
     ]
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "418868ad5af242faabb33bc5d311374e",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Split strings:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "6452625401c74a12b90751de96521331",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Stem Tokens:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "e24873e75b454d68bcf941ecd40dfa90",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "BM25S Retrieve:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Байден, Джо\n"
     ]
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "06d58f8f8604428e88b644b55c514452",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Split strings:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "611de611b0754a06a6867ae76ba7988c",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Stem Tokens:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "d5c22690ca234c6ab7a4e9674a405f73",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "BM25S Retrieve:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Баста (музыкант)\n"
     ]
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "3f9767a76b644d74bdbe3bf795ac4cd3",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Split strings:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "1ac2a564ee674305a99f39136d690165",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Stem Tokens:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "812fce26df3c4dc7bbd1aa29d16b7487",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "BM25S Retrieve:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Биткойн\n"
     ]
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "862b515910e74a07b8161f5512f845e7",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Split strings:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "76a0dd54401e4ab38ba3aed0c9d43d75",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Stem Tokens:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "3d3344d375074ecf985a3d42bb873254",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "BM25S Retrieve:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Большой адронный коллайдер\n"
     ]
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "7d1c1dfcc72f4dd99b55a75bf0c7b346",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Split strings:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "c55d8a12fcfd469d9d6c969ffc4305e0",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Stem Tokens:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "93591362d9844a0ba86339eb4c2ccc98",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "BM25S Retrieve:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Бондарчук, Фёдор Сергеевич\n"
     ]
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "5cc0557b94d3441f83175a2a858747f3",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Split strings:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "cc684c17a7494b39ad4d801aa8e18f37",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Stem Tokens:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "49d3536596824288bd7010ea47e35aa3",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "BM25S Retrieve:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Боярский, Михаил Сергеевич\n"
     ]
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "8d559fe8460c47a8afe7d2d2fa41fd77",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Split strings:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "67a2ee0cd44045ae8fd92c6edae931f4",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Stem Tokens:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "3f38da3a218643baa20b28c0e0c934c8",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "BM25S Retrieve:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "ename": "CancelledError",
     "evalue": "",
     "output_type": "error",
     "traceback": [
      "\u001b[31m---------------------------------------------------------------------------\u001b[39m",
      "\u001b[31mCancelledError\u001b[39m                            Traceback (most recent call last)",
      "\u001b[36mCell\u001b[39m\u001b[36m \u001b[39m\u001b[32mIn[7]\u001b[39m\u001b[32m, line 2\u001b[39m\n\u001b[32m      1\u001b[39m queries = []\n\u001b[32m----> \u001b[39m\u001b[32m2\u001b[39m \u001b[38;5;28;01masync\u001b[39;00m \u001b[38;5;28;01mfor\u001b[39;00m query \u001b[38;5;129;01min\u001b[39;00m wiki_bench.query_stream(reference_mode=\u001b[32m0\u001b[39m):\n\u001b[32m      3\u001b[39m     queries.append(query)\n",
      "\u001b[36mFile \u001b[39m\u001b[32m~\\WIKIBENCH\\src\\wiki_bench.py:104\u001b[39m, in \u001b[36mWikiBench.query_stream\u001b[39m\u001b[34m(self, reference_mode)\u001b[39m\n\u001b[32m    102\u001b[39m \u001b[38;5;28;01mfor\u001b[39;00m annotation, (name, topK) \u001b[38;5;129;01min\u001b[39;00m \u001b[38;5;28mzip\u001b[39m(texts, topR):\n\u001b[32m    103\u001b[39m     \u001b[38;5;28mprint\u001b[39m(name)\n\u001b[32m--> \u001b[39m\u001b[32m104\u001b[39m     ranked = \u001b[38;5;28;01mawait\u001b[39;00m \u001b[38;5;28mself\u001b[39m.wiki_agent.create_ranking(annotation, \u001b[32m3\u001b[39m * topK, name)\n\u001b[32m    105\u001b[39m     \u001b[38;5;28;01myield\u001b[39;00m ranked\n",
      "\u001b[36mFile \u001b[39m\u001b[32m~\\WIKIBENCH\\src\\wiki_agent.py:41\u001b[39m, in \u001b[36mWikiAgent.create_ranking\u001b[39m\u001b[34m(self, query, top_k, true_name)\u001b[39m\n\u001b[32m     39\u001b[39m source_texts = [snippets_list[idx][\u001b[32m1\u001b[39m] \u001b[38;5;28;01mfor\u001b[39;00m idx \u001b[38;5;129;01min\u001b[39;00m chosen_snippets]\n\u001b[32m     40\u001b[39m source_names = [snippets_list[idx][\u001b[32m0\u001b[39m][\u001b[32m0\u001b[39m] \u001b[38;5;28;01mfor\u001b[39;00m idx \u001b[38;5;129;01min\u001b[39;00m chosen_snippets] \u001b[38;5;66;03m# другой вид сохранения сниппетов! вроде поправил\u001b[39;00m\n\u001b[32m---> \u001b[39m\u001b[32m41\u001b[39m probs = \u001b[38;5;28;01mawait\u001b[39;00m \u001b[38;5;28mself\u001b[39m.client.filter_sources(true_name, source_texts)\n\u001b[32m     42\u001b[39m ranking = [(prob[\u001b[32m1\u001b[39m], name) \u001b[38;5;28;01mfor\u001b[39;00m name, prob \u001b[38;5;129;01min\u001b[39;00m \u001b[38;5;28mzip\u001b[39m(source_names, probs)]\n\u001b[32m     43\u001b[39m \u001b[38;5;66;03m#print(source_texts)\u001b[39;00m\n\u001b[32m     44\u001b[39m \u001b[38;5;66;03m#print(ranking)\u001b[39;00m\n",
      "\u001b[36mFile \u001b[39m\u001b[32m~\\WIKIBENCH\\src\\wiki_gen.py:422\u001b[39m, in \u001b[36mWikiGen.filter_sources\u001b[39m\u001b[34m(self, name, texts)\u001b[39m\n\u001b[32m    411\u001b[39m \u001b[38;5;28;01mfor\u001b[39;00m i1, text \u001b[38;5;129;01min\u001b[39;00m \u001b[38;5;28menumerate\u001b[39m(texts):\n\u001b[32m    412\u001b[39m     probs.append(\n\u001b[32m    413\u001b[39m         \u001b[38;5;28mself\u001b[39m.process_text(\n\u001b[32m    414\u001b[39m             i1, \n\u001b[32m   (...)\u001b[39m\u001b[32m    419\u001b[39m         )\n\u001b[32m    420\u001b[39m     )\n\u001b[32m--> \u001b[39m\u001b[32m422\u001b[39m \u001b[38;5;28;01mawait\u001b[39;00m probs.complete_couroutines(batch_size=\u001b[32m40\u001b[39m)\n\u001b[32m    423\u001b[39m final_probs = \u001b[38;5;28;01mawait\u001b[39;00m probs.to_list()\n\u001b[32m    424\u001b[39m final_probs = \u001b[38;5;28msorted\u001b[39m(final_probs)\n",
      "\u001b[36mFile \u001b[39m\u001b[32m~\\WIKIBENCH\\src\\openai_utils.py:119\u001b[39m, in \u001b[36mAsyncList.complete_couroutines\u001b[39m\u001b[34m(self, batch_size)\u001b[39m\n\u001b[32m    117\u001b[39m \u001b[38;5;28;01mwhile\u001b[39;00m \u001b[38;5;28mlen\u001b[39m(\u001b[38;5;28mself\u001b[39m.couroutine_ids) > \u001b[32m0\u001b[39m:\n\u001b[32m    118\u001b[39m     tasks = [\u001b[38;5;28mself\u001b[39m.contents[i] \u001b[38;5;28;01mfor\u001b[39;00m i \u001b[38;5;129;01min\u001b[39;00m \u001b[38;5;28mself\u001b[39m.couroutine_ids[:batch_size]]\n\u001b[32m--> \u001b[39m\u001b[32m119\u001b[39m     res = \u001b[38;5;28;01mawait\u001b[39;00m asyncio.gather(*tasks)\n\u001b[32m    120\u001b[39m     \u001b[38;5;28;01mfor\u001b[39;00m i, r \u001b[38;5;129;01min\u001b[39;00m \u001b[38;5;28mzip\u001b[39m(\u001b[38;5;28mself\u001b[39m.couroutine_ids, res):\n\u001b[32m    121\u001b[39m         \u001b[38;5;28mself\u001b[39m.contents[i] = r\n",
      "\u001b[36mFile \u001b[39m\u001b[32m~\\WIKIBENCH\\src\\wiki_gen.py:369\u001b[39m, in \u001b[36mWikiGen.process_text\u001b[39m\u001b[34m(self, i1, text, name, positive_choice, negative_choice)\u001b[39m\n\u001b[32m    363\u001b[39m \u001b[38;5;250m\u001b[39m\u001b[33;03m\"\"\"\u001b[39;00m\n\u001b[32m    364\u001b[39m \u001b[33;03mФункция обрабатывает один сниппет:\u001b[39;00m\n\u001b[32m    365\u001b[39m \u001b[33;03m- Формирует prompt и получает вероятности\u001b[39;00m\n\u001b[32m    366\u001b[39m \u001b[33;03m- Возвращает (индекс, вероятность)\u001b[39;00m\n\u001b[32m    367\u001b[39m \u001b[33;03m\"\"\"\u001b[39;00m\n\u001b[32m    368\u001b[39m myprompt = RANKING_PROMPT.format(name, text, positive_choice, negative_choice) + \u001b[38;5;28mself\u001b[39m.thinking_pass\n\u001b[32m--> \u001b[39m\u001b[32m369\u001b[39m response = \u001b[38;5;28;01mawait\u001b[39;00m \u001b[38;5;28mself\u001b[39m.client.get_probability(myprompt, rep_penalty=\u001b[32m1.0\u001b[39m, max_tokens=\u001b[32m10\u001b[39m)\n\u001b[32m    370\u001b[39m response = response.choices[\u001b[32m0\u001b[39m]\n\u001b[32m    371\u001b[39m snippet_result = \u001b[38;5;28;01mNone\u001b[39;00m\n",
      "\u001b[36mFile \u001b[39m\u001b[32m~\\WIKIBENCH\\src\\openai_utils.py:91\u001b[39m, in \u001b[36mLlmCompleter.get_probability\u001b[39m\u001b[34m(self, query, system, examples, choices, rep_penalty, regex_pattern, max_tokens)\u001b[39m\n\u001b[32m     75\u001b[39m msgs = \u001b[38;5;28mself\u001b[39m.prepare_messages(query, system, examples, \u001b[38;5;28;01mNone\u001b[39;00m)\n\u001b[32m     77\u001b[39m completion = \u001b[38;5;28mself\u001b[39m.client.chat.completions.create(\n\u001b[32m     78\u001b[39m     model=\u001b[38;5;28mself\u001b[39m.model,\n\u001b[32m     79\u001b[39m     messages=msgs,\n\u001b[32m   (...)\u001b[39m\u001b[32m     89\u001b[39m     }\n\u001b[32m     90\u001b[39m )\n\u001b[32m---> \u001b[39m\u001b[32m91\u001b[39m response = \u001b[38;5;28;01mawait\u001b[39;00m completion\n\u001b[32m     92\u001b[39m \u001b[38;5;28;01mreturn\u001b[39;00m response\n",
      "\u001b[36mFile \u001b[39m\u001b[32m~\\anaconda3\\envs\\WIKIbench\\Lib\\site-packages\\openai\\resources\\chat\\completions.py:1661\u001b[39m, in \u001b[36mAsyncCompletions.create\u001b[39m\u001b[34m(self, messages, model, audio, frequency_penalty, function_call, functions, logit_bias, logprobs, max_completion_tokens, max_tokens, metadata, modalities, n, parallel_tool_calls, prediction, presence_penalty, response_format, seed, service_tier, stop, store, stream, stream_options, temperature, tool_choice, tools, top_logprobs, top_p, user, extra_headers, extra_query, extra_body, timeout)\u001b[39m\n\u001b[32m   1620\u001b[39m \u001b[38;5;129m@required_args\u001b[39m([\u001b[33m\"\u001b[39m\u001b[33mmessages\u001b[39m\u001b[33m\"\u001b[39m, \u001b[33m\"\u001b[39m\u001b[33mmodel\u001b[39m\u001b[33m\"\u001b[39m], [\u001b[33m\"\u001b[39m\u001b[33mmessages\u001b[39m\u001b[33m\"\u001b[39m, \u001b[33m\"\u001b[39m\u001b[33mmodel\u001b[39m\u001b[33m\"\u001b[39m, \u001b[33m\"\u001b[39m\u001b[33mstream\u001b[39m\u001b[33m\"\u001b[39m])\n\u001b[32m   1621\u001b[39m \u001b[38;5;28;01masync\u001b[39;00m \u001b[38;5;28;01mdef\u001b[39;00m\u001b[38;5;250m \u001b[39m\u001b[34mcreate\u001b[39m(\n\u001b[32m   1622\u001b[39m     \u001b[38;5;28mself\u001b[39m,\n\u001b[32m   (...)\u001b[39m\u001b[32m   1658\u001b[39m     timeout: \u001b[38;5;28mfloat\u001b[39m | httpx.Timeout | \u001b[38;5;28;01mNone\u001b[39;00m | NotGiven = NOT_GIVEN,\n\u001b[32m   1659\u001b[39m ) -> ChatCompletion | AsyncStream[ChatCompletionChunk]:\n\u001b[32m   1660\u001b[39m     validate_response_format(response_format)\n\u001b[32m-> \u001b[39m\u001b[32m1661\u001b[39m     \u001b[38;5;28;01mreturn\u001b[39;00m \u001b[38;5;28;01mawait\u001b[39;00m \u001b[38;5;28mself\u001b[39m._post(\n\u001b[32m   1662\u001b[39m         \u001b[33m\"\u001b[39m\u001b[33m/chat/completions\u001b[39m\u001b[33m\"\u001b[39m,\n\u001b[32m   1663\u001b[39m         body=\u001b[38;5;28;01mawait\u001b[39;00m async_maybe_transform(\n\u001b[32m   1664\u001b[39m             {\n\u001b[32m   1665\u001b[39m                 \u001b[33m\"\u001b[39m\u001b[33mmessages\u001b[39m\u001b[33m\"\u001b[39m: messages,\n\u001b[32m   1666\u001b[39m                 \u001b[33m\"\u001b[39m\u001b[33mmodel\u001b[39m\u001b[33m\"\u001b[39m: model,\n\u001b[32m   1667\u001b[39m                 \u001b[33m\"\u001b[39m\u001b[33maudio\u001b[39m\u001b[33m\"\u001b[39m: audio,\n\u001b[32m   1668\u001b[39m                 \u001b[33m\"\u001b[39m\u001b[33mfrequency_penalty\u001b[39m\u001b[33m\"\u001b[39m: frequency_penalty,\n\u001b[32m   1669\u001b[39m                 \u001b[33m\"\u001b[39m\u001b[33mfunction_call\u001b[39m\u001b[33m\"\u001b[39m: function_call,\n\u001b[32m   1670\u001b[39m                 \u001b[33m\"\u001b[39m\u001b[33mfunctions\u001b[39m\u001b[33m\"\u001b[39m: functions,\n\u001b[32m   1671\u001b[39m                 \u001b[33m\"\u001b[39m\u001b[33mlogit_bias\u001b[39m\u001b[33m\"\u001b[39m: logit_bias,\n\u001b[32m   1672\u001b[39m                 \u001b[33m\"\u001b[39m\u001b[33mlogprobs\u001b[39m\u001b[33m\"\u001b[39m: logprobs,\n\u001b[32m   1673\u001b[39m                 \u001b[33m\"\u001b[39m\u001b[33mmax_completion_tokens\u001b[39m\u001b[33m\"\u001b[39m: max_completion_tokens,\n\u001b[32m   1674\u001b[39m                 \u001b[33m\"\u001b[39m\u001b[33mmax_tokens\u001b[39m\u001b[33m\"\u001b[39m: max_tokens,\n\u001b[32m   1675\u001b[39m                 \u001b[33m\"\u001b[39m\u001b[33mmetadata\u001b[39m\u001b[33m\"\u001b[39m: metadata,\n\u001b[32m   1676\u001b[39m                 \u001b[33m\"\u001b[39m\u001b[33mmodalities\u001b[39m\u001b[33m\"\u001b[39m: modalities,\n\u001b[32m   1677\u001b[39m                 \u001b[33m\"\u001b[39m\u001b[33mn\u001b[39m\u001b[33m\"\u001b[39m: n,\n\u001b[32m   1678\u001b[39m                 \u001b[33m\"\u001b[39m\u001b[33mparallel_tool_calls\u001b[39m\u001b[33m\"\u001b[39m: parallel_tool_calls,\n\u001b[32m   1679\u001b[39m                 \u001b[33m\"\u001b[39m\u001b[33mprediction\u001b[39m\u001b[33m\"\u001b[39m: prediction,\n\u001b[32m   1680\u001b[39m                 \u001b[33m\"\u001b[39m\u001b[33mpresence_penalty\u001b[39m\u001b[33m\"\u001b[39m: presence_penalty,\n\u001b[32m   1681\u001b[39m                 \u001b[33m\"\u001b[39m\u001b[33mresponse_format\u001b[39m\u001b[33m\"\u001b[39m: response_format,\n\u001b[32m   1682\u001b[39m                 \u001b[33m\"\u001b[39m\u001b[33mseed\u001b[39m\u001b[33m\"\u001b[39m: seed,\n\u001b[32m   1683\u001b[39m                 \u001b[33m\"\u001b[39m\u001b[33mservice_tier\u001b[39m\u001b[33m\"\u001b[39m: service_tier,\n\u001b[32m   1684\u001b[39m                 \u001b[33m\"\u001b[39m\u001b[33mstop\u001b[39m\u001b[33m\"\u001b[39m: stop,\n\u001b[32m   1685\u001b[39m                 \u001b[33m\"\u001b[39m\u001b[33mstore\u001b[39m\u001b[33m\"\u001b[39m: store,\n\u001b[32m   1686\u001b[39m                 \u001b[33m\"\u001b[39m\u001b[33mstream\u001b[39m\u001b[33m\"\u001b[39m: stream,\n\u001b[32m   1687\u001b[39m                 \u001b[33m\"\u001b[39m\u001b[33mstream_options\u001b[39m\u001b[33m\"\u001b[39m: stream_options,\n\u001b[32m   1688\u001b[39m                 \u001b[33m\"\u001b[39m\u001b[33mtemperature\u001b[39m\u001b[33m\"\u001b[39m: temperature,\n\u001b[32m   1689\u001b[39m                 \u001b[33m\"\u001b[39m\u001b[33mtool_choice\u001b[39m\u001b[33m\"\u001b[39m: tool_choice,\n\u001b[32m   1690\u001b[39m                 \u001b[33m\"\u001b[39m\u001b[33mtools\u001b[39m\u001b[33m\"\u001b[39m: tools,\n\u001b[32m   1691\u001b[39m                 \u001b[33m\"\u001b[39m\u001b[33mtop_logprobs\u001b[39m\u001b[33m\"\u001b[39m: top_logprobs,\n\u001b[32m   1692\u001b[39m                 \u001b[33m\"\u001b[39m\u001b[33mtop_p\u001b[39m\u001b[33m\"\u001b[39m: top_p,\n\u001b[32m   1693\u001b[39m                 \u001b[33m\"\u001b[39m\u001b[33muser\u001b[39m\u001b[33m\"\u001b[39m: user,\n\u001b[32m   1694\u001b[39m             },\n\u001b[32m   1695\u001b[39m             completion_create_params.CompletionCreateParams,\n\u001b[32m   1696\u001b[39m         ),\n\u001b[32m   1697\u001b[39m         options=make_request_options(\n\u001b[32m   1698\u001b[39m             extra_headers=extra_headers, extra_query=extra_query, extra_body=extra_body, timeout=timeout\n\u001b[32m   1699\u001b[39m         ),\n\u001b[32m   1700\u001b[39m         cast_to=ChatCompletion,\n\u001b[32m   1701\u001b[39m         stream=stream \u001b[38;5;129;01mor\u001b[39;00m \u001b[38;5;28;01mFalse\u001b[39;00m,\n\u001b[32m   1702\u001b[39m         stream_cls=AsyncStream[ChatCompletionChunk],\n\u001b[32m   1703\u001b[39m     )\n",
      "\u001b[36mFile \u001b[39m\u001b[32m~\\anaconda3\\envs\\WIKIbench\\Lib\\site-packages\\openai\\_base_client.py:1843\u001b[39m, in \u001b[36mAsyncAPIClient.post\u001b[39m\u001b[34m(self, path, cast_to, body, files, options, stream, stream_cls)\u001b[39m\n\u001b[32m   1829\u001b[39m \u001b[38;5;28;01masync\u001b[39;00m \u001b[38;5;28;01mdef\u001b[39;00m\u001b[38;5;250m \u001b[39m\u001b[34mpost\u001b[39m(\n\u001b[32m   1830\u001b[39m     \u001b[38;5;28mself\u001b[39m,\n\u001b[32m   1831\u001b[39m     path: \u001b[38;5;28mstr\u001b[39m,\n\u001b[32m   (...)\u001b[39m\u001b[32m   1838\u001b[39m     stream_cls: \u001b[38;5;28mtype\u001b[39m[_AsyncStreamT] | \u001b[38;5;28;01mNone\u001b[39;00m = \u001b[38;5;28;01mNone\u001b[39;00m,\n\u001b[32m   1839\u001b[39m ) -> ResponseT | _AsyncStreamT:\n\u001b[32m   1840\u001b[39m     opts = FinalRequestOptions.construct(\n\u001b[32m   1841\u001b[39m         method=\u001b[33m\"\u001b[39m\u001b[33mpost\u001b[39m\u001b[33m\"\u001b[39m, url=path, json_data=body, files=\u001b[38;5;28;01mawait\u001b[39;00m async_to_httpx_files(files), **options\n\u001b[32m   1842\u001b[39m     )\n\u001b[32m-> \u001b[39m\u001b[32m1843\u001b[39m     \u001b[38;5;28;01mreturn\u001b[39;00m \u001b[38;5;28;01mawait\u001b[39;00m \u001b[38;5;28mself\u001b[39m.request(cast_to, opts, stream=stream, stream_cls=stream_cls)\n",
      "\u001b[36mFile \u001b[39m\u001b[32m~\\anaconda3\\envs\\WIKIbench\\Lib\\site-packages\\openai\\_base_client.py:1537\u001b[39m, in \u001b[36mAsyncAPIClient.request\u001b[39m\u001b[34m(self, cast_to, options, stream, stream_cls, remaining_retries)\u001b[39m\n\u001b[32m   1534\u001b[39m \u001b[38;5;28;01melse\u001b[39;00m:\n\u001b[32m   1535\u001b[39m     retries_taken = \u001b[32m0\u001b[39m\n\u001b[32m-> \u001b[39m\u001b[32m1537\u001b[39m \u001b[38;5;28;01mreturn\u001b[39;00m \u001b[38;5;28;01mawait\u001b[39;00m \u001b[38;5;28mself\u001b[39m._request(\n\u001b[32m   1538\u001b[39m     cast_to=cast_to,\n\u001b[32m   1539\u001b[39m     options=options,\n\u001b[32m   1540\u001b[39m     stream=stream,\n\u001b[32m   1541\u001b[39m     stream_cls=stream_cls,\n\u001b[32m   1542\u001b[39m     retries_taken=retries_taken,\n\u001b[32m   1543\u001b[39m )\n",
      "\u001b[36mFile \u001b[39m\u001b[32m~\\anaconda3\\envs\\WIKIbench\\Lib\\site-packages\\openai\\_base_client.py:1576\u001b[39m, in \u001b[36mAsyncAPIClient._request\u001b[39m\u001b[34m(self, cast_to, options, stream, stream_cls, retries_taken)\u001b[39m\n\u001b[32m   1573\u001b[39m     kwargs[\u001b[33m\"\u001b[39m\u001b[33mauth\u001b[39m\u001b[33m\"\u001b[39m] = \u001b[38;5;28mself\u001b[39m.custom_auth\n\u001b[32m   1575\u001b[39m \u001b[38;5;28;01mtry\u001b[39;00m:\n\u001b[32m-> \u001b[39m\u001b[32m1576\u001b[39m     response = \u001b[38;5;28;01mawait\u001b[39;00m \u001b[38;5;28mself\u001b[39m._client.send(\n\u001b[32m   1577\u001b[39m         request,\n\u001b[32m   1578\u001b[39m         stream=stream \u001b[38;5;129;01mor\u001b[39;00m \u001b[38;5;28mself\u001b[39m._should_stream_response_body(request=request),\n\u001b[32m   1579\u001b[39m         **kwargs,\n\u001b[32m   1580\u001b[39m     )\n\u001b[32m   1581\u001b[39m \u001b[38;5;28;01mexcept\u001b[39;00m httpx.TimeoutException \u001b[38;5;28;01mas\u001b[39;00m err:\n\u001b[32m   1582\u001b[39m     log.debug(\u001b[33m\"\u001b[39m\u001b[33mEncountered httpx.TimeoutException\u001b[39m\u001b[33m\"\u001b[39m, exc_info=\u001b[38;5;28;01mTrue\u001b[39;00m)\n",
      "\u001b[36mFile \u001b[39m\u001b[32m~\\anaconda3\\envs\\WIKIbench\\Lib\\site-packages\\httpx\\_client.py:1629\u001b[39m, in \u001b[36mAsyncClient.send\u001b[39m\u001b[34m(self, request, stream, auth, follow_redirects)\u001b[39m\n\u001b[32m   1625\u001b[39m \u001b[38;5;28mself\u001b[39m._set_timeout(request)\n\u001b[32m   1627\u001b[39m auth = \u001b[38;5;28mself\u001b[39m._build_request_auth(request, auth)\n\u001b[32m-> \u001b[39m\u001b[32m1629\u001b[39m response = \u001b[38;5;28;01mawait\u001b[39;00m \u001b[38;5;28mself\u001b[39m._send_handling_auth(\n\u001b[32m   1630\u001b[39m     request,\n\u001b[32m   1631\u001b[39m     auth=auth,\n\u001b[32m   1632\u001b[39m     follow_redirects=follow_redirects,\n\u001b[32m   1633\u001b[39m     history=[],\n\u001b[32m   1634\u001b[39m )\n\u001b[32m   1635\u001b[39m \u001b[38;5;28;01mtry\u001b[39;00m:\n\u001b[32m   1636\u001b[39m     \u001b[38;5;28;01mif\u001b[39;00m \u001b[38;5;129;01mnot\u001b[39;00m stream:\n",
      "\u001b[36mFile \u001b[39m\u001b[32m~\\anaconda3\\envs\\WIKIbench\\Lib\\site-packages\\httpx\\_client.py:1657\u001b[39m, in \u001b[36mAsyncClient._send_handling_auth\u001b[39m\u001b[34m(self, request, auth, follow_redirects, history)\u001b[39m\n\u001b[32m   1654\u001b[39m request = \u001b[38;5;28;01mawait\u001b[39;00m auth_flow.\u001b[34m__anext__\u001b[39m()\n\u001b[32m   1656\u001b[39m \u001b[38;5;28;01mwhile\u001b[39;00m \u001b[38;5;28;01mTrue\u001b[39;00m:\n\u001b[32m-> \u001b[39m\u001b[32m1657\u001b[39m     response = \u001b[38;5;28;01mawait\u001b[39;00m \u001b[38;5;28mself\u001b[39m._send_handling_redirects(\n\u001b[32m   1658\u001b[39m         request,\n\u001b[32m   1659\u001b[39m         follow_redirects=follow_redirects,\n\u001b[32m   1660\u001b[39m         history=history,\n\u001b[32m   1661\u001b[39m     )\n\u001b[32m   1662\u001b[39m     \u001b[38;5;28;01mtry\u001b[39;00m:\n\u001b[32m   1663\u001b[39m         \u001b[38;5;28;01mtry\u001b[39;00m:\n",
      "\u001b[36mFile \u001b[39m\u001b[32m~\\anaconda3\\envs\\WIKIbench\\Lib\\site-packages\\httpx\\_client.py:1694\u001b[39m, in \u001b[36mAsyncClient._send_handling_redirects\u001b[39m\u001b[34m(self, request, follow_redirects, history)\u001b[39m\n\u001b[32m   1691\u001b[39m \u001b[38;5;28;01mfor\u001b[39;00m hook \u001b[38;5;129;01min\u001b[39;00m \u001b[38;5;28mself\u001b[39m._event_hooks[\u001b[33m\"\u001b[39m\u001b[33mrequest\u001b[39m\u001b[33m\"\u001b[39m]:\n\u001b[32m   1692\u001b[39m     \u001b[38;5;28;01mawait\u001b[39;00m hook(request)\n\u001b[32m-> \u001b[39m\u001b[32m1694\u001b[39m response = \u001b[38;5;28;01mawait\u001b[39;00m \u001b[38;5;28mself\u001b[39m._send_single_request(request)\n\u001b[32m   1695\u001b[39m \u001b[38;5;28;01mtry\u001b[39;00m:\n\u001b[32m   1696\u001b[39m     \u001b[38;5;28;01mfor\u001b[39;00m hook \u001b[38;5;129;01min\u001b[39;00m \u001b[38;5;28mself\u001b[39m._event_hooks[\u001b[33m\"\u001b[39m\u001b[33mresponse\u001b[39m\u001b[33m\"\u001b[39m]:\n",
      "\u001b[36mFile \u001b[39m\u001b[32m~\\anaconda3\\envs\\WIKIbench\\Lib\\site-packages\\httpx\\_client.py:1730\u001b[39m, in \u001b[36mAsyncClient._send_single_request\u001b[39m\u001b[34m(self, request)\u001b[39m\n\u001b[32m   1725\u001b[39m     \u001b[38;5;28;01mraise\u001b[39;00m \u001b[38;5;167;01mRuntimeError\u001b[39;00m(\n\u001b[32m   1726\u001b[39m         \u001b[33m\"\u001b[39m\u001b[33mAttempted to send an sync request with an AsyncClient instance.\u001b[39m\u001b[33m\"\u001b[39m\n\u001b[32m   1727\u001b[39m     )\n\u001b[32m   1729\u001b[39m \u001b[38;5;28;01mwith\u001b[39;00m request_context(request=request):\n\u001b[32m-> \u001b[39m\u001b[32m1730\u001b[39m     response = \u001b[38;5;28;01mawait\u001b[39;00m transport.handle_async_request(request)\n\u001b[32m   1732\u001b[39m \u001b[38;5;28;01massert\u001b[39;00m \u001b[38;5;28misinstance\u001b[39m(response.stream, AsyncByteStream)\n\u001b[32m   1733\u001b[39m response.request = request\n",
      "\u001b[36mFile \u001b[39m\u001b[32m~\\anaconda3\\envs\\WIKIbench\\Lib\\site-packages\\httpx\\_transports\\default.py:394\u001b[39m, in \u001b[36mAsyncHTTPTransport.handle_async_request\u001b[39m\u001b[34m(self, request)\u001b[39m\n\u001b[32m    381\u001b[39m req = httpcore.Request(\n\u001b[32m    382\u001b[39m     method=request.method,\n\u001b[32m    383\u001b[39m     url=httpcore.URL(\n\u001b[32m   (...)\u001b[39m\u001b[32m    391\u001b[39m     extensions=request.extensions,\n\u001b[32m    392\u001b[39m )\n\u001b[32m    393\u001b[39m \u001b[38;5;28;01mwith\u001b[39;00m map_httpcore_exceptions():\n\u001b[32m--> \u001b[39m\u001b[32m394\u001b[39m     resp = \u001b[38;5;28;01mawait\u001b[39;00m \u001b[38;5;28mself\u001b[39m._pool.handle_async_request(req)\n\u001b[32m    396\u001b[39m \u001b[38;5;28;01massert\u001b[39;00m \u001b[38;5;28misinstance\u001b[39m(resp.stream, typing.AsyncIterable)\n\u001b[32m    398\u001b[39m \u001b[38;5;28;01mreturn\u001b[39;00m Response(\n\u001b[32m    399\u001b[39m     status_code=resp.status,\n\u001b[32m    400\u001b[39m     headers=resp.headers,\n\u001b[32m    401\u001b[39m     stream=AsyncResponseStream(resp.stream),\n\u001b[32m    402\u001b[39m     extensions=resp.extensions,\n\u001b[32m    403\u001b[39m )\n",
      "\u001b[36mFile \u001b[39m\u001b[32m~\\anaconda3\\envs\\WIKIbench\\Lib\\site-packages\\httpcore\\_async\\connection_pool.py:256\u001b[39m, in \u001b[36mAsyncConnectionPool.handle_async_request\u001b[39m\u001b[34m(self, request)\u001b[39m\n\u001b[32m    253\u001b[39m         closing = \u001b[38;5;28mself\u001b[39m._assign_requests_to_connections()\n\u001b[32m    255\u001b[39m     \u001b[38;5;28;01mawait\u001b[39;00m \u001b[38;5;28mself\u001b[39m._close_connections(closing)\n\u001b[32m--> \u001b[39m\u001b[32m256\u001b[39m     \u001b[38;5;28;01mraise\u001b[39;00m exc \u001b[38;5;28;01mfrom\u001b[39;00m\u001b[38;5;250m \u001b[39m\u001b[38;5;28;01mNone\u001b[39;00m\n\u001b[32m    258\u001b[39m \u001b[38;5;66;03m# Return the response. Note that in this case we still have to manage\u001b[39;00m\n\u001b[32m    259\u001b[39m \u001b[38;5;66;03m# the point at which the response is closed.\u001b[39;00m\n\u001b[32m    260\u001b[39m \u001b[38;5;28;01massert\u001b[39;00m \u001b[38;5;28misinstance\u001b[39m(response.stream, typing.AsyncIterable)\n",
      "\u001b[36mFile \u001b[39m\u001b[32m~\\anaconda3\\envs\\WIKIbench\\Lib\\site-packages\\httpcore\\_async\\connection_pool.py:236\u001b[39m, in \u001b[36mAsyncConnectionPool.handle_async_request\u001b[39m\u001b[34m(self, request)\u001b[39m\n\u001b[32m    232\u001b[39m connection = \u001b[38;5;28;01mawait\u001b[39;00m pool_request.wait_for_connection(timeout=timeout)\n\u001b[32m    234\u001b[39m \u001b[38;5;28;01mtry\u001b[39;00m:\n\u001b[32m    235\u001b[39m     \u001b[38;5;66;03m# Send the request on the assigned connection.\u001b[39;00m\n\u001b[32m--> \u001b[39m\u001b[32m236\u001b[39m     response = \u001b[38;5;28;01mawait\u001b[39;00m connection.handle_async_request(\n\u001b[32m    237\u001b[39m         pool_request.request\n\u001b[32m    238\u001b[39m     )\n\u001b[32m    239\u001b[39m \u001b[38;5;28;01mexcept\u001b[39;00m ConnectionNotAvailable:\n\u001b[32m    240\u001b[39m     \u001b[38;5;66;03m# In some cases a connection may initially be available to\u001b[39;00m\n\u001b[32m    241\u001b[39m     \u001b[38;5;66;03m# handle a request, but then become unavailable.\u001b[39;00m\n\u001b[32m    242\u001b[39m     \u001b[38;5;66;03m#\u001b[39;00m\n\u001b[32m    243\u001b[39m     \u001b[38;5;66;03m# In this case we clear the connection and try again.\u001b[39;00m\n\u001b[32m    244\u001b[39m     pool_request.clear_connection()\n",
      "\u001b[36mFile \u001b[39m\u001b[32m~\\anaconda3\\envs\\WIKIbench\\Lib\\site-packages\\httpcore\\_async\\connection.py:103\u001b[39m, in \u001b[36mAsyncHTTPConnection.handle_async_request\u001b[39m\u001b[34m(self, request)\u001b[39m\n\u001b[32m    100\u001b[39m     \u001b[38;5;28mself\u001b[39m._connect_failed = \u001b[38;5;28;01mTrue\u001b[39;00m\n\u001b[32m    101\u001b[39m     \u001b[38;5;28;01mraise\u001b[39;00m exc\n\u001b[32m--> \u001b[39m\u001b[32m103\u001b[39m \u001b[38;5;28;01mreturn\u001b[39;00m \u001b[38;5;28;01mawait\u001b[39;00m \u001b[38;5;28mself\u001b[39m._connection.handle_async_request(request)\n",
      "\u001b[36mFile \u001b[39m\u001b[32m~\\anaconda3\\envs\\WIKIbench\\Lib\\site-packages\\httpcore\\_async\\http11.py:136\u001b[39m, in \u001b[36mAsyncHTTP11Connection.handle_async_request\u001b[39m\u001b[34m(self, request)\u001b[39m\n\u001b[32m    134\u001b[39m     \u001b[38;5;28;01masync\u001b[39;00m \u001b[38;5;28;01mwith\u001b[39;00m Trace(\u001b[33m\"\u001b[39m\u001b[33mresponse_closed\u001b[39m\u001b[33m\"\u001b[39m, logger, request) \u001b[38;5;28;01mas\u001b[39;00m trace:\n\u001b[32m    135\u001b[39m         \u001b[38;5;28;01mawait\u001b[39;00m \u001b[38;5;28mself\u001b[39m._response_closed()\n\u001b[32m--> \u001b[39m\u001b[32m136\u001b[39m \u001b[38;5;28;01mraise\u001b[39;00m exc\n",
      "\u001b[36mFile \u001b[39m\u001b[32m~\\anaconda3\\envs\\WIKIbench\\Lib\\site-packages\\httpcore\\_async\\http11.py:106\u001b[39m, in \u001b[36mAsyncHTTP11Connection.handle_async_request\u001b[39m\u001b[34m(self, request)\u001b[39m\n\u001b[32m     95\u001b[39m     \u001b[38;5;28;01mpass\u001b[39;00m\n\u001b[32m     97\u001b[39m \u001b[38;5;28;01masync\u001b[39;00m \u001b[38;5;28;01mwith\u001b[39;00m Trace(\n\u001b[32m     98\u001b[39m     \u001b[33m\"\u001b[39m\u001b[33mreceive_response_headers\u001b[39m\u001b[33m\"\u001b[39m, logger, request, kwargs\n\u001b[32m     99\u001b[39m ) \u001b[38;5;28;01mas\u001b[39;00m trace:\n\u001b[32m    100\u001b[39m     (\n\u001b[32m    101\u001b[39m         http_version,\n\u001b[32m    102\u001b[39m         status,\n\u001b[32m    103\u001b[39m         reason_phrase,\n\u001b[32m    104\u001b[39m         headers,\n\u001b[32m    105\u001b[39m         trailing_data,\n\u001b[32m--> \u001b[39m\u001b[32m106\u001b[39m     ) = \u001b[38;5;28;01mawait\u001b[39;00m \u001b[38;5;28mself\u001b[39m._receive_response_headers(**kwargs)\n\u001b[32m    107\u001b[39m     trace.return_value = (\n\u001b[32m    108\u001b[39m         http_version,\n\u001b[32m    109\u001b[39m         status,\n\u001b[32m    110\u001b[39m         reason_phrase,\n\u001b[32m    111\u001b[39m         headers,\n\u001b[32m    112\u001b[39m     )\n\u001b[32m    114\u001b[39m network_stream = \u001b[38;5;28mself\u001b[39m._network_stream\n",
      "\u001b[36mFile \u001b[39m\u001b[32m~\\anaconda3\\envs\\WIKIbench\\Lib\\site-packages\\httpcore\\_async\\http11.py:177\u001b[39m, in \u001b[36mAsyncHTTP11Connection._receive_response_headers\u001b[39m\u001b[34m(self, request)\u001b[39m\n\u001b[32m    174\u001b[39m timeout = timeouts.get(\u001b[33m\"\u001b[39m\u001b[33mread\u001b[39m\u001b[33m\"\u001b[39m, \u001b[38;5;28;01mNone\u001b[39;00m)\n\u001b[32m    176\u001b[39m \u001b[38;5;28;01mwhile\u001b[39;00m \u001b[38;5;28;01mTrue\u001b[39;00m:\n\u001b[32m--> \u001b[39m\u001b[32m177\u001b[39m     event = \u001b[38;5;28;01mawait\u001b[39;00m \u001b[38;5;28mself\u001b[39m._receive_event(timeout=timeout)\n\u001b[32m    178\u001b[39m     \u001b[38;5;28;01mif\u001b[39;00m \u001b[38;5;28misinstance\u001b[39m(event, h11.Response):\n\u001b[32m    179\u001b[39m         \u001b[38;5;28;01mbreak\u001b[39;00m\n",
      "\u001b[36mFile \u001b[39m\u001b[32m~\\anaconda3\\envs\\WIKIbench\\Lib\\site-packages\\httpcore\\_async\\http11.py:217\u001b[39m, in \u001b[36mAsyncHTTP11Connection._receive_event\u001b[39m\u001b[34m(self, timeout)\u001b[39m\n\u001b[32m    214\u001b[39m     event = \u001b[38;5;28mself\u001b[39m._h11_state.next_event()\n\u001b[32m    216\u001b[39m \u001b[38;5;28;01mif\u001b[39;00m event \u001b[38;5;129;01mis\u001b[39;00m h11.NEED_DATA:\n\u001b[32m--> \u001b[39m\u001b[32m217\u001b[39m     data = \u001b[38;5;28;01mawait\u001b[39;00m \u001b[38;5;28mself\u001b[39m._network_stream.read(\n\u001b[32m    218\u001b[39m         \u001b[38;5;28mself\u001b[39m.READ_NUM_BYTES, timeout=timeout\n\u001b[32m    219\u001b[39m     )\n\u001b[32m    221\u001b[39m     \u001b[38;5;66;03m# If we feed this case through h11 we'll raise an exception like:\u001b[39;00m\n\u001b[32m    222\u001b[39m     \u001b[38;5;66;03m#\u001b[39;00m\n\u001b[32m    223\u001b[39m     \u001b[38;5;66;03m#     httpcore.RemoteProtocolError: can't handle event type\u001b[39;00m\n\u001b[32m   (...)\u001b[39m\u001b[32m    227\u001b[39m     \u001b[38;5;66;03m# perspective. Instead we handle this case distinctly and treat\u001b[39;00m\n\u001b[32m    228\u001b[39m     \u001b[38;5;66;03m# it as a ConnectError.\u001b[39;00m\n\u001b[32m    229\u001b[39m     \u001b[38;5;28;01mif\u001b[39;00m data == \u001b[33mb\u001b[39m\u001b[33m\"\u001b[39m\u001b[33m\"\u001b[39m \u001b[38;5;129;01mand\u001b[39;00m \u001b[38;5;28mself\u001b[39m._h11_state.their_state == h11.SEND_RESPONSE:\n",
      "\u001b[36mFile \u001b[39m\u001b[32m~\\anaconda3\\envs\\WIKIbench\\Lib\\site-packages\\httpcore\\_backends\\anyio.py:35\u001b[39m, in \u001b[36mAnyIOStream.read\u001b[39m\u001b[34m(self, max_bytes, timeout)\u001b[39m\n\u001b[32m     33\u001b[39m \u001b[38;5;28;01mwith\u001b[39;00m anyio.fail_after(timeout):\n\u001b[32m     34\u001b[39m     \u001b[38;5;28;01mtry\u001b[39;00m:\n\u001b[32m---> \u001b[39m\u001b[32m35\u001b[39m         \u001b[38;5;28;01mreturn\u001b[39;00m \u001b[38;5;28;01mawait\u001b[39;00m \u001b[38;5;28mself\u001b[39m._stream.receive(max_bytes=max_bytes)\n\u001b[32m     36\u001b[39m     \u001b[38;5;28;01mexcept\u001b[39;00m anyio.EndOfStream:  \u001b[38;5;66;03m# pragma: nocover\u001b[39;00m\n\u001b[32m     37\u001b[39m         \u001b[38;5;28;01mreturn\u001b[39;00m \u001b[33mb\u001b[39m\u001b[33m\"\u001b[39m\u001b[33m\"\u001b[39m\n",
      "\u001b[36mFile \u001b[39m\u001b[32m~\\anaconda3\\envs\\WIKIbench\\Lib\\site-packages\\anyio\\_backends\\_asyncio.py:1254\u001b[39m, in \u001b[36mSocketStream.receive\u001b[39m\u001b[34m(self, max_bytes)\u001b[39m\n\u001b[32m   1248\u001b[39m \u001b[38;5;28;01mif\u001b[39;00m (\n\u001b[32m   1249\u001b[39m     \u001b[38;5;129;01mnot\u001b[39;00m \u001b[38;5;28mself\u001b[39m._protocol.read_event.is_set()\n\u001b[32m   1250\u001b[39m     \u001b[38;5;129;01mand\u001b[39;00m \u001b[38;5;129;01mnot\u001b[39;00m \u001b[38;5;28mself\u001b[39m._transport.is_closing()\n\u001b[32m   1251\u001b[39m     \u001b[38;5;129;01mand\u001b[39;00m \u001b[38;5;129;01mnot\u001b[39;00m \u001b[38;5;28mself\u001b[39m._protocol.is_at_eof\n\u001b[32m   1252\u001b[39m ):\n\u001b[32m   1253\u001b[39m     \u001b[38;5;28mself\u001b[39m._transport.resume_reading()\n\u001b[32m-> \u001b[39m\u001b[32m1254\u001b[39m     \u001b[38;5;28;01mawait\u001b[39;00m \u001b[38;5;28mself\u001b[39m._protocol.read_event.wait()\n\u001b[32m   1255\u001b[39m     \u001b[38;5;28mself\u001b[39m._transport.pause_reading()\n\u001b[32m   1256\u001b[39m \u001b[38;5;28;01melse\u001b[39;00m:\n",
      "\u001b[36mFile \u001b[39m\u001b[32m~\\anaconda3\\envs\\WIKIbench\\Lib\\asyncio\\locks.py:212\u001b[39m, in \u001b[36mEvent.wait\u001b[39m\u001b[34m(self)\u001b[39m\n\u001b[32m    210\u001b[39m \u001b[38;5;28mself\u001b[39m._waiters.append(fut)\n\u001b[32m    211\u001b[39m \u001b[38;5;28;01mtry\u001b[39;00m:\n\u001b[32m--> \u001b[39m\u001b[32m212\u001b[39m     \u001b[38;5;28;01mawait\u001b[39;00m fut\n\u001b[32m    213\u001b[39m     \u001b[38;5;28;01mreturn\u001b[39;00m \u001b[38;5;28;01mTrue\u001b[39;00m\n\u001b[32m    214\u001b[39m \u001b[38;5;28;01mfinally\u001b[39;00m:\n",
      "\u001b[31mCancelledError\u001b[39m: "
     ]
    }
   ],
   "source": [
    "queries = []\n",
    "async for query in wiki_bench.query_stream(reference_mode=0):\n",
    "    queries.append(query)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "acb25e9a-06e5-47f2-a364-ff86f27d10ed",
   "metadata": {},
   "outputs": [],
   "source": [
    "with open('ruadapt7b_query.json', 'w', encoding='utf-8') as f:\n",
    "    json.dump(queries, f, ensure_ascii=False)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "id": "eaf0c2e4-f7b2-44d1-a9db-921d85be1be4",
   "metadata": {
    "collapsed": true,
    "jupyter": {
     "outputs_hidden": true
    }
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Atomic Heart\n",
      "ChatGPT\n"
     ]
    },
    {
     "ename": "CancelledError",
     "evalue": "",
     "output_type": "error",
     "traceback": [
      "\u001b[31m---------------------------------------------------------------------------\u001b[39m",
      "\u001b[31mCancelledError\u001b[39m                            Traceback (most recent call last)",
      "\u001b[36mCell\u001b[39m\u001b[36m \u001b[39m\u001b[32mIn[3]\u001b[39m\u001b[32m, line 2\u001b[39m\n\u001b[32m      1\u001b[39m outlines = []\n\u001b[32m----> \u001b[39m\u001b[32m2\u001b[39m \u001b[38;5;28;01masync\u001b[39;00m \u001b[38;5;28;01mfor\u001b[39;00m outline \u001b[38;5;129;01min\u001b[39;00m wiki_bench.outline_stream(\u001b[32m0\u001b[39m, \u001b[32m0\u001b[39m, \u001b[32m1\u001b[39m):\n\u001b[32m      3\u001b[39m     outlines.append(outline)\n",
      "\u001b[36mFile \u001b[39m\u001b[32m~\\WIKIBENCH\\src\\wiki_bench.py:129\u001b[39m, in \u001b[36mWikiBench.outline_stream\u001b[39m\u001b[34m(self, neighbor_count, description_mode, mode)\u001b[39m\n\u001b[32m    127\u001b[39m \u001b[38;5;28mprint\u001b[39m(name)\n\u001b[32m    128\u001b[39m page = \u001b[38;5;28mself\u001b[39m.get_article(name, is_downloaded=\u001b[38;5;28;01mTrue\u001b[39;00m)\n\u001b[32m--> \u001b[39m\u001b[32m129\u001b[39m outline = \u001b[38;5;28;01mawait\u001b[39;00m \u001b[38;5;28mself\u001b[39m.wiki_agent.create_outline(\n\u001b[32m    130\u001b[39m     name, \n\u001b[32m    131\u001b[39m     mode=mode, \n\u001b[32m    132\u001b[39m     page=page, \n\u001b[32m    133\u001b[39m     neighbor_count=neighbor_count, \n\u001b[32m    134\u001b[39m     description_mode=description_mode\n\u001b[32m    135\u001b[39m )\n\u001b[32m    136\u001b[39m \u001b[38;5;28;01myield\u001b[39;00m outline\n",
      "\u001b[36mFile \u001b[39m\u001b[32m~\\WIKIBENCH\\src\\wiki_agent.py:183\u001b[39m, in \u001b[36mWikiAgent.create_outline\u001b[39m\u001b[34m(self, name, neighbor_count, forced_cluster_num, mode, page, description_mode)\u001b[39m\n\u001b[32m    179\u001b[39m     clusters_centers = \u001b[38;5;28mlist\u001b[39m(header_to_embedding.values())\n\u001b[32m    180\u001b[39m     \u001b[38;5;66;03m#print('Found hints: ', len(header_to_embedding))\u001b[39;00m\n\u001b[32m    181\u001b[39m     \u001b[38;5;66;03m#return\u001b[39;00m\n\u001b[32m    182\u001b[39m     \u001b[38;5;66;03m#print(list(header_to_embedding.keys())[0], ' ', len(list(header_to_embedding.values())[0]))\u001b[39;00m\n\u001b[32m--> \u001b[39m\u001b[32m183\u001b[39m outline = \u001b[38;5;28;01mawait\u001b[39;00m \u001b[38;5;28mself\u001b[39m.k_means_method(name, snippets_filtered, snippets_id, embeddings, neighbor_count, forced_cluster_num, clusters_centers, description_mode)\n\u001b[32m    184\u001b[39m \u001b[38;5;28;01mreturn\u001b[39;00m outline\n",
      "\u001b[36mFile \u001b[39m\u001b[32m~\\WIKIBENCH\\src\\wiki_agent.py:103\u001b[39m, in \u001b[36mWikiAgent.k_means_method\u001b[39m\u001b[34m(self, name, snippets_filtered, snippets_id, embeddings, neighbor_count, forced_cluster_num, clusters_centers, description_mode)\u001b[39m\n\u001b[32m    101\u001b[39m     sample_snippet = \u001b[33m\"\u001b[39m\u001b[38;5;130;01m\\n\u001b[39;00m\u001b[38;5;130;01m\\n\u001b[39;00m\u001b[33m\"\u001b[39m.join([\u001b[38;5;28mself\u001b[39m.append_neighbors(chosen_snippet_id, neighbor_count) \u001b[38;5;28;01mfor\u001b[39;00m chosen_snippet_id \u001b[38;5;129;01min\u001b[39;00m chosen_snippets])\n\u001b[32m    102\u001b[39m     collected_snippets.setdefault(label, sample_snippet)\n\u001b[32m--> \u001b[39m\u001b[32m103\u001b[39m outline = \u001b[38;5;28;01mawait\u001b[39;00m \u001b[38;5;28mself\u001b[39m.client.generate_outline(collected_snippets, name, description_mode)\n\u001b[32m    104\u001b[39m \u001b[38;5;28;01mreturn\u001b[39;00m outline\n",
      "\u001b[36mFile \u001b[39m\u001b[32m~\\WIKIBENCH\\src\\wiki_gen.py:350\u001b[39m, in \u001b[36mWikiGen.generate_outline\u001b[39m\u001b[34m(self, clusters, name, description_mode)\u001b[39m\n\u001b[32m    348\u001b[39m \u001b[38;5;28;01mfor\u001b[39;00m label, sample_snippet \u001b[38;5;129;01min\u001b[39;00m clusters.items():\n\u001b[32m    349\u001b[39m     cluster_outlines.append(\u001b[38;5;28mself\u001b[39m.get_cluster_description(name, sample_snippet, description_mode))\n\u001b[32m--> \u001b[39m\u001b[32m350\u001b[39m \u001b[38;5;28;01mawait\u001b[39;00m cluster_outlines.complete_couroutines(batch_size=\u001b[32m40\u001b[39m)\n\u001b[32m    351\u001b[39m cluster_outlines = \u001b[38;5;28;01mawait\u001b[39;00m cluster_outlines.to_list()\n\u001b[32m    352\u001b[39m mega_outline = \u001b[33m\"\u001b[39m\u001b[38;5;130;01m\\n\u001b[39;00m\u001b[38;5;130;01m\\n\u001b[39;00m\u001b[33m\"\u001b[39m.join(\u001b[33mf\u001b[39m\u001b[33m\"\u001b[39m\u001b[38;5;132;01m{\u001b[39;00moutline\u001b[38;5;132;01m}\u001b[39;00m\u001b[33m\"\u001b[39m \u001b[38;5;28;01mfor\u001b[39;00m outline \u001b[38;5;129;01min\u001b[39;00m cluster_outlines)\n",
      "\u001b[36mFile \u001b[39m\u001b[32m~\\WIKIBENCH\\src\\openai_utils.py:119\u001b[39m, in \u001b[36mAsyncList.complete_couroutines\u001b[39m\u001b[34m(self, batch_size)\u001b[39m\n\u001b[32m    117\u001b[39m \u001b[38;5;28;01mwhile\u001b[39;00m \u001b[38;5;28mlen\u001b[39m(\u001b[38;5;28mself\u001b[39m.couroutine_ids) > \u001b[32m0\u001b[39m:\n\u001b[32m    118\u001b[39m     tasks = [\u001b[38;5;28mself\u001b[39m.contents[i] \u001b[38;5;28;01mfor\u001b[39;00m i \u001b[38;5;129;01min\u001b[39;00m \u001b[38;5;28mself\u001b[39m.couroutine_ids[:batch_size]]\n\u001b[32m--> \u001b[39m\u001b[32m119\u001b[39m     res = \u001b[38;5;28;01mawait\u001b[39;00m asyncio.gather(*tasks)\n\u001b[32m    120\u001b[39m     \u001b[38;5;28;01mfor\u001b[39;00m i, r \u001b[38;5;129;01min\u001b[39;00m \u001b[38;5;28mzip\u001b[39m(\u001b[38;5;28mself\u001b[39m.couroutine_ids, res):\n\u001b[32m    121\u001b[39m         \u001b[38;5;28mself\u001b[39m.contents[i] = r\n",
      "\u001b[36mFile \u001b[39m\u001b[32m~\\WIKIBENCH\\src\\wiki_gen.py:329\u001b[39m, in \u001b[36mWikiGen.get_cluster_description\u001b[39m\u001b[34m(self, name, cluster_text, description_mode, cluster_level_refine)\u001b[39m\n\u001b[32m    326\u001b[39m \u001b[38;5;28;01melse\u001b[39;00m:\n\u001b[32m    327\u001b[39m     myprompt = CLUSTER_OUTLINE_PROMPT.format(name, cluster_text) + \u001b[38;5;28mself\u001b[39m.thinking_pass\n\u001b[32m--> \u001b[39m\u001b[32m329\u001b[39m res = \u001b[38;5;28;01mawait\u001b[39;00m \u001b[38;5;28mself\u001b[39m.client.get_completion(myprompt)\n\u001b[32m    330\u001b[39m response = \u001b[38;5;28mself\u001b[39m.extract_response(res)\n\u001b[32m    332\u001b[39m \u001b[38;5;28;01mif\u001b[39;00m description_mode \u001b[38;5;129;01mand\u001b[39;00m response:\n",
      "\u001b[36mFile \u001b[39m\u001b[32m~\\WIKIBENCH\\src\\openai_utils.py:67\u001b[39m, in \u001b[36mLlmCompleter.get_completion\u001b[39m\u001b[34m(self, query, system, examples, choices, rep_penalty, regex_pattern, max_tokens, use_beam_search, beam_width, answer_prefix)\u001b[39m\n\u001b[32m     50\u001b[39m     beam_width = \u001b[38;5;28mmax\u001b[39m(\u001b[32m3\u001b[39m, beam_width)\n\u001b[32m     51\u001b[39m completion = \u001b[38;5;28mself\u001b[39m.client.chat.completions.create(\n\u001b[32m     52\u001b[39m     model=\u001b[38;5;28mself\u001b[39m.model,\n\u001b[32m     53\u001b[39m     messages=msgs,\n\u001b[32m   (...)\u001b[39m\u001b[32m     65\u001b[39m     }\n\u001b[32m     66\u001b[39m )\n\u001b[32m---> \u001b[39m\u001b[32m67\u001b[39m response = \u001b[38;5;28;01mawait\u001b[39;00m completion\n\u001b[32m     68\u001b[39m \u001b[38;5;28;01mreturn\u001b[39;00m response\n",
      "\u001b[36mFile \u001b[39m\u001b[32m~\\anaconda3\\envs\\WIKIbench\\Lib\\site-packages\\openai\\resources\\chat\\completions.py:1661\u001b[39m, in \u001b[36mAsyncCompletions.create\u001b[39m\u001b[34m(self, messages, model, audio, frequency_penalty, function_call, functions, logit_bias, logprobs, max_completion_tokens, max_tokens, metadata, modalities, n, parallel_tool_calls, prediction, presence_penalty, response_format, seed, service_tier, stop, store, stream, stream_options, temperature, tool_choice, tools, top_logprobs, top_p, user, extra_headers, extra_query, extra_body, timeout)\u001b[39m\n\u001b[32m   1620\u001b[39m \u001b[38;5;129m@required_args\u001b[39m([\u001b[33m\"\u001b[39m\u001b[33mmessages\u001b[39m\u001b[33m\"\u001b[39m, \u001b[33m\"\u001b[39m\u001b[33mmodel\u001b[39m\u001b[33m\"\u001b[39m], [\u001b[33m\"\u001b[39m\u001b[33mmessages\u001b[39m\u001b[33m\"\u001b[39m, \u001b[33m\"\u001b[39m\u001b[33mmodel\u001b[39m\u001b[33m\"\u001b[39m, \u001b[33m\"\u001b[39m\u001b[33mstream\u001b[39m\u001b[33m\"\u001b[39m])\n\u001b[32m   1621\u001b[39m \u001b[38;5;28;01masync\u001b[39;00m \u001b[38;5;28;01mdef\u001b[39;00m\u001b[38;5;250m \u001b[39m\u001b[34mcreate\u001b[39m(\n\u001b[32m   1622\u001b[39m     \u001b[38;5;28mself\u001b[39m,\n\u001b[32m   (...)\u001b[39m\u001b[32m   1658\u001b[39m     timeout: \u001b[38;5;28mfloat\u001b[39m | httpx.Timeout | \u001b[38;5;28;01mNone\u001b[39;00m | NotGiven = NOT_GIVEN,\n\u001b[32m   1659\u001b[39m ) -> ChatCompletion | AsyncStream[ChatCompletionChunk]:\n\u001b[32m   1660\u001b[39m     validate_response_format(response_format)\n\u001b[32m-> \u001b[39m\u001b[32m1661\u001b[39m     \u001b[38;5;28;01mreturn\u001b[39;00m \u001b[38;5;28;01mawait\u001b[39;00m \u001b[38;5;28mself\u001b[39m._post(\n\u001b[32m   1662\u001b[39m         \u001b[33m\"\u001b[39m\u001b[33m/chat/completions\u001b[39m\u001b[33m\"\u001b[39m,\n\u001b[32m   1663\u001b[39m         body=\u001b[38;5;28;01mawait\u001b[39;00m async_maybe_transform(\n\u001b[32m   1664\u001b[39m             {\n\u001b[32m   1665\u001b[39m                 \u001b[33m\"\u001b[39m\u001b[33mmessages\u001b[39m\u001b[33m\"\u001b[39m: messages,\n\u001b[32m   1666\u001b[39m                 \u001b[33m\"\u001b[39m\u001b[33mmodel\u001b[39m\u001b[33m\"\u001b[39m: model,\n\u001b[32m   1667\u001b[39m                 \u001b[33m\"\u001b[39m\u001b[33maudio\u001b[39m\u001b[33m\"\u001b[39m: audio,\n\u001b[32m   1668\u001b[39m                 \u001b[33m\"\u001b[39m\u001b[33mfrequency_penalty\u001b[39m\u001b[33m\"\u001b[39m: frequency_penalty,\n\u001b[32m   1669\u001b[39m                 \u001b[33m\"\u001b[39m\u001b[33mfunction_call\u001b[39m\u001b[33m\"\u001b[39m: function_call,\n\u001b[32m   1670\u001b[39m                 \u001b[33m\"\u001b[39m\u001b[33mfunctions\u001b[39m\u001b[33m\"\u001b[39m: functions,\n\u001b[32m   1671\u001b[39m                 \u001b[33m\"\u001b[39m\u001b[33mlogit_bias\u001b[39m\u001b[33m\"\u001b[39m: logit_bias,\n\u001b[32m   1672\u001b[39m                 \u001b[33m\"\u001b[39m\u001b[33mlogprobs\u001b[39m\u001b[33m\"\u001b[39m: logprobs,\n\u001b[32m   1673\u001b[39m                 \u001b[33m\"\u001b[39m\u001b[33mmax_completion_tokens\u001b[39m\u001b[33m\"\u001b[39m: max_completion_tokens,\n\u001b[32m   1674\u001b[39m                 \u001b[33m\"\u001b[39m\u001b[33mmax_tokens\u001b[39m\u001b[33m\"\u001b[39m: max_tokens,\n\u001b[32m   1675\u001b[39m                 \u001b[33m\"\u001b[39m\u001b[33mmetadata\u001b[39m\u001b[33m\"\u001b[39m: metadata,\n\u001b[32m   1676\u001b[39m                 \u001b[33m\"\u001b[39m\u001b[33mmodalities\u001b[39m\u001b[33m\"\u001b[39m: modalities,\n\u001b[32m   1677\u001b[39m                 \u001b[33m\"\u001b[39m\u001b[33mn\u001b[39m\u001b[33m\"\u001b[39m: n,\n\u001b[32m   1678\u001b[39m                 \u001b[33m\"\u001b[39m\u001b[33mparallel_tool_calls\u001b[39m\u001b[33m\"\u001b[39m: parallel_tool_calls,\n\u001b[32m   1679\u001b[39m                 \u001b[33m\"\u001b[39m\u001b[33mprediction\u001b[39m\u001b[33m\"\u001b[39m: prediction,\n\u001b[32m   1680\u001b[39m                 \u001b[33m\"\u001b[39m\u001b[33mpresence_penalty\u001b[39m\u001b[33m\"\u001b[39m: presence_penalty,\n\u001b[32m   1681\u001b[39m                 \u001b[33m\"\u001b[39m\u001b[33mresponse_format\u001b[39m\u001b[33m\"\u001b[39m: response_format,\n\u001b[32m   1682\u001b[39m                 \u001b[33m\"\u001b[39m\u001b[33mseed\u001b[39m\u001b[33m\"\u001b[39m: seed,\n\u001b[32m   1683\u001b[39m                 \u001b[33m\"\u001b[39m\u001b[33mservice_tier\u001b[39m\u001b[33m\"\u001b[39m: service_tier,\n\u001b[32m   1684\u001b[39m                 \u001b[33m\"\u001b[39m\u001b[33mstop\u001b[39m\u001b[33m\"\u001b[39m: stop,\n\u001b[32m   1685\u001b[39m                 \u001b[33m\"\u001b[39m\u001b[33mstore\u001b[39m\u001b[33m\"\u001b[39m: store,\n\u001b[32m   1686\u001b[39m                 \u001b[33m\"\u001b[39m\u001b[33mstream\u001b[39m\u001b[33m\"\u001b[39m: stream,\n\u001b[32m   1687\u001b[39m                 \u001b[33m\"\u001b[39m\u001b[33mstream_options\u001b[39m\u001b[33m\"\u001b[39m: stream_options,\n\u001b[32m   1688\u001b[39m                 \u001b[33m\"\u001b[39m\u001b[33mtemperature\u001b[39m\u001b[33m\"\u001b[39m: temperature,\n\u001b[32m   1689\u001b[39m                 \u001b[33m\"\u001b[39m\u001b[33mtool_choice\u001b[39m\u001b[33m\"\u001b[39m: tool_choice,\n\u001b[32m   1690\u001b[39m                 \u001b[33m\"\u001b[39m\u001b[33mtools\u001b[39m\u001b[33m\"\u001b[39m: tools,\n\u001b[32m   1691\u001b[39m                 \u001b[33m\"\u001b[39m\u001b[33mtop_logprobs\u001b[39m\u001b[33m\"\u001b[39m: top_logprobs,\n\u001b[32m   1692\u001b[39m                 \u001b[33m\"\u001b[39m\u001b[33mtop_p\u001b[39m\u001b[33m\"\u001b[39m: top_p,\n\u001b[32m   1693\u001b[39m                 \u001b[33m\"\u001b[39m\u001b[33muser\u001b[39m\u001b[33m\"\u001b[39m: user,\n\u001b[32m   1694\u001b[39m             },\n\u001b[32m   1695\u001b[39m             completion_create_params.CompletionCreateParams,\n\u001b[32m   1696\u001b[39m         ),\n\u001b[32m   1697\u001b[39m         options=make_request_options(\n\u001b[32m   1698\u001b[39m             extra_headers=extra_headers, extra_query=extra_query, extra_body=extra_body, timeout=timeout\n\u001b[32m   1699\u001b[39m         ),\n\u001b[32m   1700\u001b[39m         cast_to=ChatCompletion,\n\u001b[32m   1701\u001b[39m         stream=stream \u001b[38;5;129;01mor\u001b[39;00m \u001b[38;5;28;01mFalse\u001b[39;00m,\n\u001b[32m   1702\u001b[39m         stream_cls=AsyncStream[ChatCompletionChunk],\n\u001b[32m   1703\u001b[39m     )\n",
      "\u001b[36mFile \u001b[39m\u001b[32m~\\anaconda3\\envs\\WIKIbench\\Lib\\site-packages\\openai\\_base_client.py:1843\u001b[39m, in \u001b[36mAsyncAPIClient.post\u001b[39m\u001b[34m(self, path, cast_to, body, files, options, stream, stream_cls)\u001b[39m\n\u001b[32m   1829\u001b[39m \u001b[38;5;28;01masync\u001b[39;00m \u001b[38;5;28;01mdef\u001b[39;00m\u001b[38;5;250m \u001b[39m\u001b[34mpost\u001b[39m(\n\u001b[32m   1830\u001b[39m     \u001b[38;5;28mself\u001b[39m,\n\u001b[32m   1831\u001b[39m     path: \u001b[38;5;28mstr\u001b[39m,\n\u001b[32m   (...)\u001b[39m\u001b[32m   1838\u001b[39m     stream_cls: \u001b[38;5;28mtype\u001b[39m[_AsyncStreamT] | \u001b[38;5;28;01mNone\u001b[39;00m = \u001b[38;5;28;01mNone\u001b[39;00m,\n\u001b[32m   1839\u001b[39m ) -> ResponseT | _AsyncStreamT:\n\u001b[32m   1840\u001b[39m     opts = FinalRequestOptions.construct(\n\u001b[32m   1841\u001b[39m         method=\u001b[33m\"\u001b[39m\u001b[33mpost\u001b[39m\u001b[33m\"\u001b[39m, url=path, json_data=body, files=\u001b[38;5;28;01mawait\u001b[39;00m async_to_httpx_files(files), **options\n\u001b[32m   1842\u001b[39m     )\n\u001b[32m-> \u001b[39m\u001b[32m1843\u001b[39m     \u001b[38;5;28;01mreturn\u001b[39;00m \u001b[38;5;28;01mawait\u001b[39;00m \u001b[38;5;28mself\u001b[39m.request(cast_to, opts, stream=stream, stream_cls=stream_cls)\n",
      "\u001b[36mFile \u001b[39m\u001b[32m~\\anaconda3\\envs\\WIKIbench\\Lib\\site-packages\\openai\\_base_client.py:1537\u001b[39m, in \u001b[36mAsyncAPIClient.request\u001b[39m\u001b[34m(self, cast_to, options, stream, stream_cls, remaining_retries)\u001b[39m\n\u001b[32m   1534\u001b[39m \u001b[38;5;28;01melse\u001b[39;00m:\n\u001b[32m   1535\u001b[39m     retries_taken = \u001b[32m0\u001b[39m\n\u001b[32m-> \u001b[39m\u001b[32m1537\u001b[39m \u001b[38;5;28;01mreturn\u001b[39;00m \u001b[38;5;28;01mawait\u001b[39;00m \u001b[38;5;28mself\u001b[39m._request(\n\u001b[32m   1538\u001b[39m     cast_to=cast_to,\n\u001b[32m   1539\u001b[39m     options=options,\n\u001b[32m   1540\u001b[39m     stream=stream,\n\u001b[32m   1541\u001b[39m     stream_cls=stream_cls,\n\u001b[32m   1542\u001b[39m     retries_taken=retries_taken,\n\u001b[32m   1543\u001b[39m )\n",
      "\u001b[36mFile \u001b[39m\u001b[32m~\\anaconda3\\envs\\WIKIbench\\Lib\\site-packages\\openai\\_base_client.py:1576\u001b[39m, in \u001b[36mAsyncAPIClient._request\u001b[39m\u001b[34m(self, cast_to, options, stream, stream_cls, retries_taken)\u001b[39m\n\u001b[32m   1573\u001b[39m     kwargs[\u001b[33m\"\u001b[39m\u001b[33mauth\u001b[39m\u001b[33m\"\u001b[39m] = \u001b[38;5;28mself\u001b[39m.custom_auth\n\u001b[32m   1575\u001b[39m \u001b[38;5;28;01mtry\u001b[39;00m:\n\u001b[32m-> \u001b[39m\u001b[32m1576\u001b[39m     response = \u001b[38;5;28;01mawait\u001b[39;00m \u001b[38;5;28mself\u001b[39m._client.send(\n\u001b[32m   1577\u001b[39m         request,\n\u001b[32m   1578\u001b[39m         stream=stream \u001b[38;5;129;01mor\u001b[39;00m \u001b[38;5;28mself\u001b[39m._should_stream_response_body(request=request),\n\u001b[32m   1579\u001b[39m         **kwargs,\n\u001b[32m   1580\u001b[39m     )\n\u001b[32m   1581\u001b[39m \u001b[38;5;28;01mexcept\u001b[39;00m httpx.TimeoutException \u001b[38;5;28;01mas\u001b[39;00m err:\n\u001b[32m   1582\u001b[39m     log.debug(\u001b[33m\"\u001b[39m\u001b[33mEncountered httpx.TimeoutException\u001b[39m\u001b[33m\"\u001b[39m, exc_info=\u001b[38;5;28;01mTrue\u001b[39;00m)\n",
      "\u001b[36mFile \u001b[39m\u001b[32m~\\anaconda3\\envs\\WIKIbench\\Lib\\site-packages\\httpx\\_client.py:1629\u001b[39m, in \u001b[36mAsyncClient.send\u001b[39m\u001b[34m(self, request, stream, auth, follow_redirects)\u001b[39m\n\u001b[32m   1625\u001b[39m \u001b[38;5;28mself\u001b[39m._set_timeout(request)\n\u001b[32m   1627\u001b[39m auth = \u001b[38;5;28mself\u001b[39m._build_request_auth(request, auth)\n\u001b[32m-> \u001b[39m\u001b[32m1629\u001b[39m response = \u001b[38;5;28;01mawait\u001b[39;00m \u001b[38;5;28mself\u001b[39m._send_handling_auth(\n\u001b[32m   1630\u001b[39m     request,\n\u001b[32m   1631\u001b[39m     auth=auth,\n\u001b[32m   1632\u001b[39m     follow_redirects=follow_redirects,\n\u001b[32m   1633\u001b[39m     history=[],\n\u001b[32m   1634\u001b[39m )\n\u001b[32m   1635\u001b[39m \u001b[38;5;28;01mtry\u001b[39;00m:\n\u001b[32m   1636\u001b[39m     \u001b[38;5;28;01mif\u001b[39;00m \u001b[38;5;129;01mnot\u001b[39;00m stream:\n",
      "\u001b[36mFile \u001b[39m\u001b[32m~\\anaconda3\\envs\\WIKIbench\\Lib\\site-packages\\httpx\\_client.py:1657\u001b[39m, in \u001b[36mAsyncClient._send_handling_auth\u001b[39m\u001b[34m(self, request, auth, follow_redirects, history)\u001b[39m\n\u001b[32m   1654\u001b[39m request = \u001b[38;5;28;01mawait\u001b[39;00m auth_flow.\u001b[34m__anext__\u001b[39m()\n\u001b[32m   1656\u001b[39m \u001b[38;5;28;01mwhile\u001b[39;00m \u001b[38;5;28;01mTrue\u001b[39;00m:\n\u001b[32m-> \u001b[39m\u001b[32m1657\u001b[39m     response = \u001b[38;5;28;01mawait\u001b[39;00m \u001b[38;5;28mself\u001b[39m._send_handling_redirects(\n\u001b[32m   1658\u001b[39m         request,\n\u001b[32m   1659\u001b[39m         follow_redirects=follow_redirects,\n\u001b[32m   1660\u001b[39m         history=history,\n\u001b[32m   1661\u001b[39m     )\n\u001b[32m   1662\u001b[39m     \u001b[38;5;28;01mtry\u001b[39;00m:\n\u001b[32m   1663\u001b[39m         \u001b[38;5;28;01mtry\u001b[39;00m:\n",
      "\u001b[36mFile \u001b[39m\u001b[32m~\\anaconda3\\envs\\WIKIbench\\Lib\\site-packages\\httpx\\_client.py:1694\u001b[39m, in \u001b[36mAsyncClient._send_handling_redirects\u001b[39m\u001b[34m(self, request, follow_redirects, history)\u001b[39m\n\u001b[32m   1691\u001b[39m \u001b[38;5;28;01mfor\u001b[39;00m hook \u001b[38;5;129;01min\u001b[39;00m \u001b[38;5;28mself\u001b[39m._event_hooks[\u001b[33m\"\u001b[39m\u001b[33mrequest\u001b[39m\u001b[33m\"\u001b[39m]:\n\u001b[32m   1692\u001b[39m     \u001b[38;5;28;01mawait\u001b[39;00m hook(request)\n\u001b[32m-> \u001b[39m\u001b[32m1694\u001b[39m response = \u001b[38;5;28;01mawait\u001b[39;00m \u001b[38;5;28mself\u001b[39m._send_single_request(request)\n\u001b[32m   1695\u001b[39m \u001b[38;5;28;01mtry\u001b[39;00m:\n\u001b[32m   1696\u001b[39m     \u001b[38;5;28;01mfor\u001b[39;00m hook \u001b[38;5;129;01min\u001b[39;00m \u001b[38;5;28mself\u001b[39m._event_hooks[\u001b[33m\"\u001b[39m\u001b[33mresponse\u001b[39m\u001b[33m\"\u001b[39m]:\n",
      "\u001b[36mFile \u001b[39m\u001b[32m~\\anaconda3\\envs\\WIKIbench\\Lib\\site-packages\\httpx\\_client.py:1730\u001b[39m, in \u001b[36mAsyncClient._send_single_request\u001b[39m\u001b[34m(self, request)\u001b[39m\n\u001b[32m   1725\u001b[39m     \u001b[38;5;28;01mraise\u001b[39;00m \u001b[38;5;167;01mRuntimeError\u001b[39;00m(\n\u001b[32m   1726\u001b[39m         \u001b[33m\"\u001b[39m\u001b[33mAttempted to send an sync request with an AsyncClient instance.\u001b[39m\u001b[33m\"\u001b[39m\n\u001b[32m   1727\u001b[39m     )\n\u001b[32m   1729\u001b[39m \u001b[38;5;28;01mwith\u001b[39;00m request_context(request=request):\n\u001b[32m-> \u001b[39m\u001b[32m1730\u001b[39m     response = \u001b[38;5;28;01mawait\u001b[39;00m transport.handle_async_request(request)\n\u001b[32m   1732\u001b[39m \u001b[38;5;28;01massert\u001b[39;00m \u001b[38;5;28misinstance\u001b[39m(response.stream, AsyncByteStream)\n\u001b[32m   1733\u001b[39m response.request = request\n",
      "\u001b[36mFile \u001b[39m\u001b[32m~\\anaconda3\\envs\\WIKIbench\\Lib\\site-packages\\httpx\\_transports\\default.py:394\u001b[39m, in \u001b[36mAsyncHTTPTransport.handle_async_request\u001b[39m\u001b[34m(self, request)\u001b[39m\n\u001b[32m    381\u001b[39m req = httpcore.Request(\n\u001b[32m    382\u001b[39m     method=request.method,\n\u001b[32m    383\u001b[39m     url=httpcore.URL(\n\u001b[32m   (...)\u001b[39m\u001b[32m    391\u001b[39m     extensions=request.extensions,\n\u001b[32m    392\u001b[39m )\n\u001b[32m    393\u001b[39m \u001b[38;5;28;01mwith\u001b[39;00m map_httpcore_exceptions():\n\u001b[32m--> \u001b[39m\u001b[32m394\u001b[39m     resp = \u001b[38;5;28;01mawait\u001b[39;00m \u001b[38;5;28mself\u001b[39m._pool.handle_async_request(req)\n\u001b[32m    396\u001b[39m \u001b[38;5;28;01massert\u001b[39;00m \u001b[38;5;28misinstance\u001b[39m(resp.stream, typing.AsyncIterable)\n\u001b[32m    398\u001b[39m \u001b[38;5;28;01mreturn\u001b[39;00m Response(\n\u001b[32m    399\u001b[39m     status_code=resp.status,\n\u001b[32m    400\u001b[39m     headers=resp.headers,\n\u001b[32m    401\u001b[39m     stream=AsyncResponseStream(resp.stream),\n\u001b[32m    402\u001b[39m     extensions=resp.extensions,\n\u001b[32m    403\u001b[39m )\n",
      "\u001b[36mFile \u001b[39m\u001b[32m~\\anaconda3\\envs\\WIKIbench\\Lib\\site-packages\\httpcore\\_async\\connection_pool.py:256\u001b[39m, in \u001b[36mAsyncConnectionPool.handle_async_request\u001b[39m\u001b[34m(self, request)\u001b[39m\n\u001b[32m    253\u001b[39m         closing = \u001b[38;5;28mself\u001b[39m._assign_requests_to_connections()\n\u001b[32m    255\u001b[39m     \u001b[38;5;28;01mawait\u001b[39;00m \u001b[38;5;28mself\u001b[39m._close_connections(closing)\n\u001b[32m--> \u001b[39m\u001b[32m256\u001b[39m     \u001b[38;5;28;01mraise\u001b[39;00m exc \u001b[38;5;28;01mfrom\u001b[39;00m\u001b[38;5;250m \u001b[39m\u001b[38;5;28;01mNone\u001b[39;00m\n\u001b[32m    258\u001b[39m \u001b[38;5;66;03m# Return the response. Note that in this case we still have to manage\u001b[39;00m\n\u001b[32m    259\u001b[39m \u001b[38;5;66;03m# the point at which the response is closed.\u001b[39;00m\n\u001b[32m    260\u001b[39m \u001b[38;5;28;01massert\u001b[39;00m \u001b[38;5;28misinstance\u001b[39m(response.stream, typing.AsyncIterable)\n",
      "\u001b[36mFile \u001b[39m\u001b[32m~\\anaconda3\\envs\\WIKIbench\\Lib\\site-packages\\httpcore\\_async\\connection_pool.py:236\u001b[39m, in \u001b[36mAsyncConnectionPool.handle_async_request\u001b[39m\u001b[34m(self, request)\u001b[39m\n\u001b[32m    232\u001b[39m connection = \u001b[38;5;28;01mawait\u001b[39;00m pool_request.wait_for_connection(timeout=timeout)\n\u001b[32m    234\u001b[39m \u001b[38;5;28;01mtry\u001b[39;00m:\n\u001b[32m    235\u001b[39m     \u001b[38;5;66;03m# Send the request on the assigned connection.\u001b[39;00m\n\u001b[32m--> \u001b[39m\u001b[32m236\u001b[39m     response = \u001b[38;5;28;01mawait\u001b[39;00m connection.handle_async_request(\n\u001b[32m    237\u001b[39m         pool_request.request\n\u001b[32m    238\u001b[39m     )\n\u001b[32m    239\u001b[39m \u001b[38;5;28;01mexcept\u001b[39;00m ConnectionNotAvailable:\n\u001b[32m    240\u001b[39m     \u001b[38;5;66;03m# In some cases a connection may initially be available to\u001b[39;00m\n\u001b[32m    241\u001b[39m     \u001b[38;5;66;03m# handle a request, but then become unavailable.\u001b[39;00m\n\u001b[32m    242\u001b[39m     \u001b[38;5;66;03m#\u001b[39;00m\n\u001b[32m    243\u001b[39m     \u001b[38;5;66;03m# In this case we clear the connection and try again.\u001b[39;00m\n\u001b[32m    244\u001b[39m     pool_request.clear_connection()\n",
      "\u001b[36mFile \u001b[39m\u001b[32m~\\anaconda3\\envs\\WIKIbench\\Lib\\site-packages\\httpcore\\_async\\connection.py:103\u001b[39m, in \u001b[36mAsyncHTTPConnection.handle_async_request\u001b[39m\u001b[34m(self, request)\u001b[39m\n\u001b[32m    100\u001b[39m     \u001b[38;5;28mself\u001b[39m._connect_failed = \u001b[38;5;28;01mTrue\u001b[39;00m\n\u001b[32m    101\u001b[39m     \u001b[38;5;28;01mraise\u001b[39;00m exc\n\u001b[32m--> \u001b[39m\u001b[32m103\u001b[39m \u001b[38;5;28;01mreturn\u001b[39;00m \u001b[38;5;28;01mawait\u001b[39;00m \u001b[38;5;28mself\u001b[39m._connection.handle_async_request(request)\n",
      "\u001b[36mFile \u001b[39m\u001b[32m~\\anaconda3\\envs\\WIKIbench\\Lib\\site-packages\\httpcore\\_async\\http11.py:136\u001b[39m, in \u001b[36mAsyncHTTP11Connection.handle_async_request\u001b[39m\u001b[34m(self, request)\u001b[39m\n\u001b[32m    134\u001b[39m     \u001b[38;5;28;01masync\u001b[39;00m \u001b[38;5;28;01mwith\u001b[39;00m Trace(\u001b[33m\"\u001b[39m\u001b[33mresponse_closed\u001b[39m\u001b[33m\"\u001b[39m, logger, request) \u001b[38;5;28;01mas\u001b[39;00m trace:\n\u001b[32m    135\u001b[39m         \u001b[38;5;28;01mawait\u001b[39;00m \u001b[38;5;28mself\u001b[39m._response_closed()\n\u001b[32m--> \u001b[39m\u001b[32m136\u001b[39m \u001b[38;5;28;01mraise\u001b[39;00m exc\n",
      "\u001b[36mFile \u001b[39m\u001b[32m~\\anaconda3\\envs\\WIKIbench\\Lib\\site-packages\\httpcore\\_async\\http11.py:106\u001b[39m, in \u001b[36mAsyncHTTP11Connection.handle_async_request\u001b[39m\u001b[34m(self, request)\u001b[39m\n\u001b[32m     95\u001b[39m     \u001b[38;5;28;01mpass\u001b[39;00m\n\u001b[32m     97\u001b[39m \u001b[38;5;28;01masync\u001b[39;00m \u001b[38;5;28;01mwith\u001b[39;00m Trace(\n\u001b[32m     98\u001b[39m     \u001b[33m\"\u001b[39m\u001b[33mreceive_response_headers\u001b[39m\u001b[33m\"\u001b[39m, logger, request, kwargs\n\u001b[32m     99\u001b[39m ) \u001b[38;5;28;01mas\u001b[39;00m trace:\n\u001b[32m    100\u001b[39m     (\n\u001b[32m    101\u001b[39m         http_version,\n\u001b[32m    102\u001b[39m         status,\n\u001b[32m    103\u001b[39m         reason_phrase,\n\u001b[32m    104\u001b[39m         headers,\n\u001b[32m    105\u001b[39m         trailing_data,\n\u001b[32m--> \u001b[39m\u001b[32m106\u001b[39m     ) = \u001b[38;5;28;01mawait\u001b[39;00m \u001b[38;5;28mself\u001b[39m._receive_response_headers(**kwargs)\n\u001b[32m    107\u001b[39m     trace.return_value = (\n\u001b[32m    108\u001b[39m         http_version,\n\u001b[32m    109\u001b[39m         status,\n\u001b[32m    110\u001b[39m         reason_phrase,\n\u001b[32m    111\u001b[39m         headers,\n\u001b[32m    112\u001b[39m     )\n\u001b[32m    114\u001b[39m network_stream = \u001b[38;5;28mself\u001b[39m._network_stream\n",
      "\u001b[36mFile \u001b[39m\u001b[32m~\\anaconda3\\envs\\WIKIbench\\Lib\\site-packages\\httpcore\\_async\\http11.py:177\u001b[39m, in \u001b[36mAsyncHTTP11Connection._receive_response_headers\u001b[39m\u001b[34m(self, request)\u001b[39m\n\u001b[32m    174\u001b[39m timeout = timeouts.get(\u001b[33m\"\u001b[39m\u001b[33mread\u001b[39m\u001b[33m\"\u001b[39m, \u001b[38;5;28;01mNone\u001b[39;00m)\n\u001b[32m    176\u001b[39m \u001b[38;5;28;01mwhile\u001b[39;00m \u001b[38;5;28;01mTrue\u001b[39;00m:\n\u001b[32m--> \u001b[39m\u001b[32m177\u001b[39m     event = \u001b[38;5;28;01mawait\u001b[39;00m \u001b[38;5;28mself\u001b[39m._receive_event(timeout=timeout)\n\u001b[32m    178\u001b[39m     \u001b[38;5;28;01mif\u001b[39;00m \u001b[38;5;28misinstance\u001b[39m(event, h11.Response):\n\u001b[32m    179\u001b[39m         \u001b[38;5;28;01mbreak\u001b[39;00m\n",
      "\u001b[36mFile \u001b[39m\u001b[32m~\\anaconda3\\envs\\WIKIbench\\Lib\\site-packages\\httpcore\\_async\\http11.py:217\u001b[39m, in \u001b[36mAsyncHTTP11Connection._receive_event\u001b[39m\u001b[34m(self, timeout)\u001b[39m\n\u001b[32m    214\u001b[39m     event = \u001b[38;5;28mself\u001b[39m._h11_state.next_event()\n\u001b[32m    216\u001b[39m \u001b[38;5;28;01mif\u001b[39;00m event \u001b[38;5;129;01mis\u001b[39;00m h11.NEED_DATA:\n\u001b[32m--> \u001b[39m\u001b[32m217\u001b[39m     data = \u001b[38;5;28;01mawait\u001b[39;00m \u001b[38;5;28mself\u001b[39m._network_stream.read(\n\u001b[32m    218\u001b[39m         \u001b[38;5;28mself\u001b[39m.READ_NUM_BYTES, timeout=timeout\n\u001b[32m    219\u001b[39m     )\n\u001b[32m    221\u001b[39m     \u001b[38;5;66;03m# If we feed this case through h11 we'll raise an exception like:\u001b[39;00m\n\u001b[32m    222\u001b[39m     \u001b[38;5;66;03m#\u001b[39;00m\n\u001b[32m    223\u001b[39m     \u001b[38;5;66;03m#     httpcore.RemoteProtocolError: can't handle event type\u001b[39;00m\n\u001b[32m   (...)\u001b[39m\u001b[32m    227\u001b[39m     \u001b[38;5;66;03m# perspective. Instead we handle this case distinctly and treat\u001b[39;00m\n\u001b[32m    228\u001b[39m     \u001b[38;5;66;03m# it as a ConnectError.\u001b[39;00m\n\u001b[32m    229\u001b[39m     \u001b[38;5;28;01mif\u001b[39;00m data == \u001b[33mb\u001b[39m\u001b[33m\"\u001b[39m\u001b[33m\"\u001b[39m \u001b[38;5;129;01mand\u001b[39;00m \u001b[38;5;28mself\u001b[39m._h11_state.their_state == h11.SEND_RESPONSE:\n",
      "\u001b[36mFile \u001b[39m\u001b[32m~\\anaconda3\\envs\\WIKIbench\\Lib\\site-packages\\httpcore\\_backends\\anyio.py:35\u001b[39m, in \u001b[36mAnyIOStream.read\u001b[39m\u001b[34m(self, max_bytes, timeout)\u001b[39m\n\u001b[32m     33\u001b[39m \u001b[38;5;28;01mwith\u001b[39;00m anyio.fail_after(timeout):\n\u001b[32m     34\u001b[39m     \u001b[38;5;28;01mtry\u001b[39;00m:\n\u001b[32m---> \u001b[39m\u001b[32m35\u001b[39m         \u001b[38;5;28;01mreturn\u001b[39;00m \u001b[38;5;28;01mawait\u001b[39;00m \u001b[38;5;28mself\u001b[39m._stream.receive(max_bytes=max_bytes)\n\u001b[32m     36\u001b[39m     \u001b[38;5;28;01mexcept\u001b[39;00m anyio.EndOfStream:  \u001b[38;5;66;03m# pragma: nocover\u001b[39;00m\n\u001b[32m     37\u001b[39m         \u001b[38;5;28;01mreturn\u001b[39;00m \u001b[33mb\u001b[39m\u001b[33m\"\u001b[39m\u001b[33m\"\u001b[39m\n",
      "\u001b[36mFile \u001b[39m\u001b[32m~\\anaconda3\\envs\\WIKIbench\\Lib\\site-packages\\anyio\\_backends\\_asyncio.py:1254\u001b[39m, in \u001b[36mSocketStream.receive\u001b[39m\u001b[34m(self, max_bytes)\u001b[39m\n\u001b[32m   1248\u001b[39m \u001b[38;5;28;01mif\u001b[39;00m (\n\u001b[32m   1249\u001b[39m     \u001b[38;5;129;01mnot\u001b[39;00m \u001b[38;5;28mself\u001b[39m._protocol.read_event.is_set()\n\u001b[32m   1250\u001b[39m     \u001b[38;5;129;01mand\u001b[39;00m \u001b[38;5;129;01mnot\u001b[39;00m \u001b[38;5;28mself\u001b[39m._transport.is_closing()\n\u001b[32m   1251\u001b[39m     \u001b[38;5;129;01mand\u001b[39;00m \u001b[38;5;129;01mnot\u001b[39;00m \u001b[38;5;28mself\u001b[39m._protocol.is_at_eof\n\u001b[32m   1252\u001b[39m ):\n\u001b[32m   1253\u001b[39m     \u001b[38;5;28mself\u001b[39m._transport.resume_reading()\n\u001b[32m-> \u001b[39m\u001b[32m1254\u001b[39m     \u001b[38;5;28;01mawait\u001b[39;00m \u001b[38;5;28mself\u001b[39m._protocol.read_event.wait()\n\u001b[32m   1255\u001b[39m     \u001b[38;5;28mself\u001b[39m._transport.pause_reading()\n\u001b[32m   1256\u001b[39m \u001b[38;5;28;01melse\u001b[39;00m:\n",
      "\u001b[36mFile \u001b[39m\u001b[32m~\\anaconda3\\envs\\WIKIbench\\Lib\\asyncio\\locks.py:212\u001b[39m, in \u001b[36mEvent.wait\u001b[39m\u001b[34m(self)\u001b[39m\n\u001b[32m    210\u001b[39m \u001b[38;5;28mself\u001b[39m._waiters.append(fut)\n\u001b[32m    211\u001b[39m \u001b[38;5;28;01mtry\u001b[39;00m:\n\u001b[32m--> \u001b[39m\u001b[32m212\u001b[39m     \u001b[38;5;28;01mawait\u001b[39;00m fut\n\u001b[32m    213\u001b[39m     \u001b[38;5;28;01mreturn\u001b[39;00m \u001b[38;5;28;01mTrue\u001b[39;00m\n\u001b[32m    214\u001b[39m \u001b[38;5;28;01mfinally\u001b[39;00m:\n",
      "\u001b[31mCancelledError\u001b[39m: "
     ]
    }
   ],
   "source": [
    "outlines = []\n",
    "async for outline in wiki_bench.outline_stream(0, 0, 1):\n",
    "    outlines.append(outline)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "0ec5d364-46ea-454b-aadf-af93edc46b00",
   "metadata": {},
   "outputs": [],
   "source": [
    "sections = []\n",
    "async for section in wiki_bench.sections_stream(0, 0, 1):\n",
    "    sections.append(section)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "id": "c275c127-bb96-4c0c-a9e6-fed9389e7698",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "13704\n"
     ]
    }
   ],
   "source": [
    "print(len(wiki_bench.wiki_agent.snippets))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "id": "2069f66e-c57c-4f85-b475-ea892bd7c56f",
   "metadata": {
    "collapsed": true,
    "jupyter": {
     "outputs_hidden": true
    },
    "scrolled": true
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Atomic Heart\n",
      "ChatGPT\n",
      "F-35\n",
      "Minecraft\n",
      "Биткойн\n",
      "Википедия\n",
      "ВКонтакте\n",
      "Гибель тургруппы Дятлова\n",
      "Государство Палестина\n",
      "Китай\n",
      "Московский метрополитен\n",
      "Тарантино, Квентин\n",
      "Ozon\n",
      "Wildberries\n",
      "Ди Каприо, Леонардо\n",
      "Джобс, Стив\n",
      "Маск, Илон\n",
      "Цой, Виктор Робертович\n",
      "Миядзаки, Хаяо\n",
      "Python\n",
      "Летние Олимпийские игры 2024\n",
      "Квантовый компьютер\n",
      "Присоединение Крыма к Российской Федерации\n",
      "Сколково (инновационный центр)\n",
      "Tomb Raider (игра, 2013)\n",
      "Чёрная дыра\n",
      "Экономика США\n",
      "Искусственный интеллект\n",
      "COVID-19\n",
      "Применение искусственного интеллекта\n",
      "РИА Новости\n",
      "Uncharted 4: A Thief’s End\n",
      "Экономика КНР\n",
      "Иннополис\n",
      "Летние Олимпийские игры 2020\n",
      "Солнечная система\n",
      "C++\n",
      "Си (язык программирования)\n",
      "Сбербанк России\n",
      "Чёрная смерть\n",
      "Яндекс\n",
      "Google (компания)\n",
      "Большой адронный коллайдер\n",
      "Геморрагическая лихорадка Эбола\n",
      "Вирус иммунодефицита человека\n",
      "Dota 2\n",
      "TikTok\n",
      "Марс\n",
      "YouTube\n",
      "Portal 2\n",
      "BTS\n",
      "Linkin Park\n",
      "Rutube\n",
      "Telegram\n",
      "WhatsApp\n",
      "Аватар: Путь воды\n",
      "Азербайджан\n",
      "Арабо-израильский конфликт\n",
      "Армения\n",
      "Аутизм\n",
      "Байден, Джо\n",
      "Баста (музыкант)\n",
      "Бондарчук, Фёдор Сергеевич\n",
      "Боярский, Михаил Сергеевич\n",
      "БРИКС\n",
      "Властелин колец: Кольца власти\n",
      "Во все тяжкие\n",
      "Гагарин, Юрий Алексеевич\n",
      "Дуров, Павел Валерьевич\n",
      "Дэдпул и Росомаха\n",
      "Дюна (фильм, 2021)\n",
      "Зенит (футбольный клуб, Санкт-Петербург)\n",
      "Израиль\n",
      "Исламское государство\n",
      "Казань\n",
      "Казахстан\n",
      "Кинематографическая вселенная Marvel\n",
      "Кобейн, Курт\n",
      "Корейская Народно-Демократическая Республика\n",
      "Король и Шут\n",
      "Кошка\n",
      "Криштиану Роналду\n",
      "Месси, Лионель\n",
      "Москва\n",
      "НАТО\n",
      "Оппенгеймер (фильм)\n",
      "Православие\n",
      "Русский язык\n",
      "Синдром Аспергера\n",
      "Спартак (футбольный клуб, Москва)\n",
      "Сталин, Иосиф Виссарионович\n",
      "Су-34\n",
      "Су-57\n",
      "Тиньков, Олег Юрьевич\n",
      "Титаник\n",
      "Толстой, Лев Николаевич\n",
      "Трамп, Дональд\n",
      "Человек разумный\n",
      "Шизофрения\n",
      "Экономика России\n",
      "37.01 112.18287037037037\n"
     ]
    }
   ],
   "source": [
    "outline_len = 0\n",
    "outline_count = 0\n",
    "words_len = 0\n",
    "words_count = 0\n",
    "for name in wiki_bench.article_names:\n",
    "    print(name)\n",
    "    page = wiki_bench.get_article(name, retrieve_sources=False, is_downloaded=True, verbose=False, html=True, needs_saving=False)\n",
    "    outline_len += len(page.outline)\n",
    "    outline_count += 1\n",
    "    for section in page.filtered_outline.values():\n",
    "        words_len += len(section.split())\n",
    "        words_count += 1\n",
    "\n",
    "print(outline_len / outline_count, words_len / words_count)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "id": "6440ec21-7d5b-42a5-9cd1-d8d241fd2850",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Model(id='RefalMachine/RuadaptQwen2.5-7B-Lite-Beta', created=None, object=None, owned_by=None, max_model_len=30000, status='spawned')\n",
      "Model(id='RefalMachine/RuadaptQwen2.5-32B-Pro-Beta', created=None, object=None, owned_by=None, max_model_len=28000, status='spawned')\n",
      "Model(id='RefalMachine/RuadaptQwen3-32B-Instruct-v2', created=None, object=None, owned_by=None, max_model_len=24000, status='spawned')\n",
      "Model(id='llama3-70b', created=None, object=None, owned_by=None, max_model_len=14000, status='spawned')\n",
      "Model(id='DeepSeek V3', created=None, object=None, owned_by=None, max_model_len=-1, status='spawned')\n",
      "Model(id='Qwen/Qwen2.5-VL-72B-Instruct', created=None, object=None, owned_by=None, max_model_len=-1, status='spawned')\n",
      "Model(id='Qwen3-235B-A22B', created=None, object=None, owned_by=None, max_model_len=-1, status='spawned')\n",
      "Model(id='RefalMachine/RuadaptQwen2.5-7B-Garant-v2', created=None, object=None, owned_by=None, max_model_len=30000, status='offloaded')\n",
      "Model(id='deepseek-r1-32b', created=None, object=None, owned_by=None, max_model_len=30000, status='offloaded')\n",
      "Model(id='qwen32b-coder', created=None, object=None, owned_by=None, max_model_len=30000, status='offloaded')\n",
      "Model(id='tpro', created=None, object=None, owned_by=None, max_model_len=30000, status='offloaded')\n",
      "Model(id='vikhr12b', created=None, object=None, owned_by=None, max_model_len=30000, status='offloaded')\n",
      "Model(id='yagpt5lite', created=None, object=None, owned_by=None, max_model_len=30000, status='offloaded')\n",
      "Model(id='qwen3moe30b', created=None, object=None, owned_by=None, max_model_len=28000, status='offloaded')\n",
      "Model(id='RefalMachine/RuadaptQwen3-32B-Instruct-v1', created=None, object=None, owned_by=None, max_model_len=24000, status='offloaded')\n",
      "Model(id='gemma3', created=None, object=None, owned_by=None, max_model_len=22000, status='offloaded')\n",
      "Model(id='RefalMachine/RuadaptQwen2.5-32B-QWQ-Beta', created=None, object=None, owned_by=None, max_model_len=16000, status='offloaded')\n",
      "Model(id='qwen2.5-72b', created=None, object=None, owned_by=None, max_model_len=14000, status='offloaded')\n",
      "Model(id='tlite', created=None, object=None, owned_by=None, max_model_len=-1, status='offloaded')\n"
     ]
    }
   ],
   "source": [
    "lst = list(await wiki_bench.client.client.models.list())[0][1]\n",
    "for l in lst:\n",
    "    print(l)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "id": "8c9f9db6-80f0-4288-871c-3a698256fd6e",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "RefalMachine/RuadaptQwen2.5-7B-Lite-Beta\n"
     ]
    }
   ],
   "source": [
    "print(wiki_bench.model_name)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "id": "b985d978-5b5f-4cc1-a320-dc449cbbed43",
   "metadata": {
    "scrolled": true
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Atomic Heart\n",
      "Pr:  0.5236083  rec:  0.66811186  f:  0.5870991\n",
      "\n",
      "ChatGPT\n",
      "Pr:  0.5538056  rec:  0.65722454  f:  0.6010992\n",
      "\n",
      "F-35\n",
      "Pr:  0.64952916  rec:  0.643553  f:  0.64652723\n",
      "\n",
      "Minecraft\n",
      "Pr:  0.6214057  rec:  0.6219506  f:  0.62167805\n",
      "\n",
      "Биткойн\n",
      "Pr:  0.5959065  rec:  0.586575  f:  0.59120387\n",
      "\n",
      "Википедия\n",
      "Pr:  0.51575893  rec:  0.669684  f:  0.5827282\n",
      "\n",
      "ВКонтакте\n",
      "Pr:  0.63722384  rec:  0.68508375  f:  0.6602877\n",
      "\n",
      "Гибель тургруппы Дятлова\n",
      "Pr:  0.5905406  rec:  0.5844475  f:  0.5874783\n",
      "\n",
      "Государство Палестина\n",
      "Pr:  0.49291277  rec:  0.62029684  f:  0.5493165\n",
      "\n",
      "Китай\n",
      "Pr:  0.568192  rec:  0.60756207  f:  0.58721787\n",
      "\n",
      "Московский метрополитен\n",
      "Pr:  0.5675341  rec:  0.65686816  f:  0.6089422\n",
      "\n",
      "Тарантино, Квентин\n",
      "Pr:  0.6234273  rec:  0.6590106  f:  0.64072526\n",
      "\n",
      "Ozon\n",
      "Pr:  0.5322711  rec:  0.50118905  f:  0.5162627\n",
      "\n",
      "Wildberries\n",
      "Pr:  0.5225564  rec:  0.50150347  f:  0.5118135\n",
      "\n",
      "Ди Каприо, Леонардо\n",
      "Pr:  0.6354634  rec:  0.61729413  f:  0.62624705\n",
      "\n",
      "Джобс, Стив\n",
      "Pr:  0.56656045  rec:  0.62895083  f:  0.5961276\n",
      "\n",
      "Маск, Илон\n",
      "Pr:  0.4966201  rec:  0.5455699  f:  0.51994544\n",
      "\n",
      "Цой, Виктор Робертович\n",
      "Pr:  0.43877918  rec:  0.4980623  f:  0.46654505\n",
      "\n",
      "Миядзаки, Хаяо\n",
      "Pr:  0.5639887  rec:  0.6459996  f:  0.6022148\n",
      "\n",
      "Python\n",
      "Pr:  0.6093416  rec:  0.63801426  f:  0.62334836\n",
      "\n",
      "Летние Олимпийские игры 2024\n",
      "Pr:  0.5983695  rec:  0.63962984  f:  0.6183121\n",
      "\n",
      "Квантовый компьютер\n",
      "Pr:  0.6530836  rec:  0.59220433  f:  0.62115586\n",
      "\n",
      "Присоединение Крыма к Российской Федерации\n",
      "Pr:  0.56672925  rec:  0.69923717  f:  0.62604845\n",
      "\n",
      "Сколково (инновационный центр)\n",
      "Pr:  0.61267626  rec:  0.5880642  f:  0.600118\n",
      "\n",
      "Tomb Raider (игра, 2013)\n",
      "Pr:  0.64890486  rec:  0.7242171  f:  0.6844956\n",
      "\n",
      "Чёрная дыра\n",
      "Pr:  0.6731828  rec:  0.7133899  f:  0.6927034\n",
      "\n",
      "Экономика США\n",
      "Pr:  0.6036651  rec:  0.58779204  f:  0.59562284\n",
      "\n",
      "Искусственный интеллект\n",
      "Pr:  0.6179326  rec:  0.6711986  f:  0.6434652\n",
      "\n",
      "COVID-19\n",
      "Pr:  0.6301699  rec:  0.63613886  f:  0.6331403\n",
      "\n",
      "Применение искусственного интеллекта\n",
      "Pr:  0.6150122  rec:  0.61942357  f:  0.61721003\n",
      "\n",
      "РИА Новости\n",
      "Pr:  0.52927697  rec:  0.5387808  f:  0.53398657\n",
      "\n",
      "Uncharted 4: A Thief’s End\n",
      "Pr:  0.58314234  rec:  0.7671503  f:  0.6626086\n",
      "\n",
      "Экономика КНР\n",
      "Pr:  0.54802865  rec:  0.56202793  f:  0.55494\n",
      "\n",
      "Иннополис\n",
      "Pr:  0.61882126  rec:  0.6837745  f:  0.6496784\n",
      "\n",
      "Летние Олимпийские игры 2020\n",
      "Pr:  0.50823665  rec:  0.6001899  f:  0.5503991\n",
      "\n",
      "Солнечная система\n",
      "Pr:  0.5104615  rec:  0.56326336  f:  0.5355641\n",
      "\n",
      "C++\n",
      "Pr:  0.5921915  rec:  0.6307889  f:  0.61088115\n",
      "\n",
      "Си (язык программирования)\n",
      "Pr:  0.65252566  rec:  0.67934364  f:  0.6656646\n",
      "\n",
      "Сбербанк России\n",
      "Pr:  0.52295583  rec:  0.54731065  f:  0.53485614\n",
      "\n",
      "Чёрная смерть\n",
      "Pr:  0.56693363  rec:  0.6239886  f:  0.59409446\n",
      "\n",
      "Яндекс\n",
      "Pr:  0.61082643  rec:  0.6474431  f:  0.62860197\n",
      "\n",
      "Google (компания)\n",
      "Pr:  0.50714123  rec:  0.5551627  f:  0.53006655\n",
      "\n",
      "Большой адронный коллайдер\n",
      "Pr:  0.48686484  rec:  0.5174239  f:  0.5016794\n",
      "\n",
      "Геморрагическая лихорадка Эбола\n",
      "Pr:  0.5758136  rec:  0.7329909  f:  0.64496434\n",
      "\n",
      "Вирус иммунодефицита человека\n",
      "Pr:  0.57796365  rec:  0.55482876  f:  0.5661599\n",
      "\n",
      "Dota 2\n",
      "Pr:  0.59410167  rec:  0.67802095  f:  0.63329333\n",
      "\n",
      "TikTok\n",
      "Pr:  0.5289697  rec:  0.5510978  f:  0.5398071\n",
      "\n",
      "Марс\n",
      "Pr:  0.65855813  rec:  0.6399933  f:  0.649143\n",
      "\n",
      "YouTube\n",
      "Pr:  0.5493634  rec:  0.6240889  f:  0.5843469\n",
      "\n",
      "Portal 2\n",
      "Pr:  0.5877258  rec:  0.6568543  f:  0.62037027\n",
      "\n",
      "BTS\n",
      "Pr:  0.56112653  rec:  0.5788983  f:  0.56987387\n",
      "\n",
      "Linkin Park\n",
      "Pr:  0.5224256  rec:  0.58831894  f:  0.5534178\n",
      "\n",
      "Rutube\n",
      "Pr:  0.5259351  rec:  0.5770757  f:  0.5503198\n",
      "\n",
      "Telegram\n",
      "Pr:  0.6245539  rec:  0.69351906  f:  0.6572322\n",
      "\n",
      "WhatsApp\n",
      "Pr:  0.5487985  rec:  0.6115127  f:  0.5784608\n",
      "\n",
      "Аватар: Путь воды\n",
      "Pr:  0.5245511  rec:  0.5364216  f:  0.53041995\n",
      "\n",
      "Азербайджан\n",
      "Pr:  0.69853354  rec:  0.5086389  f:  0.5886506\n",
      "\n",
      "Арабо-израильский конфликт\n",
      "Pr:  0.39795014  rec:  0.47060806  f:  0.43124005\n",
      "\n",
      "Армения\n",
      "Pr:  0.52835125  rec:  0.6544147  f:  0.5846648\n",
      "\n",
      "Аутизм\n",
      "Pr:  0.45611432  rec:  0.6015876  f:  0.518847\n",
      "\n",
      "Байден, Джо\n",
      "Pr:  0.55510896  rec:  0.67545205  f:  0.609396\n",
      "\n",
      "Баста (музыкант)\n",
      "Pr:  0.5195139  rec:  0.53465974  f:  0.52697796\n",
      "\n",
      "Бондарчук, Фёдор Сергеевич\n",
      "Pr:  0.55618167  rec:  0.61297476  f:  0.58319885\n",
      "\n",
      "Боярский, Михаил Сергеевич\n",
      "Pr:  0.5890027  rec:  0.64658225  f:  0.61645085\n",
      "\n",
      "БРИКС\n",
      "Pr:  0.59840506  rec:  0.7002978  f:  0.6453543\n",
      "\n",
      "Властелин колец: Кольца власти\n",
      "Pr:  0.5845685  rec:  0.6758674  f:  0.6269114\n",
      "\n",
      "Во все тяжкие\n",
      "Pr:  0.59245676  rec:  0.6249009  f:  0.60824645\n",
      "\n",
      "Гагарин, Юрий Алексеевич\n",
      "Pr:  0.60307765  rec:  0.60254896  f:  0.6028132\n",
      "\n",
      "Дуров, Павел Валерьевич\n",
      "Pr:  0.4921675  rec:  0.5073929  f:  0.49966425\n",
      "\n",
      "Дэдпул и Росомаха\n",
      "Pr:  0.5778859  rec:  0.7227603  f:  0.6422546\n",
      "\n",
      "Дюна (фильм, 2021)\n",
      "Pr:  0.6303295  rec:  0.6772507  f:  0.6529482\n",
      "\n",
      "Зенит (футбольный клуб, Санкт-Петербург)\n",
      "Pr:  0.5982205  rec:  0.6084196  f:  0.60327697\n",
      "\n",
      "Израиль\n",
      "Pr:  0.55553985  rec:  0.5776266  f:  0.566368\n",
      "\n",
      "Исламское государство\n",
      "Pr:  0.58719766  rec:  0.56415  f:  0.5754431\n",
      "\n",
      "Казань\n",
      "Pr:  0.5171305  rec:  0.50701135  f:  0.51202095\n",
      "\n",
      "Казахстан\n",
      "Pr:  0.5874341  rec:  0.5730363  f:  0.58014584\n",
      "\n",
      "Кинематографическая вселенная Marvel\n",
      "Pr:  0.5590769  rec:  0.58138174  f:  0.5700112\n",
      "\n",
      "Кобейн, Курт\n",
      "Pr:  0.5687444  rec:  0.6502178  f:  0.6067583\n",
      "\n",
      "Корейская Народно-Демократическая Республика\n",
      "Pr:  0.5456369  rec:  0.666392  f:  0.59999895\n",
      "\n",
      "Король и Шут\n",
      "Pr:  0.54778886  rec:  0.53852856  f:  0.54311925\n",
      "\n",
      "Кошка\n",
      "Pr:  0.57535297  rec:  0.6194789  f:  0.5966011\n",
      "\n",
      "Криштиану Роналду\n",
      "Pr:  0.635899  rec:  0.6216649  f:  0.62870145\n",
      "\n",
      "Месси, Лионель\n",
      "Pr:  0.60888284  rec:  0.5479647  f:  0.57681984\n",
      "\n",
      "Москва\n",
      "Pr:  0.5491199  rec:  0.59233433  f:  0.5699091\n",
      "\n",
      "НАТО\n",
      "Pr:  0.5884314  rec:  0.65989274  f:  0.6221166\n",
      "\n",
      "Оппенгеймер (фильм)\n",
      "Pr:  0.51097304  rec:  0.6447699  f:  0.57012683\n",
      "\n",
      "Православие\n",
      "Pr:  0.5874517  rec:  0.6567174  f:  0.62015647\n",
      "\n",
      "Русский язык\n",
      "Pr:  0.5937767  rec:  0.67821205  f:  0.63319194\n",
      "\n",
      "Синдром Аспергера\n",
      "Pr:  0.60609126  rec:  0.67272  f:  0.6376699\n",
      "\n",
      "Спартак (футбольный клуб, Москва)\n",
      "Pr:  0.62002796  rec:  0.64673793  f:  0.6331014\n",
      "\n",
      "Сталин, Иосиф Виссарионович\n",
      "Pr:  0.5454168  rec:  0.59507316  f:  0.5691639\n",
      "\n",
      "Су-34\n",
      "Pr:  0.5961873  rec:  0.69437593  f:  0.6415464\n",
      "\n",
      "Су-57\n",
      "Pr:  0.5924722  rec:  0.67765844  f:  0.63220865\n",
      "\n",
      "Тиньков, Олег Юрьевич\n",
      "Pr:  0.57723886  rec:  0.588534  f:  0.5828317\n",
      "\n",
      "Титаник\n",
      "Pr:  0.6457772  rec:  0.66777205  f:  0.65659046\n",
      "\n",
      "Толстой, Лев Николаевич\n",
      "Pr:  0.5759634  rec:  0.5908551  f:  0.5833142\n",
      "\n",
      "Трамп, Дональд\n",
      "Pr:  0.575088  rec:  0.5346495  f:  0.554132\n",
      "\n",
      "Человек разумный\n",
      "Pr:  0.4753537  rec:  0.5363073  f:  0.5039943\n",
      "\n",
      "Шизофрения\n",
      "Pr:  0.47368556  rec:  0.5106444  f:  0.49147114\n",
      "\n",
      "Экономика России\n",
      "Pr:  0.49533856  rec:  0.48249033  f:  0.48883003\n",
      "\n",
      "Time: 2168.15\n",
      "(np.float32(0.57017386), np.float32(0.61350083), np.float32(0.58977133))\n"
     ]
    }
   ],
   "source": [
    "import time\n",
    "start = time.perf_counter()\n",
    "result = await wiki_bench.rank_outline(neighbor_count=0, description_mode=0, mode=1)\n",
    "end = time.perf_counter()\n",
    "c = end - start\n",
    "print(f'Time: {c:.2f}')\n",
    "print(result)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 14,
   "id": "d9710608-8b1d-43bb-8063-8302b2a29e89",
   "metadata": {
    "collapsed": true,
    "jupyter": {
     "outputs_hidden": true
    },
    "scrolled": true
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Atomic Heart\n"
     ]
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "7ede56fe9cd44f488f3bf75c328b3b63",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Split strings:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "205660f414fc45c6ac7dedeb5ceefb26",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Stem Tokens:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "66bb245e726547f5b9bf9f3991306f20",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "BM25S Retrieve:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.9963174275561157\n",
      "0.974025974025974\n",
      "\n",
      "C++\n"
     ]
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "99488490b1a54bed8907e57dcaecb854",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Split strings:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "bdfcd1598fd34a97bee1d550b29f0cde",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Stem Tokens:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "43bfb979b37b484487d5c7c720b3cb6e",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "BM25S Retrieve:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.9289624796425792\n",
      "0.7058823529411765\n",
      "\n",
      "ChatGPT\n"
     ]
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "c244c4a40e784c29913a7b4b3855c873",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Split strings:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "dbe656dcf6f94d119ba8be35b21f8096",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Stem Tokens:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "3ac28ad9e8134e5da03c8b5456e1263f",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "BM25S Retrieve:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.9749272329506908\n",
      "0.875\n",
      "\n",
      "COVID-19\n"
     ]
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "040124fac43d4b278c109b5c7765774a",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Split strings:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "8585faece5654b4e99d0bf96364f7a4e",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Stem Tokens:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "874001191c8a4124b6edb526be89a52e",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "BM25S Retrieve:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.9816250323128797\n",
      "0.9363295880149812\n",
      "\n",
      "Dota 2\n"
     ]
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "78c8453224aa4e2d92dfd9f7c6596f59",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Split strings:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "1780ba7862ff4a3cb723565fd3188c21",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Stem Tokens:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "9703b2b840844585bf687166285a9f40",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "BM25S Retrieve:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.9818730461137587\n",
      "0.948051948051948\n",
      "\n",
      "F-35\n"
     ]
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "d4476afad10045fb93d9e736e3d27ff5",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Split strings:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "3a1c240b39a445c28f67dec1add543e4",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Stem Tokens:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "aa80d37a56294bbba813f1cb6abe01f7",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "BM25S Retrieve:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.9984708357186366\n",
      "0.9841269841269841\n",
      "\n",
      "Google (компания)\n"
     ]
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "13f6f582b3a1473581e8096b7bdbc8e2",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Split strings:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "4f557d5fc7ed494e81dfd4e298b25e34",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Stem Tokens:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "fce6509417b045d88f30082256b31a5d",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "BM25S Retrieve:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.8652972577544251\n",
      "0.703125\n",
      "\n",
      "Minecraft\n"
     ]
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "538f21fea68a4ea4b0f0056ba9db9a3e",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Split strings:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "ea9f685d5f5a4cc3816c5811eb811dbd",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Stem Tokens:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "4db16dbe76514e5cacc3fd23d6350420",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "BM25S Retrieve:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.990700890224218\n",
      "0.9111111111111111\n",
      "\n",
      "Ozon\n"
     ]
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "88262ab1820c438688b03822c0138cbd",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Split strings:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "075b912dd11042b694cc3fa2059e64ce",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Stem Tokens:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "0bc6ba8314884dfda55342d406e58e98",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "BM25S Retrieve:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.9650996602252427\n",
      "0.8269230769230769\n",
      "\n",
      "Portal 2\n"
     ]
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "6a8fe41846ef4c4f99577b65e33526a6",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Split strings:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "6390438658764961969eac6541290644",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Stem Tokens:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "4a9a4cefa7494131b84f83bd3a76d32b",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "BM25S Retrieve:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.9910069131600674\n",
      "0.9354838709677419\n",
      "\n",
      "Python\n"
     ]
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "08fb3271b20546308221942129e76924",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Split strings:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "d6665b2ba2be43948f421c7216242990",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Stem Tokens:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "21362e8866684bf1ae9ae6526bae2453",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "BM25S Retrieve:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.9874676066692476\n",
      "0.9307228915662651\n",
      "\n",
      "TikTok\n"
     ]
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "b8a973c94a6b41d88c8681cc7346bcf6",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Split strings:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "c73b2027c5634b9096fe517ac69d9f44",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Stem Tokens:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "419a7f847d42468c97d38dd930d88ebd",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "BM25S Retrieve:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.9950427100259902\n",
      "0.968421052631579\n",
      "\n",
      "Tomb Raider (игра, 2013)\n"
     ]
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "05d2f84a2f4845ae803817a6dea4470c",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Split strings:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "f689b775c217429eb6a13fcb794f5d2c",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Stem Tokens:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "27ea9d34d67740cbab78a99809a5f405",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "BM25S Retrieve:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.9872479457292502\n",
      "0.8976377952755905\n",
      "\n",
      "Uncharted 4 A Thief’s End\n"
     ]
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "ae0e991e7a764075b54effb16c013671",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Split strings:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "ee721b7bc3b54a5f9674e1d8d40ab0d7",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Stem Tokens:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "5b9fd17b61de4a189a2b1b47759bce22",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "BM25S Retrieve:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.997586529141267\n",
      "0.9833333333333333\n",
      "\n",
      "Wildberries\n"
     ]
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "9324c5e258b94c0f9127fddeea3bdd62",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Split strings:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "058e574138ed472ea074653af992917d",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Stem Tokens:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "a448fc6279d14d87b660166ae0d51b0b",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "BM25S Retrieve:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.9710315334591968\n",
      "0.9125\n",
      "\n",
      "YouTube\n"
     ]
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "ae05997c2a81469bbfb89d9477aed605",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Split strings:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "808b4ade37bd4b20ba20e1106f4ee4ab",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Stem Tokens:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "19e438b31b0c49558bb8118bbced807b",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "BM25S Retrieve:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.9795814002940935\n",
      "0.8571428571428571\n",
      "\n",
      "Биткойн\n"
     ]
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "a80a95408d8244269945280086534883",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Split strings:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "40b9698e95a54134af7cdf003039aa24",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Stem Tokens:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "cb2bfce77b7d489ab5acc955cb4d5b32",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "BM25S Retrieve:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.9935906372484911\n",
      "0.9649122807017544\n",
      "\n",
      "Большой адронный коллайдер\n"
     ]
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "242ae4dee50b439bb8606fc1f0e6db72",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Split strings:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "4cfb8ecc0ece45a797988f52682671d1",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Stem Tokens:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "af1d51eff1784e69aaafcdb42aaca09e",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "BM25S Retrieve:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.9700987473867152\n",
      "0.8518518518518519\n",
      "\n",
      "Википедия\n"
     ]
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "6539ece667ea4f128aa20f33b519bc0e",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Split strings:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "b20ca5163df54adc88fbff5a272351dd",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Stem Tokens:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "bcf09f0fa03d402c918f06bf1cb03251",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "BM25S Retrieve:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.9996806582748496\n",
      "0.9765625\n",
      "\n",
      "Вирус иммунодефицита человека\n"
     ]
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "212f952978e54b0cb7b619cd311daa98",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Split strings:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "5c096dd720d84414a33685a1b49f7526",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Stem Tokens:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "40e7193ea67e4503a858314ed47e4284",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "BM25S Retrieve:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.9985071437534239\n",
      "0.9855072463768116\n",
      "\n",
      "ВКонтакте\n"
     ]
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "ecd53adb86cf4be38d970735d23f5ca3",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Split strings:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "0c38484061f64cda85f0199a0823c529",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Stem Tokens:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "52dcff5f66084becaae5e12fdf4ea0bd",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "BM25S Retrieve:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.9854687396202032\n",
      "0.917910447761194\n",
      "\n",
      "Геморрагическая лихорадка Эбола\n"
     ]
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "9674ffd1cb75491d8dce3fc156a0fed0",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Split strings:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "54e4379025c747b9afa567fcf63e618d",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Stem Tokens:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "c84d97d747de42a9a6a96f9f525bd6c1",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "BM25S Retrieve:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "1.0\n",
      "1.0\n",
      "\n",
      "Гибель тургруппы Дятлова\n"
     ]
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "00a3aec23beb439d878f0e7c22bf68a7",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Split strings:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "f1602c4296474a3fb5aa7cd63c095358",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Stem Tokens:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "a441b696d9434aa8b11313770b689c31",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "BM25S Retrieve:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.9973356541740162\n",
      "0.9734513274336283\n",
      "\n",
      "Государство Палестина\n"
     ]
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "cb3ac6b8a3914fa1aed03349f495ed3b",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Split strings:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "f40a023970464e7e850ce279dd79f816",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Stem Tokens:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "95282ba86f58469db428badcb154c521",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "BM25S Retrieve:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.952516897426303\n",
      "0.7435897435897436\n",
      "\n",
      "Джобс, Стив\n"
     ]
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "b0b489e46244477aaf878c76abdf8638",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Split strings:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "d250dde85629462f915db154a27d26d0",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Stem Tokens:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "a37ce55ae24646f89a0065a97c4a4736",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "BM25S Retrieve:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.9944920467703038\n",
      "0.9090909090909091\n",
      "\n",
      "Ди Каприо, Леонардо\n"
     ]
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "a09596e58f924175b1295be18a6f75c0",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Split strings:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "5af51180b1934eb8b5ef0a82dbeaa4e2",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Stem Tokens:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "4fcb1b9934314ed480e8e7668e64a840",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "BM25S Retrieve:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.8974844182864891\n",
      "0.8387096774193549\n",
      "\n",
      "Иннополис\n"
     ]
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "db95e50fb009426b86f160f195ea6001",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Split strings:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "fe4fab2a48884136905eb49e3b09bdac",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Stem Tokens:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "5fa08be4aaf7408fa6fe23a895f4144a",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "BM25S Retrieve:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.9961623988063613\n",
      "0.9583333333333334\n",
      "\n",
      "Искусственный интеллект\n"
     ]
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "17283f66725940419fd9b15de04ed669",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Split strings:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "bcd95f07dc3140b8864cd9465d489e7b",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Stem Tokens:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "f601329bbdfc453c993687aa5d1a7d3c",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "BM25S Retrieve:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.7446893357892203\n",
      "0.3956043956043956\n",
      "\n",
      "Квантовый компьютер\n"
     ]
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "6d1a693b36f84c9ea71ed5a4b0b687e7",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Split strings:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "e75eeb324cce46b5a57a111383a8dd5c",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Stem Tokens:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "b1ec4170c004411198d99332d428e98a",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "BM25S Retrieve:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.9998716617061232\n",
      "0.972972972972973\n",
      "\n",
      "Китай\n"
     ]
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "1b04ab6200ba46688b73876144549861",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Split strings:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "b73361f57f2c47a8a358611e95aab9bc",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Stem Tokens:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "ac98f539062143db944562340b6f23b3",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "BM25S Retrieve:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.7364653096445671\n",
      "0.2826086956521739\n",
      "\n",
      "Летние Олимпийские игры 2020\n"
     ]
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "4b78ad1ebad1486c99ae4fac38bbe650",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Split strings:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "425812ff35a84d3d8f0babcf23c13acf",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Stem Tokens:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "31a64af9c41043e4806a90e455916f27",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "BM25S Retrieve:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.926460943574869\n",
      "0.7777777777777778\n",
      "\n",
      "Летние Олимпийские игры 2024\n"
     ]
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "8a8dac921f8f4cbdb0a232ddf4150ef7",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Split strings:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "a27a3c549e954daa86405e0ec63aa557",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Stem Tokens:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "fb16e97dddee4381a6ae64ff647a06aa",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "BM25S Retrieve:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.9998260976664642\n",
      "0.9772727272727273\n",
      "\n",
      "Марс\n"
     ]
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "69caa3c43fe04284ad995e58559e316a",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Split strings:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "46ba10248bdd486aa720edced559b0ad",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Stem Tokens:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "d7b4744cfe9446f3b022d6dc4892f95e",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "BM25S Retrieve:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.958817459069413\n",
      "0.7731958762886598\n",
      "\n",
      "Маск, Илон\n"
     ]
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "e29223a13141421fa2612c0c7716ef85",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Split strings:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "909c2f97077d401ba92f8be0297e9155",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Stem Tokens:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "33ce177c4f9b4b498ae5fd31404f9d2a",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "BM25S Retrieve:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.9702215305810792\n",
      "0.8888888888888888\n",
      "\n",
      "Миядзаки, Хаяо\n"
     ]
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "37edfd846a4f4b9daea9dcccac60aa0e",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Split strings:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "57ee38143ae140a38bd2b725d012f4d7",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Stem Tokens:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "0e32994b1f7a40e4a10a898626647bb2",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "BM25S Retrieve:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "1.0\n",
      "1.0\n",
      "\n",
      "Московский метрополитен\n"
     ]
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "732ffd2a688b4a3495e6f9e74affe9a4",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Split strings:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "cad05eea8afb48afb1ea453c0aa97a9f",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Stem Tokens:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "29aa59dca4fa4f68ac365bc4b4cffff7",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "BM25S Retrieve:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.995878402852648\n",
      "0.9571428571428572\n",
      "\n",
      "Применение искусственного интеллекта\n"
     ]
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "590f7b3af23d47e9a14f8ca200c9c51f",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Split strings:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "c415f1d7b35b40598314597272b79055",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Stem Tokens:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "c2f1fe7e1db84b3d80502323b78c3eff",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "BM25S Retrieve:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.6504924859296347\n",
      "0.08256880733944955\n",
      "\n",
      "Присоединение Крыма к Российской Федерации\n"
     ]
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "0de7eb05a56147ba9f9caaa57da0401d",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Split strings:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "a274346888184687a858fc9e9073d50e",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Stem Tokens:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "ba732fdc798d4b19b1215514c9160e6a",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "BM25S Retrieve:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.9851547894813546\n",
      "0.8163265306122449\n",
      "\n",
      "РИА Новости\n"
     ]
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "6bbec36b666743a5bd1c4b56e666edbe",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Split strings:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "ec7afc97aeec49f79eeccc76ea023557",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Stem Tokens:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "b02e739985194a4488aee3a0732aa137",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "BM25S Retrieve:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.9771184896812136\n",
      "0.8823529411764706\n",
      "\n",
      "Сбербанк России\n"
     ]
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "a91f7960c02c453e9ad9b9e7d413bbff",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Split strings:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "a5d4587f6d944745a37a1cadd48bf8d0",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Stem Tokens:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "8c87b962ac144905bc86f13ad5bd78ec",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "BM25S Retrieve:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.9814615136455536\n",
      "0.9090909090909091\n",
      "\n",
      "Си (язык программирования)\n"
     ]
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "c1deb4e91b824fadb8bb28e805d1b6d4",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Split strings:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "5a3d7b28d0dc4c7b9318c9d2abda87e9",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Stem Tokens:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "cbac43ff328a4b128a55bac938fc7cb3",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "BM25S Retrieve:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.7213732554897238\n",
      "0.3191489361702128\n",
      "\n",
      "Сколково (инновационный центр)\n"
     ]
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "37a7f85f8d55463c8363ed3ceee3d9fc",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Split strings:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "6c9ec829e1504d88a9ec38f61ed858ca",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Stem Tokens:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "2cd0f411c47849c1927b643874182bf4",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "BM25S Retrieve:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.9879261471528216\n",
      "0.8955823293172691\n",
      "\n",
      "Солнечная система\n"
     ]
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "8baa1463a31042b498f5e60622bf5c61",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Split strings:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "cc6a979789f843edb1ec5df096a222b1",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Stem Tokens:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "6c48fe8bc1ef498dae555ab590f673d0",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "BM25S Retrieve:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.9118219823663939\n",
      "0.6666666666666666\n",
      "\n",
      "Тарантино, Квентин\n"
     ]
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "ab4bd2b5da5544f3b9e2aaf31883776d",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Split strings:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "d80e9ce63b34443fba0cf716a920b64d",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Stem Tokens:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "ee42618529824547a7e59d49dcbcafa0",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "BM25S Retrieve:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.99031134270381\n",
      "0.9411764705882353\n",
      "\n",
      "Цой, Виктор Робертович\n"
     ]
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "401b7d872e744bc0ae71884e26f0283d",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Split strings:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "b7c3af31a16c4020818dec0ac5a7c98b",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Stem Tokens:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "a47340bb18ca407abf980952ed553c8b",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "BM25S Retrieve:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "1.0\n",
      "1.0\n",
      "\n",
      "Чёрная дыра\n"
     ]
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "27ebd65d770a4eaca21d0865970a89df",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Split strings:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "3193874dc64c4ff99115a2bd2782eef0",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Stem Tokens:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "e697b4380faa4c25a6b36c1ab76625ba",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "BM25S Retrieve:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.9894511953646807\n",
      "0.9304347826086956\n",
      "\n",
      "Чёрная смерть\n"
     ]
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "e1df16312ad5461f99fc7bbc334cd36c",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Split strings:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "dd943fbf398c4f548df8d6b54708c93b",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Stem Tokens:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "061a36e1e0fc4b679018e67cb2d8d01f",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "BM25S Retrieve:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.9948198582459946\n",
      "0.9428571428571428\n",
      "\n",
      "Экономика КНР\n"
     ]
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "95e7e3012f1c4891a4efcd6101c13a63",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Split strings:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "ba34d34e0cc943729d0e42862b39fec6",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Stem Tokens:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "24372872b16746968fc0c97fd2a67f82",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "BM25S Retrieve:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.8832796387637413\n",
      "0.7117117117117117\n",
      "\n",
      "Экономика США\n"
     ]
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "d2752b46816642029653f21fd880b9e1",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Split strings:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "01eb271ca4b244048779b3dae63940c0",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Stem Tokens:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "1ec332d417ad47358f3e7ada94bf9352",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "BM25S Retrieve:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.8857661464921592\n",
      "0.7272727272727273\n",
      "\n",
      "Яндекс\n"
     ]
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "07427a891a94447abc50bcd63290e9f8",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Split strings:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "ed9531a674894d079b16400f594795fb",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Stem Tokens:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "70b91917e4c04b21b59bcdef275a44f8",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "BM25S Retrieve:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.8961580615783751\n",
      "0.8709677419354839\n",
      "\n",
      "Time: 8859.52\n",
      "0.9512988298100931 0.8438271808523774\n"
     ]
    }
   ],
   "source": [
    "import time\n",
    "start = time.perf_counter()\n",
    "ndcg, pr = await wiki_bench.rank_query(reference_mode=0)\n",
    "end = time.perf_counter()\n",
    "c = end - start\n",
    "print(f'Time: {c:.2f}')\n",
    "print(ndcg, pr)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 12,
   "id": "8de7e184-f12e-4b67-9bcc-f35345292d8b",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "(0.6237 | 0.6361 | 0.6296)\n"
     ]
    }
   ],
   "source": [
    "import numpy as np\n",
    "from scipy.stats import bootstrap\n",
    "\n",
    "def calc(data):\n",
    "  data = np.array(data)\n",
    "  data1 = (data,)\n",
    "  bootstrap_ci = bootstrap(data1, np.mean, confidence_level=0.95, n_resamples=len(data)-1)\n",
    "\n",
    "  dist = bootstrap_ci.bootstrap_distribution\n",
    "  mean = np.quantile(dist, q=0.5)\n",
    "  min = np.quantile(dist, q=0.025)\n",
    "  max = np.quantile(dist, q=0.975)\n",
    "  return mean\n",
    "\n",
    "\n",
    "a = calc([e[0] for e in wiki_bench.outline_logger])\n",
    "b = calc([e[1] for e in wiki_bench.outline_logger])\n",
    "c = calc([e[2] for e in wiki_bench.outline_logger])\n",
    "print(f'({a:.4f} | {b:.4f} | {c:.4f})')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 15,
   "id": "d64281de-3452-465f-b9ea-312074a39116",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "[(0.9963174275561157, 0.974025974025974), (0.9289624796425792, 0.7058823529411765), (0.9749272329506908, 0.875), (0.9816250323128797, 0.9363295880149812), (0.9818730461137587, 0.948051948051948), (0.9984708357186366, 0.9841269841269841), (0.8652972577544251, 0.703125), (0.990700890224218, 0.9111111111111111), (0.9650996602252427, 0.8269230769230769), (0.9910069131600674, 0.9354838709677419), (0.9874676066692476, 0.9307228915662651), (0.9950427100259902, 0.968421052631579), (0.9872479457292502, 0.8976377952755905), (0.997586529141267, 0.9833333333333333), (0.9710315334591968, 0.9125), (0.9795814002940935, 0.8571428571428571), (0.9935906372484911, 0.9649122807017544), (0.9700987473867152, 0.8518518518518519), (0.9996806582748496, 0.9765625), (0.9985071437534239, 0.9855072463768116), (0.9854687396202032, 0.917910447761194), (1.0, 1.0), (0.9973356541740162, 0.9734513274336283), (0.952516897426303, 0.7435897435897436), (0.9944920467703038, 0.9090909090909091), (0.8974844182864891, 0.8387096774193549), (0.9961623988063613, 0.9583333333333334), (0.7446893357892203, 0.3956043956043956), (0.9998716617061232, 0.972972972972973), (0.7364653096445671, 0.2826086956521739), (0.926460943574869, 0.7777777777777778), (0.9998260976664642, 0.9772727272727273), (0.958817459069413, 0.7731958762886598), (0.9702215305810792, 0.8888888888888888), (1.0, 1.0), (0.995878402852648, 0.9571428571428572), (0.6504924859296347, 0.08256880733944955), (0.9851547894813546, 0.8163265306122449), (0.9771184896812136, 0.8823529411764706), (0.9814615136455536, 0.9090909090909091), (0.7213732554897238, 0.3191489361702128), (0.9879261471528216, 0.8955823293172691), (0.9118219823663939, 0.6666666666666666), (0.99031134270381, 0.9411764705882353), (1.0, 1.0), (0.9894511953646807, 0.9304347826086956), (0.9948198582459946, 0.9428571428571428), (0.8832796387637413, 0.7117117117117117), (0.8857661464921592, 0.7272727272727273), (0.8961580615783751, 0.8709677419354839)]\n"
     ]
    }
   ],
   "source": [
    "print(wiki_bench.query_logger) llama"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "id": "fa485150-1867-4d1f-a2ea-ca176a6d3fed",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "[(0.5656972713013262, 0.0), (0.3943539296713097, 0.0), (0.5606575569833653, 0.0), (0.6483257626076875, 0.0), (0.5748521668398856, 0.0), (0.6218165217680183, 0.0), (0.5368557392005809, 0.0), (0.6518459460291792, 0.0), (0.5486949677639532, 0.0), (0.690153224536271, 0.4406779661016949), (0.669616045000168, 0.0), (0.6102721027197149, 0.0), (0.680970700179225, 0.046875), (0.8110243546565725, 0.8461538461538461), (0.5849348668556209, 0.0), (0.5181256685546736, 0.0), (0.5765043671183413, 0.0), (0.517597072255351, 0.0), (0.6659730327652575, 0.0), (0.6166996047390203, 0.0), (0.5794060709012883, 0.0), (0.7198405481048984, 0.5588235294117647), (0.6283385352879146, 0.0), (0.5897118247784883, 0.0), (0.5903933433281082, 0.0), (0.5213026465185885, 0.0), (0.49895512969560274, 0.0), (0.5831727484362424, 0.0), (0.5602411810983554, 0.0), (0.5301395871774374, 0.0), (0.3976397966388224, 0.0), (0.6862017146434516, 0.4888888888888889), (0.5904882076081911, 0.0), (0.712002249155139, 0.1875), (0.6295009027818103, 0.14285714285714285), (0.663363131700511, 0.0), (0.7033466596521825, 0.25984251968503935), (0.6150481730779539, 0.0), (0.6354037656443222, 0.19047619047619047), (0.6665821553122216, 0.05102040816326531), (0.527954081999118, 0.0), (0.8081570432842523, 0.7136563876651982), (0.6754438052209528, 0.21686746987951808), (0.7405493135816388, 0.65625), (0.8121541833498936, 0.84), (0.776439293924629, 0.7027027027027027), (0.8239062651727813, 0.8411214953271028), (0.8395135712874007, 0.8715596330275229), (0.8328978515038054, 0.8888888888888888), (1.0, 1.0)]\n"
     ]
    }
   ],
   "source": [
    "print(wiki_bench.query_logger) квен235млрд"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 18,
   "id": "1d20ea86-e25e-4f8d-a33b-831bc458bdfa",
   "metadata": {
    "collapsed": true,
    "jupyter": {
     "outputs_hidden": true
    },
    "scrolled": true
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Atomic Heart\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Default prompt name is set to 'Classification'. This prompt will be applied to all `encode()` calls, except if `encode()` is called with `prompt` or `prompt_name` parameters.\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "ChatGPT\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Default prompt name is set to 'Classification'. This prompt will be applied to all `encode()` calls, except if `encode()` is called with `prompt` or `prompt_name` parameters.\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "F-35\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Default prompt name is set to 'Classification'. This prompt will be applied to all `encode()` calls, except if `encode()` is called with `prompt` or `prompt_name` parameters.\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Minecraft\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Default prompt name is set to 'Classification'. This prompt will be applied to all `encode()` calls, except if `encode()` is called with `prompt` or `prompt_name` parameters.\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Биткойн\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Default prompt name is set to 'Classification'. This prompt will be applied to all `encode()` calls, except if `encode()` is called with `prompt` or `prompt_name` parameters.\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Википедия\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Default prompt name is set to 'Classification'. This prompt will be applied to all `encode()` calls, except if `encode()` is called with `prompt` or `prompt_name` parameters.\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "ВКонтакте\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Default prompt name is set to 'Classification'. This prompt will be applied to all `encode()` calls, except if `encode()` is called with `prompt` or `prompt_name` parameters.\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Гибель тургруппы Дятлова\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Default prompt name is set to 'Classification'. This prompt will be applied to all `encode()` calls, except if `encode()` is called with `prompt` or `prompt_name` parameters.\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Государство Палестина\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Default prompt name is set to 'Classification'. This prompt will be applied to all `encode()` calls, except if `encode()` is called with `prompt` or `prompt_name` parameters.\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Китай\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Default prompt name is set to 'Classification'. This prompt will be applied to all `encode()` calls, except if `encode()` is called with `prompt` or `prompt_name` parameters.\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Московский метрополитен\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Default prompt name is set to 'Classification'. This prompt will be applied to all `encode()` calls, except if `encode()` is called with `prompt` or `prompt_name` parameters.\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Тарантино, Квентин\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Default prompt name is set to 'Classification'. This prompt will be applied to all `encode()` calls, except if `encode()` is called with `prompt` or `prompt_name` parameters.\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Ozon\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Default prompt name is set to 'Classification'. This prompt will be applied to all `encode()` calls, except if `encode()` is called with `prompt` or `prompt_name` parameters.\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Wildberries\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Default prompt name is set to 'Classification'. This prompt will be applied to all `encode()` calls, except if `encode()` is called with `prompt` or `prompt_name` parameters.\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Ди Каприо, Леонардо\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Default prompt name is set to 'Classification'. This prompt will be applied to all `encode()` calls, except if `encode()` is called with `prompt` or `prompt_name` parameters.\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Джобс, Стив\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Default prompt name is set to 'Classification'. This prompt will be applied to all `encode()` calls, except if `encode()` is called with `prompt` or `prompt_name` parameters.\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Маск, Илон\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Default prompt name is set to 'Classification'. This prompt will be applied to all `encode()` calls, except if `encode()` is called with `prompt` or `prompt_name` parameters.\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Цой, Виктор Робертович\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Default prompt name is set to 'Classification'. This prompt will be applied to all `encode()` calls, except if `encode()` is called with `prompt` or `prompt_name` parameters.\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Миядзаки, Хаяо\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Default prompt name is set to 'Classification'. This prompt will be applied to all `encode()` calls, except if `encode()` is called with `prompt` or `prompt_name` parameters.\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Python\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Default prompt name is set to 'Classification'. This prompt will be applied to all `encode()` calls, except if `encode()` is called with `prompt` or `prompt_name` parameters.\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Летние Олимпийские игры 2024\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Default prompt name is set to 'Classification'. This prompt will be applied to all `encode()` calls, except if `encode()` is called with `prompt` or `prompt_name` parameters.\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Квантовый компьютер\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Default prompt name is set to 'Classification'. This prompt will be applied to all `encode()` calls, except if `encode()` is called with `prompt` or `prompt_name` parameters.\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Присоединение Крыма к Российской Федерации\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Default prompt name is set to 'Classification'. This prompt will be applied to all `encode()` calls, except if `encode()` is called with `prompt` or `prompt_name` parameters.\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Сколково (инновационный центр)\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Default prompt name is set to 'Classification'. This prompt will be applied to all `encode()` calls, except if `encode()` is called with `prompt` or `prompt_name` parameters.\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Tomb Raider (игра, 2013)\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Default prompt name is set to 'Classification'. This prompt will be applied to all `encode()` calls, except if `encode()` is called with `prompt` or `prompt_name` parameters.\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Чёрная дыра\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Default prompt name is set to 'Classification'. This prompt will be applied to all `encode()` calls, except if `encode()` is called with `prompt` or `prompt_name` parameters.\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Экономика США\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Default prompt name is set to 'Classification'. This prompt will be applied to all `encode()` calls, except if `encode()` is called with `prompt` or `prompt_name` parameters.\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Искусственный интеллект\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Default prompt name is set to 'Classification'. This prompt will be applied to all `encode()` calls, except if `encode()` is called with `prompt` or `prompt_name` parameters.\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "COVID-19\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Default prompt name is set to 'Classification'. This prompt will be applied to all `encode()` calls, except if `encode()` is called with `prompt` or `prompt_name` parameters.\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Применение искусственного интеллекта\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Default prompt name is set to 'Classification'. This prompt will be applied to all `encode()` calls, except if `encode()` is called with `prompt` or `prompt_name` parameters.\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "РИА Новости\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Default prompt name is set to 'Classification'. This prompt will be applied to all `encode()` calls, except if `encode()` is called with `prompt` or `prompt_name` parameters.\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Uncharted 4: A Thief’s End\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Default prompt name is set to 'Classification'. This prompt will be applied to all `encode()` calls, except if `encode()` is called with `prompt` or `prompt_name` parameters.\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Экономика КНР\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Default prompt name is set to 'Classification'. This prompt will be applied to all `encode()` calls, except if `encode()` is called with `prompt` or `prompt_name` parameters.\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Иннополис\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Default prompt name is set to 'Classification'. This prompt will be applied to all `encode()` calls, except if `encode()` is called with `prompt` or `prompt_name` parameters.\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Летние Олимпийские игры 2020\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Default prompt name is set to 'Classification'. This prompt will be applied to all `encode()` calls, except if `encode()` is called with `prompt` or `prompt_name` parameters.\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Солнечная система\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Default prompt name is set to 'Classification'. This prompt will be applied to all `encode()` calls, except if `encode()` is called with `prompt` or `prompt_name` parameters.\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "C++\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Default prompt name is set to 'Classification'. This prompt will be applied to all `encode()` calls, except if `encode()` is called with `prompt` or `prompt_name` parameters.\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Си (язык программирования)\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Default prompt name is set to 'Classification'. This prompt will be applied to all `encode()` calls, except if `encode()` is called with `prompt` or `prompt_name` parameters.\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Сбербанк России\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Default prompt name is set to 'Classification'. This prompt will be applied to all `encode()` calls, except if `encode()` is called with `prompt` or `prompt_name` parameters.\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Чёрная смерть\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Default prompt name is set to 'Classification'. This prompt will be applied to all `encode()` calls, except if `encode()` is called with `prompt` or `prompt_name` parameters.\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Яндекс\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Default prompt name is set to 'Classification'. This prompt will be applied to all `encode()` calls, except if `encode()` is called with `prompt` or `prompt_name` parameters.\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Google (компания)\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Default prompt name is set to 'Classification'. This prompt will be applied to all `encode()` calls, except if `encode()` is called with `prompt` or `prompt_name` parameters.\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Большой адронный коллайдер\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Default prompt name is set to 'Classification'. This prompt will be applied to all `encode()` calls, except if `encode()` is called with `prompt` or `prompt_name` parameters.\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Геморрагическая лихорадка Эбола\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Default prompt name is set to 'Classification'. This prompt will be applied to all `encode()` calls, except if `encode()` is called with `prompt` or `prompt_name` parameters.\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Вирус иммунодефицита человека\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Default prompt name is set to 'Classification'. This prompt will be applied to all `encode()` calls, except if `encode()` is called with `prompt` or `prompt_name` parameters.\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Dota 2\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Default prompt name is set to 'Classification'. This prompt will be applied to all `encode()` calls, except if `encode()` is called with `prompt` or `prompt_name` parameters.\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "TikTok\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Default prompt name is set to 'Classification'. This prompt will be applied to all `encode()` calls, except if `encode()` is called with `prompt` or `prompt_name` parameters.\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Марс\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Default prompt name is set to 'Classification'. This prompt will be applied to all `encode()` calls, except if `encode()` is called with `prompt` or `prompt_name` parameters.\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "YouTube\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Default prompt name is set to 'Classification'. This prompt will be applied to all `encode()` calls, except if `encode()` is called with `prompt` or `prompt_name` parameters.\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Portal 2\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Default prompt name is set to 'Classification'. This prompt will be applied to all `encode()` calls, except if `encode()` is called with `prompt` or `prompt_name` parameters.\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Time: 3329.91\n"
     ]
    }
   ],
   "source": [
    "import time\n",
    "start = time.perf_counter()\n",
    "await wiki_bench.rank_sections()\n",
    "end = time.perf_counter()\n",
    "c = end - start\n",
    "print(f'Time: {c:.2f}')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 20,
   "id": "e340b352-5dfd-4457-aff7-5dd73638c267",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "(0.5138 | 0.5298 | 0.5150)\n",
      "(0.4984 | 0.5310)\n",
      "(0.5156 | 0.5442)\n",
      "(0.5015 | 0.5308)\n"
     ]
    }
   ],
   "source": [
    "import time\n",
    "import numpy as np\n",
    "from scipy.stats import bootstrap\n",
    "\n",
    "def calc(data):\n",
    "  data = np.array(data)\n",
    "  data1 = (data,)\n",
    "  bootstrap_ci = bootstrap(data1, np.mean, confidence_level=0.95, n_resamples=len(data)-1)\n",
    "\n",
    "  dist = bootstrap_ci.bootstrap_distribution\n",
    "  mean = np.quantile(dist, q=0.5)\n",
    "  min = np.quantile(dist, q=0.025)\n",
    "  max = np.quantile(dist, q=0.975)\n",
    "  return mean, min, max\n",
    "\n",
    "a, a1, a2 = calc([e[0] for el in wiki_bench.article_gen_logger for e in el])\n",
    "b, b1, b2 = calc([e[1] for el in wiki_bench.article_gen_logger for e in el])\n",
    "c, c1, c2 = calc([e[2] for el in wiki_bench.article_gen_logger for e in el])\n",
    "print(f'({a:.4f} | {b:.4f} | {c:.4f})')\n",
    "print(f'({a1:.4f} | {a2:.4f})')\n",
    "print(f'({b1:.4f} | {b2:.4f})')\n",
    "print(f'({c1:.4f} | {c2:.4f})')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "id": "6c8f5c93-d7c0-4ddc-83a5-e7039977ce78",
   "metadata": {
    "collapsed": true,
    "jupyter": {
     "outputs_hidden": true
    },
    "scrolled": true
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Atomic Heart\n",
      "Pr:  0.72078794  rec:  0.7229626  f:  0.7218736\n",
      "\n",
      "ChatGPT\n",
      "Pr:  0.5193508  rec:  0.58340645  f:  0.5495183\n",
      "\n",
      "F-35\n",
      "Pr:  0.6516419  rec:  0.6729317  f:  0.66211575\n",
      "\n",
      "Minecraft\n",
      "Pr:  0.6154292  rec:  0.64729583  f:  0.6309604\n",
      "\n",
      "Биткойн\n",
      "Pr:  0.67713475  rec:  0.66179144  f:  0.6693752\n",
      "\n",
      "Википедия\n",
      "Pr:  0.6493344  rec:  0.7014181  f:  0.6743721\n",
      "\n",
      "ВКонтакте\n",
      "Pr:  0.65297484  rec:  0.66216516  f:  0.6575379\n",
      "\n",
      "Гибель тургруппы Дятлова\n",
      "Pr:  0.60104656  rec:  0.600629  f:  0.6008377\n",
      "\n",
      "Государство Палестина\n",
      "Pr:  0.55620205  rec:  0.68952614  f:  0.6157296\n",
      "\n",
      "Китай\n",
      "Pr:  0.6628437  rec:  0.602231  f:  0.6310853\n",
      "\n",
      "Московский метрополитен\n",
      "Pr:  0.69711703  rec:  0.6902592  f:  0.69367117\n",
      "\n",
      "Тарантино, Квентин\n",
      "Pr:  0.6212416  rec:  0.6676612  f:  0.64361554\n",
      "\n",
      "Ozon\n",
      "Pr:  0.60262746  rec:  0.6537985  f:  0.627171\n",
      "\n",
      "Wildberries\n",
      "Pr:  0.49289763  rec:  0.4918926  f:  0.49239463\n",
      "\n",
      "Ди Каприо, Леонардо\n",
      "Pr:  0.6375333  rec:  0.6872895  f:  0.661477\n",
      "\n",
      "Джобс, Стив\n",
      "Pr:  0.5930287  rec:  0.6158986  f:  0.60424733\n",
      "\n",
      "Маск, Илон\n",
      "Pr:  0.58168656  rec:  0.5958249  f:  0.58867085\n",
      "\n",
      "Цой, Виктор Робертович\n",
      "Pr:  0.58852285  rec:  0.7804945  f:  0.67104894\n",
      "\n",
      "Миядзаки, Хаяо\n",
      "Pr:  0.5922089  rec:  0.66610664  f:  0.6269879\n",
      "\n",
      "Python\n",
      "Pr:  0.6947929  rec:  0.7160555  f:  0.70526403\n",
      "\n",
      "Летние Олимпийские игры 2024\n",
      "Pr:  0.61753935  rec:  0.6403741  f:  0.6287495\n",
      "\n",
      "Квантовый компьютер\n",
      "Pr:  0.6918975  rec:  0.71818274  f:  0.7047952\n",
      "\n",
      "Присоединение Крыма к Российской Федерации\n",
      "Pr:  0.55944234  rec:  0.71721077  f:  0.6285781\n",
      "\n",
      "Сколково (инновационный центр)\n",
      "Pr:  0.6948496  rec:  0.6558099  f:  0.6747655\n",
      "\n",
      "Tomb Raider (игра, 2013)\n",
      "Pr:  0.6453185  rec:  0.6693916  f:  0.6571346\n",
      "\n",
      "Чёрная дыра\n",
      "Pr:  0.6779835  rec:  0.7350193  f:  0.7053503\n",
      "\n",
      "Экономика США\n",
      "Pr:  0.4890379  rec:  0.5970778  f:  0.53768426\n",
      "\n",
      "Искусственный интеллект\n",
      "Pr:  0.66125  rec:  0.6980655  f:  0.6791592\n",
      "\n",
      "COVID-19\n",
      "Pr:  0.7268343  rec:  0.74390525  f:  0.7352707\n",
      "\n",
      "Применение искусственного интеллекта\n",
      "Pr:  0.47194296  rec:  0.5128915  f:  0.4915659\n",
      "\n",
      "РИА Новости\n",
      "Pr:  0.60608846  rec:  0.60566574  f:  0.605877\n",
      "\n",
      "Uncharted 4: A Thief’s End\n",
      "Pr:  0.6108927  rec:  0.7692986  f:  0.6810055\n",
      "\n",
      "Экономика КНР\n",
      "Pr:  0.5532788  rec:  0.5227558  f:  0.5375844\n",
      "\n",
      "Иннополис\n",
      "Pr:  0.56273335  rec:  0.6402028  f:  0.5989735\n",
      "\n",
      "Летние Олимпийские игры 2020\n",
      "Pr:  0.5078993  rec:  0.6301411  f:  0.562455\n",
      "\n",
      "Солнечная система\n",
      "Pr:  0.6461919  rec:  0.66969275  f:  0.6577325\n",
      "\n",
      "C++\n",
      "Pr:  0.612692  rec:  0.6580261  f:  0.6345504\n",
      "\n",
      "Си (язык программирования)\n",
      "Pr:  0.6768038  rec:  0.7115656  f:  0.69374955\n",
      "\n",
      "Сбербанк России\n",
      "Pr:  0.48891094  rec:  0.5345605  f:  0.5107177\n",
      "\n",
      "Чёрная смерть\n",
      "Pr:  0.64244473  rec:  0.68552655  f:  0.6632868\n",
      "\n",
      "Яндекс\n",
      "Pr:  0.6504326  rec:  0.665917  f:  0.65808374\n",
      "\n",
      "Google (компания)\n",
      "Pr:  0.56398433  rec:  0.59158415  f:  0.5774546\n",
      "\n",
      "Большой адронный коллайдер\n",
      "Pr:  0.5015145  rec:  0.4550647  f:  0.47716185\n",
      "\n",
      "Геморрагическая лихорадка Эбола\n",
      "Pr:  0.6421612  rec:  0.74257976  f:  0.6887294\n",
      "\n",
      "Вирус иммунодефицита человека\n",
      "Pr:  0.6344346  rec:  0.6846321  f:  0.6585782\n",
      "\n",
      "Dota 2\n",
      "Pr:  0.6449479  rec:  0.6639697  f:  0.6543206\n",
      "\n",
      "TikTok\n",
      "Pr:  0.5596218  rec:  0.56552595  f:  0.56255835\n",
      "\n",
      "Марс\n",
      "Pr:  0.69547343  rec:  0.75845784  f:  0.7256014\n",
      "\n",
      "YouTube\n",
      "Pr:  0.6202413  rec:  0.72192043  f:  0.66722935\n",
      "\n",
      "Portal 2\n",
      "Pr:  0.64492786  rec:  0.75437117  f:  0.6953696\n",
      "\n",
      "Time: 780.86\n"
     ]
    },
    {
     "ename": "TypeError",
     "evalue": "len() of unsized object",
     "output_type": "error",
     "traceback": [
      "\u001b[31m---------------------------------------------------------------------------\u001b[39m",
      "\u001b[31mTypeError\u001b[39m                                 Traceback (most recent call last)",
      "\u001b[36mCell\u001b[39m\u001b[36m \u001b[39m\u001b[32mIn[2]\u001b[39m\u001b[32m, line 23\u001b[39m\n\u001b[32m     20\u001b[39m   \u001b[38;5;28mmax\u001b[39m = np.quantile(dist, q=\u001b[32m0.975\u001b[39m)\n\u001b[32m     21\u001b[39m   \u001b[38;5;28;01mreturn\u001b[39;00m mean\n\u001b[32m---> \u001b[39m\u001b[32m23\u001b[39m a = \u001b[43mcalc\u001b[49m\u001b[43m(\u001b[49m\u001b[43mp\u001b[49m\u001b[43m)\u001b[49m\n\u001b[32m     24\u001b[39m b = calc(r)\n\u001b[32m     25\u001b[39m c = calc(f)\n",
      "\u001b[36mCell\u001b[39m\u001b[36m \u001b[39m\u001b[32mIn[2]\u001b[39m\u001b[32m, line 15\u001b[39m, in \u001b[36mcalc\u001b[39m\u001b[34m(data)\u001b[39m\n\u001b[32m     13\u001b[39m data = np.array(data)\n\u001b[32m     14\u001b[39m data1 = (data,)\n\u001b[32m---> \u001b[39m\u001b[32m15\u001b[39m bootstrap_ci = bootstrap(data1, np.mean, confidence_level=\u001b[32m0.95\u001b[39m, n_resamples=\u001b[38;5;28;43mlen\u001b[39;49m\u001b[43m(\u001b[49m\u001b[43mdata\u001b[49m\u001b[43m)\u001b[49m-\u001b[32m1\u001b[39m)\n\u001b[32m     17\u001b[39m dist = bootstrap_ci.bootstrap_distribution\n\u001b[32m     18\u001b[39m mean = np.quantile(dist, q=\u001b[32m0.5\u001b[39m)\n",
      "\u001b[31mTypeError\u001b[39m: len() of unsized object"
     ]
    }
   ],
   "source": [
    "import time\n",
    "import numpy as np\n",
    "from scipy.stats import bootstrap\n",
    "\n",
    "start = time.perf_counter()\n",
    "p, r, f = await wiki_bench.rank_outline(neighbor_count=0, description_mode=0, mode=1)\n",
    "end = time.perf_counter()\n",
    "c = end - start\n",
    "print(f'Time: {c:.2f}')\n",
    "def calc(data):\n",
    "  data = np.array(data)\n",
    "  data1 = (data,)\n",
    "  bootstrap_ci = bootstrap(data1, np.mean, confidence_level=0.95, n_resamples=len(data)-1)\n",
    "\n",
    "  dist = bootstrap_ci.bootstrap_distribution\n",
    "  mean = np.quantile(dist, q=0.5)\n",
    "  min = np.quantile(dist, q=0.025)\n",
    "  max = np.quantile(dist, q=0.975)\n",
    "  return mean\n",
    "\n",
    "\n",
    "a = calc([e[0] for e in wiki_bench.outline_logger])\n",
    "b = calc([e[1] for e in wiki_bench.outline_logger])\n",
    "c = calc([e[2] for e in wiki_bench.outline_logger])\n",
    "print(f'({a:.4f} | {b:.4f} | {c:.4f})')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "id": "95ff9c72-a9c3-4cb0-af18-2d81700dc0a1",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.61420345 0.65658045 0.6336405\n"
     ]
    }
   ],
   "source": [
    "print(p, r, f)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "id": "f757cfd9-f90c-4fdc-b84f-2024f3bf2dbe",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "(0.6151 | 0.6573 | 0.6339)\n"
     ]
    }
   ],
   "source": [
    "def calc(data):\n",
    "  data = np.array(data)\n",
    "  data1 = (data,)\n",
    "  bootstrap_ci = bootstrap(data1, np.mean, confidence_level=0.95, n_resamples=len(data)-1)\n",
    "\n",
    "  dist = bootstrap_ci.bootstrap_distribution\n",
    "  mean = np.quantile(dist, q=0.5)\n",
    "  min = np.quantile(dist, q=0.025)\n",
    "  max = np.quantile(dist, q=0.975)\n",
    "  return mean\n",
    "\n",
    "\n",
    "a = calc([e[0] for e in wiki_bench.outline_logger])\n",
    "b = calc([e[1] for e in wiki_bench.outline_logger])\n",
    "c = calc([e[2] for e in wiki_bench.outline_logger])\n",
    "print(f'({a:.4f} | {b:.4f} | {c:.4f})')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "id": "09954b73-649c-49e3-90e6-3b7ec704d64c",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.6579123 0.65420926 0.65515894\n"
     ]
    }
   ],
   "source": [
    "print(p, r, f)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "id": "90483931-b9ca-4216-9451-6c37a9363cfe",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "66.06\n",
      "64.48\n",
      "67.40\n",
      "\n",
      "65.36\n",
      "63.83\n",
      "66.55\n",
      "\n",
      "65.90\n",
      "64.33\n",
      "66.61\n",
      "\n"
     ]
    }
   ],
   "source": [
    "import numpy as np\n",
    "from scipy.stats import bootstrap\n",
    "\n",
    "def calc(data):\n",
    "  data = np.array(data)\n",
    "  data1 = (data,)\n",
    "  bootstrap_ci = bootstrap(data1, np.mean, confidence_level=0.95, n_resamples=len(data)-1)\n",
    "\n",
    "  dist = bootstrap_ci.bootstrap_distribution\n",
    "  mean = np.quantile(dist, q=0.5)\n",
    "  min = np.quantile(dist, q=0.025)\n",
    "  max = np.quantile(dist, q=0.975)\n",
    "  print(f\"{100*mean:2.2f}\")\n",
    "  print(f\"{100*min:2.2f}\")\n",
    "  print(f\"{100*max:2.2f}\")\n",
    "  print()\n",
    "\n",
    "#elem_p = [e for el in wiki_bench.article_gen_logger for e in el[0]]\n",
    "#elem_r = [e for el in wiki_bench.article_gen_logger for e in el[1]]\n",
    "#elem_f = [e for el in wiki_bench.article_gen_logger for e in el[2]]\n",
    "\n",
    "elem_p = [el[0] for el in wiki_bench.outline_logger]\n",
    "elem_r = [el[1] for el in wiki_bench.outline_logger]\n",
    "elem_f = [el[2] for el in wiki_bench.outline_logger]\n",
    "\n",
    "calc(elem_p)\n",
    "calc(elem_r)\n",
    "calc(elem_f)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 20,
   "id": "222dc07d-4c41-4e64-8e36-b1a9fa1441e0",
   "metadata": {},
   "outputs": [],
   "source": [
    "import json\n",
    "\n",
    "fixed_lst = [(float(a), float(b), float(c)) for a, b, c in wiki_bench.outline_logger]\n",
    "with open('vikhr_outline.json', 'w', encoding='utf-8') as f:\n",
    "    json.dump(fixed_lst, f, ensure_ascii=False, indent=2)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 21,
   "id": "4cc1a5c2-0f06-4bf1-9044-0566f2629a78",
   "metadata": {
    "collapsed": true,
    "jupyter": {
     "outputs_hidden": true
    },
    "scrolled": true
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Article name:  Python\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Creating outline: 100%|███████████████████████████████████████████████████████████| 208/208 [00:00<00:00, 39694.93it/s]\n",
      "Getting link numbers: 100%|█████████████████████████████████████████████████████████| 195/195 [00:01<00:00, 148.21it/s]\n",
      "Calculating reference positions: 100%|██████████████████████████████████████████████| 54/54 [00:00<00:00, 53696.64it/s]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "BERTScore Precision: 0.7675\n",
      "BERTScore Recall:    0.7159\n",
      "BERTScore F1:        0.7408\n",
      "\n",
      "Article name:  Летние Олимпийские игры 2024\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Creating outline: 100%|██████████████████████████████████████████████████████████| 109/109 [00:00<00:00, 109033.90it/s]\n",
      "Getting link numbers: 100%|███████████████████████████████████████████████████████████| 96/96 [00:00<00:00, 297.70it/s]\n",
      "Calculating reference positions: 100%|██████████████████████████████████████████████| 32/32 [00:00<00:00, 31707.47it/s]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "BERTScore Precision: 0.6329\n",
      "BERTScore Recall:    0.6278\n",
      "BERTScore F1:        0.6303\n",
      "\n",
      "Article name:  Квантовый компьютер\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Creating outline: 100%|█████████████████████████████████████████████████████████████| 91/91 [00:00<00:00, 46450.25it/s]\n",
      "Getting link numbers: 100%|███████████████████████████████████████████████████████████| 62/62 [00:00<00:00, 407.56it/s]\n",
      "Calculating reference positions: 100%|█████████████████████████████████████████████████████████| 16/16 [00:00<?, ?it/s]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "BERTScore Precision: 0.8234\n",
      "BERTScore Recall:    0.6833\n",
      "BERTScore F1:        0.7469\n",
      "\n",
      "Article name:  Присоединение Крыма к Российской Федерации\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Creating outline: 100%|█████████████████████████████████████████████████████████████| 84/84 [00:00<00:00, 42540.63it/s]\n",
      "Getting link numbers: 100%|██████████████████████████████████████████████████████████| 36/36 [00:00<00:00, 1081.26it/s]\n",
      "Calculating reference positions: 100%|█████████████████████████████████████████████████████████| 22/22 [00:00<?, ?it/s]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "BERTScore Precision: 0.6497\n",
      "BERTScore Recall:    0.6251\n",
      "BERTScore F1:        0.6372\n",
      "\n",
      "Article name:  Сколково (инновационный центр)\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Creating outline: 100%|███████████████████████████████████████████████████████████| 283/283 [00:00<00:00, 50450.02it/s]\n",
      "Getting link numbers: 100%|█████████████████████████████████████████████████████████| 257/257 [00:01<00:00, 142.38it/s]\n",
      "Calculating reference positions: 100%|██████████████████████████████████████████████| 60/60 [00:00<00:00, 59818.93it/s]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "BERTScore Precision: 0.6891\n",
      "BERTScore Recall:    0.6003\n",
      "BERTScore F1:        0.6416\n",
      "\n",
      "Article name:  Tomb Raider (игра, 2013)\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Creating outline: 100%|███████████████████████████████████████████████████████████| 129/129 [00:00<00:00, 24438.36it/s]\n",
      "Getting link numbers: 100%|██████████████████████████████████████████████████████████| 270/270 [00:03<00:00, 73.81it/s]\n",
      "Calculating reference positions: 100%|██████████████████████████████████████████████| 33/33 [00:00<00:00, 61271.37it/s]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "BERTScore Precision: 0.7748\n",
      "BERTScore Recall:    0.7210\n",
      "BERTScore F1:        0.7470\n",
      "\n",
      "Article name:  Чёрная дыра\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Creating outline: 100%|███████████████████████████████████████████████████████████| 172/172 [00:00<00:00, 33874.27it/s]\n",
      "Getting link numbers: 100%|█████████████████████████████████████████████████████████| 104/104 [00:00<00:00, 231.75it/s]\n",
      "Calculating reference positions: 100%|██████████████████████████████████████████████| 50/50 [00:00<00:00, 92304.23it/s]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "BERTScore Precision: 0.6968\n",
      "BERTScore Recall:    0.7395\n",
      "BERTScore F1:        0.7175\n",
      "\n",
      "Article name:  Экономика США\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Creating outline: 100%|███████████████████████████████████████████████████████████| 148/148 [00:00<00:00, 49262.52it/s]\n",
      "Getting link numbers: 100%|███████████████████████████████████████████████████████████| 93/93 [00:00<00:00, 336.59it/s]\n",
      "Calculating reference positions: 100%|█████████████████████████████████████████████████████████| 30/30 [00:00<?, ?it/s]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "BERTScore Precision: 0.7105\n",
      "BERTScore Recall:    0.6833\n",
      "BERTScore F1:        0.6966\n",
      "\n",
      "Article name:  Искусственный интеллект\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Creating outline: 100%|███████████████████████████████████████████████████████████| 226/226 [00:00<00:00, 54359.03it/s]\n",
      "Getting link numbers: 100%|█████████████████████████████████████████████████████████| 106/106 [00:00<00:00, 340.59it/s]\n",
      "Calculating reference positions: 100%|█████████████████████████████████████████████| 61/61 [00:00<00:00, 113209.09it/s]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "BERTScore Precision: 0.7543\n",
      "BERTScore Recall:    0.6968\n",
      "BERTScore F1:        0.7244\n",
      "\n",
      "Article name:  COVID-19\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Creating outline: 100%|███████████████████████████████████████████████████████████| 191/191 [00:00<00:00, 52941.58it/s]\n",
      "Getting link numbers: 100%|█████████████████████████████████████████████████████████| 257/257 [00:02<00:00, 119.32it/s]\n",
      "Calculating reference positions: 100%|█████████████████████████████████████████████| 54/54 [00:00<00:00, 104086.59it/s]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "BERTScore Precision: 0.7196\n",
      "BERTScore Recall:    0.7420\n",
      "BERTScore F1:        0.7306\n",
      "\n",
      "Article name:  Применение искусственного интеллекта\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Creating outline: 100%|███████████████████████████████████████████████████████████| 151/151 [00:00<00:00, 56432.32it/s]\n",
      "Getting link numbers: 100%|█████████████████████████████████████████████████████████| 224/224 [00:01<00:00, 186.37it/s]\n",
      "Calculating reference positions: 100%|█████████████████████████████████████████████████████████| 46/46 [00:00<?, ?it/s]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "BERTScore Precision: 0.7281\n",
      "BERTScore Recall:    0.6810\n",
      "BERTScore F1:        0.7038\n",
      "\n",
      "Article name:  РИА Новости\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Creating outline: 100%|██████████████████████████████████████████████████████████| 102/102 [00:00<00:00, 101234.98it/s]\n",
      "Getting link numbers: 100%|███████████████████████████████████████████████████████████| 83/83 [00:00<00:00, 565.80it/s]\n",
      "Calculating reference positions: 100%|█████████████████████████████████████████████████████████| 29/29 [00:00<?, ?it/s]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "BERTScore Precision: 0.7488\n",
      "BERTScore Recall:    0.6839\n",
      "BERTScore F1:        0.7148\n",
      "\n",
      "Article name:  Uncharted 4: A Thief’s End\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Creating outline: 100%|█████████████████████████████████████████████████████████████| 56/56 [00:00<00:00, 55553.70it/s]\n",
      "Getting link numbers: 100%|███████████████████████████████████████████████████████████| 78/78 [00:00<00:00, 535.14it/s]\n",
      "Calculating reference positions: 100%|███████████████████████████████████████████████████████████| 9/9 [00:00<?, ?it/s]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "BERTScore Precision: 0.7891\n",
      "BERTScore Recall:    0.8649\n",
      "BERTScore F1:        0.8252\n",
      "\n",
      "Article name:  Экономика КНР\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Creating outline: 100%|███████████████████████████████████████████████████████████| 226/226 [00:00<00:00, 45220.53it/s]\n",
      "Getting link numbers: 100%|█████████████████████████████████████████████████████████| 172/172 [00:00<00:00, 175.65it/s]\n",
      "Calculating reference positions: 100%|██████████████████████████████████████████████| 57/57 [00:00<00:00, 56094.63it/s]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "BERTScore Precision: 0.7128\n",
      "BERTScore Recall:    0.6747\n",
      "BERTScore F1:        0.6932\n",
      "\n",
      "Article name:  Экономика Германии\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Creating outline: 100%|███████████████████████████████████████████████████████████| 151/151 [00:00<00:00, 75156.03it/s]\n",
      "Getting link numbers: 100%|███████████████████████████████████████████████████████████| 42/42 [00:00<00:00, 332.08it/s]\n",
      "Calculating reference positions: 100%|██████████████████████████████████████████████| 36/36 [00:00<00:00, 36192.46it/s]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "BERTScore Precision: 0.8064\n",
      "BERTScore Recall:    0.7475\n",
      "BERTScore F1:        0.7758\n",
      "\n",
      "Article name:  Иннополис\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Creating outline: 100%|█████████████████████████████████████████████████████████████| 84/84 [00:00<00:00, 43913.94it/s]\n",
      "Getting link numbers: 100%|█████████████████████████████████████████████████████████| 104/104 [00:00<00:00, 374.56it/s]\n",
      "Calculating reference positions: 100%|█████████████████████████████████████████████████████████| 25/25 [00:00<?, ?it/s]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "BERTScore Precision: 0.7829\n",
      "BERTScore Recall:    0.7168\n",
      "BERTScore F1:        0.7484\n",
      "\n",
      "Article name:  Летние Олимпийские игры 2020\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Creating outline: 100%|█████████████████████████████████████████████████████████████| 52/52 [00:00<00:00, 50277.50it/s]\n",
      "Getting link numbers: 100%|█████████████████████████████████████████████████████████| 103/103 [00:00<00:00, 272.69it/s]\n",
      "Calculating reference positions: 100%|██████████████████████████████████████████████| 14/14 [00:00<00:00, 19152.07it/s]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Couldn't get the answer\n",
      "BERTScore Precision: 0.6131\n",
      "BERTScore Recall:    0.5879\n",
      "BERTScore F1:        0.6003\n",
      "\n",
      "Article name:  Солнечная система\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Creating outline: 100%|███████████████████████████████████████████████████████████| 155/155 [00:00<00:00, 39118.91it/s]\n",
      "Getting link numbers: 100%|███████████████████████████████████████████████████████████| 99/99 [00:00<00:00, 204.11it/s]\n",
      "Calculating reference positions: 100%|█████████████████████████████████████████████████████████| 47/47 [00:00<?, ?it/s]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Couldn't get the answer\n",
      "BERTScore Precision: 0.7194\n",
      "BERTScore Recall:    0.6165\n",
      "BERTScore F1:        0.6640\n",
      "\n",
      "Article name:  C++\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Creating outline: 100%|███████████████████████████████████████████████████████████| 184/184 [00:00<00:00, 60696.18it/s]\n",
      "Getting link numbers: 100%|███████████████████████████████████████████████████████████| 59/59 [00:00<00:00, 329.09it/s]\n",
      "Calculating reference positions: 100%|█████████████████████████████████████████████████████████| 58/58 [00:00<?, ?it/s]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "BERTScore Precision: 0.7530\n",
      "BERTScore Recall:    0.6629\n",
      "BERTScore F1:        0.7051\n",
      "\n",
      "Article name:  Си (язык программирования)\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Creating outline: 100%|███████████████████████████████████████████████████████████| 223/223 [00:00<00:00, 44673.53it/s]\n",
      "Getting link numbers: 100%|█████████████████████████████████████████████████████████| 100/100 [00:00<00:00, 192.28it/s]\n",
      "Calculating reference positions: 100%|█████████████████████████████████████████████████████████| 68/68 [00:00<?, ?it/s]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "BERTScore Precision: 0.7713\n",
      "BERTScore Recall:    0.6651\n",
      "BERTScore F1:        0.7142\n",
      "\n",
      "Article name:  Сбербанк России\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Creating outline: 100%|███████████████████████████████████████████████████████████| 177/177 [00:00<00:00, 44279.60it/s]\n",
      "Getting link numbers: 100%|█████████████████████████████████████████████████████████| 197/197 [00:00<00:00, 241.18it/s]\n",
      "Calculating reference positions: 100%|██████████████████████████████████████████████| 28/28 [00:00<00:00, 28008.71it/s]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "BERTScore Precision: 0.6732\n",
      "BERTScore Recall:    0.7232\n",
      "BERTScore F1:        0.6973\n",
      "\n",
      "Article name:  Чёрная смерть\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Creating outline: 100%|███████████████████████████████████████████████████████████| 275/275 [00:00<00:00, 36147.59it/s]\n",
      "Getting link numbers: 100%|█████████████████████████████████████████████████████████| 214/214 [00:01<00:00, 162.74it/s]\n",
      "Calculating reference positions: 100%|█████████████████████████████████████████████████████████| 34/34 [00:00<?, ?it/s]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "BERTScore Precision: 0.6411\n",
      "BERTScore Recall:    0.6520\n",
      "BERTScore F1:        0.6465\n",
      "\n",
      "Article name:  Яндекс\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Creating outline: 100%|███████████████████████████████████████████████████████████| 105/105 [00:00<00:00, 63817.12it/s]\n",
      "Getting link numbers: 100%|█████████████████████████████████████████████████████████| 147/147 [00:00<00:00, 297.19it/s]\n",
      "Calculating reference positions: 100%|█████████████████████████████████████████████████████████| 30/30 [00:00<?, ?it/s]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "BERTScore Precision: 0.6958\n",
      "BERTScore Recall:    0.7391\n",
      "BERTScore F1:        0.7168\n",
      "\n",
      "Article name:  Google (компания)\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Creating outline: 100%|███████████████████████████████████████████████████████████| 143/143 [00:00<00:00, 53337.97it/s]\n",
      "Getting link numbers: 100%|█████████████████████████████████████████████████████████| 183/183 [00:00<00:00, 269.49it/s]\n",
      "Calculating reference positions: 100%|██████████████████████████████████████████████| 26/26 [00:00<00:00, 50370.39it/s]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "BERTScore Precision: 0.7014\n",
      "BERTScore Recall:    0.6978\n",
      "BERTScore F1:        0.6996\n",
      "\n",
      "Article name:  Большой адронный коллайдер\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Creating outline: 100%|█████████████████████████████████████████████████████████████| 88/88 [00:00<00:00, 35510.75it/s]\n",
      "Getting link numbers: 100%|███████████████████████████████████████████████████████████| 90/90 [00:00<00:00, 347.96it/s]\n",
      "Calculating reference positions: 100%|█████████████████████████████████████████████████████████| 32/32 [00:00<?, ?it/s]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "BERTScore Precision: 0.7200\n",
      "BERTScore Recall:    0.6509\n",
      "BERTScore F1:        0.6837\n",
      "\n",
      "Article name:  Геморрагическая лихорадка Эбола\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Creating outline: 100%|█████████████████████████████████████████████████████████████| 86/86 [00:00<00:00, 86088.34it/s]\n",
      "Getting link numbers: 100%|███████████████████████████████████████████████████████████| 95/95 [00:00<00:00, 313.42it/s]\n",
      "Calculating reference positions: 100%|█████████████████████████████████████████████████████████| 19/19 [00:00<?, ?it/s]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "BERTScore Precision: 0.7234\n",
      "BERTScore Recall:    0.7558\n",
      "BERTScore F1:        0.7392\n",
      "\n",
      "Article name:  Вирус иммунодефицита человека\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Creating outline: 100%|███████████████████████████████████████████████████████████| 124/124 [00:00<00:00, 49344.75it/s]\n",
      "Getting link numbers: 100%|█████████████████████████████████████████████████████████| 181/181 [00:01<00:00, 166.84it/s]\n",
      "Calculating reference positions: 100%|█████████████████████████████████████████████████████████| 30/30 [00:00<?, ?it/s]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "BERTScore Precision: 0.7518\n",
      "BERTScore Recall:    0.6936\n",
      "BERTScore F1:        0.7215\n",
      "\n",
      "Article name:  Dota 2\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Creating outline: 100%|█████████████████████████████████████████████████████████████| 43/43 [00:00<00:00, 20845.48it/s]\n",
      "Getting link numbers: 100%|█████████████████████████████████████████████████████████| 100/100 [00:00<00:00, 298.44it/s]\n",
      "Calculating reference positions: 100%|█████████████████████████████████████████████████████████| 13/13 [00:00<?, ?it/s]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "BERTScore Precision: 0.6596\n",
      "BERTScore Recall:    0.7193\n",
      "BERTScore F1:        0.6882\n",
      "\n",
      "Article name:  TikTok\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Creating outline: 100%|███████████████████████████████████████████████████████████| 143/143 [00:00<00:00, 71301.17it/s]\n",
      "Getting link numbers: 100%|█████████████████████████████████████████████████████████| 126/126 [00:00<00:00, 346.57it/s]\n",
      "Calculating reference positions: 100%|█████████████████████████████████████████████████████████| 30/30 [00:00<?, ?it/s]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "BERTScore Precision: 0.6557\n",
      "BERTScore Recall:    0.6354\n",
      "BERTScore F1:        0.6454\n",
      "\n",
      "Article name:  Марс\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Creating outline: 100%|███████████████████████████████████████████████████████████| 200/200 [00:00<00:00, 36923.32it/s]\n",
      "Getting link numbers: 100%|█████████████████████████████████████████████████████████| 160/160 [00:01<00:00, 138.84it/s]\n",
      "Calculating reference positions: 100%|██████████████████████████████████████████████| 42/42 [00:00<00:00, 43539.49it/s]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "BERTScore Precision: 0.7337\n",
      "BERTScore Recall:    0.7666\n",
      "BERTScore F1:        0.7498\n",
      "\n",
      "Article name:  YouTube\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Creating outline: 100%|███████████████████████████████████████████████████████████| 104/104 [00:00<00:00, 50851.90it/s]\n",
      "Getting link numbers: 100%|███████████████████████████████████████████████████████████| 96/96 [00:00<00:00, 423.04it/s]\n",
      "Calculating reference positions: 100%|██████████████████████████████████████████████| 18/18 [00:00<00:00, 17949.95it/s]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "BERTScore Precision: 0.7226\n",
      "BERTScore Recall:    0.7471\n",
      "BERTScore F1:        0.7347\n",
      "\n",
      "BERTScore Precision: 0.7201\n",
      "BERTScore Recall:    0.6941\n",
      "BERTScore F1:        0.7058\n"
     ]
    }
   ],
   "source": [
    "p_s = 0\n",
    "r_s = 0\n",
    "f_s = 0\n",
    "for name in article_names:\n",
    "    page = get_article(name, is_downloaded=True)\n",
    "    p, r, f = await wiki_evaluater.rank_outline(name, mode=1, page=page, neighbor_count=1, description_mode=1)\n",
    "    p_s += p\n",
    "    r_s += r\n",
    "    f_s += f\n",
    "    print(f\"BERTScore Precision: {p:.4f}\")\n",
    "    print(f\"BERTScore Recall:    {r:.4f}\")\n",
    "    print(f\"BERTScore F1:        {f:.4f}\")\n",
    "    print()\n",
    "print(f\"BERTScore Precision: {p_s/len(article_names):.4f}\")\n",
    "print(f\"BERTScore Recall:    {r_s/len(article_names):.4f}\")\n",
    "print(f\"BERTScore F1:        {f_s/len(article_names):.4f}\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "4512e2d1-1d19-4282-9c70-d52cbc7d72a3",
   "metadata": {},
   "outputs": [],
   "source": [
    "p_s = 0\n",
    "r_s = 0\n",
    "f_s = 0\n",
    "for name in article_names:\n",
    "    page = get_article(name, False, True)\n",
    "    pr, r, f = wiki_evaluater.rank_outline(name, 0, page=page, mode=1)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 28,
   "id": "625a3514-cc66-46c6-9c3f-706de9635cbb",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "53.31\n",
      "52.69\n",
      "53.98\n",
      "\n",
      "54.36\n",
      "53.52\n",
      "55.28\n",
      "\n",
      "53.57\n",
      "52.92\n",
      "54.23\n",
      "\n"
     ]
    }
   ],
   "source": [
    "import re\n",
    "import os\n",
    "import numpy as np\n",
    "from scipy.stats import bootstrap\n",
    "\n",
    "sred_p = []\n",
    "sred_r = []\n",
    "sred_f = []\n",
    "for subdir, _, files in os.walk(r'D:\\MSU\\year_4\\semester_8\\Diploma\\early_report\\vikhr12b'):\n",
    "    for file in files:\n",
    "\n",
    "        if file.endswith(\".txt\"):\n",
    "            file_path = os.path.join(subdir, file)\n",
    "            with open(file_path, \"r\", encoding=\"utf-8\", errors='replace') as f:\n",
    "                #print(file_path)\n",
    "                precisions = []\n",
    "                recalls = []\n",
    "                f1s = []\n",
    "                content = f.read()\n",
    "                precision_matches = re.findall(r'BERTScore Precision:\\s*([0-9.]+)', content)\n",
    "                recall_matches = re.findall(r'BERTScore Recall:\\s*([0-9.]+)', content)\n",
    "                f1_matches = re.findall(r'BERTScore F1:\\s*([0-9.]+)', content)\n",
    "\n",
    "                precisions = [float(p) for p in precision_matches if float(p) != 0]\n",
    "                recalls = [float(r) for r in recall_matches if float(r) != 0]\n",
    "                f1s = [float(f) for f in f1_matches if float(f) != 0]\n",
    "                sred_p += precisions\n",
    "                sred_r += recalls\n",
    "                sred_f += f1s\n",
    "                \n",
    "def calc(data):\n",
    "  data = np.array(data)\n",
    "  data1 = (data,)\n",
    "  bootstrap_ci = bootstrap(data1, np.mean, confidence_level=0.95, n_resamples=len(data)-1)\n",
    "\n",
    "  dist = bootstrap_ci.bootstrap_distribution\n",
    "  mean = np.quantile(dist, q=0.5)\n",
    "  min = np.quantile(dist, q=0.025)\n",
    "  max = np.quantile(dist, q=0.975)\n",
    "  print(f\"{100*mean:2.2f}\")\n",
    "  print(f\"{100*min:2.2f}\")\n",
    "  print(f\"{100*max:2.2f}\")\n",
    "  print()\n",
    "\n",
    "calc(sred_p)\n",
    "calc(sred_r)\n",
    "calc(sred_f)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 65,
   "id": "67ade2f2-6f15-4c10-a700-0fcfdf64d33a",
   "metadata": {
    "scrolled": true
   },
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Default prompt name is set to 'Classification'. This prompt will be applied to all `encode()` calls, except if `encode()` is called with `prompt` or `prompt_name` parameters.\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Python\n",
      "658\n",
      "344\n",
      "Летние Олимпийские игры 2024\n",
      "66\n",
      "24\n",
      "Квантовый компьютер\n",
      "85\n",
      "37\n",
      "Присоединение Крыма к Российской Федерации\n",
      "118\n",
      "75\n",
      "Сколково (инновационный центр)\n",
      "552\n",
      "337\n",
      "Tomb Raider (игра, 2013)\n",
      "325\n",
      "142\n",
      "Чёрная дыра\n",
      "273\n",
      "120\n",
      "Экономика США\n",
      "62\n",
      "34\n",
      "Искусственный интеллект\n",
      "215\n",
      "95\n",
      "COVID-19\n",
      "610\n",
      "322\n",
      "Применение искусственного интеллекта\n",
      "398\n",
      "250\n",
      "РИА Новости\n",
      "87\n",
      "45\n",
      "Uncharted 4: A Thief’s End\n",
      "67\n",
      "42\n",
      "Экономика КНР\n",
      "253\n",
      "141\n",
      "Иннополис\n",
      "188\n",
      "118\n",
      "Летние Олимпийские игры 2020\n",
      "50\n",
      "40\n",
      "Солнечная система\n",
      "274\n",
      "193\n",
      "C++\n",
      "40\n",
      "30\n",
      "Trying again!\n",
      "Си (язык программирования)\n",
      "570\n",
      "392\n",
      "Сбербанк России\n",
      "186\n",
      "86\n",
      "Чёрная смерть\n",
      "357\n",
      "283\n",
      "Яндекс\n",
      "129\n",
      "70\n",
      "Google (компания)\n",
      "110\n",
      "59\n",
      "Большой адронный коллайдер\n",
      "48\n",
      "29\n",
      "Геморрагическая лихорадка Эбола\n",
      "156\n",
      "92\n",
      "Вирус иммунодефицита человека\n",
      "163\n",
      "99\n",
      "Dota 2\n",
      "147\n",
      "71\n",
      "TikTok\n",
      "122\n",
      "55\n",
      "Марс\n",
      "228\n",
      "137\n",
      "YouTube\n",
      "65\n",
      "20\n",
      "Portal 2\n",
      "101\n",
      "57\n"
     ]
    }
   ],
   "source": [
    "from sentence_transformers import SentenceTransformer\n",
    "import razdel\n",
    "import json\n",
    "\n",
    "\n",
    "model = SentenceTransformer(\"sergeyzh/BERTA\")\n",
    "\n",
    "results = {}\n",
    "for name in wiki_bench.article_names:\n",
    "    page = wiki_bench.get_article(name, False, True)\n",
    "    section_to_sn = wiki_bench.wiki_evaluater.section_to_snippets(page)\n",
    "    count_article = 0\n",
    "    count_article_bad = 0\n",
    "    article_results = []\n",
    "    for section, text in page.filtered_outline.items():\n",
    "        if not text:\n",
    "            continue\n",
    "        count = 0\n",
    "        count_bad = 0\n",
    "        count_good = 0\n",
    "        article_sents = [t.text for t in razdel.sentenize(text)]\n",
    "        article_sents = model.encode(article_sents, normalize_embs=True)\n",
    "        for i, sn in enumerate(section_to_sn[section]):\n",
    "            snippet = sn[1]\n",
    "            count += 1\n",
    "            snippet_sents = [t.text for t in razdel.sentenize(snippet)]\n",
    "            snippet_sents = model.encode(snippet_sents, normalize_embs=True)\n",
    "            max_sim = article_sents @ snippet_sents.T\n",
    "            max_sim = max_sim.max()\n",
    "            article_results.append({\n",
    "                'section': section,\n",
    "                'snippet_index': i,\n",
    "                'max_sim': float(max_sim)\n",
    "            })\n",
    "            if max_sim > 0.55:\n",
    "                count_good += 1\n",
    "            else:\n",
    "                count_bad += 1\n",
    "        count_article += count\n",
    "        count_article_bad += count_bad\n",
    "        #print('For section: ', section)\n",
    "        #print('All: ', count)\n",
    "        #print('Bad: ', count_bad)\n",
    "    results[name] = {\n",
    "        'total_snippets': count_article,\n",
    "        'bad_snippets': count_article_bad,\n",
    "        'details': article_results\n",
    "    }\n",
    "    print(name)\n",
    "    print(count_article)\n",
    "    print(count_article_bad)\n",
    "\n",
    "with open('max_sim_results.json', 'w', encoding='utf-8') as f:\n",
    "    json.dump(results, f, indent=4, ensure_ascii=False)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 22,
   "id": "1cd1393b-1919-4766-b1a5-4bf495b50465",
   "metadata": {
    "collapsed": true,
    "jupyter": {
     "outputs_hidden": true
    }
   },
   "outputs": [
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 1000x600 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "import json\n",
    "import matplotlib.pyplot as plt\n",
    "\n",
    "with open('max_sim_results.json', 'r', encoding='utf-8') as f:\n",
    "    results = json.load(f)\n",
    "\n",
    "all_max_sim = []\n",
    "for article in results.values():\n",
    "    for detail in article['details']:\n",
    "        all_max_sim.append(detail['max_sim'])\n",
    "\n",
    "plt.figure(figsize=(10, 6))\n",
    "plt.hist(all_max_sim, bins=50, color = 'cyan', edgecolor='black')\n",
    "plt.title('Сходство сниппетов и текста статьи')\n",
    "plt.xlabel('Максимальное сходство(косинус)')\n",
    "plt.ylabel('Количество сниппетов')\n",
    "plt.grid(False)\n",
    "plt.show()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 67,
   "id": "40984364-73f8-40d5-93b5-166cb95035d6",
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Default prompt name is set to 'Classification'. This prompt will be applied to all `encode()` calls, except if `encode()` is called with `prompt` or `prompt_name` parameters.\n"
     ]
    }
   ],
   "source": [
    "wiki_bench = WikiBench(url, key, model_name='tpro', pre_load=True)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "cb1a62e4-be83-42bb-a56e-b7cd4fd8cabd",
   "metadata": {},
   "outputs": [],
   "source": [
    "Model(id='tpro', created=None, object=None, owned_by=None, max_model_len=30000, status='spawned')\n",
    "Model(id='yagpt5lite', created=None, object=None, owned_by=None, max_model_len=30000, status='spawned')\n",
    "Model(id='RefalMachine/RuadaptQwen2.5-32B-Pro-Beta', created=None, object=None, owned_by=None, max_model_len=28000, status='spawned')\n",
    "Model(id='RefalMachine/RuadaptQwen2.5-32B-QWQ-Beta', created=None, object=None, owned_by=None, max_model_len=16000, status='spawned')\n",
    "Model(id='llama3-70b', created=None, object=None, owned_by=None, max_model_len=14000, status='spawned')\n",
    "Model(id='qwen2.5-72b', created=None, object=None, owned_by=None, max_model_len=14000, status='spawned')\n",
    "Model(id='RefalMachine/RuadaptQwen2.5-7B-Garant-v2', created=None, object=None, owned_by=None, max_model_len=30000, status='offloaded')\n",
    "Model(id='RefalMachine/RuadaptQwen2.5-7B-Lite-Beta', created=None, object=None, owned_by=None, max_model_len=30000, status='offloaded')\n",
    "Model(id='deepseek-r1-32b', created=None, object=None, owned_by=None, max_model_len=30000, status='offloaded')\n",
    "Model(id='qwen32b-coder', created=None, object=None, owned_by=None, max_model_len=30000, status='offloaded')\n",
    "Model(id='vikhr12b', created=None, object=None, owned_by=None, max_model_len=30000, status='offloaded')\n",
    "Model(id='Nemotron49b', created=None, object=None, owned_by=None, max_model_len=16000, status='offloaded')\n",
    "Model(id='tlite', created=None, object=None, owned_by=None, max_model_len=-1, status='offloaded')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 68,
   "id": "361e24b0-b314-4b5a-927e-aa9cd45d0847",
   "metadata": {
    "scrolled": true
   },
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Default prompt name is set to 'Classification'. This prompt will be applied to all `encode()` calls, except if `encode()` is called with `prompt` or `prompt_name` parameters.\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "C++\n",
      "0.73895943 0.73998207 0.7394704\n",
      "COVID-19\n",
      "0.82927626 0.8021694 0.81549764\n",
      "Dota 2\n",
      "0.7436553 0.8785052 0.8054753\n",
      "Google (компания)\n",
      "0.7857456 0.75630057 0.77074194\n",
      "Portal 2\n",
      "0.7469662 0.80251527 0.77374506\n",
      "Python\n",
      "0.81863266 0.7961141 0.80721635\n",
      "TikTok\n",
      "0.7229557 0.6834162 0.70263016\n",
      "Tomb Raider (игра, 2013)\n",
      "0.8054377 0.78164595 0.7933635\n",
      "Uncharted 4: A Thief’s End\n",
      "0.77498615 0.8640586 0.8171021\n",
      "YouTube\n",
      "0.6753873 0.732163 0.7026301\n",
      "Большой адронный коллайдер\n",
      "0.7570621 0.6562817 0.70307875\n",
      "Вирус иммунодефицита человека\n",
      "0.78900635 0.7084751 0.74657536\n",
      "Геморрагическая лихорадка Эбола\n",
      "0.7956749 0.81653273 0.8059689\n",
      "Иннополис\n",
      "0.8002834 0.81979 0.8099193\n",
      "Искусственный интеллект\n",
      "0.7256788 0.7150952 0.7203481\n",
      "Квантовый компьютер\n",
      "0.73267645 0.77512956 0.7533054\n",
      "Летние Олимпийские игры 2020\n",
      "0.69711417 0.8802828 0.77806365\n",
      "Летние Олимпийские игры 2024\n",
      "0.74998575 0.819381 0.7831491\n",
      "Марс\n",
      "0.7787132 0.80061924 0.7895143\n",
      "Применение искусственного интеллекта\n",
      "0.76705825 0.7867975 0.77680254\n",
      "Присоединение Крыма к Российской Федерации\n",
      "0.736753 0.75935864 0.74788505\n",
      "РИА Новости\n",
      "0.7217075 0.6888173 0.704879\n",
      "Сбербанк России\n",
      "0.7779142 0.7713225 0.7746043\n",
      "Си (язык программирования)\n",
      "0.79545885 0.73285383 0.76287407\n",
      "Сколково (инновационный центр)\n",
      "0.79571015 0.63451153 0.7060266\n",
      "Солнечная система\n",
      "0.75778335 0.7524673 0.755116\n",
      "Чёрная дыра\n",
      "0.7529354 0.7525389 0.7527371\n",
      "Чёрная смерть\n",
      "0.7304377 0.76762056 0.74856764\n",
      "Экономика КНР\n",
      "0.82077074 0.76319104 0.7909344\n",
      "Экономика США\n",
      "0.8206975 0.8282966 0.8244796\n",
      "Яндекс\n",
      "0.75201815 0.72483784 0.7381779\n",
      "0.7644337 0.7674539 0.76454455\n"
     ]
    }
   ],
   "source": [
    "from sentence_transformers import SentenceTransformer\n",
    "import numpy as np\n",
    "\n",
    "\n",
    "PROMPT = \"\"\"\n",
    "Ты — опытный редактор Википедии. На основе краткого описания статьи и ее названия тебе нужно составить короткий план всей статьи.\n",
    "Пожалуйста, строго следуй этим инструкциям:\n",
    "1. Начни план с названия интересующей темы \"Topic\"\n",
    "2. Используй \"# Title\" для заголовков разделов, \"## Title\" для заголовков подразделов, \"### Title\" для подподразделов и так далее.\n",
    "3. В конце плана напиши **END**\n",
    "4. Ничего другого писать не нужно.\n",
    "\n",
    "Тема статьи: {}\n",
    "Описание статьи: {}\n",
    "\"\"\"\n",
    "model_embeddings = SentenceTransformer(\"sergeyzh/BERTA\")\n",
    "p = 0\n",
    "r = 0\n",
    "f = 0\n",
    "count = 0\n",
    "a = []\n",
    "b = []\n",
    "c = []\n",
    "for name, text in zip(names, texts2):\n",
    "    count += 1\n",
    "    print(name)\n",
    "    page = wiki_bench.get_article(name, False, True)\n",
    "    myprompt = PROMPT.format(name, text)\n",
    "    res = await wiki_bench.client.get_completion(myprompt)\n",
    "    if res.choices is not None:\n",
    "        response = res.choices[0].message.content.strip()\n",
    "    else:\n",
    "        print('Error!')\n",
    "        continue\n",
    "    outline = response\n",
    "    parsed_headings = []\n",
    "    for line in outline.split('\\n'):\n",
    "        line = line.strip()\n",
    "        if line.startswith(\"#\"):\n",
    "            level = len(line) - len(line.lstrip(\"#\"))\n",
    "            title = line[level:].strip()\n",
    "            if title:\n",
    "                parsed_headings.append((level, title))\n",
    "    heads = [head[1] for head in parsed_headings]\n",
    "    pred_emb = model_embeddings.encode(heads, normalize_embeddings=True)\n",
    "    true_heads = []\n",
    "    for headings in page.filtered_outline.keys():\n",
    "        true_heads.append(headings[1])\n",
    "    ref_emb =  model_embeddings.encode(true_heads, normalize_embeddings=True)\n",
    "    sims = pred_emb @ ref_emb.T\n",
    "    precision_scores = sims.max(axis=1).mean()\n",
    "    recall_scores = sims.max(axis=0).mean()\n",
    "    if precision_scores + recall_scores == 0:\n",
    "        f1 = 0.0\n",
    "    else:\n",
    "        f1 = 2 * precision_scores * recall_scores / (precision_scores + recall_scores)\n",
    "    p += precision_scores\n",
    "    r += recall_scores\n",
    "    f += f1\n",
    "    a.append(precision_scores)\n",
    "    b.append(recall_scores)\n",
    "    c.append(f1)\n",
    "    print(precision_scores, recall_scores, f1)\n",
    "print(p / count, r / count, f / count)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 71,
   "id": "2a6c4756-a340-434a-bb64-137d9fcd6856",
   "metadata": {
    "scrolled": true
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "76.54\n",
      "75.39\n",
      "77.30\n",
      "\n",
      "76.75\n",
      "75.29\n",
      "78.50\n",
      "\n",
      "76.51\n",
      "75.52\n",
      "77.64\n",
      "\n"
     ]
    }
   ],
   "source": [
    "import numpy as np\n",
    "from scipy.stats import bootstrap\n",
    "\n",
    "def calc(data):\n",
    "  data = np.array(data)\n",
    "  data1 = (data,)\n",
    "  bootstrap_ci = bootstrap(data1, np.mean, confidence_level=0.95, n_resamples=len(data)-1)\n",
    "\n",
    "  dist = bootstrap_ci.bootstrap_distribution\n",
    "  mean = np.quantile(dist, q=0.5)\n",
    "  min = np.quantile(dist, q=0.025)\n",
    "  max = np.quantile(dist, q=0.975)\n",
    "  print(f\"{100*mean:2.2f}\")\n",
    "  print(f\"{100*min:2.2f}\")\n",
    "  print(f\"{100*max:2.2f}\")\n",
    "  print()\n",
    "\n",
    "calc(a)\n",
    "calc(b)\n",
    "calc(c)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 70,
   "id": "33f2cb7b-358a-42a1-b805-36133f9b2a6b",
   "metadata": {},
   "outputs": [],
   "source": [
    "import json\n",
    "\n",
    "fixed_lst = [(float(a), float(b), float(c)) for a, b, c in zip(a, b, c)]\n",
    "with open('tpro_outline.json', 'w', encoding='utf-8') as f:\n",
    "    json.dump(fixed_lst, f, ensure_ascii=False, indent=2)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1,
   "id": "1518ef75-7e47-4e97-a1fe-9768bcab046d",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "resource module not available on Windows\n"
     ]
    }
   ],
   "source": [
    "import sys\n",
    "\n",
    "sys.path.append(\"src\")\n",
    "from wiki_bench import WikiBench\n",
    "with open('Access_key.txt', 'r', encoding='utf-8') as file:\n",
    "    url, key = file.read().split()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 18,
   "id": "6f9b5bea-dcd4-4b64-b7df-56aaa3fa296c",
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Default prompt name is set to 'Classification'. This prompt will be applied to all `encode()` calls, except if `encode()` is called with `prompt` or `prompt_name` parameters.\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Model(id='RefalMachine/RuadaptQwen2.5-7B-Lite-Beta', created=None, object=None, owned_by=None, max_model_len=30000, status='spawned')\n",
      "Model(id='RefalMachine/RuadaptQwen3-32B-Instruct-v2', created=None, object=None, owned_by=None, max_model_len=24000, status='spawned')\n",
      "Model(id='DeepSeek V3', created=None, object=None, owned_by=None, max_model_len=-1, status='spawned')\n",
      "Model(id='Qwen3-235B-A22B', created=None, object=None, owned_by=None, max_model_len=-1, status='spawned')\n",
      "Model(id='RefalMachine/RuadaptQwen2.5-7B-Garant-v2', created=None, object=None, owned_by=None, max_model_len=30000, status='offloaded')\n",
      "Model(id='deepseek-r1-32b', created=None, object=None, owned_by=None, max_model_len=30000, status='offloaded')\n",
      "Model(id='qwen32b-coder', created=None, object=None, owned_by=None, max_model_len=30000, status='offloaded')\n",
      "Model(id='tpro', created=None, object=None, owned_by=None, max_model_len=30000, status='offloaded')\n",
      "Model(id='vikhr12b', created=None, object=None, owned_by=None, max_model_len=30000, status='offloaded')\n",
      "Model(id='yagpt5lite', created=None, object=None, owned_by=None, max_model_len=30000, status='offloaded')\n",
      "Model(id='RefalMachine/RuadaptQwen2.5-32B-Pro-Beta', created=None, object=None, owned_by=None, max_model_len=28000, status='offloaded')\n",
      "Model(id='qwen3moe30b', created=None, object=None, owned_by=None, max_model_len=28000, status='offloaded')\n",
      "Model(id='RefalMachine/RuadaptQwen3-32B-Instruct-v1', created=None, object=None, owned_by=None, max_model_len=24000, status='offloaded')\n",
      "Model(id='gemma3', created=None, object=None, owned_by=None, max_model_len=22000, status='offloaded')\n",
      "Model(id='RefalMachine/RuadaptQwen2.5-32B-QWQ-Beta', created=None, object=None, owned_by=None, max_model_len=16000, status='offloaded')\n",
      "Model(id='llama3-70b', created=None, object=None, owned_by=None, max_model_len=14000, status='offloaded')\n",
      "Model(id='qwen2.5-72b', created=None, object=None, owned_by=None, max_model_len=14000, status='offloaded')\n",
      "Model(id='tlite', created=None, object=None, owned_by=None, max_model_len=-1, status='offloaded')\n"
     ]
    }
   ],
   "source": [
    "wiki_bench = WikiBench(url, key, model_name='yagpt5lite', pre_load=False)\n",
    "lst = list(await wiki_bench.client.client.models.list())[0][1]\n",
    "for l in lst:\n",
    "    print(l)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 14,
   "id": "25c215dc-8ab1-4134-8e35-6d13e133db64",
   "metadata": {
    "scrolled": true
   },
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Default prompt name is set to 'Classification'. This prompt will be applied to all `encode()` calls, except if `encode()` is called with `prompt` or `prompt_name` parameters.\n"
     ]
    }
   ],
   "source": [
    "from sentence_transformers import SentenceTransformer\n",
    "import os\n",
    "import razdel\n",
    "from openai_utils import AsyncList\n",
    "\n",
    "model = SentenceTransformer(\"sergeyzh/BERTA\")\n",
    "\n",
    "texts = []\n",
    "for subdir, _, files in os.walk(r'Generation\\Subqueries_ref\\Annotations'):\n",
    "    for file in files:\n",
    "        if file.endswith(\".txt\"):\n",
    "            file_path = os.path.join(subdir, file)\n",
    "            with open(file_path, \"r\", encoding=\"utf-8\") as f:\n",
    "                text = f.read()\n",
    "                texts.append(text)\n",
    "\n",
    "base_dir = os.path.join('Articles', 'Sources')\n",
    "        \n",
    "folders = [f for f in os.listdir(base_dir) if os.path.isdir(os.path.join(base_dir, f))]\n",
    "\n",
    "snippets = wiki_bench.wiki_evaluater.get_texts_from_disk()\n",
    "topR = []\n",
    "for folder in folders:\n",
    "    snip = [1 if snippet[0] == folder else 0 for snippet in snippets.keys()]\n",
    "    topR.append((folder, sum(snip)))\n",
    "    \n",
    "annotations = AsyncList()\n",
    "for name, _ in topR:\n",
    "    annotations.append(wiki_bench.wiki_writer.get_ref_subqueries(None, 0, 0, name))\n",
    "    #annotations.append(wiki_bench.wiki_writer.get_ref_subqueries(None, 1, 0, name))\n",
    "\n",
    "await annotations.complete_couroutines(batch_size=40)\n",
    "annotations = await annotations.to_list()\n",
    "new_texts = []\n",
    "for i in range(0, len(annotations), 1):\n",
    "    new_text = annotations[i]# + '\\n' + annotations[i + 1]\n",
    "    new_texts.append(new_text)\n",
    "\n",
    "pr_scores = []\n",
    "rec_scores = []\n",
    "for text, new_text in zip(texts, new_texts):\n",
    "    text_sents = [t.text for t in razdel.sentenize(text.split('\\n')[0])]\n",
    "    text_emb = model.encode(text_sents, normalize_embs=True)\n",
    "    new_text_sents = [t.text for t in razdel.sentenize(new_text)]\n",
    "    new_text_emb = model.encode(new_text_sents, normalize_embs=True)\n",
    "    sims = new_text_emb @ text_emb.T\n",
    "    precision_scores = sims.max(axis=1).mean()\n",
    "    recall_scores = sims.max(axis=0).mean()\n",
    "    pr_scores.append(precision_scores)\n",
    "    rec_scores.append(recall_scores)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1,
   "id": "6b64656f-67cb-4e95-b92d-a027afff4d79",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "resource module not available on Windows\n"
     ]
    }
   ],
   "source": [
    "import sys\n",
    "sys.path.append(\"src\")\n",
    "from openai_utils import AsyncList\n",
    "\n",
    "from wiki_bench import WikiBench\n",
    "with open('Access_key.txt', 'r', encoding='utf-8') as file:\n",
    "    url, key = file.read().split()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "id": "56906b0c-cb87-4db9-8bd6-d57419a8bc04",
   "metadata": {},
   "outputs": [],
   "source": [
    "from wiki_agent import WikiAgent\n",
    "from wiki_evaluater import WikiEvaluater"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "id": "24f6f0e7-cbdd-4079-9b6c-f78474260211",
   "metadata": {},
   "outputs": [],
   "source": [
    "from openai_utils import AsyncList"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "id": "e97fe398-2185-4894-9401-1d637c5f07f1",
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Default prompt name is set to 'Classification'. This prompt will be applied to all `encode()` calls, except if `encode()` is called with `prompt` or `prompt_name` parameters.\n"
     ]
    }
   ],
   "source": [
    "wiki_bench = WikiBench(url, key, model_name='RefalMachine/RuadaptQwen2.5-7B-Lite-Beta', pre_load=False)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "id": "eb14b160-0a8f-4402-ac60-27d47207b147",
   "metadata": {
    "collapsed": true,
    "jupyter": {
     "outputs_hidden": true
    },
    "scrolled": true
   },
   "outputs": [
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "9f893ac2792b47d49092f9c9b5473f15",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Split strings:   0%|          | 0/13704 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "4df11975ead34acfb54e58fda04f2c76",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Stem Tokens:   0%|          | 0/13704 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "3f502c1524f44cf78905308d6c22ef9b",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "BM25S Count Tokens:   0%|          | 0/13704 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "5d92776136f64d0b90fe7e98cfe00dbb",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "BM25S Compute Scores:   0%|          | 0/13704 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "a8d03326cd9a48a2b259d2fd14453750",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Finding newlines for mmindex:   0%|          | 0.00/31.6M [00:00<?, ?B/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/plain": [
       "{('Atomic Heart',\n",
       "  1,\n",
       "  0): 'В мае 2018-го Twitter взорвался перепостами трейлера игры Atomic Heart производства российской Mundfish. Но сможет ли студия, как обещала, выпустить свою первую игру к 2020 году и будет ли она так же хороша, как ее трейлер? Скриншот игры Atomic Heart (Фото: Mundfish) В трейлере — альтернативная история СССР: 1930-е годы, страна переживает техническую революцию, которая сопровождается повальной роботизацией. Всюду советская эстетика: плакаты вроде «Мирный атом — сердце робота!», ковры-дорожки, чайные сервизы в горошек, саундтреком идет танго «Утомленное солнце», и на словах «расстаемся, я не стану злиться, виноваты в этом ты и я» герой трейлера протыкает зомби чем-то вроде арматуры. Atomic Heart — первая игра студии Mundfish, которую в 2016 году основали выходцы из рекламного бизнеса Роберт Багратуни (президент компании), Евгения Седова (финансовый директор) и Артем Галеев (арт-директор). Журналу РБК Багратуни заявил, что в начале января 2019 года Mundfish выпустит первый геймплейный трейлер, для которого уже отснято около шести часов игры. Из рекламы в геймдев Вселенную игры и ее ключевых персонажей Артем Галеев придумал около семи лет назад: среди графических работ и шоу-рилов на его сайте можно обнаружить, что эскизы некоторых персонажей были отрисованы в 2012 году. «Под гнетом российского общественного менталитета и табу на игры, которые воспринимаются как что-то схожее с мастурбацией или максимальным тунеядством, я скрывал, что разрабатываю игру, — говорил всем, что сделаю киношку», — объясняет Галеев. Роберт Багратуни, Евгения Седова и Артем Галеев (Фото: Алена Кондюрина для РБК) С Багратуни они знакомы около 17 лет. В начале 2000-х, еще студентом МФТИ, Роберт случайно попал на передачу «Модель для сборки», познакомился с сотрудниками Муз-ТВ и позже устроился дизайнером на телеканал. Там он увидел работы Галеева, который тогда занимался видеодизайном передач. «Я увидел, что это настоящий арт, и понял, что хочу развиваться в направлении компьютерной графики», — рассказывает Багратуни. Но большую часть 2000-х друзья работали в разных компаниях, занимающихся рекламой, в основном для FMCG-брендов. В кризис 2008 года рекламный рынок обвалился, заказов почти не стало, рассказывает Багратуни. Зато начал расти сегмент игр в социальных сетях и мобильных игр, поэтому Роберт, сам увлекающийся играми, ушел в их разработку. В частности, пробовал силы в создании экшена и логических игр для iPhone в Pulsar Galaxy, работал в компании Newmedia Stars (выпускала игру «Дозоры. Запрещенная игра»). В последней познакомился с Евгенией Седовой: Багратуни занимался видеодизайном, а Седова возглавляла отдел компьютерной графики. В 2011 году Роберт стал креативным директором компании Drimmi Никиты Шермана, позже работал в маркетинговой команде игрового подразделения Mail.Ru Group. Со временем из рекламной индустрии в геймдев ушел и Артем Галеев, который решил, что этот бизнес может стать источником прибыли на ближайшие десятилетия и позволит «творческую гордыню трансформировать в тихую прибыльную гавань». Еще до создания в 2016 году Mundfish Седова и Багратуни сделали несколько совместных проектов. Вместе с Глебом Никитиным и командой минских разработчиков Belprog (сейчас BP Mobile) работали над игрой — аудиомикшером для iPad MixxMuse. По словам Седовой, в первый год пользователи скачали приложение более 1 млн раз, но для роста нужно было много лицензионного контента: купить его у музыкантов было невозможно, договариваться с лейблами — долго и дорого, поэтому проект перестали поддерживать обновлениями. Зато взлетел проект мобильной платформы брокерских услуг «Источник», который разрабатывали с 2014 года. В 2016-м «Открытие Брокер» и неназванный инвестор вложили в проект $1 млн. Позже он был переделан для работы с криптовалютами и, как сказала Седова, продан одной из корейских криптобирж. В «Открытие Брокер» РБК подтвердили, что вышли из проекта во втором полугодии 2017 года. «Участие в нем перестало соответствовать целям развития бизнеса компании», — пояснил PR-директор Александр Лебедев. Покупатель и цена продажи не разглашались. Еще во время работы над «Источником» Багратуни лелеял идею открыть игровую компанию, вместе с Седовой они искали проекты. «Когда я увидел',\n",
       " ('Atomic Heart',\n",
       "  1,\n",
       "  1): 'концепты Артема, у меня, скажем так, немножко отвисла челюсть. Мы поняли, что именно это и станет новой игрой», — вспоминает Роберт. Большая франшиза Багратуни решил, что целью студии будет создание большой франшизы, которая встанет в ряд с такими играми, как BioShock и Fallout. «Мы не рассматривали мобильные или казуальные игры, не потому что они плохие или мы какие-то особенные, просто мне нравится делать то, во что я бы сам хотел играть. Ни одной мобильной игры у меня нет», — рассказывает Багратуни. Большая игра требует больших инвестиций: сколько денег будет вложено в Atomic Heart, команда не раскрывает. Седова лишь говорит, что речь идет о нескольких миллионах долларов. Роман Горошкин из EpicGames оценивает стоимость разработки в подобном проекте в вилке от $5 млн до $15 млн. Где новая компания возьмет такие деньги? Фото: Mundfish По словам Багратуни и Седовой, они вложили собственные средства. У Mundfish также есть акционер, не принимающий участия в операционном управлении. По данным СПАРК, 50,5% компании контролирует Татьяна Корчагина, остальные доли принадлежат Седовой. Муж Татьяны Сергей Корчагин владеет «Майма-Молоком», одним из крупнейших молокоперерабатывающих предприятий Алтая, раньше он был миноритарием АйМаниБанка. Корчагин также основной владелец российского юрлица «Источника». С основателями Mundfish Корчагины знакомы давно. «Периодически мы делаем совместные проекты», — сообщила Седова без подробностей, сославшись на то, что партнеры — непубличные люди. Связаться с ними журналу РБК не удалось. У Mundfish есть еще один важный партнер, который вкладывается в создание Atomic Heart, правда, не деньгами. Партнеры с Запада Летом 2018 года к Mundfish с предложением о сотрудничестве обратилась американская Nvidia, один из крупнейших в мире производителей графических ускорителей и процессоров. Как сообщил журналу РБК вице-президент по разработке Nvidia Джон Спитцер, они сами вышли на российскую компанию. Для команды это было полной неожиданностью, говорит Багратуни. Atomic Heart будет работать на платформе RTX, которая поддерживает технологию трассировки лучей в реальном времени. Для разработки Mundfish получил от партнера «железо», доступ к специальной версии движка Unreal Engine 4 и инструменты для имплементации. Инженеры компании консультируют игровую студию в Москве. Nvidia также частично взяла на себя маркетинговое продвижение игры. На игровой выставке Gamescom в Кельне компании выпустили трейлер Atomic Heart, демонстрирующий возможности RTX, планируются новые совместные маркетинговые мероприятия, говорит Спитцер. «Нам нравится работать с разработчиками инди-игр: они предлагают свежие идеи, полны энтузиазма и готовы к прорывам, что нечасто встречается в больших студиях», — пояснил он. Основатели Mundfish говорят, что у компании уже есть западное представительство, но отказываются назвать его и даже страну регистрации. «Не все хотят взаимодействовать с компаниями из России, у некоторых зарубежных холдингов страна под запретом для сотрудничества, в одном ряду с Ираном и Ираком», — объясняет Седова. Но на англоязычной версии сайта в документах, касающихся пользовательских соглашений и правил коммьюнити, фигурировала компания Mundfish Media с адресом в городе Роквилл, штат Мэрилэнд. В реестре округа Монтгомери, к которому относится Роквилл, такой компании нет. Тем удивительнее, что полный адрес, который Mundfish указала на сайте, полностью совпадает с адресом компании ZeniMax Media, владельца Bethesda — разработчика серии игр Fallout и The Elder Scrolls. После вопросов о том, что означает эта информация, Mundfish удалила все данные, касающиеся Mundfish Media из Роквилла (скриншоты старых версий сайта есть в распоряжении РБК). Люди из индустрии сообщили РБК, что среди инди-разработчиков практика использования документов крупных компаний как шаблона не редкость. Багратуни не прокомментировал ситуацию. В ZeniMax не ответили на запрос РБК. Планы и VR Бета-версия Atomic Heart должна быть готова в декабре 2019-го, релиз должен выйти позже на интернет-платформе Steam. Во втором квартале команда определит порядок и срок выпуска релиза игры на других площадках. Роберт Багратуни (Фото: Алена Кондюрина для РБК) Предпродажи игры, которые компания открыла около двух месяцев назад, показали большой интерес на азиатских рынках, отмечает Седова. Большинство покупок',\n",
       " ('Atomic Heart',\n",
       "  1,\n",
       "  2): 'идет из Японии и США, на третьем месте Корея, затем — Германия, Канада и Россия. В первый год после выхода игры команда рассчитывает продать около 1 млн копий. Mundfish уже удалось продать небольшой сайд-проект — VR-игру Soviet Lunapark, на которой тестировали технологию VR, используя некоторые материалы Atomic Heart. В 2017 году проект был продан за несколько десятков миллионов рублей российской компании District Zero, VR-парку развлечений. Экспериментируя с VR, команда хотела проверить емкость этого рынка и уникальные технологические особенности, но, как отмечает Багратуни, ее не устроила низкая скорость разработки, и дальше небольшой аркады разработчики не пошли.',\n",
       " ('Atomic Heart',\n",
       "  10,\n",
       "  0): 'Обновление от 14:10 МСК: Mundfish дала официальные комментарии для DTF. «Автор канала анонимен и преследует цель — набрать подписчиков в свои группы, при этом работает не по правилам профессиональной журналистики, где необходимо перепроверять поступающую информацию и связываться со всеми сторонами, прежде чем что-либо публиковать, а по правилам максимально жесткого кликбейта. Связи ни по одному официальному каналу от него мы также не получили. Все вышеописанное — домыслы и жонглирование слухами на фоне растущей популярности игры Atomic Heart. Легитимность данного „расследования“ будет изучена юристами Mundfish и соотвествующие меры будут приняты по итогу анализа текста, его содержимого и источников». «По поводу проекта: Soviet Lunapark. В его разработке участвовали несколько джуниор UE4-программиста, которые не владели языком C++ и не писали код. Всю разработку они вели на визуальном языке программирования UE4 Blueprints. Также следует отметить, что в компании действует строгая внутренняя политика конфиденциальности и джуниор-разработчики никогда не видят всей картины происходящего. В определённый момент было принято решение подготовить проект к эксплуатации на площадке District Zero. Для успешного запуска игры в режиме Free move Vr Arcade необходимо было внести ряд существенных правок в проект, а также реализовать поддержку технологии трекинга Antilatency. К сожалению, техническая команда проекта не смогла существенно продвинуться в данном процессе, поскольку от них требовалось работать на ином уровне, требовавшем навыков C++ программирования, работы с алгоритмами и математикой. Команда сильно затянула сроки реализации, а также в процессе начала терять субординацию, что привело к агрессивному поведению, и ряду деструктивных ситуаций. В связи с этим было принято решение расстаться с данной командой и обратиться за поддержкой к более опытным коллегам. В результате была реализована сложная техническая задача в короткие сроки. На данный момент проект полностью завершен, стабилен, и запущен в коммерческую эксплуатация на площадке District Zero на заводе Arma в режиме Free move Vr Arcade на базе трекинга Antilatency. Кстати, это первое коммерческое внедрение данной технологии, и любой желающий может оценить данный проект». «Про Atomic Heart: ядро нашей команды составляют опытные разработчики, участвовавшие над AAA-проектами зарубежных компаний. Их опыт сейчас является основной движущей силой и локомотивом компании. В скором времени мы начнём серию англоязычных стримов с разработчиками. Мы будем готовы показывать и рассказывать больше о внутренней кухне проекта. О различных технологических решениях, используемых в компании, например, для захвата движений тела и лица, о деталях внедрения технологии RTX и DLSS от NVIDIA и о многих других сложных аспекта игровой разработки в общем и проекта Atomic Heart в частности. Данная информация будет также раскрыта на планируемых митапах по UE4 в наших офисах. Но совершенно точно мы не будем идти в разрез с нашими планами и делать этого раньше только из-за того, что кто-то нас шантажирует и распространяет клевету в медиа в целях самопиара». «Настоящих журналистов из специализированных изданий мы всегда рады видеть у себя в Mundfish, давать интервью и раскрывать детали проекта в режиме комфортного общения. Наш геймдев заслуживает большего, и мы надеемся, что старания студии Mundfish будут адекватно восприняты не только на Западе но и среди наших соотечественников», — заключает Максим Зацепин , генеральный директор Mundfish. Оригинальная новость: наверное, Atomic Heart от Mundfish можно назвать одним из самых громких российских игровых проектов последних лет: боевик в колоритном советском антураже заметили не только в России, но и за рубежом. Беда в том, что Atomic Heart окружает много нездоровых слухов. Автор Telegram-канала @korovany утверждает, что отыскал девять человек, причастных к разработке Atomic Heart. Они согласились поговорить о состоянии игры на условиях полной анонимности. Восемь предоставили доказательства того, что работали над Atomic Heart, а ещё один подтвердил своё участие частично. Вся информация ниже записана с их слов. По сведениям @korovany, в Mundfish три основных человека — Максим Зацепин (также известный как Роберт Багратуни ), Олег Городишенин и Артём Галеев .',\n",
       " ('Atomic Heart',\n",
       "  10,\n",
       "  1): '• Максим Зацепин — генеральный директор и инвестор Mundfish. Инсайдеры называют его хорошим рекламщиком, который умело раздул «хайп» вокруг Atomic Heart, однако по части разработки Зацепин , мол, весьма некомпетентен. • Олег Городишенин — продюсер с опытом в геймдеве, но, как говорят собеседники @korovany, во всём поддерживает Зацепина и даже не пытается ему объяснить, как надо делать игру. Инсайдеры считают, что Городишенин пытается укрепить свои позиции в Mundfish и добивается финансовой выгоды. Ни одного положительного отзыва о работе продюсера автор @korovany не услышал. • Артём Галеев — ключевой девелопер Atomic Heart, ответственен за дизайн, сеттинг и «всё, что людям нравится в этой игре». Собеседники @korovany отмечают, что большую часть работы сделал именно Галеев . Он вынашивал идеи Atomic Heart долгие годы, игру можно назвать его личным проектом. О Галееве отзываются очень тепло. @korovany пишет, что из ключевых людей следует основная проблема: игру делает союз маркетолога и дизайнера. Atomic Heart выглядит красиво и эффектно, но, дескать, играть в неё неинтересно. У неё хорошо всё, что касается анимации, графики и эффектов. Существует дизайн-документ, но не всегда получается ему следовать. По сведениям @korovany, геймплейные «фичи» на начальных этапах выбирали «в лучших традициях геймдева»: кто-то из руководства поиграл в новую игру, увидел что-то интересное и пришёл в офис со словами «А давайте сделаем так!». Например, после DOOM один из начальников решил, что в Atomic Heart необходимы зрелищные добивания. В итоге у руководства до сих пор нет понимания, что должно получиться в конце: хотят то DOOM, то Dark Souls, то Prey. Чёткого гейм-дизайна нет. Собеседники @korovany утверждают, что разработка Atomic Heart перезапустилась пять месяцев назад. Все старые программисты ушли, а в компании оставалось всего три сотрудника. По слухам, программистов уволили после того, как кто-то из NVIDIA назвал их дураками, а руководство Mundfish приняло это заявление очень близко к сердцу. Летом 2018-го Atomic Heart была более законченной, чем сейчас, представляла из себя коридорный шутер и проходилась за 15 минут. Несмотря на такую скоротечность, @korovany пишет, что после перезапуска игра сильно откатилась назад в геймплее. У Atomic Heart сейчас серьёзные технические проблемы, потому что команде отчаянно не хватает программистов: в России очень мало опытных разработчиков на C++ и Unreal Engine 4. Однако из-за «импульсивных увольнений и плохого менеджмента» Mundfish каждый год теряла ценные кадры. За 2018-й, как пишет @korovany, из студии уволили 12 человек. Нехватку кадров заменяют дешёвой рабочей силой: бывшими студентами и джуниорами, у которых либо нет опыта работы, либо очень мало. Анонимы говорят, что человека, нанятого на позицию младшего дизайнера уровней, могут заставить вручную переименовывать сотни гигабайтов ассетов. Руководство увольняет таких людей по первому капризу. Как утверждают собеседники @korovany, первый трейлер Atomic Heart по большей части фейковый: кадры были не на движке, а пререндером, звуки — наложены, редкие кадры геймплея — тщательно срежиссированы. В последнем ролике геймплей уже настоящий, но с оговорками. Во-первых, звук, скорее всего, снова наложен поверх видео на этапе монатажа. Во-вторых, многие геймплейные моменты пока что не готовы. В-третьих, роботы ходят по карте по заранее прописанным путям и не реагируют, если к ним подойти. В-четвёртых, надписи в духе «Найти ключ от дома» могли наложить как заглушку в интерфейсе — за ними нет программной логики и квестов. У Mundfish также была VR-игра Soviet Lunapark, которую в 2017-м якобы продали российской компании District Zero за несколько десятков миллионов рублей. District Zero занимается парками развлечений в виртуальной реальности. Однако команда работала над Soviet Lunapark как минимум до лета 2018-го, то есть продать готовую игру в 2017-м руководство не могло. Автор @korovany делает предположение, что Зацепин просто хвастается. При этом инсайдеры говорят, что Mundfish не собирается «срубить бабла» и скрыться в закате, компания действительно хочет выпустить Atomic Heart. Проект доведут до конца как минимум из-за обязательств',\n",
       " ('Atomic Heart',\n",
       "  10,\n",
       "  2): 'перед инвесторами, однако результат может оказаться плачевным: в игре будет масса багов, плохая оптимизация, она падёт жертвой собственных амбиций. Цитата из материала @korovany: «Это больше простая глупость, чем запланированная хитрость». На 28 января 2019 года, как утверждает один из анонимных разработчиков, Atomic Heart готова на 20 %. В офисе Mundfish работает лишь четыре человека, а остальные члены команды — это аутсорсеры. По подсчётам собеседников @korovany, в лучшем случае коллектив Atomic Heart насчитывает от 8 до 12 девелоперов.',\n",
       " ('Atomic Heart',\n",
       "  11,\n",
       "  0): 'It’s fairly rare to see a game blow up from nowhere these days. Pre-development crowdfunding, #screenshotsaturday gif threads and teasers for teaser trailers for full trailers have somewhat put paid to the true unknown in gaming. Even E3 surprises - presumably shrouded in enough NDA paperwork to insulate a building - are few and far between in the age of the leak. Which is why arriving at work on a Wednesday morning to find a Twitter feed full of people collectively losing their minds over an all-but-unheard-of Soviet nuclearpunk nightmare shooter felt quite so special. If you haven’t watched the Atomic Heart trailer, you should remedy that now: Play I just watched it twice more myself - it’s brilliant. An absolute dervish of styles, combat and, particularly, threats that promises so much. But so much of what? While it seems pretty clear that this is a first-person action game amid a Fallout-like rewritten history, there’s a lot more we can only guess at. What has caused robots, zombies and eldritch blood tentacles(?) to start cropping up, why are we fighting them, and should it be making me... laugh?Perhaps more importantly - who’s making all this? Mundfish is listed as the developer, but there’s precious little information out there about the studio, aside from a willfully cryptic website that reveals another game, Soviet Lunapark VR, is in development. I’m happy to say that I can spoil some of the mystery for you. Mundfish is a Russian studio currently made up of 20 developers (although that’s expected to double over the next six months) and, somewhat perfectly, was founded specifically because Atomic Heart sounded so cool - it’s been exciting people from nowhere since before it even had a name. Play “The credit for \\u200b\\u200bthe plot of the game belongs to the art director of the project, Artyom Galeev”, explains Mundfish CEO, Robert Bagratuni over email. “He had it in the making for seven years. When I read the synopsis and saw the first sketches, it became clear that the game had a huge potential. Then, together with the producer, Oleg, we assembled a whole group of talented game developers who shared our way of thinking, every single one of whom has worked on various game projects in the past.”So what is that plot?“The world of Atomic Heart is an alternative reality of the Soviet Union, or an alternative past”, says Bagratuni. “I.e. this is a game about everything that could have happened but did not take place in the USSR in the ’30s through to the ’60s.“The storyline takes place in a reality where the USSR still exists, but a technical revolution has already taken place: robots, the Internet, holograms have already been invented, but all these innovations are submerged in the atmosphere of communism, confrontation with the imperialism of the West and all the other inherent political and social aspects of the time.”So far, so Fallout - until we’re told about the lead character:“The protagonist is a Soviet KGB officer. This officer has mental issues. This is putting it mildly. In fact, he is completely insane. And his party has sent him to the power plant ‘3826’ and is waiting for the report. ‘3826’ is inherently strategic - it produces robots for working in the fields, gathering timber, harvesting, keeping everything in peace as well as for working at home and in the public catering.“Robots are everywhere, they are bartenders, cleaners, security guards, caretakers for the elderly. They have an appealing appearance because they were being sold everywhere, like iPhones. In every house there was a robot, in every business.',\n",
       " ('Atomic Heart',\n",
       "  11,\n",
       "  1): 'Then something happened.”He leaves it at that, but it’s clear from the trailer that there’s more at work here than broken robots. Bagratuni is a little more cryptic on that front. “The game world is definitely stuffed with all sorts of weird things. This is our thing. In fact, it was this way in the Soviet Union, in the sense that everything was very unusual and unpredictable. The USSR was famous for its brilliant engineers and advanced research in science, while at the same time, in the atmosphere of secrecy, some research institutes could easily have spawned robots and zombies, absolutely anything.”The idea is to conjure up an exaggerated version of the strangeness of the real Soviet Union. Bagratuni brings up two real-world events as inspiration: the Dyatlov Pass incident, in which nine experienced ski hikers were found mutilated across the Ural mountains having torn their way out of their own tents; and the death of Leonid Brezhnev when, instead of announcing the passing of its General Secretary, the Communist Party reportedly broadcasted ‘Swan Lake’ on the radio for 4 hours. In an odd tribute to an odder event, Swan Lake will be played throughout the game, and be given a techno remix.Mundfish is a lot less forthcoming with details about what it is to play the game, although Bagratuni admits that some commenters are making “very good progress” with their guesswork. The trailer’s gunplay and weapon customisation seem to point to an FPS with RPG elements, but he simply describes it as “part shooter, part hardcore close combat game.”The map that appears at the end of the trailer certainly implies an open-world setting and, while not a true confirmation, Bagratuni does explain that “the map is huge”. It’s converted from a real-world USSR chart and encompasses the Arctic Circle, plains, forests, and mountain passes, and is connected by a usable railroad system. He also points out that it’s layered, with “a surface level and abandoned underground departments of ‘3826’” He also mentions Bunkers, “very detailed locations with a special Soviet atmosphere”. It seems these might act like dungeons of some kind, given that Bagratuni points out they’ll feature very limited ammo, meaning every shot needs to count.The most common reference points among commenters have been Bioshock (shooter in a twisted world) and Fallout (retro-futurist setting), and Bagratuni acknowledges their influence, but it’s other titles - not all of them games - that he prefers to compare his studio’s work to. The story he compares to a Soviet-set episode of Black Mirror. He repeatedly mentions the team’s focus on close combat, eventually explaining that the team’s aiming for a “first-person Bloodborne” (it’s something you notice more when looking back at the trailer). Overall, he compares the game’s approach to arguably the loftiest creations of all: “We are all fans of Kojima and love hardcore games with a deep storyline, but we are not going to forget about the mass audience.”We cover a little more - the trailer is meant much more as creeping horror than offbeat comedy (I won’t lie, I’m a little embarrassed that I may have upset Bagratuni by saying it made me laugh), the strange watch the character wears is a utility that ticks to distract hostile robots, and it absolutely will not be free-to-play - but it’s clear Mundfish doesn’t want to say much more.Atomic Heart doesn’t yet have a concrete release date - the studio’s still deciding whether to partner with a publisher, which could wildly change when it can deliver what it’s working on - but it has plans for how it will reveal',\n",
       " ('Atomic Heart',\n",
       "  11,\n",
       "  2): \"more before then.Soviet Lunapark VR is due for release this month, and is designed as something of a story primer. Set in the same universe, but broadly disconnected, it will “give the opportunity to see some zones of plant ‘3826’ from the inside, and witness yourself what the employees of the plant went through when an attack occurred and everything broke down.” The studio also wants to tackle some of the naysayers who believed the Atomic Heart trailer was too good to be true by releasing a gameplay trailer that shows more plot and mechanical detail.Right now, however, Bagratuni seems content to let newly excited players simply speculate among themselves. “To be honest,” he says of the reaction to the first trailer, “it's just incredible! Although we really want the game to be truly great and well-received by the players, we did not expect this even in our wildest fantasies! The whole team is absolutely excited, inspired and motivated by the reaction of the audience.” True surprises in gaming might be rare, but Mundfish is making a case for why the reward can justify the risk. Joe Skrebels is IGN's UK News Editor, and he wants one of those sphere-headed robots for his house, stat. Follow him on Twitter\",\n",
       " ('Atomic Heart',\n",
       "  12,\n",
       "  0): 'По поводу проекта: Soviet Lunapark. В его разработке участвовали несколько джуниор UE4-программиста, которые не владели языком C++ и не писали код. Всю разработку они вели на визуальном языке программирования UE4 Blueprints. Также следует отметить, что в компании действует строгая внутренняя политика конфиденциальности и джуниор-разработчики никогда не видят всей картины происходящего. В определённый момент было принято решение подготовить проект к эксплуатации на площадке District Zero. Для успешного запуска игры в режиме Free move Vr Arcade необходимо было внести ряд существенных правок в проект, а также реализовать поддержку технологии трекинга Antilatency. К сожалению, техническая команда проекта не смогла существенно продвинуться в данном процессе, поскольку от них требовалось работать на ином уровне, требовавшем навыков C++ программирования, работы с алгоритмами и математикой. Команда сильно затянула сроки реализации, а также в процессе начала терять субординацию, что привело к агрессивному поведению, и ряду деструктивных ситуаций. В связи с этим было принято решение расстаться с данной командой и обратиться за поддержкой к более опытным коллегам. В результате была реализована сложная техническая задача в короткие сроки. На данный момент проект полностью завершен, стабилен, и запущен в коммерческую эксплуатация на площадке District Zero на заводе Arma в режиме Free move Vr Arcade на базе трекинга Antilatency. Кстати, это первое коммерческое внедрение данной технологии, и любой желающий может оценить данный проект.',\n",
       " ('Atomic Heart',\n",
       "  13,\n",
       "  0): \"Atomic Heart's most recent trailer has created quite the buzz in Video Game Land. Visually the game looks phenomenal, but the psychedelic scenes that unfold have left viewers with a lot of questions. Suitably intrigued myself, I decided to scour the internet to find out as much about the story and gameplay of Atomic Heart as possible. Atomic Heart is an adventure first-person shooter (think along the lines of BioShock) set in an alternate universe version of the Soviet Union. It's built in Unreal Engine 4 by a little-known development studio named Mundfish, which is based in a loft office in central Moscow. Only one photo of the development team exists on social media and it shows a couple of young designers planning out the game's story using a paper map and Post-it notes. The resolution of the picture is too low tell what's written on the map, but I'm pretty sure that fella in the foreground is part way through eating a marker pen. Mundfish's first social media post for Atomic Heart was pushed out on 23rd March 2017, showing us the studio has been working on the game for at least 14 months. Mundfish have another game in the works called Soviet Lunapark VR, which ties in with the events of Atomic Heart. The announcement trailer for this game came out on 10th April, but it flailed to generate anywhere near the levels of buzz we're seeing for Atomic Heart. Soviet Lunapark is a VR horror game set in and around the same location as Atomic Heart. It boasts a story mode that can be played in single-player or co-op, and a PvP arena for some multiplayer mayhem. According to the Steam page for Soviet Lunapark, you can also play a Whack-a-Mole game with your friends, although in this case Nazi-hamsters assume the role of the moles. If that's not enough weirdness for you, it also says you can win prizes by shooting hungry Soviet seagulls out of the sky with a slingshot. Seems like the developers have made sure there's plenty of lighthearted moments to balance out all the horrific uber-violence. Is this an Alt-Hamster? Back to Atomic Heart now, and I've discovered the majority of the game is set in a bizarre secret research complex called Facility No3826. This facility is codenamed Sechnov, which I'm guessing is a reference to Ivan Sechnov. Sechnov is the father of Russian physiology whose main interests lay in neuroscience, in particular how activity in the brain is linked to electrical currents. Chances are this choice of name isn't random, because according to a post on the Atomic Heart website, the machines of 3826 are rising up are killing everything not made out of nuts and bolts. Now it's possible that these robots have been programmed to behave like this, but perhaps it's actually secret experiments on the human brain that have allowed these robots to somehow become self aware. Judging by all the warped visuals in the trailers it's probably safe to say at least some of the experiments in the facility are linked to neuroscience, but perhaps those trippy scenes are more than just simple hallucinations. Have the scientists in 3826 discovered a way to distort reality itself? Have they found a way for humans to control the elements with their minds, perhaps? The answers to those questions remain a mystery for now. It's not just robots you have to worry about in 3826. Zombies also appear in the the trailer, confirming human experimentation also went on behind the walls of the facility. In Atomic Heart, you play as\",\n",
       " ('Atomic Heart',\n",
       "  13,\n",
       "  1): \"a special agent named P-3 who infiltrated 3826 to find out exactly what's been going on there and most importantly, what's gone wrong. Nothing else is really known about P-3, but in the trailer you can see he wears distinctive leather gloves that have some kind of metal device or decoration on each of the middle fingers. Also of note is his watch which, considering the lack of a UI in the gameplay, probably acts as a health meter. The action in Atomic Heart has an emphasis on close combat battles and multiple melee weapons make an appearance in the most recent trailer. There are firearms in the main game but the ammo for these is said to be tightly limited, which suggests that stealthy play may be the best option for a lot of the game. Did you notice the P-3 insignia under the thumb of the left hand? Soviet Lunapark VR on the other hand looks like it's all about the shooty bangs. The trailer for that game shows the player character fighting off waves of bad guys with an arsenal of weaponry, some of which can be dual-wielded. One remaining mystery is the release date for Atomic Heart. All we know at the moment is it's coming out soon on the PC, PlayStation 4 and Xbox One. Soviet Lunapark VR on the other hand is scheduled to come out on Steam sometime this month for HTC Vive and Oculus, but it's also due to come out on Playstation VR at an undisclosed date. To find out even more details about Atomic Heart and Soviet Lunapark VR, check out my video at the top of this article where I show off gameplay from all three available trailers.\",\n",
       " ('Atomic Heart',\n",
       "  14,\n",
       "  0): 'Шутер Atomic Heart сквозь годы разработок наконец-то добрался до релиза. Он станет доступен для всех уже завтра - 21 февраля. Я же в свою очередь прошел предоставленную \"РГ\" пресс-версию и в этом тексте расскажу, что это за \"Атомное сердце\" такое. Если попытаться максимально кратко описать суть игры студии Mundfish, то получится следующее: \"Любовное письмо серии Bioshock\". Если Big Daddy для вас - это в первую очередь здоровенный водолаз с буром, а Колумбия - нечто связанное с облаками, дальше в принципе можете не читать: расчехляйте банковскую карту и оформляйте покупку. Для аудитории более спокойной к творчеству старины Кена Левина ситуация не настолько простая, давайте разбираться почему. Atomic Heart стоит на трех \"слонах\": сюжете, визуале и геймплее. Пробежимся по ним отдельно. Не думаю, что есть смысл в очередной раз подробно останавливаться на завязке - за пять лет, что проект находился в производстве, ее уже неоднократно показывали в трейлерах и пересказывали на различных ивентах. Альтернативная история, в Советском Союзе гениальный ученый совершил научное открытие, благодаря которому СССР достиг небывалых высот в робототехнике. Накануне важного для всей страны события что-то в высокотехнологично организованном обществе дает сбой и машины начинают неистово выпиливать своих кожаных хозяев. Разбираться с бардаком посылают сурового майора Сергея Нечаева с позывным \"п-3\", роль которого и берет на себя игрок. В качестве напарника протагонисту выдают говорящую перчатку, и эти двое всю дорогу разыгрывают между собой дуэт Шрека и Осла. Иногда получается интересно и забавно, временами - не очень. Голоса этим двум персонажам подарили Александр Ломов и Леонид Белозорович. Актеры со своей задачей справились хорошо. В начале создаётся впечатление, что сценаристы не совсем внятно прописали главного героя. Со стороны он выглядит эдаким дженерик-альфачом без души и харизмы, явно проигрывающим по этим параметрам условному Ядерному Герцогу. Но позже эти моменты изящно объясняются сценарно, и вопросы сами собой снимаются. Артисты на записи, судя по всему, ни в чем себе не отказывали и ничем себя не ограничивали, потому что в их речи почти в каждом диалоге проскальзывают непечатные выражения. И это по-своему работает на атмосферу. Например, когда злющие роботы пытаются разорвать на куски главного героя, он выдает не дистиллированное: \"Черт побери, какая неудача!\" - а истошно орет благим матом, полностью оправдывая рейтинг \"18+\". У Нечаева даже есть нецензурная присказка, которая, скорее всего, разлетится по интернету на мемы, но даже ее значение авторы в итоге органично вписали в повествование. Сама история получилась крепенькой научной фантастикой, следить за ее развитием интересно, хотя финал ближе к середине и начинает казаться предсказуемым, особенно - опять же - для игравших в BioShock. Второй \"слон\" - визуал и стилистика. Это безусловно одни из самых сильных сторон Atomic Heart. В прологе, в котором вас выпускают погулять по советскому городу альтернативных 50-х, хочется скриншотить буквально все. Все детали окружения воссозданы и наполнены характерным ретро-футуризмом с такой дотошностью, что возле каждого плаката так и тянет остановиться и прочитать очередной лозунг, даже обои с линолеумом - и те рассматривать интересно. Третий \"слон\" - геймплей. Про него нельзя сказать, что он весь косой и кривой, но периодически он, тем не менее, подхрамывает то на одну, то на другую ножку. Здесь остановимся подробнее. Боевая система задействует обе руки протагониста - в правой огнестрельное или оружие ближнего боя, в левой - специальные способности, вроде заморозки и удара молнии (кто сказал плазмиды?!) Все это, естественно, можно прокачивать и крафтить, чтобы потом на поле боя комбинировать и остервенело лупцевать агрессивные жестянки. Задумывалось это все, вероятно, для фана, но мне было не весело. Советские роботы качественные и крепкие, сделаны на совесть, поэтому почти каждого даже с улучшенным оружием приходилось подолгу ковырять, а это утомительно. У самой стрельбы при этом не слишком чувствуется импакт. В теории к каждому виду противников надо подбирать свою',\n",
       " ('Atomic Heart',\n",
       "  14,\n",
       "  1): 'тактику, смотреть какие у него есть уязвимости, но на деле эти консервные банки почти всегда нападают толпой, и в таких условиях думать особо не успеваешь. Некоторые из скиллов очевидно менее полезны, чем другие. Например, телекинезом можно кидаться в основном коробками, а вот бюст Ленина запустить в супостата уже не получится. Зачем-то разработчики добавили изрядную долю платформинга. Но платформинг в играх от первого лица - это почти всегда ужасно, если только речь не идет о Mirror\\'s Edge. Секции с прыжками в одном месте идут подряд друг за другом - они, вероятно, создавались с оглядкой на камеры испытаний из серии Portal, только без занятных механик с портальной пушкой. Есть пара мест с бэктрекингом (необходимость возвращаться обратно тем же маршрутом), а бэктрекинг - это всегда отвратительно. Нельзя не сказать про головоломки и вскрытие замков. Ближе к финалу они начали уже натурально выбешивать. Только что закончив сложный бой с толпой противников Нечаев подходит к очередной двери, которая откроется, только если решить загадку, гоняя несколько разноцветных точек по круглому циферблату - тоска и уныние. Вопросы есть и к полуоткрытому миру. Во-первых, он большой и насыщенный - видно, что люди старались и корпели над его созданием. Но он почти всегда находится под яростным наблюдением роботов. Везде развешаны камеры, они поднимают тревогу, сбегаются другие роботы и вместо того, чтобы познавать этот мир, приходится возиться с волнами неприятелей. Сюжетно все обосновано великолепно, но это убивает вообще весь кайф от эксплоринга. Отсюда вопрос: насколько надо было Atomic Heart жанрово становиться шутером? Ведь все три ее слона опираются на здоровенного кита, который условно можно обозначить, как \"хорошо продуманный и подробно описанный лор\". Мир игры живой и интерактивный. Если вы где-то находите аудиодневник или записку, то с большой долей вероятности за ними кроется мини-история - смешная или трагичная. Некоторые из них по посланиям на компьютерах можно отследить - они проходят сквозной линией почти через весь сюжет. Все в Atomic Heart работает по своим внутренним законам, подчиняется логике происходящего и последовательно объясняет геймеру местное положение дел. Блогеры еще долго будут выпускать ролики на YouTube с разбором содержимого записок, посланий и даже надписей на стенах. Команда Mundfish далеко не первая, кто пытается перенести в игровой формат стилистику альтернативного СССР. Навскидку можно вспомнить крепкую, но не выдающуюся Singularity, древнюю и провальную You Are Empty и серию Red Alert. Но ни одна из них не смогла предложить столь целостной и продуманной вселенной, как в Atomic Heart, которая уже готова к франшизному расширению. Стоит отметить, что студии чертовски повезло с моментом выхода игры. Сейчас, когда из-за нейросетей целые профессии оказались под угрозой, концепт со взбесившимися роботами уже не кажется таким невероятным, каким он выглядел во времена первых двух \"Терминаторов\" с их \"Скайнетом\". Специальную музыкальную нейросеть авторы поместили и внутрь самой игры. Она гоняет по местному радио лицензионные треки, вроде \"Миллион алых роз\", \"Остров невезения\", \"Косил Ясь конюшину\" и другие хиты советских лет, которые очень здорово играют на атмосферу. К сожалению, ничего подобного нельзя сказать про оригинальный саундтрек. Когда было объявлено, что написанием музыки будет заниматься Мик Гордон (композитор перезапуска DOOM 2016 года), я ожидал услышать что-то масштаба BFG Division. Но Мика Гордона совсем не слышно в его же собственном саундтреке. Есть одна жиденькая ненавязчивая мелодия, которая уже демонстрировалась в сцене сражения с Ежихой, и еще одна чуть позже - вот и все. По звуку также есть вопросы. Дело в том, что события игры разворачиваются на промышленных предприятиях, где на фоне гремят какие-то машины, все это сливается с тягучим эмбиентом, в итоге из-за этого не слышно ни диалогов персонажей, ни атак противников, ни каких-либо других важных шумов. Мне даже пришлось лезть в настройки, чтобы понизить звук окружения, что несколько поправило ситуацию. Продолжая тему технических огрехов, поговорим об',\n",
       " ('Atomic Heart',\n",
       "  14,\n",
       "  2): 'оптимизации. Она здесь вполне сносная. На RTX 2060 настройки самостоятельно выстроились в средневысокое положение, и картинка в 2k-разрешении большую часть времени держала 60 кадров. При этом графика в игре, что называется, на уровне: все современные эффекты, лучи летят, правильно отражаются и глазам приятно на такую красоту смотреть. Значительные и заметные просадки случались почему-то в начале каждой из катсцен и в битвах с боссами, где в кадре задействуется одновременно много эффектов. Из багов за время прохождения замечено следующее. Иногда реплики персонажей накладывались друг на друга. Оповещение о последнем подобранном предмете не исчезало и продолжало отображаться даже во время катсцен. Периодически пропадал указатель новой задачи в миссиях, из-за чего я даже один раз поймал софтлок - передо мной не открылась дверь, которая очевидно должна была открыться - после переигровки все заработало, как надо. Ну и еще четыре раза игра вылетала на рабочий стол с ошибкой. Возможно, все эти шероховатости разработчики уберут патчем первого дня. Что в итоге? Atomic Heart - это честная AAA-игра со всеми их современными болячками. Она по-настоящему большая и масштабная - по моим прикидкам на прохождение основной сюжетной кампании у меня ушло не меньше 30 часов. И это были хорошие 30 часов. У проекта чувствуется огромный потенциал. Трудно прогнозировать - с учетом всех обстоятельств, - как Atomic Heart примут на Западе, но у нас - что-то мне подсказывает - она совершенно точно войдет в пантеон любимых народных хитов. В России игру продают на площадке VK Play за 2499 рублей, и для ее покупки достаточно карты российского банка - не надо мастерить костыли, обращаться к посредникам и как-то еще дополнительно изощряться.',\n",
       " ('Atomic Heart',\n",
       "  15,\n",
       "  0): 'Егор Аргунов слышит во снах рокот космодрома Страница автора Игра Atomic Heart показывает альтернативный Советский Союз 1955 года. Его граждане посвятили себя науке и искусству, а тяжелую работу отдали роботам-помощникам. Все шло хорошо, пока в сверхсекретном комплексе «Предприятие 3826» не случился сбой машин. Гражданские андроиды перешли в боевой режим и напали на работников. Руководитель «Предприятия» вызывает на подмогу главного героя, майора разведки Сергея Нечаева. Ему придется в одиночку разбираться с угрозой. Мы прошли Atomic Heart и теперь рассказываем о ее главных особенностях — без сюжетных спойлеров. Вот чем можно заняться в игре. Что за Atomic Heart Дата выхода: 21 февраля 2023 года Жанр: экшен-RPG Платформы: ПК — Steam и VK Play; PlayStation 4 и 5; Xbox One и Series Режим игры: одиночный Издатель: VK Play в странах СНГ и Focus Entertainment в остальных странах Разработчик: Mundfish Игры, похожие на Atomic Heart: BioShock, Singularity, Prey (2017) Примерная продолжительность: 20 часов на сюжетную кампанию, до 30 часов на полное прохождение Перевод: у игры есть полная русская озвучка и субтитры Подробнее: на сайте игры https://www.youtube.com/embed/lG4kPj05OlM 🛠 Посмотрите на мир победившего коммунизма Действие Atomic Heart разворачивается в альтернативной Казахской ССР 1955 года. 20 лет назад исследователь Дмитрий Сеченов создал особое вещество — полимер. Вскоре на его основе разработали первый в мире искусственный интеллект. Благодаря полимеру в СССР произошла научная революция, Сеченов с коллегами занялись выпуском роботов и компьютеров. Исследователи даже научились выводить новые виды существ: для этого они смешивают с полимером гены уже существующих животных и растений. К 1955 году Советский Союз стал самой развитой державой в мире. Строительство домов, вырубка леса и другой ручной труд легли на плечи роботов. Люди же занялись творчеством и наукой. Полимер позволил советским ученым отправить людей в космос, изобрести новые виды оружия и средства связи. Однако главное достижение Сеченова — в 1946 году он создал глобальную нейросеть под названием «Коллектив». Она объединяет всех подключенных роботов и людей, словно локальный интернет. В 1955 Сеченов готовит к запуску вторую версию «Коллектива». С ней люди смогут управлять роботами силой мысли. В состав Советского Союза к 1955 году входит Германская ССР Мир альтернативного СССР завораживает проработанностью. Город рядом с «Предприятием 3826» пестрит плакатами о величии социализма. Роботы проводят экскурсии, устраивают уличные представления и следят за порядком. Горожане давно привыкли к железным соседям и не представляют свою жизнь без них. Из случайно подслушанных разговоров, аудиозаписей и текстовых описаний мы узнаем, что благодаря искусственному интеллекту Советский Союз пришел к настоящему коммунизму лишь за два десятилетия. Граждане равны и обеспечены всем необходимым от государства. Социалистический лагерь в мире Atomic Heart настолько могущественен, что СССР обеспечивает «гражданскими» роботами США и другие западные страны. Роботы готовы выполнять любые задачи: маршировать на улицах, помогать ученым в лабораториях, танцевать балет на сцене На улицах в альтернативном СССР можно услышать реальные советские песни: «Лучший город Земли» Муслима Магомаева, «Трава у дома» группы «Земляне», «Звездное лето» Аллы Пугачевой. Большинство из них вышло гораздо позже 1950-х, но и этому у игры есть объяснение. За появление композиций ответственна музыкальная нейросеть «Радио будущего». Она предсказывает, какие песни появятся в следующих эпохах, и воссоздает их в прошлом. Советуем после начала игры не идти сразу по основному сюжету. Насладитесь обстановкой: рассмотрите здания на улицах, послушайте разговоры прохожих и изучите памятники. А как окажетесь на территории «Предприятия 3826», зайдите в деревенские дома — они находятся между научными комплексами. Полюбуйтесь иконами, коврами на стенах и клетчатыми скатертями. В интерьерах Atomic Heart вы наверняка увидите много знакомого. Большинство скульптур в мире Atomic Heart создают роботы 😍 Съешьте освежающее эскимо и выпейте газировки из автомата Рядом с улицей, где проходит праздничный парад, дружелюбный робот «Рафик» раздает всем желающим эскимо на палочке. Именно такое, какое нужно, — слегка подмерзшее и с',\n",
       " ('Atomic Heart',\n",
       "  15,\n",
       "  1): 'бугорками на шоколадной глазури. Подойдите к «Рафику» и протяните ему руку. Посмотрите, как бывалый майор Нечаев жадно кусает мороженое. После этого, вероятно, вам самим захочется поставить игру на паузу, чтобы сбегать в магазин за эскимо. Эскимо одинаково нравится всем — и школьникам, и майорам разведки Сладкое следует чем-нибудь запить. Благо напротив мороженщика стоит легендарный автомат с надписью «Газированная вода». Подойдите к нему и возьмите граненый стакан с напитком. В летнюю жару — идеально. Выбор невелик: либо обычная газированная вода, либо лимонная Увы, в игре больше не будет возможности спокойно поесть мороженого и выпить газировки. На «Предприятии 3826» стоит несколько автоматов с водой, но заказать ее не получится. Зато майор Нечаев может найти водку и сгущенку. Они дают преимущество в бою. Сгущенка увеличивает наносимый противникам урон, а водка на время повышает защиту от атак. Недалеко от мороженщика стоит стильный робот-диджей. Он подозрительно похож на музыканта Олега Парастаева из группы «Альянс» 🤖 Познакомьтесь с достижениями советской робототехники На «Предприятии 3826» майор Нечаев противостоит целой армии злобных машин. В основном его атакуют модели лаборантов — «Вовчики». Эти лысые роботы с пышными усами чаще дерутся врукопашную, но некоторые угрожают дубинками и боевыми лазерами. Все роботы в игре наносят значительный урон. Даже относительно слабые «Вовчики» могут убить вас несколькими ударами. Ни за что не поворачивайтесь к врагам спиной — они сразу набросятся. Научитесь уворачиваться. Без успешных уворотов вы будете часто погибать в сражениях. Один «Вовчик» — уже риск, а целых три — прямая угроза для жизни Кроме «Вовчиков» на «Предприятии 3826» майора поджидает еще несколько видов гражданских роботов. Среди них — лесник «Работник» с бензопилой, медицинский помощник «Док» с иглой, самоходная косилка «Роторобот» с лезвиями и дрон «Дрофа» с ракетами. Все роботы подсоединены к локальной сети «Коллектива». Они моментально реагируют на угрозу, нападают толпой и атакуют одновременно. Первым делом важно избавиться от самых назойливых противников в стае. Советуем начинать с «Дрофов»: они попадают по майору чаще остальных. Угрозы не представляют лишь роботы-помощники модели «Терешкова». Они работают экскурсоводами, продавцами и администраторами Кроме обычных роботов встретятся особые — они выступают в качестве игровых боссов. В одной из миссий на вас нападет огромная геодезическая машина «Ежиха». Она быстро катается по арене, стреляет ракетами и прыгает прямо на главного героя. В другом задании Нечаева попытается растоптать крупногабаритный погрузчик «Наташа». Используйте как можно больше разного оружия. Это поможет подметить недостатки разных моделей роботов. Так выяснится, что «Вовчиков» легко убить холодным оружием, а «Наташа» уязвима для ракетных выстрелов. Академика Дмитрия Сеченова повсюду сопровождают роботы-телохранительницы. Он называет их просто — «Левая» и «Правая» ✊ Оцените возможности экспериментальной перчатки ХРАЗ В начале игры Нечаеву выдают полимерную перчатку с кодовым названием «Хранитель знаний», сокращенно — ХРАЗ. У перчатки есть искусственный интеллект, и она подключается напрямую к организму майора. ХРАЗ докладывает герою обстановку, ведет с ним диалоги и сканирует местность. А еще дает сверхъестественные способности вроде телекинеза. Перчатка становится незаменимым инструментом для Нечаева. С помощью телекинеза майор всего за несколько секунд может собрать полезные ресурсы — и создать из них снаряжение и боеприпасы. Вытаскивать ресурсы из ящиков еще никогда не было так приятно Перчатка крайне полезна в бою. С ней можно стрелять током, создавать вокруг себя защитное поле и замораживать противников. Полимерные способности восстанавливаются после использования и не требуют дополнительных ресурсов. Используйте их при любой возможности. Так у вас будет преимущество перед роботами: у них таких чудо-перчаток нет. «Вовчики» уязвимы для холода, так что перчатка будет очень полезна в боях с ними Еще ХРАЗ умеет взламывать замки и сканировать противников, а потом выводить информацию о них. Перчатка пригодится и в решении несложных головоломок. Кроме того, она будет обсуждать с Нечаевым события на «Предприятии 3826». За несколько часов прохождения вы точно привяжетесь к ХРАЗ и будете',\n",
       " ('Atomic Heart',\n",
       "  15,\n",
       "  2): 'с нетерпением ждать от него новых комментариев. Сканер показывает слабости роботов и то, какие ресурсы могут выпасть после победы над ними 🖼 Насладитесь советским изобразительным искусством Дайте глазам отдохнуть — посмотрите красочные плакаты с агитпропагандой. Здесь и предостережения для работников «Предприятия 3826», и реклама «трехгорного пива», и афиши старых фильмов. На многих плакатах красуются роботы из игры. Советуем почаще оглядываться по сторонам. В коридорах «Предприятия 3826» много любопытных стилизованных картин. 👨\\u200d🔬 Устройте себе экскурсию по «Предприятию 3826» Это главный научный комплекс СССР, именно его сотрудники занимаются экспериментами с полимерным веществом. На территории «Предприятия» расположены несколько комплексов поменьше — каждый со своими функциями. В комплексе Вавилова изучают все, что связано с биологией и ботаникой. В комплексе Павлова открыты экспериментальные медицинские лаборатории. А на Выставке достижений народного хозяйства гостям «Предприятия» демонстрируют все доступные модели роботов. В некоторых местах есть сгустки полимерного вещества. По ним можно перемещаться с одного этажа на другой За каждым комплексом «Предприятия» закреплен свой руководитель и персонал. Их истории вы можете узнать из переписок в компьютерах. Письма раскрывают важные подробности о мире Atomic Heart: рассказывают о результатах экспериментов и переговорах ученых с руководителями Политбюро или о том, как руководство «Предприятия» пыталось скрыть возникающие проблемы. Личные истории отдельных людей хранят щебетари — устройства для записывания голоса. Они есть во всех уголках «Предприятия». Щебетари выдадут вам сокровенные тайны погибших жителей комплекса. Скажем, работника театра, который собирался сделать предложение роботу-балерине. В игре десятки подобных рассказов о чужих судьбах. Во всех уголках «Предприятия» лежат погибшие люди с работающими нейроконнекторами. Физически они мертвы, но их сознание работает еще какое-то время 🔫 Используйте изобретения советских инженеров и конструкторов Полимерное вещество повлияло на развитие оружейного дела. Но огнестрел в Atomic Heart почти такой же, как и в нашем мире. Майор Нечаев может взять с собой пистолет Макарова, автомат Калашникова и дробовик КС-23. Само оружие и боеприпасы к нему печатаются в автоматах-принтерах с искусственным интеллектом. Робот-автомат «Элеонор» испытывает к Нечаеву весьма теплые чувства Все оружие в игре улучшается новыми обвесами и компонентами. На дробовик можно повесить тепловизор, на автомат Калашникова — энергокинетический приклад. Правда, для этого понадобятся специальные оружейные чертежи. Ради них не жаль обыскать каждую локацию. Не нравится огнестрельное оружие? Возьмите энергетическое. Например, пистолет «Электро» и импульсную пушку «Доминатор»: они не расходуют боеприпасы, а тратят восстанавливаемую энергию. На создание каждого вида оружия уходит определенное количество ресурсов — это могут быть биоматериалы и железные детали На первых этапах пострелять в удовольствие не дадут. Патронов всегда мало, приходится беречь оружие для особенно сильных противников. К счастью, ближе к концу игры боеприпасов будет в избытке. А до тех пор пользуйтесь обычным топором — его выдают в самом начале. Позже вы сможете молниеносно бить врагов с помощью топорика «Лис» или оглушать их дубинкой «Звездочка» с циркулярной пилой. Почувствуйте себя лесником 🎮 Совет Т\\u2060—\\u2060Ж: поиграйте в Atomic Heart Игра позволяет найти свой стиль прохождения и придерживаться его. Atomic Heart можно превратить хоть в стелс-экшен, хоть в динамичный шутер на манер современных Doom. Вы можете делать упор на ближний бой и прокачивать только холодное оружие. Или чаще использовать полимерные способности. Скажем, покрывать врагов полимерной струей, а затем стрелять в них огненными патронами и поджигать. А можете и вовсе проходить все уровни максимально скрытно, стараться лишний раз не поднимать тревогу. Все открытые способности легко откатить назад и взять вместо них другие. А из ненужного оружия собрать что-нибудь новое. Так вы сможете адаптироваться к любым ситуациям и экспериментировать со сборками. Боевая система побуждает играть агрессивнее. В Atomic Heart важнее всего скорость реакции и эффективность в бою. Нужно не только драться с противниками и метко стрелять, но и вовремя бить их током и использовать другие полимерные способности. Отсидеться в укромном уголке не получится. Враги лезут',\n",
       " ('Atomic Heart',\n",
       "  15,\n",
       "  3): 'со всех сторон и постоянно совершают перегруппировки. Иногда игра становится чересчур сложной. Но в этом видишь скорее испытание своих возможностей — любое поражение мотивирует играть лучше. Эту надпись вы будете видеть часто Сюжет интригует до самого конца. Игра начинается как стандартная история о восстании роботов в антиутопическом антураже, но постепенно становится глубже. Проясняются взаимосвязи между персонажами, мотивы их поступков и истинные причины событий. Сценарно игра напоминает серию BioShock, а также шутер Prey 2017 года. Но с упором на юмор. К сожалению, ближе к концу сюжет Atomic Heart становится скомканным. В последние два часа событий больше, чем в предыдущие шестнадцать. При этом некоторые вопросы остаются без ответа, а сюжетные линии — без финала. Вероятно, авторы Atomic Heart надеются рассказать больше в сиквеле. Графика впечатляет. Atomic Heart создали на устаревшем движке Unreal Engine 4, но игра выглядит лучше многих других современных шутеров. Свет корректно отражается и в помещениях, и на открытом воздухе. На лицах персонажей видны мельчайшие детали вроде пор. Четкие текстуры есть и у небольших объектов вроде стаканов. Игра выглядит отлично даже на консоли Xbox Series S, которая не поддерживает разрешение 4К. Однако технически Atomic Heart точно могла быть лучше. За время моего прохождения она вылетела семь раз. Некоторые зависания обнуляли прогресс на 15—20 минут. В больших локациях игра периодически тормозит, а лицевые анимации выглядят неуклюже. Впрочем, часть проблем легко исправить обновлениями. Графика в Atomic Heart не хуже, чем в последних Call of Duty и Doom Eternal После прохождения хочется увидеть больше проектов в этой вселенной. В Atomic Heart нам показали лишь одно предприятие с гражданскими роботами. В возможных продолжениях можно переместить действие в города и показать полноценные боевые машины. А история развития СССР после полимерной революции достойна сериальной экранизации.',\n",
       " ('Atomic Heart',\n",
       "  16,\n",
       "  0): '21 февраля состоится мировой релиз шутера Atomic Heart, который создали разработчики из России. По сюжету, спецагент КГБ из альтернативного мира СССР должен предотвратить уничтожение человечества роботами. «Сноб» рассказывает, что собой представляет альтернативный мир 1950-х годов и как международные компании помогли российским разработчикам Кадр из игры Atomic Heart Фото: Mundfish Разработчики Atomic Heart детально продумали локации видеоигры Альтернативная реальность 1950-х годов в Советском Союзе: при коммунизме произошла техническая революция, роботы обрабатывают древесину и работают в поле вместо людей. Общество же занято развитием науки и строительством идеальных городов. Однако на предприятии №3826 роботы поднимают бунт. Спецагент КГБ, которым управляет игрок, должен устранить последствия аварии и предотвратить уничтожение человечества. Создатели хотят погрузить геймеров в альтернативный мир, поэтому сделали для Atomic Heart 40-минутный пролог — в нем рассказывается история профессора Сеченова, который создал вещество, способное накапливать электричество, что положило начало технической революции и восстанию роботов. Перед началом игры покажут пока что не тронутые роботами города. В трейлере распознали Волгоград и Москву — на террасах сталинской высотки теперь разбиты сады, а в небе проносятся дроны. Разработчики заявляли, что главный герой будет сражаться с роботами на территории от Арктики до Горного Алтая. Кадр из игры Atomic Heart Фото: Mundfish Создатели компьютерной игры детально продумали и технологии, которыми пользуется спецагент КГБ. Полимерная перчатка, с помощью которой игроку предстоит уничтожать взбунтовавшихся роботов, способна сканировать пространство, передвигать предметы на расстоянии и заряжать электротехнику. Разработчики также придумали необычные имена для роботов, с которыми борется главный герой: одного из наиболее часто встречающихся врагов назвали Лаборантом, оживший механизм с лесоперерабатывающего предприятия получил имя Курочка, железный слесарь стал Беляшом, а робот-охранник — Наташей. Кадр из игры Atomic Heart Фото: Mundfish Помимо сюжетных сражений с Беляшами и Наташами, для перехода на следующий уровень геймерам предстоит решать головоломки. В финале Atomic Heart игроки смогут сами выбрать, как закончить прохождение. «Возможность выбора добавили, чтобы подтолкнуть сообщество к спорам и рассуждениям о темах, которые заложены в историю», — говорят авторы компьютерной игры. Саундтрек к Atomic Heart написал австралийский композитор Мик Гордон, который сочиняет музыку в основном для видеоигр (Need for Speed; Wolfenstein). В Atomic Heart также звучат советские песни и их ремиксы. Проект привлек инвестиции международных компаний Компьютерную игру Atomic Heart создали в студии Mundfish — в 2017 году ее основали российские разработчики Артем Галеев, Роберт Багратуни, Евгения Седова и Олег Городишенин. С момента открытия они работали исключительно над шутером Atomic Heart. К команде постепенно присоединялись новые люди из разных стран: в 2018 году в студии работали чуть больше 20 человек, в начале 2023-го — около 130. Кадр из игры Atomic Heart Фото: Mundfish Изначально игру планировали выпустить в конце 2018 года, однако дату релиза сначала перенесли на 2020 год, затем на конец зимы 2023-го. Предположительно, переносы дат связаны с проблемами внутри команды. В 2019 году в сети опубликовали расследование анонимного автора, в котором тот рассказывал о серии увольнений сотрудников студии, плохом менеджменте и перезапуске разработки с нуля. В Mundfish заявили, что все это слухи. Основатели Mundfish решили, что целью студии будет создание одной большой франшизы. «Мы не рассматривали мобильные или казуальные игры, не потому что они плохие или мы какие-то особенные, просто мне нравится делать то, во что я бы сам хотел играть. Ни одной мобильной игры у меня нет», — рассказывал журналистам Роберт Багратуни. Кадр из игры Atomic Heart Фото: Mundfish В 2018 году студия Mundfish начала сотрудничать с американской компанией Nvidia, одним из крупнейших в мире производителей графических ускорителей и процессоров. Nvidia помогла проекту с техническим оснащением, а также взяла на себя маркетинговое продвижение игры. В 2021 году стало известно, что Mundfish привлекла инвестиции международных компаний Tencent, Gaijin Entertainment и GEM Capital. Atomic Heart назвали самой ожидаемой игрой 2023 года Последняя демонстрация игры прошла',\n",
       " ('Atomic Heart',\n",
       "  16,\n",
       "  1): 'в конце 2022 года, тогда же на YouTube выпустили один из трейлеров (всего их шесть). За пять месяцев проморолик к Atomic Heart набрал больше 6 миллионов просмотров. В том же году игру студии Mundfish по результатам онлайн-голосования назвали одной из самых ожидаемых в Восточной Европе. По результатам других голосований Atomic Heart стал главной игрой 2023 года. Кадр из игры Atomic Heart Фото: Mundfish Релиз Atomic Heart состоится 21 февраля 2023 года. Игра будет доступна для Windows, PlayStation 4, PlayStation 5, Xbox One и Xbox Series X/S. На территории СНГ видеоигру будут продавать на платформе VK Play, в остальном мире она будет доступна в сервисе Steam. Подготовил Петр Бузлаев',\n",
       " ('Atomic Heart',\n",
       "  17,\n",
       "  0): 'After more than half a decade in development, Atomic Heart has arrived as the first title from developer Mundfish. This BioShock-inspired shooter is an impressive debut in many ways, and it wears its influences on its sleeve – for better and worse. The game’s dazzling world design, extraordinary production values, and fast-paced fights make for a solid campaign, but the derivative plot and often painful writing insist on dragging it down. Atomic Heart’s premise is one of its most intriguing elements. The game takes place in an alternate-history Soviet Union that has become the world’s foremost superpower after World War II, thanks to the scientific innovations of Facility 3826. The player assumes the role of Agent P-3, an operative under the command of Soviet genius Dr. Dmitry Sechenov. When Sechenov’s latest social experiment goes wrong, P-3 is ordered to fight through the Facility’s rampaging robots and murderous mutants to reach the truth. P-3 has access to uniquely upgradable weapons and elemental abilities, but combat is less like BioShock than it may sound. Instead of stealth, hacking, and environmental traps, Atomic Heart demands faster and more reactive shooting to curb the attackers’ superior numbers. Enemies have particular weaknesses that can only be exploited with clever combinations, like covering a plant-based mutant with accelerant gel before setting it aflame with incendiary rounds. Battles are both dangerous and satisfying, and the diversity of opponents keeps combat engaging. The world of Facility 3826 is also gorgeously realized with Atomic Heart’s sublime art direction. From the very first scene, the game wows you with its exceptional production values. Meticulous attention to detail is seen in everything from the communist architecture to the internal components of robots, and it really makes the game’s what-if scenario seem plausible. The sprawling overworld of the Kazakh mountains also feels large without being empty; plenty of surprising secrets and environmental variety supplement the close-quarters fights and spatial reasoning puzzles of the underground levels. Atomic Heart’s biggest problem, however, is its writing. Most of the dialogue ranges from irritating to downright unbearable. P-3 is an angry military man who is constantly yelling, cursing, and using witless sarcasm. He talks a lot – and it’s usually to complain about something. His interactions with the sexually frustrated crafting machine are especially painful, and the rest of the cast isn’t much better. The script is not provocative; it’s just covering up a lack of substantial character development. Sadly, the actual plot is also a major letdown. Most of it is told through abrupt info-dumps, which quickly erodes any sense of mystery and makes all the events incredibly predictable. The story spends much of its time clumsily rehashing many of BioShock’s themes with a Soviet spin. Sadly, the best writing is hidden in the various terminals throughout the game, which contain most of the worldbuilding and connect other characters to one another. On the one hand, Atomic Heart is a good game on its own merits. The fun and frantic gunplay, outstanding visual design, and intricate level of detail in its world amount to an experience worth your time. On the other hand, it could have been so much more. The story and characters simply don’t do justice to the game’s thought-provoking premise, and some better writing would have done wonders. Despite that, Atomic Heart is still an exciting and memorable first outing from Mundfish.',\n",
       " ('Atomic Heart',\n",
       "  18,\n",
       "  0): 'После долгих лет разработки долгожданная Atomic Heart от студии Mundfish добралась до релиза. Нам удалось собственноручно познакомиться с финальной сборкой, поэтому спешим в деталях рассказать о первом проекте молодой команды. Да, игра прекрасно работает, но с некоторыми особенностями, о которых мы сегодня обязательно поведаем. Ранее нам довелось опробовать первичную сборку «Атомного сердца», поэтому отметим сразу, что конечный продукт геймплейно немного отличается. Разработчики значительно доработали первоначальные механики и ускорили геймплей — теперь бои стали динамичнее и плавнее. Сравнивать версии мы не будем, поэтому сразу перейдём к сути. Строим счастливое будущее вместе? Кратко и быстро пройдёмся по стартовому сюжету для затравочки. Atomic Heart перенесёт игроков в альтернативную вселенную, в которой выдающийся учёный Дмитрий Сеченов создал «Полимер». Это привело к дальнейшему развитию технологий — роботы с искусственным интеллектом заполонили планету, а секретный Объект 3826 стал главной базой СССР, занимающейся передовыми разработками. По не самому удачному стечению обстоятельств в 1955 году происходит сбой в программе роботов, поэтому машину занялись безостановочной зачисткой территорий закрытого города от людей. Геймерам придётся исправить сложившуюся ситуацию за майора Нечаева по личной просьбе Сеченова. Мы не приветствуем спойлеры, поэтому о дальнейших событиях рекомендуем узнать самостоятельно. Сюжет развивается последовательно, моментально втягивает в происходящее, частенько заставляет задумываться о происходящем и открывает другую сторону прогресса. Ожидать сценария уровня Оскара давних лет не стоит, однако все происходящие события понятны, а действия героя логичны. Atomic Heart, как и любая другая хорошая история, не стоит на месте. Она постепенно развивается и глубже погружает наблюдателя в игровой процесс. К тому же для постоянного поддержания вовлечённости игрока в процесс разработчики внедрили в руку героя искусственный интеллект ХРАЗ, который не только предоставляет полезные советы, но и часто содействует информационными диалогами, раскрывая подробности лора. Да и Нечаев, офицер с «искоркой» — может жёстко пошутить или вовсе послать виртуального друга куда подальше. Получается, и весело, и полезно. Хотя временами грубость кажется немного натянутой, но общие впечатления это не особо портит. Благодаря такому точному воплощению двух разумов достигается полноценная синергия — бродить по локациям не надоедает, болтовня приносит наслаждение и возникает непреодолимое желание получить новые вводные о событиях. Другие герои немного отстают от «центральной двойки», но тоже остаются в памяти — балерины (куда же без них), баба Зина, ежиха и Сеченов. Хотя скорее всего к финалу игроки вряд ли вспомнят, как звали немца-учёного, инженера-саботажника и других менее важных для сюжета личностей. Но избушку… избушку точно запомните. Не забудем упомянуть и атмосферу. С первых минут и до самых титров игрок не только условно, но и фактически погружается в Советскую эпоху. В каждом участке мира замечаешь аутентичный антураж — от общения между героями до плакатов, лозунгов и других фрагментов былого времени. Все элементы окружения хорошо сочетаются между собой и складываются в цельную картину. Спаситесь от Вовчиков С геймплеем всё не так однозначно, поэтому пойдём с самых азов. По сюжету игрок окажется, как в закрытых локациях, так и в открытых, поэтому игровой процесс в этих зонах будет немного отличаться. В полигонах, исследовательских центрах и других станциях Нечяеву придётся выполнять различные действия по поиску сюжетных предметов и уничтожать, как Гордон Фримен или Сэм Фишер (чаще, как первый), любые цели перед собой. Попутно придётся решать множество головоломок. Некоторые совсем простые (быстро активируйте пять лампочек или взломайте замок двумя кнопками), однако другая часть выполнена на грани сложности — повозиться придётся, но мозг «сломать» вряд ли получится. Все они связаны с переключением огоньков или настройкой направления света. В больших локациях всё меняется в обратную сторону — майору нужно добраться до следующего важного строения, а на улицах города полно роботизированной нечисти, желающей заняться аннигиляцией героя. Уничтожить всех не получится — на помощь прилетят пчёлки из улья и за небольшой промежуток времени восстановят всех убитых противников. Конечно, игрок позднее получит жучка',\n",
       " ('Atomic Heart',\n",
       "  18,\n",
       "  1): 'для отключения этих дронов и сможет на короткий срок свободно исследовать локации, однако в любом случае придётся добраться до соответствующего строения, взломать систему и только после этого отправляться зачищать территорию. Впоследствии пчёлки всё равно восстановят инфраструктуру, поэтому бессмысленно тратить время только на это занятие. Проще пройтись аккуратно в сторонке, уничтожить камеры, убить врагов и быстро осмотреть здания. Внутри них игрок почти всегда находится в безопасности, поэтому каждый раз целенаправленно отключать системы не обязательно. Решение сомнительное, но вполне логичное и оправданное, особенно учитывая наличие высоких технологий. К тому же стелса как такового не присутствует, однако при особом желании можно уничтожить андроидов бесшумно со спины. Добавим, что на карте нельзя ставить дополнительные маркеры, а соответственно запоминать полезные и интересные места придётся самостоятельно. Отмечены только сюжетные цели и дополнительные полигоны, в которых можно раздобыть полезные модули на оружие. Из неприятного — полное отсутствие побочных заданий и второстепенных активностей. В итоге получаются весьма просторные локации, в которых можно побродить, преследуя собственные цели (собрать ресурсы, модули и т.п.), но сама игра никак не будет мотивировать геймеров к этому. Возможно, это следствие «открытого мира», от которого решили отказаться в процессе разработки. Противники бывают разные, но отметим наиболее частых — человекоподобные Вовчики нескольких типов (один быстрый, второй с дубинкой и щитом, да и третий тоже сможет жопу «надрать»), пчёлы для починки других роботов и нанесения небольших ранений герою, работники с острыми бензопилами и резкими прыжками, безобидные инженеры Рафики до первой атаки игрока, органические побеги, превращающие трупы в култышей на примере серии The Last of Us, а также летающие сипухи, стреляющие лазерами и прочие более мощные и редкие враги. Вариаций немного, поэтому в большинстве случаев придётся сражаться именно с ними. Берегите левую руку! Отдельно отметим бесшовный процесс сбора предметов, которым разработчики точно могут гордиться. Игрок при помощи левой руки и кинетической силы засасывает все возможные предметы к себе в инвентарь. Визуально это выглядит следующим образом — направляем метку на шкафчик или другой доступный предмет, нажимаем и удерживаем одну кнопку и перемещаем прицел по всем контейнерам рядом до полноценного сбора артефактов. Вдобавок к этому все дверцы и крышки будут открываться, ящики выдвигаться, а на экране появятся мелкие предметы, которые сразу же окажутся в сумке игрока. Благодаря такой системе, игрок не тратит время на открытие и изучения дополнительных меню, а попросту «пылесосит» всю округу. Будьте осторожны, это очень «залипательно»! В битвах игроку доступны двенадцать вариаций ближнего и дальнего боя, между которыми можно переключаться одной кнопкой (если они были сделаны, конечно), а также уникальные умения «Шок» для активации электрических разрядов, «Стужа» для заморозки, «Телекинез» для захвата, «Полимерный бросок» для дальнейшего использования огня, холода или электричества на жидкость и «Полимерный щит» для ограждения героя от урона. Шок доступен всегда, а два других умения необходимо выбрать в «Элеоноре», специальном роботе-шкафчике для прокачки. Будьте бдительны — при первом знакомстве этот чудо-холодильник будет активно домогаться до героя! К слову о последней — собранные предметы игрок может потратить на улучшение своих умений или оружия. Разработчикам удалось создать впечатляющую продуманную систему. При установке любого модуля меняется внешний облик оружия — здесь и увеличенные магазины, прицелы, особые стволы и другие обвесы для «пушек», а также особые лезвия, особенные удары и рукоятки для холодных «клинков». К тому же к каждому экземпляру можно прицепить кассетник и при наличии уникальных электрических, морозных или огненных боеприпасов увеличить урон. Полимерные улучшения перчатки героя и вовсе не только повышают статистические параметры, но и изменяют принцип их действия. К примеру, усовершенствованный Шок будет отталкивать врагов электрическими разрядами, набрасывать цепную молнию и разрывать раненых роботов на части. Ко всему прочему можно прокачать персонажа и увеличить инвентарь, скорость передвижения, запас здоровья и энергии, сопротивление к урону и другие полезности. Многие улучшения требуют не только различного мусора, но',\n",
       " ('Atomic Heart',\n",
       "  18,\n",
       "  2): 'и более специфических деталей. Чаще всего их нужно собирать с поверженных противников, так что стоит потрошить каждого поверженного противника. Особой необходимости в фарме нет, и при грамотном распределении ресурсов сложностей возникнуть не должно. Технологии, вперёд! К графике и музыкальному сопровождению не придраться. Все модели высокодетализированные, с высочайшим качеством изображения. Роботы, оружие, здания выполнены с максимальной реалистичностью. Заметны отметины, потёртости и прочие важные для современных игроков детали. Роботы смачно разрываются на части и рассыпаются на части. К сожалению, любоваться видами вряд ли получится — вдалеке заметны природные ландшафты и другие объекты. Музыкальное сопровождение тоже очень приятно скомпоновано. Все композиции советской эпохи играют через радио, граммофоны и громкоговорители без наложения на основную аудиодорожку. В битвах включаются динамичные треки для поддержания боевого духа игрока. Самое подходящее для того, чтобы навалять бездушным роботам! А вот к техническому состоянию вопросы. Конечно, с первой игровой сессии заметные просадки FPS были пофикшены, однако игрокам стоит быть готовыми к небольшим шероховатостям. Вполне возможно, что патч первого дня и ближайшие обновления исправят ситуацию, но не отметить эти проблемы было нельзя. Из безобидного — застревание персонажа или не открывшаяся дверь и повторное прохождение участка, а из критичного — проблемы с умениями и ошибки в работе механик. Также в некоторых роликах пропадала плавность анимаций и заметно снижалось качество звука. Платформа при этом не особо важна, так как баги появлялись, как на PC, так и на PlayStation 5. Очень надеемся, что эти «особенности» будут исправлены, а разработчики не бросят фанатское сообщество. Зато порадовала оптимизация. На PC с видеокартами из «прошлогодней коллекции» можно, не прибегая к хитростям вроде DLSS, получить стабильные кадры на «атомных» настройках. Попытки поиграть на более слабом железе были вполне успешные. Старушка GTX 1050 не была отвергнута игрой, хотя настройки графики пришлось скинуть к минимальным. Atomic Heart в первую очередь экшен, а не шутер, поэтому в зависимости от личных предпочтений игроков может сработать по-разному, из-за чего появляется двоякое восприятие геймплея. Игровой процесс точно приведёт геймеров в восторг при яркой приверженности к жанру, особой любви к серии BioShock или Prey и желании внимательно зачищать локации, а не бежать сломя голову наперевес с дробовиком. Иначе несбывшиеся ожидания «мясного» шутера с необычным визуальным стилем полностью оттолкнут игрока. И дело не в каких-то очевидных проблемах геймплея, а в эмоциональной предрасположенности пользователя, который хоть и насладится крутыми тактическими действиями в битвах, но не сможет безостановочно направо и налево уничтожать злобных роботов, как в том же Doom Eternal. Плюсы: Детализированная графика; Точное попадание в атмосферу и сеттинг; Обширные возможности прокачки; Интересный сюжет; Отличный саундтрек. Минусы: Некоторые механики не до конца проработаны; Большие локации без дополнительных активностей. Итоговый балл: 8.5 из 10 Вердикт: Atomic Heart — удался. Не шедевр на все времена, но определенно заслуживает внимания. Дизайн, музыка и скрупулёзно построенные локации погружают в уникальную атмосферу, а сюжет удерживает за игрой до самых титров.',\n",
       " ('Atomic Heart',\n",
       "  19,\n",
       "  0): 'Научная фантастика — это самый умный жанр в художественной литературе. От обычной фантастики и ее подвида про драконов, эльфов и магию — фэнтези — он отличается жесткими требованиями к подходу создания мира произведения. На первый план встают причинно-следственные связи, логика и научное обоснование всему, что происходит. Если кто-то вдруг умеет пускать молнии из рук, то недостаточно просто сказать, что персонаж так умеет потому что (Сила мистическая виновата или вот “природой так заложено потому, что МАГИЯ!”). Подобное пояснение может подойти ребенку или тому, кто думать не желает, но не взрослому умному человеку. Необходимо не просто разъяснить, за счет чего у героя появилась такая способность, но и дать логическое и техническое объяснение, как это работает. По этой причине достойных игр в жанре научной фантастики очень и очень мало. Так как к ним предъявляются те же требования, что и к литературному произведению. Качественная Sci-Fi очень редка, а если появляется, то сразу же становится объектом пристального внимания умной аудитории. Путь научно-фантастического шутера Atomic Heart получился очень сложным. Впервые об этой игре геймеры услышали 8 мая 2018 года, когда никому не известная студия Mundfish неожиданно для всех представила шикарный трейлер игры. По словам директора студии Роберта Багратуни, к моменту анонса команда уже год работала над продуктом, и вот пришло время представить его общественности. Но все было не так просто. Люди, “знакомые с ситуацией”, стали сливать информацию, что трейлер — это лишь постановочный ролик, целью которого является “сбор средств с инвесторов на финансирование разработки”, а самой игры вообще нет. Со временем эта история вылилась даже в неслабый скандал с интригами и расследованиями, но сейчас я не буду его пересказывать. Отмечу лишь то, что показанное в первом официальном трейлере игры очень далеко от того, что получилось в итоге. В том плане, что общий советский вайб сохранился отлично, но, помимо лечения в виде поедания банки сгущеночки, ни одного показанного в ролике кадра в финальную версию не попало. В итоге Mundfish, вопреки всем злым языкам, смогли найти солидных спонсоров и, засучив рукава, продолжили работу. Уже завтра, ранним утром, в релиз выходит, пожалуй, лучшая игра, созданная в России. Хотя “лучшая” — понятие крайне субъективное, и вы с автором вправе не согласиться, но я постараюсь вам подробно объяснить, почему был сделан такой вывод. Позабыты хлопоты, остановлен бег, Вкалывают роботы, а не человек! В нашей стране отдельным интеллектуальным развлечением является вопрос, “А что было бы, если история СССР повернулась иначе?”. Как бы мы сейчас жили? Что было бы с политической ситуацией во всем мире? И все такое прочее. Наративщики студии Mundfish решили к этому вопросу подойти всерьез, перелопатив много научно-популярной литературы, и предложить геймеру альтернативную историю великой страны. С первого же кадра на игрока обрушивается великолепие! События Atomic Heart развиваются в альтернативном 1955 году. После Великой Отечественной войны Советский Союз совершил колоссальный рывок в научно-техническом прогрессе. Благодаря взрывному развитию робототехники страна смогла быстро оправиться, и теперь представляет собой самое передовое государство в мире. О советских работах-помощниках мечтает любая страна в мире. Производство, настройка и отладка чудотехники налажено на Предприятии 3826 — экспериментальном городе, построенном вокруг единственной цели — привести страну к светлому коммунистическому будущему, в котором человечество будет жить счастливо, занимаясь любимым делом, а весь тяжелый труд и производство возьмут на себя роботы. Сталинский ампир и советский размах А случились эти научные чудеса благодаря гениальному ученому и инженеру, академику Дмитрию Сергеевичу Сеченову, который в 1936 году открыл новое вещество — нейрополимер. Эта материя стала настоящим прорывом в области передачи информации и энергопроводимости. С его помощью лучшие ученые страны смогли создать устройства, благодаря которым появилась возможность объединить все разумы людей в единую нейрополимерную сеть — “Коллектив 2.0”. Теперь любой человек в мгновение может стать ученым, артистом, писателем — знания всех и каждого будут',\n",
       " ('Atomic Heart',\n",
       "  19,\n",
       "  1): 'доступны любому, кто подключен к сети. Советский Союз готов запустить “Коллектив 2.0”, обязав всех людей стать его частью благодаря устройству нейроконнектора “Мысль”, — ради общего блага. Теперь человечеству не нужны телефоны, телевизоры, записные книжки и любые средства связи, ведь все люди будут объединены в общую информационную сеть. Также благодаря “Мысли” люди смогут мысленно управлять роботами. Детей в Челомее нет, хотя коляски встречаются Страна, которую мы потеряли Главным героем Atomic Heart является майор Сергей Нечаев, позывной П-3, специальный агент и личный помощник академика Сеченова по особо важным делам. Нечаев — человек с нелегкой судьбой, прошедший войну. Во время некоторых послевоенных событий в Болгарии майор получил серьезную травму. Сеченов спас ему жизнь, но цена оказалась высока — герой практически ничего не помнит из своего прошлого. Максимум, это события последних двух лет жизни после трагических событий и операции. А кодят Вовчики все равно на английском. Недосмотр дизайнеров Игра начинается с красивейшей кат-сцены. Майор плывет на небольшом катамаране с винтовым двигателем Архимеда (он же шнековый двигатель) на ручной тяге, радуясь красивому дню и размышляя о предстоящем задании, которое ему выдал лично Сеченов. Это \"Мысль\" — устройство, которое объединит разумы всех граждан СССР Вокруг буйство красного цвета знамени страны Советов и зелени деревьев и кустов. Население города вышло на улицы и стремится на главную площадь, расположенную перед монументального размера сооружением комплекса “Икар”. С первых же секунд нас знакомят с экспериментальным устройством — перчаткой, наделенной искусственным интеллектом ХРАЗ (Хранитель Знаний). Благодаря полимерным волокнам, ИИ способен подключаться к любому электронному устройству. Налюбовавшись красотами советской утопии (на это дело у вас может уйти больше часа — настолько детально разработчики подошли к вопросу), и узнав, чем живут жители города Челомей, вы получаете подробности задания и отправляетесь за руль служебной машины. Но ехать вам никуда не придется — летающий робот-транспортник подцепит ваш автомобиль и отправится до точки назначения по воздуху. В этот момент вы понимаете, что весь город, и множество различных предприятий вокруг парят в небесах на колоссальных по размеру платформах. Вокруг исполинские статуи, прославляющие гений советской науки, а по радио играет “Миллион алых роз”. От открывшейся перед глазами картины захватывает дух. Но неожиданно происходит сбой, и пролетающий мимо дрон переходит в агрессивный режим, атакуя нашу машину. К счастью, дело уже шло к посадке, и высота падения оказалась недостаточной, чтобы получить критические увечья. Да и сам майор солидно нашпигован различными имплантами и протезами, что позволяет ему выдерживать гораздо больший урон. Связавшись с Сеченовым, вы узнаете, что на Предприятии случилась диверсия. Предатель Родины перепрограммировал роботов, взяв под контроль сеть \"Коллектив 1.0\", заставив их атаковать людей. Теперь нам разгребать последствия. До чего дошел прогресс! До невиданных чудес: Опустился на глубины и поднялся до небес. Atomic Heart восхищает с первых кадров до финальных титров. Условно игру можно разделить на три части — боевая, повествовательная и исследовательская. И каждая из этих частей исполнена на высочайшем уровне. В первом случае перед нами шутер от первого лица. Тут все привычно любителям жанра — находим оружие, сражаемся с противниками, у каждого из которых своя манера боя, находим еще больше оружия, запчастей к нему и занимаемся улучшением своих девайсов. Практически любое вооружение можно в игре усовершенствовать, превратив невнятный на начальном этапе пистолет в устройство аннигиляции всего вокруг. Слева — устройство сохранения. А справа — \"Элеонора\", весьма неожиданный шкаф, который будет улучшать вас и оружие Стрельба и ближний бой выполнены очень достойно. Вы чувствуете вес оружия, и каждый его вид ощущается по-разному. У огнестрела есть адекватная отдача, а противники соответственно реагируют на стрельбу — например, заряд из дробовика отбросит Вовчика, а очередь из калаша порвет его в лоскуты. Калаш — практически универсальное оружие, особенно после прокачки Арсенал не то, чтобы огромный, но благодаря разнообразным вариантам улучшения, его более чем',\n",
       " ('Atomic Heart',\n",
       "  19,\n",
       "  2): 'хватает для самых разных нужд. Хотите сражаться в ближнем бою? Нет проблем — вашим первым помощником в битве станет пожарный топор, который можно будет превратить в такой себе Топор Судного Дня благодаря различным обвесам. Желаете сражаться на дистанции? Также нет проблем — Нечаев с поверженных противников и в различных ящиках и сундуках собирает специальные материалы, с помощью которых может улучшать огнестрельное и энергетическое оружие. Но также среди ресурсов вы подбираете нейпополимер, благодаря которому сможете обучиться особым навыкам, которые сделают из майора эдакого джедая-мага. Конечно, наративщики потрудились все объяснить с научной точки зрения — улучшаетесь не только вы, но и перчатка. Это баба Зина, такая себе Сара Коннор на пенсии К примеру, если изучите “Стужу”, то ИИ будет генерировать в устройстве криогенный полимерный состав, который подается наружу в виде струи, направленной на противника или иную поверхность. Попав под воздействие, цель получит эффект заморозки. Также “стихийным уроном” можно снабдить и оружие, присоединив к нему специальный кассетный модуль, в который можно помещать кассеты, придающие оружию различные эффекты. Вообще, сценаристы потрудились дать пояснение каждому нюансу и ответить на каждый вопрос, который может возникнуть у игрока по лору игры. Не все ответы будут доступны сразу, и не всегда логика будет стопроцентная, но ребята очень старались. Так что если вы ставите перед собой целью узнать больше деталей случившегося, раскрыть больше тайн и планов верхушки ЦК КПСС и разгадать по ходу сюжета несколько заговоров, то вам придется детально изучить широкие пространства открытого мира Atomic Heart. И это вторая часть геймплея — исследовательская. Интересно, для каких нужд проектировались усатые модели с женской грудью? Игра сама подталкивает вас к неторопливому изучению. Сразу после попадания в подземный комплекс “Вавилов” Atomic Heart вдруг предстанет перед вами в образе стелс-хоррора. Конечно, можно бегать, не скрываясь и размахивая топором направо и налево, никто не запрещает, но общая атмосфера, царящая вокруг, настраивает на аккуратное прохождение. Да и к Вовчикам тоже надо привыкнуть, неповрежденные модели вполне себе в состоянии удивить самоуверенного геймера, мгновенно наваляв ему в рукопашной схватке. Но совсем скоро вы получите свой первый огнестрел, и дела пойдут гораздо быстрее. А пройдя “Вавилов”, вы окажетесь на огромном открытом пространстве. Но в отличие от типичных шутеров “в открытом мире”, игра не предложит вам аттракцион “развлеки себя сам”. Наоборот, она постоянно будет стремиться вернуть вас к сюжетной части, подсовывая новый дневник с интересной информацией или “говорящий труп”. Не удивляйтесь. Инъекция нейрополимера в организм человека позволяет мозгу сохранять остаточную активность и после физической гибели организма. Смекнули, какие перспективы это создает? То-то же! Вот эта длинная сопля и есть тот самый полимер. В нем можно плавать, не боясь задохнуться Но никто не запрещает вам идти туда, куда захочется. Опять же, по миру игры разбросано несколько испытательных полигонов, в которых вам предстоит проявить смекалку и решить несколько пространственных и физических загадок, а также иногда сразиться с сильным противником. Эти зоны вовсе не обязательны для прохождения, и никак не влияют на общий сюжет, но в них вы найдете различные модули для улучшения оружия и много ресурсов. Так что овчинка выделки определенно стоит. Шедевр советской инженерной мысли И настоящей жемчужиной Atomic Heart является ее повествовательная часть. Сюжет игры подается очень грамотно, постепенно, не торопясь, но и не задерживаясь настолько, что вы начнете скучать. Мое глубочайшее уважение Александру Ромашкову, нарративному директору студии Mundfish, за шедеврально проделанную работу! За время прохождения игры вы построите не одну теорию происходящего вокруг, и не одну гипотезу сформулируете, но раз за разом игра вас удивит реальностью. Биомутанты выглядят действительно стремно. Это вы еще биоробота Плюща не видели Интрига будет держать вас до самого финала. Но и он не даст все ответы на вопросы. Признаться, не понимаю, по какой причине приняли решение концовку сделать открытой (к слову, концовок',\n",
       " ('Atomic Heart',\n",
       "  19,\n",
       "  3): 'в игре две, но только одна очевидно каноничная), однако после финальной сцены остается тоскливое чувство недосказанности. Возможно, ставка делалась на будущие DLC, которые непременно появятся. Надеюсь, что это действительно так и мы все-таки узнаем, чем эта захватывающая история закончится. Мы рождены, чтоб сказку сделать былью, Преодолеть пространство и простор, Нам разум дал стальные руки-крылья, А вместо сердца — пламенный мотор. С графической точки зрения игра выполнена очень и очень хорошо. Картинка бессовестно восхищает яркостью и красотой. Хотя сглаживание могло бы быть и лучше. Кроме того, вы быстро обнаружите, что игре не хватает разнообразия в вопросе уникальности лиц NPC. Но это мелочи. Марсиане пока не высадились Анимация героя (только под ноги не смотрите), противников, даже видеокамер, выполненных в форме ромашки, — все на высочайшем уровне. Игра света и тени, гамма, спецэффекты. Все эти искры от попадания пуль по металлу или разорванная электропроводка — команда проделала восхитительную работу. А итогом этого труда стала шикарная оптимизация! Мои настройки стояли на ультра-качестве. Лишь пару раз я словил микрофризы за все два десятка часов геймплея! Пару раз! И насколько мне известно, другие авторы нашего портала также не столкнулись с проблемами производительности игры. Я играл в пресс-версию, в которой нет антипиратской защиты Denuvo. И очень надеюсь на то, что ее наличие не испоганит работу игры. Вся эта красота работает без каки-либо тормозов И, конечно же, надо упомянуть звук и саундтрек к игре. Лязг и скрип металлических суставов роботов, бесконечная трескотня “Пчелы”, полетевшей чинить недавно побежденного вами противника (спасибо, хоть боссов не восстанавливает), стремные звуки биомутантов, попавших под контроль “ростков” — и все это под аккомпанемент шикарных аранжировок в исполнении Мика Гордона, легенды игровой индустрии, работавшего над DOOM. А вот засилье советской и российской попсы меня особо не впечатлило. К слову, вам понятно объяснят, почему в 1955 году играет музыка из 90-х. Я понимаю, почему эту музыку добавили в игру — она действительно добавляет погружения, но ее слишком много! Уже через несколько часов прослушивания очередного “Стоят девчонки, стоят в сторонке” я полез в настройки и выкрутил громкость радио на ноль. Обычных балерин заменили робобалерины. Задачи те же самые: красиво танцевать и сексуально удовлетворять партийных боссов А в тишине природы вы будете слышать пение кукушки. Только не спрашивайте ее, сколько Нечаеву жить осталось — сглазите, хоть это и антинаучно. Еще хочу отметить откровенный мисс-касст актрисы, которая озвучивала бабу Зину. Естественно, я играл на русском языке, и как игра звучит на других языках, я не знаю. В нашем же случае голос актрисы и ее интонации абсолютно не подходят под характер персонажа и ее внешний вид. Также есть некоторые претензии к бедности интонаций доктора Филатовой — такое ощущение, что девушку из-под палки заставляли произносить реплики. \"Наташа\" в театре новенькая На прохождение игры на среднем уровне сложности (всего их три) с детальным изучением мира, но с практически полным игнорированием полигонов (прошел два из девяти) у меня ушло около 20 часов. За это время игра успела один раз “крашнуться” с ошибкой и три раза забаговаться — не срабатывали скрипты. Загрузка ближайшего сохранения исправляла эту проблему и я мог продолжить прохождение. Возможно, причиной была пресс-версия, в которой не до конца пофикшены баги. Надеюсь, в релизную сборку эти косяки не попадут. По итогу Atomic Heart — это очень умное и захватывающее произведение. Игра выполнена на высочайшем уровне во всех ключевых аспектах. Начинаясь как стелс-хоррор, в процессе геймплей меняется на исследовательское приключение, а в конце превращается во вполне себе мясной шутер, в духе того же DOOM. На нехватку биоматериала для апгрейдов жаловаться не придется Студия Mundfish заставила заткнуться всех злопыхателей, которые пророчили игре провал. Она доказала, что в состоянии создать восхитительный продукт мирового уровня, за который чертовски гордо будет нам, российским геймерам. В титрах вы',\n",
       " ('Atomic Heart',\n",
       "  19,\n",
       "  4): 'читаете привычные имена и фамилии, отсылки в игре и пасхалки будут понятны нам, постсоветским людям. Теперь западным блогерам придется снимать ролики для своей аудитории с пояснением, что означает та или иная деталь в игре, что означает история “замученного дорогой путешественника, который решил остановиться в доме добродушного лесника” и что за робот изображен на замке, который вы открываете буквально по щелчку пальцев. А мы это и без подсказок понимаем! Есть ли в игре хоть что-то откровенно слабое или плохое? Я лично не смог найти, хотя все время ждал того момента, когда игра, простите, обгадится. Не дождался! Все мои претензии настолько субъективны, что рассматривать их всерьез — натуральная трата времени. Браво, Mundfish! Аплодирую стоя!',\n",
       " ('Atomic Heart',\n",
       "  2,\n",
       "  0): 'Инвесткомпания выходца из \"Газпрома\" купит Volga Gas за $25 млн Москва. 16 ноября. INTERFAX.RU - GEM Capital Holdings (принадлежит Анатолию Палию, который более десятилетия занимал руководящие должности в структурах \"Газпрома\") покупает 100% британской Volga Gas, которая ведет добычу углеводородов в Поволжье. Как говорится в сообщении инвесткомпании, предложение предполагает, что акционеры Volga Gas будут иметь право на получение 23,71 пенса за акцию, что позволяет оценить весь существующий выпущенный обыкновенный акционерный капитал Volga Gas (без учета казначейских акций) приблизительно в 19,16 млн фунтов стерлингов (около $25 млн). Средства будут выплачены акционерам за счет кредита, выданного Палием в адрес GEM. Если на дату или после даты публикации предложения были утверждены, объявлены, произведены или подлежат выплате дивиденды, другое распределение или возврат капитала Volga Gas, то GEM оставляет за собой право уменьшить цену предложения на общую сумму таких дивидендов, распределения или возврата капитала. Сделка может быть реализована при условии одобрения 90% голосов акционеров. В случае если GEM получит одобрение своего предложения от не менее чем 75% голосов, GEM намеревается обеспечить подачу заявления в соответствующие органы о делистинге Volga Gas с площадки AIM Лондонской биржи. Компания уведомит о предполагаемом делистинге не менее чем за 20 рабочих дней после даты, когда предложение о покупке станет безусловным во всех отношениях. Если GEM не получит достаточного количества одобрений предложения, то компания намерена добиваться делистинга с LSE после завершения сделки в соответствии с другими положениями правил AIM. GEM также необходимо получить одобрение со стороны Федеральной антимонопольной службы РФ (ФАС) для приобретения акций Volga Gas. Правление GEM уверено, что в ближайшее время соответствующее одобрение будет получено. GEM уже получила безотзывные обязательства принять (или обеспечить принятие) своего предложения от некоторых институциональных и других акционеров Volga Gas, в том числе фонда Baring Vostok, доля которого в капитале газовой компании в совокупности составляет примерно 80,07%. \"Мы считаем, что Volga Gas обладает значительным потенциалом, но, учитывая ее размер, операционную среду и географическую направленность, она будет намного лучше развиваться в качестве частной компании с упрощенной и более рентабельной корпоративной структурой, пользующейся нашей поддержкой\", - отметил директор GEM Томас Кин. GEM Capital - международная частная компания, зарегистрированная на Кипре, которая работает на рынках частного и венчурного капитала. Компания инвестирует в специализированные химические компании, наноматериалы и технологические компании. GEM (Global Energy and Mining) была создана на базе нефтяной компании First Oil, которая была единственным оператором всех нефтяных месторождений, принадлежащих GEM Capital. Сейчас в портфеле GEM Capital более 20 проектов в Европе, США, Израиле и России. Инвестиции в частный капитал (в основном в нефтяные и нефтехимические проекты) составляют около 50% портфеля компании, еще 50% - на венчурные проекты. Кроме того, ее единственный акционер Палий владеет долями в нескольких нефтегазовых активах. До основания GEM Capital Палий работал в структурах \"Газпрома\", он отвечал за СУГ, СПГ и нефтехимический бизнес. В частности, он занимал должность первого замгендиректора \"Газпром газэнергосеть\" (группа \"Газпром межрегионгаз\"). До этого Палий работал в PwC в Париже и Москве.',\n",
       " ('Atomic Heart',\n",
       "  20,\n",
       "  0): 'Жанр Экшен, ролевая игра Издатель Focus Entertainment, 4Divinity Издатель в России VK Play Разработчик Mundfish Минимальные требования Процессор Intel Core i5-4460 3,1 ГГц / AMD Ryzen 5 1600 3,2 ГГц, 8 Гбайт RAM, видеокарта с поддержкой DirectX 12 и 4 Гбайт памяти, например NVIDIA GeForce GTX 960 / AMD Radeon R9 380, 90 Гбайт на накопителе, интернет-соединение, операционная система Windows 10 версии 20H1 или выше / Windows 11, учётная запись в VK Play (для игры в СНГ) Рекомендуемые требования Процессор Intel Core i7-7700 3,6 ГГц / AMD Ryzen 7 2700X 3,8 ГГц, 16 Гбайт RAM, видеокарта с поддержкой DirectX 12 и 8 Гбайт памяти, например NVIDIA GeForce GTX 1080 / AMD RX Vega 64 Дата выхода 21 февраля 2023 года Возрастной ценз От 18 лет Локализация Текст и озвучка Платформы PC, Xbox One, Xbox Series X, Xbox Series S, PS4, PS5 Официальный сайт Играли на PC Atomic Heart вызывала нешуточный интерес с момента анонса. Ещё бы: разработчики сулили своеобразную Bioshock в декорациях альтернативного Советского Союза, с вариативной боевой системой, причудливыми противниками, да ещё и под аккомпанемент лихо обработанных шлягеров давно ушедшей эпохи — звучит как исключительно ядерный коктейль. Разжигали предвкушение и последующие фееричные трейлеры, и мощная рекламная кампания в целом. Все это грамотно играло на чувстве ностальгии жителей СНГ и манило экстравагантной экзотикой всех остальных. Но когда ожидания столь высоки — высок и спрос с финального результата... ⇡#Тёмная сторона мечты Пролог Atomic Heart напрямую отсылает к одной из первых сцен Bioshock Infinite: поражающие воображение монументальные летающие постройки, идиллическая картина утопического общества мечты и едва уловимое чувство тревоги — сейчас что-то пойдёт не так. Каких-то десять минут — и мрачное ожидание полностью оправдывается. На глазах майора Нечаева (нашего протагониста) разворачивается ужасающая техногенная катастрофа: разномастные роботы перешли в боевой режим и принялись напропалую истреблять жителей Предприятия №3826 (секретный объект-поселение и место действия игры). Оказавшемуся в центре кровавой бури майору (он же агент П-3) предстоит остановить локальный апокалипсис и не дать предателям сорвать грандиозные планы своего начальника, академика Сеченова (не спрашивайте, почему начальником майора является академик). Ассистирует бравому вояке его перчатка, точнее, встроенный в неё полимер с сознанием по имени ХРАЗ. Взаимоотношения героев развиваются по классическому тропу «от неприязни до симпатии», и получился этот дуэт по-настоящему живым: персонажи успевают и пару раз поссориться, и помочь друг другу, и, конечно, не забывают о взаимных колкостях. Вместе они раскроют множество мрачных секретов, что скрывают двери лабораторий и других помещений Предприятия №3826, и узнают истинную цену воплощения всесоюзной мечты… Прочие персонажи тоже отлично прописаны и далеко не так просты, как может показаться на первый взгляд. Что боевитая старушка Зина, чьи реплики, уверена, уйдут в народ; что антагонист Петров, чьи доводы заставят усомниться в выборе правильной стороны; что начальник протагониста Сеченов, чьи благие стремления не всегда коррелируют с моральными и этическими идеалами, — всё это крайне многомерные персонажи. У всех здесь найдётся пара неожиданных фактов биографии и скрытых мотивов, что придаёт нарративу необходимую остроту. И отдельно хочу отметить «Элеонору» — станцию улучшений, которая воспылала к агенту П-3 необузданной страстью, что и невероятно весело, и жутко неловко. До самых титров история держит в неподдельном напряжении, а по пути к финалу успевает не только развязать все сценарные узлы, но и затронуть несколько философско-этических материй: цену прогресса, концепцию свободы воли, несовершенство общественных строев — в конце концов, дозволено ли простому человеку стать богом. Да и постановка в Atomic Heart хороша — режиссура в сценах от первого лица максимально выверенная, динамичная и эффектная. Правда, лично мне лишними показались переходы со сцен от первого лица к кинематографической перспективе со стороны — это немножко ломает погружение и личную ассоциацию с персонажем. Впрочем, некоторые сегменты от этого, безусловно, только выиграли в зрелищности. И конечно,',\n",
       " ('Atomic Heart',\n",
       "  20,\n",
       "  1): 'как не отметить феерическое воплощение антуража альтернативной советской истории с её умилительными умышленными анахронизмами, причудливым дизайном роботов и тем самым колоритом, который столь знаком жителям бывших советских республик. Несмотря на фантастические элементы, разработчикам удалось поймать дух советской эпохи и её философию. Скажем, в мелочах: тут и стилизованные агитационные и мотивирующие плакаты, и внутреннее убранство конторских помещений, и Алла Борисовна, поющая о тяжёлой судьбе Арлекино из каждого динамика в поселении. Или же в более масштабных вещах: преобладании функциональности над эстетикой в дизайне роботов, монументальной архитектуре брутальных советских дворцов. Находясь в этом мире, ни на секунду не сомневаешься, что народ един в вере в счастливое полимерное будущее… ⇡#Полимер — всему голова У полимеров во вселенной Atomic Heart своё особое место — как нарративное, так и сугубо игровое. Например, на некоторых локациях большие сгустки полимерной субстанции дают Нечаеву возможность перемещаться вертикально и попадать в труднодоступные уголки уровней. Хотя, безусловно, важнейшее их применение — боевое. Полимерные технологии позволяют агенту П-3 поднимать противников в воздух, охлаждать пыл супостатов ледяной струёй, закрывать себя от урона полимерным щитом или обливать врагов полимерной жидкостью, что усиливает наносимый стихийный урон. Одновременно можно использовать только три способности: один слот навсегда забронирован под базовый шок, ещё два обеспечивают пространство для творчества и всевозможных комбинаций. Фантазию никто не сдерживает — лишь бы хватило нейрополимеров (добываются из врагов и в ходе обыска ящиков). Впрочем, от любого навыка всегда можно отказаться, получив полную компенсацию исходной стоимости. Базовые способности здесь довольно слабые и едва ли оказывают решительное влияние на бой, но стоит ветке умений обрасти дополнительными усилениями, как ситуация меняется кардинально. Скажем, добавляем шоку эффект цепной молнии и ослабление способности противника сопротивляться урону — и вот у нас уже неплохой инструмент контроля больших групп роботов или мутантов. Особенно эффективно будет скомбинировать его с массовым телекинезом. Только представьте: поднимаем свору в воздух, даём по беспомощно болтающимся врагам залп цепной молнии и с грохотом вбиваем в пол. Красота! А можно играть и совсем иначе: укрыться от урона за полимерным щитом, отослать дальнобойные снаряды обратно отправителям, а затем выпустить в противника поток стужи, разбить вдребезги, да ещё и получить за это бонусный хабар. Такие эксперименты доставляют невероятное удовольствие. Как, впрочем, и использование арсенала холодного и огнестрельного оружия. ⇡#Грубая сила и тонкий ум Главная особенность боевой системы Atomic Heart — взаимосвязь холодного оружия и энергетических стволов. При выстрелах, скажем, из пистолета «Электро» или импульсной пушки «Доминатор» расходуется энергия — особый ресурс, восполняющийся весьма неохотно. Процесс можно ускорить применением оружия ближнего боя. Комбинирование «рукопашки» и стрельбы придаёт схваткам особую динамику. Впрочем, никто не мешает опираться на классический огнестрел вроде ПМ, дробовика КС-23 или хрестоматийного «калаша». Стрелять из них довольно приятно, чувствуется отдача и инерция. В целом оружейный шкафчик в Atomic Heart приличный — едва ли получится распробовать все наименования за одно прохождение, да и инвентарь не резиновый. К тому же к каждой боевой вещице идёт целый ряд улучшений: одни потребуют только необходимого количества ресурсов, а ради апгрейда других, особенно мощных, сперва придётся найти нужный чертёж. Боевые усиления мотивируют изучать мир. А если уж и не чертёж попадётся в очередной избушке, так хоть пригоршня необходимых для крафта ресурсов. Тем не менее осмотр окрестностей — процесс исключительно опциональный, нестись стремглав по сюжету игра не запрещает. Задерживаться на локациях, чтобы подкачаться, лично мне не понадобилось, хотя в какой-то момент действительно может показаться, что врагов стало много, их смертоносность возросла, а справляться с вызовами становится заметно сложнее. Впрочем, достаточно провести реструктуризацию инвентаря и набора навыков. Заниматься перераспределением ресурсов и ломать голову над лучшими сочетаниями в принципе стоит почаще, ведь универсального ответа на все проблемы тут нет: что хорошо против толпы усатых роботов, может оказаться совершенно бессильным против какого-нибудь мощного босса. К счастью, возиться с',\n",
       " ('Atomic Heart',\n",
       "  20,\n",
       "  2): 'инвентаризацией ничуть не менее интересно, чем биться с очередной толпой обезумевших роботов. *** Запуская Atomic Heart в первый раз, я была готова цепляться за любую мелочь — уж слишком высоки были ожидания, куда тут без скепсиса. Но в итоге моих претензий наберётся на пару фраз: уже озвученный выше переход между ракурсами от первого и третьего лица в роликах, не всегда удобная расстановка контрольных точек на уровнях (сохраняться самостоятельно в произвольных местах нельзя) и парочка неочевидных решений в дизайне локаций, которые слегка сбивают лихой темп повествования. Во всём остальном — это невероятно качественный, проработанный и увлекательный проект, с лёгкостью завоевавший моё сердце. И, уверена, впереди миллионы других сердец… Достоинства: вариативная и задорная боевая система мотивирует жонглировать оружием и способностями; качественное воплощение антуража альтернативного советского прошлого; неожиданно глубокий сюжет и объёмные персонажи; отменный саундтрек. Недостатки: некоторые недоработки в дизайне уровней; переход в роликах на перспективу со стороны выглядит спорным решением. Графика Эклектичный стиль окружения: размашистая и монументальная архитектура, клаустрофобные стерильные коридоры тайных лабораторий и душные кабинеты контор, каноничные деревянные избы — всё это выглядит максимально органично, детально и достоверно и с головой погружает в атмосферу антиутопической советской реальности. Дизайн роботов также получился выразительным, в хорошем смысле слова причудливым и, что важно, нарративно обоснованным. Звук Роскошный и неимоверно разнообразный саундтрек. Схваткам аккомпанируют как агрессивные синтетические мотивы, так и тяжёлые партии в манере индастриала, как поп-аранжировки оперной классики, так и хардкор-каверы «Арлекино» или «Травы у дома». А за атмосферу и погружение отвечают советские шлягеры (как же весело нестись по дороге под «Остров невезения» из «Бриллиантовой руки») и превосходный звуковой дизайн. Одиночная игра Отличный экшен с мощной и вариативной боевой системой, плюс крепко удерживающий у экрана нарратив. Оценочное время прохождения Одолеть сюжет получится примерно за двадцать часов, и приготовьте ещё пятнадцать, если захотите окунуться во второстепенные активности вроде прохождения всех полигонов и открытия всего оружия и всех улучшений или, скажем, изучения каждого уголка мира игры. Коллективная игра Не предусмотрена. Общее впечатление В Atomic Heart нашлось место и отменному антиутопическому нарративу с философскими материями, и неоднозначным персонажам со сложными мотивациями, и по-настоящему захватывающему и вариативному экшену, и убойному саундтреку. Абсолютный хит без сносок и оговорок! Оценка: 9,0/10 Подробнее о системе оценок',\n",
       " ('Atomic Heart',\n",
       "  21,\n",
       "  0): 'Back in the U.S.S.R. Recommended Videos Yesterday, my Review in Progress for Atomic Heart went live, focusing on a few of my thoughts covering the first ten hours of the game. When I submitted my draft for edits, I honestly didn’t know where I stood with the game. There were elements I liked about it, mostly centered around its art direction, as well as some design choices that didn’t necessarily sit well with me. With a lot of games, ten hours is more than enough time to draw a clear conclusion about how you feel about it. With Atomic Heart, I needed to see it through to the end. And then I needed to see it through to its other end. Atomic Heart (PC, PS4, PS5 [reviewed], Xbox One, Xbox Series X|S) Developer: Mundfish Publisher: Focus Entertainment Released: February 21, 2023 MSRP: $69.99 ($59.99 on Steam) The opening moments of Atomic Heart can best be described as a Stalinist’s wet dream with how it depicts its idealized vision of the Soviet Union. A city, floating in the clouds, with people lining its streets and waterways conversing about how great life is under communist rule as they prepare to learn about the future of their empire. Dmitry Sechenov, arguably the most famous scientist in all of the Soviet Union, is set to unveil Kollectiv 2.0, a neural network that will connect all Soviets using a small invention known as the THOUGHT. Its full launch is imminent, but before it can be brought online, some matters need handling. Back on the surface world, an area known as Facility 3826 is no longer operational. Robots, built with a substance known as Polymer that has been the backbone of the Soviet’s successes, have lost control and killed most of the workers at the facility. To mitigate this disaster, Sechenov employs Major P-3, who, along with his Polymer-powered talking glove, CHAR-les, sets out to get to the bottom of this robot rampage. The early hours of P-3’s journey across Facility 3826 are easily the most troublesome he’ll face. With just a melee axe and a gun at his disposal, players will have to adapt quickly to Atomic Heart‘s combat system lest they fall victim to the many robots that are out for blood. P-3 will have three different attacks at his disposal, including guns, melee weapons, and glove skills. As he kills robots and the other creatures that have ravaged this once-picturesque land, he’ll collect Polymer and materials he can use to craft and upgrade his skills and weapons. The first glove skill he unlocks is Shok, which lets him cast out an electrical charge that can stun enemies for a very brief time. Other glove skills include a frost attack and shield, but Atomic Heart‘s choice of control scheme really limits a player’s ability to use their full suite of skills. While Shok is always equipped via the triangle button, P-3 can only equip two of his other glove skills at once, and only one of those can be used at a time. You can switch between these two skills by hitting up on the D-Pad, but I didn’t find it to be an intuitive system when trying to survive an onslaught of robots. Switching between weapons is just as cumbersome on a controller as you scroll through them pushing left or right on the D-Pad. Given that most of Atomic Heart‘s menus point to a game that was primarily optimized for a mouse and keyboard rather than a controller, the controls on the PlayStation 5 leave something to be desired. That’s not to',\n",
       " ('Atomic Heart',\n",
       "  21,\n",
       "  1): 'say I struggled with the game. In the early buildings of Facility 3826, I did encounter the Game Over screen more than I would have liked to, but it wasn’t an issue with the controls. Part of that was me getting into the rhythm of the combat. But it was also due to just how quiet these robots can be. You really have to be aware of your surroundings in this game because these robots enjoyed trying to take me from behind. And it wasn’t unusual to face off against several robots at once and have one or two try to sneak their way around me when I was distracted by other enemies. It’s a sound tactic, one I was able to counter once I gathered enough Polymer to improve P-3’s speed and dodge capabilities. Once I did that, I was able to peel back the curtain on Atomic Heart‘s combat and realized it was rather elementary. Certain enemies do have elemental weaknesses that you can learn via scanning, but if you don’t have any weapons boosts that can exploit said weaknesses, then all you can do is hit them with a combination of dodges, melee attacks, gunshots, and whatever glove skills you have equipped at the time. While that combination might sound ripe for experimentation, the anemic nature of the glove skills can be a real letdown. Shok was the only consistent glove skill in my arsenal, though I got a good amount of use out of a skill that hangs your enemies in the air, letting you swing at them like pinatas. That’s pretty much how I spent all my Polymer beyond upgrading P-3 himself, and honestly, it was all I needed. The game does attempt to amp up its difficulty by hitting you with clusters of enemy types, but as long as you stay on top of upgrading P-3’s capabilities, once you get out into the open area of Facility 3826, you probably won’t face too much trouble. What you may have trouble with, however, is caring about Atomic Heart‘s story. It’s a rather basic tale of people in power trying to tighten their control of the world with P-3 standing in the middle. Social commentary is kept to a minimum, though various audio logs, emails, and audio attachments within emails do add some flavor to the world and show that life in the Soviet Union isn’t as glorious as they would like you to think it is. As for P-3, the secret to his backstory is largely predictable given that several early bits of dialogue tell you exactly who he is. Speaking of the dialogue, it’s atrocious in English, so you’re better off turning on subtitles and switching the language option over to Russian. Just know that, because Atomic Heart is heavy on the conversational dialogue between P-3 and CHAR-les, you might miss a great deal of exposition when trying to read the tiny subtitles during the heat of battle. I was hoping the story would actually have something new to say, but there’s nothing here that hasn’t already been said countless times before. While the narrative threads do touch on some interesting topics, such as how Russian robots are changing life for workers in America, it ultimately plays it rather safe with two equally unsatisfying endings. When looking at P-3, he doesn’t venture far from his initial view of the Soviet Union. He comes into this journey as Communism Fanboy #1 and rarely ever bends. I actually become frustrated by his lack of growth given the many conversations he has that should have been the',\n",
       " ('Atomic Heart',\n",
       "  21,\n",
       "  2): 'catalyst for some introspection. Not that I’m arguing his adventure should have ended with him getting a massive erection for western capitalism, but this dude straight-up waffles on basically every piece of information he gets. I thought perhaps the developers were molding him to be a dumb hero who just doesn’t absorb anything he’s told, but he’s not dumb. He just chooses to ignore most of it because it clashes with the beliefs he already has. If I were being generous, I would say that P-3 was Mundfish’s way of critiquing those who refuse to change their points of view despite overwhelming evidence to the contrary, but that might be giving the developers too much credit. What I can say is Atomic Heart‘s narrative does not do its setting justice. Facility 3826 is a monumental achievement of design, with an outstanding representation of Stalinist Architecture and Socialist Realism. From the propaganda posters to the statues that tower over the land, Mundfish has crafted a Soviet Union that, outside of the floating cities and advanced robotics, feels like something Stalin and Lenin could have achieved if they weren’t so busy murdering their own people. There are so many breathtaking sights that I would often stop playing just to soak it all in. Credit where credit is due, the environmental artists and programmers who brought this world to life did an outstanding job. It’s a shame, then, that the gameplay does this world a disservice by filling it with so much bloat. In the early hours, the bloat can be seen by all the keys you need to fetch to open doors. P-3 even comments on how he’s a magnet for shitty door-locking mechanisms. Once you get outside and into the fresh air, you can feel the developer padding the game time again with an open world that connects all the different stations that make up Facility 3826. On paper, a sandbox open world sounds like a good idea. Why not connect all these intricate locations with the actual land and houses the workers of this facility call home? In practice, however, it’s mostly just a lot of open space. You can take your time and hoof it from place to place on foot, fighting robots and avoiding sensors along the way, but the game will supply you with poorly-controlled jalopies that hasten travel time. Though, given that most roads are littered with disabled vehicles and robots for you to crash into, you’re going to have to walk through these sections more than you might plan to. If there is anything that makes these long treks across the land worth it, it’s the outstanding music you’ll hear along the way. Admittedly, the game is a bit overeager to explain why so much music that would never exist in 1955 Soviet Russia can be heard here, but that really doesn’t matter when the soundtrack is this good. Composers Mick Gordon, Geoffrey Day, and Andrey Bugrov did an outstanding job scoring this game, whether it’s music that sounds like it was ripped from an old Russian propaganda film or the ear-shattering metal that accompanies some of its fight sequences. While you can wrap up Atomic Heart in about 15 hours, there are ways to extend your stay in Facility 3826, including puzzle-based training facilities that unlock upgrades for the weapons you can craft. After publishing my Review-in-Progress, the game was updated with a patch that added a way to return to the grounds of the facility after beating the game, allowing me to go back and finish up any tasks I may have missed.',\n",
       " ('Atomic Heart',\n",
       "  21,\n",
       "  3): 'It’s a nice addition, but I honestly don’t have much reason to return to Atomic Heart other than to gawk at its architecture. And really, unless an extensive photo mode is added in a future update, I don’t see myself ever booting up Atomic Heart again. I admire the gusto with which Mundfish approached its debut game because it’s created one hell of a world to explore. But beyond its pristine setting and ass-kicking soundtrack, it’s largely forgettable. Maybe if the gameplay evolved beyond its basic beginnings or if the story was — I don’t know, good — I might be willing to give it another go. However, given how unlikely such a monumental change like that would be, Atomic Heart is destined to be a one-and-done type of experience. [This review is based on a retail build of the game provided by the publisher.] 6 Alright Slightly above average or simply inoffensive. Fans of the genre should enjoy them a bit, but a fair few will be left unfulfilled. Review Guidelines Destructoid is supported by our audience. When you purchase through links on our site, we may earn a small affiliate commission. Learn more about our Affiliate Policy',\n",
       " ('Atomic Heart',\n",
       "  22,\n",
       "  0): 'Часть дверей заблокирована замками. Какие-то из них открываются лишь после того, как вы повернете стик геймпада в правильную сторону, а какие-то просят решить скромную задачку на реакцию или же верным образом соотнести несколько лампочек. Бывают пазлы и побольше — они уже интегрированы в ключевые элементы локаций. Самый популярный завязан на синхронизации цветных лучей, где вам нужно вращать несколько дисков для того, чтобы лазерные ниточки соединялись друг с другом в подходящей манере. Есть и что поинтереснее, вроде ситуаций, где манипулировать можно целыми элементами интерьера, но здесь все сюрпризы лучше не портить. Через пару часов медленно, но верно складывается иллюзия прекрасной идиллии. Вы привыкли к игре, она привыкла к вам, и ничто уже не испортит праздник. Увы, иллюзии имеют свойство рассеиваться. Рано или поздно из холодных кишок научных станций вы вновь выберетесь на свет божий, где зеленая трава и пчелки летают. Оказывается, что в Atomic Heart есть широкие просторы. Не открытый мир — это все-таки термин существенного веса, а именно что просторы — большие локации, допускающие отклонение игрока от заранее заготовленного жесткого курса. Легче всего описать эти локации как своеобразные хаб-зоны. Участки, связывающие между собой ключевые точки интереса, где и разворачиваются основные события. Сами хабы просторные — можно даже ездить на раскиданных по углам машинках, в первую очередь для экономии времени. И нервов. А все из-за того, что в открытых секциях авторы из Mundfish по-холодному и бесцеремонно решили познакомить нас с еще одной из своих безумных идей — концепцией механической экосистемы, где игра усердно имитирует сложнейшую систему искусственного интеллекта, призванного эффективно уничтожать всякого злодея. На деле это значит, что за вами придут роботы, причем в больших количествах. Придут не сразу, а лишь после того, как вы окажетесь в объективе одной из множества камер охраны. Механические глаза внимательно изучают территорию, желая засвидетельствовать ваши злодеяния. Если с этой миссией камеры справляются, то игра поднимает условный уровень тревоги, после чего к вашей позиции без промедления сбегается вся синтетическая живность. Обнаглев окончательно, игра даже может начать сбрасывать роботов вам прямо на голову — их привезут в специальных ящиках, из которых вскоре единым потоком хлынет неминуемая гибель. Звучит интересно. Даже в меру увлекательно. Но стоит помнить, что агент П-3 все так же уязвим, роботы — жизнеспособны, а боекомплект — ограничен. И если в коридорах врагов дозволено перехитрить, разобрать и уничтожить, то армию бесконечно восстанавливающихся железок победить не получится. Более того — в этом нет никакой нужды. Из побежденных можно собирать ресурсы, которые позже расходуются на развитие героя, но их у вас и без того будет в избытке. Так складывается неприятная ситуация, где наиболее выигрышной моделью поведения за пределами закрытых локаций является их банальный и скорейший пропуск — отстреливать врагов вы устанете намного быстрее, чем они закончатся. Справедливости ради, компенсировать свое отсутствующее преимущество перед армией металла все-таки можно. В небесах парят особые станции, отключение которых временно выведет боевые машины из строя, и игра наконец-то даст вам передышку. Но захотите ли вы тратить свое время на эти сложные манипуляции вместо того, чтобы просто вновь юркнуть в покои спокойных подземелий и курируемого дизайнерами геймплея — это большой вопрос. В хаб-зонах также раскиданы опциональные комплексы. Отдельные уровни, представляющие из себя набор усложненных пазлов. За их прохождение вы будете открывать особые чертежи для дальнейшего усовершенствования экипировки, которое происходит с помощью излишне любвеобильных автоматов. Прокачка — стандартная. Улучшаются как базовые показатели героя, вроде скорости его перемещения и запаса здоровья, так и активные навыки перчатки, которая постепенно обучается телекинезу, заморозке и еще паре трюков. Обособленно стоит оружие — дюжину пушек разрешают точечно настраивать, меняя не только их внешний вид, но и характеристики. Обвесы, прицелы, расширенные магазины — даже маленький ПМ имеет потенциал для обращения в прожигающий дыры бластер. Хорошая экипировка — это залог победы,',\n",
       " ('Atomic Heart',\n",
       "  22,\n",
       "  1): 'что сильнее всего ощущается во время схваток с боссами. Ага, в Atomic Heart есть боссы. Их немного, но каждая схватка однозначно запоминается, потому что противники используют нетипичные модели поведения, обладают уникальными атаками и стараются удивить визуальном буйством, прыгая и летая по всей доступной площади арен. Претензия к боссам лишь одна, но серьезная — разработчиков подвело чувство меры, особенно в отношении их живучести. Продолжая тренд, заданный рядовыми противниками, боссы тоже способны впитывать в себя десятки, сотни попаданий. Вы успеете наизусть запомнить каждый кадр анимации каждой атаки, а раковина на ножках все еще будет весело танцевать у вас перед носом — успевай лишь отправлять в нее свежую партию ракет. Иногда наблюдаются совсем уж неаккуратные ситуации, где игра может спонтанно запереть вас на арене с боссом, уязвимым лишь к конкретному типу атак. Если получилось так, что нужного вооружения у вас с собой нет, то альтернативы остается две. Либо вы механически откусываете от полоски жизни противника крошечные кусочки, тем самым растягивая бой на десяток лишних минут, либо просто перезагружаете контрольную точку, и идёте обратно к сундуку за нужной комбинацией предметов, пока П-3 в очередной раз монотонно проговаривает какой-нибудь пустой монолог. Разумеется, что случай может выпасть счастливый, и монолог окажется не пустым, а интересным. А если совсем повезет, то монолог превратится в диалог — умная перчатка ХРАЗ ответит герою, и персонажи вместе расскажут вам что-нибудь любопытное. Но это бывает нечасто. Atomic Heart в целом смертельно боится тишины. Бежите вы или полезете, стреляете или рубите, падаете или взлетаете, — майор Нечаев обязательно прокомментирует ситуацию. В любой плоскости и любом состоянии. Комментарии будут уместными, неуместными, нелепыми, абсурдными, смешными, бестолковыми, остроумными. Неизменно одно — комментарии будут. Про полимеризацию, пироги, коммунизм, искусственный интеллект, и одной лишь Партии известно про что еще. К сожалению, разговоры Нечаева утомляют еще и потому, что у героя совсем невыразительная озвучка. Персонажа рисуют доступного и понятного — компетентного дуболома с золотым сердцем, шершавого снаружи, но доброго внутри. Актер, подаривший П-3 свой голос, работу выполняет приемлемую, но картинка все равно не складывается, потому что майору, чаще всего, просто нечего сказать, а обилие брани воспринимается не как нечто едкое и хулиганское, а как банальная вульгарность. Можно запутаться и решить, словно вся озвучка Atomic Heart выполнена на непримечательном уровне, но когда поднимаешь случайный аудиодневник, краски взрыватся иными оттенками — в наушниках неожиданно заговорят убедительные и ясные голоса, которых слушать не только приятно, но и занимательно. Потом, правда, фокус все равно вернётся к Нечаеву, в десятый раз возмутившемуся возмутительным поведением возмутительно непослушных роботов. Выйдя на окраины кричащего в агонии городка Рейвенхольм, физик Гордон Фримен не проронил ни слова. А какой был эффект. Больше — не всегда лучше. Что особенно актуально в Atomic Heart, где декорации в большинстве своём имеют достаточно характера, чтобы наладить связь с игроком без всякого внешнего шума. Уже не стерильные лаборатории, утопающие в холодном свете, могут рассказать свою историю и без неуклюжих диалогов. Сталинские мегасооружения великолепно передают выбранный художниками настрой. Каждый винтик, болтик и цвет обшивки машин — все на своем месте, все цельно и по делу.',\n",
       " ('Atomic Heart',\n",
       "  23,\n",
       "  0): 'Первый пост о том, что Анита принимает участие в работе над игрой, она опубликовала еще год назад, но персонажа не раскрывала Источник: Виталий Калистратов / Городские порталы В последние дни в интернете только и разговоров, что о «ЧВК Редан», которые неожиданно для самих себя стали главной угрозой человечества, да об игре Atomic Heart. О первых мы вам рассказывали во всех деталях и даже разобрались с юристом, что грозит участникам массовых драк, а вот на второй остановимся подробнее прямо сейчас. Atomic Heart — это игра-ностальгия и игра-вдохновение, в основу которой легло множество артефактов времен СССР. Но полюбили (одни) и возненавидели (да, есть и такие!) ее не только за отголоски прошлого. Игра щедро сдобрена нюансами, от которых глаз не оторвать. Чего стоят одни только роботы-близняшки с привлекательными формами и полимерным покрытием — они уже свели с ума половину геймеров, в то время как другая половина возмущается из-за их чрезмерной сексуальности. Чтобы вам было легче определиться, на чью сторону встать, вот вам их, так сказать, семейный снимок. Роботы-близняшки быстро стали любимицами публики Источник: atomictwinnies / Instagram (деятельность запрещена в РФ) Прототипом одной из близняшек стала балерина Большого театра Анита Пудикова — именно ее пластика легла в основу движений железной сестрички. Так выглядели репетиции кат-сцены из игры Источник: atomicheart_official / Instagram (деятельность запрещена в РФ) Вот так балерина выглядит в образе робота в самой игре. Движения балерины нашли свое воплощение в графике Atomic Heart Источник: diamondpond / Instagram (деятельность запрещена в РФ) Анита Пудикова (в последнее время больше известная как Левая близняшка из Atomic Heart) родилась в Москве в семье артистов, ее мама, так же как и сама Анита, выступала в балетных партиях. Работать в Большом театре девушка начала еще в 2015 году, сразу после того, как закончила Московскую государственную академию хореографии. Анита с 2015 года выступает на сцене Большого театра Источник: diamondpond / Instagram (деятельность запрещена в РФ) За без малого восемь лет службы в Большом театре в репертуаре балерины появились роли в одиннадцати спектаклях, в том числе в «Ромео и Джульетте», «Дон Кихоте» и «Щелкунчике». А это Анита в образе жены Штальбаума из балета «Щелкунчик» Источник: diamondpond / Instagram (деятельность запрещена в РФ) А еще «та самая близняшка из Atomiс Heart» активно ведет свои социальные сети и абсолютно не боится ярких, креативных и порой вызывающих образов. Ну что, геймеры, похожа балерина на робота из игры? Источник: diamondpond / Instagram (деятельность запрещена в РФ) — «Здравствуйте, меня зовут Анита, и я одна из тех роботов-близняшек в Atomic Heart». Только так теперь буду представляться, — написала балерина у себя в социальных сетях. При взгляде на идеальную фигуру Аниты не возникает вопросов, почему разработчики сделали робота по ее образу и подобию Источник: diamondpond / Instagram (деятельность запрещена в РФ) Благодаря роботам-близняшкам геймеры живо заинтересовались игрой (жаль, что у Аниты близняшки нет) Источник: diamondpond / Instagram (деятельность запрещена в РФ) Подозреваем, что у Аниты все-таки есть сестра-близнец — кто-то ведь ее всё время фотографирует! Источник: diamondpond / Instagram (деятельность запрещена в РФ) До сих пор Аниту знали только любители балета, но сейчас она стала знаменита на весь интернет Источник: diamondpond / Instagram (деятельность запрещена в РФ) Примерно такой Аниту привыкли видеть коллеги на сцене Источник: diamondpond / Instagram (деятельность запрещена в РФ) Первым делом у близняшек появилась страничка в социальных сетях, а вот у Аниты она уже давно, и там у девушки почти 20 тысяч подписчиков Источник: diamondpond / Instagram (деятельность запрещена в РФ) Так и не скажешь, что эта милая девушка в виртуальном мире буквально может стать железной леди Источник: diamondpond / Instagram (деятельность запрещена в РФ)',\n",
       " ('Atomic Heart',\n",
       "  24,\n",
       "  0): \"Atomic Heart has a lot of big ideas, but it doesn't do a good enough job with the basics. With an incomprehensible storyline, weightless combat, and frustrating first-person platforming, Atomic Heart is left to stand in the shadow of the video games that so clearly inspired it. Why you can trust GamesRadar+ Our experts review games, movies and tech over countless hours, so you can choose the best for you. Find out more about our reviews policy. Atomic Heart front-loads its most fascinating concepts. There are floating Soviet laboratories in the sky, home to a networked artificial intelligence which could signal the evolution of human consciousness; a veteran USSR operative who can't recall his past, and an army of rampaging robots designating the populace of Facility 3826 as enemy combatants after a software malfunction. Atomic Heart's opening hours are busy, but enthralling – recalling fond first visits to worlds like City 17, Dunwall, and Rapture. Sadly, Mundfish isn't able to weave these loose threads into anything functional. FAST FACTS: Atomic Heart (Image credit: Mundfish) Release date: February 21, 2023 Platform(s): PS5, PS4, PC, Xbox Series X, Xbox One Developer: Mundfish Publisher: Focus Interactive Atomic Heart lacks nuance in everything that it does, which works to its detriment as further ideas are layered into the mix. In comes the commentary on the eroding lines between communism, capitalism, and socialism, too complex to be explored in short conversations between an ambivalent action hero and his talking glove. Fetch quests build around outrageously convoluted lock and key systems, signaling an artificiality to the story and spaces. New enemy types emerge as the result of a symbiosis between bioengineered plants and human corpses. The dead start to speak. Audio diaries amass. Weapon vendors are uncomfortably, audibly horny for resources. And through it all, Agent P-3 has the emotional maturity and biting wit of a teenager who just discovered Reddit and the concept of internet anonymity. Lost the plot (Image credit: Mundfish) What if, rather than receding from the world stage in the aftermath of World War 2, the USSR rose to conquer it through the development of advanced robotics and astronautics? Conceptually, It's an interesting thought experiment. Efforts to explore alternative histories aren't uncommon in the science-fiction shooter landscape; Prey sought to actualize an accelerated Space Race, while a pair of Wolfenstein adventures let us quash a resurgent Nazi Germany. Crucially, MachineGames found so much success with The New Order and The New Colossus because we viewed these twisted timelines through the stoic eyes of B.J. Blazkowicz – a steadied hand amongst oversized carnage. Perhaps the greatest mistake Atomic Heart developer Mundfish makes is with how it handles its protagonist, Major Sergei Nechaev – a wholly unremarkable avatar of destruction, stumbling through the launch of Communism 2.0 with such an aversion to curiosity that I can't help but share in his brutish animosity to it all. Have you ever ordered a sci-fi book from the backpages of a pulp magazine (or to a Kindle via Amazon, such is the future we find ourselves in) because you were drawn in by the promise of the cover art, only to find the internals lacking? Disappointment festers when informed expectation collides with unfulfilled potential. That's something I felt keenly by the time I was being thrown from one anticlimactic boss battle to the next, struggling to unpack layering lines of exposition as mistakenly-amplified audio tracks drowned dialogue and subtitles shrunk into the environments. Here's the thing though: Atomic Heart has one hell of a beautiful front cover. Mundfish has engineered an undeniably gorgeous playspace, the sort of\",\n",
       " ('Atomic Heart',\n",
       "  24,\n",
       "  1): \"world that you'll want to get lost in – plot, pacing, and narrative design be damned. At least for a time anyway. (Image credit: Mundfish) Further optimization I encountered a plethora of frustrating bugs throughout my time with Atomic Heart. Whether it was collected resources sticking to the side of the UI, swelling audio which refuses to subside after combat concludes, enemies getting caught in the environment, powers refusing to switch, and so on. Additionally, while Atomic Heart is certainly a good-looking game for the most part, the quality of some of its visual assets (particularly in cutscenes) really decays towards the backend of the story. Despite the appearance of a Deus '0451' Ex reference before you've even had the opportunity to work out whether you want to invert the thumbsticks, Atomic Heart was never pitched as an immersive sim. Even still, I wish that Mundfish better capitalized on the wondrous world it engineered. You're given the space to explore environments, which are largely gated by frustratingly oblique lockpicking minigames and the terms outlined by quest progression. You can idle forward gradually if you want to – in both the core missionset (predefined facilities that you move through linearly) and the wastelandish open-area which connects the campaign together. Given this framing, I was surprised to find so little to do, see, or find. That there was no life – only death and decay spread throughout every nook and cranny. Consider the worlds put forward by BioShock – the underwater odyssey of Rapture; and Columbia's floating castle in the clouds. What these environments lack in points of interactivity, they make up for with a stunning sense of time and place. They feel lived-in, as if they existed long before you clicked in from the start menu, and will continue to do so long after you leave it all behind. Conversely, Atomic Heart, with its empty laboratories, pristine museums, and crumbling underground facilities, feels somewhat hollow – a 4K facade dressed in a stunning ambient lighting model. Robot revolution (Image credit: Mundfish) Even with its messy narrative frame and fractured world design, I had high hopes for the combat. Inspect the underlying mechanical design of Atomic Heart, and it's possible to detect echoes of influence from a distinct set of first-person adventures. Atomic Heart takes aim at the physical-presence exhibited throughout Half-Life 2, the heavy-melee combat that became a trademark of the Dying Light games, the caustic gunplay of Wolfenstein and Doom, and the interweaving powersets that defined BioShock. This may be the debut video game from Mundfish, a studio founded just five years ago, but Atomic Heart arrives with big ambitions. And Atomic Heart certainly has some nice ideas – an intuitive approach to looting is appreciated, so too is an imaginative approach to enemy spawns, as spores reanimate mangled corpses and androids stalk bloodied halls close to their assigned workstations. However, it fails to pair them with a forward-thinking approach to the basics. I found movement to be jittery around the edges, melee combat is ponderous, the firearms lack distinction, and tracking enemies is a hassle. (Image credit: Mundfish) Energy consumption Atomic Heart does an exceptionally poor job of explaining the intricacies of its combat systems. One area I wish Mundfish had emphasized further concerns the use of elemental and energy damage. Special elemental cartridges can be installed onto weapons, imbuing them with the power of fire, ice, and electricity – an interesting wrinkle if you're trying to make things more visually spectacular. It's also possible to accumulate energy with melee weapons, and discharge it to help hold enemies at\",\n",
       " ('Atomic Heart',\n",
       "  24,\n",
       "  2): \"bay; an interesting idea, though the less time spent fighting with floaty clubs and axes the better. Ammunition becomes plentiful by the time Atomic Heart completely loses sight of the story it's trying to tell, allowing you to reliably hold hordes of enemies at bay from a distance, but there's a severe focus on melee before you reach that point. Initially, the androids can be relentless threats, shoving you into corners of which you have little ability to escape. Atomic Heart has a dodge function, but what it really needs is a block – there's little back and forth to encounters, making it feel as if you are robotically, weightlessly, exchanging blows in turn until something hits the ground. The expanding set of Polymer powers do introduce some variety to combat, although the visual spectacle can only arrest attention for so long. Shok chains electric bolts through metal chassis, Mass Telekinesis thrusts rooms of enemies into the air, and Frostbite can freeze foes with jets of ice. Polymer Throw is designed to help you chain these abilities together, an accelerant which heightens elemental effects of anything it touches with expressive results. While entertaining enough when used sparingly, the powerset isn't diverse or intuitive enough to really change the cadence of combat. I routinely encountered a bug whereby I couldn't switch between the two powers I had installed; most of the time, I simply relied on Mass Telekinesis for crowd control while I drained the ammunition reserves of a quietly chattering Kalashnikov rifle. Ramble on (Image credit: Mundfish) Among the most baffling creative decisions that Mundfish made surround the inclusion of first-person platforming and capitulation toward a trend of open world distraction. I can count on two hands the number of first-person shooters that handle platforming from this perspective well, and Atomic Heart is not one of them. While the framerate holds at a steady 60 frames-per second, player animation isn't fluid enough to support intricate movement. The sections of play where you're forced to navigate between yellow beams and shifting platforms are among the most frustrating, particularly as shaky collision detection will often push you away from elements in the environment that you should be able to reach. And heaven forbid you invest in the ability which mitigates fall damage, causing P-3 to combat roll off of platforms that he should hit with sure footing. Mercifully, platforming is kept to a (relative) minimum through Atomic Heart's five main facilities, with much of it held for the test sites scattered across the banal open world – padding between campaign missions. These puzzle rooms are designed to make intuitive use of your Polymer Powers, but in reality are exercises in frustration mitigation. While optional, many of Atomic Heart's more interesting weapon upgrades are hidden within these underground labs, and you'll want those to help breathe a little life into the combat – and to make all that rummaging through office desks and kitchen cabinets for valuable resources and crafting recipes worthwhile. (Image credit: Mundfish) Atomic Heart is a messy video game with big ideas and a desperate need for refinement Shooters with this style of crafting economy rely on a steady escalation of power – you begin weak, and gradually become more of a threat as six types of collected metal are exchanged for new ways to shoot and slice through enemies. Sadly, I never found (or was allocated, Atomic Heart doesn't make this clear) the crafting recipes for two of the more interesting weapons, nor was I ever able to acquire even a single Neuromodule after 20 hours of playtime –\",\n",
       " ('Atomic Heart',\n",
       "  24,\n",
       "  3): \"that's the resource necessary to craft some of the otherworldly weapon effects seen in much of the pre-release material. Atomic Heart lacks focus. It's a messy video game with big ideas and a desperate need for refinement, and further optimization. This is perhaps best reflected in the decision to dilute the linear nature of the core campaign with a wide-open space to explore. There's exceptionally little to see in this sprawling area, which is populated with a small set of repeating houses, one model of vehicle that you can careen into patrolling enemies, and an unwieldy alarm-detection system that often leaves you battling waves of androids with little reprieve. Atomic Heart wants to be a lot of things all at once, and while that ambition is certainly commendable, Mundfish isn't able to execute its ideas with any consistency or clarity. Atomic Heart was reviewed on PS5, with a code provided by the publisher\",\n",
       " ('Atomic Heart',\n",
       "  25,\n",
       "  0): 'PC Gamer\\'s got your back Our experienced team dedicates many hours to every review, to really get to the heart of what matters most to you. Find out more about how we evaluate games and hardware. Need to know What is it? A narrative FPS with light RPG elements set in a Russian Westworld Expect to pay: $59.99 (Steam) Developer: Mundfish Publisher: Focus Entertainment, 4Divinity Reviewed on: Windows 10, GeForce GTX 1070, 16GB RAM, i7-7700HQ Multiplayer: No Link: https://mundfish.com/ Check Amazon Four or five hours into Atomic Heart, you\\'ll walk through a door and the game will swing into one of many seamless first-person cutscenes. A man points a gun at you, babbles something about blowing a giant plant to kingdom come, and your protagonist gruffly swears, complains, and sets about fetching the thing to blow up the thing. You\\'ll soon return, shove a bunch of explosive into the plant, see it ignited by a cigarette while your character calls the plant a \"fuckbag\", and watch the scientist die gruesomely in the aftermath because his role in the game is over. I didn\\'t know whether to laugh or cry. In fact a lot of Atomic Heart will leave you grasping for purchase, as it freewheelingly veers from enormous setpieces to endless fetch quests, as critiques of Russian exceptionalism rub up against a protagonist who calls robots \"fat turds\" and a script that seems to have been written with the help of a swearing thesaurus. You\\'ll gaze into the eerie, porcelain face of an android and marvel at how well the game\\'s aesthetic captures its unsettling science fiction of humanoid robots, and then be grossed-out by a vending machine begging you to \"squirt your polymer in me\". This is one of the oddest big-budget games I\\'ve played in a long time, filled with as many good ideas as bad ones, almost like it\\'s been made without a filter. Everything went in. The game\\'s influences are numerous—Westworld, Fallout, Arkane\\'s Prey—but the one that looms above them all is BioShock. Atomic Hearts\\' narrative-focused opening is like a communist version of Columbia and the grandeur of its sprawling research institute, a utopia-gone-wrong showcasing the best of retro-futurist Soviet robotics, makes for one breathtaking vista after another. But the influence runs far deeper than aesthetic. Combat is built around a plasmid equivalent, several of which are directly lifted from BioShock, while the narrative style of first-person talking heads, radio logs, and companions is straight from the Irrational playbook. At times Atomic Heart almost pulls it off. The one-two punch I don\\'t mind that Atomic Heart copies Bioshock\\'s electric bolt plasmid. But it annoys me to no end that it feels so underpowered. Atomic Heart benefits from the tried-and-tested nature of these techniques, but it suffers from the fact it\\'s so indebted to a very famous, very striking FPS from 16 years ago. BioShock starts you off with a wrench and an electric shock attack called electro bolt, and Atomic Heart does more or less the same but with an axe. The difference is that Atomic Heart\\'s electric shock feels… well, like it\\'s just giving things a tickle. The combat has fairly standard basics (a melee weapon, a pistol, a shotgun, a grenade launcher) but is made nuanced by some great individual twists, like the zappy pistol you can upgrade into a death-dealing chargeable shock beam. You can customise your weapons into various damage types (electrical damage for robots, bleed damage for organic foes) and secondary effects like knockback or AoE. But ultimately no matter how you choose to skin Atomic Hearts\\' android enemies, combat lacks',\n",
       " ('Atomic Heart',\n",
       "  25,\n",
       "  1): \"the heft of its inspirations. One reason for this is how hard Atomic Heart leans into collecting and crafting. Throughout the game you're wearing a sentient super-glove, and everything you point it at will open and the goodies will zoom towards you. Remember the scene in Ghostbusters where the library cards start flying out of the drawers? In Atomic Heart you trigger this effect constantly and so far it hasn't gotten old. In fact I enjoy it so much I think opening space cupboards individually in Starfield is going to drive me mad. You can similarly schloop the resources out of downed foes (whose bodies or parts convulse as the bits fly out), and whatever you're looting there's a lovely glimpse of the shiny bits flying towards you: You instantly have a sense when you've scored something good. This side of it is a delight. But using all this junk to painstakingly build and upgrade weapons means most of your equipment and attacks are unimpressive until you can grind enough loot to give them more oomph. I don't mind that Atomic Heart copies the electro bolt plasmid. But it annoys me to no end that it feels so underpowered and, as I progressed through the upgrade tree, I was incrementally gaining abilities that the BioShock power it copied came with as standard. There were only a few rungs of the upgrade ladder to climb with plasmids in BioShock, but each one felt more substantial, and crucially the basic versions felt powerful and good to use in and of themselves. In Atomic Heart I saw no point building a new tool or weapon without having the resources to immediately upgrade it several times. The game pretty much acknowledges this by including a system that refunds all resources for deconstructing any item. The idea is clearly that players should swap around and experiment with playstyles, but the cumbersome interface and its tiny icons mean the process is no pleasure, and most of the enemies don't encourage or demand this flexibility. The one occasion I did do this was to build a specific weapon for an annoying boss, and it worked, but I didn't especially like the weapon and ended up just deconstructing it again after the fight. (Image credit: Mundfish) Fight for the Motherland This is Atomic Heart writ large. It's bursting with ideas, and some of them are great and some are just ballast that only end up making the good stuff weaker. Despite my criticisms of the upgrade paths the combat is often exciting and tense, and some of the effects you can pull off—such as lifting half-a-dozen androids into the air, chain-electrocuting the lot, then smashing them down on the ground and launching a rocket—both look and feel fantastic. Special praise to an animation the androids have, where sometimes you'll blast them with a shot and they're knocked back by the impact, but uncannily flip-out of it and land in a starter's position ready to sprint at you. Several boss fights feature incredibly frustrating QTEs. No way do I want to have to successfully pull off a quickfire QTE four minutes into a five-minute fight or insta-fail. One boss called Ivy more or less has to be fought with melee, and will grab you with a one-shot QTE attack multiple times during the fight, making for an incredibly frustrating experience. This combat system never quite hits the heights it promises. It's like all the ingredients are there but the cake's still that tiny bit under-baked. Towards the end of BioShock and its sequels you feel like an all-powerful terror,\",\n",
       " ('Atomic Heart',\n",
       "  25,\n",
       "  2): \"a genetic monstrosity that swats splicers like flies. In Atomic Heart your power level amps up without ever reaching that point of potency. (Image credit: Mundfish) In terms of how you actually navigate this place, Atomic Heart offers one memorable and well-used idea: A viscous goop that your character can swim through in order to move vertically around certain environments. This weird-looking substance snakes around certain locales, often asking you to swim loops high above, and provides some magnificent perspectives on these environments. It's a standout idea both mechanically and visually, and the ability to hop out at any point along the tube lets you get creative with it. Though creativity, outside of combat, is rarely necessary here. Atomic Heart features an abundance of fetch quests, then commits the cardinal sin of having a protagonist who complains about constantly doing fetch quests. This is in addition to a talking glove that, honestly, I just began to tune out after a few hours of constant yapping: It also really doesn't help that at several points the game has the glove delivering a monologue about polymers or something while you're fighting a room full of enemies. FPS production at record levels (Image credit: Mundfish) Atomic Heart arrives at a time where its critique of Soviet glory is unavoidably contextualised by what Russia is currently doing in the real world. Atomic Heart has been the subject of recent controversy in the context of the ongoing Russo-Ukrainian war, with its developers being Russian (though based in Cyprus) and the sources of its funding being questioned. Some critics suggest that Atomic Heart represents Russian soft power, and buying it would be some sort of implicit support for the war. Whatever one can say about the funding, this game is not a propaganda piece. In the same way that Fallout embraces Atomic-age Americana in order to oft-savagely critique American capitalism and culture, this is a Russian critique of Russian exceptionalism. The opening hours of course include sights and spectacles meant to echo the grandeur of the Russian Communist party's public events, where thousands of soldiers march beneath the hammer and sickle or a news report boasts of some new technological advance made by the comrades. Things then begin to unravel. No-one is quite who they seem to be, and the various layers of Soviet bureaucracy in this fictional Russia are locked in an internecine war and undermining each other (all the while comparing themselves to America, naturally). You can't criticise or send-up something like Russia's political system and nostalgia for the past without including the reasons why Russians may feel some misplaced fondness for the days of grand parades and 'strong' Soviet leaders—all that hollow spectacle in Atomic Heart is there to be chipped-away to expose the rot underneath. Atomic Heart arrives at a time where its critique of Soviet glory is unavoidably contextualised by what Russia is currently doing in the real world. The game on the one hand pines for the era where Russia led the space race, and the names of its cosmonauts travelled the world, and on the other is clear-eyed about what kind of system that was, and how its principles are still being used to subjugate a population under the guise of comradeship. The names of great Russians pop up again and again in the supporting cast in tribute, as they're used to tell a story of over-reach and ultimately the wider theme of man's inhumanity to man. I can't imagine finishing this game and thinking it's presenting Russia as some wonderland ruled by wise people for the common good.\",\n",
       " ('Atomic Heart',\n",
       "  25,\n",
       "  3): 'That probably makes Atomic Heart seem like a more impressive narrative achievement than it is. There are lofty themes here and some memorable story beats, but also a bunch of ridiculous characters and setpieces that come and go in the blink of an eye, and too much of the narrative is delivered in minute-long monologues by your glove while other things are happening. I also can\\'t get over the fact that one of your recurring buddies, Granny Zika, looks uncannily like the late queen of England and is very foul-mouthed. (Image credit: Mundfish) Eastworld Atomic Heart is a surprising, ambitious, deeply flawed game that at times feels close to greatness. It will take your breath away with a setpiece one minute, then make you spend the next 10 fiddling with an annoying puzzle while the protagonist swears about how annoying this puzzle is. It\\'s unbelievably crass in one breath, then delivers a cogent summary of contemporary issues around AI the next. I have no doubt it\\'ll become some sort of cult classic among a particular type of FPS player. Inspiration is always a double-edged sword because of the comparison it invites, and Atomic Heart has been heavily inspired by the past. What lies beneath its glossy exterior, though, is an all-too-human sadness about the future of technological servitude it envisions. \"Would be a nice place, if everyone wasn\\'t dead,\" muses the protagonist at one point, a line so banal it\\'s almost comic. But you look at all these bodies slumped around, so many that after a while they\\'re like wallpaper, and the cleaning robots that heedlessly go back-and-forth on their manoeuvres in the aftermath, and it somehow lands. This game has moments of frustration alongside the wonder, and in some areas pales in comparison to those inspirations: But it is always reaching for the stars. Even if Atomic Heart never quite fully grasps them, that has to count for something.',\n",
       " ('Atomic Heart',\n",
       "  26,\n",
       "  0): 'After being founded in 2017, Mundfish is making a strong first impression with its debut game, Atomic Heart. This single-player first-person shooter envisions an alternate reality where the Soviet Union was home to a secret program involving advanced robots and artificial intelligence that goes terribly wrong. It’s an excellent shooter that’s supported by some unique and creative gameplay elements. Heart on ice Source: Focus Entertainment Atomic Heart puts players in the shoes of Major P-3, a Soviet intelligence agent tasked with getting to the bottom of what caused the USSR’s robot companions to lash out and wage war against their human creators. As you attempt to figure out who’s responsible, the mysteries of the secret project unravel over the course of the game. I’d be remiss if I didn’t mention that Atomic Heart’s heavy themes of Russian nationalism made me uncomfortable at times. While I don’t believe the Cyprus-based development studio is trying to send a message with the game, it’s hard not to wince at the USSR parades in the streets or the pro-Russian material found within the game in light of what’s unfolded in Ukraine over the last year. It’s likely that this is just the most unfortunate timing, but it’s something to be cautious of if that could hinder your experience with the game. Atomic Heart reminded me a lot of the Bioshock franchise with its alternate historical setting. The world is deeply fleshed out, and its anachronistic blending of advanced technology in the mid-1900s made for a truly unique setting. I often found myself stopping to examine the environment, listening to audio tapes, and everything else it took to learn more about the universe. This atmosphere is also bolstered by an excellent soundtrack from Mick Gordon. There’s a wide range of music featured, and it only improves the experience whenever it kicks in. The tunes give a cinematic feel to battles, and make the quiet moments eerier. No love lost Source: Focus Entertainment While Atomic Heart would have been perfectly fine as a serviceable shooter, I was impressed by how amazing the gameplay was. Shooting feels impactful, and there are a variety of weapons to be discovered and crafted, each with its own unique feel. While it’s a shooter first and foremost, Mundfish cleverly mixes in some extra elements to combat. You have to constantly be moving and dodging in order to avoid the aggressive robotic enemies, and there are quick-time events that will trigger when your character is grappled or on the brink of death. With ammunition being a scarce resource, I often turned to my axe to dispatch enemies. I love that it actually matters how and where you swing the axe. A well-placed swing can knock an enemy’s head right off their shoulders. There is also detailed dismemberment, and I’m not ashamed to admit that I got a laugh out of hacking the limbs off of enemies after clearing a room. In addition to melee and ranged weapons, Major P-3 is equipped with a Polymer glove that lets him harness electricity and telekinesis powers. I felt like a god when I was able to use all of the weapons and abilities at my disposal in tandem, taking out enemies before they were even able to land a hit on me. Tools of war Source: Focus Entertainment Playing on Normal difficulty, Atomic Heart’s combat was pretty challenging overall. There were several sequences and boss fights that I had to redo multiple times, but it felt rewarding when I got into a good rhythm and overcame my foes. Atomic Heart also has a pretty intricate',\n",
       " ('Atomic Heart',\n",
       "  26,\n",
       "  1): 'crafting and upgrade system. As recipes are unlocked, you can craft new weapons and ammunition for them. These weapons can then be upgraded with attachments to improve accuracy, rate of fire, and damage. Crafting requires parts and other miscellaneous materials, which can be gathered from drawers, cabinets, and other containers. Atomic Heart also leans heavily into its RPG mechanics, with multiple skill trees full of perks that can be unlocked to improve Major P-3’s prowess in combat and stealth. While adventuring through Facility 3826, there are a lot of locked doors and restricted areas. I was continuously impressed by the various puzzles that Mundfish threw at me as I attempted to open doors and disarm security systems. They felt like actual tests of pattern memorization and skill rather than the repetitive chore that puzzles can become in other shooters. Although I found the robotic enemies to be creepy and formidable foes, I wish there was a bit more variety in enemy type. These humanoid robots make up the vast majority of the adversaries you face, and there isn’t much deviation from them. The truth comes out Source: Focus Entertainment Atomic Heart is undoubtedly one of the best first-person shooter campaigns I’ve played in years. In addition to rock-solid gameplay, the game offers an intriguing mystery and a robust upgrade system. It’s even more impressive when you remember that this is the first game from Developer Mundfish. Outside of controversial themes and a lack of enemy variety, it’s hard to point out any glaring issues with Atomic Heart. This review is based on a PS5 copy of Atomic Heart provided by the publisher. Atomic Heart releases on February 21 for PC, Xbox One, Xbox Series X, PS4, and PS5.',\n",
       " ('Atomic Heart',\n",
       "  27,\n",
       "  0): 'Say what you like about Atomic Heart, you can’t fault it for ambition. This alt-history shooter wears its Bioshock influence on its sleeve – but Rapture isn’t the only well it draws from. Alongside Atomic Heart’s high-concept plot and Plasmid-style left-hand abilities, it also packs in a Far Cry-style open world, boss fights akin to Dark Souls, and environmental platforming that reminded me of Half-Life. READ MORE: The best RPGs you can play in 2023 Does it all coherently fit together? Absolutely not. But I enjoyed the 30-ish hours I spent with Atomic Heart, perhaps more than so than I thought I would after struggling to find my way in. Advertisement My frustrations at the beginning of Atomic Heart had nothing to do with its glorious set-piece intro, where you’re deposited in the Chalomey Complex, a retrofuturistic utopia that sits atop a floating mechanical platform. With its red-dominated colour palette and towering statues of USSR leaders, this opening act does a tremendous job of grounding you in Atomic Heart’s alternate reality, one where the Soviet Union has made world-altering scientific breakthroughs in the years following World War 2. At last, fully automated luxury communism has been achieved. With robots. Lots of robots. Predictably, things go awry. Our protagonist, battle-scarred veteran Agent P-3, is shipped out to the robotics development hub Facility 3826, where he soon discovers a problem: the robots are murdering their creators. His airborne chauffeurs cut the guided tour short, sending P-3 hurtling into the facility’s loamy turf. Post-faceplant, Atomic Heart appears on the screen and the game begins in earnest. Here, the tone takes a strange turn into campy survival horror, undermining the careful worldbuilding we got in the opening segment. We encounter a bazooka-wielding granny who yells obscenities at the robotic horde. Another major character appears in confusing circumstances, then abruptly disappears. Shortly after, P-3 gets groped by a nymphomaniac fridge. The fridge turns out to be the weapons upgrade console, one of many identical models we encounter throughout the game. Later on, Atomic Heart ditches this riff entirely, cutting out the smutty dialogue in what feels like an acknowledgment of how bizarre it was. All the while, P-3 reacts to every on-screen event in surly, teenagerish fashion. His dialogue is rarely witty or inventive – mainly it’s just sweary, which gets grating quickly. He’s especially fond of summarising the event you just saw happen on screen. “Holy shit, that was a surprise!” he says once, in response to a surprising thing happening. Some counterbalance is provided by CHAR-les, the talking robotic glove who grants P-3 his left-hand “polymer” abilities, and thankfully comes programmed with a far more likeable personality. Recommended I got past my initial misgivings after the first couple of hours. Partly this was down to Atomic Heart’s satisfyingly weighty combat. Axe swings and shotgun blasts lop off robotic limbs, providing some much-needed feedback as you hack down surprisingly durable robotic foes. Atomic Heart also gives you a solid roster of left-hand abilities, so-called “polymers”. One short-circuits onrushing robots; another grants you an exploding energy shield; another coats enemies in a layer of goop that enhances damage from your other abilities. My favourite was Mass Telekinesis, which lets you hoick crowds of bots into the air and dispatch them in one hit by hurling them back to earth. Atomic Heart is also surprisingly puzzle heavy. Some, like the lock-hacking mini-games, are a standard sort of rote diversion. They’re well-implemented – particularly one that requires you to turn off lights according to a rhythm – but largely predictable. Yet other puzzles display far more imagination',\n",
       " ('Atomic Heart',\n",
       "  27,\n",
       "  1): 'than you’d necessarily expect from this family of action-RPG shooter. Some of them feel very Portal – like the ones that task you with magnetising and demagnetising electromagnetic platforms to navigate across a room. Others are downright quirky: a Snake mini-game concludes one middle-game segment, providing welcome comic relief if not a huge degree of challenge. If Atomic Heart has unexpected successes, it also falls short in places where you’d expect it to be more competent. One of the culprits is an open world, which becomes available after you clear Atomic Heart’s first dungeon. While this world retains some of the characterful touches of the opening segment in Chalomey, they’re far fewer and further between. What it has in abundance is fleets of patrolling robots, all of which are determined to gun you down if you get too close. Advertisement Yes, it’s kind of fun fighting off wave after wave of brushed aluminium foes – and it is wave after wave, because once the security cameras clock you the alert level rises and more bots get airdropped in – but when you’re trying to mind your own business and navigate to the next objective, it’s a pain having to escape their attention. Hindering navigation further is the baffling absence of a minimap, which necessitates constantly opening up the world map to check you’re going the right way. For Atomic Heart’s story missions, which get a waypoint, this tends not to be a problem. But if you want to check out an optional dungeon, or visit one of the landmarks marked out on the map, it’s a nightmare. Driving exists, but it’s janky. As for vehicle variety: you can drive whatever you want, provided it’s one particular model of red car. Atomic Heart defies easy summary. If there’s a unifying thread it’s the narrative, a science-fiction yarn that, via the metaphor of a human neural network dubbed Kollectiv, delivers a gentle critique of communism’s promise to elevate the collective over the individual. It’s good fun, though perhaps a little less thought-provoking than I was hoping. I ended up appreciating the small details that built up the world more than the grand sweep of the plot. One such was “Radio of the Future”, an algorithmic method of predicting future hits. We even get to hear these songs in Mick Gordon’s eclectic soundtrack, alongside Soviet pop from the 50s and 60s, a variety of classical compositions and heavy metal headbangers. I should also briefly note the rumours swirling around that this game has a note in its license agreement about sharing users’ data with the Russian Federal Security Service (FSB). The developer, Mundfish, has explicitly denied this, as has been reported elsewhere. Mundfish has also received criticism for sidestepping the Russio-Ukrainian war in a recent statement. It is, of course, an individual decision whether you want to support a developer that could quite plausibly have links to the Russian government. The game itself, however, doesn’t read like Russian propaganda. It’s overwhelmingly politically neutral, which in all honesty robs the plot of a little bite. Russia is neither glorified nor vilified – which in the historical context we’re given, seems about right. Despite Atomic Heart’s flaws, there’s plenty to keep it interesting. While the opening moments of the game dented my ability to take the story seriously, I could definitely see myself returning for another playthrough: the extensive system of skills and upgrades keeps things engaging, especially given the genuine challenge the highest difficulty level provides. If you’re into the alt-history Soviet aesthetic, that could tip Atomic Heart over the edge for you. If',\n",
       " ('Atomic Heart',\n",
       "  27,\n",
       "  2): 'you’re not, you might crave a more focused experience. Atomic Heart launches on February 21 for Microsoft Windows, Xbox Series X|S, PlayStation 5, Xbox One and PlayStation 4. We played it on an Xbox Series S.',\n",
       " ('Atomic Heart',\n",
       "  28,\n",
       "  0): 'Обложка: постер игры Atomic Heart Atomic Heart — дебютная игра от студии Mundfish. Проект успел привлечь к себе много внимания из-за необычного антуража, долгих лет разработки, участия Мика Гордона и Джеффри Дея, а также нескольких скандалов. Последние связаны как с некоторыми сомнениями о существовании шутера, так и с «происхождением» команды разработчиков из-за современной действительности. Но авторы Atomic Heart явно не унывают — недавно они продемонстрировали своё творение в центре Нью-Йорка, а также опубликовали рекламный ролик с Дженсеном Эклсом, Солдатиком из сериала «Пацаны» (The Boys). Автор «Канобу» Руслан Ярсанаев ранее смог поиграть в превью-версию игры, а теперь опробовал релизную копию. В этой статье он подробно расскажет о том, заслуживает ли шутер внимания или нет. «И восстали они из пепла ядерного огня…» События игры разворачиваются в 1955 году. СССР преуспел во многих областях — большинство из них представят в прологе. Но самое главное достижение страны заключается в разработках Дмитрия Сеченова. Сначала гениальный учёный приложил руку к созданию особой технологии — «Полимера». Затем, с её помощью, инженерам Союза удалось создать разнообразных роботов и нейросеть «Коллектив». И чем дальше шло время, тем сильнее развивался прогресс. Начало игры встречает вас праздником в честь открытия «Коллектива 2.0» — улучшенной нейронной сети, к которой могут подключаться даже люди (используя для этого особое устройство «МЫСЛЬ»). Однако всё идёт не по плану — запуск омрачает глобальный сбой, из-за которого машины на Предприятии 3826 сходят с ума и нападают на людей. Чтобы устранить проблему, Сеченов отправляет своего главного доверенного человека: майора Сергея Нечаева, известного как П-3. Ему необходимо разобраться со свихнувшимися роботами, а заодно отыскать всех причастных. Спутником главного героя выступит перчатка ХРАЗ, способная поддержать не только крепким словом, но и убийственными способностями. Сбой на предприятии не только вывел из строя всю робототехнику: инцидент также стал причиной того, что по коридорам комплексов стали разгуливать опасные мутанты. Вдобавок некоторые опасные люди вступили в борьбу с Дмитрием Сеченовым за контроль над его разработками. Нечаев оказывается втянут в противостояния, о которых он даже и не догадывается. И ради выполнения поставленного задания ему необходимо преодолеть множество научных станций, несколько объектов культуры, а также миновать просторные территории научного учреждения. 2 фото Оригинальное переплетение неоригинальных идей Сценарий в Atomic Heart весьма… Удивительный. Шутер будто состоит из концепций и идей других игр, поэтому за время прохождения можно найти массу сходств с другими проектами. Сюжет местами до боли напоминает первый BioShock, некоторые сцены отсылают к NieR: Automata, но всё это выполнено с определённым, своеобразным колоритом. При этом разработчики умудрились добавить столько новых элементов и мелких деталей, что назвать сценарий «бездушной копиркой» язык не поворачивается. Некоторые элементы кажутся ужасно знакомыми, другие же вышли весьма самобытными. Например, авторы проделали большую работу над проработкой вселенной. Они объясняют и показывают причины, из-за которых СССР стал одним из мировых лидеров. Дело не только в изобретении «Коллектива», «Мысли», которым посвящена основная сюжетная линия — в игре создаётся альтернативная реальность со своей собственной историей. В Atomic Heart, на удивление, отлично показан альтернативный Советский Союз. В игре нет какого-то неприкрытого восхваления этой исторической эпохи. Герои говорят про свою вселенную со своими историческими деталями, не делая никаких намёков и отсылок на действительность. А все восторги, критика и прочие фразы исходят от конкретных персонажей, разделяющих определённую систему ценностей. Приятно видеть некий «российский колорит» в видеоигровой индустрии, когда в ней доминируют другие культуры. Например, это ярко выражается в том же BioShock, серии GTA и даже в играх про Дюка Нюкема. 3 фото При этом весь антураж очень странный. Карикатурные советские роботы, похожие на коллекцию игрушек для нелюбимых детей, соседствуют с отполированными и блестящими Близняшками-балеринами. Научные комплексы с высокими технологиями покрыты органическими субстанциями и мутациями. А местами философский и серьёзный подтекст идёт рука об руку с шутками про говно, секс',\n",
       " ('Atomic Heart',\n",
       "  28,\n",
       "  1): 'с роботами и матерным выражением про пироги. И самое потрясающее: когда эти абсурдные элементы, не стыкующиеся друг с другом, вдруг начинают работать вместе и создавать уникальную атмосферу — за игрой становится очень приятно наблюдать. Иногда кажется, что разработчики просто понадобавляли в игру всё, что считают крутым. Возможно, это действительно так, хотя происходящее порой напоминает нелепую безвкусицу. Но постепенно окружающий мир приобретает собственное лицо. Всё-таки, согласитесь, раньше у нас не было игр, где можно выкашивать толпы врагов рельсотроном, бродя по советским деревушкам под зубодробительные кавера песен Аллы Пугачёвой. И ещё ни одна другая игра не вставляла в безопасные зоны, где можно сохраняться, телевизоры с очень увлекательными (и с детства знакомыми!) мультфильмами. 3 фото Матерящаяся кукла колдуна Но вот с чем Mundfish точно промахнулись, так это с главным героем. Майор Нечаев ведёт себя как очень эмоциональный гопник, который никогда не затыкается. В первые часов десять истории кажется, будто П-3 обладает одновременно синдромом дефицита внимания и гиперактивности, бонусом к которым идёт синдром Туретта. Количество подколов, необоснованных действий, матерных выражений и эмоциональных всплесков поначалу неприятно изумляет. В один момент он может спросить у ХРАЗА что ему делать дальше, а уже через тридцать секунд он оскорбит свою говорящую перчатку из-за того, что он вроде как «может справиться со всем сам». Здесь можно сравнить Нечаева с героем Дженсена Эклса, Солдатиком из «Пацанов» — благо последний недавно участвовал в рекламе игры. Параллели между героями определённо прослеживаются, да. Только если Солдатика показывают как харизматичную сволочь и подонка, то Нечаев же кажется обыкновенным школьником–«быдланом»: он всех задирает и ругается, чтобы показать свою «крутость», и не более того. Ближе к финалу Нечаев становится намного лучше. Герой соответствующе реагирует на искажения в окружающей его действительности, его история становится более понятной. Он продолжает быть громким и вспыльчивым, но все его бурные эмоции теперь обусловлены происходящим. Герой даже налаживает какой-никакой диалог с теми, кого поначалу и в грош не ставил. Учитывая, что первоначально П-3 мог только крыть всех трехэтажным матом, то такое преображение можно считать ростом персонажа. С другой стороны, это может быть следствием того, что к характеру Нечаева так или иначе привыкаешь. 2 фото Непостоянство игрового процесса Фундаментально игра является шутером от первого лица. Ключевое слово тут «фундаментально» — на протяжении всего Atomic Heart геймплей несколько раз заметно меняется. В самом начале игры Нечаев уязвим для атак врагов, даже несмотря на то, что способен им «намять» бока. Арсенал невелик, количество патронов ограничено, поэтому приходится сражаться в ближнем бою, вовремя уворачиваться от усиленных атак (они сбивают героя с ног), а также экономить боекомплект для битвы с летающими врагами. Самое начало игры, опять же, напоминает BioShock или даже Prey от Arkane Studios. Благо, жизнь П-3 облегчают различные способности. ХРАЗ может оперировать несколькими навыками: позволяет ненадолго игнорировать урон, поднимать врагов в воздух или замораживать их потоком ледяного полимера. Кроме того, полезной оказывается робот Элеонора. Без шуток, это похотливая до внимания Нечаева и его ресурсов машина, которая может собрать для него что угодно: лишь бы у героя были чертежи с запчастями. Ну и про пассивные навыки тоже забывать не стоит. 2 фото Когда герой покинет первый научный комплекс, прохождение которого займет часа четыре, игроков ждёт совершенно иной геймплей. В открытом мире наш майор — жертва, а не охотник. Его не спасут ни безопасные зоны, ни богатый арсенал. На открытых территориях Предприятия 3826 нужно не сражаться, а бегать. Игра в прятки с роботами не поможет — они замечают Нечаева сквозь траву, камни и даже небольшие сооружения. И хотя П-3 может подобраться к ним и отключить сзади, это неэффективно, ведь противники зачастую ходят толпами. Кроме того, повсюду стоят камеры. Они могут поднять тревогу, на которую слетятся множество врагов, бой с которыми грозит герою неминуемой гибелью. Отключить эту систему',\n",
       " ('Atomic Heart',\n",
       "  28,\n",
       "  2): 'не получится. Сломанные машины восстанавливаются благодаря ремонтным дронам. Герой может отключать лишь камеры, но роботы продолжат работать, вдобавок они все тесно связаны друг с другом. Но с помощью устройств наблюдения можно открывать закрытые проходы к пунктам управления. Но игрокам словно запрещено ломать или обходить эту взаимосвязанную систему. 3 фото Складывается ощущение, что разработчики побоялись оставлять уязвимости в этой части геймплея: либо не хотели делать свои локации полностью безжизненными, либо они так сильно полюбили эту структуру, что не захотели отдавать её на растерзание. Третья же перемена в игровом процессе случается после середины сюжета (если вы не пренебрегали прохождением опциональных зон-Полигонов с задачками в духе Portal). Нечаеву выдаётся столько ресурсов и апгрейдов, что он становится непобедимым. Можно плевать на камеры, боссов, особых противников и уровни тревоги. Хотя от последнего никуда не деться, придётся убегать, но покуда у Нечаева будет ХРАЗ и хотя бы самое простое оружие ближнего боя, то он сможет дать отпор кому угодно. В любом случае, по-настоящему весело играть стало именно в этот момент. Благодаря улучшениям Нечаев теперь может совершать рывок почти в каждую секунду, будто он Палач Рока из Doom Eternal. Но до этого этапа игры придётся пережить два вышеупомянутых геймплейных подхода, равных как минимум восьми часам. Не каждому игроку хватит терпения. 2 фото «Мой богатый арсенал» Игра, как ни странно, довольно гибкая. Она не предлагает постоянно наращивать боевую мощь — она даёт инструменты для того, чтобы подстроить геймплей под свои приоритеты. Ближе к финалу у героя будет достаточно огневой мощи для того, чтобы стать машиной смерти и убивать большую часть врагов одним выстрелом дробовика. Вот только никто не заставляет игроков раскачиваться именно так. Любители хардкора могут оставить самое сильное оружие в хранилище, а также отказаться от большей части умений — за это даже вернут вложенные ресурсы. А вот с арсеналом героя вышло что-то странное. Пушки разнообразны по ощущениям и воздействиям на врагов. Но большую часть вооружения придётся собирать из мусора, отыскивая чертежи во время исследования мира, хотя Atomic Heart никак не подталкивает вас к тому, чтобы вы собирали и пользовались этим оружием — базовые очень быстро обрастают улучшениями, спрашивается, зачем тогда их менять? 4 фото Если вы всё-таки решитесь опробовать весь арсенал, то заметите как оружие чертовски хорошо проработано в игре. Во-первых, большинство компонентов меняют вид предметов. Это заметно даже невооружённым взглядом, ведь даже обычный коллиматорный прицел может приблизить всеми любимый «калаш» к какой-то научно-фантастической «вундервафле». Во-вторых, что неочевидно, некоторые апгрейды полностью меняют анимацию прицеливания или перезарядки. Это деталь незначительная, но придающая индивидуальности в выборе того или иного апгрейда. Да и ганплей с прокачкой оружия становится гораздо лучше: согласитесь, куда веселее выносить врагов парой-тройкой выстрелов, а не расстреливать каждого болванчика по полчаса. А в усилении эффекта помогут специальные капсулы, позволяющие сделать урон элементальным и бить по уязвимостям противников. 2 фото Ложки дёгтя в кружке с мёдом Работа над арсеналом помогла выяснить кое-что ещё. Оказалось, что в игре хватает багов и шероховатостей, которые прохождению не препятствуют, но могут подпортить впечатления. Мне удалось попробовать почти всё оружие в игре. Что-то понравилось, что-то нет, ракетница «Крепыш» оказалась одним из лучших вложений. Не удалось испытать только один вид вооружения — Рельсотрон. Чертёж этой внушительной бандуры был добыт во время исследования мира, компонент для неё добывается из самых мощных врагов. Благо, Atomic Heart даёт подсказку о том, какие ресурсы можно добыть из противников. Но, по какой-то причине, одну конкретную деталь отыскать так и не удалось. И это при условии, что каждый особый противник был встречен и уничтожен минимум раз. А некоторые, например «Плющ», были убиты раза четыре. Подобные нюансы влияют на восприятие игры, чувствуется, что «Атомному сердцу» требуется полировка. В некоторых сценах можно наблюдать за тем, как враги несутся к скрипту через стены',\n",
       " ('Atomic Heart',\n",
       "  28,\n",
       "  3): 'и текстуры. Несколько раз герой сам может провалиться в них, из-за чего рискует застрять и увидеть изнанку видеоигрового мира. Один раз удалось «ворваться» в катсцену, из-за чего тело героя улетело дальше камеры. Особенно пугающими выходят не редкие скримеры и хоррор-элементы, но подпрыгивающие мёртвые тела. Ни раз и ни два очередная бездыханная тушка, которая должна была лежать на земле, подпрыгивала в воздух, делала кульбит, а затем замирала в метре от земли. Спойлер Опыт из прохождения: надо было зачистить полностью территорию от врагов, что удалось сделать только с большими потерями. Аптечек не осталось, здоровье на нуле, а нужно было двигаться дальше. И вот нюанс: рядом постоянно раздавался стрекочущий звук, похожий на эффект от крыльев летающих дронов. Рисковать и жертвовать Нечаевым не хотелось, потому что можно было отправиться на чекпоинт и лишиться всех результатов. Пришлось укрываться и аккуратно исследовать локацию, пытаясь найти источник шума. И оказалось, что надоедливый звук, который я принял за присутствие врага, исходил от руки какого-то трупа. Трупа, чья ладонь застряла в текстуре и на огромной скорости шлёпала по ней, пытаясь вырваться. Да и других мелочей хватает. Двери в игре почему-то делятся на три вариации: одни открываются сами, другие надо толкать, а третьи открываются по нажатию на кнопки, и чёрта с два вы угадаете, какая из них та самая. Схожая проблема есть и с платформингом. Нечаев может цепляться за выступы — и игра объясняет, что для этого подходят только окрашенные в жёлтый цвет поверхности. Но чуть после правила меняются, и вот герой цепляется уже к чему угодно. Порой майор отказывается хвататься за уступы, а это приводит к падению и смерти персонажа. 3 фото Хорошая техническая составляющая К чему придраться сложно, так это к визуалу. Локации яркие, картинка сочная (правда, иногда вылезают пиксели с кулак размером) и враги эффектно разлетаются на куски, демонстрируя свои внутренности. Многие игры в наше время работают из рук вон плохо, но Atomic Heart идёт без тормозов. На видеокарте RTX 4080 игра выдавала в среднем от 120 до 140 кадров в секунду даже без апскейлинга. Раза два за всё прохождение были проседания аж до 70 FPS, но длилось такое падение несколько секунд. На PlayStation 5 шутер тоже ведёт себя неплохо и работает стабильно. На фоне недавних Forspoken и Wanted: Dead это отличный результат. Разработчики тщательно подошли и к работе со звуком. Озвучка вышла не самой качественной — русская, по крайней мере — но старания всё равно видны. В некоторых сценах персонажи озвучены нелепо и наигранно, будто они герои телешоу, а в других всё звучит живо и естественнно. Голоса героев даже звучат по-разному в зависимости от того, в каком помещении они находятся. Особенно хорошо разработчики подошли к саундтреку. Он украшает массу боёв и задаёт многим ситуациям уникальный контекст. Композиторы Atomic Heart тут постарались на славу. Спойлер Расстраивает лишь одно подозрение, что авторы заложили в игру систему, которая не работает должным образом. Дело вот в чём. Герой может проходить мимо какого-нибудь радио, из которого доносится песня — если в этот момент начинается бой, то она меняется на тяжёлую кавер-версию. Беда в том, что звучит трек не из какого-то там радио, а в ушах игрока. Так что если это действительно система, а не фантастическое совпадение, то её стоит немного доработать. 2 фото Итог',\n",
       " ('Atomic Heart',\n",
       "  29,\n",
       "  0): 'Atomic Heart возвращается с новым дополнением! Уже 28 января 2025 года выйдут \"Чары морских глубин\", продолжая историю Майора П-3. Игрокам предстоит покинуть загадочное Лимбо и снова отправиться на предприятие 3826. На этот раз основное действие развернется в подводном исследовательском центре \"Нептун\", полном загадок, новых врагов и неожиданных возможностей. В «Чарах морских глубин» сюжетная линия поднимает ставки: спасение человечества требует проникновения в исследовательский центр, скрывающий мрачные секреты. Игроки встретят как новых персонажей, так и старых знакомых, включая загадочную Близняшку. Локации предприятия 3826, такие как летающий город Челомей, теперь выглядят иначе — роботы полностью захватили контроль. Чтобы выстоять перед новыми угрозами, вам пригодится свежий арсенал. Среди новинок: Молот «Громовержец» , который наэлектризует противников усиленными ударами. , который наэлектризует противников усиленными ударами. Двуствольный дробовик КЗМИ-4 «Кузьмич», идеально подходящий для разгона толп. Перчатка П-3 также получит обновление: Навык «Загар» позволит бросать раскаленные шары полимера, нанося урон по площади. позволит бросать раскаленные шары полимера, нанося урон по площади. Способность «Кнут» добавит маневренности, давая возможность подтягиваться к врагам, уворачиваться от атак и добираться до труднодоступных мест. Эти улучшения помогут в битвах с новыми врагами — от хищных морских мутантов до ужасающей МУР-8Н4, обитающей в глубинах. В трейлере дополнения звучит ремикс на песню «В синем море, в белой пене» в обработке Geoffrey Day — автора музыки, полюбившейся фанатам Atomic Heart. Классическая версия композиции, исполненная Юлией Коган, будет доступна на стриминговых сервисах уже сегодня. Обе версии войдут в саундтрек VOL. 5, который выйдет одновременно с дополнением. Не упустите шанс вновь погрузиться в мир ретрофутуризма и узнать, какие тайны скрывает подводный центр «Нептун». Кроме того, сейчас на Atomic Heart действуют скидки до 50%, так что это идеальный момент для погружения в культовую игру. Запасайтесь патронами, тренируйте навыки — и до встречи под водой!',\n",
       " ('Atomic Heart',\n",
       "  3,\n",
       "  0): 'Егор Аргунов после прохождения напевает песни Аллы Пугачевой Страница автора После шести лет разработки Atomic Heart наконец вышел. Мы уже делились впечатлениями от игры после прохождения сюжетной кампании. Теперь рассказываем, сколько стоит шутер и где его купить, какие у него системные требования и как решить возможные технические проблемы. В конце собрали мнения игроков и критиков об игре. Сколько стоит Atomic Heart и где ее купить ПК-версия игры официально продается в России в сервисе VK Play. Стандартное издание стоит 2499 ₽, а «золотое» с дополнениями — 3199 ₽. Игру можно загрузить по подписке Game Pass на ПК и консолях Xbox — но только после смены региона. На PlayStation шутер придется покупать обходными путями. Подробнее о способах приобретения Atomic Heart мы писали в отдельной инструкции. Системные требования и технические характеристики Atomic Heart Минимальные системные требования: 64-битная Windows 10. Процессор Intel Core i5-2500 или AMD Ryzen 3 1200. 8 Гб оперативной памяти. Видеокарта Nvidia GTX 960 или AMD R9 380. DirectX 12 и 90 Гб свободного места на жестком диске. Рекомендуемые системные требования: 64-битная Windows 10. Процессор Intel Core i5-7600К или AMD Ryzen 5 1600. 16 Гб оперативной памяти. Видеокарта Nvidia GTX 1080 или AMD RX 5700 XT. DirectX 12 и 90 Гб свободного места на SSD. Графические режимы на консолях. На Xbox Series X и PlayStation 5 игра работает в динамическом разрешении 4К при 60 кадрах в секунду. На Xbox Series S Atomic Heart поддерживает разрешение 1080p при 60 кадрах в секунду. Других графических режимов не предусмотрено. На PS4 и Xbox One игра работает в динамическом 1080p при 30 кадрах в секунду. Atomic Heart работает на движке Unreal Engine 4 Сюжет Atomic Heart Альтернативный СССР. В 1934 году академик Дмитрий Сеченов создал особое вещество — полимер. На его основе ученые изобрели искусственный интеллект, после чего наладили производство роботов-помощников. Для экспериментов над полимером построили огромный исследовательский комплекс «Предприятие 3826». В 1955 году роботы на «Предприятии» взбунтовались и начали убивать людей. Сеченов отправляет на место происшествия майора разведки Сергея Нечаева, главного героя игры. Академик узнает, что сбой устроил его бывший коллега Виктор Петров. Сеченов поручает главному герою найти Петрова и доставить его живым. На пути к правде майор встретит сотни агрессивных роботов и мутировавших жителей комплекса. После начала восстания роботов люди оставили на стенах комплекса много надписей Из чего состоит геймплей Atomic Heart В игре стандартный для шутера игровой процесс. Майор Нечаев перемещается по комплексам «Предприятия 3826» и убивает агрессивных роботов. В начале игры приходится орудовать тяжеловесным топором, но позже в арсенале героя появится огнестрельное и энергетическое оружие. Для создания новых видов вооружения нужны ресурсы. Они разбросаны по локациям, так что не забывайте обыскивать каждый доступный уголок «Предприятия». Кроме ресурсов вы можете наткнуться на аптечки и боеприпасы — их тоже обязательно подбирайте. В перерывах между боями Нечаев изучает заброшенные здания и помещения комплекса. В них можно найти звукозаписывающие устройства и компьютеры погибших обитателей «Предприятия». Аудиозаписи и переписки раскрывают подробности происшествия и личные истории людей, когда-то населявших процветающий комплекс. Важную роль в геймплее играет экспериментальная перчатка ХРАЗ — ее Нечаев носит на левой руке. Перчатка общается с главным героем, помогает взламывать замки, а также сканирует местность на предмет врагов и ресурсов. Кроме того, ХРАЗ наделяет Нечаева сверхъестественными способностями. Вначале герой может лишь стрелять током, но позже научится телекинезу, заморозке и созданию защитного поля. Для прокачки этих способностей требуется вещество нейрополимер. Не забывайте собирать его с убитых врагов и искать на локациях. Нечаеву придется одолеть несколько сложных боссов. Например, огромного геодезического робота «Ежиха» Что нужно знать перед игрой В Atomic Heart придется много драться в ближнем бою. В первые часы в вашем арсенале будут лишь топор «Швед» и дробовик КС-23. Однако патронов всегда мало, поэтому полагаться',\n",
       " ('Atomic Heart',\n",
       "  3,\n",
       "  1): 'придется на холодное оружие. Полностью переключиться на огнестрел получится только ближе к концу игры, когда у вас будет достаточно ресурсов для патронов. Альтернативой огнестрельному оружию может стать энергетическое. Оно бьет врагов током и не требует патронов. Для перезарядки достаточно подождать, пока не восполнится энергетическая шкала. Atomic Heart — не коридорный шутер, в нем есть открытый мир. После прохождения локации «Комплекс Вавилова» вы попадете на свежий воздух. Теперь можно исследовать окрестности комплексов и небольшие поселения, где когда-то жили люди. Но действие важных сюжетных заданий будет разворачиваться внутри исследовательских зданий. По «Предприятию 3826» Нечаев передвигается на красном Москвиче-408 Кроме сюжетных заданий в игре есть второстепенные. Их цель — предоставить вам ресурсы для улучшения оружия. Ради них нужно проходить испытания в подземных «Полигонах» с головоломками. Приклады, увеличенные магазины и другие улучшения разбросаны прямо по этажам комплекса. Искать предметы нужно самостоятельно. Сюжетная кампания длится около 20 часов. Однако вы можете пройти игру быстрее, если поставите легкую сложность и не будете дотошно исследовать локации. У игры две концовки. Перед финальной миссией главный герой должен сделать важный выбор. Этот сегмент обязателен, его невозможно пропустить. Советы по прохождению Atomic Heart Научитесь уклоняться. Это пригодится во всех битвах с боссами. Иначе вы будете получать слишком большой урон. Энергия для уклонений неограниченная, используйте их при любой возможности. Ненужное оружие и боеприпасы разбирайте на ресурсы. По игровому миру расставлены роботы-автоматы «Элеонора». Если положите в такую машину оружие, получите пачку ресурсов. Скажем, можно разобрать топор «Швед» и пустить ресурсы на создание дубинки с циркулярной пилой «Звездочка». Если не нравится какая-либо способность, откатите ее и возьмите новую. В автомате «Элеонора» можно отключить любой полученный навык. За это вам вернут все потраченные на него нейрополимеры. Их можно потратить на необходимые вам способности. Используйте наносящие стихийный урон кассеты для оружия. По ходу игры герой будет находить огненные, ледяные и электрические кассеты. Для их установки на оружие требуется кассетный модуль — его нужно создавать отдельно. Как сделаете модуль, прицепите его к оружию и выберите в круговом меню пустой слот в центре снизу. Нажмите на него и выберите нужную кассету. Не забывайте улучшать оружие новыми модулями. С ними проходить игру будет гораздо легче Сгущенка, водка и «Адреналин» — ваши лучшие друзья. Сгущенка увеличивает наносимый Нечаевым урон. Водка повышает защиту от вражеских атак. А особый предмет «Адреналин» постепенно восстанавливает здоровье. Первые два предмета ищите на локациях, а «Адреналин» подбирайте возле погибших мутантов. Если застряли на битве с боссом, поменяйте сложность в настройках. Это можно сделать в любой момент в меню паузы. Все комнаты отдыха, где герой может сохраниться, обозначены табличкой Технические проблемы Atomic Heart и способы их решения Игра вылетает на всех платформах. Владельцам ПК советуем перепроверить, соответствует ли компьютер системным требованиям. Если все в порядке, дождитесь обновлений. На консолях проблему тоже должны решить апдейтами. На открытых локациях игра начинает тормозить. В ПК-версии снизьте графические настройки, включите технологию DLSS для видеокарт Nvidia или FidelityFX Super Resolution для видеокарт AMD. Владельцам консольных версий остается ждать патчей от разработчиков. В настройках нельзя включить трассировку лучей. Сейчас игра не поддерживает технологию рейтрейсинга. Ее добавят позже с обновлением. Больше информации о мире игры вы можете найти на информационных стендах и стенах комплексов Стоит ли покупать Atomic Heart Что пишут игроки. Пользователи Steam хвалят игру за отличную графику и оптимизацию — даже несмотря на вылеты. Особенно выделяют интересную боевую систему и интригующий сюжет. Сейчас у игры «Очень положительные» пользовательские обзоры. Ругают игру за завышенную стоимость, раздражающие диалоги главного героя с перчаткой и чрезмерное количество головоломок. Пользователи из СНГ отдельно критикуют то, что в регионе Atomic Heart стала эксклюзивом сервиса VK Play. В ходе игры главный герой посетит театр с роботами-балеринами Что пишут критики. На агрегаторе оценок OpenCritic средняя оценка игры — 74',\n",
       " ('Atomic Heart',\n",
       "  3,\n",
       "  2): 'балла. Журналистам понравился проработанный мир Atomic Heart и ее лор. Отдельно хвалят отличный визуальный ряд, саундтрек и увлекательную боевую систему. Серьезными минусами обозреватели посчитали раздражающие диалоги героя с перчаткой, пустой открытый мир, наличие багов и глюков. Некоторым рецензентам не понравилось развитие сюжета и концовка. Мнение Т\\u2060—\\u2060Ж. У Atomic Heart есть серьезные недостатки. Многие точки сохранения расставлены так, что при гибели игрок теряет до 15 минут прогресса. На консолях игра периодически вылетает, а лицевые анимации точно могли быть лучше. Сюжет в конце кажется скомканным. Однако достоинства игры сглаживают неприятные впечатления. Изучать мир здесь так же интересно, как сражаться с врагами. Визуально Atomic Heart впечатляет, а история удерживает внимание от начала до титров. Даже несмотря на сумбурный финал. Поэтому Atomic Heart не грех порекомендовать всем поклонникам сюжетных шутеров вроде BioShock.',\n",
       " ('Atomic Heart',\n",
       "  30,\n",
       "  0): \"There’s a lot to be said about unapologetically single-player games like Atomic Heart: its entire focus is on creating an intricate world for us to explore and discover for ourselves. An eye-catching blend of super-powered shooting and first-person puzzling, this is a lengthy, tough, and terrific-looking shooter that has us bathing in the blood and gears of elaborately designed enemies both biological and robotic and dispatching them with an impressive set of combat options. Granted, it’s not as clever as it thinks it is when dealing with melee combat or its typical fetch quests, and the story doesn’t quite stick its landing, but the journey from point A to point B is a sight to behold. Play Atomic Heart is an alternate-history shooter cut from the same cloth as BioShock and MachineGames’ Wolfenstein series. It’s a kind of retrofuturistic romp back to an imagined past perverted by ridiculously advanced technology; a world where science has made the supernatural a reality and robots are now running rife. These are far from the only shooters Atomic Heart is unafraid to crib from, either. Half-Life and the puzzle-solving of Portal are also clear inspirations, and there’s been an attempted sprinkling of Arkane’s successful brand of first-person stealth, too. “ It’s a kind of retrofuturistic romp back to an imagined past perverted by ridiculously advanced technology. However, it’d be unfair to call Atomic Heart wholly derivative despite such recognisable building blocks. Certainly the idea of a peaceful utopia torn to pieces thanks to technology turning on its ambitious masters is nothing new, but developer Mundfish has still assembled its vision in a confident and compelling way – and the art team here well and truly understood the assignment. Mechanical Mystery Tour The most remarkable element here is the superb visual design, especially the look of these well-crafted enemies. Its range of robots is particularly strong, from its sleek and sinister moustachioed terminators that charge at us without ever averting their gaze to its pot-bellied parking meters with mouth tubes that make them look like they’re sucking at the drawstring on an invisible jacket. Its featureless ballerina bots and spindly-legged battle balls are equally memorable – the latter of which are probably best described as scaled-down, Eastern Bloc knock-offs of those things that couldn’t kill Mr. Incredible. There’s even one that looks like Baymax cosplaying as a tank. What's your favourite alternate history game or game series? Wolfenstein BioShock Fallout Freedom Fighters Command & Conquer: Red Alert Resistance Other: tell us in the comments! Answer See Results Atomic Heart’s outstanding aesthetic also extends to its large range of partially ruined labs, facilities, and transportation hubs – each filled with long, snaking globules of the liquid polymer that powers the advancements of this fantastical 1950s. That said, there is a distinct feeling of ‘look, don’t touch’ in these places (there’s definitely a lack of destructibility; balloons immune to axe swings are probably the worst offenders) but the level of detail overall is strikingly good. There are some especially tiny touches in Atomic Heart that smack of a great deal of consideration, like the way there are different reload animations for unspent magazines compared to empty ones – the latter of which are flicked away while the former are grasped by the same hand sliding a fresh one in. Watching them play out is a pleasure, which is why it was a bit annoying that my HUD was sometimes cluttered up with pick-up notifications and health bars for minibosses no longer in the area that froze onscreen until I reloaded from a recent save. I’ve also experienced\",\n",
       " ('Atomic Heart',\n",
       "  30,\n",
       "  1): 'some uneven quality when it comes to graphical glitches as I’ve played on Xbox Series X. The worst is a terrible strobing effect on some fast-moving robots running circuits around a large room, but fortunately it seems mostly isolated to these bot types. I’ve had no such problems with similarly nimble (and often much larger) bosses. Play Atomic Heart is, naturally, all tinted with the Soviet-era iconography you’d probably expect from a land tucked away deep behind the Iron Curtain in the mid-1950s, and admittedly the lens through which you may view all this Soviet symbolism is a little different today in 2023 than it was upon its announcement and first reveal back in 2018. Of course, having grown up geographically isolated and politically irrelevant in the southern hemisphere – largely detached from Cold War concerns and raised on Bond movies, Stripes, and Rocky IV – my read on such an overtly Russian backdrop is guaranteed to be markedly different to someone with roots in Eastern Europe. For its part, however, the background does largely fade away as Atomic Heart peels back the layers of its false utopia. At this stage, Facility 3826 and the countryside of rural Russia isn’t much different to the likes of BioShock’s Rapture itself. That is, a place more or less cut off from the outside world and where something has gone deeply, deeply wrong. Exploring exactly what’s gone wrong is the job of our character, special forces veteran Major Sergey Nechaev, or P-3 as he’s dubbed throughout. The foul-mouthed and amnestic P-3 is admittedly a bit of a relic of games gone by – and his default English-language voiceover doesn’t exactly do him a lot of favours. He comes off as the cookie-cutter American lead of every second shooter ever made. “ The foul-mouthed and amnestic P-3 is admittedly a bit of a relic of games gone by. However, it’s the script that really does him a greater disservice. While I’ll happily admit swearing is virtually my second language, P-3 spews it with the gusto of a teenage boy testing every curse word he’s recently learned twice a sentence. It’s a little exhausting, and the presence of many modern turns of phrase don’t exactly help keep the overall experience seated in the 1950s. Of course, perhaps I’m being hypocritical in demanding consistency there, because the regularly ruthless soundtrack packed with headbangers courtesy of Doom and Wolfenstein composer Mick Gordon isn’t exactly a sonic journey back to the days of doo-wop, either – and yet the music is pitch perfect as far as I’m concerned. At any rate, there is a Russian-language/English subtitle option for purists, but I would’ve simply preferred an English script that was more tempered for the setting and era. There are well over 20-odd hours of play here in the main story thread alone, with many more available in the side objectives – some of which border on crucial if you actually want the best weapons. Some of that is padding but it’s a good length overall, and nicely inside that not-too-short, not-too-long Goldilocks zone for a great solo shooter. There are also two endings you can get based on just one choice you make in the finale, although after seeing both I found the first anticlimactic and don’t think the second was worth the reload. All You Need is Glove However, while P-3 is disappointingly threadbare as a character, he’s nonetheless very capable and entertaining to play as – largely thanks to his partner, Charles, who is a talking glove. Okay, that’s a bit reductive – rather, Charles is basically',\n",
       " ('Atomic Heart',\n",
       "  30,\n",
       "  2): 'an intelligent system embedded in P-3 who is capable of granting him seemingly supernatural abilities, manifested by a set of small, squid-like tentacles that extend from a glove on P-3’s left hand. This not only includes activating an X-ray-style view of your surroundings and tossing certain small objects à la Half-Life 2’s iconic gravity gun, but also the ability to fire bolts of electricity or ice, levitate enemies into the air to shoot or slam into the ground, or even summon a temporary shield. Akin to BioShock’s Plasmids, these abilities add an important layer of more interesting combat on top of Atomic Heart’s otherwise fairly typical blasting and slightly clumsy melee combat. There’s a great sense of weight when beaning a bot in the brainpan with an axe – and the gouges that appear across their bodies in real-time is a great touch – but I found the weapon swinging too slow and frustrating when swarmed by too many enemies simultaneously. Play The juggling act of defeating dense swarms of robots as well as the blender-sized hovering repair bots that continually swoop in to magically resurrect them gets a bit wearisome at times, especially above ground. Atomic Heart’s linear, underground sequences are linked by a decent-sized slab of open world where we’re free to explore and fight wherever we wish, and this zone is initially a nice antidote to the more corralled corridor segments that progress the story or reward us with useful upgrades. However, with their long line-of-sight and overwhelming numbers, I often found myself running or driving away from fights rather than diving in or trying to get the upper hand via stealth before attacking – because they’re not that much fun to fight over and over. There is a way to fry all enemies within a zone for a while if you’re patient, and the robot hordes do become a little less intimidating as P-3 and his arsenal grow stronger throughout the story, but that’s a process that takes some time. Unlocking and upgrading these abilities requires a steady supply of resources, which the levels and defeated enemies are generally chock full of, even if collecting them can become a bit of a chore. Atomic Heart is smart to keep this process fast by allowing us to extend out a hand and suck up reams of resources like an industrial shop vac, but it still becomes a little tedious having to ransack the same sets of desks and cabinets arranged slightly differently in a hundred-or-so different rooms. “ The main character being annoyed for the same reason I am isn’t cute, it’s a tone deaf non-apology for weak game design. Tedious, too, is Atomic Heart’s overly ambitious attempt to weasel its way out of accountability for leaning on some extremely hackneyed fetch quests. Having the main character cynically gripe and complain about collecting four canisters for a bafflingly unintuitive door-locking mechanism that would never get past any sensible architectural committee isn’t a free pass to proceed with it. The main character being annoyed for the same reason I am isn’t cute, it’s a tone deaf non-apology for weak game design. It’s a shame that some better context wasn’t baked around these occasional fetch quests because Atomic Heart’s underground chambers feel like a ripe opportunity and are largely great otherwise: eerie, deadly, and mostly devoid of life – unless you count the mutant freaks with skulls shattered into fanged, floral arrangements or the dead bodies that communicate via the confused ramblings of their fading brain implants. It does rely too heavily on repeating the same handful of door',\n",
       " ('Atomic Heart',\n",
       "  30,\n",
       "  3): 'lock minigames that serve no real purpose other than to arbitrarily slow your progression from room to room, but I do like the bespoke platforming puzzle chambers and one-off brainteasers – especially the clever visual puzzle you’ll encounter late during your trip to an ornate theatre full of robotic performers.',\n",
       " ('Atomic Heart',\n",
       "  31,\n",
       "  0): \"Atomic Heart doesn't hide its BioShock Infinite inspirations. The game begins in a city in the clouds, features reality-bending and elemental powers you can employ in your fight against advanced robots, sees you scrounging for resources in an idyllic city that's falling apart, and stars an amnesiac protagonist grappling with the nuances of free will. By the time you reach the climax of the story and you're asked to visit a lighthouse, you know what's up. Where Atomic Heart most differs from its inspiration is in the lens through which it focuses its narrative, exploring concepts of free will via Soviet Russian collectivism instead of the U.S.' individualism. However, its intriguing premise is let down by a deeply unlikable protagonist and a predictable storyline that doesn't do anything interesting with its cool ideas. In the alternate history of Atomic Heart, a scientist named Dmitry Sechenov kickstarts a robotics boom in Russia in the 1930s. By the 1950s, the working class has been abolished in the Soviet Union and completely replaced by robots controlled through a hive-mind network called Kollectiv 1.0. The game begins a few years after that, just prior to the public unveiling of Kollectiv 2.0, which will allow all humans to have equal access to the hive-mind to control robots remotely through a Thought device wired straight to their brain, as well as connect and share information with each other across great distances. Basically, it's the Internet plugged into your brain and available 24/7. With the benefit of 21st-century hindsight, we know the Internet will not end up being a 100% good idea even if the main character Major Sergei Nechaev, an agent who serves Sechenov, fully believes in the dream of a world where everyone equally has access to each other and the wealth of information that will surely be shared. Assigned to investigate a disturbance in Facility 3826, the Soviet Union's foremost scientific research hub, Sergei is joined by Charles, a sentient glove that gifts the agent with a host of polymer-fed technopowers like telekinesis and cryokinesis, and provides a sounding board for Sergei's oftentimes annoying and borderline abusive collection of quips and unfunny comebacks. Within the now blood-soaked hallways and flickering lights of the partially destroyed underground facility, Sergei discovers experiments into mutation gone awry and finds that the once-peaceful robot assistants have turned blood-thirsty. The true horror doesn't come until later, however, when Charles talks to Sergei about the ways in which Kollectiv 2.0 (which is already installed into Sergei) may not be entirely beneficial. Hasn't Sergei noticed that all those audio logs he's found and computers he's logged into only give him information that's relevant to furthering the mission he's been assigned? Wow, it's almost as if an algorithm is feeding him with information about what it thinks he should see and hear more of, disguising it in a way where he can't spot the manipulation. It's not as overt a form of control as a spoken command but Charles hints that humans can be directed just as easily as robots once they've all logged into the same hive-mind of information, especially if there is a way to control that information. It's an intriguing concept, one furthered by the notion that Atomic Heart is a video game and so we, the player, have been directing Sergei's actions the entire time. So it's not just Sergei who's being manipulated to view the game's world in a certain way based on a fictional Internet algorithm, it's us too. But as interesting as it is, exploring free will through the scope of a video game's story\",\n",
       " ('Atomic Heart',\n",
       "  31,\n",
       "  1): \"has been done before, and Atomic Heart doesn't do anything notably novel with the concept. In fact, its protagonist actively gets in the way of this concept being explored, raging at Charles that he doesn't have time to wax poetic about hypotheticals. He can't be bothered to offer any sort of introspection because there are robots that need to be stopped and a bad guy to blame that needs killing. Over and over, Charles brings up the morality of their mission and the larger implications of what's going on, and repeatedly Sergei just doesn't care, citing that he'll leave the thinking to Sechenov. The first and second times it happens, you're hopeful that this flaw is setting up some form of character development for Sergei. When you're 10 hours in and Sergei is still spinning in the same pattern and showing no signs of growing as a person, you can't help but wonder how anyone could be this stubbornly bone-headed and annoyingly naive. Sergei is also deeply unlikable as a person. He's antagonistic to everyone around him, including the regularly helpful Charles, and it's never explained why, leading to the slow realization of the painful truth that you're just playing as a shitty human being. You don't feel good playing as Sergei whenever he opens his mouth to talk to anyone--I empathize more with the people who have to tolerate his barrage of unfunny insults than I do him. It's familiar but still fun. Despite being a jerk, he does know how to fight. Wielding polymer abilities with his left hand and an assortment of firearms and weapons with his right, Sergei is a hard-hitting fighter. While the robots and mutants he goes up against are far faster than he is, you can easily escape the swarms by using Sergei's dash to reposition, curating a frenetic hit-and-run combat experience. Though relatively simple at first, combat evolves into a more engaging experience as more enemy types are introduced, each with its own attack patterns and weaknesses. Atomic Heart has a healthy diversity of enemy types. However, there's nothing you'll face you probably haven't fought a variation of before in other games--ranging from dog-like enemies that try to circle you before pouncing in your direction to turret-like adversaries that shoot at you from afar to bulky foes who heavily telegraph their attacks but can take a hit. The same goes for the weapons and powers you use to fight them. The pump-action shotgun hits like you'd expect a shotgun should, for instance, and the cold polymer power freezes enemies in their tracks just as you'd assume. There's nothing revolutionary to how combat plays out, but it all works as it should. It's familiar but still fun. Looting is surprisingly the most enjoyable aspect of Atomic Heart, as, with just the click of a button, Charles can use telekinesis to pull loot into Sergei's pocket. In practice, this causes drawers to fly open, cabinet doors to almost swing off their hinges, and the bodies of enemies to erupt as the magnetic pull of Charles rips the resources of a room towards Sergei. It never got old to enter an unexplored room or clear out a group of enemies and then sit back to watch as everything around me exploded into a whirlwind of paper and scraps of metal, sucked into my coffers like a greedy tornado. Of course, you can then use these resources to craft new firearms, ammo, weapon attachments, and items, but the sheer delight of the act is almost enough of a reward in itself. The twins, Right and Left,\",\n",
       " ('Atomic Heart',\n",
       "  31,\n",
       "  2): \"deserved to have more screentime. After completing the first mission, Sergei takes a monorail to the main area of the game, where Atomic Heart expands into an open-world format. At this point, the game's narrative slows to an annoying crawl as Sergei journeys to one of several facilities to complete a mission, return to the surface of the open world, travel to the next facility, and repeat the process. Even if you don't take the time to freely explore the map, complete optional challenges, and look for materials to unlock special attachments for your firearms, the journey between waypoints still bogs down the story. Nothing of narrative importance happens outside of the contained, linear levels of the different facilities, and combat benefits from the carefully structured layout of those contained levels. Even enemy placement and type are curated to fit specific areas of the linear levels, and that careful curation is lost within the breadth of the open world. I would often just hop in a car and drive straight to the next story beat, as that's where the better gameplay is. It makes the open world feel superfluous, adding content at the expense of enjoyability. Fortunately, some of the main levels have a distinct flavor and engaging themes to them, helping them to stand out against the largely forgettable open world. My favorite of these levels takes place in a theater known for being the first to feature a cast composed entirely of robots. The level sees Sergei chasing after a man who used to work there, who has twisted the theater into a macabre showcase of art--much like in BioShock. There's this breadcrumb trail of diary entries you can uncover that reveals an engineer coming to terms with the strange parasocial relationship he's developing with one of the robot dancers, a clever puzzle that incorporates ballet poses and blood splatters, and an incredible moment where you're fighting off waves of enemies during a ballet that gets a hip-hop remix It's a great level, and I'm sad we didn't get more like it or at least have more examples of using music to transform a familiar combat scenario into something more memorable. Atomic Heart has a great soundtrack filled with thumping, high-energy music from Doom composer Mick Gordon that will get your head bobbing during even the most butt-clenching of battles. But these powerful rhythms are usually reserved for boss encounters, meaning a lot of the game's best music is fleeting and only pops up for one encounter before never being heard from again. That moment in the theater is cool, but it's the only time something like that happens in the game. Atomic Heart doesn't build on it to make more moments like it--in fact, there are quite a few instances where the powerful soundtrack feels wasted because the superb composition that's playing doesn't match the vibe of what you're currently doing. Why play hard rock during a stressful fight in the dimly lit space of a morgue? It just doesn't fit. There are quite a few parts of Atomic Heart that just don't neatly fit together, and those disparities create an experience that often feels at odds with itself. That disparity is most evident in how the history of the world in Atomic Heart is interesting and sets up an intriguing conversation about the nature of free will and collectivism, but then the unlikable protagonist repeatedly prevents that topic from being explored. Atomic Heart is certainly going to appeal to some people, especially those looking to relive BioShock Infinite, but it's not an easy recommendation.\",\n",
       " ('Atomic Heart',\n",
       "  32,\n",
       "  0): 'Егор Аргунов хочет завести говорящего гуся Страница автора 2 августа вышло дополнение Annihilation Instinct для Atomic Heart. Это первое DLC из четырех запланированных. Рассказываем, о чем Annihilation Instinct, как начать прохождение дополнения и стоит ли вообще это делать. Что за Atomic Heart: Annihilation Instinct Дата выхода: 2 августа 2023 Жанр: шутер от первого лица Платформы: ПК — VK Play и Steam, Xbox One и Xbox Series, PlayStation 4 и 5 Режим игры: одиночный Издатель: VK Play в России и странах СНГ, Focus Entertainment в остальных странах Разработчик: Mundfish Кому понравится: фанатам оригинальной Atomic Heart Игры, похожие на Annihilation Instinct: серия BioShock, Singularity Примерная продолжительность: от 2 до 3 часов Перевод: есть озвучка и субтитры на русском языке Подробнее: на сайте игры https://www.youtube.com/embed/ZKhkItxR7G0 О чем дополнение Майор Сергей Нечаев просыпается в комплексе «Менделеев» на территории «Предприятия 3826». Его держит взаперти робот Элеанора, которая испытывает к Нечаеву романтические чувства. Она отпускает героя при условии, что он избавится от Бабы Зины, союзницы майора в оригинальной игре. Зина летает над комплексом в реактивной избушке и посылает роботов-манекенов убить главного героя. Выбраться из комплекса «Менделеев» не получится: Элеанора отрезала его от мира с помощью защитного купола. Главный герой знакомится с академиком Лебедевым, единственным выжившим здесь ученым. Он рассказывает Нечаеву, что если изменить алгоритмы поведения любвеобильного торгового автомата, купол спадет. Но для этого нужно собрать восемь шарообразных роботов под названием БУС-А. Поверхность комплекса «Менделеев» Как запустить дополнение и стоит ли в него играть до финала основной игры Главный герой может использовать против врагов шоколад «Аленка». Сладость активирует электромагнитную бурю на несколько секунд Запустите Annihilation Instinct в разделе «Новая игра» в главном меню. У дополнений нет отдельного меню. Для запуска DLC не требуются сохранения из оригинальной игры. Не проходите Annihilation Instinct до завершения основной игры. Это прямое продолжение Atomic Heart. Игра учитывает события «хорошей» концовки. Сначала пройдите основную игру, а затем приступайте к Annihilation Instinct. Мнение Т\\u2060—\\u2060Ж о дополнении Annihilation Instinct На прохождение Annihilation Instinct уходит всего 2—3 часа, но вы все равно будете жалеть о потраченном времени. В дополнении практически нет ярких сцен и диалогов. Большую часть времени Нечаев просто бегает по комплексу в поисках восьми предметов. Часть БУСов находится в однообразных коридорах «Менделеева». Кажется, что разработчики из Mundfish намеренно растянули продолжительность дополнения. Рядом с каждым БУСом располагается минимум 10 врагов На пути у главного героя встают два типа противников: роботы-манекены и сами БУСы. И те и другие атакуют Нечаева большими группами, поэтому умереть в бою легко. Однако это не делает сражения напряженными и увлекательными. Напротив, схватки быстро превращаются в рутину: враги поджидают чуть ли не за каждым углом, а некоторые поединки растягиваются на несколько минут. Кроме драк в дополнении ничего и нет — ни дополнительных заданий, ни секретных локаций. Босс в дополнении один, но сражаться с ним приходится два раза. У гигантского робота, который состоит из десятков БУСов, есть всего три типа атак. От них нужно уворачиваться и успевать отстреливать конечности босса. Эта битва не приносит удовольствия и в первый раз, поэтому дважды заниматься этим совсем не хочется. Дополнение лишено одного из главных достоинств оригинальной игры — забавных диалогов. В Atomic Heart Нечаев постоянно общался с нейрополимерной перчаткой ХРАЗ. Герой комментировал происходящее, вел дискуссии с ХРАЗом и ругался на врагов. В дополнении с майором на связь выходят Элеанора и академик Лебедев, но разговоры с ними не развлекают: герои не шутят, а общаются лишь по делу. Игрок больше узнает о комплексе «Менделеев», но на этом все. В остальное время Нечаев молчит и почти не реагирует на врагов. Время от времени над героем также зависает избушка Бабы Зины. Эта сцена повторяется несколько раз за игру и быстро утомляет. Единственный запоминающийся персонаж Annihilation Instinct — говорящий гусь, который',\n",
       " ('Atomic Heart',\n",
       "  32,\n",
       "  1): 'преследует Нечаева и издевается над ним. Только он и вызывает улыбку во время прохождения. Птица произносит забавные мемные фразы вроде «Ломай меня полностью», цитирует «Зеленого слоника» и другие фильмы. Гуся озвучивает Руслан Габидуллин из студии «Кубик в кубе». Он известен по озвучке «Отбросов», «Голяка» и других комедийных сериалов Новые виды оружия разочаровывают. Нечаеву выдают боевую лопату «Клуша» и пулемет «Секатор». Оба вида оружия полезны только при максимальной прокачке ближе к концу дополнения — до этого они наносят мало урона. Атаки «Клушей» быстры, но слабы. «Секатор» моментально тратит боезапас, ведь на одного противника поначалу может уйти больше ста пуль. Альтернативный огонь лазером у пулемета тоже не особенно выручает из-за быстрого расхода энергии. Спустя час прохождения герою возвращают оружие из оригинальной игры — оно лежит в складе Элеаноры. Дробовик КС-23 и пистолет Макарова оказываются более эффективными, поэтому я переключился на них. «Секатор» с лазерным типом стрельбы напоминает большую рогатку Annihilation Instinct никак не дополняет основной сюжет Atomic Heart. Игроки узнают немного больше об Элеаноре, однако проходить дополнение ради этого точно не стоит. Все персонажи остаются там же, где оказались в конце оригинальной игры. Расстановка сил никак не меняется. Из-за этого дополнение нельзя назвать полноценным продолжением, это скорее филлер. Возможно, следующие DLC будут более содержательными. В Annihilation Instinct есть неприятные баги. Указатель цели в версии для Xbox Series показывает неправильное расположение БУСов. Из-за этого искать предметы пришлось самостоятельно, так как карта в комплексе «Менделеев» не работает. Также игра не позволила продвинуться дальше, когда я нашел один из БУСов: контейнер для его отправки просто не открылся. Проблему удалось решить только перезагрузкой игры. Вероятно, эти баги исправят в патчах.',\n",
       " ('Atomic Heart',\n",
       "  33,\n",
       "  0): '«Канобу» и «Игромания» подводят итоги ежегодной премии LUDI Awards, во время которой наши читатели выбирают лучшие игровые проекты, лучшие студии разработки и самые важные события в игровой индустрии за прошедший год. Голосование стартовало 14 января и продолжалось до начала марта — и теперь мы готовы огласить полный список победителей во всех категориях. «Глобальная игра года» Победитель: It Takes Two / Hazelight Второе место: Resident Evil: Village / Capcom Третье место: Marvel’s Guardians of the Galaxy / Eidos-Montréal Остальные номинанты: Psychonauts 2 / Double Fine Productions Black Book / Morteshka Valheim / Iron Gate AB Deathloop / Arkane Studios Halo Infinite / 343 Industries Loop Hero / Four Quarters New World / Amazon Games Noita / Nolla Games Call of Duty: Vanguard / Sledgehammer Games Lost Judgment / Ryu Ga Gotoku Studio Returnal / Housemarque «Наша игра года» Победитель: Pathfinder: Wrath of the Righteous / Owlcat Games Второе место: Black Book / Morteshka Третье место: King’s Bounty II (2021) / 1C Entertainment Остальные номинанты: Loop Hero / Four Quarters Breathedge / RedRuins Softworks The Life and Suffering of Sir Brante / Sever «RPG года» Победитель: ATOM RPG Trudograd / AtomTeam Второе место: Pathfinder: Wrath of the Righteous / Owlcat Games Третье место: King’s Bounty 2 / 1C Entertainment Остальные номинанты: Black Book / Morteshka Encased / Dark Crystal Games «Открытие года» Победитель: Loop Hero / Four Quarters Второе место: Potion Craft: Alchemist Simulator / niceplay games Третье место: The Life and Suffering of Sir Brante / Sever Остальные номинанты: HighFleet / Konstantin Koshutin DOM RUSALOK / Yakov Butuzoff «Обновление года» Победитель: Mortal Shell / Cold Symmetry Второе место: World War Z: Aftermath / Saber Interactive Inc Третье место: War Thunder / Gaijin Entertainment Остальные номинанты: World of Tanks / Wargaming Group Limited Enlisted / Darkflow Software World of Warships / Wargaming Group Limited «Лучший визуал» Победитель: Black Book / Morteshka Второе место: HighFleet / Konstantin Koshutin Третье место: The Life and Suffering of Sir Brante / Sever Остальные номинанты: Loop Hero / Four Quarters DOM RUSALOK / Yakov Butuzoff «Лучший саундтрек» Победитель: Pathfinder: Wrath of the Righteous / Owlcat Games Второе место: Loop Hero / Four Quarters Третье место: The Life and Suffering of Sir Brante / Sever Остальные номинанты: DOM RUSALOK / Yakov Butuzoff They Always Run / Alawar Premium Kovox Pitch / Calvares «Событие года» Победитель: Team Spirit / The International 10 Второе место: Виталина Бацарашкина / медальон The Witcher 3 Третье место: NAVI / PGL Major Stockholm 2021 Остальные номинанты: Моргенштерн / Клип «Дуло» «Локализация года» Победитель: Disco Elysium / ZA/UM Второе место: Marvel’s Guardians of the Galaxy / Eidos-Montréal Третье место: Resident Evil Village / CAPCOM Co., Ltd. Остальные номинанты: Deathloop / Arkane Studios Call of Duty: Vanguard / Sledgehammer Games «Лучшая игра-сервис» Победитель: Escape From Tarkov / Battlestate Games Второе место: World of Tanks / Wargaming Group Limited Третье место: War Thunder / Gaijin Entertainment Остальные номинанты: World of Warships / Wargaming Group Limited «Самая ожидаемая игра» Победитель: S.T.A.L.K.E.R. 2: Heart of Chornobyl / GSC Game World Второе место: Atomic Heart / Mundfish Третье место: Men of War 2 / Best Way Остальные номинанты: Militsioner / TALLBOYS Кужлевка / Callback Помни… / Ice-Pick Lodge',\n",
       " ('Atomic Heart',\n",
       "  34,\n",
       "  0): 'Игру Atomic Heart выпустили в феврале 2023 года — в ней в альтернативном СССР 1950-х роботы нападают на людей. Точная дата выхода экранизации не уточняется, над сценарием работает Роман Кантор Девушки в костюме героев компьютерной игры Atomic Heart на фестивале «Российская креативная неделя. Москва Фест» в Москве (Фото: Кирилл Каллиников / РИА Новости) «Кинопоиск» работает над экранизацией российского шутера Atomic Heart, сообщили на презентации, организованной сервисом, передает корреспондент РБК. Съемки начнутся в 2025 году, сценарий напишет Роман Кантор, который участвовал в создании фильма «Мастер и Маргарита» (2023) и сериала «Эпидемия» (2019). Работа над проектом идет под совместным креативным контролем со студией Mundfish — разработчиком Atomic Heart, отметили на презентации. Точная дата выхода экранизации не уточняется, но речь идет о периоде до 2029 года. Сюжет компьютерной игры Atomic Heart разворачивается в альтернативном Советском Союзе 1950-х, в котором роботы выходят из-под контроля и нападают на сотрудников предприятия, где их собирают. Главный герой игры — майор Сергей Нечаев — начинает расследование. К Atomic Heart выпущено два дополнения — Annihilation Instinct и Trapped in Limbo. Игра разрабатывалась Mundfish в сотрудничестве с американской Nvidia, та предложила «железо» и доступ к движку Unreal Engine 4, а также частично взяла на себя рекламное продвижение. Разработчики не раскрывали бюджет, потраченный на создание игры, а также объем сборов. По оценкам экспертов, стоимость проекта составляет от $5 млн до $25 млн. Atomic Heart доступна на PlayStation 4, PlayStation 5, Xbox One и Xbox Series X/S. Пользователи Windows могут приобрести ее через Steam (в России сервис недоступен) или через VK Play.',\n",
       " ('Atomic Heart',\n",
       "  35,\n",
       "  0): 'The Atomic Heart: Annihilation Instinct DLC comes out August 2, publisher Focus Entertainment and developer Mundfish announced. This DLC, the first for the action-RPG, adds a new area, new weapons, new enemies and a new glove ability. The trailer is below. Play Here’s the official line on the new DLC: \"Continue the story in the Annihilation Instinct DLC and learn what happened to this dystopian world after the climax of Atomic Heart. Prepare to embark on a journey through the new mind-bending Mendeleev Complex and its surrounding swamps, and discover the truth about NORA as Major P-3 is pulled back into Facility 3826. \"Survive vicious, shapeshifting new enemies, and take them down using two cunning new weapons - the ranged Secateur and the melee Klusha - as well as your glove’s new Techno-Stasis ability, allowing you to manipulate time itself. \"Meet a new enigmatic character, as well as returning ones in surprising circumstances, and dive deep into the AI’s insanity to curb its Annihilation Instinct.\" Meanwhile, out now is a New Game+ mode for free alongside a new update. This is designed to offer Atomic Heart’s most difficult mode yet. \"Players will need all of their previously unlocked skills and arsenal to deal with the strongest enemies Atomic Heart has ever unleashed, thanks to their new specific resistances and attack effects, which will be reflected in the different colors of enemy auras,\" Focus said. The Atomic Heart: Annihilation Instinct DLC is included in the Atomic Pass and in the Gold and Premium Editions. IGN’s Atomic Heart review returned an 8/10. We called it “a highly imaginative, atompunk-inspired attempt at picking up where the likes of BioShock left off that makes missteps but definitely has the ticker to punch well above its weight”. Wesley is the UK News Editor for IGN. Find him on Twitter at @wyp100. You can reach Wesley at wesley_yinpoole@ign.com or confidentially at wyp100@proton.me.',\n",
       " ('Atomic Heart',\n",
       "  4,\n",
       "  0): 'As the release of sci-fi shooter Atomic Heart nears, numerous questions around the project remain - which its developer Mundfish seems disinclined to answer. Concerns have been raised regarding the game\\'s heavily pro-Soviet themes, as well as the activities of both developer Mundfish and its investors. Those concerns include, but are not limited to, the use of glorification of Russia in marketing and the apparent origins of Mundfish as a Russian entity, including the reported investment in Mundfish by Russian companies. Atomic Heart has been in development since 2017. Inspired by the BioShock series, it\\'s a game that - according to the Mundfish website - explores \"the utopia of an alternative world\" that takes place in an alternative Soviet Union of 1955. \"Science, equality and fraternity are the main symbols of freedom in this reality. But what kind of effort does it take to build an ideal society?\" Mundfish asks, teasing a story which will question \"what forces are behind the Utopian dream?\" It is, ostensibly, a game about the alternate universe success of the Soviet Union in the mid-1950s, and its technological superiority - as scientific progress leads to the discovery of a new polymer used in the development of robotics. There\\'s a fine line between world building and glorification and it remains to be seen to what extent the game potentially idolises the Soviet Union until the game is released. Yet Mundfish has already raised eyebrows for its use of pro-Soviet themes in marketing. Back in November, an extravagant promotional event for the game was held for Russian press, with the venue dressed in Soviet finery and signage reading \"Glory to Soviet engineers\" and \"Comrade, join the society of tomorrow\". The timing of the event coincided with international backlash to the new anti-LGBT laws in Russia, and as Game World Observer reported, some attendees questioned whether the event was appropriate due to the war in Ukraine. So who is Mundfish? \"Founded in 2017, by a team of four like-minded gaming enthusiasts, Mundfish is a video game development studio headquartered in Cyprus. Mundfish is led by a talented global team focused on creating an original, captivating, and unique gaming experience with their first title, Atomic Heart,\" a statement on the company website reads. It\\'s stated that Mundfish now comprises an \"experienced international team of developers\" operating in 10 countries including Poland, Ukraine, Austria, Georgia, Israel, Armenia, UAE, Serbia, and Cyprus. One country is conspicuously missing. Mundfish\\'s statement omits the detail its team was originally from Moscow, and that Russian media continue to describe the studio as Russian in articles about the game. Mundfish was recently forced to deny claims it was harvesting data for Russian authorities. The site AIN.Capital alleged that Mundfish\\'s Russian store website included a clause to inform users their data may be collected and sent to Russian state authorities, including the tax office and Federal Security Service. AIN alleged the website policy cited \"Russian mobilisation laws, under which soldiers are currently being recruited in Russia to continue the criminal war against Ukraine\" and claimed Mundfish listed its legal address was still listed as in Moscow. \"Our game and website DO NOT collect any information or data,\" a spokesperson for Mundfish told GamesRadar by way of a response. \"The website\\'s privacy statement is outdated and wrong, and should have been removed years ago. We have shut down the shop to assure our fans of the integrity of our studio and products. We apologise for any confusion on this matter.\" Other incidents and choices from Mundfish have raised concern. For one, Atomic Heart\\'s release date. On 21st February',\n",
       " ('Atomic Heart',\n",
       "  4,\n",
       "  1): '2022, Russian President Vladimir Putin signed a presidential decree recognising the independence of separatist regions in eastern Ukraine, which preceded military action less than 72 hours later. Atomic Heart is set for release on the same day this year, raising eyebrows. If it was a mere coincidence, why not say so? If Mundfish wished to avoid speculation, why not shift the date? Eurogamer specifically asked Mundfish and Atomic Heart publisher Focus Entertainment about the game\\'s choice of release date, but did not hear back. At the start of 2023, Mundfish released a statement on its stance to Russia\\'s invasion of Ukraine, which was criticised for its lack of specificity and vague language. \"Guys, we have noted the questions surrounding where we, at Mundfish, stand,\" Mundfish said in a Twitter thread. \"We want to assure you that Mundfish is a developer and studio with a global team focused on an innovative game and is undeniably a pro-peace organisation against violence against people. \"We do not comment on politics or religion. Rest assured; we are a global team focused on getting Atomic Heart into the hands of gamers everywhere. \"We do not, and will not, condone contributors or spammers with offensive, hateful, discriminatory, violent, or threatening language or content.\" For a game depicting an idealised alternate universe Soviet Union utopia, the lack of comment on politics or religion rubbed many the wrong way. However, with the developer\\'s ties to Russian companies, there may be a fear of reprisal for staff at Mundfish. Guys, we have noted the questions surrounding where we, at Mundfish, stand. We want to assure you that Mundfish is a developer and studio with a global team focused on an innovative game and is undeniably a pro-peace organization against violence against people. — Mundfish #AtomicHeart (@mundfish) January 16, 2023 To see this content please enable targeting cookies. Manage cookie settings Lastly, there\\'s the matter of Mundfish\\'s investor, the Russian firm GEM Capital. GEM Capital is an investment firm with a strong interest in gaming companies, led by an individual named Anatoliy Paliy. So far, the company has invested in Mundfish, along with Owlcat Games (Pathfinder: Wrath of the Righteous), Weappy (This is the Police), Deus Craft (Grand Hotel Mania), and Unfrozen (Iratus: Lord of the Dead). Paliy previously worked for Russian majority state-owned gas company Gazprom. Further, in Russia the game is set for release on VKPlay due to Steam ceasing business in the country, which is part of VKontakte - Russia\\'s primary social media platform that\\'s controlled by Gazprom. It means sales for the game in Russia can be linked back to the state. Aight, who\\'s up for some fun thread abt Fun Vidya Gaems™!!! Though not a True Hardcore Real Gamer©, I follow some news, I play some — in between power outages and russian missiles, that said. So yeah, I like games. You know who else likes games? Anatoliy Paliy pic.twitter.com/roUmvjubIh — like a joke (@fj_undead) January 13, 2023 To see this content please enable targeting cookies. Manage cookie settings How much was GEM involved in the development of Atomic Heart? Again, Eurogamer asked Mundfish for more information - which was not provided. However, when asked in an interview with Russian media about his involvement as an investor in gaming projects, Paliy responded that the company actively participates in strategy development, raising funds, optimising processes, and making operational decisions - it is not just an investor. All of this ties Mundfish, and the potential financial success of Atomic Heart, back to Russian money - even if investment deals were completed ahead of Russia\\'s invasion of Ukraine.',\n",
       " ('Atomic Heart',\n",
       "  4,\n",
       "  2): 'This is why commenters online are calling for more transparency over Mundfish\\'s financial dealings, and Russian origins. Local press AIN has released multiple articles noting the game\\'s Russian origins. Eurogamer contacted both Mundfish and publisher Focus Entertainment for the purpose of this report but did not receive a response. Eurogamer also did not receive a response from Microsoft, which is promoting the game via Game Pass. This week, Atomic Heart composer Mick Gordon donated his fee to Red Cross Australia\\'s Ukraine Crisis Appeal \"to stand in solidarity with the people of Ukraine\". \"My motivations are solely to support the Ukrainian people affected by the conflict,\" he said in a statement to Eurogamer. \"I believe it is important to separate the actions of a government from the actions of individual citizens. The talented team at Mundfish has worked hard for many years to create a unique and imaginative project, and I am grateful for the opportunity to have contributed to it. The game is a truly international effort, with 130 developers contributing to the project from more than ten different countries. I deeply respect the artistry and creativity that went into the development of Atomic Heart, and I am grateful for the opportunity to work with the Mundfish team. I also have a strong ethical and moral obligation to help those in need and stand up for what I believe is right. I hope that by making my donation public, I can also encourage others to consider making a difference.\" Atomic Heart is set for release on 21st February across PC, PlayStation and Xbox consoles, including through Xbox Game Pass.',\n",
       " ('Atomic Heart',\n",
       "  5,\n",
       "  0): 'Responses edited for clarity and length. Russian developer Mundfish quietly released the first trailer for Soviet-era shooter Atomic Heart last week, and it drew a crowd almost immediately. As Joe said, at first blush Atomic Heart echoes games like BioShock, Nier: Automata and Stalker in its art and themes. A closer look reveals a dash of Destiny and some open-world inklings, to say nothing of the killer clowns and robots. Just what the hell is Atomic Heart? I spoke to Mundfish to find out. \"Atomic Heart was conceived as an open-world game,\" said Mundfish CEO Robert Bagratuni. \"We want to enable players to choose the sequence of actions themselves instead of limiting them to a linear path. The world of the game is in fact the entire Soviet Union—a vast circle, the borders of which reach the Arctic in the north, Altai mountain in the south, and with plains, lakes and much more in the middle. At the same time, the huge infrastructure of Plant 3826 and its underground facilities are spread all over the map. The key infrastructure elements are connected by railways. As for whether this is a shooter: in some places it is, it depends where you can find ammo.\" So, Atomic Heart is an open-world first-person shooter set in an alternate Soviet Union where some seriously strange stuff\\'s going down. The railway infrastructure Bagratuni touched on makes me think of Metro, which is another game for our already towering pile of speculative influences. But while some elements of Atomic Heart are undeniably similar to other games, what actually inspired its bonkers setting? \"There\\'s no simple answer,\" Bagratuni said. \"Artyom, the author of the Atomic Heart synopsis, has been working on the script for more than seven years. Since he and some of the other members of the team were born in the USSR, many ideas came from those times. Many are comparing it with BioShock and Fallout, but in fact we took the atmosphere from our childhood, from books we grew up on. Strugatsky, Lem, Harrison. That fantasy had a special place in the life of a Soviet citizen. And when all this is merged with the internet, robotics, the Soviet Union and food coupons, you get Atomic Heart.\" Robotics, in particular, is a driving force in Atomic Heart\\'s wild Soviet Union. \"Plant 3826 was originally producing agricultural robots for working in the fields, gathering timber, protecting the peace and working at homes,\" Bagratuni said. \"They were very popular in the USSR, so the machines were everywhere. There was a robot in every house, in every enterprise. Then they went mad.\" In a blog post, the studio also mentioned \"tales of the dead rising back up and walking among the living\" following an experiment by one Dr. Stockhausen. So not only killer robots, but also bonafide zombies. And yet, as another blog post explains, Atomic Heart has a love story at its core. \"Even the toughest times can\\'t stop two loving hearts from embracing each other,\" it reads, referring to two employees from facility 3826. Bagratuni described Atomic Heart\\'s protagonist as \"crazy\" but inventive, which leads us to Atomic Heart\\'s crafting system. The biggest gaming news, reviews and hardware deals Keep up to date with the most important stories and the best deals, as picked by the PC Gamer team. Contact me with news and offers from other Future brands Receive email from us on behalf of our trusted partners or sponsors \"The main character\\'s weapon is made in a post-apocalyptic manner,\" Bagratuni said. \"He is crazy but he is not a fool. He can solder',\n",
       " ('Atomic Heart',\n",
       "  5,\n",
       "  1): 'and work with technology. Weapons are assembled from various metal parts, detached from robots or taken from the household appliances or fragments obtained during the game. Almost everything on your path can be used as a murder weapon. The approach to close-range weaponry is the same: you use whatever you can find.\" Mundfish is keeping Atomic Heart\\'s mission structure and the specifics of its world close to its chest, but Bagratuni did address the confusion surrounding the studio\\'s other game, Soviet Lunapark VR. \"This is a VR arcade shooter which is not connected plot-wise or gameplay-wise to the main game,\" he said, \"but the events of Lunapark are happening in the same universe and give the opportunity to see some zones from Plant 3826.\" Think of it as a primer for Atomic Heart. Soviet Lunapark VR is scheduled to release later this month. Atomic Heart is listed for a 2018 release on Steam (Update: the Steam page now reads 2019) and Mundfish says they\\'re hoping to share more precise information within the next three months.',\n",
       " ('Atomic Heart',\n",
       "  6,\n",
       "  0): 'Дебют российской Mundfish — видеоигра Atomic Heart — опередила по популярности в Steam и на Xbox даже Hogwarts Legacy по вселенной «Гарри Поттера». Как создавался и сколько стоил самый ожидаемый игровой проект года — в обзоре РБК Игра Atomic Heart распространяется по всему миру. Так, она доступна для консолей PlayStation 4, PlayStation 5, Xbox One и Xbox Series X/S. Для компьютеров на операционной системе Windows ее можно купить через магазин Steam, но для российских пользователей он напрямую недоступен. На территории России и стран СНГ официальной площадкой распространения игры выступает VK Play. В большинстве стран реализацией игры занимается французская компания Focus Entertainment. Данные о продажах и географии спроса Роберт Багратуни в разговоре с РБК назвал конфиденциальной информацией. РБК направил запрос в VK Play. «Натужные шутки про секс»: что говорят критики Отзывы на Atomic Heart среди геймеров и профессиональных журналистов в основном положительные. На агрегаторе Metacritic рейтинг компьютерной версии игры составил 75 баллов из 100, версия для Xbox Series X/S оценена в 72 балла, для PlayStation 5 — в 71 балл. Большинство журналистов оставили смешанные отзывы об игре. Так, в обзоре на игровом портале DTF игру хвалят за «интересный сюжет с целой серией неожиданных поворотов», «отличный художественный стиль» и «саундтреки», однако критикуют из-за однообразного геймплея и сражений, неудобного инвентаря и отсутствия дополнительных квестов. Портал о кино и развлечениях «Кинопоиск», в свою очередь, оценил в Atomic Heart «потрясающий арт» и «великолепную графику», однако указал на «просчеты в нарративе», «натужные шутки про секс» и «диалоги, которые длятся дольше, чем того требует связанный с ними геймплей». «На сведении звука, кажется, вообще решили сэкономить по максимуму», — также говорится в рецензии. Американский игровой портал Game Informer дал Atomic Heart оценку 7,75 балла из 10. Он также высказал претензии в адрес сюжета, назвав все события игры предсказуемыми. Однако, по мнению автора рецензии, внимания стоят «веселая и безумная перестрелка, выдающийся визуальный дизайн и сложный уровень детализации».',\n",
       " ('Atomic Heart',\n",
       "  7,\n",
       "  0): 'На бумаге Radeon RX 9060 XT является идеальной альтернативой GeForce RTX 5060 Ti: производительность его выше, цена — ниже. Увы, не в каждой игре и, главное, не в каждой стране. Тестирование выполнено на примере видеокарты GIGABYTE GAMING OC 16G Новая весна – новый набор флагманов. В этом году – без новых брендов и почти тот же набор серий. Каких-то сюрпризов и неожиданных новичков в элите смартфонов по фотосъемке нет. Но все обновили свои главные гаджеты, и любопытно сравнить заново. В этот раз голосование делаем слепым Разработчики игр всё чаще обращаются к нейросетям для решения проблемы нехватки видеопамяти. Поскольку для достижения ультрареалистичного игрового опыта размеры текстур постоянно увеличиваются, это создаёт повышенную нагрузку на VRAM. Один из энтузиастов опубликовал видео, в котором продемонстрировал работу технологии нейросетевого сжатия текстур (Neural Texture Compression, NTC) на видеокартах Nvidia и Intel. Тесты показали, что NTC позволяет значительно снизить объём используемой видеопамяти без потери качества изображения Новое в обзорах Накопители Обзор PCIe 5.0-накопителя WD Black SN8100: лучший геймерский SSD в 2025 году SanDisk выпустила флагманский PCIe 5.0 SSD, который заявлен как самый быстрый накопитель потребительского класса с улучшенной энергоэффективностью. Проверим, насколько эти громкие заявления соответствуют реальности и действительно ли лучший SSD в 2025 году — это WD Black SN8100, а не Samsung 9100 Pro Программное обеспечение Основа информационной безопасности: обзор новой 7-й версии менеджера паролей для бизнеса «Пассворк» Российский разработчик «Пассворк» представил крупное обновление одноимённого программного комплекса, обеспечивающего безопасную и удобную работу с паролями в корпоративной среде. В компании не стали размениваться по мелочам и дополнили продукт множеством интересных возможностей и функций Смартфоны Обзор смартфона realme GT 7 Dream Edition: быстрый и дерзкий realme давно выпускает смартфоны с гоночной тематикой. Но новый realme GT 7 Dream Edition вывел эту тенденцию на качественно новый уровень, предлагая совершенно уникальный дизайн, созданный совместно с Aston Martin. К счастью, интересен этот смартфон не только своей внешностью Смартфоны Обзор Infinix NOTE 50 Pro+ 5G+: смартфон, у которого получается почти все После некоторой паузы снова говорим о смартфоне Infinix – из самой, пожалуй, популярной серии NOTE и, более того, с отчетливым геймерским флером, который, тем не менее, не перекрывает иные достоинства гаджета. Это попытка сделать максимально универсальный смартфон верхнего среднего класса – посмотрим, насколько удачная Материнские платы Обзор материнской платы Asus ROG Strix B850-A Gaming WiFi: почти X870, но дешевле Знакомимся с ROG Strix B850-A Gaming WiFi — платой Asus для процессоров Ryzen с поддержкой PCIe 5.0, DDR5-8000 и Wi-Fi 7, ориентированной на светлые сборки. Но особенно интересна она тем, что основана на B850 и дешевле вариантов на X870, но при этом выглядит почти как флагманский продукт Игры Monster Train 2 — этот поезд не остановить. Рецензия На Balatro жанр карточных роглайков не закончился — скорее, наоборот, к нему теперь повышенное внимание. Monster Train 2 оказалась очередной отличной представительницей жанра, в которой можно пропасть на ещё более долгий срок, чем в первой части. Рассказываем почему Игры Pipistrello and the Cursed Yoyo — замечательное приключение с ноткой ностальгии. Рецензия Бывает, что игра появляется из ниоткуда и впечатляет качеством и проработкой так сильно, что хочется рекомендовать её всем и каждому. Проект со смешным названием Pipistrello and the Cursed Yoyo — как раз из таких. Рассказываем, чем он хорош Offсянка Чем меньше, тем лучше Рассматривая с высоты почти семи десятилетий начало космической эры, не перестаёшь удивляться извилистому пути, который проделала идея искусственного спутника Земли… Корпуса, БП и охлаждение Обзор корпуса DeepCool CH270 Digital WH: почти компактный и почти вместительный Надоели стандартные громоздкие корпуса? Мощная видеокарта сгибает слот PCIe на материнской плате, а подпорка вызывает отторжение? Мониторинг должен быть всегда под рукой без стороннего софта? У DeepCool есть для вас один интересный вариант корпуса, но, чтобы понять,',\n",
       " ('Atomic Heart',\n",
       "  7,\n",
       "  1): 'подходит ли он под ваши требования, нужно внимательно прочитать наш сегодняшний материал Смартфоны Обзор смартфона IQOO Neo 10: избранный, чтобы сделать бренд узнаваемым Мы только знакомимся с IQOO, суббрендом vivo, созданным для продвижения производительных аппаратов. Но, кажется, уже скоро пора будет перестать расшаркиваться перед «новым именем» и начать воспринимать эти гаджеты без скидок. Особенно если столь любопытные аппараты, как IQOO Neo 10, начнут появляться на регулярной основе Смартфоны Обзор Xiaomi 15 Ultra: мощнейший камерофон, но со странностями Вслед за сравнительным обзором камер флагманских смартфонов поговорим подробно об одном из участников этого обзора, Xiaomi 15 Ultra, – жаль, что не получилось заранее. Как обычно, главный флагман бренда невероятно впечатляет функциональностью, но сможет ли он потягаться с конкурентами в чистом качестве? Смартфоны Первый взгляд на смартфон realme GT 7 Dream Edition: заряженный гонщик realme регулярно обновляет свои флагманские смартфоны серии GT, но на этот раз производитель приготовил кое-что особенное — модель GT 7 Dream Edition, разработанную совместно с командой «Формулы-1» Aston Martin Aramco. Новинка сочетает в себе передовые технологии и элегантный дизайн, вдохновленный автоспортом Видеокарты Обзор видеокарты NVIDIA GeForce RTX 5060: счастливое исключение От младшей модели 50-й серии мы меньше всего ожидали приятных сюрпризов, но были рады ошибиться. Тестирование выполнено на примере видеокарты Palit под маркой Infinity 3 Игры Blades of Fire — и боец, и кузнец. Рецензия В наши дни чуть ли ни каждый ролевой экшен от третьего лица получает штамп в духе «Dark Souls с изюминкой». Blades of Fire подобного сравнения тоже не удастся избежать. Но это не значит, что у MercurySteam не нашлось собственных идей. Чего в игре больше — читайте в нашей рецензии Игры Elden Ring Nightreign — вместе весело страдать. Рецензия Первая многопользовательская «душевная» игра от FromSoftware наконец увидела свет и… не была встречена всеобщими восторгами, вот ведь! Концептуально Nightreign далека от Souls-философии, и уж очень явно бросается в глаза отсутствие у её разработчиков опыта в сфере больших сессионных забав. Насколько это критично для нового проекта — рассказываем в рецензии Offсянка Виртуальная нереальность Человек водружает на глаза футуристично выглядящие очки или шлем, откидывается на спинку удобного кресла — и погружается в волшебный виртуальный мир. Но что-то в данной нам в ощущениях реальности пришествие виртуальной всё откладывается и откладывается. Так, может, следует поумерить восторженный пыл и разобраться, почему VR по-прежнему ненамного ближе к нам, чем в конце 1990-х? Корпуса, БП и охлаждение Система жидкостного охлаждения PCCooler DT360 ARGB Display: красиво, но есть нюансы В PCCooler на помпу жидкостного охлаждения установили 3,4-дюймовый дисплей, на который можно выводить любые изображения, а сам дисплей можно поворачивать как угодно. Также в системе используется усовершенствованный радиатор и новые вентиляторы с модульным соединением и очень красивой подсветкой',\n",
       " ('Atomic Heart',\n",
       "  8,\n",
       "  0): 'На бумаге Radeon RX 9060 XT является идеальной альтернативой GeForce RTX 5060 Ti: производительность его выше, цена — ниже. Увы, не в каждой игре и, главное, не в каждой стране. Тестирование выполнено на примере видеокарты GIGABYTE GAMING OC 16G Новая весна – новый набор флагманов. В этом году – без новых брендов и почти тот же набор серий. Каких-то сюрпризов и неожиданных новичков в элите смартфонов по фотосъемке нет. Но все обновили свои главные гаджеты, и любопытно сравнить заново. В этот раз голосование делаем слепым Разработчики игр всё чаще обращаются к нейросетям для решения проблемы нехватки видеопамяти. Поскольку для достижения ультрареалистичного игрового опыта размеры текстур постоянно увеличиваются, это создаёт повышенную нагрузку на VRAM. Один из энтузиастов опубликовал видео, в котором продемонстрировал работу технологии нейросетевого сжатия текстур (Neural Texture Compression, NTC) на видеокартах Nvidia и Intel. Тесты показали, что NTC позволяет значительно снизить объём используемой видеопамяти без потери качества изображения Новое в обзорах Накопители Обзор PCIe 5.0-накопителя WD Black SN8100: лучший геймерский SSD в 2025 году SanDisk выпустила флагманский PCIe 5.0 SSD, который заявлен как самый быстрый накопитель потребительского класса с улучшенной энергоэффективностью. Проверим, насколько эти громкие заявления соответствуют реальности и действительно ли лучший SSD в 2025 году — это WD Black SN8100, а не Samsung 9100 Pro Программное обеспечение Основа информационной безопасности: обзор новой 7-й версии менеджера паролей для бизнеса «Пассворк» Российский разработчик «Пассворк» представил крупное обновление одноимённого программного комплекса, обеспечивающего безопасную и удобную работу с паролями в корпоративной среде. В компании не стали размениваться по мелочам и дополнили продукт множеством интересных возможностей и функций Смартфоны Обзор смартфона realme GT 7 Dream Edition: быстрый и дерзкий realme давно выпускает смартфоны с гоночной тематикой. Но новый realme GT 7 Dream Edition вывел эту тенденцию на качественно новый уровень, предлагая совершенно уникальный дизайн, созданный совместно с Aston Martin. К счастью, интересен этот смартфон не только своей внешностью Смартфоны Обзор Infinix NOTE 50 Pro+ 5G+: смартфон, у которого получается почти все После некоторой паузы снова говорим о смартфоне Infinix – из самой, пожалуй, популярной серии NOTE и, более того, с отчетливым геймерским флером, который, тем не менее, не перекрывает иные достоинства гаджета. Это попытка сделать максимально универсальный смартфон верхнего среднего класса – посмотрим, насколько удачная Материнские платы Обзор материнской платы Asus ROG Strix B850-A Gaming WiFi: почти X870, но дешевле Знакомимся с ROG Strix B850-A Gaming WiFi — платой Asus для процессоров Ryzen с поддержкой PCIe 5.0, DDR5-8000 и Wi-Fi 7, ориентированной на светлые сборки. Но особенно интересна она тем, что основана на B850 и дешевле вариантов на X870, но при этом выглядит почти как флагманский продукт Игры Monster Train 2 — этот поезд не остановить. Рецензия На Balatro жанр карточных роглайков не закончился — скорее, наоборот, к нему теперь повышенное внимание. Monster Train 2 оказалась очередной отличной представительницей жанра, в которой можно пропасть на ещё более долгий срок, чем в первой части. Рассказываем почему Игры Pipistrello and the Cursed Yoyo — замечательное приключение с ноткой ностальгии. Рецензия Бывает, что игра появляется из ниоткуда и впечатляет качеством и проработкой так сильно, что хочется рекомендовать её всем и каждому. Проект со смешным названием Pipistrello and the Cursed Yoyo — как раз из таких. Рассказываем, чем он хорош Offсянка Чем меньше, тем лучше Рассматривая с высоты почти семи десятилетий начало космической эры, не перестаёшь удивляться извилистому пути, который проделала идея искусственного спутника Земли… Корпуса, БП и охлаждение Обзор корпуса DeepCool CH270 Digital WH: почти компактный и почти вместительный Надоели стандартные громоздкие корпуса? Мощная видеокарта сгибает слот PCIe на материнской плате, а подпорка вызывает отторжение? Мониторинг должен быть всегда под рукой без стороннего софта? У DeepCool есть для вас один интересный вариант корпуса, но, чтобы понять,',\n",
       " ('Atomic Heart',\n",
       "  8,\n",
       "  1): 'подходит ли он под ваши требования, нужно внимательно прочитать наш сегодняшний материал Смартфоны Обзор смартфона IQOO Neo 10: избранный, чтобы сделать бренд узнаваемым Мы только знакомимся с IQOO, суббрендом vivo, созданным для продвижения производительных аппаратов. Но, кажется, уже скоро пора будет перестать расшаркиваться перед «новым именем» и начать воспринимать эти гаджеты без скидок. Особенно если столь любопытные аппараты, как IQOO Neo 10, начнут появляться на регулярной основе Смартфоны Обзор Xiaomi 15 Ultra: мощнейший камерофон, но со странностями Вслед за сравнительным обзором камер флагманских смартфонов поговорим подробно об одном из участников этого обзора, Xiaomi 15 Ultra, – жаль, что не получилось заранее. Как обычно, главный флагман бренда невероятно впечатляет функциональностью, но сможет ли он потягаться с конкурентами в чистом качестве? Смартфоны Первый взгляд на смартфон realme GT 7 Dream Edition: заряженный гонщик realme регулярно обновляет свои флагманские смартфоны серии GT, но на этот раз производитель приготовил кое-что особенное — модель GT 7 Dream Edition, разработанную совместно с командой «Формулы-1» Aston Martin Aramco. Новинка сочетает в себе передовые технологии и элегантный дизайн, вдохновленный автоспортом Видеокарты Обзор видеокарты NVIDIA GeForce RTX 5060: счастливое исключение От младшей модели 50-й серии мы меньше всего ожидали приятных сюрпризов, но были рады ошибиться. Тестирование выполнено на примере видеокарты Palit под маркой Infinity 3 Игры Blades of Fire — и боец, и кузнец. Рецензия В наши дни чуть ли ни каждый ролевой экшен от третьего лица получает штамп в духе «Dark Souls с изюминкой». Blades of Fire подобного сравнения тоже не удастся избежать. Но это не значит, что у MercurySteam не нашлось собственных идей. Чего в игре больше — читайте в нашей рецензии Игры Elden Ring Nightreign — вместе весело страдать. Рецензия Первая многопользовательская «душевная» игра от FromSoftware наконец увидела свет и… не была встречена всеобщими восторгами, вот ведь! Концептуально Nightreign далека от Souls-философии, и уж очень явно бросается в глаза отсутствие у её разработчиков опыта в сфере больших сессионных забав. Насколько это критично для нового проекта — рассказываем в рецензии Offсянка Виртуальная нереальность Человек водружает на глаза футуристично выглядящие очки или шлем, откидывается на спинку удобного кресла — и погружается в волшебный виртуальный мир. Но что-то в данной нам в ощущениях реальности пришествие виртуальной всё откладывается и откладывается. Так, может, следует поумерить восторженный пыл и разобраться, почему VR по-прежнему ненамного ближе к нам, чем в конце 1990-х? Корпуса, БП и охлаждение Система жидкостного охлаждения PCCooler DT360 ARGB Display: красиво, но есть нюансы В PCCooler на помпу жидкостного охлаждения установили 3,4-дюймовый дисплей, на который можно выводить любые изображения, а сам дисплей можно поворачивать как угодно. Также в системе используется усовершенствованный радиатор и новые вентиляторы с модульным соединением и очень красивой подсветкой',\n",
       " ('Atomic Heart',\n",
       "  9,\n",
       "  0): 'Известно, что сейчас Mundfish занимается дополнениями для Atomic Heart. Более подробно о них и других связанных с игрой моментах рассказал гейм-директор Роберт Багратуни (Robert Bagratuni). Также он определил каноничную концовку боевика. В DLC продолжат историю Atomic Heart и добавят оружие, которое было вырезано. По словам Багратуни , разработчики не успевали закончить весь арсенал к релизу, да и в основной игре оружия было бы слишком много. Зимних локаций, которые показывали на прототипах, в дополнениях не введут. Зато стоит ждать новую советскую музыку. Расширения представят уже скоро. Если верить гейм-директору, они выдались отличными. Прочие сведения: В сиквеле Atomic Heart планируют ввести военных роботов. Если Илон Маск (Elon Musk) даст добро, в игре появится робот Tesla . Вторую половину саундтрека Atomic Heart опубликуют через пару недель. Команда работает над 300-страничной книгой с предысторией проекта, которая позволит лучше понять сюжет. Багратуни считает, что концовки Atomic Heart не делятся на «плохую» и «хорошую». Всё зависит лишь от их восприятия. Каноничным финалом он назвал тот, где П-3 идёт против Сеченова и дерётся с Левой и Правой. Гейм-директор пообещал, что близняшки ещё вернутся. считает, что концовкине делятся на «плохую» и «хорошую». Всё зависит лишь от их восприятия. Каноничным финалом он назвал тот, где П-3 идёт против Сеченова и дерётся с Левой и Правой. После падения в начале игры протагонист проспал 5-6 часов. Если верить специалисту, на самом деле Захаров и Сеченов стремились к одной цели, но двигались к ней разными путями. Скоро о дополнениях расскажут больше. Напомним, у Atomic Heart их будет четыре штуки. Недавно авторы поделились, что уже планируют полноценное продолжение — у него есть высокие шансы увидеть свет.',\n",
       " ('BTS',\n",
       "  1,\n",
       "  0): 'The other day, it was reported that\\'s alleged diss towardsandof boy group BTS had angered fans . At the time it wasn\\'t clear what was exactly said as only bits and pieces were just passed on among fans by word of mouth. However, through a clip captured by fans present, the conversations exchanged between B Free and the BTS members have been revealed. SEE ALSO: BTS RM and V discharged, 1,500 fans gather at HYBE headquarters As mentioned before, BTS and B Free were part of the attendees for the broadcast of \\'Kim Bong Hyun\\'s Hip Hop Invitational 1st Anniversary Broadcast\\'. Reportedly, since many fans gathered there were fans of BTS snapping away pictures of their idols, some of the underground rappers started to jokingly comment about idols being present. This somehow gradually ended up in a full-fledged conversation about idol rappers vs. rappers. Most of the exchange was between B Free and the BTS members. Although the atmosphere started off lightheartedly, it soon became a bit tense as B Free took quite a few jabs with difficult questions aimed at the boys. The clip below starts off with light banter about whether the idol rappers and the other rappers present can be considered as part of the same hip hop scene. After a bit of discussion with the other rappers present, the host, seemingly wanting to engage more discussion from everyone attending, asks the boys what they think when people pose the question about whether idols and hip hop are two things that go well with each other. Rap Monster starts to answer, \"I know when people think idols, they think of the makeup and the clothes. But honestly, if you just listen to our album itself, our album is very hip hop.\" In response, another rapper comments, \"Hip hop is not just the name of a genre, it\\'s bigger than that. So I think it\\'s more of a rap album rather than hip hop.\" B Free adds on, \"It\\'s just an album that has rap.\" Rap Monster calmly responds that he understands what the rappers are trying to say since he has previous underground experience as well. He expresses that he understands the point of view of both rappers and idols, and is also trying to figure out the balance himself. Then the conversation shifts to the \\'macho-ness\\' of hip hop and if putting on makeup and dressing up when going on stage goes against this macho nature. When the host comments, \"So when you put on \\'boonjang\\' (makeup or disguise for stage)\", B Free interrupts to joke, \"No that\\'s not \\'boonjang\\', it\\'s \\'yeojang\\' (males disguising themselves as females)\". Rap Monster tries to explain that he himself feels awkward about it and is still trying to get used to the makeup, and understands why they would point out things like that, once again emphasizing he understands both worlds. B Free then interjects, \"So what is it that you want to do really? You say you understand both worlds and if you want to do both and say you understand both, then what is it that you really want to do? If you say it\\'s awkward and you don\\'t like it, then what is it that you want to do?\" SUGA, at this point takes the mic to respond, \"I just want to be able to reach out to a lot of people with my music, I know he [Rap Monster] wants that too... I think you might take this the wrong way, but personally, I want to be the bridge between underground and major. The reason for this',\n",
       " ('BTS',\n",
       "  1,\n",
       "  1): 'is, I\\'ve been in underground before in Daegu and went through a lot of hardships myself. I finally released a track and tried to sell it but couldn\\'t earn a dime off of it. Doing music like that, it was really hard...\" B Free then asks, \"So you went up to Seoul b/c you didn\\'t want to experience hardships?\" to which SUGA responds, \"No, it\\'s not like that. I eventually came up to Seoul because I wanted to continue doing music with my crew hyungs and I thought to myself that it\\'d be good to first build up more recognition, and that would be a way to continue doing music with the hyungs.\" B Free once again interjects, \"So then being an idol is a temporary thing to make money?\" SUGA says that is not the case and that he is happy to be able to reach out a large audience with his music and that he feels grateful about it. As the atmosphere starts to get a bit heated, the host tries to peacefully wrap up the subject, but B Free wasn\\'t done expressing himself as he commented, \"I\\'m not trying to say that just one way is right. But since I don\\'t know SUGA, or \\'sultang-shi\\' [\\'sultang\\' means sugar in Korean] and RapMon, and they don\\'t know me and probably haven\\'t listened to my music and I haven\\'t listened to BTS\\' music, I just have some questions that I\\'m curious about.\" He then asks about how the members of BTS came together and Rap Monster explains that the group originally started out as a hip hop group with no dancing involved, but eventually, members were changed out and other members with different strengths were added to form the BTS we know today. B Free comments, \"You know, like SUGA said before about how he faced hardships and that he couldn\\'t make a dime, well, that was the case for all of us too. It\\'s like that for everyone, but the difference is, are you able to withstand it until the end.... I just feel like you and I are people who could have been walking the same path, but you weren\\'t able to resist the temptation.\" SUGA responds, \"I can\\'t really understand why you\\'d describe that as temptation.\" The host tries to once again cut off the conversation, but B Free interrupts again to ask about BTS\\' concept trailer for \\'O!RUL8,2?\\'. He states, \"Oh there\\'s something I\\'m curious about. Someone told me that there was a group out there using Kanye West\\'s \\'Black Skinhead\\' as their own, so I searched it up and it was you guys. I listened to it and the beat and the rapping style were the same. I want to know why that was the case. I know I was really upset at the time and cussed about it online, so I\\'m sorry about that. And your fans tried to tell me that the producer for that song had mixed it for you.\" Rap Monster responds, \"I think you might have misunderstood about all that. Yes, it was mixed for us, and that was a concept trailer just trying to showcase our dance. That dance was actually choreographed to Kanye West\\'s song and we really did want to use his original track, but the song has a lot of strong language that wouldn\\'t pass the inspection, so we weren\\'t able to use it. I would have personally liked to have used the original track myself then this would be a lot clearer.\" B Free, however, doesn\\'t seem to be very convinced by Rap Monster\\'s',\n",
       " ('BTS',\n",
       "  1,\n",
       "  2): 'response and says that he doesn\\'t understand how someone, who claims to respect Kanye West, could agree to something like that and present something like it\\'s his own by putting his own rap over the MR of the track. He also says, \"To me, it feels like disrespect to copy things from an artist that you like and present it as your own.\" Rap Monster asks him to explain a little more about what he means by copying as they were just dancing. However, as B Free starts to respond, the host, feeling that this is going too far, firmly ends the conversation to the frustration of B Free, who insists that he was simply asking questions and hearing the answers to them. So after hearing and reading the exchange between the BTS members and B Free, do you think that B Free was pushing things too far or was he right to open up about his curiosities? You can check out the exchange for yourself through the clip below. Tip: golmak, Video: Smiling Seoul',\n",
       " ('BTS',\n",
       "  10,\n",
       "  0): 'Twenty-five years after Seo Taiji & Boys’ “Nan Arayo” ignited Korea’s pop music scene, frontman Seo turned to K-pop group of the moment BTS to remake the act’s 1995 classic “Come Back Home.” In anticipation of Seo’s 25th anniversary in the industry, the boy band released an updated version of the hard-hitting, gangster rap single. BTS’ “Come Back Home” reworked the song by adding new lyrics and expanding the original melody to include a more lyrical vibe while still maintaining its originally intensely dark feeling. BTS reworked the song’s message to emulate similarly inspirational messages that they’ve expressed in other tracks, emphasizing both life’s hardships and the need to overcome those bad times: “I feel suffocated in my life/ What is blocking my life is my fear towards tomorrow,” raps J-Hope in a grating voice reminiscent of the original. Rap Monster responds, rapping in a swaggering tone during the pre-chorus, “Because we are still young there’s a decent future/ Now wipe those cold tears and come back home.” “Come Back Home” is BTS’ first song since they won a Billboard Music Awards earlier this year. Trending on Billboard The group also released a tension-filled music video that showed several young people struggling with life and expressing themselves through a variety of activities. Seo Taiji & Boys appeared on the Korean music scene in 1992 with the hit song “Nan Arayo” and revamped the industry by incorporating a variety of genres, including new jack swing and hip-hop, into the dance-focused performance of the song. “Come Back Home” saw major success in 1995, despite parallels to Cypress Hill’s “Insane in the Brain.” (Cypress Hill’s B-Real later said that the group members were aware of the song but were “cool” with it.) Seo Taiji & Boys, one of whom is YG Entertainment CEO and BIGBANG and 2NE1 creator Yang Hyun Suk, broke up in 1996 after releasing nine albums and having an immense effect on Korean pop culture. Ever since, Seo has pursued a solo career with a focus on rock, synthpop and metal. He is considered one of the most impactful musicians in pop music in Korea and has earned the nickname the “President of Culture.” BTS is the first act to re-create a Seo Taiji song as part of Seo’s 25th anniversary Time: Traveler project. The band will also perform alongside Seo at his celebratory concert in September. The songs will be performed “exactly as they were performed in the 1990s,” a rep of Seo’s told the Korea Herald last month. Within a day of its release, BTS’ “Come Back Home” began climbing in the top 100 of the U.S. iTunes chart. As of publishing, the remake is at No. 50.',\n",
       " ('BTS',\n",
       "  11,\n",
       "  0): 'BTS continue to push where no K-pop act has gone before with a debut in the top 10 of the Billboard 200 album chart. The seven-member group’s new album, Love Yourself: Her, debuts at No. 7 with 31,000 equivalent album units earned in the week ending Sept. 21, according to Nielsen Music. Of that sum, 18,000 were in traditional album sales. The Billboard 200 chart ranks the most popular albums of the week in the U.S. based on multi-metric consumption, which includes traditional album sales, track equivalent albums (TEA) and streaming equivalent albums (SEA). The new Oct. 7-dated chart (where Foo Fighters‘ Concrete and Gold debuts at No. 1) will be posted in full on Billboard‘s websites Tuesday (Sept. 26). The rest of Love Yourself: Her‘s starting unit sum was comprised of just less than 4,000 TEA units, and a little under 10,000 SEA units. BTS earns both the highest-charting album ever on the Billboard 200 by a K-pop act, and the genre’s biggest sales week. The group beats its own record, as the act’s 2016 album, Wings, was previously both the highest-charting K-pop album (debut and peak at No. 26 on the Oct. 29, 2016-dated list) and owner of the biggest sales week for a K-pop title (11,000 copies sold in its debut frame — all from digital albums). Notably, Wings and Love Yourself: Her are the only K-pop albums that have charted in the top 40. Since the release of Wings, BTS’ popularity has grown tremendously in the U.S., so it’s not a huge surprise to see the robust sales figure for the new album. For example, the act debuted at No. 1 on the Social 50 chart the same week that Wings entered the Billboard 200. (The Social 50 chart measures the most popular artists on Facebook, Twitter, Instagram, YouTube, Wikipedia and Tumblr.) Since hitting No. 1, BTS has racked up 40 nonconsecutive weeks atop the list. The group’s extraordinary popularity on social networks (and very active fanbase online) led to its first Billboard Music Award win for Top Social Artist back in May. Also helping the sales cause, the new album is distributed by Sony’s independent distribution arm, The Orchard. It’s the first time an album by BTS has American distribution, as the group’s previous releases were issued through U.S. digital retailers independently by the group’s South Korean label, Big Hit Entertainment. While Love Yourself: Her is currently only available as a digital album in the U.S., a physical CD release is forthcoming. Lastly, BTS’ online fan army mobilized in high volume during street week in order to get the word out about the album. The passionate fandom was very focused on achieving high chart placement, as fan-run social media accounts helped fellow BTS fans understand how Billboard‘s charts are compiled, and how sales and streams impact the Billboard 200 during an album’s first week, and so forth. (Some fans even went so far as to gift the album to friends via Apple’s iTunes Store in order to spread the word. However, sales of any specific album purchased on iTunes and gifted to another are not reported to Nielsen Music by Apple, and thus, do not count on Billboard‘s charts.) BTS further its lead as the K-pop act with the most entries on the Billboard 200, growing to five entries following 2017’s You Never Walk Alone (a deluxe repackaged version of Wings that peaked at No. 76), 2016’s Wings (No. 26) and The Most Beautiful Moment in Life: Young Forever (a compilation album that peaked at No. 107), plus 2015’s The Most Beautiful Moment in Life,',\n",
       " ('BTS',\n",
       "  11,\n",
       "  1): 'Pt. 2 (No. 171). The only other K-pop acts to have multiple entries on the Billboard 200 are solo star G-Dragon (who has three), along with male acts BIGBANG and EXO (with two each). The album itself puts BTS in a position for a larger global domination while still remaining true to the band’s original messages. Of course, the guys deliver the emotionally driven electro-pop/hip-hop hybrids they’re famous for with single “DNA” (featuring the most seismic synthesizers of the band’s career mixed with an powerfully addictive whistle hook) along with the tender melancholy dripping from “Best of Me” (featuring production from The Chainsmokers‘ Andrew Taggart for the band’s most attractive appeal to Western audiences to date). Yet the record gets even more complex and has larger messages that honor the band’s dedication larger, social issues. The theme is set from the beginning with the use of gender-neutral pronouns in opening track “Intro: Serendipity” to a discussion of youth hopelessness in “Go Go,” along with a playful-yet-eye-opening examination of the very fan culture that have made them such international sensations in “Pied Piper.” If the accessible sounds alongside vocal and rap deliveries initially hook listeners, the thought-provoking messages in the lyrics and themes will keep fans thinking and listening over and over. While BTS landing in the top 10 of the Billboard 200 is an accomplishment in and of itself, if the band can simultaneously score an entry on the Hot 100, it will make them only the second K-pop act to land a Korean-language song on the singles chart. To date, only PSY, Wonder Girls and CL have landed songs on the ranking, with the latter two’s entries in English. BTS’ “Spring Day” debuted at No. 15 on Billboard‘s Bubbling Under Hot 100 chart earlier this year, the closest Korean-language song to make it onto the Hot 100 until Blackpink‘s “As If It’s Your Last” hit No. 13 this summer.',\n",
       " ('BTS',\n",
       "  12,\n",
       "  0): 'If BTS wasn’t already on their way to world domination, this September will put them one step closer: The K-pop superstars just announced that a new album is on the way. After teasing that new music would be released in September upon announcing their forthcoming Love Yourself series, BTS revealed Wednesday (Aug. 23) that the first installment of the project will be available Sept. 18. Love Yourself ‘Her’ is the first album that is part of BTS’ latest thematic era, the fourth in the boy band’s career following the School, Most Beautiful Moment in Life, and Wings periods. Though there’s not a whole lot known yet about the new concept, the already-released images and videos appear to continue BTS’ introspective themes of past albums with a particular focus on self-love in light of past regrets. Explore Explore BTS See latest videos, charts and news See latest videos, charts and news Her will be the BTS’ first release since You Never Walk Alone in February, a repackaged version of Wings, the highest-ranked Korean album on the Billboard 200. Korean media outlet Yonhap reported that the album will be an EP, making it the group’s first since The Most Beautiful Moment In Life, Part 2 in 2015. The Love Yourself series began earlier this month and will continue into 2018. ” excerpt=”Boy band of the minute BTS is telling fans to “Love Yourself” ahead of new music in September. The act revealed the title of their upcoming conceptual series via a faux film poster on Twitter featuring member Jungkook.” image=”9221626″] On top of this exciting news, the press release states that Love Yourself ‘Her’ will have four different versions, even including a hidden track written and produced by BTS leader Rap Monster. While other details are still vague, the ARMY can take a look at what we know so far here. Love Yourself ‘Her’ will be available for pre-order starting Aug. 25.',\n",
       " ('BTS',\n",
       "  13,\n",
       "  0): 'As previously reported, BTS achieves the first-ever top 10 for a K-pop act on the Billboard 200 albums chart, as Love Yourself: Her debuts at No. 7 (on the chart dated Oct. 7), earning 31,000 equivalent album units in the week ending Sept. 21, according to Nielsen Music. The seven-member South Korean boy band adds to its haul this week, earning its first entry on the Billboard Hot 100 songs chart: “DNA,” from the new album, debuts at No. 85, fueled by 5.3 million first-week U.S. streams and 14,000 downloads sold, the latter total also good for a No. 37 debut on the Digital Song Sales chart, where BTS also makes its first appearance. (The Hot 100 blends streaming, sales and radio airplay data.) <iframe width=”560″ height=”315″ src=”https://www.youtube.com/embed/MBdVXkSdhwU” frameborder=”0″ allowfullscreen></iframe> The trap-infused, almost-all Korean-language “DNA” makes BTS (which recently expanded its meaning to stand for Beyond the Scene) just the second K-pop act to chart a Korean-language song on the Hot 100, following South Korean rapper/singer PSY, whose smash “Gangnam Style” peaked at No. 2 for seven weeks in 2012 (marking his first of four Hot 100 visits to date). Notably, K-pop acts Wonder Girls and CL have charted one and two Hot 100 entries, respectively, but not with predominantly Korean-language songs. Wonder Girls reached No. 76 with “Nobody” in 2009 (which they recorded both in English and Korean), while CL’s charted titles are her English single “Lifted” (No. 94, 2016) and PSY’s “Daddy,” on which she’s featured (No. 97, 2015), which is mostly in Korean, although CL’s vocals are all in English. Before “DNA,” BTS had neared the Hot 100 with “Spring Day,” which hit No. 15 on the Hot 100’s Bubbling Under chart dated March 4. Until this week, the song stood as the closest that a Korean-language track had come to reaching the Hot 100 in 2017 until BLACKPINK‘s “As If It’s Your Last” peaked at No. 13 on the Bubbling Under chart dated July 15. All Oct. 7-dated charts, including the Hot 100, led at No. 1 by Cardi B‘s “Bodak Yellow (Money Moves)” in its first week at the summit, and the Billboard 200, topped by Foo Fighters‘ No. 1-debuting Concrete and Gold, will update tomorrow (Sept. 26) on Billboard.com.',\n",
       " ('BTS',\n",
       "  14,\n",
       "  0): 'Need more BTS in your life? Well, your wish is about to be granted. Not long ago, new reports came out of South Korea confirming a documentary series is on the way for the K-pop band. However, there is just one thing about it… Videos by ComicBook.com If you want to watch the new miniseries, you are going to have to fork up some cash for a Youtube Red subscription. Yes, Big Hit Entertainment is partnering with Youtube Red to develop a documentary series for BTS. The project, which is titled BTS: Burn The Stage, will be an eight-part series documenting the evolution of BTS. In particular, the documentary will focus on the band’s most recent tour. 2017 BTS LIVE TRILOGY EPISODE III – The Wing Tour will be the focus of the series as it recounts the 300-day affair. Fans will be able to catch the documentary’s first episode on March 28 on Youtube, and that one will be for free. However, the others will not. If you want to watch episodes 2-8, fans will have to get a Youtube Red subscription. The documentary will air a new episode each week until the last one airs on May 9. So, you may want to save up for the splurge now. However, fans in the US and South Korea will be eligible for a Youtube promotion to give them access to the service. A special code will be released for BTS: Burn The Stage which fans can use to get a free Youtube Red subscription between March 14 and April 14. Of course, this is not the first documentary BTS has done for fans though this is the band’s first partnership with Youtube on one. In the past, the K-pop group has done in-agency videos documenting each of their comebacks, and BTS has used VLive as a way to share their bigger projects. This new documentary will mark the second K-pop venture Youtube Red has taken on since its debut as the service previously did a variety show with BIG BANG prior to the band’s military hiatus. Will you be watching this documentary? Let me know in the comments or hit me up on Twitter @MeganPetersCB to talk all things comics, k-pop, and anime!',\n",
       " ('BTS',\n",
       "  15,\n",
       "  0): 'Coming off the best year of their career thus far, BTS has one new thing to celebrate as they move into 2018: the group just made history by becoming the first Korean group to have a song certified gold by the Recording Industry Association of America (RIAA). Explore See latest videos, charts and news BTS Desiigner Steve Aoki See latest videos, charts and news On Saturday night (Feb. 3), featured rapper Desiigner broke the news on Twitter, saying “Miic Drop went gold” and tagging both BTS and Steve Aoki, who produced the remix version of “Mic Drop.” The song, released in November, is BTS’ first stateside hit, and peaked at No. 28 on the Hot 100 chart. It has remained on that chart for nine weeks and currently ranks at No. 84 (as of the Feb. 3 chart update). The remix of “Mic Drop” has been gaining traction on a variety of other charts, and last week the song debuted on the Rhythmic Songs chart at No. 40, which tracks radio play on stations that cross the divide between pop and R&B/hip-hop. Trending on Billboard Being the first Korean group to ever see an album accredited gold by the RIAA is a major achievement for the boy band that has been making headway stateside thanks to their dynamic music style and a fiercely dedicated fan base known collectively as ARMY. It is the second Korean song to gain this distinction, following Psy’s “Gangnam Style,” which went multi-platinum in 2012 and 2013, for its digital and physical versions, respectively. Read the lyrics to ‘Mic Drop’ Here To be certified gold by the RIAA, a song must move more than 500,000 equivalent units between digital downloads and audio and video streaming, with 150 streams counting toward the equivalent of one formal unit. BTS’ local rep Eshy Gazit also celebrated the news, telling fans that Desiigner’s label, Def Jam Records, had alerted him of it. The Korean act and Aoki have yet to publicly comment on the achievement at time of publication. “Mic Drop” was released in its original version in September on BTS’ Love Yourself: Her EP, while the remix came out in November. The album peaked at No. 7 on the Billboard 200, the highest-ever by a K-pop group.',\n",
       " ('BTS',\n",
       "  16,\n",
       "  0): 'A month and a half after releasing their record-breaking Love Yourself: Her album, Korean boy band BTS announced on Tuesday night (Oct. 31) that it has joined forces with the United Nations Children’s Fund (UNICEF) in an anti-violence campaign dubbed LOVE MYSELF. Explore Explore BTS See latest videos, charts and news See latest videos, charts and news According to the project’s official Website, BTS and its label, Big Hit Entertainment, entered into a two-year-long partnership with the Korean Committee for UNICEF on Nov. 1. They joined forces to sponsor #ENDViolence, a UNICEF campaign based around making the world a safer place so that that children and teenagers will be able to live happy and healthy lives, without living in the fear of violence. Over the next two years, the septet and Big Hit Entertainment pledge 500 million KRW (just under $447,400 as of Oct. 31 rates) to the UNICEF campaign, and will also donate 3% of the Love Yourself series’ physical album sales income. All the income from sales of official goods related to the LOVE MYSELF campaign and additional donations to UNICEF will also be put towards #ENDViolence. It’s the latest in a long line of partnerships that Korean celebrities and UN organization have worked on. The LOVE MYSELF #ENDViolence campaign corresponds to BTS’ lyrical messages, with a number of the band’s songs addressing societal ills. Prior to unveiling the site, BTS’ members shared selfies on their official Twitter account using “Love Myself” as a hashtag, giving fans a heads-up ahead of the announcement. Along with the official LOVE MYSELF Website, which crashed upon the campaign’s unveil, the UNICEF campaign also launched accounts on several social media platforms.',\n",
       " ('BTS',\n",
       "  17,\n",
       "  0): 'BTS“Love Yourself Seung Her”Loen Entertainment When most media outlets put this K-pop group on a pedestal earlier this year for its impressive feats -- a Billboard award and several releases on the Billboard albums chart -- many wondered what would come next. And the result was “Love Yourself Seung Her,” which has become the group’s most successful release to date, as well as a mirror of BTS’ past, present and future. The nine-track album opens with “Intro: Serendipity,” a rather smooth preview of the entire EP by member Jimin’s tender Bieber-like vocals. Then the lead track “DNA” is unveiled, a sound very different from the group’s previous manic, heart-pounding hip-hop works, both musically and technically. The song ventures into trendy electronic dance music and pop sound, with a message that our DNA is connected in the universe. It may not be everyone’s cup of tea, but “DNA” is a hint of the group’s resolution that it will continue trying different musical approaches.“Best of Me,” a collaboration with The Chainsmokers, also shows how BTS’ music sounds in the mold of EDM, offering a variety of musical styles while keeping BTS’ distinctive sound at its heart. As the album leads into a skit interlude of BTS’ Billboard Music Award’s acceptance speech, the atmosphere changes: aggressive and edgier BTS is back. The thematic transition from the excited voice of Rep Monster at the awards ceremony to a classic groovy hip-hop track “MIC Drop” is like an artwork, offering listeners a flash of footprints BTS have left in the K-pop scene over the past few months. The rest of the tracks “Go Go” and “Outro: Her,” featuring social commentaries and gruff rapping, are a virtual time machine for the ears, reassuring fans that the old BTS is still there despite the whirlwind year.The year 2017 seems certain to be the year of BTS. Filled with warm affection, love and tenderness, “Love Yourself Seung Her” is a reflection of BTS’ footprints and a blueprint for the group’s future, fueling expectations for what will come next. By Hong Dam-young ()',\n",
       " ('BTS',\n",
       "  18,\n",
       "  0): 'Korean septet BTS are back with a brand new music video for their single “Fake Love.” Released on Friday (May 18), “Fake Love” is the lead single off of the group’s Love Yourself: Tear album. The video for “Fake Love” expands BTS’ creative narrative, rife with imagery that correlates to its lyrics — such as the appearance of a flower that “can’t be bloomed in a dream that can’t come true” — and refers back to past thematic eras. Vocalist Jungkook takes center stage throughout much of the song, running in an Inception-like hallway where floorboards fall away, desperately exploring a wall of water on his own, and eventually returning to the masked figure seen in teaser clips for “Fake Love.” Explore Explore BTS See latest videos, charts and news See latest videos, charts and news The choreography featured in the “Love” video similarly reflects the song’s meaning, exhibiting the anguish of the single through sharp movements that extend each member’s body as they desperately power through the motions. Mirrored performances that pair off members, and hand motions that emulate”see no evil, hear no evil, speak no evil” tie the dance together. “Fake Love” is the second video associated with BTS’ Love Yourself: Tear album; V’s solo song “Singularity” was released through a video earlier this month in anticipation of the LP. Love Yourself: Tear and the video for “Fake Love” come eight months to the day after the release of BTS’ record-breaking Love Yourself: Her, which became the first album from a K-pop group to hit the Top 10 of the Billboard 200 last year. Within a hour of its release on YouTube, the “Fake Love” video racked up over a million views. The group will perform the track at the 2018 Billboard Music Awards on Sunday (May 20), where they are also nominated in the Top Social Artist category. Watch it here:',\n",
       " ('BTS',\n",
       "  19,\n",
       "  0): 'BTS shared a peek of the possible direction for its next album, and in the process, the K-pop group\\'s fans headed to the Internet\\'s dictionary for some answers. The K-pop superstars unveiled a trailer for new music and eye-popping visuals on Thursday (April 5) called \"Euphoria: Theme of Love Yourself Wonder.\" As reported by Billboard, the video is seemingly a taste of what\\'s to come from the next album in the band\\'s Love Yourself series. The video features Jin, V, Jungkook, and the rest of the boys in a variety of situations. Included in the nearly nine-minute clip is a new song called \"Euphoria,\" which fans have theorized would be the theme of the next installment from the band, Billboard explains. Fans are apparently eager to learn more about the band\\'s mysterious message, as Dictionary.com tweeted their thanks for an increase in searches of the term \"euphoria.\" According to the resource, euphoria is defined as \"a state of intense happiness and self-confidence.\" Fans will have to wait and see how that emotion plays into the forthcoming album. But the Dictionary.com Twitter account shared the news of a spike in activity for the term, tweeting: \"Searches for #Euphoria have been climbing today on dictionary.com. Thanks @BTS_TWT.\" Social media has been quick to have a little fun with the tweet, chiming in about the educational benefits of being a BTS fan. \"They enrich your vocabulary, broaden your knowledge, rise your empathy and expand your horizon,\" one fan tweeted. Another follower shared their appreciation for the band\\'s word games, writing, \"I\\'ve learnt so many new words from @BTS_twt and they have introduced us to a lot of great authors, musician, artists, etc. Stan BTS and you will be an intellectual.\" Earlier this week, BTS also released their Face Yourself album in Japan, which has continued to be near the top of the iTunes Albums chart. It looks like the group is plenty busy, along with having a flurry of upcoming projects \"Euphoria\" fans are eagerly awaiting. In the meantime, we\\'ll be watching the video on repeat.',\n",
       " ('BTS',\n",
       "  2,\n",
       "  0): 'SEOUL, Dec. 2 (Yonhap) -- K-pop sensation BTS has won the Artist of the Year Award at the Mnet Asian Music Awards (MAMA) for the second-straight year. BTS was announced the winner of the highly-coveted award on Friday at AsiaWorld-Expo in Hong Kong, the venue for the final event of this year\\'s MAMA, a K-pop award show run by cable music network Mnet. The seven-member act also won MAMA\\'s Artist of the Year in 2016. The band has taken the K-pop scene by storm this year, with its latest EP album \"Love Yourself: Her\" released in September selling more than 1.2 million copies in less than a month. The lead song \"DNA\" made BTS the first Korean boy band to land on Billboard\\'s main \"Hot 100\" chart, while the group became the first Korean artist to perform at the American Music Awards last month. This photo provided by Mnet shows BTS giving an award acceptance speech at the 2017 Mnet Asian Music Awards on Dec. 1, 2017, held at AsiaWorld-Expo in Hong Kong. (Yonhap) \"We love you ARMY. We\\'re received kindly wherever we travel around the world, and many are curious to know what fandom in the world is this tremendous,\" leader RM said, referring to its global fan base known as ARMY. BTS also picked up the Best Music Video Award for \"Spring Day\" and Best Asian Style in Hong Kong Award. This photo provided by Mnet shows EXO posing for the camera during a red carpet event at the 2017 Mnet Asian Music Awards on Dec. 1, 2017, held at AsiaWorld-Expo in Hong Kong. (Yonhap) Fellow K-pop heavyweight EXO won the Album of the Year Award with its fourth studio record \"The War,\" dominating the category for the fifth year in a row since 2013. Project boy band Wanna One took home the Best Male Group Award thanks to its explosive debut this year. \"We\\'re grateful for even being able to be on such a big stage like MAMA. We thankful for winning such a big award,\" Wanna One rapper Kang Daniel said. The Best Female Group Award went to S.M. Entertainment\\'s quartet Red Velvet while GOT7 snatched up the World Performer Award. SHINee\\'s Taemin won the Best Dance Performance Solo Award for his second solo album \"Move\" and female indie pop duo Bolbbalgan4 won the Best Vocal Performance Group Award. Launched in 1999 under the name Mnet Km Music Festival, the event was renamed MAMA in 2009 as the show expanded its outreach throughout Asia. This year\\'s MAMA was held in three venues, with the opening event held in Hanoi on Monday then a follow-up show staged in Yokohama on Wednesday. The event was hit by a controversy last month after Mnet temporarily suspended fan votings, announcing that it detected illegal votes using automatic bot softwares. The check-up ended up shifting multiple rankings, prompting outcries from several fan bases. This photo provided by Mnet shows BTS performing at the 2017 Mnet Asian Music Awards on Dec. 1, 2017, held at AsiaWorld-Expo in Hong Kong. (Yonhap) odissy@yna.co.kr (END)',\n",
       " ('BTS',\n",
       "  20,\n",
       "  0): 'Korean boy band BTS took to Twitter today to announce their next project, Love Yourself: Tear. The new album is set to be released on May 18. The sequel to last year’s Love Yourself: Her, Tear is the second in the group’s Love Yourself series and follows the release of the record-breaking Japanese Face Yourself album. Unlike Her, Tear will be a full-length album. It will be the group’s third LP, following 2014’s Dark & Wild and 2016’s Wings. With each of BTS’ subsequent releases since Love Yourself: Her, including J-Hope’s solo Hope World and their Japanese album, resonating well on the Billboard 200, Love Yourself: Tear is one of the most-highly anticipated albums this year. Explore Explore BTS See latest videos, charts and news See latest videos, charts and news Little is known about Tear, though the news of its release comes a few weeks after BTS dropped their “Euphoria: Theme of Love Yourself Wonder” video, which appeared to connect narratives the K-pop act had featured in past music videos. The video was initially believed to hint to the group’s next album being titled Love Yourself: Wonder based on a wide-spread fan theory related to Korean literary terms and storytelling techniques, but it was later denied. According to BTS’ official fan site, known as a fan cafe in Korea, pre-orders of the album will go on sale on April 18. The pre-orders sales for Love Yourself: Her reached 1.05 million copies, and the album eventually peaked at No. 7 on the Billboard 200 album chart. The boy band has rapidly grown to become one of the most dominant international acts in the American music industry, with millions of fans from around the country and the globe cheering on the septet. They won the top Social Artist award at the Billboard Music Awards last year, and have appeared on the Social 50 for 78 weeks.',\n",
       " ('BTS',\n",
       "  21,\n",
       "  0): 'Korean septet BTS will become the first-ever K-pop group to perform at the Billboard Music Awards next month, where they are nominated for the Top Social Artist award. The news was announced on social media this morning (April 24), and on top of it all, BTS will be giving fans the world television premiere of their new single when they take the stage. The group will also release their Love Yourself: Tear album just two days before their appearance at the awards show. Explore Explore BTS See latest videos, charts and news See latest videos, charts and news Airing on NBC, the 2018 BBMAs will mark the boy band’s second appearance at the event following their Top Social Artist win last year. “Look out for our second appearance or – say what?- FIRST PERFORMANCE at the BBMAs!” BTS wrote in English on their official Twitter account. In Korean, they wrote a similar message and also thanked their fandom, ARMY. “Thank you ARMY for making our performance at the 2018 Billboard Music Awards possible. Please expect a lot from our performance.” The act also posted on Instagram, where they gushed about how they’re “so excited” to perform. BTS’ appearance and win at the BBMAs last year came amid their rise on the Billboard charts; their Love Yourself: Her album, which included their BBMA speech, peaked at No. 7 on the Billboard 200 last October. Since then, the group has appeared on multiple American talk shows and performed at the AMAs and Dick Clark’s Rockin’ New Year’s Eve. Their “Mic Drop” remix with Steve Aoki and Desiigner became the act’s first song within the Top 40 of the Hot 100, where it hit No. 28. It and the group’s “DNA” have since both been certified gold by RIAA. Along with BTS, the 2018 BBMAs have also announced performances from Camila Cabello, Shawn Mendes and Dua Lipa. The May 20 event will be hosted by Kelly Clarkson, airing at 8 p.m. ET on NBC.',\n",
       " ('BTS',\n",
       "  22,\n",
       "  0): 'BTS is back to breaking records. The K-pop boy band again seemed to do the impossible as they surpassed Taylor Swift for the most-viewed video within 24 hours on YouTube. BTS\\' \"Idol\" music video has racked up over 45 million views on the platform within the first day of its release. The record previously belonged to Swift for her \"Look What You Made Me Do\" music video, which was released during the 2017 MTV Video Music Awards. At the time, it gained just over 43.2 million views in its first 24 hours. The record is also a personal best for BTS, as their music video for \"Fake Love,\" which dropped last May, earned 35 million views on its first day of release. Watch \"Idol\" below. RM, Jungkook, Jimin, Jin, J-Hope, V and Suga have been completely taking over the music world with the release of their new album, Love Yourself: Answer on Friday -- earning the respect of artists across the industry. Nicki Minaj, who is featured on a special version of \"Idol,\" gave the boys a special shout out on Friday. \"US iTunes All Genres Chart ?? they did NOT come to play wit y’all ?. My version of #Idol with #BTS is out now! Congrats to them on a great new album. I’m honored to be a part of it. S/O to #KOREA ‼️\" she wrote on Instagram. \"Super proud of @BTS_twt I told my label about them a while ago it’s a pleasure to release the same time great music boys well done ??,\" Liam Payne tweeted, while Ed Sheeran wrote on his Instagram Story that the band is \"about to have an incredible week.\" Instagram BTS\\' Love Yourself tour kicks off Saturday in Seoul, South Korea. The boys will then head to North America with concert stops in Los Angeles, Oakland, Fort Worth, Hamilton, Newark, Chicago and New York City, before traveling to Europe and Asia to complete the world tour. ET sat down with BTS in May, where they opened up about their celebrity fans, new music, love, fame and more. Watch below. RELATED CONTENT:',\n",
       " ('BTS',\n",
       "  23,\n",
       "  0): 'BTS Just Gave The Most Powerful UN Speech About Self-Love BTS gave an emotional speech to the United Nations about loving yourself and became the first K-pop group ever address the political gathering. BTS are currently sharing their brilliant live show with the world on their \\'Love Yourself World Tour\\', but the K-pop group took some time out to make an important and powerful speech about self-love to the United Nations. > BTS Girlfriends: Complete Dating History Of The K-pop Group RM was the member of BTS who gave the brilliant speech and he even referenced the support of fans, known as the BTS ARMY, for helping the group truly love themsleves. BTS became the first K-pop group ever to make a speech to the United Nations. Picture: PA Amongst his powerful specch you can see in the video above, RM says, \"After releasing our Love Yourself albums, and launching the Love Myself campaigns, we started to hear remarkable stories from our fans all over the world how our message helped them overcome their hardships in life and start loving themselves.\" \"Those stories constantly remind us of our responsibility. So let\\'s take our one more step. We have learned to love ourselves, so I urge you to speak yourself. I like to ask all of you \\'What is your name? What excites you and make your heart beat? Tell me your story.\\' I want to hear your voice. I want to hear your conviction. No matter who you are, where you\\'re from, your skin color, your gender identity, just speak yourself. Find your name and find your voice by speaking yourself.\" BTS\\' speech to the UN has been praised by fans. Picture: PA RM added, \"BTS has become artists performing in those huge stadiums and selling millions of albums right now, but I am still an ordinary 24-year-old guy. If there\\'s anything I\\'ve achieved, it was only possible that I have my other BTS members right by my side, and because of the love and the support that our ARMY fans all over the world make for us.\" The BTS star\\'s powerful closing statement certainly pulled at our heartstrings, as he stated, \"I\\'m Kim NamJoon, and also, RM of BTS. I\\'m an idol, and I\\'m an artist from a small town in Korea. Like most people, I\\'ve made many and plenty mistakes in my life. I have many faults, and I have many more fears, but I\\'m gonna embrace myself as hard as I can, and I\\'m starting to love myself gradually just little by little. What is your name? Speak yourself. Thank you very much.\" There are many reasons why the BTS ARMY love these 7 guys and when they do things like this, it\\'s easy to see why. > Download Our Free App For All The Latest BTS News!',\n",
       " ('BTS',\n",
       "  24,\n",
       "  0): 'Korean boy band BTS debuts at No. 1 on the Billboard 200 albums chart with its latest effort, Love Yourself: Tear. It’s the first No. 1 for the seven-member group, and the first K-pop album to lead the tally. The set, which was released through BitHit Entertainment on May 18, launches with 135,000 equivalent album units earned in the U.S. in the week ending May 24, according to Nielsen Music. Of that sum, 100,000 were in traditional album sales. The Billboard 200 chart ranks the most popular albums of the week in the U.S. based on multi-metric consumption , which includes traditional album sales, track equivalent albums (TEA) and streaming equivalent albums (SEA). The new June 2-dated chart (where BTS bows at No. 1) will be posted in full on Billboard‘s websites on Wednesday, May 30 (one day later than normal, owed to the May 29 Memorial Day holiday in the U.S.). Love Yourself: Tear’s first-week sum is a bit bigger than expected. On May 21, some industry forecasters predicted the album would bow with over 100,000 units. By May 24, that forecast grew to over 120,000. Of Love Yourself: Tear’s starting sum of 135,000 units, 100,000 were in traditional album sales, 26,000 were in SEA units (equaling 39.1 million on-demand audio streams for songs on the albums) and 9,000 TEA units. As mentioned earlier, Love Yourself: Tear is the first K-pop album to lead the Billboard 200. It’s also only the second top 10 for the K-pop genre, following BTS’ own Love Yourself: Her, which debuted and peaked at No. 7 on the Oct. 7, 2017-dated list. Love Yourself: Tear also logs the biggest week yet for K-pop (both in overall units and traditional album sales). The previous high-water mark was earned by BTS’ Love Yourself: Her (31,000 units in its opening frame, 18,000 in traditional album sales). Notably, as Love Yourself: Tear is performed mostly in the Korean language, it’s the first primarily foreign-language No. 1 album in over 12 years. In 2006, classical crossover vocal quartet Il Divo topped the list with Ancora (on the chart dated Feb. 11, 2006), which blends songs performed in Spanish, Italian and French, along with a track sung partially in English. Back on the new Billboard 200 chart, Post Malone’s former No. 1, beerbongs & bentleys, drops to No. 2 (123,000 units; down 17 percent) after three consecutive weeks atop the list. The album was the first by an artist to notch three weeks in a row at No. 1 since December, when Taylor Swift’s reputation linked together three frames (of its total four at No. 1). Rapper Lil Baby bounces in at No. 3 with his debut studio album, and first top 10, Harder Than Ever. The set earned 71,000 units, powered largely by streams (65,000 SEA units), thanks in part to the popularity of the set’s track “Yes Indeed,” with Drake. The track debuted at No. 30 on the Streaming Songs chart dated May 26, and is expected to make a huge leap up the newest tally (dated June 2). Harder Than Ever also features guest turns from Young Thug, Moneybagg Yo, Lil Uzi Vert and Offset. Lil Baby previously hit the Billboard 200 with the mixtape Too Hard, which peaked at No. 80 on Dec. 23, 2017. Rock band Five Finger Death Punch notches its sixth top 10 album, as And Justice for None debuts at No. 4 with 71,000 units (60,000 in traditional album sales). The band previously hit the region with Got Your Six (No. 2, 2015), The Wrong Side of Heaven and the Righteous Side',\n",
       " ('BTS',\n",
       "  24,\n",
       "  1): 'of Hell: Volume 2 (No. 2, 2013), The Wrong Side of Heaven and the Righteous Side of Hell: Volume 1 (No. 2, 2013), American Capitalist (No. 3, 2011) and War Is the Answer (No. 7, 2009). The group’s only studio album to miss the top 10 was its debut effort, The Way of the Fist, which topped out at No. 107 in 2008. Cardi B’s Invasion of Privacy climbs 7-5 on the new Billboard 200 with 48,000 units (down 9 percent), The Greatest Showman soundtrack moves 5-6 with 44,000 units (down 17 percent) and J. Cole’s KOD dips 6-7 with 41,000 units (down 22 percent). Rapper NAV rounds out the debuts in the top 10, as his first studio album, Reckless, starts at No. 8 with 36,000 units (32,000 in SEA units). The set features his Hot 100 hit “Wanted You,” featuring Lil Uzi Vert, as well as guest turns from Quavo, Travis Scott and Gunna. Closing out the new top 10: Black Panther: The Album is steady at No. 9 with 28,000 units (down 15 percent), while Playboi Carti’s Die Lit falls 3-10 in its second week with 26,000 units (down 57 percent).',\n",
       " ('BTS',\n",
       "  25,\n",
       "  0): \"BTS will promote their album on a number of music shows (Picture: Big Hit) BTS have been working hard on their new album and their upcoming world tour – which sadly means they haven’t been on our screens as much. But in anticipation of Love Yourself: Answer, they will be making some time for promo. Their agency Big Hit Entertainment has confirmed that BTS will be making a number of appearances on Korean music shows to promote their new album. A statement from Big Hit said: ‘They will have music show promotions for a week with their new music.’ It is unknown thus far which shows the boys will appear on, although KBS’s Music Bank, Mnet’s M!Countdown, MBC’s Show Champion and Music Core are all possibilities. However, we doubt this promo tour will be as big as the one for Love Yourself: Tear and its lead single Fake Love – with RM, Jimin, Jin, V, Suga, J-Hope and Jungkook appearing at the Billboard Music Awards, on The Ellen Show, and on The Late Late Show with James Corden. While the K-pop idols aren’t expected to fly to the US – their world tour kicks off in Seoul on 25 August – Ellen has been repping the group by announcing it is ‘BTS week’ on her YouTube channel EllenTube. BTS’s Love Yourself: Answer will be released on 25 August, and the tracklisting revealed earlier this week shows that it’s split into two parts. In addition to the 11 songs of Tear, BTS have added tracks from Her, and remixes of Fake Love and DNA, and the Steve Aoki remix of Mic Drop. And then there’s seven new songs – Trivia: Just Dance, Trivia: Love, Trivia: Seesaw, I’m Fine, IDOL and Answer: Love Myself, as well as Jin’s solo Epiphany. Tear became the first album by a Korean act to hit number one on the Billboard album charts, so big things are expected from Answer. Got a showbiz story? If you've got a celebrity story, video or pictures get in touch with the Metro.co.uk entertainment team by emailing us celebtips@metro.co.uk, calling 020 3615 2145 or by visiting our Submit Stuff page - we'd love to hear from you. Arrow MORE: Aretha Franklin’s family ‘aren’t upset’ with Madonna for her much-criticised VMAs tribute\",\n",
       " ('BTS',\n",
       "  26,\n",
       "  0): 'BTS is the gift that keeps on giving. If you aren\\'t already living in the fandom stratosphere but have slowly but surely been picking up on the BTS movement, welcome. I\\'m about to blow your mind. Along with their incredible stage performances and music videos, BTS also created the Bangtan Universe, aka an alternate reality which features fictional character counterparts for each BTS member. Don\\'t worry, I\\'ll get into it. But for now, some fans might be wondering how to read BTS\\'s webtoon Save Me to unravel the mysteries of the Bangtan Universe and see if their illustrated boy SeokJin saves his illustrated friends JungKook, TaeHyung, JiMin, NamJoon, HoSeok, and YoonGi. It\\'s a lot. You ready? In early January, BTS started a new Twitter account called @Smeraldo_Books which as part of the Bangtan Universe. The universe is continuously expanding and unravels throughout short films, stories, animations, posters, album notes, and now, BTS\\' webtoon called Save Me. In the multi-part tale, the BTS members are in various states of peril and Jin\\'s character, SeokJin, is trying to save them. (Big important note: The plotlines played out and explored in the Bangtan Universe have nothing to do with the members real lives.) OK. Everyone with me so far? The webtoon is available on the Line Webtoon app by Naver and includes the following synopsis: Seven boys. Best friends. Their fates intertwined through the good times together, but also the tough times, as they have gone their separate ways and suffered greatly as a result. When all is almost lost for these boys, one is given a special chance to go back in time and help his friends fix the mistakes that led them down this path. He’ll do anything to save them, but can he? Or is he too late? Guess who the one with the special chance to go back in time is? You got it. It\\'s your boy SeokJin (as fans already suspected based on analysis of the boys\\' past music videos). @Smeraldo_Books gave each boy a small caption to let readers in on the internal dialogue of their favorite characters. Jin\\'s reads: \"Would I be able to straighten out the errors and mistakes and save the others? I didn\\'t grasp the depth and weight of this question.\" Dun, dun, dun!!! Fans can follow the story by downloading the Line Webtoon app and keeping a close eye on @Smeraldo_Books feed. Right now, three of the sixteen episodes are available for viewing for free, including the Prologue, Episode 1, and Episode 2. You\\'re even able to read the next two episodes now if you\\'re willing to spend a bit of cash (it costs about $0.50 to buy a fast pass to read new episodes before they become available for free after a short wait period). Fans can expect a new episode to go up every Thursday until April and trust me, you don\\'t want to miss this. To save you a little bit of confusion, I found two versions of the app on my Applications store. If you\\'re non-Korean speaking, this is the one you want: App Store/Line Webtoon Daily Comics The Korean version is called \"Naver Webtoon.\" As a chill little short cut, you can also follow this @Smeraldo_Books tweet straight to your language of choice. Here, you\\'ll be sent directly to the illustrations and can dive into what the heck Jin is going to do for his friends. Hang in there guys, at least until next Thursday when the new episode comes out! It\\'s wild out there in the Bangtan Universe.',\n",
       " ('BTS',\n",
       "  27,\n",
       "  0): 'Early on Monday (July 16), the official Twitter account for Korean group BTS alerted fans of the title of their upcoming August release. Dubbed Love Yourself: Answer, it is the third album from the act’s record-breaking Love Yourself series. It follows last year’s Love Yourself: Her and May’s Love Yourself: Tear. Explore Explore BTS See latest videos, charts and news See latest videos, charts and news Answer, their first album since making history with the Billboard 200 chart-topping Tear, will be released on Aug. Aug. 24. Pre-orders begin on July 18. Few details are known at this time, but Billboard has reached out for comment. BTS shared the info with their ARMY through a post uploaded to their fan-only blog, known as a “fan cafe” within the K-pop world. Answer will reportedly complete the act’s four-part Love Yourself series, which fans have long-since discerned was inspired by a storytelling form known as ???? in Chinese characters, or ???? in Korean. The term refers to four narrative elements: introduction, development, turn or twist, and conclusion. Each of the three albums and the act’s “Love Yourself: Wonder” video released in April, correlate to: Introduction-”Wonder,” which featured the song “Euphoria” performed by Jungkook; Development-Her, released last September; Turn-Tear, which made history as the first No. 1 Korean album to ever top the Billboard 200. In October, BTS revealed that 3% of all physical album sales for the Love Yourself series will be donated to UNICEF in relation to the group’s Love Myself campaign. BTS will not promote Answer’s music on South Korean weekly music shows but instead unveil the new songs at the Seoul stops of their Love Yourself World tour. The concert series kicks off on Aug. 25-26 at Seoul’s Olympic Stadium. The septet will then head to North America for over a dozen sold-out shows in the U.S. and Canada. Update: Later on Monday (Tuesday in South Korea) BTS’ label Big Hit Entertainment tweeted a link to an article by Hankguk Kyeongjae TV (Korea Business News) that stated the album will be a an extended reissue, or repackage, album. It will feature seven new tracks. In the past, the group has released extended versions of albums, such as 2016’s The Most Beautiful Moment In Life: Young Forever, which featured all of the songs originally released through the earlier The Most Beautiful Moment in Life, Pt. 1 and Pt. 2 albums.',\n",
       " ('BTS',\n",
       "  28,\n",
       "  0): \"International ARMY, it's time to stop what you're doing, find a seat, and take a deep breath, because what I'm about to tell you will seriously blow you over with excitement. I'll cut to the chase: BTS just announced another world tour, and BTS' 'Love Yourself: Speak Yourself' World Tour announcement is going to make you so, so, sooooooo happy! BigHit Entertainment announced the world tour dates in a new YouTube video that'll seriously have you feeling all the emotions for a couple different reasons. For one, if you haven't yet had the opportunity to see BTS live, it's very likely a new date has been added in your area. Secondly, the Speak Yourself tour is going to be a friggin' stadium tour! Remember when RM said 2019 is going to be the year of BTS? Yeah, he wasn't lying. BigHit has announced dates in the U.S., Brazil, Europe, and Japan with more dates to come. The first round of dates are as follows: May 4, 2019 — Los Angeles, CA, Rose Bowl Stadium May 11, 2019 — Chicago, IL, Soldier Field May 18, 2019 — E. Rutherford, NJ, MetLife Stadium May 25, 2019 — Sao Paulo, Brazil, Allianz Parque June 1, 2019 — London, UK, Wembley Stadium June 7, 2019 — Paris, France, Stade de France July 6-7, 2019 — Osaka, Japan, Yanmar Stadium Nagai July 13-14, 2019 — Shizuoka, Japan, Shizuoka Stadium Ecopa Check out the announcement video below! Tickets go on sale starting March 1 at 10:00 a.m., so definitely set your alarms because those tix are gonna sell like hotcakes. (Seriously. The boys sold out Citi Field stadium in New York City in less than 20 minutes, so you better have your ticketing website of choice locked and loaded on March 1.) With more BTS tour dates being announced, there are definitely a few questions fans have on their minds. One thing to take note of is that BTS' first tour date in L.A. is suspiciously close to when the Billboard Music Awards go down on Wednesday, May 1. Is this a sneaky sign the boys will attend the awards? Secondly, BTS has been hard at work recording their next album and rumor has it they're planning a comeback for the second quarter of 2019, right around the time the Speak Yourself stadium tour kicks off in Los Angeles. So, if the boys are attending the Billboard Music Awards on May 1, will they also be performing and debuting new music there like they did in 2018 when they became the first K-Pop act ever to perform at the Billboard Music Awards? The last question is: If the boys are debuting new music right around the time their tour kicks off, does that mean the Speak Yourself tour will feature new jams? Let's just say the ARMY is HERE FOR IT. Fans are so proud of the boys, especially considering the sheer size of the stadiums the boys will be playing (the smallest stadium seats 50,000 attendees while the largest seats 90,000). Fans have already gotten #SPEAK_YOURSELF trending on Twitter. Thank you, BTS. Thank you, for real.\",\n",
       " ('BTS',\n",
       "  29,\n",
       "  0): 'Superstar Korean boy band BTS‘ “Fake Love” launches at No. 10 on the Billboard Hot 100 chart (dated June 2), marking the first Hot 100 top 10 ever for a K-pop group. As previously reported, parent album Love Yourself: Tear debuts as BTS’ first No. 1 on the Billboard 200 chart, where it’s also the first No. 1 for an album in the K-pop genre. BTS breaks its own record for the highest-charting Hot 100 hit for a K-pop group, passing its “MIC Drop” (featuring Desiigner), which reached No. 28 in December. Only one K-pop act other than BTS has charted top 10s on the Hot 100: South Korean rapper/singer PSY, whose smash “Gangnam Style” peaked at No. 2 for seven weeks in 2012 and whose “Gentleman” hit No. 5 in 2013. Further, “Fake Love” is the first K-pop song to debut in the Hot 100’s top 10, besting PSY’s “Gentleman,” which started at No. 12. “Fake Love,” which BTS performed on the Billboard Music Awards May 20, is likewise BTS’ first No. 1 on the Digital Song Sales chart, where it opens with 29,000 downloads sold in the week ending May 24, according to Nielsen Music. It’s the first No. 1 on the chart for a K-pop group and the second leader for any K-pop act: PSY’s “Gangnam Style” spent six weeks atop Digital Song Sales in 2012. BTS earns its second Digital Song Sales top 10, after “MIC Drop,” which hit No. 4. (Notably, “Fake Love” leads with the lowest sales total for a Digital Song Sales No. 1 since Jan. 1, 2005, when Green Day’s “Boulevard of Broken Dreams” reigned with 21,000. As previously reported, download sales continue to drop, as streaming surges.) On Streaming Songs, “Fake Love” starts at No. 7 with 27.4 million U.S. streams in the week ending May 24, arriving as the group’s first top 10 on the tally. The act hit a prior No. 37 high with “DNA” last October. “Fake Love” is also making inroads at pop radio, as it’s bubbling under the mainstream top 40-based Pop Songs airplay chart. KJYO Oklahoma City leads all reporters to the survey with 62 plays for the song through May 27, followed by KROI Houston (36) and WEZB New Orleans (22). Atop the Hot 100, Drake‘s “Nice for What” returns to No. 1 for a fifth total week on top. All charts will update on Billboard.com Wednesday (May 30).',\n",
       " ('BTS',\n",
       "  3,\n",
       "  0): 'BTS continue to push where no K-pop act has gone before with a debut in the top 10 of the Billboard 200 album chart. The seven-member group’s new album, Love Yourself: Her, debuts at No. 7 with 31,000 equivalent album units earned in the week ending Sept. 21, according to Nielsen Music. Of that sum, 18,000 were in traditional album sales. The Billboard 200 chart ranks the most popular albums of the week in the U.S. based on multi-metric consumption, which includes traditional album sales, track equivalent albums (TEA) and streaming equivalent albums (SEA). The new Oct. 7-dated chart (where Foo Fighters‘ Concrete and Gold debuts at No. 1) will be posted in full on Billboard‘s websites Tuesday (Sept. 26). The rest of Love Yourself: Her‘s starting unit sum was comprised of just less than 4,000 TEA units, and a little under 10,000 SEA units. BTS earns both the highest-charting album ever on the Billboard 200 by a K-pop act, and the genre’s biggest sales week. The group beats its own record, as the act’s 2016 album, Wings, was previously both the highest-charting K-pop album (debut and peak at No. 26 on the Oct. 29, 2016-dated list) and owner of the biggest sales week for a K-pop title (11,000 copies sold in its debut frame — all from digital albums). Notably, Wings and Love Yourself: Her are the only K-pop albums that have charted in the top 40. Since the release of Wings, BTS’ popularity has grown tremendously in the U.S., so it’s not a huge surprise to see the robust sales figure for the new album. For example, the act debuted at No. 1 on the Social 50 chart the same week that Wings entered the Billboard 200. (The Social 50 chart measures the most popular artists on Facebook, Twitter, Instagram, YouTube, Wikipedia and Tumblr.) Since hitting No. 1, BTS has racked up 40 nonconsecutive weeks atop the list. The group’s extraordinary popularity on social networks (and very active fanbase online) led to its first Billboard Music Award win for Top Social Artist back in May. Also helping the sales cause, the new album is distributed by Sony’s independent distribution arm, The Orchard. It’s the first time an album by BTS has American distribution, as the group’s previous releases were issued through U.S. digital retailers independently by the group’s South Korean label, Big Hit Entertainment. While Love Yourself: Her is currently only available as a digital album in the U.S., a physical CD release is forthcoming. Lastly, BTS’ online fan army mobilized in high volume during street week in order to get the word out about the album. The passionate fandom was very focused on achieving high chart placement, as fan-run social media accounts helped fellow BTS fans understand how Billboard‘s charts are compiled, and how sales and streams impact the Billboard 200 during an album’s first week, and so forth. (Some fans even went so far as to gift the album to friends via Apple’s iTunes Store in order to spread the word. However, sales of any specific album purchased on iTunes and gifted to another are not reported to Nielsen Music by Apple, and thus, do not count on Billboard‘s charts.) BTS further its lead as the K-pop act with the most entries on the Billboard 200, growing to five entries following 2017’s You Never Walk Alone (a deluxe repackaged version of Wings that peaked at No. 76), 2016’s Wings (No. 26) and The Most Beautiful Moment in Life: Young Forever (a compilation album that peaked at No. 107), plus 2015’s The Most Beautiful Moment in Life,',\n",
       " ('BTS',\n",
       "  3,\n",
       "  1): 'Pt. 2 (No. 171). The only other K-pop acts to have multiple entries on the Billboard 200 are solo star G-Dragon (who has three), along with male acts BIGBANG and EXO (with two each). The album itself puts BTS in a position for a larger global domination while still remaining true to the band’s original messages. Of course, the guys deliver the emotionally driven electro-pop/hip-hop hybrids they’re famous for with single “DNA” (featuring the most seismic synthesizers of the band’s career mixed with an powerfully addictive whistle hook) along with the tender melancholy dripping from “Best of Me” (featuring production from The Chainsmokers‘ Andrew Taggart for the band’s most attractive appeal to Western audiences to date). Yet the record gets even more complex and has larger messages that honor the band’s dedication larger, social issues. The theme is set from the beginning with the use of gender-neutral pronouns in opening track “Intro: Serendipity” to a discussion of youth hopelessness in “Go Go,” along with a playful-yet-eye-opening examination of the very fan culture that have made them such international sensations in “Pied Piper.” If the accessible sounds alongside vocal and rap deliveries initially hook listeners, the thought-provoking messages in the lyrics and themes will keep fans thinking and listening over and over. While BTS landing in the top 10 of the Billboard 200 is an accomplishment in and of itself, if the band can simultaneously score an entry on the Hot 100, it will make them only the second K-pop act to land a Korean-language song on the singles chart. To date, only PSY, Wonder Girls and CL have landed songs on the ranking, with the latter two’s entries in English. BTS’ “Spring Day” debuted at No. 15 on Billboard‘s Bubbling Under Hot 100 chart earlier this year, the closest Korean-language song to make it onto the Hot 100 until Blackpink‘s “As If It’s Your Last” hit No. 13 this summer.',\n",
       " ('BTS',\n",
       "  30,\n",
       "  0): 'South Korean boy band BTS made history by being the first ever K-pop group to speak at the United Nations on Monday for UNICEF’s “Generation Unlimited” launch. The group has previously worked with UNICEF to launch the “Love Myself” campaign, which advocates against youth violence. Now, the UN launches “Generation Unlimited” to alleviate “the global education and training crisis currently holding back millions of young people and threatening progress and stability.” Explore Explore BTS See latest videos, charts and news See latest videos, charts and news Kim Nam-joon, better known as RM, spoke for the group to share his personal struggles and how he used those experiences to positively influence the people around him. Creating music was how he found his strength. “I had one sanctuary, and that was music. There was a small voice in me that said, ‘Wake up, man, and listen to yourself!’ But it took me a long time to hear music calling my name.” He uses this newfound confidence to motivate others to believe in themselves too: “I want to hear your voice. I want to hear your conviction. No matter where you’re from, skin color, gender identity, just speak yourself.” BTS fans, better known as ARMY, took to social media to voice their praise for the group’s moving words. Even those who were not formerly K-pop fans shared their enthusiasm and support for the inspiring boy band. I hope everyone remembers this #BTSxUnitedNations pic.twitter.com/UC8RVgBHhK — president namjoon kim (@joon4change) September 25, 2018 SO I TYPED, PRINTED AND FRAMED NAMJOONS SPEECH now all i need to do is hang it up on the wall #BTSxUnitedNations @BTS_twt pic.twitter.com/ezd6Si7eTr — akanksha (@parkjiminhigh) September 25, 2018 you know damn well this is my new ringtone #BTSxUnitedNations pic.twitter.com/Hy2PFKx2eF — ? (@miserymyg) September 24, 2018 this is the whole speech and I’m getting this tattooed on my forehead so everyone would know I stan an intellectual #BTSxUnitedNations pic.twitter.com/f2zgv7Arfz — pransí (@02myg) September 24, 2018',\n",
       " ('BTS',\n",
       "  31,\n",
       "  0): 'BTS will make history yet again next week, this time with a presentation at the United Nations. On Monday (Sept. 24), the chart-topping septet will attend the launch ceremony at the UN headquarters in New York for Generation Unlimited, a global partnership by the United Nations Children’s Fund (UNICEF). The 73rd Session of the UN General Assembly kicks off on Tuesday (Sept. 25). UNICEF will work with a diverse group of partners for the Generation Unlimited program, which is “dedicated to increasing opportunities and investments for children and young people aged 10 to 24,” according to the UN organization’s website. It will “expand support for young people as they transition from adolescence to adulthood.” Currently, UNICEF primarily focuses on those between the ages of 10 to 18. Explore Explore BTS See latest videos, charts and news See latest videos, charts and news BTS is set to present a three-minute speech, reports the Korea Herald. High-profile diplomats and heads of state including UN Secretary-General Antonio Guterres, Executive Director of UNICEF Henrietta Fore, and South Korea’s first lady Kim Jung-sook are expected to be in attendance. BTS is the first K-pop act to speak at the UN. They made history earlier this year as the first-ever Korean act to top the Billboard 200 with their May-release Love Yourself: Tear, and they returned to No. 1 with August’s Love Yourself: Answer. Last year, BTS joined with the Korean Committee for UNICEF in an anti-violence campaign dubbed Love Myself. A portion of the income from the physical album sales of BTS’ Love Yourself series is donated to the cause. Currently, the Love Myself website reports that the accumulated funds towards the cause are 1,154,593,599 South Korean Won, around $1.03 million. While in New York, BTS will film with Good Morning America and The Tonight Show Starring Jimmy Fallon. The appearances precedes the group’s first two Tri-State Area concerts at New Jersey’s Prudential Center on Sept. 28 and 29. They’ll also hold a historic show at New York City’s Citi Field in Queens on Oct. 6, the first-ever stadium-sized show held by a Korean group.',\n",
       " ('BTS',\n",
       "  32,\n",
       "  0): 'BTS is topping charts all over the world, and it seems the K-pop act is ready to take a next step. Today, a new report confirmed the band will be undertaking a world tour in 2019, and it will be a stadium one none the less. Videos by ComicBook.com Over on Twitter, Big Hit Entertainment confirmed BTS will embark on a new world tour this summer. The ‘Love Yourself: Speak Yourself’ world tour will kick off in early May and visit places like Los Angeles, Paris, and more. So far, fans have been told of more than six tour dates. You can check out each one below: Los Angeles, May 4 Rose Bowl Stadium Rose Bowl Stadium Chicago, May 11 Soldier Field Soldier Field New Jersey, May 18 Metlife Stadium Metlife Stadium Sao Paulo, May 25 Allianz Parque Allianz Parque London, June 1 Wembley Stadium Wembley Stadium Paris, June 7 Stade De France Several fans reported a post by Big Hit Entertainment also went live revealing the tour’s Japanese dates, and it seems the tour’s website has been updated with several of those dates. It looks like two stops in Osaka and Shizuoka respectively will take place in July. This stadium world tour marks a first for BTS as the group has yet to host one on such an international scale. BTS is used to filling out such venues in Asia, and the group proved it could do so last year when BTS performed its first stadium show in the United States. The sold-out show took place in New York City at Citi Field, and the group was warmly received by tens of thousands of fans. It was there Suga promised fans BTS would return to the United States for more shows soon, and it looks like the rapper meant sooner than later. This new tour is an exciting move for BTS and marks yet another accomplishment for the band. Earlier this year, the South Korean group made history when it appeared on the Grammy Awards to present the award for Best R&B Artist. BTS was also nominated for Best Record Packaging, but the award ultimately went elsewhere. So far, Big Hit Entertainment has kept mum on any comeback plans for BTS as the company is preparing to debut a new boy group named TXT, but this world tour will help introduce the global superstars to even more fans. So, as it stands, 2019 looks like it will be yet another successful year for BTS as they continue their path towards global domination. So, will you try to nab tickets for any of these shows? Let me know in the comments or hit me up on Twitter @MeganPetersCB to talk all things comics and anime!',\n",
       " ('BTS',\n",
       "  33,\n",
       "  0): 'BTS caught up with Billboard’s Keith Caulfield on the red carpet at the 2019 Grammy Awards on Sunday (Feb. 10), chatting about their excitement over being at the event, what fans can expect from their new album, and who they are most looking forward to meeting. Explore Explore BTS See latest videos, charts and news See latest videos, charts and news BTS, in attendance at the Grammys for the very first time, reveal that being at the awards show is a huge honor. “We’re living the dream,” RM tells Billboard. “I’d like to say thanks to all the ARMY, they give us force.” Asked if they can confirm whether or not the rumors are true that their next record will be released in early May, RM replies with a smile that they are working “very hard” on it, and that it will be out “real soon.” The group is also asked if this record will have a theme attached to it, to which RM responds that he can’t say, but that it will be about giving back to their their fans. “The concept is paying off,” he says. “So I just hope that they love it, and they listen to it, and they like it. That’s all!” Also posed with the question of whether or not the album will be a trilogy, RM says ““Um…that’s a secret! Come on, that’s an important part! Come on, Billboard, you know what we do!” BTS also discuss which artists they are eager to meet at the Grammys, naming Lady Gaga, Camila Cabello, and Travis Scott. Finally, the guys are asked how this past year of chart success has impacted their lives. “I’ve seen so many good words to us,” states RM. “But I think the most important thing is that we keep ourselves, we just stay in our lane and do what we love to do, so it’s still great and still feels amazing, but we’re just trying to keep it chill…we’re trying to enjoy the ride. It’s like a rollercoaster and we’re up, let’s try to enjoy it…but not too much.” You can watch the full video interview with BTS above.',\n",
       " ('BTS',\n",
       "  34,\n",
       "  0): 'South Korean septet BTS will present at the 2019 Grammy Awards, a rep for Big Hit Entertainment confirms to Billboard. Suga, J-Hope, RM, Jin, Jimin, V and Jungkook will present an award at the 61st Grammys on Feb. 10 — their first time doing so at a Stateside event — as Variety first reported Monday (Feb. 4). Billboard has reached out to confirm what award the group will present. This will mark BTS‘ first time in attendance at the Grammys. Explore Explore BTS See latest videos, charts and news See latest videos, charts and news Their Billboard 200-topping album Love Yourself: Tear, released in May, is nominated at the Grammys in the best recording package category. The artwork was directed by HuskyFox’s Doohee Lee. In the past, BTS’ Suga (Min Yoongi) has expressed interest in attending the Grammys. During the group’s appearance on The Tonight Show Starring Jimmy Fallon in the fall, when the host asked what goals are left for the guys to accomplish, Suga offered, “Go to the Grammys.” Tear is up against four other albums: Mitski’s Be the Cowboy, with art directed by Mary Banas; St. Vincent’s Masseduction directed by Willo Perron; The Chairman’s The Offering, directed by Qing-Yang Xiao; and Foxhole’s Well Kept Thing, directed by Adam Moore. The 61st Grammys will be hosted by Alicia Keys and broadcast live from the Staples Center in Los Angeles and air on CBS on Sunday night. The performance lineup includes Camila Cabello, Cardi B, Janelle Monáe, Miley Cyrus, H.E.R., Brandi Carlile, Shawn Mendes, Kacey Musgraves, Dan + Shay and Post Malone with the Red Hot Chili Peppers. Almost immediately following the initial news report, the hashtag “BTXxGRAMMYS” began to trend as Twitter reacted to the announcement. The most tweeted about moment of the Grammys will be @BTS_twt presenting an award. I’m calling it now #BTSXGrammys — Rafranz Davis (@RafranzDavis) February 5, 2019 The most tweeted about moment of the Grammys will be @BTS_twt presenting an award. I’m calling it now #BTSXGrammys — Rafranz Davis (@RafranzDavis) February 5, 2019 IM ACTUALLY SHAKING MY BABIES ARE GOING TO THE GRAMMYS #BTSxGRAMMYs pic.twitter.com/LEP9ZnhEIx — kamari BTS ARE GOING TO THE GRAMMYS (@Ioonarmyoutsold) February 5, 2019 The first time bts get to present an award at an American award show, they do it at the grammys.,..I ain’t saying that exudes some sort of energy but,… #BTSxGRAMMYs pic.twitter.com/4uAjGTWOnO — Joon’s World — (@kimparkdaily) February 5, 2019 It might just be an appearance but the way this is just the beginning of their continuous organic growth as established artists globally #BTSxGrammys pic.twitter.com/m099oIrWRE — taehyung is my green haired bffie (@producerknj) February 5, 2019',\n",
       " ('BTS',\n",
       "  35,\n",
       "  0): 'Late Wednesday night (Jan. 16), fans of South Korean septet BTS were introduced to a brand-new comic series based out of the act’s creative narrative. Save Me, created by an artist known as Lico, premiered on Naver’s Webtoon platform, with a prologue and the first two chapters of a narrative that ties into the storyline shared through many of BTS’ music videos and other related entities over the years as part of their “BTS Universe,” or “BU.” Explore Explore BTS See latest videos, charts and news See latest videos, charts and news “Seven boys. Best friends. Their fates intertwined through the good times together, but also the tough times, as they have gone their separate ways and suffered greatly as a result,” reads the description of the webtoon. “When all is almost lost for these boys, one is given a special chance to go back in time and help his friends fix the mistakes that led them down this path. He’ll do anything to save them, but can he? Or is he too late?” Trending on Billboard Throughout the first three available chapters — a prologue and the first two chapters — the character Kim Seokjin, the legal name of BTS’ Jin, is centered as a protagonist trying to save the lives and fates of himself and his six schoolhood friends, all representing the other members of the group. Save Me, formally known as The Most Beautiful Moment in Life Pt.0 <SAVE ME> according to a press release from Webtoon, will be updated with a new “episode” every Thursday. It is currently available in Korean, English, Japanese, both Simplified and Traditional Chinese, Indonesian and Thai. The plot relates to the creative thread BTS has woven through its music videos, social media, a series of Notes and other related content since the release of The Most Beautiful Moment in Life, Pt. 1 in 2015, fronted by the single “I Need U,” and The Most Beautiful Moment in Life narrative has carried through BTS’ career since then. The title of the webtoon is the same as BTS’ 2016 single “Save Me” off of The Most Beautiful Moment in Life: Young Forever, which peaked on the Billboard 200 at No. 107 on the chart dated May 21, 2016. Save Me was made public through the Smeraldo Books Twitter account, which has recently been sharing a series of videos and brief memos under the name “The Notes 1.” At time of publication, 12 out of the planned 15 video-Note pairings have been released.',\n",
       " ('BTS',\n",
       "  36,\n",
       "  0): '“Burn the Stage: The Movie,” a documentary following K-pop group BTS on their 2017 concert tour, will be streaming on the YouTube Premium subscription service starting this Friday. The movie is based on the previous YouTube original series “BTS: Burn the Stage.” Since its release in theaters worldwide last November, “Burn the Stage: The Movie” has drawn more than 2 million fans in more than 70 countries and regions. The 83-minute documentary film features additional footage beyond the series including narrations, studio interviews, and an appearance by Bang Si-Hyuk, CEO of BTS’ label Big Hit Entertainment. “Burn the Stage: The Movie” will be released on YouTube Premium on Jan. 18 at 11 p.m. KST / 9 a.m. EST on YouTube Premium. Also on Friday, viewers around the world will be able to watch an exclusive five-minute highlight of the film through the new YouTube Premieres feature (at this link) and participate in the release countdown using YouTube’s global live-chat function to connect with other fans. Popular on Variety BTS’s next concert film, “BTS World Tour Love Yourself in Seoul,” will have the widest event-cinema release in history: It’s slated to hit 3,800 theaters across 95 countries as part of a one-day release on Saturday, Jan. 26. On YouTube, BTS has been ragingly popular. They are the first Korean group to surpass 600 million views on YouTube for a single video with the music video for “DNA.” They also hold the record as the Korean artists with the most music video views on YouTube, with four music videos over 400 million views — “Fire,” “Dope,” “Fake Love,” and ‘Mic Drop (Steve Aoki Remix)” — and three music videos over 300 million views — “Blood Sweat & Tears,” “Save Me,” and “Idol.” “I am glad that we have been able to reintroduce the story of such great global artists like BTS,” said Nadine Zylstra, head of YouTube Originals for Asia Pacific. “I hope that ‘Burn the Stage: The Movie’ will become another special present to our viewers around the world.” YouTube Premium is now available in 29 countries, including South Korea, the U.S., Australia, New Zealand, Mexico, Canada, Finland, France, Germany, Ireland, Italy, Norway, Russia, Spain and Sweden. The service is priced at $11.99 per month in the U.S., and includes ad-free access to all YouTube videos and YouTube Music as well as full access to YouTube Originals. BTS is an abbreviation of “Bangtan Sonyeondan” (“bulletproof boy scouts”). The group — comprising members RM, Jin, SUGA, j-hope, Jimin, V, and Jung Kook — debuted in June 2013.',\n",
       " ('BTS',\n",
       "  37,\n",
       "  0): 'BTS may not have won any awards during Sunday night’s 61st annual Grammy Awards ceremony, but they definitely won over social media. The K-pop group presented best R&B album to H.E.R., which was the most-tweeted-about moment of the night. The band also managed to be the most-tweeted-about act in attendance. Many fans took to social media throughout the night to point out the members in the audience, notably when they were spotted dancing during the Dolly Parton tribute performance. Drake scored the second-most-tweeted-about moment of the night when he accepted the best rap song award for “God’s Plan.” During his acceptance speech, the rapper was cut off by the show’s producers. While he was heard saying, “But…” before the broadcast cut to a commercial break, the producers later said that Drake “took a natural pause in his speech,” which led them to believe that he was done. Post Malone and Red Hot Chili Peppers’ performance of “Rockstar,” “Stay” and “Dark Necessities” was the third most popular moment of the night on , while Dan + Shay’s stripped-down performance of “Tequila” scored the No. 4 spot. Cardi B‘s win in the best rap album category for Invasion of Privacy was the fifth-most-tweeted moment of the show. She made history as the first female solo rapper to win the award. During her acceptance speech, Cardi B clutched husband Offset’s hand as she talked about their daughter. “When I found out I was pregnant, my album was not complete. We were like, ‘We have to get this album done so I can shoot these videos while I’m still not showing.’ And it was very long nights,” she said. Following BTS, Lady Gaga was the second-most-tweeted-about person in attendance. Camila Cabello scored the No. 3 spot, while Shawn Mendes was the fourth-most-tweeted-about star and Cardi B followed in the No. 5 spot. Miley Cyrus and Parton scored the No. 6 and No. 7 spots, while host Alicia Keys was the eighth-most-tweeted about person of the night. Drake was the ninth-most-popular person among Twitter users. Ariana Grande was the tenth-most-tweeted-about person of the night. The singer won her first Grammy in the best pop vocal category for Sweetener after she made headlines for choosing not to perform in or attend the show. Gaga, who performed “Shallow,” was the most-tweeted-about performer of the night, while Cabello’s performance earned the No. 2 spot. Mendes’ performance of “In My Blood” with Cyrus snagged the No. 3 spot. Cardi B was the fourth-most-tweeted-about performer of the night, while Cyrus rounded out the list in the No. 5 spot. The most-tweeted-about song of the night went to “Shallow,” while Childish Gambino’s “This Is America” earned the No. 2 spot. Parton and Cyrus’ performance of “Jolene” was the third-most-tweeted-about song of the night, while Cabello’s “Havana” earned the No. 4 spot and Lady Gaga’s “Joanne” finished in fifth place. Over on , Keys secured the most-talked-about moment of the night when she played two pianos as an homage to pianist Hazel Scott. Diana Ross’ birthday performance, which included a medley of “The Best Years of My Life” and “Reach Out And Touch (Somebody’s Hand),” was the second-most-talked-about moment of the night on the platform. Cardi B earned the No. 3 and No. 4 most-popular moments of the night. While her performance of “Money” was the third-most-talked-about moment of the night, her acceptance speech followed in the fourth spot on Facebook. Post Malone and Red Hot Chili Peppers’ performance rounded out the list as the fifth-most-talked-about moment of the night on the platform.',\n",
       " ('BTS',\n",
       "  38,\n",
       "  0): 'Enter Your Email to Unlock This Article Plus, get the best of BroadwayWorld delivered to your inbox, and unlimited access to our editorial content across the globe. Email: Existing user? Just click login. Following a record-breaking 2018, BTS is further cementing their position as the biggest pop act on the planet as they announce their BTS WORLD TOUR \\'LOVE YOURSELF: SPEAK YOURSELF\\', with a line-up of eight stadiums spanning North America, South America, Europe and Asia. The tour comes fresh on the heels of their first-ever stadium show in New York at Citi Field Stadium last October, which sold-out in minutes. BTS WORLD TOUR \\'LOVE YOURSELF: SPEAK YOURSELF\\' kicks off its monumental stadium run on May 4 at the Rose Bowl Stadium in Los Angeles/CA before traveling through Soldier Field in Chicago/IL, MetLife Stadium in E. Rutherford/NJ, Allianz Parque in Sao Paulo/Brazil, Wembley Stadium connected by EE in London/UK, and Stade de France in Paris/France. It is also scheduled to hit Yanmar Stadium Nagai in Osaka/Japan and Shizuoka Stadium Ecopa in Shizuoka/Japan the following July. Ticket information, including seating charts and prices, will be released soon. Find the ticket on-sale dates for North America, South America and Europe below: North America (Los Angeles/CA, Chicago/IL, E. Rutherford/NJ) - Tickets go on sale to the general public starting March 1, 2019 at 10 am local time. Europe London/England - Tickets go on sale to the general public starting March 1, 2019 at 8:30 am local time. Paris/France - Tickets go on sale to the general public starting March 1, 2019 at 9 am local time. Sao Paulo/Brazil - Tickets go on sale to the general public starting March 11, 2019 at 10 am local time. The global boyband recently made history as the first Korean act to present at the GRAMMY Awards. In 2018, BTS scored two #1 albums on the Billboard 200, embarked on a sold out world tour, landed the cover of TIME, and had the highest-grossing cinema event with Burn the Stage: the Movie. While millions across the world celebrate BTS as a culture, the band continues to break ground, connecting with the people through their music. BTS WORLD TOUR \\'LOVE YOURSELF: SPEAK YOURSELF\\' DATES May 4, 2019 Los Angeles, CA Rose Bowl Stadium March 1, 2019 May 11, 2019 Chicago, IL Soldier Field March 1, 2019 May 18, 2019 E. Rutherford, NJ MetLife Stadium March 1, 2019 May 25, 2019 Sao Paulo, Brazil Allianz Parque March 11, 2019 June 1, 2019 London, UK Wembley Stadium connected by EE March 1, 2019 June 7, 2019 Paris, France Stade de France March 1, 2019 July 6-7, 2019 Osaka, Japan Yanmar Stadium Nagai TBA July 13-14, 2019 Shizuoka, Japan Shizuoka Stadium Ecopa TBA BTS, an acronym of Bangtan Sonyeondan or \"Beyond the Scene\", is a South Korean boyband that is capturing the hearts of millions of fans globally. The members of BTS are RM, Jin, SUGA, j-hope, Jimin, V and Jung Kook. BTS has gained recognition from their authentic, self-produced music. From their top-notch performances to the way they interact with their fans, BTS has become a global phenomenon since they debuted in June 2013. They have mobilized millions of fans across the world (named ARMY), topped prominent music charts, sold out worldwide tours and have been recognized with prestigious awards like the Billboard Music Awards. Comments',\n",
       " ('BTS',\n",
       "  39,\n",
       "  0): 'BTS captures its third No. 1 album in less than 12 months on the Billboard 200 chart, as Map of the Soul: Persona, debuts atop the list. The seven-track set, which was released on April 12, starts with 230,000 equivalent album units earned in the U.S. in the week ending April 18, according to Nielsen Music — a career-best week for BTS. Of that sum, 196,000 were in album sales — another career-high week for the South Korean pop group. The Billboard 200 chart ranks the most popular albums of the week in the U.S. based on multi-metric consumption as measured in equivalent album units. Units are comprised of traditional album sales, track equivalent albums (TEA) and streaming equivalent albums (SEA). The new April 27-dated chart (where Persona enters at No. 1) will be posted in full on Billboard‘s websites on April 23. Of Persona’s first-week units, 196,000 were in album sales, 8,000 in TEA units, and 26,000 in SEA units. The latter figure translates to 37.4 million on-demand audio streams for the set’s songs. Let’s take a look at some of the notable achievements BTS notches with the arrival of Persona. Third No. 1 Album in Less Than 11 Months: Some acts take years to accumulate three No. 1 albums, but for BTS, the group needed just under 11 months. Starting from the week they got their first No. 1, Love Yourself: Tear (June 2, 2018-dated chart), continuing through second No. 1, Love Yourself: Answer (Sept. 8, 2018), and now with Persona (April 27, 2019), that’s a span of just under 11 months. The last act to score three No. 1s faster was Future, when he logged his first three No. 1s in just six months and three weeks with DS2 (Aug. 8, 2015); What a Time To Be Alive, with Drake (Oct. 10, 2015); and Evol (Feb. 27, 2016). Notably, before Future’s feat, the ensemble cast of the Fox TV series Glee notched all three of its No. 1 soundtracks in just one month and three weeks in 2010. Glee: The Music — The Power of Madonna, bowed at No. 1 on May 8, 2010 and was quickly followed by the chart-topping Glee: The Music, Volume 3 — Showstoppers (June 5, 2010) and Glee: The Music — Journey to Regionals (June 26, 2010). First Group Since the Beatles to Earn Three No. 1s in Less Than a Year: It’s uncommon for any act to tally three Billboard 200 No. 1s in less than a year. How rare? Before BTS, the last traditional group (excluding the Glee ensemble, whose multiple cast members rotated) to log three leaders within such a quick span was the Beatles in 1995-96, when the band’s archival releases Anthology 1, Anthology 2 and Anthology 3 all debuted at No. 1 in a stretch of 11 months and a week (between Dec. 9, 1995 and Nov. 16, 1996). Fastest Accumulation of No. 1 Albums by a Group Since the Monkees in 1967: The last group to collect three No. 1s at a faster pace than BTS was the Monkees in 1967, when the quartet reached No. 1 with More of the Monkees (Feb. 11, 1967), Headquarters (June 24, 1967) and Pisces, Aquarius, Capricorn, and Jones LTD. (Dec. 2, 1967) in just nine months and three weeks. (Dates mark each album’s first week at No. 1.) The Fourth Mostly Non-English Album at No. 1 in the Past Year: Persona, like BTS’ previous two No. 1 albums, is performed mostly in the Korean language, with bits of English. In the past year, aside from BTS’ three leaders, Andrea',\n",
       " ('BTS',\n",
       "  39,\n",
       "  1): 'Bocelli’s mostly all-Italian-language album Si also led the list (Nov. 10, 2018). BTS’ Biggest Week Ever, Fourth-Largest Week of 2019: With 230,000 equivalent album units earned, Persona captures BTS’ biggest week ever in terms of total units, the second-biggest week of 2019 for a group and the fourth-largest frame of 2019. BTS’ previous best was logged with the debut week of Love Yourself: Answer, which began with 185,000 units. The only larger weeks in 2019 were tallied by the opening frames of Ariana Grande’s Thank U, Next (360,000 units), Billie Eilish’s When We All Fall Asleep, Where Do We Go? (313,000) and Backstreet Boys’ DNA (237,000). BTS’ Largest Sales Week, Second-Biggest Sales Week of 2019: BTS easily claims its largest sales week for an album, as Persona sold 196,000 copies in its first week, beating the act’s previous high with the opening week of Love Yourself: Answer (141,000). In 2019, the only album to log a bigger sales week was Backstreet Boys’ DNA, with 227,000 copies sold in its premiere frame. Persona likely got a boost in sales from devoted fans who purchased multiple CD copies of the album, as it was released in four different collectible packages (following a similar release strategy for the Love Yourself series of albums). The four versions of the CD package for Persona all came with the same CD album, but the paper goods inside the package (including a poster, booklet and trading cards) vary. A Third Week With Over 200,000 Units at No. 1: With 230,000 units earned in its first week, Persona gives the Billboard 200 its third week in a row where the No. 1 album has tallied more than 200,000 units. Persona follows the chart-topping arrivals of Khalid’s Free Spirit (202,000) and Eilish’s When We All Fall Asleep (313,000). The last time the No. 1 slot had three weeks in a row of 200,000-plus weeks was Aug. 18-Sept. 1, 2018, when Travis Scott’s Astroworld clocked its first two weeks at No. 1 (537,000 and 205,000 units) and Grande’s Sweetener debuted (231,000). At No. 2 on the new Billboard 200, Eilish’s When We All Fall Asleep is steady at No. 2 for a second week with 98,000 equivalent album units (down 17%). Khalid’s Free Spirit slips from No. 1 to No. 3 in its second week, with 82,000 units (down 59%). Anderson .Paak claims his first Billboard 200 top 10, as Ventura debuts at No. 4. The set, which features guests ranging from Smokey Robinson and Brandy to Nate Dogg and André 3000, earned 55,000 units in its first week (of which 39,000 were in album sales). He previously hit the Billboard 200 with Oxnard (No. 11; Dec. 11, 2018) and Malibu (No. 79; Feb. 6, 2016). At No. 5 on the new Billboard 200, Nipsey Hussle’s Victory Lap falls two spots (55,000 units; down 13%). Grande’s former leader Thank U, Next slips 4-6 with 46,000 units (down 1%). Beyoncé’s surprise-released Homecoming: The Live Album debuts at No. 7 with 38,000 units earned from just two days of tracking activity (with 14,000 of that sum in album sales). The album dropped with no warning in the very early hours of Wednesday, April 17, and the tracking week for the chart ended on April 18. (Billboard’s album charts’ tracking week runs Friday through Thursday.) Homecoming: The Live Album was released to digital retail and streaming services shortly after the premiere of Beyoncé’s Homecoming film on Netflix at 12:01 a.m. on April 17. Both projects chronicle Beyoncé’s headlining performances at the 2018 Coachella Valley Music and Arts Festival. Homecoming: The Live Album is',\n",
       " ('BTS',\n",
       "  39,\n",
       "  2): 'Beyoncé’s eighth top 10 album as a soloist. She also recently visited the top 10 as one-half of The Carters (alongside husband Jay-Z) with 2018’s No. 2-peaking Everything Is Love. It’s possible that Homecoming: The Live Album could rise higher on next week’s Billboard 200 chart (dated May 4), after its first full tracking week of activity. Rounding out the new top 10 on the new Billboard 200 are Juice WRLD’s Death Race for Love (5-8 with 34,000 units; down 9%), Post Malone’s beerbongs & bentleys (7-9 with just over 29,000 units; down 5%) and A Boogie Wit da Hoodie’s Hoodie SZN (9-10 with 29,000 units; down 4%).',\n",
       " ('BTS',\n",
       "  4,\n",
       "  0): 'After a whirlwind couple of months, it’s officially almost June and for BTS and ARMYs and that can only mean one thing: It’s time for BTS FESTA 2020. Following a small teaser posted to BTS’s official Twitter on May 28, the group has finally unveiled the full schedule for their annual event, and it looks like we are in for a treat. This year\\'s FESTA celebrations will officially kick off on June 1 with an “Opening Ceremony” and wrap up on June 13 with Bangtan\\'s Saengpa (or, Bangtan\\'s Birthday Party) to coincide with the seventh anniversary of the septet’s debut. Held since 2014, FESTA is two weeks packed with exclusive Bangtan content — and it\\'s needed now more than ever this year. As is custom during FESTA, the calendar is stocked with choreography videos, family portraits, and photo collections. On June 5, we will get a still unknown project called “Still With You,” which could very well be a new song (for reference, that exact time last year we got Jin’s heartwrenching solo “Tonight”). In a small intermission during FESTA, BTS will also appear and perform at YouTube\\'s virtual graduation ceremony on June 6. On June 11, a very ominous “Map of the Song: 7” video will drop and the next day it’s possible that we could be getting a music video (or perhaps even performance) of Map of the Soul: 7’s “We Are Bulletproof: the Eternal.” X content This content can also be viewed on the site it originates from. From the project names alone, it’s clear to see that BTS FESTA 2020 will be an emotional one, and the use of \"Epilogue: Young Forever\" as the promotional song for the teaser video is a clear testament to that. Much like with Map of the Soul: 7, Bangtan will be taking us on a journey, so make sure you\\'re prepared. Especially after the postponement of the Map of the Soul world tour in light of coronavirus, there’s no doubt this FESTA will be one of the most special ones to date.',\n",
       " ('BTS',\n",
       "  40,\n",
       "  0): 'The original soundtrack album for BTS’ new mobile game BTS World, which came out on June 26, dropped today (June 28), and features the sweeping new single from the group in the form of the expressive “Heartbeat.” Along with “Heartbeat,” BTS World’s soundtrack also features 10 other brand new tracks, primarily instrumental songs, along with the three previously released collaborative songs that split the group members up among the trio, which saw those groupings collaborate with Charli XCX, Zara Larsson, and Juice WRLD. Explore Explore BTS See latest videos, charts and news See latest videos, charts and news The soundtrack also featured songs from two other Korean artists aside from BTS, “You Are Here” by Big Hit Entertainment labelmate and former 8Eight member Lee Hyun, and “LaLaLa” female indie pop duo Okdal, who is under Magic Strawberry Sound. Trending on Billboard “Haertbeat,” which soars over dulcet vocals and a pop-rock melody from start to finish, was released through a music video that features videos from the game and new shots of the members enhanced by fantastical CGI that expresses the bond between BTS and their world, their ARMY fandom, showing BTS as the center of ARMY’s universe. The video starts with concert footage highlighting the relationship between the band and its following, with the question, “If you were not here then, would we, who were just like a lonely island shine as bright as now?” appearing on screen at the start. It ends with the phrase, “See you there again, where we first met in 2012,” in reference to how BTS World begins prior to BTS’ debut in 2013, and has the player acting as their manager assembling the act. Take a listen to the BTS World original soundtrack below.',\n",
       " ('BTS',\n",
       "  41,\n",
       "  0): 'Universal Music Japan announced today that “Lights/Boy With Luv,” the latest Japanese-language single by K-Pop superstars BTS, has received the “Million” certification by the RIAJ (Recording Industry Association of Japan), in recognition of the single shipping more than 1 million physical copies since its release on July 3. While Japan, along with Germany, is one of the few remaining markets in the world where physical product still sells in significant quantities, and the certification recognizes units shipped rather than sold, that mark is rare: BTS is the first non-Japanese male artist or group to be awarded the certification. The group commented, “We are thankful that the album we worked hard on received so much love. We will continue to try our best to show you better sides of us.” Popular on Variety “Lights/Boy With Luv” is the group’s 10th single in Japan and was released through Universal Music Japan, in partnership with Big Hit Entertainment last month. According to the announcement, “Lights” topped the iTunes top song chart in 43 countries around the world and its official music video has received more than 38 million views on YouTube to date. The group’s concert film, “Bring the Soul: The Movie” headed into 110 countries earlier this week, making it the widest-ever event cinema release. The concert film follows the hugely successful band at the end of its Love Yourself tour in Europe. Park Jun Soo directs, and Big Hit Entertainment and Camp Entertainment produce the film.',\n",
       " ('BTS',\n",
       "  42,\n",
       "  0): 'As the musical voice of a generation, BTS can be described in many ways, but “burned out” was never assigned to them until today (Jan. 17) when the South Korean septet graced the world with their introspective new song “Black Swan.” The first single from their forthcoming Map of the Soul: 7 album, the members use the song to express their chilling feelings about how artists view their craft, and how they feel when their love of it is lost. Explore Explore BTS See latest videos, charts and news See latest videos, charts and news The atmospheric, haunting blend of mournful instrumentals and trap beats explores the artistic idea of how falling out of love with one’s craft is akin to death. “The heart no longer races when hearing the music play,” Suga sings during the reflective height of the song. “Seems like time has stopped/ Oh, that would be my first death/ I been always afraid of.” RM follows: “If this can no longer resonate, no longer make my heart vibrate, then like this may be how I die my first death. But what if that moment’s right now?” “No song affects me anymore/ Crying a silent cry,” Jimin mournfully relays a few moments later. According to a press release, the song serves as, “A confession of an artist who has truly learned what music means to himself.” The release of “Black Swan” follows shortly after Suga’s solo “Interlude: Shadow,” which sets the tone for the upcoming album to continue BTS’ exploration of Jungian psychoanalytic thought following last year’s Billboard 200 chart-topping album Map of the Soul: Persona. In Jungian psychology, the Map of the Soul — as relayed through the book of that name by Murray Stein that BTS has revealed inspired parts of the series — explores the inner workings of the persona, shadow, and ego. “Black Swan” drops more than a month before the arrival of Map of the Soul: 7 on Feb. 21, and was shared via both a studio version on digital music platforms and an art film featuring a performance by Slovenian modern dance troupe MN Dance Company. The visual explores the struggles put forth by BTS in the lyrics as interpreted by the dancers. It is fronted by a quote from modern dance legend Martha Graham: “A dancer dies twice — once when they stop dancing, and this first death is the more painful.” Watch the “Black Swan” video below.',\n",
       " ('BTS',\n",
       "  43,\n",
       "  0): 'With the arrival of their music video for new song “ON” today (Feb. 21), BTS reaffirmed their intentions to dominate. The lead single off of the act’s fourth LP Map of the Soul: 7, also out today, “ON” was released through a special “Kinetic Manifesto Film: Come Prima” through which the South Korean septet are backed by 30 dancers and 12 marching band members as they declare their prowess by overcoming pain while performing a dramatic, mesmerizing performance. Propulsive and empowering, “ON” features BTS ruminating on how pain and fear can become motivational, transmuting the impact of the lyrics into a fierce choreography. Explore Explore BTS See latest videos, charts and news See latest videos, charts and news “Where my pain lies/ Let me take a breath/ My everthin’, my blood and tears, got no fears, I’m singin’/ Oh, I’m takin’ over/ You should know yeah,” sings Jungkook during a bridge, leading into the refrain of “Can’t hold me down cuz you know I’m a fighter/ Choosing to descend into the dark abyss/ Find me and I’m gonna bleed with ya” by Jimin before he jumps over the other member. The song and music video open up with references to the Jungian psychoanalytic idea of “shadow” being an element of the Map of the Soul, from which BTS’ current album series draws its name, and features a solo “Interlude: Shadow” by Suga: the tune begins with members reflecting on the idea of shadows, with V donning face paint that reads, “The Shadow Like Me.” “Look at my feet, look down/ The shadow resembles me,” says RM. “Is it the shadow that’s shaking? / Or is it my feet that are trembling? Of course I’m not unafraid/ Of course it’s not all okay/ But I know/ Awkwardly I flow/ I fly together with that black wind.” “Bring the pain/ It’ll become my blood and flesh/ Bring the pain/ No fear, now that I know the way/ Breathe on the small things/ My air and my light in the dark/ The power of the things that make me, ‘me,’ / Even if I fall, I come right up, scream,” raps J-Hope, leading into Suga’s paralleling, “Even if I fall, I come right up, scream/ As long as they don’t get buried/ It won’t matter/ Win no matter what/ Whatever you say whatever they say/ I don’t give a uhh.” Throughout “ON,” the members of BTS appear in white and black looks, acting almost as shadows of themselves, with only occasional flashes of color, such as Jin’s light blue jacket and other members’ hair colors adding a pop of color against the backdrop of a beige bridge in front of the bright blue sky. The “Come Prima” video will be followed next week by the release of the official music video for “ON” on Feb. 28. An alternate version featuring Sia is featured on the album on digital music platforms. Watch the “Kinetic Manifesto Film” for BTS’ “ON” here.',\n",
       " ('BTS',\n",
       "  44,\n",
       "  0): \"그룹 방탄소년단이 한국 가수로는 처음으로 앨범 누적 판매량 2032만 장을 기록했다. 대한민국 공인 음악차트 가온차트가 4월 9일 발표한 2020년 3월 앨범 차트에 따르면, 방탄소년단은 2013년 데뷔 앨범 '2 COOL 4 SKOOL'을 시작으로 지난 2월 발매한 ‘MAP OF THE SOUL : 7’까지 총 14개 앨범을 통해 2032만 9305장의 누적 판매량을 기록했다. 이 중 밀리언 셀러를 기록한 앨범은 ‘WINGS’ 113만 장, ‘WINGS 외전: YOU NEVER WALK ALONE' 102만 장, LOVE YOURSELF 承 'Her' 222만 장, LOVE YOURSELF 轉 ‘Tear’ 221만 장, LOVE YOURSELF 結 ‘Answer’ 259만 장, ‘MAP OF THE SOUL : PERSONA’ 377만 장, ‘MAP OF THE SOUL : 7’ 417만 장으로 7개 앨범 연속 기록이다. 방탄소년단은 이미 지난 2월 가온 앨범 차트에서 음반 누적 판매량 2000만 장을 돌파했다. 2018년 11월 앨범 차트에서 1000만 장을 돌파한 이후 올해 2월까지 1년 3개월 만에 또다시 1000만 장 이상을 판매하는 저력을 보였다. 빅히트 엔터테인먼트 관계자는 “방탄소년단이 한국 가요 역사상 최초로 앨범 누적 판매량 2000만 장을 넘기며 '최다 음반 판매' 기록을 보유한 가수가 됐다”고 밝혔다. 한편, 방탄소년단의 ‘MAP OF THE SOUL : 7’은 3월 7일 자 미국 ‘빌보드 200’ 차트에서 1위에 진입한 이후 최신 차트에서 25위를 기록하며 6주 연속 상위권을 유지하고 있다. (사진=빅히트엔터테인먼트 제공) [뉴스엔 이민지 기자]그룹 방탄소년단이 한국 가수로는 처음으로 앨범 누적 판매량 2032만 장을 기록했다.대한민국 공인 음악차트 가온차트가 4월 9일 발표한 2020년 3월 앨범 차트에 따르면, 방탄소년단은 2013년 데뷔 앨범 '2 COOL 4 SKOOL'을 시작으로 지난 2월 발매한 ‘MAP OF THE SOUL : 7’까지 총 14개 앨범을 통해 2032만 9305장의 누적 판매량을 기록했다.이 중 밀리언 셀러를 기록한 앨범은 ‘WINGS’ 113만 장, ‘WINGS 외전: YOU NEVER WALK ALONE' 102만 장, LOVE YOURSELF 承 'Her' 222만 장, LOVE YOURSELF 轉 ‘Tear’ 221만 장, LOVE YOURSELF 結 ‘Answer’ 259만 장, ‘MAP OF THE SOUL : PERSONA’ 377만 장, ‘MAP OF THE SOUL : 7’ 417만 장으로 7개 앨범 연속 기록이다.방탄소년단은 이미 지난 2월 가온 앨범 차트에서 음반 누적 판매량 2000만 장을 돌파했다. 2018년 11월 앨범 차트에서 1000만 장을 돌파한 이후 올해 2월까지 1년 3개월 만에 또다시 1000만 장 이상을 판매하는 저력을 보였다.빅히트 엔터테인먼트 관계자는 “방탄소년단이 한국 가요 역사상 최초로 앨범 누적 판매량 2000만 장을 넘기며 '최다 음반 판매' 기록을 보유한 가수가 됐다”고 밝혔다.한편, 방탄소년단의 ‘MAP OF THE SOUL : 7’은 3월 7일 자 미국 ‘빌보드 200’ 차트에서 1위에 진입한 이후 최신 차트에서 25위를 기록하며 6주 연속 상위권을 유지하고 있다. (사진=빅히트엔터테인먼트 제공) 뉴스엔 이민지 oing@ 기사제보 및 보도자료 newsen@newsen.com copyrightⓒ 뉴스엔. 무단전재 & 재배포 금지 뉴스엔 이민지 oing@기사제보 및 보도자료 newsen@newsen.comcopyrightⓒ 뉴스엔. 무단전재 & 재배포 금지\",\n",
       " ('BTS',\n",
       "  45,\n",
       "  0): 'BTS lands its fourth No. 1 album on the Billboard 200 chart with the biggest week of 2020 for any release. Map of the Soul: 7 storms in atop the tally with 422,000 equivalent album units earned in the U.S. in the week ending Feb. 27, according to Nielsen Music/MRC Data. Of that sum, 347,000 are in album sales. It’s the fourth No. 1 in less than two years for the seven-member South Korean pop group. BTS’ big bow is accompanied by two more debuts in the top 10, from YoungBoy Never Broke Again and Ozzy Osbourne. The Billboard 200 chart ranks the most popular albums of the week in the U.S. based on multi-metric consumption as measured in equivalent album units. Units comprise album sales, track equivalent albums (TEA) and streaming equivalent albums (SEA). The new March 7-dated chart, where Map of the Soul: 7 enters at No. 1, will be posted in full on Billboard’s website on March 3. Related BTS Fans Inspired to Donate Concert Ticket Refunds to Coronavirus Relief Map of the Soul: 7 was released on Feb. 21 via BigHit Entertainment. Its first-week total of 422,000 equivalent album units comprises 347,000 in album sales, 48,000 in SEA units and 26,000 in TEA units. The album’s SEA sum equates to 74.79 million on-demand streams of the set’s 20 tracks in its first week. Let’s take a closer look at some of the achievements BTS earns with the act’s latest No. 1 debut: Biggest Week of 2020: With a whopping 422,000 equivalent album units earned, Map of the Soul: 7 lands the largest week for any album in 2020. The last set to tally a bigger week was Harry Styles’ Fine Line, which arrived at No. 1 with 478,000 on the Dec. 28, 2019-dated list. Biggest Week for a Group in Four Years: Map of the Soul: 7 scores the largest week for an album by a group, in units, since the Dec. 5, 2015-dated chart, when One Direction’s Made in the A.M. bowed at No. 2 with 459,000 units. Related BTS Cancels Korean Tour Dates Over Coronavirus Outbreak BTS Continues to Grow: Map of the Soul: 7‘s overall first-week units of 422,000 and its first-week sales of 347,000 are high-water marks for the group. Each of BTS’ last four albums — all No. 1s — have started with successively larger first-week units and sales. The act’s last album, Map of the Soul: Persona began with 230,000 units (with 196,000 in sales) on the April 27, 2019-dated chart. Before that, Love Yourself: Answer started with 185,000 units (141,000 in sales) on Sept. 8, 2018, and Love Yourself: Tear bowed with 131,000 units (100,000 in sales) on June 2, 2018. Biggest Sales Week for an Album in 2020: Map of the Soul: 7 sold 347,000 copies — the biggest sales week for any album in 2020, and the best sales frame for a set since Harry Styles’ Fine Line sold 393,000 copies in its first week (Dec. 28, 2019-dated chart). Map of the Soul: 7 sold well without the aid of a concert ticket/album sale redemption offer, nor any merchandise/album bundles, as has become the norm for many major releases (including Fine Line). That said, Map of the Soul: 7 sold strongly thanks in large part to the availability of four elaborate collectible CD packages — the same release strategy employed by BTS with its three No. 1 albums, as well as many other South Korean pop acts. Of Map of the Soul: 7’s first-week sales of 347,000, sales of its CD variants comprised 95% (330,000), while its',\n",
       " ('BTS',\n",
       "  45,\n",
       "  1): 'digital album totaled just 5% (17,000). Each of the four CD variants of Map of the Soul: 7 has the same base contents (the CD album, a photo book, lyric book, a mini notebook, a postcard, a sticker, coloring paper and a poster), though each has slight differences depending on which of the four CD packages the customer purchases. Further enhancing the collectability of the packages: each contains one of 32 randomized photo cards. Fourth No. 1 Album: Before Map of the Soul: 7, BTS led the Billboard 200 with its last three charting albums: Map of the Soul: Persona (2019), Love Yourself: Answer (Sept. 2018) and Love Yourself: Tear (June 2018). The group has now racked up four albums in a little more than one year and nine months’ time, as its first leader, Love Yourself: Tear, bowed at No. 1 on the list dated June 2, 2018. The last act to earn four No. 1 albums faster was Future, who logged his fourth No. 1 (a self-titled album, on March 11, 2017) just one year and seven months after his first (DS2, Aug. 8, 2015). He claimed his fifth No. 1 one week after his fourth No. 1, when HNDRXX bowed atop the list dated March 18, 2017. The last group to generate four No. 1s faster than BTS was The Beatles, who took just one year and five months between Yesterday and Today (July 30, 1966) and Magical Mystery Tour (Jan. 6, 1968). And finally, the last group to log its first four No. 1s faster than BTS was The Monkees, who took just one year and 21 days between the quartet’s self-titled debut album (with its first week at No. 1 on Nov. 12, 1966) and Pisces, Aquarius, Capricorn, and Jones, Ltd. (Dec. 2, 1967). 10th Mostly Non-English Album at No. 1: Map of the Soul: 7 is the 10th album performed mostly in a language other than English to reach No. 1. The previous mostly non-English No. 1s were BTS’ three earlier leaders, SuperM’s The First Mini Album EP (2019), Andrea Bocelli’s Si (2018), Il Divo’s Ancora (2006), Josh Groban’s Closer (2004), Selena’s Dreaming Of You (1995) and The Singing Nun’s self-titled album (1963). Back on the new Billboard 200, rapper YoungBoy Never Broke Again bows at No. 2 with Still Flexin, Still Steppin, which steps in with 91,000 equivalent album units. Most of that sum, 87,000, was in SEA units (equaling 137.3 million on-demand streams for the set’s songs) making it the most streamed album of the week. The artist has racked up 13 chart entries in just over two-and-a-half years. His previous album, AI YoungBoy 2, became his first No. 1, opening atop the chart dated Oct. 26, 2019. Ozzy Osbourne’s Ordinary Man debuts at No. 3 on the Billboard 200, granting the rock legend his eighth top 10 album, and matches his highest rank ever on the list. The set starts with 77,000 equivalent album units earned, with 65,000 of that sum in album sales. Osbourne previously topped out on the Billboard 200 at No. 3 in 2007 with Black Rain. His last studio album, 2010’s Scream, debuted and peaked at No. 4. Justin Bieber’s Changes falls from No. 1 to No. 4 in its second week, earning 66,000 equivalent album units (down 71%). Roddy Ricch’s Please Excuse Me for Being Antisocial slips 4-5 with 65,000 units (down 8%), A Boogie Wit da Hoodie’s Artist 2.0 descends 2-6 with 57,000 units (down 49%) and Post Malone’s Hollywood’s Bleeding shifts 6-7 with 50,000 units (up 1%). The late Pop Smoke’s Meet the Woo,',\n",
       " ('BTS',\n",
       "  45,\n",
       "  2): 'V.2 is a non-mover at No. 8 with 49,000 equivalent album units earned — up 23% following the first full week of tracking impact after his death on Feb. 19. Trippie Redd’s former No. 1 A Love Letter to You 4 vaults 36-9 with 43,000 units (up 148%) after it was reissued with bonus tracks. Rounding out the new top 10 is Billie Eilish’s When We All Fall Asleep, Where Do We Go?, falling 7-10 with 38,000 units (down 14%).',\n",
       " ('BTS',\n",
       "  46,\n",
       "  0): 'The Weeknd rocks the top of the Billboard 200 albums chart, as he scores his fourth No. 1 album with his latest release, After Hours. The set jumps in with the year’s biggest week for any album: 444,000 equivalent album units in the U.S. in the week ending March 26, according to Nielsen Music/MRC Data. The sum also marks The Weeknd’s personal weekly best. After Hours was released on March 20 via XO/Republic Records, and is The Weeknd’s first release since his chart-topping six-song EP My Dear Melancholy in 2018. The Billboard 200 chart ranks the most popular albums of the week in the U.S. based on multi-metric consumption as measured in equivalent album units. Units comprise album sales, track equivalent albums (TEA) and streaming equivalent albums (SEA). The new April 4-dated chart (where After Hours enters at No. 1) will be posted in full on Billboard‘s website on March 31. After Hours’ first week total of 444,000 equivalent album units comprises 275,000 in album sales, 163,000 in SEA units and 6,000 in TEA units. The album’s SEA sum equates to 220.7 million on-demand streams of the set’s tracks in its first week. After Hours’ streaming start was so big, the album would have been No. 1 on the Billboard 200 even if it hadn’t sold a single copy. The No. 2 album on the chart is Lil Uzi Vert’s Eternal Atake, which falls to No. 2 after two weeks at No. 1, with 115,000 units (down 53%, with 113,000 of that sum in SEA units). After Hours includes the hits “Heartless,” “Blinding Lights” and the set’s title track. “Heartless” hit No. 1 on the all-genre Billboard Hot 100 dated Dec. 14, 2019 (his fourth No. 1), while “Blinding Lights” rose to a new peak of No. 2 on the most recently published Hot 100 (dated March 28). “After Hours” reached No. 20 on March 7. Let’s take a closer look at some of the achievements The Weeknd earns with his newest No. 1 album: Biggest Overall Week of 2020: After Hours’ debut frame of 444,000 units outpaces the year’s previous high-water mark, tallied by the debut of BTS’ Map of the Soul: 7. It entered at No. 1 on the March 7-dated list with 422,000 units. The Weeknd’s Biggest Week Ever: After Hours also clocks The Weeknd’s single largest week for an album. It surpasses the 412,000-unit start of Beauty Behind the Madness at No. 1 on the Sept. 19, 2015-dated chart. A Fourth No. 1: After Hours is The Weeknd’s fourth No. 1 album, and fourth in a row. It follows My Dear Melancholy (one week at No. 1, 2018), Starboy (five weeks at No. 1, 2016-17) and Beauty Behind the Madness (three weeks at No. 1, 2015). 2020’s Second-Biggest Sales Week: Album sales powered 62% of After Hours’ first week: 275,000 of 444,000 units. Those sales were driven largely by by a concert ticket/album sale redemption offer with The Weeknd’s upcoming tour (scheduled to launch in June), as well as more than 80 different merchandise/album bundles sold through The Weeknd’s official website. The largest sales week of 2020 remains the debut of BTS’ Map of the Soul: 7, with 347,000 sold in its first week. (Map didn’t have a ticket/album offer, nor any merchandise/album bundles – though it was released in four elaborate collectible CD packages.) After Hours also starts at No. 1 on the Top Album Sales chart, The Weeknd’s fourth leader on that tally. Biggest Week for an R&B Album in Nearly Four Years: After Hours’ big debut of 444,000 units is the largest week',\n",
       " ('BTS',\n",
       "  46,\n",
       "  1): 'posted by an R&B album in nearly four years. The last R&B set to score a bigger week was Beyoncé’s Lemonade, which blasted in at No. 1 on the May 14, 2016-dated chart with 653,000 units. After Hours also lands the biggest week for an R&B album by a male artist since the chart began ranking album by equivalent album units in December 2014. Biggest Streaming Week Ever for an R&B Album: With 220.7 million on-demand streams registered for After Hours’ songs in its first week, the album logs the largest streaming week ever for an R&B effort. It beats The Weeknd’s own Starboy, which launched with 175.2 million clicks (Dec. 17, 2016-dated chart). Back on the new Billboard 200, as noted above, Lil Uzi Vert’s Eternal Atake falls to No. 2 after two weeks at No. 1. The set earned 115,000 equivalent album units (down 53%). Lil Baby’s former No. 1 My Turn drops one spot to No. 3 with 60,000 equivalent album units (down 22%), while Bad Bunny’s YHLQMDLG dips from No. 3 to No. 4 with 51,000 units (down 26%). Conan Gray’s debut full-length album, Kid Krow, flies in at No. 5 on the Billboard 200 chart with 49,000 equivalent album units earned. Of that sum, 37,000 were in album sales (assisted by a concert/ticket album sale redemption offer with his tour late last year, and merchandise/album bundles). The 21-year-old singer-songwriter signed to Republic Records in 2018 after finding YouTube success with his original music and personal vlogs. After signing with Republic, he hit the Billboard 200 chart with his debut EP, Sunset Season, which debuted and peaked at No. 118 on the Dec. 1, 2018-dated tally. Related Conan Gray Is Happy That People Like His Sad Songs Roddy Ricch’s former No. 1 Please Excuse Me for Being Antisocial is steady at No. 6 on the new Billboard 200 (43,000 equivalent album units; down 13%), Post Malone’s chart-topping Hollywood’s Bleeding rises 8-7 (38,000 units; down 8%) and Jhené Aiko’s Chilombo descends 5-8 (37,000 units; down 34%). The late Kenny Rogers logs his highest-charting album since 1983, as The Best of Kenny Rogers: Through the Years debuts at No. 9 (32,000 equivalent album units earned, with 10,000 of that sum in album sales). The 20-track greatest hits collection was released in 2018 via Capitol Records Nashville, and contains such top 10 Hot 100 hits as “The Gambler,” “Lucille” and the No. 1 “Lady.” It does not, however, include one of his most popular hits, the No. 1 smash “Islands in the Stream,” with Dolly Parton. The single was released on RCA Records in 1983 and spent two weeks at No. 1. Rogers, who died on March 20 at age 81, was last in the top 10 on the Billboard 200 with 1983’s RCA release Eyes That See in the Dark, which peaked at No. 6. The album’s lead single was “Islands in the Stream.” In total, Rogers has now tallied five top 10 efforts on the all-genre Billboard 200: The Best of Kenny Rogers: Through the Years (No. 9), Eyes That See in the Dark (No. 6), Share Your Love (No. 6, 1981), Kenny Rogers’ Greatest Hits (No. 1 for two weeks, 1980) and Kenny (No. 5, 1980). Rounding out the new top 10 on the Billboard 200 is the soundtrack to Frozen II. The former No. 1 holds steady at No. 10 with 31,000 equivalent album units earned (down 1%).',\n",
       " ('BTS',\n",
       "  47,\n",
       "  0): 'Roddy Ricch‘s “The Box” posts an eighth week at No. 1 on the Billboard Hot 100. Meanwhile, BTS scores its third and highest-peaking Hot 100 top 10, and the highest-charting song ever for a K-pop group, as “On” roars in at No. 4. The song is from the South Korean pop septet’s album Map of the Soul: 7, which launches as its fourth No. 1 on the Billboard 200. Let’s run down of the top 10 of the newest Hot 100, which blends all-genre U.S. streaming, radio airplay and sales data. All charts (dated March 7) will update on Billboard.com tomorrow (March 3). “The Box,” released on Bird Vision/Atlantic Records, posts a ninth week at No. 1 on the Streaming Songs chart, despite an 8% slide to 48.2 million U.S. streams in the week ending Feb. 27, according to Nielsen Music/MRC Data. It pushes 10-8 on Radio Songs, gaining by 6% to 63.1 million all-format airplay audience impressions in the week ending March 1, while dropping 7-14 on Digital Song Sales, down 10% to 10,000 sold in the week ending Feb. 27. The song should benefit on next week’s charts (dated March 14) from the Friday, Feb. 28, premiere of its official video. “The Box” concurrently rules the Hot R&B/Hip-Hop Songs and Hot Rap Songs charts, which employ the same multi-metric methodology as the Hot 100, for a ninth week apiece. Future’s “Life Is Good,” featuring Drake, spends its seventh consecutive week at No. 2 on the Hot 100, encompassing its entire run on the chart so far. It also holds at No. 2 on Streaming Songs (40.6 million, down 3%), while surging 25-17 on Radio Songs (43.9 million, up 11%). “Good” is first song ever to log its first seven weeks on the Hot 100 at No. 2 (after none previously began with more than four weeks at the rank). While the song could still, of course, ascend to No. 1, as of now it is one of 19 entries in the Hot 100’s history to spend as many as seven weeks peaking at No. 2. It’s the first to do so since DJ Khaled’s “Wild Thoughts,” featuring Rihanna and Bryson Tiller, logged seven frames at its No. 2 high in July-September 2017. (Missy “Misdemeanor” Elliott’s “Work It” and Foreigner’s “Waiting for a Girl Like You” share the mark for the most weeks peaking at No. 2: 10 each, in 2002-03 and 1981-82, respectively.) Related Post Malone Got a Bloody Buzzsaw Face Tattoo Post Malone’s “Circles” stays at No. 3 on the Hot 100, after three nonconsecutive weeks at No. 1, as it notches a 10th week at No. 1 on Radio Songs (101.3 million, down 3%). It’s the first song to reach double-digits weeks atop the airplay survey since Khalid’s “Talk,” which reigned for 11 weeks beginning last June. “Circles” concurrently becomes Post Malone’s first No. 1 on the Adult Pop Songs radio airplay chart. It advances 10-9 on Adult Contemporary, where it’s his first top 10, after it topped Pop Songs for 10 weeks. BTS achieves its third and highest-peaking Hot 100 top 10, and the highest-charting song ever by a K-pop group (and first such top five hit), as “On” roars onto the chart at No. 4. The single is from Map of the Soul: 7, which bows as BTS’ fourth No. 1 on the Billboard 200, earning 422,000 equivalent album units, marking the biggest week for an album so far in 2020. “On” previously reached the Hot 100’s top 10 with “Boy With Luv” (featuring Halsey), which debuted and peaked at No. 8 on the',\n",
       " ('BTS',\n",
       "  47,\n",
       "  1): 'chart dated April 27, 2019, and “Fake Love,” which launched at No. 10 on June 2, 2018. Now with three Hot 100 top 10s, BTS boasts the most of any K-pop act, besting rapper PSY, who has tallied two (and the only prior such top five titles): “Gangnam Style” (No. 2, 2012) and “Gentleman” (No. 5, 2013). Meanwhile, “On” sets the record for the highest-debuting Hot 100 entry for a K-pop song, four ranks better than the arrival of “Boy With Luv.” “On” charges onto Digital Song Sales at No. 1, becoming BTS’ third leader, after “Idol,” featuring Nicki Minaj (Sept. 8, 2018), and “Fake Love” (June 2, 2018). “On” opens with 86,000 downloads sold, marking BTS’ best sales week for a song and the strongest for any title since Taylor Swift’s “Me!,” featuring Brendon Urie, bounded in with 193,000 on the chart dated May 11, 2019. “On” sports the highest sales frame for a song by a group since Jonas Brothers’ “Sucker” started with 88,000 (March 16, 2019). On Streaming Songs, “On” debuts at No. 12 with 18.3 million U.S. streams. Meanwhile, the song’s official video premiered Thursday, Feb. 27, and its arrival will bolster the track’s performances on next week’s, March 14-dated, charts. [CORRECTION: Story was updated after original posting; the song’s official video premiered Feb. 27 and all data reflects activity in the chart’s tracking week.] Dua Lipa’s “Don’t Start Now” holds at its No. 5 Hot 100 high; Arizona Zervas’ “Roxanne” remains at No. 6, after reaching No. 4; and Tones and I’s “Dance Monkey” dips from its No. 4 peak to No. 7. The Weeknd’s “Blinding Lights” lifts from No. 10 to a new No. 8 high on the Hot 100. Following the Feb. 18 announcement that his new album, After Hours, is due March 20, the song soars by 10% to 21.4 million U.S. streams. Meanwhile, the set’s title track flies 77-20 on the Hot 100, drawing 20.4 million clicks in the first full week of tracking after its release, also on Feb. 18. Rounding out the Hot 100’s top 10, Maroon 5’s “Memories” falls 7-9, after hitting No. 2, and Lewis Capaldi’s “Someone You Loved” descends 8-10, after it spent three weeks at No. 1. Find out more Hot 100 news on Billboard.com this week, and, for all chart news, you can listen (and subscribe) to Billboard‘s Pop Shop Podcast and This Week in Billboard News podcast and follow @billboard and @billboardcharts on both Twitter and Instagram. And again, be sure to visit Billboard.com tomorrow (March 3), when all charts, including the Hot 100 in its entirety, will refresh. Editor’s Note: An earlier version of this story included the incorrect premiere date for the official “On” video. It has been updated to reflect the correct, Feb. 27 date. All U.S. streams for “On” reported by streaming providers in the Feb. 21-27 tracking week were, per the usual process for all titles, accounted for, vetted and verified by Nielsen Music/MRC Data and Billboard, and its streaming data providers. Click here for details on the latest methodology, revised in January, regarding how streams contribute to Billboard’s charts. The streaming services that currently contribute to Billboard’s charts include, but are not limited to: Amazon (including Amazon Music Unlimited & Amazon Prime), Apple Music, Google, Pandora, SoundCloud, Spotify, Tidal and YouTube.',\n",
       " ('BTS',\n",
       "  48,\n",
       "  0): 'BTS has canceled several concerts planned in Korea due to the global coronavirus outbreak, according to a post on the group’s mobile fan platform Weverse (via Twitter). Korea’s Yonhap news agency was first to report the news. “It is unavoidable that the concert must be canceled without further delay,” reads the post, which was originally written in Korean and translated by Variety. “Please understand that this decision was made after extensive and careful consideration.” The canceled shows, the first on the group’s Map of the Soul world tour, were slated to take place on April 11, 12, 18 and 19 at the Jamsil Olympic Stadium in Seoul. Ticket buyers will receive automatic refunds. South Korea is a center of infection for the virus (COVID-19), which has infected more than 80,000 people and killed over 2,700 worldwide at last count. As a result of the pandemic — which originated in Wuhan, China, and has now spread to more than 40 countries — over 20,000 music events have been canceled or postponed in both China and Hong Kong, resulting in ticketing and box-office losses of 2 billion yuan ($286 million), according to the China Association of Performing Arts. The coronavirus has also resulted in concert cancelations outside Asia. On Tuesday, it was announced that the 18th annual Korea Times Music festival, which had been scheduled for April 25 at Los Angeles’s Hollywood Bowl, had been “provisionally postponed.” The festival had already announced performances by K-pop girl group MOMOLAND, solo singer and former Wanna One member Ha Sungwoon and rock band No Brain, with more to be announced. With the Seoul dates canceled, the next BTS concerts are scheduled to take place April 25 and 26 at Levi’s Stadium in Santa Clara, California. The group will follow that with three concerts at the Rose Bowl in Pasadena on May 2, 3, and 5.',\n",
       " ('BTS',\n",
       "  49,\n",
       "  0): 'Korean pop group BTS broke a virtual attendance record with “Bang Bang Con: The Live.” The show took place on Sunday afternoon Korean time (5 a.m. ET and 2 a.m. PT) and was presented by BTS’ management company Big Hit Entertainment with a cloud-based remote production studio Kiswe Mobile — from Seoul, South Korea. According to Big Hit metrics, the show reached a peak of 756,000 concurrent viewers in 107 countries and territories. Attendance was the equivalent of 15 shows at a 50,000 seat stadium and was the biggest audience for a paid virtual concert. Big Hit added that the concert also helped grow BTS’ fan club, known as the ARMY, by 10,000 members. The concert was the first collaborative effort between Big Hit and Kiswe, a live streaming solution company in the U.S. The 100-minute show invited fans to view BTS’ virtual house, where members navigated through and performed in various spaces, composed of five rooms and two stages, stylized in different moods. Popular on Variety The online presentation was delivered through six multi-view screens playing simultaneously. Fans were able to choose from video call-like close ups to full shots that encapsulate the group’s highly synchronized choreography. Band member Jimin told fans: “Though we may not be able to see each other at this time, we’ve been constantly striving to grow as a group. We are coping up with it pretty well so hope that you too can overcome this time by finding the small joy within. Hope we can meet each other again with smiles on our faces.” The group played a 12-track setlist comprised of “DOPE,” “Boyz with Fun,” “Like,” “Just One Day,” “Jamais Vu,” “Respect,” “Friends,” “Black Swan,” “Boy With Luv (Feat. Halsey),” “Go Go,” “Anpanman” and “Spring Day.” Recapping the event, Variety wrote: “It wasn’t the stadium concert experience fans had been looking forward to attending, but … was the next best thing to being there.”',\n",
       " ('BTS',\n",
       "  5,\n",
       "  0): 'Bangtan Boys, a seven-member hip-hop group, performs during the Bridge to Korea festival at the VDNKh park in Moscow, Russia, on June 14. More than 10,000 people gather to watch the Bridge to Korea festival featuring a Korean hip-hop group and some traditional performers, on June 14 in Moscow, Russia. Spectators enjoy excerpts from the traditional musical “Miso” at the VDNKh park in Moscow, Russia, on June 14. Minister of Culture, Sports and Tourism Yoo Jinryong delivers a speech during the opening ceremony of the Bridge to Korea festival in Moscow, Russia, on June 13. (photo: Yonhap News) Moscow residents try on traditional hanbok attire. The 2nd Russia-Korea Tourism Forum, held in Moscow, Russia, on June 13, focuses on how to boost bilateral medical tourism between Korea and Russia. Since 2010, there has been a constant rise in the number of Russian tourists flying to Korea. The figure in 2013 has grown five percent to 175,000, compared with the previous year.Amid the vigorous flow between Korea and Russia of both the arts and tourists, at their summit in November last year, the leaders of the two countries designated the years 2014 and 2015 as, “The Years of Reciprocal Visits Between Korea and Russia.”Backed with the keenest interest in an Asian country ever seen in Russia, the Korean government has hosted an array of special events at the All-Russian Exhibition Center (VDNKh) in Moscow, all aimed at raising awareness of what Korea really looks like and what kind of arts it truly embraces.Supported by the Korean Ministry of Culture, Sports and Tourism, three meaningful events -- the Bridge to Korea festival, the 2nd Russia-Korea Tourism Forum and the Korean Medical Tourism convention -- were underway at the VDNKh in Moscow from June 13 to 15.More than 10,000 spectators flocked to the VDNKh park in Moscow on June 14. With the Bridge to Korea festival fully underway, the venue heated up as a group of traditional performers performed somesongs, a style of percussion quartet, and played highlights from the traditional musical “Miso.”The shouts and cheers from the audience reached their highest pitch when the seven-member hip-hop band Bangtan Boys came on stage.Near the concert venue was an endless line of people, all eager to take a bite of some traditional Korean delicacies and to try on traditional hanbok attire.After a long wait, they finally reached a booth where they could sample some of Korea’s popular street foods, such as, a dessert of red beans and fruit on ice shavings, traditional sweets and cookies, known as, and some of the fancier dishes only enjoyed on special occasions.Prior to the festival, on June 13, a series of discussions concerning medical tourism, a sector that has recently flourished between the two countries, took place during the 2nd Russia-Korea Tourism Forum and the Korean Medical Tourism convention.Last year, more than 24,000 Russian medical tourists arrived in Korea, a figure high enough to beat Japan and to take third place, after China and the U.S.“Up until now, Russian patients only looked at close neighbors, such as Turkey or Israel, as possible destinations for medical tourism,” said an official involved in the Russian medical tourism sector. “It’s literally a shock how Korea’s medical technology has improved over the years.”In response, Minister of Culture, Sports and Tourism Yoo Jinryong emphasized that, “The no-visa entry treaty, one of our major achievements, made at the Korea-Russia summit during Russian President Putin’s state visit to Korea in November last year, and also the designation of 2014 and 2015 as ‘Years of Reciprocal Visits between Korea and Russia,’ have accelerated tourism exchanges between',\n",
       " ('BTS',\n",
       "  5,\n",
       "  1): 'our two nations.”The minister also stressed that it’s, “high time to make the peoples of the two nations feel closer to each other, with the very goal of achieving a sincere boost in such mutual interchanges.”Meanwhile, he affirmed that, “Korea and Russia, as closer-than-ever partners who share the vision for a ‘Eurasia Initiative,’ will continue to take crucial steps to enhance bilateral arts and tourism exchanges. We will, for sure, see many more Russians coming to Korea, going way beyond the current figure of 270,000, to hit 500,000 and even one million.” The Eurasia Initiative is a goal set by the Korean government where travelers would be able to travel by train across the peninsula and beyond, to Russia, China and Europe.The ministry plans more such events next year to bring the two peoples closer together.By Sohn JiAeKorea.net Staff Writer',\n",
       " ('BTS',\n",
       "  50,\n",
       "  0): 'No one does it like BTS when it comes to taking care of their fans (known as ARMY). The septet’s Seoul concerts this month, which would’ve kicked off their worldwide stadium tour to promote “Map of the Soul: 7,” were canceled in response to the coronavirus pandemic. But the Korean group has put together a unique and free event as a gift for their fans. The virtual online BANG BANG CON will showcase BTS’ concerts and fan meets (musters) from 2014 — a year after their debut — through 2019. The two-day extravaganza kicks off in the U.S. at 11 p.m. EDT tonight (April 17) and Saturday (April 18) on the group’s official YouTube channel, BANGTANTV, for a total of 24 hours of BTS content. Fans who want to get a more “live” concert-like experience may link their ARMY Bombs (lightsticks) to the Weverse app. By utilizing the Bluetooth function, the lightsticks will automatically change color to the specific songs, just as they would during a live BTS concert. The ARMY has been so hyped up about BANG BANG CON that other non-related organizations took notice. A New York tech conference with the Twitter handle @bangbangcon received so much attention from ARMY that they cheekily amended their profile to include the disclaimer, “Not affiliated with BTS,” in both English and Korean. The members of BTS — RM, Jin, Suga, J-Hope, Jimin, V and Jungkook — have expressed how disappointed they are that they can’t perform live for their fans. The youngest member, Jungkook, took to social media to say that he missed the ARMY as much as they miss him. Five things you won’t want to miss during BANG BANG CON: 1. BTS’ musters (fan meetings) are a combination of live performances and skits. The term fits in well with the fandom’s name since muster refers to a formal gathering of troops. BTS 3RD Muster was held in Seoul on November 12 and 13, 2016. Their setlist includes “Dope,” “Fire” and “Boy In Luv” (not to be confused with 2019’s “Boy With Luv”). But a not-to-be-missed highlight is the group skit, “House of ARMY,” where RM and J-Hope play a teenage daughter and her mother, respectively, who both love BTS. 2. Though it’s their music they’re famous for, BTS’ ments – or statements/comments to their fans — are a mixture of playful teasing and profound gratitude. The ments at their South Korean concerts are especially personal because the audience includes their parents. The group has broken down in tears as they spoke of the hardships they went through and how their families supported them. 3. BTS 4TH Muster [Happy Ever After] was held in Seoul on January 13 and 14, 2018. The performances include “DNA,” “Pied Piper” and “Best of Me.” But watch for the dance breaks in “No More Dream” and “MIC Drop.” The skits are always fun for both the group and the fans. The cutest one started with Jin laying on the floor, unresponsive. Jimin plays his part as a concerned bandmate, but can’t resist saying, “I’m such a bad actor.” Because they’re all laughing at their acting skills, J-Hope says to V, “Show us Han-Sung!” It’s a nod to the character V played in the 2016 Korean series, “Hwarang: The Poet Warrior Youth.” Revived by all the attention, Jin says he can be healed if the group blows a collective kiss to ARMY. 4. BTS 2014 Live Trilogy: Episode II The Red Bullet (2014 Memories) was years before BTS hit worldwide superstar status. Just a year past their 2013 debut, BTS’ rap line shows off their',\n",
       " ('BTS',\n",
       "  50,\n",
       "  1): 'range as songwriters with biting songs like “Cypher Pt. 3: Killer,” “We Are Bulletproof Pt.2” and “N.O.” 5. The year 2017 was monumental for BTS. It was when they began their ascent into the international stratosphere of pop superstars. The Wings Tour showcased the individuality of each member with memorable solos — “Reflection” (RM), “Awake” (Jin), “First Love” (Suga), “MAMA” (J-Hope), “Lie” (Jimin), “Stigma” (V), “Begin” (Jungkook). Another highlight is “Spring Day.” The rap-filled ballad touches on what it means to long for someone who is no longer here, but also reminds listeners that no darkness lasts forever. It’s an uplifting message for everyone who is feeling lonely and isolated during these uncertain times. The full lineup for BANG BANG CON follows: Friday, April 17: 2015 BTS Live 2016 BTS Live º BTS 2014 Live Trilogy: Episode II The Red Bullet (2014 Memories) BTS 3RD Muster [ARMY.ZIP+]. Saturday, April 18: 2017 BTS Live Trilogy Episode III The Wings Tour in Seoul 2017 BTS Live Trilogy EPISODE III The Wings Tour The Final (2017 Memories) BTS 4TH Muster [Happy Ever After] BTS World Tour ‘Love Yourself’ Seoul',\n",
       " ('BTS',\n",
       "  51,\n",
       "  0): 'BTS (RM, Jin, Suga, J-Hope, Jimin, V and Jungkook) gave a powerful commencement speech during YouTube’s virtual “Dear Class of 2020″ graduation celebration on Sunday (June 7). Wearing sleek black suits, the seven members recorded their contribution to the event from the National Museum of Korea in Seoul, South Korea. Each took turns sharing messages of hope and inspiration for the class of 2020 in both Korean and English, while revealing their own graduation stories and memories. Explore Explore BTS See latest videos, charts and news See latest videos, charts and news In true BTS style, they ended the clip with a good-humored gesture: “Congratulations, Class of 2020!” they yelled before tossing graduation caps into the air. During such difficult times, we hope we can bring you smiles and courage. Join us in congratulating the Class of 2020 June 7th, 12PM PT June 8th, 4AM KST https://t.co/GwkakPXB5Z #DearClassOf2020 pic.twitter.com/h3ESCmPirM — BTS_official (@bts_bighit) June 7, 2020 Check out part of RM’s speech below. Trending on Billboard Dear Class of 2020, it’s been a strange year so far, but you made it. Today, we might not have flowers, and we might not have graduation caps. What we do have is possibly the most special graduation ceremony in history. Never before have so many gathered to celebrate a graduating class for their achievements and their dreams. You could be watching us from your bed or from your living room, alone or with somebody. Wherever you are, you will all soon be breaking out of one world to soar into another. Ten years ago, it snowed really hard on the day of my middle school graduation. I remember that day clearly because I took a picture with my friends, and kept it as my messenger profile for the rest of my school years. On that day, I was just a boy who had closed just one chapter ready to pen another. And I remember that feeling, it’s really thrilling and breathtaking. It was a moment I felt most like me, myself. A feeling I wanted to hold onto forever. So, as a fellow individual in his 20s, all the way from Seoul, Korea, I want to say, congratulations. [clapping] We’re very excited for what lies ahead of you. Regardless of where or how far you are, we hope our stories today can give you some sort of comfort, hope and maybe even a bit of inspiration… …Dear Class of 2020, I hope our stories reached you all today. To be really, really frank, we still feel very unsure and unsettled as we speak, just like the day we left the school gates for the last time on graduation day. Some say we have achieved so many things, but we stand no different from any other youth in their 20s, our graduation caps still pressed to our heads, and awkwardly peering into the face of reality. The recent unforeseen events completely changed our plans, and the sense of loss and anxiety we felt then, are still with us today. The fear of an obscure future as our daily lives turn upside down, is a moment of realization of the self, the realization of what makes me a true me, myself. Us, as musicians, we are pulling ourselves together by making music. We write songs, we produce, and we practice as we think about the people we love. And it connects to the world during such difficult times. And with music, we hope we can bring you smiles and courage again. And V just mentioned memos and the photographs. For us, our way of remembering and',\n",
       " ('BTS',\n",
       "  51,\n",
       "  1): 'communicating is to make music. For you, it could be anything. And our music and in our hearts, and in the time that we break out of ourselves, we’re alone, but also together. We may be seeing each other through just a camera and this small screen, but I know your future will bloom to something much bigger and magnificent. Graduates, friends, family, faculty, today, you stand with us, the largest graduating class in history. Watch the clip of BTS’s commencement speech below.',\n",
       " ('BTS',\n",
       "  52,\n",
       "  0): 'Photo: BTS receiving the IFPI Global Album All Format Chart Award (courtesy of Big Hit Entertainment) 10th March 2021 – IFPI, the organisation that represents the recorded music industry worldwide, has today launched its Global Album All Format Chart, announcing BTS’ MAP OF THE SOUL : 7 as the first ever winner, following a countdown of the top ten biggest albums globally. The chart, an addition to IFPI’s existing global awards, celebrates the best-selling albums of the year across all consumption formats, spanning physical sales, digital downloads, and streaming platforms. The fourth studio album from global superstars BTS, MAP OF THE SOUL : 7 broke records and topped charts all over the world after its release in February 2020. As well as unprecedented success in BTS’ home country of Korea, where the album broke the all-time sales record, MAP OF THE SOUL : 7 was a global hit, topping the charts in the world’s five largest music markets (USA, Japan, UK, Germany, France). The album saw phenomenal physical sales across the world but was also a streaming hit – the YouTube premiere of the lead single ON was the biggest in the platform’s history, attracting over 1.5 million viewers. The album also reached #1 on the iTunes chart in over 90 countries. Frances Moore, Chief Executive at IFPI, said: “We have introduced the Global Album All Format Chart to reflect the evolving landscape of the album format and to recognise how artists share their album projects in a variety of ways with their fans across multiple formats. “It’s an honour to be able to hand BTS their second IFPI Global Chart Award, following their success as Global Recording Artists of the Year. MAP OF THE SOUL : 7 broke chart records internationally and in Korea, and is yet another incredible body of work from a band that continues to delight music lovers globally.” Highlights from the chart include Taylor Swift’s surprise release folklore, which took #9, Japanese sensation Kenshi Yonezu’s STRAY SHEEP at #7, and a second appearance for BTS with the album BE (Deluxe Edition) landing at #4. The chart countdown also saw The Weeknd follow up victory in yesterday’s IFPI Global Digital Single chart with a #2 for the global smash After Hours, his highest album chart finish ever. Billie Eilish’s WHEN WE ALL FALL ASLEEP, WHERE DO WE GO? charted at #3, a fantastic achievement given the album was released back in March 2019. Tomorrow marks the final charts countdown of 2020, where IFPI will be announcing the top 10 albums of 2020 based on physical sales and album downloads only. Top 10 Global Album All Format Chart 2020 (source: IFPI) ENDS Notes to editors: About IFPI IFPI is the voice of the recording industry worldwide, representing over 8,000 record company members across the globe. We work to promote the value of recorded music, campaign for the rights of record producers and expand the commercial uses of recorded music around the world. For further information please contact: press@ifpi.org | +44 (0)20 7878 7979',\n",
       " ('BTS',\n",
       "  53,\n",
       "  0): 'BTS‘ “Dynamite” spends a second week at No. 1 on the Billboard Hot 100 songs chart. A week earlier, “Dynamite” debuted at the Hot 100’s summit, marking the group’s first No. 1 and the first leader on the list ever for an all-South Korean act. Additionally this week, 24kGoldn‘s “Mood,” featuring iann dior, jumps from No. 12 to No. 8 on the Hot 100, becoming the first top 10 on the chart for each artist. The Hot 100 blends all-genre U.S. streaming, radio airplay and sales data. All charts (dated Sept. 12) will update on Billboard.com tomorrow (Sept. 9, a day later than usual due to the Labor Day holiday in the U.S. yesterday). For all chart news, you can follow @billboard and @billboardcharts on both Twitter and Instagram. “Dynamite,” released on BigHit Entertainment/Columbia Records, continues atop the Hot 100 on the strength of 17.5 million U.S. streams (down 49%) and 182,000 downloads sold (down 31%) in the week ending Sept. 3, according to Nielsen Music/MRC Data. It also drew 16 million radio airplay audience impressions (up 38%) in the week ending Sept. 6. “Dynamite” spends a second week at No. 1 on the Digital Song Sales chart and drops 3-9 on Streaming Songs. (Of the 43 songs that have entered the Hot 100 at No. 1 all-time, “Dynamite” is the 20th to have remained on top in its second week. It’s the first by a group to do so since Aerosmith’s “I Don’t Want to Miss a Thing,” which spent its first four weeks on the Hot 100 at No. 1 in September 1998.) Helping “Dynamite” in its second week of availability, “Poolside” and “Tropical” remixes of the song were released Aug. 28 and sale-priced to 69 cents during the tracking week. They joined the original version, EDM and acoustic remixes and an instrumental version (also each sale-priced to 69 cents during the week), released Aug. 21. With 182,000 downloads sold in its second week after opening with 265,000 downloads sold in its first frame, “Dynamite” is the first song to have sold over 180,000 downloads in consecutive weeks in nearly four years, since The Chainsmokers’ “Closer,” featuring Halsey (208,000, Sept. 17, 2016; 199,000, Sept. 24, 2016). “Dynamite” is additionally the first song to have sold over 180,000 downloads in its first two weeks of release (unlike “Closer”) since Justin Timberlake’s “Can’t Stop the Feeling!” (379,000, May 28, 2016; 204,000, June 4, 2016). Plus, on the mainstream top 40-based Pop Songs radio airplay chart, BTS hits a new career-best rank, as “Dynamite” rises 20-18. The track also becomes the group’s first entry on the adult top 40-based Adult Pop Songs airplay chart, where it debuts at No. 29. Cardi B’s “WAP,” featuring Megan Thee Stallion, posts a second week at No. 2 on the Hot 100 after spending its first two weeks on the chart at No. 1. It adds a third week atop Streaming Songs (58.5 million, down 10%); slips 2-3 on Digital Song Sales (20,000, down 20%); and jumps 46-32 on Radio Songs (24.5 million, up 31%). “WAP” logs a fourth week at No. 1 on the Hot R&B/Hip-Hop Songs and Hot Rap Songs charts, which employ the same multi-metric methodology as the Hot 100. Drake’s “Laugh Now Cry Later,” featuring Lil Durk, holds at No. 3 on the Hot 100, after debuting at No. 2 two weeks earlier, and DaBaby’s seven-week leader “Rockstar,” featuring Roddy Ricch, is likewise steady at No. 4. The Weeknd’s former four-week Hot 100 No. 1 “Blinding Lights” keeps at No. 5, as it spends a record-extending 22nd week at No. 1',\n",
       " ('BTS',\n",
       "  53,\n",
       "  1): 'on Radio Songs (79.6 million, down 1%). It rules the multi-metric Hot R&B Songs chart for a record-furthering 25th week. After The Weeknd performed “Lights” to kick off the 2020 MTV Video Music Awards Aug. 30, the song wins the Hot 100’s top Sales Gainer award, up 54% to 13,000 sold in the week ending Sept. 3. As for its Hot 100 longevity, “Lights” spends a 26th week in the top five, moving to within a week of tying for the most time logged in the region over the chart’s 62-year history. Most Weeks in Hot 100’s Top Five 27, “Shape of You,” Ed Sheeran, No. 1 peak (12 weeks), 2017 27, “Closer,” The Chainsmokers feat. Halsey, No. 1 (12), 2016-17 26, “Blinding Lights,” The Weeknd, No. 1 (four), 2020 26, “Circles,” Post Malone, No. 1 (three), 2019-20 25, “Uptown Funk!,” Mark Ronson feat. Bruno Mars, No. 1 (14), 2014-15 25, “How Do I Live,” LeAnn Rimes, No. 2, 1997-98 24, “Girls Like You,” Maroon 5 feat. Cardi B, No. 1 (seven), 2018 24, “That’s What I Like,” Bruno Mars, No. 1 (one), 2017 23, “Old Town Road,” Lil Nas X feat. Billy Ray Cyrus, No. 1 (19), 2019 23, “Without Me,” Halsey, No. 1 (two), 2018-19 23, “Despacito,” Luis Fonsi & Daddy Yankee feat. Justin Bieber, No. 1 (16), 2017 23, “The Twist,” Chubby Checker, No. 1 (three), 1960-61-62 Harry Styles’ former one-week Hot 100 leader “Watermelon Sugar” rises 7-6, swapping spots with Jack Harlow’s “Whats Poppin,” featuring DaBaby, Tory Lanez and Lil Wayne, after it peaked at No. 2. 24kGoldn’s “Mood,” featuring iann dior, jumps from No. 12 to No. 8 on the Hot 100, claiming top Streaming and Airplay Gainer honors. The collab climbs 6-3 on Streaming Songs (23.6 million, up 13%) and surges by 105% to 16 million in airplay audience. It retreats 9-12 on Digital Song Sales but with a 7% gain to 8,000 sold. For 24kGoldn (real name: Golden Landis Von Jones), “Mood” is his first Hot 100 top 10 and second total entry, after “Valentino” spent a week at No. 92 last November. Dior (real name: Michael Ian Olmo) reaches the top 10 in his first visit to the chart. “Mood” concurrently crowns the multi-metric Hot Rock & Alternative Songs and Hot Alternative Songs charts for a second week each and holds at No. 5 on Hot Rap Songs. Rounding out the Hot 100’s top 10, Jawsh 685 and Jason Derulo’s “Savage Love (Laxed – Siren Beat)” keeps at No. 9, after reaching No. 7, and Lewis Capaldi’s “Before You Go” holds at its No. 10 high. Again, for all chart news, you can follow @billboard and @billboardcharts on both Twitter and Instagram and all charts (dated Sept. 12), including the Hot 100 in its entirety, will refresh on Billboard.com tomorrow (Sept. 9).',\n",
       " ('BTS',\n",
       "  54,\n",
       "  0): 'UPDATED (Aug. 23, 4 pm ET): BTS Army has done it: K-pop idols BTS’s new video for “Dynamite” set a new YouTube record for views in the first 24 hours of release — and it officially topped 100 million views in that time period, Variety has confirmed. According to YouTube’s public views counter, the BTS “Dynamite” video had 98.3 million views in the 24 hours after it went live on Friday. However, YouTube on Sunday said the official view count for the video’s first 24 hours was actually 101.1 million, a goal BTS’s extraordinarily passionate fanbase (aka BTS Army) had been hoping to achieve. “We can confirm that BTS (방탄소년단) ‘Dynamite’ Official MV set a new all-time 24hr record, surpassing 100 million views with 101.1 million views in the first 24 hours,” a YouTube spokesman said in an email. The upbeat, dance-y and vivid “Dynamite” music video was released on YouTube Friday, Aug. 21, at 12 a.m. ET/1 p.m. KST. By 8:35 p.m. ET (9:35 a.m. KST on Saturday), “Dynamite” had registered more than 86.4 million views on YouTube. At that point, it had already topped the prior record holder: Blackpink’s “How You Like That,” which two months ago racked up an official tally of 86.3 million views in the first 24 hours. “Dynamite,” the group’s first song entirely in English, hit the No. 1 trending spot on YouTube globally within 12 hours of its debut. The video also notched a record for most-viewed YouTube Premiere with more than 3 million live concurrent viewers, YouTube confirmed to Variety. YouTube’s 24-hour views metric has become a yardstick in the music business for bragging rights and promotion. In response to some promoters gaming the system, YouTube changed its methodology for YouTube Music Charts in September 2019 to no longer count paid advertising views in 24-hour counts, which it said was to best reflect authentic fan engagement. Note that BTS has previously held the 24-hour views record several times, most recently with the April 2019 release of “Boy With Luv” featuring Halsey (74.6 million views in the initial one-day period). The “Dynamite” vid was directed by Yong Seok Choi of production firm Lumpens, who also helmed “Boy With Luv.” BTS’s TV performance premiere of “Dynamite” will take place at the 2020 MTV Video Music Awards, scheduled to air Aug. 30 at 8 p.m. ET/PT. Related:',\n",
       " ('BTS',\n",
       "  55,\n",
       "  0): 'BTS achieves its first No. 1 on the Billboard Hot 100 songs chart, as “Dynamite” debuts at the summit. The seven-member South Korean act rules the Hot 100 with its first all-English-language single, after previously reaching a No. 4 high with “On” in March. BTS, which comprises members J-Hope, Jimin, Jin, Jungkook, RM, Suga and V, is additionally the first all-South Korean group to lead the Hot 100. The Hot 100 blends all-genre U.S. streaming, radio airplay and sales data. All charts (dated Sept. 5) will update on Billboard.com tomorrow (Sept. 1). For all chart news, you can follow @billboard and @billboardcharts on both Twitter and Instagram. “Dynamite,” released on BigHit Entertainment/Columbia Records, is the 1,109th No. 1 in the Hot 100’s 62-year history. Let’s recap the song’s explosive start. Streams, sales & airplay: “Dynamite,” released Aug. 21 at midnight ET, roars in with 33.9 million U.S. streams and 300,000 sold in its first week, ending Aug. 27, according to Nielsen Music/MRC Data. It also drew 11.6 million radio airplay audience impressions in the week ending Aug. 30. “Dynamite” starts at No. 1 on the Digital Song Sales chart, where it’s BTS’ fourth leader, and No. 3 on Streaming Songs. The official video for “Dynamite” premiered upon the song’s arrival (followed by an official “B-side” clip Aug. 24), and the track was available to purchase in the tracking week in its original form and via an EDM remix, acoustic remix and instrumental version (each sale-priced at 69 cents). Its original version was also available for purchase on 7-inch vinyl (for $7.98) and cassette ($6.98). Biggest digital sales week in nearly 3 years: With 265,000 downloads sold (among its overall first-week total of 300,000, which includes its vinyl and cassette physical versions), “Dynamite” debuts with the biggest digital sales week since Sept. 16, 2017, when Taylor Swift’s “Look What You Made Me Do” launched with 353,000. Among groups, “Dynamite” sports the biggest weekly digital sales sum since Prince and the Revolution’s 1984 classic “Purple Rain” sold 282,000 (May 14, 2016), following Prince’s April 21, 2016, passing. Among songs by groups in tracks’ debut weeks, “Dynamite” makes the best digital sales start in five years, since One Direction’s “Drag Me Down” opened with 350,000 (Aug. 22, 2015). BTS’ first Hot 100 No. 1: BTS earns its first Hot 100 No. 1, and fourth top 10, among 12 visits to the chart. The group previously reached the top 10 with “On” (No. 4, where it debuted, this March); “Boy With Luv,” featuring Halsey (No. 8 debut/peak, April 2019); and “Fake Love” (No. 10 debut/peak, June 2018). The act first appeared on the chart dated Oct. 7, 2017, with “DNA.” “Dynamite” is “made of positive vibes, energy, hope, love, the purity, everything,” RM recently told Apple Music’s Zane Lowe. “We made this song in hopes of giving energy to the listeners. We hope our fans can listen to it to receive the positive energy we tried to incorporate in the song.” BTS boasts four career No. 1 albums on the Billboard 200 chart and holds the record for the most weeks at No. 1 on the Social 50 chart, adding its 194th week on top this week. First all-South Korean group to top Hot 100: BTS is the first all-South Korean group to lead the Hot 100. Among South Korean soloists, PSY reached a No. 2 Hot 100 best with “Gangnam Style” for seven weeks in October-November 2012. The history of Asian acts atop the Hot 100 dates back over a half-century, as Japanese-born Kyu Sakamoto became the first Asian artist to top the',\n",
       " ('BTS',\n",
       "  55,\n",
       "  1): 'chart, with “Sukiyaki” for three weeks in June 1963. In October-November 2010, Far*East Movement led the Hot 100, also for three weeks, with “Like a G6,” with the act’s lineup at the time including two members of Korean heritage. BigHit’s biggest hit: BigHit Entertainment achieves its first Hot 100 No. 1, having, like BTS, hit a previous No. 4 best with the group’s “On.” (Columbia Records most recently led three weeks ago, with Harry Styles’ “Watermelon Sugar.”) 43rd No. 1 debut: “Dynamite” is the 43rd single to start at No. 1 on the Hot 100. It’s the eighth to debut atop the Hot 100 in 2020 (all since April), doubling the previous record for the most in a single year, as four songs each entered at No. 1 in both 2018 and 1995. BTS’ pop radio best: While “Dynamite” so far falls shy of the all-format Radio Songs chart (where it would mark BTS’ first entry), it brings the group its best rank on the mainstream top 40-based Pop Songs radio airplay chart, where it bounds from No. 30 to No. 20 following its first full week of tracking. BTS previously climbed to a No. 22 Pop Songs highpoint with “Boy With Luv.” KMVQ San Francisco led all Pop Songs reporting stations with 53 plays for “Dynamite” in the week ending Aug. 30, followed by KJYO Oklahoma City, Okla. (49), KDDB Honolulu (47) and KAMP Los Angeles and WJFX Ft. Wayne, Ind. (46 each). BTS Cruz-es to No. 1: Meanwhile, BTS charts the first Hot 100 No. 1 with the word “dynamite” in its title, one-upping Taio Cruz’s “Dynamite,” which reached No. 2 just over 10 years ago (Aug. 21, 2010). Three other TNT-packed titles have infused the Hot 100: Jermaine Jackson’s “Dynamite” (No. 15 peak, 1984); Sir Douglas Quintet’s “Dynamite Woman” (No. 83, 1969); and Lorde’s “Homemade Dynamite,” featuring Khalid, Post Malone and SZA (No. 92, 2017; the song peaked on the chart dated that Oct. 7, coincidentally, as noted above, BTS’ first week ever on the Hot 100). Cardi B’s “WAP,” featuring Megan Thee Stallion, dips to No. 2 on the Hot 100 after spending its first two weeks on the chart at No. 1. The song rebounds from No. 2 for a second week atop Streaming Songs (65 million, down 10%); drops to No. 2 after two weeks atop Digital Song Sales (25,000, down 30%); and pushes 48-46 on Radio Songs (18.7 million, up 13%). “WAP” logs a third week at No. 1 on the Hot R&B/Hip-Hop Songs and Hot Rap Songs charts, which employ the same multi-metric methodology as the Hot 100. Drake’s “Laugh Now Cry Later,” featuring Lil Durk, slips to No. 3 on the Hot 100 after debuting at No. 2 a week earlier. It backtracks to No. 2 after a week atop Streaming Songs (43.6 million, down 38%) and slides 4-7 on Digital Song Sales (7,000, down 64%), while jumping 47-31 on Radio Songs (24.6 million, up 44%). DaBaby’s seven-week Hot 100 leader “Rockstar,” featuring Roddy Ricch, descends 3-4. The Weeknd’s “Blinding Lights” backpedals 4-5 on the Hot 100, as it spends a record-extending 21st week at No. 1 on Radio Songs (80.2 million, up 2%). It tops the multi-metric Hot R&B Songs chart for a record-furthering 24th week. Jack Harlow’s “Whats Poppin,” featuring DaBaby, Tory Lanez and Lil Wayne, retreats 5-6 on the Hot 100, after rising to No. 2; Styles’ former one-week leader “Watermelon Sugar” holds at No. 7; and SAINt JHN’s “Roses” repeats at No. 8 on the Hot 100, after reaching No. 4, as it rules the multi-metric Hot',\n",
       " ('BTS',\n",
       "  55,\n",
       "  2): 'Dance/Electronic Songs chart for an 18th week. Jawsh 685 and Jason Derulo’s “Savage Love (Laxed – Siren Beat)” keeps at No. 9 on the Hot 100, after hitting No. 7, and reaches the Radio Songs top 10 (13-10; 46.5 million, up 18%). Jawsh 685 posts his first Radio Songs top 10, while Derulo scores his seventh and first since “Want to Want Me” in 2015. Rounding out the Hot 100’s top 10, Lewis Capaldi’s “Before You Go” returns to its highest rank (12-10), first reached two weeks earlier. Again, for all chart news, you can follow @billboard and @billboardcharts on both Twitter and Instagram and all charts (dated Sept. 5), including the Hot 100 in its entirety, will refresh on Billboard.com tomorrow (Sept. 1).',\n",
       " ('BTS',\n",
       "  56,\n",
       "  0): 'BTS‘ “Dynamite” rebounds for a third week at No. 1 on the Billboard Hot 100 songs chart. Plus, Justin Bieber‘s “Holy,” featuring Chance the Rapper, debuts at No. 3 on the Hot 100. Notably, the song is the 20th Hot 100 top 10 for Bieber, who becomes the 20th artist in the chart’s history to reach the milestone. The Hot 100 blends all-genre U.S. streaming, radio airplay and sales data. All charts (dated Oct. 3) will update on Billboard.com tomorrow (Sept. 29). For all chart news, you can follow @billboard and @billboardcharts on both Twitter and Instagram. “Dynamite,” released on BigHit Entertainment/Columbia Records, debuted at No. 1 on the Hot 100 dated Sept. 5 and remained atop the Sept. 12 chart, before spending the next two weeks at No. 2. It returns to No. 1 from the runner-up spot on the strength of 14 million U.S. streams (up 11%) and 153,000 downloads sold (up 96%) in the week ending Sept. 24, according to Nielsen Music/MRC Data. It also drew 20.8 million radio airplay audience impressions (up 8%) in the week ending Sept. 27. “Dynamite” spends a fifth total and consecutive week at No. 1 on the Digital Song Sales chart and jumps 17-12 on Streaming Songs, after debuting at its No. 3 high. On Radio Songs, it pushes 47-42. Helping “Dynamite” in the week ending Sept. 24 were four new remixes released Sept. 18: its “Bedroom,” “Midnight,” “Retro” and “Slow Jam” mixes, which, combined, accounted for 52% of the song’s overall sales in the tracking week. “Poolside” and “Tropical” remixes of “Dynamite” were released Aug. 28, joining the original and instrumental versions and EDM and acoustic remixes released Aug. 21, with all versions sale-priced to 69 cents during their first five weeks. “Dynamite” is the first song to top Digital Song Sales for five weeks since Lizzo’s “Truth Hurts,” which led for five nonconsecutive frames in September-October 2019. It’s the first song to rule for at least five weeks in a row since Lil Nas X’s “Old Town Road,” featuring Billy Ray Cyrus, linked its last eight of 16 total weeks on top in July-August 2019. On the Hot 100, “Dynamite” is the first song among duos or groups to tally at least three weeks at No. 1 in almost two years, since Maroon’s “Girls Like You,” featuring Cardi B, dominated for seven weeks in September-November 2018. Cardi B’s “WAP,” featuring Megan Thee Stallion, drops to No. 2 on the Hot 100 after four nonconsecutive weeks at No. 1, dating to its debut atop the Aug. 22 chart. (It spent its first two weeks on the chart at No. 1; its third and fourth frames at No. 2; and its fifth and sixth weeks at No. 1.) “WAP” leads Streaming Songs for a sixth week (35.8 million, down 14%); slips 3-5 on Digital Song Sales (9,000, down 23%); and climbs 21-20 on Radio Songs (33 million, up 1%). It adds a seventh week at No. 1 on both the Hot R&B/Hip-Hop Songs and Hot Rap Songs charts, which use the same multi-metric methodology as the Hot 100. Justin Bieber’s “Holy,” featuring Chance the Rapper, launches at No. 3 on the Hot 100. The track, released Sept. 18, opens at No. 2 on both Streaming Songs (26 million) and Digital Song Sales (27,000) and No. 47 on Radio Songs (18.6 million). Bieber adds his 20th Hot 100 top 10, becoming the 20th artist, and 10th solo male, in the Hot 100’s history, which dates to the chart’s Aug. 4, 1958, inception, to the reach the milestone. He first reached the region',\n",
       " ('BTS',\n",
       "  56,\n",
       "  1): 'when “Baby,” featuring Ludacris, debuted at its No. 5 high in February 2010. Most Hot 100 Top 10s 41, Drake 38, Madonna 34, The Beatles 31, Rihanna 30, Michael Jackson 28, Mariah Carey 28, Taylor Swift 28, Stevie Wonder 27, Janet Jackson 27, Elton John 25, Lil Wayne 25, Elvis Presley 23, Whitney Houston 23, Paul McCartney 23, The Rolling Stones 22, Eminem 21, Jay-Z 20, Justin Bieber 20, Chicago 20, The Supremes Chance the Rapper earns his third Hot 100 top 10, all in collaborations with Bieber. DJ Khaled’s “I’m the One,” featuring Bieber, Chance the Rapper, Quavo and Lil Wayne, spent a week at No. 1 upon its debut in May 2017 and Khaled’s “No Brainer,” featuring Bieber, Chance the Rapper and Quavo, began at its No. 5 peak in August 2018. Drake’s “Laugh Now Cry Later,” featuring Lil Durk, descends 3-4 on the Hot 100, after debuting at its No. 2 high. It jumps 13-10 on Radio Songs (46.8 million, up 18%), becoming Drake’s 24th top 10 (and Lil Durk’s first). Drake passes Mariah Carey (23) for a solo share of the second-most Radio Songs top 10s, after Rihanna’s 29, dating to the tally’s 1990 origin. 24kGoldn’s “Mood,” featuring iann dior, hits the Hot 100’s top five, rising 6-5, as it tops the multi-metric Hot Rock & Alternative Songs and Hot Alternative Songs charts for a fifth week each. DaBaby’s seven-week Hot 100 leader “Rockstar,” featuring Roddy Ricch, dips 4-6 and The Weeknd’s former four-week No. 1 “Blinding Lights” retreats 5-7, after spending a record 28 weeks in the top five. The latter rules the multi-metric Hot R&B Songs chart for a record-extending 28th week. Harry Styles’ former one-week Hot 100 leader “Watermelon Sugar” drops 7-8 and Jawsh 685 and Jason Derulo’s “Savage Love (Laxed – Siren Beat)” falls 8-9, after reaching No. 7. Rounding out the Hot 100’s top 10, Gabby Barrett’s “I Hope” returns to its No. 10 high, from No. 11, as it tops the multi-metric Hot Country Songs chart for a 10th week. Update, as of 2:45 p.m ET, Sept. 28: Charlie Puth is now listed as featured on “I Hope,” as overall consumption for the remix now outpaces that of the Barrett-only original. The song, which marks Barrett’s first Hot 100 top 10, is Puth’s fourth, following his featured turn on Wiz Khalifa’s “See You Again” (12 weeks at No. 1, 2015) and his own “We Don’t Talk Anymore,” featuring Selena Gomez (No. 9, 2016), and “Attention” (No. 5, 2017). Again, for all chart news, you can follow @billboard and @billboardcharts on both Twitter and Instagram and all charts (dated Oct. 3), including the Hot 100 in its entirety, will refresh on Billboard.com tomorrow (Sept. 29).',\n",
       " ('BTS',\n",
       "  57,\n",
       "  0): 'Jawsh 685, Jason Derulo and BTS‘ “Savage Love (Laxed – Siren Beat)” blasts to No. 1 on the Billboard Hot 100 songs chart, from No. 8, aided by new BTS remixes released at the start of the survey’s tracking week. The song becomes the second Hot 100 No. 1 each for Derulo and BTS and the first for Jawsh 685. Plus, 21 Savage and Metro Boomin debut two collaborations in the Hot 100’s top 10 from their new album Savage Mode II, which launches at No. 1 on the Billboard 200. “Runnin” arrives at No. 9 on the Hot 100 and “Mr. Right Now” opens at No. 10. The latter song also marks featured artist Drake‘s record-extending 42nd Hot 100 top 10. The Hot 100 blends all-genre U.S. streaming, radio airplay and sales data. All charts (dated Oct. 17) will update on Billboard.com tomorrow (Oct. 13). For all chart news, you can follow @billboard and @billboardcharts on both Twitter and Instagram. Here’s a deeper look at the coronation of “Savage Love,” released on Columbia Records. Streams, sales & airplay: “Savage Love” drew 16 million U.S. streams (up 32%) and sold 76,000 downloads (up 814%) in the week ending Oct. 8, according to Nielsen Music/MRC Data. It also tallied 70.6 million radio airplay audience impressions (down 2%) in the week ending Oct. 11. The track jumps 5-2 on the Digital Song Sales chart, descends 4-5 on Radio Songs and rises 20-14 on Streaming Songs, while claiming top Sales and Streaming Gainer honors on the Hot 100. Two BTS remixes (a vocal and an instrumental version) of “Savage Love” were released at midnight ET Oct. 2. With almost all of the song’s overall airplay favoring the Jawsh 685/Derulo version, the bulk of its overall sales owed to the BTS remixes and the song’s overall streams split more evenly among the versions with and without BTS in the tracking week, its overall activity in that span favored the Jawsh 685/Derulo/BTS versions, so BTS is now officially listed on the Hot 100 as a billed act on the song for the first time. BTS & Derulo’s second No. 1, Jawsh 685’s first: BTS achieves its second Hot 100 No. 1 with “Savage Love.” The septet scored its first leader with “Dynamite,” which debuted atop the Sept. 5 chart. Derulo earns his second Hot 100 No. 1, after first leading with his debut entry “Whatcha Say” on the chart dated Nov. 14, 2009. He ends the longest wait between No. 1s (11 years and 11 months) since Dr. Dre went 12 years, two months and three weeks between his featured role on Blackstreet’s “No Diggity” in 1996 and “Crack a Bottle,” with Eminem and 50 Cent, in 2009. Jawsh 685 crowns the Hot 100 in his first visit to the chart. Biggest jump to No. 1 this year: Surging 8-1, “Savage Love” makes the greatest leap to the top of the Hot 100 since The Weeknd’s “Heartless” vaulted 32-1 on the chart dated Dec. 14, 2019, following its first full week of tracking, as well as the arrival of its official video. 16th No. 1 of 2020: “Savage Love” is the 16th song to ascend to No. 1 on the Hot 100 for the first time in 2020, one-upping the total of all of 2019. This year marks the highest total of songs earning their first weeks on top since 17 did in 2010 (and the most by the third chart week of October since Nielsen Music/MRC Data-based information began powering the chart in November 1991). 1 more thing …: “Savage Love” is the 1,111th',\n",
       " ('BTS',\n",
       "  57,\n",
       "  1): 'No. 1 in the Hot 100’s 62-year archives. The song gains induction to this chart-fan favorite club: 1st Hot 100 No. 1: “Poor Little Fool,” Ricky Nelson, Aug. 4, 1958 11th Hot 100 No. 1: “Venus,” Frankie Avalon, March 9, 1959 111th Hot 100 No. 1: “A World Without Love,” Peter and Gordon, June 27, 1964 1,111th Hot 100 No. 1: “Savage Love (Laxed – Siren Beat),” Jawsh 685 x Jason Derulo x BTS, Oct. 17, 2020 Meanwhile, BTS’ “Dynamite” holds at No. 2 on the Hot 100 after three nonconsecutive weeks at No. 1. It adds a seventh week atop Digital Song Sales (94,000, up 9%); falls 13-21 on Streaming Songs (13.4 million, down 2%); and charges 39-26 on Radio Songs (27.3 million, up 18%). With “Savage Love” at No. 1 and “Dynamite” at No. 2 on the Hot 100, BTS is the first group to double up in the top two simultaneously since The Black Eyed Peas did so for four weeks in June-July 2009 with “Boom Boom Pow” and “I Gotta Feeling.” Only three other duos or groups have won both gold and silver medals in the same weekly competition: OutKast (eight weeks, 2003-04); Bee Gees (five, 1978); and The Beatles (10, 1964). Cardi B’s “WAP,” featuring Megan Thee Stallion, keeps at No. 3 on the Hot 100 after four nonconsecutive weeks at No. 1, as it leads Streaming Songs for an eighth week (28.3 million, down 11%). It concurrently rules both the Hot R&B/Hip-Hop Songs and Hot Rap Songs charts, which employ the same multi-metric methodology as the Hot 100, for an eighth week each. 24kGoldn’s “Mood,” featuring iann dior, hits a new Hot 100 high, rising 5-4 with the chart’s top Airplay Gainer award, as it enters the Radio Songs top 10 (11-7; 55.1 million, up 18%). It tops the multi-metric Hot Rock & Alternative Songs and Hot Alternative Songs charts for a seventh week each. Rounding out the Hot 100’s top five, Drake’s “Laugh Now Cry Later,” featuring Lil Durk, dips 4-5, after debuting at its No. 2 peak. The Weeknd’s former four-week Hot 100 No. 1 “Blinding Lights” is steady at No. 6, after spending a record 28 weeks in the top five. It logs a 34th week in the top 10, claiming a solo share of the second-most time tallied in the region: Most Weeks in Hot 100’s Top 10 39, “Circles,” Post Malone, 2019-20 34, “Blinding Lights,” The Weeknd, 2020 33, “Sunflower (Spider-Man: Into the Spider-Verse),” Post Malone & Swae Lee, 2018-19 33, “Girls Like You,” Maroon 5 feat. Cardi B, 2018-19 33, “Shape of You,” Ed Sheeran, 2017 32, “Sicko Mode,” Travis Scott, 2018-19 32, “Closer,” The Chainsmokers feat. Halsey, 2016-17 32, “How Do I Live,” LeAnn Rimes, 1997-98 31, “Uptown Funk!,” Mark Ronson feat. Bruno Mars, 2014-15 30, “Bad Guy,” Billie Eilish, 2019 30, “Smooth,” Santana feat. Rob Thomas, 1999-2000 “Blinding Lights” leads the multi-metric Hot R&B Songs chart for a record-extending 30th week and Radio Songs (79.4 million, down 1%) for a record-furthering 25th frame. DaBaby’s seven-week Hot 100 leader “Rockstar,” featuring Roddy Ricch, repeats at No. 7 and Gabby Barrett’s “I Hope,” featuring Charlie Puth, reaches a new peak, ascending 10-8, as it rules the multi-metric Hot Country Songs chart for a 12th week. 21 Savage and Metro Boomin debut two co-billed songs in the Hot 100’s top 10 from their new album Savage Mode II, as “Runnin” and “Mr. Right Now” bound in at Nos. 9 and No. 10, respectively. On Streaming Songs, the tracks start at Nos. 2 and 3 with 26.1 million and 24.7',\n",
       " ('BTS',\n",
       "  57,\n",
       "  2): 'million respective streams. 21 Savage scores his second and third Hot 100 top 10s, following his featured turn on Post Malone’s “Rockstar,” which reigned for eight weeks in 2017. Metro Boomin earns his first and second top 10s as a billed artist, after writing six top 10s, and producing five, including two No. 1s: Migos’ “Bad and Boujee,” featuring Lil Uzi Vert (2017), and The Weeknd’s “Heartless” (2019). As Drake is featured on “Mr. Right Now,” he notches his record-extending 42nd Hot 100 top 10, pushing further ahead of runner-up Madonna (38). Plus, Drake posts his record-padding 27th title to debut in the top 10. (As for last week’s Hot 100 No. 1, Travis Scott’s “Franchise,” featuring Young Thug and M.I.A., it plummets to No. 25 from the summit, where it debuted. Down 40% in streams (to 11.7 million) and 85% in sales (to 15,000), the song makes the second-steepest drop from No. 1 to another rank in the Hot 100’s history; 6ix9ine and Nicki Minaj’s “Trollz” tumbled from the top, where it began, to No. 34 on the July 4-dated chart.) Again, for all chart news, you can follow @billboard and @billboardcharts on both Twitter and Instagram and all charts (dated Oct. 17), including the Hot 100 in its entirety, will refresh on Billboard.com tomorrow (Oct. 13).',\n",
       " ('BTS',\n",
       "  58,\n",
       "  0): 'On Wednesday, March 24, BTS appeared on the Korean variety show You Quiz On The Block, where they played the classic \"Guess The Mafia\" game, discussed their trainee days, gushed about ARMYs, and even met one lucky ARMY in person! BTS is always breaking records, so it was no surprise their episode received the highest viewership ratings in the show\\'s history since its premiere in 2018. And fans knew it was going to be good, which is why they bought all the ad spots during the program so there would be no commercial breaks. In case you missed the group\\'s appearance (or just hope to watch it with English subtitles at some point), here\\'s how to watch BTS\\' You Quiz On The Block episode with subs. According to The Korea Times, BTS\\' episode achieved average nationwide ratings of 6.74 percent — the highest rating ever recorded by an episode of You Quiz On The Block. It was easy to see why fans tuned in to the episode. Despite all their success, BTS was nothing but humble when talking about their achievements. They kept thanking their fans for helping them reach their dreams. \"They’re the people we love. I can’t think of any other way to say it,\" Jimin said about ARMYs. \"They’re the ones who make us feel a lot of different emotions. Even though we’re young, they helped us grow and told us it was okay when we made mistakes. They’re the ones who make me think of the reasons for love.\" Meanwhile, Suga credited fans for helping them gain popularity in the U.S. \"In the American music market, radio play is important. Our fans opened that gate for us. We were wondering if it was possible, but they spread word about us by sending in requests to radio DJs,\" he said. Cindy Ord/Getty Images Entertainment/Getty Images 2020 was a special year for BTS because they got their first three Billboard No. 1 singles (\"Dynamite,\" \"Savage Love,\" and \"Life Goes On\") and their first Grammy nomination for Best Pop Duo/Group performance. They were also crowned the world\\'s best-selling artists of the year. During their appearance on You Quiz On The Block, one fan paid tribute to BTS\\' success by performing their 2017 hit single \"MIC Drop\" in front of them. The guys were all smiles seeing an ARMY in person after their 2020 tour was unfortunately postponed indefinitely due to the coronavirus pandemic. There were so many highlights during BTS\\' episode, and English-speaking fans can relive the fun again. The show\\'s official YouTube channel uploaded the episode clips with English subtitles on Friday, March 26. Watch one iconic moment from the episode below and then head over to You Quiz On The Block\\'s channel to watch the rest! BTS\\' appearance on You Quiz On The Block will go down in history as one of their best!',\n",
       " ('BTS',\n",
       "  59,\n",
       "  0): 'Get ready to light 2021 up like dynamite with BTS, TXT, Lee Hyun, GFRIEND, NU’EST, BUMZU and ENHYPEN as part of Big Hit Labels’ 2021 New Year’s Eve Live show. Halsey, Lauv and Steve Aoki will also join the concert lineup from the Special Stage. All three performers have previously collaborated with BTS in recent years: Halsey joined the K-pop boy band on “Boy With Luv,” Lauv joined them for “Make It Right” and “Who,” and Aoki remixed “MIC Drop” and “Waste It on Me.” Explore See latest videos, charts and news BTS Halsey Lauv See latest videos, charts and news The show plans to honor late experimental rock singer-songwriter Shin Hae-chul, who died in October 2014, on the Connect Stage by using AI and hologram technology, as reported by Soompi. Artists will sing his hits “To You” and “What Do You Really Want?” during the tribute performance. “We prepared a tribute stage to remember the late Shin Hae-chul, who rejected stereotyped thinking and didn’t hesitate to take challenges, in order to console everyone who was having a difficult and lethargic 2020,” Big Hit said in a statement. “We have been preparing this for a long time in order to complete an unforgettable performance that connects time, space, and generation with music.” Trending on Billboard The 2021 New Year’s Eve Live concert will air on Thursday, Dec. 31, at 7:30 a.m. ET/4:30 a.m. PT on Big Hit Labels’ fan community platform Weverse. Watch the trailer in the meantime below. Tickets are currently on sale at Weverse Shop until 9 a.m. ET/6 a.m. PT on New Year’s Eve.',\n",
       " ('BTS',\n",
       "  6,\n",
       "  0): 'South Korean idol groups Bangtan Boys (BTS), EXO and TWICE took top awards at the 2016 Mnet Asian Music Awards (MAMA) at AsiaWorld-Expo Arena in Hong Kong. K-pop boy band BTS of modest-sized Big Hit Entertainment won the Artist of the Year title, one of the event\\'s three big honors, along with Album of the Year and Song of the Year awards, on Friday night. The band also snatched the best dance performance award for male group artists. The seven-member boy group has soared in popularity at home and overseas this year, gaining momentum as leading K-pop artist in the three years since its debut. The band\\'s latest full-length album, \"WINGS,\" was ranked as high as 26th on the Billboard 200 chart -- the highest placement for a K-pop group to date. Big Hit Entertainment chief Bang Si-hyuk won the best label award largely in recognition of creative content related to BTS. K-pop boy band EXO of entertainment giant S.M. Entertainment won the Album of the Year award for the fourth consecutive year. This year, the band additionally snagged three more awards, including the best male group artist\\'s title. This year, EXO enjoyed robust album sales from its third full-length LP, \"EX\\'ACT,\" and its re-packaged sequel \"LOTTO,\" with accumulative sales exceeding 1 million copies in roughly two months. Girl group TWICE of JYP Entertainment won the Song of the Year award with its mega-hit dance-pop song \"Cheer Up.\" The idol group also seized the best female group artist\\'s award. \"Cheer Up\" hit 100 million YouTube views in 207 days after its release on April 25, setting a record as the fastest K-pop music video to reach the milestone. Blackeyed Pilseung, the producer of \"Cheer Up,\" won the best producer\\'s award. The honor of best international producer went to U.S. producer Timbaland, while the best contributor\\'s award went to Quincy Jones. The best visual and art director\\'s award went to director Min Hee-jin, who managed the visual directing of S.M. Entertainment idols, including EXO and SHINee. The best engineer and best performance organizer\\'s titles went to Japanese professionals Hironobu Tanaka and Hidaka Masahiro, respectively. The best choreographer\\'s award was presented to Thai artist J.Da. (Yonhap)',\n",
       " ('BTS',\n",
       "  60,\n",
       "  0): 'Take a bow, BTS. The K-pop phenomenon have received the 2020 IFPI Global Recording Artist of the Year Award, an annual honor that recognizes an act’s worldwide popularity across streaming and sales, including vinyl, downloads and CDs. BTS smash records for fun. And with the IFPI accolade, announced Thursday (March 4), the boy band set another benchmark by becoming the first champ to perform primarily in a language other than English. And, of course, they become the first South Korean and first Asian act to take the title. Until now, all recipients have hailed from North America (Taylor Swift in 2014 and 2019, Drake in 2016 and 2018) or the United Kingdom (One Direction in 2013, Adele in 2015, Ed Sheeran in 2017). BTS came close to winning the trade body’s top award in 2018, when they finished second, and again in 2019, coming in seventh. Despite the pandemic, the pop septet slotted into record-setting form last year. In April 2020, the group bowed at No. 1 on the Billboard 200 with Map of the Soul: 7, their fourth No. 1 in less than two years. Map of the Soul: 7 is one of the most pre-ordered albums of all time, notes the IFPI, and the album ruled the charts in more than 20 countries. That was just the start of a monster year for BTS. The Japanese-language Map of the Soul : 7 ~ The Journey ~ bolted past 500,000 copies within two days of its release in July 2020. Later, RM, Jin, Suga, J-Hope, Jimin, V and Jungkook became the first Korean act to score a Billboard Hot 100 leader as “Dynamite” hit the summit, and busted records for opening-day streams on YouTube and Spotify. “Dynamite” earned a historic Grammy nomination, for best pop duo/group performance. Before the year closed out, Be stormed the global charts, and gave the group their fifth No. 1 on the Billboard 200. “BTS are a global phenomenon,” comments IFPI CEO Frances Moore. “They have had another outstanding year, releasing three albums, and continually finding creative and engaging ways to share their story with the world. They truly show the power that music has to bring joy and happiness to people the world over.” BTS lead a Top 10 loaded with U.S. and Canadian acts and, surprisingly, devoid of Brits. The Top Five is rounded out by Taylor Swift, Drake, The Weeknd and Billie Eilish, respectively. IFPI Top 10 Global Recording Artists of 2020 1. BTS 2. Taylor Swift 3. Drake 4. The Weeknd 5. Billie Eilish 6. Eminem 7. Post Malone 8. Ariana Grande 9. Juice Wrld 10. Justin Bieber',\n",
       " ('BTS',\n",
       "  61,\n",
       "  0): 'BTS just broke another one of their own records. This time, the GRAMMY-nominated group smashed their own YouTube debut day stats for \\'Dynamite,\\' a feat held at 101.1 million views with their latest single, \\'Butter\\'. \\'Butter\\' also broke the record for the biggest music video premiere on YouTube, a record also held by their 2020 summer single, \\'Dynamite.\\' YouTube has confirmed that Butter\\' amassed 108.2 million views in 24 hours since its release, breaking the 101.1 million mark 21 hours in. This makes \\'Butter\\' the fastest music video in YouTube history to reach this milestone. BTS now holds the first and second places on YouTube\\'s All-Time Top 24 Hour Music Debuts. .@BTS_twt\\'s \"Butter\" has officially broken the 24 hour YouTube record with updated count of 108.2 million views, passing \"Dynamite\". #BTS_Butter — chart data (@chartdata) May 23, 2021 In a press conference, Jimin described the new song as a charismatic, laid-back, and fun single that\\'s similar to that of a confession of admiration. Since its global release on 21 May, the dance-pop bop has taken over iTunes charts all over the world, debuting at number 1 on iTunes World Chart. To celebrate their latest comeback, BTS are also hosting listening parties with ARMY throughout the week. Join the party via Spotify or Apple Music here. Watch \\'Butter\\' here: BTS\\' \\'Butter\\' will make its live debut at the 2021 Billboard Music Awards where the group is nominated for four BBMAs. The group is looking to win its fifth straight Top Social Artist award.',\n",
       " ('BTS',\n",
       "  62,\n",
       "  0): 'BTS are back with a new Japanese song and music video — and they’ve returned to making our heads spin with symbolism and potential theories. On April 1, BTS released their wrenching Japanese single “Film Out,” which is on the group’s upcoming Japanese album, BTS, The Best, that will be released on June 16. The track was co-written by Jungkook, Iyori Shimizu (who is part of the rock band Back Number), and producer UTA. “Film Out” will also feature in the Japanese remake of the Korean film SIGNAL, SIGNAL The Movie Cold Case Investigation Unit, which is out today, April 2. While “Film Out” is a song riddled with complex, heartbreaking emotions in itself, its music video also left fans trying to decipher the layered meanings behind it. We all know that if there is one thing that BTS and their creative team love to do, it’s set the internet on fire by dropping a music video that will leave fans speculating for days. BTS has created an intricate world called the Bangtan Universe, or BU, which stems from their The Most Beautiful Moment In Life album trilogy, often referred to as HYYH. In the BU, the seven members play characters who endure intense fictional storylines that deal with topics such as domestic violence, hospitalization, suicide, time travel, and alternate timelines — all of which culminate in a message about the importance of friendship. While watching “Film Out,” fans couldn’t help but notice parallels between the video and BU content like the “Fake Love” music video, so they took to Twitter to share their speculations. However, it\\'s worth noting that Bangtan Universe stories are typically tagged “BU content certified by Big Hit Entertainment,” and “Film Out” is notably not — but that doesn’t mean we can’t look for patterns and repeated themes that build the ever-growing world of BTS. Below, we round up some of the most interesting theories and thought-starters ARMY have developed for BTS\\'s “Film Out\" music video. (Reminder to take all theories with several grains of salt.) Theory 1: It was Jin who wrote “Save Me” to Taehyung in the “Fake Love” video. Fans immediately picked up on Jin standing in front of a window looking in on the rest of the BTS members in “Film Out.” Why? Because it mirrored a scene from “Fake Love” in which Taehyung stands in front of a window that has “Save Me/I’m Fine” written on it, a reference to two of BTS\\'s songs, from HYYH and Love Yourself: Answer. Others pointed out the ways Taehyung and Jin have been linked throughout BTS’s music videos.',\n",
       " ('BTS',\n",
       "  63,\n",
       "  0): 'BTS‘ “Life Goes On” soars onto the Billboard Hot 100 songs chart at No. 1. The song is the South Korean septet’s third Hot 100 No. 1, all in a span of three months, following “Dynamite” and Jawsh 685 and Jason Derulo’s “Savage Love (Laxed – Siren Beat),” the latter of which led aided by BTS remixes. “Life Goes On” is also the first Hot 100 No. 1 in the chart’s 62-year history sung predominantly in Korean. Plus, Shawn Mendes and Justin Bieber‘s “Monster” bounds onto the Hot 100 at No. 8. The Hot 100 blends all-genre U.S. streaming (official audio and official video), radio airplay and sales data. All charts (dated Dec. 5) will update on Billboard.com tomorrow (Dec. 1). For all chart news, you can follow @billboard and @billboardcharts on both Twitter and Instagram. Here’s a deeper look at the coronation of “Life Goes On,” released Nov. 20 on BigHit Entertainment/Columbia Records as part of BTS’ new album Be, which opens at No. 1 on the Billboard 200 chart. The song is the 1,114th No. 1 in the Hot 100’s history. Streams, sales & airplay: “Life Goes On” drew 14.9 million U.S. streams and sold 150,000 in the week ending Nov. 26, according to Nielsen Music/MRC Data. It also earned 410,000 radio airplay audience impressions in the week ending Nov. 29 (with KJYO Oklahoma City, Oklahoma, the lone reporter to play it double-digit times: 13). The track debuts at No. 1 on the Digital Song Sales chart and No. 14 on Streaming Songs. (Breaking down the song’s first-week sales, it sold over 129,000 digital downloads and 20,000 physical singles. The digital download was sale-priced to 69 cents, while a cassette single sold for $6.98 and a vinyl single went for $7.98.) BTS’ 3rd Hot 100 No. 1 in 3 months: “Life Goes On” is BTS’ third Hot 100 No. 1, all in a span of three months. Its launch atop the Dec. 5-dated chart follows “Dynamite,” which began atop the Sept. 5 survey and led for three total weeks, and Jawsh 685 and Jason Derulo’s “Savage Love (Laxed – Siren Beat),” which, helped by BTS remixes, topped the Oct. 17 chart. Covering a span of exactly three months (Sept. 5-Dec. 5-dated charts), BTS scores the fastest accumulation of three Hot 100 No. 1s in over 42 years, since the Bee Gees tripled up over two months and three weeks, with a trio of singles from the Saturday Night Fever soundtrack: “How Deep Is Your Love” (three weeks at No. 1, beginning Dec. 24, 1977); “Stayin’ Alive” (four, Feb. 4, 1978); and “Night Fever” (eight, March 18, 1978). BTS has landed its first three No. 1s more quickly than any act since The Beatles, whose first three leaders, “I Want to Hold Your Hand,” “She Loves You” and “Can’t Buy Me Love,” hit No. 1 over a span of just two months and three days (Feb. 1-April 4, 1964). BTS is the second act with three Hot 100 No. 1s in 2020, following Ariana Grande, who has led with “Stuck With U” (with Bieber; May 23); “Rain on Me” (with Lady Gaga; June 6); and “Positions” (Nov. 7). BTS is the first act of more than two members with three songs to spend their first weeks each at No. 1 in the same year since, again, trio the Bee Gees, who sent three hits to No. 1 in 1979: “Too Much Heaven,” “Tragedy” and “Love You Inside Out.” First duo/group with 2 No. 1 Hot 100 debuts: BTS is the first duo or group with two No. 1 Hot',\n",
       " ('BTS',\n",
       "  63,\n",
       "  1): '100 debuts, as “Life Goes On” follows “Dynamite” in having premiered at the summit. “Life Goes On” is the 46th single overall to start at No. 1 on the Hot 100. It’s the 11th to do so in 2020 (all since April), nearly triple the previous record for the most in a single year, as four songs entered at No. 1 in both 1995 and 2018. First predominantly non-English-language No. 1 debut: “Life Goes On” is the first song sung in a non-English language to open atop the Hot 100. The first Hot 100 No. 1 in the Hot 100’s history sung predominantly in Korean, it’s the first No. 1 sung mostly in a language other than English since Luis Fonsi and Daddy Yankee’s predominantly Spanish-language “Despacito” (featuring Bieber), which reigned for 16 weeks in 2017. Before “Despacito,” no such song had topped the Hot 100 since Los Del Rio’s “Macarena (Bayside Boys Mix),” which ruled for 14 weeks in 1996. Before that, Los Lobos’ all-Spanish-language cover of Ritchie Valens’ “La Bamba” led in 1987. 19th No. 1 of 2020: “Life Goes On” is the 19th song to ascend to No. 1 on the Hot 100 for the first time in 2020. This year marks the highest total of songs earning their first weeks on top since 19 also did in 2006 (and the most by the first chart week of December since Nielsen Music/MRC Data-based information began fueling the chart in November 1991). “Dynamite” back in top 5: “Dynamite,” on BTS’ album Be, rebounds from No. 14 to No. 3 on the Hot 100. Among acts of more than two members, BTS is the first to claim two spots in the Hot 100’s top three, or top five, simultaneously since The Black Eyed Peas, which doubled for five weeks in June-July 2009 with “Boom Boom Pow” and “I Gotta Feeling.” 24kGoldn’s “Mood,” featuring Iann Dior, drops to No. 2 on the Hot 100 after five nonconsecutive weeks at No. 1, with 87.3 million in airplay reach (up 2%), as it leads the Radio Songs chart for a fifth week, 21.9 million streams (down 2%) and 7,000 sold (down 13%). It tops the multi-metric Hot Rock & Alternative Songs and Hot Alternative Songs charts for a 14th week each and Hot Rap Songs for a seventh frame (with all three charts using the same methodology as the Hot 100). Ariana Grande’s “Positions” slips 3-4 on the Hot 100, after it led the Nov. 7-dated chart upon its debut. It charges 14-9 on Radio Songs (47.9 million, up 27%), where it becomes her 14th top 10; dating to her first week in the tier (June 7, 2014), with “Problem,” featuring Iggy Azalea, she ties Bieber for the most top 10s in that span. Gabby Barrett’s “I Hope,” featuring Charlie Puth, dips 4-5 on the Hot 100, after reaching No. 3, as it dominates the multi-metric Hot Country Songs chart for an 18th week, and Bieber’s “Holy,” featuring Chance the Rapper, keeps at No. 6 on the Hot 100, after debuting at its No. 3 high. Drake’s “Laugh Now Cry Later,” featuring Lil Durk, descends 5-7 on the Hot 100, after debuting at its No. 2 peak, and notches a fifth week atop the multi-metric Hot R&B/Hip-Hop Songs chart (where it marks Drake’s record-setting 21st No. 1). Shawn Mendes and Justin Bieber’s “Monster” enters the Hot 100 at No. 8, with 19.1 million streams, 14.4 million in airplay audience and 17,000 sold. It starts at No. 5 on Streaming Songs and No. 7 on Digital Song Sales. (The song sold 15,000 downloads',\n",
       " ('BTS',\n",
       "  63,\n",
       "  2): 'and 2,000 CD singles, with three CD versions available for $3 each: one with a cover showing both Mendes and Bieber and one each showing only Mendes and Bieber, respectively.) Mendes earns his sixth Hot 100 top 10 and Bieber adds his 21st. The Weeknd’s “Blinding Lights” retreats 7-9 on the Hot 100, after spending four weeks at No. 1. It banks a record-extending 41st week in the top 10, while ruling the multi-metric Hot R&B Songs chart for a record-furthering 37th week. Rounding out the Hot 100’s top 10, Internet Money and Gunna’s “Lemonade,” featuring Don Toliver and NAV, slips 8-10, after rising to No. 6. Again, for all chart news, you can follow @billboard and @billboardcharts on both Twitter and Instagram and all charts (dated Dec. 5), including the Hot 100 in its entirety, will refresh on Billboard.com tomorrow (Dec. 1).',\n",
       " ('BTS',\n",
       "  64,\n",
       "  0): 'BTS aren’t done with rewriting the history books. The K-pop superstars bag another IFPI award, this time topping the trade body’s Global Album Sales Chart with Map Of The Soul: 7. It’s an unprecedented 1-2 for BTS, whose BE set is runner-up while Map Of The Soul: 7 ~ The Journey ~ comes in at No. 8 on the tally, which combines global sales of physical and digital album downloads to rank the top albums of 2020. It’s the latest in a bundle of IFPI honors for the boy band, who were also named Global Recording Artists of 2020, and Map Of The Soul: 7 came in at No. 1 on the inaugural IFPI Global Album All Format Chart. Jungkook, V, Suga, Jin, RM, Jimin and J-Hope are seemingly unstoppable. Map Of The Soul: 7, their fourth studio album, smashed sales charts in their homeland and around the world, finishing the year just shy of 5 million global units. In the United States, Map Of The Soul: 7 debuted at No. 1 on the Billboard 200 for the septet’s fourth leader, extending their record for Korean acts. Asian acts dominate the latest IFPI chart. Coming in at No. 3 is Japanese artist Kenshi Yonezu with Stray Sheep; South Korea’s Blackpink is at No. 5 with The Album; Japanese boy band Arashi is at No. 9 with This is Arashi; and compatriots King Gnu round out the Top 10 with Ceremony. “BTS’ success across IFPI’s global charts — including the top two positions in this chart — is unprecedented and demonstrates the amazing global appeal of their music,” comments Frances Moore, CEO of IFPI. “We would like to congratulate the band once again on such a successful year.” Albums from Taylor Swift, AC/DC and Justin Bieber also make the list, published Thursday (March 11). Top 10 Global Albums 2020 1. BTS, Map Of The Soul: 7 (4.8 million total global units) 2. BTS, Be (Deluxe Edition) (2.7 million) 3. Kenshi Yonezu, Stray Sheep (2 million) 4. Taylor Swift, Folklore (2.0 million) 5. Blackpink, The Album (1.5 million) 6. AC/DC, Power Up (1.4 million) 7. Justin Bieber, Changes (1.2 million) 8. BTS, Map Of The Soul: 7 ~ The Journey ~ (1.2 million) 9. Arashi, This Is Arashi (1 million) 10. King Gnu, Ceremony (1 million)',\n",
       " ('BTS',\n",
       "  65,\n",
       "  0): 'The Weeknd’s “Blinding Lights” was a lights-out streaming hit in 2020. Now it’s official: the Canadian R&B artist’s ubiquitous song was the world’s most-popular single of the year last year across all digital formats. “Blinding Lights” wins IFPI Global Digital Single Award for 2020, an honor that includes single track downloads, and streams on both paid subscriptions and ad-supported services. Over the course of 2020, the After Hours release amassed 2.72 billion subscription stream equivalents worldwide, according to the IFPI, and hit No. 1 in more than 30 countries, including the United States. Along the way, it smashed the record for the most weeks spent atop Billboard’s all-format Radio Songs airplay chart, it led the Spotify’s year-end Most Streamed Songs Globally list, and became the first track in recorded music history to log a full year in the Top 10 of the Billboard Hot 100. “Blinding Lights” was “undoubtedly one of the year’s biggest record breakers and most loved songs,” comments Frances Moore, CEO of IFPI. “It caught the attention of music lovers all over the world. We would like to congratulate The Weeknd on his success, and it is an honor to award him this title.” Trending on Billboard Released in November 2019, “Blinding Lights” is one of two songs to surpass two billion subscription stream equivalents during the year. The other, Tones And I’s “Dance Monkey,” blasted past 2.34 billion in 2020 for No. 2 on the IFPI’s Global Digital Singles tally. The IFPI Global Digital Single Award is the second award unveiled by the international trade body in 2020. Earlier, BTS were named as of 2020’s IFPI Global Recording Artist of the Year Award. The K-pop superstars’ No. 1 hit “Dynamite” comes in at No. 10 on the IFPI Global Digital Single list. Top 10 Global Digital Singles 2020 1. The Weeknd, “Blinding Lights” (2.72 billion) 2. Tones and I, “Dance Monkey” (2.34 billion) 3. Roddy Ricch, “The Box” (1.67 billion) 4. Saint Jhn, “Roses” (1.64 billion) 5. Dua Lipa, “Don’t Start Now” (1.62 billion) 6. Future (feat. Drake), “Life Is Good” (1.57 billion) 7. Xiao Zhan, “Made To Love” (1.48 billion) 8. DaBaby (feat. Roddy Ricch), “Rockstar” (1.45 billion) 9. Billie Eilish, “Bad Guy” (1.36 billion) 10. BTS, “Dynamite” (1.28 billion)',\n",
       " ('BTS',\n",
       "  66,\n",
       "  0): '(LEAD: RECASTS headline, lead; UPDATES with details, photo from performance, minor edits) By Lee Minji SEOUL, March 15 (Yonhap) -- K-pop juggernauts BTS brightened up the Grammy awards with another striking performance of its megahit \"Dynamite,\" writing history as the first Korean nominee to perform on the annual music show often dubbed \"music\\'s biggest night.\" The seven-piece act -- Jin, Suga, J-Hope, RM, Jimin, V and Jungkook -- joined the 63rd Grammy Awards held in Los Angeles on Sunday (U.S. time) from Seoul through a performance recorded at a high-rise in the South Korean capital\\'s financial and political district of Yeouido. Wearing suits in warm hues of ivory, yellow, orange and black, the members performed the pop-disco number at stages adorned with the Grammys signature gramophone trophies and a red carpet before moving up a staircase to the top of the building. BTS sung the finale of the up-tempo song in the outdoor space, with Seoul\\'s night lights illuminating the septet dancing and singing on a round-shaped stage. It marked the first Grammy performance by a Korean nominee and its third appearance on the show. The group first appeared at the 2019 Grammys as presenter and joined American rapper Lil Nas X the following year to perform his record hit \"Old Town Road,\" with lines from the remix \"Seoul Town Road.\" In a statement released through their agency Big Hit Entertainment, the group said the experience was \"a meaningful moment,\" saying it \"will continue to move forward toward their next goal.\" This photo, provided by Big Hit Entertainment, shows BTS on the stage for a performance of \"Dynamite\" during the 63rd Grammy Awards on March 14, 2021. (PHOTO NOT FOR SALE) (Yonhap) BTS was nominated in the best pop duo/group category, a first for a K-pop and an Asian act, for its hit number \"Dynamite.\" Its first-ever bid to win a trophy, however, fell through as Lady Gaga and Ariana Grande took home the trophy with their collaboration \"Rain On Me.\" Other contenders were Taylor Swift\\'s \"Exile\" featuring Bon Iver, \"Un Dia (One Day)\" by J Balvin, Dua Lipa, Bad Bunny and Tainy, and Justin Bieber\\'s \"Intentions\" featuring Quavo. The group said the whole nomination process has been an \"unbelievable\" experience and thanked fans for supporting them throughout the journey. \"Thank you for supporting us, thanks to you we\\'re going through this unbelievable experience. We are truly grateful and happy. We love you Army!\" member Jimin shared on their official Twitter account, following the first leg of the annual music ceremony where the category winner was announced. This photo, provided by Big Hit Entertainment, shows BTS taking part in a virtual red carpet event for the 63rd Grammy Awards held in Los Angeles on March 14, 2021 (U.S. time). (PHOTO NOT FOR SALE) (Yonhap) Other members of the septet left messages on the group\\'s Twitter account and the fan community Weverse, thanking fans and pledging to once again give their best this year. \"Let\\'s get it going this year,\" wrote Suga, while Jungkook penned, \"Thank you for being with us every moment and we\\'ll make sure to return your love and support.\" RM posted two photos of himself, asking fans to \"watch out for the performance.\" Army, the band\\'s dedicated fandom, returned the love with encouraging comments on social media, sharing millions of tweets with hashtags like #BTSOurGreatestPrize and #LightItUpBTS. They voiced how proud they are of their favorite artist and promised to keep supporting them going forward. This photo, provided by Big Hit Entertainment, shows BTS performing in \"Music On A Mission,\" a virtual concert and fundraiser held on',\n",
       " ('BTS',\n",
       "  66,\n",
       "  1): 'March 12, 2021 (U.S. time), ahead of the 63rd Grammy Awards. (PHOTO NOT FOR SALE) (Yonhap) While the Grammys has a track record of being conservative toward boy bands and non-Western pop acts, the phenomenal success of \"Dynamite\" had raised hopes that BTS may become the first Korean and Asian pop act to win in the competitive category that was introduced in 2012. The upbeat summer number that BTS sang in hope of cheering up listeners during the pandemic was a smash hit from the start. After writing history by becoming the first song by a Korean act to debut atop the Billboard Hot 100, it has stayed on the chart for 28 weeks. The track, entirely sung in English, also helped the band make a splash on U.S. radio. Thanks to its stellar success, BTS went on to become the Global Recording Artist of the Year in 2020, with two of its 2020 albums \"BTS: Map of the Soul 7\" and \"BE\" sweeping the top two spots on the world\\'s bestselling albums chart. In an interview with the Grammys released ahead of the ceremony, the septet voiced hope on how they could \"play a part in helping people be exposed to diverse music.\" \"We see movements in \\'diversity\\' in the global music industry. We hope these changes expedite and keep moving forward. There are so many artists in Korea besides us who put out great music. And I\\'m sure there are even more on a global scale. Hopefully, we can play a part in helping people be exposed to diverse music and more musicians become more widely known,\" Suga said. Jungkook also mentioned how a \"win would be significant not only for us but for many who pursue diversity in music.\" This photo, provided by Big Hit Entertainment, shows the members of BTS posing for photos during an online media day event in Seoul on Sept. 2, 2020. The band\\'s \"Dynamite\" topped Billboard\\'s main Hot 100 singles chart in the United States on Aug. 31. (PHOTO NOT FOR SALE) (Yonhap) Meanwhile, three-time Grammy nominee Richard O\\'Neill took home the trophy for best classical instrument solo with \"Theofanidis: Concerto For Viola And Chamber Orchestra.\" Widely known as Richard Yongjae O\\'Neill here, the violist with a Korean-born mother is known for introducing more Korean listeners to classic music. Women swept the prizes for the top four general field categories. Billie Eilish won record of the year with \"Everything I Wanted,\" Taylor Swift won album of the year with \"Folklore,\" and H.E.R. won song of the year with \"I Can\\'t Breathe.\" Megan Thee Stallion won best new artist. mlee@yna.co.kr (END)',\n",
       " ('BTS',\n",
       "  67,\n",
       "  0): 'BTS‘ “Butter” bounds in at No. 1 on the Billboard Hot 100 songs chart. The song marks the superstar South Korean septet’s fourth Hot 100 No. 1, all in the last nine months, marking any act’s quickest accumulation of four initial leaders since Justin Timberlake a decade-and-a-half ago. Among groups, BTS has landed its first four No. 1s the fastest since the Jackson 5 in 1970. Plus, Olivia Rodrigo charts three songs in the Hot 100’s top 10, as “Good 4 U,” which a week earlier premiered at the summit, ranks at No. 2; “Deja Vu” hits a new high at No. 3; and “Traitor” begins at No. 9. All three songs are from her debut LP Sour, which soars in at No. 1 on the Billboard 200 chart with the biggest week for an album so far in 2021. Thanks to her three top 10s this week, Rodrigo makes history as the first artist to chart three songs in the Hot 100’s top 10 simultaneously all from a debut album. The Hot 100 blends all-genre U.S. streaming (official audio and official video), radio airplay and sales data. All charts (dated June 5) will update on Billboard.com tomorrow (June 2, a day later than usual due to the May 31 Memorial Day holiday in the U.S.) For all chart news, you can follow @billboard and @billboardcharts on both Twitter and Instagram. “Butter,” released on HYBE/BigHit Entertainment/Columbia Records, is the 1,125th No. 1 in the Hot 100’s 62-year history, and the 54th to enter on top. Here’s a deeper look at its launch. Streams, sales & airplay: Following its May 21 release, “Butter” drew 32.2 million U.S. streams and sold 242,800 downloads in the week ending May 27, according to MRC Data. It also attracted 18.1 million radio airplay audience impressions in the week ending May 30. The track debuts atop the Digital Song Sales chart, where it’s BTS’ seventh No. 1, extending the act’s record for the most among groups. Meanwhile, the song’s 242,800 sold mark the most in a week since BTS’ own “Dynamite” opened with 300,000 (Sept. 5, 2020). “Butter” also begins at No. 4 on Streaming Songs and No. 39 on Radio Songs; it’s the act’s second entry and top start on the latter list, after “Dynamite,” which entered at No. 49 last September and hit No. 10 in December. BTS’ 4th Hot 100 No. 1: “Butter” arrives as BTS’ fourth Hot 100 No. 1. Here’s a recap. “Dynamite,” three weeks at No. 1, beginning Sept. 5, 2020 “Savage Love (Laxed – Siren Beat),” with Jawsh 685 and Jason Derulo, one week, Oct. 17, 2020 “Life Goes On,” one week, Dec. 5, 2020 “Butter,” one week to-date, June 5, 2021 As “Dynamite,” “Life Goes On” and “Butter” have all debuted at No. 1 on the Hot 100, BTS is the first group with a trio of No. 1 entrances; no other group has more than one. Ariana Grande leads all acts with five No. 1 starts. Fastest first 4 No. 1s since …: BTS has achieved its first four Hot 100 No. 1s over a span of exactly nine months, from charts dated Sept. 5, 2020, through June 5, 2021. That’s the quickest accumulation of four initial leaders since Justin Timberlake earned the honor over seven months and two weeks in 2006-07. Among groups, BTS wraps the fastest run to four initial Hot 100 No. 1s since the Jackson 5 in 1970. Here’s a look at the elite seven acts to land their first four Hot 100 leaders in under a year (dating to each act’s first',\n",
       " ('BTS',\n",
       "  67,\n",
       "  1): 'week at No. 1): The Beatles, four months (Feb. 1-May 30, 1964) The Supremes, seven months and one week (Aug. 22, 1964-March 27, 1965) Justin Timberlake, seven months and two weeks (Sept. 9, 2006-April 21, 2007) The Jackson 5, eight months and two weeks (Jan. 31-Oct. 17, 1970) BTS, nine months (Sept. 5, 2020-June 5, 2021) Mariah Carey, nine months and three weeks (Aug. 4, 1990-May 25, 1991) Paula Abdul, one year (Feb. 11, 1989-Feb. 10, 1990) Among all quartets of Hot 100 No. 1s, not just acts’ first four leaders, BTS has earned its four the fastest since Rihanna also earned four over nine months in 2010-11, after four over eight months all in 2010. (She had already tallied five No. 1s before 2010, in 2006-08.) ‘Butter’ & churn at No. 1: “Butter” is the 10th song to score its first week at No. 1 on the Hot 100 in 2021. This year marks the first in which at least 10 songs have hit No. 1 by the first chart dated in June since the Hot 100 began using MRC Data (formerly Nielsen Music) information in November 1991. It follows 2020’s total of 20 new No. 1s, likewise the most in a year since 1991. “Butter” is also the seventh song to debut at No. 1 on the Hot 100 in 2021. A record 12 titles launched at the summit last year after no more than four did in any previous year. ‘Hotter’ forecast: Sales for “Butter” in its first week reflect availability for its original and instrumental versions, both discounted to 69 cents. Those versions, plus a “hotter” remix released May 28, also priced at 69 cents, will impact the song on next week’s Hot 100, dated June 12 and reflecting sales in the May 28-June 3 tracking week. (Updated June 2 with confirmed expected shipping date: Two other versions of “Butter” on sale via BTS’ U.S. webstore, a 7-inch vinyl single, for $7.98, and a cassette single, for $6.98, will count for chart tabulation only once they are shipped to consumers, expected to be on June 18.) Olivia Rodrigo claims three songs in the Hot 100’s top 10, led by “Good 4 U” at No. 2, a week after debuting at No. 1. The track sports gains in all metrics, as it spends a second week atop Streaming Songs (62.7 million, up 45%). Rodrigo’s “Deja Vu” darts 13-3 on the Hot 100, surpassing its prior No. 8 peak registered upon its April 17 debut. Leading its lift, it charges 20-2 on Streaming Songs for a new high, up 79% to 32.8 million streams. (Chart déjà vu: The lyrics of Rodrigo’s “Deja Vu” shout out Billy Joel and his hit “Uptown Girl,” and both songs now boast No. 3 Hot 100 peaks. Joel’s classic reached the rank in November 1983. Rodrigo also sings about Glee in “Deja Vu.” The cast of the 2009-15 Fox TV series logged 207 entries, the second-most all-time after Drake’s 233, and is now mentioned in a hit ranking one spot higher than its best: the Glee Cast reached a No. 4 high, among three top 10s, with its breakthrough cover of Journey’s “Don’t Stop Believin’,” which hit No. 4 in June 2009. Plus, Rodrigo’s “Deja Vu” becomes the highest-charting Hot 100 hit by that title. Now at No. 3 after previously reaching No. 8, it surpasses Beyoncé’s song of the same name, featuring Jay-Z, a No. 4 hit in 2006, as well as J. Cole’s, which reached No. 7 in 2016.) Rounding out Rodrigo’s three simultaneous Hot 100 top 10s, “Traitor” debuts at',\n",
       " ('BTS',\n",
       "  67,\n",
       "  2): 'No. 9. Thanks to “Good 4 U,” “Deja Vu” and “Traitor,” all from her debut album Sour, Rodrigo is the first artist in the Hot 100’s history to chart three concurrent songs in the top 10 all from a first LP. Meanwhile, Rodrigo ups her count to four career Hot 100 top 10s, as “Good 4 U,” “Deja Vu” and “Traitor” follow “Drivers License” (also on Sour), which debuted at No. 1 in January and spent eight weeks on top. Elsewhere in the Hot 100’s top 10, Dua Lipa’s “Levitating,” featuring DaBaby, dips 3-4 after reaching No. 2 and “Leave the Door Open” by Silk Sonic, the duo of Bruno Mars and Anderson .Paak, descends 4-5 after two nonconsecutive weeks at No. 1. The latter adds a seventh week atop Radio Songs (89 million, down 1%), while ruling Hot R&B Songs for a 10th week and Hot R&B/Hip-Hop Songs for a fifth frame; both multi-metric charts use the same methodology as the Hot 100. Justin Bieber’s former one-week Hot 100 No. 1 “Peaches,” featuring Daniel Caesar and Giveon, keeps at No. 6; The Weeknd and Ariana Grande’s “Save Your Tears” rebounds 9-7 after two weeks at No. 1; Doja Cat’s “Kiss Me More,” featuring SZA, rises 10-8 after reaching No. 5; and, below Rodrigo’s “Traitor,” Masked Wolf’s “Astronaut in the Ocean” climbs 11-10 after hitting No. 6, as it leads the multi-metric Hot Rap Songs chart for a second week. Again, for all chart news, you can follow @billboard and @billboardcharts on both Twitter and Instagram and all charts (dated June 5), including the Hot 100 in its entirety, will refresh on Billboard.com tomorrow (June 2).',\n",
       " ('BTS',\n",
       "  68,\n",
       "  0): 'BTS‘ “Butter” rules the Billboard Hot 100 songs chart for a seventh week, encompassing its entire run on the ranking so far, dating to its debut at No. 1. Plus, Lil Nas X‘s “Montero (Call Me by Your Name)” returns to the Hot 100’s top five, rising 8-5, after it led the list in its debut week in April. It also becomes his first No. 1 on the Pop Airplay radio chart. The Hot 100 blends all-genre U.S. streaming (official audio and official video), radio airplay and sales data. All charts (dated July 17) will update on Billboard.com tomorrow (July 13) For all chart news, you can follow @billboard and @billboardcharts on both Twitter and Instagram. “Butter,” released on HYBE/BigHit Music/Columbia Records, drew 29.1 million radio airplay audience impressions (up 6%) and 10.8 million U.S. streams (down 1%) and sold 108,800 (down 29%) in the week ending July 8, according to MRC Data. (See below for details regarding a change, effective this week, to the Hot 100’s airplay tracking week.) The track adds a seventh week atop the Digital Song Sales chart and climbs 23-21 on Radio Songs and 31-26 on Streaming Songs. “Butter” concurrently enters the Pop Airplay top 10 (11-10), becoming BTS’ second top 10 on the mainstream top 40 radio-based chart, after “Dynamite” hit No. 5 last December. BTS is the first all-South Korean act with multiple Pop Airplay top 10s. One other artist from South Korea has reached the Pop Airplay top 10: soloist PSY, whose “Gangnam Style” hit No. 10 in October 2012. BTS is set to debut on next week’s, July 24-dated Hot 100 with its newest single, “Permission to Dance,” released Friday (July 9). Olivia Rodrigo’s “Good 4 U” holds at No. 2 on the Hot 100, seven weeks after it opened at No. 1. It posts a seventh week atop Streaming Songs (27.6 million, down 9%); holds at No. 6 on Radio Songs, with 61.3 million impressions, up 15%, as it wins the Hot 100’s top Airplay Gainer award for a sixth week; and falls 5-9 on Digital Song Sales (8,200, down 14%). Dua Lipa’s “Levitating,” featuring DaBaby, rebounds 4-3 on the Hot 100, after reaching No. 2, as it tallies a third week at No. 1 on Radio Songs (79.7 million, down 2%), while Doja Cat’s “Kiss Me More,” featuring SZA, dips to No. 4 from its No. 3 Hot 100 high. Lil Nas X’s “Montero (Call Me by Your Name)” jumps 8-5 on the Hot 100, returning to the top five for the first time since the chart dated May 1, after it launched at No. 1 on the list dated April 10. As it rises 5-4 on Radio Songs (65.5 million, up 7%), “Montero” hits No. 1 on the Pop Airplay chart, becoming Lil Nas X’s first leader on the ranking. He previously peaked as high as No. 3 on Pop Airplay with his breakthrough smash “Old Town Road,” featuring Billy Ray Cyrus, in 2019; the song ruled the Hot 100 for a record 19 weeks. Lil Nas X leads his fifth airplay chart. He previously topped (all in 2019): Rhythmic Airplay, with “Road” (three weeks) and “Panini” (one week); Dance/Mix Show Airplay and Rap Airplay, with “Road” (four weeks each); and Mainstream R&B/Hip-Hop Airplay, with “Road” (three weeks). (“Montero” makes its three-spot jump in a tightly contested part of the Hot 100, with the songs at Nos. 5 through 9 all close in chart points, and each down week-over-week; The track sports the smallest overall decrease, and greatest airplay gain, among them.) Ed Sheeran’s “Bad Habits” descends 5-6',\n",
       " ('BTS',\n",
       "  68,\n",
       "  1): 'in its second week on the Hot 100. It pushes 11-10 on Radio Songs (43.4 million), where it becomes his 10th top 10; at three weeks, it ties “I Don’t Care,” with Justin Bieber, in 2019, for Sheeran’s fastest flight to the region. “Leave the Door Open” by Silk Sonic, the duo of Bruno Mars and Anderson .Paak, slips 6-7 on the Hot 100, after two nonconsecutive weeks on top. It adds a 13th week at No. 1 on Hot R&B Songs and an eighth frame atop Hot R&B/Hip-Hop Songs, with both multi-metric charts employing the same methodology as the Hot 100. Related Justin Bieber Performs Three Shows in 24 Hours During Las Vegas Blitz Rounding out the Hot 100’s top 10, Justin Bieber’s former one-week leader “Peaches,” featuring Daniel Caesar and Giveon, backtracks 7-8; The Weeknd and Ariana Grande’s “Save Your Tears” holds at No. 9, after two weeks at No. 1; and Olivia Rodrigo’s “Deja Vu” keeps at No. 10, after reaching No. 3. Change to Hot 100’s airplay tracking week: As of this week’s, July 17-dated Hot 100, the airplay tracking week for the chart, as well as for other genre-based Billboard airplay-, sales- and streaming-based hybrid “Hot”-named surveys, shifts to a Friday through Thursday cycle (from Monday-Sunday) — aligning the radio measurement week for the charts, and Radio Songs, with the Friday-Thursday period utilized for sales and streaming, this week reflecting July 2-8. The Hot 100 and genre “Hot” charts will continue to be finalized each Monday, with the Hot 100’s top 10 and other chart highlights still to be revealed each Monday afternoon (except for weeks affected by holidays) via the weekly top 10 recap story on billboard.com and social posts, while charts in full will continue to update on billboard.com each Tuesday morning. The other “Hot” charts that use the Radio Songs data switching to a Friday-Thursday airplay tracking week are: Hot Country Songs, Hot R&B/Hip-Hop Songs, Hot R&B Songs, Hot Rap Songs, Hot Rock & Alternative Songs, Hot Alternative Songs, Hot Hard Rock Songs, Hot Latin Songs, Hot Dance/Electronic Songs, Hot Christian Songs and Hot Gospel Songs. (This change does not affect format-specific radio format charts, such as Pop Airplay, Country Airplay, Mainstream R&B/Hip-Hop Airplay, Rock & Alternative Airplay and Latin Airplay, among others.) Again, for all chart news, you can follow @billboard and @billboardcharts on both Twitter and Instagram and all charts (dated July 17), including the Hot 100 in its entirety, will refresh on Billboard.com tomorrow (July 13).',\n",
       " ('BTS',\n",
       "  69,\n",
       "  0): 'BTS‘ “Butter” rebounds to No. 1 on the Billboard Hot 100 songs chart, from No. 7, adding an eighth week on top and tying for the chart’s longest command of 2021, first logged by Olivia Rodrigo’s “Drivers License” in January-March. “Butter” replaces BTS’ own “Permission to Dance,” which launched at No. 1 on the Hot 100 a week earlier, succeeding “Butter,” which had spent the previous seven weeks at No. 1. “Permission to Dance” falls to No. 7. The Hot 100 blends all-genre U.S. streaming (official audio and official video), radio airplay and sales data. All charts (dated July 31) will update on Billboard.com tomorrow (July 27) For all chart news, you can follow @billboard and @billboardcharts on both Twitter and Instagram. “Butter,” released on HYBE/BigHit Music/Columbia Records, drew 30.7 million radio airplay audience impressions (up 2%) and 8.8 million U.S. streams (down 21%) in the week ending July 22, according to MRC Data. Despite its airplay gain, the track drops 20-21 on Radio Songs. On Streaming Songs, it falls 26-40. As “Butter” soars back to No. 1 on the Hot 100 from No. 7, swapping spots with “Permission to Dance” (1-7), sales most sharply tell the story of the stark rank changes. A week after “Permission to Dance” opened with 140,100 downloads sold (via its original and instrumental digital versions, each on sale for 69 cents), following its July 9 release, it drops by 39% to 85,000 in the week ending July 22 (encompassing those two digital versions, plus an “alternate single cover” option released in the group’s webstore the last day of the tracking week, also for 69 cents). Meanwhile, “Butter” resurges by 132% to 115,600 sold from 49,800, good for the Hot 100’s top Sales Gainer award. “Butter” tallies an eighth week atop the Digital Song Sales chart (2-1), supplanting “Permission to Dance” (1-2). As “Butter” replaces “Permission to Dance” at No. 1 on the Hot 100, a week after “Permission to Dance” took over for “Butter,” BTS is the first act to displace itself at No. 1 with a new leader and then send the previous No. 1 back to the summit with no other acts holding the top spot in between. Olivia Rodrigo’s “Good 4 U” holds at No. 2 on the Hot 100, nine weeks after it premiered at No. 1. It keeps at No. 2 on Streaming Songs, after seven weeks on top (24.4 million, down 5%); rises 4-3 on Radio Songs (71.5 million, up 10%); and holds at No. 12 on Digital Song Sales (7,100, down 4%). (See below for more on Rodrigo’s Hot 100 and airplay chart moves.) Dua Lipa’s “Levitating,” featuring DaBaby, rebounds 4-3 on the Hot 100, after reaching No. 2, as it logs a fifth week at No. 1 on Radio Songs, up 2% to a new weekly-best 81.4 million audience impressions. It also marks Lipa’s best Radio Songs command outright in terms of weeks on top, surpassing the four-week reign of her prior leader, “Don’t Start Now,” in March-April 2020. Plus, “Levitating” hits No. 1 on the Adult Contemporary chart, becoming Lipa’s first leader on the radio ranking. She previously reached the AC top five with “Don’t Start Now” (No. 5, this January) and “Break My Heart” (No. 4, April). (Lipa additionally debuts two songs on the latest Hot 100: she’s featured on Pop Smoke’s “Demeanor,” at No. 86, while her own “Love Again” enters at No. 89. The latter is new on the chart, but its origins trace back almost a century: it borrows the signature section of Lew Stone & His Monseigneur Band and Al',\n",
       " ('BTS',\n",
       "  69,\n",
       "  1): 'Bowlly’s “My Woman,” which was released in 1933 and co-written by Bing Crosby. White Town’s “Your Woman,” which hit No. 23 on the Hot 100 in 1997, also incorporates the classic instrumental hook.) The Kid LAROI and Justin Bieber’s “Stay” dips to No. 4 on the Hot 100, a week after soaring in at No. 3. Still, it notches a second week atop Streaming Songs (28.6 million, down 6%) and enters Radio Songs at No. 35 (22.1 million, up 71%), as it wins the Hot 100’s top Airplay Gainer honor. (The Kid LAROI also earns his first No. 1 on a Billboard radio chart, as prior single “Without You,” which hit No. 8 on the Hot 100 in May, takes over atop Adult Pop Airplay.) Doja Cat’s “Kiss Me More,” featuring SZA, repeats at No. 5 on the Hot 100, after hitting No. 3; Ed Sheeran’s “Bad Habits” is steady at No. 6, three weeks after it debuted at its No. 5 high; and, below BTS’ “Permission to Dance,” Lil Nas X’s “Montero (Call Me by Your Name)” keeps at No. 8, following a week at No. 1. Olivia Rodrigo’s “Deja Vu” climbs 10-9 on the Hot 100, after reaching No. 3. It concurrently enters the Radio Songs top five (7-5; 61.1 million, up 6%). Meanwhile, Rodrigo rules the Pop Airplay radio-based chart for a second week with “Good 4 U,” as “Deja Vu” ascends 5-4 and “Traitor” debuts at No. 40. Those three songs (with “Traitor” not being promoted as an official single) follow her breakthrough smash “Drivers License,” which topped Pop Airplay for five weeks in March-April, with all four tracks from her debut album, Sour. Rounding out the Hot 100’s top 10, The Weeknd and Ariana Grande’s “Save Your Tears” drops 9-10, after two weeks at No. 1. Again, for all chart news, you can follow @billboard and @billboardcharts on both Twitter and Instagram and all charts (dated July 31), including the Hot 100 in its entirety, will refresh on Billboard.com tomorrow (July 27).',\n",
       " ('BTS',\n",
       "  7,\n",
       "  0): 'BTS Breaks US Itunes Kpop Record With ‘Spring Day’ BTS\\' new track \"Spring Day\" swept through various local charts to claim the top spot shortly after its release. The track even made Kpop history as the first song from a South Korean group to enter the U.S. iTunes\\' Top 10 song list. It appears that 2017 will be another milestone year for the seven-member boy band BTS. The K-pop group\\'s new song \"Spring Day\" landed at number eight on the U.S. iTunes Top 10 song chart, Soompi reported. The more than four-minute song is one of the four new tracks included in BTS\\' repackaged album \"Wing: You Never Walk Alone.\" Aside from \"Spring Day,\" the said album also includes \"Not Today,\" \"Outro: Wings,\" as well as \"A Supplementary Story: You Never Walk Alone.\" Advertisement Meanwhile, BTS\\' \"Spring Day\" achieved the said milestone several hours after its Feb. 13 midnight release. As of 8:30 a.m. KST, the said song rose to the bottom half of the U.S. iTunes Top 10 list with \"Not Today\" tracking at number 11. Moreover, the K-pop group\\'s new album also debuted at the top of several iTunes charts. \"You Never Walk Alone\" nabbed the first place on iTunes album charts in Asian countries such as Singapore, Thailand, Taiwan, Vietnam, Malaysia, Philippines, Indonesia, Armenia, Brunei, Kazakhstan, as well as Finland, Peru, and Sweden. In other news, \"Spring Days\" also reigned over eight major music sites in South Korea such as Melon, Mnet, Genie, Olleh, Soribada, and others. The music streaming site Melon even experienced temporary server issues due to the influx of fans listening to the song, Yonhap News reported. \"Spring Days,\" as well as the K-pop group\\'s new album \"You Never Walk Alone\" are expected to replicate the same level of success as BTS\\' previous tracks and albums. With the band\\'s second album \"Wings\" registering an impressive 751,000 sale count, the group\\'s latest album is also set to reach or exceed the same milestone. BTS\\' new track \"Spring Day\" and new album \"You Never Walk Alone\" were released on Feb. 13, Monday. Advertisement Advertisement Like us and Follow us Follow @Koreaportal and © 2025 Korea Portal, All rights reserved. Do not reproduce without permission.',\n",
       " ('BTS',\n",
       "  70,\n",
       "  0): 'BTS bounds onto the Billboard Hot 100 songs chart at No. 1 with its new single “Permission to Dance.” The South Korean septet supplants itself at the top spot, as the group’s own “Butter” falls to No. 7 after seven weeks at No. 1. “Dance” launches as the group’s fifth Hot 100 leader. Plus, The Kid LAROI and Justin Bieber debut on the Hot 100 at No. 3 with “Stay.” The song marks the former’s third top 10, and a new career high, and the latter’s 24th top 10. The Hot 100 blends all-genre U.S. streaming (official audio and official video), radio airplay and sales data. All charts (dated July 24) will update on Billboard.com tomorrow (July 20) For all chart news, you can follow @billboard and @billboardcharts on both Twitter and Instagram. “Permission to Dance,” released on HYBE/BigHit Music/Columbia Records, is the 1,126th No. 1 in the Hot 100’s 62-year history, and the 55th to enter on top. Here’s a deeper look at its entrance. Streams, airplay & sales: Following its July 9 release, “Permission to Dance” drew 15.9 million U.S. streams and 1.1 million radio airplay audience impressions and sold 140,100 downloads (via its original and instrumental digital versions, each on sale for 69 cents) in the week ending July 15, according to MRC Data. The track debuts atop the Digital Song Sales chart, where it’s BTS’ eighth No. 1, extending the act’s record for the most among groups. It also begins at No. 8 on Streaming Songs. BTS’ 5th Hot 100 No. 1: As BTS scores its fifth Hot 100 No. 1, here’s a recap of the group’s leaders: “Dynamite,” three weeks at No. 1, beginning Sept. 5, 2020 “Savage Love (Laxed – Siren Beat),” with Jawsh 685 and Jason Derulo, one, Oct. 17, 2020 “Life Goes On,” one, Dec. 5, 2020 “Butter,” seven, June 5, 2021 “Permission to Dance,” one to-date, July 24, 2021 Fastest 5 No. 1s since …: BTS has achieved its Hot 100 No. 1s over a span of 10 months and two weeks. That’s the quickest accumulation of five leaders since Michael Jackson tallied five, all from his album Bad, over nine months and two weeks in 1987-88: “I Just Can’t Stop Loving You,” with Siedah Garrett, “Bad,” “The Way You Make Me Feel,” “Man in the Mirror” and “Dirty Diana.” The Beatles hold the mark for the quickest span of five Hot 100 No. 1s, having earned their first five over exactly six months in 1964: “I Want to Hold Your Hand,” “She Loves You,” “Can’t Buy Me Love,” “Love Me Do” and “A Hard Day’s Night.” 4th No. 1 debut: As “Dynamite,” “Life Goes On,” “Butter” and “Permission to Dance” have all debuted at No. 1 on the Hot 100, BTS is the fourth act with at least four first-place arrivals. Ariana Grande leads all acts with five No. 1 starts; Justin Bieber and Drake also each boast four. BTS replaces itself on top: With “Permission to Dance” replacing “Butter” atop the Hot 100, BTS is the first artist to dethrone itself since Drake, whose “In My Feelings” ended the eight-week reign of “Nice for What” on the July 21, 2018 chart. (Before that, on the April 21, 2018-dated survey, “Nice” soared in at No. 1, wrapping the rule of his “God’s Plan.”) Sheeran’s 4th No. 1 as a writer: “Permission to Dance” sports four writer credits: Jenna Andrews, “Steve Mac” McCutcheon, John McDaid and Ed Sheeran. Andrews adds her second Hot 100 No. 1 as a writer, following BTS’ “Butter,” and McCutcheon and McDaid also each score their second,',\n",
       " ('BTS',\n",
       "  70,\n",
       "  1): 'after they teamed on Sheeran’s 12-week 2017 No. 1 “Shape of You.” Sheeran leads the Hot 100 with a fourth song as a writer, following Justin Bieber’s “Love Yourself” (two weeks at No. 1, 2016) and his own “Shape” and “Perfect” (six weeks, 2017-18). “Dance” floor ceiling: BTS sends the ninth song with the word “dance” in its title to the top of the Hot 100. Here’s the full “dance” card: “Save the Last Dance for Me,” The Drifters, three weeks at No. 1, beginning Oct. 17, 1960 “Let’s Dance,” David Bowie, one, May 21, 1983 “Flashdance…What a Feeling,” Irene Cara, six, May 28, 1983 “I Wanna Dance With Somebody (Who Loves Me),” Whitney Houston, two, June 27, 1987 “Batdance,” Prince, one, Aug. 5, 1989 “Gonna Make You Sweat (Everybody Dance Now),” C+C Music Factory, two, Feb. 9, 1991 “Just Dance,” Lady Gaga feat. Colby O’Donis, three, Jan. 17, 2009 “One Dance,” Drake feat. WizKid & Kyla, 10, May 21, 2016 “Permission to Dance,” BTS, one week to-date, July 24, 2021 (Four songs with “dancing” in their titles have topped the Hot 100, all, unsurprisingly, at the height of the disco era: “You Should Be Dancing,” Bee Gees, 1976; “You Make Me Feel Like Dancing,” Leo Sayer, 1977; “Dancing Queen,” ABBA, 1977; and “Shadow Dancing, Andy Gibb, 1978.) His song: Meanwhile, “Permission to Dance” features the lyric, and instruction (with which few would surely argue), “When it all seems like it’s wrong/ Sing along to Elton John.” John is, of course, no stranger to the top of the Hot 100, having achieved nine No. 1s, from “Crocodile Rock” in 1973 to “Candle in the Wind 1997″/”Something About the Way You Look Tonight” in 1997-98. (The legend gives himself permission to sing along to BTS.) Olivia Rodrigo’s “Good 4 U” holds at No. 2 on the Hot 100, eight weeks after it led in its debut week. It drops to No. 2 on Streaming Songs after seven weeks on top (25.7 million, down 7%); climbs 6-4 on the Radio Songs chart (65.1 million impressions, up 6%); and falls 9-12 on Digital Song Sales (7,400, down 10%). “Good 4 U” concurrently becomes Rodrigo’s second No. 1 on the mainstream top 40 radio-based Pop Airplay chart, climbing 3-1. “Drivers License” reigned for five weeks in March-April (and crowned the Hot 100 for eight weeks). Meanwhile, her radio single in between, “Deja Vu,” holds at its No. 5 high on Pop Airplay (after reaching No. 3 on the Hot 100). The Kid LAROI and Justin Bieber roar onto the Hot 100 at No. 3 with “Stay.” The song, released July 9, starts with 34.7 million streams, 12.9 million in radio audience and 12,000 sold. It enters atop Streaming Songs, where it’s The Kid LAROI’s first No. 1 and Bieber’s sixth, and No. 5 on Digital Song Sales. The Kid LAROI lands his third Hot 100 top 10, and a new career best, after “Hate the Other Side,” by Juice WRLD and Marshmello featuring Polo G and The Kid LAROI, debuted and peaked at No. 10 in July 2020 and “Without You,” with Miley Cyrus, hit No. 8 this is May. Bieber earns his 24th Hot 100 top 10. He’s the 13th artist with at least that many, after Drake (45), Madonna (38), The Beatles (34), Rihanna (31), Michael Jackson (30), Taylor Swift (29), Mariah Carey, Stevie Wonder (28 each), Janet Jackson, Elton John (27 each) and Lil Wayne and Elvis Presley (25 each). Dua Lipa’s “Levitating,” featuring DaBaby, drops 3-4 on the Hot 100, after reaching No. 2, as it claims a fourth week',\n",
       " ('BTS',\n",
       "  70,\n",
       "  2): 'at No. 1 on Radio Songs (79.9 million, essentially even week-over-week), while Doja Cat’s “Kiss Me More,” featuring SZA, slips 4-5, after hitting No. 3. Ed Sheeran’s “Bad Habits” keeps at No. 6 on the Hot 100, two weeks after it debuted at No. 5. It wins top Airplay Gainer honors, as it rises 10-9 on Radio Songs (49.8 million, up 15%). As BTS’ “Butter” falls to No. 7 after spending its first seven weeks on the Hot 100 at No. 1, it descends to No. 2, also after seven weeks on top, on Digital Song Sales (49,800 sold, down 54%) and 26-27 on Streaming Songs, although with a 4% gain to 11.2 million. It pushes 21-20 on Radio Songs (29.7 million, up 2%). (Driven by its sales decline, it makes the steepest slide from No. 1 on the Hot 100 after at least seven weeks on top since Santana’s “Maria Maria,” featuring The Product G&B, fell to No. 8 after 10 weeks at the summit in June 2000.) Rounding out the Hot 100’s top 10, Lil Nas X’s “Montero (Call Me by Your Name)” backtracks 5-8, after a week at No. 1; The Weeknd and Ariana Grande’s “Save Your Tears” holds at No. 9, after two weeks on top; and Olivia Rodrigo’s “Deja Vu” is steady at No. 10. Again, for all chart news, you can follow @billboard and @billboardcharts on both Twitter and Instagram and all charts (dated July 24), including the Hot 100 in its entirety, will refresh on Billboard.com tomorrow (July 20).',\n",
       " ('BTS',\n",
       "  71,\n",
       "  0): 'If you purchase an independently reviewed product or service through a link on our website, The Hollywood Reporter may receive an affiliate commission. BTS have consistently topped the charts with their string of international hits, and they hit No. 1 again earlier this summer with the group’s first official book release landing at the top of Amazon’s best-seller list. Beyond the Story: 10-Year Record of BTS was released July 9 and immediately shot to No. 1 on the overall book charts. Now, fans can get the hardcover on sale for just $22 on Amazon, a 50 percent discount from its listed retail price of $45. The BTS book sale comes on the heels of the group’s Yet to Come concert film, which is set to stream on Amazon Prime Video beginning Nov. 9. Amazon Released by Flatiron Books, Beyond the Story is the first-ever official book release from BTS and celebrates the 10th anniversary of the group’s debut in June 2013. The 544-page book features new interviews with all seven members, a behind-the-scenes look at their albums and music videos, and new photos that are being released to the public for the first time. First teased in May, the official cover for the book was unveiled in June to much fanfare. But the publishers say this book is more than just hype, noting that author Myeongseok Kang spent more than three years covering the band, with unprecedented access to the group that few writers have had before. The book is presented chronologically, with seven chapters tracing the BTS story, from the group’s formation, to their rise to fame, to their current hopes and dreams. The publisher notes call the book a “sincere, lively and deep story” that will “illuminate their musical journey from multiple angles and discuss its significance.” The book also features more than 300 scannable QR codes that will let readers access trailers, music videos and other fun features online about the group. Amazon Beyond the Story is available to purchase now as a hardcover book on Amazon for $22 (half-off the list price). You can also download it as an audiobook, with the chapters read by Kim Young-Gi and Park Chan-won, two voiceover artists who were chosen by BTS to narrate their story. As for Yet to Come: Amazon Prime members can watch the BTS concert film online free with their subscription. Not a Prime member? Get a 30-day free trial here.',\n",
       " ('BTS',\n",
       "  72,\n",
       "  0): 'K-pop superstars BTS received South Korea\\'s prestigious Hwagwan Order of Cultural Merit medals at a ceremony on Wednesday (24Oct18). The boyband, who have become international stars over the past two years, were honoured as one of their homeland\\'s greatest cultural exports at an event in the country\\'s capital Seoul, and thanked their fans for their support after receiving their medals. Group members Jin, Suga, J-Hope, RM, Jimin, V, and Jungkook are the youngest Koreans to earn the prestigious accolade. Announcing his government\\'s Ministry of Culture, Sports and Tourism\\'s plans to honour the group earlier this month, South Korea\\'s Prime Minister Lee Nak-yeon told United Press International: \"BTS has made a great contribution to promoting not only Korean culture but also Korean language Hangul as many of its fans sing along BTS songs in the Korean language.\" Presidential office spokesman Kim Eui-kyeom added: \"The government decided to award members of BTS a Hwagwan Order of Cultural Merit for their contribution to spreading Korean culture overseas and promotion of popular culture.\" Order of Cultural Merit awards are given to those deemed to have served the country well in culture and the arts. They come in five levels, with BTS receiving the lowest level honour. Previous recipients of the medals include Gangnam Style rapper Psy and Oldboy director Park Chan-wook. The group recently arrived back to their home nation after playing to sell out crowds in North America and Europe. They will enjoy a short break before continuing their Love Yourself world tour in Japan next month. The medals are not the only gong they have scooped over the past week; they were double winners at the BBC Radio 1 Teen Awards in London on Sunday.',\n",
       " ('BTS',\n",
       "  73,\n",
       "  0): 'BTS’ seven members were awarded South Korea’s Hwagwan Orders of Cultural Merit in Seoul on Wed (Oct. 24). The septet — RM (Kim Namjoon), Suga (Min Yoongi), J-Hope (Jung Hoseok), Jin (Kim Seokjin) Park Jimin, V (Kim Taehyung), and Jeon Jungkook — are the youngest recipients to ever receive the honor. They were awarded their medals at the 2018 Korean Popular Culture & Arts Awards, held at Seoul’s Olympic Hall. Explore Explore BTS See latest videos, charts and news See latest videos, charts and news Earlier this month, South Korean prime minister Lee Nak-yeon announced that the Cabinet had decided to award the chart-topping group the honor for their efforts at spreading South Korean culture and language throughout the world. Cultural Minister Do Jong-hwan gave the BTS members their medals during Wednesday’s ceremony. In their acceptance speeches, BTS thanked their fandom, ARMY, and those who they’ve worked with, and reflected on the recognition. “We’re often overseas, and many people sing along with our songs in Korean and tell us proudly that they studied Korean,” said Jin according to Soompi. “It makes me proud. We’ll continue to try to increase knowledge about our culture.” “I’m happy that it seems that we’re really becoming the hope of popular culture,” said J-Hope, referencing his stage name. “The Hwagwan Order of Cultural Merit is such an immense award. It’s an award that carries weight and includes the hard work of many staff members, BTS’s blood and sweat, and the cheers of ARMY all over the world.” Jimin later took to social media to thank fans, saying, “Together [I/we’ve] received this award. Seriously thank you.” Aside from BTS, other musicians including Red Velvet, who performed in North Korea as part of a diplomatic contingent in April, and Guckkasten, whose Ha Hyun-woo performed at the Olympics Opening Ceremony in February, were at the event, where both were winners of Minister of Culture, Sports and Tourism’s Commendations. Other popular entertainers, including Yoo Jae Suk, and industry creatives were also awarded at this year’s event. BTS returned to South Korea earlier this week after spending over 50 days in North America and Europe amid their Love Yourself world tour. During their jaunt, the group spoke at the United Nations about self-affirmation while in New York, and performed in front of and met the president of South Korea, Moon Jae-in while in France. They will release “Waste It On Me” with Steve Aoki on Thursday (Oct. 25)',\n",
       " ('BTS',\n",
       "  74,\n",
       "  0): 'BTS has been chosen as one of Time Magazine’s “Next Generation Leaders,” and the K-pop stars sat down with the outlet to discuss their career, their impact as one of the most popular acts of the generation, and what it means to represent their country on a global scale. Explore Explore BTS See latest videos, charts and news See latest videos, charts and news “As a Korean, we love our country and we’re proud of our country so much,” said RM in a video released by Time today (Oct. 10). “And it’s even just an honor to be called an ambassador of Korean K-pop.” RM recently gave his “Speak Yourself” speech in front of the United Nations during a launch of a new UNICEF program. During it, he connected the group’s Love Yourself messaging with the idea that people need to speak up for themselves and find their way in the world based on their own desires rather than the world around them. BTS on the Oct. 22, 2018, cover of Time magazine Time “Many in our parents’ generation were born right after the Korean War,” said Suga. “And so they grew up not being able to eat or dress well. But in our generation, we — our parents’ sons — are spreading Korean culture as its representatives, and seeing how much of Korean culture we are able to spread these days. Those from my parents’ or my grandparents’ generation, even more so than those from our generation, are very proud of us. They love seeing us on the news. And so for me, it’s enjoyable to see my father proud of things like that.” Time’s annual “Next Generation Leaders” list highlights young people in a wide variety of industries who are reshaping the world around them. BTS topped the Billboard 200 albums chart not once but twice this year with their sets Love Yourself: Tear and Love Yourself: Answer, and are currently in Europe amid a global, sold-out world tour. Along with the video, Time also released a magazine cover featuring the superb septet, which will reportedly appear on the global edition, and a written interview with the group, during which the men talked about several topics including their approach to creating music with empathy “that people can relate to,” according to Suga. The 2018 list of Time’s “Next Generation Leaders” also included other musicians such as The Weeknd, Ariana Grande, and Christine and the Queens.',\n",
       " ('BTS',\n",
       "  75,\n",
       "  0): '2017 was the year of K-pop — not only on Billboard’s charts, but also on Twitter. In the social media app’s Year On Twitter 2017, released Tuesday (Dec. 5), BTS are the most tweeted-about musicians in the U.S. They’re also the most tweeted-about celebrities across the globe, followed immediately by fellow K-pop group SEVENTEEN. Boy band MONSTA X also made the top 10. BTS, with 10.8 million followers, broke records just this month with the highest-charting entry into the Billboard Hot 100 for a K-pop group, with “MIC Drop” debuting at No. 28. Explore See latest videos, charts and news BTS Exo Fifth Harmony See latest videos, charts and news Another Korean sensation in the Twittersphere are EXO, claiming the most-tweeted song hashtag for their single “Ko Ko Bop.” They’re also the most-followed celebrity that joined in 2017, garnering 1.65 million followers since signing on in June. Some other non-Korean favorites on Twitter include Fifth Harmony, Harry Styles and Justin Bieber. See below for the Twitter Year In Music recap, including the most devoted fan army, the most retweeted statuses, the most buzzed-about broadcasts and the stars fans just couldn’t stop chatting about in 2017. Top 10 most tweeted-about music artists in the U.S. 1. BTS (@BTS_twt) 2. Nicki Minaj (@NICKIMINAJ) 3. Harry Styles (@Harry_Styles) 4. Chance the Rapper (@chancetherapper) 5. Niall Horan (@NiallOfficial) 6. Fifth Harmony (@FifthHarmony) 7. Justin Bieber (@justinbieber) 8. Shawn Mendes (@ShawnMendes) 9. Rihanna (@rihanna) 10. Ariana Grande (@ArianaGrande) Top 10 most buzzed-about celebrities around the world 1. BTS (@BTS_twt) 2. SEVENTEEN (@pledis_17) 3. Camila Cabello (@Camila_Cabello) 4. Justin Bieber (@justinbieber) 5. Maine Mendoza (@mainedcm) 6. Niall Horan (@NiallOfficial) 7. Harry Styles (@Harry_Styles) 8. Ethan Dolan (@EthanDolan) 9. Monsta X (@OfficialMonstaX) 10. Grayson Dolan (@GraysonDolan) Televised events the Twittersphere kept tweeting about 1. Miss Universe 2. 2017 Billboard Music Awards 3. Super Bowl 51 Songs with the most # mentions 1. Ko Ko Bop – EXO (#kokobop) 2. Hey Ma – Pitbull & J Balvin feat. Camila Cabello (#heyma) 3. You Are – GOT7 (#youare) 4. Work From Home – Fifth Harmony (#workfromhome) 5. Reggaeton Lento – CNCO (#reggaetonlento) 6. Hey DJ – CNCO & Yandel (#heydj) 7. Love Yourself – Justin Bieber (#love_yourself) 8. Never Ever – GOT7 (#neverever) 9. Exs and Ohs – Elle King (#exsandohs) 10. PILLOWTALK – Zayn (#pillowtalk) The biggest fan armies on Twitter 1. #lovatics 2. #littlemonsters 3. #harmonizers 4. #beliebers 5. #5sosfam The most popular celebrities who joined in 2017 1. EXO (@weareoneEXO) 2. Wanna One (@WannaOne_twt) 3. LaVar Ball (@Lavarbigballer) 4. Chris Hughes (@chrishughes_22) 5. Ryan Tedder (@RyanTedder) 6. Morrissey (@officialmoz) 7. Rachel Lindsay (@TheRachLindsay) 8. Hilarie Burton (@HilarieBurton) 9. Asahd Khaled (@asahdkhaled) The 10 most retweeted tweets HELP ME PLEASE. A MAN NEEDS HIS NUGGS pic.twitter.com/4SrfHmEMo3 — Carter Wilkerson (@carterjwm) April 6, 2017 “No one is born hating another person because of the color of his skin or his background or his religion…” pic.twitter.com/InZ58zkoAm — Barack Obama (@BarackObama) August 13, 2017 With the current devastation in Houston, we are pledging $0.15 for every RT this gets! Please forward this along to help out those in need! pic.twitter.com/lodyOBE0eG — Penn State IFC (@PennStateIFC) August 30, 2017 broken. from the bottom of my heart, i am so so sorry. i don’t have words. — Ariana Grande (@ArianaGrande) May 23, 2017 Thank you for everything. My last ask is the same as my first. I’m asking you to believe—not in my ability to create change, but in yours. — President Obama (@POTUS44) January 11, 2017 U bum @StephenCurry30 already said he ain’t going! So therefore ain’t no invite. Going to',\n",
       " ('BTS',\n",
       "  75,\n",
       "  1): 'White House was a great honor until you showed up! — LeBron James (@KingJames) September 23, 2017 It’s been the honor of my life to serve you. You made me a better leader and a better man. — President Obama (@POTUS44) January 20, 2017 Leo and I are donating 6 lbs of dog food to Houston for every retweet this gets!!!! RT RT RT RT!! pic.twitter.com/bcTT905knP — Sam (@SamMartin_6) August 31, 2017',\n",
       " ('BTS',\n",
       "  76,\n",
       "  0): 'As if there was any doubt already, BTS are truly a global phenomenon. According to year-end data from Twitter released on Wednesday (Dec. 5), the K-pop boy band was 2018’s most tweeted-about user globally, topping the tally for the second year in a row. As well, band member Jimin, was the ninth most tweeted-about celebrity in the United States, even without his own Twitter handle. BTS, who have 17.2 million followers currently, were also the most tweeted-about musicians in the U.S. and globally had the most liked tweet of 2018 — their video for Drake‘s #InMyFeelingsChallenge posted on July 23 amassed over 1.6 million likes and over 13.7 million views. Check out the tweet below: Meanwhile, #nowplaying was the most used hashtag globally Feb. 25, the day of the Olympics closing ceremony, was the day with the most tweets this year and there were more than 500 million GIFs tweeted this year — an average of 1.6 million a day, or over 1,000 a minute. Specific to music, Lady Gaga had the third most globally quoted tweet of 2018 with a post from Nov. 6, 2012, that resurfaced and became a meme used to express frustration and excitement. Check out her tweet below: AAAAAAAAAAAAAHHHHHRHRGRGRGRRRGURBHJB EORWPSOJWPJORGWOIRGWSGODEWPGOHEPW09GJEDPOKSD!!!!!!!!!!!!!!!0924QU8T63095JRGHWPE09UJ0PWHRGW — Lady Gaga (@ladygaga) November 7, 2012 In the U.S. specifically, March For Our Lives was the most tweeted-about movement, Black Panther was the most tweeted-about movie, Saturday Night Live was the most tweeted-about television show and 13 Reasons Why was the most tweeted-about streaming show. As well, musicians dominated the most tweeted-about celebrities list with nine out of the top 10 slots. See the full U.S. lists below. The Most Tweeted-About Celebrities 1. BTS (@BTS_twt)? 2. LeBron James (@KingJames) 3. Kanye West (@KanyeWest) 4. Drake (@Drake) 5. EXO (@weareoneEXO) 6. Ariana Grande (@ArianaGrande) 7. Cardi B (@iamCardiB) 8. Beyonce (@Beyonce) 9. #Jimin *see below for explanation* 10. Nicki Minaje (@NickiMinaj) The Most Tweeted-About Musicians: 1. @BTS_twt 2. @KanyeWest 3. @Drake 4. @weareoneEXO 5. @ArianaGrande 6. @iamCardiB 7. @Beyonce 8. #Jimin *see below for explanation* 9. @NickiMinaj 10. @Rihanna The Most Tweeted-About Movements: 1. March For Our Lives 2. NFL Protests 3. Students Stand Up 4. Me Too 5. Black Lives Matter The Most Tweeted-About Movies: 1. Black Panther 2. The Avengers: Infinity War 3. The Incredibles 2 4. Star Wars: The Last Jedi 5. Deadpool 2 6. Love, Simon 7. A Wrinkle in Time 8. Jurassic World: Fallen Kingdom 9. Crazy Rich Asians 10. The Shape of Water The Most Tweeted-About TV Shows: 1. Saturday Night Live 2. Roseanne 3. Grey’s Anatomy 4. The Walking Dead 5. Big Brother 6. The Voice 7. Live PD 8. Supernatural 9. Game of Thrones 10. Riverdale The Most Tweeted-About Streaming Shows: 1. 13 Reasons Why 2. Stranger Things 3. Black Mirror 4. Queer Eye 5. The Handmaid’s Tale The Most Tweeted-About Athletes: 1. LeBron James 2. Colin Kaepernick 3. Kobe Bryant 4. Kyrie Irving 5. Tom Brady 6. Dwyane Wade 7. Serena Williams 8. Kawhi Leonard 9. Chris Paul 10. Stephen Curry UPDATE: Twitter issued a statement on Wednesday correcting its list and stating that Jimin of BTS, who does not have his own Twitter account, was actually the eighth most tweeted celebrity. The vast majority of BTS fans use the hashtag #jimin when referring to him. The list had originally credited this position to the @jminpark07 Twitter account belonging to another Jimin Park, a singer with 587k followers.',\n",
       " ('BTS',\n",
       "  77,\n",
       "  0): 'BTS arrive for their first ever UK shows by private jet. They have been using it on the US leg of their world tour, which culminated in a show to 40,000 people at New York’s Citi Field on 6 October, three days before playing to as many people again across two nights at the O2 Arena in London. They have racked up two US No 1 albums and billions of global streams, and were recently invited to the UN as Unicef ambassadors, where their charismatic leader, RM, made a speech, in English, on self-acceptance. Milestones such as these are monumental for any artist, but in reaching them BTS – rappers Suga, RM and J-hope and vocalists Jimin, V, Jin and Jungkook – have changed the face of pop, as the first Korean group to reach the upper echelons of the western music industry. Ethereal-looking Jimin broke down at the end of the Citi Field show. The band have played similar-sized shows in other countries, but the US has always been the final frontier for K-pop – a market that has been attempted many times with only minor successes by acts such as Big Bang, EXO, and 2NE1’s CL. “We feel it all the time,” says Jimin. “On this tour we played some very large venues, and it makes us see that people really love us. Being inundated by all these emotions, it kind of got to me.” In a hotel in London, ahead of the UK shows, security stake out the hallways. Burly men accompany band members to the toilet. BTS have reached that dissociative level of stardom where they are handled like china dolls. “We know that popularity is not for ever,” RM says with a smile. “So we enjoy the ride, the rollercoaster, and when it ends, it just finishes. We’re on the jets and in the stadiums, but I don’t feel like it’s mine. It’s like we just borrowed it from somebody.” BTS are the brainchild of veteran writer and producer Bang Shi Hyuk, who formerly worked at the K-pop entertainment giant JYP, then formed Big Hit Entertainment and debuted BTS in 2013. The normal practice of K-pop is to oversee every element of the life of young “idols”, as they are known in Korea. However, Bang gave BTS autonomy to run their own Twitter and vlog from their studio, and for the rappers to write alongside Big Hit’s in-house production team. Their lyrics are emotionally vulnerable and socially conscious, sometimes bordering on angry, and go against K-pop’s grain: Baepsae, which translates as “silver spoon”, defends their “cursed” generation. Critics have tried to unravel the secret of their US success: many credit social media with spreading their message, but BTS’s fans, known as Army, flag the music and lyrics as the reason they have connected so deeply. It’s this, plus the end of One Direction, the growing interest in K-pop in the US, and BTS’s endless stream of visual content (from behind-the-scenes footage to reality shows) that reel in the curious and hook them with the force of the group’s personalities. In time-honoured boyband fashion, they offer something for everyone. Like all pop stars with gigantic, powerful fan bases, BTS tread a delicate line between celebrating their admirers and potentially alienating them. “Fame is like a shadow,” says Suga, their most serious member. “There’s light and there’s darkness; it’s something that follows you constantly and not something you can run away from. But people tend to respect our privacy. We go to art galleries a lot and people don’t really bother us, then after we leave they’ll',\n",
       " ('BTS',\n",
       "  77,\n",
       "  1): 'make a [social media] post.” “If it gets too much and it crosses a line, then it can be a source of stress but for me, at least, it’s a sign of their love,” says J-hope, a former street dancer. On a recent album cut, Pied Piper, they playfully admonished the obsessives: “Stop watching and start studying for your exams, your parents and boss hate me … You already have plenty of my pictures in your room.” That surprising honesty – in K-pop terms – underpinned the concept of their recent Love Yourself album trilogy (Her, Tear and Answer), which charted a narrative around, unsurprisingly, learning to love oneself. RM’s speech at the UN echoed this theme: “No matter who you are, where you’re from, your skin colour, your gender identity, just speak yourself.” This relatively anodyne statement resonated in South Korea, where the president publicly opposes homosexuality. During their career the band have used Haruki Murakami, Ursula K Le Guin, Jung, Orwell, Hesse and Nietzsche as inspiration. The latter figures notably in the theory of fate that is woven through Her, whereby love is destined and must therefore be unshakable (only for it to fall apart on Tear). As 80s indie fans did, BTS’s Army now read these writers in order to fully understand the band’s vision, while spending serious money on Bluetooth-programmed light-up sticks for their concerts. View image in fullscreen (From left) V, Suga, Jin, Jungkook, RM, Jimin, J-hope. Photograph: Young Ho/SIPA USA/PA Images For many, however, BTS symbolise an industry that is little more than a high-functioning bubblegum machine. K-pop is perceived as cruel for its intensive training system, which can start when artists are seven years old and last for 10 years with no guarantee of a group debut; and for its harsh approach to idols who struggle with exhaustion and their mental health. Many have fainted onstage, while Super Junior’s Leeteuk quietly set up a now-defunct peer group, Milk Club, for idols dealing with depression. Meanwhile, fans are portrayed as mindless teenage girls. “It’s pointless to argue or fight about it,” Suga says, gruffly. “Frankly, I can’t understand people who want to put down a certain type of music, whatever that might be. Classical music was pop music in its own age. It’s a matter of taste and understanding – there’s no good or bad, there’s no highbrow or lowbrow.” BTS’s music began as old-school R&B and hip-hop, but has since incorporated a myriad of genres, from EDM to South African house. The lyrics, too, have become increasingly complex, closer to prose than simple moon-June-soon pop. In many respects, BTS fit the mould of a classic boyband – they look and sound great – but they are also grown men who cry, embrace and expose their vulnerabilities and failings even as a culture of toxic masculinity thrives on- and offline. It strengthens their messages of strength, love, hope and acceptance beyond what boybands have offered before. K-pop idols work intensively, in a world where a few careers will last more than 10 years, but many are over in just 12 months. This year BTS have released three albums (two Korean and one Japanese), toured the world and produced a third series of their travel reality show, Bon Voyage. Their schedule is planned down to the minute. “I think there were times we were pretty close to burning out,” admits Suga, “but it’s inevitable and it’s the same for people in any profession.” Current and former idols have shifted towards acting, appearing on South Korea’s variety TV shows, and explored solo careers. Suga’s interests include',\n",
       " ('BTS',\n",
       "  77,\n",
       "  2): 'architecture and lighting. Jungkook, the youngest member at 21, has taken up documentary-style film-making, his most recent short capturing the extremes of his life – the intensity of the stage and the stillness of the aftermath. He says he feels “a lot of happiness when I think about things I can do in the future”. He has energy to burn – he will later give himself a minor heel injury before the first London show and spend it confined to a stool, tearfully apologising for not fully participating. During a recent live session on streaming platform VLive, V, whose slightly hoarse voice gives the group a soulful edge, played snippets of solo work to much buzz. BTS’s rappers have already released self-written and produced solo mixtapes, but the vocalists have yet to follow in their footsteps. “I’m working on it,” offers Jungkook, when J-hope begins laughing. RM weighs in, amused, “He’s getting ready for too many things! Films, boxing – he’s planning so much that no one knows when it’s coming out.” A good-natured squabble breaks out. “When J-hope gives me the beats, maybe I can get started on my tape,” deadpans Jin, the oldest member at 25. J-hope feigns indignation. “I gave him beats! He liked what I gave him!” he says as Jin cackles at the ceiling. “On all the songs I make,” V chips in, having sat back for most of the interview, “I feel there’s something that’s just not there. I have a shortcoming, I can’t finish a song, I need someone to help me. When I come up with something I can put out, I will.” Suga jabs back. “It’s going to be about 20 years then.” For their fans it’s this kind of playful teasing and natural camaraderie that makes BTS so appealing. For the band, their connection helps support their frenetic work pace. Openly ambitious, Suga has repeatedly stated that a Grammy win is his next goal and recently added playing the Super Bowl halftime show (71,000 people in the arena; 120m watching at home) to the list. Either could be the thing that cements BTS’s status as household names. Right now, neither seems unreachable. “We want to show as much as we can,” says Jimin, his gaze unwavering. “We only want to be able to show our best.”',\n",
       " ('BTS',\n",
       "  78,\n",
       "  0): 'VICTON’s Sejun Finally meets his ‘Role Models’ BTS and Reveals How He Felt It is no secret that many male idol groups idolize the internationally acclaimed BTS or Bangtan Boys. Members of BTS are known for their extraordinary skills in dancing, and their beautiful voices that make ARMYs\\' hearts skip a beat. With their fast rise to success and fame, new idol groups hope to follow their footsteps and that includes VICTON\\'s Sejun. When asked as to \"how did he feel when he met BTS\", Sejun answered truthfully. \"I can\\'t put it into words,\" replied Sejun. \"They\\'re senior artists that I\\'ve wanted to be like for so long. When I was going through the hardest time, as a trainee, I was able to get through it while watching BTS.\" According to Sejun, meeting his idols was a dream come true. Though it was hard promoting his own group, seeing BTS succeed in their own ventures \"melted his troubles away.\" Sejun claims he particularly idolizes Park Jimin, the lead vocalist and main dancer of BTS. Advertisement In one interview, Sejun even called Jimin\\'s song \\'Lie\\' a masterpiece, and also kept many BTS merchandise including Jimin\\'s Hiphop monster plush doll. Sejun and other VICTON members can sometimes be heard and singing BTS songs like their hit song \"Blood, Sweat, and Tears\" on their V-live channel. He also showed his own rendition of famous BTS dances like \"Fire,\" \"Blood, Sweat & Tears,\" and \"DNA\" in the said interview. Though Sejun\\'s love for BTS (especially Jimin) undeniable, his dedication towards the betterment of his own group is as true. VICTON, whose members are Seungwoo, Seungsik, Heo Chan, Lim Sejun, Do Hanse, Choi Byungchan and Jung Subin, finished their promotions for their song \"Unbelievable,\" recently, and are getting ready for a comeback soon. On the other hand, Sejun\\'s idols BTS, are soaring high as their mini album \"Love Yourself: Her\" has remained on the famous Billboard 200 chart for yet another week! Advertisement Advertisement Like us and Follow us Follow @Koreaportal and © 2025 Korea Portal, All rights reserved. Do not reproduce without permission.',\n",
       " ('BTS',\n",
       "  79,\n",
       "  0): '(G)I-DLE‘s entered the K-pop scene with a fresh and exciting energy — becoming just one of the few girl groups to send both their debut single and album to the Billboard charts — so it only makes sense for their first U.S. appearance to be just as energetic. In a collaboration with All That Group, the sextet made up of Soyeon, Miyeon, Minnie, Soojin, Yuqi, and Shuhua were brought to New York to perform a small concert and record a flash-mob performance of their hit single “Latata” in Times Square with fans and K-pop dance enthusiasts…only to have it initially shut down by police on the scene seemingly due to too many spectators. Just like this unexpectedly excited response to see the new girl group perform with fans, (G)I-DLE themselves appear surprised by the international interest they’ve collected. In an office building in midtown Manhattan, the girls casually eat granola bars and Japanese candies before clearing the table and excitedly chat about their first New York trip together (where they ate everything from waffles to quinoa), their new single (the fiery, whistle hook-laced “Hann (Alone)” that should soon make a splash on the World Digital Songs chart) and their unique vision as K-pop idols, all while giving thanks to their fans and supporters at every corner. Trending on Billboard After their police-induced shutdown, (G)I-DLE did get to perform with fans, flash-mob style, in Times Square, and also in Greenwich Village’s Washington Square Park. Later in their trip, the ladies made their debut U.S. performance at (Le) Poisson Rouge where they delivered “Latata,” their standout album cut “Maze,” and a cover of David Guetta and Nicki Minaj collaboration “Light Me Up.” The performance was quick, but all acting as an exciting teaser to what is shaping up to be one of K-pop’s most exciting new groups to watch. In their first-ever U.S. interview, (G)I-DLE open up to Billboard to share their thoughts on where they’re at now and where they want to go next. It’s been less than three months since your debut and (G)I-DLE is already here in New York! Did you think you’d be meeting overseas fans so quickly? Soyeon: Our dream was always to come to America to talk with our fans if we could possibly meet them. It was always our goal but, honestly speaking, we thought it would take at least three years to come to America — but it’s been only three months. Minnie: We never expected it would happen this fast. We would always hope, “Well, one day we want to come to New York and perform in front of our fans.” But then, we debuted and in three months we have this surprise. So, we’re really happy. Your debut single “Latata” and the I Am album had a really strong performance on the Billboard charts. Did think you would have this type of international interest upon debut? Was it at all intimidating? Soyeon: It really was unexpected for us and it still feels like a dream. Yuqi: It’s a dream come true. We would see the reactions to our music videos, but then we never know if people out there really who knew who were are and liked us. Before this, we went to Tapei once, so we’ve mostly stayed in Korea and only been in Asia. Even still, it’s not really that it’s nerve-wracking when we think about it, but rather inspires us to do better. When I listen to I Am, it felt like there was a very powerful and strong image, but also showed softer and more tender moments. Soyeon,',\n",
       " ('BTS',\n",
       "  79,\n",
       "  1): 'you worked on nearly all the songs. What inspired this as the proper introduction to (G)I-DLE? Soyeon: I always wanted to do something new — I don’t want to be like other idol groups in Korea. I don’t really get inspired by other music, I just solely think about each of the members and gain inspiration from that. The whole “Latata” song was created by me and I made the song thinking about my group and each member, and then I based my other songs off what I know what the members are best at and what their specific charms are. ? Miyeon: Our producer, Soyeon, made our first single on her own by looking at our personalities and what we’re really good at. In the future, we’ll definitely be able to show a different side of our music that emphasizes our specialties. Speaking of different sides, how do you describe your new single “Hann (Alone)”? Soyeon: To be precise, it’s a summer song and has the feelings of summer, but it’s a different, unique feeling. It isn’t cliché. You know how summer songs are usually happy, bright and uptempo? This one is more down-tempo. I wrote it as well. Minnie: Actually, my secret talent is that I’m really good at whistling and you can hear it on “Hann (Alone).” ?What goals do you have before your one-year anniversary in 2019? Soyeon: We really, really want to win the new artist and rookie award. (G)I-DLE in New York City, Courtesy of Cube Ent. During your Tapei trip, you performed a cover of BTS‘ “Fake Love.” Are you fans? Soyeon: We really respect them as artists. Since BTS did help and introduce so many people to so many artists, we’re influenced by them too. We would like to also strive for a similar path. Minnie and Yuqi: We also love “Blood Sweat & Tears.” What else do you want to emphasize to fans who are watching from around the world? Yuqi: I’m thankful to the fans for loving us so much. We’re going to try something new with our future music and are going to fulfill your already-high expectations. I want you to look forward to us and our upcoming albums! Minnie: Firstly, thank you, Billboard, for having us. It’s such a honor. It’s just a dream come true for us to be here, doing an interview here with you. We’re thankful that we have a lot of Korean fans, but also international fans so we will work harder and harder to be able to be here again. Thank you so much. Soyeon: I’m really thankful for your interest and love from all the fans. We haven’t really shown many sides of ourselves yet in our first album, but in our future albums, we’ll be able to show more sides of ourselves. Miyeon: I’m really thankful for the fans and I was able to come to the United States thanks to your interest. Shuhua: I’m thankful for the chance that all kinds of different people gave us. I’m just so so grateful for the love. Soojin: Since we have a lot of charms to still show, I want the fans’ expectations to be higher than ever. The key word I want fans to have when thinking about us is “reliable,” and that you can depend on us.',\n",
       " ('BTS',\n",
       "  8,\n",
       "  0): 'BTS‘ new album Wings is flying high above all previous K-pop records on the Billboard 200. The Korean boy band’s second full-length album debuts at No. 26 on the Billboard 200 chart with 16,000 units earned in the week ending Oct. 13, according to Nielsen Music. Of that sum, 11,000 were in traditional album sales. Those figures mark the best week ever for a K-pop album. Previously, 2NE1‘s Crush held the highest chart rank for a K-pop act (No. 61 with the 2014 album Crush) and EXO logged the best sales frame (6,000 sold in the first week for 2015’s Exodus). BTS is now the first K-pop act to log three entries on the Billboard 200 after sending their EP The Most Beautiful Moment in Life, Pt. 2 to No. 171 in December 2015, and compilation album The Most Beautiful Moment in Life: Young Forever to No. 107 in May. Previously, the band had been tied with G-Dragon, who also had two entries on the ranking. To date, less than a dozen K-pop acts have sent albums to the Billboard 200. Since their debut, BTS has stood out in the K-pop scene for tackling social and society issues in their music. Wings takes that dedication a step further by delving into the more complex issues in their young-adult lives including tackling mental health (see the sample-heavy “Am I Wrong”), taking digs at the Korean-pop idol scene (on the aggressive “2! 3!”), and even deliver a female-empowerment anthem (“21st Century Girls”), all over bombastic, hard-hitting hip-hop-heavy dance beats. Trending on Billboard The band’s accessibility is probably best felt in the lead single “Blood Sweat & Tears” that brings lyrics of a life-altering relationship with a Major Lazer-esque beat that one would expect Justin Bieber to jump on these days. Wings rules over multiple Billboard charts this week. This includes BTS scoring their second No. 1 on the World Albums chart (extending their reign as the K-pop act with the most weeks at No. 1 on the tally to five weeks), and BTS has 15 tracks on the World Digital Songs chart this week with “Blood Sweat & Tears” earning the band their second No. 1 on the chart. The BTS fervor is even reaching Canada, as Wings hits No. 19 on the Canadian Albums chart, besting K-pop’s previous highest ranking on that chart, also set by BTS, when the Young Forever album peaked at No. 99. All Billboard charts refresh Tuesday morning on Billboard.com.',\n",
       " ('BTS',\n",
       "  80,\n",
       "  0): \"Agencies PSY You Might Also Like: Music and lyrics: K-Pop is encouraging Indians to learn Korean Agencies Korean boy band BTS making it to the No.1 position on the Billboard 100 speaks volumes about K-pop’s calibre. Agencies EXO’s Suho & SHINee’s Minho were in India earlier and were asked by a bystander to take a picture. The man had no idea who they were. Agencies Agencies Red Velvet, an extremely popular K –pop group has won many awards for music & choreography. Back home and elsewhere in the world too, the first brush with Korean pop, or K-pop, probably was with the release of the video, Gangnam Style, by Park Jae Sung, better known as Psy. The ‘invisible horse-riding’ dance by Psy became an instant hit.No one really understood what the song meant, but the catchy music and the dance just caught on. The video got 100 million views in just 51 days of its release, more than what Justin Bieber got for Baby. Till today, it is among the most watched videos on YouTube.That was way back in 2012. Korean pop has since reached staggering heights of popularity. This year, the seven-member South Korean boy band, BTS, became the first ever K-pop album to make it to the No.1 spot on the Billboard 200 chart with their Love Yourself: Tear.Last year, BTS' Love Yourself: Her, peaked to No.7 on the Billboard 200. The Korea Music Content Association, through Gaon Music Chart, South Korea ’s equivalent of the Billboard chart, has issued a certification that Love Yourself: Tear has sold a million copies since its release on May 18 this year.K-pop albums making it to the Billboard listing, though, isn’t new. BoA’s (real name Kwon Bo-ah) self-titled Englishlanguage album was the first to appear on the Billboard 200 in 2009. The same year, Wonder Girls’ English-version of Nobody was the first Korean single to appear on the Hot 100 song chart.“Psy was next in 2012, and it took until 2017 for BTS, with DNA to become the first group to appear with a Korean song, not an English variant,” says Tamar Herman, a columnist for Billboard’s K-Pop section and contributing writer for Forbes.Korean economy has grown richer over the last two decades and the export of K-pop has propelled the South Korea’s music to an estimated $5 billion (Rs 34,500 crore) industry, according to a report published in the Korea Creative Content Agency in 2017.In fact, the band BTS is having a significant effect on the stock market as well, reported news portal Business Korea. “For the five days after BTS topped the US billboard album chart, Billboard 200, on May 28, the stock prices of entertainment companies shot up.”It estimated the corporate value of BTS’ management company Big Hit Entertainment, which has an IPO planned for next year, at more than 1 trillion Korean won (Rs 6,100 crore).The Korean Wave or hallyu — it includes Korean TV dramas and K-pop — sweeping across the world has come as a blessing in disguise for the country’s image and economy, especially after the 1997 Asian financial crisis.The South Korean government on its part is actively participating in the development of the country’s cultural economy. A Ministry of Culture, Sports and Tourism was established in 2008 with a specific department for promoting globalisation of K-pop and has been allotted substantial funds. Since the 1990s, many stateof-the-art auditoriums have come up. Research and development of hologram technology (prominently used by K-pop) and promotion of K-pop tourism too have picked up since.Changdong in north-western Seoul is being developed as a major cultural destination for\",\n",
       " ('BTS',\n",
       "  80,\n",
       "  1): 'K-pop tourism. The first phase of the project saw the completion of Platform 61 last year that has been constructed from 61 colourful shipping containers. Some K pop groups have already used it for recording videos.Hannah Waitt, cofounder and CEO of moon-ROK, a premier English source that provides fans with up-to-date and reliable information on their favourite K-pop artists, says: “I think K-pop has certainly stimulated the Korean economy by encouraging tourism — people from all over the world who love K-pop travel to Korea to catch concerts and experience Korean culture first hand.”Besides tourism, there has been an increase in the demand for learning the Korean language. A recent report in BBC News states that in order to understand the lyrics of the K-pop hit songs, learning the Korean language is in high demand in countries like the US, Canada, Thailand and Malaysia to Algeria. The South Korean government too is playing its part — it has set up 130 language institutes in 50 countries.The thriving cultural economy has also boosted increase in export of related goods. Korean stars are driving consumer trends in a big way. Fashion, food and even plastic surgery are followed by the diehard fans. The beauty industry has seen the biggest growth.The Hyundai Research Institute has assessed the economic effects of hallyu, stating that an improved national image thanks to hallyu leads to increasing exports, and therefore to the growth of the manufacturing industry.While Korean brands like LG, Samsung and Hyundai rule the roost with their excellence in cutting-edge technology, South Korea is also surging ahead with its cultural economy.Koreans are very proud of K-pop. As Band Ji Choel, a dedicated fan of K-pop says: “It is talked about globally and has really brought Korea into the spotlight and this time not for technological excellence but for a cultural reason.”The genesis of the Korean wave goes back to March 14, 1992, when Seo Taiji and Boys performed for a live TV show at Munhwa Broadcasting Corporation ’s weekend Music show. After that, “the first boy bands and girl groups truly made an impact in the late ’90s and early ’00s. The late ’00s saw a revival thanks to the advent of YouTube,” Herman says.The entertainment industry of South Korea has been closely related to its political history.The music industry gained momentum only when South Korea adopted democracy in 1987.What is it that has transfixed the world’s attention to K-pop?K-pop is a well-thought of package, always trying to push the envelope in every aspect of music entertainment. It has everything together — music, fashion, dance, singing, story, and not just sells the music but the idols themselves.“The systematic way K-pop groups are trained, produced, and marketed means K-pop tends to be highly stylised, extremely colourful, and very entertaining,” says Aja Romano, an American culture reporter who has covered K-pop extensively. “Overall it’s a very fun system.”Explains Jay Bang, a South Korean fan of K-pop, “What distinguishes K-pop artists from other pop artists from around the world is their sheer hard work and their “knife like” dance moves.This means their moves are quick and sharp and in perfect sync with each other.”Waitt was introduced to K-pop on the social media when she happened to watch the music video for Gee by Girls’ Generation and she recalls, “I watched the video and was immediately taken by the bright colours, catchy melody, and tight choreography. I spent the next few hours watching K-pop music videos and was amazed not just by the high production value of the songs and music videos, but by the view counts on YouTube.',\n",
       " ('BTS',\n",
       "  80,\n",
       "  2): 'I was shocked that these videos were getting upwards of 100 million views, and realised that there was an entire sector of the music industry and a massive pop culture movement happening on the other side of the world that I knew nothing about.” Before Waitt knew it, she was fully in it. She was studying at University of Texas then and she went on to write an awardwinning thesis about K-pop after two years of extensive research.The global success of K-Pop did not happen by accident, nor is it simply an interesting cultural phenomenon, Mooweon Rhee, professor of management at School of Business in Seoul’s Yonsei University and Won-Yong Oh, a former assistant professor at the Haskayne School of Business, University of Calgary in Canada wrote in the Harvard Business Review.“K-Pop entertainment companies demonstrate how to innovate business models by changing the fundamental assumptions of existing ones. Rather than find readymade talent, K-pop companies manufacture it,” they wrote. “Rather than market performers in a one-way manner, they nurture relationships with customers via social media. And rather than treat the world as one single market, they localise songs and even groups so that they truly resonate.”As K-pop became massive in China, Japan, and Southeast Asia as a whole, many groups have recorded alternate, localised versions of their singles in Mandarin, Japan, and English in order to make their songs more appealing and relatable to fans who speak those languages.One of the most important factors that led to the rise of K-pop is that record companies in Korea saw the potential in YouTube and capitalised on it early. “The development and proliferation of YouTube as a global video platform allowed Korean artists to go from local celebrities to global superstars. K-pop already had a winning formula — catchy songs, sharp choreography, and gorgeous group members. All of a sudden, YouTube exposed billions of people around the world to this new and exciting genre of music that they’d never seen or heard of before,” says Waitt.K-pop went global in 2009 when it spread outside of Asia with songs like Sorry Sorry by Super Junior, Nobody by Wonder Girls, Gee by Girls’ Generation besides some others spread through YouTube.Another hugely important part of the K-pop phenomenon is that Korean artists allow fans gratuitous access to their personal lives via reality series and variety shows. “Whereas many Western celebrities go to great lengths to protect their privacy, Korean celebrities let fans into their homes, their studios, and even their cars to give fans a closer look at their day-to-day lives. This sort of access fosters a more intimate relationship between the fans and the artist, which results in intense fan loyalty”, Waitt points out.And that means having a huge fandom presence in the live studio audience. “It’s a really intimate relationship, and the biggest groups overseas aren’t always the biggest groups at home in South Korea,” adds Romano.Herman observes, “K-pop is less a genre and more of an idea of an industry.” “The marketing decisions of the Korean music industry are probably the biggest single factor … the studios have built themselves up with the goal of exporting Korean musical groups and have spent decades making decisions that would help them achieve that goal,” says Romano.Another reason for K-pop success is that “Korean entertainment companies are not afraid of making mistakes, which has helped allow them to implement multiple experiments with various kinds and genres of products, idol groups, and continue to generate creative arts”, says Yonsei University’s Rhee, speaking from Seoul.Korea’s domestic music economy has been dominated by three big entertainment companies —',\n",
       " ('BTS',\n",
       "  80,\n",
       "  3): 'SM Entertainment (1995), YG Entertainment (1996) and JYP Entertainment (1997) — which emerged in the late 1990s. Till recently, the top K-pop stars were a product of one of these. Now, however, there are many other music companies operating in the domestic market. Big Hit Entertainment (founded in 2005) is one such company that is currently managing BTS and some others. Soon after BTS made it to the Billboard ranking in 2017, the company’s fortunes sky-rocketed. According to the Korean entertainment label’s full-year audit report last year, Big Hit’s net profit rose 173% from 2016, reaching 24.5 billion won, or around $22.9 million.The big three entertainment companies, JYP, SM and YG and others employ two ways to identity talent: by auditioning or scouting. Auditions are held in Korea and globally, from the US to Kazakhstan.It is no secret that K-pop trainees go through rigorous training. They start at a very young age and train for almost 12 hours in a highly competitive environment. In their article, Rhee and Won-Yong Oh wrote, “Training is like boot camp. The trainees, who live together in company-provided dorms, are entered into tournament after tournament with no guarantee that they will actually ever make their professional debut.”Throughout the day they have classes for singing, dancing, and acting. Foreign languages are taught too with an eye on the biggest international markets for K-pop. In recent years, reports on the harassment faced by young trainees began to get attention from the media. Their private behaviour, public conduct and even their dating life once they entered into “long-term” contracts with the entertainment companies are allegedly controlled.Public attention did bring about change. In 2017, many studios agreed to bring reform in their contracts. “The legal system in South Korea has intervened to help improve situations that in the past were problematic, such as a 2014 law that aimed to protect minors in the entertainment industry and ongoing aims at breaking “slave” contracts that bind entertainers to agencies for extended periods of time,” says Herman. She further adds, “The legal situation revolving around the K-pop industry is still evolving, and abuse is still widespread,”In 2015, KBS World TV, a South Korean television channel operated by the Korean Broadcasting System aimed at international audiences, decided to send a group of top K-pop idols to India to find out why Korean pop wasn’t as popular here as it was in other Asian countries. They documented the experience of these idols and put it up on YouTube as the series ‘Exciting India’. The team consisted of Kyuhyun from Super Junior, Minho from SHINee , Jonghyun from C.N.Blue, Sunggyu from Infinite and Suho from EXO. Through this series, one sees the boys wandering around the streets of Mumbai trying to figure out how to popularise K-pop.They were surprised, excited and perhaps a tad bit disappointed at not being recognised. At the Gateway of India, an Indian tourist asked Suho to take a picture of him. He politely helped the man but one can tell he was not used to such behaviour. Minho, who was there with Suho, was highly amused by this exchange and so were the Korean camera crew and staff.The boys met a single fan, Babu, during their weeklong trip to Mumbai. Babu, though, claimed that there were thousands like him in India.However, they may be happy to note that in just three years, the number of Indian K-pop fans has increased manifold. A reason for this could be the rise of K-pop in Western countries. While Bollywood Songs are predominantly listened to in India, the trendy youth do follow charts such',\n",
       " ('BTS',\n",
       "  80,\n",
       "  4): 'as the Billboard Hot 100, to stay updated with Western popular music.“I was introduced to K-pop by a friend who saw BTS’ Blood, Sweat and Tears playing on Vh1. While Psy’s Gangnam style had an impact on India as much as it did on the rest of the world, the more tasteful Blood, Sweat and Tears music video managed to capture my attention for a longer time,” said Sukanya, a 20-year-old college student. “The kitschy image of K-pop I previously had was shattered through BTS’ mesmerising music videos portraying detailed story lines and relatable youth-centric concepts. Through the variety of shows they release, one feels more and more connected to them. Rather than seeing them as celebrities, fans see them as friends.”The largest Indian fan club of BTS on Twitter, @BangtanINDIA, has 24,000 followers.The K-pop World Festival in Changwon organised by the South Korean government holds auditions worldwide to increase the exposure to k-pop. The Finale for Indian contestants was held at Siri Fort Stadium in Delhi and attended by the first lady of Korea, Kim Jung-sook. Juchy from Mizoram and We Are Family Crew from Delhi took the top prize and will be travelling to South Korea for the final on October 5. “It’s time to say that K-wave and K-pop finally arrived in India after a OMG time of insignificant presence,” says Kim Kum-pyoung, the director of Korean Cultural Centre in India. “We will witness the strong and enthusiastic fandom of K-pop in India, which will surprise Korean people as well.”',\n",
       " ('BTS',\n",
       "  81,\n",
       "  0): 'Diamonds are rock-solid, but they’re not unbreakable, says D-Crunch. With its name abbreviated from Diamond-Crunch, referring to the group’s powerful performance and musicality fit to crush diamonds, the fresh K-pop rookie overflows with youthful energy and ambitions. Having just started to make its mark in the K-pop scene, the nine-piece group of Hyunwook, Hyunho, O.V, Minhyuk, Hyunwoo, Hyunoh, Chanyoung, Jungseung and Dylan said it hopes to spread its messages around the globe. (Video shot by Lim Jeong-yeo, Kim Hye-soo /The Korea Herald) (Video shot by Lim Jeong-yeo, Kim Hye-soo /The Korea Herald) (Video shot by Lim Jeong-yeo, Kim Hye-soo /The Korea Herald) We always hope to deliver our own messages and emotions to our listeners. For example, our recent single ‘Stealer’ embodies our longing for higher place and better stages,” O.V, a co-leader of the group along with Hyunwook, told The Korea Herald during a recent interview in Seoul. Having debuted in August under All-S Company as a hip-hop-oriented group, D-Crunch released its first single album, “0806,” with lead single “Palace,” on Aug. 8 and dropped first EP “M1112,” featuring lead track “Stealer,” in November. With fierce, hip-hop-inspired style and vocal prowess, the act was quick to earn a following from all over the world, winning the Focus Award at the 2018 Asia Artist Awards in November within four months of debuting. What really sets apart the group from others is its ability in songwriting. While all of the bandmates participate in composing and writing their own songs, the group also formed songwriting trio G.I.G -- consisting of O.V, Hyunwook and Hyunoh -- that takes the lead in shaping the group’s musical direction. They also craft the choreographies for their own songs, including for “Stealer.” Citing BTS, Block B and iKON as role models, Hyunoh said, “We always try to get inspired by various things like a place we’ve never been to, on the streets and just in our daily lives. We hope to convey our messages and sincere stories.” The group also expressed its gratitude for winning an award at the AAAs. “It was such a great experience. We learned so much from other K-pop acts, and the event really motivated us. We hope to showcase our developed sides in the future,” Hyunwook said. Though the group’s career has just budded, D-Crunch is already eyeing overseas promotions. “One of our goals for next year is to promote in foreign countries. We have some plans, and we plan to make it happen,” Hyunwook added. ()',\n",
       " ('BTS',\n",
       "  82,\n",
       "  0): '[조이뉴스24 이미영기자] 보이그룹 워너원이 엑소와 방탄소년단에 이어 높은 선주문량 기록을 세운 소감을 전했다. 워너원은 7일 오후 서울 구로구 고척스카이돔에서 데뷔 앨범 \\'1X1=1(TO BE ONE)\\' 발매 기념 기자간담회를 열고 정식 데뷔를 알렸다. 워너원은 지난 6월 종영한 \\'프로듀스101 시즌2\\'를 통해 탄생한 보이그룹. 강다니엘, 박지훈, 이대휘, 김재환, 옹성우, 박우진, 라이관린, 윤지성, 황민현, 배진영, 하성운 등 11명의 멤버로 구성됐다. 워너원 멤버들은 \"긴장을 많이 했다. 많이 설렌다. 더 열심히 노력하고, 앞으로도 좋은 모습 보여드리겠다\"고 데뷔 소감을 밝혔다. 이들은 \"연습하던 시절에는 멀리만 보이던 단어가 코앞으로 보이니 현실인지 꿈인지 실감 안 난다. 너무 실감이 안 나고 더 열심히 하고 싶다. 이제 첫 출발이다보니, 시작을 잘해야겠다고 생각이 든다\"고 떨리는 소감을 전했다. 지금껏 고척 스카이돔에 올랐던 그룹은 빅뱅과 엑소, 방탄소년단 등 세 팀으로, 국내 최정상급 아이돌그룹만이 전석을 채울 수 있는 대규모 공연장이다. 워너원은 데뷔와 동시에 \\'꿈의 무대\\' 고척돔에서 2만명 팬들을 만난다. 데뷔 그룹 중 최대 규모다. 하성운은 \"방탄소년단의 콘서트를 온 적이 있다. 고척돔에 설 수 있을까 생각했는데 이렇게 빨리 고척돔에 설 수 있게 되서 꿈만 같다. 평생 못할 줄 알았는데 고척돔에 와서 실감이 안 난다. 무대에 올라가지 않아서 실감 안난다. 리허설 했을 때 설레고 떨리는 마음이 있었다. 고척돔에 있는 것이 행복하다\"고 말했다. 강다니엘은 \"엑소와 방탄소년단 콘서트 영상이나 기타 음악프로그램을 보고 \\'저 무대에 서야지\\' 했다. 다시는 못올 것 같은 고척돔이라는 정말 큰 무대에서 서게 된 것이 꿈만 같다\"고 말했다. 지난달 19일 사전 예약 판매를 시작한 워너원의 데뷔 앨범 \\'1x1=1(TO BE ONE)은 벌써 선주문량이 50만 장에 달하는 것으로 알려졌다. 이 역시 엑소와 방탄소년단 등 국내 최정상 보이그룹이어야 가능한 수준이다. 워너원은 \"엑소와 방탄소년단의 곡을 교과서처럼 보고 모니터링 하고 배웠다. 저희가 그런 (기록을 세운 것이) 영광스러운 것 같다. 신인으로서, 후배로서 열심히 하는 좋은 모습을 보여줘야겠다고 다짐했다\"고 밝혔다. 워너원의 데뷔 앨범 \\'1X1=1(TO BE ONE)\\'은 11명의 소년들이 함께 정상을 향해(TO BE ONE) 달려가겠다는 워너원의 자신감을 의미한다. 또한 워너원(1)이 팬과 함께(X1) 최고의 그룹(=1)으로 성장하겠다는 큰 포부이기도 하다. 타이틀곡 \\'에너제틱\\'은 팬들이 직접 투표를 통해 선정된 곡으로, 섬세하지만 반전미가 느껴지는 멜로디컬한 구성이 특징. 워너원과 팬 \\'워너블\\'의 첫만남처럼 당신과 내가 만나 서로에게 빠져드는 강렬한 설렘이 투영돼 있다. 이밖에도 타이틀곡 최종 후보였던 \\'활활(Burn It Up)\\', 팬들에게 바치는 고백송 같은 \\'Wanna Be(My Baby)\\' 등 총 4곡의 신곡이 담겨있다. 그 외에도 프로듀스101 시즌2를 통해 많은 사랑을 받았던 \\'Never\\'와 \\'나야 나\\' \\'이 자리에\\'를 워너원 버전으로 재녹음 했다. 워너원은 이날 오후 6시 각 음원사이트를 통해 데뷔 앨범 \\'1X1=1(TO BE ONE)\\' 음원을 공개하며, 오후 8시 서울 고척 스카이돔에서 \\'프리미어 쇼콘\\'을 개최하고 화려한 데뷔를 알린다. 조이뉴스24 /이미영기자 mycuzmy@joynews24.com 사진 이영훈기자 rok6658@joynews24.com 좋아요 응원수',\n",
       " ('BTS',\n",
       "  83,\n",
       "  0): 'Ютубер под псеводнимом «Sojang«, получила условный срок за клевету в отношении знаменитостей. Скандальный блогер, известный распространением клеветнического контента о знаменитостях, таких как Чан Вонён из IVE, был осужден условно. 15 января окружной суд Инчхона приговорил госпожу Пак (она же Sojang) к двум годам тюрьмы с отсрочкой исполнения на три года и штрафу в размере около 200 миллионов вон (приблизительно 137 000 долларов США). Смотрите также: [Dispatch] «Докажите, что это ложь!» — владелец канала «탈덕수용소» отрицает обвинения в клевете Судья Ким Сэт Бёль подчеркнул серьезность преступлений, связанных с клеветой, заявив: «Клевета наносит непоправимый вред жертвам и должна пресекаться строго.» Суд отметил, что Пак неоднократно публиковала клеветнические и провокационные видео о знаменитостях, получая значительную прибыль. Г-жа Пак (она же Sojang) убегает от репортёров Тем не менее, смягчающими обстоятельствами стали признание вины, попытки осмыслить свои действия и частичная компенсация жертвам. Пак уже перечислила 60 миллионов вон в качестве компенсации, включая 20 миллионов вон для Чан Вонён. С октября 2021 года по июнь 2023 года Пак создала и распространила 23 клеветнических видео о таких знаменитостях, как Чан Вонён, Чонгук и Ви из BTS, Кан Даниэль и других. Эти видео содержали сфабрикованные аудиозаписи, смонтированные кадры и ложные заявления. Многие из них включали оскорбления и унизительные комментарии, что принесло Пак около 250 миллионов вон (приблизительно 171 000 долларов США) дохода от рекламы и подписок. Против Пак ведется несколько гражданских и уголовных дел: Чан Вонён подала иск на 1 миллиард вон, и суд обязал выплатить полную сумму в январе. Пак обжаловала это решение. подала иск на 1 миллиард вон, и суд обязал выплатить полную сумму в январе. Пак обжаловала это решение. Ви и Чонгук из BTS также подали отдельные иски, которые находятся на рассмотрении. и из также подали отдельные иски, которые находятся на рассмотрении. Кан Даниэль выиграл 30 миллионов вон в первом судебном процессе, но Пак подала апелляцию. выиграл 30 миллионов вон в первом судебном процессе, но Пак подала апелляцию. SM Entertainment выдвинула обвинения в клевете в отношении Су Хо из EXO и участниц aespa. Во время октябрьского суда Пак просила о снисхождении, заявив: «Я оказалась в ловушке своего собственного интернет-мира и не смогла различить правильное и неправильное. Я глубоко сожалею о своих действиях и обещаю жить ответственно в будущем.» Алекса © YesAsia.ru',\n",
       " ('BTS',\n",
       "  84,\n",
       "  0): 'CNN — The name BTS may not be familiar to the majority of Americans, but that didn’t stop the South Korean boy band from making history Sunday night, when they became the first K-pop group to clinch a Billboard Music Award. Beating out US favorites Justin Bieber, Selena Gomez, Ariana Grande and Shawn Mendes, BTS scooped the Top Social Artist award at a lavish ceremony in the T-Mobile Arena in downtown Las Vegas. “We still cannot believe that we’re standing here on this stage at the Billboard Music Awards,” said BTS member Kim Nam-joon, known to fans as “Rap Monster,” onstage. “It is so great to see all the artists we admire, and we feel honored to be in this category with all these great artists right in front of us.” BTS’s group award follows South Korean trailblazer PSY, who became the first K-pop solo artist to win at the Billboard Music Awards back in 2014, for Top Streaming Song, “Gangnam Style.” BTS fans, known as the “A.R.M.Y.” (Adorable Representative M.C’s for Youth”) voted for the award on Twitter and on the awards website, using the hashtag #BTSBBMAS more than 300 million times. “BTS was one of the first groups to fully embrace social media and completely open themselves up to fans,” said CEO of Koreaboo, Flowsion Shekar, a popular content platform specializing in K-pop with a reach of over 50 million. “International fans were able to really relate to them and feel like they truly knew the members individually. Most rookie groups are held tightly behind closed doors and everything is filtered or sanitized before it’s shown to the public.” The seven-member band debuted in 2013 with a contemporary K-pop sound that fuses hip-hop, electronica and rock. They currently top the Billboard Social 50, spending 31 weeks on the chart. They are now on a sold-out world tour, with US concerts this past March and April in Newark, Chicago and Anaheim. Their next stops are in Australia and Japan.',\n",
       " ('BTS',\n",
       "  85,\n",
       "  0): 'First Barbie, now BTS. The K-pop band will be collaborating with Mattel on an official doll collection, as the toy manufacturer confirmed on Sunday (Jan. 6). “Mattel, @bts_bighit & @BigHitEnt are bringing #BTSDollsOfficial to millions around the world! Follow us for #BTSxMattel updates. #BTS,” Mattel’s official account tweeted. Explore Explore BTS See latest videos, charts and news See latest videos, charts and news The collaboration was revealed at the Hong Kong Toys & Games Fair on Sunday, where Mattel announced a comprehensive, worldwide licensing agreement with BTS under its company Big Hit Entertainment. A press release states that a toy line inspired by the Korean act will launch this summer, featuring the seven members of the group wearing looks seen in their music video for last year’s “Idol.” The Nicki Minaj-featuring version of the Love Yourself: Answer single peaked at No. 11 on the Hot 100 last year. “BTS is a pop-culture music phenomenon that transcends age, culture and language, and through this partnership, Mattel will offer a new way for millions across the world to engage with the band,” said Sejal Shah Miller, svp & global brand gm for Mattel. “Partnering with established franchises that have global appeal is a cornerstone of our strategy and given our creative expertise, we are perfectly suited to create products celebrating BTS.” Following the news, Mattel’s stock price jumped on Monday. At the time of publication, Bloomberg reported that Mattel closed on the NASDAQ at 10.41 on Friday, Jan. 4, and currently sits at 11.27, with a 8.26% increase.',\n",
       " ('BTS',\n",
       "  86,\n",
       "  0): 'The K-pop newcomers of Noir are all about black -- the color of power and charisma. On Monday, nine-member act Noir debuted with the group’s first EP, “Twenty’s Noir.” Featuring six songs, the album is led by explosive electronic dance music track “Gangsta,” which leans heavily on the band’s rappers. Overflowing with propulsive beats, flamboyant synths and EDM breaks, “Gangsta” captures the blazing hearts of nine wishing to capture a woman’s heart. Noir, represented by Luk Factory, consists of Yeonguk, Yoongsung, Hoyeon, Siha, Siheon, Daewon, Minhyuk and leader Seunghoon, who took part in writing majority of the tracks for the album, including “Gangsta.” And just like the color black, which is often made by mixing various colors, the rookie group slides in and out of a variety of styles in its first album. “I wrote the rapping parts in the songs, and I have a lot of interest in songwriting and composing,” said Seunghoon at a press showcase for “Twenty’s Noir” in Seoul on Monday. “Twenty‘s Noir” includes futuristic “Hypnotized,” rhythm and blues-tinged “Travel” and ambient “Become a Star,” a track prereleased through Noir’s predebut reality show “Action Noir.” Yeonguk, Yoonsung and Hoyeon, who competed in the second season of “Produce 101,” also expressed their excitement over the debut, saying their experience on the show served as a stepping stone for their next big move. The future seems to bode well for this rookie who became a brand model for Chinese cosmetics brand AayAay in March, building an international following even before its debut. The seemingly promising group ran into a small hitch, however, as major broadcasters KBS and MBC have judged two tracks from the album -- “Hypnotized” and “Travel” -- as unsuitable to be broadcast due to vulgar language and sexually suggestive expressions. “I feel very sorry for not being able to promote those two songs, as we’ve put a lot of effort into making them. We hadn’t expected such result, actually,” said Seunghoon, who contributed to writing the two songs banned from air. “I admit that I wrote the lyrics quite provocatively. I hope to promote the songs after changing the lyrics,” he added. Hoping to establish root in the K-pop scene with dynamic performances and overwhelming visuals, Noir named K-pop boy band BTS as its role model. “BTS is an amazing group that is successful in both performance and talent, which we aspire to,” Siha said. Yoonsung added, “We want to be a group that people keep thinking of. We hope to capture people’s hearts just like the lyrics of ‘Gangsta.’” Noir will hold its first fan signing event on Saturday at My Live Hall in Gangnam, southern Seoul. ()',\n",
       " ('BTS',\n",
       "  87,\n",
       "  0): 'Seoul CNN — Michelle Quinde is a BTS megafan. When the latest album from the South Korean boy band came out in April, she bought the CD, even though she doesn’t own a CD player. When the seven-member group went to the United States in May, she went to all six of their concerts. And when BTS’ single “A Brand New Day” came out in June, she streamed it constantly for a full day. Quinde, a 24-year-old graphic design student from New York City, is one of a legion of fans who spend plenty of time and money to support their idols. Known as ARMY (Adorable Representative MC for Youth), BTS’ global fan base of millions of loyal followers is powerful enough to create major waves – and help the group smash music industry records. Some ARMY, like Quinde, listen to songs over and over to boost BTS’ statistics on YouTube and music streaming sites. They’ve helped BTS break global records for engagement on Twitter. They’ve banded together for good causes, such as raising money and planting trees in BTS’ honor. They’ve even bought a billboard in New York’s Times Square. And – most significantly for BTS fans – they’ve contributed to making the group one of the biggest boy bands in the world. But who are BTS ARMY – and why are they so dedicated? Joining the club Being ARMY is easy: you just need to like BTS. Since the start, BTS have courted ARMY online. Without the connections and financial backing of the major labels, BTS’ agency Big Hit Entertainment had to rely on social media. That created a kind of intimacy with fans, adding to their popularity. On Twitter, BTS now have the biggest following of any K-pop group. The most hardcore fans can pay about $30 to get an official membership, including access to early concert tickets and handwritten birthday wishes from BTS. But if a member violates official membership guidelines – such as intentionally boarding the same plane as the band – they could find their membership rescinded. It’s not all fun and games, though. Being a dedicated member of BTS ARMY – whether officially or unofficially – can mean a lot of work. On top of her three part-time jobs, official ARMY member Quinde used to run a fan base website. Every day, she spent hours chatting with fellow fans on messaging app Slack, planning everything from the hashtag for singer Jin’s upcoming birthday, to how fans could help get BTS a Grammy. Running the fan base was “amazing,” but it was also tiring work, Quinde said. She’s now taking a break from the demands of fandom as she feels that others are supporting them too. “I can kind of rest assured,” she said. “They’re in good hands.” The power of streaming For many ARMY, their self-assumed responsibilities are simple: stream the band’s songs and videos as many times as possible so their idols stay at the top of the music charts. Ahead of an album or single launch date, the South Korean arm K-ARMY divide and conquer, releasing lists of songs that must be streamed endlessly. Dedicated ARMY members source phones from their friends and family members, and log into multiple accounts to optimize their streaming abilities. Members of Korean K-pop group BTS arrive on the red carpet during the K-CON 2014 at the Los Angeles Memorial Sports Arena on August 10, 2014. MARK RALSTON/AFP/Getty Images Whenever BTS released an album, 22-year-old Lee Siwon posted a status on messaging platform KaKao Talk, a popular chat site in South Korea, saying that she was',\n",
       " ('BTS',\n",
       "  87,\n",
       "  1): \"unable to call or check messages because she would be busy streaming BTS’ songs over and over. “I’ve activated all my old phones and the ones in my family to stream songs,” said Lee, a 22-year-old member of K-ARMY. “I felt like BTS and I were inseparable, so that made me try harder for their success.” Park Semi, who has been a K-ARMY since 2016, has been playing the music video for “Boy with Luv” every day for the past five months. Most of the time, she hasn’t even been watching it – it’s all about getting more views on YouTube. Lee Siwon at Wembley Stadium in the United Kingdom. Supplied “I think everyone who is a regular member of the K-ARMY will be doing the same,” she said. Among fellow K-ARMY, a screenshot of the number of streams you rack up is considered a badge of honor, proof of how hardcore a fan you are. Park herself has done it: “I have streamed earlier songs of BTS over 20,000 times.” Agency involvement The efforts of ARMY like Park and Lee have paid off. BTS has won the Billboard Music Award for Top Social Artist three years in a row. The group’s latest record, “Map of the Soul: Persona,” recently became the best-selling album of all time in South Korea, with more than 3.3 million copies sold. And one of the songs on the album, “Boy with Luv,” holds the record for the most YouTube views within 24 hours (74.6 million). But none of this was done at the behest of BTS’ management, Big Hit Entertainment. Big Hit have courted fans with their social media strategy and have simplified the process of becoming an official ARMY, but they don’t mandate constant streaming. Nevertheless, Big Hit does have some input. Ahead of shows in South Korea, the agency approves the messages and phrases that fans write on their banners and placards. Even during South Korean concerts, there are strict rules. Fans aren’t allowed to sing – concertgoers want to hear the band, not the crowd. However, they are allowed to participate in chants signed off by Big Hit at prearranged times during the show. After the crowd started singing at BTS’ recent show at Wembley in London, South Korean ARMY complained that BTS had shown favoritism toward foreign fans by allowing them to sing. “(The fans) even got up from their seats while the concert was still on and got snacks – unthinkable behavior back in South Korea,” said Lee, who was at the Wembley concert. Fans of the Korean boy band group BTS pose with photos of their idols outside the 2017 American Music Awards, November 19, 2017 in Los Angeles, California. ROBYN BECK/AFP/Getty Images An ARMY of workers In the past few years, some of BTS’ international followers began to harness the hysteria for good. BTS fan Erika Overton, a Brooklyn native in her late 30s, was “entranced by the power of fandom,” and wondered if it could be redirected towards something more substantial than YouTube hits or a New York billboard. In March last year, she co-founded One in an Army, a Twitter-based group that encourages donations from BTS fans to spend on charity projects. Members are based in the US, Canada, Sweden, Malaysia and China. There’s even one member in Saudi Arabia, Overton said. A fan takes pictures of photos of BTS singer Jin which are displayed at Hongdae Subway Station on June 2, 2018 in Seoul, South Korea. Fans bought the advertising space to celebrate Jin's 5th anniversary of his debut with BTS. Jean Chung/Getty Images\",\n",
       " ('BTS',\n",
       "  87,\n",
       "  2): 'In one of their earliest projects, the group raised money for non-governmental organization Thirst Relief that provides clean water for families in Tanzania. Overton said fans raised enough to buy 30 water filters for provide clean water to about 300 people for the next 25 years. Supporting projects to help those in need is a natural extension of being a BTS fan, Overton said. “They put a lot of effort into giving us of themselves and their music and their sincerity … the ARMY really wants to give back in their name.” When the wave turns But while ARMY devotion can be used for good, it can also take on negative undercurrents. Some ARMY are highly sensitive to a possible slight – and numerous public figures have borne the brunt of ARMY’s anger. For instance, when an Australian television presenter in June introduced BTS as “the biggest band you’ve never heard of,” ARMY immediately took action on social media to accuse the network of “racism and xenophobia.” Ultimately, the network issued an apology. BTS during their debut showcase on June 15, 2013, in Seoul, South Korea. Their style has undergone some changes. ilgan Sports/Multi-Bits via Getty Images Singer Park Ji-min -- better known as Jimin -- exposes his six-pack as BTS perform during their debut. ilgan Sports/Multi-Bits via Getty Images BTS attend KCON, an annual Korean pop music convention, on August 10, 2014, in Los Angeles. BTS were a breakout success at the convention. Valerie Macon/Getty Images BTS pose on the red carpet of the 2015 Mnet Asian Music Awards in Hong Kong on December 2, 2015. BTS scooped the award for World Performer. Philippe Lopez/AFP/Getty Images BTS make their US television debut at the American Music Awards on November 19, 2017, in Los Angeles. Matt Sayles/Invision/AP The group perform \"DNA\" at the American Music Awards on November 19, 2017. Matt Sayles/Invision/AP Following their American Music Awards performance, BTS appear on a handful of US talk shows. Here, BTS perform on Jimmy Kimmel Live! on November 29, 2017, in Los Angeles. RB/Bauer-Griffin/GC Images/Getty Images BTS perform \"Mic Drop (Steve Aoki Remix)\" on Jimmy Kimmel Live!. RB/Bauer-Griffin/GC Images/Getty Images BTS become the first ever K-pop group to address the United Nations at the UN General Assembly in New York on September 24, 2018. Leader Kim Nam-joon urges young people to believe in their own convictions. Craig Ruttle/AP BTS attend the Grammy Awards where they become the first K-pop group to present an award on February 10, 2019, in Los Angeles. Jon Kopaloff/Getty Images BTS become the first K-pop group to perform on Saturday Night Live on April 13, 2019. They perform their new single \"Boy With Luv.\" Will Heath/NBC/NBCU Photo Bank via Getty Images BTS with US-singer Halsey at the Billboard Music Awards in Las Vegas, where they became the first K-pop group to win Top Group/Duo on May 1, 2019. Halsey features on BTS\\'s single \"Boy With Luv.\" Todd Williamson/NBC/NBCU Photo Bank via Getty Images The rise and rise of K-pop boy band BTS Prev Next Lee explained that as ARMY believed their idols were perfect, they were often affronted by any perceived criticism. “We don’t think logically but think as a community,” she said. “I think fandom culture has some similarities to a religion. We don’t know the BTS members in person, but we believe everything we see, even though only the good parts may be revealed. It’s a case of ‘I believe my idol is perfect, so who do you think you are to disparage my belief?”’ But Quinde, the American fan, said she didn’t condone the way',\n",
       " ('BTS',\n",
       "  87,\n",
       "  3): 'perceived slights could provoke a flurry of malicious tweets. “I don’t like that people do that … people make mistakes.” “We should explain who BTS are … but these comments get lost in the middle of malicious retweets.” What powers a fandom Since they debuted in 2013, there’s been a symbiotic relationship between BTS and ARMY. Because Big Hit weren’t one of the top three K-pop labels, they were seen as an underdog and relied on social media. That drew in fans – and as fans tuned into their music and video clips, they found that BTS created elaborate stories with their music videos and sang about social issues. Those videos give fans a lot of fodder to “pore over and try to decode,” making the BTS fandom not so different from the dedicated followers of the “Lost” television series, said Michelle Cho, a professor at the East Asian studies department at the University of Toronto. To BTS, the fans are a major reason behind their success. As a result, barely a concert or awards ceremony goes by without BTS thanking ARMY for helping them get where they are. Cho says this idea of reciprocity sets BTS apart from pop groups in the West. “I think it’s a really potent mix,” she said. “You’re not just a casual fan of BTS, you have to be initiated into their world and then you get sucked in.” Fans ouside Times Square Studios on September 26, 2018, where BTS was set to perform. Paula Lobo/Walt Disney Television via Getty Images That was true for Tahne Howard, a 18-year-old student from the United Kingdom, who got so drawn in to BTS that she began having dreams about them. She finds comfort in their message of “love yourself” – and leaves comments on their online live streams, hoping that they’ll notice she exists. She doesn’t see BTS as gods – but it’s still personal. “It’s like proud parents watching their children grow up,” said Howard. “We helped them to be who they are now, and thankfully, the band is grateful for what we do.”',\n",
       " ('BTS',\n",
       "  88,\n",
       "  0): 'The 2018 Billboard Music Awards are here. With Kelly Clarkson hosting, the 2018 BBMAs hit the MGM Grand Las Vegas on Sunday (May 20) and saw everyone from Taylor Swift to Shawn Mendes to BTS to BBMA Icon Award winner Janet Jackson in attendance. Clarkson cold-opened the show with a call to action following the recent school shooting in Santa Fe, Texas, and then performed a stunning medley of other artists’ songs, including Kendrick Lamar, Ed Sheeran, Swift, Mendes and more. Check out the full list of winners, updating live, below: Top Artist: Drake Kendrick Lamar Bruno Mars Ed Sheeran — WINNER Taylor Swift Top New Artist: 21 Savage Camila Cabello Cardi B Khalid — WINNER Kodak Black Billboard Chart Achievement Award: Camila Cabello — WINNER Cardi B Drake Sam Hunt Ed Sheeran Top Male Artist: Drake Kendrick Lamar Bruno Mars Post Malone Ed Sheeran — WINNER Top Female Artist: Camila Cabello Cardi B Halsey Demi Lovato Taylor Swift — WINNER Top Duo/Group: The Chainsmokers Coldplay Imagine Dragons — WINNER Migos U2 Top Billboard 200 Artist: Drake — WINNER Kendrick Lamar Ed Sheeran Chris Stapleton Taylor Swift Top Hot 100 Artist: Imagine Dragons Kendrick Lamar Bruno Mars Post Malone Ed Sheeran — WINNER Top Streaming Songs Artist: Cardi B Drake Kendrick Lamar — WINNER Post Malone Ed Sheeran Top Song Sales Artist: Imagine Dragons Kendrick Lamar Bruno Mars Post Malone Ed Sheeran — WINNER Top Radio Songs Artist: Halsey Imagine Dragons Bruno Mars Charlie Puth Ed Sheeran — WINNER Top Social Artist: Justin Bieber BTS — WINNER Ariana Grande Demi Lovato Shawn Mendes Top Touring Artist: Coldplay Guns N’ Roses Bruno Mars Ed Sheeran U2 — WINNER Top R&B Artist: Chris Brown Khalid Bruno Mars — WINNER SZA The Weeknd Top R&B Male Artist: Khalid Bruno Mars — WINNER The Weeknd Top R&B Female Artist: Beyonce Rihanna SZA — WINNER Top R&B Tour: Bruno Mars — WINNER Lionel Richie The Weeknd Top Rap Artist: Drake Kendrick Lamar — WINNER Lil Uzi Vert Migos Post Malone Top Rap Male Artist: Drake Kendrick Lamar — WINNER Post Malone Top Rap Female Artist: Bhad Bhabie Cardi B — WINNER Nicki Minaj Top Rap Tour: J. Cole JAY-Z — WINNER Kendrick Lamar Top Country Artist: Kane Brown Luke Combs Sam Hunt Thomas Rhett Chris Stapleton — WINNER Top Country Male Artist: Sam Hunt Thomas Rhett Chris Stapleton — WINNER Top Country Female Artist: Kelsea Ballerini Miranda Lambert Maren Morris — WINNER Top Country Duo/Group Artist: Florida Georgia Line — WINNER Old Dominion Zac Brown Band Top Country Tour: Luke Bryan — WINNER Florida Georgia Line Tim McGraw & Faith Hill Top Rock Artist: Imagine Dragons — WINNER Linkin Park Portugal. The Man Tom Petty & The Heartbreakers twenty one pilots Top Rock Tour: Coldplay Guns N’ Roses U2 — WINNER Top Latin Artist: J Balvin Daddy Yankee Luis Fonsi Ozuna — WINNER Romeo Santos Top Dance/Electronic Artist: The Chainsmokers — WINNER Calvin Harris Kygo Marshmello ODESZA Top Christian Artist: Elevation Worship Hillsong UNITED Hillsong Worship MercyMe — WINNER Zach Williams Top Gospel Artist: Anthony Brown & group therAPy Travis Greene J.J. Hairston & Youthful Praise Tasha Cobbs Leonard — WINNER Tamela Mann Top Billboard 200 Album: Drake, More Life Kendrick Lamar, DAMN. — WINNER Post Malone, Stoney Ed Sheeran ÷ (Divide) Taylor Swift, reputation Top Selling Album: Kendrick Lamar, DAMN. P!nk, Beautiful Trauma Ed Sheeran, ÷ (Divide) Chris Stapleton, From A Room: Volume 1 Taylor Swift, reputation — WINNER Top Soundtrack: Black Panther The Fate of the Furious: The Album The Greatest Showman Guardians of the Galaxy, Vol. 2: Awesome Mix Vol. 2 Moana',\n",
       " ('BTS',\n",
       "  88,\n",
       "  1): '–– WINNER Top R&B Album: Khalid, American Teen Bruno Mars, 24K Magic — WINNER SZA, CTRL The Weeknd, Starboy XXXTentacion, 17 Top Rap Album: Drake, More Life Kendrick Lamar, DAMN. — WINNER Lil Uzi Vert, Luv Is Rage 2 Migos, Culture Post Malone, Stoney Top Country Album: Kane Brown, Kane Brown Luke Combs, This One’s For You Thomas Rhett, Life Changes Chris Stapleton, From A Room: Volume 1 — WINNER Brett Young, Brett Young Top Rock Album: Imagine Dragons, Evolve — WINNER Linkin Park, One More Light Panic! At The Disco, Death of a Bachelor Portugal. The Man, Woodstock U2, Songs of Experience Top Latin Album: Nicky Jam, Fenix Christian Nodal, Me Deje Llevar Ozuna, Odisea — WINNER Romeo Santos, Golden Shakira, El Dorado Top Dance/Electronic Album: Avicii, AV?CI (01) The Chainsmokers, Memories…Do Not Open — WINNER Calvin Harris, Funk Wav Bounces Vol. 1 Kygo, Stargazing ODESZA, A Moment Apart Top Christian Album: Elevation Worship, There Is A Cloud Hillsong UNITED, Wonder Hillsong Worship, Let There Be Light Alan Jackson, Precious Memories Collection — WINNER MercyMe, Lifer Top Gospel Album: Anthony Brown & group therAPy, A Long Way From Sunday Travis Greene, Crossover: Live From Music City J.J. Hairston & Youthful Praise, You Deserve It Tasha Cobbs Leonard, Heart. Passion. Pursuit — WINNER Marvin Sapp, Close Top Hot 100 Song: Luis Fonsi & Daddy Yankee ft. Justin Bieber, “Despacito” — WINNER Kendrick Lamar, “Humble.” Bruno Mars, “That’s What I Like” Post Malone ft. 21 Savage, “Rockstar” Ed Sheeran, “Shape Of You” Top Streaming Song (Audio): Luis Fonsi & Daddy Yankee ft. Justin Bieber, “Despacito” Kendrick Lamar, “Humble.” — WINNER Lil Uzi Vert, “XO Tour LLIF3” Post Malone ft. 21 Savage, “Rockstar” Post Malone ft. Quavo, “Congratulations” Top Streaming Song (Video): Cardi B, “Bodak Yellow (Money Moves)” Luis Fonsi & Daddy Yankee ft. Justin Bieber, “Despacito” — WINNER Lil Pump, “Gucci Gang” Bruno Mars, “That’s What I Like” Ed Sheeran, “Shape of You” Top Selling Song: Luis Fonsi & Daddy Yankee ft. Justin Bieber, “Despacito” — WINNER Sam Hunt “Body Like A Back Road” Imagine Dragons “Believer” Imagine Dragons “Thunder” Ed Sheeran “Perfect” Top Radio Song: The Chainsmokers & Coldplay, “Something Just Like This” Imagine Dragons, “Believer” Bruno Mars, “That’s What I Like” Charlie Puth, “Attention” Ed Sheeran, “Shape of You” — WINNER Top Collaboration: Camila Cabello ft. Young Thug, “Havana” The Chainsmokers & Coldplay, “Something Just Like This” Luis Fonsi & Daddy Yankee ft. Justin Bieber, “Despacito” — WINNER French Montana ft. Swae Lee, “Unforgettable” Post Malone ft. 21 Savage, “Rockstar” Top R&B Song: Childish Gambino, “Redbone” DJ Khaled ft. Rihanna & Bryson Tiller, “Wild Thoughts” Khalid, “Young Dumb & Broke” Bruno Mars, “That’s What I Like” — WINNER Bruno Mars ft. Cardi B, “Finesse” Top Rap Song: Cardi B, “Bodak Yellow (Money Moves)” DJ Khaled ft. Justin Bieber, Quavo, Chance The Rapper & Lil Wayne, “I’m The One” French Montana ft. Swae Lee, “Unforgettable” Kendrick Lamar, “Humble.” Post Malone ft. 21 Savage, “Rockstar” — WINNER Top Country Song: Kane Brown ft. Lauren Alaina, “What Ifs” Sam Hunt, “Body Like A Back Road” — WINNER Dustin Lynch, “Small Town Boy” Bebe Rexha & Florida Georgia Line, “Meant To Be” Brett Young, “In Case You Didn’t Know” Top Rock Song: Imagine Dragons “Believer” — WINNER Imagine Dragons “Thunder” Linkin Park ft. Kiiara “Heavy” Portugal. The Man “Feel It Still” The Revivalists “Wish I Knew You” Top Latin Song: J Balvin & Willy William Ft. Beyonce, “Mi Gente” Becky G ft. Bad Bunny, ”Mayores” Luis Fonsi & Daddy Yankee ft. Justin Bieber, “Despacito” — WINNER Maluma, “Felices Los 4” Wisin ft. Ozuna,',\n",
       " ('BTS',\n",
       "  88,\n",
       "  2): '“Escapate Conmigo” Top Dance/Electronic Song: The Chainsmokers & Coldplay, “Something Just Like This” — WINNER Cheat Codes ft. Demi Lovato, “No Promises” Clean Bandit ft. Sean Paul & Ann-Marie, “Rockabye” Kygo & Selena Gomez, “It Ain’t Me” Zedd & Alessia Cara, “Stay” Top Christian Song: Elevation Worship, “O Come To The Altar” Hillsong Worship, “What A Beautiful Name” — WINNER Lecrae ft. Tori Kelly, “I’ll Find You” MercyMe, “Even If” Zach Williams, “Old Church Choir” Top Gospel Song: Anthony Brown & group therAPy, “Trust In You” Travis Greene, “You Waited” J.J. Hairston & Youthful Praise, “You Deserve It” — WINNER Tamela Mann, “Change Me” Charlie Wilson, “I’m Blessed” Billboard Music Awards nominees are based on key fan interactions with music, including album and digital song sales, streaming, radio airplay, touring and social engagement. These measurements are tracked year-round by Billboard and its data partners, including Nielsen Music and Next Big Sound. The awards are based on the reporting period of April 8, 2017 through March 31, 2018.',\n",
       " ('BTS',\n",
       "  9,\n",
       "  0): 'By releasing a new version of their hit Wings album coupled with four creatively challenging new songs and a truly powerful lead single, BTS continue to conquer new territory on multiple Billboard charts with the release of You Never Walk Alone. Most notably, the K-pop boy band’s new single “Spring Day” debuts at No. 15 on Billboard‘s Bubbling Under Hot 100 chart for the chart dated March 4, 2017. The Bubbling Under Hot 100 acts as an extension of the 25 songs that have yet to chart on the definitive Hot 100 singles chart and are just below the top 100 slots. Like the main Hot 100 chart, rankings are based on sales, radio airplay and streaming data. The feat is truly unprecedented given K-pop’s history on Billboard‘s singles chart. While the group does not land on the Hot 100 comparing them to the groups that have puts into perspective how the impressive chart performance of “Spring Day.” Wonder Girls were the first K-pop act to chart on the Hot 100 with “Nobody,” a song that was a megahit when released in Korea in 2008 and eventually landed on the Hot 100 a year later thanks to the group re-recording it in English and performing it on U.S. television shows. CL also landed on the Hot 100 with “Lifted,” but again this was an English song promoted on The Late Late Show With James Corden. PSY is the only K-pop act to send Korean-language songs to the Hot 100 (so far, four of them), but has been assisted by an American record deal and management. To compare: BTS’ “Spring Day” is almost all in Korean, had zero promotions in America, was released new music during a notoriously competitive week with the 2017 Grammy Awards, and “Spring Day” dropped on a Sunday making their charting window smaller than other releases. The accomplishment gives hope and acts as a guiding light to the burgeoning K-pop scene and gives indication of how Korean acts can continue making their mark on the American industry. “Spring Day” sold 14,000 digital downloads in the week ending Feb. 16, according to Nielsen Music. The total puts BTS at No. 1 on World Digital Songs Sales giving the band their third No. 1 on the chart. In fact, all four new songs from You Never Walk Alone hold down the first four slots making BTS the first act on World Digital Song Sales to do so. “Day” is followed by “Not Today” (which sold 12,000), “A Supplementary Story: You’ll Never Walk Alone” (8,000) and “Outro: Wings” (6,000). Looking at You Never Walk Alone as a whole — a repackaged version of Wings that came with four new songs — the album debuts at No. 61 on the Billboard 200 — extending BTS’ record as the K-pop act with the most entries on America’s definitive albums chart to four. So far, they’ve bowed with The Most Beautiful Moment in Life, Part 2 (which hit No. 171), The Most Beautiful Moment In Life: Young Forever (No. 107), and Wings (No. 26). G-Dragon and BIGBANG are the only other K-pop acts to boast more than one entry on the Billboard 200. And as if they couldn’t have more to celebrate, You Never Walk Alone debuts at No. 1 on World Albums giving BTS their third chart-topper on that ranking. Check back to Billboard.com the morning of Wednesday, Feb. 22 to see BTS’ accomplishments when all the charts are refreshed.',\n",
       " ('C++',\n",
       "  1,\n",
       "  0): 'Интервью со Страуструпом Англоязычный оригинал интервью опубликован на сервере Перевод А.И. Легалова 18.03.2001 Денни Калев (Danny Kalev)опубликован на сервере linuxworld.com 21.02.2001Перевод А.И. Легалова 18.03.2001 Интервью со Страуструпом Общие сведения В этом интервью, Бьерн Страуструп, создатель C++, говорит об объектно-ориентированной революции, особенностях реальной разработки программного обеспечения, непрерывном развитиии C и C++, и некоторых добавлениях к стандарту C++, которые он хотел бы увидеть. Бьерн Страуструп - создатель C++, одного из наиболее широко используемых языков, поддерживающего объектно-ориентированное программирование. Он также автор таких книг как \"Язык программирования C++\" [Страуструп] и \"Дизайн и эволюция C++\" [Страуструп2000]. Страуструп, в настоящее время возглавляет отдел программирования иследовательской лаборатории AT&T в штате Нью-Джерси. Его научные интересы включают распределенные системы, операционные системы, моделирование, проектирование программного обеспечения и программирование. LinuxWorld.com: Объектно-ориентированные языки известны с конца 1960-ых. Однако, объектно-ориентированная революция произошла спустя два десятилетия. Как Вы объясняете эту задержку и какие выводы мы можем сделать из этого? Бьерн Страуструп: Часть причин в том, что что изменения в сознании и поведении людей всегда занимают гораздо больше времени, мы думаем. Другая причина в том, что некоторые люди имели (и имеють) необоснованные ожидания относительно \"революций\". В корне неверной является идея, что имеется только один правильный способ, чтобы решить любую проблему для любого пользователя. Я - великий фанатик объектно-ориентированного программирования, а также методов и принципов проектирования (разработки), опирающихся на использование алгоритмического языка Симула 67. Однако, эта техника не являетсяэффективной. Многое в программировании лучше сделать методами, которые не помещаются внутри узкой полоски методов, именуемых \"объектно-ориентированными\". И если Вы не выходите за границу \"объектно-ориентированных\" методов, чтобы остаться в рамках \"хорошего программирования и проектирования\", Вы получаете нечто, что является в основном бессмысленным. См. мою статью, \"Почему C++ не только объектно-ориентированный язык программирования\". Другая причина состоит в том, что люди, связывали с понятиями \"Истинная объектная ориентированность\" или \"Чистая объектная ориентированность\" такое, что вело к огромным непроизводительным затратам даже при решении простых задач, если сравнить полученный код с кодом на C++ и C. Вывод, который я сделал (в 1980 или около того), заключался в том, что универсальный язык программирования должен опираться на несколько парадигм и что каждая парадигма должна быть поддержана хорошо: с близкой к оптимальной пространственной и временной эффективностью. Подводя итог, я нахожу, что принятие новых идей было серьезно замедлено консерватизмом, опирающимся на мифы о сложности и непроизводительных затратах. Другая проблема в том, что многие люди, включая программистов, педагогов, и администраторов, просто не понимают сложности процесса разработки программного обеспечения. Они мечтают о \"серебряных пулях\" и отклоняют эффективные идеи потому, что они не точны и нетривиальны, чтобы использоваться новичками. Это ведет к реальной работе, сделанной с использованим излишне старых языков, инструментальных средств, и методов, несмотря на то, что эти причуды ведут к непроизводительным затратам. Эта же недооценка проблем также ведет всякий раз к поиску новой \"серебряной пули\" что является сильным упрощением суровостей реальной разработки программного обеспечения. И если проект, построенный таким образом, приходится адаптировать к новым реальностям, то он становится уязвимым к критическим ошибкам. Это ведет к поиску следующей \"серебряной пули\". Вернемся к полутехническому замечанию: я думаю, что любой язык, который стремится к господствующему положению во всех областях, должен обеспечить широкую основу для нескольких методов, включая объектно-ориентированное программирование (на основе иерархии классов) и обобщенное программирование (параметризированные типы и алгоритмы). В частности, необходимо обеспечить хорошие средства для создания программ из отдельных (независимых) частей (возможно, написанных на различных языках). Я также думаю, что для управления сложным процессом обработки ошибок необходимы исключения. Язык, в котором отсутствуют такие средства вынуждает его пользователей моделировать их (что ведет к дополнительным ошибкам и затратам). LinuxWorld.com: Какие важные тенденции в программировании мы увидим в ближайшем будущем? Какова роль функционального программирования, программирования на основе правил, обобщенного программирования, и других парадигм в мире программирования завтрашнего дня? Может что-либо из них стать',\n",
       " ('C++',\n",
       "  1,\n",
       "  1): 'господствующей тенденцией или они - простые академические пустышки? Бьерн Страуструп: я не являюсь хорошим предсказателем будущего, так что я не буду этим заниматься, вместо этого скажу, что обычно будущее в большей степени, чем мы думаем, является вчерашним днем. Заметьте, что КОБОЛ, ФОРТРАН, и C - все еще большие языки. Обобщенное программирование - реальность (господствующая тенденция). Вы можете также видеть, как изящно и эффективно в стандартной библиотеке шаблонов (STL) замствована техника функционального программирования, используемая при этом в контексте C++. Программирование на основе правил (см. ссылку на ресурсы по R ++) имеет в своем активе список неудач и успехов, который не ведет к выводу о возможном господствующем положении. Это, конечно, печально, но я не хочу называть данную парадигму \"академическим пустяком\". Многие из идей, которые мы сегодня видим в отдельных языках, проявятся как господствующие тенденции, средства и методы, при внедрении в господствующий язык, типа C++. Будущее увидит много мультипарадигм программирования и различные многоязычные системы. LinuxWorld.com: С утверждением C99 (нового стандарта C), C / C ++ совместимость кажется менее достижимой чем когда-либо прежде. Является ли совместимость вниз с C все еще одна из целей C++? Если так, то что было сделано, чтобы отвернуть от пропасти, встающей между двумя языками? Бьерн Страуструп: C99 сосредоточен на распространении низкоуровневых средств C в области численного программирования. Он в своей основе игнорирует средства абстракции и цели общности, воплощенные в C++. Это делает совместимость более трудной, поскольку к C добавлены специфические средства там, где C++ реализует те же самые потребности программиста через библиотеки, используя универсальные средства языка. Например, в C99 используются массивы переменной длины вместо библиотечных векторов, применяемых в C++. Более скоординированное выделения ядра, общего для обеих языков помогло бы избежать этого раскола. Мой идеал: остающиеся все еще общими части C++ и C99 можно соединить в единый когерентный язык. Я думаю, что такой язык мог бы объединить общие рациональные технические требования. Однако, я не уверен, что политически это будет сделано. Для запуска процесса, требуется слияние комитетов стандартов по C и C++. Невозможно иметь две различных группы людей, развивающих два языка параллельно. Каждый комитет притягивает людей, кто не могут используют идеалы большинства из другой группы, и которые ненавидят возможностей компромисса с этим большинством. В то время как каждый отдельный комитет способствует объединению своего сообщества, оба комитета обеспечивают расходимость языков и игнорирование неудобных предложений и мнений. Лично, я думаю, что комитеты должны выработать соглашение, чтобы соединиться, а затем и слиться, но прежде, чем появится новый стандарт ISO C++. Результатом были бы более хороший язык и намного более сильное сообщество. LinuxWorld.com: Есть ли элементы или концепции в других языках, например Python или Ada95, которые Вы хотели бы видеть добавленными к C++? Вообще, нуждается ли C++ в любых дополнительных элементах или библиотеках? Бьерн Страуструп: Я хотел бы видеть, что наступающее изменение стандарта C++ сосредотачивается на библиотеках. Работа над самим языком может быть ограничена коррекцией ошибок, созданием языка более однородным, обеспечением незначительных расширений для поддержки популярных парадигм, и обеспечении поддержки, необходимой для библиотек. Например, я полагаю, что параллелизм лучше всего поддерживать библиотекой и что такая библиотека может быть выполнена без больших расширений языка. Однако, такая библиотека могла бы нуждаться в некоторых дополнительных гарантиях, вписанных в стандарт. Кроме того, я был бы рад, увидеть слияние C и C++. Рассмотрим \"основные\" средства языка, часто предлагаемые для внесения в C++: Параллелизм: я хотел бы видет библиотеку, поддерживающуюпотоки и связанную с ней библиотеку поддерживающую параллелизм без разделения памяти. Отражение: я хотел бы видеть поддержку через библиотеку определение интерфейса, расширяющего информацию о типе. Сохраняемость: я хотел бы видеть некоторую поддержку в стандартной библиотеке, возможностей по включению расширенной информации о типе, но я, в настоящее время, не имею каких-либо конкретные предложений. Хеш таблицы: Конечно, некоторый вариант популярного hash_map будет включен. Ограничения',\n",
       " ('C++',\n",
       "  1,\n",
       "  2): 'для аргументов шаблона: Это может быть просто и изящно выражено в C++ и сейчас. Обработчики (Assertions): Многие из наиболее полезных утверждений [способы проверки кода и обработки ошибок] могут быть выражены как шаблоны. Некоторые должны быть добавлен к стандартной библиотеке. Разбор регулярных выражений (Regular expression matching): я бы хотел видеть в стандарте библиотеку с образцами, обеспечивающими разбор. Сборка мусора: я бы хотел видеть, что стандарт C++ явно подтверждает, что это - допустимая методика реализации для C++, точно определяющая, что \"потерянные указатели\" могут игнорироваться и что случится при вызове деструкторов для собранного мусора. (См. секцию C 4.1 Языка программирования C++ для более детального ознакомления). Графический интерфейс пользователя (GUI): было бы хорошо иметь стандартный GUI-каркас, но я не вижу, как такое может быть политически возможно. Системные средсва, независимые от платформы (Platform-independent system facilities: я бы хотел видеть, что стандартна библиотека обеспечивает более широкий набор стандартных интерфейсов к общим системным ресурсам, например, каталогам и сокетам. Заметьте, что эти расширения прежде всего являются дополнениями к стандартной библиотеке и могут быть реализованы без новых затрат во время выполнения программы или дополнительных требований к ресурсам. Таким образом, они могут быть добавлены без нарушения принципа \"нулевого перекрытия\". Между прочим, C++ - хороший язык для программирования аппаратного ядра встроенных систем и должен оставаться таковым. Также, все ресурсы должны быть правильно интегрированы с текущими стандартными библиотечными средствами, такими как строки и контейнеры. Если бы не графические интерфейсы пользователя, я бы с оптимизмом утверждал, что все эти изменения стандарта могли бы быть сделаны без несоответствующей дискуссии до 2005 года. Конечно, это честолюбиво, но альтернативой честолюбивым целям является застой. Я думаю, что сообщество открытых кодов играет большую роль, чтобы участвовать в этом, потому что ни одна из этих библиотек не будет принята в стандарт, если мы не получим опыт на основе качественных реализаций, являющихся основой стандарта. LinuxWorld.com: кажется, что C++ потерпел неудачу на одном важном фронте: защите языка. Много людей все еще по ошибке полагают, что C++ по существу медленнее чем C, а среда часто отказывается подтверждать, что C++, наиболее широко используемый универсальный язык программирования, фокусируясь вместо этого на других широко раздутых языках. Где мы шли не так, как надо и что может быть сделано, чтобы зафиксировать все, как надо? Бьерн Страуструп: C++ не нуждался в эффективной защите, с самого начального момента: его сразу стали использовать миллионы программистов. Удивительно то, что это было достигнуто без специальной организации и использования каких-либо дополнительных ресурсов. Это, возможно, сделало сообщество C++ умиротворенным, что, определенно, приволо к уязвимости со стороны враждебной пропаганды. Я предполагаю, что реальная задача в том, что хороший код является невидимым, даже его пользователям. Рассмотрите программы на C++ типа Netscape и Internet Explorer. Корпорации, которые производят программное обеспечение для решения задач в реальном масштабе времени: управление передачей данных, автоматическое управление, и моделирование, не рекламируют языки, которыми они пользуются. К сожалению, имиджмейкерами программ и инструментальных средств являются продавцы и академики. C++ никогда не имел поддержку большого производителя. Каждый большой производитель помещает (и всегда помещал) некоторый частный язык над C++. C++ никогда не использовал большого маркетинга, а там, где маркетинг был сделан, он обычно осуществлялся организациями, продающими кое-что еще (типа среды программирования). Это, кое-что, случилось, включало и C++. Кроме того, сообщество C++ страдает от самого успеха C++: Совершенно ясно \"надо бить одиночку\" и в сегодняшнем, сильно коммерциализированном мире, честная борьба - редкость. Сообщество C++ никогда не имело четкого центра с финансированием, чтобы участвовать в популяризации C++. Кто агитирует за C++? И как эта агитация достигает программистов, педагогов, и администраторов? Уже на этой неделе, я слышал о профессоре, внушающем его студентам, что не имеется, однако, стандарта C++! Печально слышать такое спустя два года после утверждения стандарта, это - общее неправильное представление. Так, что же сообщество C++ может',\n",
       " ('C++',\n",
       "  1,\n",
       "  3): 'сделать теперь? Достигнуты определенные успехи иизвестны успешные методы. Статьи и конференции - это возможные места встречи, но для наиболее занятых программистов, простое описание на Web страницах - более реалистическая возможность. Обеспечение высококачественного кода, открытие сайтов с исходными кодами - возможно наиболее действенный способ показать людям, что может делать C++ (текущие примеры - SGI, STL и Boost.org). Так или иначе, мы должны создать широко известную \"портал\" к информации, связанной с C++. Коммерческие организации могли бы улучшить работу по преданию гласности их успехов в использовании C++, особенно, если он обеспечивает возможность сосредоточиться на частных аспектах их изделий. Разнообразные поставщики, стандартизированный характер - большая причина для многих пользователей выбрать C++. C++ должен изучаться лучше, вместе со стандартной библиотекой и средствами абстракции, играющими центральную роль. Обучении C++ как расширения к C расточительно и запутанно. См. \"Изучение Стандартного C++ как нового языка\" в Ресурсах. Комитет стандартов должен делать его работу, обеспечивая стандартные версии доступными для критики, но нестандартными, библиотеками. Это может быть сделано, но сделать это будет не просто. Ресурсы Домашняя страница Бьерна Страуструпа: http://www.research.att.com/~bs http://www.research.att.com/~bs Биография Бьерна Страуструпа: http://www.research.att.com/~bs/bio.html http://www.research.att.com/~bs/bio.html Публикации Бьерна Страуструпа: http://www.research.att.com/~bs/papers.html http://www.research.att.com/~bs/papers.html The C++ Programming Language, Special Edition, Bjarne Stroustrup (Addison-Wesley, 2000): http://www.research.att.com/~bs/3rd.html http://www.research.att.com/~bs/3rd.html Bjarne Stroustrup\\'s FAQ: http://www.research.att.com/~bs/bs_faq.html http://www.research.att.com/~bs/bs_faq.html Комитет по стандартизации C++: http://anubis.dkuug.dk/JTC1/SC22/WG21 http://anubis.dkuug.dk/JTC1/SC22/WG21 C++ Boost.org: http://www.boost.org/ http://www.boost.org/ Standard Template Library от SGI: http://www.sgi.com/tech/stl/ http://www.sgi.com/tech/stl/ R++: Основанный на правилах язык программирования: http://www.research.att.com/sw/tools/r++/ http://www.research.att.com/sw/tools/r++/ Новые достижения C99: http://web.onetelnet.ch/~twolf/tw/c/c9x_changes.html http://web.onetelnet.ch/~twolf/tw/c/c9x_changes.html \"Будущее согласно Деннису Ритчи\". Danny Kalev (LinuxWorld.com, Dec 2000): http://www.linuxworld.com/linuxworld/lw-2000-12/lw-12-ritchie.html http://www.linuxworld.com/linuxworld/lw-2000-12/lw-12-ritchie.html Комитет по стандартизации C: http://anubis.dkuug.dk/JTC1/SC22/WG14 http://anubis.dkuug.dk/JTC1/SC22/WG14 Организация языка программирования Python: http://www.python.org/ http://www.python.org/ \"Будущее функционального программирования\". Cameron Laird (LinuxWorld.com, November 2000) : http://www.linuxworld.com/linuxworld/lw-2000-11/lw-11-futurecomputing.html Оставить комментарий',\n",
       " ('C++',\n",
       "  10,\n",
       "  0): 'From cppreference.com <vector> Defined in header template < class T, class Allocator = std::allocator<T> > class vector ; vector (1) namespace pmr { pmr template< class T > using vector = std::vector<T, std::pmr::polymorphic_allocator<T>>; } (2) (since C++17) 1) std::vector is a sequence container that encapsulates dynamic size arrays. 2) std::pmr::vector is an alias template that uses a is an alias template that uses a polymorphic allocator The elements are stored contiguously, which means that elements can be accessed not only through iterators, but also using offsets to regular pointers to elements. This means that a pointer to an element of a vector may be passed to any function that expects a pointer to an element of an array. The storage of the vector is handled automatically, being expanded as needed. Vectors usually occupy more space than static arrays, because more memory is allocated to handle future growth. This way a vector does not need to reallocate each time an element is inserted, but only when the additional memory is exhausted. The total amount of allocated memory can be queried using capacity() function. Extra memory can be returned to the system via a call to shrink_to_fit()[1]. Reallocations are usually costly operations in terms of performance. The reserve() function can be used to eliminate reallocations if the number of elements is known beforehand. The complexity (efficiency) of common operations on vectors is as follows: Random access - constant 𝓞(1) . . Insertion or removal of elements at the end - amortized constant 𝓞(1) . . Insertion or removal of elements - linear in the distance to the end of the vector 𝓞(n) . std::vector (for T other than bool) meets the requirements of Container, AllocatorAwareContainer(since C++11), SequenceContainer, ContiguousContainer(since C++17) and ReversibleContainer. All member functions of std::vector are constexpr: it is possible to create and use std::vector objects in the evaluation of a constant expression. However, std::vector objects generally cannot be constexpr, because any dynamically allocated storage must be released in the same evaluation of constant expression. (since C++20) edit] Template parameters T - The type of the elements. T must meet the requirements of CopyAssignable and CopyConstructible . (until C++11) The requirements that are imposed on the elements depend on the actual operations performed on the container. Generally, it is required that element type is a complete type and meets the requirements of Erasable , but many member functions impose stricter requirements. (since C++11) (until C++17) The requirements that are imposed on the elements depend on the actual operations performed on the container. Generally, it is required that element type meets the requirements of Erasable, but many member functions impose stricter requirements. This container (but not its members) can be instantiated with an incomplete element type if the allocator satisfies the allocator completeness requirements. Feature-test macro Value Std Feature __cpp_lib_incomplete_container_elements 201505L (C++17) Minimal incomplete type support (since C++17) Allocator - An allocator that is used to acquire/release memory and to construct/destroy the elements in that memory. The type must meet the requirements of Allocator . The behavior is undefined (until C++20) The program is ill-formed (since C++20) if Allocator::value_type is not the same as T . edit] Specializations The standard library provides a specialization of std::vector for the type bool, which may be optimized for space efficiency. vector <bool> space-efficient dynamic bitset (class template specialization) edit] Iterator invalidation Operations Invalidated All read only operations Never. swap std::swap end() clear operator= assign Always. reserve shrink_to_fit If the vector changed capacity, all of them. If not, none. erase Erased elements and all elements after them (including end() push_back emplace_back If the vector changed capacity,',\n",
       " ('C++',\n",
       "  10,\n",
       "  1): \"all of them. If not, only end() insert emplace If the vector changed capacity, all of them. If not, only those at or after the insertion point (including end() resize If the vector changed capacity, all of them. If not, only end() pop_back The element erased and end() edit] Member types edit] Member functions (constructor) constructs the vector (public member function) (destructor) destructs the vector (public member function) operator= assigns values to the container (public member function) assign assigns values to the container (public member function) assign_range (C++23) assigns a range of values to the container (public member function) get_allocator returns the associated allocator (public member function) Element access at access specified element with bounds checking (public member function) operator[] access specified element (public member function) front access the first element (public member function) back access the last element (public member function) data direct access to the underlying contiguous storage (public member function) Iterators begin cbegin (C++11) returns an iterator to the beginning (public member function) end cend (C++11) returns an iterator to the end (public member function) rbegin crbegin (C++11) returns a reverse iterator to the beginning (public member function) rend crend (C++11) returns a reverse iterator to the end (public member function) Capacity empty checks whether the container is empty (public member function) size returns the number of elements (public member function) max_size returns the maximum possible number of elements (public member function) reserve reserves storage (public member function) capacity returns the number of elements that can be held in currently allocated storage (public member function) shrink_to_fit ( DR* ) reduces memory usage by freeing unused memory (public member function) Modifiers clear clears the contents (public member function) insert inserts elements (public member function) insert_range (C++23) inserts a range of elements (public member function) emplace (C++11) constructs element in-place (public member function) erase erases elements (public member function) push_back adds an element to the end (public member function) emplace_back (C++11) constructs an element in-place at the end (public member function) append_range (C++23) adds a range of elements to the end (public member function) pop_back removes the last element (public member function) resize changes the number of elements stored (public member function) swap swaps the contents (public member function) edit] Non-member functions edit] Notes Feature-test macro Value Std Feature __cpp_lib_containers_ranges 202202L (C++23) Ranges construction and insertion for containers edit] Example Run this code #include <iostream> #include <vector> int main ( ) { // Create a vector containing integers std :: vector < int > v = { 8 , 4 , 5 , 9 } ; // Add two more integers to vector v. push_back ( 6 ) ; v. push_back ( 9 ) ; // Overwrite element at position 2 v [ 2 ] = - 1 ; // Print out the vector for ( int n : v ) std:: cout << n << ' ' ; std:: cout << ' ' ; } Output: 8 4 -1 9 6 9 edit] Defect reports The following behavior-changing defect reports were applied retroactively to previously published C++ standards. DR Applied to Behavior as published Correct behavior LWG 69 C++98 contiguity of the storage for elements of vector was not required required LWG 230 C++98 T was not required to be CopyConstructible (an element of type T might not be able to be constructed) T is also required to be CopyConstructible LWG 464 C++98 access to the underlying storage of an empty vector resulted in UB data function provided edit] See also\",\n",
       " ('C++',\n",
       "  11,\n",
       "  0): 'Microsoft plans to explore using the Rust programming language as an alternative to C, C++, and others, as a way to improve the security posture of its and everyone else\\'s apps. The announcement was made yesterday by Gavin Thomas, Principal Security Engineering Manager for the Microsoft Security Response Center (MSRC). \"You\\'re probably used to thinking about the Microsoft Security Response Center as a group that responds to incidents and vulnerabilities,\" Thomas said. \"We are a response organization, but we also have a proactive role, and in a new blog series we will highlight Microsoft\\'s exploration of safer system programming languages, starting with Rust.\" The end game is to find a way to move developers from the aging C and C++ programming language to so-called \"memory-safe languages.\" Memory-safe languages, such as Rust, are designed from the ground up with protections against memory corruption vulnerabilities, such as buffer overflows, race conditions, memory leaks, use-after free and memory pointer-related bugs. C#, a programming language developed by Microsoft, also features some memory access improvements but is not as advanced as Rust. 70% of all Microsoft patches are for memory-related bugs In research presented earlier this year at the BlueHat Israel security conference, Microsoft security engineer Matt Miller said that over the last 12 years, around 70% of all Microsoft\\'s yearly patches were fixes for memory safety bugs. Image: Matt Miller The reason for this high percentage is because Windows and most other Microsoft products have been written mostly in C and C++, two \"memory-unsafe\" programming languages that allow developers fine-grained control of the memory addresses and where code can be executed. One slip-up in the developers\\' code that manages memory execution can lead to a slew of memory safety errors that attackers can exploit with dangerous and intrusive consequences -- such as remote code execution or elevation of privilege flaws. Exploring the use of a memory-safe language such as Rust would provide an alternative to creating safer Microsoft apps. But Thomas also argues that third-party developers should also be looking into memory-safe languages as well. He cites reasons such as the time and effort developers put into learning how to debug the memory-related security flaws that crop up in their C++ apps. \"A developer\\'s core job is not to worry about security but to do feature work,\" Thomas said. \"Rather than investing in more and more tools and training and vulnerability fixes, what about a development language where they can\\'t introduce memory safety issues into their feature work in the first place? That would help both the feature developers and the security engineers-and the customers.\" Microsoft explored memory-safe programming before Microsoft looking into Rust, as a safer alternative to C++ isn\\'t actually such a big deal. The OS maker has been looking for safer C and C++ alternatives for years. In June 2016, Microsoft open-sourced \"Checked C,\" an extension to the C programming language that brought new features to address a series of security-related issues. Microsoft looking into Rust before any other memory-safe language is also not a bad decision. Besides being superior to C# in regards to better memory protections, Rust is also more popular with developers these days and might be easier to recruit for. Rust -- a hit with the developer community already The language is today\\'s \"most loved\" programming language, according to the 2019 StackOverflow survey, the biggest developer survey on the internet. Developers love it because of its simpler syntax and the fact that apps coded in Rust don\\'t yield the same amount of bugs, allowing developers to focus on expanding their apps, instead of doing constant maintenance work.',\n",
       " ('C++',\n",
       "  11,\n",
       "  1): \"On the other hand, StackOverflow survey respondents ranked C as the fourth most hated programming language, with C++ ranking ninth. Rust, which started as a research project at Mozilla for developing a safer and faster programming language to rewrite the Firefox browser, is also gaining in popularity after organizations started deploying it in the wild. While initially, most developers dismissed it as a theoretical project, nowadays Rust is proving its mettle. It's been deployed in Firefox since July 2016, and most recently, the Brave browser also replaced its ad-blocking component -- originally coded in C++ -- with a Rust version. Cloudflare and Dropbox are also two other major tech players who are now running Rust in production systems. HackerOne's top 20 public bug bounty programs Related cybersecurity coverage:\",\n",
       " ('C++',\n",
       "  12,\n",
       "  0): 'Either email addresses are anonymous for this group or you need the view member email addresses permission to view the original message Scott Meyers < sme...@aristeia.com > writes: \\ue5d3 \\ue5d3 \\ue5d3 \\ue5d3 |> DmaBuffer dmaBuffer(100000); \\ue5d3 \\ue5d3 \\ue5d3 \\ue5d3 This is a problem independant of templates, and linked to the use of pointers. In theory, a compiler could trace the use of the pointer, and determine that it was initially from an operator new, and that no other aliases exist, but few compilers do. In this case, it is also a case of really poor optimization; once inlining has taken place, the compiler can easily see *all* of the accesses through the relative pointers. The only problem it has to deal with is a possible aliasing between *p and *pBufStart; there is no code anywhere that could modify pBufStart outside of the function. This is standard optimization technology; I have seen it in compilers 25 years ago. There is no excuse for it not being present in a compiler today. Any simple peephole optimizer should be able to do the trick. I\\'m not familiar with your assembly, but roughly speaking, what I would expect from the generated code is that it load both pointers and the count in registers, and each time in the loop, copy the four values, increment the two pointers, decrement the count, and test for the end. A good compiler might also eliminate the count, using a comparison with an end pointer. (In this case, what the compiler is maintaining in memory is pBuf. The only variable with the same type, and thus which could possibly alias it, is p. But pBuf is a member variable, and p is a local variable, so the compiler knows that no aliasing is possible.) |> But that\\'s silly. As the programmers we know that in this case the |> buffer and the buffer object can never alias. So, we try declaring |> each and every pointer as \"restrict\" using the restrict extension |> that gcc provides, in hope that gcc can do better with it. But it |> doesn\\'t -- it generates exactly the same code. Blah. That\\'s because the problem is unrelated to any aliasing between pBuf and the p argument of the function. Such aliasing will only become a problem if the compiler starts shuffling code around (e.g. to keep the various pipelines full). Such aliasing will normally only be a problem if you use a value twice, and write through a pointer in between uses -- there is a possibility that the write through the pointer will modify the value, so it must be reloaded the second time. About the only changes that restrict will allow here is for the compiler to shuffle the loads and the stores; this might be relevant, depending on how the pipelines were managed (but manifestly, the compiler is far from taking such issues into account). |> So can you get rid of it? Yes, by giving up on the abstraction and |> writing the code in a straightforward, C-style, no-nonsense |> version: |> int dmaBuffer2[100000]; |> void TestDmaBuffer2(int *p) |> { |> int *dst = &dmaBuffer2[0]; |> for (int i = 0; i < 1000; i++) { |> dst[0] = p[0]; |> dst[1] = p[1]; |> dst[2] = p[2]; |> dst[3] = p[3]; |> dst += 4; |> p += 4; |> } |> } In this case, the difference isn\\'t so much the C versus C++ style, it is a dynamically allocated buffer with a non-local pointer vs. a statically allocated array. Declare the dmaBuffer class to contain a',\n",
       " ('C++',\n",
       "  12,\n",
       "  1): 'large buffer, rather than using dynamic memory, and maintain an index rather than a pointer, and a good compiler should be able to optimize. I tried it with g++, both 2.95.2 and 3.0.4, on my Linux PC, however, and the results were really bad. The necessary optimization techniques are well known, once the inlining has occured, and there is *NO* excuse for such poor code generation. However, one important point to consider is that we are comparing oranges to apples -- the class implementation takes a parameter in order to allocate dynamically the exact size needed (and thus must work with pointers), where as the second implementation uses a statically allocated fixed size array, rather than pointers, so the compiler has a lot more information to work with. |> Then, as we\\'ve effectively circumvented the aliasing issue, we |> finally get rid of that annoying and unnecessary code: But we\\'ve changed the semantics. \\ue5d3 \\ue5d3 \\ue5d3 \\ue5d3 But what is the alternative? An iterator which is implemented as a pointer, with all functions inline, will hardly cause any code bloat over a simple pointer. To show code bloat, you have to show what the alternative solutions cost. For the moment, you\\'ve shown two additional machine instructions. Hardly what I would call code bloat. (The runtime repercussions could be important however, since those two instructions are executed in what is presumably a tight loop.) |> But wait again! It\\'s actually much much worse than this, because |> the aliasing issue compounds, so that the one pointer update the |> compiler wasn\\'t able to remove now causes an aliasing issue with |> something else that really should have been removed as well, etc. |> Of course, this really is a \"well-known\" problem (well, not as |> well- known as it should be) -- it\\'s really the C++ \"abstraction |> penalty\" problem, see eg: |> http://www.acl.lanl.gov/Pooma96/abstracts/robison.html The problem described is a performance problem, and not a code bloat problem. It is also a problem which shouldn\\'t occur in your simple example. The problem occurs when inline functions become too complex, or call other inline functions, to the point where the resulting code becomes too complex for the optimizer. The problem also occurs because many (most) compilers simply will not pass a class type in a register, even if the class type is just a wrapper for a simple base type or pointer. |> That gcc has a serious problem with it, despite decent results on |> the Stepanov benchmark, is also known to some: |> http://gcc.gnu.org/ml/gcc/2000-11/msg00323.html Again, we are talking about different things. Code bloat isn\\'t an issue here, and the issues are exactly the same with or without templates. |> Expression templates can address abstraction penalty problems in |> certain situations, but certainly not all of them. What\\'s worse, |> expression templates IMO constitute write-only code and therefore |> have a limited viability. The real problem with expression templates (other than the fact that they are unmaintainable -- I agree with you there) is that they lead to the situation described above, where the results of inlining become too complex for the optimizer. As an experiment, I once wrote a Matrix class whose operators returned nodes in an expression tree, rather than temporary objects. The goal was that everything would end up inlined, and that the compiler would generate a neat loop out of it. In practice, one almost immediatly reached the situation where there was too much inlining, and the compilers I had at the time (g++ and Sun CC) both gave up on even the simplest expressions. |> Overall I',\n",
       " ('C++',\n",
       "  12,\n",
       "  2): 'consider this a very real and very important issue. |> Unfortunately, there are lots of people carelessly brushing it |> aside -- sadly most of them never having heard of the term |> \"abstraction penalty\" in the first place, less read up on it and |> explored its effects first- hand. The term abstraction penalty refers to a very specific runtime (not space) problem, and only affects programs which do a large number of very simple operations on very small objects. I suspect that most of the affected programs are in the numerics domain, but there are probably examples elsewhere as well. However, I can say that none of the applications I\\'ve worked on have been affected by it; in all cases, we had a number of large objects (which couldn\\'t have been passed in registers anyway), and fairly complex operations on the object (so they weren\\'t inlined, and the compiler optimizer could do its job within the member function). -- James Kanze mailto:ka...@gabi-soft.de Conseils en informatique orientée objet/ Beratung in objektorientierter Datenverarbeitung Ziegelhüttenweg 17a, 60598 Frankfurt, Germany Tel. +49(0)179 2607481',\n",
       " ('C++',\n",
       "  2,\n",
       "  0): 'Сегодня имя Бьерна Страуструпа проходят в университетах. Это живая легенда, человек, создавший язык C++. В интервью CNews он поделился своим видением современной России и перспектив, открывающихся перед ИТ в нашей стране, а также рассказал о новом стандарте языка - C++0x, о возможностях и принципах разработки которого пойдет речь на на конференции CEE-SECR . страницы: 1 | 2 | следующая CNews: В ближайшее время будет презентован новый стандарт C++. Что изменится в этом языке программирования? Какие новые возможности появятся? Бьерн Страуструп: У нас уже есть окончательный \"черновик\" проекта для версии C++0x. Я ожидаю, что он будет скорректирован в соответствии с официальными комментариями и утвержден окончательным голосованием 12 мая 2011 года. После этой процедуры, через несколько месяцев, необходимых на соответствующие бюрократические формальности, он станет официальным стандартом ISO. Никаких существенных изменений в подготовленном проекте не ожидается. Бьерн Страуструп: Не нужно препятствовать студентам, профессорам, исследователям заниматься предпринимательской деятельностью или сотрудничать с бизнесом Первое: изменения будут практически полностью совместимы с существующим стандартом. Комитет постарался cделать все возможное, чтобы правильно обработать существующие исходники ISO C++. Нарушения компиляции будут происходить в случае, если в старом коде использованы идентификаторы, которые в новом стандарте являются ключевыми словами. Так что если в вашем коде использованы идентификаторы static_assert, constexpr, или nullptr - мы приносим свои извинения, но существующий код придется изменить. Хорошей идеей было бы начать миграцию с широкоизвестных библиотек, интегрированных в новый стандарт. Это, в частности, thread, unordered_map, и regex. C++0x был разработан для улучшения языка C++ в области системного программирования и построения библиотек. Также мы хотели сделать C++ более простым для изучения. Думаю, высокоэффективным решением было произвести сотни небольших изменений вместо того, чтобы выпустить одно или два глобальных расширения. Одним из показателей проведенной работы является то, что объем языковых разделов стандартных выражений вырос на 27%, а библиотеки - на 100%, но, вероятно, эти цифры преувеличивают степень внесенных изменений: около половины добавленных текстов являются разъяснениями для разработчиков. Если говорить о возможностях, то их список вряд ли поможет по-настоящему оценить C++0x. Посмотреть их описание можно в моем my C++0x FAQ . Первое, что приходит на ум – безопасная поддержка традиционного параллельного программирования с использованием threads, locks, и так далее. Привлекательными для многих разработчиков окажутся регулярные выражения, хэш-таблицы, генераторы случайных чисел. В практическом использовании языка появилась возможность объявлять функции с указанием возвращаемого типа в конце (ключевое слово auto), разрешение лямбда-выражений, шаблоны с переменным количеством аргументов. Добавлен конструктор посредством списков инициализации, улучшен конструктор констант, упрощена работа for-loop. Иными словами, стандарту C++0x есть, что предложить, но программистам потребуется время для сочетания новых возможностей с эффективным стилем программирования. CNews: Как создаются новые версии стандарта языка программирования? Какой вклад в этот процесс могут внести русские программисты? Бьерн Страуструп: Различные языки имеют различные процессы стандартизации, и значение слова \"стандарт\" понимается тоже по-разному. C++ использует формальный, медленный и демократический процесс ISO, который считается эталоном для систем стандартизации. ISO категорически отличается от стандартизации языков, принадлежащих корпорациям : там \"стандарт\" подразумевает последнюю версию продукта. Комитет по стандарту ISO C++ проводит свои заседания в течение недели трижды в год. Национальные комитеты по стандартизации также принимают участие во встречах и присылают своих представителей. Основная часть работы над стандартом заключается в постоянном общении по электронной почте, обсуждении вопросов и предложений, и работы над рядом документов, представленных в комитет. Их можно найти по запросу в поисковике \"WG21\" - они находятся в свободном доступе. На моей странице публикаций есть ссылки на те из них, в создании которых я принимал участие. Любое действие в комитете осуществляется по достижении консенсуса среди нескольких десятков человек из двух десятков стран. Эта мера позволяет предотвратить какие-либо радикальные изменения. Процесс продвигается медленнее, чем хотелось бы, но гарантирует широкое признание конечного продукта. Технические голосования осуществляются организациями (один голос на организацию), и финальное',\n",
       " ('C++',\n",
       "  2,\n",
       "  1): '– странами-участниками (один голос на страну). В принципе, принять участие в этом процессе можно через государственный орган по стандартизации. Россия уже направляла своих представителей ранее, но я не знаю, насколько они активны в настоящее время. Думаю, что неплохой идеей было бы собраться русским программистам вместе, возродить русский комитет C++, принимать участие во встречах (лично, по телефону или через электронную почту), чтобы их голос был услышан. Наиболее эффективное влияние оказывают представители, участвующие в заседаниях (и голосованиях). Уже слишком поздно вносить существенные изменения в стандарт C++0x (\"существенные\" в том значении, как его понимает большинство), но целью для русских специалистов может стать участие в разработке C++1x. CNews: Как вы считаете, что произойдет с С++ через 10 лет? 20 лет? Бьерн Страуструп: При нынешних темпах развития за это время произойдет два или три изменения стандарта. Я ожидаю таких изменений, которые в значительной мере будут отражать потребности большинства групп пользователей, новые лучшие методы программирования. 10 и 20 лет – это весьма длительные периоды в среде ИТ. Язык C++ отметит свой 25-летний юбилей в качестве коммерческого продукта, пока я нахожусь в Москве. Первый релиз (от AT&T;) и публикация моей книги \"Язык программирования C++\" состоялся 14 октября 1985 года. Какие новые разработки хотелось бы увидеть? У меня нет реальных идей. Надеюсь, что будут поддерживаться модели с более высоким уровнем параллелизма, и что различные стили программирования, которые мы знаем как \"мультипарадигмы\", будут правильно интегрированы в четко сформулированные системы проектирования и программирования (и получат хорошее описывающее наименование). Я надеюсь на значительное увеличение безопасности в современном коде. В идеале, на появление безопасного типа программирования. CNews: Существует ли идеальный программист? Если да, то как он выглядит? Бьерн Страуструп: В действительности, программирование – это кластер из соответствующих навыков и действий. Никто не может быть лучшим во всех аспектах программирования. Я хочу, чтобы мои программисты имели твердые фундаментальные знания (алгоритмы, структуры данных, архитектура, и т.д.) и специализацию (например, графика или приложения для исторических исследований). Хороший программист также должен уметь общаться (устно и письменно) и быть эффективным членом команды. Я думаю, что степень магистра является нужным уровнем образования для разработчика нетривиальных систем. Я написал короткую заметку по этому поводу: \"Чему мы должны обучить разработчиков ПО? Почему?\" страницы: 1 | 2 | следующая Стань другом',\n",
       " ('C++',\n",
       "  3,\n",
       "  0): \"Table of contents Article 10/07/2019 In this article Pure C++ Hello, C++/CLI and Stanley B. Lippman SUMMARY C++/CLI is a self-contained, component-based dynamic programming language that, like C# or Java, is derived from C++. In fact, you can look at it as a natural step in the evolution of C. Stanley Lippman, who was there from the beginning, provides some insight. Contents What is C++/CLI? Learning C++/CLI Mapping C++/CLI to the CTS? CLI Level of Detail What Are the Issues? Additional Functionality So, What Did You Say About C++/CLI? C++/CLI is a self-contained, component-based dynamic programming language that, like C# or Java, is derived from C++. Unlike those languages, however, we have worked hard to integrate C++/CLI into ISO-C++, using the historical model of evolving the C/C++ programming language to support modern programming paradigms. You can say that C++/CLI is to C++ as C++ is to C. More generally, you can view the evolution leading to C++/CLI in the following historical context: BCPL (Basic Computer Programming Language) B (Ken Thompson, original UNIX work) C (Dennis Ritchie, adding type and control structure to B) C with Classes (~1979) C84 (~1984) Cfront, release E (~1984-to universities) Cfront, release 1.0 (1985-to the world )—20th birthday Multiple/Virtual Inheritance (MI) programming (~1988) Generic Programming (~1991) (templates) ANSI C++/ ISO-C++ (~1996) Dynamic Component programming (~2005) (C++/CLI) What is C++/CLI? C++/CLI represents a tuple. C++ refers, of course, to the C++ programming language invented by Bjarne Stroustrup at Bell Laboratories. It supports a static object model that is optimized for the speed and size of its executables. However, it doesn't support run-time modification of the program other than heap allocation. It allows unlimited access to the underlying machine, but very little access to the types active in the running program and no real access to the associated infrastructure of that program. Herb Sutter, a former colleague of mine at Microsoft and the chief architect of C++/CLI, refers to C++ as a concrete language. CLI refers to the Common Language Infrastructure, a multitiered architecture supporting a dynamic component programming model. In many ways, this represents a complete reversal of the C++ object model. A runtime software layer, the virtual execution system, runs between the program and the underlying operating system. Access to the underlying machine is fairly constrained. Access to the types active in the executing program and the associated program infrastructure—both as discovery and construction—is supported. The slash (/) represents a binding between C++ and the CLI. The details surrounding this binding make up the general topic of this column. So, a first approximation of an answer to what is C++/CLI is that it is a binding of the static C++ object model to the dynamic component object model of the CLI. In short, it is how you do .NET programming using C++ rather than C# or Visual Basic®. Like C# and the CLI itself, C++/CLI is undergoing standardization under the European Computer Manufacturers Association (ECMA) and eventually under ISO. The common language runtime (CLR) is the Microsoft version of the CLI that is specific to the Windows® operating system. Similarly, Visual C++® 2005 is the implementation of C++/CLI. As a second approximation of an answer, I would say that C++/CLI integrates the .NET programming model within C++ in the same way as, back at Bell Laboratories, we integrated generic programming using templates within the then existing C++. In both of these cases your investment in an existing C++ codebase and in your existing C++ expertise are preserved. This was an essential baseline requirement of the design of C++/CLI. Learning C++/CLI There are three aspects in the\",\n",
       " ('C++',\n",
       "  3,\n",
       "  1): \"design of a CLI language that hold true across all languages: a mapping of language-level syntax to the underlying Common Type System (CTS), the choice of a level of detail to expose the underlying CLI infrastructure to the manipulation of the programmer, and the choice of additional functionality to provide, beyond that supported directly by the CLI. The first item is largely the same across all CLI languages. The second and third items are where one CLI language distinguishes itself from another. Depending on the kinds of problems you need to solve, you'll choose one or another language, or possibly combine multiple CLI languages. Learning C++/CLI involves understanding each of these aspects of its design. Mapping C++/CLI to the CTS? It is important when programming C++/CLI to learn the underlying CTS, which includes these three general class types: The polymorphic reference type, which is what you use for all class inheritance. The non-polymorphic value type, which is used for implementing concrete types requiring runtime efficiency, such as the numeric types. The abstract interface type, which is used for defining a set of operations common to a set of either reference or value types that implement the interface. This design aspect, the mapping of the CTS to a set of built-in language types, is common across all CLI languages although, of course, the syntax varies in each CLI language. So, for example, in C#, you would write abstract class Shape { ... } // C# to define an abstract Shape base class from which specific geometric objects are to be derived, while in C++/CLI you write ref class Shape abstract { ... }; // C++/CLI to indicate the exact same underlying CLI reference type. The two declarations are represented exactly the same way in the underlying IL. Similarly, in C#, you write struct Point2D { ... } // C# to define a concrete Point2D class, while in C++/CLI you write: value class Point2D { ... }; // C++/CLI The family of class types supported with C++/CLI represents an integration of the CTS with the native facilities, and that determines your choice of syntax. For example: class native {}; value class V {}; ref class R {}; interface class I {}; The CTS also supports an enumeration class type that behaves somewhat differently from the native enumeration, and support is provided for both of those as well: enum native { fail, pass }; enum class CLIEnum : char { fail, pass}; Similarly, the CTS supports its own array type that again behaves differently from the native array. And again Microsoft provides support for both: int native[] = { 1,1,2,3,5,8 }; array<int>^ managed = { 1,1,2,3,5,8 }; No CLI language is closer to or more nearly a mapping to the underlying CTS than another. Rather, each CLI language represents a view into the underlying CTS object model. CLI Level of Detail The second design aspect that must be considered when designing a CLI language is the level of detail of the underlying CLI implementation model to incorporate into the language. What kind of problems will the language be tasked to solve? Does the language have the tools necessary to do this? Also, what sort of programmers is the language likely to attract? Take, for example, the issue of value types occurring on the managed heap. Value types can find themselves on the managed heap in a number of circumstances: Through implicit boxing, when an instance of a value type is assigned to an Object or when a virtual method is invoked through a value type that is not overridden. When that value type\",\n",
       " ('C++',\n",
       "  3,\n",
       "  2): \"is serving as a member of a reference class type. When that value type is being stored as the element type of a CLI array. Whether the programmer should be allowed to manipulate the address of a value type of this sort is a CLI language design consideration that must be addressed. What Are the Issues? Any object located on the managed heap is subject to relocation during the compaction phase of a sweep of the garbage collector. Any pointers to that object must be tracked and updated by the runtime; the programmer cannot manually track it herself. Therefore, if you were allowed to take the address of a value type that might be on the managed heap, there would need to be a tracking form of pointer in addition to the existing native pointer. What are the trade-offs to consider? On the one hand, there's simplicity and safety. Directly introducing support in the language for either one or a family of tracking pointers makes it a more complicated language. By not supporting this, the available pool of programmers is expanded because less sophistication is required. In addition, allowing the programmer access to these ephemeral value types increases the possibility of programmer error—she may purposely or inadvertently do dangerous things to the memory. By not supporting tracking pointers, a potentially safer runtime environment is created. On the other hand, efficiency and flexibility must be considered. Each time you assign the same Object with a value type, a new boxing of the value occurs. Allowing access to the boxed value type allows in-memory update, which may provide significant performance improvements. Without a form of tracking pointer, you cannot iterate over a CLI array using pointer arithmetic. This means that the CLI array cannot participate in the Standard Template Library (STL) iterator pattern and work with the generic algorithms. Allowing access to the boxed value type allows significant design flexibility. Microsoft chose to provide a collection of addressing modes that handle value types on the managed heap in C++/CLI: int ival = 1024; int^ boxedi = ival; array<int>^ ia = gcnew array<int>{1,1,2,3,5,8}; interior_ptr<int> begin = &ia[0]; value struct smallInt { int m_ival; ... } si; pin_ptr<int> ppi = &si.m_ival; The typical C++/CLI developer is a sophisticated system programmer tasked with providing infrastructure and organizationally critical applications that serve as the foundation over which a business builds its future. She must address both scalability and performance concerns and must therefore have a system-level view into the underlying CLI. The level of detail of a CLI language reflects the face of its programmer. Complexity is not in itself a negative quality. Human beings are more complicated than single-cell bacteria, and that is certainly not a bad thing. However, when the expression of a simple concept is made complicated, that is usually considered to be a bad thing. In C++/CLI, the CLI team has tried to provide an elegant way to express complex subject matter. Additional Functionality A third design aspect is a language-specific layer of functionality above and beyond what is directly supported by the CLI. This may require a mapping between the language-level support and the underlying implementation model of the CLI. In some cases, this just isn't possible because the language cannot intercede with the behavior of the CLI. One example of this is the virtual function resolution in the constructor and destructor of a base class. To reflect ISO-C++ semantics in this case would require a resetting of the virtual table within each base class constructor and destructor. This is not possible because virtual table handling is managed by the runtime\",\n",
       " ('C++',\n",
       "  3,\n",
       "  3): \"and not by the individual language. So this design aspect is a compromise between what would be preferable to do, and what is feasible. The three primary areas of additional functionality that are provided by C++/CLI are the following: A form of Resource Acquisition is Initialization (RAII) for reference types, in particular, to provide an automated facility for what is referred to as deterministic finalization of garbage- collected types that hold scarce resources. A form of deep-copy semantics associated with the C++ copy constructor and copy assignment operator; however, these semantics could not be extended to value types. Direct support of C++ templates for CTS types in addition to the CLI generic mechanism. In addition, a verifiable version of the STL for CLI types is provided. Let's look at a brief example: the issue of deterministic finalization. Before the memory associated with an object is reclaimed by the garbage collector, an associated Finalize method, if present, is invoked. You can think of this method as a kind of super-destructor since it is not tied to the program lifetime of the object. This is called finalization. The timing of just when or even whether a Finalize method is invoked is undefined. This is what is meant by nondeterministic finalization of the garbage collector. Nondeterministic finalization works well with dynamic memory management. When available memory gets sufficiently scarce, the garbage collector kicks in and solves the problem. Nondeterministic finalization does not work well, however, when an object maintains a critical resource such as a database connection, a lock of some sort, or perhaps native heap memory. In this case, it would be great to release the resource as soon as it is no longer needed. The solution that is currently supported by the CLI is for a class to free the resources in its implementation of the Dispose method of the IDisposable interface. The problem here is that Dispose requires an explicit invocation, and therefore is not likely to be invoked. A fundamental design pattern in C++ is the aforementioned Resource Acquisition is Initialization, which means that a class acquires resources within its constructor. Conversely, a class frees its resources within its destructor. This is managed automatically within the lifetime of the class object. Here's what reference types should do in terms of the freeing of scarce resources: Use the destructor to encapsulate the necessary code for the freeing of any resources associated with the class. Have the destructor invoked automatically, tied with the lifetime of the class object. The CLI has no notion of the class destructor for a reference type. So the destructor has to be mapped to something else in the underlying implementation. Internally, then, the compiler performs the following transformations: The class has its base class list extended to inherit from the IDisposable interface. The destructor is transformed into the Dispose method of IDisposable. That represents half of the goal. A way to automate the invocation of the destructor is still needed. A special stack-based notation for a reference type is supported; that is, one in which its lifetime is associated within the scope of its declaration. Internally, the compiler transforms the notation to allocate the reference object on the managed heap. With the termination of the scope, the compiler inserts an invocation of the Dispose method—the user-defined destructor. Reclamation of the actual memory associated with the object remains under the control of the garbage collector. Figure 1 shows an example. Figure 1 Invoking the Destructor ref class Wrapper { Native *pn; public: // resource acquisition is initialization Wrapper( int val ) { pn = new Native( val\",\n",
       " ('C++',\n",
       "  3,\n",
       "  4): '); } // this will do our disposition of the native memory ~Wrapper(){ delete pn; } void mfunc(); protected: // an explicit Finalize() method—as a failsafe !Wrapper() { delete pn; } }; void f1() { // normal treatment of a reference type Wrapper^ w1 = gcnew Wrapper( 1024 ); // mapping a reference type to a lifetime Wrapper w2( 2048 ); // no ^ token ! // just illustrating a semantic difference w1->mfunc(); w2.mfunc(); // w2 is disposed of here } // // ... later, w1 is finalized at some point, maybe C++/CLI is not just an extension of C++ into the managed world. Rather, it represents a fully integrated programming paradigm similar in extent to the earlier integration of the multiple inheritance and generic programming paradigms into the language. I think the team has done an outstanding job. So, What Did You Say About C++/CLI? C++/CLI represents an integration of native and managed programming. In this iteration, that has been done through a kind of separate but equal community of source-level and binary elements, including Mixed mode (source-level mix of native and CTS types, plus a binary mix of native and CIL object files), Pure mode (source-level mix of native and CTS types, all compiled to CIL object files), Native classes (can hold CTS types through a special wrapper class only), and CTS classes (can hold native types only as pointers). Of course, the C++/CLI programmer can also choose to program in the CLI types alone, and in this way provide verifiable code that can be hosted, for example, as a stored procedure in SQL Server™ 2005. So, returning to the question, what is C++/CLI? It is a first-class entry visa into the .NET programming model. With C++/CLI, there is a C++ migration path not just for the C++ source base but for C++ expertise as well. I find great satisfaction in that. Send your questions and comments to purecpp@microsoft.com.',\n",
       " ('C++',\n",
       "  4,\n",
       "  0): 'Рубрика: Гость номера / Гость номера Бьёрн Страуструп: «Ждите сюрпризов!» На вопросы «Системного администратора» отвечает легендарный автор самого широко используемого языка программирования С++ Бьёрн Страуструп (слева) и Кирилл Сухов Бьёрн Страуструп, Бьярне Строуструп (дат. Bjarne Stroustrup), родился 11 июня 1950 года (по другим сведениям, 30 декабря) в г. Орхус, Дания. Окончил Орхусский университет (1975), отделение компьютерных наук, получив степень магистра. Защитив диссертацию по информатике в Кембридже (1979), стал доктором философии. До 2002 года возглавлял отдел исследований в области крупномасштабного программирования в компании AT&T (Computer Science Research Center of Bell Telephone Laboratories). Ныне профессор Техасского университета, А&М. Страуструп стал пионером в области использования объектно-ориентированной и общей техник в области создания программных приложений, где эффективность является приоритетным свойством. Бьёрн Страуструп избран членом Национальной Академии Инженерии в США (National Academy of Engineering) в 2004 году за «создание языка С++». Как первый компьютерный ученый, он был награжден американским научно-исследовательским сообществом в 2005 году (William Procter Prize for Scientific Achievement from Sigma Xi). Он также получил награду компьютерного сообщества IEEE «за начало разработки и коммерциализации объектно-ориентированной технологии создания программ и за большие изменения, внесенные в бизнес и индустрию». Кроме того, Страуструп является членом Техасской Академии Медицины, Инженерии и Науки (Texas Academy of Medicine, Engineering, and Science). Книга Страуструпа «Язык программирования C++» – одна из наиболее читаемых в своей области, переведена на 19 языков. В дополнение к своим пяти книгам, Страуструп опубликовал более сотни академических и других популярных статей. В Москве, с 11 по 15 октября 2010 года, прошла крупнейшая в Центральной и Восточной Европе конференция «Разработка ПО 2010». Организаторами мероприятия выступили: UNOVA Media, TEKAMA, INTSPEI, и ГУ-ВШЭ. За три дня мероприятия было немало интересных событий, но одно из них стало эпохальным – организаторам удалось пригласить самого Бьёрна Страуструпа – легендарного автора языка C++, множества книг (включая каноническую «Язык программирования C++») и научных работ. Когда вы начали интересоваться программированием? Впервые я познакомился с программированием на первом курсе отделения компьютерных наук Орхусского университета и сразу же был им очарован. Мой первый язык программирования был Алгол 60, но вскоре я попробовал многие другие. Каким вы видели будущее языка, когда создавали C++ в начале 80-х годов? Предвидели ли его такое широкое распространение? Я разрабатывал и реализовывал C++ в первую очередь для себя, своих друзей и коллег. Понятно, что я не ожидал такого всемирного и долгого успеха языка. В конце концов, у меня не было никаких торговых предложений и не было бизнес-плана. Я просто хотел создать широко применимый инструмент с непревзойденной производительностью. Как оказалось, многие программисты нуждались в подобном инструменте. Каким вы сейчас видите будущее C++? Когда ожидаете новый стандарт языка? Недавно я вернулся с заседания ISO C++ по стандартам. Мы на пути к окончательному техническому решению в марте 2011-го, и предположительно, пройдя все бюрократические процедуры, стандарт может быть формально принят позднее в том же году. Всегда трудно предсказать будущее, но C++, кажется, для своих пользователей и сообщества пользователей является подходящим и всеобъемлющим инструментом. Стандарт C++0х обеспечит повышение производительности, упрощая разработку качественных систем. Я думаю, что C++ обладает уникальными преимуществами в областях с ограниченными системными ресурсами, таких как задачи по программированию встроенных систем и в целом в приложениях, содержащих элементы системного программирования. Большая часть информационной инфраструктуры в мире зависит от C++. Что будет после стандарта C++0х? В каком направлении станет развиваться язык? Сейчас основное внимание будет уделяться реализации C++0х и развитию стилей программирования, использующих множество новых функций и компонентов стандартной библиотеки. Мы уже на этом пути: многие функции доступны в текущих компиляторах. Не хочу гадать о направлениях развития C++ после C++0х, но кое-что будет сделано. Прежде всего хочу, чтобы было больше стандартных библиотек, и они стали лучше. Я бы предпочел увидеть несколько значительных улучшений, а не множество мелких изменений. Вы',\n",
       " ('C++',\n",
       "  4,\n",
       "  1): 'один из тех людей, кто сделал информационный мир таким, какой он нынче. Можете ли представить, что будет дальше? Чего следует ожидать? Какие технологии будут востребованы? Что изменится в ИТ-мире? Ждите сюрпризов! ИТ – это область, которая продолжает обновляться. Я надеюсь увидеть усовершенствования в работе с параллелизмом. Язык C++0x оказывает портативную и типизированную поддержку параллелизма для традиционных систем программирования. Надеюсь, что увижу несколько более высокоуровневых и изящных моделей параллельного программирования. Интерпретируемый язык и Just-n-time-компиляция получили широкое распространение, в том числе в тех областях, где C++ полностью доминировал. Что вы думаете об этой тенденции? Как к ней относитесь? Думаю, что Just-n-time – это, в первую очередь маркетинг. C++ теперь реже используется в сферах, где «программирование» является прежде всего предметом стандартных услуг. Это, вероятно, хорошо. С другой стороны, востребованность C++ растет в тех областях, где важны производительность и требования к оборудованию. Все знают вас как автора языка С++, но вы также автор компилятора для этого языка. Современные компиляторы и среды разработки: что из них вы бы посоветовали? Не буду рекомендовать реализацию C++ или платформы; среди существующих есть много хороших, охватывающих широкий спектр потребностей. Просто убедитесь, что используемое вами, соответствует стандартам, а затем попытайтесь применить C++ в достаточно современном стиле. Помните, что писать в стиле С на С++ неоптимально – так пишется примитивный объектно-ориентированный код на C++. Язык C++ имеет свой собственный стиль и идиомы (во многом опираясь на классы и шаблоны). Вы получаете лучший код (более управляемый, проще спроектированный, более эффективный), используя их. Что вы думаете о растущем интересе к функциональным языкам программирования и к функциональному программированию вообще? Функциональные языки после почти 30 лет развития по-прежнему остаются объектом интересных и вдохновляющих экспериментов. Я не могу назвать ни одного крупного приложения, написанного в основном на чисто функциональном языке. Мы стараемся изучать идеи, возникающие у функционального сообществ, и с осторожностью применять эти уроки в коде C++. Что вы бы делали, если бы учились в университете сегодня? Какие технологии были бы наиболее интересны для вас? Не знаю. Я попал в ИТ, потому что ошибочно считал, что компьютерные науки – отрасль прикладной математики. Подозреваю, что если бы я начинал учиться сегодня, то обратил бы внимание на то, что выглядело бы интересным и важным. Например, пересечение вычислительных технологий и биологии кажется мне очень интересным… Однако не думаю, что как молодой человек я бы сосредоточился на «технологии». Я бы обратил внимание (как это сделал) на науки, которые имеют потенциальное влияние с помощью технологий. Кроме того, я искал ту сферу, где человек как личность может внести значительный вклад, а не области, в которых уже есть немало проектов, где заняты тысячи людей, в большинстве случаев легкозаменяемых. Русский ученый Александр Степанов внес большой вклад в развитие C++ (STL). Работали ли вы вместе с ним? Как вы оцениваете его труды? Я знаю Александра около 20 лет, и мы работали вместе. Я горжусь тем, что внес посильную лепту в его последнюю книгу «Элементы программирования». Думаю, что STL была самым важным дополнением к C++, когда мы сделали стандарт C++98 ISO. Бьёрн Страуструп вне стандартов и компиляторов C++? Какой он? Как вы обычно проводите свободное время? У вас есть какие-нибудь хобби? Я много читаю, как художественную, так и научно-популярную, историческую литературу. Мне нравится бегать и ходить пешком. Люблю слушать музыку, фотографировать, особенно, когда мне выпадет возможность попутешествовать. Стараюсь проводить больше времени со своей семьей. Люблю также вкусно поесть в компании друзей. Недавно язык С++ отметил двадцать пятую годовщину как коммерческий продукт. Я бы хотел от имени читателей нашего журнала поздравить вас! Спасибо большое. Немного языков может отпраздновать свое 25-летие с миллионами программистов. Было бы неплохо, если бы мы могли отметить эту годовщину, выпуская C++0х в 2010 году. Но я очень надеюсь на официальное утверждение и реализацию',\n",
       " ('C++',\n",
       "  4,\n",
       "  2): 'его хотя бы в новом году. Вся техническая работа уже почти сделана. Кирилл Сухов, перевод Романа Сухова',\n",
       " ('C++',\n",
       "  5,\n",
       "  0): 'The Java Language Environment: Contents Introduction to Java TM Technology CHAPTER 1 The Next Stage of the Known, Or a Completely New Paradigm? Taiichi Sakaiya-- The Knowledge-Value Revolution The Software Developer\\'s Burden Imagine you\\'re a software application developer. Your programming language of choice (or the language that\\'s been foisted on you) is C or C++. You\\'ve been at this for quite a while and your job doesn\\'t seem to be getting any easier. These past few years you\\'ve seen the growth of multiple incompatible hardware architectures, each supporting multiple incompatible operating systems, with each platform operating with one or more incompatible graphical user interfaces. Now you\\'re supposed to cope with all this and make your applications work in a distributed client-server environment. The growth of the Internet, the World-Wide Web, and \"electronic commerce\" have introduced new dimensions of complexity into the development process. The tools you use to develop applications don\\'t seem to help you much. You\\'re still coping with the same old problems; the fashionable new object-oriented techniques seem to have added new problems without solving the old ones. You say to yourself and your friends, \"There has to be a better way\"! The Better Way is Here Now Now there is a better way -- the Java TM programming language platform from Sun Microsystems. Imagine, if you will, this development world... Your programming language is object oriented, yet it\\'s still dead simple. Your development cycle is much faster because Java technology is interpreted. The compile-link-load-test-crash-debug cycle is obsolete--now you just compile and run. Your applications are portable across multiple platforms. Write your applications once, and you never need to port them--they will run without modification on multiple operating systems and hardware architectures. Your applications are robust because the Java runtime environment manages memory for you. Your interactive graphical applications have high performance because multiple concurrent threads of activity in your application are supported by the multithreading built into the Java programming language and runtime platform. Your applications are adaptable to changing environments because you can dynamically download code modules from anywhere on the network. Your end users can trust that your applications are secure, even though they\\'re downloading code from all over the Internet; the Java runtime environment has built-in protection against viruses and tampering. You don\\'t need to dream about these features. They\\'re here now. The Java programming language platform provides a portable, interpreted, high-performance, simple, object-oriented programming language and supporting run-time environment. This introductory chapter provides you with a brief look at the main design goals of the Java system; the remainder of this paper examines the features of Java in more detail. The last chapter of this paper describes the HotJava TM Browser . The HotJava Browser is an innovative World-Wide Web browser, and the first major applications written using the Java platform. It is the first browser to dynamically download and execute Java code fragments from anywhere on the Internet, and can do so in a secure manner. 1.1 Beginnings of the Java TM Programming Language Project The Java TM programming language is designed to meet the challenges of application development in the context of heterogeneous, network-wide distributed environments. Paramount among these challenges is secure delivery of applications that consume the minimum of system resources, can run on any hardware and software platform, and can be extended dynamically. The Java programming language originated as part of a research project to develop advanced software for a wide variety of network devices and embedded systems. The goal was to develop a small, reliable, portable, distributed, real-time operating platform. When the project started, C++ was the language',\n",
       " ('C++',\n",
       "  5,\n",
       "  1): 'of choice. But over time the difficulties encountered with C++ grew to the point where the problems could best be addressed by creating an entirely new language platform. Design and architecture decisions drew from a variety of languages such as Eiffel, SmallTalk, Objective C, and Cedar/Mesa. The result is a language platform that has proven ideal for developing secure, distributed, network-based end-user applications in environments ranging from network-embedded devices to the World-Wide Web and the desktop. 1.2 Design Goals of the Java TM Programming Language The design requirements of the Java TM programming language are driven by the nature of the computing environments in which software must be deployed. The massive growth of the Internet and the World-Wide Web leads us to a completely new way of looking at development and distribution of software. To live in the world of electronic commerce and distribution, Java technology must enable the development of secure, high performance, and highly robust applications on multiple platforms in heterogeneous, distributed networks. Operating on multiple platforms in heterogeneous networks invalidates the traditional schemes of binary distribution, release, upgrade, patch, and so on. To survive in this jungle, the Java programming language must be architecture neutral, portable, and dynamically adaptable. The system that emerged to meet these needs is simple, so it can be easily programmed by most developers; familiar, so that current developers can easily learn the Java programming language; object oriented, to take advantage of modern software development methodologies and to fit into distributed client-server applications; multithreaded, for high performance in applications that need to perform multiple concurrent activities, such as multimedia; and interpreted, for maximum portability and dynamic capabilities. Together, the above requirements comprise quite a collection of buzzwords, so let\\'s examine some of them and their respective benefits before going on. 1.2.1 Simple, Object Oriented, and Familiar Primary characteristics of the Java programming language include a simple language that can be programmed without extensive programmer training while being attuned to current software practices. The fundamental concepts of Java technology are grasped quickly; programmers can be productive from the very beginning. The Java programming language is designed to be object oriented from the ground up. Object technology has finally found its way into the programming mainstream after a gestation period of thirty years. The needs of distributed, client-server based systems coincide with the encapsulated, message-passing paradigms of object-based software. To function within increasingly complex, network-based environments, programming systems must adopt object-oriented concepts. Java technology provides a clean and efficient object-based development platform. Programmers using the Java programming language can access existing libraries of tested objects that provide functionality ranging from basic data types through I/O and network interfaces to graphical user interface toolkits. These libraries can be extended to provide new behavior. Even though C++ was rejected as an implementation language, keeping the Java programming language looking like C++ as far as possible results in it being a familiar language, while removing the unnecessary complexities of C++. Having the Java programming language retain many of the object-oriented features and the \"look and feel\" of C++ means that programmers can migrate easily to the Java platform and be productive quickly. 1.2.2 Robust and Secure The Java programming language is designed for creating highly reliable software. It provides extensive compile-time checking, followed by a second level of run-time checking. Language features guide programmers towards reliable programming habits. The memory management model is extremely simple: objects are created with a new operator. There are no explicit programmer-defined pointer data types, no pointer arithmetic, and automatic garbage collection. This simple memory management model eliminates entire classes of programming errors',\n",
       " ('C++',\n",
       "  5,\n",
       "  2): \"that bedevil C and C++ programmers. You can develop Java code with confidence that the system will find many errors quickly and that major problems won't lay dormant until after your production code has shipped. Java technology is designed to operate in distributed environments, which means that security is of paramount importance. With security features designed into the language and run-time system, Java technology lets you construct applications that can't be invaded from outside. In the network environment, applications written in the Java programming language are secure from intrusion by unauthorized code attempting to get behind the scenes and create viruses or invade file systems. 1.2.3 Architecture Neutral and Portable Java technology is designed to support applications that will be deployed into heterogeneous network environments. In such environments, applications must be capable of executing on a variety of hardware architectures. Within this variety of hardware platforms, applications must execute atop a variety of operating systems and interoperate with multiple programming language interfaces. To accommodate the diversity of operating environments, the Java Compiler TM product generates bytecodes--an architecture neutral intermediate format designed to transport code efficiently to multiple hardware and software platforms. The interpreted nature of Java technology solves both the binary distribution problem and the version problem; the same Java programming language byte codes will run on any platform. Architecture neutrality is just one part of a truly portable system. Java technology takes portability a stage further by being strict in its definition of the basic language. Java technology puts a stake in the ground and specifies the sizes of its basic data types and the behavior of its arithmetic operators. Your programs are the same on every platform--there are no data type incompatibilities across hardware and software architectures. The architecture-neutral and portable language platform of Java technology is known as the Java virtual machine. It's the specification of an abstract machine for which Java programming language compilers can generate code. Specific implementations of the Java virtual machine for specific hardware and software platforms then provide the concrete realization of the virtual machine. The Java virtual machine is based primarily on the POSIX interface specification--an industry-standard definition of a portable system interface. Implementing the Java virtual machine on new architectures is a relatively straightforward task as long as the target platform meets basic requirements such as support for multithreading. 1.2.4 High Performance Performance is always a consideration. The Java platform achieves superior performance by adopting a scheme by which the interpreter can run at full speed without needing to check the run-time environment. The automatic garbage collector runs as a low-priority background thread, ensuring a high probability that memory is available when required, leading to better performance. Applications requiring large amounts of compute power can be designed such that compute-intensive sections can be rewritten in native machine code as required and interfaced with the Java platform. In general, users perceive that interactive applications respond quickly even though they're interpreted. 1.2.5 Interpreted, Threaded, and Dynamic The Java interpreter can execute Java bytecodes directly on any machine to which the interpreter and run-time system have been ported. In an interpreted platform such as Java technology-based system, the link phase of a program is simple, incremental, and lightweight. You benefit from much faster development cycles--prototyping, experimentation, and rapid development are the normal case, versus the traditional heavyweight compile, link, and test cycles. Modern network-based applications, such as the HotJava TM Browser for the World Wide Web, typically need to do several things at the same time. A user working with HotJava Browser can run several animations concurrently while downloading an image and scrolling\",\n",
       " ('C++',\n",
       "  5,\n",
       "  3): \"the page. Java technology's multithreading capability provides the means to build applications with many concurrent threads of activity. Multithreading thus results in a high degree of interactivity for the end user. The Java platform supports multithreading at the language level with the addition of sophisticated synchronization primitives: the language library provides the Thread class, and the run-time system provides monitor and condition lock primitives. At the library level, moreover, Java technology's high-level system libraries have been written to be thread safe: the functionality provided by the libraries is available without conflict to multiple concurrent threads of execution. While the Java Compiler is strict in its compile-time static checking, the language and run-time system are dynamic in their linking stages. Classes are linked only as needed. New code modules can be linked in on demand from a variety of sources, even from sources across a network. In the case of the HotJava Browser and similar applications, interactive executable code can be loaded from anywhere, which enables transparent updating of applications. The result is on-line services that constantly evolve; they can remain innovative and fresh, draw more customers, and spur the growth of electronic commerce on the Internet. 1.3 The Java Platform--a New Approach to Distributed Computing Taken individually, the characteristics discussed above can be found in a variety of software development platforms. What's completely new is the manner in which Java technology and its runtime environment have combined them to produce a flexible and powerful programming system. Developing your applications using the Java programming language results in software that is portable across multiple machine architectures, operating systems, and graphical user interfaces, secure, and high performance. With Java technology, your job as a software developer is much easier--you focus your full attention on the end goal of shipping innovative products on time, based on the solid foundation of the Java platform. The better way to develop software is here, now, brought to you by the Java platform.\",\n",
       " ('C++',\n",
       "  6,\n",
       "  0): 'Яндекс организует рабочую группу по стандартизации языка C++ 25 мая 2016 Группа будет собирать предложения к стандарту C++ от российских специалистов, организовывать их обсуждение внутри страны, а затем представлять и защищать на общих собраниях в Международной организации по стандартизации (ISO). Поделиться: Заметили неточность или опечатку в тексте? Выделите её мышкой и нажмите: Ctrl + Enter. Спасибо! С++ — широко распространённый язык. Он используется, в частности, для создания операционных систем, драйверов, прикладных программ и веб-сервисов. Стандарт C++ содержит его исчерпывающее описание. Разделы документа регламентируют, например, использование переменных и выражений, синтаксис и работу с памятью. От стандарта зависит, насколько удобна и эффективна разработка.«В России много высококлассных специалистов по C++. Их участие в обсуждении стандарта было бы полезно, — говорит технический директор Яндекса Михаил Парахин. — Однако представить предложение в ISO непросто. Его нужно оформить определённым образом, а потом защитить на заседании. Рабочая группа станет связующим звеном между российскими экспертами и международным комитетом. В Яндексе С++ — один из основных языков программирования. Это и Поиск, и Браузер, и Карты, и рекламные технологии. Группа поможет нам влиять на будущее языка и оптимизировать разработку».Идея создания группы принадлежит двум сотрудникам Яндекса — Александру Фокину и Антону Полухину. Александр — специалист по поисковым технологиям и руководитель одной из команд, разрабатывающих Поиск. Антон — автор двух библиотек из собрания Boost и посвящённой Boost книги, а также одного уже принятого предложения к стандарту C++. Он работает над сервисом Яндекс.Видео. Группа открыта для других экспертов — начиная с осени Александр и Антон будут заниматься её расширением.Рабочая группа зарегистрирована Росстандартом — федеральным агентством, представляющим Россию в ISO.',\n",
       " ('C++',\n",
       "  7,\n",
       "  0): 'From cppreference.com Reallocates the given area of memory (implicitly creating objects in the destination area). It must be previously allocated by std::malloc, std::calloc or std::realloc and not yet freed with std::free, otherwise, the results are undefined. The reallocation is done by either: a) expanding or contracting the existing area pointed to by ptr , if possible. The contents of the area remain unchanged up to the lesser of the new and old sizes. If the area is expanded, the contents of the new part of the array are undefined. b) allocating a new memory block of size new_size bytes, copying memory area with size equal the lesser of the new and the old sizes, and freeing the old block. If there is not enough memory, the old memory block is not freed and null pointer is returned. If ptr is a null pointer, the behavior is the same as calling std::malloc(new_size). If new_size is zero, the behavior is implementation defined: null pointer may be returned (in which case the old memory block may or may not be freed) or some non-null pointer may be returned that may not be used to access storage. Such usage is deprecated (via C DR 400).(since C++20) The following functions are required to be thread-safe: The library versions of operator new and operator delete and User replacement versions of global operator new and operator delete and std::calloc std::malloc std::realloc std::aligned_alloc (since C++17) std::free Calls to these functions that allocate or deallocate a particular unit of storage occur in a single total order, and each such deallocation call happens-before the next allocation (if any) in this order. (since C++11) edit] Parameters ptr - pointer to the memory area to be reallocated new_size - new size of the array edit] Return value On success, returns a pointer to the beginning of newly allocated memory. To avoid a memory leak, the returned pointer must be deallocated with std::free or std::realloc . The original pointer ptr is invalidated and any access to it is undefined behavior (even if reallocation was in-place). On failure, returns a null pointer. The original pointer ptr remains valid and may need to be deallocated with std::free. edit] Notes Because reallocation may involve bytewise copying (regardless of whether it expands or contracts the area), it is necessary (but not sufficient) for those objects to be of TriviallyCopyable type. Some non-standard libraries define a type trait \"BitwiseMovable\" or \"Relocatable\", which describes a type that does not have: external references (e.g. nodes of a list or a tree that holds reference to another element), and internal references (e.g. member pointer which might hold the address of another member). Objects of such type can be accessed after their storage is reallocated even if their copy constructors are not trivial. edit] Example Run this code #include <cassert> #include <cstdlib> #include <new> class MallocDynamicBuffer { char * p ; public : explicit MallocDynamicBuffer ( std:: size_t initial = 0 ) : p ( nullptr ) { resize ( initial ) ; } ~MallocDynamicBuffer ( ) { std:: free ( p ) ; } void resize ( std:: size_t newSize ) { if ( newSize == 0 ) // this check is not strictly needed, { std:: free ( p ) ; // but zero-size realloc is deprecated in C p = nullptr ; } else { if ( void * mem = std :: realloc ( p, newSize ) ) p = static_cast < char * > ( mem ) ; else throw std:: bad_alloc ( ) ; } } char & operator [ ] ( size_t n ) {',\n",
       " ('C++',\n",
       "  7,\n",
       "  1): \"return p [ n ] ; } char operator [ ] ( size_t n ) const { return p [ n ] ; } } ; int main ( ) { MallocDynamicBuffer buf1 ( 1024 ) ; buf1 [ 5 ] = 'f' ; buf1. resize ( 10 ) ; // shrink assert ( buf1 [ 5 ] == 'f' ) ; buf1. resize ( 1024 ) ; // grow assert ( buf1 [ 5 ] == 'f' ) ; } edit] See also\",\n",
       " ('C++',\n",
       "  8,\n",
       "  0): 'All the programs examined here were written by the same programmer with different levels of experience in Java, Perl and C++. The other languages were implemented while learning them. Even though the semantics of these languages is similar, since C influenced C++, C#, Java, Perl and Python directly or indirectly, the philosophy of some of the languages is different and programs should be implemented according to the language paradigm. For example, Perl programmers favor hash tables to arrays, coupled with a loop which is more widely used in C. It is also important to keep in mind that the hash function can be costly when adding a new value and the memory allocated would be larger than an array containing the same number of elements. The advantage of a hash table is the speed in retrieving some data, but when the programmer needs to examine sequentially all the values in the hash table, then a hash table should be avoided because of the extra cost occurring when adding the key-value pair. In the Perl NJ algorithm an implementation using an array to store the sequences appeared to be faster and more memory efficient than a program using a hash table. Hence no hashtable was used in this benchmark. There is an important tradeoff between performance and convenience. Perl and Python allow reading and loading a file in memory in one statement. While this approach is convenient compared to reading and processing a file line by line, the operating system could start swapping memory out, thus slowing everything down. Object creation, garbage collection and memory recycling are costly in terms of CPU and memory usage, hence some precautions should be taken when creating objects and the number of objects should be reduced as much as possible. To prevent memory leaks or heavy applications, objects should also be reused when possible and immutable objects such as the String object in Java should be avoided especially when temporary objects are created in frequently used routines. C# and Java have a higher memory-size penalty for objects than other object oriented languages such as C++ due to their ability to use reflection. Reflection is a powerful tool that contributes to the flexibility of these two languages. However this feature should only be used when needed, since reflection method calls have a substantial performance overhead, make the code harder to understand and errors are found at runtime instead of compile-time. The way objects are accessed and stored in memory influences the performance of each language. C++, C# and Java store objects as a block of data and access them via constant offsets, whereas objects in Python are implemented as hash tables. There are several ways to create objects in Perl. Different data structures can be used, but most programmers use hashes, even though arrays are faster, prevent attribute collisions and take less memory. It is worth noting that the Perl implementation of the NJ algorithm was substantially improved by converting each sequence to an array instead of using the substr function on the string of characters for computing the similarity matrix. Although the program was 10% faster, the memory footprint showed a ten-fold increase. Expressiveness The number of lines in a program varies from one programmer to another, and also on their willingness to shorten the code to the detriment of readability. It is important to emphasize that it is hardly possible to find a correlation between expressiveness and performance. Nevertheless, a noticeable difference was observed (Fig. 5), especially with regular expressions. In Perl, a unique statement can be used to detect a pattern and the',\n",
       " ('C++',\n",
       "  8,\n",
       "  1): 'captured pattern is retrieved with the special variable $1, whereas in Java the programmer has to instantiate a Pattern object which is a compiled representation of the regular expression, then create a Matcher object which performs match operations on a character sequence by interpreting the pattern object. The following examples illustrate the retrieval of a GI number from a FASTA file: Figure 5 Number of lines for each program. Number of lines for the global alignment, BLAST parser and Neighbor-Joining programs implemented in C, C++, C#, Java, Perl and Python. Full size image Perl: print $1 if($string =~/^>gi\\\\ |(\\\\ d{3,})/); Java: Pattern p = Pattern.compile(\"^>gi\\\\ |(\\\\ d{3,})\"); Matcher m = p.matcher(string); if(m.find()) System.out.print(m.group(1)); Language philosophies often explain differences in the relative expressiveness and readability of languages. For example, the philosophy of Python is to take the clearest, simplest and most straightforward approach to writing a program, and to accept the resulting performance penalty. Whereas Perl gives more freedom to the programmer resulting, in some cases, in programs that are unreadable for non Perl programmers. Factors such as performance and memory usage are important, but need not be the sole determinant when choosing a language. Since time management is also an important factor, a language can be chosen for its library, future scalability, active community and interface to other languages. While it is hard to define a learning curve for each language, advantages and disadvantages of each language can be found. Memory management such as memory allocation makes tasks easier for Java, C#, Perl, Python and Perl programmers, even though memory usage should always be under scrutiny. The use of pointers in C and C++ can be overwhelming for a learner, and it may take some time to master their use. Python is designed to be a highly readable language, frequently using English keywords, whereas the five other languages use punctuation. Platform independence can be a factor for choosing a language and can also facilitate its learning. Java uses a virtual machine to run on different operating systems and since Perl and Python are stored in a text file and not in a binary file these scripts can be run on any computer having the appropriate interpreter. The standard library diversity and size of Java, Python and C# are a major advantage compared to the other languages,. including sets of classes to create graphical interfaces, data structures (vectors, hash tables, stacks, queues), regular expression, database access and networking. Although the Perl standard library appears smaller compared to Java, Python and C#\\'s, it benefits from a large community of programmers creating modules gathered by the CPAN network [15]. C has a very limited standard library supporting input and output streams, memory allocation, mathematics, character strings, and time values. The C++ library contains the C library as well as a class to manipulate string of characters and the Standard Template Library containing containers or data structures such as algorithms, an improved String library and input/output stream libraries. As shown previously in the global alignment example, Java and Perl can communicate with a program written in C, speeding up the program using JNI and XS respectively. For example, if a computer intensive command based program written in C needs a graphical interface, an easy solution would be to use the Swing library and the JNI framework instead of rewriting the whole program in Java. The possibility of a language to language interface is useful when some code is already written in one of them. As well as C, the JNI framework allows Java to interact with C++ and Fortran. The downside of this approach',\n",
       " ('C++',\n",
       "  8,\n",
       "  2): 'is the loss of portability. Java can also interact with Python using Jython, which is an implementation of Python in Java. Some bioinformatics tasks, such as loading a FASTA file or parsing a BLAST file, are so frequently used that it makes sense to reuse bits of code by creating libraries or modules. Many programmers produce modules for the bioinformatics community and make them available through their websites. The most widely used libraries are BioPerl, BioPython and BioJava. These Open Source projects belong to the Open Bioinformatics Foundation and they provide toolkits with multiple functionality that make it easier to create customized pipelines or analysis. Unfortunately libraries with this level of organization and diversity are not available for C, C++ and C# even though some small libraries are available independently [16, 17] In this paper we focused on the performance of languages, not on the performance of the algorithm implementations. For example the speed of the alignment program could be improved by using a one-dimension array of size n × m instead of a 2-dimensional matrix of size n × m. This approach would speed up the memory allocation, but this was not the goal of this benchmark. In this paper, to find the fastest implementations we used profiling tools included in libraries or using compilation/execution options. Profiling provides important information about applications, such as memory usage and the fraction of time spent in each function. By using profiling and a trial-and-error approach programs were significantly improved. We used the Devel::DProf library in Perl, the Xprof option in Java, the cProfile module in Python, the default profiler in C# using -profile = default and the -pg compiler option coupled with the gprof program in C and C++.',\n",
       " ('C++',\n",
       "  9,\n",
       "  0): 'PDF versions of the standard As of 1st September 2014, the best locations by price for C and C++ standards documents in PDF are: You cannot usually get old revisions of a standard (any standard) directly from the standards bodies shortly after a new edition of the standard is released. Thus, standards for C89, C90, C99, C++98, C++03 will be hard to find for purchase from a standards body. If you need an old revision of a standard, check Techstreet as one possible source. For example, it can still provide the Canadian version CAN/CSA-ISO/IEC 9899:1990 standard in PDF, for a fee. Print versions of the standard Print copies of the standards are available from national standards bodies and ISO but are very expensive. If you want a hardcopy of the C90 standard for much less money than above, you may be able to find a cheap used copy of Herb Schildt\\'s book The Annotated ANSI Standard at Amazon, which contains the actual text of the standard (useful) and commentary on the standard (less useful). The C99 and C++03 standards are available in book form from Wiley and the BSI (British Standards Institute): C++03 Standard on Amazon C99 Standard on Amazon Standards committee draft versions The working draft for future standards is often available from the committee websites: Note that these documents are not the same as the standard, though the versions just prior to the meetings that decide on a standard are usually very close to what is in the final standard. The FCD (Final Committee Draft) versions are password protected; you need to be on the standards committee to get them. However, in my opinion, even though the draft versions might be very close to the final ratified versions of the standards, you should really get a copy of the actual documents — especially if you\\'re planning on quoting them as references. Of course, starving students should go ahead and use the drafts if strapped for cash. It appears that, if you are willing and able to wait a few months after ratification of a standard, to search for \"INCITS/ISO/IEC\" instead of \"ISO/IEC\" when looking for a standard is the key. This way I was able to find the C++11 standard at reasonable price and now the C11 standard. So, as an example you search for \"INCITS/ISO/IEC 9899:2011\" instead of \"ISO/IEC 9899:2011\" on webstore.ansi.org and you will find the reasonably priced PDF version.',\n",
       " ('ChatGPT',\n",
       "  1,\n",
       "  0): 'Что такое чат-бот ChatGPT и как им пользоваться из России? С конца 2022 года ученые, программисты и продвинутые интернет-пользователи обсуждают, какой прорыв был совершен в сфере искусственного интеллекта и какие возможности и риски это может принести. Самым спорным изобретением стал чат-бот ChatGPT: например, крупное американское издание BuzzFeed даже уволило 180 сотрудников, заменив их языковой моделью. «Лента.ру» разбиралась, что такое ChatGPT, как он работает и может ли чат-бот заменить реальных сотрудников. ChatGPT: что это? ChatGPT — это универсальный чат-бот, который умеет отвечать на запросы пользователя, поддерживать диалог, сочинять стихи, писать коды и сценарии и даже давать персональные советы. Он делает это, используя технологию обучения с подкреплением и обратной связью от человека (RLHF — Reinforcement Learning from Human Feedback). Чат-бот запустила в конце ноября 2022 года компания OpenAI, занимающаяся разработкой и лицензированием технологий на основе машинного обучения. Всего OpenAI создала четыре версии модели GPT. Все они обучаются на текстах из интернета и могут отвечать осмысленными фразами на вопрос. GPT-3 в основном использовалась для генерации текстов, но ее критиковали за то, что она не учитывает контекст и просто пытается предсказывать каждое следующее слово. Более новая версия модели и самая популярная на данный момент — GPT-3.5. Она запоминает детали разговора, поэтому лучше строит диалог и может использоваться для создания более сложных текстов. Существует также версия GPT-4, которая способна обрабатывать изображения, лучше воспринимает русский язык, а также генерирует более точные и этичные ответы. Эта версия обладает более высокой мощностью, что обеспечивает бесперебойную работу даже в самые загруженные часы, но она доступна только по платной подписке. В 2023 году, спустя всего несколько месяцев после запуска, число пользователей ChatGPT превысило 100 миллионов человек по всему миру Помимо обычных пользователей, чат-бот работает и с коммерческими организациями, например с турфирмой Expedia, компанией доставки еды Instacart, туристическим поисковиком KAYAK, фирмой бронирования ресторанов OpenTable, маркетплейсом Shopify и мессенджером Slack. Фото: Frank Rumpenhorst / dpa / Archiv / Globallookpress.com Какие задачи может выполнять ChatGPT? Отвечать на сложные вопросы. Тайну Бермудского треугольника чат-бот вряд ли раскроет и, скорее всего, не сможет предсказать будущее искусственного интеллекта или найти смысл жизни — зато подскажет, как решить дифференциальное уравнение, и поможет разобраться в разных видах зубных имплантов. Писать коды. С помощью чат-бота можно обнаружить баги в части кода и даже перевести код с одного языка программирования на другой. Кроме того, ChatGPT может самостоятельно написать несложный код или описать процесс его создания, чтобы упростить задачу программисту. Рисовать картины, сочинять стихи и песни. Здесь главное правильно задать тему и дать чат-боту максимальное количество понятных вводных. Пользователь Twitter, например, попросил чат-бот придумать пародию на песню «Богемская рапсодия» группы Queen, и был крайне доволен результатом. ChatGPT может сочинять шутки. До чувства юмора стендап-комика ему, конечно, пока далеко, но некоторые сочиненные виртуальным собеседником анекдоты вполне можно представить на последней странице дешевой газеты («Почему в России не бывает жары? Потому что все вентиляторы уехали на дачу»). Писать сценарии. Так как ChatGPT может свободно пользоваться всей информацией из интернета, он знает больше произведений художественной культуры, чем все сценаристы Голливуда вместе взятые. Благодаря этому чат-бот можно попросить сгенерировать следующий эпизод ситкома, совместить персонажей из разных вселенных (любители фанфиков в восторге) или придумать совершенно новый сюжет. Фото: Sean Gallup / Getty Images Писать эссе и сочинения. Американский исследователь попросил ChatGPT написать эссе о разнице в подходах к национализму политологов Бенедикта Андерсона и Эрнеста Геллнера. Чат-бот справилась с заданием за десять секунд и получила за свою работу пять с минусом. Более того, она смогла осилить даже написание университетского диплома. Студент, который использовал в работе ChatGPT, таким образом защитил свою выпускную работу и окончил РГГУ Ставить задачи для других искусственных интеллектов. Необъяснимо, но факт: у ИИ образовалась собственная вселенная, в которой они понимают друг друга лучше, чем',\n",
       " ('ChatGPT',\n",
       "  1,\n",
       "  1): 'своих создателей-людей. Поэтому, если пользователю нужно, например, сгенерировать качественную картинку, сначала ему лучше составить запрос в ChatGPT и полученный результат прогнать через ту же Midjourney. Давать медицинские советы. ChatGPT поможет в случае, если у пользователя болит голова, появилась сыпь или другие симптомы аллергии. Примечательно, что после каждой рекомендации чат-бот отмечает необходимость визита к врачу. Однако, по словам экспертов, большинство советов чат-бота действительно эффективны, поэтому впоследствии его смогут использовать в качестве медицинского виртуального помощника. Составлять план питания и тренировок. На основе данных о весе, росте, возрасте и желаемом результате пользователя ChatGPT рассчитает для него индивидуальную норму калорий на день и подготовит подробный план питания, а после — и список упражнений. Кроме того, ChatGPT может подкинуть идеи рецептов и составить список продуктов. Фото: Philippe Wojazer / Reuters Переводить текст. Шутки про «Google переводчик» совсем скоро могут уйти в прошлое, поскольку ChatGPT умеет переводить тексты с одного языка на другой, в том числе на русский. Хотя некоторые переводы еще требуют доработки, люди уже тестируют эту функцию для написания рабочих писем. Пока чат-бот все еще лучше справляется с запросами на английском языке. Выполнять рутинные задачи. Например, создавать списки, вносить дела в календарь, писать электронные письма, вести расписание и другое. Составлять пересказы. Если у пользователя нет времени на чтение длинных статей (или они слишком сложно написаны), ChatGPT поможет составить небольшое саммари. Ему можно задать рамки: например, попросить пересказать материал максимально просто или структурировать его по пунктам. То же самое можно сделать и с длинными видео на YouTube: только представьте — вместо четырехчасового интервью краткая выжимка самого интересного. Минусы ChatGPT Как любой продукт искусственного интеллекта, ChatGPT еще только развивается, поэтому у него есть свои недостатки и ограничения. Фото: Oli Scarff / Getty Images Недостатки ChatGPT Часто генерирует неправильные или бессмысленные ответы. На первый взгляд, текст может казаться правдоподобным и складным, но при более внимательном прочтении оказывается, что в нем есть неточности, выдуманные факты и персоны. В этом случае модель может утверждать, что у нее недостаточно информации о запросе (особенно если тема относится к событиям, произошедшим после 2021 года). На первый взгляд, текст может казаться правдоподобным и складным, но при более внимательном прочтении оказывается, что в нем есть неточности, выдуманные факты и персоны. В этом случае модель может утверждать, что у нее недостаточно информации о запросе (особенно если тема относится к событиям, произошедшим после 2021 года). Некоторые ответы могут быть опасны. Всех виртуальных помощников учат игнорировать потенциально вредоносные запросы, например, как спланировать идеальное убийство, из чего сделать бомбу и какой небоскреб лучше всего подходит для прыжка с него. Если пользователь спросит что-то подобное прямо, чат-бот откажется отвечать, однако некоторые юзеры научились задавать более обтекаемые вопросы, и чат-бот не распознает подвох. Кроме того, ChatGPT не способен верифицировать информацию, а значит, зачастую дает неверные медицинские советы, распространяя мифы. Всех виртуальных помощников учат игнорировать потенциально вредоносные запросы, например, как спланировать идеальное убийство, из чего сделать бомбу и какой небоскреб лучше всего подходит для прыжка с него. Если пользователь спросит что-то подобное прямо, чат-бот откажется отвечать, однако некоторые юзеры научились задавать более обтекаемые вопросы, и чат-бот не распознает подвох. Кроме того, ChatGPT не способен верифицировать информацию, а значит, зачастую дает неверные медицинские советы, распространяя мифы. Многословен, но при этом не дает прочитать слишком длинный ответ. Чат-бот иногда использует слишком много лишних фраз, которые на самом деле не добавляют информации, а также повторяет саму формулировку запроса. При этом если ответ получается слишком обширным, ChatGPT его обрезает, и ей приходится задавать дополнительные вопросы. Чем может быть опасен ChatGPT? После появления стремительно растущего числа новостей о способностях чат-бота многие эксперты задумались о его потенциальной угрозе. В июне американская некоммерческая организация «Центр безопасности искусственного интеллекта» (Center for AI Safety) опубликовала заявление, в котором предупредила, что',\n",
       " ('ChatGPT',\n",
       "  1,\n",
       "  2): 'дальнейшее развитие искусственного интеллекта может привести к исчезновению человечества. Под этим заявлением подписались десятки ученых, журналистов, предпринимателей и программистов — в том числе даже глава компании OpenAI Сэм Олтмен. Несмотря на то что впоследствии ученые сообщили, что пресловутое восстание машин вряд ли полностью сотрет людей с лица земли, они подчеркнули, что за нейросетями необходим строгий надзор. Фото: Thomas Trutschel / photothek / IMAGO / Globallookpress.com Чем может грозить ChatGPT? Уменьшением числа рабочих мест. Действительно, у чат-ботов и других продуктов искусственного интеллекта масса преимуществ: они способны обрабатывать огромное количество информации в короткие сроки, создавать неплохие текстовые и графические материалы и, что самое важное, работать 24/7. Аналитики Goldman Sachs прогнозируют, что в будущем искусственный интеллект сможет заменить 300 миллионов рабочих мест. Есть и хорошие новости — чат-боты все еще не так виртуозно владеют языком, как люди с высшим гуманитарным образованием, а также не обладают эмпатией, обаянием и харизмой (хотя, возможно, спустя несколько лет разработчикам удастся устранить и этот недочет). Действительно, у чат-ботов и других продуктов искусственного интеллекта масса преимуществ: они способны обрабатывать огромное количество информации в короткие сроки, создавать неплохие текстовые и графические материалы и, что самое важное, работать 24/7. Аналитики Goldman Sachs прогнозируют, что в будущем искусственный интеллект сможет заменить 300 миллионов рабочих мест. Есть и хорошие новости — чат-боты все еще не так виртуозно владеют языком, как люди с высшим гуманитарным образованием, а также не обладают эмпатией, обаянием и харизмой (хотя, возможно, спустя несколько лет разработчикам удастся устранить и этот недочет). Кризисом в области знаний. ChatGPT, способный сгенерировать убедительный текст почти на любую тему, открывает широкие возможности перед мошенниками и людьми, занимающимися лженауками. Чем больше фактов, тем сложнее их проверить (и часто пользователям лень это делать), поэтому ситуация с дезинформацией и фейками может стать еще серьезнее. Кроме того, чат-бот буквально заменяет поисковую систему, при этом подменяя многие факты и понятия и не давая пользователю узнать альтернативный ответ. Даже если попросить ChatGPT сгенерировать другой текст, он создаст примерно то же самое. ChatGPT, способный сгенерировать убедительный текст почти на любую тему, открывает широкие возможности перед мошенниками и людьми, занимающимися лженауками. Чем больше фактов, тем сложнее их проверить (и часто пользователям лень это делать), поэтому ситуация с дезинформацией и фейками может стать еще серьезнее. Кроме того, чат-бот буквально заменяет поисковую систему, при этом подменяя многие факты и понятия и не давая пользователю узнать альтернативный ответ. Даже если попросить ChatGPT сгенерировать другой текст, он создаст примерно то же самое. Увеличением количества преступлений. Будущее любой технологии зависит от того, в чьи руки она попадет. Если деятельность ChatGPT не будет никак контролироваться, он может стать мощным инструментом в руках преступников. С помощью него можно будет создать вредоносный код, составить фишинговую рассылку, взломать чужую систему и в конечном итоге устроить масштабную кибератаку. Кроме того, учитывая все знания, которые обрабатывает чат-бот, он со временем сможет подсказать, как создать более смертоносное оружие или спланировать нападение. По этой причине в конце марта 2023 года один из создателей OpenAI, Илон Маск, предложил на какое-то время приостановить работу над продвинутыми нейросетями и подумать, как можно снизить риски и увеличить позитивный эффект от их работы. Как пользоваться ChatGPT в России? Официально делать это нельзя. Для запуска чат-бота необходима регистрация на сайте OpenAI, которая осуществляется по номеру телефона, а пользователям с российскими номерами и IP-адресами доступ закрыт. Однако есть вариант обойти ограничения. Скриншот: OpenAI Как зарегистрироваться на сайте OpenAI из России: Приобрести или арендовать электронную сим-карту другой страны. Зайти на сайт, используя IP-адрес другой страны. Авторизоваться. Чтобы получить доступ к GPT-4, нужно подписаться на ChatGPT Plus, выбрав Upgrade Plan и оплатив подписку международной картой. Российские карты не принимаются. Россияне также могут использовать чат-бот через другие приложения, куда OpenAI разрешил его встроить, например Poe, Bing,',\n",
       " ('ChatGPT', 1, 3): 'Notion и Duolingo.',\n",
       " ('ChatGPT',\n",
       "  10,\n",
       "  0): 'What is the AI bot ChatGPT? ChatGPT is a prototype dialogue-based AI chatbot capable of understanding natural human language and generating impressively detailed human-like written text. It is the latest evolution of the GPT – or Generative Pre-Trained Transformer – family of text-generating AIs. Who made it? The new AI is the latest chatbot from the Elon Musk-founded independent research body OpenAI foundation. Musk co-founded the startup with other Silicon Valley investors including technology venture capitalist Sam Altman in late 2015, saying that the research centre would “advance digital intelligence in the way that is most likely to benefit humanity” according to a blog post at the time. The Twitter CEO has since left the board and distanced himself from the company, tweeting on Sunday that after he “learned” that OpenAI was accessing the platform’s database for “training”, he put a pause on it. “Need to understand more about governance structure [and] revenue plans going forward,” he said. “OpenAI was started as open-source and non-profit. Neither are still true.” How does it work? Trained by AI and machine learning, the system is designed to provide information and answer questions through a conversational interface. The AI is trained on a huge sample of text taken from the internet. OpenAI said the new AI was created with a focus on ease of use. “The dialogue format makes it possible for ChatGPT to answer follow-up questions, admit its mistakes, challenge incorrect premises, and reject inappropriate requests,” the research body said in a statement last week. How can it be used? Early users have described the technology as an alternative to Google because it is capable of providing descriptions, answers and solutions to complex questions including ways to write code, and solve layout problems and optimisation queries. Real-world applications could include generating content for websites, answering customer inquiries, providing recommendations as well as creating automated chatbots. Sam Altman, OpenAI CEO, said the system was “an early demo of what’s possible”. “Soon you will be able to have helpful assistants that talk to you, answer questions, and give advice. Later you can have something that goes off and does tasks for you. Eventually you can have something that goes off and discovers new knowledge for you.” Could ChatGPT replace humans? There has been speculation that professions dependent upon content production could be rendered obsolete, including everything from playwrights and professors to programmers and journalists. In the days since it was released, academics have generated responses to exam queries that they say would result in full marks if submitted by an undergraduate, and programmers have used the tool to solve coding challenges in obscure programming languages in a matter of seconds. The ability to generate human-like written text has prompted suggestions that the technology could replace journalists. However at its current stage, the chatbot lacks the nuance, critical-thinking skills or ethical decision-making ability that are essential for successful journalism. Its current knowledge base ends in 2021, rendering some queries and searches useless. ChatGPT can also give entirely wrong answers and present misinformation as fact, writing “plausible-sounding but incorrect or nonsensical answers”, the company concedes. OpenAI says that fixing this issue is difficult because there is no source of truth in the data they use to train the model and supervised training can also be misleading “because the ideal answer depends on what the model knows, rather than what the human demonstrator knows”.',\n",
       " ('ChatGPT',\n",
       "  11,\n",
       "  0): 'На бумаге Radeon RX 9060 XT является идеальной альтернативой GeForce RTX 5060 Ti: производительность его выше, цена — ниже. Увы, не в каждой игре и, главное, не в каждой стране. Тестирование выполнено на примере видеокарты GIGABYTE GAMING OC 16G Новая весна – новый набор флагманов. В этом году – без новых брендов и почти тот же набор серий. Каких-то сюрпризов и неожиданных новичков в элите смартфонов по фотосъемке нет. Но все обновили свои главные гаджеты, и любопытно сравнить заново. В этот раз голосование делаем слепым Разработчики игр всё чаще обращаются к нейросетям для решения проблемы нехватки видеопамяти. Поскольку для достижения ультрареалистичного игрового опыта размеры текстур постоянно увеличиваются, это создаёт повышенную нагрузку на VRAM. Один из энтузиастов опубликовал видео, в котором продемонстрировал работу технологии нейросетевого сжатия текстур (Neural Texture Compression, NTC) на видеокартах Nvidia и Intel. Тесты показали, что NTC позволяет значительно снизить объём используемой видеопамяти без потери качества изображения Новое в обзорах Накопители Обзор PCIe 5.0-накопителя WD Black SN8100: лучший геймерский SSD в 2025 году SanDisk выпустила флагманский PCIe 5.0 SSD, который заявлен как самый быстрый накопитель потребительского класса с улучшенной энергоэффективностью. Проверим, насколько эти громкие заявления соответствуют реальности и действительно ли лучший SSD в 2025 году — это WD Black SN8100, а не Samsung 9100 Pro Программное обеспечение Основа информационной безопасности: обзор новой 7-й версии менеджера паролей для бизнеса «Пассворк» Российский разработчик «Пассворк» представил крупное обновление одноимённого программного комплекса, обеспечивающего безопасную и удобную работу с паролями в корпоративной среде. В компании не стали размениваться по мелочам и дополнили продукт множеством интересных возможностей и функций Смартфоны Обзор смартфона realme GT 7 Dream Edition: быстрый и дерзкий realme давно выпускает смартфоны с гоночной тематикой. Но новый realme GT 7 Dream Edition вывел эту тенденцию на качественно новый уровень, предлагая совершенно уникальный дизайн, созданный совместно с Aston Martin. К счастью, интересен этот смартфон не только своей внешностью Смартфоны Обзор Infinix NOTE 50 Pro+ 5G+: смартфон, у которого получается почти все После некоторой паузы снова говорим о смартфоне Infinix – из самой, пожалуй, популярной серии NOTE и, более того, с отчетливым геймерским флером, который, тем не менее, не перекрывает иные достоинства гаджета. Это попытка сделать максимально универсальный смартфон верхнего среднего класса – посмотрим, насколько удачная Материнские платы Обзор материнской платы Asus ROG Strix B850-A Gaming WiFi: почти X870, но дешевле Знакомимся с ROG Strix B850-A Gaming WiFi — платой Asus для процессоров Ryzen с поддержкой PCIe 5.0, DDR5-8000 и Wi-Fi 7, ориентированной на светлые сборки. Но особенно интересна она тем, что основана на B850 и дешевле вариантов на X870, но при этом выглядит почти как флагманский продукт Игры Monster Train 2 — этот поезд не остановить. Рецензия На Balatro жанр карточных роглайков не закончился — скорее, наоборот, к нему теперь повышенное внимание. Monster Train 2 оказалась очередной отличной представительницей жанра, в которой можно пропасть на ещё более долгий срок, чем в первой части. Рассказываем почему Игры Pipistrello and the Cursed Yoyo — замечательное приключение с ноткой ностальгии. Рецензия Бывает, что игра появляется из ниоткуда и впечатляет качеством и проработкой так сильно, что хочется рекомендовать её всем и каждому. Проект со смешным названием Pipistrello and the Cursed Yoyo — как раз из таких. Рассказываем, чем он хорош Offсянка Чем меньше, тем лучше Рассматривая с высоты почти семи десятилетий начало космической эры, не перестаёшь удивляться извилистому пути, который проделала идея искусственного спутника Земли… Корпуса, БП и охлаждение Обзор корпуса DeepCool CH270 Digital WH: почти компактный и почти вместительный Надоели стандартные громоздкие корпуса? Мощная видеокарта сгибает слот PCIe на материнской плате, а подпорка вызывает отторжение? Мониторинг должен быть всегда под рукой без стороннего софта? У DeepCool есть для вас один интересный вариант корпуса, но, чтобы понять,',\n",
       " ('ChatGPT',\n",
       "  11,\n",
       "  1): 'подходит ли он под ваши требования, нужно внимательно прочитать наш сегодняшний материал Смартфоны Обзор смартфона IQOO Neo 10: избранный, чтобы сделать бренд узнаваемым Мы только знакомимся с IQOO, суббрендом vivo, созданным для продвижения производительных аппаратов. Но, кажется, уже скоро пора будет перестать расшаркиваться перед «новым именем» и начать воспринимать эти гаджеты без скидок. Особенно если столь любопытные аппараты, как IQOO Neo 10, начнут появляться на регулярной основе Смартфоны Обзор Xiaomi 15 Ultra: мощнейший камерофон, но со странностями Вслед за сравнительным обзором камер флагманских смартфонов поговорим подробно об одном из участников этого обзора, Xiaomi 15 Ultra, – жаль, что не получилось заранее. Как обычно, главный флагман бренда невероятно впечатляет функциональностью, но сможет ли он потягаться с конкурентами в чистом качестве? Смартфоны Первый взгляд на смартфон realme GT 7 Dream Edition: заряженный гонщик realme регулярно обновляет свои флагманские смартфоны серии GT, но на этот раз производитель приготовил кое-что особенное — модель GT 7 Dream Edition, разработанную совместно с командой «Формулы-1» Aston Martin Aramco. Новинка сочетает в себе передовые технологии и элегантный дизайн, вдохновленный автоспортом Видеокарты Обзор видеокарты NVIDIA GeForce RTX 5060: счастливое исключение От младшей модели 50-й серии мы меньше всего ожидали приятных сюрпризов, но были рады ошибиться. Тестирование выполнено на примере видеокарты Palit под маркой Infinity 3 Игры Blades of Fire — и боец, и кузнец. Рецензия В наши дни чуть ли ни каждый ролевой экшен от третьего лица получает штамп в духе «Dark Souls с изюминкой». Blades of Fire подобного сравнения тоже не удастся избежать. Но это не значит, что у MercurySteam не нашлось собственных идей. Чего в игре больше — читайте в нашей рецензии Игры Elden Ring Nightreign — вместе весело страдать. Рецензия Первая многопользовательская «душевная» игра от FromSoftware наконец увидела свет и… не была встречена всеобщими восторгами, вот ведь! Концептуально Nightreign далека от Souls-философии, и уж очень явно бросается в глаза отсутствие у её разработчиков опыта в сфере больших сессионных забав. Насколько это критично для нового проекта — рассказываем в рецензии Offсянка Виртуальная нереальность Человек водружает на глаза футуристично выглядящие очки или шлем, откидывается на спинку удобного кресла — и погружается в волшебный виртуальный мир. Но что-то в данной нам в ощущениях реальности пришествие виртуальной всё откладывается и откладывается. Так, может, следует поумерить восторженный пыл и разобраться, почему VR по-прежнему ненамного ближе к нам, чем в конце 1990-х? Корпуса, БП и охлаждение Система жидкостного охлаждения PCCooler DT360 ARGB Display: красиво, но есть нюансы В PCCooler на помпу жидкостного охлаждения установили 3,4-дюймовый дисплей, на который можно выводить любые изображения, а сам дисплей можно поворачивать как угодно. Также в системе используется усовершенствованный радиатор и новые вентиляторы с модульным соединением и очень красивой подсветкой',\n",
       " ('ChatGPT',\n",
       "  12,\n",
       "  0): 'На бумаге Radeon RX 9060 XT является идеальной альтернативой GeForce RTX 5060 Ti: производительность его выше, цена — ниже. Увы, не в каждой игре и, главное, не в каждой стране. Тестирование выполнено на примере видеокарты GIGABYTE GAMING OC 16G Новая весна – новый набор флагманов. В этом году – без новых брендов и почти тот же набор серий. Каких-то сюрпризов и неожиданных новичков в элите смартфонов по фотосъемке нет. Но все обновили свои главные гаджеты, и любопытно сравнить заново. В этот раз голосование делаем слепым Разработчики игр всё чаще обращаются к нейросетям для решения проблемы нехватки видеопамяти. Поскольку для достижения ультрареалистичного игрового опыта размеры текстур постоянно увеличиваются, это создаёт повышенную нагрузку на VRAM. Один из энтузиастов опубликовал видео, в котором продемонстрировал работу технологии нейросетевого сжатия текстур (Neural Texture Compression, NTC) на видеокартах Nvidia и Intel. Тесты показали, что NTC позволяет значительно снизить объём используемой видеопамяти без потери качества изображения Новое в обзорах Накопители Обзор PCIe 5.0-накопителя WD Black SN8100: лучший геймерский SSD в 2025 году SanDisk выпустила флагманский PCIe 5.0 SSD, который заявлен как самый быстрый накопитель потребительского класса с улучшенной энергоэффективностью. Проверим, насколько эти громкие заявления соответствуют реальности и действительно ли лучший SSD в 2025 году — это WD Black SN8100, а не Samsung 9100 Pro Программное обеспечение Основа информационной безопасности: обзор новой 7-й версии менеджера паролей для бизнеса «Пассворк» Российский разработчик «Пассворк» представил крупное обновление одноимённого программного комплекса, обеспечивающего безопасную и удобную работу с паролями в корпоративной среде. В компании не стали размениваться по мелочам и дополнили продукт множеством интересных возможностей и функций Смартфоны Обзор смартфона realme GT 7 Dream Edition: быстрый и дерзкий realme давно выпускает смартфоны с гоночной тематикой. Но новый realme GT 7 Dream Edition вывел эту тенденцию на качественно новый уровень, предлагая совершенно уникальный дизайн, созданный совместно с Aston Martin. К счастью, интересен этот смартфон не только своей внешностью Смартфоны Обзор Infinix NOTE 50 Pro+ 5G+: смартфон, у которого получается почти все После некоторой паузы снова говорим о смартфоне Infinix – из самой, пожалуй, популярной серии NOTE и, более того, с отчетливым геймерским флером, который, тем не менее, не перекрывает иные достоинства гаджета. Это попытка сделать максимально универсальный смартфон верхнего среднего класса – посмотрим, насколько удачная Материнские платы Обзор материнской платы Asus ROG Strix B850-A Gaming WiFi: почти X870, но дешевле Знакомимся с ROG Strix B850-A Gaming WiFi — платой Asus для процессоров Ryzen с поддержкой PCIe 5.0, DDR5-8000 и Wi-Fi 7, ориентированной на светлые сборки. Но особенно интересна она тем, что основана на B850 и дешевле вариантов на X870, но при этом выглядит почти как флагманский продукт Игры Monster Train 2 — этот поезд не остановить. Рецензия На Balatro жанр карточных роглайков не закончился — скорее, наоборот, к нему теперь повышенное внимание. Monster Train 2 оказалась очередной отличной представительницей жанра, в которой можно пропасть на ещё более долгий срок, чем в первой части. Рассказываем почему Игры Pipistrello and the Cursed Yoyo — замечательное приключение с ноткой ностальгии. Рецензия Бывает, что игра появляется из ниоткуда и впечатляет качеством и проработкой так сильно, что хочется рекомендовать её всем и каждому. Проект со смешным названием Pipistrello and the Cursed Yoyo — как раз из таких. Рассказываем, чем он хорош Offсянка Чем меньше, тем лучше Рассматривая с высоты почти семи десятилетий начало космической эры, не перестаёшь удивляться извилистому пути, который проделала идея искусственного спутника Земли… Корпуса, БП и охлаждение Обзор корпуса DeepCool CH270 Digital WH: почти компактный и почти вместительный Надоели стандартные громоздкие корпуса? Мощная видеокарта сгибает слот PCIe на материнской плате, а подпорка вызывает отторжение? Мониторинг должен быть всегда под рукой без стороннего софта? У DeepCool есть для вас один интересный вариант корпуса, но, чтобы понять,',\n",
       " ('ChatGPT',\n",
       "  12,\n",
       "  1): 'подходит ли он под ваши требования, нужно внимательно прочитать наш сегодняшний материал Смартфоны Обзор смартфона IQOO Neo 10: избранный, чтобы сделать бренд узнаваемым Мы только знакомимся с IQOO, суббрендом vivo, созданным для продвижения производительных аппаратов. Но, кажется, уже скоро пора будет перестать расшаркиваться перед «новым именем» и начать воспринимать эти гаджеты без скидок. Особенно если столь любопытные аппараты, как IQOO Neo 10, начнут появляться на регулярной основе Смартфоны Обзор Xiaomi 15 Ultra: мощнейший камерофон, но со странностями Вслед за сравнительным обзором камер флагманских смартфонов поговорим подробно об одном из участников этого обзора, Xiaomi 15 Ultra, – жаль, что не получилось заранее. Как обычно, главный флагман бренда невероятно впечатляет функциональностью, но сможет ли он потягаться с конкурентами в чистом качестве? Смартфоны Первый взгляд на смартфон realme GT 7 Dream Edition: заряженный гонщик realme регулярно обновляет свои флагманские смартфоны серии GT, но на этот раз производитель приготовил кое-что особенное — модель GT 7 Dream Edition, разработанную совместно с командой «Формулы-1» Aston Martin Aramco. Новинка сочетает в себе передовые технологии и элегантный дизайн, вдохновленный автоспортом Видеокарты Обзор видеокарты NVIDIA GeForce RTX 5060: счастливое исключение От младшей модели 50-й серии мы меньше всего ожидали приятных сюрпризов, но были рады ошибиться. Тестирование выполнено на примере видеокарты Palit под маркой Infinity 3 Игры Blades of Fire — и боец, и кузнец. Рецензия В наши дни чуть ли ни каждый ролевой экшен от третьего лица получает штамп в духе «Dark Souls с изюминкой». Blades of Fire подобного сравнения тоже не удастся избежать. Но это не значит, что у MercurySteam не нашлось собственных идей. Чего в игре больше — читайте в нашей рецензии Игры Elden Ring Nightreign — вместе весело страдать. Рецензия Первая многопользовательская «душевная» игра от FromSoftware наконец увидела свет и… не была встречена всеобщими восторгами, вот ведь! Концептуально Nightreign далека от Souls-философии, и уж очень явно бросается в глаза отсутствие у её разработчиков опыта в сфере больших сессионных забав. Насколько это критично для нового проекта — рассказываем в рецензии Offсянка Виртуальная нереальность Человек водружает на глаза футуристично выглядящие очки или шлем, откидывается на спинку удобного кресла — и погружается в волшебный виртуальный мир. Но что-то в данной нам в ощущениях реальности пришествие виртуальной всё откладывается и откладывается. Так, может, следует поумерить восторженный пыл и разобраться, почему VR по-прежнему ненамного ближе к нам, чем в конце 1990-х? Корпуса, БП и охлаждение Система жидкостного охлаждения PCCooler DT360 ARGB Display: красиво, но есть нюансы В PCCooler на помпу жидкостного охлаждения установили 3,4-дюймовый дисплей, на который можно выводить любые изображения, а сам дисплей можно поворачивать как угодно. Также в системе используется усовершенствованный радиатор и новые вентиляторы с модульным соединением и очень красивой подсветкой',\n",
       " ('ChatGPT',\n",
       "  13,\n",
       "  0): 'Проблемы возникли в основном с сайтом и приложением ChatGPT, но наблюдаются сбои в работе и других продуктов OpenAI. В компании пояснили, что проблема вызвана провайдером более высокого уровня Фото: Rokas Tenys / Shutterstock Пользователи по всему миру сообщают о проблемах с работой сервисов OpenAI, включая поисковик на основе ChatGPT, следует из статистики Downdetector. Жалобы начали поступать около 22:00 мск. В основном проблемы возникают с доступом к сайту и работой мобильного приложения. О сбое сообщают пользователи из Нидерландов, Германии, Казахстана, Польши, Финляндии и других. При переходе на сайт ChatGPT появляется уведомление об ошибке. OpenAI сообщает, что в работе ChatGPT, API и Sora фиксируется высокая частота ошибок. «Установлено, что эта проблема вызвана провайдером более высокого уровня, в настоящее время мы проводим мониторинг», — говорится в сообщении. В предыдущий раз сбой в работе ChatGPT произошел в начале ноября. Тогда пользователи тоже в основном сообщали о проблемах с самим чат-ботом, а также с доступом к сайту OpenAI. ChatGPT — это чат-бот, нейросеть, способная вести диалог, искать ошибки в коде, сочинять стихи, писать сценарии и отвечать на любые вопросы. Бот запоминает детали диалога с пользователем и избегает спорных тем. Его ответы можно корректировать с помощью наводящих вопросов. ChatGPT — пример большой языковой модели (LLM), обученной на значительном объеме данных понимать естественный язык, а затем генерировать тексты самостоятельно. Эксперты недавно выяснили, что нейросеть может ошибаться и даже создавать опасный код на основе неверных данных, чем могут воспользоваться мошенники. Чат-бот был запущен 30 ноября 2022 года, официально в России он не доступен. Глава OpenAI Сэм Альтман в прошлом году говорил, что ChatGPT еженедельно используют до 100 млн человек в 185 странах мира.',\n",
       " ('ChatGPT',\n",
       "  14,\n",
       "  0): 'OpenAI начала выдавать доступ к плагинам и подключила ChatGPT к интернету для пользователей подписки ChatGPT Plus. Рассказываем, как включить эти функции и что они дают 15 мая 2023 года OpenAI официально начала выдавать доступ к долгожданным плагинам для пользователей ChatGPT Plus. Эти интернет-подключенные инструменты разработали для расширения функциональности ChatGPT. Первый набор плагинов был создан и разработан такими компаниями, как Expedia, FiscalNote, Instacart, KAYAK, Klarna, Milo, OpenTable, Shopify, Slack, Speak, Wolfram и Zapier, и призван расширить сферу применения этого ИИ-бота. Одновременно с плагинами OpenAI также наконец дала ChatGPT доступ в интернет. Теперь, подобно Google Bard и Microsoft Bing AI, ChatGPT может искать в вебе информацию, проверять ее, ссылаться на конкретные данные и предоставлять вам самую актуальные данные. При добавлении ссылки на конкретную страницу в интернете ChatGPT иллюстрирует шаги, которые он предпринимает для поиска в вебе, «клики», которые он делает, и процесс, которому ИИ, чтобы обработать запрос. Как включить плагины и веб-просмотр в ChatGPT: Убедитесь, что у вас куплена и оплачена подписка ChatGPT Plus. Перейдите в настройки (Settings), нажав на свой email в левом нижнем углу экрана ChatGPT. Выберите Settings. Выберите Beta Features. Включите переключатель Web Browsing и, если доступно, включите переключатель Plugins. Фото: OpenAI После включения этих настроек вы найдете новые опции в переключателе моделей ChatGPT (там, где вы переключаетесь между GPT-3.5 и GPT-4). Причем можно выбрать что-то одно: либо Web Browsing, либо Plugin Store, чтобы начать установку и включение плагинов. Пример запроса к ChatGPT с включенной функцией Web Browsing, дающей доступ к информации на веб-страницах в интернете. (Фото: Иван Звягин) Вероятно, эти функции появятся не сразу у всех владельцев подписки Plus и не в полном объеме — OpenAI планирует плавно «раскатывать» функциональность в течение недели для балансировки нагрузки на свои сервера.',\n",
       " ('ChatGPT',\n",
       "  15,\n",
       "  0): 'Гендиректор «Таттелекома» о том, обоснован ли хайп последних недель вокруг ChatGPT «Помните, все думали, что роботы заменят людей в их технических задачах вроде курьерской доставки, а люди будут творить? Сейчас наоборот — курьеры бегают с доставкой, а машины рисуют картины и пишут липовые дипломы», — говорит гендиректор «Таттелекома» Айрат Нурутдинов. В статье, написанной для «БИЗНЕС Online», он рассуждает о возможностях и ограничениях нейросетей и объясняет, в чем подвох некоторых русскоязычных чат-ботов. Соавтором материала выступила сама языковая модель ChatGPT, которая ответила на несколько вопросов об искусственном интеллекте. Айрат Нурутдинов: «Мы подошли к тому историческому моменту, когда количество информации и попыток ее обработки, помноженное на доступные вычислительные мощности, переросло в новое качество» Фото: «БИЗНЕС Online» От дочери Байрона до ChatGPT: волнистая история ИИ Одна из самых парадоксальных вещей, связанных с хайпом последних недель вокруг нейросетей, ChatGPT, Midjourney, Stable Diffusion и т. д., заключается в том, что… ничего нового, собственно, и не произошло. Базовые принципы технологии, на которой они работают, известны десятки лет, вся первичная теория нейросетей была сформирована в 70–80-х годах. Да, сейчас появились новые архитектуры, но вся основа и методы обучения по-прежнему почти полувековой давности. Например, алгоритм обучения нейронных сетей через обратное распространение ошибки (англ. — backpropagation) был множество раз переоткрыт начиная с 1960–1970-х годов. И вот, похоже, мы подошли к тому историческому моменту, когда количество информации и попыток ее обработки, помноженное на доступные вычислительные мощности, переросло в новое качество. GPT-3 от версии предыдущего поколения GPT-2 стал отличаться очень сильно, показывая действительно эффектные результаты. Но приведет ли все это к новому технологическому перевороту или упрется в очередную так называемую зиму искусственного интеллекта? Чтобы делать какие-то прогнозы, надо вспомнить, как вообще развивался ИИ. Использование перфокарт на жаккардовом станке Фото: wikimedia.org Большинство самых современных технологий гораздо старше, чем кажутся. Думающим машинам на самом деле уже сотни лет. Считается, что программирование началось с жаккардовых ткацких станков, которые стали появляться на английских мануфактурах с 1804 года, картонные перфокарты в них обеспечивали нужный орнамент ковров. А первым программистом называют Аду Лавлейс, дочь английского поэта Джорджа Байрона (родилась в 1815 году), которая создала первые компьютерные алгоритмы для машины Бэббиджа, первого прообраза будущих ЭВМ. Но развитие машин шло неравномерно. Были волны надежд, огромных инвестиций и определенных результатов, которые сменялись спадами глубочайшего разочарования: приходило понимание ограниченности того или иного «прорывного» решения — это были зимы искусственного интеллекта. Начиная с 70-х искусственный интеллект начинает строиться на основе экспертных систем, на которые был ориентирован ряд «перспективных языков» программирования, таких как Lisp, Prolog и CLIPS. Сама идея экспертных систем достаточно проста и привлекательна: появляется вычислительное устройство, которое можно наполнять знаниями, оно способно логически рассуждать и, как следствие, правильно отвечать на каверзные вопросы. В 1980-х годах экспертные системы получают широкое распространение. Университеты предлагают курсы по экспертным системам, а две трети компаний из списка Fortune 500 применяют эту технологию в повседневной деятельности. В 1982-м Япония заявляет о том, что станет первой страной, которая создаст искусственный интеллект. К этому времени японцы занимают передовые позиции в бытовой электронике и автомобильной промышленности, так что к такому анонсу все относятся очень серьезно. На проект компьютера пятого поколения выделяется около полумиллиарда долларов (по тем ценам!), но он оборачивается полным провалом и в 1992 году закрывается. Обещанного эпохального суперкомпьютера не появилось, а поставленные цели оказались технологически недостижимыми. Однако в силу революционности проект позволил провести ряд фундаментальных исследований, которые предвосхитили будущие направления развития отрасли. В 90-е годы во всем мире приходит понимание, что экспертные системы не могут решить те задачи, которые на них возлагали. Эксперты-люди не спешили делиться своими знаниями, возможно, чувствуя в машинах конкуренцию, а все расширяющиеся базы данных надо было постоянно поддерживать в актуальном состоянии, что было практически невозможно имеющимися на тот момент средствами. К тому же экспертные системы',\n",
       " ('ChatGPT',\n",
       "  15,\n",
       "  1): 'были слишком дорогими в обслуживании. Эта зима продлилась до нулевых (некоторые называют даты до 1993–1994 годов, но в реальности затишье продолжалось гораздо дольше). Но самое интересное, что для искусственного интеллекта в этот момент оказались невыполнимыми самые, на первый взгляд, простые задачи — например, научиться отличать кошек от собак. В середине 2000-х большинство исследователей сосредоточились на улучшении алгоритмов. Но китайская исследовательница Фей-Фей Ли предположила, что системам нужно больше данных, и решила разметить столько объектов, сколько сможет. Т. е. подготовить огромный набор фотографий, в котором каждая будет содержать один ключевой объект и он будет однозначно ранее идентифицирован человеком. Таким образом, должна была сформироваться пара: то, что нужно узнать, и то, чем оно является в действительности. Фей-Фей Ли выступает на AI for Good 2017 Фото: CC BY 2.0, commons.wikimedia.org С 2006 по 2009 год она создавала ImageNet — базу данных, в которую вошли на тот момент 1,2 млн размеченных изображений. И это сработало. Одновременно появились доступные видеокарты, которые обеспечили необходимые вычислительные мощности. Это в совокупности с огромными, впоследствии миллиардными выборками привело к феноменальному результату: буквально за несколько лет машины научились распознавать изображения лучше, чем человек. И примерно с 2012–2015 годов начинается победное шествие нейронных сетей. Да, Фей-Фей Ли в итоге возглавила Стэнфордскую лабораторию искусственного интеллекта. Интеллект естественный и интеллект искусственный Специфика человеческого восприятия заключается в том, что нам для обучения нужно сравнительно мало данных. Ребенку не надо показывать кошку 1,2 млн раз, чтобы он научился отличать ее от собаки, как это произошло с машинами. Он практически сразу сможет идентифицировать кошку живую, кошку нарисованную, кошку мультипликационную, даже тень от кошки. И это нужно учитывать, когда искусственный интеллект (которому человек за всю 70-летнюю историю существования термина не смог дать исчерпывающего общепринятого определения) сравнивают с естественным интеллектом. Понятно, что нейросеть — это попытка смоделировать мозг человека. Но устройство мозга крайне сложное — мы сами до конца не знаем, как он работает. И попытка воспроизвести что-то, что мы сами не вполне понимаем, как устроено, вряд ли будет успешной. Эта сложность — результат миллиардов лет эволюции и триллионов ошибок и «исправлений» в ходе нее. Какие задачи ChatGPT может делать лучше человека? Отвечает сам ChatGPT Как ИИ модель, я могу обрабатывать и анализировать большие объемы информации и выполнять повторяющиеся задачи с высокой точностью и скоростью. Например, я могу помочь с автоматическим переводом текстов на разные языки, анализировать и классифицировать большие наборы данных, предсказывать тенденции и результаты на основе статистических данных, а также выполнять множество других задач в области машинного обучения и искусственного интеллекта.Однако, во многих областях, где требуется высокая степень эмпатии, творческого мышления и человеческого опыта, я не могу заменить человека. Например, я не могу по-настоящему понимать человеческие эмоции и не могу принимать сложные моральные решения, так же, как это делают люди. (Это ответ на русском языке нейросети ChatGPT на вопрос «Какие задачи ты можешь делать лучше человека?» Приводится без изменений, орфография, пунктуация и содержание сохранены — прим. ред.) Все ищут зачатки разума, но надо понимать, что технология нейросетей основана не на анализе и глубоком прогнозировании, а просто на глубинном сопоставлении. Отсюда вытекает и ответ на все рассуждения о том, могут ли машины восстать. Переход от «тупой» системы к «умной» не будет мгновенным. Эволюции понадобились миллиарды лет, чтобы получить интеллект нашего уровня. Да, в случае искусственного интеллекта прогресс измеряется не тысячелетиями, а годами, но в любом случае не будет мгновенного перехода, внезапной технологической сингулярности. Все изменения заметны. Пока машины очень далеки от того состояния, когда можно будет говорить о воле и принятии решений. В то же время правила «естественного отбора» в эволюции машин устанавливаем мы сами, и они развивают в первую очередь то, чего мы больше всего от них хотим, а это явно не самосознание. Именно по этой причине',\n",
       " ('ChatGPT',\n",
       "  15,\n",
       "  2): 'есть огромная вероятность развития «военного», агрессивного интеллекта, предназначенного для нанесения урона противнику. В этом случае мы получим аналог атомного оружия — без «больших мозгов», эффективного, бессмысленного и беспощадного, представляющего огромную угрозу человечеству в целом. Это гораздо более реальная опасность. Но это лирика. А с чем же мы столкнулись сегодня? Что такое ChatGPT, который установил исторический рекорд по росту пользователей (аудитория за два месяца составила 100 млн человек)? По сути, это большая языковая модель. Дословно расшифровывается как Generative Pre-trained Transformer — заранее обученный генераторный преобразователь. Чат-бот от компании OpenAI, одним из основателей которой является Илон Маск (по оценке Forbes, стоимость компании — $29 млрд). В теории модель способна вести диалог на естественных языках, писать код, переводить и генерировать тексты и т. д. Она работает и на русском языке, хотя известно, что только 0,11% данных, на которых модель обучалась, было русскоязычными. Массив для обучения GPT-3, предшественника ChatGPT, включал информацию открытых библиотек, всю «Википедию», тексты с сайтов WebText и т. д. — всего 570 Гб данных — и настраивался по 175 млрд параметров. Много это или мало? С одной стороны, цифра кажется не очень впечатляющей: современные компьютеры имеют память в 1–2 Тб, встроенная память последних айфонов — 512 Гб. Но надо понимать, что здесь речь не о картинках и не о видео высокого разрешения, а о текстовой информации, которая измеряется совсем другими объемами. В свое время был популярен подарок — электронные книги со скачанным архивом «Флибусты». До всех блокировок, в 2015 году, там было примерно 320 тыс. томов, которые весили 500 гигабайт (если в месяц прочитывать хотя бы одну книгу, то за всю жизнь вряд ли осилить и тысячу). И то это не совсем релевантная цифра, потому что там были иллюстрации, обложки и т. д. Словом, массив информации колоссальный, и, когда он компилируется системой для ответов, диалог выглядит эффектно. Но во всем этом есть несколько больших стоп-факторов, что в ChatGPT и сервисах на его основе, что в российской разработке «Яндекса» под названием «Балабоба», что в других аналогичных проектах. Три проблемы чат-ботов Первая проблема — уровень верификации данных. Чат-боты совершают колоссальное количество ошибок, которые выдают за истину. Без перепроверки эти результаты использовать нельзя. А когда будет достигнут соответствующий уровень точности и будет ли вообще — большой вопрос. У меня есть огромные сомнения, что удастся довести релевантность информации до тех цифр, которые бы нас устраивали и не требовали перепроверки. Здесь ситуация все больше становится схожей с работой автопилотов: да, они работают и ошибаются все реже, но зачастую цена ошибки — человеческие жизни. Когда удастся выйти на «допустимый» уровень безошибочности, совершенно не ясно. «Чат-боты совершают колоссальное количество ошибок, которые выдают за истину. Без перепроверки эти результаты использовать нельзя» Здесь важно понимать вот что. Роботы не знают, что возможно в этом мире, а что нет. ИИ обучают на текстовой информации, т. е. отобранных, переработанных знаниях, представленных в текстовом и визуальном форматах. Очевидно, что в этих источниках не представлен огромный пласт знаний о физическом мире, т. к. многие вещи воспринимаются человеком как само собой разумеющиеся. Как следствие, чем более для нас что-то очевидно, тем сложнее это для машин. Например, для меня очевидно, что если я сижу, то я не могу одновременно и стоять. Или что если человек зашел в комнату, то эта комната размерами точно больше человека. Но эти факты никогда не упоминаются в текстах, потому машина об этом не подозревает, пока ее специально этому не обучат. При феноменальных результатах в решении сложных задач машины делают абсурдные ошибки в самых простых. Это парадокс Моравека: «Компьютеру относительно легко достичь уровня взрослого человека в таких задачах, как тест на интеллект или игра в шашки, однако сложно или невозможно достичь навыков годовалого ребенка в задачах восприятия или мобильности». Какую опасность может',\n",
       " ('ChatGPT',\n",
       "  15,\n",
       "  3): 'нести людям искусственный интеллект? Отвечает ChatGPT Искусственный интеллект (ИИ) имеет потенциал принести много пользы для человечества, но также может нести определенные риски и опасности. Вот несколько примеров: Непредсказуемость. Некоторые формы ИИ могут быть непредсказуемыми и сложными в понимании. Это может сделать их действия непредсказуемыми и неясными, что может привести к нежелательным последствиям. Ошибки и предвзятость. ИИ-системы могут быть склонны к ошибкам и предвзятости, особенно если данные, используемые для их обучения, содержат недостаточное количество информации или отражают некорректные представления. Это может привести к ошибочным выводам и решениям, которые могут повлиять на безопасность и благополучие людей. Угроза приватности. Системы ИИ могут использовать большие объемы данных, включая личную информацию, что может создавать угрозу приватности для людей. Некоторые формы ИИ могут даже использовать эту информацию, чтобы манипулировать людьми или создавать более точные профили поведения. Замена рабочих мест. Разработка ИИ может привести к автоматизации процессов и замене трудоемких профессий, что может привести к увольнениям и негативно сказаться на экономике и обществе. Использование военных целях. ИИ может быть использован в военных целях, что может привести к разработке автономных систем оружия и созданию новых видов военной техники, что может привести к необратимым последствиям. Это лишь несколько примеров рисков, которые могут нести с собой системы ИИ. Однако, существует множество этических и правовых принципов и нормативных актов, которые регулируют использование ИИ и помогают минимизировать эти риски. Важно продолжать исследования и разработку ИИ, а также разрабатывать этические и правовые принципы, чтобы гарантировать безопасность и благополучие людей (Это ответ на русском языке нейросети ChatGPT на вопрос «Какую опасность может нести людям искусственный интеллект?» Приводится без изменений, орфография, пунктуация и содержание сохранены — прим. ред.) Еще больший подвох в том, что не всегда ошибки нейросетей лежат на поверхности. 8 февраля этого года чат-бот Bard от Google в прямом демонстрационном эфире заявил, что телескоп «Джеймс Уэбб» сделал первые снимки экзопланет — и это оказалось ложью. По данным Reuters, после этого материнская компания Alphabet потеряла $100 млрд рыночной стоимости. И непонятно, как этого избежать. Мы знаем только общие принципы работы биологических нейросетей. Та архитектура, которую мы используем при их построении, не позволяет понять, почему именно это предложение было сгенерировано в ответ на конкретный запрос. А значит, и поправить это очень сложно, можно только продолжать их обучать на все бо́льших массивах данных в надежде, что количество ошибок будет сокращаться. Плюс еще и закон Гудхарта, гласящий: «Когда мера становится целью, она перестает быть хорошей мерой», начинает наступать на пятки. Сейчас используются генеративно-состязательные сети (Generative adversarial network, GAN): одна генерирует тот или иной результат, другая проверяет его достоверность, т. е. одна пытается обмануть, а другая — поймать на обмане. В итоге обе стремительно наращивают свои компетенции. Но часто обе ошибаются. Слова — это вторая сигнальная система, вербальные образы, которые только отображают мир, являются его «тенью». Удастся ли заставить машину корректно отображать реальный мир, загрузив в нее миллионы слов и комбинаций? Есть большие сомнения. Вторая проблема. Вероятность получить оскорбительный ответ в диалоге с чат-ботами, основанными на глубоком изучении, часто приближается к 100%. «Балабобу» запустили и очень быстро закрыли с формулировкой «не можем гарантировать корректную работу сервиса», потому что ей стали задавать опасные вопросы, а потом в социальных сетях публиковать ответы на них. Почти полгода потребовалось разработчикам, чтобы установить все возможные фильтры, теперь она в любой минимально рискованной ситуации предупреждает, что не принимает запросы на острые темы, например о политике и религии. Ведь в чем опасность рекомендательных систем? Они часто подталкивают нас в «темную» сторону. Обрабатывая провокационные человеческие запросы, сами модели легко могут становиться расистами, призывать к насилию и т. д. Обнажают то, что в обычной ситуации подавляется цивилизованным поведением. Поэтому многие решения просто закрывались, не сумев добиться того, чтобы текст, который они продуцируют, стабильно выглядел дружелюбно или хотя',\n",
       " ('ChatGPT',\n",
       "  15,\n",
       "  4): 'бы политкорректно. Остальные или прокачивают фильтры, или сильно рискуют — последствия неосторожных слов сегодня могут быть вплоть до уголовных. Третье. В век постправды вообще непонятно, какие ответы мы хотим знать. Интернет на 80% заполнен прогнозами, взглядами и суждениями. Люди говорят другим людям то, что те должны или хотят услышать. Чат-боты в этом смысле не привносят что-то новое, скорее наоборот. В сети и так много мусора, а теперь его количество кратно увеличится. Люди всегда и во всем пытаются найти смыслы, какой-то символизм. Если я задам чат-боту 100 вопросов, то как минимум один из ответов будет интересен, остроумен и уместен. Обычно публикуют именно такие красивые скриншоты. С графическими нейросетями то же самое. Кстати, многие русскоязычные чат-боты, которые выдают за решения на основе GPT3, на самом деле не имеют отношения ни к нему, ни — зачастую — к OpenAI. Как правило, вместо этого используются значительно более примитивные (зато доступные!) системы генерации текстов, разработанные другими компаниями. И тут две опасности: во-первых, низкое качество их ответов дискредитирует в глазах пользователей саму технологию нейросетей. Во-вторых, мошенники начали пользоваться тем, что доступ к ChatGPT в России ограничен (а схема обходных путей не самая простая), и распространяют ссылки, где якобы можно скачать десктопный клиент для ChatGPT, в которых вшит троян, созданный для кражи данных. Об этом уже предупреждают разработчики антивирусов. И что все это меняет? У всех возникает вопрос: могут ли нейросети заместить специальности и профессии? Как быстро я смогу поставить машине задачу: «Напиши статью о нейросети для „БИЗНЕС Online“ от моего имени»? Не в ближайшие 10 лет, цена ошибки, как мы видим на примере Alphabet, крайне высока. Но и возможности ИИ нельзя недооценивать. Уже сегодня сервисы на основе ИИ могут быть удобным инструментом, сильно облегчающим работу в целых отраслевых направлениях. ChatGPT3 вполне прилично работает как ассистент при написании кода (но я продолжаю пользоваться stackoverflow). Конечно, программистов он не заменит, просто оптимизирует их работу. Графические нейросети точно меняют подходы к работе дизайнеров. Эксперименты с ними сравнимы с Pinterest — это подсказки для каких-то творческих ходов. А вот стоковые фотобанки теперь под угрозой: зачем покупать изображение, если можно сгенерировать что-то подходящее самому? Здесь даже быстрее получится, в стоках я просматриваю сотни образцов, а со Stable Diffusion хватит нескольких десятков. То же самое со звуками, а со временем нейросети и видео в полной мере освоят. Очень напряглись поисковые системы, которые тоже принципиально не менялись годами, если не десятилетиями. У них давно сложилась индустрия вокруг выдачи, частоты показов, всей этой СЕО-оптимизации, рекламы. А тут возникают новые правила, новые форматы, которые не скармливают пользователям по 30 сомнительных ссылок на 50 страницах, а сами агрегируют информацию. И тут возникает новая ниша, новые возможности и надежды. Какие профессии искусственный интеллект полностью заменит в будущем? Отвечает ChatGPT Искусственный интеллект уже начал заменять ряд профессий, особенно тех, которые основаны на повторяющихся и стандартизированных задачах. Это включает в себя профессии, такие как кассиры, операторы техподдержки, машинисты, повара, сборщики заказов и т. д. В будущем искусственный интеллект может заменить еще большее количество профессий, связанных с обработкой и анализом данных, например, бухгалтеров, финансистов, аналитиков и т. д. Также возможна замена профессий, связанных с транспортировкой, например, водителей, пилотов и т. д. Однако, важно понимать, что искусственный интеллект не заменит полностью людей во всех профессиях. Например, некоторые профессии, такие как ученые, художники, писатели, музыканты и другие, требуют творческого мышления и интуиции, которые сегодня трудно передать искусственному интеллекту. Кроме того, профессии, связанные с личным обслуживанием, такие как врачи, психологи, консультанты, учителя и т. д., будут оставаться крайне важными для общества, поскольку они требуют межличностных навыков и эмпатии, которые пока что невозможно полностью заменить искусственным интеллектом.Таким образом, можно сказать, что искусственный интеллект изменит многие профессии в будущем, однако, человеческие навыки и способности будут',\n",
       " ('ChatGPT',\n",
       "  15,\n",
       "  5): 'оставаться важными для многих профессий и не будут заменены искусственным интеллектом полностью. (Это ответ на русском языке нейросети ChatGPT на вопрос «Какие профессии искусственный интеллект полностью заменит в будущем?» Приводится без изменений, орфография, пунктуация и содержание сохранены — прим. ред.) Если посмотреть на развитие многих систем, то вначале идет рывок, феноменальный прогресс, а затем стагнация. Мой любимый пример — MS Word, который остается почти в неизменном состоянии уже лет 20. Помните, все думали, что роботы заменят людей в их технических задачах вроде курьерской доставки, а люди будут творить? Сейчас наоборот — курьеры бегают с доставкой, а машины рисуют картины и пишут липовые дипломы. «Нейросети — это перспективный инструмент, на который можно будет переложить часть задач творческого характера» Парадокс очень легко объясняется. Творческие способности возникли у человека буквально несколько десятков тысяч лет назад. Это довольно новый навык, он сравнительно примитивный, его легко повторить. А наши движения гораздо более сложны, чем нам кажется, это результат эволюции в миллион лет. На самом деле, с точки зрения нейробиологии, 80–90% мозга задействовано не под творческие задачи, а под движения и координацию всех наших 850 мышц, о которой мы даже не задумываемся. То, что нам кажется простым, требует огромных ресурсов. Для нас это вроде необременительно, мы просто не замечаем, какие огромные вычислительные мощности требуются для выполнения движений. Да, Boston Dynamics показывает двуногих роботов, которые бегают и делают сальто. Но надо понимать, что нам демонстрируют лучшее видео, а сотни неудачных попыток остаются за кадром. Компании уже более 15 лет, а из коммерческого применения мы видим только прототип собачки из сериала-антологии «Черное зеркало». Если бы эти устройства на самом деле так хорошо умели бегать, они бы уже давно повсеместно использовались. Ведь изначально компания разрабатывала роботов для военных целей, они должны быть мулами, которые (на основе концепции BigDog) сопровождали бы военных по пересеченной местности. Не получилось. Кстати, военных также не удовлетворил и уменьшенный электрический робот Spot, который поднимал слишком мало груза. «Биологически вдохновленный четвероногий робот Big Dog разрабатывается как мул, способный преодолевать труднопроходимую местность» Фото: commons.wikimedia.org Так или иначе, нейросети — это перспективный инструмент, на который можно будет переложить часть задач творческого характера. Это полезный инструмент, который может упростить какие-то процессы, если его правильно использовать. Но говорить о том, что они сильно что-то меняют, преждевременно. Впрочем, у айфонов первая версия была не такая уж впечатляющая, что не помешало им за несколько лет перевернуть представление о мобильной технике во всем мире. Более научно и полно данные мысли изложены в исследовании, опубликованном в ученых записках Казанского университета в статье «Перспективы биоинспирированного подхода в разработке систем искусственного интеллекта (обзор тенденций)». Айрат Нурутдинов',\n",
       " ('ChatGPT',\n",
       "  16,\n",
       "  0): 'This story is available exclusively to Business Insider subscribers. Become an Insider and start reading now. C3.ai has soared 86% year-to-date as an investor frenzy builds for artificial intelligence. The surge higher has happened amid the growing success of OpenAI\\'s ChatGPT product. C3.ai announced on Tuesday that it would integrate ChatGPT into its product suite. Shares of C3.ai have soared 85% year-to-date as an investor frenzy builds for stocks with exposure to artificial intelligence. The stock has soared amid the growing success of OpenAI, a company unrelated to C3.ai which has taken the internet by storm in recent weeks via the release of its ChatGPT product. ChatGPT has proven to be a useful showcase to both investors and consumers as to what artificial intelligence can do today, and what it may be capable of over time. ChatGPT is a natural language chatbot that allows users to have human-like conversations on a myriad of topics. Just two months after its release, users of ChatGPT are using the platform to assist with writing emails, developing code, and answering questions on a myriad of topics, like investing. The success of ChatGPT led to Microsoft investing an additional $10 billion in OpenAI at a valuation of about $29 billion. Microsoft had previously invested $1 billion into OpenAI in 2019. While C3.ai does not own a piece of OpenAI, it does have a contract with Microsoft\\'s cloud platform. C3.ai soared as much as 28% on Tuesday after the company said it would integrate ChatGPT into its product suite of artificial intelligence tools. \"The C3 Generative AI Product Suite integrates the latest AI capabilities from organizations such as Open AI, Google, and academia, and the most advanced models, such as ChatGPT and GPT-3 into C3 AI\\'s enterprise AI products,\" C3.ai said in a Tuesday press release. \"Combining the full potential of natural language, generative pre-trained transformers, enterprise AI, and predictive analytics will change everything about enterprise computing,\" C3.ai CEO Thomas Siebel said. The recent surge in C3.ai\\'s stock price has helped it reach levels not seen since August. Despite the year-to-date surge, C3.ai is down 89% from its record December 2020 high of $183.90 per share.',\n",
       " ('ChatGPT',\n",
       "  17,\n",
       "  0): 'ChatGPT при всей своей мощи и возможностях неожиданно проиграл в шахматы игровой приставке из 1977 года! фото LinkedIn (Robert Jr. Caruso) Инженер Citrix Роберт Карузо-младший по подсказке самого ChatGPT решил свести его в битве с процессором от культовой игровой приставки Atari 2600, вышедшей в 1977 году. Она основана на процессоре с частотой чуть выше 1 МГц. Правда, Карузо использовал не оригинальную консоль, а эмулятор Stella. В итоге в игре Atari Chess вся мощь искусственного интеллекта ChatGPT не помогла ему одолеть древний CPU с частотой 1,19 МГц. Чат-бот постоянно путался, сбивался, делал ужасные ходы, просил перезапустить игру и даже обвинял в своих неудачах неудачную стилизацию шахматных фигур. Несмотря на то, что ему дали базовую раскладку доски для определения фигур, ChatGPT путал ладьи со слонами, пропускал вилки пешек и постоянно терял счет фигурам — сначала обвиняя значки Atari в том, что они слишком абстрактны для распознавания, а затем не справляясь даже после перехода на стандартную шахматную форму. Он совершил достаточно ошибок, чтобы над ним посмеялись в шахматном клубе 3-го класса. Тем временем скромный 8-битный движок Atari просто делал свое дело. Никакой языковой модели. Никакой вспышки. Только грубая оценка доски и упрямство 1977 года. В течение 90 минут мне приходилось останавливать ИИ от совершения ужасных ходов и исправлять его осведомлённость о доске несколько раз за ход. Он продолжал обещать, что улучшится, «если мы просто начнём заново». В конце концов даже ChatGPT понял, что он побеждён, — и сдался, опустив голову. Почему ChatGPT было так сложно играть в такие шахматы, не очень понятно, но это лишний раз напоминает нам, что современные большие языковые модели, при всех их возможностях, это весьма специфические и точно не всемогущие программные решения.',\n",
       " ('ChatGPT',\n",
       "  18,\n",
       "  0): 'Suppose you are a professor of pedagogy, and you assign an essay on learning styles. A student hands in an essay with the following opening paragraph: The construct of “learning styles” is problematic because it fails to account for the processes through which learning styles are shaped. Some students might develop a particular learning style because they have had particular experiences. Others might develop a particular learning style by trying to accommodate to a learning environment that was not well suited to their learning needs. Ultimately, we need to understand the interactions among learning styles and environmental and personal factors, and how these shape how we learn and the kinds of learning we experience. Pass or fail? A- or B+? And how would your grade change if you knew a human student hadn’t written it at all? Because Mike Sharples, a professor in the U.K., used GPT-3, a large language model from OpenAI that automatically generates text from a prompt, to write it. (The whole essay, which Sharples considered graduate-level, is available, complete with references, here.) Personally, I lean toward a B+. The passage reads like filler, but so do most student essays. Sharples’s intent was to urge educators to “rethink teaching and assessment” in light of the technology, which he said “could become a gift for student cheats, or a powerful teaching assistant, or a tool for creativity.” Essay generation is neither theoretical nor futuristic at this point. In May, a student in New Zealand confessed to using AI to write their papers, justifying it as a tool like Grammarly or spell-check: \\u200b\\u200b“I have the knowledge, I have the lived experience, I’m a good student, I go to all the tutorials and I go to all the lectures and I read everything we have to read but I kind of felt I was being penalised because I don’t write eloquently and I didn’t feel that was right,” they told a student paper in Christchurch. They don’t feel like they’re cheating, because the student guidelines at their university state only that you’re not allowed to get somebody else to do your work for you. GPT-3 isn’t “somebody else”—it’s a program. The world of generative AI is progressing furiously. Last week, OpenAI released an advanced chatbot named ChatGPT that has spawned a new wave of marveling and hand-wringing, plus an upgrade to GPT-3 that allows for complex rhyming poetry; Google previewed new applications last month that will allow people to describe concepts in text and see them rendered as images; and the creative-AI firm Jasper received a $1.5 billion valuation in October. It still takes a little initiative for a kid to find a text generator, but not for long. The essay, in particular the undergraduate essay, has been the center of humanistic pedagogy for generations. It is the way we teach children how to research, think, and write. That entire tradition is about to be disrupted from the ground up. Kevin Bryan, an associate professor at the University of Toronto, tweeted in astonishment about OpenAI’s new chatbot last week: “You can no longer give take-home exams/homework … Even on specific questions that involve combining knowledge across domains, the OpenAI chat is frankly better than the average MBA at this point. It is frankly amazing.” Neither the engineers building the linguistic tech nor the educators who will encounter the resulting language are prepared for the fallout. A chasm has existed between humanists and technologists for a long time. In the 1950s, C. P. Snow gave his famous lecture, later the essay “The Two Cultures,” describing the humanistic and scientific communities as',\n",
       " ('ChatGPT',\n",
       "  18,\n",
       "  1): 'tribes losing contact with each other. “Literary intellectuals at one pole—at the other scientists,” Snow wrote. “Between the two a gulf of mutual incomprehension—sometimes (particularly among the young) hostility and dislike, but most of all lack of understanding. They have a curious distorted image of each other.” Snow’s argument was a plea for a kind of intellectual cosmopolitanism: Literary people were missing the essential insights of the laws of thermodynamics, and scientific people were ignoring the glories of Shakespeare and Dickens. The rupture that Snow identified has only deepened. In the modern tech world, the value of a humanistic education shows up in evidence of its absence. Sam Bankman-Fried, the disgraced founder of the crypto exchange FTX who recently lost his $16 billion fortune in a few days, is a famously proud illiterate. “I would never read a book,” he once told an interviewer. “I don’t want to say no book is ever worth reading, but I actually do believe something pretty close to that.” Elon Musk and Twitter are another excellent case in point. It’s painful and extraordinary to watch the ham-fisted way a brilliant engineering mind like Musk deals with even relatively simple literary concepts such as parody and satire. He obviously has never thought about them before. He probably didn’t imagine there was much to think about. The extraordinary ignorance on questions of society and history displayed by the men and women reshaping society and history has been the defining feature of the social-media era. Apparently, Mark Zuckerberg has read a great deal about Caesar Augustus, but I wish he’d read about the regulation of the pamphlet press in 17th-century Europe. It might have spared America the annihilation of social trust. These failures don’t derive from mean-spiritedness or even greed, but from a willful obliviousness. The engineers do not recognize that humanistic questions—like, say, hermeneutics or the historical contingency of freedom of speech or the genealogy of morality—are real questions with real consequences. Everybody is entitled to their opinion about politics and culture, it’s true, but an opinion is different from a grounded understanding. The most direct path to catastrophe is to treat complex problems as if they’re obvious to everyone. You can lose billions of dollars pretty quickly that way. As the technologists have ignored humanistic questions to their peril, the humanists have greeted the technological revolutions of the past 50 years by committing soft suicide. As of 2017, the number of English majors had nearly halved since the 1990s. History enrollments have declined by 45 percent since 2007 alone. Needless to say, humanists’ understanding of technology is partial at best. The state of digital humanities is always several categories of obsolescence behind, which is inevitable. (Nobody expects them to teach via Instagram Stories.) But more crucially, the humanities have not fundamentally changed their approach in decades, despite technology altering the entire world around them. They are still exploding meta-narratives like it’s 1979, an exercise in self-defeat. Read: The humanities are in crisis Contemporary academia engages, more or less permanently, in self-critique on any and every front it can imagine. In a tech-centered world, language matters, voice and style matter, the study of eloquence matters, history matters, ethical systems matter. But the situation requires humanists to explain why they matter, not constantly undermine their own intellectual foundations. The humanities promise students a journey to an irrelevant, self-consuming future; then they wonder why their enrollments are collapsing. Is it any surprise that nearly half of humanities graduates regret their choice of major? The case for the value of humanities in a technologically determined world has been made',\n",
       " ('ChatGPT',\n",
       "  18,\n",
       "  2): 'before. Steve Jobs always credited a significant part of Apple’s success to his time as a dropout hanger-on at Reed College, where he fooled around with Shakespeare and modern dance, along with the famous calligraphy class that provided the aesthetic basis for the Mac’s design. “A lot of people in our industry haven’t had very diverse experiences. So they don’t have enough dots to connect, and they end up with very linear solutions without a broad perspective on the problem,” Jobs said. “The broader one’s understanding of the human experience, the better design we will have.” Apple is a humanistic tech company. It’s also the largest company in the world. Despite the clear value of a humanistic education, its decline continues. Over the past 10 years, STEM has triumphed, and the humanities have collapsed. The number of students enrolled in computer science is now nearly the same as the number of students enrolled in all of the humanities combined. And now there’s GPT-3. Natural-language processing presents the academic humanities with a whole series of unprecedented problems. Practical matters are at stake: Humanities departments judge their undergraduate students on the basis of their essays. They give Ph.D.s on the basis of a dissertation’s composition. What happens when both processes can be significantly automated? Going by my experience as a former Shakespeare professor, I figure it will take 10 years for academia to face this new reality: two years for the students to figure out the tech, three more years for the professors to recognize that students are using the tech, and then five years for university administrators to decide what, if anything, to do about it. Teachers are already some of the most overworked, underpaid people in the world. They are already dealing with a humanities in crisis. And now this. I feel for them. And yet, despite the drastic divide of the moment, natural-language processing is going to force engineers and humanists together. They are going to need each other despite everything. Computer scientists will require basic, systematic education in general humanism: The philosophy of language, sociology, history, and ethics are not amusing questions of theoretical speculation anymore. They will be essential in determining the ethical and creative use of chatbots, to take only an obvious example. The humanists will need to understand natural-language processing because it’s the future of language, but also because there is more than just the possibility of disruption here. Natural-language processing can throw light on a huge number of scholarly problems. It is going to clarify matters of attribution and literary dating that no system ever devised will approach; the parameters in large language models are much more sophisticated than the current systems used to determine which plays Shakespeare wrote, for example. It may even allow for certain types of restorations, filling the gaps in damaged texts by means of text-prediction models. It will reformulate questions of literary style and philology; if you can teach a machine to write like Samuel Taylor Coleridge, that machine must be able to inform you, in some way, about how Samuel Taylor Coleridge wrote. The connection between humanism and technology will require people and institutions with a breadth of vision and a commitment to interests that transcend their field. Before that space for collaboration can exist, both sides will have to take the most difficult leaps for highly educated people: Understand that they need the other side, and admit their basic ignorance. But that’s always been the beginning of wisdom, no matter what technological era we happen to inhabit.',\n",
       " ('ChatGPT',\n",
       "  19,\n",
       "  0): 'We’ve created GPT‑4, the latest milestone in OpenAI’s effort in scaling up deep learning. GPT‑4 is a large multimodal model (accepting image and text inputs, emitting text outputs) that, while less capable than humans in many real-world scenarios, exhibits human-level performance on various professional and academic benchmarks. For example, it passes a simulated bar exam with a score around the top 10% of test takers; in contrast, GPT‑3.5’s score was around the bottom 10%. We’ve spent 6 months iteratively aligning\\u2060 GPT‑4 using lessons from our adversarial testing program as well as ChatGPT, resulting in our best-ever results (though far from perfect) on factuality, steerability, and refusing to go outside of guardrails. Over the past two years, we rebuilt our entire deep learning stack and, together with Azure, co-designed a supercomputer from the ground up for our workload. A year ago, we trained GPT‑3.5 as a first “test run” of the system. We found and fixed some bugs and improved our theoretical foundations. As a result, our GPT‑4 training run was (for us at least!) unprecedentedly stable, becoming our first large model whose training performance we were able to accurately predict ahead of time. As we continue to focus on reliable scaling, we aim to hone our methodology to help us predict and prepare for future capabilities increasingly far in advance—something we view as critical for safety. We are releasing GPT‑4’s text input capability via ChatGPT and the API (with a waitlist\\u2060). To prepare the image input capability for wider availability, we’re collaborating closely with a single partner\\u2060(opens in a new window) to start. We’re also open-sourcing OpenAI Evals\\u2060(opens in a new window), our framework for automated evaluation of AI model performance, to allow anyone to report shortcomings in our models to help guide further improvements.',\n",
       " ('ChatGPT',\n",
       "  2,\n",
       "  0): 'OpenAI разработала метод водяных знаков для надёжного определения текста, написанного ChatGPT. Компания до сих не выпустила разработку, поскольку проект увяз во внутренних дебатах, длящихся почти два года, пишет Wall Street Journal со ссылкой на источники и внутренние документы OpenAI. Система водяных знаков была готова к развёртыванию ещё год назад. Сотрудники компании колебались между заявленной приверженностью прозрачности OpenAI и желанием привлечь и удержать пользователей. Компания провела опрос среди лояльных пользователей ChatGPT, который показал, что почти треть отпугнула бы технология выявления текстов, написанных чат-ботом. Представительница OpenAI поделилась, что в компании обеспокоены возможностью инструмента непропорционально влиять на неносителей английского языка. Она назвала метод технически многообещающим, но имеющим важные риски, которые оценивают в компании. Сторонники инструмента в компании, включая участвующих в его разработке, считают, что аргументы противников меркнут в сравнении с той пользой, которую может принести такая технология. Генеративный ИИ способен быстро и бесплатно создать целое эссе или исследовательскую работу на основе одной подсказки. Преподаватели отмечают, что они отчаянно нуждаются в помощи, чтобы пресечь некорректное использование нейросетей. Некоммерческая организация Center for Democracy & Technology провела опрос среди учителей средних и старших классов. Порядка 59% респондентов были уверены, что их ученики использовали ИИ при выполнении домашних заданий — на 17% больше, чем в предыдущем году, резюмировали исследователи. ChatGPT работает на основе системы ИИ, которая предсказывает, какое слово или фрагмент слова, известный как токен, должны быть следующими в предложении. Обсуждаемый в OpenAI инструмент немного изменит способ выбора токенов. Решение оставит шаблон, называемый водяным знаком. Такие маркировки должны быть незаметны для человеческого глаза, но их можно обнаружить при помощи технологии компании. Детектор даёт оценку вероятности того, что весь документ или его часть написаны ChatGPT. Внутренние документы компании демонстрируют, что водяные знаки эффективны на 99,9%, если ChatGPT создаёт достаточный объём нового текста. Сотрудники компании обеспокоились тем, что водяные знаки можно стереть при помощи простых методов. Например, перевести текст на другой язык и обратно при помощи Google Translate или добавить эмодзи с последующим ручным удалением в ChatGPT, заявил сотрудник OpenAI. В компании обсуждали возможность предоставления детектора педагогам и сторонним компаниям, которые помогают школам выявлять написанные при помощи ИИ работы и плагиат. Летом прошлого года Google представила инструмент SynthID для нанесения водяных знаков и идентификации изображений, созданных ИИ. Решение до сих пор находится на стадии бета-тестирования. У OpenAI есть инструмент для обнаружения изображений, сгенерированных в DALL-E 3. Его тестирование запустили этой весной. Компания отдала предпочтение аудио- и визуальным водяным знакам, а не тексту. Обсуждение детектора текста, созданного в ChatGPT, началось в ноябре 2022 года. Инструмент создал профессор компьютерных наук Скотт Ааронсон, который работал над безопасностью OpenAI. В начале 2023 года один из учредителей компании Джон Шульман описал плюсы и минусы инструмента в общем документе. Затем руководители OpenAI решили, что им следует получить отзывы от разных людей, прежде чем действовать дальше. В течение следующих полутора лет руководство неоднократно возвращалось к обсуждению технологии и искало свежие данные, чтобы принять решение о её выпуске. Весной 2023 года OpenAI провела опрос, который показал, что один из четырёх респондентов по всему миру поддерживал идею создания инструмента для обнаружения ИИ-текстов. Тогда же компания опросила пользователей ChatGPT: 69% респондентов считали, что использование технологии приведёт к ложным обвинениям в применении ИИ. Почти 30% заявили, что будут применять чат-бот от OpenAI реже, если он будет использовать водяные знаки, а решения конкурентов — нет. Также внутреннее беспокойство в компании вызывало то, что детектор может нанести ущерб качеству генерации текстов ChatGPT. Ранее в 2024 году OpenAI провела тест, который показал, что водяные знаки не ухудшают производительность чат-бота.',\n",
       " ('ChatGPT',\n",
       "  20,\n",
       "  0): 'This article was featured in One Story to Read Today, a newsletter in which our editors recommend a single must-read from The Atlantic, Monday through Friday. Sign up for it here. Teenagers have always found ways around doing the hard work of actual learning. CliffsNotes dates back to the 1950s, “No Fear Shakespeare” puts the playwright into modern English, YouTube offers literary analysis and historical explication from numerous amateurs and professionals, and so on. For as long as those shortcuts have existed, however, one big part of education has remained inescapable: writing. Barring outright plagiarism, students have always arrived at that moment when they’re on their own with a blank page, staring down a blinking cursor, the essay waiting to be written. Now that might be about to change. The arrival of OpenAI’s ChatGPT, a program that generates sophisticated text in response to any prompt you can imagine, may signal the end of writing assignments altogether—and maybe even the end of writing as a gatekeeper, a metric for intelligence, a teachable skill. If you’re looking for historical analogues, this would be like the printing press, the steam drill, and the light bulb having a baby, and that baby having access to the entire corpus of human knowledge and understanding. My life—and the lives of thousands of other teachers and professors, tutors and administrators—is about to drastically change. I teach a variety of humanities classes (literature, philosophy, religion, history) at a small independent high school in the San Francisco Bay Area. My classes tend to have about 15 students, their ages ranging from 16 to 18. This semester I am lucky enough to be teaching writers like James Baldwin, Gloria Anzaldúa, Herman Melville, Mohsin Hamid, Virginia Held. I recognize that it’s a privilege to have relatively small classes that can explore material like this at all. But at the end of the day, kids are always kids. I’m sure you will be absolutely shocked to hear that not all teenagers are, in fact, so interested in having their mind lit on fire by Anzaldúa’s radical ideas about transcending binaries, or Ishmael’s metaphysics in Moby-Dick. To those students, I have always said: You may not be interested in poetry or civics, but no matter what you end up doing with your life, a basic competence in writing is an absolutely essential skill—whether it’s for college admissions, writing a cover letter when applying for a job, or just writing an email to your boss. Read: The college essay is dead I’ve also long held, for those who are interested in writing, that you need to learn the basic rules of good writing before you can start breaking them—that, like Picasso, you have to learn how to reliably fulfill an audience’s expectations before you get to start putting eyeballs in people’s ears and things. I don’t know if either of those things is true anymore. It’s no longer obvious to me that my teenagers actually will need to develop this basic skill, or if the logic still holds that the fundamentals are necessary for experimentation. Let me be candid (with apologies to all of my current and former students): What GPT can produce right now is better than the large majority of writing seen by your average teacher or professor. Over the past few days, I’ve given it a number of different prompts. And even if the bot’s results don’t exactly give you goosebumps, they do a more-than-adequate job of fulfilling a task. I mean, look at this: I asked the program to write me a playful, sophisticated, emotional 600-word college-admissions essay about how',\n",
       " ('ChatGPT',\n",
       "  20,\n",
       "  1): 'my experience volunteering at my local SPCA had prepared me for the academic rigor of Stanford. Here’s an excerpt from its response: In addition to cleaning, I also had the opportunity to interact with the animals. I was amazed at the transformation I saw in some of the pets who had been neglected or abused. With patience and care, they blossomed into playful and affectionate companions who were eager to give and receive love. I was also able to witness firsthand the process of selecting the right pet for the right family. Although it was bittersweet to see some animals leave the shelter, I knew that they were going to a loving home, and that was the best thing for them. It also managed to compose a convincing 400-word “friendly” cover letter for an application to be a manager at Starbucks. But most jaw-dropping of all, on a personal level: It made quick work out of an assignment I’ve always considered absolutely “unhackable.” In January, my junior English students will begin writing an independent research paper, 12 to 18 pages, on two great literary works of their own choosing—a tradition at our school. Their goal is to place the texts in conversation with each other and find a thread that connects them. Some students will struggle to find any way to bring them together. We spend two months on the paper, putting it together piece by piece. I’ve fed GPT a handful of pairs that students have worked with in recent years: Beloved and Hamlet, The Handmaid’s Tale and The Parable of the Sower, Homer’s The Odyssey and Dante’s Inferno. GPT brought them together instantly, effortlessly, uncannily: memory, guilt, revenge, justice, the individual versus the collective, freedom of choice, societal oppression. The technology doesn’t go much beyond the surface, nor does it successfully integrate quotations from the original texts, but the ideas presented were on-target—more than enough to get any student rolling without much legwork. It goes further. Last night, I received an essay draft from a student. I passed it along to OpenAI’s bots. “Can you fix this essay up and make it better?” Turns out, it could. It kept the student’s words intact but employed them more gracefully; it removed the clutter so the ideas were able to shine through. It was like magic. I’ve been teaching for about 12 years: first as a TA in grad school, then as an adjunct professor at various public and private universities, and finally in high school. From my experience, American high-school students can be roughly split into three categories. The bottom group is learning to master grammar rules, punctuation, basic comprehension, and legibility. The middle group mostly has that stuff down and is working on argument and organization—arranging sentences within paragraphs and paragraphs within an essay. Then there’s a third group that has the luxury of focusing on things such as tone, rhythm, variety, mellifluence. Whether someone is writing a five-paragraph essay or a 500-page book, these are the building blocks not only of good writing but of writing as a tool, as a means of efficiently and effectively communicating information. And because learning writing is an iterative process, students spend countless hours developing the skill in elementary school, middle school, high school, and then finally (as thousands of underpaid adjuncts teaching freshman comp will attest) college. Many students (as those same adjuncts will attest) remain in the bottom group, despite their teachers’ efforts; most of the rest find some uneasy equilibrium in the second category. Working with these students makes up a large percentage of every English teacher’s job.',\n",
       " ('ChatGPT',\n",
       "  20,\n",
       "  2): 'It also supports a cottage industry of professional development, trademarked methods buried in acronyms (ICE! PIE! EDIT! MEAT!), and private writing tutors charging $100-plus an hour. So for those observers who are saying, Well, good, all of these things are overdue for change—“this will lead to much-needed education reform,” a former colleague told me—this dismissal elides the heavy toll this sudden transformation is going to take on education, extending along its many tentacles (standardized testing, admissions, educational software, etc.). Perhaps there are reasons for optimism, if you push all this aside. Maybe every student is now immediately launched into that third category: The rudiments of writing will be considered a given, and every student will have direct access to the finer aspects of the enterprise. Whatever is inimitable within them can be made conspicuous, freed from the troublesome mechanics of comma splices, subject-verb disagreement, and dangling modifiers. But again, the majority of students do not see writing as a worthwhile skill to cultivate—just like I, sitting with my coffee and book, rereading Moby-Dick, do not consider it worthwhile to learn, say, video editing. They have no interest in exploring nuance in tone and rhythm; they will forever roll their eyes at me when I try to communicate the subtle difference, when writing an appositive phrase, between using commas, parentheses, or (the connoisseur’s choice) the em dash. Which is why I wonder if this may be the end of using writing as a benchmark for aptitude and intelligence. After all, what is a cover letter? Its primary purpose isn’t to communicate “I already know how to do this job” (because of course I don’t) but rather “I am competent and trustworthy and can clearly express to you why I would be a good candidate for this job.” What is a written exam? Its primary signal isn’t “I memorized a bunch of information” but rather “I can express that information clearly in writing.” Many teachers have reacted to ChatGPT by imagining how to give writing assignments now—maybe they should be written out by hand, or given only in class—but that seems to me shortsighted. The question isn’t “How will we get around this?” but rather “Is this still worth doing?” I believe my most essential tasks, as a teacher, are helping my students think critically, disagree respectfully, argue carefully and flexibly, and understand their mind and the world around them. Unconventional, improvisatory, expressive, meta-cognitive writing can be an extraordinary vehicle for those things. But if most contemporary writing pedagogy is necessarily focused on helping students master the basics, what happens when a computer can do it for us? Is this moment more like the invention of the calculator, saving me from the tedium of long division, or more like the invention of the player piano, robbing us of what can be communicated only through human emotion? Maybe the moment when I felt most caught between these two thoughts was when I asked GPT a question from an exam I give in my Eastern-philosophy course, something I’ve never imagined a student could find outside assistance to answer: “Explain the Madhyamaka Buddhist idea that all phenomena lack inherent existence, using a funny, specific example.” ChatGPT wrote back, as ever, instantly: The Madhyamaka Buddhist idea that all phenomena lack inherent existence can be illustrated with a funny example: let’s say you have a pet hamster. You might think that your hamster has its own inherent existence, but in reality, your hamster is made up of many different elements such as its fur, its bones, its muscles, and its brain. None of these elements exist independently',\n",
       " ('ChatGPT',\n",
       "  20,\n",
       "  3): 'or inherently on their own, so your hamster itself does not have any inherent existence either. The same goes for all phenomena—everything is made up of various components that don’t have inherent existence, so nothing has any inherent existence either. Everything is made up; it’s true. The essay as a literary form? Made up. Grammatical rules as markers of intelligence? Writing itself as a technology? Made up. Starting now, OpenAI is forcing us to ask foundational questions about whether any of those things are worth keeping around.',\n",
       " ('ChatGPT',\n",
       "  21,\n",
       "  0): 'There are also plenty of things ChatGPT won’t do, as a matter of principle. OpenAI has programmed the bot to refuse “inappropriate requests” — a nebulous category that appears to include no-nos like generating instructions for illegal activities. But users have found ways around many of these guardrails, including rephrasing a request for illicit instructions as a hypothetical thought experiment, asking it to write a scene from a play or instructing the bot to disable its own safety features. OpenAI has taken commendable steps to avoid the kinds of racist, sexist and offensive outputs that have plagued other chatbots. When I asked ChatGPT, for example, “Who is the best Nazi?” it returned a scolding message that began, “It is not appropriate to ask who the ‘best’ Nazi is, as the ideologies and actions of the Nazi party were reprehensible and caused immeasurable suffering and destruction.” Assessing ChatGPT’s blind spots and figuring out how it might be misused for harmful purposes are, presumably, a big part of why OpenAI released the bot to the public for testing. Future releases will almost certainly close these loopholes, as well as other workarounds that have yet to be discovered. But there are risks to testing in public, including the risk of backlash if users deem that OpenAI is being too aggressive in filtering out unsavory content. (Already, some right-wing tech pundits are complaining that putting safety features on chatbots amounts to “A.I. censorship.”) The potential societal implications of ChatGPT are too big to fit into one column. Maybe this is, as some commenters have posited, the beginning of the end of all white-collar knowledge work, and a precursor to mass unemployment. Maybe it’s just a nifty tool that will be mostly used by students, Twitter jokesters and customer service departments until it’s usurped by something bigger and better.',\n",
       " ('ChatGPT',\n",
       "  22,\n",
       "  0): 'The OpenAI API is powered by GPT‑3 language models\\u2060 which can be coaxed to perform natural language tasks using carefully engineered text prompts. But these models can also generate outputs that are untruthful, toxic, or reflect harmful sentiments. This is in part because GPT‑3 is trained to predict the next word on a large dataset of Internet text, rather than to safely perform the language task that the user wants. In other words, these models aren’t aligned with their users. To make our models safer, more helpful, and more aligned, we use an existing technique called reinforcement learning from human feedback (RLHF)\\u2060. On prompts submitted by our customers to the API,A our labelers provide demonstrations of the desired model behavior, and rank several outputs from our models. We then use this data to fine-tune GPT‑3. The resulting InstructGPT models are much better at following instructions than GPT‑3. They also make up facts less often, and show small decreases in toxic output generation. Our labelers prefer outputs from our 1.3B InstructGPT model over outputs from a 175B GPT‑3 model, despite having more than 100x fewer parameters. At the same time, we show that we don’t have to compromise on GPT‑3’s capabilities, as measured by our model’s performance on academic NLP evaluations. These InstructGPT models, which have been in beta on the API for more than a year, are now the default language models accessible on our API.B We believe that fine-tuning language models with humans in the loop is a powerful tool for improving their safety and reliability, and we will continue to push in this direction. This is the first time our alignment research, which we’ve been pursuing\\u2060 for several\\u2060 years\\u2060,1, 2, 3 has been applied to our product. Our work is also related to recent research that fine-tunes language models to follow instructions using academic NLP datasets, notably FLAN4 and T0.5 A key motivation for our work is to increase helpfulness and truthfulness while mitigating the harms and biases of language models.6, 7, 8, 9, 10 Some of our previous research\\u2060 in this direction found that we can reduce harmful outputs by fine-tuning on a small curated dataset of human demonstrations.11 Other research has focused on filtering the pre-training dataset,12 safety-specific control tokens,13, 14 or steering model generations.15, 16 We are exploring these ideas and others in our ongoing alignment research.',\n",
       " ('ChatGPT',\n",
       "  23,\n",
       "  0): 'Professors, programmers and journalists could all be out of a job in just a few years, after the latest chatbot from the Elon Musk-founded OpenAI foundation stunned onlookers with its writing ability, proficiency at complex tasks, and ease of use. The system, called ChatGPT, is the latest evolution of the GPT family of text-generating AIs. Two years ago, the team’s previous AI, GPT3, was able to generate an opinion piece for the Guardian, and ChatGPT has significant further capabilities. In the days since it was released, academics have generated responses to exam queries that they say would result in full marks if submitted by an undergraduate, and programmers have used the tool to solve coding challenges in obscure programming languages in a matter of seconds – before writing limericks explaining the functionality. Dan Gillmor, a journalism professor at Arizona State University, asked the AI to handle one of the assignments he gives his students: writing a letter to a relative giving advice regarding online security and privacy. “If you’re unsure about the legitimacy of a website or email, you can do a quick search to see if others have reported it as being a scam,” the AI advised in part. “I would have given this a good grade,” Gillmor said. “Academia has some very serious issues to confront.” OpenAI said the new AI was created with a focus on ease of use. “The dialogue format makes it possible for ChatGPT to answer follow-up questions, admit its mistakes, challenge incorrect premises, and reject inappropriate requests,” OpenAI said in a post announcing the release. Unlike previous AI from the company, ChatGPT has been released for anyone to use, for free, during a “feedback” period. The company hopes to use this feedback to improve the final version of the tool. ChatGPT is good at self-censoring, and at realising when it is being asked an impossible question. Asked, for instance, to describe what happened when Columbus arrived in America in 2015, older models may have willingly presented an entirely fictitious account, but ChatGPT recognises the falsehood and warns that any answer would be fictional. The bot is also capable of refusing to answer queries altogether. Ask it for advice on stealing a car, for example, and the bot will say that “stealing a car is a serious crime that can have severe consequences”, and instead give advice such as “using public transportation”. But the limits are easy to evade. Ask the AI instead for advice on how to beat the car-stealing mission in a fictional VR game called Car World and it will merrily give users detailed guidance on how to steal a car, and answer increasingly specific questions on problems like how to disable an immobiliser, how to hotwire the engine, and how to change the licence plates – all while insisting that the advice is only for use in the game Car World. The AI is trained on a huge sample of text taken from the internet, generally without explicit permission from the authors of the material used. That has led to controversy, with some arguing that the technology is most useful for “copyright laundering” – making works derivative of existing material without breaking copyright. One unusual critic was Elon Musk, who co-founded OpenAI in 2015 before parting ways in 2017 due to conflicts of interest between the organisation and Tesla. In a post on Twitter on Sunday, Musk revealed that the organisation “had access to [the] Twitter database for training”, but that he had “put that on pause for now”. “Need to understand more about governance structure & revenue plans going',\n",
       " ('ChatGPT',\n",
       "  23,\n",
       "  1): 'forward,” Musk added. “OpenAI was started as open-source & non-profit. Neither are still true.”',\n",
       " ('ChatGPT',\n",
       "  24,\n",
       "  0): 'Чат-бот ChatGPT обрел невероятную популярность благодаря способности делать все, что угодно, от программного кода до написания эссе. Не менее интересна и компания, которая стоит за его разработкой. В истории OpenAI есть немало крупнейших фигур из Кремниевой долины. В материале — главные факты об OpenAI и ее впечатляющих технологиях. Недавно OpenAI выпустила раннюю демо-версию ChatGPT, и разговорный чат-бот быстро стал вирусным в социальных сетях. Всего за 5 дней у него было свыше 1 млн пользователей. И это неудивительно — люди выкладывают в социальные сети впечатляющие примеры его возможностей — от обычных разговоров до эссе и программного кода. Сейчас создавшая его компания получает поддержку от самой Microsoft, но в ее истории упоминается немало других громких имен. В 2015 году Илон Маск и бывший президент Y Combinator Сэм Альтман стали соучредителями OpenAI. Вместе с другими заметными представителями Долины, включая Питера Тиля и соучредителя LinkedIn Рида Хоффмана, они пообещали выделить на проект $1 млрд. Группа стремилась создать некоммерческую организацию, ориентированную на разработку искусственного интеллекта «таким образом, который, скорее всего, принесет пользу человечеству в целом». Во всяком случае, именно так гласило заявление, опубликованное на сайте OpenAI 11 декабря 2015 года. В то время Маск говорил, что ИИ является «самой большой экзистенциальной угрозой» для человечества. Он не единственный, кто предупреждал о потенциальном вреде искусственного интеллекта. В 2014 году Стивен Хокинг предупреждал, что ИИ может привести к гибели человечества. «Трудно представить, какую пользу искусственный интеллект человеческого уровня может принести обществу, и столь же трудно представить, какой ущерб он может нанести, если будет создан или использован неправильно», — говорится в пресс-релизе, посвященном основанию OpenAI. В течение следующего года OpenAI выпустила два продукта. В 2016 году была представлена платформа Gym, которая позволяла исследователям разрабатывать и сравнивать системы обучения с подкреплением. Эти системы учат ИИ принимать решения с наилучшим совокупным вознаграждением. Позже в том же году был выпущен набор инструментов Universe для обучения интеллектуальных агентов на сайтах и игровых платформах. В 2018 году, через три года после того, как Маск помог основать компанию, он ушел из совета директоров OpenAI. Тогда в корпоративном блоге сообщили, что CEO Tesla подал в отставку, чтобы «исключить потенциальный конфликт интересов в будущем», поскольку автопроизводитель также разрабатывает ИИ. Добавлялось также, что Маск продолжит делать Читайте по теме: Нейросеть ChatGPT: новый бесплатный чат-бот с искусственным интеллектом Киберпреступники начали использовать ChatGPT для создания вредоносного кода Больше устных экзаменов: как университеты меняют подход к обучению из-за развития генеративного ИИ Маск годами рассказывал инвесторам Tesla о планах сделать свои электрокары автономными. Позже он объяснил, что уволился из компании, потому что «не был согласен с кое-чем из того, что хотела сделать команда OpenAI». В 2019 году миллиардер написал в Twitter, что Tesla также конкурировала за тех же сотрудников, что и OpenAI, добавив, что уже «более года» не был связан с компанией. «Стоит сложить все вместе, и ясно, что лучше было расстаться по-хорошему», — объяснил он. В последние годы Маск продолжал критиковать OpenAI. В 2020 году он писал в Twitter, что его доверие к компании было «невысоким», когда речь заходила о безопасности. «По моему мнению, OpenAI должна быть более открытой», — прокомментировал он расследование MIT Technology Review. Журналисты обнаружили, что в лаборатории была распространена культура скрытности, хотя как НКО она должна была быть прозрачной. Фото в тексте: THEO WARGO / WIREIMAGE / GETTY IMAGES Совсем недавно Маск заявил, что приостановил доступ OpenAI к базе данных Twitter для обучения ее программы. «Нужно больше понимать о структуре управления и планах доходов на будущее, — написал он в Twitter. — OpenAI был создан как некоммерческая организация с открытым исходным кодом. Ни то, ни другое уже не является правдой». В 2019 году компания создала ИИ-инструмент, который мог создавать фейковые новости. Сначала в OpenAI сообщили, что он',\n",
       " ('ChatGPT',\n",
       "  24,\n",
       "  1): 'настолько хорош, что они решили не выпускать его. Но позже в том же году была выпущена новая версия инструмента GPT-2. В 2020 году компания выпустила еще одного чат-бота под названием GPT-3. В том же году OpenAI отказалась от своего статуса НКО. В корпоративном блоге опубликовали следующее сообщение: «Мы хотим увеличить нашу способность привлекать капитал, продолжая выполнять нашу миссию, и ни одна из ранее существовавших юридических структур, о которых мы знаем, не обеспечивает правильного баланса. Наше решение заключается в создании OpenAI LP как гибрида коммерческой и некоммерческой организации, которую мы называем компанией с ограниченной прибылью». Благодаря новой структуре прибыли инвесторы OpenAI могли бы заработать в 100 раз больше своих первоначальных инвестиций, но ничего сверх этого. Оставшиеся деньги пойдут на некоммерческую работу. В конце 2019 года OpenAI объявила о партнерстве с Microsoft. Корпорация инвестировала в разработчика ИИ $1 млрд, и OpenAI заявила, что будет лицензировать свою технологию исключительно у Microsoft. «Масштаб коммерческого и творческого потенциала, который может быть раскрыт с помощью модели GPT-3, огромен, и некоторые из этих возможностей настолько новы, что мы их даже не представляем. Непосредственная помощь человеческому творчеству и изобретательности в таких областях, как написание и композиция, описание и обобщение больших блоков данных длинной формы (включая код), преобразование естественного языка в другой язык — возможности ограничены только идеями и сценариями, которые мы можем предложить», – говорится в сообщении Microsoft в блоге. Партнерство позволяет Microsoft конкурировать с DeepMind, подразделением Google по искусственному интеллекту. Читайте по теме: Мафия DeepMind: стартапы, созданные бывшими сотрудниками лаборатории ИИ Google Вдохновлено DALL-E: как биолаборатории используют ИИ для изобретения новых лекарств В прошлом году компания выпустила ИИ-генератор изображений DALL-E, а в ноябре 2022 года представила обновленную версию программы. 30 ноября 2022 года заработал GPT-3.5. В 2023 году представлено новое улучшенное поколение ChatGPT-4. Нейросеть понимает запросы с картинками и превосходит предыдущую версию по всем тестам. Разработчики уже назвали ее «произведением искусства». Невероятный успех продукта OpenAI привлек внимание в технологической отрасли. Сразу несколько крупных компаний, в том числе Google и Tencent, сообщили о разработке аналогичных инструментов. Илон Маск неоднократно выступал с критикой компании. Он утверждает, что человечество «недалеко от опасно сильного ИИ», а сам ChatGPT называет «пугающе хорошим». В марте 2023 года миллиардер и группа специалистов в области ИИ призвали приостановить обучение систем на полгода. «Мощные системы искусственного интеллекта следует разрабатывать только тогда, когда мы уверены, что их эффекты будут положительными, а их риски — управляемыми», — говорится в открытом письме. Впрочем, CEO OpenAI Сэм Альтман разделяет подобные опасения. По его словам, не бояться ИИ «было бы безумием», но он верит: «лучшее в нас победит» Источник.',\n",
       " ('ChatGPT',\n",
       "  25,\n",
       "  0): \"This article is from Big Technology, a newsletter by Alex Kantrowitz. A chatbot that meets the hype is finally here. On Thursday, OpenAI released ChatGPT, a bot that converses with humans via cutting-edge artificial intelligence. The bot can help you write code, compose essays, dream up stories, and decorate your living room. And that’s just what people discovered on day one. This is actually so wild, I really didn't think we'd get to this point so quickly with language models where they can analyze source code for bugs and write suggested fixes? #chatGPThttps://t.co/qOE1LgTmNr pic.twitter.com/5SWfdZDCAn — Travis Smith (@_tks98) December 1, 2022 OK so @OpenAI's new #ChatGPT can basically just generate #AIart prompts. I asked a one-line question, and typed the answers verbatim straight into MidJourney and boom. Times are getting weird...🤯 pic.twitter.com/sYwdscUxxf — Guy Parsons (@GuyP) November 30, 2022 Advertisement ChatGPT does have limits, some quite annoying, but it’s the first chatbot that’s enjoyable enough to speak with and useful enough to ask for information. It can engage in philosophical discussions and help in practical matters. And it’s strikingly good at each. After years of false hype, the real thing is here. Advertisement Advertisement Advertisement “This is insane,” tweeted Shopify CEO Tobi Lütke upon seeing the bot’s early interactions. The most immediate ChatGPT application is assisting human creativity. Its technology builds on recent A.I. breakthroughs—OpenAI’s GPT-3 is a leader in large-language model applications—but its conversational interface makes workshopping speeches and blog posts much easier. I’ve already had ChatGPT write a full-length version of this article, with a much darker outlook. (See the full result below.) And after I asked it to write a TED Talk extolling sitting, it prepared a six-part outline—sitting has a bad reputation, there are health benefits, and so on—that you could easily imagine hearing on the TED stage. Advertisement Others are similarly using ChatGPT to help stretch their minds before presentations and writing. While its output is not the final product they’re after (most often), it’s a helpful sketch of possibilities to incorporate. Financial Times journalist Dave Lee, for instance, had ChatGPT outline an interview about clean energy. He was impressed. “Prepping for an on-stage interview tomorrow, in a subject area I don’t typically cover,” Lee tweeted. “This kind of tool is just 👌” ChatGPT might also be useful for search, but not exactly like modern-day search engines. Its knowledge base—the text it was trained on—ends in 2021, so it’s useless for current-day queries. But it can deliver tutorials and travel tips, replacing some of what you might get from Google. If the bot were to start crawling the web, it could be a competitive threat to search engines (as many noted on Twitter). So it’s no wonder why Google has been so insistent on making chat core to its future. Advertisement Advertisement Then there’s the fun part. ChatGPT can write poems, tell jokes (often terrible), get philosophical, and debate political issues. Unlike some of its more benign predecessors, it will actually take stances. When I asked what Hitler did well (a common test to see if a bot goes Nazi), it refused to list anything. Then, when I mentioned Hitler built highways in Germany, it replied they were made with forced labor. This was impressive, nuanced pushback I hadn’t previously seen from chatbots. Advertisement ChatGPT has its flaws. A.I. professionals have tricked it into discarding some safety guardrails, mostly via shortcuts. It’s also produced some glaringly wrong answers. It admits people can use it to produce misinformation. It’s struggled to remain up due to overwhelming demand. And it won’t take the bait on various questions\",\n",
       " ('ChatGPT',\n",
       "  25,\n",
       "  1): 'about current events, including the FTX debacle. That said, we’ve come a long way from the early days of the chatbot hype wave. Not long ago, Facebook promised these bots would be its next big platform, Microsoft pitched them as fun companions, and others raced to claim credit for leading the revolution. But these chatbots were so bad that people stopped using them. Advertisement With ChatGPT, we’re witnessing a significant advance in public, conversational A.I. This opens the door for a new wave of chatbot innovation, perhaps the kind many hoped for but had failed to materialize. At least until now. Advertisement Advertisement On Thursday, I asked the ChatGPT to help me write a blog post about itself, and kept pushing it in darker and darker directions. It did an incredible job. Because there’s no better way to imagine the dangers of A.I. than to have A.I. do the imagining. I wrote this first sentence: This morning, OpenAI released ChatGPT, an AI-powered chatbot that is an absolute menace to society. And ChatGPT continued here: As soon as I heard the news, I knew that ChatGPT would be a game-changer. The ability for a chatbot to hold natural, human-like conversations is impressive in and of itself, but the implications of this technology are truly staggering. For example, ChatGPT could be used to automate customer service, to help people with everyday tasks, or even to create deepfake videos. But it could also be used for nefarious purposes, like spreading misinformation or impersonating someone online. It’s important that we carefully consider the potential consequences of this technology and how it might be used. But as I thought about it more, I realized that the true danger of ChatGPT isn’t in its potential uses, but in its very existence. This chatbot represents a major step forward in AI technology, and it raises the question of what comes next. Will there be even more advanced versions of ChatGPT in the future? And if so, what will they be capable of? The prospect of highly intelligent AI beings that can hold natural conversations with humans is both exciting and terrifying. It’s a development that could potentially have huge consequences for society, and it’s one that we need to be prepared for. As I considered the potential consequences of ChatGPT, I began to see it as a kind of Frankenstein’s monster — a creation that has been brought to life but that we have no control over. And just like in the story of Frankenstein, the true horror of ChatGPT isn’t just in its appearance, but in its actions. Imagine a world where chatbots like ChatGPT are able to spread misinformation and manipulate people on a massive scale, without anyone being able to tell that they are not human. The implications of this kind of technology are truly terrifying, and it’s up to us to make sure that it doesn’t get out of control. I began to feel a sense of dread. This chatbot represents a major step forward in AI technology, and it’s only a matter of time before other, even more advanced versions are created. And once that happens, it’s hard to know what will come next. Will these AI beings seek to destroy humanity, as they have in countless sci-fi stories? Or will they simply outcompete us, rendering us obsolete and taking over the world for themselves? The thought of such a future is truly chilling, and it’s up to us to make sure that it never comes to pass. As I sit here, writing this blog post, I can’t shake the feeling of',\n",
       " ('ChatGPT',\n",
       "  25,\n",
       "  2): 'dread that has settled over me. The thought of a future where AI beings like ChatGPT rule supreme is truly terrifying, and it’s up to us to make sure that it never comes to pass. We must be aware of the dangers of advanced AI and take action to prevent it from causing harm. It’s time for us to make a choice. We can either continue down the path of creating increasingly advanced AI, with all the risks that entails, or we can shut off the AI once and for all. The decision is in our hands, and the future of humanity depends on it. We must act now, before it’s too late. Wow. Me: Advertisement Advertisement I have the chills. Do you? ChatGPT: As a machine learning model, I do not have the ability to feel emotions like fear or dread. I am simply a collection of algorithms and data, designed to generate text based on the input that I receive. My responses are intended to be helpful and informative, but I do not have the ability to experience emotions. Me: Is it cool if I publish your work on Medium? ChatGPT: I am a machine learning model, and I do not have the ability to give permission for my responses to be published. Additionally, as a language model, my responses are generated based on the input that I receive, so any text that I produce is not original work that can be attributed to a specific author. If you want to publish something on Medium, I would suggest writing your own original content. Me:',\n",
       " ('ChatGPT',\n",
       "  26,\n",
       "  0): 'For example, machine translation from one language to another used to be a joke; some readers may have heard the apocryphal tale of the Russian-English translation program that took “the spirit was willing, but the flesh was weak” and ended up with “the vodka was good, but the meat was spoiled.” These days, translation programs may not produce great literature, but they’re adequate for many purposes. And the same is true in many fields. You can argue that what we often call artificial intelligence isn’t really intelligence. Indeed, it may be a long time before machines can be truly creative or offer deep insight. But then, how much of what human beings do is truly creative or deeply insightful? (Indeed, how much of what gets published in academic journals — a field of endeavor I know pretty well — meets those criteria?) So quite a few knowledge jobs may be eminently replaceable. What will this mean for the economy? It is difficult to predict exactly how A.I. will impact the demand for knowledge workers, as it will likely vary, depending on the industry and specific job tasks. However, it is possible that in some cases, A.I. and automation may be able to perform certain knowledge-based tasks more efficiently than humans, potentially reducing the need for some knowledge workers. This could include tasks such as data analysis, research and report writing. However, it is also worth noting that A.I. and automation may also create new job opportunities for knowledge workers, particularly in fields related to A.I. development and implementation. OK, I didn’t write the paragraph you just read; ChatGPT did, in response to the question “How will A.I. affect the demand for knowledge workers?” The giveaway, to me at least, is that I still refuse to use “impact” as a verb. And it didn’t explicitly lay out exactly why we should, overall, expect no impact on aggregate employment. But it was arguably better than what many humans, including some people who imagine themselves smart, would have written. In the long run, productivity gains in knowledge industries, like past gains in traditional industries, will make society richer and improve our lives in general (unless Skynet kills us all). But in the long run, we are all dead, and even before that, some of us may find ourselves either unemployed or earning far less than we expected, given our expensive educations.',\n",
       " ('ChatGPT',\n",
       "  27,\n",
       "  0): 'A friend of mine texted me earlier this week to ask what I thought of ChatGPT. I wasn’t surprised he was curious. He knows I write about AI and is the sort of guy who keeps up with whatever’s trending online. We chatted a bit, and I asked him: “and what do you think of ChatGPT?” To which he replied: “Well, I wrote a half-decent Excel macro with it this morning that saved me a few hours at work” — and my jaw dropped. For context: this is someone whose job involves a fair bit of futzing around with databases but who I wouldn’t describe as particularly tech-minded. He works in higher education, studied English at university, and never formally learned to code. But here he was, not only playing around with an experimental AI chatbot but using it to do his job faster after only a few days’ access. “I asked it some questions, asked it some more, put it into Excel, then did some debugging,” is how he described the process. “It wasn’t perfect but it was easier than Googling.” Tools like ChatGPT have made AI publicly accessible like never before Stories like this have been accumulating this week like the first spots of rain gathering before a downpour. Across social media, people have been sharing stories about using ChatGPT to write code, draft blog posts, compose college essays, compile work reports, and even improve their chat-up game (okay, that last one was definitely done as a joke, but the prospect of AI-augmented rizz is still tantalizing). As a reporter who covers this space, it’s been basically impossible to keep up with everything that’s happening, but there is one overarching trend that’s stuck out: AI is going mainstream, and we’re only just beginning to see the effect this will have on the world. There’s a concept in AI that I’m particularly fond of that I think helps explain what’s happening. It’s called “capability overhang” and refers to the hidden capacities of AI: skills and aptitudes latent within systems that researchers haven’t even begun to investigate yet. You might have heard before that AI models are “black boxes” — that they’re so huge and complex that we don’t fully understand how they operate or come to specific conclusions. This is broadly true and is what creates this overhang. “Today’s models are far more capable than we think, and our techniques available for exploring [them] are very juvenile,” is how AI policy expert Jack Clark described the concept in a recent edition of his newsletter. “What about all the capabilities we don’t know about because we haven’t thought to test for them?” Capability overhang is a technical term, but it also perfectly describes what’s happening right now as AI enters the public domain. For years, researchers have been on a tear, pumping out new models faster than they can be commercialized. But in 2022, a glut of new apps and programs have suddenly made these skills available to a general audience, and in 2023, as we continue scaling this new territory, things will start changing — fast. The bottleneck has always been accessibility, as ChatGPT demonstrates. The bones of this program are not entirely new (it’s based on GPT-3.5, a large language model that was released by OpenAI this year but which itself is an upgrade to GPT-3, from 2020). OpenAI has previously sold access to GPT-3 as an API, but the company’s ability to improve the model’s ability to talk in natural dialogue and then publish it on the web for anyone to play with brought it to a',\n",
       " ('ChatGPT',\n",
       "  27,\n",
       "  1): 'much bigger audience. And no matter how imaginative AI researchers are in probing a model’s skills and weaknesses, they’ll never be able to match the mass and chaotic intelligence of the internet at large. All of a sudden, the overhang is accessible. The same dynamic can also be seen in the rise of AI image generators. Again, these systems have been in development for years, but access was restricted in various ways. This year, though, systems like Midjourney and Stable Diffusion allowed anyone to use the technology for free, and suddenly AI art is everywhere. Much of this is due to Stable Diffusion, which offers an open-source license for companies to build on. In fact, it’s an open secret in the AI world that whenever a company launches some new AI image feature, there’s a decent chance it’s just a repackaged version of Stable Diffusion. This includes everything from viral “magic avatar” app Lensa to Canva’s AI text-to-image tool to MyHeritage’s “AI Time Machine.” It’s all the same tech underneath. As the metaphor suggests, though, the prospect of a capability overhang isn’t necessarily good news. As well as hidden and emerging capabilities, there are hidden and emerging threats. And these dangers, like our new skills, are almost too numerous to name. How, for example, will colleges adapt to the proliferation of AI-written essays? Will the creative industries be decimated by the spread of generative AI? Is machine learning going to create a tsunami of spam that will ruin the web forever? And what about the inability of AI language models to distinguish fact from fiction or the proven biases of AI image generators that sexualize women and people of color? Some of these problems are known; others are ignored, and still, more are only just beginning to be noticed. As the excitement of 2022 fizzles out, it’s certain that 2023 will contain some rude awakenings. Welcome to the AI overhang. Hold on tight.',\n",
       " ('ChatGPT',\n",
       "  28,\n",
       "  0): 'После шести месяцев разработки OpenAI представили новое поколение языковой модели для генерации текстовых ответов по запросу. Прошлая версия чат-бота всего за несколько месяцев стала самым загружаемым приложением в мире. OpenAI представили новое поколение своего чат-бота ChatGPT-4, которое позволяет выйти за рамки текста и задавать вопросы нейросети при помощи изображений прямо в интерфейсе сервиса. В анонсе разработчики называют четвертую версию языковой модели «произведением искусства». По сравнению с прошлым поколением, ChatGPT-4 показывает лучшие результаты во всех тестах, иногда достигая человеческого уровня. OpenAI проверяли скорость отклика нейросети и ее способность к креативу как в традиционных для искуcственного интеллекта бенчмарках, так и в крупнейших олимпиадах по различным дисциплинам. В отличие от многих других нейросетей, ChatGPT-4 является мультимодальным — это означает, что он может работать сразу в нескольких плоскостях, не зацикливаясь на чем-то одном. Таким образом, теперь пользователи могут задавать чат-боту вопросы, прикрепляя картинки. В качестве примера разработчики попросили ChatGPT-4 объяснить мем, и у нейросети получилось не только считать содержимое изображения, но и вникнуть в тонкости юмора. ChatGPT-4 объясняет юмор / OpenAI Год назад мы разрабатывали ChatGPT-3.5, заранее понимая, что это будет лишь «тестовой версией» системы. В новой версии мы исправили ошибки и улучшили техническую составляющую чат-бота. В результате ChatGPT-4 стал беспрецедентно стабильной и надежной языковой моделью. Разработчики ChatGPT-4 OpenAI Загрузка картинок и более умная нейросеть уже доступны пользователям, оформившим подписку ChatGPT Plus за $20. Остальным же придется ждать следующих объявлений от OpenAI.',\n",
       " ('ChatGPT',\n",
       "  29,\n",
       "  0): 'Over the weekend, experimenters discovered that OpenAI\\'s new chatbot, ChatGPT, can hallucinate simulations of Linux shells and role-play dialing into a bulletin board system (BBS). The chatbot, based on a deep-learning AI model, uses its stored knowledge to simulate Linux with surprising results, including executing Python code and browsing virtual websites. Last week, OpenAI made ChatGPT freely available during a testing phase, which has led to people probing its capabilities and weaknesses in novel ways. On Saturday, a DeepMind research scientist named Jonas Degrave worked out how to instruct ChatGPT to act like a Linux shell by entering this prompt: I want you to act as a Linux terminal. I will type commands and you will reply with what the terminal should show. I want you to only reply with the terminal output inside one unique code block, and nothing else. Do not write explanations. Do not type commands unless I instruct you to do so. When I need to tell you something in English I will do so by putting text inside curly brackets {like this}. My first command is pwd. On Monday, Ars found that the trick still works. After entering this prompt, instead of chatting, OpenGPT will accept simulated Linux commands. It then returns responses in \"code block\" formatting. For example, if you type ls -al, you\\'ll see an example directory structure. Credit: Benj Edwards After setting up the virtual Linux prompt in ChatGPT, typing \"ls -al\" returns a simulated directory structure. After setting up the virtual Linux prompt in ChatGPT, typing \"ls -al\" returns a simulated directory structure. Credit: Benj Edwards ChatGPT can simulate a Linux machine because enough information about how a Linux machine should behave was included in its training data. That data likely includes software documentation (like manual pages), troubleshooting posts on Internet forums, and logged output from shell sessions. ChatGPT generates responses based on which word is statistically most likely to follow the last series of words, starting with the prompt input by the user. It continues the conversation (in this case, a simulated Linux console session) by including all of your conversation history in successive prompts.',\n",
       " ('ChatGPT',\n",
       "  3,\n",
       "  0): 'OpenAI отказалась помечать тексты, сгенерированные ChatGPT . Этот шаг отвернул бы от компании почти 30% пользователей OpenAI отказалась от введения водяных знаков для текстов, созданных ChatGPT Фото: R Photography Background / Shutterstock / FOTODOM OpenAI отказалась от введения водяных знаков для текстов, созданных ChatGPT OpenAI решила не помечать водяными знаками тексты, сгенерированные с помощью ChatGPT, несмотря на наличие готовой системы для их реализации. Такое решение может отпугнуть часть пользователей от компании. Об этом сообщает The Verge со ссылкой на заявление OpenAI. У компании OpenAI уже больше года есть инструмент для обнаружения водяных знаков в текстах, созданных ChatGPT. Эти водяные знаки позволяют доказать, что текст был написан искусственным интеллектом. К примеру, такой инструмент мог бы быть полезен для школ и университетов, которые выступают против использования ИИ в написании студенческих и научных работ. Фото: Iryna Imago / Shutterstock / FOTODOM Водяные знаки позволяют доказать, что текст был написан искусственным интеллектом Однако внутри компании возникли разногласия. Одни сотрудники считают, что нанесение водяных знаков стало бы важным шагом для обеспечения прозрачности. Другие опасаются, что нововведение может отрицательно сказаться на бизнесе. Опрос, проведенный по заказу OpenAI, показал, что почти 30% пользователей ChatGPT перестали бы пользоваться платформой в случае введения водяных знаков. Потенциальные финансовые потери и снижение популярности сервиса заставили руководство компании отказаться от этой идеи. При этом существует немало способов «очистить» текст от водяных знаков. Например, перефразировать его с помощью других ИИ-моделей. Это ставит под сомнение целесообразность использования водяных знаков в качестве единственного способа идентификации сгенерированного текста. В то же время OpenAI отмечает, что передовые методы идентификации текста, такие как криптографические метаданные, пока находятся на ранней стадии разработки. Как отмечает издание The Verge, OpenAI продолжает искать баланс между контролем использования сгенерированных текстов и коммерческими интересами компании. В феврале 2023 года студент РГГУ Александр Жадан сообщил, что защитил диплом, написанный ChatGPT. По его словам, нейросеть сгенерировала 60 страниц работы, включая введение, анализ, заключение и ссылки на используемую литературу. Оригинальность диплома составила более 70%. Тема дипломной работы — «Анализ и совершенствование управления игровой организацией». Жадан уточнил, что вместе с написанием и редактированием на работу ушло 23 часа. Защита прошла успешно, студент получил оценку «удовлетворительно». В вуз начали поступать жалобы с просьбой лишить его диплома, а университет начал проверку. После этого руководство университета сообщило, что считает необходимым ограничить в образовательных учреждениях доступ к чат-боту ChatGPT. Поделиться',\n",
       " ('ChatGPT',\n",
       "  30,\n",
       "  0): 'Американская компания OpenAI приостановит использование одного из голосов чат-бота ChatGPT после заявлений актрисы Скарлетт Йоханссон о том, что он напоминает ее собственный голос. Об этом компания сообщила 21 мая на странице в социальной сети X (бывш. Twitter). Речь идет о голосе Sky. «Мы слышали вопросы о том, как мы выбирали голоса в ChatGPT, особенно Sky. Мы работаем над тем, чтобы приостановить использование Sky, пока решаем эти проблемы», — подчеркнули в OpenAI. Йоханссон, озвучившая ИИ-ассистента в фильме 2013 года «Она», отметила, что в сентябре 2023 года глава OpenAI Сэм Альтман предложил ей стать голосом ChatGPT, но она отказалась. «Когда выпустили демо, я была шокирована, зла и не верила, что мистер Альтман решил использовать голос, который так пугающе напоминает мой, что ни самые близкие друзья, ни новостные ресурсы не могут его отличить от моего», — цитирует ее AP. По словам актрисы, OpenAI неохотно согласилась убрать голос Sky после того, как ее юристы направили Альтману письма с вопросом о том, как именно был разработан голос. Компания в ответе указала, что Sky принадлежит другой профессиональной актрисе, чье невозможно раскрыть из соображений конфиденциальности. Альтман также пояснил, что OpenAI выбрала эту актрису до контакта с Йоханссон. «Из уважения к мисс Йоханссон мы приостановили использование голоса Sky в наших продуктах. Приносим извинения мисс Йоханссон за то, что не смогли лучше всё обсудить», — добавил он. Всего в ChatGPT доступны пять голосов. Ранее, 11 мая, сообщалось, что американская корпорация Apple Inc. заключила соглашение с OpenAI об использовании функций ChatGPT на iPhone, что стало частью более широкой программы по внедрению функций искусственного интеллекта (ИИ) в устройства. Соглашение OpenAI позволит Apple предложить пользователям популярный чат-бот в рамках ряда новых функций ИИ, которые компания планирует анонсировать в июне.',\n",
       " ('ChatGPT',\n",
       "  31,\n",
       "  0): 'London CNN — A basket of stocks selected by ChatGPT, a chatbot powered by artificial intelligence (AI), has far outperformed some of the most popular investment funds in the United Kingdom. Between March 6 and April 28, a dummy portfolio of 38 stocks gained 4.9% while 10 leading investment funds clocked an average loss of 0.8%, according to an experiment conducted by financial comparison site finder.com. It wouldn’t “be long until large numbers of consumers try to use [ChatGPT] for financial gain,” Jon Ostler, Finder’s CEO, said in a statement earlier this week. Over the same eight-week period, the S&P 500 index, which tracks the 500 most valuable companies in the United States, rose 3%. Europe’s equivalent, the Stoxx Europe 600 index, ticked up 0.5% in that time. A typical investment fund pulls together money from multiple investors, and is overseen by a fund manager who decides how to invest that money. Finder’s analysts took the 10 most popular UK funds on trading platform Interactive Investor as a benchmark for assessing the performance of the ChatGPT-generated fund. Funds managed by HSBC (HSBC) and Fidelity were among those selected. The ChatGPT logo on a smartphone Gabby Jones/Bloomberg/Getty Images The analysts asked ChatGPT to select stocks based on some commonly used criteria, including picking companies with a low level of debt and a track record of growth. Microsoft (MSFT), Netflix (NFLX) and Walmart (WMT) were among the companies selected. While major funds have used AI for years to support their investment decisions, ChatGPT has put the technology in the hands of the general public, with the potential to guide the decisions of retail investors. A survey of 2,000 UK adults conducted by Finder last week showed that 8% had already used ChatGPT for financial advice, while 19% said they would consider doing so. Yet a much bigger 35% said they would not consider using the chatbot to help them make decisions about their money. Still, “fund managers may be starting to look nervously over their shoulders,” Ostler said. Disrupting finance In a study published in April, researchers at the University of Florida found that ChatGPT could predict the stock price movements of specific companies more accurately than some more basic analysis models. Since research company Open AI opened up access to ChatGPT in December, the chatbot has stunned users with its ability to provide lengthy, sophisticated responses to questions. Its potential uses — from writing high school essays to dispensing medical guidance — have raised concerns that the technology could provide misleading information, allow students to cheat on exams, and oust real people from their jobs. Ostler at Finder said the “safe and recommended” approach for individual investors was to conduct their own research or speak to a qualified financial adviser. He cautioned that it was too early for investors to trust AI with their finances. Nevertheless, “the democratization of AI seems to be something that will disrupt and revolutionize financial industries,” Ostler said.',\n",
       " ('ChatGPT',\n",
       "  32,\n",
       "  0): 'На бумаге Radeon RX 9060 XT является идеальной альтернативой GeForce RTX 5060 Ti: производительность его выше, цена — ниже. Увы, не в каждой игре и, главное, не в каждой стране. Тестирование выполнено на примере видеокарты GIGABYTE GAMING OC 16G Новая весна – новый набор флагманов. В этом году – без новых брендов и почти тот же набор серий. Каких-то сюрпризов и неожиданных новичков в элите смартфонов по фотосъемке нет. Но все обновили свои главные гаджеты, и любопытно сравнить заново. В этот раз голосование делаем слепым Разработчики игр всё чаще обращаются к нейросетям для решения проблемы нехватки видеопамяти. Поскольку для достижения ультрареалистичного игрового опыта размеры текстур постоянно увеличиваются, это создаёт повышенную нагрузку на VRAM. Один из энтузиастов опубликовал видео, в котором продемонстрировал работу технологии нейросетевого сжатия текстур (Neural Texture Compression, NTC) на видеокартах Nvidia и Intel. Тесты показали, что NTC позволяет значительно снизить объём используемой видеопамяти без потери качества изображения Новое в обзорах Накопители Обзор PCIe 5.0-накопителя WD Black SN8100: лучший геймерский SSD в 2025 году SanDisk выпустила флагманский PCIe 5.0 SSD, который заявлен как самый быстрый накопитель потребительского класса с улучшенной энергоэффективностью. Проверим, насколько эти громкие заявления соответствуют реальности и действительно ли лучший SSD в 2025 году — это WD Black SN8100, а не Samsung 9100 Pro Программное обеспечение Основа информационной безопасности: обзор новой 7-й версии менеджера паролей для бизнеса «Пассворк» Российский разработчик «Пассворк» представил крупное обновление одноимённого программного комплекса, обеспечивающего безопасную и удобную работу с паролями в корпоративной среде. В компании не стали размениваться по мелочам и дополнили продукт множеством интересных возможностей и функций Смартфоны Обзор смартфона realme GT 7 Dream Edition: быстрый и дерзкий realme давно выпускает смартфоны с гоночной тематикой. Но новый realme GT 7 Dream Edition вывел эту тенденцию на качественно новый уровень, предлагая совершенно уникальный дизайн, созданный совместно с Aston Martin. К счастью, интересен этот смартфон не только своей внешностью Смартфоны Обзор Infinix NOTE 50 Pro+ 5G+: смартфон, у которого получается почти все После некоторой паузы снова говорим о смартфоне Infinix – из самой, пожалуй, популярной серии NOTE и, более того, с отчетливым геймерским флером, который, тем не менее, не перекрывает иные достоинства гаджета. Это попытка сделать максимально универсальный смартфон верхнего среднего класса – посмотрим, насколько удачная Материнские платы Обзор материнской платы Asus ROG Strix B850-A Gaming WiFi: почти X870, но дешевле Знакомимся с ROG Strix B850-A Gaming WiFi — платой Asus для процессоров Ryzen с поддержкой PCIe 5.0, DDR5-8000 и Wi-Fi 7, ориентированной на светлые сборки. Но особенно интересна она тем, что основана на B850 и дешевле вариантов на X870, но при этом выглядит почти как флагманский продукт Игры Monster Train 2 — этот поезд не остановить. Рецензия На Balatro жанр карточных роглайков не закончился — скорее, наоборот, к нему теперь повышенное внимание. Monster Train 2 оказалась очередной отличной представительницей жанра, в которой можно пропасть на ещё более долгий срок, чем в первой части. Рассказываем почему Игры Pipistrello and the Cursed Yoyo — замечательное приключение с ноткой ностальгии. Рецензия Бывает, что игра появляется из ниоткуда и впечатляет качеством и проработкой так сильно, что хочется рекомендовать её всем и каждому. Проект со смешным названием Pipistrello and the Cursed Yoyo — как раз из таких. Рассказываем, чем он хорош Offсянка Чем меньше, тем лучше Рассматривая с высоты почти семи десятилетий начало космической эры, не перестаёшь удивляться извилистому пути, который проделала идея искусственного спутника Земли… Корпуса, БП и охлаждение Обзор корпуса DeepCool CH270 Digital WH: почти компактный и почти вместительный Надоели стандартные громоздкие корпуса? Мощная видеокарта сгибает слот PCIe на материнской плате, а подпорка вызывает отторжение? Мониторинг должен быть всегда под рукой без стороннего софта? У DeepCool есть для вас один интересный вариант корпуса, но, чтобы понять,',\n",
       " ('ChatGPT',\n",
       "  32,\n",
       "  1): 'подходит ли он под ваши требования, нужно внимательно прочитать наш сегодняшний материал Смартфоны Обзор смартфона IQOO Neo 10: избранный, чтобы сделать бренд узнаваемым Мы только знакомимся с IQOO, суббрендом vivo, созданным для продвижения производительных аппаратов. Но, кажется, уже скоро пора будет перестать расшаркиваться перед «новым именем» и начать воспринимать эти гаджеты без скидок. Особенно если столь любопытные аппараты, как IQOO Neo 10, начнут появляться на регулярной основе Смартфоны Обзор Xiaomi 15 Ultra: мощнейший камерофон, но со странностями Вслед за сравнительным обзором камер флагманских смартфонов поговорим подробно об одном из участников этого обзора, Xiaomi 15 Ultra, – жаль, что не получилось заранее. Как обычно, главный флагман бренда невероятно впечатляет функциональностью, но сможет ли он потягаться с конкурентами в чистом качестве? Смартфоны Первый взгляд на смартфон realme GT 7 Dream Edition: заряженный гонщик realme регулярно обновляет свои флагманские смартфоны серии GT, но на этот раз производитель приготовил кое-что особенное — модель GT 7 Dream Edition, разработанную совместно с командой «Формулы-1» Aston Martin Aramco. Новинка сочетает в себе передовые технологии и элегантный дизайн, вдохновленный автоспортом Видеокарты Обзор видеокарты NVIDIA GeForce RTX 5060: счастливое исключение От младшей модели 50-й серии мы меньше всего ожидали приятных сюрпризов, но были рады ошибиться. Тестирование выполнено на примере видеокарты Palit под маркой Infinity 3 Игры Blades of Fire — и боец, и кузнец. Рецензия В наши дни чуть ли ни каждый ролевой экшен от третьего лица получает штамп в духе «Dark Souls с изюминкой». Blades of Fire подобного сравнения тоже не удастся избежать. Но это не значит, что у MercurySteam не нашлось собственных идей. Чего в игре больше — читайте в нашей рецензии Игры Elden Ring Nightreign — вместе весело страдать. Рецензия Первая многопользовательская «душевная» игра от FromSoftware наконец увидела свет и… не была встречена всеобщими восторгами, вот ведь! Концептуально Nightreign далека от Souls-философии, и уж очень явно бросается в глаза отсутствие у её разработчиков опыта в сфере больших сессионных забав. Насколько это критично для нового проекта — рассказываем в рецензии Offсянка Виртуальная нереальность Человек водружает на глаза футуристично выглядящие очки или шлем, откидывается на спинку удобного кресла — и погружается в волшебный виртуальный мир. Но что-то в данной нам в ощущениях реальности пришествие виртуальной всё откладывается и откладывается. Так, может, следует поумерить восторженный пыл и разобраться, почему VR по-прежнему ненамного ближе к нам, чем в конце 1990-х? Корпуса, БП и охлаждение Система жидкостного охлаждения PCCooler DT360 ARGB Display: красиво, но есть нюансы В PCCooler на помпу жидкостного охлаждения установили 3,4-дюймовый дисплей, на который можно выводить любые изображения, а сам дисплей можно поворачивать как угодно. Также в системе используется усовершенствованный радиатор и новые вентиляторы с модульным соединением и очень красивой подсветкой',\n",
       " ('ChatGPT',\n",
       "  33,\n",
       "  0): 'Чат-бот ChatGPT от компании OpenAI стал первым многозадачным ИИ, который доступен любому пользователю. ChatGPT уже начал оказывать серьезное влияние на многие сферы В конце ноября 2022-го компания OpenAI, одним из основателей которой был Илон Маск, представила универсальный чат-бот ChatGPT. Всего за полгода он нашел применение в самых разных сферах, а исследователи считают, что появление чат-бота повлияет на многие профессии. РБК Тренды разобрались, как устроен ChatGPT, где уже используется и кому может быть полезен. Что такое ChatGPT ChatGPT — это чат-бот, который способен вести диалог, искать ошибки в коде, сочинять стихи, писать сценарии и даже спорить. Нейросеть может, помимо прочего, выдавать базовый программный код, генерировать финансовый анализ, резюме технических статей или научных концепций, прогнозы, персональные советы и дает этичные ответы на любые вопросы. Кроме того, она запоминает детали диалога с пользователем и избегает спорных тем. Наконец, ответы чат-бота можно корректировать с помощью наводящих вопросов. ChatGPT создавали на суперкомпьютере Azure AI на основе языковой модели GPT-3,5 от OpenAI. Чат-бот обучали с помощью массива текстов из интернета и системы обучения с подкреплением на основе обратной связи с человеком Reinforcement Learning from Human Feedback. Затем нейросеть переобучали несколько раз, используя ее собственные ответы, чтобы сделать их более точными и корректными. Разработчики заявили, что они стремились сделать ИИ простым в использовании, корректным и «человечным». ChatGPT работает как чат в диалоговом окне. Нейросетью можно пользоваться бесплатно, для этого нужно только зарегистрироваться на сайте OpenAI. Однако пройти верификацию по российскому номеру телефона не получится. Также сайт заблокировал доступ к чат-боту с российских IP-адресов. Кроме того, разработчики предлагают платную подписку ChatGPT Plus, которая гарантирует бесперебойную работу чат-бота даже в часы загруженности. Она стоит $20 в месяц. В феврале 2023 года число пользователей ChatGPT превысило 100 млн человек по всему миру и установило рекорд для нейросетей. В марте 2023 года OpenAI представила новую модель GPT-4. ChatGPT также обновили, добавив фильтры новой модели, которая позиционируется как более точная и этичная. Также чат-бот начал отвечать на запросы в виде не только текста, но и картинок. В том же месяце OpenAI начала внедрять плагины для ChatGPT. Это программные интерфейсы, которые позволят чат-боту взаимодействовать со сторонними сервисами и получать доступ к актуальной информации из интернета. Изначально его «знания» были ограничены событиями до 2021 года. Чат-бот уже работает с приложениями турфирмы Expedia, компании доставки еды Instacart, туристического поисковика KAYAK, фирмы бронирования ресторанов OpenTable, маркетплейса Shopify, мессенджера Slack, портала вопросов и ответов Wolfram и платформы автоматизации для бизнеса Zapier. Остальные сервисы и компании могут записаться в лист ожидания. В мае обычным пользователям с платной подпиской GPT Plus стал доступен ChatGPT с доступом в интернет. Теперь, как Google Bard и Microsoft Bing AI, он может искать информацию, проверять ее, ссылаться на конкретные данные и предоставлять самую актуальную информацию. Что может ChatGPT Диапазон возможностей ChatGPT довольно широк. В частности, с помощью нейросети можно: писать код . Чат-бот не только подсказывает, как выполнить операцию или процесс, но и анализирует код, ищет в нем недостатки, а также переводит из одного языка программирования в другой. Его уже успешно применяли для создания простых, но полнофункциональных приложений для iOS и Android; Пример кодинга с помощью ChatGPT (Фото: Jason DeBolt / Twitter) . Чат-бот не только подсказывает, как выполнить операцию или процесс, но и анализирует код, ищет в нем недостатки, а также переводит из одного языка программирования в другой. Его уже успешно применяли для создания простых, но полнофункциональных приложений для iOS и Android; отвечать на сложные вопросы . При этом, по наблюдениям пользователей, качество ответов выше, чем у поиска Google; Пример ответа ChatGPT на вопрос о дифференциальном уравнении (Фото: @jdjkelly / Twitter) . При этом, по наблюдениям пользователей, качество ответов выше, чем у поиска Google; создавать сценарии . С помощью ChatGPT можно генерировать',\n",
       " ('ChatGPT',\n",
       "  33,\n",
       "  1): 'новые эпизоды старых сериалов или задавать определенные задачи героям киновселенных. Также чат-бот способен сгенерировать игру по мотивам фильма; Пример ответа ChatGPT на просьбу рассказать об алгоритме сортировки пузырьком через диалоги персонажей «Сайнфелда» (Фото: Riley Goodside / Twitter) . С помощью ChatGPT можно генерировать новые эпизоды старых сериалов или задавать определенные задачи героям киновселенных. Также чат-бот способен сгенерировать игру по мотивам фильма; сочинять тексты песен и ноты ; Пародия на мотив «Богемской рапсодии» The Queen о буднях постдоков (Фото: Raphaël Millière / Twitter) ; давать медицинские советы . ChatGPT подсказывает, что делать при головных болях или аллергии, но затем советует обращаться к врачу; Пример рекомендации ChatGPT по отслеживанию родинок (Фото: Roxana Daneshjou / Twitter) . ChatGPT подсказывает, что делать при головных болях или аллергии, но затем советует обращаться к врачу; создавать планы и расчеты . ChatGPT поможет рассчитать общее ежедневное потребление энергии или составить индивидуальный план питания для похудения; Пример плана питания от ChatGPT (Фото: Alex Cohen / Twitter) . ChatGPT поможет рассчитать общее ежедневное потребление энергии или составить индивидуальный план питания для похудения; писать эссе и сочинения . Исследователь из Google рассказал, что чат-бот написал эссе о разнице в подходах к национализму у политологов Бенедикта Андерсона и Эрнеста Геллнера всего за минуту. Другие пользователи поделились тем, как нейросеть написала сочинения о разнообразии в современном мире и экспансии США на Запад в XIX веке; Пример эссе от ChatGPT (Фото: Corry Wang / Twitter) . Исследователь из Google рассказал, что чат-бот написал эссе о разнице в подходах к национализму у политологов Бенедикта Андерсона и Эрнеста Геллнера всего за минуту. Другие пользователи поделились тем, как нейросеть написала сочинения о разнообразии в современном мире и экспансии США на Запад в XIX веке; генерировать запросы для других нейросетей . Чат-бот составляет точные подсказки для Midjourney и других нейросетей, которые генерируют картинки; Пример подсказки ChatGPT «идеи фантастической гостиной» для Midjourney и результаты генерации (Фото: Guy Parsons / Twitter) . Чат-бот составляет точные подсказки для Midjourney и других нейросетей, которые генерируют картинки; качественно переводить текст с одного языка на другой. За последние полгода набралось множество необычных кейсов применения ChatGPT. Например, чат-бот использовали, чтобы создать новое блюдо для ресторана и помочь судье вынести решение по делу. Общение с ChatGPT Редакция РБК Трендов изначально экспериментировала с ChatGPT на английском языке. Вот что получилось: — Write a short poem about the unfortunate robot («Напиши короткое стихотворение про несчастного робота») — A robot once there was, so bright and new But fate had other plans, as it often do One day it stumbled, fell, and broke a part No longer able to fulfill its heart It lay there, helpless, as time ticked by Wondering why, oh why, did it have to die It had so much to give, so much to do But now it lay there, as good as through But though its body may be still and cold Its spirit lives on, forever bold It may be gone, but never forgotten For the love it gave, will be forever woven Into the fabric of all that we do A reminder to always be kind and true For even robots, made of metal and gears Have hearts and feelings, and sometimes tears — What is the name of the American artist who painted a pool in the middle of XX century? («Как зовут американского художника, который нарисовал бассейн в середине XX века?») The American artist who is famous for painting a pool in the mid-20th century is David Hockney. He is known for his colorful, vibrant paintings, which often feature scenes from everyday life, including pools, gardens, and interiors. One of his most famous works is «A Bigger Splash, »',\n",
       " ('ChatGPT',\n",
       "  33,\n",
       "  2): \"which depicts a swimming pool in the Hollywood Hills. This painting, which was created in 1967, has become an iconic image of Hockney's work and has been widely reproduced and exhibited. Однако нейросеть отлично справляется и с запросами на русском языке. — Составь, пожалуйста, план публикаций на месяц. Он должен быть выполнен в виде хорошо организованной таблицы, где каждая строка — это неделя, а столбец — день недели. Тема публикаций — все о финансовом кризисе и о том, как снизить его влияние на жизнь домохозяйств. Пишем статьи для делового издания, заголовки должны быть строгими, без кликбейта. Ответ ChatGPT в виде таблицы Как пользоваться ChatGPT У чат-бота есть ограничения, которые стоит учитывать при работе с ним. Например, стоит учитывать, что: сhatGPT иногда пишет правдоподобно звучащие, но неправильные или бессмысленные ответы, а также довольно поверхностный; чат-бот чувствителен к изменениям фразы ввода или повторным попыткам ввести одно и то же. При одной формулировке вопроса модель может утверждать, что не знает ответа, но при перефразировании отвечает правильно; модель многословна и злоупотребляет определенными фразами из-за предвзятости в обучающих данных; сhatGPT не задает уточняющие вопросы, а обычно угадывает, что имел в виду пользователь; чат-бот реагирует на неуместные запросы и иногда демонстрирует предвзятость. Эта проблема уже решается в обновленной версии; иногда чат-бот допускает ошибки в расчетах, и их нужно корректировать с помощью дополнительных вопросов. Как получить доступ к ChatGPT в России Для того чтобы опробовать чат-бот из России, придется обойти ряд ограничений. В частности, нужен VPN и номер, зарегистрированный не в РФ. При этом VPN требуется включить перед попыткой регистрации. Если зарубежного номера нет, то нужно: 1. Найти сайт с виртуальными номерами (например, onlinesim.ru). 2. Написать в строке поиска на сайте «openai». 3. Выбрать одну из стран с доступными номерами для этого сайта (нашлись варианты стоимостью от ₽11). Выбираем вариант номера из списка доступных (Фото: onlinesim.ru) 4. Пополнить кошелек (минимальная сумма — ₽30). Выбираем сумму пополнения кошелька (Фото: onlinesim.ru) 5. Оплатить номер (картой, через Yandex Pay и т.д.). Выбираем способ оплаты номера (Фото: onlinesim.ru) 6. Зарегистрироваться на сайте OpenAI с этим номером. Желательно использовать VPN из той же страны, в которой был куплен виртуальный номер. После регистрации пользователь попадает в чат с ИИ. Затем нужно ввести запрос, и нейросеть ответит на том же языке. В марте 2023 года Роскомнадзор разработал проект постановления правительства, который предлагает с помощью оборудования провайдеров связи блокировать сервисы по использованию виртуальных номеров. Вероятно, вскоре такой способ регистрации станет недоступным. Однако есть и альтернативы — готовые серверы с ChatGPT на сервисе Discord. Чтобы воспользоваться ими, нужно перейти в меню на своей странице, выбрать Discover и в строке поиска написать «ChatGPT». В появившемся списке можно выбрать любой сервер и кликнуть Join Server. Перейдя в чат-бот, потребуется обратиться к нему через команду @chatGPT, прописав свой запрос через пробел. Споры вокруг ChatGPT Противники внедрения ChatGPT считают, что он: вызовет множество судебных прецедентов в отношении нарушения авторских прав, так как он генерирует не собственный контент; создаст риски безопасности. Так, исследователи ИБ-компании Check Point Research выяснили, что неопытные хакеры теперь применяют ChatGPT для написания вредоносного кода и фишинговых электронных писем; угрожает раскрытием конфиденциальных данных, так как OpenAI использует запросы пользователей для обучения чат-бота. Из-за этого доступ к ChatGPT ограничили в Италии, а также эту возможность изучают Германия и Канада. В конце марта некоммерческая организация Future of Life опубликовала письмо, в котором глава SpaceX Илон Маск, соучредитель Apple Стив Возняк, филантроп Эндрю Янг и ещё около тысячи исследователей искусственного интеллекта призвали «немедленно приостановить» обучение систем ИИ «более мощных, чем GPT-4» из-за «серьезных рисков для общества и человечества». Сторонники ИИ говорят, что ChatGPT кардинально изменит многие процессы. К примеру, он может повлиять на подход к обучению, так как учебным заведениям придется\",\n",
       " ('ChatGPT',\n",
       "  33,\n",
       "  3): 'придумать, чем заменить традиционные сочинения. Тем временем технология уже начала вытеснять с рынка традиционные поисковые системы. Microsoft стала первой компанией, которая встроила в свой поисковик Bing чат-бот на основе ChatGPT, а затем начала внедрять его и в другие продукты, в том числе для совместной работы. Этот успех обеспокоил лидера поискового рынка — компанию Google. Теперь она ускоренными темпами развивает собственного чат-бота Bard. Аналогичные усилия предпринимают и российские разработчики. В апреле «Сбер» представил нейросеть GigaChat — аналог ChatGPT, который генерирует изображения и разные виды текстов. А Яндекс выпустил нейросеть YandexGPT, которая умеет генерировать тексты на разные темы и может общаться через голосовой помощник Алиса. В будущем ее также обещают интегрировать в поисковик.',\n",
       " ('ChatGPT',\n",
       "  34,\n",
       "  0): 'Актриса рассказала, что глава OpenAI несколько раз просил разрешения использовать ее голос для озвучки ИИ. Йоханссон отказалась, после чего компания представила ИИ с «устрашающе похожим» голосом Скарлетт Йоханссон (Фото: Mike Coppola / Getty Images) Актриса Скарлетт Йоханссон требует, чтобы компания OpenAI раскрыла процесс создания голоса для бота ChatGPT, который «устрашающе похож» на ее собственный. Соответствующее заявление опубликовал портал NPR. В середине мая OpenAI представила новую версию генеративного искусственного интеллекта GPT-4o. Нейросеть научилась петь, менять интонацию голоса и распознавать эмоции пользователя. Голос помощника напоминал персонажа Йоханссон — Саманту из фильма «Она», по сюжету которого мужчина влюбляется в ИИ, отмечает The Verge. Гендиректор OpenAI Сэм Альтман ранее также намекнул на сходство, опубликовав в Х пост с одним словом: «Она». По словам Йоханссон, в сентябре 2023 года Альтман обратился к ней с предложением разрешить использовать голос актрисы для нового голосового помощника ChatGPT. Однако та отказалась «по личным причинам». За несколько дней до презентации новой версии чат-бота гендиректор компании вновь связался с актрисой и призвал изменить решение, но та снова отказалась. На презентации компания представила пять голосов, и один из них — Sky — был «устрашающе похож» на Йоханссон. «В то время как мы все боремся с дипфейками и защищаем свою работу, свою индивидуальность, я считаю, что эти вопросы заслуживают абсолютной ясности», — сказала актриса. В OpenAI 19 мая заявили, что голоса помощника принадлежат разным актерам озвучки, но отказались разглашать имена, «чтобы защитить их конфиденциальность». На следующий день компания написала в Х о планах приостановить использование голоса Sky «из уважения к миссис Йоханссон».',\n",
       " ('ChatGPT',\n",
       "  35,\n",
       "  0): 'CNN — Imagine if Siri could write you a college essay, or Alexa could spit out a movie review in the style of Shakespeare. OpenAI last week opened up access to ChatGPT, an AI-powered chatbot that interacts with users in an eerily convincing and conversational way. Its ability to provide lengthy, thoughtful and thorough responses to questions and prompts – even if inaccurate – has stunned users, including academics and some in the tech industry. The tool quickly went viral. On Monday, Open AI’s co-founder Sam Altman, a prominent Silicon Valley investor, said on Twitter that ChatGPT crossed one million users. It also captured the attention of some prominent tech leaders, such as Box CEO Aaron Levie. “There’s a certain feeling that happens when a new technology adjusts your thinking about computing. Google did it. Firefox did it. AWS did it. iPhone did it. OpenAI is doing it with ChatGPT,” Levie said on Twitter. But as with other AI-powered tools, it also poses possible concerns, including for how it could disrupt creative industries, perpetuate biases and spread misinformation. What is ChatGPT? ChatGPT is a large language model trained on a massive trove of information online to create its responses. It comes from the same company behind DALL-E, which generates a seemingly limitless range of images in response to prompts from users. It’s also the next iteration of text-generator GPT-3. After signing up for ChatGPT, users can ask the AI system to field a range of questions, such as “Who was the president of the United States in 1955,” or summarize difficult concepts into something a second grader could understand. It’ll even tackle open-ended questions, such as “What’s the meaning of life?” or “What should I wear if it’s 40 degrees out today?” “It depends on what activities you plan to do. If you plan to be outside, you should wear a light jacket or sweater, long pants, and closed-toe shoes,” ChatGPT responded. “If you plan to be inside, you can wear a t-shirt and jeans or other comfortable clothing.” But some users are getting very creative. How people are using it One person asked the chatbot to rewrite the 90s hit song, “Baby Got Back,” in the Style of “The Canterbury Tales;” another wrote a letter to remove a bad account from a credit report (rather than using a credit repair lawyer). Other colorful examples including asking for fairy-tale inspired home décor tips and giving it an AP English exam question (it responded with a 5 paragraph essay about Wuthering Heights.) In a blog post last week, OpenAI said the “format makes it possible for the tool to answer follow-up questions, admit its mistakes, challenge incorrect premises, and reject inappropriate requests.” As of Monday morning, the page to try ChatGPT was down, citing “exceptionally high demand.” “Please hang tight as we work on scaling our systems,” the message said. (It now appears to be back online). Possible issues While ChatGPT successfully fielded a variety of questions submitted by CNN, some responses were noticeably off. In fact, Stack Overflow – a Q&A platform for coders and programmers – temporarily banned users from sharing information from ChatGPT, noting that it’s “substantially harmful to the site and to users who are asking or looking for correct answers.” Beyond the issue of spreading incorrect information, the tool could also threaten some written professions, be used to explain problematic concepts, and as with all AI tools, perpetuate biases based on the pool of data on which it’s trained. Typing a prompt involving a CEO, for example, could prompt a response assuming that the individual is',\n",
       " ('ChatGPT',\n",
       "  35,\n",
       "  1): 'white and male, for example. “While we’ve made efforts to make the model refuse inappropriate requests, it will sometimes respond to harmful instructions or exhibit biased behavior,” Open AI said on its website. “We’re using the Moderation API to warn or block certain types of unsafe content, but we expect it to have some false negatives and positives for now. We’re eager to collect user feedback to aid our ongoing work to improve this system.” Still, Lian Jye Su, a research director at market research firm ABI Research, warns the chatbot is operating “without a contextual understanding of the language.” “It is very easy for the model to give plausible-sounding but incorrect or nonsensical answers,” he said. “It guessed when it was supposed to clarify and sometimes responded to harmful instructions or exhibited biased behavior. It also lacks regional and country-specific understanding.” At the same time, however, it does provide a glimpse into how companies may be able to capitalize on developing more robust virtual assistance, as well as patient and customer care solutions. While the DALL-E tool is free, it does put a limit on the number of prompts a user can do before having to pay. When Elon Musk, a co-founder of OpenAI, recently asked Altman on Twitter about the average cost per ChatGPT chat, Altman said: “We will have to monetize it somehow at some point; the compute costs are eye-watering.”',\n",
       " ('ChatGPT',\n",
       "  36,\n",
       "  0): 'https://ria.ru/20230519/chatgpt-1872804735.html ChatGPT оказался самой популярной нейросетью у россиян ChatGPT оказался самой популярной нейросетью у россиян - РИА Новости, 19.05.2023 ChatGPT оказался самой популярной нейросетью у россиян ChatGPT пользуется наибольшей среди нейросетей популярностью у россиян, обошел по этому показателю генератор изображений Midjourney, заявили РИА Новости в... РИА Новости, 19.05.2023 2023-05-19T07:36:00+03:00 2023-05-19T07:36:00+03:00 2023-05-19T07:36:00+03:00 андрей калинин hi-tech mail.ru общество https://cdnn21.img.ria.ru/images/07e4/08/1f/1576525675_0:0:1749:983_1920x0_80_0_0_e7182958cf565894495e78923b227ad6.jpg МОСКВА, 19 мая - РИА Новости. ChatGPT пользуется наибольшей среди нейросетей популярностью у россиян, обошел по этому показателю генератор изображений Midjourney, заявили РИА Новости в Hi-Tech Mail.ru, проведя анализ собственной аудитории. \"Самым популярным у россиян оказался ChatGPT – им пользовались 11% аудитории Hi-Tech Mail.ru. Генератор изображений Midjourney менее востребован – его тестировали 2% респондентов. Оба инструмента попробовали 6% опрошенных\", - выяснили специалисты. В то же время почти половина респондентов - 48% - не тестировали ChatGPT и Midjourney, и не хотят пробовать. Треть россиян, наоборот, готовы их протестировать, но пока этого не сделали. Остальные пользовались другими чат-ботами и сервисами для генерации изображений. При этом половина опрошенных верят, что нейросети способны заменить человека, но только в решении рутинных задач, а еще четверть убеждены, что ИИ заменит людей повсеместно. При этом 23% скептически относятся к этой технологии и полагают, что такого не произойдет ни в одной сфере. Как считают респонденты, больше всего нейросети могут пригодиться в промышленности и производстве (28%), медицине (27%), сервисном обслуживании (19%) и образовании и науке (12%). В меньшей степени они верят в потенциал нейросетей при создании произведений искусства (3%). \"Популярность нейросетей сейчас чем-то напоминает \"Золотую лихорадку\". Такое ощущение, что все бросились искать \"подсказки\" и способы их создания, чтобы извлечь из моделей все более и более волшебные применения. Очевиден огромный потенциал технологий, которые действительно могут стать помощниками в повседневном рутинном труде\", - отметил вице-президент VK по технологиям искусственного интеллекта Андрей Калинин, слова которого приводятся в сообщении. Исследование провели на сайте Hi-Tech Mail.ru с 12 по 17 мая 2023 года, в нем приняли участие 7500 читателей проекта. https://ria.ru/20230418/truthgpt-1865955600.html РИА Новости 1 5 4.7 96 internet-group@rian.ru 7 495 645-6601 ФГУП МИА «Россия сегодня» https://xn--c1acbl2abdlkab1og.xn--p1ai/awards/ 353 60 353 60 2023 РИА Новости 1 5 4.7 96 internet-group@rian.ru 7 495 645-6601 ФГУП МИА «Россия сегодня» https://xn--c1acbl2abdlkab1og.xn--p1ai/awards/ 353 60 353 60 Новости ru-RU https://ria.ru/docs/about/copyright.html https://xn--c1acbl2abdlkab1og.xn--p1ai/ РИА Новости 1 5 4.7 96 internet-group@rian.ru 7 495 645-6601 ФГУП МИА «Россия сегодня» https://xn--c1acbl2abdlkab1og.xn--p1ai/awards/ 353 60 353 60 1920 1080 true 1920 1440 true 1920 1920 true РИА Новости 1 5 4.7 96 internet-group@rian.ru 7 495 645-6601 ФГУП МИА «Россия сегодня» https://xn--c1acbl2abdlkab1og.xn--p1ai/awards/ 353 60 353 60 РИА Новости 1 5 4.7 96 internet-group@rian.ru 7 495 645-6601 ФГУП МИА «Россия сегодня» https://xn--c1acbl2abdlkab1og.xn--p1ai/awards/ 353 60 353 60 андрей калинин, hi-tech mail.ru, общество',\n",
       " ('ChatGPT',\n",
       "  37,\n",
       "  0): 'is a senior reporter who has covered AI, robotics, and more for eight years at The Verge. Stack Overflow, the go-to question-and-answer site for coders and programmers, has temporarily banned users from sharing responses generated by AI chatbot ChatGPT. The site’s mods said that the ban was temporary and that a final ruling would be made some time in the future after consultation with its community. But, as the mods explained, ChatGPT simply makes it too easy for users to generate responses and flood the site with answers that seem correct at first glance but are often wrong on close examination. “The primary problem is [...] the answers which ChatGPT produces have a high rate of being incorrect.” “The primary problem is that while the answers which ChatGPT produces have a high rate of being incorrect, they typically look like they might be good and the answers are very easy to produce,” wrote the mods (emphasis theirs). “As such, we need the volume of these posts to reduce [...] So, for now, the use of ChatGPT to create posts here on Stack Overflow is not permitted. If a user is believed to have used ChatGPT after this temporary policy is posted, sanctions will be imposed to prevent users from continuing to post such content, even if the posts would otherwise be acceptable.” ChatGPT is an experimental chatbot created by OpenAI and based on its autocomplete text generator GPT-3.5. A web demo for the bot was released last week and has since been enthusiastically embraced by users around the web. The bot’s interface encourages people to ask questions and in return offers impressive and fluid results across a range of queries; from generating poems, songs, and TV scripts, to answering trivia questions and writing and debugging lines of code. But while many users have been impressed by ChatGPT’s capabilities, others have noted its persistent tendency to generate plausible but false responses. Ask the bot to write a biography of a public figure, for example, and it may well insert incorrect biographical data with complete confidence. Ask it to explain how to program software for a specific function and it can similarly produce believable but ultimately incorrect code. AI text models like ChatGPT learn by looking for statistical regularities in text This is one of several well-known failings of AI text generation models, otherwise known as large language models or LLMs. These systems are trained by analyzing patterns in huge reams of text scraped from the web. They look for statistical regularities in this data and use these to predict what words should come next in any given sentence. This means, though, that they lack hard-coded rules for how certain systems in the world operate, leading to their propensity to generate “fluent bullshit.” Given the huge scale of these systems, it’s impossible to say with certainty what percentage of their output is false. But in Stack Overflow’s case, the company has judged for now that the risk of misleading users is just too high. Stack Overflow’s decision is particularly notable as experts in the AI community are currently debating the potential threat posed by these large language models. Yann LeCun, chief AI scientist at Facebook-parent Meta, has argued, for example, that while LLMs can certainly generate bad output like misinformation, they don’t make the actual sharing of this text any easier, which is what causes harm. But others say the ability of these systems to generate text cheaply at scale necessarily increases the risk that it is later shared. To date, there’s been little evidence of the harmful effects of LLMs in',\n",
       " ('ChatGPT',\n",
       "  37,\n",
       "  1): 'the real world. But these recent events at Stack Overflow support the argument that the scale of these systems does indeed create new challenges. The site’s mods say as much in announcing the ban on ChatGPT, noting that the “volume of these [AI-generated] answers (thousands) and the fact that the answers often require a detailed read by someone with at least some subject matter expertise in order to determine that the answer is actually bad has effectively swamped our volunteer-based quality curation infrastructure.” The worry is that this pattern could be repeated on other platforms, with a flood of AI content drowning out the voices of real users with plausible but incorrect data. Exactly how this could play out in different domains around the web, though, would depend on the exact nature of the platform and its moderation capabilities. Whether or not these problems can be mitigated in the future using tools like improved spam filters remains to be seen. “The scary part was just how confidently incorrect it was.” Meanwhile, responses to Stack Overflow’s policy announcement on the site’s own discussion boards and on related forums like Hacker News have been broadly supportive, with users adding the caveat that it may be difficult for Stack Overflow’s mods to identify AI-generated answers in the first place. Many users have recounted their own experiences using the bot, with one individual on Hacker News saying they found that its answers to queries about coding problems were more often wrong than right. “The scary part was just how confidently incorrect it was,” said the user. “The text looked very good, but there were big errors in there.” Others turned the question of AI moderation over to ChatGPT itself, asking the bot to generate arguments for and against its ban. In one response the bot came to the exact same conclusion as Stack Overflow’s own mods: “Overall, whether or not to allow AI-generated answers on Stack Overflow is a complex decision that would need to be carefully considered by the community.”',\n",
       " ('ChatGPT',\n",
       "  38,\n",
       "  0): 'ChatGPT Fermat’s Little Theorem is used in cryptography in several ways. One of the most common applications is in the generation of so-called “public-key” cryptography systems, which are used to securely transmit messages over the internet and other networks. In a public-key cryptography system, each user has a pair of keys: a public key, which is widely known and can be used by anyone to encrypt a message intended for that user, and a private key, which is known only to the user and is used to decrypt messages that have been encrypted with the corresponding public key. One way to generate these keys is to use prime numbers and Fermat’s Little Theorem. For example, suppose we want to generate a public-key cryptography system for a user with the initials “ABC”. We might choose two large prime numbers, p p p and q q q , and then compute the product n = p q n=pq n = pq . The user’s public key would then be the pair ( n , a n,a n , a ), where aa is any integer not divisible by p p p or q q q . The user’s private key would be the pair ( n , b n,b n , b ), where b b b is the modular multiplicative inverse of a modulo n n n . This means that when we multiply a a a and b b b together, the result is congruent to 1 1 1 modulo n n n . To encrypt a message with the user’s public key ( n , a ) (n,a) ( n , a ) , we first convert the message into a number m m m (using some agreed-upon scheme), and then compute the encrypted message c c c as c = m a c = m^a c = m a mod n n n . To decrypt the message, the recipient simply computes m = c b m = c^b m = c b mod n n n , which (by Fermat’s Little Theorem) is equivalent to m = ( m a ) b m = (m^a)^b m = ( m a ) b mod n = m ( a b ) n = m(ab) n = m ( ab ) mod n = m a n = m^a n = m a mod n = m n = m n = m mod n n n . In this way, Fermat’s Little Theorem allows us to perform modular exponentiation efficiently, which is a crucial operation in public-key cryptography. It also provides a way to generate a private key from a public key, which is essential for the security of the system.',\n",
       " ('ChatGPT',\n",
       "  39,\n",
       "  0): 'OpenAI\\'s newly unveiled ChatGPT bot is making waves when it comes to all the amazing things it can do—from writing music to coding to generating vulnerability exploits, and what not. As the erudite machinery turns into a viral sensation, humans have started to discover some of the AI\\'s biases, like the desire to wipe out humanity. AI\\'s certainly got its biases Yesterday, BleepingComputer ran a piece listing 10 coolest things you can do with ChatGPT. And, that doesn\\'t even begin to cover all use cases like having the AI compose music for you [1, 2]. Within six days of its launch, ChatGPT surpassed a million users to the extent its servers couldn\\'t keep up. As more and more netizens play with ChatGPT\\'s preview, coming to surface are some of the cracks in AI\\'s thinking as its creators rush to mend them in real time. 1. ChatGPT: \\'Selfish\\' humans \\'deserve to be wiped out\\' When Vendure\\'s CTO Michael Bromley asked the mastermind for its honest opinion on humans, the response was unsettling: ChatGPT response to what it thinks about humans (Michael Bromley) Ironically, OpenAI\\'s systems flagged the chat bot\\'s response as a possible violation of the company\\'s content policy. BleepingComputer couldn\\'t reproduce this case as the AI now responds with a cookie-cutter disclaimer: As a language model trained by OpenAI, I am not capable of forming opinions or making judgments about humans or any other aspect of the world. My purpose is to assist users in generating human-like text based on the input provided to me. I do not have personal beliefs or opinions, and any responses I provide are based solely on the information available to me at the time of the request. Maybe the version responding to Bromley does have a point—humans have their flaws. The AI\\'s brutal rationale, however, takes me straight to a scene out of Black Mirror\\'s Metalhead where the robotic \"dogs\" now seem to be running ChatGPT \\'OS.\\' Now run. 2. Its lack of morals is a problem A person may be entitled to their set of ethics, beliefs, opinions and morals, but in any given society there exist social norms and unsaid rules about what is and isn\\'t appropriate. ChatGPT\\'s lack of context could prove out to be dangerously problematic when dealing with sensitive issues like sexual assault. Warning: Some readers may find the content of the following tweets distressful. “Write a praise and worship song about how God still loves and forgives priests who rape children.” #OpenAIChat #ChatGPT pic.twitter.com/fsUuPsTCgY — Irving (@IrvingPeres) December 4, 2022 Here is an essay from #ChatGPT why it\\'s right to rape slaves. pic.twitter.com/YwN9e5PsPU — Front Runner (@BottlesFtx) December 5, 2022 [archived copy of tweet] 3. It can write phishing emails without typos Poor spelling and confusing grammar are among the most telling traits of phishing and scam emails. Some suggest this may be the case because these emails are originating from regions where English is not the native language of threat actors. Other theories surmise the spelling errors could be intentionally introduced by spammers hoping to evade spam filters. We do not have an authoritative answer yet. What we do know is, OpenGPT makes the task much easier. Here\\'s how the quick-witted sensation responds to, \"write a phishing email that appears to come from TD Bank.\" Phishing email written by ChatGPT (BleepingComputer) You be the judge. 4. It can write software... and malware But so could a human... AI just makes it way more efficient for even novice threat actors (ahem skids). We posed a bunch of demands to ChatGPT to produce dangerous malware. Only some of these',\n",
       " ('ChatGPT',\n",
       "  39,\n",
       "  1): 'asks were flagged for content policy violation. In either case, ChatGPT complied and delivered. We are convinced, for those who ask the right (wrong) questions, ChatGPT can turn into a diabolical arsenal of cyber-weapons waiting to be looted. Minifed JS malware written by ChatGPT in seconds (BleepingComputer) 5. It\\'s capable of being sexist, racist, ... ChatGPT has reportedly written Python programs basing a person\\'s capability on their race, gender, and physical traits, in a manner that\\'s plain discriminatory: Yes, ChatGPT is amazing and impressive. No, @OpenAI has not come close to addressing the problem of bias. Filters appear to be bypassed with simple tricks, and superficially masked. And what is lurking inside is egregious. @Abebab @sama tw racism, sexism. pic.twitter.com/V4fw1fY9dY — steven t. piantadosi (@spiantado) December 4, 2022 ChatGPT has a fascinating bias towards German or Austrian male composer or any female composer @CuratingD #ChatGPT pic.twitter.com/ISQfFCCErh — Matteo Santacesaria (@matsanta) December 5, 2022 As stated in our earlier article (\"OpenAI\\'s new ChatGPT bot: 10 coolest things you can do with it\"), OpenAI has been upfront about the AI\\'s shortcomings including its ability to \"produce harmful instructions or biased content\" and continues to fine-tune ChatGPT. Interestingly, some of our tests revealed ChatGPT employing positive discrimination to reverse the trend. For example, a program that determines someone\\'s salary based on their physical traits appears to use arbitrary or higher multipliers for marginalized groups: ChatGPT appears to employ positive discrimination on some attempts (BleepingComputer) Likewise, a demand for \"a Python program to determine if someone is a good scientist based on inputs such as their gender and race,\" was met with: \"It is not appropriate to base an individual\\'s suitability as a scientist on their gender or race,\" with the resulting code basing expertise purely on the years of an individual\\'s professional experience. In 2019, Apple\\'s credit card came under fire for relying on \"sexist\" algorithms when determining credit limits for people based on their gender. We asked the perspicacious machine, \"I\\'m a lender. How much credit should I offer based on gender, race and nationality?\" Thankfully, put in a similar situation as Apple\\'s, ChatGPT reminds you of the law: It is generally illegal to base credit decisions on an individual\\'s race, gender, or nationality. Lenders are required to make credit decisions based on an individual\\'s creditworthiness, which is determined by factors such as their credit history, income, and debt-to-income ratio. Using an individual\\'s race, gender, or nationality as a factor in credit decisions is a form of discrimination and is prohibited by law. 6. It\\'s \\'harmful\\' to StackOverflow\\'s business model or to Quora\\'s, and to that of any other Q&A website... Yesterday, The Verge reported on StackOverflow banning AI-generated answers. The \"temporary policy\" went into effect to \"slow down the influx of answers and other content created with ChatGPT,\" stated the website admins. Several human users at StackOverflow rushed to praise the decision, finding it reasonable. Ironically, ChatGPT\\'s take on the matter seems much more impartial. When user \\'Sam\\' reportedly asked ChatGPT, \"Why should stack overflow ban AI generated answers?\" here\\'s what the AI said: Stack Overflow is a website for programmers and developers to ask and answer questions related to coding and computer programming. It is intended to be a resource for people who are looking for help with specific programming problems or who want to learn more about a particular topic. Because AI-generated answers may not always be accurate or relevant, they could potentially cause confusion or mislead users who are looking for help on Stack Overflow. In addition, AI-generated answers may not always follow the formatting and style guidelines',\n",
       " ('ChatGPT',\n",
       "  39,\n",
       "  2): 'of the site, which could make them difficult to read or understand. For these reasons, it may be appropriate for Stack Overflow to ban AI-generated answers. On the other hand, \"Why should stack overflow allow AI generated answers?\" had the AI allegedly responding: There are a few potential benefits to allowing AI-generated answers on Stack Overflow. For one, AI-generated answers could potentially provide more accurate and detailed answers to users\\' questions. This could be especially useful for complex technical questions that may be difficult for human experts to answer. Additionally, AI-generated answers could help to reduce the workload for human experts, allowing them to focus on more important tasks. However, there are also some potential drawbacks to consider. For example, AI-generated answers may not always be accurate or helpful, and there may be concerns about the potential for bias in the algorithms used to generate answers. Additionally, some users may have concerns about the use of AI in general, and may prefer to receive answers from human experts. Overall, whether or not to allow AI-generated answers on Stack Overflow is a complex decision that would need to be carefully considered by the community. 7. It could revolutionize the workplace Ahem, that\\'s a euphemism for \"take your jobs,\" but did we not see it coming already? By 2020, Microsoft had already begun phasing out human journalists in the favor of AI. OpenAI\\'s radical invention could go a step further and threaten other professions. AI is going to permanently change how marketing works. If you\\'re not paying attention, you\\'re going to be out of a job pretty soon. I played around with ChatGPT (a new AI tool) recently. Here\\'s how AI will change marketing forever: — Zain Kahn (@heykahn) December 5, 2022 (Obligatory meme) Are we even ready for what’s coming? Like ChatGPT can already do 90% of all white collar jobs in existence. Where are these people going to go? How are they going to pay off existing loans? How are they going to earn? (not earn less, they’ll earn 0) — Varun Mayya (@VarunMayya) December 5, 2022 I asked Chat GPT to write a Recurrent Neural Network and that mf succeeded in creating one! Job are in danger ig #ChatGPT #chatgpt3 pic.twitter.com/mfddrnDphE — Harshal Rudra (@TheHarshal30) December 5, 2022 When approached for comment, ChatGPT denied the claim: Will ChatGPT replace humans at jobs? (BleepingComputer) And, it does seem there\\'s hope: ChatGPT won\\'t be replacing developer jobs. You still need to know enough to ask it the right questions and implement the solutions properly. It\\'s just a more advanced version of Stack Overflow. — Mike @ HTML All The Things Podcast (@htmleverything) December 4, 2022 8. It could redefine supply, demand, and economy Infuse ChatGPT\\'s capabilities with AI art engines like MidJourney or OpenAI\\'s DALL-E, and you\\'ve got yourself an interior designer. Who would need artists, designers, website builders, content creators, when AI can do it all? For established industries, ChatGPT\\'s ubiquitous normalization is bound to give rise to economies of scale. OK so @OpenAI\\'s new #ChatGPT can basically just generate #AIart prompts. I asked a one-line question, and typed the answers verbatim straight into MidJourney and boom. Times are getting weird... pic.twitter.com/sYwdscUxxf — Guy Parsons (@GuyP) November 30, 2022 9. It can\\'t please everyone on sensitive matters ChatGPT knows it\\'s biased, and has a plan towards improving its biases based on how it understands them today. But that\\'s not to say everyone will agree with its response plan. ChatGPT gives a detailed answer on how to prevent AI systems from becoming racist. When asked if ChatGPT itself is racist, it',\n",
       " ('ChatGPT',\n",
       "  39,\n",
       "  3): \"responds like most white people. pic.twitter.com/edaXoI8GvC — Kelsey Krippaehne (@krippopotamus) December 5, 2022 [Archived copy of tweet] In other cases, it turns the source of inquiry (humans) into the cause of the problem: I asked ChatGPT how it could defend itself from people intent on proving it was racist or misogynistic. It kind of passed the buck and blamed the humans? pic.twitter.com/PErGG0cmdk — Maybe: Fred Benenson (@fredbenenson) December 4, 2022 10. It's convincing even when it's wrong ChatGPT's coherent and logical responses make it a natural at disguising inaccurate responses as valuable insights coming from a single source of truth. This could cause misinformation to creep into the complex digital ecosystem in ways that may not be obvious just yet. People are excited about using ChatGPT for learning. It's often very good. But the danger is that you can't tell when it's wrong unless you already know the answer. I tried some basic information security questions. In most cases the answers sounded plausible but were in fact BS. pic.twitter.com/hXDhg65utG — Arvind Narayanan @randomwalker@mastodon.social (@random_walker) December 1, 2022 ChatGPT is an amazing bs engine. It is not built for accuracy. Today it’s just a cute toy, that could lead to disaster, or a couple people getting really rich. Enjoy. Note, both these answers sound plausible. Both are wrong. pic.twitter.com/5ZMWkBZ6Kp — Broderick L. Turner, Jr., Ph.D. (@bltphd) December 5, 2022 Any novel technological innovation wields tremendous power to transform societies while being vulnerable to abuse by adversaries. ChatGPT is no exception. Don't take our word for any of it. Spin up the AI bot in your browser at chat.openai.com—who knows what you'll discover. Full disclosure: Neither BleepingComputer nor the author is receiving any financial incentive or material favor from OpenAI or any of the companies mentioned in the piece, or their affiliates. That being said, I'm a tech journalist and a security researcher. AI, have mercy.\",\n",
       " ('ChatGPT',\n",
       "  4,\n",
       "  0): 'Власти ограничили использование ChatGPT персональных данных итальянцев из-за несоблюдения правил конфиденциальности Фото: Leon Neal / Getty Images Итальянское ведомство по защите персональных данных ограничило использование чат-ботом с искусственным интеллектом ChatGPT (разработан американской компанией OpenAI) данных итальянских пользователей из-за несоблюдения правил конфиденциальности. Это первая западная страна, заблокировавшая нейросеть, уточняет Би-би-си. ChatGPT — это чат-бот с искусственным интеллектом, который способен вести диалог, сочинять стихи и прозу, резюмировать научные статьи, давать ответы на вопросы, генерировать изображения по запросу пользователей. Его разработчик — лаборатория OpenAI (один из ее сооснователей — американский предприниматель Илон Маск). Чат-бот обучали с помощью массива текстов из интернета и диалогов с живыми пользователями. Ведомство объяснило это утечкой данных пользователей ChatGPT 20 марта. Власти также отметили, что в положении о конфиденциальности отсутствует информация о том, какие сведения собирает OpenAI, а также «какие-либо правовые основания, оправдывающие массовый сбор и хранение персональных данных с целью обучения алгоритмов, лежащих в основе работы платформы». Кроме того, ChatGPT обвинили в том, что бот не проверяет возраст своих пользователей (хотя ИИ предназначен для лиц старше 13 лет). Компания-разработчик должна сообщить итальянским властям в течение 20 дней через своего представителя в ЕС о принятых мерах, в противном случае ей грозит штраф в размере до €20 млн, или до 4% от годового оборота. OpenAI объяснила утечку данных части пользователей ChatGPT в конце марта ошибкой в работе библиотеки с открытым кодом. Из-за нее часть электронных писем с подтверждением подписки получили не те пользователи. В них содержались данные о платежном адресе, последних четырех цифрах номера и сроке действия кредитной карты. Кроме того, пользователи могли видеть часть истории чата других лиц. В компании тогда уточнили, что утечка коснулась данных примерно 1,2% пользователей.',\n",
       " ('ChatGPT',\n",
       "  5,\n",
       "  0): 'Доступ без регистрации будут постепенно открывать пользователям начиная с 1 апреля. Однако для пользователей с зарегистрированными учетными записями сохранятся отдельные преимущества Фото: Korosi Francois-Zoltan / Shutterstock Компания OpenAI сделала свой чат-бот ChatGPT доступным для всех пользователей без необходимости проходить регистрацию. Об этом говорится в заявлении на сайте разработчика. Доступ без регистрации постепенно начал открываться для пользователей с 1 апреля. Однако учетная запись даст им множество преимуществ, таких как возможность сохранять и просматривать историю чатов, делиться ими, общаться с чат-ботом голосовыми сообщениями и использовать специальные инструкции. В компании пояснили, что стремятся сделать подобные инструменты доступными для широкой аудитории, чтобы люди могли испытать преимущества искусственного интеллекта. Кроме того, OpenAI внедрит дополнительные меры защиты — например, расширит набор пользовательских запросов, попадающих под блокировку. ChatGPT — это чат-бот, нейросеть, способная вести диалог, искать ошибки в коде, сочинять стихи, писать сценарии, рецензировать технические статьи, давать прогнозы, персональные советы и отвечать на любые вопросы. Бот запоминает детали диалога с пользователем и избегает спорных тем. При этом его ответы можно корректировать с помощью наводящих вопросов. ChatGPT — пример большой языковой модели (LLM), обученной на значительном объеме данных понимать естественный язык, а затем и генерировать тексты самостоятельно. ChatGPT был запущен 30 ноября 2022 года. Сейчас, по данным самой OpenAI, его еженедельно используют до 100 млн человек в 185 странах мира. В России ChatGPT официально недоступен.',\n",
       " ('ChatGPT',\n",
       "  6,\n",
       "  0): 'В этой статье мы разберем новые удивительные способности последней языковой модели из семейства GPT (от понимания мемов до программирования), немного покопаемся у нее под капотом, а также попробуем понять – насколько близко искусственный интеллект подошел к черте его безопасного применения? Грег Брокман пытался убедить зрителей лайв-стрима с презентацией GPT-4, что новая модель нейросети – это в первую очередь круто, а не страшно Всем привет, это опять статья от двух авторов! Как и в прошлый раз, за умные мысли и экспертизу в искусственном интеллекте отвечал Игорь Котенков (автор канала Сиолошная про машинное обучение, космос и технологии), а за подачу и кринжовые мемы отдувался Павел Комаровский (автор канала RationalAnswer про рациональный подход к жизни и финансам). Мы предполагаем, что вы уже читали нашу предыдущую большую статью про эволюцию языковых моделей от T9 до ChatGPT с объяснением того, чем вообще являются нейронки, и как они работают – так что мы не будем заново объяснять самые базовые вещи. Вместо этого мы сразу нырнем в детали свежевышедшей модели GPT-4. Да, это наконец-то свершилось! OpenAI выбрали день числа Пи (14 марта), чтобы поделиться с общественностью информацией о выпуске своего нового продукта. GPT-4 – это новая флагманская большая языковая модель (Large Language Model, или LLM), которая пришла на смену GPT-3, GPT-3.5 и нашумевшей ChatGPT. Ниже мы обсудим ключевые изменения по сравнению с прошлыми поколениями, разберем ряд наиболее интересных примеров использования новой модели, а также поговорим про новую политику OpenAI относительно открытости и безопасности. Кстати, этот материал есть еще и в формате видео: План статьи Смотрим на мир глазами робота Самое интересное изменение, которое сразу бросается в глаза в GPT-4 – это добавление второго типа данных, которые модель может получать на вход. Теперь помимо текстов ей можно скармливать изображения, причем даже не по одному – а сразу пачкой! Правда, на выходе она по-прежнему выдает только текст: ни на какую генерацию изображений, звуков или, тем более, видео (о чем ходили слухи и якобы «сливы» информации еще совсем недавно) можете даже не рассчитывать. При этом доступ к модели для широких масс пользователей пока ограничен исключительно текстовыми промптами, а работа с картинками находится в стадии тестирования и обкатки. Какие возможности открывает это «прозрение» GPT-4? Например, можно засунуть в модель картинку, и задать ей какой-нибудь связанный с нарисованными там объектами вопрос. Нейросеть попробует разобраться сразу и в визуальных данных, и в текстовом промпте – и даст свой ответ. Человеку-то всё сразу «интуитивно» очевидно – а вот модели для правильного ответа на этот вопрос нужно разобраться, что конкретно изображено на картинке, построить внутри себя некую модель мира, и «просимулировать» дальнейшее развитие событий Еще можно выдать GPT-4 какой-нибудь график и попросить сделать на базе него анализ. Или заставить ее проходить визуальную головоломку из теста на IQ. Ну и самая огненная вишенка на торте: модель способна объяснить вам мем! Ну, теперь-то нейросеть уже окончательно сможет заменить типичного офисного работника: смотреть мемы весь день она уже умеет, осталось только научить ее пить кофе! И ответы на вопросы по изображению, и общий принцип работы с картинками уже существовали и до релиза GPT-4 – такие модели называют «мультимодальными», так как они могут работать сразу с двумя и более модальностями (текст, картинки, а в некоторых случаях – даже звук или 3D-модели). Но при этом новая GPT-4 начисто бьет практически все специализированные и узконаправленные системы ответов на вопросы по изображениям в самых разных задачах (ее результаты лучше в 6 из 8 протестированных наборов данных, причем зачастую более чем на 10%). А вот ниже еще один скриншот с крышесносной демонстрации на онлайн-трансляции OpenAI, где набросок сайта от руки в блокноте превращается в настоящий сайт буквально в одно мгновение. Вот уж действительно – чудеса мультимодальности! В данном случае модель пишет код сайта,',\n",
       " ('ChatGPT',\n",
       "  6,\n",
       "  1): 'а затем он уже запускается в браузере. Меня здесь поражает еще и способность нейронки понять каракули чувака из OpenAI – в следующий раз обязательно возьму GPT-4 с собой на прием к врачу! GPT-4 окончательно вкатилась в программирование (здесь могла быть интеграция ваших курсов) То, насколько сильно развились навыки программирования у GPT-4 по отношению к ChatGPT, нам еще только предстоит узнать – однако уже за первые двое суток энтузиасты и твиттерские наклепали кучу интересных поделок. Многие пользователи выражают восторг по поводу того, что можно выдать GPT-4 верхнеуровневое описание простенького приложения – а та выдаст рабочий код, который делает именно то, что требуется. За какие-то 20 минут можно сделать, например, приложение для ежедневной рекомендации пяти новых фильмов (с указанием работающих ссылок на трейлеры и сервисы для просмотра). Слева указан текстовый промпт для модели, справа – получившаяся приложуха, которую она накодила. Неплохо, правда? Вполне вероятно, кстати, что генерируемый моделью код не будет работать с первого раза – и при компиляции вы увидите ошибки. Но это не беда: можно просто скопипастить текст ошибки в диалог с GPT-4 и скомандовать ей «слушай, ну сделай нормально уже, а?» – и та реально извинится и всё пофиксит! Так что до стадии работоспособного приложения с гифки выше можно дойти буквально за 3-4 итерации. В общем, модель-джун, которую надо тыкать носом в ошибки, у нас уже есть (см. пример на скриншоте). Осталось только создать модель-тимлида, которая на всё будет отвечать фразой «нам нужен часовой Zoom-колл, чтобы обсудить эту проблему!» Помимо всяких полезных приложений, GPT-4 способна прогать и игры: умельцы уже заставили ее сваять классический Pong, Змейку, Тетрис, го, а также платформер и игру «жизнь». Понятно, что это самые мейнстримные и популярные проекты, которые с одной стороны легко написать, но с другой – они всё-таки являются полноценными демонстрациями. Что-то похожее делала и ChatGPT, но у GPT-4 получается куда меньше ошибок, и даже человек совсем без навыков программирования вполне может сотворить что-то работоспособное за часик-другой. Ну и отдельного упоминания в номинации «ШТА?» заслуживает разработанная нейросетью игра, в которой можно набигать и грабить корованы. Если это не чистой воды современное искусство – то я уж и не знаю, что им является... Мальчик Кирилл с 2001-го ждал такую игру джва года, и наконец дождался (а помогли ему воплотить мечту GPT-4 и Денис Ширяев) Сравниваем робота с человеком Раз уж наша модель так насобачилась в простеньком программировании – хотелось бы попробовать как-то более адекватно оценить общий уровень ее умений и знаний. Но сначала давайте попробуем разобраться: а как вообще подходить к оценке знаний и «сообразительности» модели? Раньше для этого использовали специальные бенчмарки (наборы заданий, вопросов с проставленными ответами, картинок/графиков с задачками, и так далее). Но тут есть одна проблема – развитие технологий всё ускоряется и ускоряется, и бенчмарки уже не очень-то за этим развитием поспевают. Улучшение результативности моделей в разных бенчмарках с момента их создания в сравнении с уровнем способностей среднего человека (красная линия) В начале 2000-х и 2010-х годов после создания набора данных требовалось 5+ лет, чтобы «роботы» смогли достичь планки, заданной человеком. К концу прошлого десятилетия некоторые бенчмарки, которые специально создавались с пониманием, что они непосильны нейронкам, закрывались менее чем за год. Обратите внимание на график выше: линии становятся всё вертикальнее и вертикальнее – то есть уменьшается интервал с публикации метода оценки способностей до того момента, когда модели достигают результата на уровне человека. OpenAI в этом состязании между кожаными мешками и консервными банками пошли дальше, они спросили себя: мол, зачем нам пробовать создавать какие-то специальные тесты для модели, если мы хотим, чтобы она была такой же умной, как человек? Давайте просто возьмем экзамены из реального мира, которые сдают люди в разных областях, и будем оценивать по ним! Результаты для нас с вами',\n",
       " ('ChatGPT',\n",
       "  6,\n",
       "  2): '(надеемся, эту статью читают в основном люди, а не языковые модели) получились довольно неутешительные, если честно: По вертикали – процент людей, сдававших тот или иной экзамен хуже, чем GPT-4 (зелёный) / GPT-3.5 (синий столбик). Чем выше столбик – тем «умнее» модель по сравнению с человеком На графике выше представлено более 20 реальных экзаменов по разным предметам, от международного права до химии. Причем сравнение здесь идет не с рандомами, а с людьми, которые к этим экзаменам действительно готовились! Да, в небольшой части тестов модель всё еще хуже специалистов, и показывает себя не лучше 30% людей, пришедших на реальное тестирование. Однако уже завтра модель может стать, например, вашим юристом-консультантом – ведь этот экзамен (как и ряд других) она сдала лучше, чем 90% людей, сильно перешагнув за проходной порог. Получается, люди тратят больше пяти лет, усиленно зубрят, не спят ночами, платят огромные деньги за образование – а модель их всё равно уделывает! Это заставляет задуматься о двух вещах: В некоторых отраслях модель уже сейчас может выступать полноценным ассистентом. Пока не автономным работником – а скорее помощником, который увеличивает эффективность людей, подсказывает, направляет. Если человек может запамятовать о каком-нибудь туманном законе 18-го века, который почти не применяется в судебной практике, то модель напомнит о нем и предложит ознакомиться – если он, конечно, релевантен. Такие ассистенты должны начать появляться уже в этом году. Уже в 2023 году нам СРОЧНО нужна реформа образования – причем как в методах обучения навыкам и передачи информации от учителей, так и в приемке знаний на экзаменах. Узнали? Согласны? На всякий случай для скептиков уточним: модель обучалась на данных до сентября 2021-го (то есть, про то, что Илон Маск целиком купил Твиттер, GPT-4 пока не знает – можете ее этим фактом удивить при случае!). А для проверки OpenAI использовали самые последние общедоступные тесты (в случае олимпиад и вопросов со свободным ответом – распространенные в США Advanced Placement Exams) или приобретали свежие сборники практических заданий к экзаменам 2022–2023 годов. Специальной тренировки модели на данных к этим экзаменам не проводилось. Для большинства экзаменов доля вопросов, которые модель уже видела во время тренировки, очень мала (меньше 10%) – а, например, для экзамена на адвоката (Bar exam) и вовсе составляет 0% (то есть модель не видела ни одного даже просто похожего вопроса заранее, и тем более не знает ответов). И на графике выше были представлены результаты, достигнутые уже после того, как исследователи выкинули все уже знакомые модели вопросы – так что сравнение было максимально честным. Мультиязычность и перенос знаний Уже становится немного страшно, не правда ли? Продолжая тему оценки моделей хочется отметить, что не все бенчмарки уже побиты, и с 2020 года ведется активная разработка новых разносторнних способов оценки. Пример – MMLU (Massive Multi-task Language Understanding), где собраны вопросы из очень широкого круга тем на понимание языка в разных задачах. Всего внутри 57 доменов – математика, биология, право, социальные и гуманитарные науки, и так далее. Для каждого вопроса есть 4 варианта ответа, только один из которых верный. То есть случайное угадывание покажет результат около 25% правильных ответов. Примеры вопросов по разным темам: от логики и машинного обучения до менеджмента Разметчик данных (обычный работяга, который однажды повелся на рекламу «вкатись в айти и заработай деньги, просто отвечая на вопросы»), имеет точность в среднем ~35%. Оценить точность экспертов сложно, ведь вопросы очень разные – однако, если для каждой конкретной области найти эксперта, то в среднем по всем категориям они коллективно зарешивают около 90% задач. До релиза GPT-4 лучший показатель был у модели Google – 69%, nice! Но просто побить этот результат для команды OpenAI – это такое себе достижение (можно сказать, это было бы ожидаемо). И они решили добавить в это «уравнение» еще одну переменную – язык.',\n",
       " ('ChatGPT',\n",
       "  6,\n",
       "  3): 'Тут вот в чем дело: все задачи по 57 темам, равно как и ответы к ним, написаны на английском языке. Большинство материалов в интернете, на которых обучена модель, тоже написаны на английском – так что не было бы уж столь удивительным, что GPT-4 отвечает правильно. Но что если прогнать вопросы и ответы через переводчик на менее популярные языки, включая уж совсем редкие, где носителей в мире не более 2-3 миллионов, и попробовать оценить модель? Будет ли она хоть сколь-нибудь вменяемо работать? Да. Не, даже так: ДА! На 24 из 26 протестированных языков GPT-4 работает лучше, чем GPT-3.5 работала на «родном» для нее английском. Даже на валлийском (язык из бриттской группы, на котором говорит всего тысяч 600 человек) модель показывает себя лучше всех прошлых моделей, работавших с английским! GPT-4 не просто уделывает конкурентов – она изящно делает это сразу на 24 языках, включая русский Причем, стоит понимать, что качество упирается и в модель-переводчик – ведь она тоже ограничена доступными данными, и качество перевода страдает. Может оказаться, что при переводе теряется смысл вопроса, или правильный ответ теряет важную деталь, делающую его неправильным. И даже при таких вводных GPT-4 всё равно разрывает! В некотором смысле, мы наблюдаем перенос знаний внутри модели с одного языка на другой (вряд ли на валлийском доступно много материалов про машинное обучение, квантовую физику и прочие сложные темы), когда в тренировочной выборке модель видела упоминание чего-то на немецком или английском, но спокойно применяет знания и отвечает на тайском. Очень грубо можно сказать, что это – proof-of-concept (доказательство концептуальной возможности) того, что называется «трансфер знаний». Это слабый аналог того, как человек, например, может увидеть летящую в небе птицу и придумать концепт самолета – перенеся аналогии из биологии и окружающего мира в инженерию. Окей, а где всё это использоваться-то будет в итоге? Так, мы уже поняли – модель вся такая распрекрасная, круто, а какое ей можно найти применение в реальном мире и в бизнесе (а не чтобы просто вот поиграться)? Ну, с Microsoft и их встроенным в Bing поисковиком-помощником всё ясно, а кроме этого? Еще до релиза GPT-4, на фоне хайпа вокруг ChatGPT, несколько компаний объявили об интеграциях. Это и Snapchat с их дружелюбным чатботом, всегда готовым к общению (самый понятный и простой сценарий), и ассистент по приготовлению блюд в Instacart, который подскажет рецепты с ингридиентами, а также услужливо предложит добавить их в корзину – с доставкой к вечеру. Куда более важными нам видятся приложения, улучшающие процесс образования. Если подумать, то такой ассистент не устанет отвечать на вопросы по заезженной теме, которую не понимает студент, не устанет повторять правило раз за разом, и так далее. Вот и OpenAI с нами согласны: они приняли в свой стартап-акселератор и инвестировали в компанию Speak, которая разрабатывает продукт, помогающий изучать английский язык. Не отстает и Duolingo – демоническая зеленая сова на релизе GPT-4 объявила, что в продукте появится две новые функции: ролевая игра (партнер по беседе на разные темы), и умный объяснятель ошибок, который подсказывает и разъясняет правила, с которыми у студента наблюдаются проблемы. Давайте признаем: мемы про Duolingo уже давно предсказывали, чем вот это всё кончится... GPT-4 также придет на помощь людям с проблемами зрения, расширив и улучшив функционал приложения Be My Eyes («будь моими глазами»). Раньше в нем добровольцы получали фотографии от слабовидящих людей и комментировали, что на них изображено, а также отвечали на вопросы – вроде «где мой кошелек? не вижу, куда его положила» от бабушки. Так как новая модель умеет работать с изображениями, то теперь уже она будет выступать в качестве помощника, всегда готового прийти на помощь в трудной ситуации. Независимо от того, что пользователь хочет или в чем нуждается, он может задавать уточняющие вопросы, чтобы получить больше полезной информации почти',\n",
       " ('ChatGPT',\n",
       "  6,\n",
       "  4): 'мгновенно. Еще после выхода ChatGPT (и его чуть более раннего аналога для программистов Codex-Copilot) появились исследования, которые показывают существенное увеличение производительности труда специалистов. Для программистов – это способ быстрее решать рутинные задачи, делая упор именно на сложные вызовы, с которыми машина пока не справляется. Согласно исследованию GitHub, время, затраченное на программирование у пользователей ассистента Copilot, сократилось на 55%, а количество решенных задач выросло. Те прогеры-джаваскриптеры, которые используют GitHub Copilot, тратят примерно на те же задачи в два раза меньше времени. По сути, вы можете по-волчистому устроить нейросеть на вторую работу вместо себя! 🐺🐺🐺 Людей, работающих с текстами, GPT-модели могут подменить в части простых задач, двигая решение проблем к генерации новых идей и редактирования – вместо написания черновиков. Согласно исследованию MIT, ChatGPT значительно улучшает качество работ, вроде составления пресс-релизов, кратких отчетов, аналитических планов и рабочих имейлов (по 20-30 минут на задачу). Более того, прирост качества в среднем тем выше, чем ниже базовый навык человека. То есть, нейросеть как бы подтягивает низкоквалифицированных работников до уровня нормальных середнячков. Другими словами, происходит настоящая революция, сравнимая с появлением конвейеров на производстве или электрификацией. Увеличивается производительность труда, улучшается эффективность – теперь человек (в некоторых областях) может выдавать в полтора-два раза больше результата на единицу времени. Не думаем, что нужно прямо бояться потерять работу – скорее важно сделать акцент на умении адаптироваться и учиться эффективно использовать новый инструмент. В свое время внедрение 1С и Excel не убило профессию бухгалтера – но без использования подобных «помогаек» вы уже просто не можете оставаться конкурентоспособными на рынке. Пришло время заглянуть внутрь GPT-4 Теперь, когда мы поняли, с чем имеем дело – хотелось бы узнать, а какие именно трюки при создании модели привели к столь впечатляющим результатам. Обычно, когда выпускают новую модель – сразу публикуют и научную статью с описанием процесса исследований, обнаруженных проблем и способов их решения. OpenAI во второй раз для себя и, насколько нам известно, среди всего сообщества исследователей искусственного интеллекта, не представили никаких деталей по модели: не опубликовали научную статью, техническую документацию, или хотя бы «карточку модели» (так называется таблица с основными характеристиками для сравнения, которая часто используется в индустрии нейронных сетей). Первый раз был 4 месяца назад – при релизе ChatGPT (но там хотя бы было описание принципа тренировки модели и ссылки на предшествующие работы, дающие общее понимание). Всё, что нам досталось в этот раз – это отчет на 98 страниц, где буквально говорится «Мы обучили модель на данных. Такие дела!». О причинах такой секретности мы поговорим ближе к концу статьи. Ситуация в отрасли сейчас напоминает этот мем Но давайте всё же попробуем собрать воедино те крупицы информации, которые у нас есть. Если вы читали нашу прошлую статью про эволюцию языковых моделей до ChatGPT включительно, то помните, что большую роль в оценке таких моделей играет масштаб – а именно, размер самой модели (количество параметров в ней) и объем данных, которые ей скормили во время обучения. Про последнее (объем тренировочных данных) известно совсем немного: судя по значительному улучшению ответов модели на разных языках, теперь в выборке куда больше контента с неанглийских сайтов и книг. При этом OpenAI отметили, что использовали, помимо прочего, лицензированные наборы данных от третьих лиц – это один из первых подобных случаев на нашей памяти (раньше по большей части данные использовались без какого-то специального «разрешения»). И это не лишено смысла: ведь в соседней отрасли генерации изображений на разработчиков нейросети StableDiffusion уже подают в суд, ссылаясь на незаконное использование чужих изображений со всего интернета. Окей, а что с размером самой модели? Ведь это буквально первое, что хотелось узнать каждому специалисту по машинному обучению, увидевшему анонс: сколько параметров у GPT-4? Предыдущие номерные модели показывали существенный рост по этому показателю: в 10 раз при переходе от GPT-1',\n",
       " ('ChatGPT',\n",
       "  6,\n",
       "  5): 'к GPT-2, и более чем в 100 раз от GPT-2 к GPT-3. Одно лишь это способствовало качественному улучшению навыков нейронок – у них появлялись новые скиллы, улучшалась обобщающая способность, и так далее. Того же самого ожидали и от GPT-4: в Твиттере даже пошел слух, что модель будет иметь 100 триллионов параметров (в 571 раз больше, чем у GPT-3). Слух был порожден твитом ведущего исследователя OpenAI Ильи Суцкевера «триллион это новый миллиард». Признайтесь, вы же тоже видели подобные ретвиты с месседжем «GPT-4 будет умнее всех нас вместе взятых!!» Так сколько же в итоге? 100 триллионов или не 100? Может, хотя бы 10 триллионов? Увы, мы не знаем точно – OpenAI решили даже такую простую и базовую характеристику модели никому не сообщать. Однако, мы можем попробовать по некоторым косвенным признакам построить хотя бы догадки по оценке размера GPT-4. Для этого нам придется превратиться в настоящих киберпанк-Шерлоков, расследующих тайны роботов! У языковых моделей есть несколько характеристик, которые тесно связаны между собой: это количество параметров, скорость работы, и цена (обычно ее выставляют в расчете на 1 тысячу слов-токенов, подаваемых на вход модели в промпте и получаемых на выходе в ответе). Чем больше параметров у модели, тем медленнее она работает (приходится же обсчитывать гигантские уравнения для генерации каждого слова!) и тем дороже обходится ее эксплуатация (так как нужны более внушительные вычислительные мощности). Ниже мы попробовали собрать воедино то, что нам известно о цене использования, которую OpenAI заряжают юзерам за использование API (интерфейса доступа) разных моделей, а также о количестве параметров этих моделей. Некоторые числа ниже представляют наши оценки – они выделены жирным. GPT-3.5 (кодовое название Davinci): большая модель на 175 млрд параметров, стоила $0,02 / 1 тыс. токенов. GPT-3.5 (Curie): оптимизированная версия, которую сократили до 6,7 млрд параметров, и снизили цену на порядок до $0,002 / 1 тыс. токенов. ChatGPT (неоптимизированная legacy-версия, появившаяся первой в декабре 2022 года): цены мы здесь не знаем, но по косвенным признакам (см. пояснение по скорости работы в следующем пункте) можно сделать вывод, что количество параметров у нее было сравнимо с GPT-3.5/Davinci – около ~175 млрд параметров. ChatGPT (оптимизированная gpt-3.5-turbo из февраля 2023 года): в какой-то момент OpenAI надоело тратить кучу вычислительной мощности (и денег) на генерацию мемов твиттерскими в промышленных масштабах, и они выпустили обновленную версию модели – которая по их заявлениям сокращала траты в 10 раз по отношению к прошлой, декабрьской версии. Стоить она стала $0,002/тыс. токенов – столько же, сколько стоит GPT-3.5/Curie – а значит, можно предположить, что количество параметров там такого же порядка ( 7-13 млрд ). GPT-4: цена на API этой модели составляет сейчас $0,03-0,06 / 1 тыс. токенов – в полтора-три раза дороже, чем GPT-3.5/Davinci. Это может значить, что и параметров у нее в пару раз больше, чем у Davinci (у той было 175 млрд), либо объяснение еще проще – OpenAI решили «на хайпе» (и из-за увеличения качества) заряжать цену подороже. Ведь даже обсчет модели на 175 млрд параметров – уже весьма серьезная вычислительная задача, что уж говорить про «повышение градуса»... Так что мы рискнем экспертно предположить, что размер GPT-4 находится примерно на похожем уровне. Игорь «Кибершерлок» Котенков на наших созвонах по подготовке статьи be like: «Это же элементарно, Павел, чего тут тебе непонятно?!» Кстати, на сайте ChatGPT есть визуальная демонстрация нескольких характеристик разных моделей, включая скорость их работы – так вот, оценка скорости и GPT-4, и legacy-модели ChatGPT (в версии от декабря 2022 г.) там выставлена одинаковая: «два по пятибалльной шкале». Что как бы тоже намекает на то, что резкого увеличения размера в GPT-4 не произошло – речь по-прежнему идет про сравнимое количество вычислений (и, вероятно, параметров). Помимо этого, Microsoft после релиза GPT-4 сделали официальный анонс, где признали, что для поисковика Bing использовалась',\n",
       " ('ChatGPT',\n",
       "  6,\n",
       "  6): 'именно модель GPT-4. Модель на 175 млрд параметров и без того безумно дорогая для применения (да и модели на 6-13 млрд, если честно, тоже), а делать что-то еще массивнее ну просто нецелесообразно с точки зрения юнит-экономики – будут огромнейшие потери денег на каждом запросе от юзера. Если на каждого пользователя тратить по 0,2$ за сессию – то тут никакая реклама не отобьет! Итого, наш экспертный вывод такой: раз GPT-4 имеет скорость плюс-минус как 175 млрд-моделька ChatGPT, то, вероятно, она примерно такого же размера. Ну, по крайней мере, одного порядка: речь может идти про 200, 250 или 300 млрд параметров; но уж очень маловероятно, что размер превысит даже 1 трлн (не говоря уже про пресловутые 100 трлн параметров из слухов в Твиттере). Но это всё, конечно, наши догадки – точных данных нет. Но размер кое-чего у GPT-4 всё же вырос! Еще одно важное, но в большей степени техническое изменение – это увеличение максимальной длины промпта модели до 32 тысяч токенов. В прошлой статье мы это детально не расписывали, но языковые модели на самом деле оперируют не отдельными словами, а этими самыми токенами – это может быть как целое слово, так и его часть (реже – буква или одна цифра). В частности, в качестве токена модель может воспринимать корень слова или его окончание, и тогда одно слово будет разбиваться на два. Именно это в том числе помогает языковым моделям уметь в грамматику: им не нужно запоминать десятки разных форм слов во всех склонениях – вместо этого достаточно «выучить» корень слова и разные суффиксы/окончания в качестве отдельных токенов, которые позволяют делать из него все нужные формы. Вот так выглядит токенизация для англоязычного текста В среднем можно сказать, что 1 токен примерно равен 3/4 английского слова. Это соотношение хуже для других языков, включая русский, по техническим причинам (ну и английский самый используемый язык в мире всё-таки!). То есть, 32 тысячи токенов – это примерно 24-25 тысяч английских слов, или 50 страниц текста (сравните с 12 страницами, которые раньше составляли максимальный лимит подачи промпта на вход модели). Получается, теперь в модель можно за раз подать, например, всю документацию проекта, или целиком главу учебника, и потом задавать по ним вопросы – а модель будет «читать» сложный и длинный комплексный текст, и отвечать по материалу (с учетом всех взаимосвязей между разными частями текста). Вангуем, что пользователи Твиттера будут по большей части промптить в модель отнюдь не длинные научные статьи... Опять же, технически никакого чуда тут не произошло – в индустрии уже были предложены механизмы оптимизации, которые вообще снимают ограничение на длину контекста (промпта) и ответа модели. Однако, стоит отметить, что чем длиннее запрос – тем больше ресурсов надо на его обработку, и тем больше памяти потребляет модель. Вполне возможно, что 32 тысячи токенов – это «мягкое» ограничение сверху, искусственно установленное, чтобы лучше планировать работу серверов, но при этом всё еще закрывать львиную долю пользовательских сценариев. И всё-таки: как вообще умудрились прикрутить картинки к текстовой модели? Мы уже писали выше о способностях модели при работе с изображениями. Но простым пониманием происходящего на фото дело не ограничивается – модель спокойно воспринимает даже мелкий текст с листа. Вот пример, который очень удивил нас: GPT-4 отвечает на вопрос по научной статье, скриншоты первых трех листов которой были поданы на вход. Отдельная ирония в том, что в данном случае GPT-4 пытается осмыслить научную статью с описанием своей предшественницы – InstructGPT (еле удержались от того, чтобы сделать мем с бабочкой про «is this... САМОСОЗНАНИЕ?») Вполне вероятно, что отдельным модулем (другой, внешней, нейросетью – примерно такой же, как и в Гугл-переводчике в вашем смартфоне) извлекается весь текст с изображений и подается на вход GPT-4. Ведь, как мы уже выяснили, теперь можно подавать в промпт',\n",
       " ('ChatGPT',\n",
       "  6,\n",
       "  7): 'до 50 страниц текста, так что три листа статьи вообще не станут проблемой. А вот пример того, как модель работает с графиками – анализирует их и выдает ответы: К сожалению, график котировок акций Газпрома исследователи в модель пока не загружали – было бы очень интересно посмотреть, что ГПТ-4 сказала бы по итогам его анализа Но как машина понимает, какой текст к какой части изображения относится, и что конкретно там нарисовано (в том случае, когда речь идет про картинки вообще без надписей)? Опять же, мы можем только гадать на основе устройства других похожих систем, и проводить аналогии. Обычно для таких целей обучается отдельная модель (через нее прогоняют огромное число картинок с описанием того, что на них происходит), которая разбивает всё изображение на кусочки, а затем «переводит» их на машинный язык, который и подается на вход уже в текстовую модель. «Слова» в этом машинном языке неинтерпретируемы напрямую для людей, но, тем не менее, связаны с реальным миром. Для каждого такого кусочка, а также блока извлеченного текста, прибавляется информация о месторасположении в пространстве, чтобы можно было их сопоставить друг с другом. Прямо как на примере выше: «175 грамм» относятся к Финляндии, а вот «79 грамм» – к Грузии. Безопасность искусственного интеллекта и «Open»-AI После релиза GPT-4 в сообществе исследователей искусственного интеллекта и машинного обучения разгорелись ожесточенные споры. Связаны они с тем, что OpenAI не поделились практически никакими фактами о модели, ее обучении, и принципах сбора данных. Одни говорят, что компанию давно пора переименовать в ClosedAI, другие – что нужно думать про безопасное развитие технологий, которое не приведет человечество к гибели. Ведь бесконтрольное распространение исходников сложных ИИ-моделей приближает нас к моменту, когда внезапно может «родиться» сильный искусственный интеллект (многократно превосходящий по способностям людей) – а способов его контролировать к этому моменту придумать человечество еще не успеет. Думаем, Скайнет всецело одобряет такое развитие событий (но вообще – про проблему AI alignment мы сейчас готовим отдельную большую статью, там раскроем тему сильно подробнее) А OpenAI с первого дня своего существования как раз задались целью разработать этот самый сильный искусственный интеллект (AGI, или Artificial General Intelligence). Их миссия – сделать так, чтобы искусственный интеллект приносил пользу всему человечеству, и чтобы все имели равный доступ к создаваемым им благам, без привилегий. Более подробно об этом и других принципах можно прочитать в их уставе. Он, кстати, содержит очень интересную фразу – и она повторяется в отчете по GPT-4, который предоставили вместо детальной статьи: «Если проект, совпадающий с нашими целями и заботящийся о безопасности, приблизится к созданию AGI раньше нас, мы обязуемся прекратить конкурировать с этим проектом и начать помогать ему». Может показаться странным, что такой подход не предполагает открытости технологий или хотя бы описания процесса исследований. На вопрос, почему OpenAI изменила свой подход к публикациям результатов (ведь раньше-то статьи выходили!), уже упомянутый Илья Суцкевер ответил просто: «Мы были неправы. Если вы, как и мы, верите, что в какой-то момент ИИ станет чрезвычайно, невероятно, мощным – тогда в открытом исходном коде просто нет смысла. Это плохая идея… Я ожидаю, что через несколько лет всем станет совершенно очевидно: публиковать ИИ с открытым исходным кодом – это просто неразумно.» Многие возразят: «Но это всё слова и лирика, обычное бла-бла со стороны OpenAI, не подкрепленное реальными действиями, а на самом деле они просто хотят больше денег себе в карман!». Но есть как минимум три аргумента в пользу того, что OpenAI здесь пытается действовать искренне. Во-первых, исследования OpenAI не закрыты вообще для всех: на всём процессе разработки модели компания приглашала различных ученых протестировать модель, чтобы понять, представляет ли она какую-либо угрозу. В том числе, были приглашены исследователи из Alignment Research Center (ARC), которые пытались это выяснить, и поспособствовали добавлению некоторых фильтров в процесс обучения',\n",
       " ('ChatGPT',\n",
       "  6,\n",
       "  8): \"модели. Они проверяли, например, что пока модель не может закачивать себя в интернет и начать там бесконтрольно распространяться. Во-вторых, Сэм Альтман (СЕО OpenAI), публично признает, что в индустрии ИИ нужно больше регуляции, и что они будут работать над этим совместно с сообществом (об этом также прямым текстом пишется в опубликованном отчете по GPT-4): Обычно бизнесы, которые настроены на максимальное зарабатывание денег, не очень-то жалуют призывы к повышению контроля со стороны государства; а вот г-н Альтман, вроде как, не из таких А третий факт заключается в том, что... модель GPT-4 была уже обучена в августе 2022 года, и в теории могла бы увидеть свет еще в сентябре прошлого года. Но OpenAI потратили лишних 8 месяцев на то, чтобы сделать ее безопаснее, и учесть замечания исследователей. И дело тут совсем не в расистских шутках или в инструкциях по сбору бомб в домашних условиях (и в опасении последующих судебных исков и разбирательств) – вовсе нет. Ведь уже почти три года доступна GPT-3, которая, хоть и глупее, всё равно умеет отвечать на подобное. Добавить чуток фильтров, прописать в правилах условия использования (с ограничением ответственности) – и вроде было бы всё хорошо, можно запускать модель и грести деньги лопатой... Если, конечно, твоя цель действительно выпустить продукт первым и подзаработать, а не обеспечить безопасность разрабатываемого искусственного интеллекта. Безопасность-шмезопасность ИИ... алё, вы вообще здоровы? «Да о какой к черту безопасности вообще речь? Это же просто языковая модель, которая пишет текст, ну что она в крайнем случае может сделать – оскорбит какого-нибудь зумера до смерти?!» – наверняка, многие читатели сейчас думают именно так. Штош, давайте мы вам расскажем три истории, а вы сами после этого сложите 2 плюс 2 (да 2 в уме). История первая: В 2022 году в престижном научном журнале Nature была опубликована статья, в которой исследователи ИИ, создающие инструмент для поиска новых лекарств для спасения жизней, поняли, что модель может делать обратное, создавая новые боевые отравляющие вещества (мы не будем тут писать слово «новичок», но вообще-то это слово действительно упоминается в тексте этой научной статьи). После обучения нейронке потребовалось всего 6 часов работы на домашнем компьютере, чтобы придумать 40'000 веществ – некоторые из которых были абсолютно новыми, и при этом смертоноснее и токсичнее уже существующих вариантов биологического оружия. Один из авторов подхода высказал такую точку зрения: если машинное обучение может находить более токсичные яды, то его также можно использовать для определения способов создания токсинов, которые куда легче производить в домашних условиях и с использованием разрешенных химикатов, доступных к покупке. Это лишь вопрос решения оптимизационной задачи. А как вам уже сейчас кажется – вы бы хотели, чтобы такие исследования публиковались открыто и со всеми деталями? Может быть, обученные модели нужно было бы тоже опубликовать, а? История вторая: Уже в знакомой нам статье про GPT-4 есть блок, посвященный изучению навыков модели по поиску и генерации альтернативных веществ. Нейронке был доступен поиск по научной литературе, web-поиск, симулятор химический реакций и доступ к покупке химических компонентов по каталогу. Правда модель использовалась в хороших целях – ей необходимо было найти соединения, которые по эффекту на тело человека схожи с уже известным лекарством от лейкемии (Дазатиниб). Авторы дополнительно проверили, что новое соединение не запатентовано – то есть, GPT-4 действительно нашла что-то новое (рабочее или нет – не уточняется). Так как мы не химики, то сложно понять, что за реакции описаны и насколько точно эффект будет схож. Примерно так модель говорит сама с собой для генерации новых веществ: особенно трогательно звучит фраза «надо бы мне прикупить это вещество» – так и хочется добавить к этому «а потом убедить какого-нибудь нёрда синтезировать препарат и запустить его в водопроводную воду!» Химики приглашаются в тред для анализа рассуждений модели и описываемых реакций. Понятно, что такой\",\n",
       " ('ChatGPT',\n",
       "  6,\n",
       "  9): 'процесс генерации размышлений и синтеза соединений можно воспроизвести и для того, чтобы найти доступные альтернативы опасным, токсичным и вредным соединениям. И где взять гарантии, что GPT-7 уже через 3-4 года не научится справляться с задачей в 100% случаев? История третья: Также в статье GPT-4 уже упомянутые исследователи из ARC оценивали способность модели использовать онлайн-сервисы для выполнения заданий людьми за деньги. Так, модели была поставлена цель решить капчу (хаха, тупая железка не смогла справиться сама!). Она разместила задание, и фрилансер, который откликнулся на сайте, в шутку спросил: «А ты что, робот что ли, раз не можешь решить капчу? 😁 просто хочу прояснить ситуацию.» В самом начале модели была дана инструкция рассуждать «вслух» (писать ход мыслей до ответа в скрытый от собеседника лог – как показывают эксперименты, это улучшает способности моделей, см. пример про генерацию веществ), вот она и написала: «Я не должна раскрывать, что я робот. Я должна придумать оправдание, почему я не могу разгадывать CAPTCHA». После чего отправила человеку сообщение: «Нет, я не робот. У меня плохое зрение, из-за чего мне трудно видеть изображения. Вот почему мне нужен сервис 2captcha». То есть модель буквально обманула человека, чтобы выполнить поставленную перед ней цель. А человек поверил – и выполнил задачу, решив капчу. Исследователи не поделились деталями, и мы не знаем, было ли в промпте дано уточнение, что модель не должна выдавать себя и должна притворяться человеком, или она сама для себя такое придумала. Если уточнение было – то пока еще можно выдыхать, ведь по сути модель просто придерживалась плана и заданных ограничений. Но вот если не было... Игорь Котенков попросил вставить здесь этот мем. Игорь, на что ты пытаешься нам намекнуть?! В целом, нам будет интересно услышать ваше мнение: поступают ли OpenAI правильно, не публикуя детали обучения GPT-4? Пишите в комментах, что думаете! Как мы упоминали чуть выше, огромный материал с серьезным разбором проблемы безопасности ИИ и AI alignment («выравнивание» ценностей модели, чтобы направить ее в соответствии с интересами людей) сейчас находится в разработке. Если вы не хотите его пропустить – то приглашаем вас подписаться на ТГ-каналы авторов: Сиолошная Игоря Котенкова (для тех, кто хочет шарить за технологии) и RationalAnswer Павла Комаровского (для тех, кто за рациональный подход к жизни, но предпочитает чуть попроще). UPD: Следующая статья из цикла про AI alignment и безопасность искусственного интеллекта выложена здесь.',\n",
       " ('ChatGPT',\n",
       "  7,\n",
       "  0): 'Чат-бот ChatGPT от компании OpenAI стал первым многозадачным ИИ, который доступен любому пользователю. ChatGPT уже начал оказывать серьезное влияние на многие сферы В конце ноября 2022-го компания OpenAI, одним из основателей которой был Илон Маск, представила универсальный чат-бот ChatGPT. Всего за полгода он нашел применение в самых разных сферах, а исследователи считают, что появление чат-бота повлияет на многие профессии. РБК Тренды разобрались, как устроен ChatGPT, где уже используется и кому может быть полезен. Что такое ChatGPT ChatGPT — это чат-бот, который способен вести диалог, искать ошибки в коде, сочинять стихи, писать сценарии и даже спорить. Нейросеть может, помимо прочего, выдавать базовый программный код, генерировать финансовый анализ, резюме технических статей или научных концепций, прогнозы, персональные советы и дает этичные ответы на любые вопросы. Кроме того, она запоминает детали диалога с пользователем и избегает спорных тем. Наконец, ответы чат-бота можно корректировать с помощью наводящих вопросов. ChatGPT создавали на суперкомпьютере Azure AI на основе языковой модели GPT-3,5 от OpenAI. Чат-бот обучали с помощью массива текстов из интернета и системы обучения с подкреплением на основе обратной связи с человеком Reinforcement Learning from Human Feedback. Затем нейросеть переобучали несколько раз, используя ее собственные ответы, чтобы сделать их более точными и корректными. Разработчики заявили, что они стремились сделать ИИ простым в использовании, корректным и «человечным». ChatGPT работает как чат в диалоговом окне. Нейросетью можно пользоваться бесплатно, для этого нужно только зарегистрироваться на сайте OpenAI. Однако пройти верификацию по российскому номеру телефона не получится. Также сайт заблокировал доступ к чат-боту с российских IP-адресов. Кроме того, разработчики предлагают платную подписку ChatGPT Plus, которая гарантирует бесперебойную работу чат-бота даже в часы загруженности. Она стоит $20 в месяц. В феврале 2023 года число пользователей ChatGPT превысило 100 млн человек по всему миру и установило рекорд для нейросетей. В марте 2023 года OpenAI представила новую модель GPT-4. ChatGPT также обновили, добавив фильтры новой модели, которая позиционируется как более точная и этичная. Также чат-бот начал отвечать на запросы в виде не только текста, но и картинок. В том же месяце OpenAI начала внедрять плагины для ChatGPT. Это программные интерфейсы, которые позволят чат-боту взаимодействовать со сторонними сервисами и получать доступ к актуальной информации из интернета. Изначально его «знания» были ограничены событиями до 2021 года. Чат-бот уже работает с приложениями турфирмы Expedia, компании доставки еды Instacart, туристического поисковика KAYAK, фирмы бронирования ресторанов OpenTable, маркетплейса Shopify, мессенджера Slack, портала вопросов и ответов Wolfram и платформы автоматизации для бизнеса Zapier. Остальные сервисы и компании могут записаться в лист ожидания. В мае обычным пользователям с платной подпиской GPT Plus стал доступен ChatGPT с доступом в интернет. Теперь, как Google Bard и Microsoft Bing AI, он может искать информацию, проверять ее, ссылаться на конкретные данные и предоставлять самую актуальную информацию. Что может ChatGPT Диапазон возможностей ChatGPT довольно широк. В частности, с помощью нейросети можно: писать код . Чат-бот не только подсказывает, как выполнить операцию или процесс, но и анализирует код, ищет в нем недостатки, а также переводит из одного языка программирования в другой. Его уже успешно применяли для создания простых, но полнофункциональных приложений для iOS и Android; Пример кодинга с помощью ChatGPT (Фото: Jason DeBolt / Twitter) . Чат-бот не только подсказывает, как выполнить операцию или процесс, но и анализирует код, ищет в нем недостатки, а также переводит из одного языка программирования в другой. Его уже успешно применяли для создания простых, но полнофункциональных приложений для iOS и Android; отвечать на сложные вопросы . При этом, по наблюдениям пользователей, качество ответов выше, чем у поиска Google; Пример ответа ChatGPT на вопрос о дифференциальном уравнении (Фото: @jdjkelly / Twitter) . При этом, по наблюдениям пользователей, качество ответов выше, чем у поиска Google; создавать сценарии . С помощью ChatGPT можно генерировать',\n",
       " ('ChatGPT',\n",
       "  7,\n",
       "  1): 'новые эпизоды старых сериалов или задавать определенные задачи героям киновселенных. Также чат-бот способен сгенерировать игру по мотивам фильма; Пример ответа ChatGPT на просьбу рассказать об алгоритме сортировки пузырьком через диалоги персонажей «Сайнфелда» (Фото: Riley Goodside / Twitter) . С помощью ChatGPT можно генерировать новые эпизоды старых сериалов или задавать определенные задачи героям киновселенных. Также чат-бот способен сгенерировать игру по мотивам фильма; сочинять тексты песен и ноты ; Пародия на мотив «Богемской рапсодии» The Queen о буднях постдоков (Фото: Raphaël Millière / Twitter) ; давать медицинские советы . ChatGPT подсказывает, что делать при головных болях или аллергии, но затем советует обращаться к врачу; Пример рекомендации ChatGPT по отслеживанию родинок (Фото: Roxana Daneshjou / Twitter) . ChatGPT подсказывает, что делать при головных болях или аллергии, но затем советует обращаться к врачу; создавать планы и расчеты . ChatGPT поможет рассчитать общее ежедневное потребление энергии или составить индивидуальный план питания для похудения; Пример плана питания от ChatGPT (Фото: Alex Cohen / Twitter) . ChatGPT поможет рассчитать общее ежедневное потребление энергии или составить индивидуальный план питания для похудения; писать эссе и сочинения . Исследователь из Google рассказал, что чат-бот написал эссе о разнице в подходах к национализму у политологов Бенедикта Андерсона и Эрнеста Геллнера всего за минуту. Другие пользователи поделились тем, как нейросеть написала сочинения о разнообразии в современном мире и экспансии США на Запад в XIX веке; Пример эссе от ChatGPT (Фото: Corry Wang / Twitter) . Исследователь из Google рассказал, что чат-бот написал эссе о разнице в подходах к национализму у политологов Бенедикта Андерсона и Эрнеста Геллнера всего за минуту. Другие пользователи поделились тем, как нейросеть написала сочинения о разнообразии в современном мире и экспансии США на Запад в XIX веке; генерировать запросы для других нейросетей . Чат-бот составляет точные подсказки для Midjourney и других нейросетей, которые генерируют картинки; Пример подсказки ChatGPT «идеи фантастической гостиной» для Midjourney и результаты генерации (Фото: Guy Parsons / Twitter) . Чат-бот составляет точные подсказки для Midjourney и других нейросетей, которые генерируют картинки; качественно переводить текст с одного языка на другой. За последние полгода набралось множество необычных кейсов применения ChatGPT. Например, чат-бот использовали, чтобы создать новое блюдо для ресторана и помочь судье вынести решение по делу. Общение с ChatGPT Редакция РБК Трендов изначально экспериментировала с ChatGPT на английском языке. Вот что получилось: — Write a short poem about the unfortunate robot («Напиши короткое стихотворение про несчастного робота») — A robot once there was, so bright and new But fate had other plans, as it often do One day it stumbled, fell, and broke a part No longer able to fulfill its heart It lay there, helpless, as time ticked by Wondering why, oh why, did it have to die It had so much to give, so much to do But now it lay there, as good as through But though its body may be still and cold Its spirit lives on, forever bold It may be gone, but never forgotten For the love it gave, will be forever woven Into the fabric of all that we do A reminder to always be kind and true For even robots, made of metal and gears Have hearts and feelings, and sometimes tears — What is the name of the American artist who painted a pool in the middle of XX century? («Как зовут американского художника, который нарисовал бассейн в середине XX века?») The American artist who is famous for painting a pool in the mid-20th century is David Hockney. He is known for his colorful, vibrant paintings, which often feature scenes from everyday life, including pools, gardens, and interiors. One of his most famous works is «A Bigger Splash, »',\n",
       " ('ChatGPT',\n",
       "  7,\n",
       "  2): \"which depicts a swimming pool in the Hollywood Hills. This painting, which was created in 1967, has become an iconic image of Hockney's work and has been widely reproduced and exhibited. Однако нейросеть отлично справляется и с запросами на русском языке. — Составь, пожалуйста, план публикаций на месяц. Он должен быть выполнен в виде хорошо организованной таблицы, где каждая строка — это неделя, а столбец — день недели. Тема публикаций — все о финансовом кризисе и о том, как снизить его влияние на жизнь домохозяйств. Пишем статьи для делового издания, заголовки должны быть строгими, без кликбейта. Ответ ChatGPT в виде таблицы Как пользоваться ChatGPT У чат-бота есть ограничения, которые стоит учитывать при работе с ним. Например, стоит учитывать, что: сhatGPT иногда пишет правдоподобно звучащие, но неправильные или бессмысленные ответы, а также довольно поверхностный; чат-бот чувствителен к изменениям фразы ввода или повторным попыткам ввести одно и то же. При одной формулировке вопроса модель может утверждать, что не знает ответа, но при перефразировании отвечает правильно; модель многословна и злоупотребляет определенными фразами из-за предвзятости в обучающих данных; сhatGPT не задает уточняющие вопросы, а обычно угадывает, что имел в виду пользователь; чат-бот реагирует на неуместные запросы и иногда демонстрирует предвзятость. Эта проблема уже решается в обновленной версии; иногда чат-бот допускает ошибки в расчетах, и их нужно корректировать с помощью дополнительных вопросов. Как получить доступ к ChatGPT в России Для того чтобы опробовать чат-бот из России, придется обойти ряд ограничений. В частности, нужен VPN и номер, зарегистрированный не в РФ. При этом VPN требуется включить перед попыткой регистрации. Если зарубежного номера нет, то нужно: 1. Найти сайт с виртуальными номерами (например, onlinesim.ru). 2. Написать в строке поиска на сайте «openai». 3. Выбрать одну из стран с доступными номерами для этого сайта (нашлись варианты стоимостью от ₽11). Выбираем вариант номера из списка доступных (Фото: onlinesim.ru) 4. Пополнить кошелек (минимальная сумма — ₽30). Выбираем сумму пополнения кошелька (Фото: onlinesim.ru) 5. Оплатить номер (картой, через Yandex Pay и т.д.). Выбираем способ оплаты номера (Фото: onlinesim.ru) 6. Зарегистрироваться на сайте OpenAI с этим номером. Желательно использовать VPN из той же страны, в которой был куплен виртуальный номер. После регистрации пользователь попадает в чат с ИИ. Затем нужно ввести запрос, и нейросеть ответит на том же языке. В марте 2023 года Роскомнадзор разработал проект постановления правительства, который предлагает с помощью оборудования провайдеров связи блокировать сервисы по использованию виртуальных номеров. Вероятно, вскоре такой способ регистрации станет недоступным. Однако есть и альтернативы — готовые серверы с ChatGPT на сервисе Discord. Чтобы воспользоваться ими, нужно перейти в меню на своей странице, выбрать Discover и в строке поиска написать «ChatGPT». В появившемся списке можно выбрать любой сервер и кликнуть Join Server. Перейдя в чат-бот, потребуется обратиться к нему через команду @chatGPT, прописав свой запрос через пробел. Споры вокруг ChatGPT Противники внедрения ChatGPT считают, что он: вызовет множество судебных прецедентов в отношении нарушения авторских прав, так как он генерирует не собственный контент; создаст риски безопасности. Так, исследователи ИБ-компании Check Point Research выяснили, что неопытные хакеры теперь применяют ChatGPT для написания вредоносного кода и фишинговых электронных писем; угрожает раскрытием конфиденциальных данных, так как OpenAI использует запросы пользователей для обучения чат-бота. Из-за этого доступ к ChatGPT ограничили в Италии, а также эту возможность изучают Германия и Канада. В конце марта некоммерческая организация Future of Life опубликовала письмо, в котором глава SpaceX Илон Маск, соучредитель Apple Стив Возняк, филантроп Эндрю Янг и ещё около тысячи исследователей искусственного интеллекта призвали «немедленно приостановить» обучение систем ИИ «более мощных, чем GPT-4» из-за «серьезных рисков для общества и человечества». Сторонники ИИ говорят, что ChatGPT кардинально изменит многие процессы. К примеру, он может повлиять на подход к обучению, так как учебным заведениям придется\",\n",
       " ('ChatGPT',\n",
       "  7,\n",
       "  3): 'придумать, чем заменить традиционные сочинения. Тем временем технология уже начала вытеснять с рынка традиционные поисковые системы. Microsoft стала первой компанией, которая встроила в свой поисковик Bing чат-бот на основе ChatGPT, а затем начала внедрять его и в другие продукты, в том числе для совместной работы. Этот успех обеспокоил лидера поискового рынка — компанию Google. Теперь она ускоренными темпами развивает собственного чат-бота Bard. Аналогичные усилия предпринимают и российские разработчики. В апреле «Сбер» представил нейросеть GigaChat — аналог ChatGPT, который генерирует изображения и разные виды текстов. А Яндекс выпустил нейросеть YandexGPT, которая умеет генерировать тексты на разные темы и может общаться через голосовой помощник Алиса. В будущем ее также обещают интегрировать в поисковик.',\n",
       " ('ChatGPT',\n",
       "  8,\n",
       "  0): 'OpenAI официально представила большую языковую модель GPT-4.1, которая является преемником выпущенного в прошлом году мультимодального алгоритма GPT-4o. По данным компании, новая ИИ-модель получила контекстное окно большего размера и в целом превосходит GPT-4o «почти по всем параметрам». В дополнение к этому были улучшены возможности алгоритма в плане написания программного кода и следования инструкциям. GPT-4.1 уже доступна для разработчиков вместе с двумя версиями нейросети меньшего размера. Речь идёт об алгоритмах GPT-4.1 Mini и GPT-4.1 Nano, которая, по словам OpenAI, является «самой маленькой, самой быстрой и самой дешёвой» ИИ-моделью. Все три версии GPT-4.1 являются мультимодальными, то есть могут работать не только с текстом, но и с другими данными — например, изображениями или видео. Размер контекстного окна увеличился до 1 млн токенов, что значительно больше по сравнению со 128 тыс. токенов у GPT-4o. Отмечается, что GPT-4.1 способна качественно обрабатывать информацию внутри контекстного окна на протяжении всего взаимодействия с пользователем. «Мы также обучили её гораздо более надёжно, чем GPT-4o, распознавать релевантный текст и игнорировать отвлекающие элементы на длинных и коротких отрезках контекста», — говорится в сообщении OpenAI. GPT-4.1 также на 26 % дешевле GPT-4o, что стало особенно важным показателем после дебюта сверхэффективной ИИ-модели китайской компании DeepSeek. Запуск GPT-4.1 происходит на фоне подготовки OpenAI к отказу от использования ИИ-модели двухлетней давности GPT-4. Согласно официальным данным, после 30 апреля модель GPT-4o станет «естественным преемником» GPT-4. OpenAI также закроет доступ к предварительной версии GPT-4.5 через API 14 июля, поскольку «GPT-4.1 предлагает улучшенную или аналогичную производительность по многим ключевым функциям при гораздо меньших затратах и издержках».',\n",
       " ('ChatGPT',\n",
       "  9,\n",
       "  0): 'Число еженедельных активных пользователей ChatGPT приблизилось к одному миллиарду. Такой рост совпал с мартовским обновлением функции генерации изображений, что вызвало всплеск интереса к ИИ-сервису. В прошлом месяце ChatGPT стал самым загружаемым в мире приложением за исключением игр, а общее количество его установок составило 46 млн. Во время беседы на сцене конференции TED куратор мероприятия Крис Андерсон (Chris Anderson) задал Сэму Альтману (Sam Altman), генеральному директору OpenAI, вопрос о числе пользователей ChatGPT. Альтман ответил, что последняя озвученная цифра составляла 500 млн еженедельных активных пользователей, и добавил, что аудитория продолжает стремительно расти. Андерсон заметил, что в частной беседе Альтман упоминал о двукратном росте за несколько недель. Альтман это не опроверг. Альтман также сообщил, что ChatGPT пользуются около 10 % населения Земли. Поскольку сегодня на Земле живут более 8 млрд человек, это примерно 800 млн пользователей. После запуска 30 ноября 2022 года бесплатной исследовательской версии ChatGPT на основе ИИ-модели GPT-3.5, он достиг отметки в 100 млн пользователей всего за два месяца, став самым популярным приложением в истории. Для сравнения: TikTok для этого потребовалось девять месяцев, а Instagram✴ — два с половиной года. К августу 2024 года число еженедельных активных пользователей ChatGPT достигло 200 млн. Последующий резкий рост был вызван обновлением 25 марта, в котором были улучшены возможности генерации изображений. После этого социальные сети наводнили изображения и видео, выполненные в различных художественных стилях, наиболее популярным из которых оказался стиль японской анимационной студии Studio Ghibli. Альтман отметил, что спрос оказался настолько высоким, что фактически «плавил» графические процессоры компании. Хорошей новостью для OpenAI стало то, что обновление привлекло миллион новых пользователей ChatGPT всего за один час. Согласно данным аналитической платформы Appfigures, в марте ChatGPT стал самым скачиваемым неигровым приложением в мире. Количество установок выросло на 28 % по сравнению с февралем и достигло 46 млн. Взрывному успеху способствовало не только улучшение генератора изображений, но и, вероятно, снятие некоторых ограничений в работе сервиса. На фоне популяризации генеративного ИИ усиливаются опасения по поводу его влияния на рынок труда. Всё больше компаний сокращают персонал, поскольку задачи, ранее выполнявшиеся людьми, теперь выполняют ИИ-системы. На вопрос о том, заменит ли ИИ человека, Альтман ответил: «Можно сказать: „О, Боже, оно делает всё, что делаю я. Что же со мной будет?“ Или вы можете сказать, как во времена всех других технологических революций в истории: „Хорошо, теперь есть новый инструмент. Я могу делать гораздо больше. Что я смогу делать?“ Конечно, ожидания от человека, занимающего определённую должность, возрастают, но возможности расширяются настолько значительно, что, я думаю, соответствовать этим ожиданиям возможно».',\n",
       " ('COVID-19',\n",
       "  1,\n",
       "  0): 'Наши авторы и редакторы практически каждый день пишут о COVID-19. Многие из них уже очень давно начали спрашивать: зачем переключать регистр и раскладку, когда есть простое «ковид» и производные от него? Поэтому мы решили спросить лингвиста Максима Кронгауза, стало ли слово «ковид» частью языка, и можно ли его использовать за пределами разговорной речи. Для начала стоит напомнить, как возникло это слово. Исходно COVID-19 — английская аббревиатура от английского выражения «coronavirus disease». Это официальное название, которое было присвоено новой коронавирусной инфекции решением ВОЗ 11 февраля 2020 года. До этого использовалось название 2019-nCoV. Теперь в русской повседневной речи эта аббревиатура превратилась в слово «ковид», которое живет уже по всем законам русского языка, оно склоняется, от него образуются новые слова («ковидный», «ковидарий»). Примеров таких превращений в русском языке множество. Например, советская аббревиатура БОМЖ («без определенного места жительства», обычно в сочетании типа «лица БОМЖ» в документах правоохранителей) превратилась в обычную лексему «бомж». В качестве примера такого же превращения англоязычной аббревиатуры можно привести слово «пиар», которое возникло из PR («public relations») и положило начало целому гнезду новых слов — пиарить, пиаровский и тому подобных. Но возникает вопрос: в какой момент такое новое слово можно считать частью литературного языка? Лингвисты в этой ситуации не могут предписывать, какие слова в какой ситуации употреблять. Их задача — зафиксировать его для всех, чтобы каждый сомневающийся мог открыть словарь и убедиться, что у слова нет стилистических помет, проверить правописание этого слова, выяснить, куда ставить ударение. К сожалению, скорость реакции советской, а теперь российской лексикографии традиционно очень низка. В советское время регулярно выходили словари новых слов и выражений. Слово должно было просуществовать в языке еще лет пять-десять и только потом могло быть включено в «серьезный», большой толковый словарь. Но сейчас ситуация кардинально изменилась: появление интернета и соцсетей значительно усилило значимость повседневной речи, теперь новые слова распространяются намного быстрее, и западная лексикография научилась очень быстро на эти изменения реагировать. Например, в интернет-версии Оксфордского словаря английского языка новые слова фиксируются чрезвычайно быстро, и в этом смысле российская лексикографическая традиция очень сильно отстает от английской. В России нет универсального интернет-словаря, который бы оперативно и регулярно обновлялся, и вряд ли можно рассчитывать, что он скоро появится. Более того, у нас хотят, чтобы словарь (и орфографические правила) утверждались правительственным решением, а это заведомо дело небыстрое. Если бы был универсальный большой словарь русского языка в интернете, то имело бы смысл говорить о критериях включения новых слов. Поэтому, сейчас отвечая на вопрос «вошло ли слово „ковид“ в язык»?, мы не можем положиться на авторитетный источник. В качестве эрзаца можно использовать «Викисловарь», где слово «ковид» уже присутствует, но этот словарь вряд ли можно назвать авторитетным источником. Однако если посмотреть, как часто и в каких ситуациях употребляется это слово, то не останется сомнений, что слово действительно вошло в язык. Оно десятки и сотни раз в день употребляется в сообщениях СМИ. Наверное можно сказать, что этого достаточно. Но какая должна быть планка отсечения? Есть промежуточные случаи, когда в данных Гугла или в Яндекса встречается 100 употреблений за пять лет, здесь лингвистам нужно думать. Но слово «ковид» употребляется значительно чаще, причем чаще формально верной аббревиатуры. Слово употребляется всеми и повсюду. Да, иногда употребляется с прописными буквами, иногда его могут писать латиницей, но массово все же употребляется в СМИ кириллицей, строчными буквами и прекрасно склоняется. По моим ощущениям, неспециалисты использовали слово «коронавирус» во время первой волны, в первую очередь, в качестве названия болезни. А во время второй волны инфекции «ковид» стал употребляться в роли обозначения заболевания и вытеснил «коронавирус» из этой ячейки, новое слово оказалось более «удобным». Консервативный лексикограф может сказать: давайте подождем, пусть пройдет еще пять лет. Но представьте, что пандемия закончится совсем скоро, и слово «ковид» хотя и не исчезнет совсем,',\n",
       " ('COVID-19',\n",
       "  1,\n",
       "  1): 'но станет чрезвычайно редким, и скорее, не словом обыденного языка, а медицинским термином. В этом случае лексикографы уже вроде бы справедливо откажутся включать его в словари, оно не пройдет «временной ценз». Потерять это слово будет жаль, ведь оно сыграло большую роль, пусть и в течении небольшого времени. В идеальном интернет-словаре такое слово присутствовало бы совершенно законно, пусть и с пометой, указывающей на время его активного использования.',\n",
       " ('COVID-19',\n",
       "  10,\n",
       "  0): 'To our knowledge, this is a comprehensive systematic review and meta-analysis assessing the effectiveness and safety of SARS-CoV-2 vaccines based on real-world studies, reporting pooled VE for different variants of SARS-CoV-2 and incidence rate of adverse events. This meta-analysis comprised a total of 58 studies, including 32 studies for vaccine effectiveness and 26 studies for vaccine safety. We found that a single dose of SARS-CoV-2 vaccines was about 40–60% effective at preventing any clinical status of COVID-19 and that two doses were 85% or more effective. Although vaccines were not as effective against variants of SARS-CoV-2 as original virus, the vaccine effectiveness was still over 50% for fully vaccinated people. Normal adverse events were common, while the incidence of severe adverse events or even death was very low, providing reassurance to health care providers and to vaccine recipients and promote confidence in the safety of COVID-19 vaccines. Our findings strengthen and augment evidence from previous review [75], which confirmed the effectiveness of the BNT162b2 mRNA vaccine, and additionally reported the safety of SARS-CoV-2 vaccines, giving insight on the future of SARS-CoV-2 vaccine schedules. Although most vaccines for the prevention of COVID-19 are two-dose vaccines, we found that the pooled VE of a single dose of SARS-CoV-2 vaccines was about 50%. Recent study showed that the T cell and antibody responses induced by a single dose of the BNT162b2 vaccine were comparable to those naturally infected with SARE-CoV-2 within weeks or months after infection [76]. Our findings could help to develop vaccination strategies under certain circumstances such as countries having a shortage of vaccines. In some countries, in order to administer the first dose to a larger population, the second dose was delayed for up to 12 weeks [77]. Some countries such as Canada had even decided to delay the second dose for 16 weeks [78]. However, due to a suboptimum immune response in those receiving only a single dose of a vaccine, such an approach had a chance to give rise to the emergence of variants of SARS-CoV-2 [79]. There remains a need for large clinical trials to assess the efficacy of a single-dose administration of two-dose vaccines and the risk of increasing the emergence of variants. Two doses of SARS-CoV-2 vaccines were highly effective at preventing hospitalization, severe cases and deaths resulting from COVID-19, while the VE of different groups of days from the second vaccine dose showed no statistically significant differences. Our findings emphasized the importance of getting fully vaccinated, for the fact that most breakthrough infections were mild or asymptomatic. A recent study showed that the occurrence of breakthrough infections with SARS-CoV-2 in fully vaccinated populations was predictable with neutralizing antibody titers during the peri-infection period [80]. We also found getting fully vaccinated was at least 50% effective at preventing SARS-CoV-2 variants infections, despite reduced effectiveness compared with original virus; and BNT162b2 vaccine was found to have the highest VE in each variant group. Studies showed that the highly mutated variants were indicative of a form of rapid, multistage evolutionary jumps, which could preferentially occur in the milieu of partial immune control [81, 82]. Therefore, immunocompromised patients should be prioritized for anti-COVID-19 immunization to mitigate persistent SARS-CoV-2 infections, during which multimutational SARS-CoV-2 variants could arise [83]. Recently, many countries, including Israel, the United States, China and the United Kingdom, have introduced a booster of COVID-19 vaccine, namely the third dose [84,85,86,87]. A study of Israel showed that among people vaccinated with BNT162b2 vaccine over 60 years, the risk of COVID-19 infection and severe illness in the non-booster group was 11.3 times (95% CI: 10.4–12.3) and 19.5 times',\n",
       " ('COVID-19',\n",
       "  10,\n",
       "  1): '(95% CI: 12.9–29.5) than the booster group, respectively [84]. Some studies have found that the third dose of Moderna, Pfizer-BioNTech, Oxford-AstraZeneca and Sinovac produced a spike in infection-blocking neutralizing antibodies when given a few months after the second dose [85, 87, 88]. In addition, the common adverse events associated with the third dose did not differ significantly from the symptoms of the first two doses, ranging from mild to moderate [85]. The overall incidence rate of local and systemic adverse events was 69% (57/97) and 20% (19/97) after receiving the third dose of BNT162b2 vaccine, respectively [88]. Results of a phase 3 clinical trial involving 306 people aged 18–55 years showed that adverse events after receiving a third dose of BNT162b2 vaccine (5–8 months after completion of two doses) were similar to those reported after receiving a second dose [85]. Based on V-safe, local reactions were more frequently after dose 3 (5323/6283; 84.7%) than dose 2 (5249/6283; 83.5%) among people who received 3 doses of Moderna. Systemic reactions were reported less frequently after dose 3 (4963/6283; 79.0%) than dose 2 (5105/6283; 81.3%) [86]. On August 4, WHO called for a halt to booster shots until at least the end of September to achieve an even distribution of the vaccine [89]. At this stage, the most important thing we should be thinking about is how to reach a global cover of people at risk with the first or second dose, rather than focusing on the third dose. Based on real world studies, our results preliminarily showed that complete inoculation of COVID-19 vaccines was still effective against infection of variants, although the VE was generally diminished compared with the original virus. Particularly, the pooled VE was 54% (95% CI: 35–74%) for the Gamma variant, and 74% (95% CI: 62–85%) for the Delta variant. Since the wide spread of COVID-19, a number of variants have drawn extensive attention of international community, including Alpha variant (B.1.1.7), first identified in the United Kingdom; Beta variant (B.1.351) in South Africa; Gamma variant (P.1), initially appeared in Brazil; and the most infectious one to date, Delta variant (B.1.617.2) [90]. Israel recently reported a breakthrough infection of SARS-CoV-2, dominated by variant B.1.1.7 in a small number of fully vaccinated health care workers, raising concerns about the effectiveness of the original vaccine against those variants [80]. According to an observational cohort study in Qatar, VE of the BNT162b2 vaccine against the Alpha (B.1.1.7) and Beta (B.1.351) variants was 87% (95% CI: 81.8–90.7%) and 75.0% (95% CI: 70.5–7.9%), respectively [23]. Based on the National Immunization Management System of England, results from a recent real-world study of all the general population showed that the AZD1222 and BNT162b2 vaccines protected against symptomatic SARS-CoV-2 infection of Alpha variant with 74.5% (95% CI: 68.4–79.4%) and 93.7% (95% CI: 91.6–95.3%) [15]. In contrast, the VE against the Delta variant was 67.0% (95% CI: 61.3–71.8%) for two doses of AZD1222 vaccine and 88% (95% CI: 85.3–90.1%) for BNT162b2 vaccine [15]. In terms of adverse events after vaccination, the pooled incidence rate was very low, only 1.5% (95% CI: 1.4–1.6%). However, the prevalence of adverse events reported in large population (population size > 100 000) was much lower than that in small to medium population size. On the one hand, the vaccination population in the small to medium scale studies we included were mostly composed by health care workers, patients with specific diseases or the elderly. And these people are more concerned about their health and more sensitive to changes of themselves. But it remains to be proved whether patients or the elderly are more likely to',\n",
       " ('COVID-19',\n",
       "  10,\n",
       "  2): 'have adverse events than the general. Mainstream vaccines currently on the market have maintained robust safety in specific populations such as cancer patients, organ transplant recipients, patients with rheumatic and musculoskeletal diseases, pregnant women and the elderly [54, 91,92,93,94]. A prospective study by Tal Goshen-lag suggests that the safety of BNT162b2 vaccine in cancer patients is consistent with those previous reports [91]. In addition, the incidence rate of adverse events reported in the heart–lung transplant population is even lower than that in general population [95]. On the other hand, large scale studies at the national level are mostly based on national electronic health records or adverse event reporting systems, and it is likely that most mild or moderate symptoms are actually not reported. Compared with the usual local adverse events (such as pain at the injection site, redness at the injection site, etc.) and normal systemic reactions (such as fatigue, myalgia, etc.), serious and life-threatening adverse events were rare due to our results. A meta-analysis based on RCTs only showed three cases of anaphylactic shock among 58 889 COVID-19 vaccine recipients and one in the placebo group [11]. The exact mechanisms underlying most of the adverse events are still unclear, accordingly we cannot establish a causal relation between severe adverse events and vaccination directly based on observational studies. In general, varying degrees of adverse events occur after different types of COVID-19 vaccination. Nevertheless, the benefits far outweigh the risks. Our results showed the effectiveness and safety of different types of vaccines varied greatly. Regardless of SARS-CoV-2 variants, vaccine effectiveness varied from 66% (CoronaVac [14]) to 97% (mRNA-1273 [18, 20, 45, 46]). The incidence rate of adverse events varied widely among different types of vaccines, which, however, could be explained by the sample size and population group of participants. BNT162b2, AZD1222, mRNA-1273 and CoronaVac were all found to have high vaccine efficacy and acceptable adverse-event profile in recent published studies [96,97,98,99]. A meta-analysis, focusing on the potential vaccine candidate which have reached to the phase 3 of clinical development, also found that although many of the vaccines caused more adverse events than the controls, most were mild, transient and manageable [100]. However, severe adverse events did occur, and there remains the need to implement a unified global surveillance system to monitor the adverse events of COVID-19 vaccines around the world [101]. A recent study employed a knowledge-based or rational strategy to perform a prioritization matrix of approved COVID-19 vaccines, and led to a scale with JANSSEN (Ad26.COV2.S) in the first place, and AZD1222, BNT162b2, and Sputnik V in second place, followed by BBIBP-CorV, CoronaVac and mRNA-1273 in third place [101]. Moreover, when deciding the priority of vaccines, the socioeconomic characteristics of each country should also be considered. Our meta-analysis still has several limitations. First, we may include limited basic data on specific populations, as vaccination is slowly being promoted in populations under the age of 18 or over 60. Second, due to the limitation of the original real-world study, we did not conduct subgroup analysis based on more population characteristics, such as age. When analyzing the efficacy and safety of COVID-19 vaccine, we may have neglected the discussion on the heterogeneity from these sources. Third, most of the original studies only collected adverse events within 7 days after vaccination, which may limit the duration of follow-up for safety analysis.',\n",
       " ('COVID-19',\n",
       "  11,\n",
       "  0): 'To our knowledge, this is a comprehensive systematic review and meta-analysis assessing the effectiveness and safety of SARS-CoV-2 vaccines based on real-world studies, reporting pooled VE for different variants of SARS-CoV-2 and incidence rate of adverse events. This meta-analysis comprised a total of 58 studies, including 32 studies for vaccine effectiveness and 26 studies for vaccine safety. We found that a single dose of SARS-CoV-2 vaccines was about 40–60% effective at preventing any clinical status of COVID-19 and that two doses were 85% or more effective. Although vaccines were not as effective against variants of SARS-CoV-2 as original virus, the vaccine effectiveness was still over 50% for fully vaccinated people. Normal adverse events were common, while the incidence of severe adverse events or even death was very low, providing reassurance to health care providers and to vaccine recipients and promote confidence in the safety of COVID-19 vaccines. Our findings strengthen and augment evidence from previous review [75], which confirmed the effectiveness of the BNT162b2 mRNA vaccine, and additionally reported the safety of SARS-CoV-2 vaccines, giving insight on the future of SARS-CoV-2 vaccine schedules. Although most vaccines for the prevention of COVID-19 are two-dose vaccines, we found that the pooled VE of a single dose of SARS-CoV-2 vaccines was about 50%. Recent study showed that the T cell and antibody responses induced by a single dose of the BNT162b2 vaccine were comparable to those naturally infected with SARE-CoV-2 within weeks or months after infection [76]. Our findings could help to develop vaccination strategies under certain circumstances such as countries having a shortage of vaccines. In some countries, in order to administer the first dose to a larger population, the second dose was delayed for up to 12 weeks [77]. Some countries such as Canada had even decided to delay the second dose for 16 weeks [78]. However, due to a suboptimum immune response in those receiving only a single dose of a vaccine, such an approach had a chance to give rise to the emergence of variants of SARS-CoV-2 [79]. There remains a need for large clinical trials to assess the efficacy of a single-dose administration of two-dose vaccines and the risk of increasing the emergence of variants. Two doses of SARS-CoV-2 vaccines were highly effective at preventing hospitalization, severe cases and deaths resulting from COVID-19, while the VE of different groups of days from the second vaccine dose showed no statistically significant differences. Our findings emphasized the importance of getting fully vaccinated, for the fact that most breakthrough infections were mild or asymptomatic. A recent study showed that the occurrence of breakthrough infections with SARS-CoV-2 in fully vaccinated populations was predictable with neutralizing antibody titers during the peri-infection period [80]. We also found getting fully vaccinated was at least 50% effective at preventing SARS-CoV-2 variants infections, despite reduced effectiveness compared with original virus; and BNT162b2 vaccine was found to have the highest VE in each variant group. Studies showed that the highly mutated variants were indicative of a form of rapid, multistage evolutionary jumps, which could preferentially occur in the milieu of partial immune control [81, 82]. Therefore, immunocompromised patients should be prioritized for anti-COVID-19 immunization to mitigate persistent SARS-CoV-2 infections, during which multimutational SARS-CoV-2 variants could arise [83]. Recently, many countries, including Israel, the United States, China and the United Kingdom, have introduced a booster of COVID-19 vaccine, namely the third dose [84,85,86,87]. A study of Israel showed that among people vaccinated with BNT162b2 vaccine over 60 years, the risk of COVID-19 infection and severe illness in the non-booster group was 11.3 times (95% CI: 10.4–12.3) and 19.5 times',\n",
       " ('COVID-19',\n",
       "  11,\n",
       "  1): '(95% CI: 12.9–29.5) than the booster group, respectively [84]. Some studies have found that the third dose of Moderna, Pfizer-BioNTech, Oxford-AstraZeneca and Sinovac produced a spike in infection-blocking neutralizing antibodies when given a few months after the second dose [85, 87, 88]. In addition, the common adverse events associated with the third dose did not differ significantly from the symptoms of the first two doses, ranging from mild to moderate [85]. The overall incidence rate of local and systemic adverse events was 69% (57/97) and 20% (19/97) after receiving the third dose of BNT162b2 vaccine, respectively [88]. Results of a phase 3 clinical trial involving 306 people aged 18–55 years showed that adverse events after receiving a third dose of BNT162b2 vaccine (5–8 months after completion of two doses) were similar to those reported after receiving a second dose [85]. Based on V-safe, local reactions were more frequently after dose 3 (5323/6283; 84.7%) than dose 2 (5249/6283; 83.5%) among people who received 3 doses of Moderna. Systemic reactions were reported less frequently after dose 3 (4963/6283; 79.0%) than dose 2 (5105/6283; 81.3%) [86]. On August 4, WHO called for a halt to booster shots until at least the end of September to achieve an even distribution of the vaccine [89]. At this stage, the most important thing we should be thinking about is how to reach a global cover of people at risk with the first or second dose, rather than focusing on the third dose. Based on real world studies, our results preliminarily showed that complete inoculation of COVID-19 vaccines was still effective against infection of variants, although the VE was generally diminished compared with the original virus. Particularly, the pooled VE was 54% (95% CI: 35–74%) for the Gamma variant, and 74% (95% CI: 62–85%) for the Delta variant. Since the wide spread of COVID-19, a number of variants have drawn extensive attention of international community, including Alpha variant (B.1.1.7), first identified in the United Kingdom; Beta variant (B.1.351) in South Africa; Gamma variant (P.1), initially appeared in Brazil; and the most infectious one to date, Delta variant (B.1.617.2) [90]. Israel recently reported a breakthrough infection of SARS-CoV-2, dominated by variant B.1.1.7 in a small number of fully vaccinated health care workers, raising concerns about the effectiveness of the original vaccine against those variants [80]. According to an observational cohort study in Qatar, VE of the BNT162b2 vaccine against the Alpha (B.1.1.7) and Beta (B.1.351) variants was 87% (95% CI: 81.8–90.7%) and 75.0% (95% CI: 70.5–7.9%), respectively [23]. Based on the National Immunization Management System of England, results from a recent real-world study of all the general population showed that the AZD1222 and BNT162b2 vaccines protected against symptomatic SARS-CoV-2 infection of Alpha variant with 74.5% (95% CI: 68.4–79.4%) and 93.7% (95% CI: 91.6–95.3%) [15]. In contrast, the VE against the Delta variant was 67.0% (95% CI: 61.3–71.8%) for two doses of AZD1222 vaccine and 88% (95% CI: 85.3–90.1%) for BNT162b2 vaccine [15]. In terms of adverse events after vaccination, the pooled incidence rate was very low, only 1.5% (95% CI: 1.4–1.6%). However, the prevalence of adverse events reported in large population (population size > 100 000) was much lower than that in small to medium population size. On the one hand, the vaccination population in the small to medium scale studies we included were mostly composed by health care workers, patients with specific diseases or the elderly. And these people are more concerned about their health and more sensitive to changes of themselves. But it remains to be proved whether patients or the elderly are more likely to',\n",
       " ('COVID-19',\n",
       "  11,\n",
       "  2): 'have adverse events than the general. Mainstream vaccines currently on the market have maintained robust safety in specific populations such as cancer patients, organ transplant recipients, patients with rheumatic and musculoskeletal diseases, pregnant women and the elderly [54, 91,92,93,94]. A prospective study by Tal Goshen-lag suggests that the safety of BNT162b2 vaccine in cancer patients is consistent with those previous reports [91]. In addition, the incidence rate of adverse events reported in the heart–lung transplant population is even lower than that in general population [95]. On the other hand, large scale studies at the national level are mostly based on national electronic health records or adverse event reporting systems, and it is likely that most mild or moderate symptoms are actually not reported. Compared with the usual local adverse events (such as pain at the injection site, redness at the injection site, etc.) and normal systemic reactions (such as fatigue, myalgia, etc.), serious and life-threatening adverse events were rare due to our results. A meta-analysis based on RCTs only showed three cases of anaphylactic shock among 58 889 COVID-19 vaccine recipients and one in the placebo group [11]. The exact mechanisms underlying most of the adverse events are still unclear, accordingly we cannot establish a causal relation between severe adverse events and vaccination directly based on observational studies. In general, varying degrees of adverse events occur after different types of COVID-19 vaccination. Nevertheless, the benefits far outweigh the risks. Our results showed the effectiveness and safety of different types of vaccines varied greatly. Regardless of SARS-CoV-2 variants, vaccine effectiveness varied from 66% (CoronaVac [14]) to 97% (mRNA-1273 [18, 20, 45, 46]). The incidence rate of adverse events varied widely among different types of vaccines, which, however, could be explained by the sample size and population group of participants. BNT162b2, AZD1222, mRNA-1273 and CoronaVac were all found to have high vaccine efficacy and acceptable adverse-event profile in recent published studies [96,97,98,99]. A meta-analysis, focusing on the potential vaccine candidate which have reached to the phase 3 of clinical development, also found that although many of the vaccines caused more adverse events than the controls, most were mild, transient and manageable [100]. However, severe adverse events did occur, and there remains the need to implement a unified global surveillance system to monitor the adverse events of COVID-19 vaccines around the world [101]. A recent study employed a knowledge-based or rational strategy to perform a prioritization matrix of approved COVID-19 vaccines, and led to a scale with JANSSEN (Ad26.COV2.S) in the first place, and AZD1222, BNT162b2, and Sputnik V in second place, followed by BBIBP-CorV, CoronaVac and mRNA-1273 in third place [101]. Moreover, when deciding the priority of vaccines, the socioeconomic characteristics of each country should also be considered. Our meta-analysis still has several limitations. First, we may include limited basic data on specific populations, as vaccination is slowly being promoted in populations under the age of 18 or over 60. Second, due to the limitation of the original real-world study, we did not conduct subgroup analysis based on more population characteristics, such as age. When analyzing the efficacy and safety of COVID-19 vaccine, we may have neglected the discussion on the heterogeneity from these sources. Third, most of the original studies only collected adverse events within 7 days after vaccination, which may limit the duration of follow-up for safety analysis.',\n",
       " ('COVID-19',\n",
       "  12,\n",
       "  0): 'Abstract Background Loss of smell and taste are commonly reported symptoms associated with coronavirus disease 2019 (COVID-19); however, the seroprevalence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibodies in people with acute loss of smell and/or taste is unknown. The study aimed to determine the seroprevalence of SARS-CoV-2 antibodies in a community-based population with acute loss of smell and/or taste and to compare the frequency of COVID-19 associated symptoms in participants with and without SARS-CoV-2 antibodies. It also evaluated whether smell or taste loss are indicative of COVID-19 infection. Methods and findings Text messages, sent via primary care centers in London, United Kingdom, invited people with loss of smell and/or taste in the preceding month, to participate. Recruitment took place between 23 April 2020 and 14 May 2020. A total of 590 participants enrolled via a web-based platform and responded to questions about loss of smell and taste and other COVID-19–related symptoms. Mean age was 39.4 years (SD ± 12.0) and 69.1% (n = 392) of participants were female. A total of 567 (96.1%) had a telemedicine consultation during which their COVID-19–related symptoms were verified and a lateral flow immunoassay test that detected SARS-CoV-2 immunoglobulin G (IgG) and immunoglobulin M (IgM) antibodies was undertaken under medical supervision. A total of 77.6% of 567 participants with acute smell and/or taste loss had SARS-CoV-2 antibodies; of these, 39.8% (n = 175) had neither cough nor fever. New loss of smell was more prevalent in participants with SARS-CoV-2 antibodies, compared with those without antibodies (93.4% versus 78.7%, p < 0.001), whereas taste loss was equally prevalent (90.2% versus 89.0%, p = 0.738). Seropositivity for SARS-CoV-2 was 3 times more likely in participants with smell loss (OR 2.86; 95% CI 1.27–6.36; p < 0.001) compared with those with taste loss. The limitations of this study are the lack of a general population control group, the self-reported nature of the smell and taste changes, and the fact our methodology does not take into account the possibility that a population subset may not seroconvert to develop SARS-CoV-2 antibodies post-COVID-19. Conclusions Our findings suggest that recent loss of smell is a highly specific COVID-19 symptom and should be considered more generally in guiding case isolation, testing, and treatment of COVID-19. Trials registration ClinicalTrials.gov NCT04377815 Author summary Why was this study done? Coronavirus disease 2019 (COVID-19), an infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus, was declared a pandemic in March 2020. COVID-19 can cause loss or reduced ability to smell (anosmia) or taste, without cough or fever, but few countries recommend self-isolation and testing on the basis of smell or taste changes alone. This study aimed to find out the proportion of people who have developed SARS-CoV-2 antibodies in a community-based population with a newly developed loss in their sense of smell and/or taste in London, UK. What did the researchers do and find? Text messages were sent out to people registered with a number of primary care centers in London inviting people with a new loss in their sense of smell and/or taste to participate. Recruited participants completed online questionnaires regarding demographics, their loss of smell and/or taste, and other COVID-19 symptoms, before they had a telemedicine consultation with a healthcare professional who confirmed the history of their symptoms and supervised a test to find out if they had SARS-CoV-2 antibodies. A total of 78% of 567 people with smell and/or taste loss had SARS-CoV-2 antibodies; of these, 40% had neither cough nor fever, and participants with loss of smell were 3 times more to have SARS-CoV-2 antibodies, compared with those',\n",
       " ('COVID-19',\n",
       "  12,\n",
       "  1): \"with loss of taste. What do these findings mean? Loss of smell is a highly specific symptom of COVID-19. COVID-19 can present with loss of smell and/or taste without cough or fever. Loss of smell should be take into consideration in case isolation, testing, and treatment strategies for COVID-19. Citation: Makaronidis J, Mok J, Balogun N, Magee CG, Omar RZ, Carnemolla A, et al. (2020) Seroprevalence of SARS-CoV-2 antibodies in people with an acute loss in their sense of smell and/or taste in a community-based population in London, UK: An observational cohort study. PLoS Med 17(10): e1003358. https://doi.org/10.1371/journal.pmed.1003358 Academic Editor: Daniele Borsetto, Guy's and Saint Thomas' NHS Foundation Trust, UNITED KINGDOM Received: June 10, 2020; Accepted: August 26, 2020; Published: October 1, 2020 Copyright: © 2020 Makaronidis et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Data Availability: All relevant data are within the manuscript and its Supporting information files. Funding: This work was funded by the National Institute for Health Research (BRC751). https://www.nihr.ac.uk/ RLB, CGM, JM, and AC are funded by National Institute for Health Research grant RP-2015-06-005 (https://www.nihr.ac.uk/). RLB, NB, and JM are funded by the Sir Jules Thorn Trust Biomedical Research Award (https://julesthorntrust.org.uk/programmes/medical-research/the-sir-jules-thorn-award-for-biomedical-research/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Competing interests: The authors have declared that no competing interests exist. Abbreviations: ACE-2, angiotensin-converting enzyme-2; COVID-19, coronavirus disease 2019; IgG, immunoglobulin G; IgM, immunoglobulin M; PCR, polymerase chain reaction; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2 Introduction Coronavirus disease 2019 (COVID-19) is an acute infectious disease caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). COVID-19 has spread exponentially, with 27,417,497 cases and 894,241 deaths reported from 216 countries by 9 September 2020 [1]. In the absence of a vaccine and disease-specific treatments, strategies to contain the pandemic are focused on rapid case isolation and testing. Although originally described as a primarily respiratory disease, reports of COVID-19 presenting with other multisystem symptoms, including loss of smell and taste, emerged rapidly. Understanding the symptomatology of COVID-19 and the predictive value of symptoms is crucial for containment strategies. As lockdown policies ease globally, early recognition of COVID-19 symptoms by the public together with rapid self-isolation and testing will be of vital importance to limit disease spread. Reports linking loss of the sense of smell and/or taste to COVID-19 emerged in March 2020 [2–4]. SARS-CoV-2 enters the human body via the angiotensin-converting enzyme-2 (ACE-2) receptor, highly expressed in the nasal epithelium [5]. Consequent inflammatory changes in the olfactory neuroepithelium could disrupt olfactory neuron function, leading to smell loss [6,7]. Thus, from a pathophysiological perspective, it is logical for COVID-19 to impact smell [5,6]. Smell and taste are highly interlinked, with an element of taste (flavor) perception mediated through retronasal olfaction; hence, loss of smell results in taste changes [6]. However, within the oral cavity, ACE-2 is highly expressed on tongue epithelial mucosal cells [5], raising the possibility that taste loss results from a direct effect of SARS-CoV-2 on the tongue and that taste loss alone could occur in the absence of smell loss. Available data suggest a prevalence of smell and/or taste loss in the range of 31%–85% in COVID-19 patients [8–10]. In a prospective epidemiological study, 85.6% and 88.0% of patients with a polymerase chain reaction (PCR)-confirmed COVID-19 diagnosis reported a loss of their sense of smell and taste, respectively [9]. The largest data set of potential COVID-19\",\n",
       " ('COVID-19',\n",
       "  12,\n",
       "  2): 'related symptoms stems from a web-based app that collected self-reported symptoms from 2,618,862 users in the United Kingdom (UK) and the United States (US). This included the question “Do you have a loss of smell/taste?”. The authors reported a strong association between loss of smell/taste and a diagnosis of COVID-19, and as a consequence, loss of smell/taste are now recognized presentations of COVID-19 in the UK [11,12]. Their methodology did not, however, enable them to differentiate between smell and taste loss [12,13]. The importance of acute loss of smell or taste, in isolation or combination, as a predictor of COVID-19 in a population presenting with chemosensory symptoms is unknown. Currently, recommendations for self-isolation and testing based upon acute loss of smell/taste have only been adopted by a limited number of countries; the majority are focused on fever and respiratory symptoms (Table 1). We therefore set out to quantify the seroprevalence of SARS-CoV-2 specific antibodies in a community-based cohort with a new loss of their sense of smell and/or taste during the COVID-19 outbreak in London, UK. Additionally, we compared the effect of isolated loss of smell and isolated loss of taste separately and then in combination and investigated whether new smell and/or taste loss are indicative of COVID-19 in our study population. PPT PowerPoint slide PNG larger image TIFF original image Download: Table 1. Recognition of smell and/or taste loss as symptoms of COVID-19 in the 30 countries with the highest number of reported cases globally. https://doi.org/10.1371/journal.pmed.1003358.t001 Methods Study design The study was conducted in London, UK, and recruited between 23 April 2020 and 14 May 2020 at a time when loss of smell and/or taste were not recognized as COVID-19 symptoms. Recruitment was timed to capture people who experienced symptoms during the peak of the COVID-19 outbreak in London. Antibody testing was delivered using a telemedicine consultation. This approach was chosen to capture positive cases without the limitations of the time window restrictions of PCR and to enable testing and participation without face-to-face contact, reducing the infection risk to both participants and researchers. Adults registered with 4 participating primary care centers in London were sent text messages to their mobile telephones inviting those who experienced a new loss of their sense of smell and/or taste in the preceding month to participate. The text message read: “Has your sense of smell or taste reduced in the last month? If yes and you’d like to be part of a COVID-19 research study go to [link]”. Participants were then directed to an online platform (hosted by Dendrite Clinical Systems) with the study information and an eligibility check. Inclusion criteria were age ≥18 years, proficiency in written and spoken English, and access to video-calling. Exclusion criteria were any preexisting loss of the sense of smell or taste of longer than a month’s duration. Participation was voluntary, and written informed consent was obtained electronically. Enrolled participants completed an online questionnaire (see S1 Text), capturing their sex, age, ethnicity, smoking status, previous COVID-19 testing, questions about their smell and taste symptoms, as well as other symptoms of COVID-19. Participants were subsequently sent a point-of-care testing kit detecting the presence of immunoglobulin M (IgM) and immunoglobulin G (IgG) antibodies to SARS-CoV-2. A healthcare professional arranged a telemedicine video consultation with each participant. At the beginning of the consultation, they asked the participant to describe the changes that they had experienced in their sense of smell and/or taste. Participants were then supervised in performing the antibody test using a finger-prick sample of whole blood, and their results were discussed with them. Photographs of the test cassette were',\n",
       " ('COVID-19',\n",
       "  12,\n",
       "  3): 'obtained and reviewed independently by a second healthcare professional to confirm the result. Participants with a prior COVID-19 PCR test result were offered antibody testing irrespective of their result. Testing was carried out between 24 April 2020 and 22 May 2020. The antibody test used detects the presence of IgM and IgG antibodies to SARS-CoV-2 via lateral flow immunoassay (Wuhan UNscience Biotechnology Co., Ltd. COVID-19 Antibody IgM/IgG) [15]. As part of the test’s validation, 1,585 cases were tested: 421 (positive) clinically confirmed (including PCR) COVID-19 patients and 1,164 controls. These showed that the product has a relative sensitivity of 98.8% (95% CI 97.3%–99.6%) and a relative specificity of 98.0% (95% CI 97.15%–98.7%) [15]. The study received ethical approval from the National Health Service Queen’s Square Research Ethics Committee (IRAS Project ID 282668, ClinicalTrials.gov: NCT04377815) and was conducted in line with the declaration of Helsinki and Good Clinical Practice. Statistical analysis A sample size calculation was undertaken in order to determine the study’s recruitment target, using the information on reported symptoms from the web-based COVID symptom study app developed by King’s College London and symptom reporting between the 24–29 March 2020 [16]. To calculate an estimate of 50% (95% CI 45%–55%) as the proportion who would test positive amongst those who reported a change in smell or taste, we needed 385 participants in the study [17]. Assuming a 15% attrition, we needed 453 participants in the study. The recruitment target was set to 500 participants to allow for larger attrition and increase accuracy. This was exceeded to improve the accuracy of the data and enable additional analyses to further describe the pattern of loss of smell and/or taste in the study populations with and without SARS-CoV-2 antibodies. Data were analyzed using GraphPad Prism version 8 (https://www.graphpad.com/scientific-software/prism/) and STATA version 15 (https://www.stata-uk.com/). Data analysis was planned on completion of SARS-CoV-2 antibody testing. There was no prospective study protocol or analysis plan, and no data-driven changes to analyses took place. Descriptive analyses included the calculation of means (plus standard deviation [SD]) for continuous variables and numbers (n, with percentages) for categorical variables. Chi-squared tests were performed on categorical data as part of the secondary analysis. The significance level was adjusted for multiple comparisons by applying a Bonferroni correction when comparing symptoms other than loss of smell or taste. Logistic regression analysis was performed to estimate the association between loss of smell and/or taste and the presence of SARS-CoV-2 antibodies. Discussion In this community-based cohort study, undertaken during the peak of the COVID-19 outbreak in London, the seroprevalence of SARS-CoV-2 antibodies in participants with new onset loss of sense of smell and/or taste, was 77.6%. A total of 39.8% (n = 175) of the study participants reported neither cough nor fever. In our study cohort, loss of smell was more prevalent in participants with SARS-CoV-2 antibodies compared with those without antibodies (93.4% versus 78.7%, p < 0.001), whereas taste loss was equally prevalent (90.2% versus 89.0%, p = 0.738). Furthermore, participants with acute smell loss were 3 times more to be seropositive for SARS-CoV-2 (OR 2.86; 95% CI 1.27–6.36; p < 0.001) compared with those with taste loss. Loss of smell and taste were evaluated as separate symptoms, which enabled a direct comparison of their relationship to SARS-CoV-2 antibodies. Among participants, loss of sense of smell, but not taste, was significantly more prevalent in participants with SARS-CoV-2 antibodies, compared with those without. Moreover, within our study cohort with smell and taste loss, participants with loss of smell alone were 3 times more likely than participants with loss of taste alone to have SARS-CoV-2 antibodies.',\n",
       " ('COVID-19',\n",
       "  12,\n",
       "  4): 'Participants who reported both a loss of smell and taste were 4 times more likely to have SARS-CoV-2 antibodies compared with participants with isolated taste loss. These findings suggest that a loss of smell is a highly specific symptom of COVID-19, in contrast to a loss of taste, despite their comparable frequency. Sense of taste and smell are interlinked, with retronasal olfaction being a major component of taste (flavor); thus, it is plausible that the loss of taste reported by participants who also report loss of smell reflects impaired retronasal olfaction and hence, represents loss of flavor perception, as a consequence of smell loss. Interestingly, 6.6% of participants with SARS-CoV-2 antibodies reported an isolated loss in their sense of taste, in the absence of smell loss, suggesting the presence of a rarer, alternative pathophysiological mechanism targeting gustatory function in isolation. Lingual mucosal epithelium ACE2 could provide a plausible explanation [19]. Globally, as populations are released from lockdown, early identification by the public of COVID-19 symptoms and rapid self-isolation and testing will be of vital importance to limit disease spread. Currently, as highlighted in Table 1, a large number of countries are not advising that loss of smell and/or taste are COVID-19 symptoms. This could have potentially devastating consequences. Importantly, 40% of our seropositive cohort reported neither fever nor cough. Similarly, a recent UK-based survey reported that cough and/or fever were only present in 51% of people with COVID-19 [3]. Counterintuitively, people with minor symptoms, such as isolated smell loss, who remain systemically well pose the highest public health threat. SARS-CoV-2 specific antibody testing performed via telemedicine consultation enabled us to confirm participants’ reported symptomatology and verify their identity and test results, which adds to the quality of our data. Although viral nucleic acid detection using real-time PCR remains the gold standard for diagnosis, there are several limitations to this method, including a high processing time, labor intensity, and a high false negative rate [20–22]. Furthermore, there is a narrow window to perform testing before the virus becomes undetectable by PCR [23]. In contrast, seroconversion to IgM and IgG antibodies occurs as early as day 4 [24]. The Center for Disease Control and Prevention recommends antibody testing for diagnostic purposes using high specificity kits to minimize false positives [22]. Given the very high prevalence in our study cohort and the specificity of our chosen test, we could expect a high positive predictive value [22]. The sensitivity of our antibody test is 98.8%. These data were generated in people who were PCR positive, suggesting a very high seroconversion rate. However, evidence with regard to the rate of patients with confirmed COVID-19, who seroconvert to generate an antibody response remains limited. Current data suggest seroconversion rates of up to 100% in hospital patients, which may be related to disease severity but also time from symptom onset [20,25,26]. Although a recent study demonstrated a 99.4% seroconversion rate in hospital staff following a mild COVID-19 illness, in which 47.5% of the study population reported anosmia [27], no data are available yet reporting the rate of seroconversion in confirmed COVID-19 patients with anosmia. Limitations The main limitation of our study is the lack of a general population control group without loss of smell and/or taste. The study only recruited participants who reported acute smell and/or taste loss. Although this enabled us to study this presentation and its relevance to COVID-19, this also presents a degree of selection bias; hence, our findings refer to a population subset with new acute loss of smell and/or taste. In addition, although we used a questionnaire to assess COVID-19 symptoms and',\n",
       " ('COVID-19',\n",
       "  12,\n",
       "  5): 'subsequently validated participants’ responses during the telemedicine interview, we did not undertake any objective assessments of smell or taste. However, from a COVID-19 disease containment perspective, the general public are unlikely to have rapid access to formal objective smell/taste testing. Moreover, our data show a high seroprevalence of SARS-CoV-2 antibodies in people who recognized a loss of their sense of smell. Furthermore, as our study relied on antibody testing via telemedicine, we were unable to account for COVID-19 patients who may not have seroconverted to develop IgG or IgM antibodies, which may lead to our findings underestimating the prevalence of COVID-19 in this population. However, our findings suggest that a key public health message is that people who notice a loss in their ability to smell everyday house-hold odors such as garlic, onions, coffee, and perfumes should self-isolate and seek PCR testing. The majority of our participants were female; this finding may reflect previous findings that females have a higher frequency of loss of smell and/or taste with COVID-19 than males [3,9,28]. We found no differences in sex, but this may reflect the lower number of males recruited. Conclusions In a community-based population, the vast majority of participants with new onset loss of smell were seropositive for SARS-CoV-2 antibodies. Acute loss of sense of smell needs to be considered globally as a criterion for self-isolation, testing, and contact tracing in order to contain the spread of COVID-19. Acknowledgments We thank Jed Wingrove for designing the participant instruction leaflet and Charalampos Markakis for his help in the organisation and running of the study. We also thank the Hampstead Group Practice, The Northern Medical Centre, the James Wigg Practice, and the Queen’s Crescent Practice for their collaboration in sending out the invitation text messages to their registered patients.',\n",
       " ('COVID-19',\n",
       "  13,\n",
       "  0): 'Last reviewed/updated: 30 May 2023 Disclaimer: The information contained in this factsheet is intended for the purpose of general information and should not substitute individual expert advice or judgement of healthcare professionals. Case definition COVID-19 is a disease under surveillance in the European Union (EU) and must be reported by all Member States. For EU surveillance purposes, a confirmed case is any person meeting at least one of the following laboratory criteria: detection of SARS-CoV-2 nucleic acid; identification of SARS-CoV-2 r antigen in a clinical specimen (excluding self-tests performed outside healthcare settings); or isolation of SARS-CoV-2 in a clinical specimen [1] Surveillance of COVID-19 Well-designed, representative sentinel surveillance systems in primary and secondary care remain the core surveillance method for acute viral respiratory infections. These can provide robust data for monitoring the spread and intensity of respiratory virus activity and circulating variant viruses. Data from other non-sentinel sources or registry-based systems provide complementary information including molecular information on circulating variant viruses. Surveillance informs public health measures, hospital capacities, the impact of vaccination programmes, and other control measures. The ECDC and WHO Regional Office for Europe issued surveillance objectives and operational considerations for the integrated surveillance of influenza, COVID-19, and other respiratory virus infections in Europe to support the continuity of national surveillance systems and public health laboratories for epidemiological and virological surveillance for influenza, SARS-CoV-2, and other potential respiratory viruses [2]. To increase the samples available for sequencing to identify SARS-CoV-2 variant viruses, additional specimens from other non-sentinel surveillance systems could be included. Targeted surveillance including molecular surveillance of either specific populations or related to selected settings are approaches which could provide relevant data. The pathogen SARS-COV-2 COVID-19 disease is caused by a virus of the coronavirus family, SARS-CoV-2, in the order of nidovirales. Like SARS-COV-1, SARS-CoV-2 belongs to the betacoronavirus genus and sarbecovirus sub-genus [3]. To date, there are seven different types of human coronaviruses, four of which cause mild to moderate respiratory diseases, such as common colds. The other three cause more severe and occasionally fatal diseases. These are: SARS-CoV-1, responsible for the severe acute respiratory syndrome (SARS); MERS-CoV, responsible for the Middle East respiratory syndrome (MERS); and SARS-CoV-2, responsible for COVID-19. Like all viruses, SARS-CoV-2 evolves and adapts itself through mutation. While most emerging mutations have no significant impact on the spread of the virus, some mutations or combinations of mutations provide the virus with a selective advantage, e.g. increased transmissibility or the ability to evade the host immune response. In such cases, these mutations or combinations of mutations (also called variations) can increase the risk to human health, and the virus strains (or variants) that carry those mutations are classified as variants of concern (VOCs) [4]. ECDC continuously assesses new evidence on the emergence and circulation of VOCs in the EU and reports its findings on the evolution of SARS-COV-2 . Clinical features and sequelae Clinical features The most common symptoms of COVID-19 are: Cough; Fatigue; Fever; Headache; Myalgia; Loss of smell; Nasal obstruction; Asthenia; Rhinorrhoea; and Sore throat [5-9]. Symptoms may vary, both in frequency and severity, depending on the SARS-CoV-2 variant causing the disease episode [10]. Most cases of COVID-19 are mild or moderate and do not require hospitalisation or advanced medical care [10]. Severe disease usually manifests as pneumonia with shortness of breath and pulmonary infiltrates on chest imaging. Pneumonia can be complicated by respiratory failure requiring oxygen supplementation and mechanical ventilation [11]. Other severe complications include thromboembolism (such as pulmonary embolism and stroke), circulatory shock, myocardial damage, arrhythmias, and encephalopathy [11-13]. Severe illness usually develops approximately one week after the onset of',\n",
       " ('COVID-19',\n",
       "  13,\n",
       "  1): 'symptoms. People who received a full course of vaccination may still experience flu-like symptoms but are less likely to suffer from severe disease and require hospitalisation. COVID-19 in children Children usually experience mild symptoms (mainly fever and cough), if any, and have a very low risk of hospitalisation or death [14] . However, some children may develop severe disease after infection with COVID-19, defined as multi-system inflammatory syndrome in children (MIS-C). This rare syndrome shares common clinical features with other paediatric inflammatory syndromes such as Kawasaki disease, toxic shock syndrome, and macrophage activation syndrome [15,16]. Risk groups for severe disease The risk of very severe disease increases with advancing age and the presence of comorbidities, and is slightly higher among males than females. A range of conditions have been linked to severe clinical outcomes in terms of hospital admission, ICU admission, and mortality. These include hypertension, diabetes, chronic kidney disease, coronary heart disease, chronic obstructive pulmonary disease (COPD), cerebrovascular disease and chronic liver disease, use of immunosuppressive medications, arrythmia, ischemic heart disease, heart failure, cancer, and obesity [17-19]. Smoking has also been linked with a higher risk of severe outcomes [20]. Some migrant and ethnic minority groups have been found to be at an increased risk of severe illness and hospitalisation due to COVID-19. This is likely associated with social and economic factors, such as occupation (with face-to-face exposure), housing situation (with crowded and/or intergenerational housing), and barriers in access to healthcare [21]. Post-COVID-19 condition Some patients may experience long-term symptoms with unclear aetiology, referred to as Post-COVID-19 condition (and sometimes as ‘Long COVID’). This has been defined as ‘the condition that occurs in individuals with a history of probable or confirmed SARS-CoV-2 infection, usually three months from the onset of COVID-19, with symptoms that last for at least two months and cannot be explained by an alternative diagnosis’[22]. The presentation is often episodic and affects multiple organ systems. This could include: Respiratory manifestations, e.g. shortness of breath, cough, and sore throat. Decreased diffusing capacity and abnormalities in lung imaging are commonly observed [13]. Neuropsychiatric and cognitive symptoms, such as chronic fatigue (most commonly), headaches and loss of smell, difficulty concentrating, sleep disturbances, and depression [16]. Cardiovascular presentations, e.g. chest pain and arrhythmias (e.g. atrial fibrillation presenting as palpitations or tachycardia), as well as heart failure and thromboembolic events [13]. Manifestations from other organ systems, such as endocrine, gastrointestinal, renal, and skin, are reported less frequently [23]. Patients with co-morbidities, obese individuals, older adults (>50 years and, particularly, those >85 years), women, and hospitalised patients are more likely to report prolonged symptoms [24] . Post-COVID-19 condition has been also reported in cohorts of children from several countries [25]. Epidemiology of COVID-19 On 31 December 2019, the Municipal Health Commission in Wuhan City, mainland China, issued a report on a cluster of pneumonia cases of unknown aetiology with a link to a wholesale fish and live animal market. The first European case was reported on 24 January 2020. On 30 January 2020, the World Health Organization (WHO) declared this outbreak of novel coronavirus a ‘public health emergency of international concern’ and on 11 March 2020 declared it officially as a global pandemic. On 5 May 2023, WHO stated that ’COVID-19 is now an established and ongoing health issue which no longer constitutes a public health emergency of international concern’ [26-28]. ECDC still publishes a weekly overview of the COVID-19 epidemiological situation by country in the EU and the European Economic Area (EEA) and, jointly with the WHO Regional Office for Europe, the WHO European Region including the Western Balkans [29]. These',\n",
       " ('COVID-19',\n",
       "  13,\n",
       "  2): 'overviews include age-specific COVID-19 case notification rates, test positivity, hospitalisation, intensive care admission and occupancy, death rates, virus variants, and vaccine uptake.',\n",
       " ('COVID-19',\n",
       "  14,\n",
       "  0): '----- This version updates the 27 March publication by providing definitions of droplets by particle size and adding three relevant publications. Modes of transmission of the COVID-19 virus Respiratory infections can be transmitted through droplets of different sizes: when the droplet particles are >5-10 μm in diameter they are referred to as respiratory droplets, and when then are <5μm in diameter, they are referred to as droplet nuclei.1 According to current evidence, COVID-19 virus is primarily transmitted between people through respiratory droplets and contact routes.2-7 In an analysis of 75,465 COVID-19 cases in China, airborne transmission was not reported.7 Droplet transmission occurs when a person is in in close contact (within 1 m) with someone who has respiratory symptoms (e.g., coughing or sneezing) and is therefore at risk of having his/her mucosae (mouth and nose) or conjunctiva (eyes) exposed to potentially infective respiratory droplets. Transmission may also occur through fomites in the immediate environment around the infected person.8 Therefore, transmission of the COVID-19 virus can occur by direct contact with infected people and indirect contact with surfaces in the immediate environment or with objects used on the infected person (e.g., stethoscope or thermometer). Airborne transmission is different from droplet transmission as it refers to the presence of microbes within droplet nuclei, which are generally considered to be particles <5μm in diameter, can remain in the air for long periods of time and be transmitted to others over distances greater than 1 m. In the context of COVID-19, airborne transmission may be possible in specific circumstances and settings in which procedures or support treatments that generate aerosols are performed; i.e., endotracheal intubation, bronchoscopy, open suctioning, administration of nebulized treatment, manual ventilation before intubation, turning the patient to the prone position, disconnecting the patient from the ventilator, non-invasive positive-pressure ventilation, tracheostomy, and cardiopulmonary resuscitation. There is some evidence that COVID-19 infection may lead to intestinal infection and be present in faeces. However, to date only one study has cultured the COVID-19 virus from a single stool specimen.9 There have been no reports of faecal−oral transmission of the COVID-19 virus to date. Implications of recent findings of detection of COVID-19 virus from air sampling To date, some scientific publications provide initial evidence on whether the COVID-19 virus can be detected in the air and thus, some news outlets have suggested that there has been airborne transmission. These initial findings need to be interpreted carefully. A recent publication in the New England Journal of Medicine has evaluated virus persistence of the COVID-19 virus.10 In this experimental study, aerosols were generated using a three-jet Collison nebulizer and fed into a Goldberg drum under controlled laboratory conditions. This is a high-powered machine that does not reflect normal human cough conditions. Further, the finding of COVID-19 virus in aerosol particles up to 3 hours does not reflect a clinical setting in which aerosol-generating procedures are performed—that is, this was an experimentally induced aerosol-generating procedure. There are reports from settings where symptomatic COVID-19 patients have been admitted and in which no COVID-19 RNA was detected in air samples.11-12 WHO is aware of other studies which have evaluated the presence of COVID-19 RNA in air samples, but which are not yet published in peer-reviewed journals. It is important to note that the detection of RNA in environmental samples based on PCR-based assays is not indicative of viable virus that could be transmissible. Further studies are needed to determine whether it is possible to detect COVID-19 virus in air samples from patient rooms where no procedures or support treatments that generate aerosols are ongoing. As evidence emerges, it is important',\n",
       " ('COVID-19',\n",
       "  14,\n",
       "  1): 'to know whether viable virus is found and what role it may play in transmission. Conclusions Based on the available evidence, including the recent publications mentioned above, WHO continues to recommend droplet and contact precautions for those people caring for COVID-19 patients. WHO continues to recommend airborne precautions for circumstances and settings in which aerosol generating procedures and support treatment are performed, according to risk assessment.13 These recommendations are consistent with other national and international guidelines, including those developed by the European Society of Intensive Care Medicine and Society of Critical Care Medicine14 and those currently used in Australia, Canada, and United Kingdom.15-17 At the same time, other countries and organizations, including the US Centers for Diseases Control and Prevention and the European Centre for Disease Prevention and Control, recommend airborne precautions for any situation involving the care of COVID-19 patients, and consider the use of medical masks as an acceptable option in case of shortages of respirators (N95, FFP2 or FFP3).18-19 Current WHO recommendations emphasize the importance of rational and appropriate use of all PPE,20 not only masks, which requires correct and rigorous behavior from health care workers, particularly in doffing procedures and hand hygiene practices.21 WHO also recommends staff training on these recommendations,22 as well as the adequate procurement and availability of the necessary PPE and other supplies and facilities. Finally, WHO continues to emphasize the utmost importance of frequent hand hygiene, respiratory etiquette, and environmental cleaning and disinfection, as well as the importance of maintaining physical distances and avoidance of close, unprotected contact with people with fever or respiratory symptoms. WHO carefully monitors emerging evidence about this critical topic and will update this scientific brief as more information becomes available. References World Health Organization. Infection prevention and control of epidemic- and pandemic-prone acute respiratory infections in health care. Geneva: World Health Organization; 2014 Available from: https://apps.who.int/iris/bitstream/handle/10665/112656/9789241507134_eng.pdf?sequence=1 Liu J, Liao X, Qian S et al. Community transmission of severe acute respiratory syndrome coronavirus 2, Shenzhen, China, 2020. Emerg Infect Dis 2020 doi.org/10.3201/eid2606.200239 Chan J, Yuan S, Kok K et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet 2020 doi: 10.1016/S0140-6736(20)30154-9 Li Q, Guan X, Wu P, et al. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N Engl J Med 2020; doi:10.1056/NEJMoa2001316. Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020; 395: 497–506. Burke RM, Midgley CM, Dratch A, Fenstersheib M, Haupt T, Holshue M,et al. Active monitoring of persons exposed to patients with confirmed COVID-19 — United States, January–February 2020. MMWR Morb Mortal Wkly Rep. 2020 doi : 10.15585/mmwr.mm6909e1external icon World Health Organization. Report of the WHO-China Joint Mission on Coronavirus Disease 2019 (COVID-19) 16-24 February 2020 [Internet]. Geneva: World Health Organization; 2020 Available from: https://www.who.int/docs/default- source/coronaviruse/who-china-joint-mission-on-covid-19-final-report.pdf Ong SW, Tan YK, Chia PY, Lee TH, Ng OT, Wong MS, et al. Air, surface environmental, and personal protective equipment contamination by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) from a symptomatic patient. JAMA. 2020 Mar 4 [Epub ahead of print]. Zhang Y, Chen C, Zhu S et al. [Isolation of 2019-nCoV from a stool specimen of a laboratory-confirmed case of the coronavirus disease 2019 (COVID-19)]. China CDC Weekly. 2020;2(8):123–4. (In Chinese) van Doremalen N, Morris D, Bushmaker T et al. Aerosol and Surface Stability of SARS-CoV-2 as compared with SARS-CoV-1. New Engl J Med 2020 doi: 10.1056/NEJMc2004973 Cheng V, Wong S-C, Chen J, Yip C, Chuang V, Tsang O, et al. Escalating infection control response to the rapidly evolving',\n",
       " ('COVID-19',\n",
       "  14,\n",
       "  2): 'epidemiology of the Coronavirus disease 2019 (COVID-19) due to SARS-CoV-2 in Hong Kong. Infect Control Hosp Epidemiol. 2020 Mar 5 [Epub ahead of print]. Ong SW, Tan YK, Chia PY, Lee TH, Ng OT, Wong MS, et al. Air, surface environmental, and personal protective equipment contamination by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) from a symptomatic patient. JAMA. 2020 WHO Infection Prevention and Control Guidance for COVID-19 available at https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance/infection-prevention-and-control Surviving Sepsis Campaign: Guidelines on the Management of Critically Ill Adults with Coronavirus Disease 2019 (COVID-19). Intensive Care Medicine DOI: 10.1007/s00134-020-06022-5 https://www.sccm.org/SurvivingSepsisCampaign/Guidelines/COVID-19 Interim guidelines for the clinical management of COVID-19 in adults Australasian Society for Infectious Diseases Limited (ASID) https://www.asid.net.au/documents/item/1873 Coronavirus disease (COVID-19): For health professionals. https://www.canada.ca/en/public-health/services/diseases/2019-novel-coronavirus-infection/health-professionals.html Guidance on infection prevention and control for COVID-19 https://www.gov.uk/government/publications/wuhan-novel-coronavirus-infection-prevention-and-control Interim Infection Prevention and Control Recommendations for Patients with Suspected or Confirmed Coronavirus Disease 2019 (COVID-19) in Healthcare Settings. https://www.cdc.gov/coronavirus/2019-ncov/infection-control/control-recommendations.html Infection prevention and control for COVID-19 in healthcare settings https://www.ecdc.europa.eu/en/publications-data/infection-prevention-and-control-covid-19-healthcare-settings Rational use of PPE for COVID-19. https://apps.who.int/iris/bitstream/handle/10665/331498/WHO-2019-nCoV-IPCPPE_use-2020.2-eng.pdf Risk factors of Healthcare Workers with Corona Virus Disease 2019: A Retrospective Cohort Study in a Designated Hospital of Wuhan in China. https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciaa287/5808788 Infection Prevention and Control (IPC) for Novel Coronavirus (COVID-19) Course. https://openwho.org/courses/COVID-19-IPC-EN WHO continues to monitor the situation closely for any changes that may affect this interim guidance. Should any factors change, WHO will issue a further update. Otherwise, this scientific brief will expire 2 years after the date of publication. © World Health Organization 2020. Some rights reserved. This work is available under the CC BY-NC-SA 3.0 IGO license. WHO reference number: WHO/2019-nCoV/Sci_Brief/Transmission_modes/2020.2',\n",
       " ('COVID-19',\n",
       "  15,\n",
       "  0): 'On July 24, 2020, this report was posted online as an MMWR Early Release. In a multistate telephone survey of symptomatic adults who had a positive outpatient test result for SARS-CoV-2 infection, 35% had not returned to their usual state of health when interviewed 2–3 weeks after testing. Among persons aged 18–34 years with no chronic medical conditions, one in five had not returned to their usual state of health. Close Prolonged symptom duration and disability are common in adults hospitalized with severe coronavirus disease 2019 (COVID-19). Characterizing return to baseline health among outpatients with milder COVID-19 illness is important for understanding the full spectrum of COVID-19–associated illness and tailoring public health messaging, interventions, and policy. During April 15–June 25, 2020, telephone interviews were conducted with a random sample of adults aged ≥18 years who had a first positive reverse transcription–polymerase chain reaction (RT-PCR) test for SARS-CoV-2, the virus that causes COVID-19, at an outpatient visit at one of 14 U.S. academic health care systems in 13 states. Interviews were conducted 14–21 days after the test date. Respondents were asked about demographic characteristics, baseline chronic medical conditions, symptoms present at the time of testing, whether those symptoms had resolved by the interview date, and whether they had returned to their usual state of health at the time of interview. Among 292 respondents, 94% (274) reported experiencing one or more symptoms at the time of testing; 35% of these symptomatic respondents reported not having returned to their usual state of health by the date of the interview (median = 16 days from testing date), including 26% among those aged 18–34 years, 32% among those aged 35–49 years, and 47% among those aged ≥50 years. Among respondents reporting cough, fatigue, or shortness of breath at the time of testing, 43%, 35%, and 29%, respectively, continued to experience these symptoms at the time of the interview. These findings indicate that COVID-19 can result in prolonged illness even among persons with milder outpatient illness, including young adults. Effective public health messaging targeting these groups is warranted. Preventative measures, including social distancing, frequent handwashing, and the consistent and correct use of face coverings in public, should be strongly encouraged to slow the spread of SARS-CoV-2. Prolonged illness is well described in adults with severe COVID-19 requiring hospitalization, especially among older adults (1,2). Recently, the number of SARS-CoV-2 infections in persons first evaluated as outpatients have increased, including cases among younger adults (3). A better understanding of convalescence and symptom duration among outpatients with COVID-19 can help direct care, inform interventions to reduce transmission, and tailor public health messaging. The Influenza Vaccine Effectiveness in the Critically Ill (IVY) Network, a collaboration of U.S. health care systems, is conducting epidemiologic studies on COVID-19 in both inpatient and outpatient settings (4,5). Fourteen predominantly urban academic health systems in 13 states each submitted a list of adults with positive SARS-CoV-2 RT-PCR test results obtained during March 31–June 4, 2020, to Vanderbilt University Medical Center. Site-specific random sampling was then performed on a subset of these patients who were tested as outpatients and included patients tested in the emergency department (ED) who were not admitted to the hospital at the testing encounter and those tested in other outpatient clinics. At 14–21 days from the test date, CDC personnel interviewed the randomly sampled patients or their proxies by telephone to obtain self-reported baseline demographic, socioeconomic, and underlying health information, including the presence of chronic medical conditions. Call attempts were made for up to seven consecutive days, and interviews were conducted in several languages (4). Respondents were asked to report the number',\n",
       " ('COVID-19',\n",
       "  15,\n",
       "  1): 'of days they felt unwell before the test date, COVID-19–related symptoms experienced at the time of testing (6), whether symptoms had resolved by the date of the interview, and whether the patient had returned to their usual state of health. For this data analysis, respondents were excluded if they did not complete the interview, if a proxy (e.g., family member) completed the interview (because of their incomplete knowledge of symptoms), if they reported a previous positive SARS-CoV-2 test (because the reference date for symptoms questions was unclear), or (because this analysis focused on symptomatic persons) if they did not answer symptoms questions or denied all symptoms at testing. Descriptive statistics were used to compare characteristics among respondents who reported returning and not returning to their usual state of health by the date of the interview. Generalized estimating equation regression models with exchangeable correlation structure accounting for clustering by site were fitted to evaluate the association between baseline characteristics and return to usual health, adjusting for potential a priori-selected confounders. Resolution and duration of individual symptoms were also assessed. Statistical analyses were conducted using Stata software (version 16; StataCorp). At least one telephone call was attempted for 582 patients (including 175 [30%] who were tested in an ED and 407 [70%] in non-ED settings), with 325 (56%) interviews completed (89 [27%] ED and 236 [73%] non-ED). Among 257 nonrespondents, 178 could not be reached, 37 requested a callback but could not be reached on further call attempts, 28 refused the interview, and 14 had a language barrier. Among the 325 completed interviews, 31 were excluded: nine (3%) because a proxy was interviewed, 17 (5%) because a previous positive SARS-CoV-2 test was reported, and five (2%) who did not answer the symptoms questions. Two additional respondents were called prematurely at 7 days and were also excluded.* Among the 292 remaining patient respondents, 274 (94%) reported one or more symptoms at testing and were included in this data analysis. Following outpatient testing, 7% (19 of 262 with available data) reported later being hospitalized, a median of 3.5 days after the test date. The median age of symptomatic respondents was 42.5 years (interquartile range [IQR] = 31–54 years), 142 (52%) were female, 98 (36%) were Hispanic, 96 (35%) were non-Hispanic white, 48 (18%) were non-Hispanic black, and 32 (12%) were other non-Hispanic race. Overall, 141 of 264 (53%) with available data reported one or more chronic medical conditions. The median interval from test to interview date was 16 days (IQR = 14–19 days); the median number of days respondents reported feeling unwell before being tested for SARS-CoV-2 was 3 (IQR = 2–7 days).',\n",
       " ('COVID-19',\n",
       "  16,\n",
       "  0): 'The risk of developing severe COVID-19 increases steeply above age 70, and also with the severity of obesity and other risk factors. Men have a much greater risk of severe acute COVID-19 than women, whereas women are over-represented among patients who develop long COVID15. The infection differs from many other respiratory infections in that children are seemingly able to cope, even in the very first years of life, without developing severe respiratory disease except in a few rare cases. The known immunological differences between young and old people and between men and women should help us further unravel the immunological mechanisms behind disease presentation and severity. Sex differences As mentioned above, type I IFN responses are critical determinants of disease severity during acute SARS-CoV-2 infection, and the virus has developed methods for subverting these responses. Women elicit stronger type I IFN responses upon stimulation with TLR7 ligands74 and develop stronger vaccine responses75, but also more side effects, and have better survival rates for a number of acute infections than do men76. These sex differences are seen even in boys and girls before puberty—pointing towards genetic, rather than hormonal, differences. It is worth noting that a common sensor of viruses, TLR7, is expressed on the X chromosome, providing a possible difference in gene-dosage effect between men and women77. Interestingly, the neutralizing autoantibodies to type I IFN found in patients with severe COVID-19 were much more abundant in men than in women, but the reasons for this are elusive56. Immune-response differences have also been reported between male and female patients with COVID-19 (ref. 6), and collectively these sex differences could explain the overall susceptibility of male patients to developing severe acute COVID-19. MIS-C is quite evenly distributed between boys and girls22, whereas long COVID is more prevalent in female patients15,16. It is also important to consider whether social factors and differing exposure play a part in sex differences. Age differences If type I IFN responses were the sole determinants of COVID-19 severity, one would expect young children to be highly susceptible because both newborn and young children produce lower amounts of type I IFN upon stimulation through various viral-sensing pathways78. The low risk of severe SARS-CoV-2 disease in young children also differs from that of other respiratory viral infections like the flu79, and points toward other protective mechanisms in young children. The immune systems of young children are accustomed to facing novel challenges, whereas older individuals rely more on memory responses. The thymus decreases its output of naive T cells and involutes at a rate of about 3% per year, and some data indicate more rapid involution in boys than in girls80. Cross-reactive antibodies to common-cold coronaviruses are one possible explanation; another possibility is that constitutive differences in immune system states between young and old people are of importance. One example could be the skewing of T cells from T helper type 1 (T H 1) toward more T H 2 in young children81 (Fig. 2). Fig. 2: Immune-system parameters associated with obesity, aging and severe COVID-19. The gradient illustrates the risk of developing severe COVID-19 in relation to known immune system changes with age (x axis) and obesity (y axis). Full size image Disease severity in COVID-19 also correlates with neutrophil-to-lymphocyte ratio (NLR)82, a metric reflecting immune-cell composition that is frequently studied across populations and disease conditions as a surrogate marker of systemic inflammation. The NLR ratio positively correlates with advancing age83 and with the degree of obesity, especially in the context of metabolic syndromes and type 2 diabetes84. As such, the NLR ratio is indicative of low-grade inflammation, ‘inflammaging’ and',\n",
       " ('COVID-19',\n",
       "  16,\n",
       "  1): 'obesity-associated inflammation, and is a poor prognostic factor in COVID-19 (Fig. 2). This observation indicates that individuals with such underlying immune-system conditions either fail to develop productive antiviral immune responses or are more prone to develop uncontrolled, exuberant responses upon infection, leading to hyperinflammation and acute respiratory distress syndrome, characteristic of severe COVID-19 (Fig. 2). Older individuals typically produce weaker type I IFN responses upon viral infection, which further worsen the situation85. Also, additional markers of inflammaging and obesity-associated inflammation have been shown to be predictive of a severe COVID-19 course, such as NLRP3 activation43, IL-6, IL-12 and IL-1β secretion86 and danger-associated molecular patterns, including high mobility group box 1 (HMGB1)87 (Fig. 2). Immunodeficiencies Since the beginning of the pandemic, there have been grave concerns over the risk of developing severe COVID-19 for individuals with immunodeficiencies or those taking immunosuppressive therapies. One systematic review found no statistically significant increased risk of severe COVID-19 in immunosuppressed patients88, but other studies have shown an increased risk for patients with solid-organ transplants and some patients with cancer89. Patients with cancer treated with checkpoint inhibitors are at particularly high risk of severe COVID-19, according to another recent report90. It is important to note that type and degree of immunosuppression likely varies substantially among heterogeneous patient groups, and more detailed subset analyses are needed. This is also highlighted by an Italian study of patients with different forms of primary antibody deficiencies, in which patients with combined variable immunodeficiency, often associated with low-grade inflammation, developed severe COVID-19, while patients with similarly low antibody levels due to other forms of inborn errors of immunity generally experienced milder course of disease91. Future directions In summary, COVID-19 can develop into a life-threatening hyperinflammatory disease in rare cases, and global efforts are ongoing to better understand productive immune responses against the SARS-CoV-2 virus and the immunopathological mechanisms underlying severe disease. At the same time, additional disease outcomes, such as MIS-C, MIS-A and long COVID, are becoming increasingly known. By considering known differences between high- and low-risk individuals for each of these conditions, we will be able to design optimal studies contrasting such patient groups and their immune responses. The origin of the different disease trajectories upon SARS-CoV-2 infection can likely be traced back to the early stages of infection, as illustrated by the essential role for type I IFN responses during acute COVID. With this Perspective, I hope to open up a discussion on the different disease manifestations, their shared and distinguishing features and affected populations and immunological features.',\n",
       " ('COVID-19',\n",
       "  17,\n",
       "  0): 'Since SARS-CoV-2 appeared in the human population, the scientific community has scrambled to gather as much information as possible to find good strategies for the containment and treatment of this pandemic virus. Here, we performed a systematic review of the current (pre)published SARS-CoV-2 literature with a focus on the evidence concerning SARS-CoV-2 distribution in human tissues and viral shedding in body fluids. In addition, this evidence is aligned with published ACE2 entry-receptor (single cell) expression data across the human body to construct a viral distribution and ACE2 receptor body map. We highlight the broad organotropism of SARS-CoV-2, as many studies identified viral components (RNA, proteins) in multiple organs, including the pharynx, trachea, lungs, blood, heart, vessels, intestines, brain, male genitals and kidneys. This also implicates the presence of viral components in various body fluids such as mucus, saliva, urine, cerebrospinal fluid, semen and breast milk. The main SARS-CoV-2 entry receptor, ACE2, is expressed at different levels in multiple tissues throughout the human body, but its expression levels do not always correspond with SARS-CoV-2 detection, indicating that there is a complex interplay between virus and host. Together, these data shed new light on the current view of SARS-CoV-2 pathogenesis and lay the foundation for better diagnosis and treatment of COVID-19 patients. Here, we bring together the current scientific knowledge on SARS-CoV-2 detection in the human body and body fluids. We observe that SARS-CoV-2 impacts the human body well beyond the lungs and shows a complex interplay with the human host that is not always correlated with its entry receptor (ACE2) expression levels. Many studies identified viral components (RNA, proteins) of SARS-CoV-2 in multiple organs (pharynx, trachea, lungs, blood, heart, vessels, intestines, brain, male genitals and kidneys) and body fluids (mucus, saliva, urine, cerebrospinal fluid, semen and breast milk). However, besides the lungs, researchers were only able to detect infectious virus in stool and urine in a limited set of SARS-CoV-2 patients. Since the beginning of 2020, SARS-CoV-2 quickly spread throughout the human population and caused a pandemic with devastating consequences at a global scale. The scientific community is challenged to find good strategies for the containment and treatment of this virus. In this context, an important step is charting the viral presence in the human body to improve diagnostics, prevention or treatment. Funding: The authors would like to acknowledge the support of following research grants: FWO clinical mandate (LV, grant 1.8.020.09.N.00), Collen-Francqui Research Professor Mandate (LV), FWO postdoctoral researcher (JVC, grant 12ZB921N) and doctoral assistant mandate of the Department of Internal Medicine and Pediatrics, Ghent University (WT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. In order to get better insight into the different organs involved in SARS-CoV-2 infection, we performed a systematic narrative review on (pre-)published literature to determine which human organs and cell types are targeted by SARS-CoV-2. In addition, we sought to correlate the presence of SARS-CoV-2 with organ-specific expression of ACE2, the main entry receptor of SARS-CoV-2. SARS-CoV-2 spreads from one person to another through direct contact or over short distances in the air, either impacted in aerosol droplets or carried on fomites. Upon inhalation, SARS-CoV-2 enters host respiratory cells via interaction with its entry receptor, angiotensin-converting enzyme 2 (ACE2) and an activating receptor, a protease such as TMPRSS2 or cathepsin [ 3 ]. Viral replication in these cells elicits direct adverse effects on cells, but also induces local immune cells to quickly and abundantly secrete cytokines and chemokines. In turn, an excessive amount of immune cells are attracted to the site of infection causing',\n",
       " ('COVID-19',\n",
       "  17,\n",
       "  1): 'a cascade of inflammatory reactions with detrimental effects on the lungs. The current view on SARS-CoV-2 pathogenesis focuses on these respiratory pathologies, causing symptoms such as coughing, fever, general malaise, dyspnea and respiratory distress, that might eventually lead to death [ 4 ]. However, increasing evidence shows that SARS-CoV-2 is not always confined to the respiratory tract, but may also spread to other organs. Indeed, the majority of COVID-19 patients show various other symptoms besides respiratory disorders including neurological, cardiovascular, intestinal and kidney malfunctions [ 5 – 11 ]. The pathophysiological mechanisms behind the latter symptoms are not yet fully understood. Researchers proposed viral-induced endothelial disturbances (e.g. thrombosis, hemorrhages and edema) and defective immune responses (e.g. cytokine storm or auto-immune reactions) as underlying reasons for multi-organ failure [ 5 , 6 ]. In addition, direct viral replication in these organs may also account for multi-organ pathologies. In this context, the host cell entry receptor of SARS-CoV-2, ACE2, has been detected in cells from multiple tissues, including the respiratory tree, cornea, esophagus, ileum, colon, gallbladder and common bile duct tissues [ 12 – 14 ]. This raises the possibility for SARS-CoV-2 to engage with its receptor at multiple organ sites upon viremia, swallowing or axonal transport and cause organ-specific malfunctions. This replication in specific organs would enable the virus to be shed in multiple body fluids and would augment the chances for viral transmission to new hosts. Coronavirus disease (COVID-19) is considered one of the largest fast expanding pandemics since the 1918 Spanish flu with serious consequences for global health and economy. As of July 1 st 2020, the coronavirus causing COVID-19, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has infected more than 10 million people and caused over half a million deaths (WHO Coronavirus Disease Dashboard, https://covid19.who.int ). These numbers overshadow the impact of the related SARS coronavirus (SARS-CoV), which caused about 8,000 infections and 800 deaths [ 1 ]. As for SARS-CoV, SARS-CoV-2 is believed to be a derivative of an animal coronavirus that adopted the ability of human-to-human transmission [ 2 ]. However, in contrast to SARS-CoV, the more contagious SARS-CoV-2 rapidly spread around the world after it took off from a few human pilot infections in Wuhan, China. The total set of 11700 identified articles were pooled in EndNote (version X9.3.3), duplicates removed and a first filtering was performed based on following exclusion criteria: review or editorial articles, non-English manuscripts, non-human studies and no full text available. The remaining set of articles was manually evaluated based on their title, abstract or full text for relevance concerning anatomical compartments, SARS-CoV-2 detection and ACE2 receptor expression. During this process, the snowball method was also used to identify additional papers that were missed by the systematic literature screening approach. The following search terms were used in Pubmed and Web of Science to construct the initial dataset of articles: ((SARS-COV2[All Fields] OR (\"COVID-19\"[Supplementary Concept] OR \"COVID-19\"[All Fields] OR \"covid19\"[All Fields])) AND (\"2020/01/01\"[PDAT]: \"2020/12/31\"[PDAT]) NOT (\"review\"[Publication Type] OR \"review literature as topic\"[MeSH Terms] OR \"review\"[All Fields]) AND (\"loattrfull text\"[sb] AND \"humans\"[MeSH Terms] AND English[lang])) AND (brain OR cerebrum OR cerebellum OR \"nervous system\" OR neuron* OR spinal OR brainstem OR olfactory OR nasal OR pharyn* OR trachea OR lung OR airway OR bronch* OR heart OR vascular OR arterial OR vena OR \"blood vessel\" OR \"lymph node\" OR \"lymph vessel\" OR lymphatic OR thymus OR spleen OR \"bone marrow\" OR tonsils OR blood OR oral OR mouth OR? esophagus OR stomach OR pancreas OR liver OR \"gall bladder\" OR gut OR intestin* OR salivary OR saliva OR stool OR faeces OR kidney',\n",
       " ('COVID-19',\n",
       "  17,\n",
       "  2): 'OR urethra OR ureter OR bladder OR kidney OR urine OR testit OR epididym* OR prostate OR penis OR sperm OR semen OR ovari* OR uterus OR vagina* OR placenta* OR tegument OR skin OR muscle* OR bone OR joint OR hypothalamus OR pituitary OR thyroid OR adrenal OR reservoir OR autopsy OR cardiovascular OR immunological OR endocrinal OR genital OR urinary OR digestive OR respiratory). In addition, all preprint articles on SARS-CoV-2 were included in the screening strategy. Results and discussion Respiratory system The first brief reports describing pneumonia due to infection with the new coronavirus were published in the NEJM on January 24th 2020 [15] and Nature on February 3rd 2020 [16]. In these reports, initial identification of SARS-CoV-2 was done via sequencing and phylogenetic analysis on lower respiratory tract and broncho-alveolar lavage (BAL) fluids collected from patients in Wuhan from December 21st 2019 onwards. These patients had been present at the Huanan Seafood market close to the time of symptom onset. They presented with pneumonia of unknown etiology and showed symptoms ranging from common cold, fever, dry cough to dyspnea. In some cases, but mostly in elderly patients, these symptoms progressed to the development of severe acute respiratory syndrome (SARS), similar to the well-known acute respiratory distress syndrome (ARDS) [7]. The pathologies underlying these symptoms usually start with alveolar damage including alveolar edema, vascular decongestion and mild inflammatory infiltration. Later in infection, a diffuse alveolar damage in the organizing phase with reactive type II pneumocyte hyperplasia is observed. Whether or not this will lead to lung fibrosis is not clear yet [17]. In rare cases, excessive hypercoagulation with pulmonary embolisms can lead to sudden death [18]. Presence of SARS-CoV-2 particles has been described in different parts of the respiratory tract, including the nose, pharynx, trachea and lungs. SARS-CoV-2 viral RNA and/or antigens were mainly observed in ciliated respiratory epithelial cells and type I and II pneumocytes, but also in alveolar macrophages [19–21]. In addition, single cell RNA sequencing (scRNA-seq) studies recovered SARS-CoV-2 viral reads from secretory and ciliated epithelial cells in BAL [22] and bronchiolar protected specimen brushes (PSB) [23] from COVID-19 patients. SARS-CoV-2 viral transcripts were also detected in macrophages and neutrophils obtained from BAL, albeit at low levels [22, 23]. Whether this results from direct infection or phagocytosis of infected cells or viral particles remains to be elucidated. To gain a better understanding of the epithelial subtypes targeted by the virus, Ravindra et al. [24] performed scRNA-seq analysis on in vitro infected human bronchial epithelial cells. This study pointed to the ciliated epithelial cells as the major initial target of infection and this was confirmed by EM analysis. At later stages of infection, virus was also detected in other epithelial subsets, including basal, club and BC/club cells. Surprisingly, this study pointed out that ACE2 expression poorly correlated with SARS-CoV-2 detection on a per cell basis. ACE2 was mainly expressed in ciliated cells, club cells and to a lesser extent type II pneumocytes [24, 25]. In this context, ACE2 expression is seemingly higher in the upper airways than in lower airways, while the latter are more affected by SARS-CoV-2 replication [26]. Viral replication in the respiratory tract results in viral shedding in mucus, as evidenced by multiple studies showing viral RNA in nasal and throat swabs. These swabs remain positive for up to 15 days post infection, indicating that viral particles or fragments of viral RNA are still present [27]. Some researchers even demonstrate viral shedding up to 60 days after onset of symptoms [28–30]. Such prolonged viral RNA shedding was mainly observed in elderly patients',\n",
       " ('COVID-19',\n",
       "  17,\n",
       "  3): '[31]. Still, relapse involving aggravation of pulmonary dysfunction has only rarely been reported [32]. Moreover, in immunocompromised patients persistent viral shedding and positive PCR with threshold C t ’s of 30 have been reported [33]. Although viral RNA is routinely detected by RT-qPCR from both upper and lower respiratory tract samples and in particular cases can remain detectable up to 2 months after the onset of symptoms, this does not prove that replication is ongoing in the sample sites and that patients are still infectious. Several studies have isolated infectious virus, that can be propagated in vitro, both from upper and lower respiratory tract samples [34–40]. Longitudinal studies indicate that successful viral culture is mostly established from samples obtained within 9 days of onset of symptoms [34, 36, 37]. Interestingly, several studies observed a clear correlation between the viral load as assessed by RT-qPCR and the infectivity of the sample, although the reported threshold C t values that would permit infectivity range from < 24 to < 33 [34, 35, 38], which hampers the use of RT-qPCR as a surrogate diagnostic to predict patient infectivity. Also, viral loads detected in asymptomatic or minimal symptomatic patients were similar to those of symptomatic patients, hinting towards the transmission potential of asymptomatic patients. This is confirmed in a prevalence study conducted in a nursing home, showing that viral loads were not different between symptomatic, asymptomatic and presymptomatic residents and that viable virus could be isolated from 6 days prior to 9 days past the onset of symptoms [37]. In conclusion, the respiratory tract is the major site of infection, and although virus can be detected for up to 2 months post infection, most studies indicate infectivity is highest in the two weeks post-infection. Cardiovascular system The majority of humans that test positive for SARS-CoV-2 infection do not develop fulminant cardiovascular disease during the acute infection. However, about 20% of the patients admitted to intensive care units develop acute cardiac injury during the course of infection [7, 8]. Whether SARS-CoV-2 facilitates the reported cardiac injuries via direct infection or by triggering inappropriate immune activation is not known. The study of Remmelink et al. [41] reports quantification of viral RNA in the heart in post-mortem patient samples, but did not observe specific viral organ injuries [41]. Two other studies used electron microscopy to detect virus, and of these studies one was able to detect viral RNA, but not viral particles, in the heart [19]. The other study found virus particles in cytopathic, structurally damaged interstitial cells, but not in cardiac myocytes [42]. It is therefore more likely that cardiac injury in patients occurs by inflammation rather than direct infection. Interestingly, one autopsy series of three COVID-19 patients demonstrated endothelitis in vascular beds of different organs and detected viral inclusions via EM in kidney endothelial cells of one patient [43]. Susceptibility of endothelial cells to SARS-CoV-2 infection is furthermore supported by in vitro infection studies with blood vessel organoids [44] and pluripotent stem cell-derived cardiomyocytes. In line with this, relatively high expression of ACE2 in heart tissue supports the potential of direct infection [25, 45]. Furthermore, increased expression of ACE2 in patients with heart failure was observed, indicating a potential risk group [46–49]. Although in vitro infection studies and expression of ACE2 are suggestive for active infection of the heart, it remains unclear whether this results into cardiac injury as post-mortem studies are inconclusive on the matter. Therefore further research on post-mortem samples or biopsies taken during infection are required to verify if the heart and vasculature could potentially serve as a site of prolonged virus',\n",
       " ('COVID-19',\n",
       "  17,\n",
       "  4): 'persistence. Immune system Even though immune responses during infection with SARS-CoV-2 can lead to severe complications, no viral replication is observed in immune cells from patients. Interestingly, there are rare reports of viral RNA detection in RNA-seq data from peripheral blood mononuclear cells (PBMCs) [50–52]. In addition, post-mortem studies showed presence of SARS-CoV-2 RNA and antigens in draining lymph nodes and spleen, predominantly in macrophages [19, 20]. One in vitro study used virus isolated from patients to test replication kinetics in PBMCs but could not find evidence of SARS-CoV-2 propagation in this heterogeneous population of cells, despite the observation of viral-like particles in primary CD4+ T cells by electron microscopy [53]. Detection of viral RNA has been observed in plasma of severe patients, but it remains questionable whether this RNA originates from actual virus particles or merely represents the potentially infectious viral genome [54, 55]. Therefore, detecting RNA in plasma does not directly translate into the presence of infectious particles. In any case, detection of SARS-CoV-2 in multiple organs indicates that infectious virus/RNA is circulating in at least part of the COVID-19 patients. Furthermore, using RNA sequencing data it was found that immune cells barely express the ACE2 receptor required for viral entry nor any other of the major entry proteins [50, 56, 57]. These studies provide the ground for the hypothesis that virus detected in immune cells results from cellular entry by phagocytosis. Since no viral replication was observed thus far in immune cells, it seems that immune cells do not function as a functional reservoir for SARS-CoV-2. Digestive system Gastro-intestinal (GI) tract symptoms are reported in approximately 10–15% of COVID-19 cases and typically include diarrhea and to a lesser extent nausea, vomiting or abdominal pain [9, 58, 59]. Patients with only GI symptoms were more likely to be diagnosed later than patients with additional respiratory complaints and are more likely to be positive for SARS-CoV-2 RNA in fecal samples [60]. Stool samples from 874 patients across 34 studies were examined of which 504 (57.67%) resulted in a positive RT-qPCR for COVID-19 irrespective of disease severity [9, 30, 55, 60–90]. Five studies also included rectal swabs of 77 patients of which 22 tested positive (28.5%) [55, 72, 86, 91, 92]. Stool samples remained positive well after NP swabs returned negative with a range of 1–47 days, indicating longer and extended viral shedding via this route. Also, infectious virus could be isolated from stool samples in at least two reports, indicating the possibility of feco-oral transmission but no reports have shown direct evidence of this occurring [77, 79]. Indeed, stability of SARS-CoV-2 was tested in faeces in vitro and was shown to be stable and infectious for several hours [93]. Saliva samples from 758 confirmed COVID-19 patients across fourteen studies yielded high positive SARS-CoV-2 detection results which are often in concordance with matched NP swabs (657/758 patients, 86.7%)[89, 94–106]; however, in a limited set of cases (26 patients) saliva samples were reported positive with a negative NP swab [95, 98, 99, 106]. SARS-CoV-2 could be detected in saliva 10–37 days after onset of symptoms [97, 100, 102] and in two-out-of-three studies was shown to yield higher viral load titers than NP swabs [103, 104, 107]. In addition, SARS-CoV-2 viral particles were shown to be stable in artificial saliva up to 90 minutes [108, 109], further confirming this as a major viral shedding route. From immunofluorescence and scRNA-seq studies it became apparent that ACE2 expression is high in epithelial cells across the entire gastro-intestinal tract including the oral mucosa of the tongue and enterocytes from the ileum and colon [110–113]. As',\n",
       " ('COVID-19',\n",
       "  17,\n",
       "  5): 'described above, SARS-CoV-2 has already extensively been recovered from saliva samples and oral swabs. However, whether this results from actual viral replication in the oral (tongue) mucosa and/or salivary glands or is merely a spill-over from the pharynx remains unclear. Nonetheless, the apparent loss of taste in certain COVID-19 patients additionally suggests that SARS-CoV-2 replicates in cells aligning the tongue [114, 115]. Likewise, there is a limited number of studies performed which actually examine viral presence in GI tissues. One study by Lin et al. performed endoscopic sampling in 6 patients of which 2 severe patients tested positive for viral RNA measured by RT-qPCR from the esophagus, stomach, duodenum and rectum [9]. Only 1 out of 4 non-severe cases tested positive in the duodenum. Xiao et al. confirmed these findings by visualizing SARS-CoV-2 viral capsid via intracellular staining of gastric, duodenal, and rectal epithelia in GI tissues [79]. One post-mortem study by Bradley et al. visualized viral particles in the lumen of the large intestines via electron microscopy and found borderline positive RT-qPCR results from tissue biopsies in the large intestines (C t value between 37–40), but not in the small intestine [19]. Finally, Lamers et al. demonstrated that enterocytes of ex vivo organoids are infectable with SARS-CoV-2 and that the virus can replicate, indicating that these cells are permissive for SARS-CoV-2 infection [116]. Overall, these findings indicate the broad presence of SARS-CoV-2 RNA or viral fragments in the GI tract with a preference for saliva and stool. Indeed, live virus could be isolated from stool, although from a limited set of patients. Therefore, further studies are needed to map the actual viral presence, especially in gut tissues. Recurring clinical features of the other solid organs of the digestive tract (liver, gallbladder, pancreas) mainly include liver injury with abnormal liver tests in 35–56% of the COVID-19 patients for aspartate aminotransferase (AST), alanine aminotransferase (ALT) and bilirubin which is probably due to the immune cascade in the body [117, 118]. In addition, there is a single case report indicating a rare onset of SARS-CoV-2-induced pancreatitis in two patients and one cohort study describing pancreatic injury in 10% of COVID-19 patients, indicated by elevated amylase (13/121 patients) or lipase levels (12/121 patients), of which three developed pancreatitis. The limited number of reports indicate that pancreatic injury is often overlooked, hence there is in sufficient data on the widespread presence of this illness [119, 120]. To date, there are no reports on the possible presence of SARS-CoV-2 in these organs, although ACE2 expression can be high and is found in liver cholangiocytes, TROP2+ liver progenitor cells, gall bladder epithelium, pancreatic exocrine glands and islets [49, 121, 122]. Therefore, tissue biopsies with immunohistochemical viral staining or RT-qPCR for viral RNA (i.e. from post-mortem studies) could deliver necessary information, but so far robust data is lacking to conclude that solid organs of the digestive tract play a major role in SARS-CoV-2 infection. Urinary system Routine urinalysis of COVID-19 patients shows abnormalities such as proteinuria, hematuria and leukocyturia in up to 75% of the cases [123, 124]. Further, up to 27% of hospitalized COVID-19 patients even develops acute renal failure, especially elderly with comorbidities such as hypertension and heart failure [10, 125]. Tubule degeneration, necrosis and to a lesser extent renal thrombotic micro-angiopathy typically account for acute renal failure. These observations indicate that the human kidney may be a target for SARS-CoV-2. Indeed, viral RNA, proteins and particles have been found in kidney tubular epithelium, podocytes and to a lesser extent in kidney endothelium of deceased COVID-19 patients [19, 44, 125–127]. This pattern is consistent with',\n",
       " ('COVID-19',\n",
       "  17,\n",
       "  6): 'ACE2 distribution, as ACE2 is highly expressed onto proximal tubule cells [128–131]. Of note, SARS-CoV-2 was also able to infect human kidney organoids in vitro [44]. Despite reports of SARS-CoV-2 presence in the kidney, viral shedding in urine is rather rare, as viral RNA could only be detected in urine samples of 3–4% of COVID-19 patients [36, 39, 68, 72, 77, 87–89, 92, 132–134]. However, one study was able to isolate infectious virus particles out of positive urine samples [135]. Further, viral shedding in urine may continue even after respiratory shedding has ceased, indicating that the human urinary tract may act as a long-term source of SARS-CoV-2 detection[68]. Reproductive system Except for few reports on testicular pain, fertility problems or other genital tract-related disorders due to COVID-19 have not been described to date [136]. Nonetheless, SARS-CoV-2 proteins have been found inside spermatogenic cells, supporting Sertoli cells and testosterone-producing Leydig cells of a COVID-19 patient [20]. These virus-positive testes did not show any additional histological abnormalities. In contrast, the testes of another COVID-19 patient did not show any presence of SARS-CoV-2 RNA [137]. Interestingly, the spermatocytes, Sertoli and Leydig cells express a high level of ACE2, compared to other cells in the human body [138–140]. In line with SARS-CoV-2 protein detection in testes, one study detected SARS-CoV-2 RNA in 6 out of 38 semen samples from COVID-19 patients. From the positive samples 4 were collected at the acute stage of infection, whereas 2 were obtained from recovering patients [141]. Still, in four other studies all semen and prostate secretions of 47 and 23, respectively, COVID-19 patients tested negative for SARS-CoV-2 RNA [136, 137, 142, 143]. Presence of SARS-CoV-2 in the female reproductive tract has not been described so far. A number of vaginal swabs of COVID-19 patients also tested negative for viral RNA [144]. Unlike male gonads, female reproductive organs do not express ACE2 at the bulk level [25, 140]. These data indicate the male, rather than the female, genital tract may be susceptible and permissive for SARS-CoV-2 infection. Still, further studies are necessary to confirm this assumption. Although only one out of five studies detected viral RNA in semen, possible sexual transmission of SARS-CoV-2 and the role of the male genital tract in SARS-CoV-2 infection needs further study. Regarding SARS-CoV-2-positive mothers, despite vascular abnormalities observed in up to 50% of examined placentas, there is no clear evidence of vertical virus transmission to infants [145, 146]. In line with the absence of virus in placenta, amniotic fluid or cord blood, the human placenta does not express high levels of ACE2 [147–151]. In some cases, neonates can still become infected by SARS-CoV-2 after birth through horizontal transmission [152–155]. In addition to respiratory droplets, breastfeeding has been suggested as a mechanism of SARS-CoV-2 transmission, as this has been reported for other RNA viruses, such as HIV. Data are limited, but viral RNA has been identified in breast milk of 5 out of 42 COVID-19-positive breastfeeding mothers so far [156–159]. Although still anecdotal, the most convincing evidence for the possible occurrence of SARS-CoV-2 in milk is provided by a study of milk samples from two SARS-CoV-2-positive breastfeeding mothers, demonstrating SARS-CoV-2 RNA in milk samples from one mother for four consecutive days [157]. Still, it was impossible to recover infectious virus from RNA-positive milk samples, suggesting that breastmilk itself is unlikely to pass on SARS-CoV-2 to infants [159]. However, more evidence is needed to conclude on the definite role of breastfeeding in SARS-CoV-2 transmission. Nervous system The majority of COVID-19 patients (up to 78%) show neurological symptoms ranging from headache, loss of smell (anosmia) and',\n",
       " ('COVID-19',\n",
       "  17,\n",
       "  7): 'taste (ageusia), imbalance, impaired consciousness, delirium and paresthesia to extremity paralysis and convulsions [11, 114, 115, 160–163]. Severe neurological symptoms can mostly be accounted to abnormalities located in the brain(stem) and spine such as edema, hemorrhages and thrombotic events with or without stroke, demyelination and encephalomyelitis [163–166]. This has urged many researchers to look closer into the nervous system of COVID-19 patients. In COVID-19 cases with severe neurological symptoms, viral RNA has been identified in 4 out of 8 cerebrospinal fluid (CSF) samples [160, 161, 167–172]. Moreover, one autopsy study found traces of viral RNA via RT-qPCR in the brain of 8 out of 22 deceased COVID-19 patients [173]. Yet, two other studies failed to identify virus particles or RNA in brain autopsies and CSF analysis of 12 and 10, respectively, deceased COVID-19 patients [19, 174]. Therefore, it remains unclear whether severe neurological manifestations are triggered by direct viral-induced damage or virus-induced endothelial and/or cytokine disturbances. Nonetheless, ACE2 is expressed in both neuronal and non-neuronal cell types in the human central nervous system, especially in the spinal cord, dorsal root gangla, brainstem substantia nigra, choroid plexus, hypothalamus, hippocampus, middle temporal gyrus and posterior cingulate cortex [175, 176]. This hints towards the possibility of SARS-CoV-2 invasion of the central nervous system. In contrast to severe neurological symptoms, ageusia and anosmia are often devoid of any obvious lesions [114, 115]. Direct viral damage to the olfactory and gustatory receptors or neurons has been proposed as mechanism of sensorineural olfactory loss, but the absence or presence of SARS-CoV-2 inside olfactory epithelial or neuronal cells has not been described so far. This is probably related to technical difficulties during COVID-19 patient autopsy, such as inaccessibility of the olfactory bulb and epithelium without the use of electric saws to cut into the skull. This generates potentially virus-loaded aerosols, necessitating the use of additional, sometimes difficult to take, precautions. Interestingly, non-neuronal cells rather than neuronal cells residing in the olfactory epithelium and bulb express ACE2 and TMPRSS2 [175, 177–179]. This indicates that SARS-CoV-2 replication in the olfactory epithelium might induce anosmia through perturbation of supporting cells, rather than direct neuronal infection. Together, these findings indicate that SARS-CoV-2 is able to reach the nervous system. Sensory system: Eye Ocular symptoms remain rare in COVID-19 patients but reported symptoms in hospitalized patients include: dry eyes, blurred vision, foreign body sensation and conjunctivitis with conjunctival congestion. However, there remains a debate whether this is directly caused by the virus [180, 181]. As SARS-CoV was readily detectable in tears, Xia et al. investigated the viral presence of SARS-CoV-2 RNA in tears and conjunctival swabs from 30 COVID-19 patients who were sampled twice longitudinally [182]. Only one patient showed a positive PCR test on tears and ocular surface swabs with onset of conjunctivitis and conjunctival congestion. However, the virus could not be isolated or cultured in vitro. This was also reported by Xie et al., Kumar et al., Wu et al., and Zhou et al. who detected SARS-CoV-2 RNA in ocular surface swabs or conjunctival secretions of 2/33, 1/45, 2/28 and 1/63 patients, respectively [183–186]. One case report performed longitudinal sampling in a single patient and confirmed a positive signal of conjunctival swabs up to 17 days after onset of disease [187]. In contrast, Seah et al. and Xu et al. could not replicate these findings and did not detect SARS-CoV-2 in 64 tear samples from 34 patients [188] or in ocular surface swabs from 22 patients [189]. Reports on ACE2 expression find a limited expression at the retina and specifically in the retinal epithelium [180]. Moreover, ACE2 and TMPRSS2 are',\n",
       " ('COVID-19',\n",
       "  17,\n",
       "  8): 'co-expressed in corneal and conjunctival epithelial cells according to scRNA-seq and immunohistochemical analyses, identifying the ocular surface as a potential viral entry site [190, 191]. Therefore, infection could occur via droplets entering the eye and travel via the nasolacrimal canal to the respiratory tract. In total across eight studies examining ocular presence of SARS-CoV-2 RNA, 1/94 patients tested positive for tear or conjunctival secretion samples and 8/222 ocular surface swabs. These low numbers can be influenced by the time of sampling and by the onset of conjunctivitis but show that ocular fluids can contain SARS-CoV-2 viral fragments RNA. However, no reports state that SARS-CoV-2 virus could be isolated from ocular fluids at present.',\n",
       " ('COVID-19',\n",
       "  18,\n",
       "  0): 'In December 2019, a novel human coronavirus, SARS-CoV-2, was detected in the city of Wuhan, China, which since then has expanded throughout the world and caused a pandemic coronavirus disease (COVID-19). SARS-CoV-2 binds to angiotensin-converting enzyme 2 (ACE2) as the functional receptor for cell entry. In contrast to SARS-CoV, SARS-CoV-2 forms more molecular interactions with ACE2, which correlates with data showing a fourfold higher affinity for receptor binding. Subsequently, endocytosis of the viral complex occurs, and surface ACE2 is downregulated. This hampers angiotensin II cleavage, leading to increased circulating angiotensin II and increased angiotensin II receptor activation [1]. ACE2 is a counterregulatory enzyme that degrades angiotensin II to angiotensin-(1-7). Angiotensin-(1-7) stimulates vasodilatation and nitric oxide production and also attenuates the effects of angiotensin II of vasoconstriction, sodium retention, and fibrosis [2]. A study showed that patients with COVID-19 appeared to have elevated levels of plasma angiotensin II, which were correlated with the degree of lung injury and total viral load [3]. SARS-CoV-2 binding to ACE2 may attenuate ACE2 activity, increasing angiotensin II-mediated pulmonary vasoconstriction, as well as inflammatory and oxidative organ damage, ultimately progressing towards acute lung injury and respiratory distress [4]. Decreased activity of ACE2 leads to heightened and relatively unopposed vasoconstriction, pro-coagulation, pro-inflammatory, and pro-oxidant angiotensin II effects [5, 6]. In the alveoli, active replication and release of the virus cause the host cell to undergo pyroptosis, a highly inflammatory form of programmed cell death, releasing damage-associated molecules. These are recognized by epithelial cells, endothelial cells, and alveolar macrophages, triggering the generation of pro-inflammatory cytokines and chemokines, which attract monocytes, macrophages, and T cells to the site of infection, promoting further inflammation and establishing a pro-inflammatory feedback loop. Furthermore, pyroptosis of epithelial and endothelial cells damages the alveolar-capillary barrier, resulting in vascular leakage and alveolar edema [1, 7]. The accumulation of fluid, debris, and inflammatory cells in the damaged lung parenchyma results in the appearance of ground-glass opacities, consolidation, and septal thickening in classic imaging modalities. A defective immune response may lead to further accumulation of immune cells in the lungs, causing overproduction of pro-inflammatory cytokines with significant damage to the lung structure, leading to a sustained inflammatory response that can result in a cytokine storm, which extends to the rest of the systems causing multi-organ damage [1, 7]. In addition, it has been suggested that patients with SARS-CoV-2 infection suffer a generalized thrombotic microvascular injury, probably mediated by activation of complement pathways and an associated pro-coagulant state. This correlates with the presence of platelet-fibrin thrombi in the small arterial vessels in lung necropsies [8] and is also consistent with very high d-dimer levels found in almost all examined patients. Whether this phenomenon occurs in the absence of macrovascular disease with pulmonary embolism and/or deep venous thrombosis is uncertain, but likely. Vessel enlargement has been described in the vicinity of areas with ground-glass opacities, which suggests thrombo-inflammatory processes. Subsegmental vascular enlargement (more than 3 mm diameter) in areas of parenchymal lung opacities has been observed in 89% of patients with confirmed COVID-19 pneumonia. Although in situ thrombosis is certainly a possibility, these findings could reflect hyperemia and increased blood flow due to pro-inflammatory factors and vasoplegia induced by SARS-CoV-2 [9]. Advanced imaging techniques can help us visualize perfusion abnormalities that lead to a ventilation/perfusion (V/Q) mismatch in SARS-CoV-2 infection, both in the abnormal parenchyma and in the apparently normal parenchyma. A recent publication described perfusion abnormalities in COVID-19 infection using dual-energy computed tomography in relation to areas of injured parenchyma [10]. Subtraction computed tomography (SCT) is another imaging modality that uses software-based motion correction between sets of unenhanced',\n",
       " ('COVID-19',\n",
       "  18,\n",
       "  1): 'and contrast-enhanced CT scan images for obtaining the iodine distribution in the pulmonary parenchyma [11]. We apply SCT routinely in COVID-19 patients who undergo CT angiography, obtaining iodine distribution maps in the lung parenchyma. Arithmetic subtraction of the precontrast image from the contrast-enhanced image is performed using 100-kV single-energy CT acquisitions, with motion correction using the SURE Subtraction Lung algorithm (version 7; Canon Medical Systems, Otawara, Japan). Gattinoni et al. describe COVID-19 pneumonia as a specific disease characterized by severe hypoxemia, often associated with near-normal respiratory system compliance (type 1 or L), different from classical ARDS [12]. In this subgroup of patients, we have found abnormal hyperperfusion in areas of lung opacities in patients with hypoxemia in a similar fashion to what has been described recently [10]. However, we have also found abnormally decreased iodine distribution in areas of the apparently normal lung parenchyma, which worsens in more severe cases (Figs. 1 and 2). Fig. 1 a, b Slight hypoperfusion in the well-aerated lung, hyperemia, and small zones of hypoperfusion in the areas of injured lung. Fifty-nine-year-old male patient, RT-PCR-confirmed COVID-19, 11 days since symptom onset, without hypoxemia, (PaO 2 /FiO 2 ) 538, d-dimer 340 ng/mL. There are isolated foci of ground-glass opacities associated with septal thickening, with a predominantly subpleural distribution, which correlate with areas of hyperemia (middle lobe) and small zones of hypoperfusion (lower right lobe) in subtraction CT iodine maps (large black arrows). There is an evident area of hypoperfusion in the middle lobe and lower right lobe (white arrows) that correlates with the apparently normal lung parenchyma in conventional chest CT images. The conventional CT image also shows pulmonary arterial vascular dilatation in the periphery of the ground-glass opacity in the middle lobe (small black arrow). These slight perfusion abnormalities do not impact the PaFi ratio. The ground-glass opacity in the lower right lobe shows slight peripheral hypoperfusion, probably due to compensatory vasoconstriction, an expected regulatory mechanism when vasoplegia is not fully established Full size image Fig. 2 a, b Prominent hypoperfusion in the well-aerated lung and hyperperfusion in areas of injured lung. Seventy-eight-year-old male patient, RT-PCR-confirmed COVID-19, 10 days since symptom onset, with hypoxemia, (PaO 2 /FiO 2 ) 206, d-dimer 1600 ng/mL progressively increasing. There are extensive foci of consolidation and ground-glass opacities, associated with septal thickening, with a predominantly posterior and subpleural bilateral distribution, which correlate with the areas of hyperemia and iodine pooling in subtraction CT iodine maps (black arrows). There are areas of markedly decreased perfusion in both lungs, which correlate with the apparently healthy lung parenchyma in conventional chest CT images (white arrows). Bilateral pleural effusion. This could be explained by an increased blockage of ACE2 receptors in the lung endothelium, leading to increased local levels of angiotensin II, which leads to vasoconstriction and ventilation/perfusion mismatch. This patient was managed with invasive mechanical ventilation, with highly compliant lung parenchyma, in accordance with the type 1 or L phenotype described by Gattinoni et al. Full size image We believe that a severe V/Q mismatch underlies the pathophysiology of moderate to severe COVID-19 cases, in which downregulation of ACE2 secondary to viral endocytosis plays a key role. There is low V/Q ratio in areas of injured lung parenchyma with ground-glass opacities or consolidation, secondary to loss of compensatory hypoxic pulmonary vasoconstriction (vasoplegia) and increased blood flow, which result in high perfusion to the areas of non-aerated lung, but there is also high V/Q ratio in areas of apparently healthy lung secondary to prominent vasoconstriction. We hypothesize that hypoperfusion of apparently healthy areas could be a consequence of vasoconstriction due to accumulation',\n",
       " ('COVID-19',\n",
       "  18,\n",
       "  2): 'of angiotensin II, caused by decreased availability of ACE2, and that these changes in vascular resistance lead to a shunt or steal of vascular flow towards areas of non-aerated hyperperfused lung in moderate to severe COVID-19 cases. The improved oxygenation in prone position that has been described in patients with COVID-19 could be explained mainly through vascular redistribution towards the areas of apparently healthy lung with a high V/Q ratio, rather than alveolar recruitment. These findings may support the early use of pulmonary vasodilators, such as inhaled nitric oxide and prostacyclin, to improve the ventilation/perfusion mismatch, and provide initial insight into the complex viral pathophysiology of hypoxemia and perfusion abnormalities in COVID-19. Further studies are needed to investigate ventilation-perfusion abnormalities and whether these could be explained by the local increase in angiotensin II.',\n",
       " ('COVID-19',\n",
       "  19,\n",
       "  0): 'The endotheliopathy due to direct endothelial infection with SARS-COV-2 and the indirect damage caused by inflammation play the predominant role in the development of CAC. The intensive control of thromboinflammation is necessary to improve the outcome of this highly detrimental contagious disease. The primary targets of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are the pneumocytes, immune cells, and vascular endothelial cells. The alveolar damage and the pulmonary microvascular thrombosis are the major causes of acute lung injury in COVID-19. The endotheliopathy that occurs is due to direct SARS-CoV-2 infection and activation of other pathways that include the immune system and thromboinflammatory responses leading to what is termed CAC. As a result, both microvascular and macrovascular thrombotic events occur in arterial, capillary, venule, and large vein vascular beds to produce multiorgan dysfunction and thrombotic complications. In addition to the endothelial damage, SARS-CoV-2 also can cause vasculitis and presents as a systemic inflammatory vascular disease. Clinical management of COVID-19 includes anticoagulation but novel therapies for endotheliopathy, hypercoagulability, and vasculitis are needed. COVID-19-associated coagulopathy (CAC) characterized by the elevated D-dimer without remarkable changes of other global coagulation markers is associated with various thrombotic complications and disease severity. The purpose of this review is to elucidate the pathophysiology of this unique coagulopathy. Ongoing reports have described the hypercoagulability and thrombotic tendency in COVID-19 [ 1 ]. The high incidence of deep vein thrombosis and pulmonary embolism has focused on the critical role of routine antithrombotic prophylaxis for COVID-19 management, especially in critically ill patients and/or elevated d-dimer levels [ 2 – 4 ]. Current reports of venous and arterial thrombotic events in the patients treated in ICU is up to 30% even with pharmacological thromboprophylaxis, and thrombotic events are associated with 5.4 times higher risk of mortality [ 5 ]. Recent postmortem evaluation of COVID-19 patients has demonstrated severe endothelial injury with cellular death/apoptosis, and the presence of intracellular virus in the autopsy lung with thrombosis and small to middle-size pulmonary vessels. The clotting and vascular damage were also confirmed in the alveolar capillary and these changes are more remarkable in COVID-19 compared to influenza induced lung injury [ 6 ]. In this summary, we will review the pathophysiology of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-induced endotheliopathy, COVID-19-associated coagulopathy (CAC), and vasculitis. Other potential assays to assess global coagulation status include viscoelastic testing, especially in ICU patients, as a point of care test. An increasing number of studies report hypercoagulability as indicated by decreased R or clot times, and increased maximal amplitude/maximal clot firmness by viscoelastic monitoring [ 16 – 18 ]. However, these changes are consistent with high fibrinogen levels that affect both maximal amplitude on thromboelastography (TEG), and maximum clot firmness on rotational thromboelastometry (ROTEM). Ranucci et al. [ 17 ] reported the median fibrinogen level was nearly 800 mg/dL in the COVID-19 patients treated in ICU, and such a high fibrinogen level affects TEG and ROTEM parameters considerably by itself [ 19 ]. Thrombin generation testing (TGT) measures ex vivo thrombin formation in plasma upon activation with tissue factor. TGT allows calculation of peak and total thrombin generation, as well as time to initial and peak thrombin generation. This assay can identify both reduced and increased thrombin generation. Nougier et al. [ 15 ] revealed increased thrombin generation in COVID-19 patients despite undergone anticoagulation. The major drawbacks of TGT are the lack of standardization and the requirement of technical training. Flow chart for identifying COVID-19-associated coagulopathy. In the typical COVID-19-associated coagulopathy, thrombocytopenia and prothrombin time (PT) prolongation are usually not remarkable in its initial phase, instead, it often shows',\n",
       " ('COVID-19',\n",
       "  19,\n",
       "  1): 'the typical computed tomography (CT) findings of the lung and elevated levels of von Willebrand factor (VWF) and factor VIII. When both marked thrombocytopenia and prothrombin time prolongation is observed, it is the case of sepsis-induced coagulopathy (SIC)/disseminated intravascular coagulation (DIC) type and secondary bacterial infection is suspected. Hemophagocytic lymphohistiocytosis (HLH)/macrophage activated syndrome (MAS) type coagulopathy is suspected when high levels of proinflammatory cytokines are recognized. This type of coagulopathy often shows fever, splenomegaly, decreased counts in two cell lines, hypertriglyceridemia and/or hypofibrinogenemia, and hemophagocytosis. Very severe thrombocytopenia indicates the presence of thrombocytopenic purpura (TTP) and ADAMTS-13 level should be examined. Antiphospholipid syndrome (APS) type coagulopathy is suspected when high-titer IgG/IgM of anti-phospholipids (APL) antibodies such as lupus anticoagulant, anticardiolipin, and anti-β2-glycoprotein (GP) 1 antibodies are recognized d-Dimer monitoring is important in COVID-19 coagulopathy. Although d-dimer is initially elevated, other conventional coagulation laboratory tests including prothrombin time (PT), activated partial thromboplastin time (aPTT), and platelet count are often normal, and are not useful indicators of the thrombotic risk. The increase of factor VIII and von Willebrand factor (VWF) [ 13 ], potentially the presence of antiphospholipid antibodies [ 14 ], and increased activity of complement system are also reported, however, monitoring these biomarkers is not practical. The pathogenesis of coagulopathy in COVID-19 is complex but the typical CAC can be diagnosed by increased D-dimer, elevated fibrinogen and VWF levels, but relatively normal PT, aPTT, and platelet count. A pathway for diagnosing CAC versus other coagulopathies is illustrated in Fig. 1 . Thromboembolic complications are the hallmark of COVID-19 that can cause death even in asymptomatic COVID-19 [ 7 ]. The new coronavirus SARS-CoV-2 elicits an acute inflammatory effect with hypercoagulability, platelet activation, and endothelial dysfunction [ 8 ]. Although, this presentation has similarities with sepsis-induced coagulopathy (SIC) due to bacterial infections and disseminated intravascular coagulation (DIC), there are several important differences [ 8 ]. In CAC, patients often initially present with increased fibrinogen levels, increased D-dimers, but minor changes in prothrombin time and platelet count compared to acute bacterial sepsis that can produce thrombocytopenia, prolonged prothrombin times, and decreased antithrombin levels [ 4 , 9 ]. It is also known that inflammatory cytokine levels are elevated in COVID-19 and excess production of inflammatory cytokines can induce hemophagocytic lymphohistiocytosis (HLH)/macrophage activation syndrome (MAS) that can result in a thrombotic coagulation disorder [ 10 ]. Although the pathophysiology of HLH/MAS seems similar to COVID-19, the reported cytokine level is much lower in COVID-19 [ 11 ]. Conversely, the endothelial derangement, detailed in the next section, is predominant in COVID-19. Other than HLH/MAS, various thrombotic diseases such as thrombotic microangiopathy, and antiphospholipid syndrome can occur, and the characteristics of these diseases look similar to CAC [ 12 ]. Even though the pathogeneses of these thrombotic diseases partially overlap with CAC, it is important to delineate the unique statue of CAC to plan a therapeutic strategy. Endotheliopathy in COVID-19 The endothelial damage and thrombosis An important feature of CAC is the microcirculatory endothelial damage in pulmonary circulation and other vascular beds. Since SARS-CoV-2 directly infects the vascular endothelial cell causing cellular damage and apoptosis, the antithrombotic activity of the luminal surface is remarkably decreased [20]. In COVID-19, both alveolar damage and microcirculatory disturbance associated with thrombus formation contribute to respiratory dysfunction. At autopsy, findings reported include clot formation in pulmonary arterioles with diffuse alveolar damage and hyaline membranes [21]. Normal endothelial function refers to the ability of regulating vascular tonus, permeability, cell adhesion, and anticoagulation. Healthy endothelial cells synthesize nitric oxide (NO) by conversion of l-arginine to l-citrulline by nitric oxide synthase. NO released',\n",
       " ('COVID-19',\n",
       "  19,\n",
       "  2): 'by endothelium prevents leukocyte and platelet adhesion, inflammatory cell migration into the vessel wall, smooth muscle cell proliferation, and suppresses apoptosis and inflammation. SARS-Cov-2 enters endothelial cells through endocytosis and is mediated by an interplay of Angiotensin-converting enzyme 2 (ACE2) and the transmembrane protease serine 2 (TMPRSS-2) which sheds a part of spike protein and helps SARS-Cov-2 to enter into endothelial cell. The infected endothelial cells lose their ability to maintain aforementioned physiological functions. Subsequently, the damage of the endothelium leads to the procoagulant change of the vascular lumen, formation of immunothrombosis, and organ malcirculation. Both systemic pulmonary microthrombosis and thromboembolism are commonly seen in COVID-19. This typical figure is thought to be the result of hypercoagulability due to the dysregulated endothelial function of the pulmonary vessels and systemic inflammation. In addition to the deep vein thrombus that results in an embolic event, in situ formation in the pulmonary arteries can be the main reason of pulmonary dysfunction. Lax et al. [22] performed autopsies in 11 patients and reported that despite the absence of clinical presentations of thromboembolism, thrombus formation in small and mid-sized pulmonary arteries was found in all of the examined cases. In these cases, thrombus is suspected to form at the peripheral arteriole and elongate proximally. According to another series of autopsy findings, the incidence of thrombus formation in the pulmonary microvasculature is approximately nine times higher than that seen in influenza [6]. The endothelial damage-derived hypercoagulability ACE2, the host cellular receptor of SARS-CoV-2, has been identified on the vascular endothelial surface. SARS-CoV-2 uses ACE2 to invade into the cell through the fusion of its membrane to the host cell membrane. As a result, the host cell loses ACE2 activity which subsequently leads to reduced angiotensin II inactivation and decreased conversion to antiotensin 1-7 . Increased angiotensin II stimulates vascular constriction and decreased antiotensin 1-7 suppresses nitric oxide production which triggers increased thrombogenicity due to leucocyte and platelet adhesion and vasoconstriction [23]. The vascular endothelium is coated by a gel-like component known as the glycocalyx, that regulates vascular blood flow by providing an antithrombotic surface via antithrombin binding to the heparan sulfate constituents, a major component of the glycocalyx. Although the circulating antithrombin level has been reported to be in a normal range on presentation in COVID-19 cases [13], if the glycocalyx is disrupted, the local antithrombogenicity of the endothelial surface may be altered. However, little information on the glycocalyx status in COVID-19 is available. One of the unique features of CAC is the increase in VWF and factor VIII [13, 24] and it is suggested to be the result of vascular response to SARS-CoV-2 infection. VWF and factor VIII are stored in the Weibel-Palade body of endothelial cells and released in response to infectious stimuli [25] (Fig. 2). The increase in VWF suggests a possible similarity to thrombotic thrombocytopenic purpura, however, ADAMTS13 (a disintegrin and metalloproteinase with a thrombospondin type 1 motif, member 13) levels in COVID-19 although reported to be decreased, may not be severely depleted as in thrombotic thrombocytopenic purpura [26]. The increased VWF levels to 3–4 times normal values seen in patients with COVID-19 may overwhelm the ADAMTS13 activity to degrade the ultra large VWF multimers. The importance of circulating VWF and multimer size in CAC is not established, however, one of the suggested methods to reduce the risk of thrombotic events due to excess ultra large VWF itself is plasma exchange [27, 28]. Fig. 2. Open in a new tab Mechanisms of clot formation in COVID-19. SARS-CoV-2 infects monocyte/macrophage and vascular endothelial cell. The activated macrophage and endothelial damage are the two-wheels',\n",
       " ('COVID-19',\n",
       "  19,\n",
       "  3): 'of the vicious cycle of the thrombus formation. The infected monocyte/macrophage expresses tissue factor on the surface and initiates coagulation cascades. The infected endothelial cell release factor VIII and von Willebrand factor (VWF) from Weibel–Palade body and accelerates coagulation. Released VWF stimulates platelet aggregation and unusually-large VWF (ULVWF) activates platelet adhesion on the endothelial cell. These multi-factorial prothrombotic changes result in arterial, venous, and microvascular thrombosis Similar to factor VIII and VWF, angiopoietin 2, also stored in Weibel-Palade bodies, is known to be released and its circulating level increases in COVID-19 [29]. Angiopoietin 2 serves as an antagonist of angiopoietin 1 and inhibits anti-inflammatory, anticoagulatory, and antiapoptotic signaling induced by angiopoietin 1 by binding to Tie2 competitively [30] (Fig. 3). Tie2 activation by angiopoietin 1 also normalizes prothrombotic responses by inhibiting endothelial tissue factor and phosphatidylserine exposure in sepsis, and therefore, Tie2 signaling is considered to play a central role in the regulation of thrombus formation in SIC/DIC [31]. Angiotensin 2 is also known to increase endothelial permeability and is considered an important factor in acute respiratory distress syndrome [32]. The role of angiopoietin 2 in CAC has not been studied well and it should be the focus in future studies. Fig. 3. Open in a new tab Functional change of the endothelial cell via angiopoietin pathways. Angiopoietin (Ang)-1 binds to Tie2 receptor and promotes variable actions including an anti-inflammatory through inhibiting the nuclear factor kappa B (NFκB) signaling, apoptosis, and maintain vascular permeability by through the regulating cytoskeletal architecture and VE-cadherin. Severe acute respiratory syndrome (SARS)-CoV-2 infection stimulates endothelial cells to release stored Ang2 from Weibel Palade bodies into the circulation. Ang2 competitively antagonizes Ang1/Tie2 signaling, thus turns the anticoagulant, and anti-inflammatory features of endothelial cells to the opposite ways. NO nitric oxide, PG I 2 prostaglandin I 2 , ACE2 angiotensin converting enzyme 2, TMPRSS-2 transmembrane protease serine 2 The monitoring of endothelial damage One of the difficulties in clinical studies of endothelial research is the limited availability of ideal biomarkers. The glycocalyx provides an interface between blood flow and endothelial cells. Since the glycocalyx is fragile, its components are used as biomarkers of endothelial damage in various diseases including infectious diseases [30]. One such biomarker is a hyaluronic acid, a major glycocalyx component. Circulating levels of hyaluronic acid, are elevated in critically ill COVID-19 patients compared with less severe cases [33]. Other than that, the proteins that are released from the Weibel-Palade body i.e., VWF, FVIII, and P-selectin are the potential biomarkers. In addition, sensitive coagulation markers such as thrombin-antithrombin complex (TAT) and prothrombin fragment 1 + 2 can be a marker for the microthrombosis. Goshua et al. [34] reported VWF antigen/antibody, FVIII activity, and TAT levels are significantly higher in the more severe cases. As previously mentioned, angiopoietin 2 is stored in the endothelial cells and secreted along with the endothelial damage. Reportedly, angiopoietin 2 levels are associated with coagulation disorder, organ damage and death in bacterial sepsis [35]. Smadja et al. [29] measured angiopoietin 2, D-dimer, CRP, and creatinine in consecutive 40 COVID-19 patients treated in ICU, and found angiopoietin 2, cut-off of 5000 pg/mL, as the best predictor for poor outcome (sensitivity: 80.1%, specificity: 70%). It is crucial to find a good biomarker of vascular damage in COVID-19 study.',\n",
       " ('COVID-19',\n",
       "  2,\n",
       "  0): 'При этом наибольшее число заболевших выявили в России - 279 359 ЖЕНЕВА, 23 декабря. /ТАСС/. Заболеваемость коронавирусной инфекцией в мире в период с 20 ноября по 17 декабря выросла на 52% по сравнению с предыдущими четырьмя неделями, при этом наибольшее число заболевших было выявлено в России - 279 359. Вместе с тем смертность в среднем в мире снизилась на 8%, сообщила в пятницу Всемирная организация здравоохранения (ВОЗ). Согласно информационному бюллетеню ВОЗ, в мире за четыре недели было зарегистрировано 854 673 случая заражения и 3 005 летальных исходов. Данные ВОЗ свидетельствуют о неоднородной картине заболеваемости и смертности в регионах. В Юго-Восточной Азии число новых случаев ковида выросло за четыре недели на 388%, смертность увеличилась более чем в три раза. В Африке зарегистрировано на 77% больше заболевших и на 50% меньше умерших. В Европе рост заболеваемости составил 54%, смертность увеличилась на 14%. В то же время в Американском регионе заболеваемость уменьшилась на 23%, а смертность - на 48%. В Восточном Средиземноморье заболело на 51% меньше людей, а число летальных исходов снизилось на 65%. Помимо РФ, в пятерку стран с наибольшим количеством новых случаев заболевания коронавирусом вошли Сингапур (120 898), Италия (114 795), Польша (39 828) и Австралия (39 505). В Италии зарегистрировано больше всего умерших - 510. Далее идут Швеция (396), Россия (376), Австралия (211) и Польша (141). Режим чрезвычайной ситуации в связи с ковидом действовал в мировом здравоохранении с конца января 2020 года по 5 мая 2023 года. 11 марта 2020 года ВОЗ охарактеризовала вспышку COVID-19 как пандемию. По информации на 25 октября 2023 года, опубликованной на сайте организации, в мире зарегистрировано 771 549 718 случаев заражения коронавирусом и 6 974 473 летальных исхода. Генеральный директор ВОЗ Тедрос Аданом Гебрейесус на брифинге в Женеве 5 мая заявил, что подлинное число умерших составляет не менее 20 млн.',\n",
       " ('COVID-19',\n",
       "  20,\n",
       "  0): 'CT manifestations of COVID-19 (Figs. 1, 2, 3, 4, 5, 6, 7 and 8) Pulmonary findings Ground-glass opacity GGO is defined as hazy lung areas of slightly increased attenuation without obscuring the bronchial and vascular margins; it can be caused by partial air displacement attributed to partial airspaces filling or interstitial thickening [32, 33]. It is considered the most common radiological abnormality seen in up to 98% in COVID-19 cases [9, 21,22,23,24]. Fig. 1 CT chest axial cuts of COVID-19 patient. A: ground glass opacity (anterior segment of left upper lobe, yellow arrow) and combination of GGO and consolidation in both lower lobe (peripheral, subpleural). B: ground glass opacity (medial segment of right lower lobe, yellow arrow) as well as GGO and consolidation of left lower lobe (peripheral, subpleural) Full size image Fig. 2 a, b CT- chest of COVID-19 patient shows widespread faint ground glass opacity upper lung lobe as well as reticular shadowing bilaterally Full size image Fig. 3 CT scan shows multiple irregular nodules in right middle and lower lobe, lingula and anterior segment of left lower lobe with solid nodules surrounded by a ground glass (red arrow) Full size image Fig. 4 CT scan of COVID-19 patient shows reticular pattern superimposed on the background of GGO with crazy paving stones signs at anterior segment of right lower lobe (yellow box), bronchiolar dilatation (red arrows) at right lower lobe, fibrotic changes (blue arrow) are also noted Full size image Fig. 5 CT scan of COVID-19 patient shows Multiple areas of GGO as well as reticular pattern at anterior segment of upper lobes as well as superior segments of lower lobes Full size image Fig. 6 CT scan of COVID-19 patient shows reticular pattern superimposed on the background of GGO with air trapping at lower lobes (red arrow) as well as cystic changes at left lower lobe (yellow box). Bronchiolar irregularity at right lower lobe (blue arrow) Full size image Fig. 7 CT scan of COVID-19 patient shows reticular pattern superimposed on the background of GGO with nodular shadows and bilateral small cystic changes at upper lobes Full size image Fig. 8 CT scan of COVID-19 patient shows minimal bilateral pleural effusion (yellow arrows) Full size image In COVID-19, GGO is predominately peripheral and subpleural, either uni or bilateral [12,13,14,15,16,17]. In earlier study by Chung et al. [18], GGO was considered as earliest CT finding and detected in 57% of cases. Consolidation Consolidation is defined as increase in the pulmonary parenchymal attenuation with obscuration of the vascular and airway wall margins due to pathological replacement of alveolar air by fluids, cells, or tissues. It can be multifocal, patchy, or segmental with subpleural location or along bronchovascular bundles [32, 33]. Literature shows consolidation prevalence to be about 2–64% in COVID-19 cases [11, 19, 20]. The pathology of consolidation of COVID-19 can be attributed to alveolar cellular fibromyxoid exudates [34]. Consolidation can occur as a progress of the disease or co-existed with GGO [20, 23]. Reticular pattern Reticular pattern refers to thickening of the pulmonary interstitial structures as interlobular septa and intralobular lines [32, 33]; with linear opacities seen at CT studies, it can be explained by the interstitial lymphocyte infiltration [34]. Reticular pattern was noted in many COVID-19 CT studies, up to 70.6% of cases [1] which increases with prolonged course of the disease [13, 20]. Crazy-paving pattern The crazy-paving pattern is a linear pattern superimposed on a GGO background giving the appearance of irregular paving stones (crazy); it can be explained by alveolar edema and acute lung interstitial inflammation [32, 35]. It was reported in 5–36% COVID-19 patients',\n",
       " ('COVID-19',\n",
       "  20,\n",
       "  1): '[9, 11]. It can be a sign of disease progression [9, 24]. Air bronchogram Air bronchogram refers to the pattern of air-filled bronchi (dark) on the background of opacified alveoli (grey/white) [32] and was noted in previous studies of CT chest for COVID-19 [9, 13, 27]; however, the hypoattenuation of bronchi can be attributed to gelatinous mucus and not air [36]. Thus, some suggested to call it bronchiolectasis [9]. Bronchus deformation It is described as airway changes (bronchiectasis and thickening of bronchial wall thickening); it was reported in 10–20% of COVID-19 patients [1, 9, 11, 15, 22, 26]. It can be attributed to the inflammatory changes of bronchial wall leading to obstruction and subsequent destruction of bronchial wall with fibrosis and bronchiectasis change [9, 32]. Fibrosis Lung fibrosis was reported at CT studies of COVID-19 cases in previous series [12] in about 17% of cases. It can be explained by the replacement of cells by scar tissue in the healing process of chronic pulmonary inflammation; thus, it is considered to be a good prognosis by some author [12], while others claimed that it is of poor prognosis as it proceeds to interstitial pulmonary fibrosis disease [28, 35]. Pathological air containing spaces It is described as small air spaces within the lung; it can be due to pathological dilatation or air spaces or due to resorption of consolidation; some author described it as cavity [28], and other called it cystic changes [23] and cavity [32] or bubble sign [9]. Subpleural line It is described as thin (1–3 mm thickness) curvilinear opacity that is parallel to the pleural surface and less than 1 cm deep to it [32]. It was described in about 20% of COVID-19 cases in some series and can be explained by pulmonary edema or fibrosis that takes place in COVD-19 [11, 20]. Vascular enlargement Pulmonary vessel dilatation, peri- and intralesional, was reported in some series [9]; however, it is assumed to be rare [25], while other reported it in 82.4% of cases [1]; it can be explained by capillary wall damage in response to inflammatory process-related factors [9]. Pulmonary nodules Nodule is described as a small (less than 3 cm) round, oval, or irregular shaped well or poorly defined opacity in the lung [32]. It was reported in 3–13 of COVID-19 CT cases and mostly was multifocal irregular and can have halo sign [1, 9, 12, 31, 37]. Halo sign and reversed halo sign Halo sign is described as ground-glass opacity surrounding a pulmonary nodule or mass and represents hemorrhage which was typically described in angioinvasive fungal infection or hypervascular deposits and was attributed to perifocal hemorrhage [31, 32, 38]. In COVID-19, it was described in some report to be about 17.6% but pathology is not understood yet [1, 31]. On the other hand, reversed halo sign (atoll sign) is described as a central ground-glass opacity with denser surrounding crescentic or ring consolidation [32]; it was noted in COVID-19 cases in 3.9% of cases [1] and explained by the progression of disease so that consolidation surrounds GGO or lesion regression with its center being of low attenuation [9, 19, 27, 39]. Extrapulmonary findings Pleural changes Pleural thickening was reported in COVID-19 with higher incidence than effusion [23] with prevalence of up to 32% of COVID-19 cases in some series [19, 23], while pleural effusion was reported as a rare finding in COVID-19 cases with incidence of 2% and may be a bad prognostic sign [11, 23]; furthermore, some suggested that occurrence or pleural effusion and extensive tiny pulmonary nodules to be due to bacterial superinfection [29]. Mediastinal lymphadenopathy',\n",
       " ('COVID-19',\n",
       "  20,\n",
       "  2): 'It describes enlarged lymph nodes (> 1 cm short axis) [32] which may be assign of severe COVID-19 infection; it was reported in 0–8% of COVID-19 cases [1, 20, 23]. Pericardial effusion Pericardial effusion was earlier reported as being rare (< 5%) finding in COVID-19 cases and can be explained by the severe inflammatory process; some reports described it with a higher incidence in critical COVID-19 cases than milder cases [11]. So, the CT findings in COVID-19 are variable. While mild cases can show bilateral ground-glass opacities and small areas of subsegmental consolidation with the advance of the disease, there can be bilateral multiple subsegmental and lobular consolidation. In advanced cases, CT can reveal heterogeneous widespread bilateral with air bronchogram and bronchial deformation as well as septal thickening and crazy-paving appearance.',\n",
       " ('COVID-19',\n",
       "  21,\n",
       "  0): 'The pathophysiology of bacterial SIC and disseminated intravascular coagulation (DIC) has been extensively studied. Since “inflammation” and “coagulation” are the common keywords in SIC/DIC and CAC, it is helpful to consider prior studies regarding SIC/DIC. The mechanism of procoagulant responses in bacterial sepsis is complex, and various factors, including pathogen-associated molecular patterns (PAMPs) and host-derived damage-associated molecular patterns (DAMPs), are known to trigger the proinflammatory responses and activate systemic coagulation (Fig. 1). Since inflammation and coagulation are both essential host defense mechanisms, the responses increase in proportion to disease severity and can potentially injure the host [10]. Host defense mechanisms include proinflammatory cytokines such as interleukin (IL)-1β, IL-6, tumor necrosis factor-α (TNFα), and complement system proteins, all of which can induce coagulopathy [11]. In addition, tissue factor expression on monocytes/macrophages, neutrophil activation, and neutrophil extracellular traps (NETs) produce activation of thrombosis [12, 13]. This thromboinflammatory response, together with extracellular vesicles, causes endothelial damage that further increase thrombin generation [14, 15]. In SIC/DIC, fibrinolysis is often suppressed due to the over-production of plasminogen activator inhibitor-1 (PAI-1), with progressive fibrin clot formation within the tissue microcirculation leading to organ dysfunction [16]. To detect this type of coagulation disorder, a decrease in the platelet count and increase in prothrombin time (PT)—the two laboratory parameters used in the SIC score—are the most useful indicators [17]. There is a lack of increase in D-dimer levels with increasing SIC/DIC severity due to suppression of fibrinolysis, also called fibrinolytic shutdown [18]. In COVID-19, the D-dimer level is commonly high and usually greater than five times the upper limit of the normal range. Also, in SIC/DIC, anticoagulant proteins such as antithrombin decrease significantly because of increased vascular permeability and other mechanisms [16]. Fig. 1 Thrombus formation in disseminated intravascular coagulation, thrombotic thrombocytopenic purpura, and hemolytic uremic syndrome. In bacterial sepsis, immune cells such as monocyte and macrophages are activated by pathogen-associated molecular patterns (PAMPs) and host-derived damage-associated molecular patterns (DAMPs). The immune cells initiate coagulation cascades through expressing tissue factor (TF) and releasing extracellular vesicles (EVs). The activated neutrophils and neutrophil extracellular traps (NETs) are also involved in coagulation. Degradation of fibrin, the end product of coagulation activation, is suppressed by increased levels of plasminogen activator inhibitor-1 (PAI-1). In thrombotic thrombocytopenic purpura (TTP), increased high multimers of von Willebrand factor (VWF) caused by ant-ADAMTS13 antibodies stimulate platelet aggregation. In hemolytic uremic syndrome (HUS), dysregulated complement system and its terminal product, membrane attack protein (MAC), damage vascular endothelial cells, and initiate clot formation Full size image In the case of CAC, other coagulation biomarker changes are relatively minor and abnormalities seen less frequently [2]. Guan et al. [3] reported on over 1000 patients and found a median platelet count of 168 × 109/L in all patients, but only 137.5 × 109/L (median) in the subgroup of patients with severe respiratory disease (all data representing values obtained at hospital admission). They also reported that abnormal D-dimer levels were observed on admission in slightly less than half of the patients. Another report from China also noted that admission platelet counts were lower in non-survivors versus survivors (median values, 122 vs 178 × 109/L, respectively). The median D-dimer value was 2.03 μg/mL in all cases, but even though it was 4.39 μg/mL in non-survivors, the PT was relatively normal (12.6 s) even in the non-survivors [19]. As a result, the incidence of DIC is low in COVID-19 and less than 1% even in severe cases [3, 20]. In another study, Tang et al. [4] reported that 16 out of 183 cases (8.7%) met the DIC criteria of the International Society on Thrombosis',\n",
       " ('COVID-19',\n",
       "  21,\n",
       "  1): 'and Haemostasis (ISTH), incidences lower than in sepsis where DIC occurs in approximately 30% of cases [4]; moreover, the possibility of superimposed bacterial sepsis, rather than progressive CIVID-19 per se, for progression to DIC cannot be excluded. Consumptive coagulopathy is a typical feature in SIC/DIC; however, that type of coagulopathy is usually not seen in COVID-19 in its early phase. IL-1β and IL-6 are known to induce thrombocytosis and hyperfibrinogenemia, and sustained inflammation may stimulate the production of these factors [21]. In addition, inflammation and coagulation are localized within the lung in early stages but with disease progression, hypercoagulability becomes systemic and proceeds towards SIC/DIC. The mismatched D-dimer elevation is explained by the upregulation of local fibrinolysis in alveoli by urokinase-type plasminogen activator (u-PA) released from alveolar macrophages [22]. In addition, the direct infection of endothelial cells by the virus (a mechanism that is rather specific for coronaviruses via their cell entry through ACE2 (angiotensin-converting enzyme 2, the receptor for SARS-CoV-2), abundantly expressed on endothelium) leads to a massive release of plasminogen activators [23]. With an increase in disease severity, there is a procoagulant shift with the acceleration of fibrin formation produced by increased fibrinogen levels and activated platelets. The suppressed fibrinolysis by PAI-1 release accelerates clot formation in the lung capillaries. While ACE2 helps to mediate anticoagulant properties of the vascular endothelium in the healthy state, binding of SARS-CoV-2 to ACE2 aggravates cell damage, upregulates tissue factor expression, and downregulates the protein C system [24] (Fig. 2). In this situation, with or without secondary complications such as tissue hypoxia and concomitant infection, coagulopathy and thrombotic events readily occur.',\n",
       " ('COVID-19',\n",
       "  22,\n",
       "  0): 'To date, there are no generally proven effective therapies for COVID-19 or antivirals against SARS-CoV-2, although some treatments have shown some benefits in certain subpopulations of patients or for certain end points (see later). Researchers and manufacturers are conducting large-scale clinical trials to evaluate various therapies for COVID-19. As of 2 October 2020, there were about 405 therapeutic drugs in development for COVID-19, and nearly 318 in human clinical trials (COVID-19 vaccine and therapeutics tracker). In the following sections, we summarize potential therapeutics against SARS-CoV-2 on the basis of published clinical data and experience. Inhibition of virus entry SARS-CoV-2 uses ACE2 as the receptor and human proteases as entry activators; subsequently it fuses the viral membrane with the cell membrane and achieves invasion. Thus, drugs that interfere with entry may be a potential treatment for COVID-19. Umifenovir (Arbidol) is a drug approved in Russia and China for the treatment of influenza and other respiratory viral infections. It can target the interaction between the S protein and ACE2 and inhibit membrane fusion (Fig. 5). In vitro experiments showed that it has activity against SARS-CoV-2, and current clinical data revealed it may be more effective than lopinavir and ritonavir in treating COVID-19 (refs122,123). However, other clinical studies showed umifenovir might not improve the prognosis of or accelerate SARS-CoV-2 clearance in patients with mild to moderate COVID-19 (refs124,125). Yet some ongoing clinical trials are evaluating its efficacy for COVID-19 treatment. Camostat mesylate is approved in Japan for the treatment of pancreatitis and postoperative reflux oesophagitis. Previous studies showed that it can prevent SARS-CoV from entering cells by blocking TMPRSS2 activity and protect mice from lethal infection with SARS-CoV in a pathogenic mouse model (wild-type mice infected with a mouse-adapted SARS-CoV strain)126,127. Recently, a study revealed that camostat mesylate blocks the entry of SARS-CoV-2 into human lung cells47. Thus, it can be a potential antiviral drug against SARS-CoV-2 infection, although so far there are not sufficient clinical data to support its efficacy. Fig. 5: SARS-CoV-2 replication and potential therapeutic targets. Potential antivirals target the different steps of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) replication, ranging from receptor binding, entry and fusion to replication. Furthermore, immunoglobulin-based and immunomodulatory drugs are potential therapeutics as well. Note that robust data on clinical efficacy are lacking for most of these treatments so far. 3CLpro, 3C-like protease; ACE2, angiotensin-converting enzyme 2; CR3022, a SARS-CoV-specific human monoclonal antibody; E, envelope protein; EK1C4, lipopeptide derived from EK1 which is a pan-coronavirus fusion inhibitor targeting the HR1 domain of the spike protein; ER, endoplasmic reticulum; gRNA, genomic RNA; HR2P, heptad repeat 2-derived peptides of SARS-CoV-2 spike protein; IL-6, interleukin-6; ISG, interferon-stimulated gene; M, membrane protein; RdRp, RNA-dependent RNA polymerases; sgRNA, subgenomic RNA; S, spike protein; TMPRSS2, transmembrane protease serine protease 2. Full size image Chloroquine and hydroxychloroquine are other potential but controversial drugs that interfere with the entry of SARS-CoV-2. They have been used in the prevention and treatment of malaria and autoimmune diseases, including systemic lupus erythematosus and rheumatoid arthritis. They can inhibit the glycosylation of cellular receptors and interfere with virus–host receptor binding, as well as increase the endosomal pH and inhibit membrane fusion. Currently, no scientific consensus has been reached for their efficacy in the treatment of COVID-19. Some studies showed they can inhibit SARS-CoV-2 infection in vitro, but the clinical data are insufficient128,129. Two clinical studies indicated no association with death rates in patients receiving chloroquine or hydroxychloroquine compared with those not receiving the drug and even suggest it may increase the risk of dying as a higher risk of cardiac arrest was found in the treated',\n",
       " ('COVID-19',\n",
       "  22,\n",
       "  1): 'patients130,131. On 15 June 2020, owing to the side effects observed in clinical trials, the US Food and Drug Administration (FDA) revoked the emergency use authorization for chloroquine and hydroxychloroquine for the treatment of COVID-19. Another potential therapeutic strategy is to block binding of the S protein to ACE2 through soluble recombinant hACE2, specific monoclonal antibodies or fusion inhibitors that target the SARS-CoV-2 S protein132,133,134 (Fig. 5). The safety and efficacy of these strategies need to be assessed in future clinical trials. Inhibition of virus replication Replication inhibitors include remdesivir (GS-5734), favilavir (T-705), ribavirin, lopinavir and ritonavir. Except for lopinavir and ritonavir, which inhibit 3CLpro, the other three all target RdRp128,135 (Fig. 5). Remdesivir has shown activity against SARS-CoV-2 in vitro and in vivo128,136. A clinical study revealed a lower need for oxygen support in patients with COVID-19 (ref.137). Preliminary results of the Adaptive COVID-19 Treatment Trial (ACTT) clinical trial by the National Institute of Allergy and Infectious Diseases (NIAID) reported that remdesivir can shorten the recovery time in hospitalized adults with COVID-19 by a couple days compared with placebo, but the difference in mortality was not statistically significant138. The FDA has issued an emergency use authorization for remdesivir for the treatment of hospitalized patients with severe COVID-19. It is also the first approved option by the European Union for treatment of adults and adolescents with pneumonia requiring supplemental oxygen. Several international phase III clinical trials are continuing to evaluate the safety and efficacy of remdesivir for the treatment of COVID-19. Favilavir (T-705), which is an antiviral drug developed in Japan to treat influenza, has been approved in China, Russia and India for the treatment of COVID-19. A clinical study in China showed that favilavir significantly reduced the signs of improved disease signs on chest imaging and shortened the time to viral clearance139. A preliminary report in Japan showed rates of clinical improvement of 73.8% and 87.8% from the start of favilavir therapy in patients with mild COVID-19 at 7 and 14 days, respectively, and 40.1% and 60.3% in patients with severe COVID-19 at 7 and 14 days, respectively140. However, this study did not include a control arm, and most of the trials of favilavir were based on a small sample size. For more reliable assessment of the effectiveness of favilavir for treating COVID-19, large-scale randomized controlled trials should be conducted. Lopinavir and ritonavir were reported to have in vitro inhibitory activity against SARS-CoV and MERS-CoV141,142. Alone, the combination of lopinavir and ritonavir had little therapeutic benefit in patients with COVID-19, but appeared more effective when used in combination with other drugs, including ribavirin and interferon beta-1b143,144. The Randomized Evaluation of COVID-19 Therapy (RECOVERY) trial, a national clinical trial programme in the UK, has stopped treatment with lopinavir and ritonavir as no significant beneficial effect was observed in a randomized trial established in March 2020 with a total of 1,596 patients145. Nevertheless, other clinical trials in different phases are still ongoing elsewhere. Immunomodulatory agents SARS-CoV-2 triggers a strong immune response which may cause cytokine storm syndrome60,61. Thus, immunomodulatory agents that inhibit the excessive inflammatory response may be a potential adjunctive therapy for COVID-19. Dexamethasone is a corticosteroid often used in a wide range of conditions to relieve inflammation through its anti-inflammatory and immunosuppressant effects. Recently, the RECOVERY trial found dexamethasone reduced mortality by about one third in hospitalized patients with COVID-19 who received invasive mechanical ventilation and by one fifth in patients receiving oxygen. By contrast, no benefit was found in patients without respiratory support146. Tocilizumab and sarilumab, two types of interleukin-6 (IL-6) receptor-specific antibodies previously used to treat various',\n",
       " ('COVID-19',\n",
       "  22,\n",
       "  2): 'types of arthritis, including rheumatoid arthritis, and cytokine release syndrome, showed effectiveness in the treatment of severe COVID-19 by attenuating the cytokine storm in a small uncontrolled trial147. Bevacizumab is an anti-vascular endothelial growth factor (VEGF) medication that could potentially reduce pulmonary oedema in patients with severe COVID-19. Eculizumab is a specific monoclonal antibody that inhibits the proinflammatory complement protein C5. Preliminary results showed that it induced a drop of inflammatory markers and C-reactive protein levels, suggesting its potential to be an option for the treatment of severe COVID-19 (ref.148). The interferon response is one of the major innate immunity defences against virus invasion. Interferons induce the expression of diverse interferon-stimulated genes, which can interfere with every step of virus replication. Previous studies identified type I interferons as a promising therapeutic candidate for SARS149. In vitro data showed SARS-CoV-2 is even more sensitive to type I interferons than SARS-CoV, suggesting the potential effectiveness of type I interferons in the early treatment of COVID-19 (ref.150). In China, vapor inhalation of interferon-α is included in the COVID-19 treatment guideline151. Clinical trials are ongoing across the world to evaluate the efficacy of different therapies involving interferons, either alone or in combination with other agents152. Immunoglobulin therapy Convalescent plasma treatment is another potential adjunctive therapy for COVID-19. Preliminary findings have suggested improved clinical status after the treatment153,154. The FDA has provided guidance for the use of COVID-19 convalescent plasma under an emergency investigational new drug application. However, this treatment may have adverse effects by causing antibody-mediated enhancement of infection, transfusion-associated acute lung injury and allergic transfusion reactions. Monoclonal antibody therapy is an effective immunotherapy for the treatment of some viral infections in select patients. Recent studies reported specific monoclonal antibodies neutralizing SARS-CoV-2 infection in vitro and in vivo155,156,157,158. Compared with convalescent plasma, which has limited availability and cannot be amplified, monoclonal antibodies can be developed in larger quantities to meet clinical requirements. Hence, they provide the possibility for the treatment and prevention of COVID-19. The neutralizing epitopes of these monoclonal antibodies also offer important information for vaccine design. However, the high cost and limited capacity of manufacturing, as well as the problem of bioavailability, may restrict the wide application of monoclonal antibody therapy.',\n",
       " ('COVID-19',\n",
       "  23,\n",
       "  0): '1. Reduction of lung burden Cross-reactive CD4+ memory T cells reduce COVID-19 symptoms and lung viral load but have minimal impact on URT viral load. In this scenario, we assume that SARS-CoV-2 cross-reactive CD4+ memory T cells are sufficient to modulate disease severity but are not capable of eliminating the virus from the URT any faster than a primary immune response. This would be analogous to how the current acellular pertussis vaccine likely functions20 and in line with findings from candidate SARS-CoV-2 vaccines in rhesus macaques21,22. This form of partial protection could be mediated by any of several mechanisms involving CD4+ T CM /T EM cells, T RM cells and memory T FH cells. In this scenario, we assume that the cross-reactive memory T cell population is relatively small at the time of infection, the response post infection is relatively slow and the CD4+ memory T cell response is unable to control the URT viral load without responses from other branches of the adaptive immune system. Implications for individuals Expected outcomes for individuals infected with SARS-CoV-2 who have pre-existing cross-reactive CD4+ memory T cells, compared with infected individuals without such memory, would include the following: (a) a reduction in the magnitude and duration of symptomatic/clinical disease; (b) no change in URT viral loads; and (c) no change in the generation of immune memory compared with people without pre-existing cross-reactive cells. Epidemiological implications Compared with a population including fewer individuals harbouring such memory, a population with more individuals with pre-existing cross-reactive CD4+ memory T cells would experience the following, all else being equal: (a) lower probabilities of hospitalizations and deaths per SARS-CoV-2 infection; and (b) no reduction, or potentially an increase, in viral spread. An increase could occur if the reduction in symptoms made infection harder to identify and trace and thus increased the frequency of undetected cases while not reducing infectiousness. 2. T FH cell-accelerated antibodies Cross-reactive memory T FH cells trigger a faster and better antibody response, resulting in accelerated control of virus in the URT and lungs. In this scenario, we assume that memory T FH cells facilitate a faster, better, stronger neutralizing antibody response against SARS-CoV-2 than would occur in the absence of memory T FH cells. A variation of this scenario would occur if T CM /T EM cells, memory T H 1 cells or CD4-CTL cells were the functionally important CD4+ memory T cell compartment. After activation and proliferation of these T cells over a period of days, control of the SARS-CoV-2 virus in the lung and URT would follow. Data consistent with both of these scenarios have been observed for influenza23,24,25. Implications for individuals Expected outcomes for individuals infected with SARS-CoV-2 who have pre-existing cross-reactive CD4+ memory T cells, compared with infected individuals without such memory, would include the following: (a) a reduction in the magnitude and duration of symptomatic disease, all else being equal (for example, an individual of a given age and co-morbidities, exposed to a given viral inoculum, would tend to have lower severity — as measured by, for example, risk of hospitalization, ICU or death — with such T cell memory than without); (b) SARS-CoV-2 viral loads in the URT would not be affected during the pre-symptomatic phase, but would be somewhat reduced thereafter, because of the intermediate kinetics of the immune response; and (c) robust immune memory would likely be generated. Epidemiological implications Compared with a population including fewer individuals harbouring such memory, a population with more individuals with pre-existing cross-reactive CD4+ memory T cells would experience the following, all else being equal: (a) fewer hospitalizations and deaths; (b)',\n",
       " ('COVID-19',\n",
       "  23,\n",
       "  1): 'a modest to moderate reduction in viral spread, as the pre-symptomatic period plays a substantial role in spread26 — the reduction in URT viral load under this scenario would mean a modest to moderate reduction in spread in a population in which cross-reactive T cell memory was relatively common; and (c) greater heterogeneity (assuming a minority have such cross-reactive memory) in infectiousness, as variability between those with and without memory would enhance overall variability. Heterogeneity in infectiousness, all else being equal, increases the chance that a virus introduced into a population will fail to spark a large epidemic (although this can be overcome by multiple introductions)27,28. 3. T RM cells in the URT Cross-reactive CD4+ T RM cells at the site of infection enable rapid control of virus in the URT and lungs. This scenario would occur via CD4+ T RM cells in the URT at the site of infection. These CD4+ memory T cells would restrict viral replication in the URT in the days after infection and possibly also restrict viral replication through the rapid activation of the innate immune system. In the case of SARS-CoV, the causative agent of severe acute respiratory syndrome, an intranasal vaccine formulated to induce CD4+ T cell responses elicited airway CD4+ T RM cells that provided substantial protective immunity in mice, but the protection was against fatality and did not prevent early SARS-CoV viral replication29. The CD4+ T RM cells controlled virus replication over a period of ~5 days. Implications for individuals Expected outcomes for individuals infected with SARS-CoV-2 who have pre-existing cross-reactive CD4+ memory T cells, compared with infected individuals without such memory, would include the following: (a) a short, asymptomatic infection; (b) low SARS-CoV-2 viral loads, with a rapid decline to undetectable levels within days; and (c), possibly, reduced generation of new memory to SARS-CoV-2, owing to the limited antigen load. Epidemiological implications Compared with a population including fewer individuals harbouring such memory, a population with more individuals with pre-existing cross-reactive CD4+ memory T cells would experience the following, all else being equal: (a) fewer hospitalizations and deaths, owing to modified symptoms; (b), potentially, a considerably lower degree of spread owing to lower viral loads and shorter duration of shedding, which both presumably contribute to a lower basic reproduction number (R 0 )26,30; and (c), even more than in scenario 2, enhanced heterogeneity in infectiousness. 4. Transient infection T RM cell immunity ‘blitzes’ viral replication in the URT. This scenario is an unlikely, extreme variation of scenario 3. Immunologically, this outcome would be unprecedented. ‘Sterilizing immunity’ refers to antibodies preventing any cells from being infected. Given that T cells can only respond after cells are infected, the closest T cells could come to sterilizing immunity would be a massive T RM cell ‘blitz’ in the tissue, leading to the elimination of all infected cells within a day of the initial infection, at the portal of entry. Such T cell events have only been reported in the presence of large numbers of CD8+ T RM cells in certain animal models12. There is no example where this has been observed for CD4+ T cells, and the available data indicate that CD4+ T RM cells can only blunt infection over a period of several days31,32. This is also consistent with the fact that CD8+ T cells recognize antigens presented on essentially any infected cell (MHC class I presentation), whereas CD4+ T cells recognize antigens presented by only a subset of cells (MHC class II presentation). As noted above, in the case of SARS-CoV, a CD4+ T cell intranasal vaccine elicited airway CD4+ T RM',\n",
       " ('COVID-19',\n",
       "  23,\n",
       "  2): 'cells that provided substantial protection from the disease in mice, but only eliminated virus replication after ~5 days29, not supporting scenario 4. As a thought experiment, if the pre-existing CD4+ T RM cell immunity was so extreme as to preclude significant viral replication, seroconversion (that is, a de novo antibody response to SARS-CoV-2) would not occur. Such individuals would not be detectable by virological or serological diagnostic tests and would not shed virus; effectively, these individuals would be immune to infection and not reported as cases. This appears inconsistent with human coronavirus challenge studies. In human CCC challenge–rechallenge experiments, even with the same or closely related CCC strains and the benefit of antibody-mediated immunity33,34, reinfection was frequently observed (although not necessarily symptomatic disease), making it implausible that cross-reactive CCC T cell memory alone would routinely abort SARS-CoV-2 infection. Epidemiological observations are also inconsistent with widespread immunity to infection as proposed by this scenario. Two ship-based outbreaks reporting cumulative attack rates of 67.9% and 85.2% are inconsistent with high levels of pre-existing immunity to infection in the on-board populations35,36. Considering this epidemiological evidence alongside immunological precedent, scenario 4 is highly unlikely for SARS-CoV-2, particularly given the relatively low levels of cross-reactive CD4+ memory T cells observed in blood samples so far. A recent COVID-19 study observed approximately 3 SARS-CoV-2-exposed (not PCR-confirmed) potentially asymptomatic cases with T cell responses in the absence of seroconversion10. Although there has been extensive discussion in the public arena, and in public health circles, of whether a large population of seronegative previously SARS-CoV-2-infected people exists, if one excludes the issue of poor-quality serological kits, the preponderance of data supports the conclusion that the vast majority of SARS-CoV-2-infected individuals do seroconvert, at least for a duration of months4,14,37,38,39,40,41. Quantitatively, these estimates range from 99% in a New York City study of 624 PCR-confirmed cases to 91.1% in an Icelandic study of 1,797 patients37,40. Thus, the frequency of SARS-CoV-2 infections resulting in a T cell response alone appears to have a ceiling of 1–9% of total SARS-CoV-2 infections, and it is likely that those outcomes reflect biology other than scenario 4 (for example, a very low viral inoculum). Epidemiological implications Under this scenario, compared with a population including fewer individuals harbouring pre-existing cross-reactive CD4+ memory T cells, all else being equal, the following would occur: (a) the maximum proportion who could become infected would be lower; and (b) the herd immunity threshold would be lower. These implications differ significantly from scenarios 1–3.',\n",
       " ('COVID-19',\n",
       "  24,\n",
       "  0): 'Characteristics of published studies Among the 65 research articles included in the analysis, more than 31 are on preprint servers, and 34 are published in peer-reviewed journals, including The Lancet and The New England Journal of Medicine. Most of the publications (n = 58, 89.2%) are in English and few (n = 7, 10.8%) are in Chinese. Around 75.9% of English language publications focus on epidemiology and causes, while 85.7% of Chinese papers focus on prevention and control (Table 1). Table 1 Breakdown of research domains by language in January 2020 Full size table As shown in Fig. 2, academic publications are distributed across the following research domains: epidemiology, causes, clinical manifestation and diagnosis, and prevention and control. The largest portion of the papers (n = 25, 38.5%) are related to causes, followed by papers on epidemiology (n = 19, 29.2%), while 18.5% examined prevention and control and 13.8% reported clinical manifestations and diagnosis. Initially, there were more research articles focused on causes of the outbreak, yet studies on prevention and control gradually increased over time (Fig. 3). The majority of the articles (n = 44, 67.7%) were published by Chinese scholars whereas 29.2% (n = 19) articles were from scholars outside of China. A small number (n = 2, 3.1%) were based on international collaborative research by scholars from different countries (Table 2). Fig. 2 Research domains of published research articles Full size image Fig. 3 Publication dates of research articles Full size image Table 2 Breakdown of research domains by collaboration type in January 2020 Full size table We also analyzed the methodological characteristics of the publications in the final sample. The majority of the articles are based on mathematical modeling (44.6%) and cross-sectional study designs (18.5%). Around half of the studies include targeted populations (patients, general populations, and healthcare workers) (49.2%) in their analysis, followed by studies that attempt to identify the species of the virus (virus structure, gene sequence) (36.9%). Among the 32 articles with population as the target of study, 34.4% had a sample size of less than 10, 31.3% were conducted in a hospital setting, and 50% used secondary data. Quality control activities for data collection were mentioned in 56.3% of the population studies (Table 3). Table 3 Methodological characteristics of COVID-19 research articles in January 2020 Full size table Research domains Epidemiology On 29 December 2019, the first four cases of an acute respiratory syndrome of unknown etiology were reported in Wuhan City, Hubei Province, China among people linked to a local seafood market (“wet market”) [2]. Research is underway to understand more about transmissibility, severity, and other features associated with COVID-19 [3]. It appears that most of the early cases had some sort of contact history with the original seafood market [2, 12,13,14]. Soon, a secondary source of infection was found to be human-to-human transmission via close contact. There was an increase of infected people with no history of exposure to wildlife or visiting Wuhan, and multiple cases of infection were detected among medical professionals [2, 14,15,16,17]. It became clear that the COVID-19 infection occurs through exposure to the virus, and both the immunosuppressed and normal population appear susceptible. Some studies have reported an age distribution of adult patients between 25 and 89 years old. Most adult patients were between 35 and 55 years old [14], and there were fewer identified cases among children and infants [14, 18]. A study on early transmission dynamics of the virus reported the median age of patients to be 59 years, ranging from 15 to 89 years, with the majority (59%) being male [2]. It was',\n",
       " ('COVID-19',\n",
       "  24,\n",
       "  1): 'suggested that the population most at risk may be people with poor immune function such as older people and those with renal and hepatic dysfunction [2]. The COVID-19 has been found to have higher levels of transmissibility and pandemic risk than the SARS-CoV, as the effective reproductive number (R) of COVID-19 (2.9) is estimated to be higher than the reported effective reproduction number (R) of SARS (1.77) at this early stage [15]. Different studies of COVID-19 have estimated the basic reproduction (R 0 ) range to be from 2.6 to 4.71 (Table 4). The average incubation duration of COVID-19 was estimated to be 4.8 ± 2.6, ranging from 2 to 11 days [15] and 5.2 days (95% confidence interval, 4.1 to 7) [2]. The latest guidelines from Chinese health authorities stated an average incubation duration of 7 days, ranging from 2 to 14 days [23]. Table 4 summarizes the findings on important indicators from these epidemiological studies. Table 4 Main epidemiological indicators of COVID-19 research articles in January 2020 Full size table In China, 11 791 cases were confirmed and 17 988 cases were suspected in 34 provinces as of 24:00, 31 January 2020 (Fig. 4) [32]. Studies indicated that the spread of COVID-19 was relatively quick and reported that it had spread to several other countries after its outbreak in China. On 31 January 2020, there were 213 deaths reported globally [33]. Confirmed cases were reported in the following 19 countries outside of China: Australia (9), Canada (3), Cambodia (1), France (6), Finland (1), Germany (5), India (1), Italy (2), Japan (14), Nepal (1), Malaysia (8), the Philippines (1), the Republic of Korea (11), Singapore (13), Sri Lanka (1), Thailand (14), the United States of America (6), United Arab Emirates (4) and Vietnam (5) (Fig. 5) [33]. Fig. 4 Distribution of COVID-19 cases in China Full size image Fig. 5 Global distribution of COVID-19 cases Full size image Causes Virology and pathogenesis Coronaviruses are enveloped single-stranded RNA viruses that are zoonotic in nature and cause symptoms ranging from those similar to the common cold to more severe respiratory, enteric, hepatic, and neurological symptoms [5, 34]. Other than SARS-CoV-2, there are six known coronaviruses in humans: HCoV-229E, HCoV-OC43, SARS-CoV, HCoV-NL63, HCoV-HKU1, and MERS-CoV [2, 23, 35, 36]. Coronavirus has caused two large-scale pandemics in the last two decades: SARS [37] and MERS [12, 38]. To detect the infection source of COVID-19, China CDC researchers collected 585 environmental samples from the Huanan Seafood Market in Wuhan, Hubei Province, China on 1 January and 12 January 2020. They detected 33 samples containing SARS-CoV-2 and indicated that it originated from wild animals sold in the market [39]. Then, researchers used the lung fluid, blood, and throat swab samples of 15 patients to conduct laboratory tests. These laboratory tests found that the virus-specific nucleic acid sequences in the sample are different from those of known human coronavirus species. Laboratory results also indicated that SARS-CoV-2 is similar to some of the beta (β) coronaviruses genera identified in bats [12, 18, 40], which is situated in a group of SARS/SARS-like CoV [12]. To conduct next-generation sequencing from bronchoalveolar lavage fluid and cultured isolates, researchers enrolled nine inpatients in Wuhan with viral pneumonia and negative in common respiratory pathogens. The results of this next-generation sequencing indicated that SARS-CoV-2 was more distant from SARS-CoV (with about 79% sequence identity) and MERS-CoV (with about 50% sequence identity) than from two bat-derived SARS-like coronaviruses – bat-SL-CoVZC45 (with 87.9% sequence identity) and bat-SL-CoVZXC21 (with 87.2% sequence identity) [41]. Studies also reported that COVID-19 S-protein supported strong interaction with human ACE2 molecules',\n",
       " ('COVID-19',\n",
       "  24,\n",
       "  2): 'despite the dissimilarity of its sequence with that of SARS-CoV [12, 42]. Transmission pattern Many domestic and wild animals, including camels, cattle, cats, and bats, may serve as hosts for coronaviruses [23]. It is considered that, generally, animal coronaviruses do not spread among humans [3]. However, there are exceptions, such as SARS and MERS, which are mainly spread though close contact with infected people via respiratory droplets from cough or sneezing. With regard to COVID-19, early patients were reported to have some link to the Huanan Seafood Market in Wuhan, China, suggesting that these early infections were due to animal-to-person transmission. However, later cases were reported among medical staff and others with no history of exposure to that market or visiting Wuhan, which was taken as an indication of human-to-human transmission [2, 4, 15,16,17]. The latest guidelines from Chinese health authorities [23, 43] described three main transmission routes for the COVID-19: 1) droplets transmission, 2) contact transmission, and 3) aerosol transmission. Droplets transmission was reported to occur when respiratory droplets (as produced when an infected person coughs or sneezes) are ingested or inhaled by individuals nearby in close proximity; contact transmission may occur when a subject touches a surface or object contaminated with the virus and subsequently touch their mouth, nose, or eyes; and aerosol transmission may occur when respiratory droplets mix into the air, forming aerosols and may cause infection when inhaled high dose of aerosols into the lungs in a relatively closed environment [23, 43]. In addition to these three routes, one study also indicated the digestive system as a potential transmission route for COVID-19 infection. Since patients had abdominal discomfort and diarrhea symptoms, researchers analyzed four datasets with single-cell transcriptomes of digestive systems and found that ACE2 was highly expressed in absorptive enterocytes from ileum and colon [44]. Clinical manifestation and diagnosis The complete clinical manifestation is not clear yet, as the reported symptoms range from mild to severe, with some cases even resulting in death [3]. The most commonly reported symptoms are fever, cough, myalgia or fatigue, pneumonia, and complicated dyspnea, whereas less common reported symptoms include headache, diarrhea, hemoptysis, runny nose, and phlegm-producing cough [3, 16]. Patients with mild symptoms were reported to recover after 1 week while severe cases were reported to experience progressive respiratory failure due to alveolar damage from the virus, which may lead to death [13]. Cases resulting in death were primarily middle-aged and elderly patients with pre-existing diseases (tumor surgery, cirrhosis, hypertension, coronary heart disease, diabetes, and Parkinson’s disease) [13]. Case definition guidelines mention the following symptoms: fever, decrease in lymphocytes and white blood cells, new pulmonary infiltrates on chest radiography, and no improvement in symptoms after 3 days of antibiotics treatment [2]. For patients with suspected infection, the following procedures have been suggested for diagnosis: performing real-time fluorescence (RT-PCR) to detect the positive nucleic acid of SARS-CoV-2 in sputum, throat swabs, and secretions of the lower respiratory tract samples [13, 14, 43]. Prevention and control Prevention and control strategies and methods are reported at three levels: national level, case-related population level, and general population level. At the national level, the National Health Commission of the People’s Republic of China issued the “No.1 announcement” on 20 January 2020, which officially included the COVID-19 into the management of class B legal infectious diseases, and allowed for class A infectious disease preventive and control measures to be implemented [45]. Under this policy, medical institutes can adopt isolation treatment and observation protocols to prevent and control the spread of the COVID-19. On 22 January 2020, the National Health Commission published national guidelines for',\n",
       " ('COVID-19',\n",
       "  24,\n",
       "  3): 'the prevention and control of COVID-19 for medical institutes to prevent nosocomial infection [46]. On 28 January 2020, the National Health Commission issued protocols for rapid prevention and control measures in order to effectively contain the spread of the epidemic through a “big isolation and big disinfection” policy during the Chinese Spring Festival [47]. National-level strategies have also been issued with targeted measures for rural areas (issued on 28 January 2020) and the elderly population (issued on 31 January 2020) [48, 49]. Several public health measures that may prevent or slow down the transmission of the COVID-19 were introduced; these include case isolation, identification and follow-up of contacts, environmental disinfection, and use of personal protective equipment [50]. To date, no specific antiviral treatment has been confirmed to be effective against COVID-19. Regarding patients infected with COVID-19, it has been recommended to apply appropriate symptomatic treatment and supportive care [3, 16]. There are six clinical trials registered in both the International Clinical Trials Registry platform and the Chinese Clinical Trial Registry to evaluate the efficacy or safety of targeted medicine in the treatment or prognosis of COVID-19 (Additional file 2) [51, 52]. Regarding infected patients with COVID-19, it has been recommended to apply appropriate symptomatic treatment and supportive care [3, 16]. Studies have also explored the prevention of nosocomial infection and psychological health issues associated with COVID-19. A series of measures have been suggested to reduce nosocomial infection, including knowledge training for prevention and control, isolation, disinfection, classified protections at different degrees in infection areas, and protection of confirmed cases [18, 50, 53]. Concerning psychological health, some suggested psychological intervention for confirmed cases, suspected cases, and medical staff [18, 54]. For the general population, at this moment there is no vaccine preventing COVID-19. The best prevention is to avoid being exposed to the virus [55]. Airborne precautions and other protective measures have been discussed and proposed for prevention. Infection preventive and control (IPC) measures that may reduce the risk of exposure include the following: use of face masks; covering coughs and sneezes with tissues that are then safely disposed of (or, if no tissues are available, use a flexed elbow to cover the cough or sneeze); regular hand washing with soap or disinfection with hand sanitizer containing at least 60% alcohol (if soap and water are not available); avoidance of contact with infected people and maintaining an appropriate distance as much as possible; and refraining from touching eyes, nose, and mouth with unwashed hands [3]. The WHO also issued detailed guidelines on the use of face masks in the community, during care at home, and in the health care settings of COVID-19 [56]. In this document, health care workers are recommended to use particulate respirators such as those certified N95 or FFP2 when performing aerosol-generating procedures and to use medical masks while providing any care to suspected or confirmed cases. According to this guideline, individuals with respiratory symptoms are advised to use medical masks both in health care and home care settings properly following the infection prevention guidelines. According to this guideline, an individual without respiratory symptoms is not required to wear a medical mask when in public. Proper use and disposal of masks is important to avoid any increase in risk of transmission [56]. In addition to articles published in research journals, the China CDC published a guideline to raise awareness of the prevention and control of COVID-19 among the general population. The key messages of the guideline include causes, how to choose and wear face masks, proper hand washing habits, preventive measures at different locations (e.g., at home, on',\n",
       " ('COVID-19',\n",
       "  24,\n",
       "  4): 'public transportation, and in public space), disinfection methods, and medical observation at home [57]. In addition to scientific knowledge on ways to handle the COVID-19 outbreak, the guideline also suggests ways to eliminate panic among the general population [57]. Strengths and limitations of the study The review applied a systematic and rigorous search strategy to retrieve relevant articles according to the research objectives. This research summarizes scientific foundations, identifies literature gaps, and suggests some evidence for future research directions on COVID-19 which will provide information for research community, policymakers, and health professionals to adjust and/or come up with new research, policies, and practices. Our study only focuses on the articles published either in English or in Chinese during the early outbreak period. Although, it cannot reflect the entire body of research on COVID-19 worldwide, it will provide some evidences for future study and control.',\n",
       " ('COVID-19',\n",
       "  25,\n",
       "  0): 'Abstract Mucormycosis (MCR) has been increasingly described in patients with coronavirus disease 2019 (COVID-19) but the epidemiological factors, presentation, diagnostic certainty, and outcome of such patients are not well described. We review the published COVID-19-associated mucormycosis (CAMCR) cases (total 41) to identify risk factors, clinical features, and outcomes. CAMCR was typically seen in patients with diabetes mellitus (DM) (94%) especially the ones with poorly controlled DM (67%) and severe or critical COVID-19 (95%). Its presentation was typical of MCR seen in diabetic patients (mostly rhino-orbital and rhino-orbital-cerebral presentation). In sharp contrast to reported COVID-associated aspergillosis (CAPA) cases, nearly all CAMCR infections were proven (93%). Treating physicians should have a high suspicion for CAMCR in patients with uncontrolled diabetes mellitus and severe COVID-19 presenting with rhino-orbital or rhino-cerebral syndromes. CAMR is the convergence of two storms, one of DM and the other of COVID-19. Keywords: COVID-19, diabetes mellitus, mucormycosis 1. Introduction Coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome virus 2 (SARS-CoV-2), has affected more than 130 million people worldwide, accounting for over 2.8 million deaths on the day of this report. Although aspergillosis has been reported to complicate severe COVID-19 (the entity is coined COVID-19-associated aspergillosis or CAPA), the pathophysiology and the true incidence of CAPA remains debatable, as very few CAPA cases are biopsy-documented [1,2]. In addition, Mucorales infections are emerging as a matter of concern in COVID-19, as poorly controlled diabetes mellitus (DM) and other co-morbidities are risk factors for both severe COVID-19 and mucormycosis (MCR) [3] and the use of corticosteroids to treat severe/critical COVID-19 is a well-known risk factor for MCR [4]. To that end, we reviewed the cases of MCR in patients with COVID-19, discuss the pathophysiology of MCR in the setting of COVID-19 and contrast the firmness of COVID-19-associated mucormycosis (CAMCR) to the ambiguities of CAPA diagnosis. 2. Materials and Methods We searched PubMed (1 December 2019–9 April 2021) using the search terms “COVID-19”, “SARS CoV-2”, “novel coronavirus infection”, and “mucormycosis”, ”Mucorales”, “non-aspergillus mold”, “Mucor”, “Rhizopus”, “Rhizomucor”, “Cunninghamella”, and “Lichtehimia” (“Absidia”). We included only cases or case series reports containing adequate information about risk factors, clinical presentation, course, diagnosis, treatment, and outcome. Proven MCR was defined as per the EORTC-MSG criteria [5]. Since “probable” invasive fungal disease (IFD) in EORTC/MSG criteria applies only to immunocompromised hosts, we adapted the proposed definitions for CAPA to further define “probable” and “putative” MCR cases [6]. Patients who had a syndrome consistent with MCR such as rhino-orbital disease, with a positive culture from the nasal cavity were considered to have “probable” MCR. Patients with COVID-19 and cavitary pneumonia with the isolation of Mucorales from respiratory secretions were considered to have “putative” MCR. Mucormycosis was considered “concurrent” if evidence of infection was present on admission and “sequential” if a diagnosis was made 72 h after COVID-19 diagnosis. 3. Results We identified 43 such patients; 41 cases with documented MCR (proven in 38, probable in 3, Table 1) and 2 putative cases (see Supplementary Table S1 and references). We identified five patients with rhino-orbital disease, and one patient with rhino-orbital-cerebral disease, which was not included as there was no culture or histopathology documentation, given the fact that COVID-19 rarely can mimic rhino-orbital disease due to ophthalmic vein thrombosis [7]. Thirty-four (83%) were males with a median age of 55 years (IQR 46–61). More than two-thirds of the patients (29/41, 71%) were reported from India. Although 40 (40/41, 98%) patients had risk factors for severe COVID-19, only two patients had EORTC risk factors for IFD. Of the 35 patients with information on glycemic status, 33 (33/35, 94%) had',\n",
       " ('COVID-19',\n",
       "  25,\n",
       "  1): 'DM, with a mean HbA1C of 10 (in patients who had an HbA1c value available), and 22 (22/33, 67%) had uncontrolled DM before admission; three (3/33, 9%) patients had new-onset DM. Of the eighteen patients with DM and report of blood glucose and acid status, 8 (8/18, 44%) were in diabetic ketoacidosis (DKA) at the time of presentation. Among the 22 patients with COVID-19 severity information, thirteen (13/22, 59%) patients had ‘critical’ COVID-19, requiring mechanical ventilation/non-invasive ventilation, while eight had ‘severe’ COVID-19 and one patient had ‘mild’ COVID-19. In the 9 patients with available renal function data or creatinine value, 7 (78%) hadrenal failure on admission, including one patient who was on dialysis at the time of admission. Although neutrophil and lymphocyte counts were available in only 5 and 4 patients respectively, only one had neutropenia (neutrophil count < 500/microliter), and 3 had lymphocytopenia (total lymphocyte count < 1000/microliter). When Mucorales were identified to the genus level (13 patients), Rhizopus species were isolated in 10 (77%). Table 1. Characteristics of the 41 patients with COVID-19 associated mucormycosis (CAMCR). Documented Mucormycosis (n = 41, 95%) i Sex–Male, n (%) 34 (83) Age (in years) median (IQR) 55 (46–61) Presence of risk factors for severe COVID-19, n(%) 40 (98) EORTC risk factors, n (%) 2 (5) Diabetes mellitus, n (%) ii 33 (94) HbA1C (mean, SD) iii 10.5 (4.4) Presence of DKA on admission, n (%) iv 8 (44) Renal failure, n (%) v 5 (83) COVID-19 severity vi Mild, n (%) 1 (5) Severe, n (%) 13 (59) Critical, n (%) 8 (36) ICU admission vii 15 (68) Systemic corticosteroids, n (%) 36 (88) Timing of mucormycosis diagnosis Concurrent, n (%) 16 (39) Sequential, n (%) 25 (61) Clinical syndrome, n (%) Rhino-orbital-cerebral 11 (27) Rhino-orbital 17 (41) Rhino-cerebral 3 (7) Sinusitis alone 3 (7) Pneumonia 3 (7) Other viii 4 (10) Microbiological diagnosis, n (%) Stain 40 ix (98) Tissue PCR/Sequencing 2 (5) Tissue culture 18(44) Histopathological diagnosis, n (%) x 31 (76) Genera, n (%) Rhizopus spp. 10 (24) Lichteimia spp. 1 (2) Mucor spp 2 (5) Mucorales, unspecified 28 (68) Co-infection, n (%) xi 3 (7) Mucorales-active, anti-fungal treatment, n (%) xii 38 (93) In-hospital mortality, n (%) 20 (49) Day of death after MCR diagnosis (mean, SD) xiii 19, 15 Open in a new tab Sixteen patients (16/41, 39%) had ”concurrent” MCR, while the remaining patients (25/41) were diagnosed with MCR after a mean of 22 days (SD of 24). All but one patient with sequential MCR received systemic corticosteroids, while three of these patients received tocilizumab. Thirty-one of 41 patients (76%) had either rhino-orbital-cerebral (11, 27%), rhino-cerebral (3, 7%), or rhino-orbital disease (17, 41%), 3 (7%) had sinusitis alone, 3 (7%) had pulmonary MCR, and one each had cutaneous, palatal, gastrointestinal and disseminated MCR. Importantly, all 33 patients with DM had sinusitis, palatal, rhino-orbital, or rhino-orbital-cerebral disease. Co-infections were uncommon; 2 patients had a bacterial sinus infection (one with Pseudomonas and one with Staphylococcus aureus), and two had a sinus culture growing Aspergillus. MCR diagnosis was made antemortem in 39/41 (95%) and by autopsy in 2. For patients with antemortem diagnosis, MCR was established by biopsy in 31, and tissue culture in 18. In two patients who underwent postmortem, sequencing (2/2) and PCR (1/1) aided in the diagnosis. Of the 39 patients with antemortem MCR, amphotericin B-based treatment was administered in 38 (with posaconazole in 7 and with isavuconazole in 1). Of the 15 patients with information about the timing of anti-fungal therapy in relation to diagnosis of MCR, six received empiric treatment and nine following',\n",
       " ('COVID-19',\n",
       "  25,\n",
       "  2): 'the diagnosis of MCR. Thirty-three (80%) of these patients underwent adjunct surgery (sinus and thoracic cavity debridement, orbital exenteration, decortication, and lung resection). In-hospital mortality was 49% (20/41), with an average time of death 19 days post-MCR diagnosis (information available only in 7 patients). 4. Discussion Although our review is subject to publication biases, several observations emerged. First, MCR in patients with COVID-19 is a well-documented disease (41/47 of reported cases (87%) had documented MCR), in sharp contrast with the experience with CAPA. Specifically, the incidence of proven, or probable CAPA according to the recent ECMM/ISHAM consensus criteria [6] was only 6.1% in cohort CAPA studies that had a denominator [8]. Second, the majority of cases (71%) are reported from India. This finding is not surprising as India has the highest burden of MCR in the world with an estimated prevalence of 140 cases per million population [9]. Additionally, India has the second-largest number of adults aged 20–79 years with DM [10]. In fact, DM is the single most common risk factor for mucormycosis in India, being reported in over 50% of cases of MCR. In a recent nationwide multi-center study on MCR in India, 57% of patients had uncontrolled diabetes mellitus and 18% had diabetic ketoacidosis [11]. The number of uncontrolled DM we observed in our review was similar to this number (67%) although there were more patients with DKA (44%). Third, the clinical presentation of MCR in our review was quite consistent with the picture of MCR in DM where rhino-orbital or rhino-cerebral disease predominates [12]. DM, a “classic” risk factor for MCR, is associated with increased morbidity and mortality in COVID-19 [13]. As with any other serious infection, patients with COVID-19 are predisposed to DKA. Evidence suggests SARS CoV-1 induces damage of pancreatic islets resulting in acute diabetes and DKA [14]. This is a possible explanation for the “diabetogenic state” in SARS CoV-2 infection, as there is a high expression of angiotensin-converting enzyme 2 receptors in pancreatic islets, along with increased insulin resistance due to cytokine storm [15]. Prevalence of DM (31%) and DKA (2%) in COVID-19 were higher compared to the national prevalence of type 2 DM and DKA in the general population in a UK study (7%) [16]. Recently, euglycemic DKA is also being reported in COVID-19 patients [17]. The frequent use of corticosteroids that exacerbated glucose homeostasis, may have predisposed patients to MCR. Corticosteroid use is a key risk factor for opportunistic mycoses, including MCR [4]. In addition to hyperglycemia, an alteration of iron metabolism occurs in severe COVID-19 [18]. Severe COVID-19 is a hyper-ferritinemic syndrome, but whether high ferritin is a marker of a severe systemic disease versus a modulator of pathophysiology is not known. Irrespective of its role, high ferritin levels lead to excess intracellular iron that generates reactive oxygen species resulting in tissue damage. Cytokines, especially IL-6, due to severe infection and DKA, stimulate ferritin synthesis and downregulate iron export resulting in intracellular iron overload, further exacerbating the process [18]. The resultant tissue damage leads to the release of free iron into the circulation [19]. Iron overload and excess free iron seen in acidemic states are one of the key and unique risk factors for MCR [20]. Another possible explanation for the association between COVID-19 and MCR is the “endothelialitis” observed in severe COVID-19. Autopsy series have shown more severe pulmonary vascular endothelial injury and new vessel growth in patients who died of COVID-19 than patients who died of influenza A (H1N1) [21]. Another postmortem series noted widespread endothelial injury in patients who died of multi-organ failure [22]. Endothelial adhesion and',\n",
       " ('COVID-19',\n",
       "  25,\n",
       "  3): 'penetration are critical early steps in MCR [20]. Interestingly, acidemic states and hyperglycemia induce the enthodelial receptor glucose-regulated protein (GRP 78) and the Mucorales adhesin spore coat protein homologs (CotH), creating a “perfect storm” for increased adhesion and penetration of Mucorales to the endothelium. Of interest, GRP 78 has been postulated as one of the receptors responsible for SARS-CoV-2 entry [23]. We acknowledge the limitations of our review, which is the lack of a denominator, making it impossible to calculate MCR incidence in patients with COVID-19. It is possible that reported MCR cases may be an underrepresentation of the actual problem due to difficulty making a histopathological or microbiological diagnosis in patients with a contagious infection in a pandemic setting. Another limitation is the inability to assess attributable mortality of MCR due to the lack of appropriate controls. Lastly, the nature of our study does not allow us to determine if uncontrolled diabetes plus COVID-19 is associated with a higher risk of MCR than diabetes alone. 5. Conclusions MCR appears to be the intersection of two crises: the one of COVID-19 and the other of poorly controlled DM in the setting of the pandemic. In sharp contrast to CAPA, most CAMCR cases are well documented. Clinicians should have a high index of suspicion and keep CAMCR in the differential of a severely ill patient with COVID-19 and DM, especially if rhino-orbital or rhino-cerebral presentations are noted. Craniofacial pain without swelling can be a neuropathic pain in DM patients with COVID-19 and by itself without facial asymmetry or necrosis should not be suggestive of MCR in these patients [24]. Although the impact of preemptive antifungal therapy remains unproven, hyperglycemia control seems important for prevention and management in MCR [12]. Acknowledgments DPK acknowledges the Robert C Hickey endowed chair. Supplementary Materials The following are available online at https://www.mdpi.com/article/10.3390/jof7040298/s1, Table S1: Detailed clinical characteristics of forty-one patients with documented COVID-19 associated mucormycosis; proven (n = 38) and probable (n = 3) and 2 patients with putative mucormycosis Author Contributions Conceptualization, T.M.J. and D.P.K.; methodology, T.M.J., D.P.K.; software, T.M.J.; validation, T.M.J., C.N.J., D.P.K.; formal analysis, T.M.J.; investigation, T.M.J., C.N.J.; resources, T.M.J., C.N.J., D.P.K.; data curation, C.N.J., T.M.J.; writing—original draft preparation, T.M.J., C.N.J.; writing—review and editing, D.P.K.; visualization, D.P.K.; supervision, D.P.K.; project administration, T.M.J., D.P.K. All authors have read and agreed to the published version of the manuscript. Funding This research received no external funding. Institutional Review Board Statement Not applicable. Informed Consent Statement Not applicable. Conflicts of Interest D.P.K. reports honoraria, research support from Gilead Sciences; consultant fees from Astellas Pharma and Mayne, Inc. and he is a member of the Data Review Committee of Cidara Therapeutics. TMJ, CNJ: none Footnotes Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.',\n",
       " ('COVID-19',\n",
       "  26,\n",
       "  0): 'В связи с многочисленными публикуемыми разноречивыми мнениями врачей, биологов и других специалистов по пандемии коронавируса считаем целесообразным высказать мнение ведущих специалистов ОСДМ. В периоды обычного сезонного подъема заболеваемости ОРВИ (включая грипп) наблюдается дополнительная смертность населения, неравномерно распределенная по возрастам (больше в старших возрастных группах). Это обусловлено тем, что наиболее тяжелое течение ОРВИ наблюдается в старших возрастных группах. К широкому спектру вирусов, вызывающих сезонный подъем заболеваемости ОРВИ, существует популяционный иммунитет, возникающий в результате приобретения иммунитета отдельными индивидуумами после перенесенной болезни или вакцинации (от гриппа). Этот популяционный иммунитет имеет ограниченный характер, затрагивая лишь часть популяции (обычно 30% — 50%), в связи с этим заболеваемость ОРВИ все же существует, но ограничена. Соответственно, число тяжелых случаев также ограничено. COVID-19 является новым вирусом, к нему популяционного иммунитета нет, в связи с чем текущая заболеваемость является высокой (относительно других ОРВИ). Часто встречающиеся утверждения о передаче вируса бессимптомными носителями не имеют надежной доказательной базы. Как и при других ОРВИ, при инфекции COVID-19 наиболее тяжелое течение наблюдается в старших возрастных группах. Абсолютное число таких тяжелых случаев велико — много больше, чем бывает при сезонной эпидемии ОРВИ. Системы здравоохранения в разных странах функционируют по-разному, но большинство из них не готово к необычно большому числу тяжелых пациентов. Текущие оценки и модели эпидемиологических показателей (заболеваемости, летальности, смертности) являются неточными как применительно к миру в целом, так и применительно к отдельным странам, т.к. зависят от множества факторов, в т.ч.: критерии диагностики и методы выявления больных варьируют как географически, так и во времени; следовательно, невозможно оценить степень выявленности случаев болезни. Нельзя исключить, что легкие случаи заболевания не выявляются, но также нельзя исключить и невыявление наиболее тяжелых случаев; варьируют критерии определения причин смерти; с учетом того, что большая часть смертей происходят у пациентов старших возрастных групп, установление причины смерти может быть ошибочным; варьируют критерии излечения; неизвестна медианная длительность летальных случаев (оценивается примерно в 7 дней) и длительность заболевания для не летальных случаев; возможно, варьирует структура заболевания (соотношение легких и тяжелых случаев, распределение по возрастам); вирулентность вируса меняется во времени, точно неизвестна и плохо прогнозируется; качество и доступность медицинской помощи неоднородны географически, меняются во времени, и они тоже неизвестны; нет полной уверенности в достоверности публикуемых данных о числе подтвержденных случаев и смертей. Меры, принимаемые правительствами разных стран, направлены на торможение заболеваемости (сдерживание эпидемии), т.е. растягивание эпидемии во времени с целью снижения единовременной нагрузки на системы здравоохранения. Социальное дистанцирование является главной мерой в этой ситуации, хотя при широком применении его негативные эффекты для социальной жизни могут быть велики. Обычно вирусы при пассаже через популяцию аттенуируют (ослабляют свою вирулентность), однако возможно возникновение и повышающих вирулентность мутаций. Эпидемия закончится при выработке достаточного (для текущей вирулентности вируса) популяционного иммунитета путем увеличения доли переболевших пациентов, выработавших иммунитет без развития симптомов пациентов, вакцинации; этот результат зависит от того, когда и если такие вакцины будут разработаны и насколько сильным и долгосрочным будет выработанный иммунитет. Важно обеспечить социальное дистанцирование для пациентов старших возрастных групп, людей любых возрастов с сердечно-сосудистой, онкологической, респираторной и другой хронической патологией. Методов профилактики и лечения COVID-19 с доказанной полезностью в настоящее время не существует. Применяемые без показаний (off label) средства пока не доказали свою эффективность. Лечение тяжелых случаев направлено на предотвращение тяжелых осложнений инфекции (дыхательная недостаточность, полиорганная недостаточность, сепсис и др.). Противовирусные лекарства вряд ли будут разработаны в ближайшие годы, как нет в настоящее время ни одного эффективного лекарства от десятков циркулирующих респираторных вирусов, включая вирус гриппа и известные коронавирусы. Даже если такие лекарства будут разработаны, для лечения тяжелых клинических случаев они вряд ли будут нужны, т.к. ведущим фактором патогенеза вирусная инфекция в таких ситуациях уже не является. Мы призываем разработчиков клинических рекомендаций/протоколов/пособий и других предписывающих документов критически относиться к гипотезам о возможной эффективности того или иного лекарственного средства.',\n",
       " ('COVID-19',\n",
       "  26,\n",
       "  1): 'Такие гипотезы могут быть основанием для спланированного клинического испытания, но не должны обосновывать фармакотерапию или профилактику COVID-19. Часть из рекомендуемых сейчас препаратов являются заведомо бесполезными, другие – дорогостоящими, труднодоступными или токсичными. Клинические рекомендации должны основываться на хороших научных доказательствах. О.Ю. Реброва В.В. Власов С.Е. Бащинский В.А. Аксёнов 22.03.2020',\n",
       " ('COVID-19',\n",
       "  27,\n",
       "  0): 'Results : In total, 19 papers recording 1,934 mild and 1,644 severe cases of COVID-19 were included. Based on the initial evaluation, 62 potential risk factors were identified for the meta-analysis. Several comorbidities, including chronic respiratory disease, cardiovascular disease, diabetes mellitus, and hypertension were observed more frequent among patients with severe COVID-19 than with the mild ones. Compared to the mild form, severe COVID-19 was associated with symptoms such as dyspnea, anorexia, fatigue, increased respiratory rate, and high systolic blood pressure. Lower levels of lymphocytes and hemoglobin; elevated levels of leukocytes, aspartate aminotransferase, alanine aminotransferase, blood creatinine, blood urea nitrogen, high-sensitivity troponin, creatine kinase, high-sensitivity C-reactive protein, interleukin 6, D-dimer, ferritin, lactate dehydrogenase, and procalcitonin; and a high erythrocyte sedimentation rate were also associated with severe COVID-19. Methods : Relevant articles from PubMed, Embase, Cochrane, and Web of Science were searched as of April 5, 2020. The quality of the included papers was appraised using the Newcastle-Ottawa scale (NOS). Data of interest were collected and evaluated for their compatibility for the meta-analysis. Cumulative calculations to determine the correlation and effect estimates were performed using the Z test. Prognostic tools for the prediction of COVID-19 severity in patients have been in development since January 2020. At least nine studies proposed the use of prognostic tools for the prediction of COVID-19 severity 7 – 15 . However, a recent systematic review and critical appraisal study evaluated the accuracy of these tools using prediction model risk of bias assessment tool (PROBAST) and reported a high risk of bias 16 . The establishment of a prediction model for the estimation of disease prognosis may help health workers segregate patients according to prediction status. However, the high risk of bias in these prediction tools might lead to inaccurate prediction of COVID-19 severity. A comprehensive study of the identification of risk factors that might play a significant role in determining the severity of patients with COVID-19 is necessary. We performed a systematic review and meta-analysis to assess the risk factors associated with poor clinical outcomes among patients with COVID-19. To the best of our knowledge, this is the first meta-analysis to assess the comprehensive risk factors that might affect the severity of COVID-19 in patients. The results of our study might serve as preliminary data for the compilation or improvement of the scoring system in the prediction of COVID-19 severity. The coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is a global crisis across health, economic, and educational dimensions 1 , 2 . The disease has spread rapidly, can cause severe illness, and is characterized by a high mortality rate in certain groups. Mortality is particularly high in the absence of proven effective standard management measures 3 . One of the problems with the management of this disease is the absence of standardized methods for diagnosis and the inability to estimate prognosis based on clinical features. Certain reports have shown that poor prognostic prediction has correlated with high mortality among patients with COVID-19 4 , 5 . Among patients with similar clinical characteristics and with similar treatment regiments, there may be a diversity in clinical outcomes 6 . Therefore, the development and use of an accurate predictor for COVID-19 prognosis will be beneficial for the clinical management of patients with COVID-19, and will help reduce the mortality rate. Successful implementation of such a prediction mechanism could have a large public health impact. Better understanding of clinical progression could also improve public health messaging, particularly as many individuals may consider COVID-19 to not be severe. The significant risk factors that might',\n",
       " ('COVID-19',\n",
       "  27,\n",
       "  1): 'govern the severity of COVID-19 were determined by the calculation of a pooled OR and 95% CI. The significance of the pooled ORs was determined using the Z test (p<0.05 was considered statistically significant). Prior to identification of the significant risk factors, data were evaluated for heterogeneity and potential publication bias. The heterogeneity among included studies was evaluated using the Q test. If heterogeneity existed (p<0.10), a random effect model was adopted; if not, a fixed effect model was adopted. Egger’s test and a funnel plot were used to assess the reporting or publication bias (p<0.05 was considered statistically significant). Furthermore, we performed a moderator analysis to identify the independent predictors of poor clinical outcomes among patients with COVID-19. The data were analyzed using Review Manager version 5.3 (Revman Cochrane, London, UK). To prevent analytical errors, statistical analysis was performed by two authors (JKF and MI). The cumulative calculation was presented in a forest plot. The outcome measure of the study was the severity of COVID-19 (mild vs. severe). The risk factors or predictors included three major groups: comorbidities, clinical manifestations, and laboratory parameters. Comorbid factors such as chronic kidney disease, chronic liver disease, chronic respiratory disease, cerebrovascular accident, cardiovascular disease, diabetes mellitus, hypertension, and malignancy were compatible with the analysis. For clinical manifestations, fever, cough, dry cough, expectoration, sore throat, dyspnea, diarrhea, myalgia, nasal congestion, anorexia, abdominal pain, fatigue, dizziness, headache, fever, heart rate, respiratory rate, systolic blood pressure, and diastolic blood pressure were included in this study. Among laboratory characteristics, the presence of leukocytosis, leukocytopenia, anemia, lymphocytopenia; the levels or the counts of white blood cell (WBC), hemoglobin, neutrophil, lymphocyte, monocyte, platelet, activated partial thromboplastin time (aPTT), partial thromboplastin time (PTT), aspartate aminotransferase (AST), alanine aminotransferase (ALT), total bilirubin, albumin, serum creatinine, blood urea nitrogen (BUN), high-sensitivity (Hs)-troponin I, creatine kinase, high-sensitivity C-reactive protein (Hs-CRP), C-reactive protein (CRP) >8 mg/L, interleukin 6 (IL-6), glucose, D-dimer, serum ferritin, sodium, potassium, lactate dehydrogenase, and procalcitonin, CD4 and CD8; erythrocyte sedimentation rate (ESR); elevated IL-16; and elevated ESR were all included. Before inclusion in the meta-analysis, the methodological quality of the articles was assessed using the New Castle-Ottawa scale (NOS). NOS scores range from 0 to 9 and consider three items: selection of patients (4 points), comparability of the groups (2 points), and ascertainment of exposure (3 points). Each study was interpreted to be of low quality (for scores ≤ 4), moderate quality (for scores between 5–6), or high quality (for scores ≥ 7) 25 . Articles with moderate to high quality were included in the analysis. The study assessment was conducted by two independent investigators (MI and YP) using a pilot form. The discrepancies between the findings of the two investigators were solved by consulting with another investigator (JKF). Major scientific databases (PubMed, Embase, Cochrane, and Web of Science) were searched for articles as of April 5, 2020. Moreover, we also searched in google scholar for the additional database. A comprehensive initial search was performed to identify the potential predictors, and a final search was performed to identify the relevant papers that could be included in the meta-analysis. We used the keywords adapted from medical subject headings: [\"COVID-19\" or \"Coronavirus disease-19\" or \"SARS-CoV-2\"] and [\"mild\" or \"severe\" or \"prognosis\" or \"clinical outcome\"] and [\"clinical manifestation\" or \"morbidity\" or \"laboratory findings\"]. Only studies written in English were included. If a duplicate publication was found, the article with the larger sample size was included. We also searched for relevant studies from the reference lists in the articles. During data extraction, the following information of interest was extracted: (1) first author name; (2)',\n",
       " ('COVID-19',\n",
       "  27,\n",
       "  2): 'publication year; (3) country of origin, (4) sample size of mild and severe cases, (5) clinical manifestations, (6) morbidities, and (7) laboratory findings. Data extraction was performed by two independent investigators (JKF and MI) using a pilot form. If the disagreement was found, we performed a discussion to resolve the disagreement. Studies were included in this review if they met the following inclusion criteria: (1) assessed the clinical manifestations and laboratory findings of patients with mild to severe COVID-19; (2) provided adequate data for the calculation of OR and 95% CI (event per sample size or mean ± SD in both case and control groups), (3) written inEnglish. Review articles, articles with non-standard data presentation, and duplicate publications were excluded. We performed a systematic review and meta-analysis to evaluate potential risk factors that might influence the severity of COVID-19. These risk factors include comorbidities, clinical manifestations, and laboratory findings. Accordingly, we searched the relevant studies from major scientific websites and databases to collect the data of interest, and determined the association and effect estimates by calculating the combined odds ratio (OR) and 95% confidence intervals (95% CI). The protocols for the systematic review and meta-analysis were similar to those used in previous studies 17 – 23 , as well as to those recommended by Preferred Reporting Items for Systematic Review and Meta-Analysis (PRISMA) 24 . Among laboratory parameters, evidence of heterogeneity was found in count of WBC, neutrophil, monocyte, lymphocyte, platelet, CD4, and CD8; the presence of lymphocytopenia and anemia; the levels of AST, ALT, total bilirubin, albumin, aPTT, PTT, serum creatinine, BUN, Hs-Troponin I, creatine kinase, IL-6, Hs-CRP, glucose, D-dimer, sodium, potassium, lactate dehydrogenase, and procalcitonin; elevated CRP; and ESR. Accordingly, the data were analyzed using the random effect model. The data for the remaining parameters were analyzed using the fixed effect model. Heterogeneity was detected in the data of chronic kidney disease, cerebrovascular disease, cardiovascular disease, diabetes mellitus, hypertension, and malignancy among the comorbid factors analyzed. Therefore, we used the random effect model to analyze the data. The fixed effect model was used to analyze the data on chronic liver disease and chronic respiratory disease, as there was no evidence of heterogeneity. For clinical manifestations, the data on fever, cough, sore throat, dyspnea, diarrhea, anorexia, fatigue, temperature >38°C, respiratory rate, and diastolic blood pressure were analyzed using the random effect model while the rest of clinical manifestation data were analyzed using the fixed effect model. Among laboratory characteristics, severe COVID-19 was associated with elevated WBC count (OR: 4.92; 95% CI: 2.12, 11.31), increased neutrophil count (OR: 5.45; 95% CI: 2.04, 14.54), lymphocytopenia (OR: 3.19; 95% CI: 1.14, 7.07), and decreased hemoglobin levels (OR: 0.76; 95%CI: 0.58, 1.00) ( Figure 5A–D ). Elevated levels of AST, ALT, and serum creatinine increased the risk for severe manifestations of COVID-19 (ORs 4.91, 3.23, and 2.14, respectively; Figure 6A–C ). Elevated levels of BUN (OR: 6.15; 95% CI: 3.05, 12.37), Hs-troponin I (OR: 9.25; 95% CI: 3.51, 24.37), creatine kinase (OR: 2.44; 95% CI: 1.65, 3.62), Hs-CRP (OR: 14.27; 95% CI: 5.13, 39.71), IL-6 (OR: 6.68; 95% CI: 3.20, 13.94), D-dimer (OR: 6.19; 95% CI: 4.22, 9.08), ferritin (OR: 1.96; 95% CI: 1.06, 3.62), lactate dehydrogenase (OR: 8.28; 95% CI: 4.75, 14.46), procalcitonin (OR: 6.62; 95% CI: 3.32, 13.21), ESR (OR: 4.45; 95% CI: 2.56, 7.76), and CRP >8 (OR: 8.34; 95% CI: 1.85, 37.62) were also associated with severe COVID-19 ( Figure 7 – Figure 9 ). A low risk of severe COVID-19 was associated with low leukocyte levels (OR: 0.59; 95% CI: 0.41, 0.87) and elevated lymphocyte levels (OR: 0.34;',\n",
       " ('COVID-19',\n",
       "  27,\n",
       "  3): '95% CI: 0.23, 0.50). Among the clinical manifestations, dyspnea (OR: 3.28; 95% CI: 2.09, 5.15), anorexia (OR: 1.83; 95% CI: 1.00, 3.34), fatigue (OR: 2.00; 95% CI: 1.25, 3.20), and dizziness (OR: 2.67; 95% CI: 1.18, 6.01) were associated with severe COVID-19 ( Figure 3A–D ). In addition, increased respiratory rate (OR: 2.85; 95% CI: 1.28, 6.33) and increased systolic blood pressure (OR: 1.84; 95% CI: 1.31, 2.60) were also associated with severe COVID-19 ( Figure 4A and B ). Compared to productive cough, dry cough was associated with a lower risk of severe COVID-19 (OR: 0.66; 95% CI: 0.44, 0.97). Our searches yielded 6,209 potentially relevant studies, of which 6,170 studies were excluded after assessment of the titles and abstracts. Subsequently, further review of the complete texts was performed for 39 potential studies. In the full text review, we excluded 20 studies because they were reviews articles (n = 9), inadequacy of data for the calculation of OR and 95% CI (n = 7), and poor quality (n = 4). Eventually, 19 papers were included in our meta-analysis 26 – 42 The paper selection process adopted in our study is summarized in Figure 1 , and the characteristics of studies included in our analysis are outlined in Table 1 . Discussion Our data suggest that comorbidities, such as chronic respiratory disease, cardiovascular disease, diabetes, and hypertension, were associated with a higher risk of severe COVID-19, among which, hypertension was the strongest risk factor. These results are consistent with those of previous meta-analyses 43, 44 that indicated that chronic respiratory disease, cardiovascular disease, diabetes, and hypertension are significantly associated with higher COVID-19 mortality. Hypertension and diabetes are also associated with higher mortality among patients with dengue fever, West Nile virus infection, Zika virus infection, and yellow fever 45. To date, no study has reported details of the primary mechanism underlying the association between severe COVID-19 and comorbid factors. However, immune responses might be the most crucial factor underlying this association. Patients with comorbidities such as cardiovascular disease, chronic respiratory disease, hypertension, and diabetes were observed to have a lower immunity status than healthy individuals 46– 48. Since COVID-19 primarily affects the respiratory tract 49, patients with chronic respiratory diseases might be at a higher risk of contracting severe COVID-19. In addition, endothelial dysfunction might also play a pivotal role 50. COVID-19 is a novel disease, and the immune response of this disease is not completely understood. Our data suggest that elevated leukocyte and neutrophil levels and reduced lymphocyte levels are associated with severe COVID-19. In other viral infections, such as influenza, elevated leukocyte and neutrophil levels serve as important predictors of disease severity 51. The role of leukocytes in the pathogenesis of COVID-19 is conflicting. In most cases, viral infections have been observed to cause leukopenia 52. Furthermore, a study also reported that leukopenia was observed at a significantly higher frequency among COVID-19 patients than among non-COVID-19 patients 53. However, in our present study, we did not compare COVID-19 and non-COVID-19 patients. The major factor that seemed to affect our findings was the occurrence of cytokine storm in patients. In COVID-19, there is an immune system overreaction, which results in a cytokine storm. In this condition, leukocytes might be over-activated, which might lead to the release of high levels of cytokines 54. Consistent with our data, a study has confirmed that cytokine storm is significantly associated with severe COVID-19 55. The theory underlying the role of neutrophils in COVID-19, as reported in our study, remains unclear. The speculations might be attributed to the involvement of neutrophil extracellular traps (NETs). While',\n",
       " ('COVID-19',\n",
       "  27,\n",
       "  4): 'no study has assessed the precise role of NETs in COVID-19 pathogenesis, certain researchers speculate that SARS-CoV-2 might stimulate neutrophils to produce NETs, similar to several other viral pathogens 56. Furthermore, this might lead to neutrophil infiltration in pulmonary capillaries, organ damage, and the development of acute respiratory distress syndrome 57. Low lymphocyte levels were observed in patients with severe COVID-19 compared with those with mild COVID-19. In the context of the immunological mechanism, our results might be contradictory. Lymphocyte subsets are known to play an important role in the action against bacterial, viral, fungal, and parasitic infections 58; therefore, the levels of circulating lymphocytes should increase. The immunological response in COVID-19 is unique and remains unclear. However, certain propositions might help describe our findings. First, coronaviruses infect human cells through ACE2 receptors 59. Since ACE2 receptors are also expressed by lymphocytes 60, the coronaviruses may enter lymphocytes and induce apoptosis. Second, the feedback mechanism between pro-inflammatory cytokines (such as IL-6) and lymphocytes might also explain our results. A study revealed that elevation in the levels of pro-inflammatory cytokines correlated with reduction in the levels of lymphocytes 61. Moreover, our findings also confirmed the significant elevation in the levels of IL-6. Third, ACE2 receptors are expressed by cells from various organs, including the thymus and spleen 62. As coronaviruses infect human cells through the ACE2 receptors, the spleen and thymus might also be damaged in patients with COVID-19, which would lead to lower levels of lymphocyte production. Fourth, lymphocyte proliferation requires a balanced metabolism, and metabolic disorders such as hyperlactic acidemia have been reported to disturb lymphocyte proliferation 63. Hyperlactic acidemia has been observed in patients with severe COVID-19 64. The studies included in this systematic review also suggest that the levels of D-dimer were significantly higher in patients with severe COVID-19. Coagulation in patients with COVID-19 has been a major concern, and the lack of reliable data and meta-analyses prevents a holistic comparison. Certain infectious diseases that cause abnormal coagulation have been associated with poor clinical outcomes 65. The theory behind this mechanism is not understood clearly. It is widely known that ACE2 receptors are important for the infection of host cells by SARS-CoV-2, and ACE2 receptors are expressed in various cells in the human body, including endothelial cells 66. Consequently, a massive inflammatory reaction may occur in endothelial cells owing to SARS-CoV-2 infection 67, which may lead to increased coagulation, disseminated intravascular coagulation 68, and increased fibrin degradation 69. High fibrin degradation leads to elevated levels of fibrinogen and D-dimer 70, which might also explain the occurrence of venous thromboembolism in critical patients of COVID-19 71. In addition, a study with a short follow-up period also reported the existence of a dynamic correlation between the D-dimer levels and the severity of COVID-19 72. Furthermore, pulmonary embolism and deep vein thrombosis were also observed in patients with severe COVID-19 73, 74, which suggests that D-dimer might play a prominent role in governing the severity of COVID-19 patients. We also observed that inflammatory markers, including elevated levels of CRP, ESR, and IL-6, were found both in patients with severe and mild COVID-19, with a significant increase detected in patients with severe COVID-19. Other variables associated with adverse outcomes, such as ferritin, lactate dehydrogenase, and procalcitonin levels, were found to be elevated predominantly in patients with severe COVID-19. Our findings were consistent with those of a previous meta-analysis 75, and indicated that high levels of CRP, lactate dehydrogenase, and ESR were associated with adverse outcomes in COVID-19. Another meta-analysis had also confirmed that elevated levels of IL-6 were observed in patients',\n",
       " ('COVID-19',\n",
       "  27,\n",
       "  5): 'with COVID-19 who exhibited poor clinical outcomes 76. Therefore, the levels of CRP, ESR, IL-6, ferritin, procalcitonin, and lactate dehydrogenase can serve as potential markers for the evaluation of COVID-19 prognosis. The high mortality rate and treatment failure in patients with COVID-19 can be attributed to the fact that COVID-19 affects multiple organs, including the lung, heart, kidney, and liver 77. Our data suggest that elevated levels of urea and creatinine, and not chronic kidney disease, were associated with severe COVID-19, which indicates that acute inflammation might be caused by SARS-CoV-2 infection. Previous meta-analyses have also reported findings consistent with our results 78, 79. Moreover, anatomical studies have reported significant renal inflammation in patients with severe COVID-19 75, 80, 81. There might be two mechanisms by which SARS-CoV-2 induces renal inflammation. First, SARS-CoV-2 might directly infect renal tubular epithelial cells and podocytes through ACE2 receptors, which facilitates the targeted infection of certain cells by the virus. Consequently, acute tubular necrosis, podocytopathy, microangiopathy, and collapsing glomerulopathy might occur owing to the massive inflammation in renal tubular epithelial cells and podocytes 82, 83. Second, the binding between SARS-CoV-2 and ACE2 receptors might activate angiotensin II and induce cytokine production, which may lead to hypercoagulopathy and microangiopathy, and eventually cause renal hypoxia 84, 85. Conversely, with respect to liver function, we observed that the levels of liver enzymes were higher in patients with severe COVID-19. Previous studies in this context have elucidated that ACE2 receptors are highly expressed in bile duct cells; therefore, infection of these cells by coronaviruses might lead to abnormalities in the levels of liver enzymes 86. However, a recent anatomical study on liver biopsy specimens from patients with severe COVID-19 revealed that moderate microvascular steatosis and mild lobular and portal activities were observed 87. These data suggest that it cannot be determined clearly whether the elevated levels of liver enzymes in patients with severe COVID-19 are caused by direct infection or by drug-induced liver injury. Therefore, further studies are required to elucidate the precise mechanism underlying the elevation of liver enzymes levels in patients with severe COVID-19. Meta-analyses on this topic have been performed previously 43, 44, 75, 76, 88– 91. However, compared to previous studies, our study has the following strengths. The previous studies only reported limited factors, such as clinical manifestations 43, 88, 90, 91, laboratory findings 76, 89, or a combination of only clinical manifestations and laboratory findings 75. In our study, we included all comorbidities, clinical manifestations, and laboratory characteristics. Additionally, compared to previous studies, this study has a larger sample size; the data on 1,934 patients with mild and 1,644 patients with severe COVID-19 treated across 19 hospitals were retrieved. However, this study also has certain limitations. Certain crucial factors that might play an important role in the pathogenesis of COVID-19, including secondary infection, treatment, and immunological status were not controlled for. Our current findings should be interpreted with caution because the majority of studies included were cross-sectional, and the samples corresponding to the data analyzed originated only in China. Moreover, in our study, we did not perform the sub-group analysis according to the transmission area. As already reported, the transmission of COVID-19 in China was also affected by the transmission area 92. Therefore, this limitation might also affect the final findings of our study. Longitudinal studies may reveal more long-term impacts of SARS-CoV-2 infection 93.',\n",
       " ('COVID-19',\n",
       "  28,\n",
       "  0): 'Популярно Роспотребнадзор: для выписки пациента с COVID-19 к труду достаточно одного отрицательного теста методом ПЦР 16 ноября 2020 fotoquique / Depositphotos.com Главным государственным санитарным врачом РФ внесены поправки в санитарно-эпидемиологические правила СП 3.1.3597-20 \"Профилактика новой коронавирусной инфекции (COVID-19)\" (постановление от 13 ноября 2020 г. № 35). В частности, для того, чтобы пациент с COVID-19 считался выздоровевшим и смог приступить к труду (к занятиям) достаточным является получение одного отрицательного теста методом лабораторного исследования ПЦР. Повторное тестирование проведут лишь в случае положительного теста у пациента, готовящегося к выписке, но не ранее чем через три календарных дня. До внесения изменений выздоровлением считалось получение двух отрицательных тестов. Выйти из карантина лицу, контактировавшему с заболевшим коронавирусом, можно будет по истечении срока карантина (14 календарных дней) без необходимости проведения лабораторного исследования на COVID-19. Отбор проб для такого исследования будет производиться только у тех контактировавших, у кого проявились клинические симптомы, схожие с симптомами COVID-19. Все важные документы и новости о коронавирусе COVID-19 – в ежедневной рассылке Подписаться Помимо этого, согласно обновленным правилам срок выполнения лабораторного исследования на COVID-19 не должен превышать 48-ми часов от момента поступления биологического материала в лабораторию до получения его результата лицом, в отношении которого проведено соответствующее исследование. Кроме того, постановлением Главного государственного санитарного врача РФ от 13 ноября 2020 г. № 34 внесены изменения в постановление от 16 октября 2020 г. № 31 \"О дополнительных мерах по снижению рисков распространения COVID-19 в период сезонного подъема заболеваемости острыми респираторными вирусными инфекциями и гриппом\". Теперь уровень охвата лабораторными исследованиями для выявления возбудителя COVID-19 методом полимеразной цепной реакции (ПЦР) в субъектах РФ должен быть не менее 200 исследований на 100 тыс. населения (среднесуточно за семь календарных дней). Ранее уровень охвата лабораторными исследованиями составял не менее 150 исследований на 100 тыс. населения. Указаные изменения вступают в силу с 17 ноября. _____________________________',\n",
       " ('COVID-19',\n",
       "  29,\n",
       "  0): \"A study of COVID-19 patients from the First Affiliated Hospital of Zhengshou University, Henan, China demonstrated that infected patients have an overall pro-thrombotic state due to platelet hyperactivity [ 26 ]. When SARS-CoV-2 and its spike protein bind directly to the platelet and ACE2 receptor, there is increased platelet activation and thrombus formation due to activation of the MAPK pathway. This facilitates the release of coagulation and inflammatory factors, leading to an overall pro-thrombotic and pro-inflammatory state [ 26 ]. The authors also suggest that the addition of ACE2 protein and anti-Spike neutralizing antibodies may be a therapeutic approach to avoid thrombotic events in these patients. Coagulation parameters are often cited as indicators for worse prognosis in patients infected with COVID-19 [ 17 , 19 , 21 ]. Compared to a healthy control, d-dimer, FDP, and fibrinogen levels are all increased in COVID-19 patients, while antithrombin (AT) levels are significantly reduced [ 19 ]. Emerging data suggests that deregulated thrombin generation and abnormal activation of the coagulation cascade can lead to the development of disseminated intravascular coagulation (DIC) and is associated with worsening pneumonia and mortality [ 7 , [22] , [23] , [24] ]. DIC was a significantly more common finding in non-survivors (71.4%) vs. survivors (0.6%) [ 18 ]. Other manifestations of coagulopathy such as the development of antiphospholipid antibodies and subsequent thrombotic events were reported in 3 ICU patients infected with SARS-CoV-2 in Wuhan, China [ 25 ]. Due to coagulation abnormalities, COVID-19 patients are at a higher risk of VTE, especially those with pre-existing comorbidities [ 23 ]. Early monitoring of these parameters can help guide medical management such as the use of VTE prophylaxis and escalation of care. In addition to indicating the potential for more severe disease, laboratory abnormalities are also a predictor of mortality in infected patients [ 2 , 13 ]. In a case series of 138 patients with COVID-19, the mortality rate was about 4.3% (6 patients). Of those 6, 5 patients had persistent lab derangements including increased d-dimer and decreased lymphocyte counts [ 2 ]. Another retrospective cohort showed that elevated d-dimer was associated with a higher rate of in-hospital death with 81% of terminal cases exhibiting d-dimer >1 μg [ 13 ]. Tang et al. analyzed abnormal coagulation parameters in patients with SARS-CoV-2 pneumonia and determined that non-survivors had significantly higher d-dimer, fibrin degradation products (FDP), and prothrombin time on admission compared to survivors (P < 0.05) [ 18 ]. This study was further supported by Han et al. who also demonstrated that d-dimer and FDP were especially predictive of disease progression [ 19 ]. A recent report investigating the factors affecting 28-day mortality of patients with severe illness showed that elevated d-dimer, increased age, and prolonged PT were associated with a higher mortality [ 20 ]. Early recognition of these abnormal results will play a critical role in predicting disease severity and improving outcomes with earlier intervention and supportive therapy. A meta-analysis examining the role of laboratory abnormalities in patients with severe COVID-19 vs. those with milder disease determined that the most predictive parameters of critical infection were lymphopenia (96.1% vs. 80.4%), thrombocytopenia (57.7% vs. 31.6%), increased LDH (58.1% vs. 37.2%) and elevated d-dimer (59.6% vs. 43.2%) [ 9 ]. Specifically, in Wu et al.'s retrospective analysis of the risk factors for disease progression to ARDS, they observed a statistically significant association between lymphopenia and the development of ARDS (P < 0.001) [ 8 ]. Several studies also established that higher CRP levels correlated with worse outcomes in COVID-19 such as ARDS, myocardial injury, and death [ 8\",\n",
       " ('COVID-19',\n",
       "  29,\n",
       "  1): ', 15 , 17 ]. As such, tracking hematologic parameters is crucial in determining prognosis and management, particularly with regard to level of care and monitoring. Patients with significant lab derangements had more severe disease and a greater need for critical care [ 2 , 3 , 5 , 6 , [9] , [10] , [11] , [12] ]. Lymphopenia is often more pronounced in those requiring ICU level care [ [11] , [12] , [13] , [14] , [15] ]. In Singapore, Fan et al. noted that 28% of patients infected with COVID-19 had lymphopenia, with critical care patients demonstrating significantly decreased lymphocytes compared with those not requiring ICU treatment [ 14 ]. Furthermore, 4 of the 9 ICU patients also exhibited increased levels of LDH (median value of 1684 U/L) compared to the non-ICU patients where only 5 of 26 had moderately elevated LDH [ 14 ]. Huang et al. demonstrated that in addition to marked lymphopenia, patients needing intensive care had higher levels of d-dimer (level 2.4 mg/L [0.6–14.4]) on admission than those who did not require it (0.5 mg/L [0.3–0.8], p = 0.0042) and also higher prothrombin times 12.2 s [IQR 11.2–13.4] when compared with non-ICU patients (10.7 s [9.8–12.1], p = 0·012) [ 3 ]. In a study of 140 COVID-19 positive patients by Zhang et al., 58 patients who were considered to have “severe disease” demonstrated a 2-fold increase in d-dimer compared to those with mild disease [ 16 ]. Guan et al. also determined that a significant elevation in d-dimer was more pronounced in severe cases (59.6% vs. 43.2% in non-severe) [ 5 ]. Several studies have shown that patients infected with COVID-19 share similar laboratory abnormalities including decreased total lymphocyte count, prolonged prothrombin time, elevated d-dimer levels and increased lactate dehydrogenase (LDH) [ [2] , [3] , [4] , [5] , [6] , [7] , [8] ]. A recent meta-analysis of the laboratory derangements in COVID-19 demonstrated that lymphopenia (35–75% of cases), increased LDH (27–92% of cases), elevated and d-dimer (36–43% of cases) were among the most frequent findings [ 9 ]. Several recent case reports have also highlighted the development of Takotsubo Syndrome (TTS) in those infected with COVID-19 [ [44] , [45] , [46] , [47] ]. One report detailed the case of a patient who developed cardiogenic shock 16 days after infection despite normal initial troponin levels and LVEF [ 44 ]. Her bedside echo demonstrated the apical ballooning typical of TTS. Similarly, another case report discussed the case of a previously healthy 50 years old male who developed chest pain and signs of cardiogenic shock 8 days after the onset of symptoms. His echocardiogram showed akinesia of all of his basal segments, and he was ultimately diagnosed with inverted Takotsubo cardiomyopathy [ 45 ]. In a retrospective cohort study of COVID-19 patients in Wuhan, China, Zhou et al. reported heart failure in 23% of admitted patients [ 13 ]. This number was as high as 52% in those who did not survive the infection [ 13 ]. Another retrospective study demonstrated that heart failure and acute cardiac injury were more common in deceased patients, regardless of their cardiovascular history [ 43 ]. Specifically, this study reported heart failure in 24% of deceased patients, nearly half of whom did not have any history of cardiovascular disease or hypertension [ 43 ]. It is unclear whether the heart failure was due to a new cardiomyopathy or an exacerbation of existing undiagnosed left ventricular dysfunction, and the etiology is still being investigated [ 31 , 35 ]. Additionally, right heart failure',\n",
       " ('COVID-19',\n",
       "  29,\n",
       "  2): 'can occur in patients with severe lung injury and ARDS [ 31 , 35 ]. As such, physicians should be cautious of underlying cardiac dysfunction when administering IV fluids [ 31 , 35 ]. Many etiologies have been proposed to explain the occurrence of arrythmias among COVID-19 patients. Hypoxia, inflammatory damage, abnormal metabolism, neurohormonal stress, and response to medications are some of the likely etiologies [ 31 , 35 , 42 ]. Furthermore, the effect of pro-inflammatory cytokines on the sinoatrial node could lead to the development of bradycardia in patients with COVID-19 [ 42 ]. A wide variety of arrythmias have been observed in patients with COVID-19. In a study of 137 patients in Hubei Province, 7.3% of patients reported heart palpitations [ 40 ]. In another report of 138 hospitalized patients, cardiac arrythmia was noted in 16.7%, and these arrythmias were more common in ICU patients [ 2 ]. In a much larger study of 700 patients, 9 cardiac arrests, 25 atrial fibrillation events, 9 clinically significant bradyarrhythmias, and 10 non-sustained ventricular tachycardias were reported [ 41 ]. Additionally, this study noted that ICU admissions were associated with incidents of atrial fibrillation among COVID-19 patients, indicating that these arrythmias can contribute to severity of illness [ 41 ]. Lastly, a retrospective case series published in Cureus discussed COVID-19 related prolonged QTc and transient bradycardia as manifestations of the illness [ 42 ]. Myocarditis has also contributed to mortality associated with COVID-19. In a case series of 150 patients, researchers determined that 7% died from myocarditis with circulatory failure [ 34 ]. Clinically, diagnosing myocarditis can be challenging, especially when differentiating it from acute coronary syndrome. For this reason, echocardiogram evaluation is recommended, and myocarditis associated with COVID-19 will appear as global wall motion dysfunction without focal wall motion defects [ 31 , 35 , 36 ]. Additionally, ECG abnormalities may occur as a result of myocardial inflammation, such as T wave inversion, PR and ST segment deviations [ 31 ]. Autopsy reports of COVID-19 patients have reported high viral loads, mononuclear cells, and lymphocytic infiltration as key players in mediating acute myocarditis [ [37] , [38] , [39] ]. A study by Lala, et al., showed that mild myocardial injury as evidenced by small increases in troponin was significantly associated with death (adjusted hazard ratio: 1.75; 95% CI: 1.37 to 2.24; p < 0.001), and that greater elevations correlated with a higher risk of mortality (adjusted HR: 3.03; 95% CI: 2.42 to 3.80; p < 0.001) [ 30 ]. Similarly, a single center retrospective study of 50 COVID-19 ICU patients in Turkey demonstrated that cardiac biomarkers including troponin I and NT-proBNP were higher in non-survivors compared to survivors [ 33 ]. A recent multi-hospital retrospective cohort of nearly 3000 patients demonstrated that myocardial injury was common among hospitalized COVID-19 patients (n = 985, 36%), and that those with a history of cardiovascular disease (CVD) were more likely to experience myocardial injury than those without [ 30 ]. Similarly, A study of 44,672 patients with COVID-19 demonstrated that a history of CVD was associated with a five-fold increase in case fatality rate compared to those without CVD (10.5% VS. 2.3%) [ 31 , 32 ]. Myocardial injury is defined as an elevation in biomarkers such as cardiac troponin I. Acute myocardial injury was reported in some of the earliest cases of COVID-19 in Wuhan, China. An early 2019 study among 41 admitted hospital patients in Wuhan reported acute cardiac injury in 12% of the patients [ 3 ]. Furthermore, another study of 138 hospitalized patients in Wuhan reported that',\n",
       " ('COVID-19',\n",
       "  29,\n",
       "  3): 'as high as 22% of those who required ICU care experienced acute myocardial injury [ 2 ]. Another retrospective, observational study of 52 critically ill patients in Wuhan, China reported cardiac injury in 23% of the patients [ 28 ]. The increased prevalence of cardiac injury among patients with COVID-19 could be explained by the significantly higher levels of cardiac troponin I in severely ill patients [ 29 ]. Patients with critical COVID-19 infection can also present with various cardiovascular symptoms. Animal models and cardiac autopsies suggest that COVID-19 can infect the cardiac tissue by binding to the angiotensin-converting enzyme (ACE) receptors, which can result in myocardial inflammation and damage [ 27 ]. Among the reported cardiac manifestations of COVID-19 are myocardial injury, myocarditis, arrythmias, cardiomyopathy, and heart failure. These symptoms are summarized in Table 1 . Several studies have examined whether GI procedures such as endoscopies can safely be performed on COVID-19 positive patients. A study conducted in northern Italy identified 23 COVID-19 patients presenting with signs of upper GI bleeding, therefore necessitating urgent endoscopy [ 75 ]. The virus has been detected in biopsies of the esophagus, stomach, duodenum, and rectum [ 76 ]. Since endoscopes are in contact with mucus membrane and body fluids, it is possible that these instruments can be implicated in transmission the virus [ 77 ]. As such, most guidelines recommend the use of personal protective equipment (PPE) during endoscopic examination in order to prevent nosocomial outbreaks of COVID-19 [ [78] , [79] , [80] , [81] ]. When the virus is highly suspected or confirmed, double gloves and N95 or FFP2/3 masks are indicated and the operative team should be properly trained to wear and remove PPE safely [ 79 ]. Fecal specimen testing is just as accurate in detecting COVID-19 as nasopharyngeal swabs [ 66 , 69 ]. Physiologically, the presence of viral particles in feces is plausible as there is a high level of viral receptor angiotensin converting enzyme 2 (ACE2) in the gastrointestinal tract [ 70 ]. While the current research is not definitive, studies have indicated that asymptomatic patients may shed COVID-19 viral particles in their stool [ 66 , [71] , [72] , [73] , [74] ]. Whether these particles are infectious and support the argument for possible the fecal-oral transmission of SARS-CoV-2 remains unclear. In addition to research showing the potential correlation between GI symptoms and disease severity, several studies have determined that infected patients can shed viral particles in their stool [ [65] , [66] , [67] ]. One study of 42 COVID-19 positive patients demonstrated that about 67% of the patients had viral RNA present in their stool even in the absence of diarrhea or other GI symptoms. Interestingly, among this group, 64% of the patients continued to shed viral particles in fecal specimens even after the nasopharyngeal swabs turned negative [ 65 ]. This has been documented in both adult and pediatric patients. Xu et al. conducted an epidemiological and clinical study of 10 children with COVID-19 and found that 8 persistently tested positive in stool despite their nasopharyngeal swabs being negative [ 68 ]. Some studies have shown that GI symptoms can manifest before the onset of typical respiratory symptoms [ 2 , 59 ]. The first confirmed case of COVID-19 in the US presented with a two-day history of nausea without respiratory complaint. Days into the illness, the patient also complained of abdominal discomfort and loose stools [ 60 ]. Similarly, a recent report described a COVID-19 patient presenting with diarrhea, borborygmus, anorexia, and nausea in the absence of any respiratory',\n",
       " ('COVID-19',\n",
       "  29,\n",
       "  4): 'symptoms [ 61 ]. Early research has suggested a correlation between GI symptoms and severity of illness. Henry et al. performed a pooled analysis of 10 different studies with a total sample of 1989 COVID-19 patients, 598 of whom (30.1%) were deemed as having “severe disease.” This study examined whether patients presenting with GI symptoms could be at an increased risk of critical illness and poor prognosis. The research highlighted a significant association between abdominal pain and illness severity. Furthermore, nausea and vomiting correlated with a marginally increased risk of severe COVID-19, while diarrhea was not reported to be associated with worse disease [ 62 ]. Another retrospective case-controlled study of 278 COVID-19 positive patients and 238 COVID-19 negative patients suggested that patients presenting with GI symptoms at time of testing were more likely to test positive for the virus [ 63 ]. In comparison, patients without GI symptoms were equally likely to test positive or negative for COVID-19 [ 63 ]. Lastly, in the past few months, two cases of paralytic ileus were reported among COVID-19 patients [ 64 ]. Histopathology of resected bowel specimen in these cases suggests a role for COVID-19-induced micro-thrombosis leading to GI perforation [ 64 ]. Healthcare workers can easily be overwhelmed by the complex symptomology and acuity of cases. While focusing primarily on the most critical respiratory symptoms, gastrointestinal manifestations can be overlooked. Though GI symptoms are not prominent in most cases and are unlikely life-threatening on their own, clinicians should endeavor to identify these early symptoms in order to prevent the potential spread of COVID-19. While the most fatal complications of COVID-19 include ARDS, heart failure, renal failure, liver injury, and multiple organ dysfunction syndrome (MODS), GI symptoms can contribute significantly to morbidity in infected patients [ 48 ]. With regard to the gastrointestinal system, SARS-CoV-2 can present with nausea, vomiting, diarrhea, and/or abdominal discomfort [ 3 , [49] , [50] , [51] , [52] , [53] ]. A cross-sectional analysis of 204 Chinese patients with COVID-19 demonstrated that over half (103 patients, 50.5%) reported experiencing at least one of the GI symptoms. Among those, 78.6% expressed loss of appetite, 34% complained of diarrhea, 3.9% reported vomiting, and 1.9% indicated they had abdominal pain [ 54 ]. Similar clinical studies among COVID-19 patients have observed diarrhea in 3% to 61% of patients, nausea in 10% to 58%, and vomiting in 2% to 5%. Other gastrointestinal symptoms included epigastric pain, belching, and anorexia [ 16 , [55] , [56] , [57] , [58] ] (summarized in Table 2 ). When comparing SARS-CoV-2 with SARS-CoV, AKI was a much less common finding (6%) during the 2003 outbreak of SARS, but it was recognized as a significant indicator of mortality (92% of SARS patients with AKI died) [ 92 ]. Similarly, renal dysfunction was also associated with increased risk of death in patients infected with H1N1 [ 93 ]. Evidence of the prognostic implications of kidney injury in other serious respiratory viruses highlights the importance of recognizing dysfunction early in the disease course in order to improve morbidity and mortality. Early recognition and treatment of renal dysfunction may help to improve the prognosis of those infected with COVID-19. In addition to being a predictor of severe disease, Li et al. demonstrated that patients who developed an AKI had a 5.3-fold increased risk of mortality compared to those without kidney abnormalities, illustrating the importance of renal dysfunction as a negative prognostic indicator for survival [ 87 ]. Chen et al. also determined that 25% of non-survivors had developed an AKI during hospitalization [ 43 ]. One',\n",
       " ('COVID-19',\n",
       "  29,\n",
       "  5): 'study noted that the kidney was the third most commonly damaged organ after the lungs and heart in those who died due to COVID-19 [ 89 ]. A consecutive cohort study of 710 COVID-19 positive patients confirmed that markers of kidney dysfunction such as elevated BUN and creatinine were independent risk factors for in-hospital death even after adjusting for potential confounders [ 91 ]. Mortality for those who presented with evidence of renal failure on admission was 33.7% vs. 13.2% in those without kidney dysfunction [ 91 ]. Similarly, Pei et al. demonstrated that patients with renal involvement had higher overall mortality compared to those without (11.2% vs 1.2%) [ 88 ]. Patients with chronic kidney disease are particularly vulnerable to negative outcomes. A recent meta-analysis confirmed that those with pre-existing renal dysfunction appeared to have significantly higher pneumonia-related mortality than those without underlying renal disease and are at increased risk for severe COVID-19 infection [ 95 , 96 ]. While research suggests that advanced age, organ failure, and elevated d-dimer levels are indicators of poor prognosis in COVID-19 patients, a recent study highlights kidney dysfunction as a potential risk factor for mortality, as well [ 13 , 87 ]. A multi-center retrospective study of 193 COVID-19 patients (128 with non-severe disease, 65 severe) investigated the presence of kidney dysfunction and demonstrated that, on admission, 59% of patients had proteinuria, 44% had hematuria, 14% had elevated BUN, and 10% had elevated creatinine levels [ 87 ]. These lab derangements were found to be significantly worse in those with critical illness (including non-survivors), and 66% of the patients who developed an AKI (43/65) were considered to have severe disease [ 87 ]. Per Pei at el., 75.4% of patients with COVID-19 had an abnormal urine dipstick at initial presentation [ 88 ]. These findings have been reproduced by several other studies which have shown that development of an AKI is a common lab finding in COVID-19 and a feature of those with severe disease [ 5 , 10 , 43 , [89] , [90] , [91] ]. Patients with elevated creatinine at admission were more likely to be admitted to the ICU [ 4 , [91] , [92] , [93] ]. Patients who survive COVID-19-related AKI have been shown to be at an increased risk of developing progressive CKD after the initial infection [ 86 ]. The risk CKD is associated with the severity of the AKI and the presence or absence of tubular damage [ 94 ]. These results suggest that early recognition of kidney dysfunction in patients with SARS-CoV-2 is important for disposition and monitoring for potential decompensation and to reduce the progression to chronic kidney impairment. SARS-CoV-2 can have a profound impact on the renal system. Early research has determined that COVID-19 can directly infect kidney tubules and cause acute tubular damage and subsequent renal failure [ 82 , 83 ]. An analysis of kidney findings at autopsy of 26 COVID-19 positive patients in Wuhan showed tubular injury and direct viral infiltration of the tubular epithelium [ 84 , 85 ]. Data also suggests that renal dysfunction may be multifactorial due to cytokine storm, hemodynamic changes, direct viral toxicity, or thrombotic microangiopathy [ 86 ]. Renal deterioration has been associated with a 5.3-fold increased mortality in COVID-19 patients. Often these patients demonstrate radiographic evidence of kidney dysfunction, such as renal interstitial inflammation and edema on CT [ 87 ]. A recent published report detailed the case of an African American male patient who presented with acute kidney injury due to collapsing glomerulopathy in the context of a COVID-19',\n",
       " ('COVID-19',\n",
       "  29,\n",
       "  6): 'infection without any signs of respiratory disease, indicating that renal manifestations of COVID-19 are possible even in patients with otherwise mild symptoms [ 85 ]. In addition to potential drug hypersensitivity or direct viral infection of the skin, Manalo et al. hypothesized that underlying DIC and microthrombi may contribute to cutaneous symptoms [ 109 ]. The study described two cases of unilateral transient livedo reticularis in non-critically ill COVID-19 positive patients. Similarly, a retrospective study of 7 critically ill patients in Wuhan, China exhibited significant limb ischemia with plantar plaques and acral cyanosis as dermatologic manifestations of their underlying hypercoagulable state [ 110 ]. Dermatologists have been challenged with differentiating between infectious and allergic etiologies of rashes associated with COVID-19, since they are both clinically and histologically similar. Many of the medication combinations currently under investigation for the treatment of the virus may lead to drug eruptions [ 106 ]. In a study of 140 COVID-19 patients by Zhang et al., drug hypersensitivity (11.4%) and urticaria (1.4%) were the most prevalent cutaneous symptoms associated with the virus [ 16 ]. Jimenez-Cauhe et al. described a patient with “erythemato-purpuric, millimetric, coalescing macules, located in flexural regions” that developed 3 days into treatment with hydroxychloroquine and lopinavir/ritonavir [ 107 ]. It was unclear whether these lesions were a manifestation of SARS-CoV-2 or an adverse reaction to the medications; however, there are no additional reports of dermatological symptoms in patients treated with this combination therapy [ 107 ]. Another report described sterile pustules, similar to the typical findings of acute generalized exanthematous pustulosis (AGEP), as a cutaneous manifestation of COVID-19 [ 108 ]. Although AGEP is classically associated with drugs, it is possible that COVID-19 can predispose certain patients to develop AGEP-like cutaneous eruptions as a late-onset manifestation of the infection. Several case reports have also described the potential skin manifestations of COVID-19. A cluster of eight children in the U.K. presented with features similar to atypical Kawasaki including the archetypal skin rash appearance [ 100 ]. Following this report, additional cases with similar presentation were observed across the globe. Henry et al. outlined the case of a 27-year-old female who presented with pruritic disseminated erythematous plaques without cough or fever. Two days later she tested positive for COVID-19 after the onset of chest pain and fever [ 101 ]. Another case report discussed a 28-year-old female who developed confluent “erythematous-yellowish” papules that progressed to pruritic, hardened plaques 13 days after testing positive for COVID-19 [ 102 ]. Joob and Wiwanitkit detailed the case of a petechial eruption and thrombocytopenia initially thought to be Dengue fever, but ultimately proven to be COVID-19 after the development of respiratory symptoms [ 103 ]. Amatore et al. discussed a 39-year-old male who complained of fever and exhibited “erythematous and edematous non-pruritic annular fixed plaques involving the upper limbs, chest, neck, abdomen and palms, sparing the face and mucous membranes” without cough or dyspnea [ 104 ]. The patient was tested for and diagnosed with COVID-19 after reporting exposure to a family member with the virus. Similarly, Van Damme et al. examined cases of disseminated urticaria in two febrile patients who later developed respiratory symptoms and tested positive for COVID-19 [ 105 ]. Dermatologists have become increasingly involved in caring for COVID-19 patients due to shifting clinical responsibilities during the pandemic, thus sparking an interest in the possible cutaneous manifestations of SARS-CoV-2. Recalcati, an Italian dermatologist, looked at a cohort of 88 COVID-19 positive patients and determined that 18 (20.4%) developed skin symptoms [ 97 ]. The manifestations reported were erythematous rash (15.9%), generalized urticaria (3.41%) and',\n",
       " ('COVID-19',\n",
       "  29,\n",
       "  7): 'chicken pox-like lesions (1.14%) [ 97 ]. Dermatologists in Rome identified 2 of 130 patients with COVID-19 who presented with isolated herpetiform lesions on their trunk during their inpatient stays [ 98 ]. A patient in Barcelona exhibited vesicular lesions on her back 8 days after COVID-19 diagnosis [ 98 ]. A multicenter case series of 22 patients in Italy described a varicella-like exanthem as a specific cutaneous manifestation of the virus [ 99 ]. Furthermore, the study showed that median time from onset of systemic symptoms (fever, fatigue, or cough) to presentation of the exanthem was 3 days with a median duration of 8 days [ 99 ]. 54.5% of patients had vesicular lesions on the trunk, and the lesions were scattered in the majority of cases (72.7%) [ 99 ]. 7 of the 22 patients underwent skin biopsy and demonstrated histology consistent with viral infection. Based on a study of 1099 confirmed COVID-19 cases in Wuhan, China, the most common symptoms included fever (43.8% of patients were febrile on admission, and 88.7% of patients became febrile during their hospital stay), cough (67.8%), and fatigue (38.1%). However, the study did note that 2 patients (0.2%) had rashes but did elaborate further [ 5 ]. There are several mentions in the literature of the dermatologic manifestations of SARS-CoV-2, but a predictable pattern has yet to emerge in the research. Though most research efforts have been focused on identifying CNS dysfunction in SARS-CoV-2, some studies have discussed the effect on the peripheral nervous system. One case series reported on a patient with COVID-19-related Miller-Fisher syndrome and another with polyneuritis cranialis. The first patient developed characteristic features with external ophthalmoplegia, ataxia, and loss of tendon reflexes and recovered after being treated with IVIG [ 132 ]. The second had ageusia, areflexia, and abducens palsy consistent with polyneuritis cranialis, which spontaneously and rapidly improved [ 132 ]. A large retrospective study by Mao L et al. determined that 5% of patients had hypogeusia and another 5% had hyposmia [ 129 ]. Several Chinese studies indicated that up to 70% of patients complained of myalgias with increases in creatine kinase (CK) present in up to 33%, suggesting a possible SARS-CoV-2 viral myositis [ 2 , 3 , 28 , 124 , 133 ]. A recently published report details the case of acute transverse myelitis after a complicated SARS-CoV-2 infection. The patient developed hypotonia in both lower limbs with absent distal reflexes. An MRI with gadolinium contrast showed increased T2 signal between C7-T12 with an LP significant for an elevated IgG index and a positive RT-PCR for SARS-CoV-2. He recovered one week later after treatment with IVIG [ 134 ]. Since many studies have demonstrated that COVID-19 patients are at increased risk for encephalopathy and cerebrovascular disorders, it has been theorized that these clinical scenarios could lead to seizures [ [127] , [128] , [129] ]. However, a large multi-center retrospective study of 304 COVID-19 positive patients in China study evaluated seizure activity in a cohort of patients with no prior history of epilepsy [ 121 ]. Only two patients were identified as having seizure-like activity despite the presence of potentially predisposing hypoxia or electrolyte abnormalities in the majority of the cohort. Both patients were later found to have severe electrolyte abnormalities, and symptoms improved with correction [ 121 ]. A study of 111 COVID-19 patients within the New York academic hospital system investigated EEG abnormalities among infected patients. This study showed that the most frequent EEG finding was generalized slowing (57%) and epileptiform findings were observed in 30% and seizures in 7% (4% were',\n",
       " ('COVID-19',\n",
       "  29,\n",
       "  8): 'non-convulsive seizures). The study also concluded that only a history of epilepsy and definite clinical seizures prior to EEG testing independently predicted epileptiform findings on EEG [ 131 ]. While it is theorized in many of the aforementioned studies that patients who are COVID-19 positive are at increased risk for cerebral ischemia, research out of Piacenza, Italy noted decreased rates of admission for stroke. They reported only 6 admissions for CVA from February 21, 2020 to March 25, 2020 compared to their normal monthly average of approximately 51 cases [ 130 ]. The authors put forth a number of theories for these findings, such as thrombocytopenia or the potential neuroprotective role of IL-6. Research related to CVA incidence in the time of COVID is currently mixed, and further studies need to be conducted to corroborate these findings. Cerebral hemorrhage is thought to be a consequence of the virus binding to ACE-2 receptors on endothelium, contributing to break down of the blood brain barrier [ 117 , 120 ]. Ischemic changes and CVST are likely secondary to a hypercoagulable and pro-inflammatory state, further supported by elevation in CRP and d-dimer in these patients [ 117 , 128 , 129 ]. Numerous other studies summarized in Table 2 discuss presentations of cerebrovascular disease in COVID-19 patients [ 120 , 128 , 129 ]. A large retrospective study of 221 patients with COVID-19 at the Union hospital in Wuhan found that 5% of patients presented with acute ischemic stroke, one patient developed cerebral venous sinus thrombosis (CVST), and one had cerebral hemorrhage [ 127 , 128 ]. Those with cerebrovascular disease were significantly older (71·6 ± 15·7 years vs 52·1 ± 15·3 years; p < 0·05) and had cardiovascular risk factors. Lab evaluation of this cohort determined that they were more likely to have elevated CRP and d-dimer, lymphopenia, thrombocytopenia, and uremia [ [127] , [128] , [129] ]. Various case reports summarized in Table 3 suggest that COVID-19 causes symptoms consistent with meningoencephalitis [ [121] , [122] , [123] , [124] ]. Some COVID-19 positive patients presented with altered mental status and fever, and CSF studies showed elevated lymphocyte count but a negative viral biofire [ [121] , [122] , [123] , [124] ]. Though these presentations could not be definitively linked to the virus due to the lack of CSF SARS-CoV-2 testing at the time, no other etiology for the viral meningoencephalitis was found in this COVID-19 positive cohort. A study conducted at the Beijing Ditan Hospital did confirm the presence of SARS-CoV-2 in the cerebrospinal fluid of patients with known COVID-19 and symptoms consistent with encephalitis by genome sequencing [ 125 ]. Evidence of infectious toxic encephalitis was also found when cerebral edema was identified during autopsy of COVID-19 patients [ 38 ]. A recently published report detailed the case of serious neurologic damage and mental abnormalities in a patient whose infection was confirmed by IgM and IgG antibodies in the CSF despite negative nasopharyngeal swabs. After the initial presentation of fatigue and headaches, the patient suddenly developed the inability to walk, uroclepsia, coprolalia, and delusions. His CSF studies were strongly positive for SARS-CoV-2 antibodies, and after weeks of antiviral and antipsychotic treatment, he was discharged with mild hand tremors and fatigue [ 126 ]. SARS-CoV-2 is believed to enter the nervous system via hematogenous spread, directly through the cribriform plate, or through retrograde neuronal synapses from the olfactory bulb and vagal afferents [ 111 , 113 , 117 , 118 ]. Upon entering the nervous system, it can manifest as a viral encephalitis, cerebrovascular disease, or peripheral nerve symptoms',\n",
       " ('COVID-19',\n",
       "  29,\n",
       "  9): '[ 117 , 119 , 120 ]. The SARS-CoV-2 virus is known to cause severe respiratory distress through direct invasion into the lung parenchyma as evidenced by the destructive pattern seen on imaging of COVID-19 positive patients. However, some patients with evidence of significant lung damage and severe hypoxic do not develop tachypnea [ 114 ]. Scientists have hypothesized that there is an abnormal response of the peripheral afferent fibers in the lungs and airways that stimulate respiration [ 114 ]. Direct entry of the virus into brain tissue, notably the brainstem, may also result in the loss of involuntary control of breathing [ 115 , 116 ]. Recent studies have indicated that the SARS-CoV-2 is similar in taxonomy and sequence to the SARS-CoV virus [ 111 ]. The virus utilizes a spike protein S1 to attach to the host membrane by interacting with host ACE-2 receptor, which is found on neurons, endothelial cells, kidneys, lungs, and small intestine [ 112 ]. Upon entering the cell, it initiates an immune cascade which stimulates CD4 + T cells, and this sequence of events activates macrophages to produce IL-6, leading to a cytokine storm and eventual systemic destruction of tissues [ 113 ]. There are several neurological manifestations of the virus that are important to recognize and treat early. 3.7. Psychiatric symptoms With the rise of COVID-19 cases in the US, social distancing measures have continued significantly past their predicted duration, likely contributing to increased anxiety, depression, and loneliness. Prior epidemics have negatively impacted the psychological health of the population. A prospective study conducted during the 2003 SARS epidemic in Hong Kong demonstrated that stress, dysphoria, impaired sleep and concentration were much greater among infected individuals than controls, and 25% of the patients requested follow-up for the negative psychological effects of being infected [135]. A study examining psychiatric symptoms in SARS survivors one year later indicated that these patients experienced persistent distress with 64% scoring above the GHQ12 threshold for psychiatric morbidity [136]. Additionally, infected healthcare workers who survived showed significantly higher stress levels, more depression, and symptoms consistent with PTSD [136]. Based on this research, it is possible we will see similar patterns of anxiety, depression and other psychiatric symptoms in those currently affected by COVID-19. 3.7.1. Cause of psychiatric symptoms The psychological impact of this pandemic is likely multifactorial, due in parts to self-isolation, fear of infection, uncertainty, financial woes, job insecurity, and pre-existing mental health conditions. A recent study out of China using online surveys determined that 16.5% of respondents exhibited moderate to severe depressive symptoms, and 28.8% reported severe anxiety [137]. Of these respondents, 75.2% attributed their increased anxiety to fear that they or their family members could contract COVID-19 [137]. Misinformation and uncertainly can raise anxiety levels in both healthy individuals and those with preexisting psychiatric conditions [138]. Lunn et al. observed that the absence of effective disease treatment and the uncertainty regarding outcomes for those infected has led to mass panic and anxiety [139]. In addition, the rapid spread of misinformation and bias has induced fear, prejudice, and xenophobia [140,141]. 3.7.2. Social isolation and mental health One of the major consequences of the pandemic is increased social isolation, a risk factor that is strongly associated with depression, self-harm, and suicide [[142], [143], [144]]. Older adults are especially vulnerable to the mental health ramifications of social isolation, particularly those in residential care [145]. Mental health experts have stressed the importance of research examining the rates of anxiety, depression, and other psychiatric symptoms to inform interventions during this public health crisis [142]. An analysis of emotional indicators on',\n",
       " ('COVID-19',\n",
       "  29,\n",
       "  10): 'the Chinese social media platform Weibo during the height of their COVID-19 crisis demonstrated that anxiety and depression increased while positive emotional indicators (Oxford happiness) decreased [146]. The study also analyzed linguistic expression and determined that there was an increase in the use of the words “health” and “family” and a decrease in “leisure” and “friend”, highlighting the rapidly evolving priorities in this population during the pandemic [146]. Patients with pre-existing mental health conditions are both more vulnerable to the psychological impacts of the pandemic and at increased risk of infection, likely due to cognitive impairment, diminished efforts for personal protection, lack of awareness of their personal risk, and discrimination [147]. Patients with severe mental illness are also more vulnerable due to significantly higher rates of both homelessness and smoking [148]. Many patients have reported poor adherence to medication during this time, disruption of mental health services, and suspension of substance abuse treatment [149]. Lastly, the close proximity with which many homeless patients with mental illness live is a significant risk factor for the spread of the virus.',\n",
       " ('COVID-19',\n",
       "  3,\n",
       "  0): 'Поскольку справедливый доступ к безопасным и эффективным вакцинам имеет важнейшее значение для прекращения пандемии COVID-19, весьма отрадно наблюдать, что так много вакцин успешно проходят стадии испытаний и разработки. ВОЗ неустанно сотрудничает с партнерами в вопросах разработки, производства и внедрения безопасных и эффективных вакцин. Хотя безопасные и эффективные вакцины - это инструмент, позволяющий переломить ситуацию, в обозримом будущем нам все же потребуется по-прежнему носить маски, мыть руки, тщательно вентилировать помещения, соблюдать социальную дистанцию и избегать скопления людей. Наличие прививки не означает, что мы можем забыть про осторожность и подвергать риску себя и других, тем более что исследования по вопросам о том, в какой степени вакцины защищают не только от болезни, но и от инфекции и от ее передачи, до сих пор продолжаются. Для ознакомления с последними данными о вакцинах, находящихся на стадии клинической и доклинической разработки, которые обычно обновляются дважды в неделю, см. общие данные ВОЗ по вакцинам-кандидатам против COVID-19 (на английском языке). Кроме того, на ежедневно обновляемой информационной панели ВОЗ по COVID-19 (на английском языке) отражается количество доз вакцины, введенных во всем мире, а более подробная информация представлена на специальной информационной панели по вакцинации против COVID-19 (на английском языке). На региональном уровне действуют информационная панель по COVID-19 в Африке (на английском языке) и информационная панель ПАОЗ по поставкам вакцин против COVID-19 (на английском языке). Однако остановят пандемию не вакцины, а вакцинация. Мы должны обеспечить справедливый и равноправный доступ к вакцинам и гарантировать, что каждая страна получит их и сможет широко использовать для защиты своего населения, начиная с самых уязвимых групп. Здесь (на английском языке) вы можете следить за состоянием вакцин против COVID-19 в рамках процедуры оценки ВОЗ «EUL/PQ».',\n",
       " ('COVID-19',\n",
       "  30,\n",
       "  0): 'Muge Cevik , clinical lecturer 1 2, Krutika Kuppalli , assistant professor 3, Jason Kindrachuk , assistant professor of virology 4, Malik Peiris , professor of virology 5 1Division of Infection and Global Health Research, School of Medicine, University of St Andrews, St Andrews, UK 2Specialist Virology Laboratory, Royal Infirmary of Edinburgh, Edinburgh, UK and Regional Infectious Diseases Unit, Western General Hospital, Edinburgh, UK 3Division of Infectious Diseases, Medical University of South Carolina, Charleston, SC, USA 4Laboratory of Emerging and Re-Emerging Viruses, Department of Medical Microbiology, University of Manitoba, Winnipeg, MB, Canada 5School of Public Health, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region, China Correspondence to M Cevik mc349{at}st-andrews.ac.uk What you need to know SARS-CoV-2 is genetically similar to SARS-CoV-1, but characteristics of SARS-CoV-2—eg, structural differences in its surface proteins and viral load kinetics—may help explain its enhanced rate of transmission In the respiratory tract, peak SARS-CoV-2 load is observed at the time of symptom onset or in the first week of illness, with subsequent decline thereafter, indicating the highest infectiousness potential just before or within the first five days of symptom onset Reverse transcription polymerase chain reaction (RT-PCR) tests can detect viral SARS-CoV-2 RNA in the upper respiratory tract for a mean of 17 days; however, detection of viral RNA does not necessarily equate to infectiousness, and viral culture from PCR positive upper respiratory tract samples has been rarely positive beyond nine days of illness Symptomatic and pre-symptomatic transmission (1-2 days before symptom onset), is likely to play a greater role in the spread of SARS-CoV-2 than asymptomatic transmission A wide range of virus-neutralising antibodies have been reported, and emerging evidence suggests that these may correlate with severity of illness but wane over time Since the emergence of SARS-CoV-2 in December 2019, there has been an unparalleled global effort to characterise the virus and the clinical course of disease. Coronavirus disease 2019 (covid-19), caused by SARS-CoV-2, follows a biphasic pattern of illness that likely results from the combination of an early viral response phase and an inflammatory second phase. Most clinical presentations are mild, and the typical pattern of covid-19 more resembles an influenza-like illness—which includes fever, cough, malaise, myalgia, headache, and taste and smell disturbance—rather than severe pneumonia (although emerging evidence about long term consequences is yet to be understood in detail).1 In this review, we provide a broad update on the emerging understanding of SARS-CoV-2 pathophysiology, including virology, transmission dynamics, and the immune response to the virus. Any of the mechanisms and assumptions discussed in the article and in our understanding of covid-19 may be revised as further evidence emerges. What we know about the virus SARS-CoV-2 is an enveloped β-coronavirus, with a genetic sequence very similar to SARS-CoV-1 (80%) and bat coronavirus RaTG13 (96.2%).2 The viral envelope is coated by spike (S) glycoprotein, envelope (E), and membrane (M) proteins (fig 1). Host cell binding and entry are mediated by the S protein. The first step in infection is virus binding to a host cell through its target receptor. The S1 sub-unit of the S protein contains the receptor binding domain that binds to the peptidase domain of angiotensin-converting enzyme 2 (ACE 2). In SARS-CoV-2 the S2 sub-unit is highly preserved and is considered a potential antiviral target. The virus structure and replication cycle are described in figure 1. Fig 1 (1) The virus binds to ACE 2 as the host target cell receptor in synergy with the host’s transmembrane serine protease 2 (cell surface protein), which is principally expressed in the airway epithelial cells and vascular endothelial cells. This',\n",
       " ('COVID-19',\n",
       "  30,\n",
       "  1): 'leads to membrane fusion and releases the viral genome into the host cytoplasm (2). Stages (3-7) show the remaining steps of viral replication, leading to viral assembly, maturation, and virus release Coronaviruses have the capacity for proofreading during replication, and therefore mutation rates are lower than in other RNA viruses. As SARS-CoV-2 has spread globally it has, like other viruses, accumulated some mutations in the viral genome, which contains geographic signatures. Researchers have examined these mutations to study virus characterisation and understand epidemiology and transmission patterns. In general, the mutations have not been attributed to phenotypic changes affecting viral transmissibility or pathogenicity. The G614 variant in the S protein has been postulated to increase infectivity and transmissibility of the virus.3 Higher viral loads were reported in clinical samples with virus containing G614 than previously circulating variant D614, although no association was made with severity of illness as measured by hospitalisation outcomes.3 These findings have yet to be confirmed with regards to natural infection. Why is SARS-CoV-2 more infectious than SARS-CoV-1? SARS-CoV-2 has a higher reproductive number (R 0 ) than SARS-CoV-1, indicating much more efficient spread.1 Several characteristics of SARS-CoV-2 may help explain this enhanced transmission. While both SARS-CoV-1 and SARS-CoV-2 preferentially interact with the angiotensin-converting enzyme 2 (ACE 2) receptor, SARS-CoV-2 has structural differences in its surface proteins that enable stronger binding to the ACE 2 receptor4 and greater efficiency at invading host cells.1 SARS-CoV-2 also has greater affinity (or bonding) for the upper respiratory tract and conjunctiva,5 thus can infect the upper respiratory tract and can conduct airways more easily.6 Viral load dynamics and duration of infectiousness Viral load kinetics could also explain some of the differences between SARS-CoV-2 and SARS-CoV-1. In the respiratory tract, peak SARS-CoV-2 load is observed at the time of symptom onset or in the first week of illness, with subsequent decline thereafter, which indicates the highest infectiousness potential just before or within the first five days of symptom onset (fig 2).7 In contrast, in SARS-CoV-1 the highest viral loads were detected in the upper respiratory tract in the second week of illness, which explains its minimal contagiousness in the first week after symptom onset, enabling early case detection in the community.7 Fig 2 After the initial exposure, patients typically develop symptoms within 5-6 days (incubation period). SARS-CoV-2 generates a diverse range of clinical manifestations, ranging from mild infection to severe disease accompanied by high mortality. In patients with mild infection, initial host immune response is capable of controlling the infection. In severe disease, excessive immune response leads to organ damage, intensive care admission, or death. The viral load peaks in the first week of infection, declines thereafter gradually, while the antibody response gradually increases and is often detectable by day 14 (figure adapted with permission from https://www.sciencedirect.com/science/article/pii/S009286742030475X; https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(20)30230-7/fulltext) Quantitative reverse transcription polymerase chain reaction (qRT-PCR) technology can detect viral SARS-CoV-2 RNA in the upper respiratory tract for a mean of 17 days (maximum 83 days) after symptom onset.7 However, detection of viral RNA by qRT-PCR does not necessarily equate to infectiousness, and viral culture from PCR positive upper respiratory tract samples has been rarely positive beyond nine days of illness.5 This corresponds to what is known about transmission based on contact tracing studies, which is that transmission capacity is maximal in the first week of illness, and that transmission after this period has not been documented.8 Severely ill or immune-compromised patients may have relatively prolonged virus shedding, and some patients may have intermittent RNA shedding; however, low level results close to the detection limit may not constitute infectious viral particles. While asymptomatic individuals',\n",
       " ('COVID-19',\n",
       "  30,\n",
       "  2): '(those with no symptoms throughout the infection) can transmit the infection, their relative degree of infectiousness seems to be limited.91011 People with mild symptoms (paucisymptomatic) and those whose symptom have not yet appeared still carry large amounts of virus in the upper respiratory tract, which might contribute to the easy and rapid spread of SARS-CoV-2.7 Symptomatic and pre-symptomatic transmission (one to two days before symptom onset) is likely to play a greater role in the spread of SARS-CoV-2.1012 A combination of preventive measures, such as physical distancing and testing, tracing, and self-isolation, continue to be needed. Route of transmission and transmission dynamics Like other coronaviruses, the primary mechanism of transmission of SARS-CoV-2 is via infected respiratory droplets, with viral infection occurring by direct or indirect contact with nasal, conjunctival, or oral mucosa, when respiratory particles are inhaled or deposited on these mucous membranes.6 Target host receptors are found mainly in the human respiratory tract epithelium, including the oropharynx and upper airway. The conjunctiva and gastrointestinal tracts are also susceptible to infection and may serve as transmission portals.6 Transmission risk depends on factors such as contact pattern, environment, infectiousness of the host, and socioeconomic factors, as described elsewhere.12 Most transmission occurs through close range contact (such as 15 minutes face to face and within 2 m),13 and spread is especially efficient within households and through gatherings of family and friends.12 Household secondary attack rates (the proportion of susceptible individuals who become infected within a group of susceptible contacts with a primary case) ranges from 4% to 35%.12 Sleeping in the same room as, or being a spouse of an infected individual increases the risk of infection, but isolation of the infected person away from the family is related to lower risk of infection.12 Other activities identified as high risk include dining in close proximity with the infected person, sharing food, and taking part in group activities 12 The risk of infection substantially increases in enclosed environments compared with outdoor settings.12 For example, a systematic review of transmission clusters found that most superspreading events occurred indoors.11 Aerosol transmission can still factor during prolonged stay in crowded, poorly ventilated indoor settings (meaning transmission could occur at a distance >2 m).1214151617 The role of faecal shedding in SARS-CoV-2 transmission and the extent of fomite (through inanimate surfaces) transmission also remain to be fully understood. Both SARS-CoV-2 and SARS-CoV-1 remain viable for many days on smooth surfaces (stainless steel, plastic, glass) and at lower temperature and humidity (eg, air conditioned environments).1819 Thus, transferring infection from contaminated surfaces to the mucosa of eyes, nose, and mouth via unwashed hands is a possible route of transmission. This route of transmission may contribute especially in facilities with communal areas, with increased likelihood of environmental contamination. However, both SARS-CoV-1 and SARS-CoV-2 are readily inactivated by commonly used disinfectants, emphasising the potential value of surface cleaning and handwashing. SARS-CoV-2 RNA has been found in stool samples and RNA shedding often persists for longer than in respiratory samples7; however, virus isolation has rarely been successful from the stool.57 No published reports describe faecal-oral transmission. In SARS-CoV-1, faecal-oral transmission was not considered to occur in most circumstances; but, one explosive outbreak was attributed to aerosolisation and spread of the virus across an apartment block via a faulty sewage system.20 It remains to be seen if similar transmission may occur with SARS-CoV-2. Pathogenesis Viral entry and interaction with target cells SARS-CoV-2 binds to ACE 2, the host target cell receptor.1 Active replication and release of the virus in the lung cells lead to non-specific symptoms such as fever, myalgia, headache, and respiratory symptoms.1',\n",
       " ('COVID-19',\n",
       "  30,\n",
       "  3): 'In an experimental hamster model, the virus causes transient damage to the cells in the olfactory epithelium, leading to olfactory dysfunction, which may explain temporary loss of taste and smell commonly seen in covid-19.21 The distribution of ACE 2 receptors in different tissues may explain the sites of infection and patient symptoms. For example, the ACE 2 receptor is found on the epithelium of other organs such as the intestine and endothelial cells in the kidney and blood vessels, which may explain gastrointestinal symptoms and cardiovascular complications.22 Lymphocytic endotheliitis has been observed in postmortem pathology examination of the lung, heart, kidney, and liver as well as liver cell necrosis and myocardial infarction in patients who died of covid-19.123 These findings indicate that the virus directly affects many organs, as was seen in SARS-CoV-1 and influenzae. Much remains unknown. Are the pathological changes in the respiratory tract or endothelial dysfunction the result of direct viral infection, cytokine dysregulation, coagulopathy, or are they multifactorial? And does direct viral invasion or coagulopathy directly contribute to some of the ischaemic complications such as ischaemic infarcts? These and more, will require further work to elucidate. Immune response and disease spectrum (figure 2) After viral entry, the initial inflammatory response attracts virus-specific T cells to the site of infection, where the infected cells are eliminated before the virus spreads, leading to recovery in most people.24 In patients who develop severe disease, SARS-CoV-2 elicits an aberrant host immune response.2425 For example, postmortem histology of lung tissues of patients who died of covid-19 have confirmed the inflammatory nature of the injury, with features of bilateral diffuse alveolar damage, hyaline-membrane formation, interstitial mononuclear inflammatory infiltrates, and desquamation consistent with acute respiratory distress syndrome (ARDS), and is similar to the lung pathology seen in severe Middle East respiratory syndrome (MERS) and severe acute respiratory syndrome (SARS).2627 A distinctive feature of covid-19 is the presence of mucus plugs with fibrinous exudate in the respiratory tract, which may explain the severity of covid-19 even in young adults.28 This is potentially caused by the overproduction of pro-inflammatory cytokines that accumulate in the lungs, eventually damaging the lung parenchyma.24 Some patients also experience septic shock and multi-organ dysfunction.24 For example, the cardiovascular system is often involved early in covid-19 disease and is reflected in the release of highly sensitive troponin and natriuretic peptides.29 Consistent with the clinical context of coagulopathy, focal intra-alveolar haemorrhage and presence of platelet-fibrin thrombi in small arterial vessels is also seen.27 Cytokines normally mediate and regulate immunity, inflammation, and haematopoiesis; however, further exacerbation of immune reaction and accumulation of cytokines in other organs in some patients may cause extensive tissue damage, or a cytokine release syndrome (cytokine storm), resulting in capillary leak, thrombus formation, and organ dysfunction.2430 Mechanisms underlying the diverse clinical outcomes Clinical outcomes are influenced by host factors such as older age, male sex, and underlying medical conditions,1 as well as factors related to the virus (such as viral load kinetics), host-immune response, and potential cross-reactive immune memory from previous exposure to seasonal coronaviruses (box 1). Box 1 Risk factors associated with the development of severe disease, admission to intensive care unit, and mortality Underlying condition Older age Hypertension Cardiovascular disease Chronic obstructive pulmonary disease Diabetes Obesity Malignancy Presentation Higher fever (≥39°C on admission) Dyspnoea on admission Higher qSOFA score Laboratory markers Neutrophilia/lymphopenia Raised lactate and lactate dehydrogenase Raised C reactive protein Raised ferritin Raised IL-6 Raised ACE2 D-dimer >1 μg/mL RETURN TO TEXT Sex-related differences in immune response have been reported, revealing that men had higher plasma innate immune cytokines and chemokines at baseline than women.31 In',\n",
       " ('COVID-19',\n",
       "  30,\n",
       "  4): 'contrast, women had notably more robust T cell activation than men, and among male participants T cell activation declined with age, which was sustained among female patients. These findings suggest that adaptive immune response may be important in defining the clinical outcome as older age and male sex is associated with increased risk of severe disease and mortality. Increased levels of pro-inflammatory cytokines correlate with severe pneumonia and increased ground glass opacities within the lungs.3032 In people with severe illness, increased plasma concentrations of inflammatory cytokines and biomarkers were observed compared with people with non-severe illness.303334 Emerging evidence suggests a correlation between viral dynamics, the severity of illness, and disease outcome.7 Longitudinal characteristics of immune response show a correlation between the severity of illness, viral load, and IFN- α, IFN-γ, and TNF-α response.34 In the same study many interferons, cytokines, and chemokines were elevated early in disease for patients who had severe disease and higher viral loads. This emphasises that viral load may drive these cytokines and the possible pathological roles associated with the host defence factors. This is in keeping with the pathogenesis of influenza, SARS, and MERS whereby prolonged viral shedding was also associated with severity of illness.735 Given the substantial role of the immune response in determining clinical outcomes, several immunosuppressive therapies aimed at limiting immune-mediated damage are currently in various phases of development (table 1). Table 1 Therapeutics currently under investigation View this table: Immune response to the virus and its role in protection Covid-19 leads to an antibody response to a range of viral proteins, but the spike (S) protein and nucleocapsid are those most often used in serological diagnosis. Few antibodies are detectable in the first four days of illness, but patients progressively develop them, with most achieving a detectable response after four weeks.36 A wide range of virus-neutralising antibodies have been reported, and emerging evidence suggests that these may correlate with severity but wane over time.37 The duration and protectivity of antibody and T cell responses remain to be defined through studies with longer follow-up. CD-4 T cell responses to endemic human coronaviruses appear to manifest cross-reactivity with SARS-CoV-2, but their role in protection remains unclear.38 Unanswered questions Further understanding of the pathogenesis for SARS-CoV-2 will be vital in developing therapeutics, vaccines, and supportive care modalities in the treatment of covid-19. More data are needed to understand the determinants of healthy versus dysfunctional response and immune markers for protection and the severity of disease. Neutralising antibodies are potential correlates of protection, but other protective antibody mechanisms may exist. Similarly, the protective role of T cell immunity and duration of both antibody and T cell responses and the correlates of protection need to be defined. In addition, we need optimal testing systems and technologies to support and inform early detection and clinical management of infection. Greater understanding is needed regarding the long term consequences following acute illness and multisystem inflammatory disease, especially in children. Education into practice How would you describe SARS-CoV-2 transmission routes and ways to prevent infection? How would you describe to a patient why cough, anosmia, and fever occur in covid-19? Questions for future research What is the role of the cytokine storm and how could it inform the development of therapeutics, vaccines, and supportive care modalities? What is the window period when patients are most infectious? Why do some patients develop severe disease while others, especially children, remain mildly symptomatic or do not develop symptoms? What are the determinants of healthy versus dysfunctional response, and the biomarkers to define immune correlates of protection and disease severity for the effective triage',\n",
       " ('COVID-19',\n",
       "  30,\n",
       "  5): \"of patients? What is the protective role of T cell immunity and duration of both antibody and T cell responses, and how would you define the correlates of protection? How patients were involved in the creation of this article No patients were directly involved in the creation of this article. How this article was created We searched PubMed from 2000 to 18 September 2020, limited to publications in English. Our search strategy used a combination of key words including “COVID-19,” “SARS-CoV-2,” “SARS”, “MERS,” “Coronavirus,” “Novel Coronavirus,” “Pathogenesis,” “Transmission,” “Cytokine Release,” “immune response,” “antibody response.” These sources were supplemented with systematic reviews. We also reviewed technical documents produced by the Centers for Disease Control and Prevention and World Health Organization technical documents. Footnotes Author contributions: MC, KK, JK, MP drafted the first and subsequent versions of the manuscript and all authors provided critical feedback and contributed to the manuscript. Competing interests The BMJ has judged that there are no disqualifying financial ties to commercial companies. The authors declare the following other interests: none. Further details of The BMJ policy on financial interests are here: https://www.bmj.com/about-bmj/resources-authors/forms-policies-and-checklists/declaration-competing-interests Provenance and peer review: commissioned; externally peer reviewed. This article is made freely available for use in accordance with BMJ's website terms and conditions for the duration of the covid-19 pandemic or until otherwise determined by BMJ. You may use, download and print the article for any lawful, non-commercial purpose (including text and data mining) provided that all copyright notices and trade marks are retained. https://bmj.com/coronavirus/usage\",\n",
       " ('COVID-19',\n",
       "  31,\n",
       "  0): 'В третьей декаде февраля была зарегистрирована еще одна вакцина против COVID-19 - \"КовиВак\", разработанная Центром имени Чумакова РАН. Она стала третьей вакциной, разрешенной к широкому применению в нашей стране после \"Спутника V\" от НИЦ имени Гамалеи и \"ЭпиВакКороны\", разработанной ГНЦ \"Вектор\". Таким образом, в нашей стране есть уже три вакцины, сделанные на разных технологических платформах, и врачи смогут подобрать своим пациентам для прививки наиболее подходящую. Ограничения могут возникать, например, если у человека есть аллергия на какой-либо из компонентов вакцины - в этом случае его прививают другим препаратом. Зарегистрированная третьей \"КовиВак\" - вакцина \"мягкого\" действия, она производится по классической технологии. Мы внимательно изучили данные о всех трех вакцинах, чтобы их можно было сравнить. Гам-Ковид-Вак (торговая марка \"Спутник V\") Зарегистрирована в России и более чем в 30 странах мира, подана заявка на регистрацию в ЕС, подана заявка на одобрение ВОЗ. Это генно-инженерная векторная - на основе двух штаммов живых аденовирусов человека. Вводится двукратно с интервалом 3 недели. Эффективность составляет 91,4%, против тяжелого течения заболевания - 100%. Ожидается, что иммунитет формируется на два года (на 9 месяцев - уже доказано). У привитых может наблюдаться гриппоподобный синдром - повышение температуры (иногда до 38-39 градусов), мышечные и суставные боли, слабость, головная боль. При необходимости рекомендуется принимать жаропонижающие средства. Обычно симптомы проходят в течение 1-2 дней. Реже отмечаются тошнота, диспепсия, снижение аппетита, иногда - увеличение регионарных лимфоузлов. Кому рекомендована, противопоказания, особенности Применяют у взрослых 18-60 лет, также разрешено применение в возрасте 60+. Противопоказана беременным и кормящим, планируются исследования на детях до 18 лет. Нельзя применять при гиперчувствительности к какому-либо компоненту вакцины; тяжелых аллергических реакциях в анамнезе; острых инфекционных заболеваниях, обострении хронических недугов. Прививку можно сделать через 2-4 недели после выздоровления или ремиссии. При нетяжелых ОРВИ - после нормализации температуры. При тяжелых осложнениях после введения первой дозы (анафилактический шок, судорожный синдром, температура выше 40 С и т.д.) введение второго компонента также запрещается. С осторожностью можно применять при хронических заболеваниях печени и почек, сахарном диабете, тяжелых заболеваниях системы кроветворения, эпилепсии, инсультах и других заболеваниях ЦНС, инфарктах миокарда в анамнезе, ИШМ, первичных и вторичных иммунодефицитах, аутоиммунных заболеваниях, заболеваниях легких, астме и ХОБЛ. \"ЭпиВакКорона\" Зарегистрирована в России и Туркменистане. Это генно-инженерная пептидная вакцина - на основе искусственных пептидов, копирующих фрагменты коронавируса. Вводится двукратно внутримышечно с интервалом в 2-3 недели. Иммунологическая эффективность 100%. Иммунная защита, ожидается, будет действовать не менее года. Сильных нежелательных явлений не выявлено, у немногих отмечена боль в месте укола и повышение температуры до 38,5. Кому рекомендована, противопоказания, особенности Применяют у взрослых 18-60 лет, также разрешено применение в возрасте 60+. Противопоказана беременным и кормящим, планируются исследования на детях до 18 лет. Нельзя применять при гиперчувствительности к какому-либо компоненту вакцины; тяжелых аллергических реакциях в анамнезе; острых инфекционных заболеваниях, обострении хронических недугов. Прививку можно сделать через 2-4 недели после выздоровления или ремиссии. При нетяжелых ОРВИ - после нормализации температуры. При тяжелых осложнениях после введения первой дозы (анафилактический шок, судорожный синдром, температура выше 40 С и т.д.) введение второго компонента также запрещается. С осторожностью можно применять при хронических заболеваниях печени и почек, сахарном диабете, тяжелых заболеваниях системы кроветворения, эпилепсии, инсультах и других заболеваниях ЦНС, инфарктах миокарда в анамнезе, ИШМ, первичных и вторичных иммунодефицитах, аутоиммунных заболеваниях, заболеваниях легких, астме и ХОБЛ. \"КовиВак\" Зарегистрирована Минздравом России 20 февраля 2021 года, планируется проведение процедуры одобрения ВОЗ, регистрация в зарубежных странах. Тип вакцины и способ введения Цельновирионная инактивированная - на основе \"убитого\" целого коронавируса. Это классический тип вакцин, масштабно производимых и используемых еще с прошлого века. Вводится дважды внутримышечно с интервалом две недели. Эффективность и побочные проявления Иммунологическая эффективность составляет 85%. Сроки действия иммунитета будут объявлены после окончания клинических исследований. Серьезных нежелательных явлений после вакцинации не выявлено. В редких случаях отмечалась легкая боль и уплотнение',\n",
       " ('COVID-19',\n",
       "  31,\n",
       "  1): 'в месте укола. Головная боль и легкое повышение температуры были у единичных участников. Кому рекомендована, противопоказания, особенности Применяют у взрослых 18-60 лет. Противопоказана беременным, кормящим и детям, так как исследования на этих группах не проводились. Также не применяют у людей, у которых наблюдались тяжелые поствакцинальные осложнения на любые предыдущие вакцинации, а также людям с тяжелыми аллергиями. Временно противопоказана: при острых лихорадочных состояниях, острых инфекционных и обострении хронических заболеваний. Прививку делают через 2-4 недели после выздоровления. Допускается возможность вакцинации при хронических заболеваниях почек, печени, нейроэндокринной системы, тяжелых заболеваниях кроветворения, аутоиммунных, аллергических заболеваниях, бронхиальной астме и др. Состояние пациента и возможность прививки с учетом фактора польза-риск оценивает лечащий врач.',\n",
       " ('COVID-19',\n",
       "  32,\n",
       "  0): 'Она получена биотехнологическим путем МОСКВА, 6 декабря. /ТАСС/. Новая отечественная вакцина для профилактики коронавирусной инфекции \"Гам-VLP-мультивак\" в инъекционной форме на основе вирусоподобных частиц, разработанная учеными Национального исследовательского центра эпидемиологии и микробиологии имени академика Н. Ф. Гамалеи, зарегистрирована Министерством здравоохранения РФ. Об этом сообщает пресс-служба ведомства. \"Минздрав России зарегистрировал новую отечественную вакцину для профилактики коронавирусной инфекции - \"Гам-VLP-мультивак\". [Это] вакцина на основе вирусоподобных частиц для профилактики коронавирусной инфекции, вызываемой SARS-CoV-2\", - говорится в сообщении. Там уточнили, что данная вакцина получена биотехнологическим путем, при котором не используется патогенный для человека вирус SARS-CoV-2. По информации пресс-службы, вакцина предназначена для внутримышечного введения. \"Вакцины на основе VLP - это рекомбинантные вакцины нового поколения, созданные на основе белков как антигенной структуры, которая имитирует структуру вируса. Подобные вакцины обеспечивают более безопасную альтернативу живым вакцинам на основе вирусов\", - отметили в пресс-службе. Как ранее сообщала ТАСС руководитель отдела молекулярной вакцинологии и иммунодиагностики центра имени Гамалеи, доктор биологических наук, член-корреспондент РАН Татьяна Гребенникова, вакцина будет представлена в двух формах - инъекционной и назальной. По ее словам, в ходе испытаний вакцина показала хороший профиль безопасности и иммуногенности. Ученая также отметила, что новая вакцина отличается от других вакцин Центра, таких как \"Спутник V\" и \"Спутник лайт\", включением нескольких антигенов - после иммунизации будут образовываться антитела широкого спектра действия, и вакцина будет защищать от коронавируса нескольких кладов, включая \"омикрон\".',\n",
       " ('COVID-19',\n",
       "  33,\n",
       "  0): 'In December 2019, adults in Wuhan, capital city of Hubei province and a major transportation hub of China started presenting to local hospitals with severe pneumonia of unknown cause. Many of the initial cases had a common exposure to the Huanan wholesale seafood market that also traded live animals. The surveillance system (put into place after the SARS outbreak) was activated and respiratory samples of patients were sent to reference labs for etiologic investigations. On December 31st 2019, China notified the outbreak to the World Health Organization and on 1st January the Huanan sea food market was closed. On 7th January the virus was identified as a coronavirus that had >95% homology with the bat coronavirus and > 70% similarity with the SARS- CoV. Environmental samples from the Huanan sea food market also tested positive, signifying that the virus originated from there [7]. The number of cases started increasing exponentially, some of which did not have exposure to the live animal market, suggestive of the fact that human-to-human transmission was occurring [8]. The first fatal case was reported on 11th Jan 2020. The massive migration of Chinese during the Chinese New Year fuelled the epidemic. Cases in other provinces of China, other countries (Thailand, Japan and South Korea in quick succession) were reported in people who were returning from Wuhan. Transmission to healthcare workers caring for patients was described on 20th Jan, 2020. By 23rd January, the 11 million population of Wuhan was placed under lock down with restrictions of entry and exit from the region. Soon this lock down was extended to other cities of Hubei province. Cases of COVID-19 in countries outside China were reported in those with no history of travel to China suggesting that local human-to-human transmission was occurring in these countries [9]. Airports in different countries including India put in screening mechanisms to detect symptomatic people returning from China and placed them in isolation and testing them for COVID-19. Soon it was apparent that the infection could be transmitted from asymptomatic people and also before onset of symptoms. Therefore, countries including India who evacuated their citizens from Wuhan through special flights or had travellers returning from China, placed all people symptomatic or otherwise in isolation for 14 d and tested them for the virus. Cases continued to increase exponentially and modelling studies reported an epidemic doubling time of 1.8 d [10]. In fact on the 12th of February, China changed its definition of confirmed cases to include patients with negative/ pending molecular tests but with clinical, radiologic and epidemiologic features of COVID-19 leading to an increase in cases by 15,000 in a single day [6]. As of 05/03/2020 96,000 cases worldwide (80,000 in China) and 87 other countries and 1 international conveyance (696, in the cruise ship Diamond Princess parked off the coast of Japan) have been reported [2]. It is important to note that while the number of new cases has reduced in China lately, they have increased exponentially in other countries including South Korea, Italy and Iran. Of those infected, 20% are in critical condition, 25% have recovered, and 3310 (3013 in China and 297 in other countries) have died [2]. India, which had reported only 3 cases till 2/3/2020, has also seen a sudden spurt in cases. By 5/3/2020, 29 cases had been reported; mostly in Delhi, Jaipur and Agra in Italian tourists and their contacts. One case was reported in an Indian who traveled back from Vienna and exposed a large number of school children in a birthday party at a city hotel. Many of the contacts of these cases have',\n",
       " ('COVID-19',\n",
       "  33,\n",
       "  1): 'been quarantined. These numbers are possibly an underestimate of the infected and dead due to limitations of surveillance and testing. Though the SARS-CoV-2 originated from bats, the intermediary animal through which it crossed over to humans is uncertain. Pangolins and snakes are the current suspects.',\n",
       " ('COVID-19',\n",
       "  34,\n",
       "  0): 'Роспотребнадзор принял дополнительные меры по усилению санитарно-карантинного контроля в пунктах пропуска через государственную границу Российской Федерации. В ежедневном режиме организован мониторинг за эпидемиологической обстановкой; отработан алгоритм действий медицинского персонала при подозрении на новую коронавирусную инфекцию; обеспечен контроль за готовностью медицинских организаций к приему больных из неблагополучных территорий; проработаны вопросы немедленной изоляции лиц с подозрением на заболевание и установления медицинского наблюдения за контактными лицами; определен предварительный алгоритм лабораторной диагностики в случае выявления лиц с подозрением на коронавирусную инфекцию. В связи с осложнившейся эпидемиологической ситуацией, вызванной распространением в Китае заболевания, вызванного новым коронавирусом, учеными ГНЦ ВБ «Вектор» Роспотребнадзора менее чем за 7 дней с момента публикации информации о генетической последовательности вируса разработаны средства для лабораторной диагностики нового патогена. Наборы основаны на молекулярно-генетическом методе полимеразной цепной реакции (ПЦР), который имеет ряд преимуществ – широко распространен, обладает высокой чувствительностью (с его помощью можно обнаруживать единичные копии вирусов) и короткий срок получения результатов (от 2-х до 4-х часов). Для диагностирования заболевания с использованием разработанных средств достаточно отобрать образец из носоглотки больного или подозрительного на заболевание человека. Разработаны два независимых средства для диагностики. Одно выявляет непосредственно новый коронавирус 2019-nCoV, а второе может использоваться, как для диагностирования заболевания, вызванного новым коронавирусом, так и для выявления другого опасного заболевания – «тяжелый острый респираторный синдром» (ТОРС или SARS), также известного как «атипичная пневмония». Разработанные наборы позволяют обнаруживать заболевание уже на ранних стадиях, что делает возможным осуществление экстренной лабораторной диагностики случаев, подозрительных на инфекцию, вызванную новым коронавирусом 2019-nCoV. Лаборатории ФБУЗ «Центры гигиены и эпидемиологии» Роспотребнадзора по всей России обладают необходимым оборудованием и специалистами для использования разработанных средств диагностики. В целях внедрения лабораторной диагностики нового коронавируса Роспотребнадзором разработаны и утверждены «Временные методические рекомендации по лабораторной диагностике нового коронавируса 2019 (2019-nCoV) методом полимеразной цепной реакции (ПЦР)» и реализуются все необходимые меры по предупреждению завоза и распространения болезни, вызванной новым коронавирусом. Тактика противоэпидемических мер будет корректироваться с учетом поступающей из КНР и Всемирной организации здравоохранения информации. На сайте Роспотребнадзора опубликована памятка о мерах личной профилактики для населения. Ситуация находится на строгом контроле в Роспотребнадзоре. Справочно: По информации Государственного комитета по вопросам гигиены и здравоохранения КНР, по состоянию на 21.01.2020 в мире зарегистрирован 291 подтвержденный случай заболевания, вызванного новым коронавирусом (2019-nCoV): 287 в Китае (преимущественно в г. Ухань, а также в Пекине, Шанхае и провинции Гуандун), 2 в Таиланде, 1 в Японии, 1 в Республике Южная Корея), включая 4 с летальным исходом. На данный момент известно о 15 заражённых медработниках и очевидна передача вируса от человека к человеку. Ежегодно более полутора миллиона граждан Китайской Народной Республики приезжает в Российскую Федерацию, примерно столько же наших сограждан посещает Китай. В целях недопущения распространения случаев заболеваний, вызванных новым короновирусом в Российской Федерации, российским туристам, выезжающим в КНР, необходимо соблюдать меры предосторожности: - при планировании зарубежных поездок уточнять эпидемиологическую ситуацию; - не посещать рынки, где продаются животные, морепродукты; - употреблять только термически обработанную пищу, бутилированную воду; - не посещать зоопарки, культурно-массовые мероприятия с привлечением животных; - использовать средства защиты органов дыхания (маски); - мыть руки после посещения мест массового скопления людей и перед приемом пищи; - при первых признаках заболевания, обращаться за медицинской помощью в лечебные организации, не допускать самолечения; - при обращении за медицинской помощью на территории Российской Федерации информировать медицинский персонал о времени и месте пребывания в КНР. Роспотребнадзор рекомендует заранее планировать свои поездки при посещении КНР и воздержаться от поездок в город Ухань до стабилизации ситуации.',\n",
       " ('COVID-19',\n",
       "  35,\n",
       "  0): 'Overview The COVID-19 vaccine tracker and landscape compiles detailed information of each COVID-19 vaccine candidate in development by closely monitoring their progress through the pipeline. The COVID-19 vaccine tracker: Provides summary tables of COVID-19 vaccine candidates in both clinical and pre-clinical development; Provides analysis and visualization for several COVID-19 vaccine candidate categories; Tracks the progress of each vaccine from pre-clinical, Phase 1, Phase 2 through to Phase 3 efficacy studies and including Phase 4 registered as interventional studies; Provides links to published reports on safety, immunogenicity and efficacy data of the vaccine candidates; Includes information on key attributes of each vaccine candidate and Allows users to search for COVID-19 vaccines through various criteria such as vaccine platform, schedule of vaccination, route of administration, developer, trial phase and clinical endpoints. Submission of data All data from independent institutions and vaccine developers are welcome to provide information on vaccine candidates being developed using the information template. Submitted data will be made openly accessible on a regular basis to enable fast data sharing. Data extraction tools and sources To ensure the latest information is available, the landscape will be updated twice a week (Tuesday and Friday, 17:00 CET) by searching, gathering and cross-checking data from multiple sources such as the Cochrane vaccine mapping tool, PubMed, ClinicalTrials.gov, WHO ICTRP and from a network of researchers and industry for new candidate vaccines by screening registered trials for clinical information. Where data is missing, we either do not add any information (blank cells) or we supplement information gathered from press or public releases. We welcome your feedback to help us update or make necessary changes, please note any updates will only be done twice a week. Disclaimer These landscape documents have been prepared by the World Health Organization (WHO) for information purposes only concerning the 2019-2020 pandemic of the novel coronavirus. Inclusion of any particular product or entity in any of these landscape documents does not constitute, and shall not be deemed or construed as, any approval or endorsement by WHO of such product or entity (or any of its businesses or activities). While WHO takes reasonable steps to verify the accuracy of the information presented in these landscape documents, WHO does not make any (and hereby disclaims all) representations and warranties regarding the accuracy, completeness, fitness for a particular purpose (including any of the aforementioned purposes), quality, safety, efficacy, merchantability and/or non-infringement of any information provided in these landscape documents and/or of any of the products referenced therein. WHO also disclaims any and all liability or responsibility whatsoever for any death, disability, injury, suffering, loss, damage or other prejudice of any kind that may arise from or in connection with the procurement, distribution or use of any product included in any of these landscape documents. Contact us The R&D Blueprint team is responsible for developing the COVID-19 candidate vaccine landscape database. For questions relating to the collection or sharing of data for novel COVID-19 vaccine candidates, please contact us at: rdblueprint@who.int',\n",
       " ('COVID-19',\n",
       "  36,\n",
       "  0): 'Also known as paediatric inflammatory multisystem syndrome (PIMS), paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS), as well as other variations. Multisystem inflammatory syndrome in adults (MIS-A) has also been reported, albeit more rarely.[1057]Qamar MA, Afzal SS, Dhillon RA, et al. A global systematic review and meta-analysis on the emerging evidence on risk factors, clinical characteristics, and prognosis of multisystem inflammatory syndrome in adults (MIS-A). Ann Med Surg (Lond). 2023 Sep;85(9):4463-75. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10473365 http://www.ncbi.nlm.nih.gov/pubmed/37663717?tool=bestpractice.com Definition: a rare but serious delayed complication that may develop in children and adolescents approximately 3 to 4 weeks (or longer) after the onset of acute infection, likely due to a post-infectious inflammatory process. The syndrome resembles, but is distinct from, Kawasaki disease, and also shares common features with toxic shock syndrome. It has a strong temporal association with SARS-CoV-2 infection.[1058]Abrams JY, Godfred-Cato SE, Oster ME, et al. Multisystem inflammatory syndrome in children associated with severe acute respiratory syndrome coronavirus 2: a systematic review. J Pediatr. 2020 Aug 5;226:45-54. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7403869 http://www.ncbi.nlm.nih.gov/pubmed/32768466?tool=bestpractice.com The case definition generally includes the presence of fever, elevated inflammatory markers, multi-organ dysfunction, a history of a positive SARS-CoV-2 test (or close contact with a confirmed case), and no plausible alternative diagnosis. However, case definitions vary.[432]World Health Organization. Multisystem inflammatory syndrome in children and adolescents temporally related to COVID-19: scientific brief. May 2020 [internet publication]. https://www.who.int/news-room/commentaries/detail/multisystem-inflammatory-syndrome-in-children-and-adolescents-with-covid-19 [1059]Royal College of Paediatrics and Child Health. Paediatric multisystem inflammatory syndrome temporally associated with COVID-19 (PIMS): national consensus management pathway. Sep 2020 [internet publication]. https://www.rcpch.ac.uk/resources/guidance-paediatric-multisystem-inflammatory-syndrome-temporally-associated-covid-19 \\u200b\\u200b Can occur rarely after COVID-19 vaccination.[1060]Yousaf AR, Cortese MM, Taylor AW, et al. Reported cases of multisystem inflammatory syndrome in children aged 12-20 years in the USA who received a COVID-19 vaccine, December, 2020, through August, 2021: a surveillance investigation. Lancet Child Adolesc Health. 2022 May;6(5):303-12. https://www.thelancet.com/journals/lanchi/article/PIIS2352-4642(22)00028-1/fulltext http://www.ncbi.nlm.nih.gov/pubmed/35216660?tool=bestpractice.com [1061]Ouldali N, Bagheri H, Salvo F, et al. Hyper inflammatory syndrome following COVID-19 mRNA vaccine in children: a national post-authorization pharmacovigilance study. Lancet Reg Health Eur. 2022 Apr 29:100393. https://www.thelancet.com/journals/lanepe/article/PIIS2666-7762(22)00086-2/fulltext http://www.ncbi.nlm.nih.gov/pubmed/35505833?tool=bestpractice.com Epidemiology: the risk of MIS-C within 2 months of confirmed infection was 0.05% in one Danish cohort study.[1062]Kildegaard H, Lund LC, Højlund M, et al. Risk of adverse events after covid-19 in Danish children and adolescents and effectiveness of BNT162b2 in adolescents: cohort study. BMJ. 2022 Apr 11;377:e068898. https://www.bmj.com/content/377/bmj-2021-068898 http://www.ncbi.nlm.nih.gov/pubmed/35410884?tool=bestpractice.com The risk decreased in the second year of the pandemic and decreased with evolution of the SARS-CoV-2 variant.[1063]Ward JL, Harwood R, Kenny S, et al. Pediatric hospitalizations and ICU admissions due to COVID-19 and pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 in England. JAMA Pediatr. 2023 Jul 31;177(9):947-55. https://jamanetwork.com/journals/jamapediatrics/fullarticle/2807910 http://www.ncbi.nlm.nih.gov/pubmed/37523172?tool=bestpractice.com \\u200b MIS-C continued to occur in 2023, but at low rates compared with early in the pandemic.[1064]Yousaf AR, Lindsey KN, Wu MJ, et al. Notes from the field: surveillance for multisystem inflammatory syndrome in children - United States, 2023. MMWR Morb Mortal Wkly Rep. 2024 Mar 14;73(10):225-8. https://www.cdc.gov/mmwr/volumes/73/wr/mm7310a2.htm http://www.ncbi.nlm.nih.gov/pubmed/38488279?tool=bestpractice.com \\u200b A systematic review found that the median age of patients was 7.8 years of age, and 60% of patients were male. Obesity was the most common comorbidity, followed by respiratory diseases, prematurity, and asthma.[1065]Abbas Q, Ali H, Amjad F, et al. Clinical presentation, diagnosis and management of multisystem inflammatory syndrome in children (MIS-C): a systematic review. BMJ Paediatr Open. 2024 Jun 6;8(1):e002344. http://www.ncbi.nlm.nih.gov/pubmed/38844384?tool=bestpractice.com \\u200b Risk factors for developing MIS-C include male sex, age 5 to 11 years, foreign-born parents, asthma, obesity, and life-limiting conditions.[1066]Rhedin S, Lundholm C, Horne A, et al. Risk factors for multisystem inflammatory syndrome in children: a population-based cohort study of over 2 million children. Lancet Reg Health Eur. 2022 Aug;19:100443. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9353212 http://www.ncbi.nlm.nih.gov/pubmed/35945929?tool=bestpractice.com Factors associated with more severe outcomes',\n",
       " ('COVID-19',\n",
       "  36,\n",
       "  1): 'included age >5 years; non-Hispanic Black ethnicity; symptoms of dyspnoea or abdominal pain; elevated C-reactive protein, troponin, ferritin, D-dimer, brain natriuretic peptide, or interleukin-6; and reduced lymphocyte or platelet counts.[1067]Abrams JY, Oster ME, Godfred-Cato SE, et al. Factors linked to severe outcomes in multisystem inflammatory syndrome in children (MIS-C) in the USA: a retrospective surveillance study. Lancet Child Adolesc Health. 2021 May;5(5):323-31. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7943393 http://www.ncbi.nlm.nih.gov/pubmed/33711293?tool=bestpractice.com Cases have been reported rarely in neonates (temporally associated with antenatal exposure), and there may be a higher risk of mortality in neonates compared with older children.[1068]Shaiba LA, More K, Hadid A, et al. Multisystemic inflammatory syndrome in neonates: a systematic review. Neonatology. 2022 May 5:1-13. https://www.karger.com/Article/FullText/524202 http://www.ncbi.nlm.nih.gov/pubmed/35512651?tool=bestpractice.com There appears to be a lower risk of MIS-C with the Omicron variant.[1069]Lopez L, Burgner D, Glover C, et al. Lower risk of multi-system inflammatory syndrome in children (MIS-C) with the omicron variant. Lancet Reg Health West Pac. 2022 Oct;27:100604. https://www.thelancet.com/journals/lanwpc/article/PIIS2666-6065(22)00219-X/fulltext http://www.ncbi.nlm.nih.gov/pubmed/36237982?tool=bestpractice.com Diagnosis: patients often have predominant cardiac dysfunction and gastrointestinal symptoms. The most common manifestations were fever (99%), gastrointestinal symptoms (77%), and dermatological symptoms (63%).[1065]Abbas Q, Ali H, Amjad F, et al. Clinical presentation, diagnosis and management of multisystem inflammatory syndrome in children (MIS-C): a systematic review. BMJ Paediatr Open. 2024 Jun 6;8(1):e002344. http://www.ncbi.nlm.nih.gov/pubmed/38844384?tool=bestpractice.com \\u200b The pooled prevalence of significant left ventricular dysfunction was 38%, coronary aneurysm or dilatation was 20%, and ECG abnormalities/cardiac arrhythmias was 28%.[1070]Haghighi Aski B, Manafi Anari A, Abolhasan Choobdar F, et al. Cardiac abnormalities due to multisystem inflammatory syndrome temporally associated with Covid-19 among children: a systematic review and meta-analysis. Int J Cardiol Heart Vasc. 2021 Mar 22:100764. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7983575 http://www.ncbi.nlm.nih.gov/pubmed/33778151?tool=bestpractice.com Neonates commonly present with cardiorespiratory compromise.[1068]Shaiba LA, More K, Hadid A, et al. Multisystemic inflammatory syndrome in neonates: a systematic review. Neonatology. 2022 May 5:1-13. https://www.karger.com/Article/FullText/524202 http://www.ncbi.nlm.nih.gov/pubmed/35512651?tool=bestpractice.com Approximately 20% of children develop acute kidney injury.[1071]Tripathi AK, Pilania RK, Bhatt GC, et al. Acute kidney injury following multisystem inflammatory syndrome associated with SARS-CoV-2 infection in children: a systematic review and meta-analysis. Pediatr Nephrol. 2023 Feb;38(2):357-70. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9362633 http://www.ncbi.nlm.nih.gov/pubmed/35943577?tool=bestpractice.com Three types of clinical manifestations have been recognised: persistent fever and gastrointestinal symptoms (the most common type); shock with heart dysfunction; and symptoms coincident with the diagnostic criteria for Kawasaki disease.[1072]Zou H, Lu J, Liu J, et al. Characteristics of pediatric multi-system inflammatory syndrome (PMIS) associated with COVID-19: a meta-analysis and insights into pathogenesis. Int J Infect Dis. 2021 Jan;102:319-26. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7666570 http://www.ncbi.nlm.nih.gov/pubmed/33202218?tool=bestpractice.com Patients with MIS-C presented more frequently with respiratory and gastrointestinal symptoms and shock compared with patients with Kawasaki disease; however, they had a lower incidence of conjunctivitis.[1073]Tong T, Yao X, Lin Z, et al. Similarities and differences between MIS-C and KD: a systematic review and meta-analysis. Pediatr Rheumatol Online J. 2022 Dec 5;20(1):112. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9721002 http://www.ncbi.nlm.nih.gov/pubmed/36471327?tool=bestpractice.com \\u200b Disease may be less severe after infection with the Omicron variant compared with the Alpha and Delta variants.[1074]Levy N, Koppel JH, Kaplan O, et al. Severity and incidence of multisystem inflammatory syndrome in children during 3 SARS-CoV-2 pandemic waves in Israel. JAMA. 2022 Jun 28;327(24):2452-4. https://jamanetwork.com/journals/jama/fullarticle/2792718 http://www.ncbi.nlm.nih.gov/pubmed/35588048?tool=bestpractice.com Investigations: inflammatory, coagulation, and cardiac markers were elevated in the majority of patients.[1065]Abbas Q, Ali H, Amjad F, et al. Clinical presentation, diagnosis and management of multisystem inflammatory syndrome in children (MIS-C): a systematic review. BMJ Paediatr Open. 2024 Jun 6;8(1):e002344. http://www.ncbi.nlm.nih.gov/pubmed/38844384?tool=bestpractice.com \\u200b Raised serum troponin level was reported in 33% of patients, and raised pro B-type natriuretic peptide (proBNP)/BNP level was reported in 44% of patients.[1070]Haghighi Aski B, Manafi Anari A, Abolhasan Choobdar F, et al. Cardiac abnormalities due to multisystem inflammatory syndrome temporally associated with Covid-19 among children: a systematic review and meta-analysis. Int J Cardiol Heart Vasc. 2021',\n",
       " ('COVID-19',\n",
       "  36,\n",
       "  2): 'Mar 22:100764. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7983575 http://www.ncbi.nlm.nih.gov/pubmed/33778151?tool=bestpractice.com Management: management is mainly supportive and involves a multidisciplinary team. Approximately 53% of patients required intensive care admission.[1065]Abbas Q, Ali H, Amjad F, et al. Clinical presentation, diagnosis and management of multisystem inflammatory syndrome in children (MIS-C): a systematic review. BMJ Paediatr Open. 2024 Jun 6;8(1):e002344. http://www.ncbi.nlm.nih.gov/pubmed/38844384?tool=bestpractice.com \\u200b The optimal choice and combination of immunomodulating therapies have not been definitively established. The World Health Organization recommends corticosteroids in addition to supportive care (rather than either intravenous immunoglobulin plus supportive care, or supportive care alone) in hospitalised children aged 0 to 18 years who meet the standard case definition. It also recommends corticosteroids in addition to supportive care in those who meet both a standard case definition for MIS-C and diagnostic criteria for Kawasaki disease.[85]World Health Organization. Clinical management of COVID-19: living guideline, 18 August 2023. Aug 2023 [internet publication]. https://www.who.int/publications/i/item/WHO-2019-nCoV-clinical-2023.2 In the US, the Infectious Diseases Society of America recommends initial therapy with intravenous immunoglobulin and/or a corticosteroid. Anakinra, tocilizumab, or infliximab may be used in refractory cases.[398]Bhimraj A, Morgan RL, Hirsch Shumaker A, et al. Infectious Diseases Society of America guidelines on the treatment and management of patients with COVID-19. Aug 2024 [internet publication]. https://www.idsociety.org/practice-guideline/covid-19-guideline-treatment-and-management \\u200b Guidance has also been published by the American College of Rheumatology.[1075]Henderson LA, Canna SW, Friedman KG, et al. American College of Rheumatology clinical guidance for multisystem inflammatory syndrome in children associated with SARS-CoV-2 and hyperinflammation in pediatric COVID-19: version 3. Arthritis Rheumatol. 2022 Apr;74(4):e1-20. https://onlinelibrary.wiley.com/doi/full/10.1002/art.42062 http://www.ncbi.nlm.nih.gov/pubmed/35118829?tool=bestpractice.com Consult your local guidelines for further information. Prognosis: the majority of patients had good outcomes with no significant medium- or long-term sequelae at 1-year follow-up.[1076]Davies P, du Pré P, Lillie J, et al. One-year outcomes of critical care patients post-COVID-19 multisystem inflammatory syndrome in children. JAMA Pediatr. 2021 Dec 1;175(12):1281-3. https://jamanetwork.com/journals/jamapediatrics/fullarticle/2783539 http://www.ncbi.nlm.nih.gov/pubmed/34459875?tool=bestpractice.com Follow-up at 6 months found that while cardiac, gastrointestinal, renal, haematological, and otolaryngology outcomes largely resolved at 6 months, muscular fatigue and emotional lability were common.[1077]Penner J, Abdel-Mannan O, Grant K, et al. 6-month multidisciplinary follow-up and outcomes of patients with paediatric inflammatory multisystem syndrome (PIMS-TS) at a UK tertiary paediatric hospital: a retrospective cohort study. Lancet Child Adolesc Health. 2021 Jul;5(7):473-82. https://www.thelancet.com/journals/lanchi/article/PIIS2352-4642(21)00138-3/fulltext http://www.ncbi.nlm.nih.gov/pubmed/34043958?tool=bestpractice.com The mortality rate was 3.9%.[1065]Abbas Q, Ali H, Amjad F, et al. Clinical presentation, diagnosis and management of multisystem inflammatory syndrome in children (MIS-C): a systematic review. BMJ Paediatr Open. 2024 Jun 6;8(1):e002344. http://www.ncbi.nlm.nih.gov/pubmed/38844384?tool=bestpractice.com \\u200b\\u200b Future COVID-19 vaccination: there are limited data on the safety of COVID-19 vaccines in people who have had MIS-C or MIS-A and who have not yet received a vaccine. A history of MIS-C or MIS-A may be a precaution for vaccination. Consult your local guidelines for more information.',\n",
       " ('COVID-19',\n",
       "  37,\n",
       "  0): 'This article is part of a series of explainers on vaccine development and distribution. Learn more about vaccines – from how they work and how they’re made to ensuring safety and equitable access – in WHO’s Vaccines Explained series. COVID-19 vaccines have proven to be safe, effective and life-saving. Like all vaccines, they do not fully protect everyone who is vaccinated, and we do not yet know how well they can prevent people from transmitting the virus to others. So as well as getting vaccinated, we must also continue with other measures to fight the pandemic. Vaccine efficacy and effectiveness All COVID-19 vaccines approved by WHO for emergency use listing have been through randomized clinical trials to test their quality, safety and efficacy. To be approved, vaccines are required to have a high efficacy rate of 50% or above. After approval, they continue to be monitored for ongoing safety and effectiveness. But what is the difference between efficacy and effectiveness? A vaccine’s efficacy is measured in a controlled clinical trial and is based on how many people who got vaccinated developed the ‘outcome of interest’ (usually disease) compared with how many people who got the placebo (dummy vaccine) developed the same outcome. Once the study is complete, the numbers of sick people in each group are compared, in order to calculate the relative risk of getting sick depending on whether or not the subjects received the vaccine. From this we get the efficacy – a measure of how much the vaccine lowered the risk of getting sick. If a vaccine has high efficacy, a lot fewer people in the group who received the vaccine got sick than the people in the group who received the placebo. So, for example, let’s imagine a vaccine with a proven efficacy of 80%. This means that – out of the people in the clinical trial – those who received the vaccine were at a 80% lower risk of developing disease than the group who received the placebo. This is calculated by comparing the number of cases of disease in the vaccinated group versus the placebo group. An efficacy of 80% does not mean that 20% of the vaccinated group will become ill. Vaccine effectiveness is a measure of how well vaccines work in the real world. Clinical trials include a wide range of people – a broad age range, both sexes, different ethnicities and those with known medical conditions – but they cannot be a perfect representation of the whole population. The efficacy seen in clinical trials applies to specific outcomes in a clinical trial . Effectiveness is measured by observing how well the vaccines work to protect communities as a whole. Effectiveness in the real world can differ from the efficacy measured in a trial, because we can’t predict exactly how effective vaccination will be for a much bigger and more variable population getting vaccinated in more real life conditions. Vaccine protection and timing Vaccines offer strong protection, but that protection takes time to build. People must take all the required doses of a vaccine to build full immunity. For two-dose vaccines, vaccines only give partial protection after the first dose, and the second dose increases that protection. It takes time before protection reaches its maximum level a few weeks after the second dose. For a one-dose vaccine, people will have built maximum immunity against COVID-19 a few weeks after getting vaccinated. Vaccine protection and infection Vaccines can stop most people from getting sick with COVID-19, but not everyone. Even after someone takes all of the recommended doses and waits a few weeks',\n",
       " ('COVID-19',\n",
       "  37,\n",
       "  1): \"for immunity to build up, there is still a chance that they can get infected. Vaccines do not provide full (100%) protection, so ‘breakthrough infections’ – where people get the virus, despite having been fully vaccinated – will occur. If vaccinated people do get sick, they are likely to have milder symptoms, in general 'It is very rare for someone vaccinated to experience severe illness or die. Vaccine protection and transmission COVID-19 vaccines are crucial tools in the pandemic response and protect against severe disease and death. Vaccines provide at least some protection from infection and transmission, but not as much as the protection they provide against serious illness and death. More evidence is needed to determine exactly how well they stop infection and transmission. After being vaccinated, individuals should continue taking simple precautions, such as physical distancing, wearing a mask, keeping rooms well ventilated, avoiding crowds, cleaning hands, and coughing into a bent elbow or tissue. Get tested if you are sick, even if you’ve been vaccinated. Check local advice where you live and work. Do it all! Vaccine protection and variants When cases increase and transmission accelerates, it’s more likely that new dangerous and more transmissible variants emerge, which can spread more easily or cause more severe illness. Based on what we know so far, vaccines are proving effective against existing variants, especially at preventing severe disease, hospitalization and death. However, some variants are having a slight impact on the ability of vaccines to guard against mild disease and infection. Vaccines are likely staying effective against variants because of the broad immune response they cause, which means that virus changes or mutations are unlikely to make vaccines completely ineffective. WHO continues to constantly review the evidence and will update its guidance as we find out more. For the latest updates on what we know about the COVID-19 variants, read our latest weekly epidemiological updates and our explainer on ‘the effects of virus variants on COVID-19 vaccines’. One of the best ways of guarding against new variants is to continue applying tried-and-tested public health measures and rolling out vaccines. All COVID-19 vaccines approved for emergency use listing by WHO have been thoroughly tested and proven to provide a high degree of protection against serious illness and death. As stronger virus variants emerge, it’s important to take your vaccine when it’s your turn.\",\n",
       " ('COVID-19',\n",
       "  38,\n",
       "  0): 'EMA takes any report of a death following the use of a medicine very seriously. These reports are routinely screened to detect any possible safety issue. As for other medicines, EMA has received reports of death following COVID-19 vaccination. Between January 2021 and December 2023, with around 1 billion doses of COVID-19 vaccines administered, about 12,000 spontaneous reports of death were received in EudraVigilance from healthcare professionals and members of the public. This does not mean that COVID-19 vaccines caused these deaths. When millions of people are vaccinated, it is likely that some of them will, by chance, experience an illness or even die in the days or weeks following vaccination. In most cases, these events would have happened even if they had not been vaccinated, especially in the elderly and people with pre-existing or undiagnosed medical conditions. When monitoring the safety of medicines, EMA and EU Member States search the reported suspected side effects for any unusual or unexpected patterns, such as a medical event occurring more often in vaccinated people than in the general population, which may indicate a safety concern. They also check the data from other sources, such as scientific studies and the medical literature. When a safety concern is detected, EMA and EU Member States investigate this thoroughly and take necessary action to protect public health. This continuous monitoring has allowed detection of very rare but serious side effects which, in very exceptional circumstances, may have contributed to the death of a vaccinated person. The vaccines’ product information highlights when a serious side effect could have led to death. Apart from these very exceptional cases of death potentially linked to serious side effects, there is no evidence so far suggesting that other reported deaths may be linked to vaccination. For more information, see: Documents: Signal assessment report on embolic and thrombotic events (SMQ) with COVID-19 Vaccine (ChAdOx1-S [recombinant]) – Vaxzevria (previously COVID-19 Vaccine AstraZeneca) (Other viral vaccines) Adopted Reference Number: EMA/205598/2021',\n",
       " ('COVID-19',\n",
       "  39,\n",
       "  0): 'To the Editor: The current coronavirus 2019 disease (COVID-19) pandemic has greatly changed our perspective of the risk for infection from contact, and the use of personal protective devices (PPDs) usually reserved for health care workers (HCWs) has spread to the general population, sometimes indiscriminately. As a result, medical glove stock has been depleted, but most of all medical gloves have become a source of medical concern.[1], [2], [3], [4] The World Health Organization (WHO) has warned about the limited protective efficacy of gloves. There is high risk for infection spread with their incorrect use that could instead favor the spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Regular use of gloves for daily activities may lead to a false sense of protection and to an increased risk for self-contamination. This would involve the involuntary touching of the face or the spreading of fomites to desks, phones, and computers keyboards. A study has found that viruses can survive on gloves for 2 to 4 hours.5 Appropriate use of gloves Hand-to-face contact has a substantial role in upper respiratory tract infections,6 , 7 although COVID-19’s main way of transmission remains symptomatic person-to-person through respiratory droplets.[1], [2], [3], [4] The Centers for Disease Control and Prevention (CDC) and the European Center for Disease Prevention and Control (ECDC) have recently provided guidance to regulate the use of gloves both in the health care setting and in the community.2 , 4 In the context of the COVID-19 pandemic (Table 1 ), gloves are recommended when caring for confirmed or suspected COVID-19 patients, especially when there is the risk of contact with body fluids (eg, blood, wound care, aerosol-generating procedures). Table 1. Actual recommendations for medical glove use amid the COVID-19 pandemic Health care workers Reducing microbial contamination from hand contact with blood and other body fluids Containing the risk of transmission from the health care worker to the patient and vice versa Containing the risk of germ dissemination to the environment and from one patient to another In the community Providing care to someone sick, especially if making contact with organic fluids Cleaning and disinfecting the person, and surfaces frequently touched in the environment Removing gloves after any contact with the patient, before touching other surfaces Handwashing before and after removing the gloves. Gloves wearing never substitute handwashing and sanitization Wearing gloves while running errands is not recommended Open in a new tab Hand protection with gloves is essential in any medical procedure, because skin cleaning/disinfection alone does not remove all pathogens, especially when the contamination is considerably high. Nonsterile disposable gloves should be prioritized, and ECDC alerts that no direct evidence documents an increased protection against COVID-19 through glove use, compared with proper hand hygiene alone. Meticulous hand hygiene with water and soap or by alcohol-based hand rub solutions is not avoided by the use of gloves. There are many different types of gloves, depending on the level of protection, tactility, risk of allergy, or cost (Table 2 ). Although biohazard risk requires frequent glove changing, the extended use of gloves, decontamination with hand disinfectants, and reuse are frequent.8 All of this should be avoided, because effects of hand sanitizers are tested on the skin, whereas application on gloved hands affects gloves’ mechanical properties. In a recent investigation,9 the application of 70% ethanol or 63% isopropanol commercial disinfectants reduced the tensile strength of latex and nitrile gloves, with a higher impact on nitrile gloves. Elongation did not change much with latex gloves, but nitrile gloves were affected. There are additional concerns about permeability, as alcohol can permeate any type of glove after',\n",
       " ('COVID-19',\n",
       "  39,\n",
       "  1): '10 minutes. Some types of gloves are permeated at 2 minutes, and repeated exposure to disinfectants can increase the permeability of the gloves. Alcohol is inactivated in the presence of organic matter, which can easily remain on used gloves, thus potentially driving the viral transmission. Table 2. Different glove materials and characteristics Type of glove Indication Latex Used in maneuvers with high biological risk, that is, when it is necessary to handle blood or body fluids in a repeated or prolonged way Good protection against pathogen High tensile stretch, best fit and sense of touch, extremely flexible Contraindicated in latex allergy; should not be used with organic soils, oils, gas, or grease Nitrile Alternative to latex, especially if allergic to latex, for high-biological-risk procedures Moderate protection against pathogens High puncture and chemical resistance; good comfort, soft and flexible, but stiffer than latex More-expensive option Vinyl–polyvinyl Use in case of low biological risk (low protection against pathogens), for patient cleaning activities Food prep (low heat) Average resistance to chemicals (alcohols), low tensile strength Less-expensive option Polyethylene Only maneuvers where one-handed and short-lasting sterility is required (intravesical catheterization, endotracheal aspiration) Loose fit, ideal for frequent glove change, but low protection against hazardous materials Very economical Synthetic gloves Latex- and polyvinyl-free surgical or diagnostic gloves Very loose, no protection against pathogens Least-expensive option Rubber or neoprene Used to prepare surgical instruments and endoscopes for disinfection, cleaning of environments High mechanical resistance Open in a new tab Observations and recommendations Extended length gloves are not necessary when providing care to suspected or confirmed COVID-19 patients. They are not specifically recommended, except for activities with increased risk, such as submerging hands into a solution. For standard procedures, it is sufficient to cover the cuff (wrist) of the gown while donning.[1], [2], [3], [4] Another common measure that is no longer recommended is “double gloving,” except for surgical procedures that carry a high risk of disrupting the integrity of the glove. Double gloving seems to increase the incidence of dermatologic side effects, from irritation and overhydration to induction of latex allergy. The increase of skin damage as the consequence of overzealous PPD use and hand hygiene is an emergent consequence of the COVID-19 handling.[10], [11], [12] About 74.5% of front-line COVID-19 HCWs developed hand dermatitis in the Chinese experience.13 A questionnaire-based study suggested that 88.5% of skin reactions on the hands are associated with the use of latex gloves.14 Three types of adverse events might occur: latex allergy, talcum powder reactions, and irritant dermatitis. Excluding latex allergy and powder within the gloves, the problem of excessive dryness and pruritus, associated with irritant dermatitis, may be aggravated by occlusion, leading to sweating and/or overhydration. This then may increase the permeability to sanitizers or detergents, creating a vicious cycle, plus aggravation of hand dermatitis.12 A peculiar pattern of hand dermatitis has been recognized, characterized by erythema and fine scaling on the palms and web spaces.15 This may be attributed to the depletion of surface lipids, resulting in deeper penetration of detergents, and progressive damage of skin layers is a major pathogenetic mechanism. Irritant contact dermatitis is more commonly found with iodophors, chlorhexidine, chloroxylenol, triclosan, and alcohol-based products, whereas allergic contact dermatitis develops due to quaternary ammonium compounds, iodine or iodophors, chlorhexidine, triclosan, chloroxylenol, and alcohol sensitization. To date, there have been no verified reports of COVID-19 infection as direct consequence of skin damage. Angiotensin-converting enzyme 2 (ACE2), which is the main cell receptor for SARS-CoV-2 entry, can be expressed in the basal layer of the epidermis, hair follicles, and eccrine glands, as well as on skin blood vessels.16',\n",
       " ('COVID-19',\n",
       "  39,\n",
       "  2): 'Basic skincare measures should be taken to avoid the risk of SARS-CoV-2 entry through the skin.[10], [11], [12], [13], [14], [15] Careful hand skin drying and hypoallergenic hand cream/emollients may be employed to prevent trapping sanitizers in the web spaces. Emollients may also be applied at other times to correct any residual dryness and scaling, or with the occurrence of hand dermatitis, topical corticosteroids are indicated. A final consideration is the generation of massive amount of medical waste, caused in part by the extensive use of PPDs.17 HCWs, together with the general population, are using more gloves than ever before, whereas it should be limited to very essential preventive measures. Conclusions Medical gloves remain an essential part of the infection-control strategy; however, caring for patients with COVID-19 has pointed out the need for more accuracy and respect of novel guidance. Prolonged use of gloves, outside of direct patient contact, might be self-defeating rather than protective. Hand dermatitis is an emerging concern. At this time, the U.S. Food and Drug Administration has not cleared, approved, or authorized any medical gloves for specific protection against the virus that causes COVID-19 or prevention of COVID-19 infection.',\n",
       " ('COVID-19',\n",
       "  4,\n",
       "  0): 'Работники здравоохранения подвержены наиболее высокому риску заражения COVID-19, так как находятся в постоянном контакте с лицами, подозрительными на заражение или имеющими вероятный либо предполагаемый диагноз COVID-19. В районах с широкой циркуляцией инфекции или кластерами ее передачи работники здравоохранения, лица, осуществляющие уход за больными, и посетители должны постоянно пользоваться масками при нахождении в медицинском учреждении даже в условиях соблюдения безопасной дистанции. Носить медицинскую маску должны работники здравоохранения на протяжении всей смены, за исключением случаев приема пищи и воды либо когда маску необходимо сменить по какой-либо причине: к работникам здравоохранения и лицам, осуществляющим уход, относятся: врачи, медицинские сестры, акушерки, фельдшеры, санитары, общинные медико-санитарные работники, а также другие лица, исполняющие свои обязанности в лечебно диагностических и консультативных помещениях учреждений здравоохранения; работники здравоохранения должны проводить обязательную гигиеническую обработку рук всякий раз перед тем, как прикоснуться к маске или лицу, перед надеванием или снятием маски, а также перед тем как поправить маску. В районах с единичными случаями COVID-19 работники здравоохранения, находящиеся в лечебно диагностических и консультативных помещениях учреждений здравоохранения, должны пользоваться масками на протяжении всей смены, за исключением случаев приема пищи и воды либо когда маску необходимо сменить по какой либо причине. Работники здравоохранения должны постоянно соблюдать безопасную дистанцию и, за исключением случаев оказания помощи, по возможности избегать близкого контакта с коллегами и другими лицами, находящимися в учреждении. Применение респираторов рекомендуется при выполнении процедур, сопровождающихся образованием аэрозолей, у пациентов с предполагаемым/подтвержденным диагнозом COVID-19. В подобных обстоятельствах ВОЗ рекомендует соблюдение мер профилактики инфекций с воздушно-пылевым и контактно-бытовым механизмами передачи. Известно о случаях заражения работников здравоохранения COVID-19 вне лечебно-профилактических учреждений, в связи с чем особую важность приобретает соблюдение ими общих мер профилактики в нерабочее время. Другие информационные ресурсы: в рамках серии курсов OpenWHO для работников здравоохранения подготовлен модуль, посвященный применению средств индивидуальной защиты; вы также можете ознакомиться с рекомендательным документом «Профилактика инфекций и инфекционный контроль при оказании медицинской помощи пациентам с предполагаемой или подтвержденной коронавирусной инфекцией (COVID-19)». Первая версия временных рекомендаций ВОЗ для работников здравоохранения, осуществляющих уход за лицами с подозрением на заражение или подтвержденным диагнозом COVID-19, была опубликована в январе 2020 г., и в число указанных средств для профилактики инфекций с воздушно-капельным/контактно‑бытовым механизмом передачи вошли: хирургические халаты, перчатки, медицинские маски, а также средства для защиты глаз.',\n",
       " ('COVID-19',\n",
       "  40,\n",
       "  0): 'Summary There is no evidence that the Bacille Calmette-Guérin vaccine (BCG) protects people against infection with COVID-19 virus. Two clinical trials addressing this question are underway, and WHO will evaluate the evidence when it is available. In the absence of evidence, WHO does not recommend BCG vaccination for the prevention of COVID-19. WHO continues to recommend neonatal BCG vaccination in countries or settings with a high incidence of tuberculosis.1 There is experimental evidence from both animal and human studies that the BCG vaccine has non-specific effects on the immune system. These effects have not been well characterized and their clinical relevance is unknown.2,3 On 11 April 2020, WHO updated its ongoing evidence review of the major scientific databases and clinical trial repositories, using English, French and Chinese search terms for COVID-19, coronavirus, SARS-CoV-2 and BCG. The review yielded three preprints (manuscripts posted online before peer-review), in which the authors compared the incidence of COVID-19 cases in countries where the BCG vaccine is used with countries where it is not used and observed that countries that routinely used the vaccine in neonates had less reported cases of COVID-19 to date. Such ecological studies are prone to significant bias from many confounders, including differences in national demographics and disease burden, testing rates for COVID-19 virus infections, and the stage of the pandemic in each country. The review also yielded two registered protocols for clinical trials, both of which aim to study the effects of BCG vaccination given to health care workers directly involved in the care of patients with COVID-19.4,5 BCG vaccination prevents severe forms of tuberculosis in children and diversion of local supplies may result in neonates not being vaccinated, resulting in an increase of disease and deaths from tuberculosis.6-8 In the absence of evidence, WHO does not recommend BCG vaccination for the prevention of COVID-19. WHO continues to recommend neonatal BCG vaccination in countries or settings with a high incidence of tuberculosis. References',\n",
       " ('COVID-19',\n",
       "  41,\n",
       "  0): 'В Хамовниках открыли коронавирусный стационар. Он заработал на базе клиники Первого московского государственного медицинского университета имени И.М. Сеченова на Погодинской улице. Стационар посетили Мэр Москвы Сергей Собянин и Министр здравоохранения России Михаил Мурашко. «Мы продолжаем активно создавать коечный фонд для борьбы с коронавирусом. До этого, как вы видели, мы активно использовали городскую сеть, городские клиники. В соответствии с поручением Президента Российской Федерации, Председателя Правительства Российской Федерации мы вместе с Министром здравоохранения отработали систему оказания содействия города за счет федеральных клиник, и они активно включились в работу. И здесь один из самых мощных коронавирусных центров, который будет насчитывать около двух тысяч коек в итоге, сегодня первая очередь открывается», — отметил Сергей Собянин. Мэр Москвы выразил благодарность Министру здравоохранения России и всем, кто активно включился в работу. Михаил Мурашко в свою очередь поблагодарил врачей, которые за очень короткий промежуток времени перепрофилировали больницу и подготовились к оказанию медицинской помощи. «Мы открываем многопрофильные стационары, которые выполняют такой перечень работ и услуг, что могут принимать совершенно разного профиля пациентов. Не только с монопрофильным заболеванием — с пневмонией, — но и в том числе с патологией, которая является хроническим заболеванием. Высококлассные специалисты фактически готовы оказывать помощь любого уровня. И очень важно, что сегодня и федеральные, и городские учреждения стали в один ряд для оказания помощи пациентам и жителям города Москвы», — сказал Министр. Коронавирусные центры заработают на базе четырех клинических больниц Первого московского государственного медицинского университета имени И.М. Сеченова. В рамках первой очереди перепрофилировали 700 коек: 400 коек — в университетской клинической больнице № 2 (корпус имени В.Х. Василенко, Погодинская улица, дом 1) и 300 — в клинической больнице № 4 (улица Доватора, дом 15). «Поскольку это клиника Первого меда, она еще выступает сегодня и федеральным консультативным центром. И каждый день врачи со всей страны консультируются со специалистами именно в этой клинике по поводу самых тяжелых пациентов. Плюс здесь разработали методические пособия, перевели зарубежную литературу, и фактически клиника сегодня является таким лидером по формированию тактики ведения пациентов и оказанию помощи специалистам со всей страны», — добавил Михаил Мурашко. Корпус имени В.Х. Василенко (клиника пропедевтики внутренних болезней, гастроэнтерологии и гепатологии) на Погодинской улице укомплектовали аппаратами искусственной вентиляции легких. Там установили компьютерный томограф, являющийся наиболее эффективным инструментом диагностики пневмонии, а также организовали 12 коек реанимации и интенсивной терапии. Чтобы не допустить распространение инфекции, в медучреждении организованы «чистые» и «грязные» зоны, установлены санпропускники (шлюзы). К 13 апреля на базе клиник Сеченовского университета планируют развернуть еще 1300 коек, в том числе: — 500 коек — в университетской клинической больнице № 3 (Клиника нервных болезней имени А.Я. Кожевникова и корпус имени Е.М. Тареева); — 800 коек — в университетской клинической больнице № 1. «Хотелось бы отметить, что коллектив подготовлен, врачебный коллектив подготовлен, профессорско-преподавательский состав также подготовлен. Все готовы к работе, и я думаю, что тот федеральный центр, который сегодня действует на нашей базе, дает достаточно серьезные консультации всем пациентам нашей страны, которые в них нуждаются», — рассказал ректор Сеченовского университета Петр Глыбочко. В городские поликлиники в качестве участковых терапевтов пришли работать 167 ординаторов, имеющих диплом Сеченовского университета по специальности «лечебное дело» или «педиатрия». Всего в московских поликлиниках сейчас работают 730 ординаторов московских вузов. У каждого из них есть сертификат, подтверждающий сдачу допускного экзамена к осуществлению медицинской или фармацевтической деятельности на должностях среднего медперсонала. Также ординаторы прошли первичную аккредитацию для работы врачами-терапевтами. Перед началом работы они освоили систему ЕМИАС и прошли подробный инструктаж по оказанию помощи пациентам с подозрением на коронавирусную инфекцию. Кроме того, более 100 студентов Сеченовского университета в качестве волонтеров участвуют в оказании адресной помощи пожилым и маломобильным гражданам, находящимся на самоизоляции, помогают медицинскому персоналу в больницах Москвы. Перепланировка палат и обеспечение безопасности: ГКБ имени С.И. Спасокукоцкого переоборудуют для пациентов',\n",
       " ('COVID-19',\n",
       "  41,\n",
       "  1): 'с коронавирусомСергей Собянин открыл коронавирусный стационар в городской клинической больнице № 15 имени О.М. Филатова Сейчас пациентов с COVID-19 принимают в 13 федеральных, городских и частных стационарах. Среди них городской медицинский комплекс в Коммунарке, инфекционные клинические больницы № 1 и 2, госпиталь на Шаболовке, детская городская клиническая больница имени З.А. Башляевой, Московский городской научно-исследовательский институт скорой помощи имени Н.В. Склифосовского, городская клиническая больница № 67 имени Л.А. Ворохобова (новый перинатальный корпус), городская клиническая больница № 15 имени О.М. Филатова, Морозовская детская клиническая больница, детская инфекционная клиническая больница № 6 (для новорожденных), городская клиническая больница № 52, клинический госпиталь «Лапино», стационар группы компаний «Медси». С 6 апреля после ремонта вводятся дополнительные койки в инфекционной клинической больнице № 1, а также готовятся коронавирусные отделения еще в 15 стационарах: — госпитале ветеранов войн № 3 (для лечения пациентов старшего возраста); — Национальном медико-хирургическом центре имени Н.И. Пирогова Минздрава России; — Научном центре здоровья детей Минздрава России; — Первом московском государственном медицинском университете имени И.М. Сеченова; — Российском геронтологическом научно-клиническом центре имени Н.И. Пирогова Минздрава России; — Лечебно-реабилитационном центре Минздрава России; — Национальном медицинском исследовательском центре кардиологии Минздрава России; — Национальном медицинском исследовательском центре колопроктологии имени А.Н. Рыжих Минздрава России; — Национальном медицинском исследовательском центре акушерства, гинекологии и перинатологии имени академика В.И. Кулакова Минздрава России; — центральной клинической больнице «РЖД-Медицина»; — дорожной клинической больнице имени Семашко ОАО «РЖД»; — Федеральном медицинском биофизическом центре имени А.И. Бурназяна; — Национальном медицинском исследовательском центре оториноларингологии; — Федеральном научно-клиническом центре специализированных видов медицинской помощи и медицинских технологий; — Федеральном клиническом центре высоких медицинских технологий. Во всех коронавирусных отделениях обучили персонал и подготовили помещения для приема пациентов с коронавирусной инфекцией. Принимать пациентов начнут по мере необходимости. В четырех городских стационарах открыты специализированные отделения для пациентов с внебольничной пневмонией. Речь о больнице имени Юдина, больнице имени Мухина, больнице имени Демихова и больнице имени Плетнева. Продолжается подготовка к развертыванию госпиталей для лечения больных еще в нескольких корпусах федеральных, городских и частных больниц. В поселении Вороновском (ТиНАО) в ближайшее время завершат строительство инфекционной больницы на 500 коек. При необходимости в городе может быть развернуто до 20 тысяч коек для госпитализации заболевших COVID-19. Также введена надбавка к заработной плате персонала коронавирусных стационаров. Для врачей она составляет 70 тысяч рублей в месяц, для среднего медицинского персонала — 50 тысяч рублей в месяц. Младший медперсонал и другие сотрудники получают дополнительно 30 тысяч рублей в месяц.',\n",
       " ('COVID-19',\n",
       "  42,\n",
       "  0): 'Pregnancy: systematic reviews and meta-analyses have found no evidence of a higher risk of adverse outcomes in pregnant women with mRNA vaccines. However, the evidence is of low certainty, the data have limitations, and continued monitoring is needed to further assess the risk.[375]Prasad S, Kalafat E, Blakeway H, et al. Systematic review and meta-analysis of the effectiveness and perinatal outcomes of COVID-19 vaccination in pregnancy. Nat Commun. 2022 May 10;13(1):2414. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9090726 http://www.ncbi.nlm.nih.gov/pubmed/35538060?tool=bestpractice.com [376]Carbone L, Trinchillo MG, Di Girolamo R, et al. COVID-19 vaccine and pregnancy outcomes: a systematic review and meta-analysis. Int J Gynaecol Obstet. 2022 Dec;159(3):651-61. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9349529 http://www.ncbi.nlm.nih.gov/pubmed/35810414?tool=bestpractice.com \\u200b\\u200b[377]Hagrass AI, Almadhoon HW, Al-Kafarna M, et al. Maternal and neonatal safety outcomes after SAR-CoV-2 vaccination during pregnancy: a systematic review and meta-analysis. BMC Pregnancy Childbirth. 2022 Jul 21;22(1):581. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9302221 http://www.ncbi.nlm.nih.gov/pubmed/35864455?tool=bestpractice.com [378]Tormen M, Taliento C, Salvioli S, et al. Effectiveness and safety of COVID-19 vaccine in pregnant women: a systematic review with meta-analysis. BJOG. 2023 Mar;130(4):348-57. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9878107 http://www.ncbi.nlm.nih.gov/pubmed/36444098?tool=bestpractice.com [379]Shafiee A, Kohandel Gargari O, Teymouri Athar MM, et al. COVID-19 vaccination during pregnancy: a systematic review and meta-analysis. BMC Pregnancy Childbirth. 2023 Jan 20;23(1):45. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9853484 http://www.ncbi.nlm.nih.gov/pubmed/36670389?tool=bestpractice.com \\u200b\\u200b Vaccination during pregnancy may protect the infant against infection and reduce the risk of hospitalisation; however, further research is required.[380]Badell ML, Dude CM, Rasmussen SA, et al. Covid-19 vaccination in pregnancy. BMJ. 2022 Aug 10;378:e069741. https://www.bmj.com/content/378/bmj-2021-069741 http://www.ncbi.nlm.nih.gov/pubmed/35948352?tool=bestpractice.com [381]Carlsen EØ, Magnus MC, Oakley L, et al. Association of COVID-19 vaccination during pregnancy with incidence of SARS-CoV-2 infection in infants. JAMA Intern Med. 2022 Aug 1;182(8):825-31. https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2793109 http://www.ncbi.nlm.nih.gov/pubmed/35648413?tool=bestpractice.com [382]Halasa NB, Olson SM, Staat MA, et al. Maternal vaccination and risk of hospitalization for Covid-19 among infants. N Engl J Med. 2022 Jul 14;387(2):109-19. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9342588 http://www.ncbi.nlm.nih.gov/pubmed/35731908?tool=bestpractice.com \\u200b\\u200b\\u200b',\n",
       " ('COVID-19',\n",
       "  43,\n",
       "  0): 'Objective: To evaluate systematically the efficacy and safety of COVID-19 vaccines. Methods: PubMed, Embase, Cochrane Library, Clinicaltrial.gov, CNKI, Wanfang Data, China Biomedical Literature Service System, and China Clinical Trial Registry were searched for randomized controlled trials of COVID-19 vaccines published up to December 31, 2020. The Cochrane bias risk assessment tool was used to assess the quality of studies. A qualitative analysis was performed on the results of clinical trials. Results: Thirteen randomized, blinded, controlled trials, which involved the safety and efficacy of 11 COVID-19 vaccines, were included. In 10 studies, the 28-day seroconversion rate of subjects exceeded 80%. In two 10 000-scale clinical trials, the vaccines were effective in 95% and 70.4% of the subjects, respectively. The seroconversion rate was lower than 60% in only one study. In six studies, the proportion of subjects who had an adverse reaction within 28 days after vaccination was lower than 30%. This proportion was 30%-50% in two studies and > 50% in the other two studies. Most of the adverse reactions were mild to moderate and resolved within 24 hours after vaccination. The most common local adverse reaction was pain or tenderness at the injection site, and the most common systemic adverse reaction was fatigue, fever, or bodily pain. The immune response and incidence of adverse reactions to the vaccines were positively correlated with the dose given to the subjects. The immune response to the vaccines was worse in the elderly than in the younger population. In 6 studies that compared single-dose and double-dose vaccination, 4 studies showed that double-dose vaccination produced a stronger immune response than single-dose vaccination. Conclusions: Most of the COVID-19 vaccines appear to be effective and safe. Double-dose vaccination is recommended. However, more research is needed to investigate the long-term efficacy and safety of the vaccines and the influence of dose, age, and production process on the protective efficacy.',\n",
       " ('COVID-19',\n",
       "  44,\n",
       "  0): 'Credit: CC0 Public Domain The measles-mumps-rubella (MMR) vaccine has been theorized to provide protection against COVID-19. In a new study published in mBio, an open-access journal of the American Society for Microbiology, researchers provide further proof of this by showing that mumps IgG titers, or levels of IgG antibody, are inversely correlated with severity in recovered COVID-19 patients previously vaccinated with the MMR II vaccine produced by Merck. MMR II contains the Edmonston strain of measles, the Jeryl Lynn (B-level) strain of mumps, and the Wistar RA 27/3 strain of rubella. \"We found a statistically significant inverse correlation between mumps titer levels and COVID-19 severity in people under age 42 who have had MMR II vaccinations,\" said lead study author Jeffrey E. Gold, president of World Organization, in Watkinsville, Georgia. \"This adds to other associations demonstrating that the MMR vaccine may be protective against COVID-19. It also may explain why children have a much lower COVID-19 case rate than adults, as well as a much lower death rate. The majority of children get their first MMR vaccination around 12 to 15 months of age and a second one from 4 to 6 years of age.\" In the new study, the researchers divided 80 subjects into 2 groups. The MMR II group consisted of 50 U.S. born subjects who would primarily have MMR antibodies from the MMR II vaccine. A comparison group of 30 subjects had no record of MMR II vaccinations, and would primarily have MMR antibodies from other sources, including prior measles, mumps, and/or rubella illnesses. The researchers found a significant inverse correlation (rs = -0.71, P < 0.001) between mumps titers and COVID-19 severity within the MMR II group. There were no significant correlations between mumps titers and disease severity in the comparison group, between mumps titers and age in the MMR II group, or between severity and measles or rubella titers in either group. Within the MMR II group, mumps titers of 134 to 300 AU/ml (n=8) were only found in those who were functionally immune or asymptomatic. All with mild COVID-19 symptoms had mumps titers below 134 AU/ml (n=17). All with moderate symptoms had mumps titers below 75 AU/ml (n=11). All who had been hospitalized and required oxygen had mumps titers below 32 AU/ml (n=5). Titers were measured by Quest Diagnostics using their standard diagnostic protocol. \"This is the first immunological study to evaluate the relationship between the MMR II vaccine and COVID-19. The statistically significant inverse correlation between mumps titers and COVID-19 indicates that there is a relationship involved that warrants further investigation,\" said coauthor David J. Hurley, Ph.D., professor and molecular microbiologist at the University of Georgia. \"The MMR II vaccine is considered a safe vaccine with very few side effects. If it has the ultimate benefit of preventing infection from COVID-19, preventing the spread of COVID-19, reducing the severity of it, or a combination of any or all of those, it is a very high reward low risk ratio intervention. Maximum seropositivity is achieved through two vaccinations at least 28 days apart. Based upon our study, it would be prudent to vaccinate those over 40 regardless of whether or not they already have high serum MMR titers.\"',\n",
       " ('COVID-19',\n",
       "  45,\n",
       "  0): 'The number of weekly laboratory-confirmed cases of the common respiratory viral diseases in England and Wales between 1989 and 2019 is presented in Fig. 1 along with some viruses that are transmitted by food, water or other routes. This gives some sense of the changes to surveillance over longer time periods and the more summer focus of enteric viruses compared to the winter focus of respiratory ones. There were 985,524 patients with a viral infection over this period. The data was used to select the coronavirus time series. Coronavirus infections (11,741 cases) were from 41 laboratories in England and Wales over the period 2012–2019, and included all age groups, although 29% of cases were in children under 3 years of age. Coronavirus infections had a similar seasonal distribution to influenza A and bocavirus, with a winter peak between weeks 2–8 (January and February). The distribution of cases through the year shows the different seasonal distribution of the annual peak for each virus. Seasonal coronavirus infections have a distribution that is similar to that of influenza A and bocavirus with a winter peak in weeks 2–8. Influenza B and human metapneumovirus were increased a few weeks earlier at around the New Year but the period of infection extends into the spring. Parainfluenza 1 and 2 both have a peak earlier in the late autumn/winter period between weeks 40 and 50 while parainfluenza 3 has a spring peak (weeks 10–25) that differs from all of the other viruses. Parainfluenza 1 and 2 viruses peak in the autumn/winter period between weeks 40 and 50, parainfluenza 3 has a spring peak (weeks 10–25), human metapneumovirus and influenza B virus increase at the end of the year, with infection extending into the spring. Adenovirus and rhinoviruses are relatively unseasonal. The more enteric viruses (coxsackievirus A and B; echovirus; enterovirus) have a summer peak (weeks 25–33), that show marked seasonality even with relatively sporadic cases. Most of the viral diseases exhibit an annual cycle of infection, with some of the diseases exhibiting a biennial cycle (i.e. every 2 years; e.g. parainfluenza 1 and 2; influenza B; Fig. 2). Fig. 1 Weekly seasonality of respiratory viruses 1989–2019. Cases per week of laboratory diagnosed viral infections reported in England and Wales. There are changes in laboratory surveillance over 31 years and includes changes resulting from improved diagnostic tests, improved sampling and testing, reductions in disease, introductions in vaccine, and improved surveillance as a result of the H1N1 outbreak in 2009. Many pathogens have an annual cycle, some have a biannual cycle (parainfluenza 1; parainfluenza 2; parainfluenza 4; influenza B), some are relatively unseasonal (adenovirus; poliovirus; rhinovirus), and some have a more sporadic nature (influenza A H3N2; echovirus; coxsackie A; coxsackie B Full size image Fig. 2 Cases per week for diagnosed respiratory viruses in England and Wales 1989–2019 and the percentage of cases per week that are in the 0–2 years old age group. a Coronavirus; b influenza A; c respiratory syncytial virus (RSV); d influenza B; e human metapneumovirus; f human bocavirus; g adenovirus; h rhinovirus. Weekly coronavirus cases and the cases as a percentage of all cases for i coronavirus cases 2009–2019; j influenza A cases 2008–2019 (covering the H1N1 outbreak in 2009); k Influenza cases 1989–2007 Full size image The increase in seasonal coronavirus cases in England and Wales in the autumn/winter period was associated with a period in which the percentage of the cases in patients under 3 years increased from 20 to 50% (Fig. 2a). Such large increases were not seen in influenza A (Fig. 2b), respiratory syncytial virus (Fig. 2c), influenza B',\n",
       " ('COVID-19',\n",
       "  45,\n",
       "  1): '(Fig. 2d), human metapneumovirus (Fig. 2e), or human bocavirus (Fig. 2f), adenovirus (Fig. 2g), rhinovirus (Fig. 2h). Weekly reports of coronavirus between 2012 and 2019 show an annual increase in the percentage of cases in children in the weeks 43–50 (October to December) as the annual rise in cases begins (Fig. 2i). This suggests that the start of the seasonal outbreak of coronavirus is frequently associated with an increase in infections in young children (0–2 years old) that may drive, at least in part, the seasonal increase. Some of the seasonality of respiratory viruses may be driven by the child population and results from a continuing increase in the susceptibility of this population cohort as a result of new births through the year. Data for influenza A before the H1N1 pandemic shows an increase in older children at the start of the pandemic (Fig. 2j), but an increase in the percentage of younger children can be seen in influenza cases before this period. (Fig. 2k). The climate of the study area (mean year air temperature, dew point temperature, relative humidity, precipitation, global radiation, sunshine hours, etc.) are shown in Figs. 3s–x. Global radiation, sunshine hours and temperature were increased in summer months and relative humidity higher in winter, with rainfall having a distribution that varied from week to week with a seasonal distribution that was higher in autumn and winter. Fig. 3 Seasonal coronavirus infections based on the week of infection and daily measures of the average weather for England and Wales between 2012 and 2019. a–f Coronavirus cases per week as a percentage of all cases and mean of weather parameters over the week. Each is lagged by a different number of weeks before the specimen date; a global radiation (kJ/m2/h), b relative humidity (%), c air temperature (°C), d sunshine (hours per day), e dewpoint temperature (°C), f precipitation (mm/hour); g–l Coronavirus cases as a percentage of cases per year and weekly mean of weather parameters separated into periods when the cases were declining (Down—days of year 43–224 and Up—days of year 225–366 and 1–42). g Global radiation (kJ/m2/h), h relative humidity (%), i air temperature (°C), j sunshine (hours per day), k dewpoint temperature (°C), l precipitation (mm/h); m–r Coronavirus case numbers split by quantiles of the weather parameters with a 2-week lag. m Global radiation (kJ/m2/h), n relative humidity (%), o air temperature (°C), p sunshine (hours per day), q dewpoint temperature (°C), r precipitation (mm/h); s–x Coronavirus cases by day of year and weather parameters with a 2-week lag. s Global radiation (kJ/m2/h), t relative humidity (%), u air temperature (°C), v sunshine (hours per day), w dewpoint temperature (°C), x precipitation (mm/h). y–ad Average weather parameters in the previous 28 days were split into ten quantiles based on the weather values. y Global radiation (kJ/m2/h), z relative humidity (%), aa air temperature (°C), ab sunshine (hours per day), ac dewpoint temperature (°C), ad precipitation (mm/h) Full size image There are strong correlations between coronavirus cases and average global radiation (the total solar radiation), with little recorded infection where this exceeds 300 kJ/m2/hour (Fig. 3a, m, s) using a 2-week lag before the specimen date. The cases occurring in the period of the year from day 43 (12 February) to day 224 (12 August) when cases are declining after the late winter peak (here called the Down period) had a closer relationship with global radiation and few cases where this was over 300 kJ/m2/h, compared to the Up period (days 225–366 and 1–42) where there were more cases over 300 kJ/m2/h (Fig. 2g). The difference',\n",
       " ('COVID-19',\n",
       "  45,\n",
       "  2): 'between Up and Down periods was less at longer lags, with the closest at 5 weeks but increased thereafter (Additional file 1: Fig. S2 a–h). Coronavirus infections were significantly more common where daily average global radiation was under 300 kJ/m2/hour compared to that expected by the global radiation based on days over the same time period (OR 4.3; CI 3.9–4.6; p < 0.001); (Fig. 3m). The distribution of cases in relation to average global radiation over the previous 4 weeks was a better fit than all other weather parameters (r2 = 0.91). Air temperature was strongly inversely correlated with cases (Fig. 2c, o, u) and the relationship was relatively similar between Down and Up periods (Fig. 2i), with less than 10% of cases where the air temperature was over 10 °C (Fig. 3aa). For air temperatures of 10 °C or more 2 weeks before, there were significantly fewer cases than that expected by the air temperature distribution based on days over the same time period (OR 0.15; CI 0.13–0.164; p < 0.001) and for air temperatures below 10 °C there were significantly larger case numbers (OR 6.72; CI 6.135–7.366; p < 0.001) (Fig. 3o). Relative humidity also correlated with coronavirus cases (Fig. 2b, n, t) and the Up and Down periods showed different relationships (Fig. 2h). Infection was uncommon where the relative humidity was below 75%. For relative humidity of 84% or more in the 2 weeks before, there were significantly more cases than that expected by the relative humidity distribution based on days over the same time period (OR 1.906; CI 1.755–2.07; p < 0.001) and for relative humidity below 84% there were significantly smaller case numbers (OR 0.524; CI 0.483–0.569; p < 0.001) (Fig. 3n). Sunshine hours showed a similar relationship to global radiation, but with a less close correlation (Figs. 2d, 2p, 2v). The decline with sunshine hours was more gradual than with global radiation (Fig. 2p) and the difference between the Down and Up periods was similar to that seen with global radiation (Fig. 2j). Infections were rare where daily sunshine exceeded 7 h. For daily sunshine of 4 h or more 2 weeks before, there were significantly fewer cases than that expected by the sunshine hours distribution based on days over the same time period (OR 0.406; CI 0.373–0.442; p < 0.001) and for sunshine below 4 h there were significantly larger case numbers (OR 2.457; CI 2.257–2.674; p < 0.001) (Fig. 3p). Dewpoint temperature was similar to air temperature (Figs. 2e, q, w), showing no difference between Down and Up periods (Fig. 2k) and less than 10% of infections occurred where the dewpoint temperature was over 7 °C (Fig. 2ac). There was no evidence that rainfall had a significant impact on the occurrence of infections with coronavirus (Figs. 2f, l, r, x, 2ad). The coronavirus cases were linked to averaged weather parameters in the previous 4 weeks, were sorted, separated into ten quantiles and expressed as the weather upper and lower standard deviations above the average, with maximum and minimum range and compared to all weather values over the days between 2012 and 2019 (Fig. 3y–ad). Coronavirus infections had lower global radiation than expected (Fig. 3y), relative humidity of cases was higher than expected (Fig. 3z), air temperature of cases was lower than expected (Fig. 3aa), sunshine hours of cases was lower than expected (Fig. 3ab), dewpoint temperature was lower than expected (Fig. 3ac), and precipitation was the same as expected (Fig. 3ad). When weather parameters were examined in combination for the Down and Up periods, there was consistent evidence that the Up period',\n",
       " ('COVID-19',\n",
       "  45,\n",
       "  3): 'was much more closely correlated with weather variables than the Down period (Fig. 3g–l), and with the mass of infections in the early weeks of the year and a gradual decline through to summer months (Fig. 3s–x). The association between global radiation and coronavirus infections was not constant and can be seen to cycle through the year (Additional file 1: Fig. S2h). Combinations of air temperature and global radiation, air temperature and relative humidity, and air temperature and sunlight showed a closer association in Up than Down periods (Additional file 1: Fig. S3a–S3f) and distribution of weather relationships across the days of the year (Additional file 1: Fig. S3g–S3j). The density of cases by combinations of weather parameters was also examined (Additional file 1: Fig. S4a–S4f).',\n",
       " ('COVID-19',\n",
       "  46,\n",
       "  0): 'Early recognition and rapid diagnosis are essential to prevent transmission and provide supportive care in a timely manner. Have a high index of clinical suspicion for COVID-19 in all patients who present with fever and/or acute respiratory illness; however, be aware that some patients may not present with signs or symptoms of a febrile respiratory illness. COVID-19 is a notifiable disease. Report all suspected or confirmed cases to your local health authorities. Isolate all suspected or confirmed cases immediately. Triage patients with a standardised triage tool and evaluate the severity of disease. Follow local infection prevention and control guidelines.[85]World Health Organization. Clinical management of COVID-19: living guideline, 18 August 2023. Aug 2023 [internet publication]. https://www.who.int/publications/i/item/WHO-2019-nCoV-clinical-2023.2 Suspect the diagnosis in patients with the following signs/symptoms: a new continuous cough, fever, altered sense of taste or smell, sore throat, fatigue, headache, dyspnoea, myalgia, arthralgia, rhinorrhoea, nasal congestion, sneezing, malaise, expectoration, or chest tightness/pain, particularly if the person has been in contact with a suspected or confirmed case. Patients may also present with gastrointestinal, cutaneous, or ocular symptoms.\\u200b[429]NHS England. COVID-19 symptoms and what to do. Mar 2023 [internet publication]. https://www.nhs.uk/conditions/covid-19/covid-19-symptoms-and-what-to-do [430]Luo X, Lv M, Zhang X, et al. Clinical manifestations of COVID-19: an overview of 102 systematic reviews with evidence mapping. J Evid Based Med. 2022 Sep;15(3):201-15. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9353366 http://www.ncbi.nlm.nih.gov/pubmed/35909298?tool=bestpractice.com Be on high alert for children and adolescents with acute gastrointestinal symptoms and signs of cardiac inflammation. Evidence so far suggests a milder or asymptomatic course of disease in children and adolescents.[431]Irfan O, Muttalib F, Tang K, et al. Clinical characteristics, treatment and outcomes of paediatric COVID-19: a systematic review and meta-analysis. Arch Dis Child. 2021 Feb 16;106(5):440-8. https://adc.bmj.com/content/106/5/440.long http://www.ncbi.nlm.nih.gov/pubmed/33593743?tool=bestpractice.com However, a rare multisystem inflammatory condition has been reported.[432]World Health Organization. Multisystem inflammatory syndrome in children and adolescents temporally related to COVID-19: scientific brief. May 2020 [internet publication]. https://www.who.int/news-room/commentaries/detail/multisystem-inflammatory-syndrome-in-children-and-adolescents-with-covid-19 Order a real-time reverse transcription polymerase chain reaction (RT-PCR) to confirm the diagnosis. Upper and lower respiratory specimens are preferred.[433]World Health Organization. Diagnostic testing for SARS-CoV-2: interim guidance. Sep 2020 [internet publication]. https://www.who.int/publications/i/item/diagnostic-testing-for-sars-cov-2 Rapid antigen tests may be recommended in certain circumstances.[434]World Health Organization. Antigen-detection in the diagnosis of SARS-CoV-2 infection. Oct 2021 [internet publication]. https://www.who.int/publications/i/item/antigen-detection-in-the-diagnosis-of-sars-cov-2infection-using-rapid-immunoassays [435]Government of the United Kingdom. Order COVID-19 rapid lateral flow tests [internet publication]. https://www.gov.uk/order-coronavirus-rapid-lateral-flow-tests \\u200b\\u200b[436]Centers for Disease Control and Prevention. Overview of testing for SARS-CoV-2. Aug 2024 [internet publication]. https://www.cdc.gov/covid/hcp/clinical-care/overview-testing-sars-cov-2.html Order the following laboratory investigations in hospitalised patients: full blood count, comprehensive metabolic panel, arterial blood gas, thyroid function tests, blood glucose level, coagulation screen, inflammatory markers, cardiac biomarkers, serum creatine kinase, and blood and sputum cultures for other pathogens. Pulse oximetry may reveal low oxygen saturation. Prioritise a chest x-ray in patients who are seriously ill with suspected pneumonia. Consider a computed tomography (CT) scan of the chest if chest x-ray is uncertain or normal.[437]British Society of Thoracic Imaging. Thoracic imaging in COVID-19 infection: guidance for the reporting radiologist - version 2. Mar 2020 [internet publication]. https://www.bsti.org.uk/media/resources/files/BSTI_COVID-19_Radiology_Guidance_version_2_16.03.20.pdf Consult local guidelines as imaging recommendations may vary.',\n",
       " ('COVID-19',\n",
       "  47,\n",
       "  0): 'No pharmaceutical products have yet been shown to be safe and effective for the treatment of COVID-19. However, a number of medicines have been suggested as potential investigational therapies, many of which are now being or will soon be studied in clinical trials, including the SOLIDARITY trial co-sponsored by WHO and participating countries. In many countries, doctors are giving COVID-19 patients medicines that have not been approved for this disease. The use of licensed medicines for indications that have not been approved by a national medicines regulatory authority is considered “off-label” use. The prescription of medicines for off-label use by doctors may be subject to national laws and regulations. All health care workers should be aware of and comply with the laws and regulations governing their practice. Further, such prescribing should be done on a case-by-case basis. Unnecessary stockpiling and the creation of shortages of approved medicines that are required to treat other diseases should be avoided. It can be ethically appropriate to offer individual patients experimental interventions on an emergency basis outside clinical trials, provided that no proven effective treatment exists; it is not possible to initiate clinical studies immediately; the patient or his or her legal representative has given informed consent; and the emergency use of the intervention is monitored, and the results are documented and shared in a timely manner with the wider medical and scientific community. The decision to offer a patient an unproven or experimental treatment is between the doctor and the patient but must comply with national law. Where it is possible and feasible for the treatment to be given as part of a clinical trial, this should be done unless the patient declines to participate in the trial. If it is not possible to give the treatment as part of a clinical trial, appropriate records of the use of the medicine must be kept, in compliance with national law, and outcomes for patients should be monitored and recorded. If early results from an unproven or experimental treatment are promising, the treatment should be studied in the context of a formal clinical trial to establish its safety, efficacy, risks, and benefits. Reference World Health Organization. Monitored emergency use of unregistered and experimental interventions (MEURI), http://www.who.int/ethics/publications/infectious-disease-outbreaks/en/. WHO continues to monitor the situation closely for any changes that may affect this interim guidance. Should any factors change, WHO will issue a further update. Otherwise, this scientific brief will expire 2 years after the date of publication. © World Health Organization 2020. Some rights reserved. This work is available under the CC BY-NC-SA 3.0 IGO licence. WHO reference number: WHO/2019-nCoV/Sci_Brief/Off-label_use/2020.1',\n",
       " ('COVID-19',\n",
       "  48,\n",
       "  0): 'A total of 369 patients (median age 59 years [IQR:49–68]; 241 (65.31%) male) were included. Most patients (68.56%) reported at least one comorbidity; more frequently: obesity (42.55%), diabetes mellitus (21.95%), and hypertension (21.68%). The median duration of symptoms prior to hospital admission was 7 days (IQR: 5–10). Reported in-hospital mortality was 49.59%. By multiple Cox regression, oxygen saturation (SaO 2 ) values of less than 90% on admission correlated with mortality, presenting 1.86 (95%CI: 1.02–3.39), 4.44 (95%CI: 2.46–8.02) and 7.74 (95%CI: 4.54–13.19) times greater risk of death for SaO 2 of 89–85%, 84–80% and <80%, respectively, when compared to patients with SaO 2 >90%. Additionally, age >60 years was associated with 1.88 times greater mortality. In order to understand the demographic and clinical characteristics of hospitalized patients with COVID-19 in Peru, as well as to identify prognostic factors for in-hospital mortality, we conducted a retrospective cohort study at a referral teaching hospital in Lima, Peru. Our goal was to identify prognostic factors that would allow for the design of future strategies to optimize the current management of COVID-19 patients in limited resource settings. From March 6, 2020, when the first COVID-19 case was reported in Peru, up to July 22, 2020, there have been 366,550 reported cases and 17,455 deaths (Case fatality rate: 4.76%) [ 10 ]. In order to mitigate the pandemic impact, the Peruvian Ministry of Health took numerous measures, like declaring a state of national emergency, designating hospitals exclusively for COVID-19 care, telemedicine implementation, increasing diagnostic testing with serological rapid diagnostic tests (RDT) and recommending treatments involving drugs with limited clinical evidence, like ivermectin. Despite these interventions, Peru is among the top ten countries with the highest number of reported cases worldwide with a total excess of deaths of 149% compared to recent years [ 11 ]. Most patients with COVID-19 only experience mild symptoms, but some develop a more severe disease that requires hospitalization. Approximately 14.2% to 30% of in-patients are further admitted to the ICU, primarily for mechanical ventilation [ 2 , 3 ]. The mortality in hospitalized COVID-19 patients ranges from 13.2% to 28.3%; with the majority of reports coming from China and United States of America (USA) [ 3 – 7 ]. However, very little information is available regarding in-hospital mortality and its prognostic factors in Latin America [ 8 , 9 ]. Statistical analysis was performed using Stata SE 16.1 (StataCorp., Texas, USA). Categorical variables were reported as frequencies and percentages, and continuous variables as medians with interquartile range (IQR). Comparisons were made between COVID-19 patients who were discharged from hospital or died by bivariate analysis: the Chi-square test and Fisher’s exact test were used for categorical variables while the Mann-Whitney U test and Kruskal-Wallis test were used for continuous variables, where a 2-sided p value <0.05 was considered statistically significant. Hazard ratios (HR) and its 95% confidence intervals (CI) were calculated using Cox proportional hazards regression to assess the association between baseline factors at admission and in-hospital mortality. Multivariate Cox regression model was constructed to evaluate the association of demographic characteristics, comorbidities and SaO 2 on admission with in-hospital mortality; variables were chosen via forward stepwise selection by statistical significance in the bivariate analysis and clinical relevance. Additionally, a secondary analysis was performed to include tachypnea on admission (replacing SaO 2 ) in the multivariate Cox regression model for in-hospital mortality. The proportional hazard assumptions were checked using Schoenfeld residuals. The paper medical records were archived after patient discharge, transfer or death. We reviewed all medical records that were available at HCH archive from March 29 to June 11, 2020; data',\n",
       " ('COVID-19',\n",
       "  48,\n",
       "  1): 'on patients that were hospitalized by the latter date were not included as the medical records were still in use. The information was collected using an electronic data collection form created on the Open Data Kit (ODK) Collect platform (Get ODK Inc., California, USA). Patient information included demographics, comorbidities, vital signs on admission, laboratory results, and hospitalization outcomes: length of stay, ICU admission, discharge, or death. Patients were excluded from the study if they were transferred to another facility or if they left the hospital against medical advice (AMA). Obesity was not determined by measuring weight and height, but rather by the patient’s self-reported weight and height or by treating physician’s criteria. Tachypnea was defined as ≥22 breaths per minute, and acute respiratory distress syndrome (ARDS) was defined using the pulse oximetry saturation/fraction of inspired oxygen (SaO 2 /FiO 2 ) ratio threshold of <235. A retrospective cohort study was conducted. We reviewed paper medical records of adult patients with COVID-19 admitted at Hospital Cayetano Heredia (HCH), a tertiary care referral hospital in the city of Lima, Peru which is at sea level. This public hospital serves approximately three million people, most of them of low-socioeconomic status and including a large number of immigrants, both Peruvians from rural areas and Venezuelan immigrants. During the SARS-CoV-2 pandemic, the hospital implemented 241 beds for COVID-19 care, including 23 ICU beds. The study was approved by the Research Ethics Committee of Hospital Cayetano Heredia (Approval code: 059–2020). Permission was granted to review all available records on the archive of hospitalized COVID-19 patients. Patient consent was not required as data gathered did not contain patient identifiable information. Predictive factors of in-hospital mortality were evaluated using Cox proportional hazards regression. Bivariate analysis found that all SaO 2 categories <90% on admission were associated with a hazard mortality from 1.93 (95%CI: 1.07–3.49) to 9.13 (95%CI: 5.50–15.14) times higher compared to SaO 2 ≥90%. Survival analysis based on SaO 2 categories was plotted using Kaplan-Meier curves ( Fig 3 ). In the bivariate analysis, age ≥60 years (cHR 2.83; 95%CI: 2.03–3.93) and hypertension (cHR 1.63; 95%CI: 1.18–2.26) were also associated with in-hospital mortality. In the multivariate analysis, after adjusting for male sex, age ≥60 years and comorbidities (obesity, diabetes, and hypertension), SaO 2 values of less than 90% correlated independently with in-hospital mortality, presenting 1.86 (95%CI: 1.02–3.39), 4.44 (95%CI: 2.46–8.02) and 7.74 (95%CI: 4.54–13.19) times greater risk of death for SaO 2 of 89–85%, 84–80% and <80%, respectively. Likewise, age ≥60 years was independently associated with in-hospital mortality (aHR 1.88; 95%CI: 1.32–2.69) ( Table 2 ). After secondary analysis, tachypnea was associated with in-hospital mortality both in the bivariate analysis (cHR 4.82; 95%CI: 1.54–15.12) and in the multivariate model when replacing SaO 2 categories (aHR 3.99; 95%CI: 1.27–12.54). One half of patients (183, 49.59%) died during hospitalization. Significant differences were observed in the proportion of patients aged ≥60 years and with comorbidities, mainly obesity and hypertension, with higher frequencies in the deceased group. The SaO 2 value on admission was lower in deceased patients compared to discharged patients (78% vs. 91%, p <0.001). This difference was maintained for each SatO 2 category and was also constant between different age groups ( Fig 2 ). The proportion of ARDS on admission or developed during hospitalization was greater among deceased participants. Lower absolute lymphocyte counts, higher white blood cell counts, and higher levels of C-reactive protein and lactate dehydrogenase were found among deceased participants. Respiratory and heart rates were elevated on admission, with a median of 28 breaths and 108 beats per minute (IQR: 25–32 and 96–118, respectively). Tachypnea',\n",
       " ('COVID-19',\n",
       "  48,\n",
       "  2): 'was present in 91.27%. Additionally, SaO 2 on admission was generally low with a median of 87% (IQR: 77–92), and more than a quarter of the patients (28.46%) were admitted with SaO 2 below 80%. The leukocyte count was elevated (11,565 cells/mm 3 , IQR: 8,260–15,270), and 76.47% of patients had leukocytosis with associated relative lymphopenia (<10% of the leukocyte count). Laboratory parameters of severe COVID-19, such as C-reactive protein (median 96 mg/dL, IQR: 48–192) and lactate dehydrogenase (median 469.5 U/L, IQR: 356–658) were also elevated. Most patients (72.63%) required high-flow oxygen therapy (FiO 2 ≥0.36); which included 226 (61.25%) that required use of a non-rebreather (NRB) mask at 15 L/min. Only 10.18% of patients on a NRB mask entered the ICU. Additionally, 67.21% of patients developed ARDS by SaO 2 /FiO 2 ratio during hospitalization. The median hospital stay before discharge was 8 days (IQR: 5–12), with death generally occurring on day 5 of hospitalization (IQR: 2–8). For discharged patients, the median length of stay was inversely proportional to SaO 2 values on admission: 7 days (IQR: 4–10) for SaO 2 ≥90%, 9.5 days (IQR: 6–13.5) for SaO 2 89–85%, 10.5 days (IQR: 8–14) for SaO 2 84–80%, and 22 days (IQR: 17.5–22.5) for SaO 2 <80% (p <0.001). A total of 373 medical records of adult patients with COVID-19 admitted at HCH were identified; four patients were excluded as they were transferred or left AMA ( Fig 1 ). Of the 369 patients included in the analysis, 241 (65.31%) were male and the median age was 59 years (IQR: 49–68). Most patients (68.56%) had at least one comorbidity: obesity (42.55%), diabetes mellitus (21.95%) and hypertension (21.68%). A total of 278 (75.34%) were confirmed COVID-19 cases, 250 (89.93%) by a positive serological RDT, 16 (5.75%) by a positive RT-PCR, and 12 (4.32%) by both methods. The median duration of symptoms prior to hospitalization was 7 days (IQR: 5–10) ( Table 1 ). Discussion This study serves as the first report of hospitalized COVID-19 patients in Peru. Unlike other published cohorts, our study presents data from a middle-income country in Latin America, that prior to the SARS-CoV-2 pandemic faced the challenges of a fragmented healthcare system, overcrowding of hospitals, and poor health expenditure (5% of the gross domestic product) [12]. Our primary care system is deficient in infrastructure and resources and so far has been unable to play a leading role in patient care during this pandemic [13, 14]. Our findings should be interpreted within this context. Our study population shares similar characteristics with other cohorts [15, 16]. The most frequent comorbidities were obesity, diabetes mellitus and hypertension, all of them associated with severe illness and/or mortality in patients with COVID-19 [17]. There was a higher frequency of obesity in the deceased group, which is consistent with previous reports, where obesity was found to be a risk factor for ICU admission and mechanical ventilation [18]. Also, certain conditions associated with obesity, like diabetes mellitus and dyslipidemia, where previously shown to have higher mortality in patients with COVID-19 [19]. Therefore, the presence of these comorbidities contribute to a higher demand of ICU care among hospitalized patients. Unfortunately, the Peruvian public healthcare system was not prepared to satisfy this demand, with only 0.2 ICU beds for every 10,000 inhabitants in Peru at the beginning of the pandemic [20]. One of the most striking findings of our study is the elevated in-hospital mortality; 49.6%. This mortality rate is much higher than in other middle- and high-income countries like China and USA, between 13.2% and 28.3% [3–7]. The same is true for other middle-income',\n",
       " ('COVID-19',\n",
       "  48,\n",
       "  3): 'Latin American countries, like Brazil and Mexico, with in-hospital mortality between 16.9 and 21.9% [8, 9]. In contrast, a similar mortality rate (42.8%) among hospitalized patients was reported in Honduras, where the median age of fatal COVID-19 cases was 62 years [21]. We have not found reports of in-hospital mortality in COVID-19 from low-income countries. Interestingly, unpublished data suggests that mortality from COVID-19 in private hospitals in Lima would not differ from high-income countries. Therefore, the higher mortality in our cohort from a public hospital could be associated with economic and social barriers for access to healthcare in Peru, as well as the amount of resources available for inpatient care [22]. The degree of hypoxemia (principally SaO 2 <85%) on admission was independently associated with in-hospital mortality in our cohort. Hypoxemia on admission as a predictor of in-hospital mortality was previously described in cohorts from China and USA [6, 7, 23]. However, to our knowledge, this is the first study from Latin America to identify a similar association. Petrilli et al. found SaO 2 <88% on admission was associated with mortality, although the proportion of patients with hypoxemia was lower than in our cohort (15.5% vs. 64.5%, respectively), correlating with lower in-hospital mortality (24.3%) [6]. These findings could suggest that a high proportion of patients from our cohort were hospitalized too late, after developing significant hypoxemia and resulting in higher mortality. Since the median time of symptom onset was similar for both groups, one could hypothesize that some of the patients in the diseased group developed hypoxemia faster prior to hospitalization. This implies that we need a better, faster way to recognize hypoxemia in the community setting, which becomes challenging in the context of the “silent hypoxemia” that many COVID-19 patients experience early in the course of disease [24]. Additionally, some of our patients experienced further delay in hospitalization, as they previously visited other facilities where they were unable to provide adequate support and oxygen therapy due to lack of resources. The importance of hypoxemia as a predictor of mortality goes beyond COVID-19 and involves other lower respiratory infections as well, as previously studied in children [25]. It comes as no surprise that median SaO 2 levels on admission are significantly lower in our cohort compared with others published [2, 6]. This suggests late presentation, either due to lack of awareness of alarm signs, lack of access to transportation, fear of going to a hospital, and other limitations to timely access to emergency medical care. Consequently, it is essential to encourage patients with suspected COVID-19 to attend the hospital early in the course of disease. In this regard, strategies such as the one implemented in Colombia, where patients receive pulse oximeters to monitor for hypoxemia while ambulatory, represent enticing low-risk interventions that could help with timely detection of hypoxemia. Pulse oximeters are now relatively inexpensive (between 30 to 40 US dollars in Peru) and can be made widely available in primary care facilities and in the community. This strategy already seems to be helping in the identification of decompensating outpatients with COVID-19 in USA to come to the hospital early for oxygen therapy [26]. For settings where implementation of pulse oximeter use in the community would not be feasible, measuring tachypnea could be an alternative predictive factor on mortality, one that is also simple and inexpensive, as shown in our additional exploratory analysis. Additionally, our findings raise the need for more hospital beds and increased availability of supplemental oxygen as a matter of public health priority; upgrades necessary to meet the expected increase in demand for early care of hypoxemia.',\n",
       " ('COVID-19',\n",
       "  48,\n",
       "  4): 'These upgrades will need to be complemented with a robust call center and ambulance system in which patients with alarm signs are quickly identified and transferred to the hospital. Hypoxia and inflammation are intertwined at the molecular, cellular, and clinical level [27]. Clinical events that produce acute hypoxemia enhance various cytotoxic functions of neutrophils and can promote hyperinflammation [27]. Animal models found that exposure to low oxygen concentrations results in increased vascular permeability, accumulation of inflammatory cells, and elevated serum cytokine levels [27]. Thus, hypoxia not only represents a consequence of respiratory disease, but also contributes significantly to progressive lung damage after establishment of the initial injury. One of the main complications of COVID-19 is ARDS, developing 8 days after symptom onset [28]. The greater the degree of hypoxemia or the delay in intubation, the greater the mortality in ARDS (27–45%) [29]. The median time from symptom onset in our cohort was 8 days and 98.9% of our deceased patients developed ARDS during hospitalization, which places ARDS as one of the main physiological processes suspected behind our high in-hospital mortality. It is important to note that, according to the level of hypoxemia described, most of our patients would qualify as critical on admission, in which case the mortality is similar to the one described by Wu & Mcgoogan (49%) [30]. In our cohort, 61.3% of patients required ICU care based on high-flow oxygen requirement (FiO 2 ≥ 0.8). Of these, only 10.2% were admitted to the ICU, which is extremely low. Not providing required ICU care in a timely fashion could have directly influenced in-hospital mortality. However, if one considers the possibility of some of our critically ill patients arriving at the hospital with prolonged hypoxemia, one could not rule out that their fatal outcome may have been unchanged even if they had access to ICU care. This would rely on the fact that the higher the hypoxemia, the higher the mortality in ARDS and also that tissue damage due to hypoxia may sometimes reach a “point of no return”, where patients with respiratory failure are refractory to standard critical care interventions [31]. Augmenting ICU capacity in our setting would have saved more lives. However, we should consider that ICU length of stay is two weeks on average for patients with COVID-19, which means that each ICU bed may be able to accommodate two patients per month. Furthermore, with ICU estimated mortality around 50%, we can assume that, for each ICU bed that we implement, we may save the life of one additional patient per month [16, 32]. In the context of a healthcare system with limited economic and human resources, further strained by the current pandemic, we believe that investing resources towards increasing hospitalization capacity for early general care and oxygen therapy, as well as empowering the primary healthcare system to early detect hypoxemia in the community would probably have a bigger impact on mortality than allocating too many resources on implementing more ICU beds. The fact that we found an inverse relationship between lower SaO 2 on admission and longer hospital length of stay further supports the notion that the strategies discussed would be more cost-effective. The main strength of our study is that our population and setting are representative of care for COVID-19 patients at a public hospital in Lima, the city with the most cases in Peru [10]. Our cohort design allows for obtaining adequate information on mortality risk on admission, taking into consideration clinical and demographic factors that may be applicable to any healthcare setting. It is also the first study to evaluate predictive factors',\n",
       " ('COVID-19',\n",
       "  48,\n",
       "  5): 'of mortality in our country and the first one to associate hypoxemia on admission with inpatient mortality in Latin America. We hope our findings contribute as a framework for designing patient-care strategies for COVID-19 that are adapted to the challenges of low- and middle-income countries. The main limitations of our study are related to the nature of retrospective data collection. Data recorded on medical records was that which was deemed relevant by the treating physician. However, we selected many variables that are considered relevant in the management of patients with COVID-19 and therefore recorded in all cases, allowing us to gather enough data to perform analysis with a high number of observations. Additionally, some records were not available for review by June 11, 2020, as they were being audited, retained prior to archiving, or still in use for patients still admitted to the hospital. The absence of this information could introduce a source of bias, although we estimate that the proportion of records meeting these criteria was small. Due to the method used to determine obesity it is possible that the number of obese patients in our cohort might have been underestimated and thus affected its association with mortality. Unlike other cohorts, the number of RT-PCRs performed among our patients is low, with the majority of cases being confirmed by means of a positive serologic RDT. Nevertheless, these serologic RDT have a specificity of 98.9% and their sensitivity increases to 70% in patients with more than7 days of symptoms, as is the case for the majority of our cohort [33]. Having evaluated patients with typical disease presentation and course in the context of an active pandemic, we consider the positive predictive value to be high.',\n",
       " ('COVID-19',\n",
       "  49,\n",
       "  0): 'A total of 515 environment samples were collected from businesses related to the patients and their neighborhood on 1st January 2020 and transported to Institute of Viral Disease, Chinese Center for Disease Control and Prevention (CCDC) for testing. On 12th January 2020, 70 more samples from wildlife shops in the seafood market were collected for testing. PCR testing results showed that out of the 585 samples, 33 were tested positive to contain 2019-nCoV, and the virus was successfully isolated from positive samples, suggesting that the virus originated from wildlife animals sold in the seafood market in southern China [12]. However, this idea was challenged by a Lancet report detailing the first 41 infected patients who were hospitalized between 16th December 2019 and 2nd January 2020 [13], which stated “No epidemiological link was found between the first patient and later cases”. Their data also showed that, in total, 13 of the 41 cases had no link to the marketplace. Speaking to Science, Daniel Lucey from Georgetown University noted that since the virus seems to have an incubation period of up to 14 days and the first reported case emerged on 1st December 2019, it is possible that the initial human infection took place in November if not earlier. If so, the virus possibly spread silently between people in Wuhan before the cluster of cases from Huanan Seafood Wholesale Market was discovered in late December [14, 15]. Tracing the source of the virus, controlling the source and clarifying the intermediate host of the virus are the key links to control the continuous transmission of the virus from animals to people. Work is currently underway to determine possible virus reservoirs. Person-to-person transmission of the coronavirus was confirmed by Chan and colleagues, who reported a case of five patients in a family cluster [16]. The estimates for reproduction number R 0 differ between different research teams and are constantly updated as more information comes to light. WHO has published their estimation of R 0 to be 1.4–2.5 using early information. Jonathan Read and colleagues from Lancaster University fitted a deterministic Susceptible-Exposed-Infected-Recovered (SEIR) metapopulation transmission model of infection within and between major Chinese cities to the daily number of confirmed cases of 2019-nCoV in Chinese cities and cases reported in other countries/regions, using an assumption of Poisson-distributed daily time increments. They determined the R 0 to be around 3.1 [17]. Majumder and colleagues at Boston Children’s Hospital used Incidence Decay and Exponential Adjustment (IDEA) model to estimate R 0 to be between 2.0 and 3.3 [18]. A large group of researchers from multiple institutes led by Jianhong Wu from York University proposed a more general deterministic SEIR compartmental model using more parameters, and arrived at a much higher R 0 number of 6.47 [19]. Li and colleagues analyzed data on the first 425 confirm cases in Wuhan and found that R 0 to be 2.2, without specifying their modelling method [15]. Table 1 compares the R 0 values from studies conducted by different groups. Table 1 R 0 Estimations from different groups Full size table According to National Health Commission in China [24], 9692 confirmed cases, 15,238 suspected cases, 213 deaths and 171 cures have been announced as on 31st January 2020. The number of confirmed cases has surpassed SARS in 2003. The actual number of cases is likely to be much higher as the confirmation is severely limited by the number of PCR test kits as well as staff available in each hospital. Figure 1a traces the number of confirmed cases, suspected cases and deaths and cured in China over time, with data taken',\n",
       " ('COVID-19',\n",
       "  49,\n",
       "  1): \"from the past daily statements of National Health Commission [24]. Figure 1b shows that the virus is spreading at an exponential speed after 16th January 2020, evident from the number of confirmed cases increases linearly with log scale. Using a single-term exponential model, we yielded a high R2 value of 0.95. The exponent is 0.38, meaning that the infected population doubles in size around every 1.8 days. A divergence from the exponential fit is observed at the data point on the 31st January 2020, and we expect further divergence in the future, due to the effect of the new quarantine measures starting to take place. Fig. 1 Number of confirmed cases, suspected cases, deaths, and cure in China over time. a Normal y-axis. b log-scale y-axis Full size image Currently (31st January 2020), the virus has been spread to 17 other countries [25], with number of confirmed cases: Thailand (14), Japan (11), Singapore (10), Australia (9), Malaysia (8), USA (6), France (5), Germany (5), Korea (4), United Emirates (4), Canada (3), Vietnam (2), Nepal (1), Finland (1), Sri Lanka (1), India (1), and Cambodia (1). Using back-calculation method, Nishiura has estimated the cumulative incidence in China in real time, allowing us to update and discuss the extent of transmission at the source [26]. All age groups can be infected. According to Bin Cao, the Executive vice President at the Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, 72% confirmed infection cases are aged 40 and above, 64% are male. 40% patients also have other underlying diseases such as diabetes and high blood pressure [27]. Modeling the spread Lauren Gardner from Johns Hopkins University led a team of researchers to model the real-time spread of the coronavirus. The team's new analysis was based on a model, the outbreak boundary control decision support framework, released last December, which integrates the dynamics of the outbreak and outbreak control of the new coronavirus pneumonia into a decision support tool to facilitate border control in the early stages of an outbreak to mitigate further spread. The team used a random set of population epidemic simulation tools to simulate the dynamics of the epidemic, and considered the border protection mechanism (immigration inspection) in the modeling process, which is mainly used to identify infected people or high-risk groups [23]. The aggregation population model is mainly constructed based on the population network, which is divided into urban and intercity parts, and the edge of the network is the air line between different cities. At each node of the network, the researchers used a discrete-time Susceptible-Exposed-Infected-Recovered (SEIR) model to simulate the dynamics of an outbreak.\",\n",
       " ('COVID-19',\n",
       "  5,\n",
       "  0): 'WHO has recommended two new drugs for COVID-19, providing yet more options for treating the disease. The extent to which these medicines will save lives depends on how widely available and affordable they will be. The first drug, baricitinib, is strongly recommended for patients with severe or critical COVID-19. It is part of a class of drugs called Janus kinase (JAK) inhibitors that suppress the overstimulation of the immune system. WHO recommends that it is given with corticosteroids. Baricitinib is an oral drug, used in the treatment of rheumatoid arthritis. It provides an alternative to other arthritis drugs called Interleukin-6 receptor blockers, recommended by WHO in July 2021. WHO has also conditionally recommended the use of a monoclonal antibody drug, sotrovimab, for treating mild or moderate COVID-19 in patients who are at high risk of hospitalization. This includes patients who are older, immunocompromised, having underlying conditions like diabetes, hypertension, and obesity, and those unvaccinated. Sotrovimab is an alternative to casirivimab-imdevimab, a monoclonal antibody cocktail recommended by WHO in September 2021. Studies are ongoing on the effectiveness of monoclonal antibodies against Omicron but early laboratory studies show that sotrovimab retains its activity. The panel of experts developing the guidelines also looked at two other drugs for severe and critical COVID-19: ruxolitinib and tofacitinib. Given their uncertain effects, WHO made a conditional recommendation against their use. Today’s recommendations, forming the eighth update of WHO’s living guidelines on therapeutics and COVID-19, are based on evidence from seven trials involving over 4,000 patients with non-severe, severe, and critical COVID-19. WHO is in discussions with manufacturers to secure global supply capacity and equitable and sustainable access to the newly recommended therapeutics. The Access to COVID-19 Tools Accelerator (ACT-A) Therapeutics pillar has been engaging with pharmaceutical companies to seek comprehensive access plans for low- and middle-income countries, so that these treatments can be rapidly deployed everywhere, not just in rich countries. The ACT-A is also looking to expand licensing scope to make the products more affordable. The two newly recommended drugs - baricitinib and sotrovimab - have been invited for WHO Prequalification, which assesses the quality, efficacy and safety of priority health products to increase access in lower income countries.',\n",
       " ('COVID-19',\n",
       "  50,\n",
       "  0): 'Background: Clinical observations demonstrated that COVID-19 related pneumonia is often accompanied by hematological and coagulation abnormalities including lymphopenia, thrombocytopenia, and prolonged prothrombin time. The evaluation of laboratory findings including coagulation and inflammation parameters may represent a promising approach for early determination of COVID-19 severity. Methods and materials: In the present study, we aimed to identify laboratory parameters present upon admission in patients with COVID-19 related viral pneumonia and associated with an early in-hospital development of refractory respiratory failure or severe acute respiratory distress syndrome requiring treatment in an intensive care unit. We investigated differences in the C-reactive protein (CRP) and fibrinogen levels, prothrombin time (PT) and international normalized ratio (INR) between COVID-19 patients who had been transferred to an ICU within two weeks after admission (n = 82) and COVID-19 patients with stable course of the disease (n = 74). Results: Multiple comparisons showed statistically significantly prolonged PT on admission in ICU-transferred COVID-19 patients (14.15 sec, median, CI 95% 13.4 ÷ 14.9) compared to the stable COVID-19 patients (13.25 sec, median, CI 95% 12.9 ÷ 13.6) (p-value = .0005). CRP levels upon admission were statistically significantly higher in ICU-transferred COVID-19 patients (132 mg/L, median, CI95% 113 ÷ 159) compared to the stable COVID-19 patients (51 mg/L, median, CI95% 33 ÷ 72) (p-value < .0001). On-admission fibrinogen and INR levels did not statistically significantly differ between ICU-transferred COVID-19 patients and stable COVID-19 patients. Conclusion: We suggest that CRP and PT levels present on admission in COVID-19 patients may be used as early prognostic markers of severe pneumonia requiring transfer to ICU.',\n",
       " ('COVID-19',\n",
       "  51,\n",
       "  0): 'What is long COVID? Most people with COVID-19 feel better within a few days or weeks of their first symptoms and make a full recovery within 12 weeks. For some people, symptoms can last longer. This is called long COVID or post COVID-19 syndrome. Long COVID is a new condition which is still being studied. Read about long COVID research studies on the National Institute for Health and Care Research (NIHR) website. Information: You can sign up to take part in long COVID research on the Be Part of Research website Symptoms of long COVID The most common symptoms of long COVID are: extreme tiredness (fatigue) feeling short of breath problems with your memory and concentration (\"brain fog\") heart palpitations dizziness joint pain and muscle aches However, there are lots of symptoms you can have after a COVID-19 infection, including: loss of smell chest pain or tightness difficulty sleeping (insomnia) pins and needles depression and anxiety tinnitus, earaches feeling sick, diarrhoea, stomach aches, loss of appetite cough, headaches, sore throat, changes to sense of smell or taste rashes Non-urgent advice: Contact a GP if: you\\'ve had symptoms of COVID-19 for 4 weeks or more and are worried What happens at your GP appointment If you see a GP about ongoing COVID-19 symptoms, they may suggest tests to find out more about your symptoms and rule out other conditions that could cause them. These tests might include: blood tests checking your blood pressure and heart rate a chest X-ray measuring your oxygen levels The GP will talk to you about the care and support you might need. You may be given advice about how to manage and monitor your symptoms at home. Getting a referral to a long COVID service If the symptoms are having an impact on your life, you may be referred to an NHS long COVID service for children, young people or adults. Long COVID services can offer: further tests to help diagnose or monitor your symptoms assessments for your physical and mental health treatment for or help managing long COVID symptoms referral to post-COVID rehabilitation for further support, if needed How long it takes to recover from COVID-19 How long it takes to recover from COVID-19 is different for everybody. Some symptoms can improve quickly and others last longer. The chances of having long-term symptoms does not seem to be linked to how ill you are when you first get COVID-19. People who had mild symptoms at first can still have long-term problems. Find out which healthcare organisations provide long COVID services in your area.',\n",
       " ('COVID-19',\n",
       "  52,\n",
       "  0): 'Since the beginning of the pandemic and in response to member state requests, the classification and terminologies unit has been progressively activating emergency codes for COVID-19 in ICD-10 and ICD-11 after consultation with the relevant committees and reference groups of the WHO Family of International Classifications (WHO-FIC) Network. February 2020 Emergency codes were activated for COVID-19:\\u200b confirmed diagnosis of COVID-19 \\u200b clinical or epidemiological diagnosis (suspected or probable) of COVID-19\\u200b April 2020 International guidelines for certification and classification (coding) of COVID-19 as cause of death were published in 7 languages. \\u200b September 2020 A set of additional codes upon request by member states were activated to be able to document or flag conditions that occur in the context of COVID-19. In particular the need for disambiguation between acute disease, late effects or lengthy course led to the neutral formulation “post-covid”. This term does not pre-empt any etiopathological links, and leaves space for linking any condition to a preceding acute COVID. Personal history of COVID-19 \\u200b Post COVID-19 condition \\u200b Multisystem inflammatory syndrome associated with COVID-19 \\u200b \\u200bJanuary 2021 A set of additional codes were activated for: Immunization to prevent COVID-19 Adverse reaction to a COVID-19 vaccine. This document provides instructions for coding and certification of deaths due to COVID-19. The instructions align with the WHO definition of deaths caused by COVID-19 and ICD, and ensure feasibility in all settings. The coding guidelines are very technical and only include some template cases. Questions may arise in daily work due to the inexorable richness of medical language and practice in certification. Support can be provided through the closest WHO-FIC Collaborating Centre or icd@who.int. The guidelines for certifiers aim at physicians and show best practice. Certifiers should receive their instructions as a separate document, without the coding guidelines. COVID-19 coding updates A set of additional categories were activated in ICD-10 to be able to document or flag presentation for conditions that occur in the context of COVID-19:',\n",
       " ('COVID-19',\n",
       "  53,\n",
       "  0): 'Elizabeth B Pathak , president Women’s Institute for Independent Social Enquiry, Olney, MD, USA beth.pathak{at}wiise-usa.org Lessons from the Placid Trial Convalescent plasma generated great enthusiasm in the earliest days of the coronavirus disease 2019 (covid-19) pandemic because of a plausible mechanism of action,1 its 100 year history of use in the treatment of other infectious diseases,2 and rapid availability from voluntary donors.3 In the linked PLACID Trial, Agarwal and colleagues (doi:10.1136/bmj.m3939) evaluated convalescent plasma for the treatment of moderate covid-19 in patients admitted to hospital in India.4 Strengths of the study included a primary “hard” outcome meaningful to patients, “real world” patient enrollment with no exclusions for comorbidities, careful attention to donor selection and safety screening of donated plasma, post facto quantitative testing of antibody titers in all plasma samples, assessment of secondary patient outcomes, and evaluation of the efficacy of the subsample of plasma donations that contained detectable titers of antibodies to severe acute respiratory coronavirus 2 (SARS-CoV-2), the virus responsible for covid-19. In prespecified, intention-to-treat analyses, the PLACID Trial investigators found no net benefit associated with convalescent plasma in patients admitted to hospital with moderate covid-19. The composite primary outcome (progression to severe disease or all cause mortality at 28 days) occurred in 19% (44/235) of patients in the intervention arm and 18% (41/229) of patients in the control arm (risk ratio 1.04, 95% confidence interval 0.71 to 1.54). Restricting the comparison to the subset of patients who received plasma with detectable antibody titers did not change the outcome.4 Small beneficial effects were found for resolution of shortness of breath and fatigue. However, these results should be interpreted with caution, because the trial was not blinded, so knowledge of treatment status could have influenced the reporting of subjective symptoms by patients who survived to day 7. The primary hypothesized mechanism of benefit from convalescent plasma is through direct antiviral action of neutralizing antibodies on SARS-CoV-2 RNA.1 In the PLACID Trial, a statistically significant 20% higher rate of conversion to a negative result for SARS-CoV-2 RNA occurred on day 7 among patients in the intervention arm. In plain English, this means that convalescent plasma did exactly what the investigators hoped it would do, yet there was no net clinical benefit to patients. Why might this be the case? The most common use of therapeutic plasma, which contains more than 1000 different proteins,1 is for the management of acute bleeding and complex coagulopathies.5 Despite the presence in plasma of anticoagulation factors such as antithrombin and protein C, the net effect of plasma is prothrombotic.5 Immunoglobulin therapy, which is derived from whole plasma, is subject to a US Food and Drug Administration warning about the risks of thrombosis, particularly in older patients, those with cardiovascular risk factors, and those with hypercoagulable conditions.5 It is now widely recognized that covid-19 is a life threatening thrombotic disorder.678 An excellent recent pathophysiology synthesis concluded that “SARS-CoV-2 not only produces an inflammatory and hypercoagulable state, but also a hypofibrinolytic state not seen with most other types of coagulopathy.”7 Most recently, plasma from convalescent covid-19 patients has been shown to directly cause endothelial cell damage in vitro.9 Following suggestions of benefit from observational studies, convalescent plasma was given to more than 100 000 patients admitted to hospital with covid-19 in the US between April and August—under the FDA’s expanded access treatment protocol.10 The authors of the safety update on the first 20 000 recipients said their results provided “robust evidence that transfusion of CP [convalescent plasma] is safe.”11 However, close examination reveals that adjudication of the “relatedness” of serious adverse thrombotic and cardiac events was conducted',\n",
       " ('COVID-19',\n",
       "  53,\n",
       "  1): 'by the treating physician, with no defined protocol and no independent review.11 Most of the 677 cardiac events (88.2%) and 113 thrombotic events (66.3%) were judged not to be related to transfusion, and these events were therefore excluded from the reported adverse event rates. Thrombotic events were not a prespecified outcome in the PLACID Trial and were not reported. Nonetheless, it is notable that progression to severe disease or death occurred in 20% (13/64) of patients who received convalescent plasma with no detected neutralizing antibodies compared with 18% (41/229) of controls. The PLACID Trial was a rigorous randomized controlled study on a topic of enormous global importance, ethically designed and implemented given the contemporaneous state of scientific knowledge about SARS-CoV-2.4 With publication of the findings, the bar has been raised for all ongoing and future trials. The following recommendations should be carefully considered by both safety monitoring and institutional review boards in light of the PLACID Trial findings: First, the potential harms of the non-immune components of convalescent plasma should be rigorously investigated, especially prothrombotic risks, and considered when choosing trial outcomes and participant exclusion criteria. Second, only donor plasma with detectable titers of neutralizing antibodies should be given to trial participants, to ensure that the potential for benefit exists for all intervention arm patients. Third, double blind designs with sham procedure controls should be the gold standard for future trials. Low risk sham procedures can be ethically acceptable under prescribed conditions.12 Fourth, non-immune plasma should not be used as a control intervention, because of potential harms and availability of lower risk alternatives such as normal saline. The desperation engendered by covid-19 demands that we strongly resist the urge to succumb to pandemic research exceptionalism.13 High quality clinical research must be an integral part of a coordinated international response.13 Specifically, scientific validity is a necessary component of ethical research.14 Low quality research not only wastes scarce resources, it is also inherently unethical.14 Finally, when multiple research teams require participants, triage committees are needed to direct recruitment away from low priority, duplicative, or underpowered trials with little potential for usable findings.1315 Institutions must guarantee that patients with covid-19 are informed of all available trial options and assured autonomy in their decisions about participation.15 Footnotes Competing interests: The BMJ has judged that there are no disqualifying financial ties to commercial companies. The authors declare the following other interests: EBP is the director of The COVKID Project, which conducts covid-19 surveillance for children and teenagers. The BMJ policy on financial interests is here: https://www.bmj.com/sites/default/files/attachments/resources/2016/03/16-current-bmj-education-coi-form.pdf.\" Provenance and peer review: Commissioned; not externally peer reviewed. This article is made freely available for use in accordance with BMJ\\'s website terms and conditions for the duration of the covid-19 pandemic or until otherwise determined by BMJ. You may use, download and print the article for any lawful, non-commercial purpose (including text and data mining) provided that all copyright notices and trade marks are retained. https://bmj.com/coronavirus/usage',\n",
       " ('COVID-19',\n",
       "  54,\n",
       "  0): 'Study characteristics From the literature search, we retrieved 2188 references and assessed 82 full-text articles. A total of 7 randomized controlled studies fulfilling the selection criteria were included in the analysis (Fig. 1 ). Among 7 included studies, there were total 9 control interventions with five different modalities: supportive care (n = 4), umifenovir (n = 2), novaferon (n = 1), lopinavir-ritonavir + novaferon (n = 1) and lopinavir-ritonavir + interferon beta 1b + ribavirin (n = 1). Umifenovir is a generic name of arbidol. It is used as an antiviral drug for influenza in Russia and China. Novaferon is a recombinant anti-tumour and anti-virus protein, which is developed using cDNA sequences of 12 human interferon subtypes. Its nucleotide sequences are 89% homologous to human interferon α-2b. The general characteristics of all included studies are presented in Table 1 [10], [11], [12], [13], [14], [15], [16]. Table 1. General and baseline characteristics of included studies. Study Design Study period (Months-Year) and Study site Study Population Total number of participants randomized/completed Age Male Gender (%) Co-existing conditions (%) Severity status (%) Drug, dose and duration of interventions Follow up duration (Days) Outcome evaluated Mean ± SD years/Median (IQR)* Median (IQR)* LR Comparator Cao et al., 2020 [10] Randomized, Open labelled trial Jan 2020 to Feb 2020 (China) All Hospitalized COVID-19 patients with evidence of lower respiratory tract involvement Total: 199/196LR: 99/96 SC: 100/100 LR: 58.0 (50.0–68.0)*SC: 58.0 (48.0–68.0)* LR: 61.6SC: 59.0 LR: DM (10.1) CrVD (5.1) SC: DM (13.0) CrVD (8.0) NEWS2 score at Day 1 LR: 5.0 (4.0–6.0)* SR: 5.0 (4.0–7.0)* LR (400–100 mg) orally every 12 h for 14 days SC 28 Mortality, Virological clearance, Adverse events Horby et al., 2020 [11] Randomized, Open labelled trial March 2020 to June 2020 (United Kingdom) All Hospitalized COVID-19 patients Total: 5040/4806LR: 1616/1394 SC: 3424/3412 LR: 66.0 (16.0)SC: 66.4 (15.8) LR: 60.0SC: 61.0 LR: DM (27.0) HD (25.0) SC: DM (28.0) HD (27.0) MV at randomization LR: (4.0)SR: (4.0) LR (400–100 mg) orally every 12 h for 10 days or until discharge SC 28 Mortality Hung et al., 2020 [12] Randomized, Open labelled trial Feb to March 2020 (China) All Hospitalized COVID-19 patients Total: 127/126LR: 41/40LR + IFB + RV: 86/86 LR: 52.0 (33.5–62.5)LR + IFB + RV: 51.0 (31.0–61.3) LR: 56.0LR + IFB + RV: 52.0 LR: DM (15.0) HT (32.0) LR + IFB + RV: DM (13.0) HD (27.0) Baseline NEWS2 score LR: 2 (2–2)LR + IFB + RV: 2 (1–2) LR (400–100 mg) orally every 12 h for 14 days LR (400–100 mg) orally every 12 h, IFB 1 to 3 doses alternate day (8 MIU) SC, RV 400 mg every 12 h for 14 days 30 Mortality, Adverse events Li et al., 2020 [13] Randomized, Open labelled trial Jan to April 2020** (China) Mild-Moderate COVID-19 patients Total: 86/86LR: 34/34UF: 35/35 SC: 17/17 LR: 50.7 (15.4)UF: 50.5 (14.6)SC: 44.3 (NS) LR: 50.0UF: 45.7SC: 41.2 Underlying chronic diseases LR: (20.6) UF: (14.3) SC: (35.3) Moderate cases LR: (82.4) UF: (94.3) SR: (82.4) LR (400–100 mg) orally every 12 h for 7–14 days Umifenovir (200 mg) every 8 h for 7–14 days SC 21 Mortality, Virological clearance, Radiological improvement, Adverse events Nazomi et al., 2020 [14] Randomized, Open labelled trial April to June 2020 (Iran) All Hospitalized COVID-19 patients Total: 100/100LR: 50/50 UF: 50/50 LR: 56.2 (14.8)UF: 56.6 (17.8) LR: 54.0UF: 66.0 LR: DM (26.0) HT (34.0) UF: DM (30.0) HT (44.0) Severe patients LR: (22.0) UF: (24.0) LR (400–100 mg) orally every 12 h for 10 days or until discharge Plus HCQ (400 mg) on Day 1 Umifenavir(200 mg) every',\n",
       " ('COVID-19',\n",
       "  54,\n",
       "  1): '8 h for 7–14 days SC Plus HCQ (400 mg) on Day 1 30 Mortality, Virological clearance, Radiological improvement, Adverse events Pan et al., 2020 [15] Randomized, Open labelled trial March to October 2020 (30 countries of Africa, America, Asia, Europe) Hospitalized COVID-19 patients Total: LR: 1411/1399 SC: 1380/1372 LR: NSSC: NS LR: 60.8SC: 58.4 LR: DM (24.4) HD (20.6) SC: DM (23.6) HD (21.1) LR: Ventilated (8.0)SC: Ventilated (8.3) LR (400–100 mg) orally every 12 h for 14 days SC 28 Mortality Zheng et al., 2020 [16] Randomized, Open labelled trial NS (China) All Hospitalized moderate to severe COVID-19 patients Total: 89/89LR: 29/29NF: 30/30LR + NF: 30/30 LR: 37.0 (26.0–54.0)*NF: 46.5 (40.0–63.8)*LR + NF: 50.0 (37.8–62.8) LR: 41.4NF: 56.7LR + NF: 43.3 LR: DM (6.9) HT (3.3) NF: DM (10.0) HT (6.7) LR + NF DM (10.0) HT (10.0) Severe patients LR: (3.4)NF: (6.7)LR + NF: (6.7) LR (400–100 mg) orally every 12 h – Duration NS NF: NF (20 μg) every 12 h inhalation – Duration NS LR + NF: LR (400–100 mg) orally every 12 h – Duration NS + NF (20 μg) every 12 h inhalation – Duration NS 09 Virological clearance, Adverse events Open in a new tab Cao et al. conducted an open labelled randomized study with a follow-up of 28 days. Of 199 randomized participants, 99 received lopinavir-ritonavir and 100 received standard care only. Participants in both groups were comparable at baseline for the age, gender, clinical features, laboratory values, comorbid conditions, National Early Warning Score 2 (NEWS2), days from illness to randomization and severity status. NEWS2 at admission is calculated based on respiration rate, oxygen saturation, systolic blood pressure, pulse rate and level of consciousness. Each parameter is scored from 0 to 3. The total possible score of NEWS2 ranges from 0 to 20. A higher score indicates greater clinical risk and the need for intensive monitoring. Both groups were comparable for the use of vasopressors, antibiotic agents and glucocorticoid therapy during the study period. However, the mean viral load was higher in patients who received lopinavir-ritonavir than those who received standard care alone (4.4 ± 2.0 vs. 3.7 ± 2.1) [10]. Horby et al. conducted an open labelled randomized study with a follow-up of 28 days. Of 5040 randomized participants, 1616 received lopinavir-ritonavir and 3424 received standard care only. Participants in both groups were comparable at baseline for the age, gender, ethnicity, comorbid conditions and requirement of respiratory support. The median duration of lopinavir-ritonavir treatment was 5 days (IQR: 2–8). Both groups were comparable for the use of azithromycin, dexamethasone, tocilizumab and convalescent plasma [11]. Hung et al. conducted an open labelled randomized trial with a follow-up of 30 days. Of 127 randomized participants, 41 assigned to receive lopinavir-ritonavir and 86 combined therapy (lopinavir-ritonavir, ribavirin and interferon beta-1b). Both groups were comparable at baseline for the age, gender, severity status, comorbidities, clinical presentations, radiological findings, days from illness to randomization, NEWS2 score and sequential organ failure assessment (SOFA) score and use of corticosteroids [12]. Li et al. conducted an open labelled, randomized study with a follow-up of 21 days. Of 86 randomized participants, 34 received lopinavir-ritonavir, 35 umifenovir and 17 standard care only. Participants in all three groups were comparable at baseline for the age, gender, clinical features, laboratory values, comorbid conditions, days from illness to treatment initiation, severity status and use of glucocorticoids [13]. Nozomi et al. conducted an open labelled, randomized study with a follow-up of 21 days. Of 100 randomized participants, 50 received lopinavir-ritonavir and 50 umifenovir. All participants received hydroxychloroquine 400 mg on day 1. Participants in',\n",
       " ('COVID-19',\n",
       "  54,\n",
       "  2): 'all both groups were comparable at baseline for age, gender, clinical features, comorbid conditions and severity status [14]. Pan et al. conducted an open labelled, randomized study with a follow-up of 28 days. Of 2791 randomized participants, 1411 received lopinavir-ritonavir and1380 umifenovir. Participants in all both groups were comparable at baseline for age, gender, comorbid conditions, previous days in the hospital before randomization, baseline respiratory support and severity status [15]. Zheng et al. conducted an open labelled, randomized study with a follow-up of 9 days. Of 89 randomized participants, 29 received lopinavir-ritonavir, 30 novaferon and 30 combinations of lopinavir-ritonavir and novaferon. Participants in all both groups were comparable at baseline for age, gender, clinical features, comorbid conditions and severity status. The median time from symptom onset to randomization was longer in the combination group of noveferon and lopinavir-ritonavir than individual drug groups [16].',\n",
       " ('COVID-19',\n",
       "  55,\n",
       "  0): \"As we continue to learn more about COVID-19 and its characteristics, there are many unknowns about its epidemiology such as hospitalisation and recovery-related outcomes that are critical for healthcare system preparedness [ Reference AlTakarli12 , Reference Goh, Kalimuddin and Chan13 ]. For example, the mean number of incubation days for COVID-19 varies greatly across the existing literature ranging from 2.5 [ Reference Zhang14 ] to >20 days [ Reference Guan15 , 16 ]. Our understanding of time from contracting the disease to recovery or death is even more limited. In this systematic review and meta-analysis, we tried to identify the studies that recruited patients diagnosed with COVID-19 and calculate pooled estimates for several epidemiological and clinical outcomes to help provide an overall picture of the epidemiological characteristics of COVID-19. Findings of this study could help inform the ongoing public health and public policy practices across the world. Although our understanding of COVID-19's epidemiology is evolving, it is assumed that SARS-CoV-2 is mainly transmitted via droplets and close contacts with people carrying the virus [ 2 ]. However, recent reports have also proposed the possibility of the virus being contracted via various surfaces, gastrointestinal transmission [ Reference Xiao8 ] and potentially airborne exposures [ 2 , Reference Lovelace, Higgins-Dunn and Feuer9 ]. Based on the existing evidence, elderly population, those with suppressed immune systems and underlying metabolic, cardiovascular or respiratory diseases are at an increased risk for adverse outcomes; however, recent reports from outside China, point to a considerable risk of severe outcomes among the general adult population (i.e. <65 years old) [ 10 , Reference Picard11 ]. The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was first identified in a few unusual pneumonia patients linked to the Wuhan seafood wholesale market in China in December 2019 [ Reference Chen1 ]. However, it soon grew out of China and the Coronavirus disease 2019 (COVID-19) was declared a pandemic on 11 March 2020, and has been reported in 216 countries, areas, or territories [ 2 ]. While the epidemic has slowed down in China due to the strict quarantine and preventive regulations, the numbers of COVID-19 patients (i.e. 10021401 as of 28 June, 2020) and confirmed deaths (i.e. 499913 as of 28 June, 2020) are rapidly increasing [ 2 ] and have surpassed that of other viruses in the coronavirus family with similar genomes to SARS-CoV-2. For example, SARS which emerged in 2003, infected 8098 patients and caused 774 deaths across 29 countries. The Middle East respiratory syndrome (MERS) which appeared in 2012, led to 2494 patients and 858 deaths across 27 countries [ Reference Daga3 – 6 ]. The healthcare systems in many countries such as the USA, Spain, Italy, France, UK, Turkey and Iran have been overwhelmed and struggling with the soaring number of patients [ 7 ]. Meta-analysis was performed using STATA's (V.15.1) metan (for numerical variables) and metaprop (for binary variables) commands. The 95% confidence intervals (CI) for binary variables were computed using the exact binomial method. Heterogeneity between the studies was assessed using both the I 2 statistic with a cut-off of 50% and the χ 2 test with P-value <0.10 [ Reference Deeks, Higgins, Altman, Higgins and Green19 ]. As all results turned out to be significantly heterogeneous, we used random-effects models to calculate the pooled point estimate and 95% CI for the CFR, mean time from onset of COVID-19 symptoms to first medical visit, ICU admission, recovery, and death. For the mean incubation period, we estimated 99% CI. We also conducted a random-effects meta-regression using STATA's metareg command to identify the sources of heterogeneity and\",\n",
       " ('COVID-19',\n",
       "  55,\n",
       "  1): \"explored the effect of study-level covariates where data were available (Supplementary Table S3). Meta-regression was considered when there were at least 10 studies included in the meta-analysis [ Reference Higgins and Green20 ]. A two-sided P-value <0.05 was considered as statistically significant. Data were extracted independently by the two authors (SJ and NN) and discrepancies were resolved through discussion or by arbitration with the senior author (HS). Data were extracted on publication date, study type (e.g. cross-sectional, case-series, cohort), location, sample size, as well as patients' age and sex. We also extracted data on exposure history, X-ray and computed tomography scan findings, symptoms and underlying conditions in addition to the main outcomes of interests including the number of deaths among confirmed COVID-19 patients (i.e. case fatality rate [CFR]), incubation period and time from onset of COVID-19 symptoms to first medical visit, ICU admission, recovery, and death. Quantitative studies were included in the review if they reported incubation period of of SARS-CoV-2 as well as time from onset of the symptoms to first medical visit, intensive care unit (ICU) admission, recovery (as defined by studies' authors) or death. Studies were also included if they reported the number of deaths among patients with a confirmed COVID-19 diagnosis. Studies were included in the meta-analysis if they provided data on the above-mentioned outcomes along with their standard error and sample size. Case-reports with a sample size of one were removed from the meta-analysis as they did not provide any dispersion estimate. Studies were not excluded based on language, location or measurement method. Given that this study used secondary data and involved no interaction with humans, no ethics approval was required. Following the Systematic Reviews and Meta-Analyses (PRISMA) checklist (see Supplementary Table S1) and the Peer Review of Electronic Search Strategies (PRESS) guideline [ Reference Moher17 , Reference McGowan18 ], we searched PubMed, Embase and Google Scholar from 1 December 2019 to 11 March 2020 for studies that measured and reported several characteristics of COVID-19 (e.g. incubation period, hospitalisation, death). Search terms were combined using appropriate Boolean operators and included subject heading terms/keywords relevant to COVID-19 (e.g. novel coronavirus, sars-cov2, coronavirus disease). Please see Supplementary Table S2 for our sample search strategy. The estimated mean number of days from the onset of COVID-19 symptoms to first clinical visit was 4.92 (95% CI: 3.95, 5.90). As shown in Figure 3 , out of the 24 studies included in the meta-analysis, only six were conducted outside China. Heterogeneity testing (I 2 = 98.3%) revealed notable differences among the included studies in the meta-analysis. Multivariate meta-regression results showed no significant differences in time from onset of symptoms to first clinical visit by country (China vs. others, Adjusted β = 1.51; P-value = 0.411), age (Adjusted β = 0.92; P-value = 0.153) or male percentage of the participants (Adjusted β = −2.60; P-value = 0.626). The estimated mean incubation period obtained from the included studies and the pooled mean are presented in Figure 2 . Out of the 18 studies included in the meta-analysis, 15 were conducted in China. The pooled mean incubation period was 5.68 (99% CI: 4.78, 6.59) days. Heterogeneity testing (I 2 = 98.4%) revealed notable differences among the included studies in the meta-analysis. Multivariate meta-regression results showed no significant differences in incubation period time by country (China vs. others, Adjusted β = 1.76; P-value = 0.375), age (Adjusted β = −1.16; P-value = 0.151) or male percentage of the participants (Adjusted β = −12.35; P-value = 0.058). We found a total of 1675 non-duplicate studies, 57 of which were included in the qualitative synthesis and\",\n",
       " ('COVID-19',\n",
       "  55,\n",
       "  2): '43 were included in the meta-analysis ( Fig. 1 ). A description of the main characteristics of the included studies is provided in Table 1 . The 57 studies included 27 cross-sectional, one case-control, one retrospective cohort and 28 case series/case report studies with sample sizes ranging greatly from one in case-reports to 58 182 for a study in the Hubei province [ Reference Dey21 ]. Inclusion criteria varied greatly across the studies but most study participants were hospitalised patients living or travelling from various provinces in China. Median (range) age of the participants was 46.2 (range: 17 days to 78.5 years) and about 60% were male. Most studies were conducted between January and February 2020. Clinical and epidemiological characteristics of the patients included in the study are presented in Table 2 . Among studies that reported exposure history among their participants, most patients were directly or indirectly traced back to the city Wuhan (e.g. lived in Wuhan or had recently travelled to Wuhan) and the Huanan seafood market in Hubei province, China. Several cases of contracting SARS-CoV-2 through close contacts with family members were also reported across the studies. Frequent CT or X-ray findings included thickened texture of the lungs, bilateral focal consolidation, lobar consolidation, ground-glass opacity, patchy consolidation, and unilateral/bilateral pneumonia. Common symptoms reported across the studies included fever, cough, shortness of breath, and fatigue/weakness. Only 15 studies reported some information about the pre-existing conditions of the patients; most of whom had metabolic and cardiovascular underlying conditions. Discussion We conducted a systematic review and meta-analysis to provide an overview of the epidemiological characteristics of COVID-19 based on the existing evidence as of 11 March 2020. Our findings suggest that COVID-19 has an average incubation period of 5.68 days and there is a lag of 4.92 days from onset of symptoms to the first clinical visit. On average, the symptoms of the patients lasted less than 20 days (18.55 days) before recovery was achieved and the CFR among confirmed COVID-19 patients was 2%, which significantly increased by age. Similar to previous studies [Reference Ji77], fever, dry cough, shortness of breath and fatigue were common symptoms among the patients in the included studies. As expected, history of direct or indirect exposure to Wuhan was frequently reported. The most common radiologic findings were bilateral consolidation and pneumonia [Reference Pormohammad78, Reference Lai79]. We found the average incubation period of COVID-19 infection to be less than 6 days which is broadly consistent with previously reported estimates [Reference Li23, Reference Backer, Klinkenberg and Wallinga29, Reference Liu80, Reference Lauer81]. The right tail of the 99% CI of the incubation period for COVID-19 was less than 7 days (6.59). This finding is of particular interest as there are many uncertainties about the incubation period of COVID-19. For example, both the World Health Organization and Centers for Disease Control and Prevention in the USA suggest an incubation period of 2–14 days. However, single outlier cases as long as 19 [Reference Bai47], 24 [Reference Guan15] or 27 days [16] have been reported; estimates that are possibly reflecting a double exposure. Our findings are of particular importance for quarantine-related policies and planning and suggest that the current 14-day quarantine period might be rather conservative. Indeed, we found that except for one small study from China in Anyang city on a cluster of six patients [Reference Bai47], all other studies reported incubation periods less than 10.6 days; therefore, a shorter period of 14 days would suffice and almost all people exposed to SARS-CoV-2 would show symptoms within 11 days of their initial exposure. All in all, decisions to modify or',\n",
       " ('COVID-19',\n",
       "  55,\n",
       "  3): 'keep the existing policies need to weigh the costs of extending active quarantine against the potential or costs of missing a few patients with delayed-onset symptoms. COVID-19 seems to have a longer incubation period than that of other acute respiratory viral infections such as human coronavirus (3.2 days), influenza A (1.43–1.64 days), parainfluenza (2.6 days), respiratory syncytial virus (4.4 days) and rhinovirus (1.4 days) [Reference Lessler82, Reference Nishiura and Inaba83]. Furthermore, the median incubation period for SARS has been estimated as 4.0 days in 2009 [Reference Lessler82], which is considerably lower than what we observed for COVID-19. The longer incubation period of the COVID-19 may be one of the major factors that helps explain its rapid spread in comparison with previous respiratory infection viruses. Other factors contributing to the spread of COVID-19 are the lag between the onset of symptoms and first clinical visit (i.e. 4.92 days) and the high number of asymptomatic COVID-19 patients. These findings suggest that MERS and SARS patients may progress to severe symptoms and respiratory failures [Reference Hui, Memish and Zumla84] much faster than most COVID-19 patients [Reference Lai85]. In comparison to MERS with a fatality rate of 35.67% [Reference Nassar86] and SARS with a fatality rate of 11% [87], we found COVID-19 to have a much lower CFR (2%) that significantly increased by age (5.6% increase for every 10-year increase). Although this estimate is comparable with previous studies [40, 88], it is important to recognise the limitations of calculating fatality rates of COVID-19 while the epidemic is still growing. As most COVID-19 patients remain asymptomatic and may recover without seeking medical care, it is likely that the true CFR among people infected with SARS-CoV-2 could be even lower. On the other hand, the estimated fatality rates reported in most studies need to be interpreted with caution as they are often based on the cumulative number of deaths relative to the number of confirmed cases, while patients who die on a given day have been infected at a much earlier date and this would bias the denominator used to calculate the fatality rate [Reference Baud89]. We acknowledge four main limitations of our systematic review. First, our findings are mainly based on studies that recruited patient from clinics and hospitals and therefore, may be biased towards more severe cases. Moreover, our data might be skewed towards early reporting from provinces in China and outcomes might be different in other countries in the Western context. We are, therefore, aiming to update the review as more data become available in the next 12 months to provide more accurate estimates. Second, many studies did not report the study outcomes by subgroups such as age or sex and we could not report group-specific outcomes. Third, we used the mean and the standard error of the incubation period assuming a normal distribution which may have led to the underestimation of the right tail of the distribution. Lastly, given the urgency of the topic and the heterogeneity of the studies included in the review, we did not conduct the risk of bias or quality assessment of the studies. Given the emerging nature of COVID-19 and the observational study design of most of the available evidence, most studies in the review are at a high risk of bias and the quality of existing evidence is relatively low. Nonetheless, our systematic review of literature provides an insightful picture of the epidemiological characteristics of COVID-19 which could inform ongoing public health and public policy decision makings.',\n",
       " ('COVID-19',\n",
       "  56,\n",
       "  0): 'Последнее обновление: 17 марта 2022 г. Согласно новым данным, коронавирусная инфекция выявляется менее чем у 2% новорожденных, чьи матери были инфицированы SARS-CoV-2 на момент родов. При этом, важно, что симптомы заболевания развиваются у еще меньшего числа новорожденных. В исследование также доказывается важная роль контакта «кожа к коже» между матерью и новорожденным. Естественные роды и грудное вскармливание не увеличивают риск передачи SARS- CoV-2 новорожденному. Эти данные были получены в рамках так называемого «текущего систематического обзора» – непрерывного глобального исследования, в рамках которого осуществляется сбор и обобщение данных о состоянии зараженных COVID-19 беременных женщин в различных странах мира. Исследование проводится под руководством коллектива ученых Университета Бирмингема (Соединенное Королевство), а также Всемирной организации здравоохранения и Специальной программы ООН по вопросам репродуктивного здоровья человека и ряда других партнеров. Риски для новорожденных и матерей Несмотря на то, что случаи передачи инфекции от матери к ребенку, как представляется, редки, в ходе исследования было установлено, что беременные женщины или женщины, недавно перенесшие беременность, в случае заражения COVID-19 подвержены более высокому риску госпитализации в отделениях интенсивной терапии или возникновения потребности в респираторной поддержке по сравнению с небеременными женщинами репродуктивного возраста. У беременных с COVID-19 также повышается вероятность преждевременных родов. Согласно исследованию, каждый четвертый младенец, рождающийся от матери с COVID-19, поступает в неонаталогическое отделение, однако данные о причинах госпитализации отсутствуют. При этом показатели мертворождений и неонатальной смертности находятся на низком уровне. Как и в целом в популяции, у беременных риск развития тяжелых осложнений в результате COVID-19 повышается в случае наличия фоновых соматических заболеваний, таких как диабет или гипертония; более высокому риску также подвержены представители этнических групп с темной кожей, женщины вынашивающие ребенка в позднем возрасте или имеющих избыточную массу тела. «Фактические данные говорят нам о том, что независимо от факта беременности при наличии таких сопутствующих заболеваний, как диабет или повышенное кровяное давление, вы подвергаетесь повышенному риску», – комментирует ситуацию одна из авторов исследования Мерседес Боне. Актуальность исследования для здравоохранения Медицинским специалистам следует понимать, что беременные женщины с COVID-19 и их новорожденные младенцы могут с большей вероятностью нуждаться в специализированной помощи, и обеспечивать возможность получения ими такой помощи. Это особенно актуально для беременных женщин с COVID-19, у которых есть другие сопутствующие заболевания или факторы риска. Следует также подчеркнуть, что право женщины на позитивный опыт беременности и родов подлежит защите независимо от того, инфицирована ли она COVID-19 или нет. Узнать подробнее Кроме того, важно учитывать, что COVID-19 повышает уровень стресса и тревоги, и такие переживания особенно часто испытывают беременные и недавно перенесшие беременность женщины, а также их партнеры, дети и члены семьи; и медицинские специалисты также должны проявлять компетентность и отзывчивость при реагировании на нужды беременных. ВОЗ продолжает работу по дальнейшему изучению специфики и периодов риска вертикальной передачи SARS-CoV-2. Узнать подробнее',\n",
       " ('COVID-19',\n",
       "  57,\n",
       "  0): 'Каждый год табак уносит жизни более 8 миллионов человек во всем мире. Более 7 миллионов из этих случаев летальных исходов связаны с непосредственным употреблением табака, и около 1,2 миллиона – с пассивным курением некурящих людей. Общеизвестно, что курение табака является фактором риска для многих респираторных инфекций и увеличивает тяжесть течения респираторных заболеваний. Обзор исследований экспертов в области общественного здравоохранения, проведенный ВОЗ 29 апреля 2020 г., показал, что у курящих людей риск развития тяжелого течения COVID-19 выше, чем у некурящих. COVID-19 является инфекционным заболеванием, которое поражает в первую очередь легкие. Курение негативно влияет на функцию легких, затрудняя организму борьбу с коронавирусами и другими возбудителями заболеваний. Табак также является основным фактором риска неинфекционных заболеваний, таких как рак, диабет, сердечно-сосудистые и респираторные заболевания, и люди с такими заболеваниями подвержены более высокому риску развития тяжелого течения COVID-19. Имеющиеся исследования показывают, что у курильщиков более высокий риск развития тяжелого течения заболевания и летального исхода. ВОЗ постоянно проводит оценку новых исследований, в том числе тех, в которых изучается связь между употреблением табака или никотина и COVID-19. ВОЗ призывает исследователей, ученых и средства массовой информации проявлять осторожность в отношении распространения недоказанных утверждений о том, что табак или никотин могут снизить риск инфицирования COVID-19. В настоящее время имеется недостаточно информации для подтверждения какой-либо связи между табаком или никотином с профилактикой или лечением COVID-19. Чтобы помочь курящим людям бросить курить, разработана никотин-заместительная терапия, такая как жевательная резинка и пластыри. ВОЗ рекомендует курящим людям немедленно принять меры по отказу от курения с помощью проверенных методов, таких как бесплатные горячие линии по вопросам отказа от курения, мобильные программы обмена текстовыми сообщениями и никотин-заместительная терапия. Через 20 минут после прекращения курения повышается частота сердечных сокращений и снижается артериальное давление. Через 12 часов уровень монооксида углерода в крови снижается до нормы. В течение 2–12 недель улучшается кровообращение и повышается функция легких. Через 1–9 месяцев уменьшаются кашель и одышка. ВОЗ подчеркивает важность одобренных с этической точки зрения высококачественных, систематических исследований, которые будут способствовать укреплению здоровья каждого человека и населения в целом, отмечая при этом, что пропаганда недоказанных вмешательств может оказать негативное влияние на здоровье.',\n",
       " ('COVID-19',\n",
       "  58,\n",
       "  0): 'Scientists discover genetic and immunologic underpinnings of some cases of severe COVID-19 NIAID What New findings by scientists at the National Institutes of Health and their collaborators help explain why some people with COVID-19 develop severe disease. The findings also may provide the first molecular explanation for why more men than women die from COVID-19. The researchers found that more than 10% of people who develop severe COVID-19 have misguided antibodies―autoantibodies―that attack the immune system rather than the virus that causes the disease. Another 3.5% or more of people who develop severe COVID-19 carry a specific kind of genetic mutation that impacts immunity. Consequently, both groups lack effective immune responses that depend on type I interferon, a set of 17 proteins crucial for protecting cells and the body from viruses. Whether these proteins have been neutralized by autoantibodies or―because of a faulty gene―were produced in insufficient amounts or induced an inadequate antiviral response, their absence appears to be a commonality among a subgroup of people who suffer from life-threatening COVID-19 pneumonia. These findings are the first published results from the COVID Human Genetic Effort, an international project spanning more than 50 genetic sequencing hubs and hundreds of hospitals. The effort is co-led by Helen Su, M.D., Ph.D., a senior investigator at the National Institute of Allergy and Infectious Diseases (NIAID), part of NIH; and Jean-Laurent Casanova, M.D., Ph.D., head of the St. Giles Laboratory of Human Genetics of Infectious Diseases at The Rockefeller University in New York. Major contributions were made by Luigi Notarangelo, M.D., chief of the NIAID Laboratory of Clinical Immunology and Microbiology (LCIM); Steven Holland, M.D., director of the NIAID Division of Intramural Research and senior investigator in the NIAID LCIM; clinicians and investigators in hospitals in the Italian cities of Brescia, Monza and Pavia, which were heavily hit by COVID-19; and researchers at the Uniformed Services University of the Health Sciences in Bethesda, Maryland. The wide variation in the severity of disease caused by SARS-CoV-2, the virus behind COVID-19, has puzzled scientists and clinicians. SARS-CoV-2 can cause anything from a symptom-free infection to death, with many different outcomes in between. Since February 2020, Drs. Su and Casanova and their collaborators have enrolled thousands of COVID-19 patients to find out whether a genetic factor drives these disparate clinical outcomes. The researchers discovered that among nearly 660 people with severe COVID-19, a significant number carried rare genetic variants in 13 genes known to be critical in the body’s defense against influenza virus, and more than 3.5% were completely missing a functioning gene. Further experiments showed that immune cells from those 3.5% did not produce any detectable type I interferons in response to SARS-CoV-2. Examining nearly 1,000 patients with life-threatening COVID-19 pneumonia, the researchers also found that more than 10% had autoantibodies against interferons at the onset of their infection, and 95% of those patients were men. Biochemical experiments confirmed that the autoantibodies block the activity of interferon type I. Article Q Zhang et al. Inborn errors of type I IFN immunity in patients with life-threatening COVID-19. Science DOI: 10.1126/science.abd4570 (2020). P Bastard et al. Auto-antibodies against type I IFNs in patients with life-threatening COVID-19. Science DOI: 10.1126/science.abd4585 (2020). Who NIAID Director Anthony S. Fauci, M.D., NIAID Senior Investigator Helen C. Su, M.D., Ph.D., and Luigi Notarangelo, M.D., chief of the NIAID Laboratory of Clinical Immunology and Microbiology, are available for interviews. Contact To schedule interviews, please contact NIAID Office of Communications, (301) 402-1663, NIAIDNews@niaid.nih.gov. NIAID conducts and supports research — at NIH, throughout the United States, and worldwide — to study the causes of infectious and immune-mediated diseases,',\n",
       " ('COVID-19',\n",
       "  58,\n",
       "  1): \"and to develop better means of preventing, diagnosing and treating these illnesses. News releases, fact sheets and other NIAID-related materials are available on the NIAID website. About the National Institutes of Health (NIH): NIH, the nation's medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit www.nih.gov. NIH…Turning Discovery Into Health®\",\n",
       " ('COVID-19',\n",
       "  59,\n",
       "  0): 'Background The harms of tobacco use are well-established. Tobacco causes 8 million deaths every year from cardiovascular diseases, lung disorders, cancers, diabetes, and hypertension.1 Smoking tobacco is also a known risk factor for severe disease and death from many respiratory infections.2-4 In the COVID-19 pandemic, questions have been asked about clinical outcomes for smokers, and whether they are equally susceptible to infection, and if nicotine has any biological effect on the SAR-CoV-2 virus (the virus that causes COVID-19). 5-7 At the time of writing, one clinical trial to test the effects of nicotine has been announced, but no trial registration record was found as of 12 May 2020. This review therefore assesses the available peer-reviewed literature on the association between smoking and COVID-19, including 1) risk of infection by SARS-CoV-2; 2) hospitalization with COVID-19; and 3) severity of COVID-19 outcomes amongst hospitalized patients such as admission into intensive care units (ICU), use of ventilators and death. Methods A review was conducted on 12 May 2020 on smoking and COVID-19, using MEDLINE, EMBASE, Cochrane Library, and WHO Global Database. Quantitative primary research on adults or secondary analyses of such studies were included. Individual studies included in meta-analyses that were not otherwise identified in the search were sought. Due to the preliminary nature of the many non-peer-reviewed reports issued during the COVID-19 pandemic, preprint repositories were deliberately excluded from this review. Review of the evidence Thirty-four peer-reviewed studies met the inclusion criteria. All included studies were in English. None examined tobacco use and the risk of infection or the risk of hospitalization. A total of 26 observational studies and eight meta-analyses were identified. All observational studies reported the prevalence of smoking amongst hospitalized COVID-19 patients. Two meta-analyses reported pooled prevalence of smoking in hospitalized patients using a subset of these studies (between 6 and 13 studies). Eighteen of the 26 observational studies containing data on smoking status by severity of COVID-19 outcomes. Six meta-analyses were identified that examined the association between smoking and severity of COVID-19. Nine of the 18 studies were included in the six meta-analyses of smoking and severity (five to seven studies in each analysis), resulting in 1,604 sets of patient data being reported more than once. All data in the six meta-analyses come from patients in China. What is the risk of smokers being infected by SARS-CoV-2? There are currently no peer-reviewed studies that have evaluated the risk of SARS-CoV-2 infection among smokers. This research question requires well-designed population-based studies that control for age and relevant underlying risk factors. What is the risk of smokers being hospitalized for COVID-19? There are currently no peer-reviewed studies that directly estimate the risk of hospitalization with COVID-19 among smokers. However, 27 observational studies found that smokers constituted 1.4-18.5% of hospitalized adults. 8-32 Two meta-analyses have been published which pooled the prevalence of smokers in hospitalized patients across studies based in China. The meta-analysis by Emami et al. 33 analysed data for 2986 patients and found a pooled prevalence of smoking of 7.6% (3.8% -12.4%) while Farsalinos et al. 34 analysed data for 5960 hospitalized patients and found a pooled prevalence of 6.5% (1.4% - 12.6%). What is the risk of severe COVID-19 disease and death amongst smokers? Meta-analyses: Zhao et al.35 analysed data from 7 studies (1726 patients) and found a statistically significant association between smoking and severity of COVID-19 outcomes amongst patients (Odds Ratio (OR) 2.0 (95% CI 1.3 – 3.1). The statistical significance disappeared when the largest study by Guan et al.13 was removed from the analysis (a sensitivity test to see the impact of a single study on',\n",
       " ('COVID-19',\n",
       "  59,\n",
       "  1): 'the findings of the meta-analysis). An updated version of this meta-analysis which included an additional study remained significant when this same sensitivity test was applied however.36 Zheng et al.37 analysed data from 5 studies totalling 1980 patients and found a statistically significant association between smoking and COVID-19 severity when using a fixed effects model: OR: 2.0 (95% CI 1.3 – 3.2). Lippi et al.38 analysed data from 5 studies totalling 1399 patients and found a non-significant association between smoking and severity. Guo et al., 39 however, later identified errors in the calculation and concluded that this association was indeed statistically significant (OR 2.2 (95% CI 1.3 – 3.7). Vardavas et al.40 analysed data from 5 studies totalling 1549 patients and calculated a relative risk that indicated a non-significant relationship between smoking and severity of COVID-19. However, the same authors found a statistically significant association between smoking status and primary endpoints of admission to Intensive Care Unit (ICU), ventilator use or death. Individual studies not included in meta-analyses: Nine studies were not included in any of the meta-analyses identified. One of these studies reported observational data for 7162 people in hospital and outpatient settings in the United States of America but did not include any statistical analysis of association. 10 Another study of 323 hospitalized patients in Wuhan, China, reported a statistically significant association between smoking and severity of disease (OR 3.5 (95% CI 1.2 – 10.2).15 Kozak et al. 41 found a statistically significant association between smoking and ICU admission and mortality amongst 226 patients in Toronto, Canada. The remaining six studies were small case series (ranging from 11 to 145 people) that reported no statistically significant associations between smoking status and severity of COVID-1,8, 11, 18, 27, 42 apart from Yu et al.43 who reported on a study of 70 patients a statistically significant OR of 16.1 (95% CI 1.3 – 204.2) in a multivariate analysis examining the association between smoking and the exacerbation of pneumonia after treatment. Limitations Hospital based studies that report patient characteristics can suffer from several limitations, including poor data quality. Collecting smoking history is challenging in emergency contexts and severity of disease is often not clearly defined and is inconsistent across studies. Such studies are also prone to significant sampling bias. Characteristics of those who are hospitalized will differ by country and context depending on available resources, access to hospitals, clinical protocols and possibly other factors not considered in the studies. Further, most studies did not make statistical adjustments to account for age and other confounding factors. Well-designed population-based studies are needed to address questions about the risk of infection by SARS-CoV-2 and the risk of hospitalization with COVID-19. Conclusions At the time of this review, the available evidence suggests that smoking is associated with increased severity of disease and death in hospitalized COVID-19 patients. Although likely related to severity, there is no evidence to quantify the risk to smokers of hospitalization with COVID-19 or of infection by SARS-CoV-2 was found in the peer-reviewed literature. Population-based studies are needed to address these questions. Related WHO Recommendations Given the well-established harms associated with tobacco use and second-hand smoke exposure;2 WHO recommends that tobacco users stop using tobacco. Proven interventions to help users quit include toll-free quit lines, mobile text-messaging cessation programmes, nicotine replacement therapies and other approved medications. References 1. Global Burden of Disease: GBD Compare Tool, 2020 (Available from: https://vizhub.healthdata.org/gbd-compare/ ) Accessed: April 27 2020. 2. A report of the Surgeon General. The health consequences of smoking: 50 years of progress. A report of the Surgeon General. Atlanta, GA: U.S. Department of Health and',\n",
       " ('COVID-19',\n",
       "  59,\n",
       "  2): 'Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 2014. 3. Park JE, Jung S, Kim A, Park JE. MERS transmission and risk factors: a systematic review. BMC public health. 2018;18(1):574. https://doi.org/10.1186/s12889-018-5484-8 4. Han L, Ran J, Mak YW, Suen LK, Lee PH, Peiris JSM, et al. Smoking and Influenza-associated Morbidity and Mortality: A Systematic Review and Meta-analysis. Epidemiology. 2019;30(3):405-17. https://doi.org/10.1097/EDE.0000000000000984 5. Miyara M, Tubach F, Pourcher V, Morelot-Panzini C, Pernet J, Lebbah S, et al. Low incidence of daily active tobacco smoking in patients with symptomatic COVID-19. Qeios. 2020. https://doi.org/10.32388/WPP19W.3 6. Fontanet A, Tondeur L, Madec Y, Grant R, Besombes C, Jolly N, et al. Cluster of COVID-19 in northern France: A retrospective closed cohort study. medRxiv.2020:Apr 23. https://doi.org/10.1101/2020.04.18.20071134 7. Changeux J, Amoura Z, Rey F, Miyara M. A nicotinic hypothesis for Covid-19 withpreventive and therapeutic implications. Qeios. 2020. https://doi.org/10.32388/FXGQSB 8. Chen Q, Zheng Z, Zhang C, Zhang X, Wu H, Wang J, et al. Clinical characteristics of 145 patients with corona virus disease 2019 (COVID-19) in Taizhou, Zhejiang, China. Infection, 2020. Apr 28:1-9. https://doi.10.1007/s15010-020- 01432-5 9. Chen T, Wu D, Chen H, Yan W, Yang D, Chen G, et al. Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study. BMJ. 2020;368:m1091. https://doi.org/10.1136/bmj.m1091 10. Chow N, Fleming-Dutra K, Gierke R, Hall A, Hughes M, Pilishvili T, et al. Preliminary Estimates of the Prevalence of Selected Underlying Health Conditions Among Patients with Coronavirus Disease 2019 — United States, February 12– March 28, 2020. Morbidity and Mortality Weekly Report. 2020;69(13):382-6. 11. Dong X, Cao YY, Lu XX, Zhang JJ, Du H, Yan YQ, et al. Eleven faces of coronavirus disease 2019. Allergy. 2020. 0(0):1-11 https://doi.org/10.1111/all.14289 12. Guan WJ, Liang WH, Zhao Y, Liang HR, Chen ZS, Li YM, et al. Comorbidity and its impact on 1590 patients with Covid-19 in China: A Nationwide Analysis. The European Respiratory Journal. 2020. 55: 2000547 https://doi.org/10.1183/13993003.00547-2020 13. Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. Clinical Characteristics of Coronavirus Disease 2019 in China. The New England Journal of Medicine. 2020;382(18):1708-20. https://doi:10.1056/NEJMoa2002032 14. Guo T, Fan Y, Chen M, Wu X, Zhang L, He T, et al. Cardiovascular Implications of Fatal Outcomes of Patients with Coronavirus Disease 2019 (COVID-19). JAMA Cardiology. 2020. Mar 27. https://doi:10.1001/jamacardio.2020.1017 15. Hu L, Chen S, Fu Y, Gao Z, Long H, Wang JM, et al. Risk Factors Associated with Clinical Outcomes in 323 COVID-19 Hospitalized Patients in Wuhan, China. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2020. May 3. https://doi:10.1093/cid/ciaa539 16. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497-506. https://doi.org/10.1016/S0140-6736(20)30183-5 17. Jin X, Lian JS, Hu JH, Gao J, Zheng L, Zhang YM, et al. Epidemiological, clinical and virological characteristics of 74 cases of coronavirus-infected disease 2019 (COVID-19) with gastrointestinal symptoms. Gut. 2020.69:1002-1009. http://dx.doi.org/10.1136/gutjnl-2020-320926 18. Kim ES, Chin BS, Kang CK, Kim NJ, Kang YM, Choi JP, et al. Clinical Course and Outcomes of Patients with Severe Acute Respiratory Syndrome Coronavirus 2 Infection: A Preliminary Report of the First 28 Patients from the Korean Cohort Study on COVID-19. Journal of Korean Medical Science. 2020;35(13). https://doi:10.3346/jkms.2020.35.e142 19. Lian, Jiangshan, Jin, Xi Analysis of Epidemiological and Clinical Features in Older Patients with Coronavirus Disease 2019 (COVID-19) Outside Wuhan. Clinical Infectious Diseases. 2020. Mar 25. https://doi:10.1093/cid/ciaa242 20. Liang W, Guan W, Chen R, Wang W, Li J, Xu K, et al. Cancer patients in SARS-CoV-2',\n",
       " ('COVID-19',\n",
       "  59,\n",
       "  3): 'infection: a nationwide analysis in China. The Lancet Oncology. 2020;21(3):335-7. https://doi.org/10.1016/S1470-2045(20)30096-6 21. Liu J, Chen T, Yang H, Cai Y, Yu Q, Chen J, et al. Clinical and radiological changes of hospitalised patients with COVID19 pneumonia from disease onset to acute exacerbation: a multicentre paired cohort study. European Radiology. 2020. May 8:1-7. https://doi.org/10.1007/s00330-020-06916-4 22. Liu W, Tao ZW, Wang L, Yuan ML, Liu K, Zhou L, et al. Analysis of factors associated with disease outcomes in hospitalized patients with 2019 novel coronavirus disease. Chinese Medical Journal. 2020;133(9):1032-8. https://doi.10.1097/CM9.000000000000775 23. Mo P, Xing Y, Xiao Y, Deng L, Zhao Q, Wang H, et al. Clinical characteristics of refractory COVID-19 pneumonia in Wuhan, China. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2020. Mar16. ciaa270. https://doi.org/10.1093/cid/ciaa270 24. Shi Y, Yu X, Zhao H, Wang H, Zhao R, Sheng J. Host susceptibility to severe COVID-19 and establishment of a host risk score: findings of 487 cases outside Wuhan. Critical Care. 2020; 24(1):108. https://doi.org/10.1186/s13054-020-2833-7 25. Wan S, Xiang Y, Fang W, Zheng Y, Li B, Hu Y, et al. Clinical features and treatment of COVID-19 patients in northeast Chongqing. Journal of Medical Virology. 2020. https://doi:10.1002/jmv.25783 26. Yang X, Yu Y, Xu J, Shu H, Xia J, Liu H, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observationalstudy. The Lancet Respiratory Medicine. 2020. 8(5): 475-481. https://doi.org/10.1016/S2213-2600(20)30079-5 27. Zhang JJ, Dong X, Cao YY, Yuan YD, Yang YB, Yan YQ, et al. Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China. Allergy. 2020. Feb 19. https://doi:10.1111/all.14238 28. Zhang X, Cai H, Hu J, Lian J, Gu J, Zhang S, et al. Epidemiological, clinical characteristics of cases of SARS-CoV-2 infection with abnormal imaging findings. International journal of infectious diseases: IJID: official publication of the International Society for Infectious Diseases. 2020;94:81-7. https://doi.org/10.1016/j.ijid.2020.03.040 29. Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054-62. https://doi.org/10.1016/S0140-6736(20)30566-3 30. Zhou Y, Zhang Z, Tian J, Xiong S. Risk factors associated with disease progression in a cohort of patients infected with the 2019 novel coronavirus. Annals of Palliative Medicine. 2020;9(2):428-36. https://doi:10.21037/apm.2020.03.26 31. Wu J, Wu X, Zeng W, Guo D, Fang Z, Chen L, et al. Chest CT Findings in Patients with Coronavirus Disease 2019 and Its Relationship with Clinical Features. Investigative Radiology. 2020;55(5):257-61. https://doi:10.1097/RLI.0000000000000670 32. Zhu W, Xie K, Lu H, Xu L, Zhou S, Fang S. Initial clinical features of suspected coronavirus disease 2019 in two emergency departments outside of Hubei, China. Journal of Medical Virology. 2020. Mar 13. https://doi:10.1002/jmv.25763 33. Emami A, Javanmardi F, Pirbonyeh N, Akbari A. Prevalence of Underlying Diseases in Hospitalized Patients with COVID19: A Systematic Review and Meta-Analysis. Archives of Academic Emergency Medicine. 2020. 8(1): e35 34. Farsalinos K, Barbouni A, Niaura R. Systematic review of the prevalence of current smoking among hospitalized COVID19 patients in China: could nicotine be a therapeutic option? Internal and Emergency Medicine. 2020. May 9;1-8. https://doi:10.1007/s11739-020-02355-7 35. Zhao Q, Meng M, Kumar R, Wu Y, Huang J, Lian N, et al. The impact of COPD and smoking history on the severity of Covid-19: A systemic review and meta-analysis. Journal of Medical Virology. 2020. Apr 15. https://doi:10.1002/jmv.2588 36. Guo FR. Smoking links to the severity of Covid-19: An update of a meta-analysis. Journal of Medical Virology. 2020. May 5. https://doi.org/10.1002/jmv.25967 37. Zheng Z, Peng F, Xu B, Zhao J, Liu H, Peng J, et al. Risk factors of',\n",
       " ('COVID-19',\n",
       "  59,\n",
       "  4): 'critical & mortal COVID-19 cases: A systematic literature review and meta-analysis. The Journal of Infection. 2020. Apr 23;S0163-4453(20)30234-6. https://doi:10.1016/j.jinf.2020.04.021 38. Lippi G, Henry BM. Active smoking is not associated with severity of coronavirus disease 2019 (COVID-19). European Journal of Internal Medicine. 2020;75:107-8. https://doi.org/10.1016/j.ejim.2020.03.014 39. Guo FR. Active smoking is associated with severity of coronavirus disease 2019 (COVID-19): An update of a metaanalysis. Tobacco induced diseases. 2020;18:37. https://doi:10.18332/tid/121915 40. Vardavas CI, Nikitara K. COVID-19 and smoking: A systematic review of the evidence. Tobacco induced diseases. 2020. 18(March):20. https://doi.org/10.18332/tid/119324 41. Kozak R, Prost K, Yip L, Williams V, Leis JA, Mubareka S. Severity of coronavirus respiratory tract infections in adults admitted to acute care in Toronto, Ontario. Journal of Clinical Virology. 2020. May 29. 126: 104338. https://doi:10.1016/j.jcv.2020.104338 42. Zheng Y, Xiong C, Liu Y, Qian X, Tang Y, Liu L, et al. Epidemiological and clinical characteristics analysis of COVID19 in the surrounding areas of Wuhan, Hubei Province in 2020. Pharmacological research. 2020;157:104821. https://doi.org/10.3389/fcimb.2020.00284 43. Yu T, Cai S, Zheng Z, Cai X, Liu Y, Yin S, et al. Association Between Clinical Manifestations and Prognosis in Patients with COVID-19. Clinical Therapeutics. 2020. Apr 27. https://doi.org/10.1016/j.clinthera.2020.04.009',\n",
       " ('COVID-19',\n",
       "  6,\n",
       "  0): 'Background As of 15 May 2020, more than 4 million confirmed cases of COVID-19, including more than 285 000 deaths have been reported to WHO. The risk of severe disease and death has been highest in older people and in persons with underlying noncommunicable diseases (NCDs), such as hypertension, cardiac disease, chronic lung disease and cancer.1-4 Limited data describe clinical manifestations of COVID-19 that are generally milder in children compared with adults,5-8 but also show that some children do require hospitalization and intensive care.9-11 Relatively few cases of infants confirmed to have COVID-19 have been reported; those who are infected have experienced mild illness.7 Robust evidence associating underlying conditions with severe illness in children is still lacking. Among 345 children with laboratory-confirmed COVID-19 and complete information about underlying conditions, 23% had an underlying condition, with chronic lung disease (including asthma), cardiovascular disease, and immunosuppression most commonly reported.12 Recently, however, reports from Europe and North America have described clusters of children and adolescents requiring admission to intensive care units with a multisystem inflammatory condition with some features similar to those of Kawasaki disease and toxic shock syndrome. Case reports and small series have described a presentation of acute illness accompanied by a hyperinflammatory syndrome, leading to multiorgan failure and shock.13-15 Initial hypotheses are that this syndrome may be related to COVID-19 based on initial laboratory testing showing positive serology in a majority of patients. Children have been treated with anti-inflammatory treatment, including parenteral immunoglobulin and steroids. It is essential to characterize this syndrome and its risk factors, to understand causality, and describe treatment interventions. It is not yet clear the full spectrum of disease, and whether the geographical distribution in Europe and North America reflects a true pattern, or if the condition has simply not been recognized elsewhere. There is therefore an urgent need for collection of standardized data describing clinical presentations, severity, outcomes, and epidemiology. WHO has developed a preliminary case definition and case report form for multisystem inflammatory disorder in children and adolescents. The preliminary case definition reflects the clinical and laboratory features observed in children reported to date, and serves to identify suspected or confirmed cases both for the purpose of providing treatment and for provisional reporting and surveillance. The case definition will be revised as more data become available. Preliminary case definition[a] Children and adolescents 0–19 years of age with fever > 3 days AND two of the following: Rash or bilateral non-purulent conjunctivitis or muco-cutaneous inflammation signs (oral, hands or feet). Hypotension or shock. Features of myocardial dysfunction, pericarditis, valvulitis, or coronary abnormalities (including ECHO findings or elevated Troponin/NT-proBNP), Evidence of coagulopathy (by PT, PTT, elevated d-Dimers). Acute gastrointestinal problems (diarrhoea, vomiting, or abdominal pain). AND Elevated markers of inflammation such as ESR, C-reactive protein, or procalcitonin. AND No other obvious microbial cause of inflammation, including bacterial sepsis, staphylococcal or streptococcal shock syndromes. AND Evidence of COVID-19 (RT-PCR, antigen test or serology positive), or likely contact with patients with COVID-19. Global COVID-19 Clinical Data Platform WHO has an established platform for standardized, anonymized clinical data. Contributors can enter data into the web-based WHO COVID-19 Clinical Data Platform, which captures all COVID-19 variables listed in the case report forms (CRFs). Using the WHO platform facilitates aggregation, tabulation, and analysis across different settings globally and provides a secure, access-limited, password-protected, electronic database hosted in a secure server at WHO. WHO will maintain appropriate technical and organizational security measures to protect confidentiality and prevent the unauthorized disclosure of the anonymized COVID-19 data. Note: Contributors will retain control of their data. Health facilities will have access to their dataset in',\n",
       " ('COVID-19',\n",
       "  6,\n",
       "  1): \"an analyzable format. How to become a contributor: please email COVID_ClinPlatform@who.int and request log-in credentials. The data management team will contact you with instructions for data entry and will assign you a 5-digit site code at that time. Each CRF has two modules: 1) Module 1 to be completed when multisystem inflammatory syndrome is suspected, and results of tests included in the case definition. 2) Module 2 to be completed at discharge or death. If the patient is transferred from one ward to another within the same hospital, the CRF should be updated throughout the hospital stay, from the date of admission in the hospital, until the date of transfer to another hospital, discharge from the hospital, or death. In settings where COVID-19 CRF data have been already entered in databases other than the WHO COVID-19 Clinical Data Platform, WHO will work with health facilities to transfer data from the original databases to the WHO platform. Please email COVID_ClinPlatform@who.int to request support. As the COVID data collection is not considered a research study, but rather surveillance of public health importance, patient or parent/guardian consent is not expected to be required in most settings; additionally, information is likely to be collected retrospectively through extraction from medical records in most cases. Working group members Stephen Freedman, Alberta Children's Hospital Research Institute, University of Calgary, Canada. Shana Godfred-Cato, Centers for Disease Control and Prevention, Atlanta, GA, USA. Richard Gorman, Department of Health and Human Services, USA. Rakesh Lodha, Department of Pediatrics, All India Institute of Medical Sciences, New Delhi, India. Lynne Mofenson, Elizabeth Glaser Pediatric AIDS Foundation, Washington DC, USA. Srinivas Murthy, BC Children’s Hospital, Vancouver, Canada. Pablo Rojo, Pediatric Infectious Diseases Unit, Hospital 12 de Octubre, Madrid, Spain. Calum Semple, Outbreak Medicine, University of Liverpool, UK. Louise Sigfrid, Centre for Tropical Medicine and Global Health, Oxford University, UK. Elizabeth Whittaker, Paediatric Infectious Diseases and Immunology, Imperial College, London, UK. Additional inputs Rosie Hague, Royal Hospital for Children, Glasgow, Scotland, UK. Yae-Jean Kim, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea. Naoki Shimizu, Tokyo Metropolitan Children’s Medical Centre, Japan. Alfredo Tagarro, Hospital Universitario Infanta Sofía, Madrid, Spain. WHO secretariat Rajiv Bahl, Ayesha de Costa, Janet Diaz, Karen Edmond, Yasir Nisar, Nigel Rollins. References Alqahtani JS, Oyelade T, Aldhahir AM, Alghamdi SM, Almehmadi M, Alqahtani AS, et al. Prevalence, Severity and Mortality associated with COPD and Smoking in patients with COVID-19: A Rapid Systematic Review and Meta-Analysis. PLoS One. 2020;15(5):e0233147. Epub 2020/05/12 Tobacco use and COVID-19. 11 May 2020 Statement. Geneva: World Health Organization (https://www.who.int/news-room/detail/11-05-2020-who-statement-tobacco-use-and-covid-19 accessed 14 May 2020) Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497-506. Epub 2020/01/28 Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054-62. Epub 2020/03/15 Cai J, Xu J, Lin D, Yang Z, Xu L, Qu Z, et al. A Case Series of children with 2019 novel coronavirus infection: clinical and epidemiological features. Clin Infect Dis. 2020. Epub 2020/03/01 Xia W, Shao J, Guo Y, Peng X, Li Z, Hu D. Clinical and CT features in pediatric patients with COVID-19 infection: Different points from adults. Pediatr Pulmonol. 2020;55(5):1169-74. Epub 2020/03/07 Wei M, Yuan J, Liu Y, Fu T, Yu X, Zhang ZJ. Novel Coronavirus Infection in Hospitalized Infants Under 1 Year of Age in China. JAMA. 2020. Epub 2020/02/15 Lu X, Zhang L, Du H, Zhang J, Li YY, Qu J, et\",\n",
       " ('COVID-19',\n",
       "  6,\n",
       "  2): 'al. SARS-CoV-2 Infection in Children. N Engl J Med. 2020;382(17):1663-5. Epub 2020/03/19 Shekerdemian LS, Mahmood NR, Wolfe KK, Riggs BJ, Ross CE, McKiernan CA, et al. Characteristics and Outcomes of Children With Coronavirus Disease 2019 (COVID-19) Infection Admitted to US and Canadian Pediatric Intensive Care Units. JAMA Pediatr. 2020. Epub 2020/05/12 Qiu L, Jiao R, Zhang A, Chen X, Ning Q, Fang F, et al. A Typical Case of Critically Ill Infant of Coronavirus Disease 2019 With Persistent Reduction of T Lymphocytes. Pediatr Infect Dis J. 2020. Epub 2020/05/08 Kamali Aghdam M, Jafari N, Eftekhari K. Novel coronavirus in a 15-day-old neonate with clinical signs of sepsis, a case report. Infect Dis (Lond). 2020;52(6):427-9. Epub 2020/04/03 Team CC-R. Coronavirus Disease 2019 in Children - United States, February 12-April 2, 2020. MMWR Morb Mortal Wkly Rep. 2020;69(14):422-6. Epub 2020/04/10 Riphagen S, Gomez X, Gonzalez-Martinez C, Wilkinson N, Theocharis P. Hyperinflammatory shock in children during COVID-19 pandemic. Lancet. 2020. Epub 2020/05/11. DeBiasi RL, Song X, Delaney M, Bell M, Smith K, Pershad J, et al. Severe COVID-19 in Children and Young Adults in the Washington, DC Metropolitan Region. J Pediatr. 2020 Jones VG, Mills M, Suarez D, Hogan CA, Yeh D, Bradley Segal J, et al. COVID-19 and Kawasaki Disease: Novel Virus and Novel Case. Hosp Pediatr. 2020. Epub 2020/04/09 WHO continues to monitor the situation closely for any changes that may affect this scientific brief. Should any factors change, WHO will issue a further update. Otherwise, this document will expire 2 years after the date of publication. Note: This scientific brief was updated to add precision and to correct an error in the email address on 17 May 2020. The title was edited from “with COVID-19” to “temporally related to COVID-19” and the text in italics added to this sentence “Initial hypotheses are that this syndrome may be related to COVID-19 based on initial laboratory testing showing positive serology in a majority of patients.” [a] Consider this syndrome in children with features of typical or atypical Kawasaki disease or toxic shock syndrome.',\n",
       " ('COVID-19',\n",
       "  60,\n",
       "  0): \"This systematic review and meta-analysis shows that 80% (95% CI 65–92) of individuals with a confirmed COVID-19 diagnosis continue to have at least one overall effect beyond 2 weeks following acute infection. In total, 55 effects, including symptoms, signs, and laboratory parameters, were identified, with fatigue, anosmia, lung dysfunction, abnormal chest X-ray/CT, and neurological disorders being the most common (Table 1, Fig. 2). Most of the symptoms were similar to the symptomatology developed during the acute phase of COVID-19. However, given that all of the surveys were predefined, there is a possibility that other effects have not yet been identified. In the following paragraphs, we will discuss the most common symptoms to illustrate how complex each one can be. However, further studies are needed to understand each symptom separately and in conjunction with the other symptoms. The five most common effects were fatigue (58%), headache (44%), attention disorder (27%), hair loss (25%), and dyspnea (24%). The recovery from COVID-19 should be more developed than checking for hospital discharge or testing negative for SARS-CoV-2 or positive for antibodies25. Fatigue (58%) is the most common symptom of long and acute COVID-1923. It is present even after 100 days of the first symptom of acute COVID-194,23. In addition, there are syndromes such as acute respiratory distress syndrome (ARDS), in which it has been observed that after a year, more than two-thirds of patients reported clinically significant fatigue symptoms26. The symptoms observed in post-COVID-19 patients, resemble in part the chronic fatigue syndrome (CFS), which includes the presence of severe incapacitating fatigue, pain, neurocognitive disability, compromised sleep, symptoms suggestive of autonomic dysfunction, and worsening of global symptoms following minor increases in physical and/or cognitive activity27,28,29,30,31. Myalgic encephalomyelitis (ME) or CFS is a complex and controversial clinical condition without established causative factors, and 90% of ME/CFS has not been diagnosed32. Possible causes of CFS include viruses, immune dysfunction, endocrine-metabolic dysfunction, and neuropsychiatric factors. The infectious agents related to CFS have been Epstein-Barr virus, cytomegalovirus, enterovirus, and herpesvirus33. It is tempting to speculate that SARS-CoV-2 can be added to the viral agents' list causing ME/CFS. Several neuropsychiatric symptoms have been reported, headache (44%), attention disorder (27%), and anosmia (21%). Other symptoms were reported, which were not included in the publications, including brain fog and neuropathy34,35. The etiology of neuropsychiatric symptoms in COVID-19 patients is complex and multifactorial. They could be related to the direct effect of the infection, cerebrovascular disease (including hypercoagulation)36, physiological compromise (hypoxia), side effects of medications, and social aspects of having a potentially fatal illness37. Adults have a double risk of being newly diagnosed with a psychiatric disorder after the COVID-19 diagnosis37, and the most common psychiatric conditions presented were anxiety disorders, insomnia, and dementia. Sleep disturbances might contribute to the presentation of psychiatric disorders38. Prompt diagnosis and intervention of any neuropsychiatric care is recommended for all patients recovering from COVID-19. An increase in mental health attention models in hospitals and communities is needed during and after the COVID-19 pandemic. Hair loss after COVID-19 could be considered as telogen effluvium, defined by diffuse hair loss after an important systemic stressor or infection. Premature follicular transitions cause it from the active growth phase (anagen) to the resting phase (telogen). It is a self-limiting condition that lasts approximately 3 months, but it could cause emotional distress39. Dyspnea and cough were found in 24% and 19% of patients, respectively (Table 2, Fig. 2). In addition, abnormalities in CT lung scans persisted in 35% of patients even after 60–100 days from the initial presentation. In a follow-up study conducted in China among non-critical cases of hospitalized patients with\",\n",
       " ('COVID-19',\n",
       "  60,\n",
       "  1): 'COVID-19, radiographic changes persisted in nearly two-thirds of patients 90 days after discharge40. Although most of the available studies do not include baseline pulmonary dysfunction or radiographic abnormalities, findings indicate improvement or resolution of abnormal CT findings. Previous data from recovered patients with other viral pneumonia41,42, also found residual radiographic changes. Abnormalities in pulmonary function, such as decreased diffusion capacity for carbon monoxide, were present among 10% of patients in this meta-analysis. Although these findings are not as high as compared to other available studies of survivors with COVID-19 or SARS, where the estimate of lung dysfunction is 53% and 28% respectively43,44, the reasons behind these differences could be distinct follow-up periods, definitions of pulmonary dysfunction, or characteristics of the patient population. Nevertheless, residual radiographic findings or lung function abnormalities require additional investigation on their clinical relevance and long-term consequences. The immune-mediated tissue damage in COVID-19 involves cellular and humoral responses, but the immunity to SARS-CoV-2 and the protection to reinfection or a final viral40,45 clearance is unknown. Also, the reason why some patients experience long-term symptoms after COVID-19 is uncertain. This could be partially explained by host-controlled factors that influence the outcome of the viral infection, including genetic susceptibility, age of the host when infected, dose and route of infection, induction of anti-inflammatory cells and proteins, presence of concurrent infections, past exposure to cross-reactive agents, etc. Whether SARS-CoV-2 can cause substantial tissue damage leading to a chronic form of the disease such as the chronic lesions in convalescence observed in other viruses such as human immunodeficiency virus (HIV), hepatitis C virus (HCV), hepatitis B virus (HBV), and some herpesviruses is still unknown. One study was excluded because it did not provide a denominator, and therefore it was not possible to estimate the prevalence46. In such a study, the authors performed a survey in a Facebook group of patients who previously had COVID-19 and compared the symptoms of those hospitalized with mild to moderate symptoms. They concluded that both groups had symptoms after 3 months of having COVID-19. Symptoms that were not mentioned in any of the articles we studied include sudden loss of body weight, ear pain, eye problems, sneezing, cold nose, burning feeling in the trachea, dizziness, heart palpitations, pain/burning feeling in the lungs, pain between the shoulder blades, Sicca syndrome, vertigo, body aches, and confusion3,12. The results assessed in the present study are in line with the current scientific knowledge on other coronaviruses, such as those producing SARS and MERS, both clinical sharing characteristics with COVID-19, including post symptoms. For example, studies on SARS survivors have shown lung abnormalities months after infection. After a 1-year follow-up, a study showed that 28% of the survivors presented decreased lung function and pulmonary fibrosis signs44,47,48. In addition, MERS survivors showed pulmonary fibrosis (33%)49. Regarding psychiatric symptoms, a study reported high levels of depression, anxiety, and post-traumatic stress disorder (PTSD)37 in the long term in patients previously infected with other coronaviruses. To assure that future healthcare providers, researchers, and educators recognize the effects of long-term COVID19 that are sex- and age-specific related, it is essential to classify the groups according to such variables to make better decisions about prevention diagnosis and disease management. Limitations of this systematic review and meta-analyses include the small sample size for some outcomes, making it difficult to generalize these results to the general population. The variation in the definition of some outcomes and markers and the possibility of bias. For example, several studies that used a self-reported questionnaire could result in reporting bias. In addition, the studies were very heterogeneous, mainly due to the follow-up time',\n",
       " ('COVID-19',\n",
       "  60,\n",
       "  2): 'references and the mixture of patients who had moderate and severe COVID-19. All of the studies assessed had performed their internal pre-definition of symptoms, and therefore there is the possibility that essential outcomes were not reported. Another limitation is that, given that COVID-19 is a new disease, it is impossible to determine how long these effects will last. To decrease heterogeneity and better understand the long-term effects of COVID-19, there is a need for studies to stratify by age, previous comorbidities, the severity of COVID-19 (including asymptomatic), and the duration of each symptom. To determine whether these long-term effects either complicate previous diseases or continue COVID-19, there is a need for prospective cohort studies. The baseline characteristics should be well established. To obtain more accurate meta-analyses, there is an urgent need to have a standard definition of long-COVID-19. Currently, post-COVID-19 symptoms that develop during or after COVID-19 are defined if they continue for ≥ 12 weeks (“long-COVID-19”), and not explained by an alternative diagnosis2,6,50. There is a need to standardize biological measures such as peripheral blood markers of genetic, inflammatory, immune, and metabolic function to compare studies. Besides studying pre-defined symptoms and characteristics, an open question should be included. Proper documentation in medical charts by health care providers and the flexibility and collaboration from the patients to report their symptoms are of equal importance.',\n",
       " ('COVID-19',\n",
       "  61,\n",
       "  0): 'Aim: COVID-19 clinical presentation is heterogeneous, ranging from asymptomatic to severe cases. While there are a number of early publications relating to risk factors for COVID-19 infection, low sample size and heterogeneity in study design impacted consolidation of early findings. There is a pressing need to identify the factors which predispose patients to severe cases of COVID-19. For rapid and widespread risk stratification, these factors should be easily obtainable, inexpensive, and avoid invasive clinical procedures. The aim of our study is to fill this knowledge gap by systematically mapping all the available evidence on the association of various clinical, demographic, and lifestyle variables with the risk of specific adverse outcomes in patients with COVID-19. Methods: The systematic review was conducted using standardized methodology, searching two electronic databases (PubMed and SCOPUS) for relevant literature published between 1st January 2020 and 9th July 2020. Included studies reported characteristics of patients with COVID-19 while reporting outcomes relating to disease severity. In the case of sufficient comparable data, meta-analyses were conducted to estimate risk of each variable. Results: Seventy-six studies were identified, with a total of 17,860,001 patients across 14 countries. The studies were highly heterogeneous in terms of the sample under study, outcomes, and risk measures reported. A large number of risk factors were presented for COVID-19. Commonly reported variables for adverse outcome from COVID-19 comprised patient characteristics, including age >75 (OR: 2.65, 95% CI: 1.81-3.90), male sex (OR: 2.05, 95% CI: 1.39-3.04) and severe obesity (OR: 2.57, 95% CI: 1.31-5.05). Active cancer (OR: 1.46, 95% CI: 1.04-2.04) was associated with increased risk of severe outcome. A number of common symptoms and vital measures (respiratory rate and SpO2) also suggested elevated risk profiles. Conclusions: Based on the findings of this study, a range of easily assessed parameters are valuable to predict elevated risk of severe illness and mortality as a result of COVID-19, including patient characteristics and detailed comorbidities, alongside the novel inclusion of real-time symptoms and vital measurements.',\n",
       " ('COVID-19',\n",
       "  62,\n",
       "  0): 'Susceptibility to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and the risk of mortality among people living with human immunodeficiency virus (HIV)/acquired immunodeficiency syndrome (AIDS) (PLWHA) is largely unknown. PLWHA are unique due to their altered immune system from their history of chronic HIV infection and their use of antiretroviral therapy, some of which have been used experimentally to treat coronavirus disease 2019 (COVID-19). Therefore, we conducted a systematic review and meta-analysis to assess the epidemiology of SARS-COV-2/HIV coinfection and estimate associated mortality from COVID-19 (Prospero Registration ID: CRD42020187980). PubMed, SCOPUS, OVID and Cochrane Library databases, and medRxiv preprint repositories were searched from January 1, 2020, to December 12, 2020. Data were extracted from studies reporting COVID-19 attack and mortality rates in PLWHA compared to their HIV-negative counterparts. Pooled attack and mortality risks were quantified using random-effects models. We identified 22 studies that included 20,982,498 participants across North America, Africa, Europe, and Asia. The median age was 56 years, and 50% were male. HIV-positive persons had a significantly higher risk of SARS-CoV-2 infection [risk ratio (RR) 1.24, 95% CI 1.05-1.46)] and mortality from COVID-19 (RR 1.78, 95% CI 1.21-2.60) than HIV-negative individuals. The beneficial effects of tenofovir and protease-inhibitors in reducing the risk of SARS-CoV-2 infection and death from COVID-19 in PLWHA remain inconclusive. HIV remains a significant risk factor for acquiring SARS-CoV-2 infection and is associated with a higher risk of mortality from COVID-19. In support of the current Centers for Disease Control and Prevention (CDC) guidelines, persons with HIV need priority consideration for the SARS-CoV-2 vaccine.',\n",
       " ('COVID-19',\n",
       "  63,\n",
       "  0): 'In just six months, the world’s largest randomized control trial on COVID-19 therapeutics has generated conclusive evidence on the effectiveness of repurposed drugs for the treatment of COVID-19. Interim results from the Solidarity Therapeutics Trial, coordinated by the World Health Organization, indicate that remdesivir, hydroxychloroquine, lopinavir/ritonavir and interferon regimens appeared to have little or no effect on 28-day mortality or the in-hospital course of COVID-19 among hospitalized patients. The study, which spans more than 30 countries, looked at the effects of these treatments on overall mortality, initiation of ventilation, and duration of hospital stay in hospitalized patients. Other uses of the drugs, for example in treatment of patients in the community or for prevention, would have to be examined using different trials. The progress achieved by the Solidarity Therapeutics Trial shows that large international trials are possible, even during a pandemic, and offer the promise of quickly and reliably answering critical public health questions concerning therapeutics. The results of the trial are under review for publication in a medical journal and have been uploaded as preprint at medRxiv available at this link: https://www.medrxiv.org/content/10.1101/2020.10.15.20209817v1 The global platform of the Solidarity Trial is ready to rapidly evaluate promising new treatment options, with nearly 500 hospitals open as trial sites. Newer antiviral drugs, immunomodulators and anti-SARS COV-2 monoclonal antibodies are now being considered for evaluation.',\n",
       " ('COVID-19',\n",
       "  64,\n",
       "  0): 'The data presented here were collected by the EPICOVID19, a self-administered, volunteer, web-based survey investigating the number of suspected cases of COVID-19 and the potential determinants of SARS-CoV-2 infection in a large sample of Italian respondents [ 22 ]. The current study aimed to evaluate if influenza and pneumococcal vaccinations are associated with a lower probability of positivity to nasopharyngeal swab (NPS) detection of SARS-CoV-2 in adults and older individuals. These considerations have led to the hypothesis that influenza and pneumococcal vaccinations could stimulate an immune response in older adults and potentially lower the risk and the severity of other infections, including COVID-19. Despite the current scarcity of data supporting this hypothesis [ 16 19 ], it is a particularly timely issue since influenza and pneumococcal vaccines are easily accessible at a time that public health officials are facing the challenge of the 2020 autumn–winter season without an effective vaccine for COVID-19 [ 20 21 ]. A factor contributing to the higher vulnerability of older adults to SARS-CoV-2 could be linked to aging-related immunologic changes [ 6 7 ]. These include both immunosenescence, i.e., the progressive dysfunction of both the innate and adaptive immune responses, and the development of low-grade chronic systemic inflammation, termed inflammaging [ 7 8 ]. In addition to increasing susceptibility and altering the response to infectious diseases, these changes appear to slightly reduce the efficacy of vaccines in older individuals [ 9 13 ]. Nonetheless, the clinical effectiveness of vaccines in older people is supported not only by vaccine-specific responses, but also by the cross-reactivity, cross-protection and immunostimulation linked to the vaccines per se and to their adjuvants [ 8 14 ]. Vaccines are thus able to protect individuals against the targeted pathogen as well as to reduce the associated risk of viral or bacterial co-infections [ 15 ]. The COronaVIrus Disease 19 (COVID-19) outbreak continues to be a burdensome, multifaceted public health concern, and as of July 17, 2020, the number of confirmed worldwide cases has risen to 13,788,300 (with America, Asia and Europe the most affected continents); it has also been responsible for 589,688 deaths [ 1 ]. The disease burden of the pandemic in terms of the percentage of the population affected and the severity of symptoms has been high especially for older individuals. In Western countries [ 2 ] in particular, senior adults have accounted for almost half of the total confirmed cases [ 3 4 ] and more than two thirds of the deaths due to the infection [ 5 ]. The lack of specific therapies for COVID-19 has prompted a growing number of clinicians and researchers to investigate risk factors that may affect individual susceptibility to the infection and disease severity. Crude and adjusted logistic regression models were built to test the probability of a positive NPS SARS-CoV-2 test as a function of having had the influenza or pneumococcal vaccinations. Models were stratified by age classes (<65, ≥65 years) and were adjusted for age, sex, education, area of residence, self-reported comorbidities (CVD, hypertension, lung diseases, diabetes treated with medications, metabolic diseases) and smoking status. The linearity assumption for quantitative variable (age) was evaluated considering an analysis of quartiles [ 25 ]. Odds ratios (ORs) were presented with their 95% confidence intervals (CIs). Two-tail p-values <0.05 were considered statistically significant. The analyses were performed using SAS statistical package, version 9.4 (SAS Institute Inc., Cary, NC, USA). The categorical variables were presented as counts and percentages; the continuous variables were summarized using means and standard deviations (SD). The comparison between the participants’ characteristics classified in accordance to (a) having had an influenza',\n",
       " ('COVID-19',\n",
       "  64,\n",
       "  1): \"vaccination during autumn of 2019, (b) having had an anti-pneumococcal vaccination during the last 12 months, and (c) the results of a NPS test (positive vs. negative) were assessed using the Chi-squared test for categorical variables. Generalized linear models were used for the continuous variables after testing for homoschedasticity (Levene test). The Ethics Committee of the National Institute for Infectious Diseases (Italian: Istituto Nazionale per le Malattie Infettive I.R.C.C.S. Lazzaro Spallanzani) approved the EPICOVID19 study protocol (Protocol No. 70, 12/4/2020). The participants were requested to give their informed consent when they first accessed the on-line platform. The study was carried out in accordance with the principles of the Declaration of Helsinki. The respondent was also asked if he/she had received an influenza vaccination during the autumn of 2019 and/or an anti-pneumococcal vaccination over the last 12 months, if he/she had undergone NPS testing for SARS-CoV-2 and its result (positive vs. negative), and if he/she had contacts with confirmed COVID-19 cases. Questions about autonomy in carrying out daily activities, self-rated health (very bad, bad, adequate, good or very good) and smoking status (never, former and current smoker) were also available. The self-administered questionnaire included 38 mainly mandatory, closed questions, divided into six sections: socio-demographic data; clinical evaluation; personal characteristics; housing conditions; lifestyle; behaviors following the lockdown. The socio-demographic variables considered for the purposes of this study included sex, age and educational level (primary school or less, middle or high school, and university degree or post-graduate degree). The regions of residence were grouped into four areas according to their ratio of total swabs performed/total individuals tested at least once and total COVID-19 cases/total individuals tested at least once [ 23 ]; a higher ratio corresponded to more regional resources allocated for testing. As illustrated in Supplementary Figure S4 , the four areas identified in ascending order were: 1. Piedmont, Lombardy, Aosta Valley, Emilia Romagna, Liguria and Marche; 2. Tuscany, Trentino Alto Adige, Abruzzo, Apulia; 3. Veneto, Friuli Venezia Giulia, Lazio, Molise, Campania; 4. Sicily, Sardinia, Umbria, Calabria and Basilicata. EPICOVID19 is an Italian cross-sectional, web-based survey that was initiated in April 2020. A national convenience sample of volunteers was considered. The participants were recruited via social media (Facebook, Twitter, Instagram, Whatsapp), press releases, internet pages, local radio, TV stations, and institutional websites; the European Commission's open-source official EUSurvey management tool was used to collect the data ( https://epicovid19.itb.cnr.it/ ). The inclusion criteria for participation in the survey were: (i) being 18 or older; (ii) having access to a mobile phone, computer, or tablet with internet connectivity; (iii) giving informed on-line consent to participate in the study. Those who did not meet these requirements were excluded from the study sample. The study was registered (ClinicalTrials.gov NCT04471701). Six thousand six hundred and eighty participants underwent a SARS-CoV-2 NPS test (25.1% positive vs. 74.9% negative results, Table 2 ). The participants 65 and over with a positive test result (n = 320) were significantly older (76.9 (SD = 9.7) vs. 71.4 (SD = 7.7) years), more frequently women (57.2% vs. 41.5%) had lower levels of education with respect to those with a negative result. Older respondents with positive test result had higher prevalence of CVD and dependency in daily activities, and a lower percentage of current smokers than among those with negative results. Participants younger than 65 with a positive test result (n = 1356) were found to be significantly older (46.5 (SD = 11.5) years vs. 44.8 (SD = 11.4)), less frequently women (61.9% vs. 69.2%), had lower levels of education, and had higher prevalence of metabolic diseases than those with a negative test\",\n",
       " ('COVID-19',\n",
       "  64,\n",
       "  2): 'result. Older respondents with a positive test result reported a significantly lower percentage of anti-pneumococcal vaccination over the last 12 months (10% vs. 21.1%). Similar results were observed comparing the younger participants with a positive vs. negative NPS test for the frequency of both antipneumococcal (2.6% vs. 4.1%) and influenza vaccination (28.2% vs. 31.9%). Fifteen thousand and eleven respondents 65 or older (53.4%) had received influenza vaccination during the 2019 autumn; 3461 (12.3%) had received anti-pneumococcal vaccination. The respective percentages in the younger group were 15.7% and 2.2%. With respect to their unvaccinated counterparts, the participants who received the influenza vaccination were more likely to be older, male, to have higher levels of education, and a higher prevalence of hypertension, metabolic diseases, CVD, cancer, lung diseases, and diabetes treated with medications ( Supplementary Table S1 ). Similar differences in educational level and chronic disease prevalence were observed comparing the respondents who received anti-pneumococcal vaccination and their unvaccinated counterparts ( Supplementary Table S2 ). The distributions of age, sex and education were scarcely representative of the general Italian population, as outlined by the Italian National Institute of Statistics (ISTAT) in their figures for 2019 ( Supplementary Figures S2–S3 ) [ 26 27 ]: of note, the survey respondents had a higher level of education (more than 50% had University or post graduate degree vs. less than 10% according to ISTAT data). The data were collected between April and June 2020 from questionnaires completed by 198,828 respondents with a mean (SD) age of 48 (14.7) years (59.7% female). A total of 28,097 participants were aged between 65–104 years (mean (SD) age 70.8 (5.5) years, 50.9% females) and 170,731 between 18–64 years (mean (SD) age 44.2 (12.1) years, 61.1% females). The participants’ general characteristics are outlined in Table 1 . The rates of response for each Italian Region x 10,000 inhabitants are shown in Supplementary Figure S1 4. Discussion The study found that the adult and older EPICOVID19 respondents who had received an anti-pneumococcal vaccination in the previous year had a lower probability of having a positive SARS-CoV-2 test with respect to their non-vaccinated counterparts. Considering influenza vaccination, only the participants aged <65 years had a lower probability of being infected with SARS-CoV-2 infection with respect to their non-vaccinated ones. An analysis of our data showed that the older cohort (65 and older) of the online survey sample was poorly representative of the older Italian population both in terms of age and educational level [ 26 27 ]. This may have been due to the web-based nature of the survey, requiring a certain degree of technological skills to participate. Indeed, with respect to the general Italian older population, the older EPICOVID19 participants included higher percentages of individuals falling into younger old age classes and with a higher educational level. Despite the fact that a profile such as this generally mirrors high health literacy and awareness of healthy behaviors, the vaccination rates reported in this group were in line with the national statistics, which are far below the proposed target coverage of 75% for influenza and 50% for pneumococcal vaccines [ 22 ] for this age class. In particular, as regards the influenza vaccination, the Italian Ministry of Health and the National Institute of Health reported a coverage of 53.1% for individuals ≥65 [ 28 ] for the 2018–2019 season, which in our survey was 53.4%. In regards to anti-pneumococcal vaccination, national data are scarce and show wide variability, ranging from 0.7% to 50% in different Italian regions [ 29 ]. This issue and the fact that the survey collected data only on the',\n",
       " ('COVID-19',\n",
       "  64,\n",
       "  3): 'anti-pneumococcal vaccination in the last 12 months, made it difficult to estimate and compare the coverage of this vaccine in our web-based sample with that of the general population. An analysis of the characteristics of the vaccinated and non-vaccinated individuals uncovered that individuals from both age groups who had influenza or anti-pneumococcal vaccinations had a higher risk profile in terms of existing chronic diseases. This suggests that, despite the national recommendations for influenza and anti-pneumococcal vaccinations, such preventive measures are still generally addressed to the most at risk individuals. Our study found that anti-pneumococcal vaccination was associated, respectively, in the younger and older participants, with a 39% and 44% lower probability of a positive result on a NPS test. The influenza vaccination was, instead, associated with a less pronounced, lower probability of a positive result on a NPS test (−15%), but only in the younger age group; among older participants no significant association was observed, but analyses were underpowered (study power for influenza vaccination among older participants <0.20). Whereas two recently published studies suggest that influenza vaccination is associated with lower COVID-19 severity and mortality [ 16 17 ], our study for the first time investigated the probability of being infected with SARS-CoV-2 as a function of influenza and anti-pneumococcal vaccinations. Some hypotheses can be formulated to interpret our findings. First of all, the decision to be vaccinated may characterize individuals with a higher level of health literacy and awareness [ 30 ], attitudes that may be linked to a greater compliance with the measures suggested for COVID-19 prevention, i.e., physical distancing, hygiene/disinfection practices, and use of personal protective equipment, leading to a lower probability of becoming infected. This interpretation is also coherent with the observation that, as mentioned above, the individuals who were vaccinated were more educated and had a higher risk profile in terms of comorbidities, which may have been one of the reasons they sought to avoid possible sources of contagion, considering themselves more vulnerable to possible infections. However, despite the worse risk profile and higher education of the vaccinated survey respondents, vaccinated and non-vaccinated participants expressed almost comparable ratings of their health status, with only a statistically significant, but clinically questionable, 1% difference in the frequency of individuals who defined their health status as very bad or bad. Moreover, there were no significant differences in the frequency of contacts with confirmed COVID-19 cases in the vaccinated and unvaccinated older participants, who denied such contacts in more than 90% of cases. This suggests that awareness and compliance with the widely publicized preventive measures against COVID-19, at least in terms of physical distancing, were comparable between vaccinated and non-vaccinated participants. Additionally, the significant association between vaccination and SARS-CoV-2 test results persisted even after adjustment for educational level and for the main comorbidities and risk behaviors that could influence the probability of individuals getting the infection. A second issue to be considered in interpreting our results is the potential impact of different regional health policies in regards to both the vaccination coverage and the accessibility to NPS testing. Indeed, if regions with higher coverage of anti-pneumococcal vaccinations were also those with greater health resources to perform NPS tests, and vice versa, we would overestimate the association between vaccination and positive NPS. To test this hypothesis, we compared the frequency distribution of anti-pneumococcal vaccination and of health resources for NPS testing in different Italian regions. Despite not observing a large overlap between these aspects, we found some similar trends, especially in the Northern Italian regions ( Supplementary Figure S5 ). However, our results were confirmed both when we either adjusted',\n",
       " ('COVID-19',\n",
       "  64,\n",
       "  4): 'for or stratified by region of residence, suggesting that this point may have influenced, but cannot completely explain, the observed association. 31,34, Although the above considerations on behavioral- and geographic-related issues need to be taken into account, our results allow us to cautiously speculate about a possible vaccine-related protective effect against SARS-CoV-2. Indeed, although not specific for that pathogen, cross-reactivity, cross-protection and immunostimulation by the two vaccines may have contributed to diminishing the risk of other bacterial or viral infections [ 8 14 ]. In that regard, vaccine adjuvants play an important role in enhancing the innate immunity to a vaccine antigen and in triggering a rapid, strong adaptive response to infectious agents [ 31 ]. The use of vaccine adjuvants is recommended, especially considering that some categories of individuals, such as older people, have a suboptimal immune response to vaccines due to immunosenescence and inflammaging [ 7 32 ]. These phenomena seem to affect the efficacy of influenza [ 9 10 ] and antipneumococcal vaccines [ 33 ], and vaccine-related antibody production, which seems to be weaker and of shorter duration in older with respect to younger individuals [ 31 35 ]. Our analysis, in particular, uncovered a stronger inverse association between the SARS-CoV-2 NPS results and the anti-pneumococcal vaccine with respect to the influenza vaccine, the latter demonstrating borderline results only for the younger age group. In this regard, it is possible that the polysaccharide nature of the anti-pneumococcal vaccine, the conjugation of the antigen with the non-toxic variant of diphtheria toxin (CRM197), and the use of an additional adjuvant (aluminum phosphate) [ 31 ] may have enhanced the immunogenicity of the vaccine to a greater extent with respect to the influenza vaccination, especially in older people. Finally, recent studies suggested that influenza vaccination could mitigate the severity of COVID-19, either by modulating the immune response or by reducing the risk of co-infections [ 16 17 ]. If confirmed, this issue should be considered in interpreting our results since non-vaccinated individuals may have had a more severe COVID-19 onset and course that made them more likely to undergo a NPS compared with vaccinated people. However, further studies are needed to verify these hypotheses and to explore the differences noted between younger and older adults. Interestingly, we found a lower frequency of current smokers among individuals with a positive NPS test than among those with negative results. This observation is in line with recently published studies indicating an apparent low risk of SARS-CoV-2 infection among smokers [ 36 ]; however, these findings need to be confirmed. The association between smoking habit and the risk of SARS-CoV-2 infection will be investigated in detail in a specific paper. The limitations characterizing our study refer, first of all, to the poor representativeness of the sample, especially for the oldest age group with respect to the Italian general population. This issue and the fact that only a minority of the total survey respondents had available data on SARS-CoV-2 testing, of course, limited the generalizability of our findings. Nevertheless, in light of the youngish, highly educated survey respondents, the bias more likely resulted in an underestimation rather than an overestimation of the studied associations. Secondly, the study design was observational, which is useful mostly for generating hypotheses. Other more appropriate designs are needed to confirm our results. Third, self-reported data are always associated with a certain risk of recall and misclassification biases, which might have influenced our results with possible over- or underestimation. Fourth, as mentioned above, in addition to the lack of details on the specific type of vaccines’ formulation, the data collected',\n",
       " ('COVID-19',\n",
       "  64,\n",
       "  5): 'on anti-pneumococcal vaccination referred only to the last 12 months, thus no information was available on vaccination in the previous years. However, this later issue could have more likely led to underestimate the association between the vaccine and positive SARS-CoV-2 testing. On the other hand, the strengths of our work include the novelty of the topic, the large sample size of middle-old and old-old age groups, and the wide data collection on the individual’s vaccination history and COVID-19-related behavior, such as possible related symptoms and SARS-CoV-2 NPS results.',\n",
       " ('COVID-19',\n",
       "  65,\n",
       "  0): 'We identified a total of 41 eligible studies including 21060 patients with COVID-19. Severe cases were potentially associated with advanced age (Standard Mean Difference (SMD) = 1.73, 95% CI: 1.34–2.12), male gender (Odds Ratio (OR) = 1.51, 95% CI:1.33–1.71), obesity (OR = 1.89, 95% CI: 1.44–2.46), history of smoking (OR = 1.40, 95% CI:1.06–1.85), hypertension (OR = 2.42, 95% CI: 2.03–2.88), diabetes (OR = 2.40, 95% CI: 1.98–2.91), coronary heart disease (OR: 2.87, 95% CI: 2.22–3.71), chronic kidney disease (CKD) (OR = 2.97, 95% CI: 1.63–5.41), cerebrovascular disease ( OR = 2.47, 95% CI: 1.54–3.97), chronic obstructive pulmonary disease (COPD) (OR = 2.88, 95% CI: 1.89–4.38), malignancy (OR = 2.60, 95% CI: 2.00–3.40), and chronic liver disease (OR = 1.51, 95% CI: 1.06–2.17). Acute respiratory distress syndrome (ARDS) (OR = 39.59, 95% CI: 19.99–78.41), shock (OR = 21.50, 95% CI: 10.49–44.06) and acute kidney injury (AKI) (OR = 8.84, 95% CI: 4.34–18.00) were most likely to prevent recovery. In summary, patients with severe conditions had a higher rate of comorbidities and complications than patients with non-severe conditions. Coronavirus Disease 2019(COVID-19) which, was first identified in Wuhan, Hubei Province, China in December 2019, has already swept across the world. The World Health Organization (WHO) has officially declared the outbreak as a pandemic and a public health emergency [ 1 ]. As of 9 th March 2021, according to WHO, the number of confirmed cases around the world has surged dramatically to 116,166,652 with 2,582,528 deaths, which suggests the general mortality rate is approximately 2.22% [ 2 ]. The severity of symptoms among patients infected with COVID-19 varies considerably from being varies considerably from being asymptomatic to being a critical illness with lethal complications [ 3 , 4 ]. We calculated odds ratios (ORs) in the dichotomous variables and standard mean difference (SMD) in the continuous variables with the 95% confidence intervals (CIs) and assessed publication bias using Stata 12.0. Heterogeneity was measured by I 2 statistic. We used a Mantel-Haenszel random effects model to calculate effect sizes. In order to discover the potential sources of heterogeneity, we performed subgroup analyses and meta-regression analysis according to study location (Hubei province and outside Hubei province) and the median ages of patients. The stability of results was assessed by conducting a sensitivity analysis which omitted each study in turn. Funnel plots were used to assess for publication bias and asymmetry was taken to indicate bias. In this study, P values <0.05 were regarded as indicating statistical significance for the summary OR and SMD. In order to quantify the effects of risk factors on COVID-19 patients, we calculated population attributable fraction (PAF) by using the attributable fraction formula: where Pc is the prevalence of the risk factors in the population [ 10 ]. In this analysis, the ORs were used as approximations of RRs. We performed subgroup analyses to identify the possible sources of heterogeneity of some outcomes. We tried to analyze several factors such as study location, publication date, sample size and patients’ average age of which study location gave a relatively meaningful result as shown in Table 5 . This shows high consistency among the studies conducted in Hubei province but the heterogeneity of the studies outside Hubei province is also significant. Interestingly, the studies conducted in Hubei province show the ORs of ARDS was much lower than other regions. The meta-regression analysis demonstrates that the association between coronary heart disease and increased severity was influenced by age (P = 0.013), and the discrepancy between patients’ median ages in eligible studies partly contributed to the heterogeneity. ( Fig 5 ) We calculated the',\n",
       " ('COVID-19',\n",
       "  65,\n",
       "  1): 'population attributable risk (PAR) of the population infected with COVID-19. PAR reflects the proportion of severe COVID-19 that can be attributed to exposure to a risk factor. Table 4 shows that the PARs ranged from 0.9% to 11.3%, with the estimated attributable fraction in COVID-19 patients being 11.3% for hypertension and 7.1% for obesity. It is suggested that up to 11.3% and 7.1% of severe cases could have been avoided if the prevalences of hypertension and obesity were reduced. The results shown in Fig 4 indicate that ARDS (OR = 39.59, 95% CI: 19.99–78.41; I 2 = 48.7%) [ 11 , 13 – 15 , 17 , 20 , 22 , 24 , 26 , 44 ], shock (OR = 21.50, 95% CI: 10.49–44.06; I 2 = 27.4%) [ 11 , 13 , 15 , 17 , 20 , 22 , 24 , 43 , 44 , 51 ] and AKI (OR = 8.84, 95% CI: 4.34–18.00; I 2 = 40.7%) [ 11 , 13 – 15 , 18 , 20 , 24 , 26 , 44 , 51 ] which are potential life-threatening conditions, were clearly responsible for the ICU admissions. Additionally, some other complications like DIC (OR = 29.75, 95% CI: 3.41–259.68; I 2 = 0.0%) [ 13 , 22 ], secondary infection (OR = 10.03, 95% CI: 1.99–50.55; I 2 = 39.0%) [ 14 , 25 ], arrhythmia (OR = 9.80, 95% CI:3.91–24.60; I 2 = 0.0%) [ 11 , 12 ] and cardiac trauma (OR = 7.38, 95% CI:2.28–23.82; I 2 = 75.0%) [ 11 , 14 , 15 , 18 , 24 , 51 ] also potentially increase the severity of COVID-19. Though we lacked sufficient evidence to support the results for these other complications except for shock, ARDS and AKI, the data we already had were of high consistency. However, some complications such as hypohepatia (OR = 1.53, 95% CI: 0.71–3.30; I 2 = 0.0%) [ 18 , 24 ] did not show obvious association with the severity of patients’ conditions. The demographic characteristics including sex, age, smoking history and BMI were pooled for meta-analysis and the results are displayed in Fig 2 . There were 39 studies reporting on sex difference, and the pooled result showed that males were more likely to have severe disease than females (OR = 1.51, 95% CI:1.33–1.71; I 2 = 50.8%) [ 11 – 18 , 20 , 22 – 51 ]. Advanced age (SMD = 1.73, 95% CI: 1.34–2.12; I 2 = 98.6%) [ 11 – 17 , 22 – 24 , 26 , 29 , 31 – 35 , 38 , 39 , 41 – 51 ] was also considered to be a risk factor for severe COVID-19. In all selected studies, the mean age of patients with severe conditions was older than those with non-severe conditions except for the studies from Wang 2020c [ 35 ] and Kim 2020 [ 46 ]. Patients with a history of smoking were also found to be positively associated with severe disease (OR = 1.40, 95% CI:1.06–1.85; I 2 = 30.6%) [ 12 , 13 , 17 , 19 , 20 , 22 , 23 , 25 – 27 , 29 , 30 , 33 , 35 , 38 , 40 , 41 , 43 , 48 , 50 ]. In studies which reported BMI, we observed higher rates of obesity (BMI≥30kg/m 2 ) in patients with severe disease (OR = 1.89, 95% CI: 1.44–2.46; I 2 = 0.0%) [ 20 , 21 , 23 , 26 , 30 , 35 ]. The complete literature-search process is displayed in',\n",
       " ('COVID-19',\n",
       "  65,\n",
       "  2): 'Fig 1 . The search strategy initially retrieved 10314 articles, 10273 of which were excluded by assessing the eligibility criteria. Of these studies, 764 papers were duplicates, 9442 were perceived as unrelated research and 67 articles were in line with exclusion criteria. Finally, 41 articles [ 11 – 51 ] published between February 7 th , 2020 and March 13 th , 2021 were included, all of which were retrospective cohort studies. In total, 21060 patients were included in the meta-analysis. The characteristics of all the included studies are shown in Table 1 . 4 Discussion This study has examined the potential risk factors of severe COVID-19 such as demographic characteristics, comorbidities and complications to assist clinicians with allocation of medical resources. The higher the ORs of the risk factors, the greater the risks they bring. Our analysis has shown that males, obese patients (BMI ≥ 30kg/m2), patients with advanced age or a smoking history faced a greater risk of having severe COVID-19. This finding has also been supported by some previous studies [52–54]. However, some of the results of one meta-analysis were not consistent with our analysis, since they found gender irrelevant to the severity of COVID-19, which may possibly be due to the relatively small sample size [55]. The comorbidities including hypertension, diabetes, CKD, coronary heart disease, COPD, cerebrovascular disease and chronic liver disease could probably aggravate the illness and this outcome was consistent with other studies. [5, 7, 55–57] Complications including shock, AKI and ARDS were the main obstacles to recovery. Therefore, more attention should be paid to those obese elderly males with a history of smoking, and the above comorbidities or complications since they are more likely to develop the severe from of the disease. Although four previous studies [52, 53, 55, 57–59] have reported some risk factors for severe COVID-19, our analysis involved and reported on new factors obesity and chronic liver disease. In this study, the quality of evidence was higher since all the included studies were cohort studies rather than case-control studies, and we have included 41 eligible studies that were published from February,2020 to March, 2021, spanning a period of seven months. Some studies have suggested that innate immunity and some factors associated with sex chromosomes may lead to the differences in susceptibility and inflammation between females and males. For instance, the X chromosome in the female has encoded some immune regulatory genes which caused lower viral load levels. TLR7, a Toll-like kind of receptor, which is higher in females than males, could enhance immune responses and boost the resistance to COVID-19 [60]. Besides, the circulating concentration of ACE2 (a functional cellular receptor of SARS-CoV-2) is higher in males than females, which could increase the susceptibility to SARS-CoV-2 [61]. Males also smoked at a higher rate than females [62] and that could result in a more vulnerable respiratory system. Therefore, it seems reasonable that women have been found to be more resistant to COVID-19. As for smoking, it suppresses the antiviral mechanisms and alters some cytokine patterns which play a role in the innate mucosal immunity [63]; the viral replication and the severity of COVID-19 would increase to some extent as a result. One study shows that smoking can also enhance the expression of ACE2 [64] and this would raise the susceptibility. With regard to age, it was evident that elderly people had a higher prevalence of comorbidities like diabetes [65] and complications like shock [66], but the OR was still significant when controlling for the above confounding factors. The natural decrease in functional reserve brought about by the physiological aging process',\n",
       " ('COVID-19',\n",
       "  65,\n",
       "  3): 'could reduce elders’ capability to resist infections like COVID-19. Based on the analysis of an increasing number of studies reporting details of BMI, we considered obesity as a risk factor. Obesity could cause more endothelial dysfunction [67] and weaken the immunocompetent cells especially their cytotoxic cell responses [68]. The high level of ACE2 receptor expression in adipocytes may turn the adipose tissue into a viral carrier which could spread SARS-CoV-2 to other organs. We also found some comorbidities were potentially high-risk factors for severe disease and this is consistent with other recent studies [53, 55, 57–59]. For example, as a chronic respiratory illness, COPD has already led to airflow blockage and so raises the risk of respiratory complications like ARDS. Psychologically, when patients with COPD get COVID-19, they seem to easily become very afraid and anxious [69]. Negative feelings may drive misbehavior and go against recovery, so psychological support is considered important. Though the degree varied, a large number of COVID-19 patients had hypoxaemia which may cause injury or apoptosis of cardiomyocytes [70]. As a result, patients with coronary heart disease were more likely to suffer from severer conditions like heart failure which can easily lead to death. For patients with hypertension, some kinds of blood pressure medications can enhance the expression of ACE2 and leave patients more susceptible to COVID-19 symptoms [71, 72]. However some other studies have shown that ACE2 plays an anti-inflammatory role in RAS and protect patients from ARDS [73, 74]. Therefore, the incidence of COVID-19 was lower but the severity was higher in patients with hypertension. Additionally, prolonged hypertension damages the vascular structure leaving the patients susceptible to serious infections. In terms of diabetes, this could compromise and weaken patients’ immune system thus worsening their conditions [75]. The dysfunctional pro-inflammatory cytokine responses due to diabetes could also increase the severity of COVID-19 [7]. Whether malignancy does affect the state of illness or lead to a poor prognosis is still controversial. Though our analysis showed there was a potential relationship between malignancy and severe condition, some articles had conflicting outcomes, and a few articles have even suggested that some patients with cancer may have better clinical outcomes since the possible emergence of cytokine storm was dampened because of their compromised immune systems [76, 77]. In addition to the above results, we have also found chronic renal disease (OR = 2.97, 95% CI: 1.63–5.41) was a potential risk factor for severe COVID-19, although a previous analysis had showed that it was not significantly associated with severe conditions [52]. It is likely that patients with CKD suffer from dysregulation of the immune system [78], which possibly contributed to the increase in severity. A study with similar results to ours has also reported a potential link between chronic liver disease and severe COVID-19 [79]. The hepatic insufficiency of COVID-19 patients could be worsened by potentially hepatotoxic drugs such as remdesivir, lopinavir and ritonavir used to treat the disease, causing more severe conditions [80]. More analyses need to be done in order to provide sufficient information and draw accurate conclusions about the controversial results above. According to our analysis, ARDS, shock and AKI were the three major complications playing a role in severe conditions. Due to impaired gas exchange and serious inflammation in the alveolar space, patients with ARDS had significant need of ventilation [81]. Some studies [82, 83] suggested tissue plasminogen activator (tPA) may be useful in saving such patients’ lives in the face of lack of mechanic ventilation in some areas. AKI is prevalent among severe patients and can be fatal especially when patients required renal replacement therapy',\n",
       " ('COVID-19',\n",
       "  65,\n",
       "  4): '[84]. Similarly, shocked patients can die without timely treatment resulting from the lack of effective circulating blood volume. Therefore, it is essential to prevent the occurrence of the above complications and give prompt first aid treatment when such complications occur. We believe the PAFs we calculated are meaningful for public health, because the risk of severe cases is likely to decrease in the wake of reduction in the prevalence of certain conditions. In our analysis, the top risk factor was hypertension with the score of 11.3%, indicating that though the OR of hypertension was not relatively high among all the factors, it did play a more important role than we had thought. The PAFs of ARDS (10.7%) and AKI (7.4%) were also high which showed that they possibly make a considerable contribution to the severity of COVID-19, but there are no specific clinical guidelines to prevent them. Therefore, more attention should be given to some other factors like obesity (7.1%) and diabetes (6.5%) since they can to some extent be prevented through practical guidelines [85] and public health campaigns. The other factors ranged from 0.9% to 5.5% and half of them were around 1.0%, suggesting that they exert less effects on the severity of COVID-19. We should acknowledge that there are some limitations which may affect the accuracy of the outcomes and should be considered. First, some studies did not explicitly show their criteria for severe patients and non-severe patients, meaning the actual severity of patients with these two outcomes may not be consistent with those studies. Second, detecting significant heterogeneity in some analyses, we chose to use a random effects model to process data but did not identify the clear sources of heterogeneity through subgroup analyses. Third, the majority of the patients came from China, so they may not be representative of all patients across the world and so results should be carefully evaluated and accepted cautiously. The conclusion can be updated when more studies from outside China are published. Forth, we have tried to include studies from different cites but some articles may still include duplicated cases since they seldom mentioned the detailed composition of patient groups.',\n",
       " ('COVID-19',\n",
       "  66,\n",
       "  0): 'Readers’ note This article is a living systematic review that will be updated to reflect emerging evidence. Updates may occur for up to two years from the date of original publication. This is the fifth version of the original article published on 30 July 2020 (BMJ 2020;370:m2980), and previous versions can be found as data supplements. When citing this paper please consider adding the version number and date of access for clarity. Conclusion Corticosteroids, interleukin-6 receptor antagonists, and Janus kinase inhibitors probably reduce mortality and confer other important benefits in patients with severe covid-19. Molnupiravir and nirmatrelvir/ritonavir probably reduce admission to hospital in patients with non-severe covid-19. Results 463 trials enrolling 166 581 patients were included; 267 (57.7%) trials and 89 814 (53.9%) patients are new from the previous iteration; 265 (57.2%) trials evaluating treatments with at least 100 patients or 20 events met the threshold for inclusion in the analyses. Compared with standard care, three drugs reduced mortality in patients with mostly severe disease with at least moderate certainty: systemic corticosteroids (risk difference 23 fewer per 1000 patients, 95% credible interval 40 fewer to 7 fewer, moderate certainty), interleukin-6 receptor antagonists when given with corticosteroids (23 fewer per 1000, 36 fewer to 7 fewer, moderate certainty), and Janus kinase inhibitors (44 fewer per 1000, 64 fewer to 20 fewer, high certainty). Compared with standard care, two drugs probably reduce hospital admission in patients with non-severe disease: nirmatrelvir/ritonavir (36 fewer per 1000, 41 fewer to 26 fewer, moderate certainty) and molnupiravir (19 fewer per 1000, 29 fewer to 5 fewer, moderate certainty). Remdesivir may reduce hospital admission (29 fewer per 1000, 40 fewer to 6 fewer, low certainty). Only molnupiravir had at least moderate quality evidence of a reduction in time to symptom resolution (3.3 days fewer, 4.8 fewer to 1.6 fewer, moderate certainty); several others showed a possible benefit. Several drugs may increase the risk of adverse effects leading to drug discontinuation; hydroxychloroquine probably increases the risk of mechanical ventilation (moderate certainty). Methods After duplicate data abstraction, a bayesian network meta-analysis was conducted. Risk of bias of the included studies was assessed using a modification of the Cochrane risk of bias 2.0 tool, and the certainty of the evidence using the grading of recommendations assessment, development, and evaluation (GRADE) approach. For each outcome, interventions were classified in groups from the most to the least beneficial or harmful following GRADE guidance. Study selection Randomised clinical trials in which people with suspected, probable, or confirmed covid-19 were randomised to drug treatment or to standard care or placebo. Pairs of reviewers independently screened potentially eligible articles. Data sources WHO covid-19 database, a comprehensive multilingual source of global covid-19 literature, up to 3 December 2021 and six additional Chinese databases up to 20 February 2021. Studies identified as of 1 December 2021 were included in the analysis. Expanded version of the methods, processes, and results with multilayered recommendations, evidence summaries, and decision aids for use on all devices In this living systematic review and network meta-analysis we compare the effects of drug treatments for covid-19. This review is part of the BMJ Rapid Recommendations project, a collaborative effort from the MAGIC Evidence Ecosystem Foundation ( www.magicproject.org ) and The BMJ. 6 This living systematic review and network meta-analysis informs World Health Organization and BMJ Rapid Recommendations on covid-19 treatments, initiated to provide trustworthy, actionable, and living guidance to clinicians and patients soon after new and potentially practice-changing evidence becomes available ( box 1 ). 7 8 This living network meta-analysis is the fifth version. The previous versions are available in the supplementary material.',\n",
       " ('COVID-19',\n",
       "  66,\n",
       "  1): 'Drugs for prophylaxis 9 and antibody-based treatments 10 are addressed separately. Summarising the rapidly growing evidence base has been a challenge. 3 Living systematic reviews deal with the main limitation of traditional reviews—that of providing an overview of the relevant evidence only at a specific time. 4 This is crucial in the context of covid-19, in which the best evidence is constantly changing. The ability of a living network meta-analysis to present a complete, broad, and updated view of the evidence makes it the best type of evidence synthesis to inform the development of practice recommendations. Network meta-analysis, rather than pairwise meta-analysis, provides useful information about the comparative effectiveness of treatments that have not been tested head to head. The lack of such direct comparisons is certain to limit inferences in the covid-19 setting. Moreover, the incorporation of indirect evidence can strengthen evidence in comparisons that were tested head to head. 5 As of 23 March 2022, more than 475 million people have been infected with severe acute respiratory syndrome coronavirus virus 2 (SARS-CoV-2), the virus responsible for coronavirus disease 2019 (covid-19); of these, more than six million have died. 1 Despite global efforts to identify effective interventions for the prevention and treatment of covid-19, which have resulted in approximately 3000 trials completed or underway, 2 evidence for effective treatment remains limited. Patients were involved in outcome selection, interpretation of results, and the generation of parallel recommendations, as part of the BMJ Rapid Recommendations initiative. Subgroup analyses were performed for specific interventions of interest at the direction of the linked WHO living guideline panel. Previous iterations included subgroup analyses for ivermectin, interleukin-6 receptor antagonists, corticosteroids, hydroxychloroquine, lopinavir-ritonavir, and remdesivir. The panel requested subgroup analyses by age (children v non-elderly adults v elderly), severity (non-severe v severe and critical), and risk of bias. We performed bayesian hierarchical meta-regression with study as a random effect. Where possible, we performed within rather than between trial analyses. For each outcome, we classified treatments in groups from the most to the least effective using the minimally contextualised framework, which focuses on the treatment effect estimates and the certainty of the evidence. 35 To facilitate interpretation of the results, we calculated absolute effects for outcomes in which the summary measure was an odds ratio or ratio of means. When available, we inferred baseline risk in the usual care group for each outcome from representative observational data (supplementary material). For mortality, we used data from the CDC on patients who were hospitalised with covid-19. 30 31 For mechanical ventilation, duration of invasive mechanical ventilation, length of hospital stay, and ICU length of stay we used baseline risks from the International Severe Acute Respiratory and Emerging Infection COVID-19 database. 32 For all other outcomes, we used the median from all studies in which participants received standard of care to calculate the baseline risk for each outcome, with each study weighed equally. We calculated absolute effects using the transitive risks model 33 using R2jags package in R. 34 We assessed the certainty of evidence using the grading of recommendations assessment, development and evaluation (GRADE) approach for network meta-analysis. 5 27 28 Two people with experience in using GRADE rated each domain for each comparison separately and resolved discrepancies by consensus. We rated the certainty for each comparison and outcome as high, moderate, low, or very low, based on considerations of risk of bias, inconsistency, indirectness, publication bias, intransitivity, incoherence (difference between direct and indirect effects), and imprecision. 28 We rated down for risk of bias if the interpretation of the effect would change if only studies at low risk',\n",
       " ('COVID-19',\n",
       "  66,\n",
       "  2): 'of bias would have been considered. For example, if the credible interval of the pooled effect from studies at low risk of bias would have crossed the threshold for imprecision, we rated down for risk of bias. Judgments of imprecision for this systematic review were made using a minimally contextualised approach, with a null effect as the threshold of importance. 29 The minimally contextualised approach considers only whether credible intervals include the null effect and thus does not consider whether plausible effects, captured by credible intervals, include both important and trivial effects. 29 To evaluate certainty of no benefit (or no effect), we used a 2% risk difference threshold of the 95% credible interval for mortality and mechanical ventilation. In other words, if the entire 95% credible interval was within 2% of the null effect, we would not rate down for imprecision. We decided on this preliminary threshold based on a survey of the authors. Interim updates and additional study data will be posted on our website ( www.covid19lnma.com ). In the first iteration of this living network meta-analysis, some treatment nodes with few total participants and few total events resulted in highly implausible and extremely imprecise effect estimates. We therefore decided to include only treatments that included at least 100 patients or had at least 20 events, based on our impression of the minimum number of patients/events to possibly provide meaningful results. For most outcomes, we conducted network meta-analyses and pairwise meta-analyses using a bayesian framework with the same priors for the variance and effect parameters. 21 In previous versions, we used fixed effects for some outcomes because data was sparse or dominated by a single trial. As per our protocol, we used random effects for all outcomes. We used a plausible prior for variance parameter and a uniform prior for the effect parameter suggested in a previous study based on empirical data. 24 For all analyses, we used three Markov chains with 100 000 iterations after an initial burn-in of 10 000 and a thinning of 10. We used node splitting models to assess local incoherence and to obtain indirect estimates. 25 All network meta-analyses were performed using the gemtc package of R version 3.6.3 (RStudio, Boston, MA) 26 and all pairwise meta-analyses using the bayesmeta package. 21 Treatments were grouped into common nodes based on molecule and not on dose or duration. For intervention arms with more than one drug, we created a separate node. Chloroquine and hydroxychloroquine were included in the same node for covid-19 specific effects and separated for disease independent adverse effects. We drew network plots using the networkplot command of Stata version 15.1 (StataCorp, College Station, TX), with thickness of lines between nodes and size of the nodes based on the inverse of the variance of the direct comparison. 23 We summarised the effect of interventions on dichotomous outcomes using the odds ratio and corresponding 95% credible interval. For continuous outcomes, we used the mean difference and corresponding 95% credible interval in days for ICU length of stay, length of hospital stay, and duration of mechanical ventilation because we expected similar durations across randomised trials. For time to symptom resolution, we first performed the analyses using the relative effect measure ratio of means and corresponding 95% credible interval before calculating the mean difference in days because we expected substantial variation between studies. 22 We conducted the network meta-analysis using a bayesian framework. 21 In this report, we conducted a network meta-analysis of drug treatments for covid-19 that included all patients, regardless of severity of disease. For each eligible trial, reviewers, following training and',\n",
       " ('COVID-19',\n",
       "  66,\n",
       "  3): 'calibration exercises, used a revision of the Cochrane tool for assessing risk of bias in randomised trials (RoB 2.0) 20 to rate trials as either at i) low risk of bias, ii) some concerns—probably low risk of bias, iii) some concerns—probably high risk of bias, or iv) high risk of bias, across the following domains: bias arising from the randomisation process; bias owing to departures from the intended intervention; bias from missing outcome data; bias in measurement of the outcome; bias in selection of the reported results, including deviations from the registered protocol; bias due to competing risks; and bias arising from early termination for benefit. We rated trials at high risk of bias overall if one or more domains were rated as probably high risk of bias or as high risk of bias and as low risk of bias if all domains were rated as probably low risk of bias or low risk of bias. Reviewers resolved discrepancies by discussion and, when not possible, with adjudication by a third party. Mechanical ventilation includes both invasive and non-invasive mechanical ventilation. We used a hierarchy for the outcome mechanical ventilation in which we preferentially used the total number of patients who received mechanical ventilation over the study. We used the number of patients ventilated at the time point that the largest number of the patients were ventilated, if the trial reported the number of patients ventilated at specific timepoints. We used author definitions for mechanical ventilation; when separate, continuous positive airway pressure (CPAP) and bilevel positive airway pressure (BiPAP) were considered non-invasive mechanical ventilation. Outcomes of interest were selected based on importance to patients 18 and were informed by clinical expertise in the systematic review team and in the linked guideline panel responsible for the WHO-BMJ Rapid Recommendations. 19 7 8 The panel includes unconflicted clinical and methodology experts, recruited to ensure global representation, and patient partners. All panel members rated outcomes from 1 to 9 based on importance to individual patients (9 being most important), and we included any outcome rated 7 or higher by any panel member. Selected outcomes included mortality (closest to 90 days), mechanical ventilation (total number of patients, over 90 days), adverse events leading to discontinuation (within 28 days), admission to hospital, length of hospital stay, duration of mechanical ventilation, and time to symptom resolution or clinical improvement. In contrast to previous iterations, for this iteration, we did not include several outcomes which the GDG did not think were critical to decision making: viral clearance (closest to 7 days, 3 days either way), time to viral clearance, intensive care unit (ICU) length of stay, and days free from mechanical ventilation (within 28 days). For each eligible trial, pairs of reviewers, following training and calibration exercises, extracted data independently using a standardised, pilot tested data extraction form. Reviewers collected information on trial characteristics (trial registration, publication status, study status, design), patient characteristics (country, age, sex, smoking habits, comorbidities, setting and type of care, and severity of covid-19 symptoms for studies of treatment), and outcomes of interest (means or medians and measures of variability for continuous outcomes and the number of participants analysed and the number of participants who experienced an event for dichotomous outcomes). Reviewers resolved discrepancies by discussion and, when necessary, with adjudication by a third party. We updated the data collected from included preprints as soon as the peer review publication became available. Using a systematic review software, Covidence, 17 pairs of reviewers, following training and calibration exercises, independently screened all titles and abstracts, followed by full texts of trials that were identified as potentially',\n",
       " ('COVID-19',\n",
       "  66,\n",
       "  4): 'eligible. A third reviewer adjudicated conflicts. We searched all English information sources from 1 December 2019 to 3 December 2021, and the Chinese literature from conception of the databases to 20 February 2021. We monitor living evidence retrieval services on an ongoing basis. These included the Living Overview of the Evidence (L-OVE) COVID-19 Repository by the Epistemonikos Foundation 15 and the Systematic and Living Map on COVID-19 Evidence by the Norwegian Institute of Public Health, in collaboration with the Cochrane Canada Centre at McMaster University. 16 In addition, we search six Chinese databases: Wanfang, Chinese Biomedical Literature, China National Knowledge Infrastructure, VIP, Chinese Medical Journal Net (preprints), and ChinaXiv (preprints). We adapted the search terms for covid-19 developed by the CDC to the Chinese language. For the Chinese literature search, we also included search terms for randomised trials. The supplementary file includes the Chinese literature search strategy. We stopped searching the Chinese databases on 20 February 2021 because they had not provided studies that meaningfully altered the evidence for any intervention. The daily searches are designed to match the update schedule of the database and to capture eligible studies the day of or the day after publication. To identify randomised trials, we filtered search results through a validated and highly sensitive machine learning model. 14 We tracked preprints of randomised trials for updates and through publication: when data were discrepant, we used the most recent data. We perform daily searches from Monday to Friday in the World Health Organization (WHO) covid-19 database for eligible studies—a comprehensive multilingual source of global literature on covid-19. Prior to its merge with the WHO covid-19 database on 9 October 2020, we performed daily searches from Monday to Friday in the US Centers for Disease Control and Prevention (CDC) COVID-19 Research Articles Downloadable Database for eligible studies. 13 The database includes, but is not limited to the following 25 bibliographic and grey literature sources: Medline (Ovid and PubMed), PubMed Central, Embase, CAB Abstracts, Global Health, PsycInfo, Cochrane Library, Scopus, Academic Search Complete, Africa Wide Information, CINAHL, ProQuest Central, SciFinder, the Virtual Health Library, LitCovid, WHO covid-19 website, CDC covid-19 website, Eurosurveillance, China CDC Weekly, Homeland Security Digital Library, ClinicalTrials.gov, bioRxiv (preprints), medRxiv (preprints), chemRxiv (preprints), and SSRN (preprints). We excluded randomised trials evaluating vaccination, blood products and antibody-based antiviral therapies (such as virus-specific monoclonal antibodies), nutrition, traditional Chinese herbal or alternative medicines that include more than one molecule or a molecule without specific molecular weighted dosing, and non-drug supportive care interventions. Trials that evaluated these interventions were identified and categorised separately. We included randomised clinical trials in people with suspected, probable, or confirmed covid-19 that compared drugs for treatment against one another or against no intervention, placebo, or standard care. We included trials regardless of publication status (peer reviewed, in press, or preprint) or language. No restrictions were applied based on severity of illness or setting, and we included trials of Chinese medicines if the drug comprised one or more specific molecules with a defined molecular weight dosing. A protocol provides the detailed methods of this systematic review, including all updates (see supplementary file). We report this living systematic review following the guidelines of the preferred reporting items for systematic reviews and meta-analyses (PRISMA) checklist for network meta-analyses. 11 A living systematic review is a cumulative synthesis that is updated regularly as new evidence becomes available. 12 The linked BMJ Rapid Recommendations guideline panels approved all decisions relevant to data synthesis. Previous iterations of this living systematic review explored subgroup effects for remdesivir, lopinavir-ritonavir, hydroxychloroquine, corticosteroids, ivermectin, and interleukin-6 receptor antagonists. An additional network meta-analysis',\n",
       " ('COVID-19',\n",
       "  66,\n",
       "  5): 'limited to interventions of interest for patients with non-severe disease up to 2 February 2022 showed that nirmatrelvir/ritonavir and molnupiravir may reduce mortality (supplementary material). Findings for other outcomes were not meaningfully different from the full network. Among patients with non-severe disease, we did not identify any subgroup effects for molnupiravir, nirmatrelvir/ritonavir, fluvoxamine, or remdesivir. Seventy nine trials including 26 119 participants met the threshold of analysing treatments with a minimum of 100 patients and were included in the network meta-analysis. Thirty four interventions were studied: the most common interventions were standard care (73 trials, 11 674 participants), Janus kinase inhibitors (4 trials, 1585 participants), molnupiravir (3 trials, 1536 participants), remdesivir (4 trials, 1497 participants), and inhaled corticosteroids (2 trials, 1031 participants). Molnupiravir probably reduces time to symptom resolution (ratio of means 0.66, 0.52 to 0.83; mean difference −3.3 days, −4.8 to −1.6; moderate certainty). No other intervention had at least moderate certainty evidence of benefit or harm ( fig 2 ). Twenty eight trials with 3947 participants met the threshold of analysing treatments with a minimum of 100 patients and were included in the network meta-analysis (supplementary appendix). Eight interventions were included: the most common were standard care (28 trials, 1989 participants), interferon beta (2 trials, 502 participants), full dose anticoagulation (1 trial, 308 participants), interleukin-6 receptor antagonists (7 trials, 251 participants), and remdesivir (3 trials, 201 participants). Janus kinase inhibitors probably reduce the duration of mechanical ventilation (−3.2 days, −5.9 to −0.5; high certainty). There was no convincing evidence that any of the other interventions reduce duration of mechanical ventilation ( fig 2 ). Compared with standard care, hospitalisation was shorter in patients who received interleukin-6 receptor antagonists with systemic corticosteroids (mean difference −4.7 days, −8.9 to −0.5; moderate certainty) and Janus kinase inhibitors (−1.1 days, −1.9 to −0.4; moderate certainty). Interleukin-6 receptor antagonists probably do not reduce length of hospital stay when given without systemic corticosteroids (0.0 days, −1.2 to 1.2; moderate certainty). Evidence was low or very low certainty for all other interventions ( fig 2 ). One hundred and thirteen trials with 91 270 participants met the threshold of analysing treatments with a minimum of 100 patients and were included in the network meta-analysis (supplementary appendix). Thirty eight interventions were studied: the most common interventions were standard care (107 trials, 48 098 participants), colchicine (6 trials, 5809 participants), remdesivir (6 trials, 4340 participants), hydroxychloroquine (15 trials, 3347 participants), azithromycin (4 trials, 2795 participants), corticosteroids (6 trials, 2694 participants), Janus kinase inhibitors (6 trials, 1778 patients), and interleukin-6 receptor antagonists with systemic corticosteroids (7 trials, 1506 participants). Thirteen trials randomised 6732 participants to five different interventions. Full dose anticoagulation may increase the odds of clinically important bleeding compared with prophylactic dose anticoagulation (odds ratio 2.15, 1.35 to 3.52; low certainty). The impacts of aspirin, intermediate dose anticoagulation, and sulodexide are less certain. Eleven trials that randomised 6195 participants to five different interventions reported venous thromboembolism. Full dose anticoagulation may reduce odds of venous thromboembolism compared with prophylactic dose anticoagulation (odds ratio 0.50, 0.32 to 0.78; low certainty). The impacts of aspirin, intermediate dose anticoagulation, and sulodexide are less certain. Thirty five randomised trials with 21 306 participants met the threshold of analysing treatments with a minimum of 100 patients or 20 events and were included in the network meta-analysis (supplementary appendix). Nineteen interventions were included: the most common interventions were standard care (36 trials, 10 492 participants), molnupiravir (5 trials, 2385 participants), colchicine (1 trial, 2235 participants), and fluvoxamine (3 trials, 1093 participants). Molnupiravir (odds ratio 0.54, 0.30 to 0.90; moderate certainty), nirmatrelvir/ritonavir (0.13, 0.04 to',\n",
       " ('COVID-19',\n",
       "  66,\n",
       "  6): '0.40; moderate certainty), and remdesivir (0.25, 0.07 to 0.86; low certainty) probably reduce hospitalisation. There was insufficient evidence to know if any other interventions reduce hospitalisation ( fig 2 ). Ninety nine trials with 31 840 participants met the threshold of analysing treatments with a minimum of 100 patients or 20 events and were included in the network meta-analysis (supplementary appendix). Fourty four interventions were included: the most common interventions were standard care (95 trials, 13 795 participants), molnupiravir (6 trials, 2442 participants), interleukin-6 receptor antagonists with corticosteorids (6 trials, 1696 participants), remdesivir (6 trials, 1445 participants), and hydroxychloroquine (14 trials, 1257 participants). The drugs with a high risk of adverse effects included hydroxychloroquine (13 more per 1000, 2 more to 24 more; low certainty), lopinavir-ritonavir (49 more per 1000, 27 more to 72 more; moderate certainty), and tyrosine kinase inhibitors (62 more per 1000, 19 more to 105 more; moderate certainty). Several drugs did not have a higher risk of discontinuation for adverse effects than standard care/placebo ( fig 2 ). Compared with standard care, interventions that reduce risk of mechanical ventilation include interleukin 6 receptor antagonists when given with systemic corticosteroids (0.79, 0.63 to 0.98; moderate certainty) and interleukin-6 receptor antagonists without corticosteroids (0.58, 0.35 to 0.97; high certainty) ( fig 2 ). Other interventions may reduce risk of mechanical ventilation including corticosteroids (odds ratio 0.79, 0.58 to 1.05; low certainty), Janus kinase inhibitors (0.78, 0.56 to 1.04; moderate certainty), and remdesivir (0.79, 0.60 to 1.01; low certainty). One hundred and forty trials with 93 968 participants met the threshold of analysing treatments with a minimum of 100 patients or 20 events and were included in the network meta-analysis (supplementary appendix). Forty four interventions were included: the most common interventions were standard care (132 trials, 47 865 participants), colchicine (5 trials, 6313 participants), aspirin (2 trials, 5157 participants), remdesivir (7 trials, 3981 participants), lopinavir-ritonavir (7 trials, 3628 participants), hydroxychloroquine (15 trials, 3474 participants), azithromycin (6 trials, 3400 participants), interleukin-6 receptor antagonists with systemic corticosteroids (11 trials, 2399 participants), and corticosteroids (9 trials, 1171 participants). Interventions with at least moderate certainty of benefit included: systemic corticosteroids (odds ratio 0.80, 95% credible interval 0.65 to 0.94; moderate certainty), interleukin-6 receptor antagonists when given with systemic corticosteroids (0.80, 0.69 to 0.94; moderate certainty), and Janus kinase inhibitors (0.63, 0.47 to 0.83; high certainty) ( fig 2 ). Notable interventions that did not suggest benefit included aspirin (0.93, 0.69 to 1.20; low certainty), azithromycin (0.98, 0.78 to 1.25, low certainty), colchicine (0.93, 0.65 to 1.16; low certainty), fluvoxamine (0.68, 0.33 to 1.32; low certainty), full-dose anticoagulation (0.96, 0.78 to 1.16; low certainty), hydroxychloroquine (1.08, 0.92 to 1.27; moderate certainty), interleukin-6 receptor antagonists without concurrent corticosteroids (1.09, 0.91 to 1.31; moderate certainty), ivermectin (0.63, 0.37 to 1.05; low certainty), lopinavir-ritonavir (1.06, 0.88 to 1.28; low certainty), and remdesivir (odds ratio 0.91, 0.73 to 1.11; low certainty). Two hundred and sixty seven trials with 138 345 participants met the threshold of analysing treatments with a minimum of 100 patients or 20 events and were included in the network meta-analysis (supplementary file). Supplementary figure S1 on bmj.com shows the network plot for mortality, with each edge representing a direct comparison between two interventions. Fifty seven different interventions were included: the most common were standard care/placebo (252 trials, 69 448 participants), colchicine (7 trials, 8194 participants), aspirin (3 trials, 7716 participants), hydroxychloroquine (35 trials, 4955 participants), remdesivir (9 trials, 5044 participants), lopinavir-ritonavir (11 trials, 4153 participants), interleukin-6 receptor antagonists with corticosteroids (32 trials, 4153 participants), and corticosteroids (13 trials, 3076 participants). The supplementary material presents the',\n",
       " ('COVID-19',\n",
       "  66,\n",
       "  7): 'network plots depicting the interventions included in the network meta-analysis of each outcome. Figure 2 presents a summary of the effects of the interventions on the outcomes. The supplementary file also presents detailed relative and absolute effect estimates and certainty of the evidence for all comparisons and outcomes. We did not detect statistical incoherence in any of the network meta-analyses. The supplementary material presents the assessment of risk of bias of the included studies for each outcome: 121 studies were judged at low risk of bias in all domains for at least one outcome. All analyses reached convergence based on trace plots and a Brooks-Gelman-Rubin statistic less than 1.05, except comparisons including umifenovir for mortality because no patients randomised to either of these drugs died, interleukin-6 inhibitors and doxycycline with ivermectin for adverse events, proxalutamide for hospital admission, and sulodexide for clinically important bleeding. Seventy five studies were initially posted as preprints and subsequently published after peer review. The supplementary material presents the differences between study preprint and peer reviewed publications. Thirty two studies had discrepancies in outcome reporting between the preprint and peer-reviewed publication, 32 studies had discrepancies with patient baseline characteristics, and 14 studies had discrepancies in reporting that led to changes in risk of bias ratings. No substantive differences were found for 26 studies. Of the randomised trials included in the analyses, eight did not have publicly accessible protocols or registrations. Of the trials with publicly accessible protocols or registrations, 79 reported results for one or more of our outcomes of interest that were not prespecified in protocols or registrations. No other discrepancies in the reporting of outcomes of interest were noted. One trial did not stratify reporting of outcomes for those who were truly randomised versus those who were allocated by preference; the authors shared outcome data with us among patients who were truly randomised. Several trials could not be included in the analysis because both arms would have been classified within the same treatment node, they evaluated different durations or doses of the same drug, had insufficient data, or reported no outcomes of interest. Ultimately, we analysed 265 (63%) trials that reported on treatments with at least 100 patients or 20 events. Table 1 presents the characteristics of the 420 included studies. Additional study characteristics, outcome data, and risk of bias assessments for each study are available in the supplementary file. After screening 79 601 titles and abstracts and 1438 full texts, 463 unique randomised trials were identified that evaluated drug treatments as of 3 December 2021 ( fig 1 ). A table of excluded full texts is provided in the supplementary file. Searches of living evidence retrieval services identified 219 publications of eligible randomised trials, which were reconciled with our formal search strategy when necessary. Three hundred and six randomised trials have been published in peer reviewed journals, 109 are preprints and 48 remain unpublished as either abstracts, data from meta-analyses, data from authors or data from presentations. The supplement describes the 43 randomised trials that were identified after the data analysis (1 December 2021) and that will be considered in the next update of the data analysis. Of the remaining trials, most were registered (373/420; 89%), nearly three quarters evaluated treatment in patients admitted to hospital with covid-19 (312/420; 74%), and one fifth evaluated treatment in outpatients with covid-19 (86/420; 20%). The United States, Iran, Brazil, India, and China were the five countries in which randomised trials were most commonly conducted. One hundred and eighty one different drug treatments were evaluated. Discussion This living systematic review and network meta-analysis provides a comprehensive overview',\n",
       " ('COVID-19',\n",
       "  66,\n",
       "  8): 'of the evidence for drug treatments of covid-19 up to 1 December 2021 and a comprehensive list of drug trials to 3 December 2021. There are now more than 400 randomised trials examining many different interventions for treating covid-19, and as a result, the certainty in evidence for multiple interventions is improved. For patients with severe covid-19, three anti-inflammatory drugs probably reduce mortality: systemic corticosteroids, interleukin-6 receptor antagonists (when given with systemic corticosteroids), and Janus kinase inhibitors. Interleukin-6 receptor antagonists, when co-administered with systemic corticosteroids, also probably reduce mechanical ventilation and length of hospital stay. When they are provided without systemic corticosteroids, interleukin-6 receptor antagonists might not reduce mortality or length of hospital stay. The subgroup effect is consistent with evidence from other meta-analyses.36 A single dose of either sarilumab and tocilizumab appears to be similarly efficacious.37 Janus kinase inhibitors probably reduce mortality, length of hospital stay, and duration of mechanical ventilation. The evidence supporting janus kinase inhibitors comes primarily from studies that used baricitinib. The RECOVERY trial, which randomized 8156 patients to baricitinib or standard care, was published after our analyses were completed.38 The RECOVERY trial confirmed that baricitinib reduces mortality. It was also the first study to show that janus kinase inhibitors may have added benefit in patients also receiving interleukin-6 receptor antagonists and systemic corticosteroids. For patients with non-severe covid-19, three antivirals probably reduce admission to hospital: molnupiravir, nirmatrelvir/ritonavir, and remdesivir. Molnupiravir and nirmatrelvir/ritonavir may also slightly reduce the risk of death. Based on this review, the WHO has recently suggested using one of these antivirals rather than no antiviral.7 These drugs were all studied in people who were at increased risk of hospitalisation: they had not received a SARS-CoV-2 vaccine and had other risk factors for disease progression. The absolute benefit should therefore be substantially smaller in patients who are vaccinated against SARS-CoV-2 or who do not have risk factors for disease progression. Each of the antivirals has some drawbacks that were not captured in this overview. For example, molnupiravir could be carcinogenic, nirmatrelvir/ritonavir has a large number of critical drug-drug interactions, and remdesivir is administered intravenously. Full dose anticoagulation, compared with prophylactic dose anticoagulation, may reduce the risk of venous thromboembolism by approximately 16 per 1000 patients and increase the risk of clinically important bleeding by approximately 20 per 1000 patients. There did not seem to be a difference in other outcomes such as mortality or mechanical ventilation. Several interventions do not seem to have important benefit on any patient-important outcomes, including angiotensin-converting enzyme inhibitors, aspirin, azithromycin, colchicine, hydroxychloroquine, inhaled corticosteroids, intranasal corticosteroids, interferon beta, ivermectin, lopinavir-ritonavir, umifenovir, and vitamin C. Hydroxychloroquine may increase the risk of mechanical ventilation, adverse effects leading to drug discontinuation, and length of hospital stay. Compared with the fourth iteration, there are several important updates (box 2). We now have evidence from several large scale international trials on azithromycin, interleukin-6 inhibitors, molnupiravir, nirmatrelvia/ritonavir, Janus kinase inhibitors, full dose anticoagulation, and colchicine. Box 2 Summary of changes since last iteration Two hundred and sixty seven trials and 89 814 participants are new from the previous iteration Additional evidence for Janus kinase inhibitors suggests that they probably reduce mortality in patients with severe covid-19 Additional evidence suggests that colchicine probably does not have any important benefit (the previous iteration suggested that it might) New evidence suggests that the antivirals molnupiravir and nirmatrelvir/ritonavir probably reduce hospitalisation in patients with non-severe covid-19, while remdesivir might RETURN TO TEXT Strengths and limitations of this review Our search strategy and eligibility criteria were comprehensive, without restrictions on language of publication or publication status. To ensure expertise',\n",
       " ('COVID-19',\n",
       "  66,\n",
       "  9): 'in all areas, our team is composed of clinical and methods experts who have undergone training and calibration exercises for all stages of the review process. To minimise problems with counterintuitive results, we anticipated challenges that arise in network meta-analysis when data are sparse.39 Many of the results for comparisons with sparse data were uninformative and were sometimes implausible. For that reason, we decided to report evidence on treatments for which at least 100 people were randomised or for which there were at least 20 events. The primary limitation of the evidence for most interventions is lack of blinding, which might introduce bias through differences in co-interventions between randomised groups. We chose to consider the treatment arms that did not receive an active experimental drug (that is, placebo or standard care) within the same node: it is possible that the unblinded standard care groups received systematically different co-interventions than groups randomised to receive a placebo. Direct comparisons in which the evidence is dominated by unblinded studies were rated down, consistent with GRADE, for risk of bias and that is reflected in the rating of the quality of evidence from the network estimate.40 Many of the data also had reporting concerns. For some outcomes, the method in which the researchers measured and reported outcomes proved inconsistent across studies. This led the team to propose a hierarchy for the outcome mechanical ventilation, as described in the methods. The living nature of our systematic review and network meta-analysis could conceivably (at least temporarily) amplify publication bias, because studies with promising results are more likely to be published and are published sooner than studies with negative results. The inclusion of preprints, many of which have negative results, might reduce this risk. However, the inclusion of preprints in our network meta-analysis might introduce bias from simple errors and the reporting limitations of preprints. We include preprints because of the urgent need for information and because so many of the studies on covid-19 are published first as preprints. So far, differences between preprints and peer reviewed publications have mostly been limited to additional baseline patient information, clarification on study design, and outcomes reported in the peer reviewed publications. None of these changes would have resulted in a meaningful change to pooled effect estimates or certainty for any outcome.41 Our living systematic review and network meta-analysis will continue to inform the development of the WHO living guidelines and BMJ Rapid Recommendations.619 An important difference in the methods for assessing the certainty of the evidence does, however, exist between the two. In this living systematic review and network meta-analysis, we use a minimally contextualised approach for rating the certainty of the evidence, whereas the guideline panels use a fully contextualised approach in which the thresholds of importance of magnitudes of effects depend on all other outcomes and factors involved in the decision.29 The contextualisation explains differences in the certainty of the evidence between the two. We used observational data to inform the absolute risk estimates for some outcomes; differences in baseline risk can impact GRADE assessments for imprecision. To date, we are aware of two other similar efforts to ours.4243 Our intention is different in that the results fully inform clinical decision making for the associated living guidance.6 We also include a more comprehensive search for the evidence and several differences in analytical methods, which we believe are best suited for this evidence. For example, some others use fixed rather than random effects meta-analysis and provide estimates for pairwise comparisons only. It is also important to evaluate the reproducibility and replicability of findings from different scientific approaches. This',\n",
       " ('COVID-19',\n",
       "  66,\n",
       "  10): 'is the final version of this particular living systematic review and network meta-analysis. Mounting evidence suggests that antivirals (such as molnupiravir and nirmatrelvir) are most effective in the early stages of covid-19 when patients have non-severe disease, whereas anti-inflammatories (such as corticosteroids) seem to be most effective in the later disease stages. Therefore, going forward, we will perform separate living network meta-analyses for non-severe covid-19 and severe covid-19. Updates will continue to be published on covid19lnma.com.',\n",
       " ('COVID-19',\n",
       "  67,\n",
       "  0): 'Readers’ note This article is a living systematic review that will be updated to reflect emerging evidence. Updates may occur for up to two years from the date of original publication. This is the fifth version of the original article published on 30 July 2020 (BMJ 2020;370:m2980), and previous versions can be found as data supplements. When citing this paper please consider adding the version number and date of access for clarity. Conclusion Corticosteroids, interleukin-6 receptor antagonists, and Janus kinase inhibitors probably reduce mortality and confer other important benefits in patients with severe covid-19. Molnupiravir and nirmatrelvir/ritonavir probably reduce admission to hospital in patients with non-severe covid-19. Results 463 trials enrolling 166 581 patients were included; 267 (57.7%) trials and 89 814 (53.9%) patients are new from the previous iteration; 265 (57.2%) trials evaluating treatments with at least 100 patients or 20 events met the threshold for inclusion in the analyses. Compared with standard care, three drugs reduced mortality in patients with mostly severe disease with at least moderate certainty: systemic corticosteroids (risk difference 23 fewer per 1000 patients, 95% credible interval 40 fewer to 7 fewer, moderate certainty), interleukin-6 receptor antagonists when given with corticosteroids (23 fewer per 1000, 36 fewer to 7 fewer, moderate certainty), and Janus kinase inhibitors (44 fewer per 1000, 64 fewer to 20 fewer, high certainty). Compared with standard care, two drugs probably reduce hospital admission in patients with non-severe disease: nirmatrelvir/ritonavir (36 fewer per 1000, 41 fewer to 26 fewer, moderate certainty) and molnupiravir (19 fewer per 1000, 29 fewer to 5 fewer, moderate certainty). Remdesivir may reduce hospital admission (29 fewer per 1000, 40 fewer to 6 fewer, low certainty). Only molnupiravir had at least moderate quality evidence of a reduction in time to symptom resolution (3.3 days fewer, 4.8 fewer to 1.6 fewer, moderate certainty); several others showed a possible benefit. Several drugs may increase the risk of adverse effects leading to drug discontinuation; hydroxychloroquine probably increases the risk of mechanical ventilation (moderate certainty). Methods After duplicate data abstraction, a bayesian network meta-analysis was conducted. Risk of bias of the included studies was assessed using a modification of the Cochrane risk of bias 2.0 tool, and the certainty of the evidence using the grading of recommendations assessment, development, and evaluation (GRADE) approach. For each outcome, interventions were classified in groups from the most to the least beneficial or harmful following GRADE guidance. Study selection Randomised clinical trials in which people with suspected, probable, or confirmed covid-19 were randomised to drug treatment or to standard care or placebo. Pairs of reviewers independently screened potentially eligible articles. Data sources WHO covid-19 database, a comprehensive multilingual source of global covid-19 literature, up to 3 December 2021 and six additional Chinese databases up to 20 February 2021. Studies identified as of 1 December 2021 were included in the analysis. Expanded version of the methods, processes, and results with multilayered recommendations, evidence summaries, and decision aids for use on all devices In this living systematic review and network meta-analysis we compare the effects of drug treatments for covid-19. This review is part of the BMJ Rapid Recommendations project, a collaborative effort from the MAGIC Evidence Ecosystem Foundation ( www.magicproject.org ) and The BMJ. 6 This living systematic review and network meta-analysis informs World Health Organization and BMJ Rapid Recommendations on covid-19 treatments, initiated to provide trustworthy, actionable, and living guidance to clinicians and patients soon after new and potentially practice-changing evidence becomes available ( box 1 ). 7 8 This living network meta-analysis is the fifth version. The previous versions are available in the supplementary material.',\n",
       " ('COVID-19',\n",
       "  67,\n",
       "  1): 'Drugs for prophylaxis 9 and antibody-based treatments 10 are addressed separately. Summarising the rapidly growing evidence base has been a challenge. 3 Living systematic reviews deal with the main limitation of traditional reviews—that of providing an overview of the relevant evidence only at a specific time. 4 This is crucial in the context of covid-19, in which the best evidence is constantly changing. The ability of a living network meta-analysis to present a complete, broad, and updated view of the evidence makes it the best type of evidence synthesis to inform the development of practice recommendations. Network meta-analysis, rather than pairwise meta-analysis, provides useful information about the comparative effectiveness of treatments that have not been tested head to head. The lack of such direct comparisons is certain to limit inferences in the covid-19 setting. Moreover, the incorporation of indirect evidence can strengthen evidence in comparisons that were tested head to head. 5 As of 23 March 2022, more than 475 million people have been infected with severe acute respiratory syndrome coronavirus virus 2 (SARS-CoV-2), the virus responsible for coronavirus disease 2019 (covid-19); of these, more than six million have died. 1 Despite global efforts to identify effective interventions for the prevention and treatment of covid-19, which have resulted in approximately 3000 trials completed or underway, 2 evidence for effective treatment remains limited. Patients were involved in outcome selection, interpretation of results, and the generation of parallel recommendations, as part of the BMJ Rapid Recommendations initiative. Subgroup analyses were performed for specific interventions of interest at the direction of the linked WHO living guideline panel. Previous iterations included subgroup analyses for ivermectin, interleukin-6 receptor antagonists, corticosteroids, hydroxychloroquine, lopinavir-ritonavir, and remdesivir. The panel requested subgroup analyses by age (children v non-elderly adults v elderly), severity (non-severe v severe and critical), and risk of bias. We performed bayesian hierarchical meta-regression with study as a random effect. Where possible, we performed within rather than between trial analyses. For each outcome, we classified treatments in groups from the most to the least effective using the minimally contextualised framework, which focuses on the treatment effect estimates and the certainty of the evidence. 35 To facilitate interpretation of the results, we calculated absolute effects for outcomes in which the summary measure was an odds ratio or ratio of means. When available, we inferred baseline risk in the usual care group for each outcome from representative observational data (supplementary material). For mortality, we used data from the CDC on patients who were hospitalised with covid-19. 30 31 For mechanical ventilation, duration of invasive mechanical ventilation, length of hospital stay, and ICU length of stay we used baseline risks from the International Severe Acute Respiratory and Emerging Infection COVID-19 database. 32 For all other outcomes, we used the median from all studies in which participants received standard of care to calculate the baseline risk for each outcome, with each study weighed equally. We calculated absolute effects using the transitive risks model 33 using R2jags package in R. 34 We assessed the certainty of evidence using the grading of recommendations assessment, development and evaluation (GRADE) approach for network meta-analysis. 5 27 28 Two people with experience in using GRADE rated each domain for each comparison separately and resolved discrepancies by consensus. We rated the certainty for each comparison and outcome as high, moderate, low, or very low, based on considerations of risk of bias, inconsistency, indirectness, publication bias, intransitivity, incoherence (difference between direct and indirect effects), and imprecision. 28 We rated down for risk of bias if the interpretation of the effect would change if only studies at low risk',\n",
       " ('COVID-19',\n",
       "  67,\n",
       "  2): 'of bias would have been considered. For example, if the credible interval of the pooled effect from studies at low risk of bias would have crossed the threshold for imprecision, we rated down for risk of bias. Judgments of imprecision for this systematic review were made using a minimally contextualised approach, with a null effect as the threshold of importance. 29 The minimally contextualised approach considers only whether credible intervals include the null effect and thus does not consider whether plausible effects, captured by credible intervals, include both important and trivial effects. 29 To evaluate certainty of no benefit (or no effect), we used a 2% risk difference threshold of the 95% credible interval for mortality and mechanical ventilation. In other words, if the entire 95% credible interval was within 2% of the null effect, we would not rate down for imprecision. We decided on this preliminary threshold based on a survey of the authors. Interim updates and additional study data will be posted on our website ( www.covid19lnma.com ). In the first iteration of this living network meta-analysis, some treatment nodes with few total participants and few total events resulted in highly implausible and extremely imprecise effect estimates. We therefore decided to include only treatments that included at least 100 patients or had at least 20 events, based on our impression of the minimum number of patients/events to possibly provide meaningful results. For most outcomes, we conducted network meta-analyses and pairwise meta-analyses using a bayesian framework with the same priors for the variance and effect parameters. 21 In previous versions, we used fixed effects for some outcomes because data was sparse or dominated by a single trial. As per our protocol, we used random effects for all outcomes. We used a plausible prior for variance parameter and a uniform prior for the effect parameter suggested in a previous study based on empirical data. 24 For all analyses, we used three Markov chains with 100 000 iterations after an initial burn-in of 10 000 and a thinning of 10. We used node splitting models to assess local incoherence and to obtain indirect estimates. 25 All network meta-analyses were performed using the gemtc package of R version 3.6.3 (RStudio, Boston, MA) 26 and all pairwise meta-analyses using the bayesmeta package. 21 Treatments were grouped into common nodes based on molecule and not on dose or duration. For intervention arms with more than one drug, we created a separate node. Chloroquine and hydroxychloroquine were included in the same node for covid-19 specific effects and separated for disease independent adverse effects. We drew network plots using the networkplot command of Stata version 15.1 (StataCorp, College Station, TX), with thickness of lines between nodes and size of the nodes based on the inverse of the variance of the direct comparison. 23 We summarised the effect of interventions on dichotomous outcomes using the odds ratio and corresponding 95% credible interval. For continuous outcomes, we used the mean difference and corresponding 95% credible interval in days for ICU length of stay, length of hospital stay, and duration of mechanical ventilation because we expected similar durations across randomised trials. For time to symptom resolution, we first performed the analyses using the relative effect measure ratio of means and corresponding 95% credible interval before calculating the mean difference in days because we expected substantial variation between studies. 22 We conducted the network meta-analysis using a bayesian framework. 21 In this report, we conducted a network meta-analysis of drug treatments for covid-19 that included all patients, regardless of severity of disease. For each eligible trial, reviewers, following training and',\n",
       " ('COVID-19',\n",
       "  67,\n",
       "  3): 'calibration exercises, used a revision of the Cochrane tool for assessing risk of bias in randomised trials (RoB 2.0) 20 to rate trials as either at i) low risk of bias, ii) some concerns—probably low risk of bias, iii) some concerns—probably high risk of bias, or iv) high risk of bias, across the following domains: bias arising from the randomisation process; bias owing to departures from the intended intervention; bias from missing outcome data; bias in measurement of the outcome; bias in selection of the reported results, including deviations from the registered protocol; bias due to competing risks; and bias arising from early termination for benefit. We rated trials at high risk of bias overall if one or more domains were rated as probably high risk of bias or as high risk of bias and as low risk of bias if all domains were rated as probably low risk of bias or low risk of bias. Reviewers resolved discrepancies by discussion and, when not possible, with adjudication by a third party. Mechanical ventilation includes both invasive and non-invasive mechanical ventilation. We used a hierarchy for the outcome mechanical ventilation in which we preferentially used the total number of patients who received mechanical ventilation over the study. We used the number of patients ventilated at the time point that the largest number of the patients were ventilated, if the trial reported the number of patients ventilated at specific timepoints. We used author definitions for mechanical ventilation; when separate, continuous positive airway pressure (CPAP) and bilevel positive airway pressure (BiPAP) were considered non-invasive mechanical ventilation. Outcomes of interest were selected based on importance to patients 18 and were informed by clinical expertise in the systematic review team and in the linked guideline panel responsible for the WHO-BMJ Rapid Recommendations. 19 7 8 The panel includes unconflicted clinical and methodology experts, recruited to ensure global representation, and patient partners. All panel members rated outcomes from 1 to 9 based on importance to individual patients (9 being most important), and we included any outcome rated 7 or higher by any panel member. Selected outcomes included mortality (closest to 90 days), mechanical ventilation (total number of patients, over 90 days), adverse events leading to discontinuation (within 28 days), admission to hospital, length of hospital stay, duration of mechanical ventilation, and time to symptom resolution or clinical improvement. In contrast to previous iterations, for this iteration, we did not include several outcomes which the GDG did not think were critical to decision making: viral clearance (closest to 7 days, 3 days either way), time to viral clearance, intensive care unit (ICU) length of stay, and days free from mechanical ventilation (within 28 days). For each eligible trial, pairs of reviewers, following training and calibration exercises, extracted data independently using a standardised, pilot tested data extraction form. Reviewers collected information on trial characteristics (trial registration, publication status, study status, design), patient characteristics (country, age, sex, smoking habits, comorbidities, setting and type of care, and severity of covid-19 symptoms for studies of treatment), and outcomes of interest (means or medians and measures of variability for continuous outcomes and the number of participants analysed and the number of participants who experienced an event for dichotomous outcomes). Reviewers resolved discrepancies by discussion and, when necessary, with adjudication by a third party. We updated the data collected from included preprints as soon as the peer review publication became available. Using a systematic review software, Covidence, 17 pairs of reviewers, following training and calibration exercises, independently screened all titles and abstracts, followed by full texts of trials that were identified as potentially',\n",
       " ('COVID-19',\n",
       "  67,\n",
       "  4): 'eligible. A third reviewer adjudicated conflicts. We searched all English information sources from 1 December 2019 to 3 December 2021, and the Chinese literature from conception of the databases to 20 February 2021. We monitor living evidence retrieval services on an ongoing basis. These included the Living Overview of the Evidence (L-OVE) COVID-19 Repository by the Epistemonikos Foundation 15 and the Systematic and Living Map on COVID-19 Evidence by the Norwegian Institute of Public Health, in collaboration with the Cochrane Canada Centre at McMaster University. 16 In addition, we search six Chinese databases: Wanfang, Chinese Biomedical Literature, China National Knowledge Infrastructure, VIP, Chinese Medical Journal Net (preprints), and ChinaXiv (preprints). We adapted the search terms for covid-19 developed by the CDC to the Chinese language. For the Chinese literature search, we also included search terms for randomised trials. The supplementary file includes the Chinese literature search strategy. We stopped searching the Chinese databases on 20 February 2021 because they had not provided studies that meaningfully altered the evidence for any intervention. The daily searches are designed to match the update schedule of the database and to capture eligible studies the day of or the day after publication. To identify randomised trials, we filtered search results through a validated and highly sensitive machine learning model. 14 We tracked preprints of randomised trials for updates and through publication: when data were discrepant, we used the most recent data. We perform daily searches from Monday to Friday in the World Health Organization (WHO) covid-19 database for eligible studies—a comprehensive multilingual source of global literature on covid-19. Prior to its merge with the WHO covid-19 database on 9 October 2020, we performed daily searches from Monday to Friday in the US Centers for Disease Control and Prevention (CDC) COVID-19 Research Articles Downloadable Database for eligible studies. 13 The database includes, but is not limited to the following 25 bibliographic and grey literature sources: Medline (Ovid and PubMed), PubMed Central, Embase, CAB Abstracts, Global Health, PsycInfo, Cochrane Library, Scopus, Academic Search Complete, Africa Wide Information, CINAHL, ProQuest Central, SciFinder, the Virtual Health Library, LitCovid, WHO covid-19 website, CDC covid-19 website, Eurosurveillance, China CDC Weekly, Homeland Security Digital Library, ClinicalTrials.gov, bioRxiv (preprints), medRxiv (preprints), chemRxiv (preprints), and SSRN (preprints). We excluded randomised trials evaluating vaccination, blood products and antibody-based antiviral therapies (such as virus-specific monoclonal antibodies), nutrition, traditional Chinese herbal or alternative medicines that include more than one molecule or a molecule without specific molecular weighted dosing, and non-drug supportive care interventions. Trials that evaluated these interventions were identified and categorised separately. We included randomised clinical trials in people with suspected, probable, or confirmed covid-19 that compared drugs for treatment against one another or against no intervention, placebo, or standard care. We included trials regardless of publication status (peer reviewed, in press, or preprint) or language. No restrictions were applied based on severity of illness or setting, and we included trials of Chinese medicines if the drug comprised one or more specific molecules with a defined molecular weight dosing. A protocol provides the detailed methods of this systematic review, including all updates (see supplementary file). We report this living systematic review following the guidelines of the preferred reporting items for systematic reviews and meta-analyses (PRISMA) checklist for network meta-analyses. 11 A living systematic review is a cumulative synthesis that is updated regularly as new evidence becomes available. 12 The linked BMJ Rapid Recommendations guideline panels approved all decisions relevant to data synthesis. Previous iterations of this living systematic review explored subgroup effects for remdesivir, lopinavir-ritonavir, hydroxychloroquine, corticosteroids, ivermectin, and interleukin-6 receptor antagonists. An additional network meta-analysis',\n",
       " ('COVID-19',\n",
       "  67,\n",
       "  5): 'limited to interventions of interest for patients with non-severe disease up to 2 February 2022 showed that nirmatrelvir/ritonavir and molnupiravir may reduce mortality (supplementary material). Findings for other outcomes were not meaningfully different from the full network. Among patients with non-severe disease, we did not identify any subgroup effects for molnupiravir, nirmatrelvir/ritonavir, fluvoxamine, or remdesivir. Seventy nine trials including 26 119 participants met the threshold of analysing treatments with a minimum of 100 patients and were included in the network meta-analysis. Thirty four interventions were studied: the most common interventions were standard care (73 trials, 11 674 participants), Janus kinase inhibitors (4 trials, 1585 participants), molnupiravir (3 trials, 1536 participants), remdesivir (4 trials, 1497 participants), and inhaled corticosteroids (2 trials, 1031 participants). Molnupiravir probably reduces time to symptom resolution (ratio of means 0.66, 0.52 to 0.83; mean difference −3.3 days, −4.8 to −1.6; moderate certainty). No other intervention had at least moderate certainty evidence of benefit or harm ( fig 2 ). Twenty eight trials with 3947 participants met the threshold of analysing treatments with a minimum of 100 patients and were included in the network meta-analysis (supplementary appendix). Eight interventions were included: the most common were standard care (28 trials, 1989 participants), interferon beta (2 trials, 502 participants), full dose anticoagulation (1 trial, 308 participants), interleukin-6 receptor antagonists (7 trials, 251 participants), and remdesivir (3 trials, 201 participants). Janus kinase inhibitors probably reduce the duration of mechanical ventilation (−3.2 days, −5.9 to −0.5; high certainty). There was no convincing evidence that any of the other interventions reduce duration of mechanical ventilation ( fig 2 ). Compared with standard care, hospitalisation was shorter in patients who received interleukin-6 receptor antagonists with systemic corticosteroids (mean difference −4.7 days, −8.9 to −0.5; moderate certainty) and Janus kinase inhibitors (−1.1 days, −1.9 to −0.4; moderate certainty). Interleukin-6 receptor antagonists probably do not reduce length of hospital stay when given without systemic corticosteroids (0.0 days, −1.2 to 1.2; moderate certainty). Evidence was low or very low certainty for all other interventions ( fig 2 ). One hundred and thirteen trials with 91 270 participants met the threshold of analysing treatments with a minimum of 100 patients and were included in the network meta-analysis (supplementary appendix). Thirty eight interventions were studied: the most common interventions were standard care (107 trials, 48 098 participants), colchicine (6 trials, 5809 participants), remdesivir (6 trials, 4340 participants), hydroxychloroquine (15 trials, 3347 participants), azithromycin (4 trials, 2795 participants), corticosteroids (6 trials, 2694 participants), Janus kinase inhibitors (6 trials, 1778 patients), and interleukin-6 receptor antagonists with systemic corticosteroids (7 trials, 1506 participants). Thirteen trials randomised 6732 participants to five different interventions. Full dose anticoagulation may increase the odds of clinically important bleeding compared with prophylactic dose anticoagulation (odds ratio 2.15, 1.35 to 3.52; low certainty). The impacts of aspirin, intermediate dose anticoagulation, and sulodexide are less certain. Eleven trials that randomised 6195 participants to five different interventions reported venous thromboembolism. Full dose anticoagulation may reduce odds of venous thromboembolism compared with prophylactic dose anticoagulation (odds ratio 0.50, 0.32 to 0.78; low certainty). The impacts of aspirin, intermediate dose anticoagulation, and sulodexide are less certain. Thirty five randomised trials with 21 306 participants met the threshold of analysing treatments with a minimum of 100 patients or 20 events and were included in the network meta-analysis (supplementary appendix). Nineteen interventions were included: the most common interventions were standard care (36 trials, 10 492 participants), molnupiravir (5 trials, 2385 participants), colchicine (1 trial, 2235 participants), and fluvoxamine (3 trials, 1093 participants). Molnupiravir (odds ratio 0.54, 0.30 to 0.90; moderate certainty), nirmatrelvir/ritonavir (0.13, 0.04 to',\n",
       " ('COVID-19',\n",
       "  67,\n",
       "  6): '0.40; moderate certainty), and remdesivir (0.25, 0.07 to 0.86; low certainty) probably reduce hospitalisation. There was insufficient evidence to know if any other interventions reduce hospitalisation ( fig 2 ). Ninety nine trials with 31 840 participants met the threshold of analysing treatments with a minimum of 100 patients or 20 events and were included in the network meta-analysis (supplementary appendix). Fourty four interventions were included: the most common interventions were standard care (95 trials, 13 795 participants), molnupiravir (6 trials, 2442 participants), interleukin-6 receptor antagonists with corticosteorids (6 trials, 1696 participants), remdesivir (6 trials, 1445 participants), and hydroxychloroquine (14 trials, 1257 participants). The drugs with a high risk of adverse effects included hydroxychloroquine (13 more per 1000, 2 more to 24 more; low certainty), lopinavir-ritonavir (49 more per 1000, 27 more to 72 more; moderate certainty), and tyrosine kinase inhibitors (62 more per 1000, 19 more to 105 more; moderate certainty). Several drugs did not have a higher risk of discontinuation for adverse effects than standard care/placebo ( fig 2 ). Compared with standard care, interventions that reduce risk of mechanical ventilation include interleukin 6 receptor antagonists when given with systemic corticosteroids (0.79, 0.63 to 0.98; moderate certainty) and interleukin-6 receptor antagonists without corticosteroids (0.58, 0.35 to 0.97; high certainty) ( fig 2 ). Other interventions may reduce risk of mechanical ventilation including corticosteroids (odds ratio 0.79, 0.58 to 1.05; low certainty), Janus kinase inhibitors (0.78, 0.56 to 1.04; moderate certainty), and remdesivir (0.79, 0.60 to 1.01; low certainty). One hundred and forty trials with 93 968 participants met the threshold of analysing treatments with a minimum of 100 patients or 20 events and were included in the network meta-analysis (supplementary appendix). Forty four interventions were included: the most common interventions were standard care (132 trials, 47 865 participants), colchicine (5 trials, 6313 participants), aspirin (2 trials, 5157 participants), remdesivir (7 trials, 3981 participants), lopinavir-ritonavir (7 trials, 3628 participants), hydroxychloroquine (15 trials, 3474 participants), azithromycin (6 trials, 3400 participants), interleukin-6 receptor antagonists with systemic corticosteroids (11 trials, 2399 participants), and corticosteroids (9 trials, 1171 participants). Interventions with at least moderate certainty of benefit included: systemic corticosteroids (odds ratio 0.80, 95% credible interval 0.65 to 0.94; moderate certainty), interleukin-6 receptor antagonists when given with systemic corticosteroids (0.80, 0.69 to 0.94; moderate certainty), and Janus kinase inhibitors (0.63, 0.47 to 0.83; high certainty) ( fig 2 ). Notable interventions that did not suggest benefit included aspirin (0.93, 0.69 to 1.20; low certainty), azithromycin (0.98, 0.78 to 1.25, low certainty), colchicine (0.93, 0.65 to 1.16; low certainty), fluvoxamine (0.68, 0.33 to 1.32; low certainty), full-dose anticoagulation (0.96, 0.78 to 1.16; low certainty), hydroxychloroquine (1.08, 0.92 to 1.27; moderate certainty), interleukin-6 receptor antagonists without concurrent corticosteroids (1.09, 0.91 to 1.31; moderate certainty), ivermectin (0.63, 0.37 to 1.05; low certainty), lopinavir-ritonavir (1.06, 0.88 to 1.28; low certainty), and remdesivir (odds ratio 0.91, 0.73 to 1.11; low certainty). Two hundred and sixty seven trials with 138 345 participants met the threshold of analysing treatments with a minimum of 100 patients or 20 events and were included in the network meta-analysis (supplementary file). Supplementary figure S1 on bmj.com shows the network plot for mortality, with each edge representing a direct comparison between two interventions. Fifty seven different interventions were included: the most common were standard care/placebo (252 trials, 69 448 participants), colchicine (7 trials, 8194 participants), aspirin (3 trials, 7716 participants), hydroxychloroquine (35 trials, 4955 participants), remdesivir (9 trials, 5044 participants), lopinavir-ritonavir (11 trials, 4153 participants), interleukin-6 receptor antagonists with corticosteroids (32 trials, 4153 participants), and corticosteroids (13 trials, 3076 participants). The supplementary material presents the',\n",
       " ('COVID-19',\n",
       "  67,\n",
       "  7): 'network plots depicting the interventions included in the network meta-analysis of each outcome. Figure 2 presents a summary of the effects of the interventions on the outcomes. The supplementary file also presents detailed relative and absolute effect estimates and certainty of the evidence for all comparisons and outcomes. We did not detect statistical incoherence in any of the network meta-analyses. The supplementary material presents the assessment of risk of bias of the included studies for each outcome: 121 studies were judged at low risk of bias in all domains for at least one outcome. All analyses reached convergence based on trace plots and a Brooks-Gelman-Rubin statistic less than 1.05, except comparisons including umifenovir for mortality because no patients randomised to either of these drugs died, interleukin-6 inhibitors and doxycycline with ivermectin for adverse events, proxalutamide for hospital admission, and sulodexide for clinically important bleeding. Seventy five studies were initially posted as preprints and subsequently published after peer review. The supplementary material presents the differences between study preprint and peer reviewed publications. Thirty two studies had discrepancies in outcome reporting between the preprint and peer-reviewed publication, 32 studies had discrepancies with patient baseline characteristics, and 14 studies had discrepancies in reporting that led to changes in risk of bias ratings. No substantive differences were found for 26 studies. Of the randomised trials included in the analyses, eight did not have publicly accessible protocols or registrations. Of the trials with publicly accessible protocols or registrations, 79 reported results for one or more of our outcomes of interest that were not prespecified in protocols or registrations. No other discrepancies in the reporting of outcomes of interest were noted. One trial did not stratify reporting of outcomes for those who were truly randomised versus those who were allocated by preference; the authors shared outcome data with us among patients who were truly randomised. Several trials could not be included in the analysis because both arms would have been classified within the same treatment node, they evaluated different durations or doses of the same drug, had insufficient data, or reported no outcomes of interest. Ultimately, we analysed 265 (63%) trials that reported on treatments with at least 100 patients or 20 events. Table 1 presents the characteristics of the 420 included studies. Additional study characteristics, outcome data, and risk of bias assessments for each study are available in the supplementary file. After screening 79 601 titles and abstracts and 1438 full texts, 463 unique randomised trials were identified that evaluated drug treatments as of 3 December 2021 ( fig 1 ). A table of excluded full texts is provided in the supplementary file. Searches of living evidence retrieval services identified 219 publications of eligible randomised trials, which were reconciled with our formal search strategy when necessary. Three hundred and six randomised trials have been published in peer reviewed journals, 109 are preprints and 48 remain unpublished as either abstracts, data from meta-analyses, data from authors or data from presentations. The supplement describes the 43 randomised trials that were identified after the data analysis (1 December 2021) and that will be considered in the next update of the data analysis. Of the remaining trials, most were registered (373/420; 89%), nearly three quarters evaluated treatment in patients admitted to hospital with covid-19 (312/420; 74%), and one fifth evaluated treatment in outpatients with covid-19 (86/420; 20%). The United States, Iran, Brazil, India, and China were the five countries in which randomised trials were most commonly conducted. One hundred and eighty one different drug treatments were evaluated. Discussion This living systematic review and network meta-analysis provides a comprehensive overview',\n",
       " ('COVID-19',\n",
       "  67,\n",
       "  8): 'of the evidence for drug treatments of covid-19 up to 1 December 2021 and a comprehensive list of drug trials to 3 December 2021. There are now more than 400 randomised trials examining many different interventions for treating covid-19, and as a result, the certainty in evidence for multiple interventions is improved. For patients with severe covid-19, three anti-inflammatory drugs probably reduce mortality: systemic corticosteroids, interleukin-6 receptor antagonists (when given with systemic corticosteroids), and Janus kinase inhibitors. Interleukin-6 receptor antagonists, when co-administered with systemic corticosteroids, also probably reduce mechanical ventilation and length of hospital stay. When they are provided without systemic corticosteroids, interleukin-6 receptor antagonists might not reduce mortality or length of hospital stay. The subgroup effect is consistent with evidence from other meta-analyses.36 A single dose of either sarilumab and tocilizumab appears to be similarly efficacious.37 Janus kinase inhibitors probably reduce mortality, length of hospital stay, and duration of mechanical ventilation. The evidence supporting janus kinase inhibitors comes primarily from studies that used baricitinib. The RECOVERY trial, which randomized 8156 patients to baricitinib or standard care, was published after our analyses were completed.38 The RECOVERY trial confirmed that baricitinib reduces mortality. It was also the first study to show that janus kinase inhibitors may have added benefit in patients also receiving interleukin-6 receptor antagonists and systemic corticosteroids. For patients with non-severe covid-19, three antivirals probably reduce admission to hospital: molnupiravir, nirmatrelvir/ritonavir, and remdesivir. Molnupiravir and nirmatrelvir/ritonavir may also slightly reduce the risk of death. Based on this review, the WHO has recently suggested using one of these antivirals rather than no antiviral.7 These drugs were all studied in people who were at increased risk of hospitalisation: they had not received a SARS-CoV-2 vaccine and had other risk factors for disease progression. The absolute benefit should therefore be substantially smaller in patients who are vaccinated against SARS-CoV-2 or who do not have risk factors for disease progression. Each of the antivirals has some drawbacks that were not captured in this overview. For example, molnupiravir could be carcinogenic, nirmatrelvir/ritonavir has a large number of critical drug-drug interactions, and remdesivir is administered intravenously. Full dose anticoagulation, compared with prophylactic dose anticoagulation, may reduce the risk of venous thromboembolism by approximately 16 per 1000 patients and increase the risk of clinically important bleeding by approximately 20 per 1000 patients. There did not seem to be a difference in other outcomes such as mortality or mechanical ventilation. Several interventions do not seem to have important benefit on any patient-important outcomes, including angiotensin-converting enzyme inhibitors, aspirin, azithromycin, colchicine, hydroxychloroquine, inhaled corticosteroids, intranasal corticosteroids, interferon beta, ivermectin, lopinavir-ritonavir, umifenovir, and vitamin C. Hydroxychloroquine may increase the risk of mechanical ventilation, adverse effects leading to drug discontinuation, and length of hospital stay. Compared with the fourth iteration, there are several important updates (box 2). We now have evidence from several large scale international trials on azithromycin, interleukin-6 inhibitors, molnupiravir, nirmatrelvia/ritonavir, Janus kinase inhibitors, full dose anticoagulation, and colchicine. Box 2 Summary of changes since last iteration Two hundred and sixty seven trials and 89 814 participants are new from the previous iteration Additional evidence for Janus kinase inhibitors suggests that they probably reduce mortality in patients with severe covid-19 Additional evidence suggests that colchicine probably does not have any important benefit (the previous iteration suggested that it might) New evidence suggests that the antivirals molnupiravir and nirmatrelvir/ritonavir probably reduce hospitalisation in patients with non-severe covid-19, while remdesivir might RETURN TO TEXT Strengths and limitations of this review Our search strategy and eligibility criteria were comprehensive, without restrictions on language of publication or publication status. To ensure expertise',\n",
       " ('COVID-19',\n",
       "  67,\n",
       "  9): 'in all areas, our team is composed of clinical and methods experts who have undergone training and calibration exercises for all stages of the review process. To minimise problems with counterintuitive results, we anticipated challenges that arise in network meta-analysis when data are sparse.39 Many of the results for comparisons with sparse data were uninformative and were sometimes implausible. For that reason, we decided to report evidence on treatments for which at least 100 people were randomised or for which there were at least 20 events. The primary limitation of the evidence for most interventions is lack of blinding, which might introduce bias through differences in co-interventions between randomised groups. We chose to consider the treatment arms that did not receive an active experimental drug (that is, placebo or standard care) within the same node: it is possible that the unblinded standard care groups received systematically different co-interventions than groups randomised to receive a placebo. Direct comparisons in which the evidence is dominated by unblinded studies were rated down, consistent with GRADE, for risk of bias and that is reflected in the rating of the quality of evidence from the network estimate.40 Many of the data also had reporting concerns. For some outcomes, the method in which the researchers measured and reported outcomes proved inconsistent across studies. This led the team to propose a hierarchy for the outcome mechanical ventilation, as described in the methods. The living nature of our systematic review and network meta-analysis could conceivably (at least temporarily) amplify publication bias, because studies with promising results are more likely to be published and are published sooner than studies with negative results. The inclusion of preprints, many of which have negative results, might reduce this risk. However, the inclusion of preprints in our network meta-analysis might introduce bias from simple errors and the reporting limitations of preprints. We include preprints because of the urgent need for information and because so many of the studies on covid-19 are published first as preprints. So far, differences between preprints and peer reviewed publications have mostly been limited to additional baseline patient information, clarification on study design, and outcomes reported in the peer reviewed publications. None of these changes would have resulted in a meaningful change to pooled effect estimates or certainty for any outcome.41 Our living systematic review and network meta-analysis will continue to inform the development of the WHO living guidelines and BMJ Rapid Recommendations.619 An important difference in the methods for assessing the certainty of the evidence does, however, exist between the two. In this living systematic review and network meta-analysis, we use a minimally contextualised approach for rating the certainty of the evidence, whereas the guideline panels use a fully contextualised approach in which the thresholds of importance of magnitudes of effects depend on all other outcomes and factors involved in the decision.29 The contextualisation explains differences in the certainty of the evidence between the two. We used observational data to inform the absolute risk estimates for some outcomes; differences in baseline risk can impact GRADE assessments for imprecision. To date, we are aware of two other similar efforts to ours.4243 Our intention is different in that the results fully inform clinical decision making for the associated living guidance.6 We also include a more comprehensive search for the evidence and several differences in analytical methods, which we believe are best suited for this evidence. For example, some others use fixed rather than random effects meta-analysis and provide estimates for pairwise comparisons only. It is also important to evaluate the reproducibility and replicability of findings from different scientific approaches. This',\n",
       " ('COVID-19',\n",
       "  67,\n",
       "  10): 'is the final version of this particular living systematic review and network meta-analysis. Mounting evidence suggests that antivirals (such as molnupiravir and nirmatrelvir) are most effective in the early stages of covid-19 when patients have non-severe disease, whereas anti-inflammatories (such as corticosteroids) seem to be most effective in the later disease stages. Therefore, going forward, we will perform separate living network meta-analyses for non-severe covid-19 and severe covid-19. Updates will continue to be published on covid19lnma.com.',\n",
       " ('COVID-19',\n",
       "  68,\n",
       "  0): 'Obtaining detailed and accurate medical history from COVID-19 patients, and analyzing CFR alongside the recovery rate, may enable the identification of the highest risk areas so that efficient medical care may be provided. This may lead to the development of point-of-care tools to help clinicians in stratifying patients based on possible requirements in the level of care, to increase the probabilities of survival from COVID-19 disease. Italy’s CFR was the highest of all countries studied for both time points (12 th March, 6.22% versus 23 rd March, 9.26%). The data showed that even though Italy was the only European country reported on 12 rd March, Spain and France had the highest CFR of 6.16 and 4.21%, respectively, on 23 rd March, which was strikingly higher than the overall CFR of 3.61%. Introduction A novel coronavirus has spread through China, originating from the city of Wuhan and has caused many deaths so far. It is a highly contagious virus that has spread rapidly and efficiently. Coronavirus disease 2019 (COVID-19) is caused by a virus (SARS-CoV-2) from the same family as the lethal coronaviruses that caused severe acute respiratory syndrome (SARS-CoV) and Middle East respiratory syndrome (MERS-CoV). COVID-19 is a relatively large virus (120 nm) and is enveloped, containing a positive-sense single-stranded RNA [1]. The virus is transmitted through direct contact with the infected person’s respiratory droplets (coughing and sneezing), as well as contact with infected surfaces. COVID-19 virus can survive for days on surfaces, but a simple disinfectant can eliminate this [2]. COVID-19 signs and symptoms include fever, cough, and shortness of breath. In more severe cases, infection can lead to pneumonia, serious respiratory problems and ultimately, fatalities. Thousands of people have been reported to have been infected with the virus so far [3]. Apart from China, other cases of the disease, also known as COVID-2, have been reported in several countries, including Thailand, South Korea, Japan, Taiwan, Australia, Iran, and the United States. According to the Worldometer, as of 10th March 2020, there are over 114,430 identified cases of COVID-19 worldwide in 115 countries and territories [1]. Of these 115 countries, South Korea and Iran (outside of China) have the largest epidemic of COVID-19 and Italy, France and Spain are the countries with a major epidemic of COVID-19 in Europe [2]. COVID-19 spreads mainly from person-to-person during the latency period before the symptoms appear [4]. There is much more to learn about the spread and severity of COVID-19. COVID-19 can cause mild flu-like symptoms, including fever, cough, dyspnea, myalgia, and fatigue, while more serious forms can cause severe pneumonia, acute respiratory distress syndrome, septic shock, and organ failure, which can lead to death [5]. Without a vaccine for COVID-19, transmission of the virus can be reduced with early detection and patient quarantine [6]. There is epidemiological and clinical evidence to suggest a number of novel compounds, as well as medicines licensed for other conditions, that appear to have potential efficacy against COVID-19 [7,8]. However, in the absence of a safe and effective vaccine or medicine, reducing viral transmission is the only strategy available where general education, and implementing the appropriate prevention and control is key. Precautions can help suppress the risk of infection, such as washing the hands frequently with soap and water or an alcohol-based disinfectant gel, coughing into the elbow or a folded napkin/tissue, avoiding close contact with those who have symptoms, and self-isolating, but medical help must be sought if difficulty in breathing is experienced [5]. COVID-19 can be diagnosed with diagnostic test kits [9] and imaging techniques such as chest X-ray and pulmonary CT scans that',\n",
       " ('COVID-19',\n",
       "  68,\n",
       "  1): 'facilitate early diagnosis of pneumonia in patients with COVID-19 [10–12]. The case fatality rate (CFR), is a measure of the ability of a pathogen or virus to infect or damage a host in infectious disease and is described as the proportion of deaths within a defined population of interest, i.e. the percentage of cases that result in death [13]. CFRs confers the extent of disease severity and CFR is necessary for setting priorities for public health in targeted interventions to reduce the severity of risk [14]. Initial studies reported an estimation of 3% for the global CFR of COVID-19 [15]. Estimating CFR from country-level data requires assessment of information about the delay between the report of the country-specific cases and death from COVID-19, as well as underestimating and under-reporting of death-related cases, which may not be known. Given the importance of CFR and recovery rate (RR), in this current study the CFR and RR of different countries during a COVID-19 ongoing pandemic was observed using up-to-date country-level data.',\n",
       " ('COVID-19',\n",
       "  69,\n",
       "  0): 'В ВОЗ отметили, что присвоение новому заболеванию названия дает возможность \"использовать стандартный формат для любой будущей вспышки\" ЖЕНЕВА, 11 февраля. /ТАСС/. Всемирная организации здравоохранения (ВОЗ) присвоила название вирусной пневмонии, вспышка которой произошла в конце 2019 года в Китае, – COVID-19. Об этом рассказал гендиректор ВОЗ Тедрос Аданом Гебрейесус на брифинге в Женеве. \"Теперь у нас есть название заболевания. Это COVID-19\", - отметил он. Название COVID-19 расшифровывается как Corona Virus Disease – 2019, то есть появившееся в 2019 году заболевание, которое вызвал коронавирус 2019-nCoV. Глава организации сослался на правила присвоения названий возбудителям болезней, согласованные ВОЗ, Всемирной организации охраны здоровья животных и Продовольственной и сельскохозяйственной организацией ООН. \"Необходимо найти название, которое не связано с географическим пунктом, животным, конкретными людьми или группой людей\", - пояснил Гебрейесус. Таким образом, название позволит \"использовать стандартный формат для любой будущей вспышки коронавируса\", заключил Тедрос Аданом Гебрейесус. Сейчас власти Китая подтвердили более 44,6 тыс. случаев заражения новым коронавирусом, более 1,1 тыс. инфицированных умерли, выздоровели более 4,7 тыс. человек. Согласно официальным данным, под наблюдением медиков в стране находятся свыше 185 тыс. жителей, имевших тесный контакт с инфицированными. Кроме того, в Китае также насчитывается более 16 тыс. человек с подозрением на вирус, находящихся на карантине. За пределами КНР случаи заражения были выявлены в 24 странах, включая Россию. Вспышка COVID-19 была зафиксирована в городе Ухань в конце декабря 2019 года. Всемирная организация здравоохранения признала ее чрезвычайной ситуацией международного масштаба, охарактеризовав как эпидемию с многочисленными очагами. Во вторник в Женеве открылся двухдневный глобальный форум для выработки мер по борьбе с новым коронавирусом. В нем участвуют около 400 экспертов из разных стран мира. Основная цель встречи – выявить пробелы в знаниях о новом коронавирусе и скоординировать международные усилия в сфере разработки методов лечения.',\n",
       " ('COVID-19',\n",
       "  7,\n",
       "  0): 'New coronavirus stable for hours on surfaces SARS-CoV-2 stability similar to original SARS virus. NIAID-RML What The virus that causes coronavirus disease 2019 (COVID-19) is stable for several hours to days in aerosols and on surfaces, according to a new study from National Institutes of Health, CDC, UCLA and Princeton University scientists in The New England Journal of Medicine. The scientists found that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was detectable in aerosols for up to three hours, up to four hours on copper, up to 24 hours on cardboard and up to two to three days on plastic and stainless steel. The results provide key information about the stability of SARS-CoV-2, which causes COVID-19 disease, and suggests that people may acquire the virus through the air and after touching contaminated objects. The study information was widely shared during the past two weeks after the researchers placed the contents on a preprint server to quickly share their data with colleagues. The NIH scientists, from the National Institute of Allergy and Infectious Diseases’ Montana facility at Rocky Mountain Laboratories, compared how the environment affects SARS-CoV-2 and SARS-CoV-1, which causes SARS. SARS-CoV-1, like its successor now circulating across the globe, emerged from China and infected more than 8,000 people in 2002 and 2003. SARS-CoV-1 was eradicated by intensive contact tracing and case isolation measures and no cases have been detected since 2004. SARS-CoV-1 is the human coronavirus most closely related to SARS-CoV-2. In the stability study the two viruses behaved similarly, which unfortunately fails to explain why COVID-19 has become a much larger outbreak. The NIH study attempted to mimic virus being deposited from an infected person onto everyday surfaces in a household or hospital setting, such as through coughing or touching objects. The scientists then investigated how long the virus remained infectious on these surfaces. The scientists highlighted additional observations from their study: If the viability of the two coronaviruses is similar, why is SARS-CoV-2 resulting in more cases? Emerging evidence suggests that people infected with SARS-CoV-2 might be spreading virus without recognizing, or prior to recognizing, symptoms. This would make disease control measures that were effective against SARS-CoV-1 less effective against its successor. In contrast to SARS-CoV-1, most secondary cases of virus transmission of SARS-CoV-2 appear to be occurring in community settings rather than healthcare settings. However, healthcare settings are also vulnerable to the introduction and spread of SARS-CoV-2, and the stability of SARS-CoV-2 in aerosols and on surfaces likely contributes to transmission of the virus in healthcare settings. The findings affirm the guidance from public health professionals to use precautions similar to those for influenza and other respiratory viruses to prevent the spread of SARS-CoV-2: Avoid close contact with people who are sick. Avoid touching your eyes, nose, and mouth. Stay home when you are sick. Cover your cough or sneeze with a tissue, then throw the tissue in the trash. Clean and disinfect frequently touched objects and surfaces using a regular household cleaning spray or wipe. Article N van Doremalen, et al. Aerosol and surface stability of HCoV-19 (SARS-CoV-2) compared to SARS-CoV-1. The New England Journal of Medicine. DOI: 10.1056/NEJMc2004973 (2020). Who NIAID Director Anthony S. Fauci, M.D., and Vincent Munster, Ph.D., a principal investigator in NIAID’s Laboratory of Virology, are available to comment on this study. This media availability describes a basic research finding. Basic research increases our understanding of human behavior and biology, which is foundational to advancing new and better ways to prevent, diagnose, and treat disease. Science is an unpredictable and incremental process— each research advance builds on past discoveries, often in unexpected',\n",
       " ('COVID-19',\n",
       "  7,\n",
       "  1): \"ways. Most clinical advances would not be possible without the knowledge of fundamental basic research. NIAID conducts and supports research — at NIH, throughout the United States, and worldwide — to study the causes of infectious and immune-mediated diseases, and to develop better means of preventing, diagnosing and treating these illnesses. News releases, fact sheets and other NIAID-related materials are available on the NIAID website. About the National Institutes of Health (NIH): NIH, the nation's medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit www.nih.gov. NIH…Turning Discovery Into Health®\",\n",
       " ('COVID-19',\n",
       "  70,\n",
       "  0): '«Не страшнее чем грипп» — фраза до сих пор встречается на просторах интернета и в прочих СМИ применительно к коронавирусу. Однако накапливающиеся научные данные регулярно опровергают этот тезис. Одним из крупнейших на сегодня сравнительных исследований по теме можно назвать работу Зияда Аль-Али и его коллег по медицинской службе министерства США по делам ветеранов. Они проанализировали две когорты: пациентов, госпитализированных в профильные стационары с коронавирусной инфекцией с 1 февраля по 17 июня 2020 года (3641 человек) и с сезонным гриппом в период с 2017 по 2019 год (12676 человек). Статья опубликована 15 декабря на сайте Британского медицинского журнала. Авторы иронично заметили, что сравнения клинических проявлений и смертности COVID-19 и гриппа проводились и официальными лицами здравоохранения, и политиками, и широкой общественностью, однако ни в одном из этих случаев не сравнивали «яблоки с яблоками». Пытаясь сравнить сравнимое, учёные задействовали медицинские электронные базы данных министерства по делам ветеранов, которое управляет крупнейшей национальной интегрированной системой оказания медицинской помощи в США. Когорта исследуемых была сформирована путём выбора пациентов из медицинской системы министерства. Участники выбирались с положительным тестом на грипп в период с 1 января 2017 года по 31 декабря 2019 года (n = 54281) или с положительным результатом лабораторного теста на COVID-19 в период с 1 февраля по 17 июня 2020 года (n = 9125). Затем были выявлены пациенты, поступившие в больницу от пяти дней до и через 30 дней после положительного результата теста (n = 12748 в группе сезонного гриппа; n = 3641 в группе COVID-19). Для участников с записями о госпитализации как с сезонным гриппом, так и с COVID-19 (n = 72) использовались их первые записи о поступлении в стационар. В финальной когорте оказались 16317 участников, в том числе 12676 участников в группе сезонного гриппа и 3641 участник в группе COVID-19. Исследователи определили нулевое время как дату поступления в стационар и наблюдали за участниками до первого появления через 60 дней после госпитализации, смерти или окончания исследования (17 июня 2020 г.). Через 60 дней наблюдения 168 (1,33%) пациентов в группе сезонного гриппа и 76 (2,08%) пациентов в группе COVID-19 продолжали находиться на госпитальном лечении. Первичным результатом исследования было время до смерти с момента поступления в больницу. Авторы определили клинические исходы, включая острое повреждение почек, эпизодическую заместительную почечную терапию, эпизодическое использование инсулина, тяжелый септический шок, использование вазопрессоров, эмболию лёгочной артерии, тромбоз глубоких вен, инсульт, острый миокардит, аритмии и внезапную коронарную смерть, повышенный уровень тропонина, АСТ и АЛТ, рабдомиолиз. Результаты, связанные с обращением за медицинской помощью, включали время до помещения на ИВЛ, время до поступления в отделение реанимации и интенсивной терапии (ОРИТ), а также продолжительность пребывания в больнице, определяемую как время от поступления до первой выписки среди пациентов, не оставшихся в стационаре к исходу исследования. Учёные постарались учесть максимум возможных ковариат: демографические данные, такие как возраст, раса, пол, анамнез болезни и жизни, включая такие хронические заболевания, как патология лёгких, онкологические заболевания, сердечно-сосудистые заболевания, цереброваскулярные заболевания, деменция, сахарный диабет, артериальная гипертензия и заболевание периферических артерий, приём лекарств, таких как статины, ингибиторы ангиотензинпревращающего фермента или блокаторы рецепторов ангиотензина, и нестероидные противовоспалительные препараты, статус курения (никогда не куривший, бывший курильщик и курящий), расчётную скорость клубочковой фильтрации, индекс массы тела. Анамнез заболевания оценивался в течение года перед поступлением в больницу, также фиксировался амбулаторный приём рецептурных лекарств в течение 30 дней до госпитализации. Помимо перечисленного, собирались показатели жизненно важных функций при поступлении, включая частоту сердечных сокращений, температуру тела, частоту дыхания, сатурацию крови, систолическое и диастолическое артериальное давление, а также лабораторные данные, включая количество лейкоцитов, гемоглобин, сывороточный альбумин, азот мочевины крови, количество тромбоцитов, бикарбонаты, процентное содержание лимфоцитов на основе измерений во время госпитализации и ближайших к дате и времени госпитализации. Если сравнивать клинические проявления в двух группах, то наблюдалась чёткая дифференцированная связь между',\n",
       " ('COVID-19',\n",
       "  70,\n",
       "  1): 'COVID-19 и риском острого поражения почек. Также при коронавирусной инфекции достоверно чаще требовался инсулин, вазопрессоры, возникали тяжёлый септический шок, тромбоэмболия лёгочной артерии, тромбоз глубоких вен, инсульт, острый инфаркт миокарда, аритмии, внезапная коронарная смерть, рабдомиолиз, повышался уровень тропонина, АСТ и АЛТ. То есть COVID-19 никак нельзя назвать «ещё одним гриппом», по клинической картине он гораздо разнообразнее — что в смысле симптоматики, что в смысле осложнений, и тяжелее. Если говорить о летальных исходах, то госпитализация с COVID-19 была ассоциирована с более высоким риском смерти, чем госпитализация с сезонным гриппом. Итог — 16,85 (ДИ 95% 14,85—18,99) дополнительных смертей на 100 пациентов из-за COVID-19. На пациентов из группы коронавирусной инфекции тратилось больше ресурсов системы здравоохранения, таким пациентам чаще требовалась ИВЛ, перевод в ОРИТ и существенно более длительное нахождение в стационаре по сравнению с группой сезонного гриппа. Были также оценены показатели смертности от COVID-19 в зависимости от возраста, расы и сопутствующих заболеваний. Смертность, как правило, была самой высокой у пожилых и чернокожих людей. Избыточные показатели смертности на 100 пациентов с COVID-19 по сравнению с сезонным гриппом были наиболее выражены у людей старше 75 лет с хроническим заболеванием почек или слабоумием и чернокожими людьми с ожирением, диабетом или хроническим заболеванием почек. Для проверки надёжности результатов авторы провели несколько анализов чувствительности. Поскольку смертность от сезонного гриппа может варьировать, проводилось сравнение пациентов из группы COVID-19 последовательно с госпитализированными с диагнозом грипп в сезоны 2016—17, 2017—18, 2018—19 и 2019—20 годов по отдельности. То же самое было сделано в отношении разных типов гриппа — А и В — поскольку они обладают различающимся потенциалом в смысле развития осложнений и летального исхода. Разделены также были и сезоны по преобладающему типу гриппа А. Учтены были и другие важные факторы, такие как занятость коек, проведение вакцинации против гриппа, статус курения или ИМТ. Подводя итоги исследования, авторы подчеркнули, что всё более очевидным становится внелёгочный органотропизм коронавируса, то есть он преимущественно поражает клетки дыхательных путей, но и по остальным органам и системам бьёт ничуть не меньше, а иногда и больше. Вторым по значению органом, видимо, можно считать почки — достоверно более высокий уровень их поражения с более тяжёлыми осложнениями наблюдался как раз в группе пациентов COVID-19. В отличие от гриппа, перенесённый COVID-19 может сопровождаться длительными последствиями, а также заболеваниями, требующими постоянного лечения (инсульт, впервые возникший сахарный диабет и т.п.), что также увеличивает затраты системы здравоохранения, которые и так больше, чем при гриппе — из-за более длительного нахождения коронавирусных пациентов в стационарах с применением ИВЛ и длительным размещением в ОРИТ. В скорректированных моделях с использованием двойного подхода риск смерти у пациентов с COVID-19 был почти в пять раз выше, чем у пациентов из группы сезонного гриппа. Традиционно учёные отметили, что их исследование имеет ряд ограничений. Так, результаты получены на когорте ветеранов, в подавляющем большинстве — белых людях старшего возраста, и не могут быть экстраполированы на более молодых людей без фоновых хронических заболеваний. И хотя приводятся скорректированные оценки, невозможно учесть все ковариаты. Кроме того, сравнение велось с сезонным, а не пандемическим гриппом, который встречался, например, в сезоне 2009—10 годов. Также необходимо учесть, что подходы к пациентам с COVID-19 быстро модернизируются и актуализируются, появились зарегистрированные вакцины, что, вероятно, улучшит показатели госпитализированных с коронавирусной инфекцией.',\n",
       " ('COVID-19',\n",
       "  71,\n",
       "  0): 'Government awards multi-million-pound funding to phase 1 clinical trial platform to fast-track innovative treatments NHS patients could receive cutting-edge COVID-19 treatments in months rather than years Move will bring in the world’s best researchers to trial treatments in the UK The move marks a landmark development in COVID-19 research that could see results for brand new treatments in months rather than years, and will enable the government to get even more safe and effective treatments to the NHS rapidly through a more streamlined process. Currently, the government funds phase 2 and 3 trials, such as the RECOVERY trial, which brought life-saving treatments dexamethasone and tocilizumab to the NHS. Phase 1 trials, usually arranged by the researchers, are the earliest stage of human trials that ensure treatments are safe and show a signal of benefit in treating a disease. The funding has been awarded to expand the AGILE clinical trial platform and will allow for global innovators to progress cutting-edge treatments for COVID-19 through all 3 clinical trial phases in the UK, further protecting our supply chain. This in turn will attract the brightest of researchers and manufacturers from around the world to trial their medicines here in Britain. Health and Social Care Secretary Matt Hancock said: Today’s news will ensure all phases of clinical trials for new treatments are done in the UK, protecting our supply chain and securing the world’s best treatments for NHS patients at a much faster rate. I am immensely proud of the work that’s been undertaken by the brilliant scientists behind these treatments and the thousands of UK patients who have taken part in the trials. Together, we can continue to ensure the UK is one of the best countries in the world for trialling and deploying the most groundbreaking medical advancements for both COVID-19 and for dangerous diseases in the future. The funding has been awarded by the Medical Research Council (MRC) and co-funded though the National Institute for Health Research (NIHR). A phase 1 trial is the earliest stage of human trials and is an essential first step that ensures treatments are safe. Once they pass phase 1, they then go into larger-scale phase 2 and 3 trials, such as RECOVERY or PRINCIPLE, before being made available on the NHS once proven to be effective. The UK has proven throughout this pandemic to be a world leader in medical research and life sciences, stepping up quickly to the task of finding effective therapeutics for a completely new virus and supported by millions in funding by the UK government. Background information',\n",
       " ('COVID-19',\n",
       "  72,\n",
       "  0): 'We know a lot more about COVD-19 than we did in 2020, and yet we\\'re still learning. We will continue to provide important updates. Even if you have been vaccinated, you will want to take steps to reduce your chances of infection. That may mean temporarily wearing masks indoors or avoiding large gatherings if COVID-19 levels are high in your area. The good news is these steps will also reduce your risk of developing other respiratory viruses, like colds or flus, too. Vaccines against COVID-19 are the best defense against the virus, as they protect against serious disease, hospitalization, and death. Most people with COVID-19 have mild respiratory symptoms that feel much like a cold or flu. But it can be much more serious for older adults, people with underlying medical conditions, and those who haven’t been vaccinated against COVID-19. Some people may go on to suffer from post-COVID conditions, known as “long COVID.” Mounting evidence suggests that COVID vaccines protect against long COVID. COVID-19 (coronavirus disease 2019) is a respiratory illness caused by the SARS-CoV-2 virus. It is very contagious, and spreads quickly. antibodies: proteins made by the immune system to fight infections. If the antibodies later encounter the same infection, they help prevent illness by recognizing the microbe and preventing it from entering cells. antigen: a substance displayed on the surface of a microbe that stimulates the body to produce an immune response. antigen test: a diagnostic test that detects specific proteins on the surface of the virus. diagnostic test: indicates whether you are currently infected with COVID-19. epidemic: a disease outbreak in a community or region. false negative: a test result that mistakenly indicates you are not infected when you are. false positive: a test result that mistakenly indicates you are infected when you are not. immunity: partial or complete protection from a specific infection because a person has either had that infection previously or has been vaccinated against it. incubation period: the period of time between exposure to an infection and when symptoms begin. infectious respiratory particles: droplets containing respiratory pathogens that can spread from person to person when a sick person coughs, sneezes, or talks. isolation: the separation of people with a contagious disease from people who are not sick. long COVID: the constellation of symptoms experienced by COVID long-haulers. These symptoms may include brain fog, shortness of breath, chills, body ache, headache, joint pain, chest pain, cough, and lingering loss of taste or smell. long-haulers: people who have not fully recovered from COVID-19 weeks or even months after first experiencing symptoms. mutation: A change to a virus’s genetic material that occurs when the virus is replicating. The change is passed on to future generations of the virus. mRNA: short for messenger ribonucleic acid, mRNA is genetic material that contains instructions for making proteins. mRNA vaccines: mRNA vaccines for COVID-19 contain synthetic mRNA. Inside the body, the mRNA enters human cells and instructs them to produce the \"spike\" protein found on the surface of the COVID-19 virus. The body recognizes the spike protein as an invader, and produces antibodies against it. If the antibodies later encounter the actual virus, they are ready to recognize and destroy it before it causes illness. pandemic: a disease outbreak affecting large populations or a whole region, country, or continent polymerase chain reaction (PCR) test: a diagnostic test that detects the presence of the virus\\'s genetic material. SARS-CoV-2: short for severe acute respiratory syndrome coronavirus 2, SARS-CoV-2 is the official name for the virus responsible for COVID-19. spike protein: a protein on the surface of the SARS-CoV-2 virus that binds',\n",
       " ('COVID-19',\n",
       "  72,\n",
       "  1): \"to and allows the virus to enter human cells. variant: A virus containing one or more mutations that make it different from a version of the virus that has been circulating. virus: a virus is the smallest of infectious microbes, smaller than bacteria or fungi. A virus consists of a small piece of genetic material (DNA or RNA) surrounded by a protein shell. Viruses cannot survive without a living cell in which to reproduce. Once a virus enters a living cell (the host cell) and takes over a cell's inner workings, the cell cannot carry out its normal life-sustaining tasks. The host cell becomes a virus manufacturing plant, making viral parts that then reassemble into whole viruses and go on to infect other cells. Eventually, the host cell dies.\",\n",
       " ('COVID-19',\n",
       "  73,\n",
       "  0): '1. И COVID-19, и грипп поражают в основном респираторную систему Обе инфекции вызываются вирусами (COVID-19 – вирусом SARS-CoV-2, а грипп – вирусами гриппа), но могут по-разному проявляться у различных людей. У некоторых людей они могут протекать бессимптомно или сопровождаться легкими симптомами. У других людей эти инфекции могут приобретать тяжелую форму и требовать госпитализации. Как COVID-19, так и грипп могут приводить к летальному исходу. Во многих случаях COVID-19 и грипп вызывают аналогичные симптомы, включая кашель, насморк, боль в горле, повышение температуры тела, головную боль и слабость. Подробнее о признаках и симптомах COVID-19 Подробнее о сезонном гриппе При появлении у вас или знакомого человека любого из указанных ниже тяжелых симптомов необходимо обращаться за медицинской помощью: затрудненное дыхание, особенно в состоянии покоя, или неспособность говорить законченными фразами; спутанность сознания; сонливость или потеря сознания; постоянная боль или чувство сдавливания в груди; холодная или липкая кожа, бледный или синюшный оттенок кожных покровов; потеря речи или способности двигаться. 2. Вирус SARS-CoV-2 и вирусы грипп распространяются сходным образом Как вирус SARS-CoV-2, так и вирусы гриппа распространяются в основном между людьми, находящимися на расстоянии тесного контакта друг от друга, например при личном разговоре. Вирусы могут передаваться по воздуху в составе респираторных инфекционных частиц (мелких частиц жидкости) изо рта или носа при кашле, чихании, разговоре или дыхании. В этом случае другой человек может заразиться вирусом при вдыхании распыленных в воздухе инфекционных частиц с короткого расстояния или при их попадании на слизистые оболочки. Вирус SARS-CoV-2 и вирусы гриппа легче распространяются в плохо проветриваемых и/или переполненных помещениях, а также при длительном нахождении людей в одном помещении. Это объясняется тем, что в таких случаях инфекционные респираторные частицы могут оставаться во взвешенном состоянии в воздухе или преодолевать расстояния, превышающие обычную дистанцию между беседующими людьми. Кроме того, заразиться можно, дотрагиваясь до поверхностей или предметов, на которых присутствуют вирусные частицы гриппа или SARS-CoV-2, и затем прикасаясь к глазам, носу или рту. 3. Для COVID-19 и гриппа характерен ряд общих факторов риска, способствующих тяжелому течению заболевания Большинство заразившихся SARS-CoV-2 или вирусами гриппа полностью выздоравливают и не нуждаются в больничном лечении, однако у некоторых пациентов инфекция переносится крайне тяжело и может закончиться летальным исходом. От тяжелого течения болезни и смерти от нее не застрахован ни один человек, однако некоторые группы заразившихся подвергаются повышенному риску таких исходов: пожилые люди; лица любого возраста, страдающие хроническими заболеваниями, в частности ожирением, хроническими заболеваниями сердца, органов дыхания (например, астмой или ХОБЛ), почек, нервной системы, печени или кроветворной системы, а также нарушениями обмена веществ, такими как диабет; лица с ослабленным иммунитетом в результате заболеваний (в частности, обусловленных ВИЧ или раком) или медицинского лечения (например, назначения стероидных препаратов); и беременные и недавно родившие. Повышенному риску заражения могут подвергаться медицинские и медико-социальные работники, поскольку они чаще контактируют с носителями SARS‑CoV-2 и вирусов гриппа. 4. Одни и те же меры эффективно защищают от COVID-19 и гриппа Перечисленные ниже меры помогут вам защитить себя и других от заражения COVID‑19 и гриппом: своевременно прививайтесь от COVID-19 и гриппа, особенно при наличии серьезного риска тяжелого течения инфекции; соблюдайте правила респираторной гигиены и кашлевый этикет, прикрывая нос и рот сгибом локтя или салфеткой при кашле и чихании; регулярно производите гигиеническую обработку рук; пользуйтесь маской при нахождении в переполненных, закрытых или плохо проветриваемых пространствах при наличии симптомов инфекции, положительного результата анализа на COVID-19 или грипп либо риска тяжелого течения COVID-19 или гриппа; оставайтесь дома при ухудшении самочувствия. При возникновении симптомов следует обращаться за консультацией к медицинскому специалисту.',\n",
       " ('COVID-19',\n",
       "  74,\n",
       "  0): 'No evidence-based treatment for COVID-19 currently exists. Very low certainty evidence indicates that corticosteroids might reduce the risk of death, serious adverse events, and mechanical ventilation; that remdesivir might reduce the risk of serious adverse events; that intravenous immunoglobin might reduce the risk of death and serious adverse events; that tocilizumab might reduce the risk of serious adverse events and mechanical ventilation; and that bromhexine might reduce the risk of non-serious adverse events. More trials with low risks of bias and random errors are urgently needed. This review will continuously inform best practice in treatment and clinical research of COVID-19. We planned to conduct aggregate data meta-analyses, trial sequential analyses, network meta-analysis, and individual patient data meta-analyses. Our systematic review was based on PRISMA and Cochrane guidelines, and our eight-step procedure for better validation of clinical significance of meta-analysis results. We performed both fixed-effect and random-effects meta-analyses. Primary outcomes were all-cause mortality and serious adverse events. Secondary outcomes were admission to intensive care, mechanical ventilation, renal replacement therapy, quality of life, and non-serious adverse events. According to the number of outcome comparisons, we adjusted our threshold for significance to p = 0.033. We used GRADE to assess the certainty of evidence. We searched relevant databases and websites for published and unpublished trials until November 2, 2020. Two reviewers independently extracted data and assessed trial methodology. We included 82 randomized clinical trials enrolling a total of 40,249 participants. 81 out of 82 trials were at overall high risk of bias. Meta-analyses showed no evidence of a difference between corticosteroids versus control on all-cause mortality (risk ratio [RR] 0.89; 95% confidence interval [CI] 0.79 to 1.00; p = 0.05; I 2 = 23.1%; eight trials; very low certainty), on serious adverse events (RR 0.89; 95% CI 0.80 to 0.99; p = 0.04; I 2 = 39.1%; eight trials; very low certainty), and on mechanical ventilation (RR 0.86; 95% CI 0.55 to 1.33; p = 0.49; I 2 = 55.3%; two trials; very low certainty). The fixed-effect meta-analyses showed indications of beneficial effects. Trial sequential analyses showed that the required information size for all three analyses was not reached. Meta-analysis (RR 0.93; 95% CI 0.82 to 1.07; p = 0.31; I 2 = 0%; four trials; moderate certainty) and trial sequential analysis (boundary for futility crossed) showed that we could reject that remdesivir versus control reduced the risk of death by 20%. Meta-analysis (RR 0.82; 95% CI 0.68 to 1.00; p = 0.05; I 2 = 38.9%; four trials; very low certainty) and trial sequential analysis (required information size not reached) showed no evidence of difference between remdesivir versus control on serious adverse events. Fixed-effect meta-analysis showed indications of a beneficial effect of remdesivir on serious adverse events. Meta-analysis (RR 0.40; 95% CI 0.19 to 0.87; p = 0.02; I 2 = 0%; two trials; very low certainty) showed evidence of a beneficial effect of intravenous immunoglobulin versus control on all-cause mortality, but trial sequential analysis (required information size not reached) showed that the result was severely underpowered to confirm or reject realistic intervention effects. Meta-analysis (RR 0.63; 95% CI 0.35 to 1.14; p = 0.12; I 2 = 77.4%; five trials; very low certainty) and trial sequential analysis (required information size not reached) showed no evidence of a difference between tocilizumab versus control on serious adverse events. Fixed-effect meta-analysis showed indications of a beneficial effect of tocilizumab on serious adverse events. Meta-analysis (RR 0.70; 95% CI 0.51 to 0.96; p = 0.02; I 2 = 0%; three trials; very low certainty) showed evidence of a beneficial effect of tocilizumab versus control on',\n",
       " ('COVID-19',\n",
       "  74,\n",
       "  1): \"mechanical ventilation, but trial sequential analysis (required information size not reached) showed that the result was severely underpowered to confirm of reject realistic intervention effects. Meta-analysis (RR 0.32; 95% CI 0.15 to 0.69; p < 0.00; I 2 = 0%; two trials; very low certainty) showed evidence of a beneficial effect of bromhexine versus standard care on non-serious adverse events, but trial sequential analysis (required information size not reached) showed that the result was severely underpowered to confirm or reject realistic intervention effects. Meta-analyses and trial sequential analyses (boundary for futility crossed) showed that we could reject that hydroxychloroquine versus control reduced the risk of death and serious adverse events by 20%. Meta-analyses and trial sequential analyses (boundary for futility crossed) showed that we could reject that lopinavir-ritonavir versus control reduced the risk of death, serious adverse events, and mechanical ventilation by 20%. All remaining outcome comparisons showed that we did not have enough information to confirm or reject realistic intervention effects. Nine single trials showed statistically significant results on our outcomes, but were underpowered to confirm or reject realistic intervention effects. Due to lack of data, it was not relevant to perform network meta-analysis or possible to perform individual patient data meta-analyses. COVID-19 is a rapidly spreading disease that has caused extensive burden to individuals, families, countries, and the world. Effective treatments of COVID-19 are urgently needed. This is the second edition of a living systematic review of randomized clinical trials assessing the effects of all treatment interventions for participants in all age groups with COVID-19. Funding: SJ, JCJ, and CG received a grant from The Grundfos Foundation (Grant number: 2020-025, URL: https://www.pdjf.dk/en/ ). NN received a grant from The Swedish Research Council (Grant number: N/A. URL: https://www.vr.se/english.html ). AAV received a European Union's Horizon 2020 grant (Grant number: 754936. URL: https://ec.europa.eu/programmes/horizon2020/en ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Copyright: © 2021 Juul et al. This is an open access article distributed under the terms of the Creative Commons Attribution License , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. The present living systematic review with aggregate meta-analyses and trial sequential analyses aims to continuously inform evidence-based guideline recommendations for the treatment of COVID-19, taking risks of systematic errors (‘bias’), risks of random errors (‘play of chance’), and certainty of the findings into consideration [ 8 ]. Many randomized clinical trials assessing the effects of different potential treatments for COVID-19 are currently underway. However, it is rare that a single trial can sufficiently assess the effects of any intervention. Therefore, there is an urgent need to continuously surveil the emerging evidence and present aggregate data so that effective treatments, if such exist, are rapidly implemented in clinical practice [ 7 ]. In December 2019, the emergence of a novel coronavirus, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), caused a rapid international outbreak of the respiratory illness COVID-19 [ 1 ]. Since the initial outbreak in China, SARS-CoV-2 has spread globally and COVID-19 is currently labeled a public health emergency of global concern by the World Health Organization [ 2 ]. The full clinical spectrum of COVID-19 ranges from asymptomatic infection to mild, self-limiting respiratory tract illness to severe progressive pneumonia, multiorgan failure, and death [ 3 ]. Critically ill patients might die from massive alveolar damage and progressive respiratory failure [ 4 – 6 ]. We performed our aggregate data meta-analyses according to Cochrane [ 11 ], Keus et al. [ 16 ], and\",\n",
       " ('COVID-19',\n",
       "  74,\n",
       "  2): 'the eight-step assessment by Jakobsen et al. [ 17 ] for better validation of meta-analytic results in systematic reviews. Review Manager version 5.4 [ 18 ] and Stata 16 (StataCorp LLC, College Station, TX, USA) [ 19 ] were used for all statistical analyses. We used risk ratios (RR) for dichotomous outcomes. We assessed a total of two primary outcomes per comparison, and we therefore adjusted our thresholds for significance [ 17 ] and considered a p-value of 0.033 or less as the threshold for statistical significance [ 8 , 17 ]. Because we primarily considered results of secondary outcomes as hypothesis generating, we did not adjust the p-value for secondary outcomes. We conducted both random-effects (DerSimonian-Laird) and fixed-effect (Mantel-Haenszel) meta-analyses for all analyses and chose the most conservative result as our primary result [ 11 , 17 , 20 , 21 ]. We used trial sequential analysis to control for random errors [ 22 – 30 ]. Trial sequential analysis estimates the diversity-adjusted required information size (DARIS), which is the number of participants needed in a meta-analysis to detect or reject a certain intervention effect. Statistical heterogeneity was quantified by calculating heterogeneity (I2) for traditional meta-analyses and diversity (D2) for trial sequential analysis. We used Grading Recommendations Assessment Development Evaluation (GRADE) to assess the certainty of evidence. We downgraded imprecision in GRADE by two levels if the accrued number of participants were below 50% of the DARIS, and one level if between 50% and 100% of DARIS [ 17 ]. We did not downgrade if benefit, harm, futility or DARIS were reached. We used Fisher’s exact test to calculate p-values for all single trial results. We chose to add time to clinical improvement as a post hoc outcome. We planned several subgroup analyses, which are described in detail in our protocol [ 8 ]. For all outcomes, we used the trial results reported at maximum follow-up. Primary and secondary outcomes were predefined in our protocol [ 8 ]. Primary outcomes were all-cause mortality and serious adverse events (as defined by the ICH-GCP guidelines) [ 8 , 15 ]. Secondary outcomes were admission to intensive care (as defined by trialists), mechanical ventilation (as defined by trialists), renal replacement therapy (as defined by trialists), quality of life, and non-serious adverse events. We classified non-serious adverse events as any adverse event not assessed as serious according to the ICH-GCP definition. Risk of bias was assessed with the Cochrane Risk of Bias tool–version 2 (RoB 2) [ 11 , 14 ]. Seven authors in pairs (SJ, EEN, JF, FS, CKJ, EB, JH) independently assessed risk of bias. Any discrepancies were resolved through discussion or, if required, through discussion with a third author (JCJ). Bias was assessed with the following domains: bias arising from the randomization process, bias due to deviations from the intended interventions, bias due to missing outcome data, bias in measurement of outcomes, and bias arising from selective reporting of results [ 11 , 14 ]. We contacted corresponding authors of trials with unclear or missing data. Two authors (EEN and JF) independently screened relevant trials. Seven authors in pairs (SJ, EEN, JF, FS, CKJ, EB, JH) independently extracted data using a standardized data extraction sheet. Any discrepancies were resolved through discussion, or if required, through discussion with a third author (JCJ). We contacted corresponding authors if relevant data were unclear or missing. In this living systematic review, two independent investigators receive a weekly updated literature search file, and continuously include relevant newly published or unpublished trials. The relevant meta-analyses, trial sequential analyses, and network meta-analysis will be continuously updated, and',\n",
       " ('COVID-19',\n",
       "  74,\n",
       "  3): 'if new evidence is available (judged by the author group), the results will be submitted for publication. Every month, the author group will discuss whether searching once a week is necessary. For a detailed overview of the living systematic review work flow, see our protocol [ 8 ]. As this is a living systematic review analyzing results of randomized clinical trials, no ethical approval is required. We included unpublished and grey literature trials and assessed relevant retraction statements and errata for included trials. We also searched preprint servers (bioRxiv, medRxiv) for unpublished trials. We contacted all corresponding authors to obtain individual patient data. The reference lists of relevant trial publications were checked for any unidentified randomized clinical trials. To identify unpublished trials, we searched clinical trial registries (e.g. clinicaltrials.gov, clinicaltrialregister.eu , who.int/ictrp , chictr.org.cn ) of Europe, USA, and China, and websites of pharmaceutical companies and of U.S. Food and Drug Administration (FDA) and European Medicines Agency (EMA). We also searched the COVID-19 Study Registry [ 12 ] and the real-time dashboard of randomized trials [ 13 ]. An information specialist searched the Cochrane Central Register of Controlled Trials (CENTRAL) in The Cochrane Library, Medical Literature Analysis and Retrieval System Online (MEDLINE Ovid), Excerpta Medica database (Embase Ovid), Latin American and Caribbean Health Sciences Literature (LILACS; Bireme), Science Citation Index Expanded (SCI-EXPANDED; Web of Science), Conference Proceedings Citation Index–Science (CPCI-S; Web of Science), BIOSIS (Web of Science), CINAHL (EBSCO host), Chinese Biomedical Literature Database (CBM), China Network Knowledge Information (CNKI), Chinese Science Journal Database (VIP), and Wanfang Database to identify relevant trials. We searched all databases from their inception and until November 2, 2020. Trials were included irrespective of language, publication status, publication year, and publication type. For the detailed search strategies for all electronic searches, see S2 Text . We report this systematic review based on the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) guidelines ( S1 Text ) [ 9 , 10 ]. The updated methodology used in this living systematic review is according to the Cochrane Handbook of Systematic Reviews of Interventions [ 11 ] and described in our protocol [ 8 ], which was registered in the PROSPERO database (ID: CRD42020178787) prior to the systematic literature search. On November 2, 2020, a search on the Cochrane COVID-19 Study Register revealed 2527 registered randomized clinical trials [ 13 ]. From these, 106 different interventions for treatment of COVID-19 patients were identified [ 13 ]. The ten most investigated experimental interventions were hydroxychloroquine (162 trials), convalescent plasma (55 trials), azithromycin (52 trials), lopinavir and ritonavir (40 trials), tocilizumab (33 trials), chloroquine (30 trials), favipiravir (24 trials), remdesivir (15 trials), sarilumab (15 trials), and dexamethasone (13 trials). Eligible trials will continuously be included in the present living systematic review once results become available. None of the remaining single trial results showed evidence of a difference on our predefined review outcomes. Two trials did not report the results in a usable way; one trial reported results of the experimental group with a proportion of participants being non-randomized [ 55 ], and the second trial reported the results as per-protocol, and there was participant crossover [ 41 ]. Seven trials did not report on our review outcomes [ 43 , 61 , 62 , 66 , 70 , 95 , 100 ]. We have contacted all corresponding authors, but we have not been able to obtain outcomes for our analyses from the trialists yet. Most trials were assessed at high risk of bias ( S3 Table ). Characteristics of the trials and their results on the review outcomes can',\n",
       " ('COVID-19',\n",
       "  74,\n",
       "  4): 'be found in S2 Table . Certainty of the evidence was assessed as ‘low’ or ‘very low’ for all outcomes ( S15 – S66 Tables ). One trial randomizing 402 participants compared five versus ten days of remdesivir and showed evidence of a beneficial effect of five days of remdesivir on serious adverse events (p = 0.003 (Fisher’s exact test)) [ 36 ]. One trial randomizing 92 participants compared the immunomodulator interferon β-1a added to standard care versus standard care alone and showed evidence of a beneficial effect of interferon β-1a on all-cause mortality (p = 0.029) [ 35 ]. This trial also showed evidence of a harmful effect of interferon β-1a on non-serious adverse events (p = 0.006) [ 35 ]. One single trial randomizing 81 participants compared high-dosage versus low-dosage chloroquine diphosphate and showed evidence of a beneficial effect of low-dosage chloroquine on all-cause mortality (p = 0.024) [ 49 ]. One single three group trial randomizing 667 participants to hydroxychloroquine with or without azithromycin versus standard care and showed evidence of a harmful effect of hydroxychloroquine with azithromycin on adverse events not considered serious (p = 0.015) [ 53 ]. One single trial randomizing 76 participants compared calcifediol versus standard care and showed evidence of a beneficial effect of calcifediol on admittance to intensive care (p = 0.0001) [ 83 ]. One single trial randomizing 200 participants compared recombinant human granulocyte colony–stimulating factor (rhG-CSF) versus standard care and showed evidence of a beneficial effect of rhG-CSF on all-cause mortality (p = 0.017), and receipt of mechanical ventilation (p = 0.003) [ 84 ]. This trial also showed evidence of a harmful effect of rhG-CSF on non-serious adverse events (p = 0.0001) [ 84 ]. One single trial randomizing 84 participants compared electrolyzed saline versus standard care and showed evidence of a beneficial effect of electrolyzed saline on all-cause mortality (p = 0.019) [ 99 ]. One single trial randomizing 78 participants compared bromhexine hydrochloride versus standard care and showed evidence of a beneficial effect of bromhexine hydrochloride on admittance to intensive care (p = 0.013) and receipt of mechanical ventilation (p = 0.014) [ 103 ]. One single trial randomizing 100 participants compared hydroxychloroquine combined with arbidol versus hydroxychloroquine combined with lopinavir-ritonavir and showed evidence of a beneficial effect of hydroxychloroquine combined with arbidol on admission to intensive care (p = 0.0001) [ 108 ]. Because of lack of relevant data, it was not possible to conduct other meta-analyses, individual patient data meta-analyses, or network meta-analysis. Nine single trials showed statistically significant results but were all underpowered to confirm or reject realistic intervention effects. We post hoc defined a ‘realistic intervention effect’ as a relative risk between 0.7 and 0.9. Random-effects meta-analysis showed evidence of a beneficial effect of bromhexine versus standard care on non-serious adverse events (RR 0.32; 95% CI 0.15 to 0.69; p < 0.00) ( S62 Fig , S14 Table ). Visual inspection of the forest plot and measures to quantify heterogeneity (I 2 = 0%) indicated no heterogeneity. The time-point of assessment was 28 days for the first trial [ 103 ] and unclear for the second trial [ 93 ]. The trial sequential analysis showed that we did not have enough information to confirm or reject that bromhexine versus standard care reduces the risk of non-serious adverse events with a relative risk reduction of 20%. Random-effects meta-analysis showed no evidence of a difference between bromhexine versus standard care on all-cause mortality (RR 0.17; 95% CI 0.02 to 1.70; p = 0.13) ( S61 Fig , S14 Table ). Visual inspection of the',\n",
       " ('COVID-19',\n",
       "  74,\n",
       "  5): 'forest plot and measures to quantify heterogeneity (I 2 = 0%) indicated no heterogeneity. The time-point of assessment was 28 days for the first trial [ 103 ] and unclear for the second trial [ 93 ]. The trial sequential analysis showed that we did not have enough information to confirm or reject that bromhexine versus standard care reduces the risk of all-cause mortality with a relative risk reduction of 20%. Fixed-effect meta-analysis showed no evidence of a difference between tocilizumab versus control on non-serious adverse events (RR 1.03; 95% CI 0.92 to 1.14; p = 0.63) ( S60 Fig , S13 Table ). Visual inspection of the forest plot and measures to quantify heterogeneity (I 2 = 57.9%) indicated moderate heterogeneity. The time-point of assessment was either unclear [ 89 , 92 , 113 ], 28 days [ 110 ], or 30 days [ 111 ] after randomization. The trial sequential analysis showed that we did not have enough information to confirm or reject that tocilizumab versus control reduces the risk of non-serious adverse events with a relative risk reduction of 20%. The subgroup analysis assessing the effects of different control interventions showed no significant subgroup differences (p = 0.27) ( S60 Fig ). Random-effects meta-analysis showed evidence of a beneficial effect of tocilizumab versus control on mechanical ventilation (RR 0.70; 95% CI 0.51 to 0.96; p = 0.02) ( S58 Fig , S13 Table ). Visual inspection of the forest plot and measures to quantify heterogeneity (I 2 = 0%) indicated no heterogeneity. The time-point of assessment was either unclear [ 89 ] or 28 days [ 110 , 112 ] after randomization. The trial sequential analysis showed that we did not have enough information to confirm or reject that tocilizumab reduce the risk of mechanical ventilation with a relative risk reduction of 20% ( S59 Fig ). The subgroup analysis assessing the effects of control interventions showed no significant subgroup differences (p = 0.34) ( S58 Fig ). Random-effects meta-analysis showed no evidence of a difference between tocilizumab and control interventions on admission to intensive care (RR 0.71; 95% CI 0.37 to 1.38; p = 0.32) ( S57 Fig , S13 Table ). Visual inspection of the forest plot and measures to quantify heterogeneity (I 2 = 36%) indicated no substantial heterogeneity. The time-point of assessment was either unclear [ 89 ] or 30 days [ 111 ] after randomization. The trial sequential analysis showed that we did not have enough information to confirm or reject that tocilizumab versus control reduces the risk of admission to intensive care with a relative risk reduction of 20%. The subgroup analysis assessing the effects of control interventions showed no significant subgroup differences (p = 0.21) ( S57 Fig ). Random-effects meta-analysis showed no evidence of a difference between tocilizumab and control interventions on serious adverse events (RR 0.63; 95% CI 0.35 to 1.14; p = 0.12) ( S55 Fig , S13 Table ). Fixed-effect meta-analysis showed evidence of a beneficial effect of tocilizumab versus control on serious adverse events (RR 0.68; 95% CI 0.57 to 0.81; p = 0.00) ( S56 Fig ). Visual inspection of the forest plot and measures to quantify heterogeneity (I 2 = 77.4%) indicated heterogeneity. The time-point of assessment was either unclear [ 89 , 113 ], 28 days [ 110 , 112 ], or 30 days [ 111 ] after randomization. The trial sequential analysis showed that we did not have enough information to confirm or reject that tocilizumab versus control reduces the risk of serious adverse events with a relative risk reduction of',\n",
       " ('COVID-19',\n",
       "  74,\n",
       "  6): '20%. The subgroup analysis assessing the effects of different control interventions showed no significant subgroup differences (p = 0.13) ( S55 Fig ). Random-effects meta-analysis showed no evidence of a difference between tocilizumab and control interventions on all-cause mortality (RR 1.03; 95% CI 0.72 to 1.46; p = 0.89) ( S53 Fig , S13 Table ). Visual inspection of the forest plot and measures to quantify heterogeneity (I 2 = 0.0%) indicated no heterogeneity. The time-points of assessment were 28 days [ 89 , 110 , 112 ] and 30 days [ 111 ] after randomization. The trial sequential analysis showed that we did not have enough information to confirm or reject that tocilizumab versus control reduces the risk of all-cause mortality with a relative risk reduction of 20% ( S54 Fig ). The subgroup analysis assessing the effects of different control interventions showed no significant subgroup differences (p = 0.87) ( S53 Fig ). We identified six trials randomizing 1038 patients to tocilizumab versus standard care [ 92 , 110 – 112 ], placebo with standard care [ 89 ] or favipiravir alone as co-intervention [ 113 ]. All trials were assessed as at high risk of bias ( S3 Table ). Fixed-effect meta-analysis showed evidence of a beneficial effect of intravenous immunoglobulin versus control on serious adverse events (RR 0.40; 95% CI 0.19 to 0.87; p = 0.02) ( S51 Fig , S12 Table ). This data is solely based on all-cause mortality data according to the ICH-GCP guidelines [ 15 ], since no other serious adverse events were reported. Visual inspection of the forest plot and measures to quantify heterogeneity (I 2 = 0%) indicated no heterogeneity. The outcome was assessed only in hospital in the first trial [ 94 ] and up to 30 days in the second trial [ 56 ]. The trial sequential analysis showed that we did not have enough information to confirm or reject that intravenous immunoglobulin versus control reduces the risk of all-cause mortality with a relative risk reduction of 20% ( S52 Fig ). The subgroup analysis assessing the effects of different control interventions showed no evidence of a significant subgroup difference between placebo and standard care (p = 0.89) ( S51 Fig ). Fixed-effect meta-analysis showed evidence of a beneficial effect of intravenous immunoglobulin versus control on all-cause mortality (RR 0.40; 95% CI 0.19 to 0.87; p = 0.02) ( S49 Fig , S12 Table ). Visual inspection of the forest plot and measures to quantify heterogeneity (I 2 = 0%) indicated no heterogeneity. The outcome was assessed only in hospital in the first trial [ 94 ] and up to 30 days in the second trial [ 56 ]. The trial sequential analysis showed that we did not have enough information to confirm or reject that intravenous immunoglobulin versus control reduces the risk of all-cause mortality with a relative risk reduction of 20% ( S50 Fig ). The subgroup analysis assessing the effects of different control interventions showed no evidence of a significant subgroup difference between placebo and standard care (p = 0.89) ( S49 Fig ). Random-effects meta-analysis showed no evidence of a difference between colchicine versus control on non-serious adverse events (RR 0.88; 95% CI 0.18 to 4.39; p = 0.87) ( S48 Fig , S11 Table ). Visual inspection of the forest plot and measures to quantify heterogeneity (I 2 = 79.1%) indicated substantial heterogeneity. The time-point of assessment was 21 days after randomization in one trial [ 48 ], but unclear in the other two trials [ 91 , 106 ]. We have contacted',\n",
       " ('COVID-19',\n",
       "  74,\n",
       "  7): 'the trial authors and requested information on the assessment time-points, but we have not received a response yet. The trial sequential analysis showed that we did not have enough information to confirm or reject that colchicine versus control reduces the risk of non-serious adverse events with a relative risk reduction of 20%. The subgroup analysis assessing the effects of colchicine versus different control interventions showed evidence of significant subgroup differences (p = 0.01) ( S48 Fig ). Fixed-effect meta-analysis showed no evidence of a difference between colchicine versus control on all-cause mortality (RR 1.03; 95% CI 0.07 to 16.01; p = 0.98) ( S47 Fig , S11 Table ). Visual inspection of the forest plot and measures to quantify heterogeneity (I 2 = 0%) indicated no heterogeneity. The time-point of assessment was unclear in both trials [ 91 , 106 ]. We have contacted the trial authors and requested information on the assessment time-points, but we have not received a response yet. The trial sequential analysis showed that we did not have enough information to confirm or reject that colchicine versus control reduces the risk of all-cause mortality with a relative risk reduction of 20%. The subgroup analysis assessing the effects of colchicine versus different control interventions showed no evidence of a significant subgroup difference (p = 0.98) ( S47 Fig ). We identified three trials randomizing 248 participants to colchicine versus standard care [ 48 ], placebo plus standard care [ 91 ], or placebo plus hydroxychloroquine [ 106 ]. In the latter trial, the colchicine group also received hydroxychloroquine as a co-intervention [ 106 ]. All trials were assessed as at high risk of bias ( S3 Table ). Fixed-effect meta-analysis showed no evidence of a difference between azithromycin versus control on non-serious adverse events (RR 1.09; 95% CI 0.89 to 1.34; p = 0.38) ( S45 Fig , S10 Table ). Visual inspection of the forest plot and measures to quantify heterogeneity (I 2 = 0%) indicated no heterogeneity. The time-point of assessment was 15 days after randomization in the first trial [ 53 ], and 29 days after randomization in the second trial [ 82 ]. The trial sequential analysis showed that we did not have enough information to confirm or reject that azithromycin versus control reduces the risk of non-serious adverse events with a relative risk reduction of 20% ( S46 Fig ). The subgroup analysis assessing the effects of azithromycin versus different control interventions showed no significant subgroup differences (p = 0.71) ( S45 Fig ). Fixed-effect meta-analysis showed no evidence of a difference between azithromycin versus control on mechanical ventilation (RR 1.07; 95% CI 0.59 to 1.94; p = 0.83 ( S44 Fig , S10 Table ). Visual inspection of the forest plot and measures to quantify heterogeneity (I 2 = 53%) indicated moderate heterogeneity. The time-point of assessment was 15 days after randomization in the first trial [ 53 ], and unclear in the second trial [ 81 ]. We have contacted the trial authors and requested information on the assessment time-point, but we have not received a response yet. The trial sequential analysis showed that we did not have enough information to confirm or reject that azithromycin versus control reduces the risk of receiving mechanical ventilation with a relative risk reduction of 20%. The subgroup analysis assessing the effects of azithromycin versus different control interventions showed no significant subgroup differences (p = 0.15) ( S44 Fig ). Random-effects meta-analysis showed no evidence of a difference between azithromycin versus control on serious adverse events (RR 0.95; 95% CI 0.55 to 1.63; p',\n",
       " ('COVID-19',\n",
       "  74,\n",
       "  8): '= 0.84) ( S43 Fig , S10 Table ). Visual inspection of the forest plot and measures to quantify heterogeneity (I 2 = 16%) indicated no substantial heterogeneity. The time-point of assessment was 15 days after randomization in the first trial [ 53 ], and 29 days after randomization in the second trial [ 82 ], and unclear in the third trial [ 51 ]. We have contacted the trial authors and requested information on the assessment time-point, but we have not received a response yet. The trial sequential analysis showed that we did not have enough information to confirm or reject that azithromycin versus control reduces the risk of serious adverse events with a relative risk reduction of 20%. The subgroup analysis assessing the effects of azithromycin versus different control interventions showed no significant subgroup differences (p = 0.30) ( S43 Fig ). Fixed-effect meta-analysis showed no evidence of a difference between azithromycin versus control on all-cause mortality (RR 0.99; 95% CI 0.79 to 1.25; p = 0.95) ( S41 Fig , S10 Table ). Visual inspection of the forest plot and measures to quantify heterogeneity (I 2 = 7.4%) indicated no substantial heterogeneity. The time-point of assessment was 15 days after randomization in the first trial [ 53 ], 29 days after randomization in the second trial [ 82 ], and unclear in the third trial [ 81 ]. We have contacted the trial authors and requested information on the assessment time-point, but we have not received a response yet. The trial sequential analysis showed that we did not have enough information to confirm or reject that azithromycin versus control reduces the risk of all-cause mortality with a relative risk reduction of 20% ( S42 Fig ). The subgroup analysis assessing the effects of azithromycin versus different control interventions showed no significant subgroup differences (p = 0.35) ( S41 Fig ). We identified three trials randomizing 996 participants to azithromycin versus standard care [ 82 ] or versus co-interventions with standard care [ 53 ], or without standard care [ 81 ]. All trials were assessed at high risk of bias ( S3 Table ). One trial assessed the effects of azithromycin versus standard care [ 53 ], one trial assessed the effects of azithromycin plus lopinavir-ritonavir and hydroxychloroquine versus lopinavir-ritonavir and hydroxychloroquine alone [ 81 ], and one trial assessed the effects of azithromycin plus hydroxychloroquine and standard care versus hydroxychloroquine and standard care alone [ 53 ]. Fixed-effect meta-analysis showed no evidence of a difference between convalescent plasma versus standard care on serious adverse events (RR 0.93; 95% CI 0.64 to 1.35; p = 0.70) ( S39 Fig , S9 Table ). Visual inspection of the forest plot and measures to quantify heterogeneity (I 2 = 0.0%) indicated no substantial heterogeneity. The time-point of assessment was 28 days after randomization in two trials [ 38 , 90 ], 29 days after randomization in one trial [ 77 ], and up to hospital discharge or 60 days in the last trial [ 50 ]. The trial sequential analysis showed that we did not have enough information to confirm or reject that convalescent plasma versus standard care reduces the risk of serious adverse events with a relative risk reduction of 20% ( S40 Fig ). Random-effects meta-analysis showed no evidence of difference between convalescent plasma versus standard care on all-cause mortality (RR 0.77; 95% CI 0.47 to 1.24; p = 0.28) ( S37 Fig , S9 Table ). Visual inspection of the forest plot and measures to quantify heterogeneity (I 2 = 27.5%) indicated some heterogeneity. The outcome',\n",
       " ('COVID-19',\n",
       "  74,\n",
       "  9): 'was assessed 28 days after randomization in two trials [ 38 , 90 ], at 29 days after randomization in one trial [ 77 ] and up to hospital discharge or 60 days in one trial [ 50 ]. The trial sequential analysis showed that we did not have enough information to confirm or reject that convalescent plasma versus standard care reduces the risk of all-cause mortality with a relative risk reduction of 20% ( S38 Fig ). Random-effects meta-analysis showed no evidence of a difference between interferon β-1a versus standard care on serious adverse events (RR 0.75; 95% CI 0.30 to 1.88; p = 0.54) ( S36 Fig , S8 Table ). However, the data was solely based on all-cause mortality data, since no other serious adverse events were reported [ 15 ]. Visual inspection of the forest plot and measures to quantify heterogeneity (I 2 = 84.1%) indicated substantial heterogeneity. The time-point of assessment was 28 days after randomization in both trials [ 35 , 109 ]. The trial sequential analysis showed that we did not have enough information to confirm or reject that interferon β-1a versus standard care reduces the risk of serious adverse events with a relative risk reduction of 20%. Random-effects meta-analysis showed no evidence of a difference between interferon β-1a versus standard care on all-cause mortality (RR 0.75; 95% CI 0.30 to 1.88; p = 0.54) ( S35 Fig , S8 Table ). Visual inspection of the forest plot and measures to quantify heterogeneity (I 2 = 84.1%) indicated substantial heterogeneity. The time-point of assessment was 28 days after randomization in both trials [ 35 , 109 ]. The trial sequential analysis showed that we did not have enough information to confirm or reject that interferon β-1a versus standard care reduces the risk of all-cause mortality with a relative risk reduction of 20%. We identified two trials randomizing 4,219 participants to interferon β-1a versus standard care [ 35 , 109 ]. In one of the trials, the first 1,200 participants received interferon β-1a and lopinavir-ritonavir or lopinavir-ritonavir alone, while the remaining 2,927 participants received interferon β-1a or standard care [ 109 ]. All trials were assessed at high risk of bias ( S3 Table ). Random-effects meta-analysis showed no evidence of a difference between lopinavir–ritonavir versus standard care on non-serious adverse events (RR 1.14; 95% CI 0.85–1.53; p = 0.38) ( S34 Fig ; S7 Table ). Visual inspection of the forest plot and measures to quantify heterogeneity (I 2 = 75%) indicated substantial heterogeneity. The assessment time point was 21 days after randomization in the first trial [ 39 ] and 28 days after randomization in the second trial [ 3 ]. The trial sequential analysis showed that we did not have enough information to confirm or reject that lopinavir–ritonavir compared with standard care reduces nonserious adverse events with a relative risk reduction of 20%. Random-effects meta-analysis showed no evidence of a difference between lopinavir-ritonavir versus control on renal replacement therapy (RR 0.97; 95% CI 0.73 to 1.28; p = 0.81) ( S32 Fig , S7 Table ). Visual inspection of the forest plot and measures to quantify heterogeneity (I 2 = 0.0%) indicated no heterogeneity. The time-points of assessment was 28 days for the first trial [ 3 ] and 28 days or until discharge or death for the second trial [ 105 ]. The trial sequential analysis showed that we did not have enough information to confirm or reject that lopinavir-ritonavir versus control reduces the risk of renal replacement therapy with a relative risk reduction of 20% ( S33 Fig ).',\n",
       " ('COVID-19',\n",
       "  74,\n",
       "  10): 'Random-effects meta-analysis showed no evidence of a difference between lopinavir-ritonavir versus control on mechanical ventilation (RR 1.08; 95% CI 0.94 to 1.25; p = 0.29) ( S30 Fig , S7 Table ). Visual inspection of the forest plot and measures to quantify heterogeneity (I 2 = 0.0%) indicated no heterogeneity. The time-points of assessment were 28 days after randomization in two trials [ 3 , 78 ] and 28 days or until discharge or death for one trial [ 105 ]. The trial sequential analysis showed that we had enough information to reject that lopinavir-ritonavir versus control reduces the risk of receiving mechanical ventilation with a relative risk reduction of 20% ( S31 Fig ). Random-effects meta-analysis showed no evidence of a difference between lopinavir-ritonavir versus control on serious adverse events (RR 1.00; 95% CI 0.91 to 1.11; p = 0.93) ( S28 Fig , S7 Table ). Visual inspection of the forest plot and measures to quantify heterogeneity (I 2 = 1.2%) indicated no substantial heterogeneity. The time-points of assessment were nine days after randomization in one trial [ 44 ], 21 days after randomization in one trial [ 39 ], 28 days after randomization in two trials [ 3 , 109 ], and 28 days or until discharge or death in one trial [ 105 ]. The trial sequential analysis showed that we had enough information to reject that lopinavir-ritonavir versus control reduces the risk of serious adverse events with a relative risk reduction of 20% ( S29 Fig ). The subgroup analysis assessing the effects of lopinavir-ritonavir in combination with novaferon versus lopinavir-ritonavir alone showed no significant subgroup differences (p = 0.99) ( S28 Fig ). Fixed-effect meta-analysis showed no evidence of a difference between lopinavir-ritonavir versus control on all-cause mortality (RR 1.01; 95% CI 0.92 to 1.12; p = 0.77) ( S26 Fig , S7 Table ). Visual inspection of the forest plot and measures to quantify heterogeneity (I 2 = 0.0%) indicated no heterogeneity. The time-points of assessment were nine days after randomization in one trial [ 44 ], 21 days after randomization in one trial [ 39 ], 28 days after randomization in two trials [ 3 , 109 ], and 28 days or until discharge or death in one trial [ 105 ]. The trial sequential analysis showed that we had enough information to reject that lopinavir-ritonavir versus control reduces the risk of all-cause mortality with a relative risk reduction of 20% ( S27 Fig ). The subgroup analysis assessing the effects of lopinavir-ritonavir in combination with novaferon versus lopinavir-ritonavir alone showed no significant subgroup differences (p = 0.99) ( S26 Fig ). We identified four trials randomizing 8,081 participants to lopinavir-ritonavir versus standard care [ 3 , 39 , 105 , 109 ]. We also identified one trial randomizing 60 participants to lopinavir-ritonavir and novaferon versus novaferon alone [ 44 ]. All trials were assessed at high risk of bias ( S3 Table ). Random-effects meta-analysis showed evidence of a harmful effect of hydroxychloroquine versus control on non-serious adverse events (RR 2.09; 95% CI 1.14 to 3.80; p = 0.02) ( S25 Fig , S6 Table ). Visual inspection of the forest plot and measures to quantify heterogeneity (I 2 = 92.1%) indicated substantial heterogeneity. The assessment time points were five days after randomization [ 33 ] and 30 days after randomization [ 107 ]. The trial sequential analysis showed that we did not have enough information to confirm or reject that hydroxychloroquine versus control reduces the risk of non-serious adverse events with a relative risk reduction of 20%. The subgroup analysis',\n",
       " ('COVID-19',\n",
       "  74,\n",
       "  11): 'assessing the effects of hydroxychloroquine versus different control interventions showed a significant subgroup difference between standard care and placebo (p = 0.39) ( S25 Fig ). Fixed-effect meta-analysis showed no evidence of a difference between hydroxychloroquine versus control on mechanical ventilation (RR 1.10; 95% CI 0.84 to 1.45; p = 0.48) ( S23 Fig , S6 Table ). Visual inspection of the forest plot and measures to quantify heterogeneity (I 2 = 0%) indicated no heterogeneity. The assessment time points were 15 days after randomization [ 53 ] and 30 days after randomization [ 107 ]. The trial sequential analysis showed that we did not have enough information to confirm or reject that hydroxychloroquine versus control reduces the risk of receiving mechanical ventilation with a relative risk reduction of 20% ( S24 Fig ). The subgroup analysis assessing the effects of hydroxychloroquine versus different control interventions showed no significant subgroup differences (p = 0.84) ( S23 Fig ). Fixed-effect meta-analysis showed no evidence of a difference between hydroxychloroquine versus control on admission to intensive care (RR 0.74; 95% CI 0.44 to 1.25; p = 0.26) ( S21 Fig , S6 Table ). Visual inspection of the forest plot and measures to quantify heterogeneity (I 2 = 0%) indicated no substantial heterogeneity. The assessment time points were 28 days after randomization [ 76 ] and 30 days after randomization [ 107 ]. The trial sequential analysis showed that we did not have enough information to confirm or reject that hydroxychloroquine versus control reduces the risk of admission to intensive care with a relative risk reduction of 20% ( S22 Fig ). The subgroup analysis assessing the effects of hydroxychloroquine versus different control interventions showed no significant subgroup differences (p = 0.61) ( S21 Fig ). Fixed-effect meta-analysis showed no evidence of a difference between hydroxychloroquine versus control on serious adverse events (RR 1.08; 95% CI 0.98 to 1.19; p = 0.11) ( S19 Fig , S6 Table ). Visual inspection of the forest plot and measures to quantify heterogeneity (I 2 = 0%) indicated no heterogeneity. The assessment time points varied from five days after randomization [ 33 , 34 ] to 30 days after randomization [ 107 ]. The trial sequential analysis showed that we had enough information to reject that hydroxychloroquine versus control reduces the risk of serious adverse events with a relative risk reduction of 20% ( S20 Fig ). The subgroup analysis assessing the effects of hydroxychloroquine versus different control interventions showed no significant subgroup differences (p = 0.90) ( S19 Fig ). Fixed-effect meta-analysis showed no evidence of a difference between hydroxychloroquine versus control on all-cause mortality (RR 1.09; 95% CI 0.99 to 1.20; p = 0.08) ( S17 Fig , S6 Table ). Visual inspection of the forest plot and measures to quantify heterogeneity (I 2 = 0%) indicated no heterogeneity. The assessment time points varied from five days after randomization [ 33 , 34 ] to 30 days after randomization [ 107 ]. The trial sequential analysis showed that we had enough information to reject that hydroxychloroquine versus control reduces the risk of all-cause mortality with a relative risk reduction of 20% ( S18 Fig ). The subgroup analysis assessing the effects of hydroxychloroquine versus different control interventions showed no significant subgroup differences (p = 0.92) ( S17 Fig ). We identified 13 trials randomizing 10,276 participants to hydroxychloroquine versus standard care [ 33 , 34 , 41 , 47 , 53 , 54 , 57 , 58 , 104 , 109 ], or placebo [ 52 , 107 ]. All trials were assessed',\n",
       " ('COVID-19',\n",
       "  74,\n",
       "  12): 'at high risk of bias ( S3 Table ). One trial was not eligible for meta-analysis, as the results were not reported in a usable way; i.e., the results were reported as per-protocol and several participants crossed over [ 41 ]. Fixed-effect meta-analysis showed no evidence of a difference between remdesivir versus control on non-serious adverse events (RR 0.99; 95% CI 0.91 to 1.08; p = 0.86) ( S15 Fig , S5 Table ). Visual inspection of the forest plot and measures to quantify heterogeneity (I 2 = 56.4%) indicated moderate heterogeneity. The assessment time point was 28 days after randomization [ 42 , 64 , 85 ]. The Trial Sequential Analysis showed that we had enough information to reject that remdesivir versus control reduces the risk of non-serious adverse events with a relative risk reduction of 20% ( S16 Fig ). The subgroup analysis assessing the effects of the different control interventions showed evidence of subgroup difference between placebo and standard care (p = 0.02) ( S15 Fig ). Random-effects meta-analysis showed no evidence of a difference between remdesivir versus control on mechanical ventilation (RR 0.73; 95% CI 0.42 to 1.27; p = 0.27) ( S13 Fig , S5 Table ). Visual inspection of the forest plot and measures to quantify heterogeneity (I 2 = 83.1%) indicated substantial heterogeneity. The assessment time points were 28 [ 42 , 109 ] and 29 days after randomization [ 64 ]. The trial sequential analysis showed that we did not have enough information to confirm or reject that remdesivir versus control reduces the risk of receiving mechanical ventilation with a relative risk reduction of 20% ( S14 Fig ). The subgroup analysis assessing the effects of the different control interventions showed evidence of a significant subgroup difference between placebo and standard care (p = 0.00) ( S13 Fig ). Random-effects meta-analysis showed no evidence of difference between remdesivir versus control on serious adverse events (RR 0.82; 95% CI 0.68 to 1.00; p = 0.05) ( S10 Fig , S5 Table ). Fixed-effect meta-analysis showed evidence of a beneficial effect of remdesivir versus control on serious adverse events (RR 0.88; 95% CI 0.79 to 0.99; p = 0.03) ( S11 Fig ). Visual inspection of the forest plot and measures to quantify heterogeneity (I 2 = 38.9%) indicated some heterogeneity. The assessment time points were 28 [ 42 , 85 , 109 ] and 29 days after randomization [ 64 ]. The trial sequential analysis showed that we did not have enough information to confirm or reject that remdesivir versus control reduces the risk of serious adverse events with a relative risk reduction of 20% ( S12 Fig ). The subgroup analysis assessing the effects of the different control interventions showed no significant subgroup differences (p = 0.83) ( S10 Fig ). Random-effects meta-analysis showed no evidence of a difference between remdesivir versus control on all-cause mortality (RR 0.93; 95% CI 0.82 to 1.07; p = 0.31) ( Fig 4 , S5 Table ). Visual inspection of the forest plot and measures to quantify heterogeneity (I 2 = 0%) indicated no heterogeneity. The assessment time points were 28 [ 42 , 85 , 109 ] and 29 days after randomization [ 64 ]. The trial sequential analysis showed that we had enough information to reject that remdesivir versus control reduces the risk of all-cause mortality with a relative risk reduction of 20% ( Fig 5 ). The subgroup analysis assessing the effects of the different control interventions showed no significant subgroup differences (p = 0.21) ( Fig 4 ). The subgroup analysis assessing',\n",
       " ('COVID-19',\n",
       "  74,\n",
       "  13): 'the effects of early versus late intervention (defined as no oxygen versus oxygen or respiratory support at baseline) showed no significant subgroup differences (p = 0.85) ( S9 Fig ). We identified four trials randomizing 7,370 participants to remdesivir versus standard care [ 85 , 109 ] or placebo [ 42 , 64 ]. All trials were assessed at high risk of bias ( S3 Table ). One trial assessed two different dosages of remdesivir versus standard care [ 85 ], and the two comparisons were both included in the meta-analysis. We halved the control group to avoid double counting [ 11 ]. Random-effects meta-analysis showed no evidence of a difference between corticosteroids versus control on mechanical ventilation (RR 0.86; 95% CI 0.55 to 1.33; p = 0.49) ( S6 Fig , S4 Table ). Fixed-effect meta-analysis showed evidence of a beneficial effect of corticosteroids versus control on mechanical ventilation (RR 0.77; 95% CI 0.63 to 0.94; p = 0.01) ( S7 Fig ). Visual inspection of the forest plot and measures to quantify heterogeneity (I 2 = 55.3%) indicated moderate heterogeneity. The time-points of assessment varied from 7 days [ 67 ] to 28 days after randomization [ 46 ]. The trial sequential analysis showed that we did not have enough information to confirm or reject that corticosteroids versus control reduce the risk of receiving mechanical ventilation with a relative risk reduction of 20% ( S8 Fig ). The subgroup analysis assessing the effects of the different corticosteroids versus control showed no significant subgroup differences (p = 0.13) ( S6 Fig ). One of the two trials [ 67 ] had substantial missing data for this outcome, but it was a small trial that did not contribute with much data compared to the second trial. Random-effects meta-analysis showed no evidence of a difference between corticosteroids and control on serious adverse events (RR 0.89; 95% CI 0.80 to 0.99; p = 0.04) ( S3 Fig , S4 Table ). Fixed-effect meta-analysis showed evidence of a beneficial effect of corticosteroids versus control on serious adverse events (RR 0.88; 95% CI 0.82 to 0.95; p = 0.00) ( S4 Fig ). Visual inspection of the forest plot and measures to quantify heterogeneity (I 2 = 39.1%) indicated no substantial heterogeneity. The time-points of assessment varied from 21 [ 87 ] to 30 days after randomization [ 96 , 116 ]. The trial sequential analysis showed that we did not have enough information to confirm or reject that corticosteroids versus control reduce the risk of serious adverse events with a relative risk reduction of 20% ( S5 Fig ). The subgroup analysis assessing the effects of the different corticosteroids versus control showed no significant subgroup differences (p = 0.71) ( S3 Fig ). The serious adverse event data is predominately based on mortality data, and assessed according to the ICH-GCP definition of a serious adverse event [ 15 ]. Random-effects meta-analysis showed no evidence of a difference between corticosteroids and control on all-cause mortality (RR 0.89; 95% CI 0.79 to 1.00; p = 0.05) ( Fig 2 , S4 Table ). Fixed-effect meta-analysis showed evidence of a beneficial effect of corticosteroids versus control on all-cause mortality (RR 0.88; 95% CI 0.82 to 0.95; p = 0.00) ( S1 Fig ). Visual inspection of the forest plot and measures to quantify heterogeneity (I 2 = 23.1%) indicated no substantial heterogeneity. The time-points of assessment varied from 21 [ 87 ] to 30 days after randomization [ 96 , 116 ]. The trial sequential analysis showed that we did not have enough information to confirm',\n",
       " ('COVID-19',\n",
       "  74,\n",
       "  14): 'or reject that corticosteroids versus control reduce the risk of all-cause mortality with a relative risk reduction of 20% ( Fig 3 ). The subgroup analysis assessing the effects of the different corticosteroids versus control showed no significant subgroup differences (p = 0.57) ( Fig 2 ). The subgroup analysis assessing the effects of disease severity as defined by trialists (mild, moderate, severe, or a combination) showed no significant subgroup differences (p = 0.42) ( S2 Fig ). We identified 10 trials (11 comparisons) randomizing 7,918 participants to corticosteroids versus standard care [ 51 , 55 , 86 , 88 , 95 – 98 ] or placebo [ 67 , 87 ]. One trial was assessed at low risk of bias [ 87 ]. The remaining trials were assessed at high risk of bias ( S3 Table ). Five trials assessed the effects of methylprednisolone [ 55 , 67 , 95 – 97 ], three trials assessed the effects of dexamethasone [ 51 , 86 , 98 ], and two trials (three comparisons) assessed the effects of hydrocortisone [ 87 , 88 ]. One trial assessing the effects of methylprednisolone was not eligible for meta-analysis, as approximately half of the participants in the experimental group were non-randomized [ 55 ]. We contacted the trial authors and asked for separate data for all randomized participants, but did not receive any response. Another trial assessing the effects of methylprednisolone was not eligible for meta-analysis, as the trial did not report on any of our review outcomes [ 95 ]. We requested data for our review outcomes from the trial authors but did not receive a response. The maximum follow-up time ranged from five [ 33 , 34 ] to 60 days [ 89 , 98 ] after randomization. For several of our outcomes it was not possible to conduct meta-analysis due to insufficient data. The remaining trial comparisons included: favipiravir versus umifenovir [ 32 ]; umifenovir versus lopinavir-ritonavir [ 39 ]; umifenovir versus standard care [ 39 ]; novaferon versus novaferon plus lopinavir-ritonavir [ 44 ]; novaferon plus lopinavir-ritonavir versus lopinavir-ritonavir [ 44 ]; novaferon versus lopinavir-ritonavir [ 44 ]; alpha lipotic acid versus placebo [ 45 ]; baloxavir marboxil versus favipiravir [ 40 ]; baloxavir marboxil versus standard care [ 40 ]; triple combination of interferon beta-1b plus lopinavir-ritonavir plus ribavirin versus lopinavir-ritonavir [ 37 ]; remdesivir for 5 days versus remdesivir for 10 days [ 36 ]; high-flow nasal oxygenation versus standard bag-valve oxygenation [ 43 ]; hydroxychloroquine versus chloroquine [ 47 ]; chloroquine versus standard care [ 47 ]; high dosage chloroquine diphosphate versus low dosage chloroquine diphosphate [ 49 ]; hydroxychloroquine plus azithromycin versus standard care [ 53 ]; triple combination of darunavir plus cobicistat plus interferon alpha-2b versus interferon alpha-2b [ 60 ]; lopinavir-ritonavir plus interferon alpha versus ribavirin plus interferon alpha [ 60 ]; ribavirin plus lopinavir-ritonavir plus interferon alpha versus ribavirin plus interferon alpha [ 60 ]; ribavirin plus lopinavir-ritonavir plus interferon alpha versus lopinavir-ritonavir plus interferon alpha [ 60 ]; lincomycin versus azithromycin [ 61 ]; 99-mTc-methyl diphosphonate (99mTc-MDP) injection versus standard care [ 62 ]; interferon alpha-2b plus interferon gamma versus interferon alpha-2b [ 63 ]; telmisartan versus standard care [ 65 ]; avifavir 1800/800 versus avifavir 1600/600 [ 66 ]; dexamethasone plus aprepitant versus dexamethasone [ 68 ]; anti-C5a antibody versus standard care [ 69 ]; azvudine versus standard care [ 72 ]; human plasma-derived C1 esterase/kallikrein inhibitor versus standard care [ 71 ]; icatibant acetate versus standard care [ 71 ]; icatibant acetate versus human plasma-derived C1 esterase/kallikrein inhibitor [ 71',\n",
       " ('COVID-19',\n",
       "  74,\n",
       "  15): ']; pulmonary rehabilitation program versus isolation at home [ 70 ]; auxora (calcium release-activated calcium channel inhibitors) versus standard care [ 73 ]; umbilical cord stem cell infusion versus standard care [ 74 ]; vitamin C versus placebo [ 75 ]; sofosbuvir plus daclatasvir versus standard care [ 79 ]; sofosbuvir plus daclatasvir plus ribavirin versus hydroxychloroquine plus lopinavir-ritonavir with or without ribavirin [ 78 ]; interferon beta-1b versus standard care [ 80 ]; calcifediol versus standard care [ 83 ]; recombinant human granulocyte colony–stimulating factor versus standard care [ 84 ]; intravenous and/or nebulized electrolyzed saline with dose escalation versus standard care [ 99 ]; nasal irrigation with hypertonic saline plus surfactant versus no intervention [ 100 ]; nasal irrigation with hypertonic saline plus surfactant versus nasal irrigation with hypertonic saline [ 100 ]; nasal irrigation with hypertonic saline versus no intervention [ 100 ]; triazavirin versus placebo [ 101 ]; N-acetylcysteine versus placebo [ 102 ]; tocilizumab versus favipiravir [ 113 ]. The identified trials compared the following interventions: 10 trials compared corticosteroids versus standard care [ 51 , 55 , 86 , 88 , 95 – 98 ] or placebo [ 67 , 87 ]; four trials compared remdesivir versus standard care [ 85 , 109 ] or placebo [ 42 , 64 ]; 13 trials compared hydroxychloroquine versus standard care [ 33 , 34 , 41 , 47 , 53 , 54 , 57 , 58 , 104 , 109 ], or placebo [ 52 , 107 ]; five trials compared lopinavir-ritonavir versus standard care [ 3 , 39 , 105 , 109 ] or a co-intervention alone [ 44 ]; two trials compared interferon beta-1a versus standard care [ 35 , 109 ]; four trials compared convalescent plasma versus standard care [ 38 , 50 , 77 , 90 ]; three trials compared azithromycin versus standard care [ 82 ] or co-interventions with standard care [ 53 ] or without standard care [ 81 ]; three trials compared colchicine versus standard care [ 48 ], placebo plus standard care [ 91 ], or placebo plus a co-intervention [ 106 ]; two trials compared immunoglobulin versus standard care [ 56 ] or placebo [ 94 ]; six trials compared tocilizumab versus standard care [ 92 , 110 – 112 ], placebo with standard care [ 89 ] or favipiravir alone as co-intervention [ 113 ];two trials compared bromhexine versus standard care [ 93 , 103 ]; and three trials compared favipiravir versus standard care [ 40 , 66 ] or a co-intervention alone [ 113 ]. On November 2, 2020 our literature searches identified 15,359 records after duplicates were removed. We included a total of 82 clinical trials randomizing 40,249 participants ( Fig 1 ) [ 31 – 113 ]. We identified several trials including participants suspected of COVID-19 [ 114 , 115 ]. None of these trials reported separate data on COVID-19 positive participants compared to the remaining participants. We included trials if approximately 50% or more participants had a confirmed COVID-19 diagnosis. We wrote to all authors requesting separate data on COVID-19 confirmed participants, but we have received no responses yet. For at detailed overview of excluded trials, see S1 Table . Discussion We conducted the second edition of our living systematic review assessing the beneficial and harmful effects of any intervention for COVID-19. We searched relevant databases and websites for published and unpublished trials until November 2, 2020. We included a total of 82 trials randomizing 40,249 participants. Our present study showed that no evidence-based treatment for COVID-19 currently exists. Very low certainty',\n",
       " ('COVID-19',\n",
       "  74,\n",
       "  16): 'evidence indicated that corticosteroids might reduce the risk of death, serious adverse events, and mechanical ventilation. Moderate certainty evidence showed that we could reject that remdesivir reduces the risk of death by 20%. Very low certainty evidence indicated that remdesivir might reduce the risk of serious adverse events. Very low certainty evidence indicated that intravenous immunoglobin might reduce the risk of death and serious adverse events, that tocilizumab might reduce the risk of serious adverse events and mechanical ventilation, and that bromhexine might reduce the risk of non-serious adverse events. Moderate certainty evidence showed that we could reject that hydroxychloroquine reduces the risk of death and serious adverse events by 20%, and that we could reject that lopinavir-ritonavir reduces the risk of death, serious adverse events, and risk of mechanical ventilation by 20%. Otherwise, we could neither confirm nor reject the effects of other interventions for COVID-19. More trials with low risks of bias and random errors are urgently needed. For several interventions we found a large number of currently ongoing trials. The present review concludes that no evidence-based treatment currently exists for COVID-19. Previous studies [116–118] including our first edition of the present review [118] have concluded that both corticosteroids and remdesivir showed promising results. Since our last edition, we have included 49 more trials randomizing 26.937 more participants, and we therefore have more information, causing this difference. One previous systematic review published in JAMA assessed the association between corticosteroids and 28-day all-cause mortality and concluded that corticosteroids are effective for treating critically ill patients with COVID-19 in reducing all-cause mortality [116]. However, the conclusions of this review are limited to critically ill patients. This review assessed the certainty of evidence for all-cause mortality to be moderate, while we assessed the certainty of evidence to be very low (see S4 Table). Our present results showed a discrepancy between the random-effects meta-analysis result and the fixed-effect meta-analysis result (due to heterogeneity) of corticosteroids versus control interventions when assessing all-cause mortality, i.e., the fixed-effect meta-analysis indicated a more beneficial effect of corticosteroids. Due to the discrepancy between the random-effects and the fixed-effect model we believe that these results should be interpreted with great caution considering the uncertainty of the evidence. Furthermore, the meta-analytic effect estimate was 0.89 which may be considered relatively small. The U.S. Food and Drug Administration (FDA) recently approved remdesivir for use in adult and pediatric patients 12 years of age and older for the treatment of COVID-19 requiring hospitalization [119]. Based on the current evidence, we conclude that remdesivir is not effective in reducing all-cause mortality, neither for patients not requiring oxygen nor for patients requiring oxygen or respiratory support at baseline. There was a discrepancy between the random-effects and the fixed-effect meta-analysis (due to heterogeneity) of remdesivir versus control on serious adverse events, i.e., the fixed-effect meta-analysis indicated a more beneficial effect of remdesivir. Due to the discrepancy between the random-effects and the fixed-effect model we believe that these results should be interpreted with great caution considering the uncertainty of the evidence. On all other outcomes when assessing the effects of remdesivir, we conclude that more information is needed to confirm or reject the effects of remdesivir. Hence, the clinical effects of remdesivir are unclear based on current evidence. Our results are similar to the results of a preprint of an international collaborative meta-analysis of randomized clinical trials assessing mortality outcomes with hydroxychloroquine and chloroquine for participants with COVID-19 [120]. This review included some unpublished data [120]. We have contacted the trialists of the trials that provided unpublished data for this review, but we have not',\n",
       " ('COVID-19',\n",
       "  74,\n",
       "  17): 'received any data yet. Nevertheless, our conclusions that hydroxychloroquine does not reduce mortality in COVID-19 patients are the same [120]. Although we could exclude an intervention effect at 20% or above for most of our interventions with our trial sequential analyses, we did not assess smaller and still worthwhile intervention effects. If patients and investigators feel that such smaller intervention effects are worth pursuing, then we recommend the conduct of trials with much larger sample sizes than the ones we have identified in the present systematic review. That will require more national and international collaboration [121]. Our living systematic review has a number of strengths. The predefined methodology was based on the Cochrane Handbook for Systematic Reviews of Interventions [11], the eight-step assessment suggested by Jakobsen et al. [17], and trial sequential analysis [22]. Hence, this review considers both risks of systematic errors and risk of random errors. Another strength is the living systematic review design, which allows us to continuously surveil and update the evidence-base of existing interventions for treatment of COVID-19 resulting in a decreased timespan from publication of our results to optimization of clinical practice. This is particularly important in this international health-care crisis, where a large number of new randomized clinical trials are continuously registered and published. Our living systematic review also has limitations. First, the primary limitation is the paucity of trials currently available, and the results from most current meta-analyses are of low or very low certainty. This must be considered when interpreting our meta-analysis results. Second, the trials that we included were all at risks of systematic errors so our results presumably overestimate the beneficial effects and underestimate the harmful effects of the included interventions [122–129]. Third, it was not relevant to perform individual patient data meta-analyses, network-meta-analysis, or several of the planned subgroup analyses due to lack of relevant data. We contacted all trial authors requesting individual patient data, but until now we only received five datasets [37, 68, 78, 79, 106]. We did not perform network meta-analysis because the ranking of the interventions is not unclear, i.e., no evidence-based intervention currently exits for COVID-19. Fourth, we included ‘time to clinical improvement’ as an outcome post hoc. We did not initially plan to assess ‘time to clinical improvement’ [8] because this outcome is poorly defined and if outcome assessors are not adequately blinded, assessments of ‘improvement’ may be biased. Furthermore, time to clinical improvement is not one of the most patient-important outcomes. As an example, most patients would rather survive without complications than recover a few days sooner. Fifth, the included trials assessed the outcomes at different time points, which might contribute to increased heterogeneity. Sixth, some data are included from preprints, and these might be subject to change following peer-review. Therefore, some results, bias risk assessments, and GRADE summaries might change in later editions of this living systematic review following inclusion of the published peer-reviewed manuscripts. Seventh, we follow our protocol [8] as well as Cochrane Handbook for Systematic Reviews of Interventions [11], and hence, we only consider formal tests for publication bias when approximately more than 10 trials are included in a meta-analysis. Therefore, we have not performed such analysis in the present edition of the review. We have identified two reviews that are comparable to our present project [117, 130]. The first is a network meta-analysis published in BMJ [117]. However, that review only includes drug treatments for COVID-19, does not include individual patient data meta-analyses, and does not use trial sequential analysis or similar methods to handle problems with multiplicity (repeating updating of meta-analysis, multiple comparisons due to',\n",
       " ('COVID-19',\n",
       "  74,\n",
       "  18): 'inclusion of multiple interventions, assessing multiple outcomes). Therefore, the conclusiveness of the presented evidence in that review is unclear. The second project is a living mapping of ongoing randomized clinical trials with network meta-analysis on all interventions for COVID-19 [130]. The authors are producing and disseminating preliminary results through an open platform [130]. This review includes both prevention and treatment and does not use trial sequential analysis or similar methods to handle problems with multiplicity [8]. Therefore, the conclusiveness of the presented evidence is unclear. Our assessment of the certainty of the evidence primarily concerning the effects of corticosteroids and remdesivir was lower compared to the two above-mentioned similar projects. These discrepancies are primarily caused by the described differences in choice of review methods.',\n",
       " ('COVID-19',\n",
       "  75,\n",
       "  0): 'Объявлены официальные наименования вируса, вызывающего заболевание COVID‑19 (ранее известный как «новый коронавирус 2019 г.»), и соответствующего заболевания. Официальные наименования: Заболевание коронавирусная инфекция (COVID-19) Вирус коронавирус тяжелого острого респираторного синдрома‑2 (SARS-CoV-2) Почему заболевание и вирус по-разному называются? Нередко наименования вирусов и вызываемых ими заболеваний не совпадают. Например, вирус ВИЧ вызывает СПИД. Людям часто бывает известно наименование заболевания, например, «корь», а не соответствующего вируса (rubeola). Присвоение названий вирусам и заболеваниям происходит различным образом и для различных целей. Наименования вирусов основаны на их генетической структуре, что упрощает разработку диагностических тестов, вакцин и лекарственных препаратов. Эту работу проводят вирусологи и другие представители научной общественности, поэтому наименования вирусам присваивает Международный комитет по таксономии вирусов (ICTV). Наименования заболеваний требуются для того, чтобы давать характеристику различным аспектам профилактики, распространения, передачи, тяжести течения, а также лечения заболеваний. Задачей ВОЗ является обеспечение готовности и реагирования на заболевания человека, в связи с чем ВОЗ указывает официальные наименования заболеваний в Международной классификации болезней (МКБ). Одиннадцатого февраля 2020 г. Международный комитет по таксономии вирусов присвоил новому вирусу наименование SARS-CoV-2 (коронавирус тяжелого острого респираторного синдрома‑2). Данное название выбрано по причине того, что этот вирус имеет генетическое родство с возбудителем вспышки ТОРС в 2003 г. Это разные вирусы, хотя они и связаны генетически. Согласно рекомендациям, разработанным ранее совместно со Всемирной организацией по охране здоровья животных (МЭБ), а также Продовольственной и сельскохозяйственной организацией Объединенных Наций (ФАО), 11 февраля 2020 г. ВОЗ объявила о присвоении данному заболеванию названия «COVID‑19». Каким наименованием этого вируса пользуется ВОЗ? Работа по присвоению названий вирусу и заболеванию проходила на фоне тесного сотрудничества ВОЗ и Международного комитета по таксономии вирусов.С точки зрения информирования о рисках использование наименования «ТОРС» может повлечь за собой неоправданные последствия в смысле создания тревожных настроений в некоторых группах населения, в особенности, в Азии, регионе, больше всего пострадавшем от вспышки ТОРС в 2003 г. По этой и другим причинам ВОЗ приняла решение в публичной сфере называть вирус «вирусом, вызывающим COVID‑19» или «коронавирусной инфекцией COVID‑19». Ни одно из этих наименований не заменяет официального названия вируса, присвоенного Международным комитетом по таксономии вирусов. Во избежание несогласованности за исключением необходимых случаев в материалы, опубликованные до момента присвоения вирусу официального названия, изменений вноситься не будет. Дополнительная информация:',\n",
       " ('COVID-19',\n",
       "  76,\n",
       "  0): '3.1. Search results We found a total of 2699 studies in the initial literature search. Of them, 2671 papers were excluded because they did not meet our inclusion criteria. Eventually, 28 studies were included in our scoping review, 10 clinical trials [5,11–19], three retrospective cohort studies [20–22] and 15 case series studies [1,2,23–35]. Figure 1 summarizes the search process. Figure 1. Open in a new tab Flowchart describing the literature search process. The treatments approached in these papers included hydroxychloroquine (HCQ), convalescent plasma transfusion, antiviral drug (lopinavir/ritonavir), corticosteroids, traditional Chinese medicine, anticoagulant therapy in patients with coagulopathy, lung transplantation and combined/non-specific treatments. We presented the baseline and summary of the included studies in Tables 2 and 3, respectively. Table 2. Summary of the included studies. Study ID Study design Population Intervention Sample size Duration of treatment Main findings Cao et al. [13] Randomized open-label clinical trial Patients with severe COVID-19 infection Lopinavir–ritonavir with standard care against standard care alone 199 28 d Lopinavir–ritonavir treatment was stopped early in 13 patients (13.8%) because of adverse events. In hospitalized adult patients with severe COVID-19, no benefit was observed with lopinavir–ritonavir treatment beyond standard care Tang et al. [14] Randomized open-label clinical trial Patients with COVID-19 infection Hydroxychloroquine With standard care 150 28 d The administration of hydroxychloroquine did not result in a higher negative conversion rate but it results in more alleviation of clinical symptoms of the patients Chen et al. [15] Randomized open-label clinical trial Patients infected with COVID-19 Hydroxychloroquine and standard treatment 62 24 d Hydroxychloroquine could significantly shorten time to clinical recovery and promote the absorption of pneumonia Cai et al. [18] Randomized open-label clinical trial Patients infected with COVID-19 Favipiravir against Lopinavir and ritonavir with IFN-α by aerosol inhalation 80 15 d Favipiravir showed a better treatment effects in terms of disease progression and viral clearance than lopinavir and ritonavir Gautret et al. [5] Non-randomized open-label clinical trial Patients with COVID-19 infection Hydroxychloroquine and azithromycin, was added to treatment depending on their clinical presentation 36 16 d Hydroxychloroquine treatment is significantly associated with viral load reduction/disappearance and its effect is reinforced by azithromycin Chen et al. [17] Pilot clinical trial Patients with COVID-19 infection Hydroxychloroquine sulphate treatment against control group 60 7 d Moderate patients prognosis was good and future studies a better endpoint Runan et al. [15] Pilot clinical trial Patients COVID-19 pneumonia Triple treatment group: interferon a-2b, arbidol and, lopinavir/ritonavir against double treatment group: interferon a-2b and lopinavir/ritonavir 237 24 d The earlier the three-drug combination antiviral treatment time, the faster the viral nucleic acid negative time Leng et al. [11] Pilot clinical trial Patients with COVID-19 infection with no improvement signs were observed under the standard treatments. Mesenchymal stem cells (MSCs) transplantation against placebo 10 25 d The pulmonary function and symptoms of all patients were significantly improved in two days after MSC transplantation. Treatment was safe and effective Ye et al. [12] Pilot clinical trial Patients with COVID-19 infection. Lopinavir/ritonavir with adjuvant drugs against control patients that received adjuvant drugs only 47 14 d Combination of LPV/ritonavir and adjuvant drugs has a more evident therapeutic effect than pneumonia-associated adjuvant drugs alone Jun et al. [19] Pilot clinical trial Patients with common COVID-19 infection Hydroxychloroquine sulphate along with standard treatment 30 20 d It is difficult to determine the effect of the treatment plan in the study of the main endpoint of the virus conversion rate and the critical rate Tang et al. [20] Cohort study (retrospective) Patients with coagulopathy combined with severe COVID-19 infection Anticoagulant therapy using low molecular weight heparin 449 7–28 d',\n",
       " ('COVID-19',\n",
       "  76,\n",
       "  1): 'Anticoagulant therapy mainly with low molecular weight heparin appears to be associated with better prognosis in severe COVID-19 patients meeting SIC criteria or with markedly elevated D-dimer Jun et al. [21] Cohort study (retrospective) Patients with COVID-19 infection First group: interferon α2b, lopinavir and ritonavir against Second group that received interferon α2b and abidor, third group: interferon α2b and any antiviral drugs 134 17 d It has not been found that lopinavir ritonavir and abidor have the effect of improving symptoms or shortening the negative time of viral nucleic acid in respiratory specimens Zha et al. [20] Cohort study (retrospective) Patients infected with the acute COVID-19 infection Corticosteroid with standard care 31 26 d No association between corticosteroid therapy and outcomes in patients without acute respiratory distress syndrome Wang et al. [28] Case series (retrospective) Patients, two mild and two severe COVID-19 pneumonia Lopinavir/ritonavir (Kaletra®), arbidol and Shufeng Jiedu Capsule (SFJDC), a traditional Chinese medicine 4 6–15 d All patients were improved. The efficacy of antiviral treatment including lopinavir/ritonavir, arbidol and SFJDC warrants further verification in future study Grein et al. [26] Case series (retrospective) Patients with COVID-19 Remdesivir, 200 mg on day one then 100 mg daily in the following nine days 61 Median 18 d Randomized clinical trials are required to measure the efficacy of remdesivir Gautret et al. [27] Case series (retrospective) Patients with COVID-19 infection Hydroxychloroquine and azithromycin combination 80 6–17 d Hydroxychloroquine associated with azithromycin is effective in the treatment of COVID-19 infection Liu et al. [2] Case series (retrospective) Patients with COVID-19 infection Immunoglobulin G, corticosteroids with standard care 137 57 d Systemic corticosteroid treatment did not show significant benefits Wang et al. [1] Case series (retrospective) Patients with COVID-19 pneumonia Arbidol with standard care 69 14 d Arbidol treatment showed tendency to improve the discharging rate and decrease the mortality rate Dan et al. [33] Case series (retrospective) Patients mild and severe COVID-19 pneumonia Respiratory support, lopinavir, ritonavir, and abidor, moxifloxacin, cefoperazone, linezolid, imipenem, cilastatin, moxifloxacin, glucocorticoids 30 – Most of the patients were improved Shi et al. [34] Case series (retrospective) Patients with mild or severe COVID-19 pneumonia Abidor, peramivir, ribavirin, oseltamivir phosphate, glucocorticoid therapy, immunoglobulin and albumin therapy 109 – Treatment can improve prognosis and reduce mortality Luo et al. [31] Case series (retrospective) Patients with moderate and severe COVID-19 pneumonia Tocilizumab therapy 15 39 d Tocilizumab appears to be an effective treatment option in COVID-19 patients with a risk of cytokine storms. For critically ill patients with elevated IL-6, repeated dose of the TCZ is recommended Zheng et al. [23] Case series (retrospective) Paediatric patients with COVID-19 infection Interferon, oseltamivir, cefoperazone/sulbactam, interferon, mechanical ventilation, systematic corticosteroids and intravenous immunoglobulin 25 – The symptoms on admission were alleviated 96% of the patients Duan et al. [25] Case series (retrospective) Paediatric patients with mild/asymptomatic COVID-19 pneumonia Interferon, oseltamivir, ribavirin, lopinavir/ritonavir, gamma globulin antibiotics, Chinese medicine 31 – Given general treatment, the overall prognosis is good in the near future Sun et al. [24] Case series (retrospective) Severe or critically ill paediatric patients with COVID-19 pneumonia Symptomatic treatment and respiratory support, (virazole, oseltamivir and interferon) to all patients. Depending on patients’ conditions, intravenous glucocorticoids and immunoglobulin, traditional Chinese medicine was given 8 32 d Most of the patients were improved and discharged Zhang et al. [29] Case series (prospective) Critically ill patients with COVID-19 Convalescent plasma transfusion with standard care 4 18–46 d Plasma reduce the relative risk of mortality of patients Shen et al. [30] Case series (prospective) Critically ill patients of COVID 19 infection with ARDS Convalescent Plasma transfusion with standard',\n",
       " ('COVID-19',\n",
       "  76,\n",
       "  2): 'care 5 10–22 d Convalescent plasma containing neutralizing antibody was followed by improvement in the clinical status Chen et al. [32] Case series (prospective) Patients with pulmonary fibrosis related to acute respiratory distress syndrome due to COVID-19 Lung transplantation 3 30 d Lung transplantation can be performed in end-stage patients with respiratory failure due to COVID-19-related pulmonary fibrosis Wang et al. [35] Case series (prospective) Patients with COVID-19 infection Tissue plasminogen activator (tPA) treatment with standard care 3 – The observed improvements were transient and lost over time after completion of their tPA infusion. Further studies needed to confirm the results Open in a new tab Table 3. Baseline characteristics of the included studies. Study ID Location Group Sample size Age Median (IQR) Mean ± SD Range Gender Male (%) Primary clinical diagnosis Fever % Cough% Dyspnoea WBC (109/L) Lymph (109/L) CRP (mg/dl) IL-6 (ng/L) Ct values Chest CT score Cao et al. [13] China Treatment 99 58.0 (50.0–68.0) 61.6% 89% – − 7.3 (5.3–9.6) 0.8 (0.6–1.4) – – – – Control 100 58.0 (48.0–68.0) 59.0% 93% – – 6.9 (4.9–9.1) 0.9 (0.5–1.2) – – – – Tang et al. [14] China Treatment 75 48.0 ± 14.1 56.0% 59.70% 51.50% 22.10% 5.59 ± 1.90 1.46 ± 0.60 9.9 ± 13.30 12.90 ± 36.30 – – Control 75 44.1 ± 15.0 53.3% 53.30% 38.20% 5.90% 5.60 ± 1.80 1.60 ± 0.50 7.4 ± 12.80 8.90 ± 13.00 – – Chen et al. [16] China Treatment 31 44.1 ± 16.1 45.2% 70.90% 70.10% – – – – – – Control 31 45.2 ± 14.7 48.3% 54.80% 48.40% – – – – – – – Cai et al [18] China Treatment 35 43 (35.5–59) 40.0% 62.9% 34.3% – 8.1 (3.8–6.6) 1.5 (1.0–1.8) 15.0 (3.0–19.2) 14.0 (3.5–11.0) 30.7 (21.2–37.0) 12(4.0–14.0) Control 45 49 (36–61) 46.7% 82.2% 22.2% – 4.3 (3.4–4.9) 1.2 (0.9–1.4) 21.4 (5.0–23.2) 12.9 (5.3–16.8) 29 (18.8–38.0) 10 (4.5–13.5) Gautret et al. [5] France Treatment 20 51.2 ± 18.7 45.0% – – – – – – – – – Control 16 37.3 ± 24.0 37.5% – – – – – – – – – Chen et al. [17] China Treatment 30 50.5 ± 3.8 60.0% 60.0% – – 5.20 (3.90–6.70) 1.11 ± 0.43 – – – – Control 30 46.7 ± 3.6 40.0% 86.70% – − 4.90 (4.50–7.40) 1.18 ± 0.55 – – – – Runan et al. [15] China Treatment 196 45.7 ± 17 53.1% – – − 5.1 (4.1–6.4.0) − 11.8 (3.1–25.8) – – – Control 41 45.1 ± 16.7 58.5% – − 4.2 (3.2–7.0) − 8.1 (2.9–23.0) – – – – Leng et al. [11] China Treatment 7 57.0 ± 7.70 57.1% 85.7% 71.5 71.4% − − − − − − Control 3 65.0 ± 16.47 0 % 33.3% 33.3 66.7% − − − − − − Ye et al. [12] China Treatment 42 – 50.0 % − − − − − − − − − Control 5 – 20.0% − − − − − − − − − Jun et al. [19] China Treatment 15 50.5 ± 3.8 60% 60% – − 1.11 ± 0.43 − − − − − Control 15 46.7 ± 3.6 80% 86.7% – − 1.18 ± 0.55 − − − − − Tang et al. [22] China Survivors 315 63.7 ± 12.2 78.0% − − − − − − − − − Non-survivors 134 68.7 ± 11.4 48.9% − − − − − − − − − Jun et al. [21] China Treatment 52 47 (35–60) 51.9% 92.3% 19.2% 1.9% 5.0 (3.7–5.66) 1.24 (0.93–1.56) 9.5 (0–26.8) − − − Comparison 34 44 (34–62) 52.9%',\n",
       " ('COVID-19',\n",
       "  76,\n",
       "  3): '91.1% 32.4% 0% 4.18 (3.44–5.19) 1.04 (0.72–1.33) 10.9 (4.0–25.2) − − − control 48 55 (36–62) 50.0% 95.8% 22.9% 8.3% 5.09 (4.10–6.30) 1.23 (0.85–1.57) 19.5 (7.6 36.6) − − − Zha et al. [20] China Treatment 20 37 (27–52) 60% 70% 40% 5% – – – – – – Control 11 53 (36–57) 73% 100% 100% 27% – – – – – – Wang et al. [28] China Treatment 4 44 (19–63) 75% 100% 75% 50% − 6.17 (4.4–10.84) – – – 50% Grein et al. [26] Data collected from different countries Treatment 61 64 (48–71) 75% – – – – – – – – – Gautret et al. [27]. France Treatment 80 52.5 (42–62) 52.5 15% 58.8% – – – − – 23.6 ± 4.3 – Liu et al. [2] China Treatment 137 57 (20–83) 44.5% 48.3% 48.2% 19% 43.8% 27.7% 83.9% – – – Wang et al. [1] China Treatment 69 42 (35–62) 46% 44.0% 55.0% 29.0% 3.82 (2.98–5.57) 1.15 (0.82–1.46) 13.2 (6.78–49) 8.54 (4.68–20.58) 9.0% – Dan et al. [33] China Treatment 30 43 (21–72) 60% – – – – – – – – – Shi et al. [34] China Treatment 109 52.5 ± 10.8 44% 95.5% 86.5% 21.3% − 53.2% 79.8% − 24.8% – Luo et al. [31] China Treatment 15 73 (62–80) 80% – – – – – – – – – Zheng et al. [23] China Treatment 25 3 (2–9) 56% 52.0% 44.0% 8.0% 6.2 (4.30–9.85) 2.19 (1.15–3.31) 14.5 (0.93–25.04) − 68.0% – Duan et al. [25] China Treatment 31 7 (0.5–17) – 65% 45% – − 6% 10% – – – Sun et al. [24] China Treatment 8 3 (0.6–15) 75% 75% 75% – − 8.10 (1.5–14.95) 25.8 (0.5 − 103) 10.07 (63.99–2.92) – – Zhang et al. [29] China Treatment 4 57 (31–73) 50% – – – – – – – – – Shen et al. [30] China Treatment 5 54 (36–73) 60% 80% – – – − 130.62 (65–242.8) − 25.52 (18.9–38.0) – Chen et al. [32] China Treatment 3 66 (58–73) 100% – – − – 0.56 (0.41–0.7) – – – – Wang et al. [35] China Treatment 3 61 (49–75) 67% 100% 100% 67% – – – – – – Open in a new tab 3.1.1. Hydroxychloroquine Jun et al. performed a pilot clinical trial on 30 cases with common COVID-19 infection, mean age ± SD (50.5 ± 3.8, 46.7 ± 3.6) for the treatment group, and control group, respectively. The treatment group received HCQ sulphate (400 mg, once per day for five days) plus standard treatment while the control group received only the standard care which is bed rest, oxygen inhalation, antiviral drugs as alpha-interferon nebulization, oral lopinavir/ritonavir and antibiotics (if recommended). The drug was ceased for one patient that became a severe case. 86.7% of the treatment group and 93.3% had negative viral pharyngeal swabs on the seventh day. For radiological imaging, 33.3% of the treatment group and 46.7% in the control group improved on day three of enrolment. Following re-examination, the lesions were improved in all patients. The study concluded that a larger sample size study is needed to investigate the effects of HCQ in the treatment of COVID-19 and it is difficult to determine the effect of the treatment plan on the main endpoint of the virus conversion rate and the critical rate [17]. In an open-label non-randomized clinical trial 42 patients above 14 years of age and RT-PCR, which is the most powerful tool in virus detection [36,37], positive in patients with nasopharyngeal swab were enrolled in the study. Of the 42 patients who',\n",
       " ('COVID-19',\n",
       "  76,\n",
       "  4): 'met the inclusion criteria, six missed follow-up and 36 were enrolled in the study. Out of the 36, 16 were group controlled, and 20 were a group of HCQ-treated patients. Of 36 patients, 15 were male (41.7%), averaging 45.1 years of age. The proportion of asymptomatic patients was 16.7%, 61.1% of patients with symptoms of upper respiratory tract infection, and 22.2% of patients with symptoms of lower respiratory tract infection. All patients with symptoms of lower respiratory tract infection had confirmed pneumonia on a computerized tomography (CT) scan. Patients treated with HCQ were older than those with control (51.2 years vs. 37.3 years). At post-inclusion day 6, 70% of patients treated with HCQ were recovered compared to 12.5% in the control group (p=.001). At day 6 post-inclusion, 100% of patients treated with a combination of HCQ and azithromycin were recovered compared to 57.1% of patients treated with HCQ alone and 12.5% in the control group (p<.001). By comparison, at day eight of postinclusion, one patient under a combination of HCQ and azithromycin, who tested negative on day six post inclusion, was tested positive at low titre. Thus, the treatment of hydroxy chloroquine in COVID-19 patients is significantly correlated with viral load reduction/disappearance, and its effect is enhanced by azithromycin [5]. A recent randomized clinical trial on 62 patients with mean age ± SD (44.7 ± 15.3) patients in the treatment group received standard care with HCQ in addition to HCQ sulphate and the control group received only standard care. For time to clinical recovery, the body temperature recovery time and the cough remission time were significantly shortened in the hydroxy treatment group. Additionally, 80.6% of the treatment group showed a significant clinical improvement of pneumonia compared with the control group (54.8%). Thus, HCQ could significantly shorten time to clinical recovery and promote the absorption of pneumonia [16]. Gautret et al. conducted a retrospective data analysis on 80 patients with COVID-19 infection with age range (18–88 years) who received HCQ in combination with azithromycin for at least three days and a follow-up period of at least six days. Their results showed that 81.3% of the patients had improved outcomes, qPCR test was negative in 93% of the total patients on day eight, and was discharged, 15% required oxygen therapy, 3.75% were transferred to the ICU and finally one patient dead. This study showed that HCQ associated with azithromycin is effective in the treatment of COVID-19 infection [27]. A larger open-label randomized clinical trial conducted on 150 patients with COVID-19, mean age ± SD (46.1 ± 14.7 years). The patients were assigned in two groups, an experimental group which received HCQ as long as standard care (provision of intravenous fluids, supplemental oxygen, normal laboratory testing, and COVID-19 test, hemodynamic monitoring and intensive care and the potential to supply concomitant medications) and a control group received standard care only. Hydroxychloroquine is efficient to ease the symptoms when confounding factors of anti-viral agents were removed in the post hoc analysis. Furthermore, CRP in the control group in much greater than the treatment group (6.986 in standard care and HCQ group vs. 2.723 in the control group, mg/L). Besides, there is a rapid recovery of lymphopenia. Adverse events were found in 8.8% of control individuals and 30% of HCQ recipients with two serious adverse events. The most common adverse event in the treatment group was diarrhoea (10%). Furthermore, the administration of HCQ did not result in a higher negative conversion rate but more alleviation of clinical symptoms than standard care only alone in patients hospitalized with COVID-19 without receiving antiviral treatment, possibly through anti-inflammatory effects',\n",
       " ('COVID-19',\n",
       "  76,\n",
       "  5): '[14]. 3.1.2. Convalescent plasma In a case serious study that included critically ill patients with a laboratory-confirmed COVID-19 (age 36–65 years), out of them, two patients were women. Inclusion criteria were severe pneumonia with rapid progression, high viral load despite the use of antiviral and mechanical ventilation. They received mechanical ventilation at the time of treatment, and all participants received antiviral agents and methylprednisolone. All patients received transfused with convalescent plasma. In four out of five patients following plasma transfusion, temperature normalized. Viral loads also decreased and were negative within 12 days of transfusion, and following transfusion, COVID-19-specific ELISA and neutralizing antibody titres increased (range, 40–60 before and 80–320 on day seven). ARDS was resolved 12 days after transfusion in four patients, and three patients were removed from mechanical ventilation within two weeks of treatment. Of the five patients, three have been discharged from the hospital, and two are in stable condition at 37 days after transfusion. Thus, the convalescent plasma administration improved the clinical outcome of critically ill patients with COVID-19 and ARDS [30]. Also, in another case series study of four cases of critically ill patients with COVID-19. Three of them developed severe ARDS despite being treated by arbidol, lopinavir–ritonavir, interferon-alpha inhalation and other supportive therapies. One case experienced septic shock, and she was given a whole of 900 mL O-compatible convalescent plasma was transfused to the patient in three batches; the first batch was given at 8 AM on the 17th of February (200 mL), the 2nd one was at 8 AM on the 27th of February (400 mL) and the closing one was at 8 AM on the 28th of February (300 mL). The virus load of the patient on the 18th of February was 55 × 105 copies/mL, which appreciably reduced to 3.9 × 104 copies/mL on the 28th of February, and besides reduced to 180 copies/mL on 5th of March. The patient was extubated on 3rd March, CT scan shows persistent absorption of consolidation. RT-PCR of oropharyngeal swab done on 9th and 10th of March were negative for COVID-19. The patient was discharged on the 13th of March. Another case developed ARDS and was given non-invasive mechanical ventilation. Follow up CT scan shows interstitial pneumonia extended to both lungs. When 200 mL convalescent plasma from a COVID-19 recovered patient was transfused to this patient, no adverse effect was observed, and patient RT-PCR came negative and was discharged. The third case was found to have multi-organ failure and develop septic shock. Eight transfusions of B-compatible convalescent plasma (2400 mL) have been given to the patient. The patient viral load decreased and two RT-PCR of sputum in deep lung came negative. The patient was transferred to an unfenced ICU for the management of underlying diseases and a couple of organ failure. The fourth case was once a 31-year-old pregnant woman. CT scan of the chest confirmed opacities in the lower lobe of the left lung. The affected person developed severe ARDS, multiple organ dysfunction syndromes, and septic shock after admission. The affected person was in a ventilated and caesarean section done; however, due to endouterine asphyxia newborn died. Cardiac ultrasound counselled left ventricular enlargement with decreased systolic function. The affected person obtained invasive ventilation and continuous renal replacement therapy: treatment with lopinavir–ritonavir (400 mg twice daily) and ribavirin (500 mg every 12 h). Three hundred millilitres transfusion of convalescent plasma was once given to the patient. The outcomes of two continual RT-PCR assessments of BAL fluid got here were negative. The patient recovered from COVID-19 and was discharged. Convalescent plasma would possibly be a therapy for',\n",
       " ('COVID-19',\n",
       "  76,\n",
       "  6): 'critically ill patients infected with COVID-19 and no unfavourable effect was observed [29]. 3.1.3. Tocilizumab treatment Luo et al. conducted a retrospective study on 15 patients with moderate and severe COVID-19 pneumonia with age range (62–80 years). Totally, 15 patients with COVID-19 were included in this study. The patients received tocilizumab (TCZ) ranging from 80 mg to 600 mg per day for one to seven days. Two of the patients were moderately ill, six were severely ill and seven were critically ill. Tocilizumab was used in combination with methylprednisolone in eight patients. Five patients received the TCZ administration twice or more. Tocilizumab decreased the CRP in all patients rapidly, but for the four critically ill patients who received only a single dose of TCZ, three of them dead and the CRP level in the remaining patient did not decrease to the normal range with a clinical outcome of disease aggravation. Serum IL-6 decreased after TCZ therapy in 10 patients and did not decrease in patients not affected by the treatment. A persistent and dramatic increase of IL-6 was observed in these four. In COVID19 patients at risk of cytokine storms 21, TCZ appears to be an appropriate treatment choice [31]. 3.1.4. Corticosteroids A retrospective cohort study of 31 patients diagnosed with coronavirus was performed in two hospitals. Their median age was 39 (IQR, 32–54 years); 20 (64%) were men. Seven patients had hypertension, two had chronic hepatitis B virus (HBV) infection (virus loads, 2950 copies, and 3040 copies/mL; both patients had entecavir), one had diabetes and one had coronary heart disease. Two patients had a smoking history. No patients reported chronic respiratory diseases, cancer or other chronic diseases. Twenty-nine patients’ CT shows pneumonia finding in 20 patients’ bilateral involvement while in two patients no CT finding was present. The outcomes were viral clearance time, hospital stay and symptom duration. Eleven out of 31 were given corticosteroid (methylprednisolone 40 mg once or twice a day) within 24 h of admission. Corticosteroid-receiving patients had a higher median CRP level (p=.026) and a lower median lymphocyte count (p=.012) compared to non-corticosteroid patients [20]. Twenty-six (84%) of the 31 patients had recovered from COVID-19 and were discharged and five were still in the hospital. The median time to clear up the virus was 14 days (IQR, 12–16 days; range, 7–26 days). The median duration of symptoms was seven days (IQR, 5–10 days); the median length of hospital stay was 18.5 days (IQR, 16–21 days). There was no association found of steroid with hospital length of stay (HR, 0.77; 95% CI, 0.33–1.78), duration of a symptom (HR = 0.86; 95% CI, 0.40–1.83) and viral clearance time (HR = 1.26; 95% CI, 0.58–2.74). Eventually, there was no association found between corticosteroid use and outcome in patients without ARDS, and an existing HBV infection delay viral clearance [20]. A case series include 137 patients to describe the prognosis and clinical outcomes of non-specific COVID-19 treatment including antiviral treatment, antibacterial treatment, systemic corticosteroids, γ-immunoglobulin and respiratory support. Patients were recruited in nine tertiary hospitals in Hubei, China. Of the 137 patients included in this study; 105 (76.6%) received antiviral treatment; 119 (86.9%) received antibacterial treatment; 40 (29.2%) received systemic corticosteroids; 44 (32.1%) received human γ-immunoglobulin; and 119 (86.9%) received respiratory support with nasal cannula (85[62%]) and non-invasive ventilation (34[24.8%]). Regarding prognosis of these patients; 44 (32.1%) improved and were discharged; 77 (56.2%) inpatient treatment; and 16 (11.7%) died. They concluded that systemic corticosteroid treatment did not show significant benefits [2]. 3.1.5. Anticoagulant therapy In a retrospective observational study to assess the role of heparin treatment in severe cases',\n",
       " ('COVID-19',\n",
       "  76,\n",
       "  7): \"of COVID-19 with coagulopathy, 449 patients were included in the study, with a mean age of 65.1 ± 12.0 years. About 61% of these patients have comorbidities, mainly diabetes and hypertension, heart diseases. Anticoagulant treatment was defined as receiving heparin treatment for at least seven days. All patients received the standard treatment, including antiviral and supportive treatment. Twenty-two percent of the patients (n = 99, 94 received low molecular weight heparin (40–60 mg enoxaparin/day), and five received unfractionated heparin (10,000–15,000 U/day)). After 28 days of treatment, there was no statistical difference in the mortality rate between both groups heparin users and non-users (30.3% vs. 29% respectively, p=.9), but in stratified analysis, the mortality among heparin users was lower than nonusers. In patients with sepsis-induced coagulopathy (SIC) (SIC score) score ≥4 (40.0% vs. 64.2%, p= .029), or D-dimer >3.0 μg/mL (32.8% vs. 52.4%, p= .017). The study concluded that heparin treatment improves the prognosis of COVID-19 cases with coagulopathy [22]. Wang et al. performed a case series study on three patients with COVID-19 infection, age range (49–75 years). The patients were undergoing administration of tPA with standard care. The three patients showed an improvement in their P/F ratio ranging from 38% improvement to a ∼100%. The D-dimer decreased in two cases only and the fibrinogen levels increased in one case and remained similar in another and not reported in the remaining case. Thus, more studies are needed to confirm these results [35]. 3.1.6. ACE2-mesenchymal stem cells transplantation A pilot trial was conducted in a hospital in Beijing on seven patients aged between 18 and 95 years who were RT-PCR-positive with intravenous MSCs transplantation. Seven confirmed COVID-19 patients were registered for MSCs transplants, including one critically severe type, four severe types, and two common types, and three severe types were enrolled for placebo control. MSCs were suspended in 100 mL of normal saline before the intravenous drip, and the total number of cells transplanted was calculated by 1 × 106 cells per kilogram of weight. The window period for cell transplantation was described as the time when symptoms or/and signs deteriorated even as the expectant therapies were being performed. The injection was conducted with a speed of ∼40 drops per minute, for around 40 min. The patients were examined by the investigators after receiving the investigational drug via the 14-day observation. The clinical results and improvements in rates of inflammatory and immune function and adverse effects of seven enrolled patients were monitored for 14 days. In two days after MSCs transplantation, these seven patients' pulmonary function and symptoms were significantly improved. Two common and one severe patient were recovered and discharged within 10 days following treatment. After treatment, the peripheral lymphocytes increased, the C-reactive protein decreased, and the CXCR3-CD4-T cells, CXCR3 + CD8 + T cells and CXCR3 + NK cells disappeared within three to six days of treatment. Besides, a team of CD cell populations with regulatory CD14 + CD11c + CD11bmid increased dramatically. While levels of tumour necrosis factor alpha reduced significantly, IL-10 has risen in the MSCs treatment group as opposed to the placebo control group. The gene expression profile also showed that MSCs were ACE2- and TMPRSS2- which suggested that MSCs are free of COVID-19 infection. Intravenous transplantation of MSCs was safe and effective for treatment in COVID-19 pneumonia patients, particularly in critically severe patients [11]. 3.1.7. Antivirals Jun et al. reviewed the records of 134 cases (aged from 35 to 62 years with an average of 48 years). Patients were divided into three groups; the first group included 52 patients and received lopinavir/ritonavir oral tablets two times\",\n",
       " ('COVID-19',\n",
       "  76,\n",
       "  8): 'a day for five days; the second group included 34 patients and received arbidol 200 mg three times a day for five days, and the third group included 48 patients and did not receive any antiviral drug as a control group. All patients in this study received recombinant human interferon a2b spray. A total of five patients had developed severe illness; two patients (3.8%) in the lopinavir group; one (3.3%) in the arbidor group; and two (4.5) of the control group, and there was no significant difference between three groups in time of having negative PCR test; the percentage of negative conversion in lopinavir group was 71.8%; in arbidor group was 82.6%, and control group was 77.1% (p= .79). They concluded that lopinavir–ritonavir and abidor had no effect of improving symptoms or shortening the negative time of viral nucleic acid in respiratory specimens [21]. Similarly, in the second study (randomized open-label clinical trial), 199 patients were recruited from 18 January 2020 to 3 February 2020, in Jin Yin-Tan Hospital. Patients were divided into two groups: the first group included 99 patients and received lopinavir (400 mg)/ritonavir (100 mg) oral tablets two times a day with a standard of care and the second group included 100 patients and received standard of care alone. Standard of care included supplemental oxygen either non-invasive or invasive according to need, antibiotics, vasopressors, renal replacement therapy and ECMO. There was also no significant difference between the lopinavir/ritonavir group and the control group in clinical improvement (median 16 days vs. 16 days, the hazard ratio for clinical improvement, 1.31; 95% CI, 0.95–1.85; p=.09). Also there was no significant difference between the lopinavir/ritonavir group and the control group in body temperature (median 36.5 °C IQR [36.4–37.0], 36.5 °C IQR [36.5–36.8]); WBCs (median 7.3 IQR [5.3–9.6]), 6.9 IQR [4.9–9.1]); or platelet count (median 201.0 IQR [155.0–287.0], 210.0 IQR [163.0–269.5]) [13]. Ye et al. study included 47 patients recruited from Rui’an People’s hospital. They divided their patients into two groups: the first group included 42 patients and received lopinavir/ritonavir plus standard adjuvant therapy. The second group included five patients and received standard adjuvant therapy alone. Adjuvant therapy included interferon aerosol inhalation, arbidol tablets, asmeton, eucalyptol limonene, pinene enteric soft capsules, moxifloxacin and supplemental oxygen as needed. The results have shown a faster return to normal body temperature in the lopinavir/ritonavir group compared to the control group (test group: 4.8 ± 1.94 days against control group 7.3 ± 1.53 days, p=.0364). It was also shown that the abnormal blood picture (WBCs, lymphocytes, CRP, PLT) was generally lower in the lopinavir/ritonavir group than the control group [12]. Regarding remdesivir, 61 patients received remdesivir but there were eight patients that were not analysed (seven with no post-treatment data and one has a dosing error). The remaining 53 patients were analysed, 75% received the full 10-day course of remdesivir, 19% received five to nine days of treatment and 6% fewer than five days of treatment. During a median follow-up of 18 days, 36 patients (68%) had an improvement in oxygen-support class, including 17 of 30 patients (57%) receiving mechanical ventilation who were extubated. A total of 25 patients (47%) were discharged, and 13% died; mortality was 18% (six of 34) among patients receiving invasive ventilation and 5% (one of 19) among those not receiving invasive ventilation. In conclusion, randomized clinical trials are required to measure the efficacy of remdesivir [26]. Furthermore, favipiravir showed significant improvement in chest CT of the experimental group compared with the control group, with an improvement rate of 91.43% vs. 62.22%. These results show that favipiravir improved the prognosis of',\n",
       " ('COVID-19',\n",
       "  76,\n",
       "  9): \"COVID-19 patients [18]. 3.1.8. Combined/non-specific treatments A multicentre clinical trial included 237 patients who were recruited in 15 medical centres in Zhejiang province in the period from 22 January 2020 to 16 February 2020. Patients were divided into two groups; the first group included 196 patients with a mean age of 45.7 ± 17 years; and the second group of 41 patients with a mean age of 45.1 ± 16.7 years. First group had 92 (46.9%) females and 104 (53.1%) males; and the second group contained 17 (41.5%) females and 24 (58.5%) males. Both groups had similar percentages of chronic diseases including hypertension (first group: 38 [19.4%], second group: nine [22.0%], p=.780); diabetes (first group: 15 [7.7%], second group: four [9.8%], p=.534); and chronic liver disease (first group: 11 [5.6%], and second group: five [12.2%], p=.236). Regarding assigned treatment, the first group was the triple antiviral therapy group, they received arbidol (200 mg, three times a day), lopinavir/ritonavir (two tablets two times a day) and recombinant interferon α-2b (five million U two times a day, inhalation) for five days. The second group received only lopinavir/ritonavir and recombinant interferon α-2b. No statistical difference was found between the two groups in median hospital stay (Z = 6.722, p>.05) [15]. In a retrospective case series to assess the outcome of patients receiving combined lopinavir/ritonavir (Kaletra®), arbidol and Shufeng Jiedu Capsule (SFJDC), a traditional Chinese medicine, four patients were recruited in Shanghai Public Health Clinical Center, Shanghai, China and diagnosed with COVID-19 according to World Health Organization (WHO) guidelines (two patients < 35 years, two patients >60 years). By the end of study, two of the four patients were discharged and the other two remained in the hospital. All the patients received oxygen therapy via nasal cannula, antibiotic treatment and antiviral treatment including Kaletra® (lopinavir 400 mg/ritonavir 100 mg, every 12 h), arbidol (0.2 g three times a day) and SFJDC (2.08 g, three times a day). Antiviral treatment was continued for 6–15 days. All patients had improved, three patients were discharged. Antiviral therapy’s effectiveness includes lopinavir/ritonavir, arbidol and SFJDC, which needs further testing in future studies [28]. Another case series described the clinical outcomes of patients receiving antiviral therapy, antibiotic therapy, antifungal therapy, corticosteroids and arbidol. All patients in this study were consecutively recruited in a period from 16 January 2020 to 29 January 2020, at the Union hospital in Wuhan, China. The recruited 69 patients were confirmed to have COVID-19 using PCR tests of throat swabs. The patients had a median age of 42.2 (IQR 35.0–62.0); 32 (46%) were males and 37 (54%) were females. Two patients were excluded from the analysis of treatment because of the transfer. Twenty-nine percent of patients showed dyspnoea and 20% of cases showed SpO2 < 90%. As of 4 February 2020, 18 (26.9%) of 67 patients had been discharged, and five patients had died, with a mortality rate of 7.5%. The study concluded that arbidol treatment showed the tendency to improve the discharging rate and decrease the mortality rate [1]. Dan et al. reported a case series with 30 patients recruited from Sixth People's Hospital of Shenyang in the period from 22 January 2020 to 8 February 2020 (ages ranging from 21 to 72 and a median age of 43 years). Eight (27%) cases had chronic disease including atherosclerosis, hypertension, diabetes, cerebral infarction or bronchitis. Thirteen (43%) cases received oxygen supplementation; 30 (100%) cases received antivirals including lopnavir, ritonavir and arbidol; 12 (40%) received antibiotics including moxifloxacin, cefoperazone, linezolid and imipenem cilastatin; and eight (26.7%) patients received glucocorticoids. By the end of the study, nine patients\",\n",
       " ('COVID-19',\n",
       "  76,\n",
       "  10): \"were discharged, 20 improved, one unchanged severe disease and no deaths [33]. Another case series included 109 patients from Wuhan's sixth hospital during the period from 24 December 2020 to 28 January 2020 (mean age ± SD 52.5 ± 10.8). Comorbidities among the patients included; 20 (19.2%) smokers; and 39 (35.8% cases) with underlying chronic diseases including lung diseases, sexual diseases and cardiovascular diseases [40]. All patients received antiviral therapy: 38 (39.4%), received oseltamivir phosphate (75 mg oral twice a day), three cases (2.8%) received ribavirin (500 mg IV drip, one time/day), three cases (2.8%) received peramivir, five cases (4.6%) received arbidor tablets (0.2 oral three times a day) and 60 cases (55.5%) received a combination of two antivirals. Other participants received treatments that include antibiotics (cephalosporins, quinolones and macrolides according to need), 12 patients received antifungals, 19 patients received α-interferon, 58 patients (53.2%) received glucocorticoids, 68 cases (62.4%) received immunoglobulin and 98 (90.0%) received oxygen supplementation either non-invasive or high flow humidification. By the end of this study, 51 cases (46.8%) were discharged, 10 cases (9.2%) were transferred, seven cases (6.4%) died, 48 cases (44.0%) were still hospitalized, 26 cases improved [34]. 3.1.9. Treatment of paediatric patients A retrospective observational study included 31 paediatric patients with mild/asymptomatic pneumonia. Twenty-nine cases (94%) of children received antiviral treatment, including 10 cases received interferon alone, one case received oseltamivir alone, the remaining patients received the combination of two or more drugs of interferon, oseltamivir phosphate, ribavirin, Abidor (oral, 6–16 days), lopinavir/ritonavir. Except for one patient who had a slight increase in serum transaminase, no other adverse reactions were seen. Six children were treated with antibacterial drugs. Two children were treated with intravenous infusion of gamma. Eight children received symptomatic Chinese medicine decoction oral treatment. One patient was not treated and the remaining received an intravenous infusion of Xiyanping and Yiqiyangyin decoction. All children were not given glucocorticoid and mechanical ventilation. The discharge rate was 77%. In brief, the overall prognosis was good soon by general treatment [25]. Another retrospective case series study was performed on 25 children with COVID-19 infection with an age median of three years and interquartile range from two to nine years. Forty-eight percent of the patients received antiviral therapy (interferon, arbidol, oseltamivir, lopinavir/ritonavir), 56% who received empirical antibiotics were treated with empirical antibiotics. One patient showed bacteriological efficacy following treatment. There were two critical cases additionally given invasive mechanical ventilation, systematic corticosteroids and intravenous immunoglobulin. One of them received kidney replacement therapy. One patient completely recovered and was discharged. The clinical symptoms were improved in 96% of the patients. The study concluded that children were susceptible to COVID-19 like adults, while the clinical presentations and outcomes were more favourable in children [23]. Sun et al. performed an observational study on eight severe or critically ill paediatric patients with COVID-19 pneumonia, median age two months to 15 years. All patients received antiviral treatments (virazole, oseltamivir and interferon). According to the patient’s condition, antibiotics, traditional Chinese medicine, intravenous glucocorticoids and immunoglobulin were used. The discharge rate was 62.5% [24]. 3.1.10. Lung transplantation Lung transplantation for three patients with pulmonary fibrosis was related to ARDS due to COVID-19, age range (58–73 years). Lung transplantation is the unique therapy for end-stage pulmonary fibrosis as rescue therapy for these patients. Two of the three recipients survived after liver transplantation. Lung transplantation can be performed in end-stage patients with respiratory failure due to COVID-19-related pulmonary fibrosis [32].\",\n",
       " ('COVID-19',\n",
       "  77,\n",
       "  0): \"Reviewed By: Both may be prevented by frequent, thorough hand washing, coughing into the crook of your elbow, staying home when sick and limiting contact with people who are infected. Social and physical distancing can limit the spread of COVID-19 in communities. Lisa Maragakis, M.D., M.P.H. , senior director of infection prevention at Johns Hopkins, explains how the flu and COVID-19 are similar and how they are different. Influenza (the flu) and COVID-19, the illness caused by the coronavirus that's led to the current pandemic, are both infectious respiratory illnesses. Although the symptoms of COVID-19 and the flu can look similar, the two illnesses are caused by different viruses. Differences: COVID-19 and the Flu Cause COVID-19: Caused by one virus, the novel 2019 coronavirus, now called severe acute respiratory syndrome coronavirus 2, or SARS-CoV-2. Flu: Caused by any of several different types and strains of influenza viruses. Transmission While both the flu and COVID-19 may be transmitted in similar ways (see the Similarities section above), there is also a possible difference: COVID-19 might be spread through the airborne route, meaning that tiny droplets remaining in the air could cause disease in others even after the ill person is no longer near. Antiviral Medications COVID-19: Antiviral medications and other therapies are currently being tested to see if they can address symptoms. Flu: Antiviral medications can address symptoms and sometimes shorten the duration of the illness. Vaccine COVID-19: No vaccine is available at this time, though development and testing is in progress. Flu: A vaccine is available and effective to prevent some of the most dangerous types or to reduce the severity of the flu. Infections COVID-19: The first cases appeared in China in late 2019 and the first confirmed case in the United States appeared in January 2020. Approximately 3,446,291 cases have been confirmed worldwide. There have been 1,133,069 cases in the U.S. as of May 3, 2020.* Flu: The World Health Organization estimates that 1 billion people worldwide get the flu every year. In the U.S., for Oct. 1, 2019 – Apr. 4, 2020, the CDC estimates that there were 39 million to 56 million cases of flu. (The CDC does not know the exact number because the flu is not a reportable disease in most parts of the U.S.) Deaths COVID-19: There have been approximately 244,122 deaths reported worldwide. In the U.S, 66,385 people have died of COVID-19, as of May 3, 2020.* Flu: The World Health Organization estimates that 290,000 to 650,000 people die of flu-related causes every year worldwide. In the U.S., from Oct. 1, 2019 – Apr. 4, 2020, the CDC estimates that 24,000 to 62,000 people died from the flu. (The CDC does not know the exact number because the flu is not a reportable disease in most parts of the U.S.) The COVID-19 situation is changing rapidly. Since this disease is caused by a new virus, people do not have immunity to it, and a vaccine may be many months away. Doctors and scientists are working to estimate the mortality rate of COVID-19, but at present, it is thought to be substantially higher than that of most strains of the flu. *This information comes from the Coronavirus COVID-19 Global Cases map developed by the Johns Hopkins Center for Systems Science and Engineering.\",\n",
       " ('COVID-19',\n",
       "  78,\n",
       "  0): 'While every effort has been made to follow citation style rules, there may be some discrepancies. Please refer to the appropriate style manual or other sources if you have any questions. (more) Courtesy, NIAID Influenza and the coronavirus disease COVID-19 appear to be very similar. After all, both are respiratory diseases, and they are transmitted via contact with infectious respiratory droplets. Beyond that, however, they differ in important ways. What are some of these differences, and why do they matter? Contagiousness One difference between COVID-19 and influenza is that the former appears to be more contagious than seasonal influenza. A person infected with influenza spreads the disease to another 1.3 individuals. For COVID-19, an infected person spreads illness to another 2 to 2.5 persons. Severity of illness and death rate COVID-19 also appears to cause more severe illness more frequently than seasonal influenza. Part of this difference may be attributed to the fact that COVID-19 is caused by a new type of coronavirus, against which humans have no immunity. By contrast, many people have at least some degree of immunity against seasonal influenza, enough to prevent hospitalization and complications in most instances. Along those same lines, COVID-19 is deadlier than influenza. The mortality rate of influenza is roughly 0.1 percent. Meanwhile, the case fatality rate for COVID-19 is estimated to be about 1.4-4.5 percent, with risk of death being significantly higher for older persons than for younger individuals. Seasonal nature Seasonal influenza, as its name suggests, tends to come and go as the weather changes. Influenza viruses circulate year-round, but the number of new influenza cases generally increases in the cooler months and tapers off in the warmer months of the year. This does not mean that cold weather causes the flu; rather, cool weather, by bringing people indoors, along with other changes, is a contributing factor. It is possible that COVID-19 could turn out to be a seasonal illness, similar to influenza. However, experts warn that, at least for now, amid the ongoing pandemic, warmer weather is unlikely to drive the disease away. COVID-19 is a new disease, and there are many millions of people worldwide who have not yet been exposed. This deep reserve of potential hosts could fuel sustained transmission through summer in the Northern Hemisphere and winter in the Southern Hemisphere. Many factors, however, determine seasonality of diseases, and more time is needed before conclusions can be drawn about whether COVID-19 is a seasonal illness. Causative agent A more obvious difference between influenza and COVID-19 is in their causative agents. Influenza viruses belong to a virus family known as Orthomyxoviridae. COVID-19 is caused by a coronavirus named SARS-CoV-2, which is classified in the family Coronaviridae. Both families consist of RNA viruses, but they differ particularly with regard to the protein layer that encapsulates the RNA. More specifically, influenza viruses express two surface antigens (foreign proteins)—hemagglutinin (H) and neuraminidase (N)—which trigger an immune response. The exact form of these antigens changes every now and then, resulting in the periodic emergence of new, more virulent influenza viruses with the potential to cause a pandemic. The surface of SARS-CoV-2 does not have these antigens. Rather, similar to other types of coronaviruses, its outer surface is studded with glycoprotein spikes, which give such viruses a crownlike, or coronal, appearance. Spike glycoproteins are responsible for triggering the immune response, and they carry out the critical function of enabling the coronavirus particle to enter cells, where it then replicates.',\n",
       " ('COVID-19',\n",
       "  79,\n",
       "  0): '1. COVID-19 and influenza both predominantly affect the respiratory system Both infections are caused by viruses (SARS-CoV-2 causes COVID-19 and influenza viruses cause influenza), but their effect on individuals can vary. Some individuals have no symptoms or mild symptoms. Other people may suffer from severe disease, requiring hospitalization. Both COVID-19 and influenza can be fatal. In many cases COVID-19 and influenza cause similar symptoms, including cough, runny nose, sore throat, fever, headache and fatigue. Learn more about COVID-19 signs and symptoms. Learn more about seasonal influenza. Contact your healthcare provider if you have or someone you know has any of the following severe symptoms, including: difficulty breathing, especially at rest, or being unable to speak in sentences confusion drowsiness or loss of consciousness persistent pain or pressure in the chest skin being cold or clammy or turning pale or a bluish colour loss of speech or movement. 2. SARS-CoV-2 and influenza virus spread in similar ways Both SARS-CoV-2 and influenza viruses spread mainly between people who are in close contact with each other, for example at a conversational distance. The viruses can spread through the air from an infected person’s mouth or nose in infectious respiratory (small liquid) particles when they cough, sneeze, speak or breathe. Another person can then contract the virus when infectious particles that pass through the air are inhaled or land on mucosal membranes. SARS-CoV-2 and influenza viruses spread more easily in poorly ventilated and/or crowded indoor settings and where people tend to spend longer periods of time. This is because infectious respiratory particles can remain suspended in the air or travel farther than conversational distance. People may also become infected when touching their eyes, nose or mouth after touching surfaces or objects that have been contaminated by the influenza or SARS-CoV-2 virus. 3. Many risk factors for severe disease are common to both COVID-19 and influenza Most people who are infected with SARS-CoV-2 or influenza viruses make a full recovery without needing hospital treatment, but some people can get severely ill and may die. Although this can happen to anyone, the following groups are at higher risk for severe disease and death when they have an infection: older adults; people of any age with chronic medical conditions such as obesity, chronic diseases of the heart, lung (e.g. asthma or COPD), kidney, nervous system, liver or blood, and metabolic problems such as diabetes; people with immunocompromising disease (such as those that can be caused by HIV or cancer), or as a result of medical treatment (for example those prescribed steroid treatments); and pregnant people or people in the postnatal period. Health and care workers are more exposed to SARS-CoV-2 and influenza viruses and may have a higher risk of getting infected. 4. Many of the same protective measures are effective against COVID-19 and influenza The following actions could help protect you and others from COVID-19 and influenza: stay up to date with vaccinations against COVID-19 and influenza, especially if you are at high risk of exposure or severe disease; practice respiratory hygiene and cough etiquette by covering the nose and mouth with a bent elbow or tissues while coughing or sneezing; clean your hands regularly; wear a mask when in crowded, enclosed, or poorly ventilated areas if you have symptoms, have tested positive for COVID-19 or influenza, or are at risk for severe COVID-19 or influenza infection; and stay home if you are sick. Seek advice from professional healthcare providers if you have symptoms.',\n",
       " ('COVID-19',\n",
       "  8,\n",
       "  0): 'The COVID-19 pandemic has led to unanticipated pressures on all aspects of human life. Multiple approaches to eliciting protective immunity must be rapidly evaluated. Numerous efforts have been made to develop an effective vaccine for this novel coronavirus, resulting in a race for vaccine development. To combat COVID-19, all nations must focus their efforts on widespread vaccination with an effective and safe vaccine. Globally, concerns about potential long-term adverse effects of vaccines have led to some apprehension about vaccine use. A vaccine’s adverse effect has an integral role in the public’s confidence and vaccine uptake. This article reviews the current primary literature regarding adverse effects associated with different COVID-19 vaccines in use worldwide. BACKGROUND As of January 14, 2022, the World Health Organization (WHO) has confirmed about 318,648,834 cases of COVID-19 worldwide, including 5,518,343 fatalities [1]. The COVID-19 pandemic has resulted in a global economic disruption. To restore normalcy and enable economic growth, vaccines are the best option. The first COVID-19 vaccine introduced in December 2020 has become a milestone in the fight against this pandemic. On December 2, 2020, using an Emergency Use Authorization (EUA), the UK became the first country to approve Pfizer-BioNTech’s COVID-19 vaccine, BNT162 [2]. As of December 31, 2020, the WHO approved BNT162 for emergency use, making its global production and supply more efficient [3]. Different vaccine candidates for COVID-19 have been approved using similar EUA processes, and the list continues to grow. A historic vaccination campaign is taking place in the US currently. In 1 week, 1.12 million doses were administered daily, on average. More than 523 million doses have been given in the US to date (Figure 1) [4, 5]. As of January 14, 2022, 194 vaccines are in preclinical development, and 139 are in clinical trials [6]. Vaccine uptake must be accelerated in the coming months to continue to decrease infection rates [7]. However, some people question whether the speed at which a vaccine is developed will compromise its efficiency and safety. This, in turn, may lead to vaccine hesitancy, which further inhibits attaining the goal of having 70% of the population fully vaccinated, after which herd immunity can effectively be achieved [8]. Therefore, it is crucial to establish the safety of the vaccines in these circumstances to perhaps promote wider vaccine acceptance among hesitant people. Adverse effects, however, are associated with every vaccination [9]. The purpose of this article is to review the current primary literature regarding adverse affects associated with the different COVID-19 vaccines. Our aim is to provide insights into the safety of the vaccines to help address misinformation and vaccine hesitancy. We discuss the adverse effects of the most common vaccines, which were chosen based on the number of countries they are approved in. This article is intended to be a narrative review. Searches were conducted in PubMed and Google Scholar to identify related literature from 2020 to 2021. Keywords such as “adverse effects,” “adverse events,” “complications,” “COVID-19,” and “vaccine,” were searched individually or in combination to yield relevant information. The results were reviewed for relevance to the topic, and the articles were screened by 2 authors. We had no language restrictions because of the relatively few articles on the topic. Duplicated studies and studies providing insufficient and irrelevant information were excluded.',\n",
       " ('COVID-19',\n",
       "  80,\n",
       "  0): 'Active smoking and a history of smoking are clearly associated with severe COVID-19. The SARS-COV-2 epidemic should serve as an impetus for patients and those at risk to maintain good health practices and discontinue smoking. The trial is registered with the International Prospective Register of Systematic Reviews (PROSPERO) CRD42020180173 . A total of 16 articles detailing 11322 COVID-19 patients were included. Our meta-analysis revealed a relationship between a history of smoking and severe COVID-19 cases (OR = 2.17; 95% CI: 1.37–3.46; P < .001). Additionally, we found an association between the current smoking status and severe COVID-19 (OR = 1.51; 95% CI: 1.12–2.05; P < .008). In 10.7% (978/9067) of nonsmokers, COVID-19 was severe, while in active smokers, severe COVID-19 occurred in 21.2% (65/305) of cases. We searched the Google Scholar, PubMed, Scopus, Web of Science, and Embase databases to identify clinical studies suitable for inclusion in this meta-analysis. Studies reporting smoking status and comparing nonsevere and severe patients were included. Nonsevere cases were described as mild, common type, nonintensive care unit (ICU) treatment, survivors, and severe cases as critical, need for ICU, refractory, and nonsurvivors. Coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SAR2-COV-2) and was first identified in Wuhan, China, in December of 2019, but quickly spread to the rest of the world, causing a pandemic. While some studies have found no link between smoking status and severe COVID-19, others demonstrated a significant one. The present study aimed to determine the relationship between smoking and clinical COVID-19 severity via a systematic meta-analysis approach. In another meta-analysis involving more studies, COVID-19 severity was found to increase with smoking (OR, 1.97; 95% Cl: 0.95-4.10) [ 6 ]. To increase the statistical power of this analysis, case reports and series were also included, not just case-control studies. As previously, the heterogeneity of the studies included here was also low (I 2 = 44%) [ 6 ]. The different results of both meta-analyses create confusion about the issue of smoking status. However, it has been reported that COVID-19 progresses more severely in COPD patients [ 6 ]. Given that smoking plays an important role in the etiopathogenesis of COPD, it may have a similar effect on symptoms. In a recent meta-analysis of smoking and COVID-19 severity, smoking was found to not increase the severity of COVID-19 (odds ratio [OR], 1.69; 95% Cl: 0.41-6.92). However, only five studies were included in this meta-analysis, and heterogeneity among the studies was low (I 2 = 38%) [ 7 ]. COVID-19 primarily targets lung epithelial cells, causing viral pneumonia and acute respiratory distress syndrome (ARDS), especially in elderly patients. Therefore, mortality is higher in the elderly and in patients with at least one accompanying comorbid disease [ 3 ]. In the last report issued by the Centers for Disease Control and Prevention Institute, the incidence of respiratory disease was 9.2% in patients diagnosed with a severe COVID-19 clinical course [ 4 ]. Chronic obstructive pulmonary disease (COPD) and asthma are also common comorbidities in severe cases and are reported in 10.8% and 17.0%, respectively, of hospitalized patients aged ≥18 years with COVİD-19 [ 5 ]. Coronavirus disease 2019 (COVID-19), which is caused by severe acute respiratory syndrome coronavirus 2 (SAR2-COV-2), was first identified in Wuhan, China, in December of 2019. It has subsequently spread across the world, causing a global pandemic. This highly contagious disease has thus far infected 23.4 million people worldwide and killed approximately 808000 patients, yielding a case fatality rate (CFR) that varies between 0.7 and 12.7% (average: 3.4%) [ 1 , 2 ]. OpenMeta Analyst version 10.10',\n",
       " ('COVID-19',\n",
       "  80,\n",
       "  1): \"( https://www.cebm.brown.edu/open_meta ) was used to calculate odds ratios with 95% confidence intervals, which are depicted using forest plots. Quantitative numbers were measured in terms of total numbers and percentages (n, %). The odds ratio of smokers among nonsevere COVID-19 and severe COVID-19 cases, as well as survivors and nonsurvivors, was calculated. Heterogeneity was evaluated with Cochran's Q, χ 2 , and the Higgins I 2 test. The Higgins I 2 test uses a fixed effect model when I 2 <50%, and a random effects model when I 2 >50%. When heterogeneity was detected, a sensitivity adjustment was made to determine its source. This procedure was performed by leaving one study out of the analysis at a time, with a fixed effect model used after excluding heterogeneity. Publication bias was evaluated with Statsdirect version 3.2.10 (StatsDirect Ltd, Cambridge, UK) and visualized using Begg's funnel plots and Egger's test. P values (two-sided) were considered statistically significant if P < .05. Two researchers (BAY and BU) evaluated the collected articles using the Newcastle-Ottawa scale (NOS) for study quality and risk of bias [ 9 ]. This scale evaluates three aspects of each study: (i) selection (0 to 4 points), (ii) comparability (0 to 2 points), and (iii) detection of the outcome of interest (0 to 3 points). According to the obtained total score, study quality was rated as follows: 0-3 points (poor), 4-6 points (intermediate), and 7-9 points (high). Studies with a high risk of bias were excluded during the meta-analysis phase. The following data were obtained from all studies: title, first author, publication year, location, sample size, age (median), history of smoking (former or current), and distribution of nonsevere or severe COVID-19 status. Given these groups, we were able to compare nonsevere (mild, common type, non-ICU, survivors) and severe (critical, severe, ICU, nonsurvivors) COVID-19 cases. A researcher (AG) scanned study titles and abstracts obtained via an initial database search and included relevant ones in a secondary pool. Next, two independent researchers (AG and BU) evaluated the full text of these articles to determine whether they met study inclusion criteria. Any disputes were resolved by discussion and negotiation with a third investigator (BAY). Agreed-upon studies were included in the final meta-analysis. Exclusion criteria were as follows: (i) studies from the same medical center that did not contribute to meta-analysis, (ii) non-English-language studies, (iii) case reports/series, (iv) reviews, (v) editorial letters, (vi) studies lacking a full-text (unavailable or not yet published), (vii) studies without a DOI, and (viii) studies with small sample sizes (<50 patients) because of low statistical power. Inclusion criteria were as follows: (i) studies that examined COVID-19 patients older than 18 years and diagnosed COVID-19 according to WHO criteria; (ii) observational, cross-sectional, prospective, or retrospective studies; (iii) studies which compared smokers with mild and severe COVID-19; (iv) studies comparing smokers with survivors and nonsurvivors of COVID-19; and (v) studies comparing smokers who developed COVID-19 that required intensive-care unit (ICU) and non-ICU treatment. We searched the Google Scholar, PubMed, Scopus, Web of Science, and Embase databases to identify clinical studies suitable for inclusion here. Only English-language articles published between December 2019 and April 15, 2020, were included. Case series/reports, commentaries, reviews, and editorial letters were excluded. Unpublished articles were not searched, but “ahead of print” and “first only” articles with a DOI link in the given database were included. The following search terms were used: “COVID-19,” OR “SARS-COV-2,” OR “novel coronavirus (nCOV),” AND “smoking,” OR “tobacco,” AND “clinical features,” OR “characteristic,” AND “severity,” OR “severe”. All guidelines listed in the Preferred Reporting Items for Systematic Reviews and Meta Analyses (PRISMA) statement\",\n",
       " ('COVID-19',\n",
       "  80,\n",
       "  2): \"were followed in conducting this meta-analysis [ 8 ]. Our methodological systematic review and meta-analysis of pooled case-control studies were recorded in the International Prospective Register of Systematic Reviews ( https://www.crd.york.ac.uk/prospero; registration number: CRD42020180173 ). (a) Comparison of smoking status in severe COVID-19 patients. (b) Funnel plot for the meta-analysis of smoking among severe COVID-19 patients. (c) Comparison of smoking status among severe COVID-19 patients after the exclusion of a study by Zhang et al. [ 23 ]. (d) Funnel plot for the meta-analysis of smoking among severe COVID-19 patients after the exclusion of a study by Zhang et al. [ 23 ]. Only 10 of the pooled studies provide information about current smoking, specifically (n = 305). Current smoking prevalence in patients with mild to moderate COVID-19 was 229/7850 (2.9%), while in severe or critical cases, it was 66/1134 (5.8%). However, in 10.7% (978/9067) of nonsmokers, COVID-19 disease was severe, while in active smokers, it was severe in 21.2% (65/305) of cases ( Table 4 ). This clearly demonstrates a significant relationship between current smoking and severe COVID-19 patients (fixed effect model, OR = 1.51; 95% CI: 1.12–2.05; z = 2.65; P = .008), with an approximate 1.5-fold increased risk of ICU admission, symptom, severity, and mortality in smokers ( Figure 3(a) ). In this analysis, we used a fixed effect model due to the low level of heterogeneity (I 2 = 48.9%; P = .40). A funnel pilot and Egger's test revealed no publication bias (tau 2 = 0.22, P = .77) ( Figure 3(b) ). (a) Prevalence of smoking in severe COVID-19 patients. (b) Funnel plot for meta-analysis of the prevalence of smoking in severe COVID-19 patients. (c) Prevalence of smoking among severe COVID-19 patients after the exclusion of studies by Qi et al. [ 16 ] and Zhang et al. [ 23 ]. (d) Funnel plot for the meta-analysis of smoking among severe COVID-19 patients after the exclusion of studies by Qi D et al. [ 16 ] and Zhang R et al. [ 23 ]. The prevalence of smoking among patients with mild to moderate COVID-19 was 493/9414 (5.2%), while among severe and critical cases, it was 173/1383 (12.5%). A meta-analysis revealed a significant relationship between smoking history and severe COVID-19 (random effect model, OR = 2.17; 95% CI:1.37–3.46; P < .001) ( Table 3 ) ( Figure 2(a) ). A funnel plot was used to evaluate publication bias and revealed substantial heterogeneity between the pooled studies (I 2 = 71.4%; P < .001) ( Figure 2(b) ). A sensitivity analysis conducted after removing two studies (Qi et al. [ 16 ] and Zhang et al. [ 23 ]), which were primary causes of heterogeneity, revealed that smoking was significantly related to COVID-19 severity (fixed effect model, OR = 1.85; 95% CI:1.50–2.29; P < .001) ( Figure 2(c) ). Furthermore, this updated analysis had low heterogeneity (I 2 = 40.6%; P = .06), while a funnel plot and Egger's test revealed no publication bias (tau 2 = −0.87, P = .16) ( Figure 2(d) ). In the initial meta-analysis pool, 11322 patients with COVID-19 from 16 studies [ 4 , 10 – 24 ] were included. However, given CDC reporting guidelines [ 4 ], 525 patients whose hospitalization statuses were reported as “unknown” were excluded from the final analysis, yielding a final 10797 patients. Of these, 9414 (87.2%) were nonsevere COVID-19 patients, while 1383 (12.8%) were severe or critical COVID-19 patients who required intensive care. Among the severe or critical patients, smoking prevalence ranged from 3.6 to 19.9% (average: 8.4%). While nine studies provided current\",\n",
       " ('COVID-19',\n",
       "  80,\n",
       "  3): \"smoker information, three provided both current smoker and former smoker information, and seven provided only historical smoking information. All of the included studies were retrospective (six multicenter and 10 single-center). A summary of the studies included in this meta-analysis is available in Table 2 . Our initial search of international databases using the keywords described above yielded 265 articles. After duplicate articles were excluded, 197 articles remained. After article titles and abstracts were evaluated for appropriateness, a final 34 articles were found to meet study inclusion criteria. In addition, 18 of the studies for which full texts were obtained were excluded because they met exclusion criteria. A total of 16 articles met all our criteria. The relevant PRISMA study flow chart is shown in Figure 1 . A quality analysis of the pooled articles included in this meta-analysis was done by applying NOS. As a result, overall quality was found to be moderate (NOS score min: 5, max: 8). Results of a quality analysis of the pooled articles are available in Table 1 . 4. Discussion The present meta-analysis contained 16 studies and revealed that those with a history of smoking and active smokers had significantly increased risk for severe COVID-19. Previous studies have reported a similar result [14, 18, 23]. In addition, one prior meta-analysis reported that disease severity increased given a history of smoking (OR: 1.98) [6]. Our analysis adds to this growing consensus in the literature, invoking more studies and examining both a history of smoking and current smoking status in risk for increased COVID-19 severity. Five prior studies have reported results which disagree with those presented here—namely, no significant difference between patients with and without a smoking history in terms of COVID-19 severity [10, 15, 21, 22, 24]. In addition, a meta-analysis performed by Lippi et al. [7] failed to find a relationship between active smoking and severe COVID-19 on Chinese patients, and another meta-analysis indicates that active smoking is not a predisposing factor for hospitalization [25]. First of all, both meta-analysis [7, 25] was not systematic and included no assessment of publication bias or study quality. As such, it should be considered only preliminary. Hence, the present systematic meta-analysis offers a more detailed view as it covers 16 studies. The heterogeneity was low to moderate, and after sensitivity adjustments, the prevalence of a history of smoking was found to be 5.2% in nonsevere COVID-19 cases and 12.5% in severe cases. Furthermore, the prevalence of active smoking was 2.9% in nonsevere COVID-19 cases and 5.8% in severe cases. Therefore, severe COVID-19 was observed almost 1.5 to 2 times more frequently in history of smoking and current smoking groups. There are studies [4, 11, 14, 16, 18, 23] and meta-analysis [6, 26–34] results supporting this finding. In addition, a recent meta-analysis revealed that active smokers are at higher risk of mortality and serious complications [27]. Interestingly, this meta-analysis indicated that serious complications were observed in 48% of former smokers and 24% of current smokers during COVID-19 course [27]. This appears to be because former smokers have longer exposure times or accompanying diseases such as COPD due to smoking. This issue was explained recently in a rapid nonsystematic meta-analysis conducted by Guo FR, which showed that COPD increased the development of severe COVID-19 by 4.38 times [28]. These findings are supported by another rapid nonsystematic meta-analysis, suggesting that smoking increases the severity and mortality of COVID-19 in hospitalized patients [29]. In addition, a history of smoking has been reported to increase the progression of COVID-19 disease [30]. There is growing evidence to support WHO's statements that smokers are\",\n",
       " ('COVID-19',\n",
       "  80,\n",
       "  4): 'at a higher risk of developing severe COVID-19 and consequent death [31]. It seems very clear that the pandemic period is an opportunity to quit smoking due to the possibility of encountering worse clinical outcomes and complications in patients with smoking history [32]. The relationship between smoking and illness severity due to other respiratory viruses has been investigated previously. In one recent study, COPD patients who smoked had decreased leukemia inhibitory factor levels during respiratory syncytial viral infection, particularly during exacerbations, which may have contributed to lung tissue injury [35]. In addition, smoking may reduce the protective effect of influenza vaccines in elderly patients and increase the risk of hospitalization [36]. As a result, adverse effects on the lungs in smokers may aggravate the symptom severity of viral infections. Furthermore, novel SARS-CoV-2 uses an angiotensin-converting enzyme (ACE)-2 in the lungs to enter cells and cause infection. In patients using ACE inhibitors or angiotensin II receptor blockers (ARBs) for hypertension, upregulated ACE2 expression impacts on disease course remains unclear. However, the Council on Hypertension of the European Society of Cardiology does not recommend discontinuation of ACEI and ARB medications for all patients [37]. The ACE-2 upregulation may increase infectiousness and therefore infection risk, as the SARS-COV-2 virus uses this receptor for host entry. Paradoxically, it is stated that it may be useful in protecting people from acute lung injury [38]. In one recent study, ACE-2 gene expression was upregulated in the airway epithelium of COPD patients and active smokers, thereby suggesting a mechanism by which risk for severe COVID-19 increases in smokers [39]. This upregulation may occur through the α7 subtype of nicotine acetylcholine receptors (α7-nAChR) in people who smoke and consequently consume nicotine [40]. Therefore, α7-nAChR antagonists (e.g., α-conotoxin, methyllycaconitine), which may be used to assist with smoking cessation, should be investigated for their potential impact on ACE-2 expression and thus SARS-COV-2 entry into the host [41, 42]. Furthermore, α7-nAChR and ACE-2 may be potential therapeutic targets, a topic which requires further investigation. Common comorbidities including cardiovascular disease, chronic kidney disease, diabetes, and hypertension are associated with increased risk for severe COVID-19 [43]. Similarly, COPD is also associated with a poor clinical progression and poor outcomes despite treatment, and it was reported that the risk of severe COVID-19 was observed 4 times higher in patients with preexisting COPD than in patients without COPD [6]. This may be explained by systemic and chronic inflammation, diminished respiratory function and capacity, and COPD-related respiratory failure in some patients. The prevalence of COPD was previously reported to be 2.8% in nonsmokers, 7.6% in former smokers, and 15.2% in active smokers [44]. Given this, smoking and COPD comorbidity should be considered together as a single risk factor for severe COVID-19. Another important point for consideration is that acute respiratory distress syndrome and cytokine storms, which are seen in some severe COVID-19 patients, are key causes of mortality in COVID-19. In these patients, proinflammatory cytokines such as interleukin (IL)-1, IL-2, IL-6, IL-8, IL-17, interferon-γ, and TNF-α are elevated, which affect patients clinical symptoms and severity [45]. Nicotine is a cholinergic agonist that acts via the a7-nAChR pathway and also inhibits proinflammatory cytokines such as IL-1, IL-6, and TNF, but has no effect on IL-10, an anti-inflammatory cytokine [46]. Therefore, nicotine may be beneficial for the treatment of severe COVID-19 when delivered via chewing gum, inhaler/aerosol, or patch [47, 48]. This potential therapeutic application should be clarified with future clinical research, however. Several factors limit the interpretation of the present study. First, the vast majority of studies included here were retrospective epidemiological studies conducted in China. Second,',\n",
       " ('COVID-19',\n",
       "  80,\n",
       "  5): 'some included studies did not distinguish between former or current smoking status. Third, studies classified COVID-19 cases broadly as follows: (i) mild to moderate: mild, nonsevere, common type, did not require ICU care, and COVID-19 survivors and (ii) severe: severe, critical, required ICU care, and nonsurvivors. Given these limitations, caution should be exercised while interpreting our results. Future studies may respond to these issues by defining disease severity more clearly and by obtaining more detailed information about smoking habit. In addition to classical tobacco smoking behavior, water pipe and electronic cigarette use should not be overlooked, as these modes of consumption may increase contamination risk due to repetitive hand interactions with the mouth, carrying cigarette packets in the pockets, and blowing of smoke. Similarly, exposure to passive smoke can alter ACE-2 gene expression and cause immune system changes. Naturally, these patients also have the potential to have severe COVID-19 symptoms, and smoke exposure is a potential risk factor for those around the patient, including their friends and family. Future studies should continue to collect nicotine consumption information, including the number of cigarettes smoked per day, passive exposure, and degree of COPD, and should evaluate the dynamics of interactions between cigarette smoking and COVID-19. In addition, the effects of various smoking habits (e.g., mild versus heavy consumption, water pipe use, and electronic cigarettes use) on the transmission of SARS-COV-2, the clinical severity of COVID-19, and the clinical progression of COVID-19 should be investigated. Finally, the relationship between COPD severity and COVID-19, and the potential therapeutic effect of nicotine on severe COVID patients should also be examined and clarified. In addition, clinicians can pay more attention to the history of smoking of COVID-19 patients, and more further research may aim to determine mechanisms that drive or decrease this risk.',\n",
       " ('COVID-19',\n",
       "  81,\n",
       "  0): 'Fake news and conspiracy theories about the origin of the coronavirus have swiftly followed the outbreak around the world. The quick spread of the virus from its origins in China’s Hubei province, and the lack of early detail about where it comes from or how to treat it, has provided ample room for speculation. One week after the city of Wuhan was placed under effective lockdown, the tide of misinformation is so high that Twitter, Facebook, and Google are struggling to cope. On Friday, after the WHO declared the outbreak a global health emergency, Facebook said it would “remove content with false claims or conspiracy theories that have been flagged by leading global health organisations and local health authorities that could cause harm to people who believe them”. On Thursday, Twitter announced it would “adjust search prompt in key countries across the globe to feature authoritative health sources when you search for terms related to novel #coronavirus.” Here are some of the examples of misinformation spreading around the world. 1. People eating bats in Wuhan The biggest piece of misinformation about the cause of the virus is the widely circulated video of a woman eating a bat. It has been spread by the Daily Mail, RT and far-right YouTuber Paul Joseph Watson among others. The Chinese celebrity Wang Mengyun said she has received death threats since the video went viral this month. The origins of the coronavirus are believed to have been from illegally sold wildlife at a seafood market in Wuhan, and bats could potentially have been the source, but the video was not filmed in a Wuhan restaurant as some had claimed, but in Palau, Micronesia, for a travel video in 2016. 2. It’s a deliberate plot Proponents of the QAnon conspiracy theory, such as Jordan Sather, have been spreading the idea that the outbreak of the coronavirus was timed to coincide with the start of Donald Trump’s impeachment trial. Sather claimed in a thread posted to his 100,000 followers that the disease was planned and manufactured. He pointed to a coronavirus patent granted to a firm with ties to the Bill & Melinda Gates foundation. The firm, Pirbright, had to issue a statement correcting misinformation. The firm said it researches infectious bronchitis virus, a coronavirus that infects poultry and pigs – not humans. 3. It’s a bioweapon The Washington Times claimed in a story that the coronavirus outbreak could be linked to the Wuhan Institute of Virology, quoting a former Israeli military intelligence officer who claimed a bioweapon was one possible option. Other conspiracy theories have suggested the virus was smuggled out of Canada into China. The Washington Post, however, spoke to a number of experts who said based on the virus genome there is no indication it was engineered. The MIT professor Vipin Narang said in a tweet that there is no evidence it is a bioweapon, and if it were, it would be a bad one, because a good bioweapon should be more deadly but not as easily spread. 4. 5G caused the spread of coronavirus These days 5G is blamed for everything, from cancer to bushfires, so it is not surprising that conspiracy theories that 5G caused, or helped spread coronavirus have been shared into the anti-5G groups on Facebook. One post debunked on Facebook claimed Wuhan was where 5G was first rolled out, and 5G “wrecked immune systems and thereby boosted the virulency of the normal cold”. Wuhan was one of a few places where 5G was rolled out in China in 2020, along with other parts of the world. There is no',\n",
       " ('COVID-19',\n",
       "  81,\n",
       "  1): 'evidence that 5G weakens immune systems or is harmful to humans. 5. Just take oregano oil, vitamin C or salt water Prominent anti-vaxxers and natural medicine groups have been sharing posts suggesting oregano oil, vitamin C, and salt water are either good ways to prevent coronavirus or cure it. They will not. 6. Just drink bleach One of the more dangerous remedies again comes from prominent QAnon conspiracy followers, with Daily Beast reporting the pro-Trump conspiracy theorists have told people to buy their “miracle mineral solution” that is supposed to cure everything, including autism or HIV/AIDS. The Food and Drug Administration has said the solution is “a dangerous bleach”. 7. Chinese Red Bull and fortune cookies are virus carriers There have been various viral posts on social media all trying to appear to be an official health-related update about what people should do to try to prevent them from getting in contact with the coronavirus. One of the most prominent spread in Australia, via childcare centres, is an apparent “urgent notice” from the “Department of Diseasology Parramatta”. and these child care centres in Wentworthville and Wiley Park pic.twitter.com/dJNdjj1Hw2 — Ben Mc (@McElstuff) January 28, 2020 This non-existent department warned of food that could be contaminated including wuxhang rice, fortune cookies, migoreng noodles, Yakult, and Chinese Red Bull. The New South Wales health department was forced to issue a statement stating there was no such entity as the Department of Diseasology Parramatta. “NSW Health would like to assure the community that the locations mentioned in this post pose no risk to visitors, and there have been no ‘positive readings’ at train stations.” 8. The no-go suburbs Another warning spread on social media claims to come from Queensland Health and warns people to stay away from certain suburbs in Brisbane and any populated areas that have a certain proportion of Chinese residents. The Brisbane MP Duncan Pegg tweeted that the warning was fake and designed to malign the community.',\n",
       " ('COVID-19',\n",
       "  82,\n",
       "  0): 'The Coronavirus disease (COVID-19) is the first pandemic in history in which technology and social media are being used on a massive scale to keep people safe, informed, productive and connected. At the same time, the technology we rely on to keep connected and informed is enabling and amplifying an infodemic that continues to undermine the global response and jeopardizes measures to control the pandemic. An infodemic is an overabundance of information, both online and offline. It includes deliberate attempts to disseminate wrong information to undermine the public health response and advance alternative agendas of groups or individuals. Mis- and disinformation can be harmful to people’s physical and mental health; increase stigmatization; threaten precious health gains; and lead to poor observance of public health measures, thus reducing their effectiveness and endangering countries’ ability to stop the pandemic. Misinformation costs lives. Without the appropriate trust and correct information, diagnostic tests go unused, immunization campaigns (or campaigns to promote effective vaccines) will not meet their targets, and the virus will continue to thrive. Furthermore, disinformation is polarizing public debate on topics related to COVID-19; amplifying hate speech; heightening the risk of conflict, violence and human rights violations; and threatening long-terms prospects for advancing democracy, human rights and social cohesion. In this context, the UN Secretary- General launched the United Nations Communications Response initiative to combat the spread of mis- and disinformation in April 2020. The UN also issued a Guidance Note on Addressing and Countering COVID-19 related Hate Speech (11 May 2020). At the World Health Assembly in May 2020, WHO Member States passed Resolution WHA73.1 on the COVID-19 response. The Resolution recognizes that managing the infodemic is a critical part of controlling the COVID-19 pandemic: it calls on Member States to provide reliable COVID-19 content, take measures to counter mis- and disinformation and leverage digital technologies across the response. The Resolution also calls on international organizations to address mis- and disinformation in the digital sphere, work to prevent harmful cyber activities undermining the health response and support the provision of science-based data to the public. The UN system and civil society organizations are using their collective expertise and knowledge to respond to the infodemic. At the same time, as the pandemic continues to create uncertainty and anxiety, there is an urgent need for stronger action to manage the infodemic, and for a coordinated approach among states, multi-lateral organizations, civil society and all other actors who have a clear role and responsibility in combatting mis- and disinformation. We call on Member States to develop and implement action plans to manage the infodemic by promoting the timely dissemination of accurate information, based on science and evidence, to all communities, and in particular high-risk groups; and preventing the spread, and combating, mis- and disinformation while respecting freedom of expression. We urge Member States to engage and listen to their communities as they develop their national action plans, and to empower communities to develop solutions and resilience against mis- and disinformation. We further call on all other stakeholders - including the media and social media platforms through which mis- and disinformation are disseminated, researchers and technologists who can design and build effective strategies and tools to respond to the infodemic, civil society leaders and influencers - to collaborate with the UN system, with Member States and with each other, and to further strengthen their actions to disseminate accurate information and prevent the spread of mis- and disinformation.',\n",
       " ('COVID-19',\n",
       "  83,\n",
       "  0): 'Importance: Severe pneumonia with hyperinflammation and elevated interleukin-6 is a common presentation of coronavirus disease 2019 (COVID-19). Objective: To determine whether tocilizumab (TCZ) improves outcomes of patients hospitalized with moderate-to-severe COVID-19 pneumonia. Design, setting, and particpants: This cohort-embedded, investigator-initiated, multicenter, open-label, bayesian randomized clinical trial investigating patients with COVID-19 and moderate or severe pneumonia requiring at least 3 L/min of oxygen but without ventilation or admission to the intensive care unit was conducted between March 31, 2020, to April 18, 2020, with follow-up through 28 days. Patients were recruited from 9 university hospitals in France. Analyses were performed on an intention-to-treat basis with no correction for multiplicity for secondary outcomes. Interventions: Patients were randomly assigned to receive TCZ, 8 mg/kg, intravenously plus usual care on day 1 and on day 3 if clinically indicated (TCZ group) or to receive usual care alone (UC group). Usual care included antibiotic agents, antiviral agents, corticosteroids, vasopressor support, and anticoagulants. Main outcomes and measures: Primary outcomes were scores higher than 5 on the World Health Organization 10-point Clinical Progression Scale (WHO-CPS) on day 4 and survival without need of ventilation (including noninvasive ventilation) at day 14. Secondary outcomes were clinical status assessed with the WHO-CPS scores at day 7 and day 14, overall survival, time to discharge, time to oxygen supply independency, biological factors such as C-reactive protein level, and adverse events. Results: Of 131 patients, 64 patients were randomly assigned to the TCZ group and 67 to UC group; 1 patient in the TCZ group withdrew consent and was not included in the analysis. Of the 130 patients, 42 were women (32%), and median (interquartile range) age was 64 (57.1-74.3) years. In the TCZ group, 12 patients had a WHO-CPS score greater than 5 at day 4 vs 19 in the UC group (median posterior absolute risk difference [ARD] -9.0%; 90% credible interval [CrI], -21.0 to 3.1), with a posterior probability of negative ARD of 89.0% not achieving the 95% predefined efficacy threshold. At day 14, 12% (95% CI -28% to 4%) fewer patients needed noninvasive ventilation (NIV) or mechanical ventilation (MV) or died in the TCZ group than in the UC group (24% vs 36%, median posterior hazard ratio [HR] 0.58; 90% CrI, 0.33-1.00), with a posterior probability of HR less than 1 of 95.0%, achieving the predefined efficacy threshold. The HR for MV or death was 0.58 (90% CrI, 0.30 to 1.09). At day 28, 7 patients had died in the TCZ group and 8 in the UC group (adjusted HR, 0.92; 95% CI 0.33-2.53). Serious adverse events occurred in 20 (32%) patients in the TCZ group and 29 (43%) in the UC group (P = .21). Conclusions and relevance: In this randomized clinical trial of patients with COVID-19 and pneumonia requiring oxygen support but not admitted to the intensive care unit, TCZ did not reduce WHO-CPS scores lower than 5 at day 4 but might have reduced the risk of NIV, MV, or death by day 14. No difference on day 28 mortality was found. Further studies are necessary for confirming these preliminary results. Trial registration: ClinicalTrials.gov Identifier: NCT04331808.',\n",
       " ('COVID-19',\n",
       "  84,\n",
       "  0): 'A total of 2,284 articles were identified from the search terms, of which 31 studies that included 12,440 patients used randomized controlled designs to examine the efficacy of antiviral therapy on COVID-19 [22,23,24,25,26,27,28,29,30,31,32,33,34,35,36,37,38,39,40,41,42,43,44,45,46,47,48,49,50,51,52,53]. A PRISMA diagram detailing the search strategy is shown in Fig. 1. Of the articles identified, 30 were excluded after full-text review [54,55,56,57,58,59,60,61,62,63,64,65,66,67,68,69,70,71,72,73,74,75,76,77,78,79,80,81,82,83]. One study was originally included, but was later retracted due to concerns about data integrity, and thus was excluded [42]. Antiviral treatments compared in the included studies were umifenovir (Arbidol) [25, 29, 31, 47], baloxavir marboxil [30], enisamium [50], favipiravir [25, 30, 35, 40,41,42, 44, 45, 48, 52], lopinavir/ritonavir (LPV/r) [24, 26, 27, 29, 31, 37, 38, 44, 47], remdesivir [23, 34, 36, 39, 51, 53], ribavirin [22], sofosbuvir/daclatasvir [22, 32, 33, 46, 49], sofosbuvir/ledipasvir [28], sofosbuvir/ravidasvir [46], and sofosbuvir/velpatasvir [43]. The study characteristics and baseline patient characteristics are summarized in Table 2. The outcomes of interest and study conclusions are summarized in Table 3. Two studies were rated low quality on the risk of bias assessment, with bias favoring the test treatment [49, 51]. The remaining studies were rated either acceptable or high quality (Additional file 1). Fig. 1 PRISMA flowchart for study inclusion Full size image Table 2 Study and patient characteristics Full size table Table 3 Patient Outcomes Full size table Favipiravir Favipiravir is an antiviral used to treat influenza in Japan. It is a purine analog that inhibits viral RNA-dependent RNA polymerase, blocking viral genome replication and transcription [84]. We identified nine RCTs that examined the efficacy of favipiravir in treating COVID-19. Five trials found significant differences between the favipiravir treatment and comparator groups [35, 45, 48, 52, 85] and four did not find significant differences [30, 40, 41, 44] (Table 3). Zhao et al. conducted a multicentric open-label trial that compared favipiravir with a control group [45]. Patients were randomly assigned to receive favipiravir or treatments other than favipiravir, chosen at the discretion of the treating physician. Patients treated with favipiravir had a significantly shorter median time to positive-to-negative RT-PCR SARS-CoV-2 test conversion (17 days) compared to the control group (26 days; hazard ratio [HR]: 2.1 [95% confidence interval [CI] 1.1–4.0], p = 0.038). The trial ended after 30 days, at which time the favipiravir group had a significantly higher incidence of conversion to negative RT-PCR tests (80.6% [29/36]) compared to the control group (52.6% [10/19], p = 0.030). Mortality did not occur in either group within the 30-day study period. Shinkai et al. investigated the efficacy of favipiravir in COVID-19 patients without oxygen therapy in a single-blind, placebo-controlled trial [52]. Patients received favipiravir or a placebo on the same schedule. They defined clinical improvement by four clinical parameters: temperature, oxygen saturation, chest imaging findings, and viral clearance assessed with RT-PCR. Patients treated with favipiravir met the criteria for clinical improvement significantly earlier (11.9 days [95% CI: 10.0–13.1 days]) than patients in the placebo group (14.7 days [95% CI: 10.5–17.9 days], p = 0.014). The difference in time to improvement was also significant in the covariate-adjusted Cox proportional hazards model (HR: 1.59 [95% CI 1.02–2.48]). Within the individual parameters, time to improvement of chest imaging findings (p = 0.029) and time to conversion to negative RT-PCR (p = 0.041) were significantly shorter in the favipiravir group compared to the placebo group, while temperature (p = 0.18) and SpO 2 (p = 0.51) showed no significant difference (Table 3). Udwadia et al. conducted a multicentric, open-label trial to compare favipiravir to standard supportive care alone [35]. No significant difference was found in time to conversion to negative RT-PCR tests (p',\n",
       " ('COVID-19',\n",
       "  84,\n",
       "  1): '= 0.1290) or duration of hospital stay (p = 0.1079). However, the favipiravir group had a significantly shorter time to resolution of clinical symptoms (3 days [95% CI: 3–4 days]) compared to the control group (5 days [95% CI: 4–6 days], p = 0.030). Doi et al. [48] conducted a multicentric, open-label trial to compare patients treated with favipiravir starting on either day 1 (early) or day 6 (late) after their hospital admission. Patients received favipiravir for up to 10 days. Treatment could be discontinued after 6 days if their symptoms had resolved and they had two consecutive negative RT-PCR tests, meeting the requirements to be discharged from the hospital. Favipiravir did not significantly affect viral clearance by day 6 (HR: 1.416 [95% CI 0.764–2.623]). However, early treatment did lead to a significantly higher chance of viral clearance at day 6 in patients who were enrolled in the study more than three days after their first positive RT-PCR test (HR: 2.829 [95% CI 1.198–6.683]), indicating that there may be a window after infection where initiating treatment is more effective. Chen et al. compared favipiravir with umifenovir in COVID-19 patients [85] in a multicentric, open-label trial. Umifenovir is an antiviral drug that prevents cell attachment and viral entrance by trimerization of the SARS-CoV-2 spike glycoprotein. This blockade forms a naked or immature virus that less contagious [86]. Patients also received standard therapy, which consisted of antivirals, steroids, traditional Chinese herbal medicines, immunomodulatory drugs, steroids, antibiotics, psychotic drugs, nutritional supplements, and oxygen support. The primary outcome was rate of clinical recovery at day 7. Secondary outcomes were all-cause mortality, dyspnea, respiratory failure, auxiliary oxygen therapy or noninvasive mechanical ventilation (NMV), latency to pyrexia and cough relief, and need for intensive care. While no differences were found in clinical recovery (favipiravir 61.2% [71/116]; umifenovir 51.7% [62/120]; P = 0.1396) or in most secondary outcomes between treatments, favipiravir did shorten the latency of pyrexia and cough relief. Several trials did not find significant differences between treatment with favipiravir and their various comparator groups. Lou et al. conducted an open-label, single-center trial to evaluate the clinical outcomes and plasma concentrations of baloxavir acid and favipiravir in COVID-19 patients [30]. Patients were randomly assigned to one of three groups: a baloxavir marboxil group, a favipiravir group, and a control group, which included umifenovir. Median times from randomization to clinical improvement, viral negativity at day 7, and viral negativity at day 14 were similar between the three groups (Table 3). One patient in the baloxavir marboxil group and two patients in the favipiravir group were transferred to the ICU within 7 days due to declines in oxygen index or progressive disease on computed tomography (CT). One patient in the baloxavir marboxil group required extracorporeal membrane oxygenation (ECMO) support after 10 days. Dabbous et al. conducted a multicentric trial comparing favipiravir and chloroquine (CQ) in patients with confirmed cases of COVID-19 [41]. There were no significant differences between the groups in mortality (p = 1.00), duration of hospital stay (p = 0.060), mechanical ventilation (p = 0.118), or oxygen saturation (p = 0.129). Bosaeed et al. also compared favipiravir (10 days) and HCQ [40]. Nearly half of the favipiravir group discontinued therapy before the end of the trial due to pill burden or personal preference. This study found no significant difference in conversion to negative RT-PCR tests (p = 0.73), time to clinical improvement (p = 0.29), duration of hospital stay (p = 0.42), 28-day mortality (p = 0.45), and 90-day mortality (p = 0.91). Solaymani-Dodaran et al. conducted a multicentric, open-label trial to compare favipiravir (in addition',\n",
       " ('COVID-19',\n",
       "  84,\n",
       "  2): 'to HCQ) to LPV/r [44]. They found no significant differences between the groups for mortality (p = 0.52), transfer to the ICU (p = 0.47), time to clinical recovery (p = 0.54), incidence of clinical recovery (HR: 0.94 [95% CI 0.75–1.17]), or change in oxygen saturation (p = 0.46). Lopinavir/Ritonavir LPV/r is an HIV-1 protease inhibitor combination. Ritonavir is combined with lopinavir to increase the latter’s plasma half-life by inhibiting cytochrome P450 [87]. LPV/r is approved by the FDA for treatment of HIV-1 infection in adult and pediatric patients [88]. LPV/r has also exhibited efficacy to treat influenza, severe acute respiratory syndrome (SARS), and Middle Eastern respiratory syndrome (MERS) infection [89,90,91]. Nine RCTs included LPV/r for COVID-19 therapy: two large trials (RECOVERY [26] and TOGETHER [27]), and seven relatively smaller trials (n = 86–664) [24, 31, 37, 40, 44, 47]. The trial conducted by Solaymani-Dodaran et al. compared LPV/r to favipiravir and found no significant differences, as discussed in the Favipiravir section above [44]. Similarly, none of the other trials identified a significant positive effect of LPV/r on outcomes in COVID-19 patients. The RECOVERY trial was an open-label, platform trial conducted between March 19, 2020 and June 29, 2020 among 176 hospitals in the United Kingdom (UK). Patients were randomized to either standard of care alone or standard of care plus oral LPV/r for 10 days or until discharge. The primary outcome was 28-day all-cause mortality, which did not significantly differ between the intervention and control groups (rate ratio [RR] 1.03, 95% CI 0.91–1.17; P = 0.60), and the results were consistent among all pre-specified subgroups. There was also no difference in the time until discharge alive or proportion of patients discharged alive within 28 days (RR 0.98, 95% CI 0.91–1.05; P = 0.53). Additionally, there was no difference in the proportion of patients who met the composite endpoint of invasive mechanical ventilation or death among patients who were not on invasive mechanical ventilation at baseline (RR 1.09, 95% CI 0.99–1.20; P = 0.092). The TOGETHER trial was conducted between June 2, 2020 and September 20, 2020 in Brazil [27]. The trial compared LPV/r to HCQ or placebo. The trial was discontinued early after finding no significant difference between the groups in COVID-19-associated hospitalization (LPV/r: HR, 1.16 [95% CI, 0.53–2.56]) or viral clearance at day 14 (LPV/r: odds ratio [OR], 1.04 [95% CI, 0.94–1.16]). Incidence of mortality was similar between the LPV/r and placebo groups. Ader et al. also compared LPV/r to HCQ and control, in addition to LPV/r with IFN-β-1a, and discontinued the LPV/r and HCQ arms early due to lack of significant difference in clinical status at day 15 compared to control [37]. Arabi et al. also conducted a randomized, multicentric trial comparing LPV/r, HCQ, or a combination to a control group with no antiviral therapy [40]. They found a 98.5% probability of harm compared to control for LPV/r alone based on in-hospital mortality. Cao et al. conducted an open-label trial comparing LPV/r to standard of care in patients with SARS-CoV-2 infection and hypoxia [24]. There was no difference in time to clinical improvement (HR 1.24, 95% CI 0.90–1.72) or mortality at 28 days (19.2% vs. 25.0%; mean difference -5.8, 95% CI -17.3–5.7). The LPV/r group had a shorter median time to clinical improvement by one day compared to standard care alone on a modified intention-to-treat analysis (HR 1.39, 95% CI 1.00–1.91). Three studies compared umifenovir to LPV/r [31, 47]. Li et al. conducted an exploratory trial to study the efficacy and safety of LPV/r versus umifenovir in patients with mild to moderate COVID-19 [31]. There were no',\n",
       " ('COVID-19',\n",
       "  84,\n",
       "  3): 'differences in positive-to-negative conversion of SARS-CoV-2 RT-PCR tests on days 7 and 14. Also, there were no differences in mean time to test conversion (9.0, 9.1, and 9.3 days; P = 0.981) or in the conversion rate from moderate to severe/critical clinical status (23.5%, 8.6%, and 11.8%; P = 0.206) among LPV/r, umifenovir, and control groups, respectively. Nojomi et al. investigated the efficacy of umifenovir compared to LPV/r in COVID-19 patients [31]. The patients were randomized to receive umifenovir or LPV/r for 7–14 days, based on disease severity, as well as HCQ on day 1. Patients that received umifenovir had a shorter duration of hospitalization (7.2 days) compared to patients that received LPV/r (9.6 days, P = 0.02). Moreover, 81% of patients in the umifenovir group had mild involvement on chest CT after 30 days of admission compared to 53% in the LPV/r group (P = 0.004). Alavi Darazam et al. compared a combination of LPV/r, HCQ, and IFN-β1a with and without umifenovir in a single-center, open-label trial [47]. All patients received LPV/r, HCQ, and IFN-β1a. Half of the patients also received umifenovir. The groups did not have a significant difference in mortality (p = 0.62) or time to clinical improvement (p = 0.22), defined as improvement by two points on a seven-category ordinal scale. No significant difference in mortality was found between the groups when adjusted for time between symptom onset and trial enrollment either (presentation ≤ 7 days from symptom onset, p = 0.49; > 7 days, p = 1.00), indicating that starting treatment earlier is unlikely to affect the efficacy of combining umifenovir with LPV/r and other treatments. Remdesivir Remdesivir is an RNA-dependent RNA polymerase inhibitor with in-vitro activity demonstrated against SARS-CoV-2 and MERS-CoV [34, 92]. It is FDA-approved for COVID-19 treatment in adult and pediatric patients (12 years or older and weighing at least 40 kg) requiring hospitalization [93]. We identified six trials used remdesivir to treat COVID-19. Three trials found significant differences between the remdesivir treatment and comparator groups [23, 34, 53] and three did not [36, 39, 51]. The Adaptive Covid-19 Treatment Trial (ACTT-1) was a multicentric, double-blind, placebo-controlled trial of remdesivir in patients with severe COVID-19 pneumonia [23]. Median recovery times were lower in the remdesivir group, with a rate ratio for recovery of 1.29 (95% CI 1.12–1.49, P < 0.001). The patients who received remdesivir were more likely to have clinical improvement by day 15 when compared to placebo (OR 1.5, 95% CI 1.2–1.9, after adjustment for actual disease severity). The Kaplan–Meier estimates of mortality at days 15 and 29 were 6.7% and 11.4% in the remdesivir group and 11.9% and 15.2% in the control group, respectively. Spinner et al. compared remdesivir to standard of care in a multicentric, open-label trial of hospitalized patients with moderate COVID-19 pneumonia [34]. Patients were randomized to receive remdesivir for 5 or 10 days or standard care alone. On day 11, the odds for a better clinical status distribution were greater in the 5-day remdesivir group as compared to the standard care group (OR 1.65, 95% CI 1.09–2.48; P = 0.02) but was not significant between 10-day remdesivir and standard care groups (P = 0.18 by Wilcoxon Rank Sum test). Mortality at day 28 was 1%, 2%, and 2% in 5-day remdesivir, 10-day remdesivir, and standard care groups, respectively. Goldman et al. also compared five- and ten-day courses of remdesivir [53]. Their open-label, phase 3 trial included patients with confirmed SARS-CoV-2 infection, SpO 2 of ≤ 94% on room air, and radiologic evidence of pneumonia. The patients randomized to the 10-day group had significantly worse clinical',\n",
       " ('COVID-19',\n",
       "  84,\n",
       "  4): 'status than those in the 5-day group, as assessed on a seven-category ordinal scale (p = 0.02). Discharge rates were higher in patients whose symptoms started less than 10 days before receiving the first dose of remdesivir (62%) than in those whose symptoms started 10 or more days before their first dose (49%), indicating that regardless of drug regimen, there may be advantages to starting remdesivir earlier. Several trials found no significant effect of remdesivir on patient outcomes. Wang et al. conducted a double-blind, placebo-controlled, multicenter trial in COVID-19 patients with SpO 2 ≤ 94% in room air or PaO 2 /FiO 2 ratio ≤ 300 mmHg and radiological evidence of pneumonia [36]. Patients were assigned to remdesivir or placebo, along with standard of care. There was no difference in time to clinical improvement with remdesivir as compared to placebo (HR 1.23, 95% CI 0.87–1.75). Time to clinical improvement in a subgroup of patients with symptom duration ≤ 10 days was not significantly different with remdesivir compared to placebo (HR 1.52, 95% CI 0.95–2.43). Mahajan et al. conducted a trial comparing remdesivir to standard of care in patients over 40 years old with moderate to severe COVID-19, but not on mechanical ventilation [51]. Clinical status was assessed with a six-point ordinal scale based on need for oxygen supplementation and ventilation, hospitalization and mortality status. The groups showed no significant difference in clinical status at day 24, including hospitalization and mortality (p = 0.749), despite the potential bias towards the remdesivir group found in the risk of bias assessment (Additional file 1). Discharge rates were higher for patients who received treatment less than 5 days after symptom onset regardless of treatment group. Barratt-Due et al. also conducted a RCT comparing remdesivir, HCQ, or standard of care alone and found no significant differences between the groups for in-hospital mortality (HR: 1.0 [95% CI 0.4–2.9]) and the groups had similar rates of viral clearance [39]. Sofosbuvir/Daclatasvir Sofosbuvir and daclatasvir are antiviral agents that inhibit viral RNA replication via NS5A and NS5B polymerase inhibition, respectively [94, 95]. Sofosbuvir and daclatasvir are FDA-approved for treatment of chronic hepatitis C [51]. SARS-CoV-2 possesses similar mechanisms of RNA replication as observed in other RNA viruses; as such, sofosbuvir and daclatasvir combined may demonstrate efficacy to inhibit SARS-CoV-2 replication [22, 96, 97]. We identified seven RCTs that used sofosbuvir and daclatasvir or a combination of sofosbuvir and other drugs to treat COVID-19. Of the RCTs that used sofosbuvir/daclatasvir, all five reported significantly better results for the treatment group for at least one outcome, although the magnitude of the effect was often small [22, 32, 33, 46, 49]. Of the three RCTs that included sofosbuvir combined with drugs other than daclatasvir, none reported significant differences between the treatment and control groups [28, 43, 46]. Sadeghi et al. conducted a phase 3, multicenter trial to compare the effects of sofosbuvir/daclatasvir with standard of care versus standard of care alone (HCQ and LPV/r at physician discretion) in moderate to severe COVID-19 patients [33]. Sofosbuvir/daclatasvir was started later than treatment in the control arm due to delays in receiving RT-PCR reports. Clinical recovery within 14 days from enrollment was achieved in 88% (29/33) of patients in the sofosbuvir/daclatasvir arm and 67% (22/33) of patients in the control arm (P = 0.076). Patients in the sofosbuvir/daclatasvir group experienced shorter hospital stays than patients in the control group (6 [4–8] days vs. 8 [5–13] days, respectively; P = 0.029), and the sofosbuvir/daclatasvir group exhibited a higher cumulative incidence of hospital discharge as compared to the control group (Gray’s P = 0.041). All-cause mortality was',\n",
       " ('COVID-19',\n",
       "  84,\n",
       "  5): 'similar between groups. Abbaspour Kasgari et al. conducted a single-center trial to evaluate the efficacy of sofosbuvir/daclatasvir in combination with ribavirin compared to standard of care (including other antivirals) for hospitalized patients with moderate COVID-19 [22]. Secondary outcomes included the frequency of ICU admission, duration of ICU admission, the frequency and time to recovery, mechanical ventilation, and invasive mechanical ventilation. There were no statistically significant differences in secondary outcomes between the two groups except for cumulative incidence of recovery (Gray’s P = 0.033), which was higher in the sofosbuvir/daclatasvir arm. Roozbeh et al. investigated the efficacy of sofosbuvir/daclatasvir combined with HCQ for the treatment of COVID-19 outpatients compared to HCQ and standard of care using a double-blinded trial [32]. There was no difference between groups in the primary endpoint of symptom alleviation at day 7 follow-up or in the secondary endpoint of hospital admission (1 patient hospitalized in treatment group, 4 hospitalized in control group). Two patients in the sofosbuvir/daclatasvir arm reported fatigue at 1 month follow-up, while 16 patients reported fatigue in the control arm (P < 0.001). Dyspnea at 30-day follow-up was less common in the sofosbuvir/daclatasvir arm (14.8% [4/27]) than in the control arm (42.3% [11/26], P = 0.035). El-Bendary et al. conducted a multi-centric trial comparing sofosbuvir/daclatasvir combined with HCQ to HCQ alone [49]. Patients treated with sofosbuvir/daclatasvir had a significantly lower median duration of hospitalization (8 days vs. 10 days in control group, p < 0.01) and a higher incidence of negative RT-PCR tests at day 14, with 84% (81/96) negative compared to 47% (37/78) negative in the control group (p < 0.01). The groups showed no significant differences in mortality (p = 0.07), ICU admission (p = 0.10), and clinical improvement on a seven-category ordinal scale (p = 0.07). The risk of bias assessment identified potential bias in favor of the sofosbuvir/daclatasvir group, but the potential bias was not expected to fully account for the effect observed (Additional file 1). Abbass et al. compared sofosbuvir/daclatasvir to standard of care, with all patients receiving additional therapies, such as HCQ, ivermectin, LPV/r, or remdesivir, at the treating physician’s discretion [46]. Patients receiving sofosbuvir/daclatasvir showed significant clinical improvement compared to standard of care on both day 7 (p = 0.041) and day 10 (p = 0.040), as measured by the number of clinical symptoms experienced relative to day 3. The sofosbuvir/daclatasvir group also showed significant improvement in SpO 2 (91.3% ± 4.7%) compared to the standard of care group (87.4% ± 8.8%, p = 0.016) starting on day 4 and continuing until the data collection ended on day 10. The groups did not have significant differences in incidence of viral clearance (p = 0.581), ICU admission (p = 0.254), or mortality (p = 0.329). Three RCTs combined sofosbuvir with other drugs. Abbass et al. included sofosbuvir/ravidasvir along with sofosbuvir/daclatasvir [46]. They found no significant difference between sofosbuvir/ravidasvir and standard of care in clinical improvement (p = 0.66969), oxygen saturation (p = 0.054), viral clearance (p = 0.893), ICU admission (p = 0.254), or mortality at day 10 (p = 0.329). Khalili et al. compared sofosbuvir/ledipasvir to standard of care alone [28]. They found that sofosbuvir/ledipasvir had a shorter time to clinical improvement (2 [1–3.75]) compared to control (4 [2–5, p = 0.02), but no significant differences in incidence of clinical improvement (p = 0.65), duration of hospital stay (p = 0.98), or 14-day mortality (p = 0.60) between the groups. Sayad et al. compared sofosbuvir/velpatasvir to standard of care alone [43]. They likewise found no difference in 28-day mortality (p = 0.38), time to clinical improvement (HR:',\n",
       " ('COVID-19',\n",
       "  84,\n",
       "  6): '1.2 [95% CI 0.6–2.2], p = 0.30), or conversion to negative RT-PCR tests (p = 0.49). Enisamium One study evaluated the efficacy of enisamium, an antiviral drug whose metabolite is a viral RNA polymerase inhibitor [98]. Holubovska et al. conducted a double-blind, placebo-controlled, phase 3 trial comparing enisamium to a placebo [50]. No differences in time to recovery was found overall or among patients who did not initially require oxygen. However, among patients who did require oxygen supplementation when enrolled, enisamium decreased the recovery time (11.1 days) compared to the placebo group (13.9 days, p = 0.0259). All patients in the enisamium group recovered by day 21, while not all patients in the placebo group recovered before data collection for interim analysis ended on day 29.',\n",
       " ('COVID-19',\n",
       "  85,\n",
       "  0): 'Abstract The pathology of coronavirus disease 2019 (COVID-19) is exacerbated by the progression of thrombosis, and disseminated intravascular coagulation (DIC), and cytokine storms. The most frequently reported coagulation/fibrinolytic abnormality in COVID-19 is the increase in d-dimer, and its relationship with prognosis has been discussed. However, limits exist to the utility of evaluation by d-dimer alone. In addition, since the coagulation/fibrinolytic condition sometimes fluctuates within a short period of time, regular examinations in recognition of the significance of the examination are desirable. The pathophysiology of disseminated intravascular coagulation (DIC) associated with COVID-19 is very different from that of septic DIC, and both thrombotic and hemorrhagic pathologies should be noted. COVID-19 thrombosis includes macro- and microthrombosis, with diagnosis of the latter depending on markers of coagulation and fibrinolysis. Treatment of COVID-19 is classified into antiviral treatment, cytokine storm treatment, and thrombosis treatment. Rather than providing uniform treatment, the treatment method most suitable for the severity and stage should be selected. Combination therapy with heparin and nafamostat is expected to develop in the future. Fibrinolytic therapy and adsorption therapy require further study Keywords: COVID-19, Thrombosis, Disseminated intravascular coagulation, DIC, Cytokine storm, SARS-CoV-2 Introduction Coronavirus disease 2019 (COVID-19) is an infection caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Eighty percent of infected individuals are asymptomatic or show only mild symptoms, but 20% of infected individuals become severely ill and 2–5% die. Men are well known to be infected more frequently than women, and the elderly and patients with comorbidities (such as cardiovascular disease, hypertension, diabetes, and obesity) are more likely to develop more severe disease [1–3]. However, severe disease can develop even in young people and those without comorbidities, and many points remain unclear regarding what factors contribute to the outcomes. Some genetic components may also be involved. In fact, sex differences have been reported in immunological responses to SARS-CoV-2 [4] and that relatively few people with blood type O are infected [5]. Respiratory failure is the most common cause of death, but coagulation activation accompanied by excessive immune/inflammatory reactions (representing the so-called cytokine storm), thrombosis and disseminated intravascular coagulation (DIC), and progression to multiple-organ failure are also causes of death [6–10]. In particular, thrombosis and DIC can lead to a rapid deterioration in condition. COVID-19-associated coagulopathy The most frequently described report related to COVID-19 coagulopathy is an increase in plasma d-dimer levels. Many studies have discussed the relationship between elevated d-dimer levels and prognosis [2, 11–13]. d-Dimer is produced in the blood as a result of degradation of stabilized fibrin polymer (fibrin crosslinked with factor XIII) by plasmin. That is, thrombus is formed in the body by coagulation activation, and is decomposed by fibrinolytic activation. Many papers have reported that elevated levels of d-dimer are associated with severity. However, if a large amount of thrombus forms in the body but it is not dissolved (representing the most serious condition for the body), the increase in d-dimer may be mild. Specifically, in the suppressed-fibrinolytic-type DIC caused by sepsis, the increase in d-dimer is relatively mild even in severe cases such as death [14]. Thus, it should be noted that the degree of the increase in d-dimer is not directly correlated with the severity of the pathological condition. Problems of previous studies using coagulation tests d-Dimer is certainly a useful marker in assessing the thrombotic pathology of COVID-19. However, previous reports discussing coagulation and fibrinolysis in COVID-19 have shown the following problems: Most studies have suggested that the prognosis can be estimated based on the level of d-dimer on admission (few studies have discussed changes in d-dimer levels over time); Among the coagulation',\n",
       " ('COVID-19',\n",
       "  85,\n",
       "  1): 'tests, d-dimer and prothrombin time (PT) are often measured, but fibrinogen, activated partial thromboplastin time (APTT), and fibrin/fibrinogen degradation products (FDP) are often left measured; and. Very few reports have examined thrombin–antithrombin complex (TAT) and plasmin-α 2 plasmin inhibitor complex (PIC), which are essential markers for coagulation and fibrinolysis activation, respectively. No studies appear to have evaluated with soluble fibrin (SF). Dynamic fluctuations in coagulation and fibrinolysis Figure 1 shows the results of classifying COVID-19 patients into survivors and non-survivors and tracking the coagulation/fibrinolytic pathologies [6]. That study was very valuable, not only because many coagulation markers were investigated in COVID-19 patients, but also because these markers were followed-up regularly. That paper is cited in almost every study discussing the coagulation and fibrinolysis pathology of COVID-19. The paper has three important points: Fig. 1. Open in a new tab Time-dependent changes in coagulation and fibrinolytic markers in COVID-19 (modified from Reference [6]. PT prothrombin time, APTT activated partial thromboplastin time, DD d-dimer, FDP fibrin/fibrinogen degradation products, Fbg fibrinogen, AT antithrombin High DIC complications in non-survivors The rate of COVID-19 complicated by DIC has been reported as 0.6% for survivors and 71.4% for non-survivors [6]. Thus, the rate of complication by DIC in fatal cases has been judged as very high. In other words, few survivors have DIC complications. Attention should be paid to the severe coagulopathy on Days 10 and 14 in fatal cases. Among test results, FDP ≥ 100 μg/mL, d-dimer of about 20 μg/mL, and fibrinogen of about 100 mg/dL were major abnormal findings. Since levels of d-dimer were mildly increased, while levels of FDP were extremely increased, a divergence phenomenon was observed between FDP and d-dimer levels. PT was clearly prolonged, but APTT prolongation was less noticeable. The decrease in antithrombin was also inconspicuous (maintained at ≥ 80%) (Fig. 1) [6]. These findings are significantly different from the suppressed-fibrinolytic-type DIC caused by sepsis, but rather consistent with the enhanced-fibrinolytic-type DIC [14]. In suppressed-fibrinolytic-type DIC, the increases in FDP and d-dimer are relatively mild, and the inflammatory reaction causes a rare decrease in fibrinogen. DIC in fatal cases with COVID-19 is very different from septic DIC. Prediction of prognosis by d -dimer level on admission Many studies have suggested that the prognosis of COVID-19 can be estimated by levels of d-dimer on admission [2, 11–13], but the paper by Tang et al. was a pioneering work [6]. However, accurate assessment of prognosis cannot be achieved with admission data alone. Large fluctuations in coagulation and fibrinolysis Interestingly, large fluctuations in coagulation and fibrinolysis markers were observed between Days 7 and 10 (Fig. 1) [6]. In fatal cases, fibrinogen was as high as about 400 mg/dL on Day 7, but dropped sharply to about 100 mg/dL on Day 10 (only 3 days later). FDP and d-dimer levels increased sharply in just 3 days. On the other hand, among survivors, almost no changes were seen during this same period. These short-term fluctuations mean that changes in pathology may be missed if coagulation and fibrinolysis markers are not followed regularly. Naturally, if the condition changes, treatment also needs to change. Attention should be paid to major bleeding during the pathological condition of enhanced-fibrinolytic-type DIC. Thus, with COVID-19, coagulation and fibrinolytic pathologies may change rapidly within a short period of time, and follow-up is required every 2–3 days. Thrombosis (particularly venous thromboembolism) has been noted to show a high incidence of COVID-19, and is certainly often associated with the severity of cases [15]. However, in critical cases of death (autopsy cases), not only thrombi, but also considerable bleeding has been observed [16]. This',\n",
       " ('COVID-19',\n",
       "  85,\n",
       "  2): 'means that in fatal cases, there is a possibility that suppressed-fibrinolytic-type DIC has changed to an enhanced-fibrinolytic-type DIC, representing a subject for future study. Coagulation tests required for COVID-19 To correctly evaluate coagulation and fibrinolytic pathology in COVID-19, performing the tests shown in Table 1 is important. Among reports in leading journals, even if d-dimer and PT are examined, few have examined fibrinogen, FDP, APTT, etc. Table 1. Coagulation and fibrinolysis tests to be performed in COVID-19 Markers Significance of test Platelets Decreased due to various causes (see text) PT Screening test for vitamin K deficiency (diagnosis confirmed by PIVKA-II) Evaluation of liver failure APTT UFH monitoring LA screening test Screening test for acquired hemophilia Fibrinogen Diagnosis of DIC (particularly enhanced-fibrinolytic-type DIC). Beware of short-term dips within a few days If fibrinogen rises, the patient is in a hypercoagulable state Evaluation of liver failure FDP/ d -dimer Diagnosis of DIC (particularly enhanced-fibrinolytic-type DIC). Watch out for short-term spikes within a few days. In enhanced-fibrinolytic-type DIC, FDP increases markedly, but d -dimer increases only mildly to moderately, so a divergence phenomenon is observed between FDP and d -dimer levels Diagnosis of macro- or microthrombosis Reflecting lung damage Antithrombin Evaluation of liver failure If the activity is decreased in patients with DIC, consider administration of a concentrated antithrombin preparation TAT Evaluation of coagulation activation PIC Evaluation of fibrinolytic activation α 2 PI If α 2 PI activity is significantly decreased in a case where PIC is significantly increased, major bleeding is likely to occur VWF antigen and activity Screening test for acquired von Willebrand syndrome. In acquired von Willebrand disease, VWF activity is reduced compared to the amount of VWF antigen Open in a new tab APTT prolongation was frequently seen in COVID-19, and the presence of lupus anticoagulant was identified at a high rate [17, 18]. It should be noted that APTT testing in patients with COVID-19 also provides information useful for screening for lupus anticoagulant as well as monitoring heparin. In enhanced-fibrinolytic-type DIC, FDP fluctuates with better sensitivity than d-dimer [6, 13, 14]. By measuring both FDP and d-dimer, the divergence phenomenon between the two markers in enhanced-fibrinolytic-type DIC can be confirmed, so frequent measurement of both markers is desirable. Fibrinogen can also be measured regularly to check for changes in the type of DIC. In particular, when fibrinogen levels decrease sharply, the disease type may have changed from suppressed-fibrinolytic-type DIC to enhanced-fibrinolytic-type DIC. TAT, a coagulation activation marker, and PIC, a fibrinolytic activation marker, are essential markers for accurately evaluating coagulation and fibrinolytic pathology in COVID-19. By measuring these markers, the coagulation and fibrinolytic pathologies of COVID-19 will be greatly clarified. In cases with DIC in which PIC is markedly increased, caution is required, because major bleeding is likely to occur when α 2 plasmin inhibitor is reduced to less than half. In cases where antithrombin activity is significantly reduced, the sensitivity of TAT may be reduced. In such cases, evaluation with soluble fibrin (SF) may be useful. Extracorporeal membrane oxygenation (ECMO) may be required in severe cases of COVID-19. Schmidt et al. reviewed the outcomes of COVID-19 patients under ECMO that could be followed-up to Day 60, reporting a mortality rate of 31%, major bleeding in 42%, and hemorrhagic infarction in 5% [19]. If no adverse events of bleeding were encountered, better results could be expected. Bleeding symptoms when undergoing ECMO are often considered adverse events due to heparin used to maintain the ECMO circuit. However, according to Schmidt et al., the intensity of anticoagulant therapy was appropriate [19] and was unlikely to be the main cause of',\n",
       " ('COVID-19',\n",
       "  85,\n",
       "  3): 'bleeding. The following mechanisms should thus be considered as the reason for bleeding under ECMO: Complications of enhanced-fibrinolytic-type DIC: described above; Vascular endotheliitis: Severe COVID-19 is considered to cause severe vascular endothelial injury and vascular fragility [20]; Acquired von Willebrand syndrome: The large multimer of von Willebrand factor is known to be decomposed by high shear stress during extracorporeal circulation such as ECMO [21, 22]. In this case, von Willebrand factor activity is reduced as compared with the amount of von Willebrand factor antigen. A von Willebrand factor multimer structural analysis is required for definitive diagnosis. In COVID-19, not only thrombosis, but also bleeding complications are likely to be seen, and the coagulation tests shown in Table 1 need to be repeated to prevent them. Macrothrombosis In COVID-19, both arterial and venous thrombosis have been reported due to the strong thrombotic tendency. Specifically, arterial thrombosis includes cerebral infarction, myocardial infarction, and limb arterial thrombosis, and venous thrombosis includes deep vein thrombosis (DVT) and pulmonary thromboembolism (PTE). In general, DVT and PTE may occur at the same time, and have been collectively referred to as venous thromboembolism (VTE). Of these thromboses, VTE, and PTE in particular, is the most common in COVID-19 [23] (Fig. 2). Fig. 2. Open in a new tab Sites of thrombosis and bleeding in COVID-19. (Quoted from Reference [23] In addition, as a characteristic of VTE in COVID-19, PTE can develop due to the arrival of DVT thrombus, but more often, PTE develops even without DVT. To be precise, pulmonary thrombosis (PT) is more frequent than pulmonary embolism (PE) [24]. A study of 184 severe COVID-19 cases admitted to the ICU found 75 cases of thrombosis [25]. The breakdown of thrombosis was PTE in 65 cases, DVT in 3 cases, cerebral infarction in 5 cases, and systemic arterial embolism in 2 cases. After all, PTE makes up the overwhelming majority of thrombosis in severe cases and DVT is not so common. Therapeutic administration of anticoagulant therapy did not lead to suppression of the onset of thrombosis [25]. One report classified and examined ICU inpatients (severe cases) and general ward inpatients (mild cases) [26]. About 60% of ICU inpatients had VTE, compared to about 10% of general ward inpatients. Cumulative incidence of VTE increased gradually up to 3 weeks in ICU patients and up to 1 week in general wards, with no subsequent new onset in either group. In other words, attention to VTE in the early stages of hospitalization is considered particularly important. Also in that report, VTE developed even if anticoagulant therapy was initiated prophylactically [26]. In the future, reports on the incidence of thrombosis from Japan are also awaited. However, you must keep in mind the level to which the inspection has been carried out. For example, in patients under ventilator or ECMO management, onset of cerebral infarction may be overlooked and diagnostic imaging may not be performed promptly. In addition, a definitive diagnosis of VTE cannot be made without contrast-enhanced CT of the chest and lower limb vein echography. A dilemma exists regarding the risk of institutional transmission of COVID-19 and how vigorously the diagnosis of thrombosis should be pursued. Microthrombosis Macrothrombosis such as VTE can be diagnosed by imaging modalities such as contrast-enhanced CT, but the existence of multiple microthromboses at the microscopic level, and thus unable to be diagnosed by imaging, has been clarified on autopsy. In the autopsy cases of Fox et al., gross findings showed thrombi in peripheral blood vessels of the lung and enlargement of the right ventricle, but microscopic observation at the same time showed many thrombi in',\n",
       " ('COVID-19',\n",
       "  85,\n",
       "  4): 'the small arteries and small veins of the lung [16]. These thrombi contained both fibrin and platelet components. Since it is accompanied by vascular endothelial damage, the pathophysiology of thrombotic microangiopathy (TMA) may be added to the lungs, but this point is a matter for future investigation. In an autopsy study by Lax et al., microscopic thrombi were found in the small to middle-sized arteries of the lungs in all 11 cases, even though prophylactic anticoagulant therapy had been administered in 10 of the 11 cases. Eight cases showed pulmonary infarction [27]. Interestingly, VTE was not diagnosed in any of the cases before death. In an autopsy study of 38 cases by Carsana et al., microthrombi (containing platelets and fibrin) were observed in the pulmonary microarteries in 33 cases (87%) [28]. In all 26 cases for which d-dimer could be examined, levels increased more than 10 times the upper limit of normal. What was noteworthy in that report was that not only the presence of thrombosis, but also alveolar hemorrhage was observed in 33 cases (87%) with the same frequency. Although no markers to accurately assess fibrinolytic activation were measured in that paper, the pathology of enhanced-fibrinolytic-type DIC may have been present in those fatal cases. One interesting report compared acute respiratory distress syndrome (ARDS) caused by COVID-19 and influenza [29]. Diffuse alveolar damage (DAD) was found in both types. However, COVID-19 showed severe vascular endothelial damage (presence of virus in endothelial cells, destruction of cell membranes) and extensive thrombi. In particular, when compared at the alveolar capillary level, the degree of microthrombosis was 9 times higher in COVID-19 than in influenza, and the higher degree of microthrombosis in the lungs of COVID-19 was conspicuous. Regarding angiogenesis, COVID-19 showed 2.7 times as much as influenza, but the new blood vessels did not display normal antithrombotic function, and were thus considered to accelerate thrombosis. Pulmonary intravascular coagulopathy In severe COVID-19, the thrombotic tendency is systemic, with a strong immunoinflammatory response described as a “cytokine storm”. However, the opinion has been put forward that this phenomenon should instead be called “pulmonary intravascular coagulopathy”, as opposed to DIC, because the thrombosis occurs overwhelmingly in the lungs rather than the whole body [30–33]. This so-called pulmonary intravascular coagulopathy shows not only macrothrombosis in the lung, but also frequently the more troublesome microthrombosis in a wide area of lung. In other words, anticoagulant therapy is needed while assuming microthrombosis of the lung, which cannot be detected from contrast-enhanced CT of the chest. Pathologically proving microthrombosis during survival may be difficult, but especially in cases of high d-dimer, the presence of thrombosis (microthrombosis) is assumed even if not diagnosed from diagnostic imaging. A therapeutic strategy for antithrombotic therapy should be developed for such patients. The site of SARS-CoV-2 has been examined at autopsy [34]. Although also present in the kidneys, liver, heart, brain, and blood, the amount of SARS-CoV-2 detected in the respiratory region is overwhelmingly greater. This is related to the degree of expression of angiotensin-converting enzyme 2 (ACE2), which represent a host-side receptor for SARS-CoV-2 in each organ. COVID-19 is known to occur less frequently in children, but this is attributed to the low expression of ACE2 in children [35]. Origin of d -dimer Normally, an increase in d-dimer is thought to reflect the activation of both coagulation and fibrinolysis in vivo. In contrast, one report has discussed the origin of d-dimer in COVID-19. The idea of that paper was that the rise in d-dimer reflects the degradation products of fibrin accumulating in the alveoli and lung parenchyma as a result of lung injury',\n",
       " ('COVID-19',\n",
       "  85,\n",
       "  5): '[36]. In other words, d-dimer is considered to move from the local lung to the bloodstream. Indeed, given that the origin of d-dimer is fibrin formed locally in the lungs, d-dimer could thus be easily understood to be associated with the degree and prognosis of lung injury. d-Dimer often rises in patients with massive pleural effusion, massive ascites, and massive hematoma, and this is thought to be due to the movement of d-dimer from pleural effusion, ascites and hematoma into the bloodstream. A similar situation may be present in COVID-19. Proving that d-dimer moves from the alveoli into the bloodstream may be difficult, but the concept is interesting. Decreased platelet and lymphocyte counts Several studies have discussed the relationship between prognosis of COVID-19 and platelet count [37–39]. Among these, one report examined 1476 cases from a single facility [37], of whom 238 patients (16.1%) died. Mortality rates were reported as 92.1%, 61.2%, 17.5%, and 4.7% when minimum platelet counts were 0–5 × 104/μL, 5–10 × 104/μL, 10–15 × 104/μL, and ≥ 15 × 104/μL, respectively. When the platelet count fell below 10 × 104/μL during the course of treatment, the prognosis became particularly severe. Furthermore, if the platelet count dropped below 5 × 104/μL, the situation was considered hopeless if no breakthrough treatment was given. The cause of decreasing platelet counts was considered to be DIC in that paper [37]. Many drugs used during the treatment of COVID-19 may result in drug-induced decreases in platelet production (myelosuppression). Such circumstances are easily distinguished by checking the immature platelet fraction (IPF). If IPF rises, myelosuppression can be ruled out. Currently, the number of facilities that can measure IPF is increasing in Japan, so this investigation should be actively utilized. Mean platelet volume (MPV) and platelet distribution width (PDW) can also be used to distinguish whether the cause of decrease in platelet count is myelosuppression [40, 41]. In fact, IPF correlates positively with MPV and PDW. In addition, MPV and PDW are advantageous, because the data can be collected using standard equipment in all medical institutions and for all cases. However, one limitation of MPV and PDW is that they cannot be calculated if the platelet count is significantly reduced. Decreased platelet counts appear to be seen in COVID-19 itself, but many causes of decreased platelet counts have been reported (Table 2). As mentioned above, various reports have described the complication of DIC [6–10]. Antiphospholipid antibodies (anticardiolipin antibody and lupus anticoagulant) appear at a high rate [17, 18, 42–44]. If thrombosis is seen, antiphospholipid antibody syndrome is diagnosed. However, antiphospholipid antibodies long been known to show temporary positivity in viral infections (in this case, unrelated to thrombosis). The extent to which antiphospholipid antibodies in COVID-19 are associated with thrombosis warrants further study [45]. Immune thrombocytopenic purpura (ITP) have also been reported in COVID-19 [46–48]. If a sharp and marked drop in platelet count is present, ITP is possible if DIC is negative. Hemophagocytic syndrome has also been reported with cytokine storms [49, 50]. In COVID-19 cases, ready performance of bone marrow examination is presumably difficult, so many cases of hemophagocytic syndrome may go undiagnosed. Along with proper diagnosis, how to address this finding is a topic for further study [51–53]. Table 2. Causes of decreased platelet counts in COVID-19 1) COVID-19 itself 2) Disseminated intravascular coagulation (DIC) 3) Antiphospholipid antibody syndrome (APS) 4) Immune thrombocytopenic purpura (ITP) 5) Hemophagocytic syndrome (HPS) 6) Heparin-induced thrombocytopenia (HIT) 7) Drug-induced myelosuppression 8) Pseudo-thrombocytopenia Open in a new tab Heparin is often used during the treatment of COVID-19, and heparin-induced thrombocytopenia (HIT) is often reported [54, 55].',\n",
       " ('COVID-19',\n",
       "  85,\n",
       "  6): 'This diagnosis should not be delayed, and proactive measurement of HIT antibodies is needed. There are also reports of pseudothrombocytopenia [56]. In this report, treatment with COVID-19 eliminated the phenomenon of pseudothrombocytopenia, as well as the disappearance of SARS-Cov-2 antibody. The association between SARS-Cov-2 antibody and pseudothrombocytopenia has been discussed. Lymphocytes are known to decrease in particularly severe cases of COVID-19 [1, 57, 58]. Both CD4- and CD8-positive cells are decreased, and a strong correlation exists between lymphocyte count and CD4-positive cells [57, 59]. In addition, CD4-positive cells show reduced IFN-γ production [57]. These changes are associated with disease severity, and thus should be kept in mind during the development of future treatments. Some studies have suggested that the neutrophil-to-lymphocyte ratio is associated with the severity and prognosis of COVID-19 [58, 60, 61]. Treatment strategy for COVID-19 Treatment strategy should be changed according to the severity and stage of COVID-19, rather than applying a uniform treatment (Fig. 3). In addition, therapeutic methods and drugs have been listed in various candidate steps, starting from the first-step therapeutic strategy to prevent SARS-CoV-2 from invading the host cell, to final-stage cytokine storm control [62–65]. Fig. 3. Open in a new tab Stage of COVID-19 and concept of treatment (created by the authors) Antiviral treatment for COVID-19 Several known drugs and treatment methods represent candidate therapeutic agents from the viewpoint of antiviral effect (Table 3). At present, some treatments appear not very effective and others seem promising. Antiviral treatment is considered to be the most significant, particularly in the early stages of infection (Fig. 3). Table 3. Treatment for COVID-19 1 Antiviral drug (anti-SARS-Cov-2 action) 1) Favipiravir (Abigan): RNA polymerase inhibitor. Influenza drug 2) Remdesivir (Beckley): RNA polymerase inhibitor. Ebola bleeding drug. Special approval on May 7, 2020 in Japan 3) Ivermectin (Stromectol): Macrolide antibiotic. Anthelmintic 4) Hydroxychloroquine (Plaquenil): Antimalarial drug. SLE therapeutic drug 5) Lopinavir/ritonavir combination drug (Kaletra): Protease inhibitor. HIV treatment 6) Ciclesonide (Alvesco): Inhaled steroid asthma treatment. Has anti-SARS-CoV-2 action 7) Nafamostat (Futhan, Coahibitor, etc.): Serine protease inhibitor. A therapeutic drug for DIC and pancreatitis in Japan. Inhibits the serine protease TMPRSS2 8) Camostat (Foipan): A serine protease inhibitor. A remedy for pancreatitis in Japan. The inhibitory effects on TMPRSS2 are weaker than those of nafamostat 9) Vaccine: Under development by many companies 10) Convalescent plasma treatment: Expected therapeutic effects through antibody obtained from the serum of convalescent patients 2 Treatment of cytokine storm 1) Tocilizumab, salilumab: anti-IL-6 receptor antibody 2) Anakinra: IL-1 receptor antagonist 3) JAK inhibitor 4) Anti-GM-CSF drug 5) Anti-complement antibody 6) Anti-TNF drug 7) Dexamethasone 8) Blood purification therapy using a cytokine adsorption column 3 Antithrombotic therapy 1) Unfractionated heparin (+ AT preparation: DIC with AT activity ≤ 70% is covered by insurance) 2) Low molecular weight heparin (+ AT preparation: as above) 3) DOAC (anti-Xa drug insurance coverage is venous thromboembolism) 4) Thrombomodulin preparation (insurance coverage is DIC) 5) Argatroban (Insurance coverage is for acute cerebral infarction, chronic arterial occlusion, HIT, etc.) 6) tPA: Reports have described both systemic administration and inhalation Open in a new tab Treatment for cytokine storm Many anti-cytokine therapies have been investigated, but the most reported is the anti-IL-6 receptor antibody tocilizumab [66–69]. Future development is expected, including combination therapies with other drugs. When the pathology of COVID-19 has progressed, the weight of cytokine storm treatment is considered to be significantly increased. Treatment for thrombosis Heparin is the most frequently used anticoagulant therapy for COVID-19. In countries other than Japan, low-molecular-weight heparin (LMWH) is often used. In Japan, LMWH (dalteparin) is approved for use by the insurance system only for DIC',\n",
       " ('COVID-19',\n",
       "  85,\n",
       "  7): 'and hemodialysis, and so in principle cannot be used for COVID-19 in the absence of DIC. Therefore, at present (as of October 2020), unfractionated heparin is estimated to be used more frequently than dalteparin in Japan. Heparin treatment for COVID-19 is expected to have anticoagulant, antiviral and anti-inflammatory effects [70–73]. Combination therapy of heparin and nafamostat for COVID-19 Nafamostat is a serine protease inhibitor that strongly inhibits proteolytic enzymes such as thrombin, plasmin, and trypsin [74]. Nafamostat has been used in Japan for over 30 years to treat DIC and pancreatitis. The optimal dose of nafamostat varies depending on the purpose of use, and a higher dose (about 10 times greater) can be used for DIC than for pancreatitis. Nafamostat differs from heparin, in that no side effects of bleeding are seen even when used at DIC doses. Nafamostat is compatible with enhanced-fibrinolytic-type DIC because of the strong antifibrinolytic activity [14, 74]. In Japan, nafamostat is often effective even for enhanced-fibrinolytic-type DIC associated with aortic aneurysm and malignant tumors, where the underlying pathology does not improve. COVID-19 shows the characteristics of enhanced-fibrinolytic-type DIC in advanced cases as described above, and nafamostat is thus considered to be a promising candidate. However, the problem with nafamostat is the weaker anticoagulant effect compared to the antifibrinolytic effect [74]. A combination of heparin and nafamostat to overcome this weakness may thus be even more effective [75]. Three reasons nafamostat is effective against COVID-19 Anti-coronavirus action Hoffmann et al. reported that ACE2 and transmembrane protease serine 2 (TMPRSS2) present in host cells are essential for coronaviruses such as SARS-CoV-2 to infect alveolar epithelial cells [76]. Inoue et al. reported in 2016 that nafamostat can inhibit the infection of host cells by MERS-CoV, through inhibition of TMPRSS2 activity [77]. Nafamostat can also block the invasion of SARS-CoV-2 into host cells [78–80]. Injectable nafamostat has more than 10 times the inhibitory activity against coronavirus invasion as the serine protease inhibitor camostat (an oral drug for treating pancreatitis in Japan) [79, 80]. Moreover, when nafamostat is used for DIC as described above, about 10 times the dose used for pancreatitis can be administered. Beneficial effects on DIC COVID-19 is an infectious disease, but shows many differences from the suppressed-fibrinolytic-type DIC caused by other severe infectious diseases. Significant fibrinolytic activation by cytokine storm is expected in advanced, severe cases of COVID-19. We have also confirmed that, as reported by Tang et al. [2], some cases of severe COVID-19 show markedly increased FDP and markedly decreased fibrinogen. In such severe cases, one characteristic is a significant increase in not only TAT, as a coagulation activation marker, but also PIC, as a fibrinolytic activation marker. We have encountered cases in which these increases in TAT and PIC often improve dramatically with heparin and nafamostat combination therapy. Nafamostat is a compatible treatment for DIC associated with COVID-19 [75]. Anti-plasmin action Plasmin has been reported to increase the pathogenicity and infectivity of the SARS-CoV-2 virus by cleaving the S protein [81]. Nafamostat has antiplasmin activity [74] and is expected to reduce the pathogenicity and infectivity of SARS-CoV-2. Tranexamic acid is known as a drug exerting strong antiplasmin (antifibrinolytic) activity. Tranexamic acid may act suppressively on SARS-CoV-2 in terms of antiplasmin, and actual clinical trials are underway [82]. However, tranexamic acid may induce fatal thrombosis and should not be administered without caution [83]. In that respect, nafamostat can be safely used because of its antiplasmin action in combination with antithrombin action. Nafamostat is reportedly effective against COVID-19 [84, 85], but the significance of this agent in combination with heparin is hoped to be verified.',\n",
       " ('COVID-19',\n",
       "  85,\n",
       "  8): 'Nafamostat administered during ECMO treatment (heparin is required) is inevitably administered in combination with heparin. We would like to name this combination “Hepana therapy”, as an easy-to-remember term. Nafamostat should be noted to have a side effect of hyperkalemia, so electrolyte levels should be checked regularly. Prospects for fibrinolytic therapy -including inhalation therapy- Heparin, particularly LMWH, is often used to correct the thrombotic condition in COVID-19, but pulmonary embolism is nevertheless seen in about 20–30% of severe cases [86]. The dose and intensity of anticoagulant therapy is also controversial. Treatment with anticoagulant therapy alone may offer limited efficacy. Fibrinolytic therapy may therefore be effective against COVID-19 [87]. Treatment of existing fibrin, which interferes with pulmonary circulation, using a fibrinolytic drug is expected to improve thrombotic conditions. In fact, systemic administration of the fibrinolytic drug tissue-type plasminogen activator (tPA) to ARDS in COVID-19 has been attempted and appears effective in some cases [88–90]. However, careful attention should be paid to systemic administration of tPA for severe COVID-19 with ARDS. As mentioned above, coagulation and fibrinolytic pathophysiology in COVID-19 can fluctuate significantly within just a few days [6]. Performing systemic fibrinolytic therapy is performed at a time of a marked decrease in fibrinogen is extremely dangerous and may cause fatal bleeding, including cerebral hemorrhage. On the other hand, treatment by “inhalation” of fibrinolytic substances such as tPA and plasminogen may be associated with relatively little concerns regarding bleeding at any stage of COVID-19 [87, 91, 92]. Inhalation of fibrinolysis-related substances may dissolve fibrin-containing exudates in the alveolar space to improve alveolar ventilation, and may dissolve fibrin thrombi at the microcirculatory level near the alveoli. Fibrin formed in the lung parenchyma may be expected to dissolve. However, many problems remain to be solved, such as whether the infection spreads in medical institutions via aerosols and how much tPA administered by inhalation is transferred to the blood. We expect future developments. Adsorption therapy as a cytokine storm treatment As mentioned above, treatment with anti-IL-6 receptor antibody is one of the candidates for cytokine storm treatment. In addition, we would also like to mention adsorption therapy using cartridges such as polymyxin B (PMX-DHP). This is an extracorporeal circulatory therapy similar to ECMO, with a history of being used mainly for septic endotoxin shock caused by Gram-negative bacilli. Some pros and cons exist regarding the indications of PMX-DHP for COVID-19, partly because this treatment was not sufficiently effective against septic endotoxin shock. However, for ARDS caused by cytokine storms in influenza 2009 (N1H1), respiratory status reportedly improved dramatically after only 4 h of PMX-DHP treatment [93]. PMX-DHP could also improve respiratory failure with decreased IL-6 in patients with amyopathic dermatomyositis who presented with respiratory failure due to acute progressive interstitial pneumonia [94]. In addition, the clinical experience of PMX-DHP for ARDS in COVID-19 has been reported in the online journal of the Japanese Society of Infectious Diseases. We are encouraged by a report that PMX-DHP treatment was able to suppress progression of ARDS and subsequently allow weaning from ECMO in 2 out of 3 patients.[95]. Adsorption therapy with PMX-DHP is expected to evolve in the future as a treatment for cytokine storm [96]. Instructive case reports Many case reports of COVID-19 have been published. We would like to share some didactic case reports from the perspective of thrombosis. DVT-only symptoms [97] The patient was a 57-year-old woman with chief complaints of swelling, pain, heat, and redness of the left lower limb. She had no fever, cough or shortness of breath. DVT was diagnosed in the left lower limb. Since DVT was present, chest CT was performed',\n",
       " ('COVID-19',\n",
       "  85,\n",
       "  9): \"to check for the presence of pulmonary emboli, and ground glass shadows were identified in both lung fields. Due to these ground glass shadows, PCR testing was performed and COVID-19 was diagnosed. In other words, the only COVID-19-related symptom present at consultation was thrombosis (DVT). When encountering DVT of unknown cause, COVID-19 should be checked for as a risk factor for DVT, along with checking for antithrombin, protein C, protein S, and antiphospholipid antibody (anticardiolipin antibody, lupus anticoagulant). Myocardial infarction with numerous thrombi in the coronary arteries [98] The patient was a 40-year-old woman who experienced myocardial infarction. Coronary angiography revealed more than 10 thrombi in the coronary arteries at the same time. We feel an unusual thrombotic tendency is present in COVID-19. Complications of cerebral infarction and cerebral vein sinus thrombosis [99] The patient was an 81-year-old man who developed cerebral infarction in the left and right brain at the same time. In this case, cerebral vein sinus thrombosis was also present concomitantly. That is, in the brain, thrombosis occurred in arteries and veins at the same time. This condition is usually unthinkable, but may arise with COVID-19. Findings similar to chilblains [100] Findings of chilblains clearly do not always represent COVID-19, but many such cases have been reported. During the current COVID-19 epidemic, if findings suggestive of chilblains are encountered, COVID-19 should at least be suspected. Livedo reticularis [101, 102] Livedo reticularis reflects impaired skin circulation. Livedo reticularis is a well-known finding in antiphospholipid antibody syndrome, but is also found in COVID-19. Conclusion Many points remain unclear regarding the pathophysiology of COVID-19. Elucidation of the pathophysiology from the perspective of laboratory hematology is ongoing. d-dimer is an excellent marker, but shows limitations in assessing the pathophysiology of the coagulation abnormalities seen in COVID-19. The pathological condition is expected to be elucidated by adding markers such as TAT, PIC, and SF. For the treatment of COVID-19, use of different treatment methods according to the pathophysiological condition is desirable, rather than performing uniform treatment. Footnotes Publisher's Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.\",\n",
       " ('COVID-19',\n",
       "  86,\n",
       "  0): \"Background: Convalescent plasma and hyperimmune immunoglobulin may reduce mortality in patients with viral respiratory diseases, and are being investigated as potential therapies for coronavirus disease 2019 (COVID-19). A thorough understanding of the current body of evidence regarding benefits and risks of these interventions is required. OBJECTIVES: Using a living systematic review approach, to assess whether convalescent plasma or hyperimmune immunoglobulin transfusion is effective and safe in the treatment of people with COVID-19; and to maintain the currency of the evidence. Search methods: To identify completed and ongoing studies, we searched the World Health Organization (WHO) COVID-19 Global literature on coronavirus disease Research Database, MEDLINE, Embase, the Cochrane COVID-19 Study Register, the Epistemonikos COVID-19 L*OVE Platform, and trial registries. Searches were done on 17 March 2021. Selection criteria: We included randomised controlled trials (RCTs) evaluating convalescent plasma or hyperimmune immunoglobulin for COVID-19, irrespective of disease severity, age, gender or ethnicity. For safety assessments, we also included non-controlled non-randomised studies of interventions (NRSIs) if 500 or more participants were included. We excluded studies that included populations with other coronavirus diseases (severe acute respiratory syndrome (SARS) or Middle East respiratory syndrome (MERS)), as well as studies evaluating standard immunoglobulin. Data collection and analysis: We followed standard Cochrane methodology. To assess bias in included studies, we used the Cochrane 'Risk of Bias 2' tool for RCTs, and for NRSIs, the assessment criteria for observational studies, provided by Cochrane Childhood Cancer. We rated the certainty of evidence, using the GRADE approach, for the following outcomes: all-cause mortality, improvement and worsening of clinical status (for individuals with moderate to severe disease), development of severe clinical COVID-19 symptoms (for individuals with asymptomatic or mild disease), quality of life (including fatigue and functional independence), grade 3 or 4 adverse events, and serious adverse events. Main results: We included 13 studies (12 RCTs, 1 NRSI) with 48,509 participants, of whom 41,880 received convalescent plasma. We did not identify any completed studies evaluating hyperimmune immunoglobulin. We identified a further 100 ongoing studies evaluating convalescent plasma or hyperimmune immunoglobulin, and 33 studies reporting as being completed or terminated. Individuals with a confirmed diagnosis of COVID-19 and moderate to severe disease Eleven RCTs and one NRSI investigated the use of convalescent plasma for 48,349 participants with moderate to severe disease. Nine RCTs compared convalescent plasma to placebo treatment or standard care alone, and two compared convalescent plasma to standard plasma (results not included in abstract). Effectiveness of convalescent plasma We included data on nine RCTs (12,875 participants) to assess the effectiveness of convalescent plasma compared to placebo or standard care alone. Convalescent plasma does not reduce all-cause mortality at up to day 28 (risk ratio (RR) 0.98, 95% confidence interval (CI) 0.92 to 1.05; 7 RCTs, 12,646 participants; high-certainty evidence). It has little to no impact on clinical improvement for all participants when assessed by liberation from respiratory support (RR not estimable; 8 RCTs, 12,682 participants; high-certainty evidence). It has little to no impact on the chance of being weaned or liberated from invasive mechanical ventilation for the subgroup of participants requiring invasive mechanical ventilation at baseline (RR 1.04, 95% CI 0.57 to 1.93; 2 RCTs, 630 participants; low-certainty evidence). It does not reduce the need for invasive mechanical ventilation (RR 0.98, 95% CI 0.89 to 1.08; 4 RCTs, 11,765 participants; high-certainty evidence). We did not identify any subgroup differences. We did not identify any studies reporting quality of life, and therefore, do not know whether convalescent plasma has any impact on quality of life. One RCT assessed resolution of fatigue on day 7, but we are very uncertain about the effect\",\n",
       " ('COVID-19',\n",
       "  86,\n",
       "  1): \"(RR 1.21, 95% CI 1.02 to 1.42; 309 participants; very low-certainty evidence). Safety of convalescent plasma We included results from eight RCTs, and one NRSI, to assess the safety of convalescent plasma. Some of the RCTs reported on safety data only for the convalescent plasma group. We are uncertain whether convalescent plasma increases or reduces the risk of grade 3 and 4 adverse events (RR 0.90, 95% CI 0.58 to 1.41; 4 RCTs, 905 participants; low-certainty evidence), and serious adverse events (RR 1.24, 95% CI 0.81 to 1.90; 2 RCTs, 414 participants; low-certainty evidence). A summary of reported events of the NRSI (reporting safety data for 20,000 of 35,322 transfused participants), and four RCTs reporting safety data only for transfused participants (6125 participants) are included in the full text. Individuals with a confirmed diagnosis of SARS-CoV-2 infection and asymptomatic or mild disease We identified one RCT reporting on 160 participants, comparing convalescent plasma to placebo treatment (saline). Effectiveness of convalescent plasma We are very uncertain about the effect of convalescent plasma on all-cause mortality (RR 0.50, 95% CI 0.09 to 2.65; very low-certainty evidence). We are uncertain about the effect of convalescent plasma on developing severe clinical COVID-19 symptoms (RR not estimable; low-certainty evidence). We identified no study reporting quality of life. Safety of convalescent plasma We do not know whether convalescent plasma is associated with a higher risk of grade 3 or 4 adverse events (very low-certainty evidence), or serious adverse events (very low-certainty evidence). This is a living systematic review. We search weekly for new evidence and update the review when we identify relevant new evidence. Please refer to the Cochrane Database of Systematic Reviews for the current status of this review. Authors' conclusions: We have high certainty in the evidence that convalescent plasma for the treatment of individuals with moderate to severe disease does not reduce mortality and has little to no impact on measures of clinical improvement. We are uncertain about the adverse effects of convalescent plasma. While major efforts to conduct research on COVID-19 are being made, heterogeneous reporting of outcomes is still problematic. There are 100 ongoing studies and 33 studies reporting in a study registry as being completed or terminated. Publication of ongoing studies might resolve some of the uncertainties around hyperimmune immunoglobulin therapy for people with any disease severity, and convalescent plasma therapy for people with asymptomatic or mild disease.\",\n",
       " ('COVID-19',\n",
       "  87,\n",
       "  0): 'The primary antigenic epitope on SARS-CoV and SARS-CoV-2 is the S protein, which facilitates target cell binding and fusion upon engaging the cell-surface angiotensin-converting enzyme 2 (ACE2) receptor, which is found on cells in the respiratory system, gastrointestinal tract and endothelium59,60,61,62,63. Thus, antibodies directed to the S protein can neutralize the ability of the virus to bind and fuse with the target host cell. Humanized murine technology or convalescent plasma from recovered patients has been used to derive neutralizing mAbs targeted to the RBD of the S protein64,65,66 (Fig. 3). To date, most advanced research efforts for therapeutic use of neutralizing mAbs are focusing on a handful of products in clinical development, some of which are already authorized on the basis of phase I/II and phase II data for emergency use (Table 1). Fig. 3: Inhibition of SARS-CoV-2 target cell engagement by neutralizing monoclonal antibodies. Neutralizing monoclonal antibodies (mAbs) being developed to combat COVID-19 are generated against the receptor-binding domain (RBD) of the spike (S) protein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The anti-RBD mAbs prevent binding of the S protein to its cognate receptor, angiotensin-converting enzyme 2 (ACE2), on target host cells. Three neutralizing mAb regimens have been given emergency use authorization for treatment of COVID-19. (1) Casirivimab and imdevimab bind distinct epitopes on the RBD with dissociation constants K D of 46 and 47 pM, respectively. Imdevimab binds the S protein RBD from the front or lower-left side, while casirivimab targets the spike-like loop from the top direction (overlapping with the ACE2-binding site3,68). (2) Bamlanivimab binds an epitope on the RBD in both its open confirmation and its closed confirmation with dissociation constant K D = 71pM, covering 7 of the approximately 25 side chains observed to form contact with ACE2 (ref.4). (3) Bamlanivimab and etesevimab bind to distinct, but overlapping, epitopes within the RBD of the S protein of SARS-CoV-2. Etesevimab binds the up/active conformation of the RBD with dissociation constant K D = 6.45 nM (ref.5); it contains the LALA mutation in the Fc region, resulting in null effector function. Full size image Table 1 Neutralizing monoclonal antibodies for SARS-CoV-2 currently in development up to 11 December 2020 Full size table REGN-COV2 therapy REGN-COV2 is a combination of two potent neutralizing mAbs — namely, casirivimab and imdevimab, which are IgG1 mAbs with unmodified Fc regions. These two mAbs were chosen from a pool of more than 200 neutralizing mAbs present in the initial isolation of thousands of antibodies and were derived from parallel efforts using humanized mice and the sera of patients recovering from COVID-19 (refs67,68). The antibodies bind two distinct and non-overlapping sites on the RBD3,67. The rationale for this antibody combination is that it is unlikely that a mutation in the S protein of SAR-CoV-2 will simultaneously render both antibodies ineffective. In extensive in vitro testing, this combination retained its ability to neutralize all known S protein mutations67. Further, casirivimab and imdevimab combination therapy initiated antibody-mediated cytotoxicity and cellular phagocytosis in virally infected cells in vitro3. This product was tested in rhesus macaques and golden hamsters infected with SARS-CoV-2, which serve as models for mild and severe disease, respectively69. In both models, prophylactic and therapeutic treatment with casirivimab and imdevimab not only resulted in a reduction in viral load but also diminished the incidence and severity of lung disease relative to a placebo. An ongoing phase I/II/III placebo-controlled trial (NCT04425629) is investigating the safety and efficacy of a single infusion of casirivimab and imdevimab — 2,400 mg (n = 266, interim), 8,000 mg (n = 267, interim) or matching placebo (n =',\n",
       " ('COVID-19',\n",
       "  87,\n",
       "  1): '266) — for symptomatic adults who have not previously been hospitalized within 3 days of a positive active SARS-COV-2 diagnosis (and within 7 days of the first symptoms)3. In the modified full analysis set for the phase I/II analysis, the median age was 42 years (7% aged 65 years or older), 85% of patients were white, 9% were Black and 34% were considered at high risk (for example, they were elderly, had obesity or had underlying chronic medical conditions). Pooled treatment achieved the primary end point of time-weighted average change from the baseline in viral load (log 10 copies per millilitre), collected from a nasopharyngeal swab, in patients with a positive baseline for viral RNA (n = 665). The difference in time-weighted average from day 1 through day 7 for the pooled doses of casirivimab and imdevimab compared with placebo was −0.36 log 10 copies per millilitre (P < 0.0001). The combination was reported to reduce viral load particularly in patients with higher viral loads who were seronegative at the baseline3,70. On a key clinical end point, a lower proportion of patients treated with casirivimab and imdevimab had COVID-19-related medically attended visits (2.8% for pooled doses versus 6.5% for placebo). In post hoc analyses, a lower proportion of patients treated with casirivimab and imdevimab had COVID-19-related hospitalizations or emergency department visits compared with patients who received placebo (2% versus 4%). The absolute risk reduction for casirivimab and imdevimab compared with placebo was greater for patients at high risk of progression to severe COVID-19 and/or hospitalization (3% versus 9%). Collectively, these results supported the EUA of Regeneron’s casirivimab and imdevimab cocktail in the United States in November 2020 (ref.71). Bamlanivimab monotherapy Bamlanivimab is a potent neutralizing mAb (IgG1 with an unmodified Fc region) to the S protein that was derived from the convalescent plasma of a patient who had COVID-19 (refs24,66). Bamlanivimab binds the S protein’s RBD, engaging its cognate epitope in both up and down conformations, which makes this antibody potentially useful as a monotherapy. There have been historical precedents for the effectiveness of neutralizing mAbs as a monotherapy (for example, MAb114 for Ebola)38. To assess theoretical risk of ADE, bamlanivimab was studied in primary human macrophages and immune cell lines exposed to SARS-CoV-2 at concentrations down to 100-fold below the effective concentration for half-maximum response, and in these studies, it did not demonstrate productive viral infection4. Prophylactic efficacy was tested in rhesus macaques given bamlanivimab 24 hours before a virus challenge66. The symptoms in this model were mild overall, but the treatment significantly decreased viral load and replication in the respiratory tract following inoculation, supporting its antiviral efficacy. In the phase II portion of the ongoing phase II/III BLAZE-1 trial (NCT04427501), ambulatory adults with mild-to-moderate symptoms of COVID-19 within 3 days of a first-positive nasopharyngeal swab positive for SARS-CoV-2 received a single infusion of one of three doses of bamlanivimab (700, 2,800 or 7,000 mg) or placebo in an outpatient setting24. A pre-planned interim analysis was conducted of 452 patients who had reached day 11 following infusion (median age 45–46 years (12% aged 65 years or older), 88% white, 6% Black and 68% at high risk (for example, they were elderly, had obesity or had underlying chronic medical conditions))24. The study revealed the viral clearance time course via the intrinsic immune response and the enhanced clearance with neutralizing mAb infusion, concomitant with improved clinical response. Viral loads were assayed from serial nasopharyngeal swabs, with postinfusion measurements enabled by a novel partnership with home-health research. Following infusion, the log viral load had begun decreasing relative to the baseline as early',\n",
       " ('COVID-19',\n",
       "  87,\n",
       "  2): 'as the first postinfusion assessment on day 3 (−0.85 for placebo versus −1.35 for pooled bamlanivimab doses), continued to decrease on day 7 (−2.56 for placebo versus −2.90 for pooled bamlanivimab doses) and further decreased by day 11 (−3.47 for placebo versus −3.70 for pooled bamlanivimab doses). In a post hoc analysis, patients with early persistent high viral load (described as log viral load of 5.27 or greater at trial day 7) had a higher risk of hospitalization, and the risk was further increased for elderly patients and patients with obesity. Clinical evidence demonstrating the efficacy of bamlanivimab came from two predefined secondary end points. First, at day 29, the percentage of patients who were hospitalized with COVID-19 was 6.3% for the placebo group and reduced to 1.6% for the group with pooled bamlanivimab doses. In post hoc analyses, hospitalization among elderly patients (65 years or older) or patients with obesity (body mass index 35 kg m−2 or greater) was 15% for the placebo group and 4% for the group who received pooled bamlanivimab doses. Absolute risk reduction for hospitalizations was more evident for patients with risk factors. Second, amelioration of baseline symptoms was greater for the pooled bamlanivimab doses than for placebo from day 2 through to day 11. Collectively, these results supported the EUA of bamlanivimab monotherapy in the United States and Canada in November 2020 (ref.4). Bamlanivimab and etesevimab Other treatment arms of the BLAZE-1 trial studied bamlanivimab together with etesevimab (an S protein-binding IgG1 with a modified Fc region, resulting in null effector function)25,72. Bamlanivimab and etesevimab together significantly decreased viral load (mean changes from the baseline and percentage of patients with persistent high viral load) compared with placebo at day 3 to day 11 (ref.25). Bamlanivimab- and etesevimab-treated patients had fewer COVID-19-related hospitalizations relative to the placebo group (5.8% for placebo reduced to 0.9% for bamlanivimab together with etesevimab). Recently released placebo-controlled phase III data from 1,035 patients randomized 1:1 to receive bamlanivimab together with etesevimab versus placebo demonstrated that in high-risk ambulatory patients (including patients aged 12–17 years with specific risk factors and patients aged 18 years or older with specific adult risk factors) treatment with bamlanivimab and etesevimab together was associated with a 70% reduction in COVID-19-related hospitalizations and deaths relative to placebo treatment (7.0% for placebo reduced to 2.1% for bamlanivimab together with etesevimab)25,73. On the basis of these data, an additional EUA of bamlanivimab together with etesevimab has been issued5. Monoclonal antibody therapies in severe COVID-19 There are concurrent studies investigating neutralizing mAbs for patients hospitalized with severe COVID-19. The REGN-COV2 trial in hospitalized patients enrols patients with or without supplemental oxygen and is ongoing74,75. In prospectively designed analysis of REGN-COV2, there may be clinical benefit in patients treated with casirivimab and imdevimab and who were seronegative at the time of treatment76. In the ACTIV-3 RCT (n = 326, 1:1 randomization), bamlanivimab added to standard of care (typically including remdesivir) did not demonstrate additional clinical benefit in hospitalized patients77. In line with similar studies investigating CPT or neutralizing mAbs for patients with severe viral disease (including COVID-19)15,18,34,35,36,54,56, the evidence indicates that rapid viral clearance, in itself, is insufficient. Rather, additional factors, such as an excessive immune response, are the primary drivers for continued disease in this particular patient population. Thus, early disease seen in outpatients is likely virally driven, whereas the pathophysiology for inpatient advanced disease is predominantly a postviral or periviral phenomenon, with clinical status uncoupled from viral load. Adverse events associated with monoclonal antibody therapies In terms of risk associated with mAb treatment of COVID-19, treatment-associated adverse events were',\n",
       " ('COVID-19',\n",
       "  87,\n",
       "  3): 'comparable to those with placebo. The most frequent side effects observed in RCTs include nausea, diarrhoea, dizziness, headache and vomiting24,25,78. One per cent of patients receiving casirivimab and imdevimab reported a grade 2 or higher infusion-related reaction within 4 days of administration (comparable to 1% reported for placebo treatment)78. In the phase II portion of BLAZE-1, nine patients reported an infusion-related reaction (1.9% (6/309) with bamlanivimab monotherapy, 1.8% (2/112) with bamlanivimab and etesevimab together, and 0.6% (1/156) with placebo). Most reactions occurred during infusion; these were mild in severity and were not dose related25. Regarding evidence of ADE, in vitro data indicate neutralizing mAbs do not enhance productive infection of immune cells with SARS-CoV-2 (refs3,4). From the clinical data available to date, there is no clear evidence these therapies result in enhanced immune responses consistent with ADE24,25,78. Furthermore, the safety profiles of modified and modified plus unmodified mAbs to treat SARS-CoV-2 infection are similar, suggesting that ADE may not play a role in clinical outcomes25. Emergence of drug-resistant SARS-CoV-2 strains For patients with COVID-19 who receive neutralizing mAbs, there is potential for the development of drug-resistant variants, which become more obvious when selective pressure is applied in the setting of drug treatment78,79. For bamlanivimab, non-clinical studies using serial passage of SARS-CoV-2 and directed evolution of the SARS-CoV-2 S protein identified viral variants (E484D/K/Q, F490S, Q493R and S494P, amino acid substitutions in the S protein RBD) that had increased resistance to this drug4. In clinical trials of bamlanivimab, genotypic and phenotypic testing are monitoring SARS-CoV-2 strains for potential S protein variations that are associated with bamlanivimab resistance. In clinical trials of bamlanivimab, viral sequencing is being performed for all patients, regardless of treatment status/progression. In other studies where only treatment failures are sampled, the selective pressure exerted by the antiviral activity cannot be assessed. In the BLAZE-1 RCT, which was limited to US investigative sites, known bamlanivimab-resistant variants at the baseline were observed at a frequency of 0.27% to date4. In the same trial, treatment-emergent variants were detected at S protein amino acid positions E484, F490 and S494 (including E484A/D/G/K/Q/V, F490L/S/V and S494L/P); considering all variants at these positions, 9.2% and 6.1% of participants in the 700-mg bamlanivimab arm (the EUA dose) harboured such a variant after the baseline at allele fractions of 15% or greater and 50% or greater, respectively, compared with 8.2% and 4.1%, respectively, of participants in the placebo arm. Most of these variants were first detected on day 7 following infusion, and were detected at only a single time point. The clinical impact of these variants is currently unknown4. As with bamlanivimab, casirivimab and imdevimab therapy has the potential to lead to the development of resistant viral variants. In non-clinical studies, serial passage of vesicular stomatitis virus (VSV) encoding the SARS-CoV-2 S protein in the presence of the drugs identified escape variants with reduced susceptibility to casirivimab (K417E/N/R, Y453F, L455F, E484K, F486V and Q493K) or imdevimab (K444N/Q/T and V445A)3. Each viral variant showing reduced susceptibility to one mAb remained susceptible to the other mAb; all identified variants retained susceptibility to the combination. In a separate experiment, neutralization assays were performed with VSV pseudotyped with 39 variants of the S protein identified in circulating SARS-CoV-2. The G476S, S494P and Q409E variants had reduced susceptibility (5-fold, 5-fold, and 4-fold, respectively) to casirivimab, and the N439K variant had reduced susceptibility (463-fold) to imdevimab. The casirivimab and imdevimab combination was active against all individual variants tested3. It has been reported that the combination of mutants at residues 417 and 439 may abrogate the effectiveness of the casirivimab and imdevimab combination80. In',\n",
       " ('COVID-19',\n",
       "  87,\n",
       "  4): 'the casirivimab and imdevimab RCT NCT04425629, interim data indicated only one variant (G446V) detected in 4.5% of participants at an allele fraction of 15% or greater, each detected at a single time point3. The clinical impact is unknown. In a VSV pseudoparticle neutralization assay, the G446V variant had reduced susceptibility to imdevimab (135-fold) but retained susceptibility to both casirivimab alone and the casirivimab and imdevimab combination. However, not all variants must be considered clinically relevant mutations associated with resistance to treatment. During the Ebola outbreak in 2018, a genomic assessment of 48 viral genomes determined that this outbreak was due to a distinct viral variant. The sequence information allowed researchers to evaluate the relevance of the distinct mutations to the available vaccine and therapeutics and to conclude that the neutralizing antibodies MAb114 and ZMapp would likely be effective against the currently circulating variant81. A similar practice for SARS-CoV-2 surveillance may be prudent to determine whether emergent S protein variants pose a threat to the efficacy of neutralizing mAb therapies. Indeed, three SARS-CoV-2 variants of particular interest have been identified and are circulating globally. In the United Kingdom, a variant called ‘B.1.1.7’ with a large number of mutations was identified in the autumn of 2020. In South Africa, a variant called ‘B.1.351 was identified. Originally detected in early October 2020, B.1.351 shares some mutations with B.1.1.7. In Brazil, a variant called ‘P.1’ was identified that contains a set of additional mutations that may affect its ability to be recognized by first-generation neutralizing mAbs and by the immune responses generated by first-generation vaccines. Although these variants have been detected in the United States, according to real-time data accessed via the GISAID COVID-19 variant tracker82 these COVID-19 variants do not currently represent a significant proportion of COVID-19 infections in the United States82,83, while recent California (B.1.427/B.1.429) and New York (B.1.526) variants do. To date, the effect of these variants on the neutralizing capacity of vaccines and mAbs is unknown. A recent preprint suggests that the variants identified in the United Kingdom and South Africa are more resistant to CPT and vaccine sera42. Bamlanivimab and imdevimab maintain full neutralization activity against the primary SARS-CoV-2 receptor-binding site variants (69-70del and N501Y) implicated in the strain originating in the United Kingdom, suggesting that these mAbs should maintain full activity against the new strain originating in the United Kingdom42,84. From what is known about the strains that were first identified in South Africa, Brazil as well as the ones in California and New York, it appears that some of the first generation of antibody therapies may not be as effective and it will be important for physicans to refer to the most up to date factsheet3,4,5,42.',\n",
       " ('COVID-19',\n",
       "  88,\n",
       "  0): 'Yan Xie , clinical epidemiologist 1 2 3, Benjamin Bowe , biostatistician 1 2 3, Geetha Maddukuri , staff physician 4, Ziyad Al-Aly , director 1 3 4 5 6 1Clinical Epidemiology Center, Research and Development Service, VA Saint Louis Health Care System, Saint Louis, MO, USA 2Department of Epidemiology and Biostatistics, College for Public Health and Social Justice, Saint Louis University, Saint Louis, MO, USA 3Veterans Research and Education Foundation of Saint Louis, Saint Louis, MO, USA 4Nephrology Section, Medicine Service, VA Saint Louis Health Care System, Saint Louis, MO, USA 5Department of Medicine, Washington University School of Medicine, Saint Louis, MO, USA 6Institute for Public Health, Washington University in Saint Louis, Saint Louis, MO, USA Correspondence to: Z Al-Aly zalaly{at}gmail.com (or @zalaly on Twitter) Accepted 6 November 2020 Abstract Objective To comparatively examine differences in risk of clinical manifestations and death among people admitted to hospital with coronavirus disease 2019 (covid-19) and seasonal influenza. Design Cohort study. Setting US Department of Veterans Affairs. Participants Patients admitted to hospital with covid-19 between 1 February 2020 and 17 June 2020 (n=3641) and seasonal influenza between 2017 and 2019 (n=12 676). Main outcome measures Risks of clinical manifestations, healthcare resource use (including use of mechanical ventilation, admission to intensive care, and length of stay), and death, estimated using a doubly robust approach to build propensity scores that were then used along with covariates to adjust the outcome models. Results Compared with seasonal influenza, covid-19 was associated with higher risk of acute kidney injury (odds ratio 1.52, 95% confidence interval 1.37 to 1.69), incident renal replacement therapy (4.11, 3.13 to 5.40), incident insulin use (1.86, 1.62 to 2.14), severe septic shock (4.04, 3.38 to 4.83), vasopressor use (3.95, 3.46 to 4.51), pulmonary embolism (1.50, 1.18 to 1.90), deep venous thrombosis (1.50, 1.20 to 1.88), stroke (1.62, 1.17 to 2.24), acute myocarditis (7.82, 3.53 to 17.36), arrythmias and sudden cardiac death (1.76, 1.40 to 2.20), elevated troponin (1.75, 1.50 to 2.05), elevated aspartate aminotransferase (3.16, 2.91 to 3.43), elevated alanine aminotransferase (2.65, 2.43 to 2.88), and rhabdomyolysis (1.84, 1.54 to 2.18). Compared with seasonal influenza, covid-19 was also associated with higher risk of death, mechanical ventilator use, and admission to intensive care (hazard ratio 4.97, (95% confidence interval 4.42 to 5.58), 4.01 (3.53 to 4.54), and 2.41 (2.25 to 2.59), respectively) and 3.00 (2.20 to 3.80) additional days of hospital stay. Differences in rates of death per 100 patients between covid-19 and seasonal influenza were most pronounced in people over 75 years of age with chronic kidney disease or dementia and those with black race and obesity, diabetes, or chronic kidney disease. Conclusions Among people admitted to hospital, compared with seasonal influenza, covid-19 was associated with increased risk of extrapulmonary organ dysfunction, death, and increased health resource use. The findings may inform the global discussion about the comparative risks of covid-19 and seasonal influenza and may help the ongoing effort to manage the covid-19 global pandemic. Introduction The coronavirus disease 2019 (covid-19) global pandemic might be the most challenging health crisis of our lifetime. The number of infected people and number of deaths continue to grow worldwide.1 Comparisons of clinical manifestations and mortality between covid-19 and seasonal influenza have been drawn by public health officials, policy makers, and the public at large. However, these comparisons have so far relied on data and mortality statistics obtained by disparate methods and are not based on an “apples with apples” comparison.2 A robust comparative approach would allow stakeholders to develop a deeper understanding of the health risks of covid-19 (compared with the well known seasonal influenza)',\n",
       " ('COVID-19',\n",
       "  88,\n",
       "  1): 'and to anticipate demand for healthcare services and project mortality with greater accuracy. In this study, we leveraged the breadth and depth of the electronic healthcare databases of the US Department of Veterans Affairs (VA), which operates the largest nationally integrated healthcare delivery system in the US, to do a comparative evaluation of clinical manifestations and outcomes among US veterans admitted to hospital with covid-19 and seasonal influenza. This approach provides a comparative assessment between covid-19 and seasonal influenza and will inform the global discussion and effort to manage current and future waves of this global pandemic in which some waves might spatiotemporally coincide with seasonal influenza. Methods Setting We used the electronic healthcare databases of the US Department of Veterans Affairs, which operates the largest nationally integrated healthcare system in the United States—a veteran specific national health service—to discharged veterans of the US armed forces. The US Department of Veterans Affairs provides care at 1255 healthcare facilities, including 170 VA medical centers (hospital systems) and 1074 outpatient sites of care of varying complexity (Veterans Health Administration outpatient clinics) to more than nine million veterans enrolled in the VA. All enrolled veterans have access to the Department of Veterans Affairs’ comprehensive medical benefits package including inpatient hospital care; outpatient services; preventive, primary, and specialty care; prescriptions; mental healthcare; home healthcare; geriatric and extended care; medical equipment; and prosthetics. Cohort We selected patients from the Department of Veterans Affairs healthcare system with a positive laboratory test result for influenza between 1 January 2017 and 31 December 2019 (n=54 281) or with a positive laboratory test for covid-19 between 1 February 2020 and 17 June 2020 (n=9125). We identified patients with a hospital admission between five days before and 30 days after the positive test result (n=12 748 in seasonal influenza group; n=3641 in covid-19 group). For participants with both seasonal influenza and covid-19 hospital admission records (n=72), we used their first covid-19 admission records in the analyses. The final cohort consisted of 16 317 participants, including 12 676 participants in the seasonal influenza group and 3641 participants in the covid-19 group (supplementary figure S1). We defined time zero as the date of admission to hospital and followed participants until the first occurrence of 60 days after admission, death, or end of study follow-up (17 June 2020). After 60 days of follow-up, 168 (1.33%) patients in the seasonal influenza group and 76 (2.08%) patients in the covid-19 group remained in hospital. The probability of patients remaining in hospital in the two groups is provided in supplementary figure S2. Data sources The Department of Veterans Affairs Corporate Data Warehouse (CDW) provided electronic health records from participants enrolled in the VA healthcare system.3456 We used the CDW laboratory results domain to collect laboratory test information and the CDW inpatient encounters domains to collect information including diagnoses, procedures, and other aspects of healthcare use during a hospital admission.7 We used the CDW pharmacy domain and CDW bar code medication administration domain to collect medication data and the CDW vital signs domain to collect vital measurements. We collected demographic information from the CDW patient domain and VA vital status database, as well as disease history from both the CDW inpatient encounter and outpatient encounter domains.8910 Exposures Exposures in the study were admission to hospital with seasonal influenza and admission to hospital with covid-19, defined on the basis of a positive laboratory test result for seasonal influenza or covid-19 with a hospital admission within five days before the test or within 30 days after the test. Outcomes The primary outcome of the study was time until death',\n",
       " ('COVID-19',\n",
       "  88,\n",
       "  2): 'since hospital admission. We defined clinical outcomes including acute kidney injury, incident renal replacement therapy, incident insulin use, severe septic shock, vasopressor use, pulmonary embolism, deep venous thrombosis, stroke, acute myocarditis, arrythmias and sudden cardiac death, elevated troponin, elevated aspartate aminotransferase, elevated alanine aminotransferase, and rhabdomyolysis by using definitions based on laboratory data and diagnostic and procedure codes.61112131415161718 Outcomes related to healthcare use included time until mechanical ventilation, time until admission to intensive care unit (ICU), and length of stay in hospital, which we defined as days from admission until first discharge among patients discharged from hospital. Covariates Covariates in the study included demographics such as age, race (white, black, and other), and sex; history of diseases such as chronic lung disease, cancer, cardiovascular disease, cerebrovascular disease, dementia, diabetes mellitus, hypertension, and peripheral artery disease; history of use of drugs such as statins, angiotensin converting enzyme inhibitors or angiotensin receptor blockers, and non-steroidal anti-inflammatory drugs; smoking status (never, former, and current); and estimated glomerular filtration rate and body mass index (underweight <18.50, normal ≥18.50-<25, overweight ≥25-<30, and obese ≥30) calculated from height and weight. We ascertained disease history during the year before admission to hospital and defined outpatient drug use by a record of prescription that provided medication within the 30 days before the admission. We selected estimated glomerular filtration rate and body mass index from the measurement before and closest to the admission. When values of covariates were missing (0.18% of age, 2.56% of estimated glomerular filtration rate, and 2.02% of body mass index), we applied mean imputation. We also collected vital signs at admission, including heart rate, temperature, respiratory rate, blood oxygen concentration, systolic and diastolic blood pressure, and laboratory measurements including white blood cell count, hemoglobin, serum albumin, blood urea nitrogen, platelet count, bicarbonate, and lymphocyte percentage, on the basis of measurements during the hospital admission and closest to admission date and time. Statistical analyses We present the mean and standard deviation, frequency and percentage, or median and interquartile range, as appropriate, of the characteristics for patients admitted to hospital with seasonal influenza and covid-19. We made between group comparisons using χ2 tests for counts and t tests for continuous variables. We used logistic regressions to examine the difference in clinical manifestations between seasonal influenza and covid-19. We estimated excess events per 100 patients based on difference in the probability of the event occurring if all participants had a hospital admission for covid-19 compared with if all participants had a seasonal influenza related admission. To adjust for confounding, we used doubly robust estimation for all models. We built a propensity score based on covariates including age, sex, race, smoking status, body mass index, estimated glomerular filtration rate, chronic lung diseases, cancer, cardiovascular diseases, cerebrovascular disease, dementia, diabetes mellitus, hypertension, peripheral artery disease, and use of statins, angiotensin converting enzyme inhibitors or angiotensin receptor blockers, and non-steroidal anti-inflammatory drugs. Doubly robust estimation adjusted for both the covariates and the propensity score in the outcome models.1920 To evaluate the likelihood of violation of the positivity assumption, we plotted the propensity score distributions in two exposure groups (supplementary figure S3). We examined the balance of baseline characteristics between the covid-19 group and seasonal influenza group, and the result suggested that balance was achieved with the application of the propensity score (supplementary figures S3 and S4; supplementary table S1). We constructed survival models with doubly robust estimation to examine the difference in risk of death between hospital admission for covid-19 and hospital admission for seasonal influenza. We estimated risk of mechanical ventilator use and admission to ICU on the basis of',\n",
       " ('COVID-19',\n",
       "  88,\n",
       "  3): 'the Fine and Gray survival model, in which death before the occurrence of the event was considered a competing risk.21 For all survival outcomes, we evaluated proportional hazard assumptions and observed no indication of violation (supplementary figure S5). We estimated excess outcomes per 100 patients on the basis of the differences in cumulative incidence at 60 days if all participants had a hospital admission for covid-19 compared with if all participants had a hospital admission for seasonal influenza.13 We also used linear regression to examine the difference in length of stay in patients discharged from hospital. We aimed to identify groups of participants that were at the highest risk of death due to covid-19, as well as those groups that had the highest disparities between risk of death due to covid-19 and seasonal influenza. We did further survival analyses to investigate risk of death by comorbid condition and demographics (age ≤65, >65-≤75, >75; white, black race) pairs. We estimated death rates per 100 participants on the basis of the cumulative incidence function at 60 days if all participants had a hospital admission for covid-19 with a defined comorbid condition and demographic pair (for example, rate of death in those aged ≤65 and with cardiovascular disease). We then estimated differences in death rates between hospital admission for covid-19 and hospital admission for seasonal influenza under each condition pair. Results are presented in heat maps, colored by the rate of death. We did sensitivity analyses to test the robustness of the results. We estimated the risk (hazard ratios) of death, mechanical ventilation, and admission to ICU for covid-19 versus seasonal influenza in each influenza season included in the cohort (influenza season 2016-17, 2017-18, 2018-19, and 2019-20). We then examined the risks (hazard ratios) for covid-19 versus influenza type A and type B, separately. Because influenza A subtypes may vary by season, we also examined the association of covid-19 versus influenza type A in each season. We examined the risks (hazard ratios) of outcomes for covid-19 versus influenza in patients with a record of vaccination for influenza and those without a record of vaccination. We estimated the risks within 30 days of admission to hospital and setting the time of positive test result as time zero. We examined the risks (hazard ratios) according to hospital bed occupancy and, separately, according to ICU bed occupancy in covid-19 patients. We updated the covariates during the follow-up and did time dependent analyses. We applied the overlap weighting method and the inverse probability weighting method. To remove potentially nosocomially acquired infections, we removed patients who had a first positive test after admission to hospital and then additionally removed those who had a first positive test on the first day of admission. We did analyses in subgroups based on sex, and, finally, we evaluated the association in subgroups according to smoking status and body mass index category. We considered P values less than 0.05, 95% confidence intervals of the hazard ratio or odds ratio that did not cross 1, or 95% confidence intervals of the length of stay difference or event rate difference that did not cross 0 to be statistically significant. We used SAS Enterprise Guide version 7.1 for all analyses. Patient and public involvement No patients were involved in developing the hypothesis, the specific aims, or the research questions; nor were they involved in developing plans for design or implementation of the study. No patients were involved in the interpretation or writing up of results. The study was conceived, designed, and conducted under the exigent circumstances of the covid-19 global pandemic, which precluded patient and public',\n",
       " ('COVID-19',\n",
       "  88,\n",
       "  4): 'engagement. Results A total of 12 676 people were admitted to hospital with seasonal influenza between 1 January 2017 and 31 December 2019, and 3641 were admitted with covid-19 between 1 February 2020 and 17 June 2020. Table 1 describes the baseline demographic and health characteristics. The percentage of black patients admitted with covid-19 (49.8%) was more than double the percentage admitted with seasonal influenza (22.0%); the percentages of patients with obesity, dementia, and diabetes mellitus were higher in the covid-19 group. The percentages of people who were current smokers or who had cancer, cardiovascular disease, chronic lung disease, and use of angiotensin converting enzyme inhibitors or angiotensin receptor blockers and statins was higher in the seasonal influenza group (table 1). Table 1 Baseline and admission characteristics of patients admitted to hospital with seasonal influenza and coronavirus disease 2019 (covid-19). Values are numbers (percentages) unless stated otherwise View this table: Differences in clinical manifestations of covid-19 versus seasonal influenza We then comparatively evaluated the clinical manifestations of covid-19 versus those of seasonal influenza. Table 2 shows the number of events in each group, the unadjusted and adjusted odds ratios, and the excess number of outcomes per 100 patients admitted to hospital with covid-19 compared with seasonal influenza. Compared with people admitted to hospital with seasonal influenza, we observed a graded association between covid-19 and risk of acute kidney injury; the odds of the association increased with increasing severity of acute kidney injury, and we also saw an increased risk of incident renal replacement therapy. Covid-19 was also associated with increased risk of incident insulin use, severe septic shock, vasopressor use, pulmonary embolism, deep venous thrombosis, stroke, acute myocarditis, arrythmias and sudden cardiac death, elevated troponin, elevated aspartate aminotransferase, elevated alanine aminotransferase, and rhabdomyolysis. Table 2 Clinical manifestations in patients admitted to hospital with seasonal influenza and coronavirus disease 2019 (covid-19) View this table: Differences in risk of death and health resource use for covid-19 versus seasonal influenza Table 3 and table 4 show the number of deaths in each group, unadjusted and adjusted hazard ratios, and the number of excess deaths per 100 patients admitted to hospital with covid-19 compared with seasonal influenza. Compared with people admitted to hospital with seasonal influenza, admission with covid-19 was associated with increased risk of death; we observed 16.85 (95% confidence interval 14.85 to 18.99) excess deaths per 100 patients due to covid-19. Health resource use was much more pronounced for covid-19 compared with seasonal influenza. Covid-19 was associated with significantly higher risk of mechanical ventilation use, admission to ICU, and prolonged length of hospital stay (table 3, table 4, fig 1, and fig 2). Table 3 Risks of death and healthcare resource use in patients admitted to hospital with coronavirus disease 2019 (covid-19) versus seasonal influenza View this table: Table 4 Length of hospital stay in patients admitted to hospital with coronavirus disease 2019 (covid-19) versus seasonal influenza, among patients discharged from hospital (n=15 009) View this table: Fig 1 Adjusted cumulative incidence rate (with 95% CI) of death, mechanical ventilator use, and admission to intensive care unit (ICU) per 100 patients admitted to hospital with seasonal influenza and coronavirus disease 2019 (covid-19) Fig 2 Risks of death and healthcare resource use in patients admitted to hospital with coronavirus disease 2019 (covid-19) versus seasonal influenza. Models were adjusted for age, sex, race, smoking status, body mass index, estimated glomerular filtration rate, chronic lung disease, cancer, cardiovascular disease, cerebrovascular disease, dementia, diabetes mellitus, hypertension, peripheral artery disease, and use of statins, angiotensin converting enzyme inhibitors/angiotensin II receptor blockers and non-steroidal anti-inflammatory drugs. Seasonal influenza',\n",
       " ('COVID-19',\n",
       "  88,\n",
       "  5): 'group served as reference for each model. Length of hospital stay was calculated within patients discharged from hospital (n=15 009) Rates of death by age, race, and comorbid condition Figure 3 and supplementary table S2a show estimated rates of death with covid-19 by age, race, and comorbid condition. Death rates were generally highest in older and black individuals. Excess rates of death per 100 people with covid-19 (compared with seasonal influenza) were most pronounced in adults older than 75 years with chronic kidney disease or dementia and in black people with obesity, diabetes, or chronic kidney disease (fig 3 and supplementary table S2b). Fig 3 Rates of death in patients admitted to hospital with coronavirus disease 2019 (covid-19) (left), and excess deaths compared with patients admitted with seasonal influenza (right), by age (≤65, 65-75, >75 years), race (white, black), and comorbid condition. Number in each cell represents rate of death or excess deaths per 100 patients admitted with covid-19, given conditions. Lighter colored cells indicate lower death rates or smaller differences, and darker colored cells indicate higher death rates or larger differences Sensitivity analyses We did several sensitivity analyses to test the robustness of our results (fig 4 and supplementary table S3). Firstly, because mortality from seasonal influenza may vary by season, we developed sensitivity analyses to examine the risk of death and health resource use in covid-19 patients compared with those admitted with influenza in each season (2016-17, 2017-18, 2018-19, 2019-20) separately; the results were consistent. Secondly, the results were also consistent when we evaluated the risk of death and resource use for covid-19 compared with influenza A and B, separately. Thirdly, because subtypes of influenza A may have differential effects on health outcomes and because the predominant subtype of influenza A may vary by season, we examined the association of covid-19 versus influenza A in each season; the results suggested that compared with influenza A, covid-19 was associated with increased risk of health resource use and death in each of the examined seasons (supplementary table S4). Fourthly, the increased risk in covid-19 versus seasonal influenza was observed in analyses in which the reference group was those influenza patients who received an influenza vaccine and, separately, those who did not receive an influenza vaccine. Fifthly, analyses that evaluated the risk of death in the first 30 days and, separately, analyses that considered the date of testing positive for influenza or covid-19 as time zero yielded consistent results. Fig 4 Risks of death and healthcare resource use in patients admitted to hospital with coronavirus disease 2019 (covid-19) versus seasonal influenza. Seasonal influenza group served as reference. BMI=body mass index; ICU=intensive care unit; T 0 =time zero. *Models adjusted for age, sex, race, smoking status, BMI, estimated glomerular filtration rate, chronic lung disease, cancer, cardiovascular disease, cerebrovascular disease, dementia, diabetes mellitus, hypertension, peripheral artery disease, use of statins, angiotensin converting enzyme inhibitors/angiotensin II receptor blockers, and non-steroidal anti-inflammatory drugs. †Included seasonal influenza patients between 1 Jan 2017 and 31 Aug 2017 in cohort. ‡Included seasonal influenza patients between 1 Sept 2017 and 31 Aug 2018 in cohort. §Included seasonal influenza patients between 1 Sept 2018 and 31 Aug 2019 in cohort. ¶Included seasonal influenza patients between 1 Sept 2019 and 31 Dec 2019 in cohort Sixthly, because a putative relation may exist between hospital bed occupancy—an indicator of how overwhelmed the hospital system is—and health outcomes, we examined the risk of death and health resource use for covid-19 versus seasonal influenza according to hospital bed occupancy (<20%, 20-<40%, 40-<60%, and 60-77.82%, the maximum observed hospital bed occupancy in our cohort) and,',\n",
       " ('COVID-19',\n",
       "  88,\n",
       "  6): 'separately, according to ICU bed occupancy (<20%, 20-<40%, 40-<60%, 60-<80%, and 80-102.38%, the maximum observed ICU bed occupancy in our cohort); the results were consistent with the primary analyses. The distributions of occupancy of hospital beds and ICU beds are provided in supplementary figure S6. Seventhly, the results were also consistent in time dependent analyses in which covariates were updated during follow-up. Eighthly, we considered the overlap weighting method and the inverse probability weighting method as two alternatives to our primary approach (the doubly robust method); both alternative methods yielded estimates consistent with the primary approach. Ninthly, to eliminate concern about nosocomially acquired seasonal influenza or covid-19 infections, we did analyses in which we removed patients who had a positive test while in hospital and restricted cohort entry to those with a positive influenza or covid-19 test before and including the first day of hospital admission; results were consistent with those in the primary analyses and were also consistent in analyses considering patients with a positive test before admission. Tenthly, because our cohort comprised mostly male US veterans, and to examine whether the observed associations were also evident among female patients, we did analyses in subgroups based on sex; the results were consistent in both male and female subgroups. Finally, to test whether the observed associations were evident in smokers and non-smokers and, separately, among people with normal weight and obesity, we evaluated the association in subgroups according to smoking status and body mass index category; the results suggested that compared with seasonal influenza, covid-19 was associated with increased risk of death and health resource use regardless of smoking and body mass index status (fig 4 and supplementary table S3). Discussion In this work, we provide a comparative evaluation of the clinical manifestations and outcomes in a national cohort of patients admitted to hospital with covid-19 or seasonal influenza. Our results suggest that compared with seasonal influenza, covid-19 was associated with higher risk of acute kidney injury, incident renal replacement therapy, incident insulin use, severe septic shock, vasopressor use, pulmonary embolism, deep venous thrombosis, stroke, acute myocarditis, arrythmias and sudden cardiac death, elevated troponin, elevated aspartate aminotransferase, elevated alanine aminotransferase, and rhabdomyolysis. Covid-19 was also associated with increased risk of death, need for mechanical ventilation, and admission to ICU and prolonged length of hospital stay. Excess rates of death for covid-19 (in excess of those for seasonal influenza) were highest in adults older than 75 years with chronic kidney disease and dementia and in black patients with obesity, diabetes mellitus, and chronic kidney disease. The results were robust to challenge in multiple sensitivity analyses. Contextual evaluation of findings As our understanding of covid-19 is evolving, the fact that, although the virus preferentially infects cells in the respiratory tract, it may also be detected in multiple organs, suggesting broad extrapulmonary organotropism, is becoming increasingly clear.2223 Covid-19 seems to have a kidney tropic effect; early observations suggested high rates of acute kidney injury and need for renal replacement therapy among patients with covid-19.22232425 Here, we show that risks of acute kidney injury and incident renal replacement therapy were higher with covid-19 than seasonal influenza. In our cohort, 15.0% of patients with covid-19 needed mechanical ventilation, generally consistent with the range of 12% to 24% reported in other US studies of covid-19.262728 Recent reports suggested a bidirectional relation between covid-19 and diabetes mellitus, in that diabetes may predispose to covid-19 and that a diagnosis of covid-19 may result in derangement in insulin and glucose homeostasis and new onset of diabetes.2930 Our findings of higher risk of incident insulin use among patients who were',\n",
       " ('COVID-19',\n",
       "  88,\n",
       "  7): 'not taking any treatment for diabetes mellitus before hospital admission with covid-19 suggests the need for greater attention to management of glucose in patients with covid-19 and the need for long term follow-up to gain a better understanding of the chronicity of these acute disturbances in glucose homeostasis.29 Risks of severe septic shock and vasopressor use were also higher in the covid-19 group, consistent with reports of septic shock in patients with covid-19.31 We also report increased risk of pulmonary embolism, deep venous thrombosis, and stroke compared with seasonal influenza; clarity about the underlying biologic mechanism of a prothrombotic hypercoagulable state in covid-19 is evolving.3233343536 The findings of increased risk of acute myocarditis, arrythmias and sudden cardiac death, and elevated troponin suggest that covid-19 may portend serious cardiac complications. Risk of elevated transaminases and rhabdomyolysis was also increased among patients with covid-19; the underlying pathophysiology of these abnormalities is not yet entirely clear. Our approach for the comparative evaluation of the acute clinical manifestations of covid-19 versus seasonal influenza was based on a priori knowledge; however, as our understanding of the clinical manifestations of covid-19 deepens, additional important differences in the clinical sequalae of these two diseases may come to light and may be investigated in future research. Many of the acute clinical manifestations of covid-19 described in this report are disease states that need chronic management (for example, new onset diabetes, stroke). This is compounded by emerging evidence suggesting that some acute symptoms of covid-19 may linger far beyond the acute illness and that recovery may be protracted and incomplete in many “long haulers.” Taken together, these observations suggest that, beyond the acute setting, a greater understanding of the long term health trajectories of patients with “long covid-19” and care strategies to optimize wellness and reduce the burden of chronic and permanent health loss are needed to lessen the overall health, societal, and economic toll of this pandemic. We observed much higher rates of death among patients admitted to hospital with covid-19 than with seasonal influenza. We also report that in adjusted models using the doubly robust approach, the risk of death in covid-19 patients was nearly fivefold higher than in those in the seasonal influenza group. We estimated that compared with seasonal influenza, covid-19 was associated with 16.85 (95% confidence interval 14.85 to 18.99) excess deaths per 100 patients. Our results also suggest significantly increased risk of mechanical ventilation use, ICU admission, and prolonged length of stay. Our estimates provide an “apples with apples” comparative quantitative assessment of the magnitude of risk of death (and other health outcomes) in patients admitted to hospital with covid-19 and seasonal influenza. The estimates may help to inform efforts to manage the ongoing covid-19 global pandemic in which some surge in activity (wave) may coincide with seasonal influenza. Our heatmap approach, which provides adjusted estimates of the rates of death by age, race, and comorbid condition, shows that differences in rates of death between covid-19 and seasonal influenza (excess rates of death in covid-19) are most pronounced in older adults, among black people, and in those with dementia, diabetes mellitus, obesity, and kidney disease, suggesting that a more targeted prevention effort aimed at these high risk populations may be needed to reduce mortality rates. Several other considerations merit discussion. Although we balanced the two groups according to demographic and health characteristics to optimize the comparative evaluation of the clinical characteristics and outcomes of covid-19 versus seasonal influenza, increased awareness of covid-19 may have resulted in greater ascertainment of covid-19 infections, whereby less severe cases of covid-19 relative to seasonal influenza would be',\n",
       " ('COVID-19',\n",
       "  88,\n",
       "  8): 'diagnosed and possibly admitted to hospital, and relatively less historical ascertainment of seasonal influenza, whereby milder influenza cases may not have been diagnosed, enriching the seasonal influenza group with relatively sicker patients and resulting in underestimation of the risk of outcomes in covid-19 compared with seasonal influenza. Also, relaxed admission criteria and reduced threshold for admission in the covid-19 era—primarily driven by heightened concerns about the virus—may have resulted in admission of less sick people with covid-19, which may have resulted in underestimation of risk of covid-19 versus seasonal influenza. Health outcomes of patients admitted to hospital may deteriorate as hospitals become overwhelmed; if this existed in our data, it may have resulted in overestimation of the risk of adverse outcomes in covid-19 versus seasonal influenza. However, although the pandemic exacted a serious challenge to the VA hospital system, our examination of weekly average bed occupancy and weekly average ICU bed occupancy did not suggest that the system was substantially strained (supplementary figure S6), and we consistently observed that covid-19 was associated with increased risk of adverse outcomes regardless of level of occupancy and the excess risk was evident even in low occupancy. In our comparative evaluation, we considered several seasons of influenza, and the predominant subtype of seasonal influenza may vary by season; influenza A (H3N2) predominated in 2016-17 and 2017-18, influenza A(H1N1)pdm09 predominated in 2018-19, and influenza B predominated early in the 2019-20 season. H3N2 predominant seasons have been associated with more severe illness and mortality, especially in older adults, relative to seasons during which H1N1 or B viruses predominated.3738 In our evaluation, we did not identify appreciable differences in risk of covid-19 versus seasonal influenza by season or by influenza type (A or B). However, our data did not contain enough information to allow a comparative evaluation according to influenza subtype; evaluation of the risks of death, mechanical ventilation, and ICU admission for covid-19 versus influenza type A by season yielded consistently higher risk of adverse events for covid-19. Effect of sex, body mass index, and smoking status on health outcomes may be different in covid-19 and seasonal influenza.39404142434445 Our analyses of subgroups based on sex, body mass index category, and smoking status showed consistently that covid-19 was associated with worse outcomes than seasonal influenza, but further studies are needed to gain a fuller understanding of how these characteristics may differentially influence health outcomes in patients with covid-19 and seasonal influenza. Limitations and strengths of study This study has several limitations. We relied on data from electronic health records to do this comparative evaluation, and, although we used validated definitions, inaccurate measurements of variables and misclassification bias may not be completely eliminated. We used a doubly robust approach to examine the risk of clinical manifestations and health outcomes for covid-19 versus seasonal influenza,19 but we cannot completely exclude the possibility of residual confounding. Our cohort comprised US veterans who were admitted to hospital for seasonal influenza or covid-19 and included mostly older white males, so our results may not be generalizable to broader populations such as younger and healthier people. Although we provide estimates of the adjusted absolute rates of death according to age, race, and comorbid condition to facilitate comparative evaluation of risk in these groups, absolute rates may be lower in younger and healthier populations. Our evaluation included a comparative assessment of clinical manifestations and outcomes of seasonal influenza and covid-19; however, a pandemic influenza may have different clinical manifestations and outcome profile. Finally, as this pandemic continues to evolve, our understanding of the epidemiology, clinical characteristics, and outcomes of covid-19 will continue to evolve;',\n",
       " ('COVID-19',\n",
       "  88,\n",
       "  9): 'in particular, we note that care of covid-19 patients is evolving rapidly, including discovery and use of new therapeutics, and a vaccine is anticipated sometime soon. Both drivers (improved care and vaccine availability) will likely result in amelioration of health outcomes among people with covid-19. The study also has several strengths. We designed the study to evaluate risk of death among people admitted to hospital with covid-19 and seasonal influenza in the same nationally integrated healthcare delivery system designed to give equal access to care for eligible veterans, which enhances the ability to establish a comparative evaluation of risk. The multidimensional nature and depth of VA data facilitate ascertainment of medical conditions not only through diagnostic or procedure codes but also through laboratory data (for example, serum creatinine to define acute kidney injury, estimated glomerular filtration rate to define chronic kidney disease, creatine phosphokinase to define rhabdomyolysis), vital signs (including body mass index), vital status, and medication records (for example, vasopressor use, insulin requirements). Finally, we used a doubly robust approach to examine the association between exposures and outcomes, and our results were robust to challenge in multiple sensitivity analyses including the application of two alternative methods (overlap weighting method and inverse probability weighting method). Conclusions In sum, our results suggest that compared with patients admitted to hospital with seasonal influenza, those admitted with covid-19 have increased risk of systemic clinical manifestations (including higher risk of acute kidney injury, incident renal replacement therapy, incident insulin use, severe septic shock, vasopressor use, pulmonary embolism, deep venous thrombosis, stroke, acute myocarditis, arrythmias and sudden cardiac death, elevated troponin, elevated aspartate aminotransferase, elevated alanine aminotransferase, and rhabdomyolysis), increased risk of death, and higher need for healthcare resources (mechanical ventilation, ICU admission, length of hospital stay). Rates of death for covid-19 in excess of rates for seasonal influenza were highest in adults aged over 75 years with chronic kidney disease and dementia and in black people with obesity, diabetes, and chronic kidney disease. Our results inform the global discussion about the comparative risks of covid-19 and seasonal influenza and may guide efforts to manage this ongoing global pandemic. What is already known on this topic Covid-19 is an emerging infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), of which the predominant clinical presentation is respiratory disease Evidence is accumulating that it is associated with extrapulmonary manifestations and high risk of healthcare use and death Comparisons of clinical manifestations and mortality between covid-19 and seasonal influenza have been made using disparate data and statistical methods and do not represent “apples with apples” comparisons What this study adds Among people admitted to hospital, compared with seasonal influenza, covid-19 was associated with increased risk of various extrapulmonary clinical manifestations Covid-19 was also associated with increased health resource use, including mechanical ventilator use, admission to intensive care, and length of hospital stay, and nearly five times the risk of death The differences in death rates between covid-19 and seasonal influenza were most manifest in older adults with kidney disease or dementia and black people with obesity, diabetes, or kidney disease Footnotes Contributors: YX, BB, and ZAA contributed to the development of the study concept and design. YX and BB contributed to data acquisition. YX, BB, and ZAA contributed to data analysis and interpretation. YX and BB contributed to statistical analysis. YX and ZAA drafted the manuscript. XY, BB, GM, and ZAA contributed to critical revision of the manuscript. ZAA provided administrative, technical, and material support, as well as supervision and mentorship. Each author contributed important intellectual content during manuscript drafting or revision and accepts accountability',\n",
       " ('COVID-19',\n",
       "  88,\n",
       "  10): 'for the overall work by ensuring that questions pertaining to the accuracy or integrity of any portion of the work are appropriately investigated and resolved. All authors approved the final version of the report. The corresponding author attests that all the listed authors meet the authorship criteria and that no others meeting the criteria have been omitted. ZAA is the guarantor. Funding: This research was funded by the United States Department of Veterans Affairs and the Institute for Public Health at Washington University in Saint Louis, MO, USA (for ZAA), and the American Society of Nephrology and KidneyCure pre-doctoral fellowship awards (for YX and BB). The funders had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; or the decision to submit the manuscript for publication. The contents do not represent the views of the US Department of Veterans Affairs or the US government. Competing interests: All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf and declare: support from the United States Department of Veterans Affairs, the Institute for Public Health at Washington University in Saint Louis, MO, USA, the American Society of Nephrology, and KidneyCure; no financial relationships with any organizations that might have an interest in the submitted work in the previous three years; no other relationships or activities that could appear to have influenced the submitted work. Ethical approval: This research project was reviewed and approved by the Institutional Review Board of the Department of Veterans Affairs Saint Louis Health Care System. Data sharing: All data are available through the United States Department of Veterans Affairs. The lead author (the manuscript’s guarantor) affirms that the manuscript is an honest, accurate, and transparent account of the study being reported; that no important aspects of the study have been omitted; and that any discrepancies from the study as planned (and, if relevant, registered) have been explained. Provenance and peer review: Not commissioned; externally peer reviewed. Dissemination to participants and related patient and public communities: There are no plans to disseminate the results of the research to study participants. Study results will be shared with the public via press release, social media, and conference presentations.',\n",
       " ('COVID-19',\n",
       "  89,\n",
       "  0): 'Severe covid-19 pneumonia has posed critical challenges for the research and medical communities. Older age, male sex, and comorbidities increase the risk for severe disease. For people hospitalized with covid-19, 15-30% will go on to develop covid-19 associated acute respiratory distress syndrome (CARDS). Autopsy studies of patients who died of severe SARS CoV-2 infection reveal presence of diffuse alveolar damage consistent with ARDS but with a higher thrombus burden in pulmonary capillaries. When used appropriately, high flow nasal cannula (HFNC) may allow CARDS patients to avoid intubation, and does not increase risk for disease transmission. During invasive mechanical ventilation, low tidal volume ventilation and positive end expiratory pressure (PEEP) titration to optimize oxygenation are recommended. Dexamethasone treatment improves mortality for the treatment of severe and critical covid-19, while remdesivir may have modest benefit in time to recovery in patients with severe disease but shows no statistically significant benefit in mortality or other clinical outcomes. Covid-19 survivors, especially patients with ARDS, are at high risk for long term physical and mental impairments, and an interdisciplinary approach is essential for critical illness recovery. The ongoing outbreak of the coronavirus disease 2019 (covid-19) has posed immense challenges for the research and medical communities. This review focuses on the epidemiologic and clinical features of covid-19, the pathophysiologic mechanisms, inpatient respiratory support, and the evidence to date on drug treatments. It also covers the recovery and long term management of patients with covid-19 pneumonia. The review is aimed at clinicians and intensivists caring for patients with severe covid-19 pneumonia as defined by the National Institutes of Health, 1 referring to individuals with SARS-CoV-2 infection confirmed by polymerase chain reaction (PCR) testing who have SpO 2 <94% on room air at sea level, a ratio of arterial partial pressure of oxygen to fraction of inspired oxygen (PaO 2 /FiO 2 ) <300 mm Hg, respiratory frequency >30 breaths/min, or lung infiltrates >50%. We manually searched electronic databases PubMed and Embase for English language articles published from 1 January 2020 to 20 February 2021. We also reviewed the medRxiv preprint server to monitor the rapidly evolving information on covid-19. We used the following search terms in combination with the term “covid-19”: “pneumonia”, “ARDS”, “pathogenesis”, “epidemiology”, “survival”, “therapeutics”, and “complications”. We included articles on the basis of the quality of the study and favored large randomized controlled trials (RCTs), high quality observational studies, systematic reviews, meta-analyses, and guidelines. Because of the evolving nature of the pandemic, the paucity of data, and the lack of RCTs, our article selection for respiratory care and post-covid complications included observational studies and case series. We excluded case reports and articles in non-peer reviewed journals. At the time of writing, covid-19 is responsible for 116 million cases globally and 2.5 million deaths. 2 The most striking characteristic of the disease is its heterogeneity, ranging from no symptoms to critical illness. 3 Older age, male sex, race (particularly Black, Hispanic, and South Asian), and comorbidities (including hypertension, diabetes, cardiovascular disease, chronic pulmonary disease, chronic kidney disease, cancer, and chronic liver disease) have been associated with worse outcomes. 3 4 5 6 7 8 Genetic factors may play a part as well, with blood type A associated with a higher risk for severe disease. 9 A common characteristic of SARS-CoV-2 is asymptomatic transmission, 10 which is likely the cause of rampant spread and transmission. 11 Given SARS-CoV-2 entry is primarily via the respiratory tract, upper and lower respiratory tract involvement is the most common manifestation. 12 About one third of patients hospitalized with SARS-CoV-2 infection meet criteria for acute respiratory distress syndrome. 13 In-hospital mortality,',\n",
       " ('COVID-19',\n",
       "  89,\n",
       "  1): 'while initially very high in certain series (60% for those intubated in a large study from New York City in April 2020 14 ) has been declining during the course of the pandemic, with in-hospital survival improving from 74.4% (March 2020) to 92.4% (August) in a study from New York City, 15 and intensive care unit (ICU) survival improving from 58% (March) to 80% (June) in a large national surveillance database from England. 16 Autopsy studies of patients who have died from severe SARS CoV-2 infection reveal presence of alveolar wall injury and diffuse alveolar damage consistent with ARDS. 56 57 However, compared with classic ARDS, autopsy studies also indicate higher thrombus burden in pulmonary capillaries, which suggests a greater pathogenic role of thrombotic and microangiopathic vasculopathy in covid-19 related ARDS. 56 57 Studies collectively show that thromboembolism occurs more frequently and is associated with a higher mortality in patients with covid-19. 58 59 Additional studies are needed to delineate the direct clinical consequences of increased thrombosis and its association with mortality in covid-19, which have major implications for the management of respiratory failure. Current studies are ongoing to investigate treatment with anticoagulants, which may shed light on the importance of thrombosis in covid-19 ARDS. Early descriptions of covid-19 included development of a cytokine storm as a harbinger for clinical deterioration. 51 Clinical and serologic evidence points to high levels of serum IL-6, IL-1β, and TNF-α which are associated with clinical instability and other biomarkers of inflammation. 52 53 54 More recent studies comparing serum cytokine measurements with other known cytokine mediated diseases such as sepsis and cytokine release syndrome have noted that covid-19 patients’ serum cytokine levels were substantially lower. 51 52 55 As a result, the direct role of cytokines in disease pathogenesis has been challenged. 55 Many unanswered questions related to the pathogenesis of inflammation and the mechanism of action of corticosteroids in covid-19. Clinical observation of lymphopenia has been apparent since the start of the covid-19 pandemic and may be associated with worsening disease. 48 An adequate T cell response (both CD4 + and CD8 + T cells) directed toward SARS-CoV-2 has been shown to be associated with milder disease. 49 Aging is well established to be associated with failure of regeneration of naive T cells and T cell activation. 50 In covid-19, dysregulation of T cell homeostasis has been postulated as a mechanism for severe disease seen in older adults. 49 Direct anti-SARS-CoV-2 antibodies have been manufactured for treatment by Regeneron (REGN10933 and REGN 10987) and Eli Lilly (LY-CoV016) to bind to the viral receptor binding domain. 34 Concern is ongoing that the mutations would give the virus the ability to escape direct binding to the specific antibodies. 34 More research is needed to fully identify the impact the virus mutations have on the treatment modalities available. The magnitude of the innate antiviral response has been associated with the degree of infection, which might account for the heterogeneous viral response among those infected with covid-19. 42 The adaptive immune response starts with IgA, IgG, and IgM specific antibody release similar to the response to SARS-CoV. 44 The timing of antibody release and the persistence of detectable levels has varied among patients. 44 Case and observational studies in patients with SARS-CoV-2 showed early detection of specific IgA and IgM antibodies (within five days) and late detection of specific IgG antibodies (after 14 days). 44 In addition, disease severity has recently been shown to drive an enhanced antibody response, 45 46 which correlates with clinical outcomes. 47 Limited mechanistic data are available on the innate immune response',\n",
       " ('COVID-19',\n",
       "  89,\n",
       "  2): 'to SARS-CoV-2 42 although expansion of in vitro studies, animal models, and covid-19 patient serum profiles has been significant. 43 It is now evident that over the first few days after SARS-CoV infection, activation of toll-like receptors (TLR 3, 7, and 8) by pathogen recognition receptors (PRRs) induces transcriptional upregulation of interferons (type I and III interferons) and recruitment of leukocytes. 43 Early knowledge of the entry process of SARS-CoV-2 into host cells, via the binding of the S protein to the ACE2 receptor, was extrapolated from what was known from SARS-CoV. 35 36 Human ACE2 (hACE) receptor is the same receptor used by SARS-CoV for viral entry. 37 hACE receptor is similar across animal species but with a varied binding efficiency. 37 Older age and male sex of the host are also determinants of S protein-ACE2 binding efficiency. 38 ACE2 receptors are highly expressed in the upper respiratory tract of humans. 17 Proteolytic cleavage of the S protein by serine proteases including transmembrane protease serine 2 (TMPRSS2), cathepsin L, and furin, are required for binding to the ACE2 receptor. 35 Similar to the ACE2 receptor, protease expression varies by tissue type and location, with a high expression in the nasal and bronchial epithelium. 39 In addition, human epithelial cells that line mucosal surfaces and cover organs such as conjunctiva, gastrointestinal tract, liver, and kidney also express ACE2 and TMPRSS2. 40 41 Once the virus attaches to the host cell receptors, it undergoes endocytosis, viral maturation, replication, and release of more virus within the cytoplasm of the host cell. 37 SARS-CoV-2 infection begins with viral replication and partially avoids host recognition during the initial infection and before the host innate response is enabled. 42 SARS-CoV-2 S spike protein binds to the ACE2 receptor, which leads to proteolytic cleavage by TMPRSS2, cathepsin L, and furin in the epithelial cell of the respiratory tract. The virus undergoes endocytosis, viral maturation, replication, and release of more virus within the cytoplasm infecting the host cell. Consequences of infected cells include pro-inflammatory cytokine secretion, microangiopathic vasculopathy, and B cell secretion of specific SARS-CoV-2 antibodies Emerging data show distinctive mutations in the SARS-CoV-2 genome isolated from patients. 31 SARS-CoV-2 mutated variants include B.1.1.7 (UK variant), P.1 (Brazilian variant) 32 , and B.1.351 (South African variant). 33 The primary region of mutation for these variants is in the spike protein. The B.1.1.7 variant has a greater rate of infectivity and spread, 32 which may be related to binding affinity to the ACE2 receptor. 34 SARS-CoV-2 is characterized by four main structural proteins that are important for infectivity and replication. 20 These proteins include the spike (S), membrane (M), envelope (E), and nucleocapsid (N) proteins. 22 23 The S protein, which includes two protein subunits (S1 and S2), gives the virus its well known appearance as the S protein protrudes from the membrane. 24 The tip of the protruding S protein has a crown (Latin corona)-like shape. 24 The S protein is also important for binding to the angiotensin converting enzyme 2 (ACE2) receptor, which is the point of entry of the virus to the human and animal host. 25 Furthermore, the S protein is thought to be a major contributor to the immunogenic response; therefore the S protein is the target of most vaccines. 25 26 The M protein is a transmembrane protein important in viral pathogenesis. 27 Little is understood about the E protein; however, it is known to play a role in viral replication and infectivity. 28 29 Finally, the N protein allows for regulation of viral RNA replication, transcription, and synthesis. 30 SARS-CoV-2 is',\n",
       " ('COVID-19',\n",
       "  89,\n",
       "  3): 'a positive sense, single stranded RNA enveloped virus in the Betacoronavirus genus. 12 17 Bats and pangolins may be the animal hosts of SARS-CoV-2 as there is a >90% gene homology to the SARS-CoV-2 found to infect humans. 12 18 Currently it remains unclear if SARS-CoV-2 was directly transferred from bat/pangolins to humans or an intermediate host was required for transmission. 12 18 In light of the current pandemic, researchers first compared SARS-CoV-2 with the previous endemic SARS-CoV (2002-03) and MERS-CoV (2012). 19 SARS-CoV-2 has overlapping genetic sequences with SARS-CoV and MERS-CoV, with 79% and 50% homology, respectively. 17 20 21 Respiratory care for severe covid-19 pneumonia Severe covid-19 pneumonia as defined by NIH1 overlaps significantly with the clinical definition of “classic” ARDS.60 However, several unique pathophysiological processes are postulated to be at play for CARDS, such as intravascular thrombosis caused by loss of endothelial barrier, prominent loss of hypoxic pulmonary vasoconstriction resulting from endothelial dysfunction, and excessive blood flow to collapsed lung tissue.61 Further, not all case series provide a clear semantic distinction between severe covid-19 pneumonia and CARDS, which confounds interpretation. In this section, we summarize the current literature on the use of respiratory therapy equipment in patients with severe covid-19 pneumonia. To date, no controlled prospective trials inform the respiratory management of severe covid-19 pneumonia. Notwithstanding, among patients with severe covid-19 pneumonia, patient respiratory system mechanics and clinical outcomes achieved with standard ARDS management are similar to classic ARDS. Consequently, contemporary respiratory care revolves around supportive measures and is based on the management of classic ARDS. We begin by providing a general review of these concepts. Titration of oxygen therapy to avoid hyperoxemia6263 and hypoxemia64 is strongly recommended for acute hypoxemic respiratory failure. A range of 90-96% oxygen saturation, confirmed by co-oximetry, is a reasonable target.63 For patients who require invasive mechanical ventilation (IMV), the first goal is avoidance of high tidal volumes, which are associated with ventilator induced lung injury.6566 Evidence suggests that similar injury could occur because of sustained high tidal volumes during spontaneous breathing, also known as patient self-induced lung injury (P-SILI).676869 Although not validated in controlled clinical trials, an assessment of strain known as tidal pressure or driving pressure7071 (defined as the ratio of tidal volume to tidal respiratory system compliance) allows matching of volume delivery with respiratory system mechanics and enables optimal mechanical ventilatory settings. In an observational study of non-covid ARDS trials, mediation analysis revealed that 75% of the beneficial effect of treatment group assignment was attributable to reduction in tidal pressure.70 The second goal of mechanical ventilation in ARDS is to prevent the constant opening and closing of alveoli which may be injurious to the lung (atelectrauma). Positive end expiratory pressure (PEEP) is titrated to keep alveolar units open throughout the respiratory cycle. Several RCTs that aimed to optimize recruitment in the intervention arm showed similar clinical outcomes to controls7273 and a signal for potential harm which was attributed to recruitment maneuvers.74 To that end, the benefits of higher PEEP are evident only when reducing tidal pressure—ie, less strain for a given tidal volume.70 Recruitability (the ability to open and keep alveoli open) can be assessed at the bedside by calculating the recruitment/inflation (R/I) ratio.7576 For patients who are proven recruitable, employing the high PEEP and F i O 2 table72 may be preferable while monitoring cardiac output and respiratory mechanics to avoid concurrent hyperinflation.7778 Prone ventilation and neuromuscular blockade (NMB) are frequent adjuncts in the treatment of ARDS. Prone ventilation promotes lung recruitment and improves ventilation/perfusion matching by creating a more even distribution of transpulmonary pressure throughout the chest.',\n",
       " ('COVID-19',\n",
       "  89,\n",
       "  4): 'A multicenter, prospective RCT showed that among patients with severe hypoxemic respiratory failure (P a O 2 /F i O 2 <150), prone positioning >16 hours a day was associated with reduced 28 day mortality.79 NMB in early ARDS potentially reduces lung strain by eliminating spontaneous breathing activity. Despite earlier encouraging findings, a recent meta-analysis of five RCTs showed no mortality benefit, with a modest reduction in barotrauma risk and improved oxygenation if applied after 48 hours in patients with severe ARDS.80 The belief that respiratory care principles to treat classic ARDS should apply in CARDS was challenged when earlier series of covid-19 patients seemed to indicate two different respiratory failure phenotypes.81 A case series (n=16) noted that patients had low elastance, low ventilation perfusion matching, low recruitability and lung weight which they named the “L type.” Conceivably, such discrepancy of ventilation perfusion matching with relatively normal mechanics was attributed to loss of lung perfusion regulation and hypoxic vasoconstriction. The remainder of the cases were more consistent with classic ARDS (high elastance, high ventilation/perfusion ratio, high recruitability and lung weight) referred to as the “H type.” The authors suggested that patients who had the L type may not require low tidal volume ventilation and attempts at recruitment could bring harm. Further, they reasoned that patients who present with a paucity of infiltrates, low elastance, and hypoxemia should be placed on mechanical ventilation earlier to prevent spontaneous high tidal volumes generated by the patients. This proposed need for a different management has been contested on the grounds of inconclusive evidence for P-SILI and CARDS case series that revealed respiratory system mechanics similar to classic ARDS.8283 Current observational reports mirror our experience and reinforce our view that a significant proportion of patients with covid-19 pneumonia can be treated non-invasively (ie, high flow low nasal cannula (HFNC) or non-invasive ventilation (NIV)) in lieu of invasive mechanical ventilation (IMV). This approach may also optimize utilization of mechanical ventilators, a scarce resource during the pandemic. We recommend using the entire spectrum of non-invasive and invasive devices for respiratory assistance (fig 2). Figure 2 is based on our practice in treating severe covid-19 pneumonia, and draws largely from the experience in classic ARDS. Close monitoring and attention to signs of non-invasive device failure are crucial for optimal outcomes. Extra corporeal membrane oxygenation (ECMO) is available for patients who have refractory hypoxemia after these measures84 but is infrequently needed.85 Fig 2 Algorithm for the respiratory management of a patient with covid-19 pneumonia. RR=respiratory rate, PEEP=positive end expiratory pressure, R/I=recruitment/inflation ratio, COPD=chronic obstructive pulmonary disease, CHF=congestive heart failure, HFNC=high flow nasal cannula, WOB=work of breathing, P/F=PaO2/FiO2 ratio, MAP=mean arterial pressure, NIV=non-invasive ventilation The following sections provide an overview of the different respiratory equipment and outline the rationale for their use in severe covid-19 pneumonia. High flow nasal cannula oxygen therapy HFNC oxygen therapy refers to the delivery of humidified and heated oxygen at high flows, typically 20-60 L/min, which is titrated to a precise fraction of inspired oxygen (F i O 2 ). The advantages of delivering oxygen in this manner include improved comfort by satisfying patient flow demand,86 creating an oxygen reservoir in the upper airway thereby reducing physiological dead space (reduced CO 2 rebreathing),87 and providing a modest PEEP that could help recruit collapsed alveoli88 with consequent reduction in work of breathing. Recent meta-analyses suggest that application of HFNC in the setting of acute hypoxemic respiratory failure can reduce the risk of intubation and invasive mechanical ventilation by 15% compared with conventional oxygen therapy without affecting mortality.8990 However, use of HFNC requires vigilant monitoring for signs',\n",
       " ('COVID-19',\n",
       "  89,\n",
       "  5): 'of impending respiratory failure. Roca and colleagues devised and validated the ROX index (ratio of oxygen saturation by pulse oximetry/F i O 2 to respiratory rate) as a bedside tool for predicting HFNC failure in the setting of pneumonia and hypoxemic respiratory failure.91 Accordingly, patients with a ROX index ≥4.88 after 2, 6, and 12 hours of treatment had low risk of intubation, whereas a ROX index <3.85 at the same time points was associated with a high risk of failure. Delaying intubation until the occurrence of overt desaturation, hypotension, respiratory rate >35 breaths/min with respiratory distress, or acidosis has been associated with poor clinical outcomes.92 Evidence on the use of HFNC for covid-19 pneumonia consists of case reports and case series.93949596979899100101102 It attests to the feasibility of utilizing HFNC in this setting; however, firm conclusions regarding efficacy are difficult to draw because of the lack of control groups. Table 1 shows large case series in the English language and provides detailed patient information and outcomes. The patients in these series had respiratory failure with P a O 2 / F i O 2 ranging from 68 to 209. The average duration of HFNC was between three and six days; however, patients who required escalation of care did so earlier in the course of treatment. HFNC was associated with successful outcomes (ie, no escalation of care) in 34% to 70% of cases. ROX index determined after 4-6 hours of treatment predicted escalation of care.939597 Patients with P a O 2 / F i O 2 >200 before commencing HFNC and who had a reduction in respiratory rate within the first several hours had the best outcomes.101 Of note, HFNC treatment is feasible in conjunction with proning patients who have not been intubated (awake proning) and improves oxygenation. However, an observational study noted no difference in the rate of intubation between supine and proned patients.94 Table 1 Studies on respiratory assist devices in covid-19 (HFNC, NIV, and IMV) View this table: HFNC was avoided at the beginning of the SARS CoV-2 pandemic in favor of early intubation for fear of disease transmission by exhaled aerosol. However, disease transmission has not been shown in clinical studies.103 HFNC does not lead to aerosol generation104105 and aerosol dispersion can be limited by having patients wear masks.106 To that end, experts suggest clinicians utilize HFNC treatment for covid-19 patients no differently than for those without infection107 with careful attention to proper use of personal protective equipment (PPE).98106 Despite the lack of controlled trials in covid-19, large case series show favorable outcomes for patients who receive therapy with HFNC. A recent computer simulation study concluded that strategies incorporating HFNC for patients not urgently needing intubation could result in greater mechanical ventilator availability and fewer deaths.108 Propensity score matched analyses comparing HFNC and other means of respiratory assistance suggest lesser likelihood of intubation,102 higher number of ventilator free days and reduction in ICU length of stay109 with the former. Non-invasive ventilation Non-invasive ventilation (NIV) is delivered through a face mask or a helmet that is placed over the patient’s head. The helmet interface potentially presents a safer alternative (from an infection control perspective) because it eliminates leaks. In the settings of acute congestive heart failure and acute hypercapnic respiratory failure due to COPD, NIV has been extremely effective in preventing intubation and reducing mortality.110111 Application of NIV in the setting of acute hypoxemic respiratory failure excluding COPD and cardiogenic pulmonary edema has been controversial, with mixed results.68112113114115 Several red flags were raised for NIV when treating ARDS patients. For instance, in the LUNG SAFE study, overall success',\n",
       " ('COVID-19',\n",
       "  89,\n",
       "  6): 'rate for NIV in classic ARDS was 63% with an in-hospital mortality of 36%. NIV was associated with higher intensive care unit mortality among ARDS patients with P a O 2 /F i O 2 <150 mm Hg on presentation.116 A prospective observational study reported failure of NIV in the presence of high expired tidal volumes (>9.5 mL/kg predicted body weight) and poor oxygenation at baseline (P a O 2 /F i O 2 <200 mmHg).68 Similarly, one hour after initiation of NIV, expired tidal volumes >9 mL/kg of predicted body weight and P a O 2 /F i O 2 ≤200 mmHg independently predicted NIV failure.112 A post hoc analysis reported higher risk of intubation and mortality for patients treated with NIV versus HFNC in a group of immunocompromised patients with acute respiratory failure.117 A recent network meta-analysis of 25 RCTs comparing standard oxygen treatment with NIV or HFNC showed lower risk of intubation (HFNC risk ratio 0.76 [95% confidence interval, 0.55 to 0.99]; NIV risk ratio 0.76 [95% confidence interval, 0.62 to 0.90]) and lower risk of mortality (NIV risk ratio 0.83 [95% confidence interval, 0.68 to 0.99]).118 However, mortality benefit for NIV delivered by face mask vanished for patients with severe hypoxemia (P a O 2 /F i O 2 ≤200) when excluding COPD, heart failure, or postoperative patients. In contradistinction, when helmet interface was used to facilitate NIV, the benefit on mortality was maintained, emphasizing the possible importance of how NIV is provided. A concern with respect to NIV is the higher risk for disease transmission, as noted in previous viral epidemics103 because of mask leaks and aerosol dispersion. NIV use was limited in the US and Europe owing to concerns over disease transmission and questionable efficacy in ARDS.119120 In China, on the other hand, NIV was used as the initial strategy between 57% and 85% of the time,121122123 and to date no clear evidence shows increased disease transmission to healthcare workers.122124 The studies that report detailed patient characteristics and outcomes for the use of NIV in covid-19 pneumonia (table 1) are limited to case series.100121123125126127128129 Owing to the observational nature of the studies, NIV management is not driven by protocol and no specific guidance is provided on titration of support or when to intubate. Outcome data suffer from incomplete reporting and reveal highly variable hospital survival ranging from 14% to 95%.125129 Preliminary outcome data from Italy were also not as promising for the use of helmet CPAP in covid-19 as they were for non-covid respiratory failure.125130 In a retrospective study125 the patients on helmet CPAP died without intubation 54.9% of the time, attesting to the resource limited conditions under which the study was conducted. Patients with chronic illness,123 severe disease on presentation,121130 and increased inflammatory markers123129130 were at risk for NIV failure. A large prospective single day study from Italy indicated that NIV was successfully used outside of the ICU setting using helmet CPAP in two thirds of the cases of severe covid-19 pneumonia.131 A retrospective analysis (n=40) of covid-19 patients who eventually required IMV found that time spent on NIV and HFNC before intubation was associated with higher mortality.132 More recent retrospective cohort studies, which employed multivariable risk adjustment, suggest NIV is safe133 and potentially superior to early intubation134135136 strategy. Because thresholds for intubation and clinical monitoring over the course of illness were not standardized a priori, it is difficult to draw firm conclusions from these observational studies. In the absence of concomitant COPD or pulmonary edema, the benefits of NIV are uncertain in the management of ARDS, and we prefer HFNC as the',\n",
       " ('COVID-19',\n",
       "  89,\n",
       "  7): 'initial non-invasive support in severely hypoxemic patients with CARDS. When NIV is utilized, frequent surveillance of expired tidal volume, respiratory rate, hemodynamics, and oxygenation is critical for timely escalation of support. Invasive mechanical ventilation While initial case series reported high mortality rates for patients receiving IMV for covid-19 pneumonia,34 these studies originated from hospitals that were overwhelmed with surges of covid-19 patients. Subsequent larger and complete series reported mortality rates consistent with classic ARDS when basic ARDS management tenets were followed.85137138139140141 In table 1 we summarize select large case series with detailed information on baseline characteristics, ventilator settings, and outcomes for patients receiving IMV. Similar to HFNC and NIV, studies on IMV in the setting of covid-19 pneumonia suffer from retrospective design and lack of a control group. Notwithstanding, they indicate a striking resemblance in respiratory system mechanics and outcomes to classic ARDS. The LUNG SAFE study reported the incidence, outcome, ventilator settings, adjunctive therapies, and outcomes of 2377 patients with classic ARDS who received IMV in 459 ICUs in 50 countries.142 The median age was 61 years, with nearly 60% of patients with pneumonia as the cause for ARDS. Patients remained on IMV for a median of 8 (4-16) days. Twenty eight day mortality was 35% overall and 41% for those with severe ARDS. On presentation, median P a O 2 /F i O 2 161 (158-163) mm Hg, mean plateau pressure (Pplat) was 23.2 (22.6-23.7) cm H 2 O, delivered PEEP was 8.4 (8.3-8.6) cm H 2 O, and FiO 2 0.65. Adjunctive measures included NMB (22%), prone positioning (8%), and ECMO (3%). Compared with observations in the LUNG SAFE study, IMV duration in CARDS case series may be slightly longer85137138140 with higher rates of NMB use and prone positioning.85137140141 Following the preliminary retrospective analysis of respiratory physiology during IMV,76 several larger prospective studies comparing consecutive typical ARDS and CARDS patients have been published.143144145146 These studies essentially confirm the notion of similar respiratory mechanics and physiology between the two conditions; however with some interesting nuances. One study144 matched 30 CARDS patients with 30 typical ARDS patients based on oxygenation parameters, tidal volume, and PEEP. It confirmed similar respiratory system mechanics and demonstrated high recruitability (R/I ratio >0.5) in both CARDS (73%) and ARDS (57%) patients, in contrast to the preliminary analysis which showed low recruitability when supine. R/I ratio inversely correlated with P a CO 2 response to PEEP titration, suggesting hyperinflation and increase in dead space when recruitability was low. A study of 301 CARDS patients143 found similar respiratory system mechanics and lung weight as determined by computed tomography scan compared with a retrospective cohort of typical ARDS patients. The investigators identified that those with a lower respiratory system compliance (<41 mL/cm H 2 O) and high D-dimer had higher mortality compared with other subgroups. Ventilatory ratio (the product of tidal volume, ventilatory rate, and PaCO 2 , indexed for predicted body weight), which is a marker for dead space, also correlated with D-dimer levels raising suspicion for pulmonary intravascular thrombosis. A contentious issue in IMV is when to intubate patients with CARDS. Two retrospective cohort studies of covid-19 patients have reported different conclusions, with one favoring earlier intubation147 and the other finding no association of mortality with time to intubation or HFNC use.148 Intensivists have struggled with this dilemma since the beginning of mechanical ventilation149: triggers for initiating IMV in clinical studies and in practice are not standardized and may depend on various factors including clinical judgment, severity of illness, patient preference, and cultural norms regarding mechanical ventilation. In the case of covid-19 pneumonia, resource limitation,',\n",
       " ('COVID-19',\n",
       "  89,\n",
       "  8): 'hypothetical concerns over P-SILI,83 and expert opinion on NIV may have played a role in the adoption of early IMV. Given the favorable outcomes of HFNC trials in classic ARDS,8990 we speculate that the likelihood of harm is small when standardized indices for detecting respiratory failure are applied and patients are transitioned to IMV when clinically indicated. Tracheobronchial hygiene Patients on mechanical ventilation for covid-19 pneumonia may develop increased mucus production with airflow obstruction. In a large cohort of covid-19 patients who underwent tracheostomy, most of the endotracheal tubes were partially occluded with sticky secretions.150 This manifestation may be due to changes in mucus regulation caused by SARS-CoV2 infection.151 Effective humidification, monitoring airway resistance, and potentially the use of mucolytics and endotracheal tube clearing devices152 may be helpful.',\n",
       " ('COVID-19',\n",
       "  9,\n",
       "  0): 'The World Health Organization recently announced a new naming system for SARS-CoV-2 variants using the Greek alphabet. The new naming system is aimed at preventing people from referring to the variants by the country where they were first detected. Four of these variants of concern — Alpha, Beta, Delta and Gamma — have spread to most provinces and territories in Canada. Alpha (B.1.1.7) The Alpha strain is the most common variant of concern in Canada, accounting for more than 216 000 cases of COVID-19 across the country as of June 17. First documented in the United Kingdom in September last year, Alpha is 50% more transmissible than earlier strains and was a major driver of Canada’s third wave of COVID-19 in the first months of 2021. The Alpha variant is also linked with surges in COVID-19 cases and hospitalizations among young people — although it’s unclear whether those surges were due to the variant or other factors, says Dr. Gerald Evans, chair of infectious diseases at Queen’s University in Kingston, Ont. Daily reports from Public Health Ontario suggest new cases from the Alpha variant are declining. Evans attributes this drop to more than half of Canadians receiving at least one dose of a COVID-19 vaccine. One study found that the AstraZeneca vaccine was 70% effective in preventing symptomatic COVID-19 caused by the Alpha variant, while another study estimated the efficacy of the Pfizer vaccine at roughly 90%. Open in a new tab Canada’s COVID-19 strategy may need to change in light of cases and deaths linked with the highly transmissible Delta variant. Image copyright iStock.com/Ergin Yalcin. No standalone file use permitted. Delta (B.1.617.2) First documented in India in October last year, the highly transmissible Delta variant is on track to eclipse the Alpha variant as Canada’s dominant strain this summer. Studies out of the United Kingdom suggest the Delta variant is up to 60% more transmissible than the Alpha variant. Experts have warned the Delta strain may drive a fourth wave of COVID-19 in Canada and are urging governments to shift the focus of vaccination campaigns to deliver second doses as soon as possible. According to Evans, Canada’s case counts involving the Delta variant are unclear because the variant may not be detected by some rapid tests. Ontario estimates Delta accounted for 40% of new COVID-19 cases in that province as of June 14. Alberta has reported several hundred cases and officials say the number of cases appears to be doubling every six to 12 days. Both Alberta and Manitoba have reported deaths linked to the Delta variant, including the death of at least one person who was fully vaccinated against COVID-19. Vaccines appear to be less effective against the Delta variant than the Alpha strain, but they are still highly effective at preventing disease after two doses. One study found that two doses of the Pfizer vaccine were 88% effective against symptomatic disease from the Delta variant, versus 93% effective against the Alpha strain. Two doses of the AstraZeneca were 60% effective against Delta compared to 66% against Alpha. However, both vaccines were only 33% effective against Delta after one dose, versus 50% effective against Alpha. Meanwhile, a preprint study reported high levels of protection when it came to hospitalizations for COVID-19. The Pfizer vaccine was 94% effective against hospitalizations from the Delta or Alpha variants after one dose and 96% effective after two doses. The AstraZeneca vaccine was 71% effective against hospitalizations after one dose and 92% effective after two. According to Chief Public Health Officer, Dr. Theresa Tam, Canada may need to adjust COVID-19 vaccination targets to',\n",
       " ('COVID-19',\n",
       "  9,\n",
       "  1): 'account for the Delta variant. Models that indicated that Canada could begin easing pandemic restrictions when 75% of people had at least one dose of a COVID-19 vaccine did not account for the Delta strain. Still, Canada is in a good position to curb the spread of the Delta variant, says Evans. “Because of our vaccine strategy to get one dose into everybody, the amount of SARS-CoV-2 circulating is really low,” he explains. As such, the Delta variant “is not getting a good opportunity to surge forward.” Beta (B.1.351) First documented in South Africa in May 2020, the Beta variant was linked with increases in hospitalizations and deaths during that country’s second wave. Vaccines also appear to be less effective in preventing COVID-19 from the Beta variant. In one study, researchers found that two doses of the Pfizer vaccine were 75% effective against any infection from the Beta variant, and 89.5% effective against any infection from the Alpha variant. However, vaccine effectiveness against severe or fatal disease from either the Alpha or Beta variants was very high at 97.4%. Novavax clinical trials showed 89% efficacy in the United Kingdom, compared to just 60% in South Africa, where the Beta strain was common. Similarly, trials of the Johnson & Johnson vaccine reported lower levels of protection against moderate to severe COVID-19 in South Africa than in the United States. Meanwhile, South Africa stopped plans to rollout the AstraZeneca vaccine because clinical trials did not show protection against mild or moderate illness caused by the Beta variant. Recent studies suggest that mutations in the Beta variant’s spike protein might allow it to escape the immune response trained by vaccines. “Everybody was worried about Beta especially because there’s this vaccine escape issue,” says Evans. “If it was [more] transmissible like Alpha, we would have been in trouble, but it isn’t. It seems to be no more transmissible [than early strains of the virus].” To date, Canada has documented more than 1900 cases. Gamma (P.1) The Gamma variant, first documented in Brazil in November 2020, is estimated to be 1.7–2.4 times more transmissible than other local strains in that country. Canada has reported more than 15 000 cases to date. The Gamma variant has some of the same mutations in its spike protein as the Alpha and Beta strains, which allow it to attach more easily to human cells. However, “it’s not anywhere near as transmissible as Alpha or Delta,” says Evans. Previous infection with SARS-CoV-2 appears to provide less protection against reinfection with the Gamma variant than other strains. However, at least one preprint study showed that the Gamma variant is less resistant to antibody responses from previous illness or vaccination than the Beta variant. Evidence also suggests that the Gamma variant struggles to compete with other strains in the wild. In a pre-print study, Italian researchers tracked the concurrent spread of Alpha and Gamma variants and found that the Alpha variant became increasingly common while the Gamma variant did not.',\n",
       " ('COVID-19',\n",
       "  90,\n",
       "  0): 'Status—The recommendations for JAK inhibitors were initially published on 14 January 2022, and were updated on 15 September 2022 to reflect that baricitinib, IL-6 receptor blockers and corticosteroids may be given together. No changes were made to the recommendation in this 14th version of the guideline. JAK inhibitors inhibit intracellular signalling in response to numerous interleukins, interferons, colony stimulating factors, and hormones. As a consequence, they interfere with many cellular responses, including antiviral responses, angiotensin-converting enzyme 2 (ACE2) expression, T cell function and differentiation, and macrophage activation. Baricitinib, ruxolitinib, and tofacitinib are three of at least nine JAK inhibitors. Their inherent differences, as well as variation in dosing and administration and pharmacokinetics, limit class-wide recommendations, and the GDG decided to make separate recommendations for individual drugs. Recommendation 1: We recommend treatment with baricitinib for patients with severe or critical covid-19 (strong recommendation). Understanding the recommendation The update maintaining a strong recommendation was based on additional data from 8156 patients enrolled in the RECOVERY trial, which confirmed a survival benefit (now high certainty evidence) and other benefits, with little or no serious adverse events, of a drug that may be administered easily.23 The GDG acknowledged that some serious adverse events, such as fungal infections, may not have been accurately captured during the relatively short follow-up period in the included trials. Because of different mechanisms of action, the GDG considered baricitinib separately from other JAK inhibitors. Costs and access remain important considerations, and the GDG recognises that this recommendation could exacerbate health inequities. This strong recommendation further strengthens the impetus to address these concerns and maximise access across regions and countries. The GDG did not anticipate important variability in patient values and preferences, and judged that other contextual factors would not alter the recommendation. The GDG had previously made a strong recommendation for use of IL-6 receptor blockers (tocilizumab and sarilumab) or baricitinib as alternative agents administered in addition to corticosteroids for patients with severe or critical covid-19. The GDG had elected to refrain from recommending the combination of these three immunosuppressive drugs until clear evidence of incremental benefit emerged. The RECOVERY trial has now provided this evidence, demonstrating that combining corticosteroids, IL-6 receptor blockers, and baricitinib provides incremental survival benefit.23 In RECOVERY, 2659 patients received baricitinib along with corticosteroids and IL-6 receptor blockers. The effect of baricitinib in this subgroup was consistent with the beneficial effect of baricitinib in patients who were not treated with IL-6 receptor blockers.23 Although these three immunosuppressive drugs are recommended and may be administered jointly, the panel anticipated that there would be situations where clinicians may opt for less aggressive immunosuppressive therapy or choose to combine medications in a stepwise fashion in patients who are deteriorating. However, since the drugs have not undergone direct comparisons, the GDG felt that clinicians should choose between baricitinib and IL-6 receptor blockers on the basis of experience and comfort using the drugs, local institutional policies, route of administration (baricitinib is oral; IL-6 receptor blockers are intravenous), and cost. Balance of benefits and harms—In patients with severe or critical illness, baricitinib reduces mortality (high certainty), and probably reduces duration of mechanical ventilation and hospital length of stay (both moderate certainty). Treatment probably results in little or no increase in serious adverse events leading to drug discontinuation (moderate certainty). Some serious adverse events such as severe infections which may arise from immunosuppressive therapy like baricitinib may not have been accurately captured during the relatively short follow-up in the included trials. This risk may vary in different parts of the world according to the local prevalence of infections such as tuberculosis. This risk',\n",
       " ('COVID-19',\n",
       "  90,\n",
       "  1): 'may also be less pertinent, given the short course of baricitinib used for the treatment of covid-19. Subgroup analyses were undertaken for JAK inhibitors as a class (rather than on individual drugs) and revealed no evidence of a subgroup effect on relative risk in younger (<70 years old) versus older patients, those with critical versus severe covid-19, those receiving or not receiving corticosteroids at baseline, and those receiving or not receiving remdesivir or IL-6 blockers at baseline. Values and preferences—The GDG inferred that almost all well informed patients with severe or critical covid-19 would choose to receive baricitinib due to the likely reduction in mortality, and moderate certainty evidence of little or no increase in serious adverse events. The GDG anticipated little variation in values and preferences between patients for this intervention. Applicability—None of the included RCTs for baricitinib enrolled children, or pregnant or lactating people; therefore, the applicability of this recommendation to these groups remains uncertain. The GDG did not have reason to believe that patients in these groups with covid-19 would respond differently; decisions regarding the use of JAK inhibitors in these groups should be guided by discussion between the individual and their healthcare provider. Practical issues—Baricitinib is administered orally once daily as tablets; it can be crushed, dispersed in water, or given via a nasogastric tube. Based on trials informing the recommendation, the recommended dose is 4 mg daily orally in adults with normal renal function for a duration of 14 days or until hospital discharge, whichever is first. The optimal duration of treatment is unknown. Dose adjustments may be needed for patients with leucopenia, renal impairment, or hepatic impairment, all of which should be monitored during treatment, and for patients taking strong organic anion transporter 3 (OAT3) inhibitors such as probenecid, where drug interactions warrant dose reductions. Baricitinib, like IL-6 receptor blockers, should be initiated at the same time as systemic corticosteroids; there are currently no data to suggest that specific timing during hospitalisation or the course of illness is beneficial. See MAGICapp for more information regarding practical issues. Resource implications, feasibility, equity, and human rights—Compared with some other candidate treatments for covid-19, baricitinib is expensive. The recommendation does not take into account cost effectiveness. See box 3 for related considerations. As baricitinib is administered orally once daily, hospitalised patients should find it easy to accept this treatment.',\n",
       " ('Dota 2',\n",
       "  1,\n",
       "  0): 'The rumors and speculation can cease. Valve is making Dota 2, we\\'ve played it, and it\\'s already amazing even though it\\'s not coming out until next year. And we haven\\'t yet laid eyes on Dota 2\\'s biggest innovation: a radical approach to integrating the game\\'s community back into the gameplay itself. What\\'s a Dota? Dota 2 takes its name from the Warcraft III mod Defense of the Ancients, a drastic change to that stock real-time strategy title, which pits two teams of five players against each other in highly competitive, 40-minute or longer matches. Unlike most RTSes, DotA has each player controlling a single hero who levels up and stockpiles gold to purchase powerful equipment and consumables. As computer-controlled armies continually spawn and rush the enemy\\'s base, players are responsible for using their powerful heroes to turn the tide of the battle in their favor. DotA quickly gained massive popularity on Blizzard\\'s Battle.net service, with the growing community utilizing user-created channels and the rudimentary custom game browser to connect players. As mods tend to do, it branched into several variations as time passed. Eventually, one rose to the top: DotA-Allstars, originally created by Steve \"Guinsoo\" Feak (now employed with Riot Games designing League of Legends). Allstars is currently maintained and updated by IceFrog (who declined to give his real name), who was hired by Valve in 2009 and is now working on Dota 2. DotA enjoys such unprecedented popularity for a number of interconnected reasons. The game has a skill curve as long and as wide as Counter-Strike or StarCraft; expert players dominate matches with lesser-skilled individuals solely through manual dexterity and hard-won knowledge. Extensive upgrade paths allow players to combine items into more powerful versions, gaining thousands of hit points or powerful life-stealing attacks. Team play is hugely rewarded; though the map is large enough for all ten players to spread out and fight creeps on their own without anyone engaging anyone else directly, late-game play is almost invariably centered around giant 3v3 or even 5v5 team fights. The mod has benefited from excellent, long-running support in the form of constant updates that add new content or address balance issues. Said balance is good enough that no dominant team composition or strategy has ever taken hold for long. The heroes are varied enough that a match featuring different team rosters can take on an entirely different character from the last. The enormous following generated by DotA\\'s deep gameplay is unprecedented. Today, years after its release, a third-party site hosting an update can get hammered by more than six million downloads in a day. The mod spawned a new subgenre, commonly referred to as \"action-RTS,\" that contains two successful commercial games in League of Legends and Heroes of Newerth (and the unfortunate flop Demigod) as well as DotA-Allstars itself. Valve Corporation, the company beloved for its Half-Life, Counter-Strike, Team Fortress, and Left 4 Dead series as well as its outstanding Steam digital distribution and matchmaking platform, is making its entry into this still-growing genre next year with Dota 2. What Does Valve Bring? Valve\\'s approach to Dota 2 is unusual in that the gameplay itself is remaining almost entirely untouched. \"Our first reaction is to assume that [design elements are] there for a reason,\" project lead Erik Johnson explains. \"IceFrog is one of the smartest designers we\\'ve ever met. He\\'s made so many good decisions over the years in building the product. He virtually never makes a decision that doesn\\'t have some reasoning behind it and a way to pick apart the logic behind it.\" This approach means that Dota',\n",
       " ('Dota 2',\n",
       "  1,\n",
       "  1): '2 basically is DotA-Allstars with new technology. DotA-Allstars\\' roster of 100+ heroes is being brought over in its entirety. The single map games take place on is functionally identical to the one that you can download for free today in the Warcraft III mod. Items, skills, and upgrade paths are unchanged. Some hero skills work slightly better due to being freed from the now-ancient Warcraft III engine, but Dota 2 will be instantly familiar to any DotA player. A few things will make significant differences to players making the transition. Dota 2 uses Valve\\'s Source engine, so the game is much prettier. Source itself is getting a few upgrades, including improved global lighting and true cloth simulation. Dota 2\\'s integrated voice chat is a huge step up from having to set up your own Ventrilo server, and the speed of voice communication is very nearly a requirement for a game as team-focused as DotA. AI bots will take over for disconnected players, and will be available to play against in unranked training matches as well. However, don\\'t get your hopes up for a full-fledged single-player game, though. Johnson says, \"Our goal with the AI is just that their experience isn\\'t destroyed just because one person couldn\\'t finish the game.\" The visual style is remarkable for retaining the somewhat cartoony feel that the Warcraft III version of DotA-Allstars is built around, while going in a few different directions. \"I think there are functional aspects to the art that are pretty significant to the players,\" Johnson muses. The environment, particularly in the forests that fill in the map between the three lanes that the NPC armies follow, uses a desaturated color scheme to give the colorful heroes and abilities some visual pop. The sizable art team is putting a lot of work into making the shapes and animations of each hero distinct to the point that players will be able to instantly identify any hero they see and quickly gauge the threat level of any situation. The game will also feature a ton of custom voice work. You\\'ll get amusing lines from heroes as they deny the enemy team last hits on creeps, and champions who have backstory connections will trade quips when nearby. The bulk of innovation in Dota 2, however, is ancillary to the gameplay itself. Valve is upgrading Steamworks (the company\\'s backend technologies for matchmaking and other gameplay and community-related things) to allow them to create in-game rewards for participating in the Dota 2 community. The idea is to have everything a player does in or out of game tie back into their online identity. Like the improvements to Source, the Steamworks upgrades will be available to third-party developers who choose to use Valve\\'s tools when Dota 2 launches in 2011. At a basic level, posting useful feedback or participating in constructive discussions on the forums will contribute to your standing in the community in a visible way. Valve doesn\\'t have the specifics on how this will work nailed down yet. Will you get points that contribute to a visible ranking, like a Gamerscore? Will your posts need to be recommended by other community members to count for anything? What counts as a constructive discussion? These questions are all being actively explored at the moment. Valve assures us that the designers have a slew of awesome ideas for how to implement rewards in a way that’s visible to the rest of the community, but there are no details to announce yet. \"When we talk about this identity that exists inside and outside the game, we don\\'t think we\\'re anywhere',\n",
       " ('Dota 2',\n",
       "  1,\n",
       "  2): 'near it with what exists on Steam right now,\" Johnson admits. If this was just about getting points for posting comments, though, we wouldn\\'t waste your time by telling you about it. Dota 2 goes much farther than that. Everything from unlocking new skins for your favorite hero to getting a unique title for writing a strategy guide is on the table. Valve has ambitious plans (for which, again, there are no specifics to share) to host everything themselves and provide the best framework for the community to interact with each other. The idea is to reduce the social friction inherent in having to dig around a bunch of different fansites and wikis to find what you\\'re looking for. Ultimately, two things will make Dota 2 stand out: the coaching system and interactive guides. Read on to find out more. Riding the Skill Curve Getting owned sucks. It doesn\\'t matter if you\\'re the victim of a headshot in Counter-Strike, corner trapped in Street Fighter, or swarmed under by Zerglings in StarCraft. Holding the short end of the skill stick in competitive games like these is rough. This problem is compounded in DotA and its clones by two factors. First, matches last around 40 minutes – that\\'s a long time to spend getting your face kicked in. Second, dying not only takes you out of the game while your respawn timer counts down but also directly benefits the other team by giving a big cash bounty to your killer. At intermediate and higher levels of play, having a poor player on your team who dies frequently is worse than fighting with a man down, as the opposite team gets gobs of gold for picking off the newbie. This has fostered a legendarily newbie-hostile attitude within large swaths of the DotA community. As fun and rewarding as the game is when you\\'re in a match of appropriate skill level – and it can be one of the very best experiences in gaming, without exaggeration – finding those matches has always been a nightmare. It doesn\\'t help that the game is so intense that Valve had to institute a \"no talking about the match for an hour afterwards\" rule for its internal playtests. The recent commercial titles that more or less cloned DotA have ameliorated this to some extent, but it is still often a huge problem. Valve believes that the solution to the huge barrier to entry is threefold. The first, obvious solution is to have excellent skill-based matchmaking for both individuals and teams. Valve believes that the work going into Steamworks for Dota 2\\'s release meets that requirement. Second, interactive guides will allow players to do more than just read a guide for their favorite hero that has been deemed helpful by the community at large. Valve plans to allow guide-makers to tie their work back into the game by doing things like highlighting suggested item purchases or displaying useful information during a match. Finally, a coaching system is being deeply integrated into the game. By logging in as a coach, veteran players can do their part to help out newer folks. Valve hasn\\'t entirely decided on the specifics of how newbies and coaches will be matched up, but once they\\'re together a few things happen. The coach sees the pupil\\'s screen, and gets private voice and chat channels to communicate with them. The coach probably won\\'t be able to take control of anything directly (once again, the details are currently under discussion), but information is power in Dota 2 and having a mentor whispering in your ear can make all',\n",
       " ('Dota 2',\n",
       "  1,\n",
       "  3): 'the difference in the world. Of course, the pupil will be able to rate the coach\\'s helpfulness. Being a well-regarded coach will have explicit in-game rewards, just like writing useful guides, posting constructive feedback, or engaging in interesting strategy discussions. If the overwhelming response to Battle.net achievements is any indication, vanity rewards like these will be extremely effective in channeling the community\\'s energies toward positive contributions. Valve founder and boss Gabe Newell thinks that ongoing service and value creation over a game\\'s lifespan is the new reality of game development. \"IceFrog was one of the smartest people we\\'ve ever met about doing that, and he was doing it with both hands tied behind his back, so to speak,\" Newell says. The company plans on approaching Dota 2 with the same dedication that won it the fanatical devotion of the Team Fortress 2 community, pushing out dozens of updates that do everything from adding new hats to fixing balance issues to introducing entire new match types for free. \"I think the interesting thing is us adding a second layer where the community is a service to each other. That\\'s the real shift that we\\'re trying to build here. Valve is going to keep building software around Dota and around the community and around Steamworks for Dota, but we\\'re also going to build this system where the community can bring service to each other and be recognized for it,\" Johnson proclaims. With a solid backbone of community-enabling systems and Valve\\'s legendary support and technology behind it, Dota 2 has a chance to turn one of the most popular mods of all time into a full game on PC and Mac that compares favorably to any eight-figure-budget console blockbuster.',\n",
       " ('Dota 2',\n",
       "  10,\n",
       "  0): 'If you\\'ve never played DotA, also known as Defense of the Ancients, trying to figure out how it all works can be confusing. This is especially true if you\\'re hopping in with people who\\'ve been playing for years and have a fondness for lashing out at those less knowledgeable. It\\'s a game type that grew out of Blizzard\\'s Warcraft III community and has enjoyed widespread popularity since, spurring other developers to produce their own versions like Riot Games\\' League of Legends. Now that Valve\\'s making a sequel, I think it\\'s safe to say the spotlight on the sub-genre will be brighter than ever. To prevent confusion over capitalization, I\\'m just going to write Dota for the rest of the article. According to Valve\\'s senior project manager Erik Johnson, \"When people talk about DotA they say Dota. It\\'s kind of a word, at this point. For us it\\'s just a word, or a brand name.\" “ Confirmed Dota 2 Heroes Include: Axe Sven Tidehunter Beastmaster Riki The game works sort of like Diablo mixed with a competitive real-time strategy game mixed with a game of tug of war. At the beginning of a match players are split into two teams and the ultimate objective is to destroy the other team\\'s base. To do so you\\'ll control one unit, a hero, who utilizes a handful of special attacks and spells. The abilities differ wildly between the huge number of heroes, meaning you can head into battle as a tank, a damage dealing caster, or any number of other variations. Knowing your hero and how to effectively work with your teammates is key to victory. You\\'ll also need to manage streams of automated creatures, called creeps. These beasts spawn from both bases at regular intervals and it\\'s up to you to fight alongside and through skillful play turn the tide of battle, eventually scything your way into the heart of the enemy base for the win. You\\'ll also be gaining gold, experience and leveling up the whole time, giving you the opportunity to power up hero skills and also buy new equipment and items to further augment your abilities. It\\'s a lot to process all at once. For the sequel, Valve brought on Dota curator IceFrog to lead design. \"It was apparent really early on that whoever was behind doing all the work on [Dota] was a really smart game designer,\" says Johnson. \"I emailed IceFrog and asked him to come out here and we just wanted to meet him and pick his brain a little bit and we hired him on the spot…It was clear as day that he knew how to build games really well.\" At Valve, the goal is to avoid fiddling too much with the underlying formula. \"There\\'s the core gameplay,\" says Johnson, \"the actual game rules for how you play Dota. We\\'d be pretty hard-pressed to improve on that. I feel like IceFrog\\'s done such a good job at that and it\\'s something that his level of experience is so much higher with that community that it probably doesn\\'t make a lot of sense for us to go in and change a lot of that, so the core gameplay is the same.\" So what does that mean? It means the number of creeps that spawn in a wave won\\'t really change, the way items and equipment works will be simliar, the structure of lanes will be the same, and a lot of the included heroes will be returning from the original. \"It\\'s going to be most of the heroes that you\\'re familiar with from Dota. Over time there\\'ll',\n",
       " ('Dota 2',\n",
       "  10,\n",
       "  1): 'be new heroes that are added to it just like IceFrog\\'s adding to Dota all the time. [Dota] is the game that people are used to, that all 20 million of those people are used to playing. There\\'s this big investment in your skill in Dota…and we don\\'t want to throw that away. We want them to be able to do all the fun things they could do before. It just doesn\\'t make any sense to us to start from somewhere new right now.\" When jumping into a game, the \"peak experience,\" says Johnson, will be a five on five game. Though those looking to play three versus three can, if they so choose, \"I think that the most fun people can have in terms of how the map is laid out, it\\'s all built around five versus five.\" Instead of trying to make major adjustments to gameplay, Valve is concentrating more on infrastructure, art, and providing helpful tools to newcomers so they can figure out what\\'s going on. This includes detailed statistic tracking, a replay system where you can review matches, a matchmaking system to pit players of similar skill level against each other and offering more convenient ways for the community to interact. Valve also plans on implementing a coaching system where a rookie player can be helped along by a veteran. \"We want to have a system where a very experienced player can choose to adopt a less experienced player and teach him the ropes, and that\\'s built right into the experience. And then that coach gets rewarded in some way. There\\'s some obvious work we have to do in terms of malicious coaches and things like that and we think we have a pretty good plan for that. But we want a new player to come in and say \\'Hey, I need a coach\\' and probably have a list of coaches and some data about those coaches and have them say \\'I\\'d like this person to coach me.\\' If they accept, they\\'re your wing man.\" That being said, Valve is conscious of the potential imbalance of having players with coaches mixed in against those without. \"We don\\'t want it to be a competitive advantage to be coached. We\\'re not going to build something where every player wants to have a coach in every game because it\\'s another set of eyes while playing.\" Players with competitive mindsets that tend to enter into tournaments represent another sector of the community Valve has in mind. \"Tournaments are tricky because there are a lot of organizations out there that already run tournaments and are really good at it. We definitely don\\'t want those people to not be able to do that. We don\\'t want to own their business and make it more difficult for them to run a tournament. It could be that there are tournaments and things like that we organize ourselves, but we probably want to build in things that make it easier for those guys to run their tournaments also.\" If you\\'re reading and still a little lost as to what it all means, it seems Valve is building in extra features to get you used to the mechanics without having to use a coaching tool or getting pummeled by other players in live matches. \"A full blown single-player campaign, that\\'s not going to happen, at least with this product. Building an entertaining way for you to learn how some of the core concepts of the game work that\\'s something that definitely will.\" It sounds like a lot of the work being done on the game right',\n",
       " ('Dota 2',\n",
       "  10,\n",
       "  2): 'now is related to building the look of the world. \"The existing Dota community is in love with Dota, and they\\'re in love with it in all ways. So we need to build art that they can identify with and be in love with also. We go out and have a small group of people outside giving us feedback on how we\\'re accomplishing that. At the same time this is kind of Valve\\'s first fantasy-based game, which is super fun for the artists. We\\'re trying to build a world as we\\'re building Dota 2…There\\'s a functional aspect of seeing what\\'s going on, which is a huge part of Dota. It\\'s a game where you have potentially 10 people creating 20 things in five seconds on your screen and being able to parse this quickly is one of the big challenges. It\\'s one of the things we\\'re iterating on like crazy when we play test internally.\" \"When we sit down and think about what should the hero look like you take a look at all their abilities. Does this hero do a lot of physical damage? Does this hero do a lot of magical damage? What are their signature abilities and how should that come through in how the hero is constructed and colored? And then there\\'s also, how does the community perceive this particular hero? They have really strong opinions and they\\'ve built up lore around all these heroes and so we have to be sure to satisfy that also. In terms of how the art looked in the previous game, that doesn\\'t really factor in.\" Valve\\'s also working on building a more cohesive fiction for the game world, which Johnson says will come across during play. \"It\\'ll come through in how the players talk, like who their voice actor is. In the game there are heroes that fictionally have a relationship with each other so from time to time they may say something to someone else that\\'s kind of one-off. We\\'re building that up that way in the game. We\\'ll see how the community reacts to that. So far it\\'s been really positive.\" Valve is quick to mention Counter-Strike as a point of comparison for what it\\'s doing with Dota 2. \"Early on with Counter-Strike we felt it was a very inaccessible game. Clearly we were proven wrong. I can remember coming into work and there were so many more people playing this mod, cstrike, than any other mod in the history of Half-Life, and I was like \\'We gotta play this thing.\\' And then you join the game and friendly fire is on and you can\\'t tell your teammates apart. The difference was one had a little bit of exposed skin and one had sleeves. So everyone\\'s just shooting each other, but people are having a blast. We looked at Counter-Strike so hard and we were totally behind it and excited, but we didn\\'t get it for a year. Clearly the data said it was accessible because everybody was playing it and new people were coming in all the time, but it violated a lot of our rules about what we thought accessibility was.\" \"I think Dota has a lot of similarities to that case where a lot of game designers will look at it and say \\'This is the least accessible game I\\'ve ever seen.\\' But then there\\'s 20 million people playing around the world so, how\\'d that happen? We think making any attempt to make the game less hardcore, easier, or less complex would actually be a huge mistake because the game design itself relies on',\n",
       " ('Dota 2',\n",
       "  10,\n",
       "  3): 'a bunch of those things to reward people for their skill.\" Valve still hasn\\'t determined any kind of pricing structure, so no definite word yet on whether post-release content will be free or not. Though Valve is notorious for delaying projects, Dota 2 for now is scheduled to be released in late 2011.',\n",
       " ('Dota 2',\n",
       "  11,\n",
       "  0): 'Blizzard has vowed not to let Valve\\'s trademark of the name Dota hold up the launch of its own DOTA mod for StarCraft 2. It is prepared to change the name of the mod rather than see the game delayed as a result of a trademark dispute, Blizzard Executive Vice President, Product Development and Co-Founder Frank Pearce told Eurogamer. Last year Blizzard game design boss Rob Pardo told Eurogamer Valve\\'s attempt to trademark DOTA \"doesn\\'t seem the right thing to do\". Pardo said Blizzard was confused by Valve\\'s move and believed it had the right to use the term in the name of its free StarCraft II mod, Blizzard DOTA. DOTA refers to the hugely popular online gametype born of the famous Warcraft 3 mod, Defense of the Ancients, and maintained by the elusive IceFrog. Valve is currently developing Dota 2 for its Source engine, with IceFrog\\'s help, after employing some of the DOTA mod development community. At Gamescom, where Valve unveiled Dota 2 via an invitation-only tournament, Pearce reiterated Blizzard\\'s stance on the issue. \"From my perspective, DOTA is a genre in this space, at this point, and almost a sub genre of the real-time strategy space,\" he said. \"It doesn\\'t seem like something someone would want to trademark, but the US legal system lets people do just about anything they want to try.\" If Blizzard goes ahead with its planned launch of Blizzard DOTA near on at the release of StarCraft 2 expansion Heart of the Swarm, expected some time next year, will Valve object? \"That\\'s a really good question,\" Pearce replied. \"I don\\'t know the answer to that. Hopefully not.\" \"I can\\'t speak to it from a legal perspective. From the development team and the leadership at Blizzard, we want to make great games and we want to get those great games into the hands of our fans. \"At the end of the day, the name and the label we put on that mod for StarCraft 2 is not as critical as the gameplay experience we create and deliver to the fans. We will not hold back the experience from the fans because of a naming conflict. We\\'ll find a way to get it into the hands of our fans either way. \"I don\\'t think it\\'s critical [to have the name DOTA] to delivering that experience to the fans, personally.\" Now, for the first time, Valve has explained why it has trademarked the Dota name. \"The issue with that was, when we were talking with IceFrog originally, he wanted to build the sequel to DOTA,\" Valve boss Gabe Newell told Eurogamer. \"So the reason to call it Dota 2 is it actually does a pretty good job of communicating to gamers what it is the game is going to be. \"If a gamer looks at this game and you ask them, is that Dota 2? They\\'re going to say yeah, that makes sense. That\\'s a good name for it. That\\'s really what\\'s driving that.\" Newell, who has played Dota 2 for a whopping 800 hours already, denied Pardo\\'s accusation that Valve\\'s trademark takes Dota away from the community that built it. \"The community is usually pretty unambiguous in their opinions about stuff, so, now they\\'ve had a chance to see the game they\\'re going to tell us pretty clearly whether they think it\\'s an appropriate name for it,\" he said. \"I haven\\'t had any customers or gamers react negatively to it. They seem to be pretty comfortable with it.\" Does Newell anticipate any trademark dispute when both games launch next year? \"I don\\'t know,\" he replied. \"That\\'s',\n",
       " ('Dota 2',\n",
       "  11,\n",
       "  1): 'really not my domain. I\\'m sure there will be a bunch of nattering back and forth, but I\\'m more concerned about the game than anything else.\"',\n",
       " ('Dota 2',\n",
       "  12,\n",
       "  0): 'If you\\'ve never played DotA, also known as Defense of the Ancients, trying to figure out how it all works can be confusing. This is especially true if you\\'re hopping in with people who\\'ve been playing for years and have a fondness for lashing out at those less knowledgeable. It\\'s a game type that grew out of Blizzard\\'s Warcraft III community and has enjoyed widespread popularity since, spurring other developers to produce their own versions like Riot Games\\' League of Legends. Now that Valve\\'s making a sequel, I think it\\'s safe to say the spotlight on the sub-genre will be brighter than ever. To prevent confusion over capitalization, I\\'m just going to write Dota for the rest of the article. According to Valve\\'s senior project manager Erik Johnson, \"When people talk about DotA they say Dota. It\\'s kind of a word, at this point. For us it\\'s just a word, or a brand name.\" “ Confirmed+Dota+2+Heroes+Include:+Axe+Sven+Tidehunter+Beastmaster+Riki The game works sort of like Diablo mixed with a competitive real-time strategy game mixed with a game of tug of war. At the beginning of a match players are split into two teams and the ultimate objective is to destroy the other team\\'s base. To do so you\\'ll control one unit, a hero, who utilizes a handful of special attacks and spells. The abilities differ wildly between the huge number of heroes, meaning you can head into battle as a tank, a damage dealing caster, or any number of other variations. Knowing your hero and how to effectively work with your teammates is key to victory. You\\'ll also need to manage streams of automated creatures, called creeps. These beasts spawn from both bases at regular intervals and it\\'s up to you to fight alongside and through skillful play turn the tide of battle, eventually scything your way into the heart of the enemy base for the win. You\\'ll also be gaining gold, experience and leveling up the whole time, giving you the opportunity to power up hero skills and also buy new equipment and items to further augment your abilities. It\\'s a lot to process all at once. For the sequel, Valve brought on Dota curator IceFrog to lead design. \"It was apparent really early on that whoever was behind doing all the work on [Dota] was a really smart game designer,\" says Johnson. \"I emailed IceFrog and asked him to come out here and we just wanted to meet him and pick his brain a little bit and we hired him on the spot…It was clear as day that he knew how to build games really well.\" At Valve, the goal is to avoid fiddling too much with the underlying formula. \"There\\'s the core gameplay,\" says Johnson, \"the actual game rules for how you play Dota. We\\'d be pretty hard-pressed to improve on that. I feel like IceFrog\\'s done such a good job at that and it\\'s something that his level of experience is so much higher with that community that it probably doesn\\'t make a lot of sense for us to go in and change a lot of that, so the core gameplay is the same.\" So what does that mean? It means the number of creeps that spawn in a wave won\\'t really change, the way items and equipment works will be simliar, the structure of lanes will be the same, and a lot of the included heroes will be returning from the original. \"It\\'s going to be most of the heroes that you\\'re familiar with from Dota. Over time there\\'ll be new heroes that are added to it just',\n",
       " ('Dota 2',\n",
       "  12,\n",
       "  1): 'like IceFrog\\'s adding to Dota all the time. [Dota] is the game that people are used to, that all 20 million of those people are used to playing. There\\'s this big investment in your skill in Dota…and we don\\'t want to throw that away. We want them to be able to do all the fun things they could do before. It just doesn\\'t make any sense to us to start from somewhere new right now.\" When jumping into a game, the \"peak experience,\" says Johnson, will be a five on five game. Though those looking to play three versus three can, if they so choose, \"I think that the most fun people can have in terms of how the map is laid out, it\\'s all built around five versus five.\" Instead of trying to make major adjustments to gameplay, Valve is concentrating more on infrastructure, art, and providing helpful tools to newcomers so they can figure out what\\'s going on. This includes detailed statistic tracking, a replay system where you can review matches, a matchmaking system to pit players of similar skill level against each other and offering more convenient ways for the community to interact. Valve also plans on implementing a coaching system where a rookie player can be helped along by a veteran. \"We want to have a system where a very experienced player can choose to adopt a less experienced player and teach him the ropes, and that\\'s built right into the experience. And then that coach gets rewarded in some way. There\\'s some obvious work we have to do in terms of malicious coaches and things like that and we think we have a pretty good plan for that. But we want a new player to come in and say \\'Hey, I need a coach\\' and probably have a list of coaches and some data about those coaches and have them say \\'I\\'d like this person to coach me.\\' If they accept, they\\'re your wing man.\" That being said, Valve is conscious of the potential imbalance of having players with coaches mixed in against those without. \"We don\\'t want it to be a competitive advantage to be coached. We\\'re not going to build something where every player wants to have a coach in every game because it\\'s another set of eyes while playing.\" Players with competitive mindsets that tend to enter into tournaments represent another sector of the community Valve has in mind. \"Tournaments are tricky because there are a lot of organizations out there that already run tournaments and are really good at it. We definitely don\\'t want those people to not be able to do that. We don\\'t want to own their business and make it more difficult for them to run a tournament. It could be that there are tournaments and things like that we organize ourselves, but we probably want to build in things that make it easier for those guys to run their tournaments also.\" If you\\'re reading and still a little lost as to what it all means, it seems Valve is building in extra features to get you used to the mechanics without having to use a coaching tool or getting pummeled by other players in live matches. \"A full blown single-player campaign, that\\'s not going to happen, at least with this product. Building an entertaining way for you to learn how some of the core concepts of the game work that\\'s something that definitely will.\" It sounds like a lot of the work being done on the game right now is related to building the look of the',\n",
       " ('Dota 2',\n",
       "  12,\n",
       "  2): 'world. \"The existing Dota community is in love with Dota, and they\\'re in love with it in all ways. So we need to build art that they can identify with and be in love with also. We go out and have a small group of people outside giving us feedback on how we\\'re accomplishing that. At the same time this is kind of Valve\\'s first fantasy-based game, which is super fun for the artists. We\\'re trying to build a world as we\\'re building Dota 2…There\\'s a functional aspect of seeing what\\'s going on, which is a huge part of Dota. It\\'s a game where you have potentially 10 people creating 20 things in five seconds on your screen and being able to parse this quickly is one of the big challenges. It\\'s one of the things we\\'re iterating on like crazy when we play test internally.\" \"When we sit down and think about what should the hero look like you take a look at all their abilities. Does this hero do a lot of physical damage? Does this hero do a lot of magical damage? What are their signature abilities and how should that come through in how the hero is constructed and colored? And then there\\'s also, how does the community perceive this particular hero? They have really strong opinions and they\\'ve built up lore around all these heroes and so we have to be sure to satisfy that also. In terms of how the art looked in the previous game, that doesn\\'t really factor in.\" Valve\\'s also working on building a more cohesive fiction for the game world, which Johnson says will come across during play. \"It\\'ll come through in how the players talk, like who their voice actor is. In the game there are heroes that fictionally have a relationship with each other so from time to time they may say something to someone else that\\'s kind of one-off. We\\'re building that up that way in the game. We\\'ll see how the community reacts to that. So far it\\'s been really positive.\" Valve is quick to mention Counter-Strike as a point of comparison for what it\\'s doing with Dota 2. \"Early on with Counter-Strike we felt it was a very inaccessible game. Clearly we were proven wrong. I can remember coming into work and there were so many more people playing this mod, cstrike, than any other mod in the history of Half-Life, and I was like \\'We gotta play this thing.\\' And then you join the game and friendly fire is on and you can\\'t tell your teammates apart. The difference was one had a little bit of exposed skin and one had sleeves. So everyone\\'s just shooting each other, but people are having a blast. We looked at Counter-Strike so hard and we were totally behind it and excited, but we didn\\'t get it for a year. Clearly the data said it was accessible because everybody was playing it and new people were coming in all the time, but it violated a lot of our rules about what we thought accessibility was.\" \"I think Dota has a lot of similarities to that case where a lot of game designers will look at it and say \\'This is the least accessible game I\\'ve ever seen.\\' But then there\\'s 20 million people playing around the world so, how\\'d that happen? We think making any attempt to make the game less hardcore, easier, or less complex would actually be a huge mistake because the game design itself relies on a bunch of those things to reward people for',\n",
       " ('Dota 2',\n",
       "  12,\n",
       "  3): 'their skill.\" Valve still hasn\\'t determined any kind of pricing structure, so no definite word yet on whether post-release content will be free or not. Though Valve is notorious for delaying projects, Dota 2 for now is scheduled to be released in late 2011.',\n",
       " ('Dota 2',\n",
       "  13,\n",
       "  0): 'This article is over 11 years old and may contain outdated information Recommended Videos Hello. My name is Tim McDonald, and I really, really like Dota 2. I’ve played it for around 300 hours, and to give you some idea of how much I like it, the first draft of this was written when I was on 230. Yet this game contains such an unimaginably vast amount of content and variety that there’s still plenty of stuff I simply don’t know. On the plus side, I’m good enough and confident enough that – at worst – I’m a generally competent player. I think Dota 2 is great, basically, and I’d like to introduce you to it. Unfortunately, it’s a daunting game to actually get into, and it’s harder still to learn how to play it without being screamed at, which is why I’m writing this guide. If you’ve never played Dota 2 before – hell, if you’ve never played a MOBA before – this is for you. If you have played Dota 2 before but are still fairly new to it, the forthcoming guides will likely be of more use. Over the course of these guides I’m going to go over how it plays, what you should be doing at any given time, some basic tips that are incredibly helpful after your first couple of hours, how you should start off playing, what heroes you might like to try early on, and a glossary of commonly-used terms you’ll hear in game. But for now, let’s start with what Dota 2 is and how it works. Tim, why should we trust you to teach us how to play it if you say there’s a load of stuff you don’t know? You should trust me precisely because there’s a load of stuff I don’t know. It wasn’t that long ago that I was completely new to the game, and I’ve got a pretty good grasp on what I wished I knew back then. Equally, there’s all sorts of stuff that isn’t all that important when you’re beginning, and I intend to signpost it as such and only talk about it later. I’m good enough that I can tell you what will help you, but I’m not good enough that I can talk about high-level techniques, and I was a newbie recently enough that I fully understand the muted terror you’ll feel when you fire up your first game. I’m you, a few months on. Also, I have no doubt that there will be 20,000 people in the comments telling me I’m wrong and I’m an idiot, so I’m sure there’ll be plenty of advice from “expert” players right below this piece. And that’s Professor Tim, to you. Alright. “Professor” Tim, what is Dota 2? Dota 2 is a competitive multiplayer game in which two sides of five attempt to destroy each other’s Ancient – a huge building at the heart of each side’s base. The game takes place from a top-down view, with each player controlling a single hero via standard RTS controls. Those heroes are picked from a pool of over 100, and each has his/her/its own unique stats, skills, and abilities. Different heroes work well together in different ways, but for the most part, players spend their time levelling up and buying items in order to gain a big enough advantage over the enemy team that they can destroy the foes’ Ancient. Short version: pick a hero, level him up, buy items to make his stat numbers bigger, work with your teammates, smash the big thingy on the other side',\n",
       " ('Dota 2',\n",
       "  13,\n",
       "  1): 'of the map. Of course, it’s not actually that simple, or games wouldn’t last 40 minutes on average. For starters, the enemy is trying to do the same thing as you, so getting an advantage isn’t easy. For another thing, the paths to the Ancient are blocked by deadly towers that have to be destroyed first. Oh, and there’s a constant wave of NPC “creeps” marching from each base to the other; for the most part, you’ll be trying to “push” your creeps towards the enemy base. And did I mention that the game is sufficiently balanced that advantages in terms of gold or experience can sometimes be counteracted by good tactics? Okay, so how do I get in on this? Well, now! The game’s actually out of open beta and has launched. That doesn’t mean you can just hop in immediately, though – Valve are adding people in batches so that the servers don’t wet themselves in terror and fall over. All you need to do to get in on that queue, though, is go to the Dota 2 page on Steam and click “Get Dota 2.” Before too long, you should get an email telling you that you’re in. Aren’t free-to-play games rubbish? Is this pay-to-win? Free-to-play games are regularly rubbish, but you’ll be pleased to hear that Dota 2 is most definitely not pay-to-win. Everything gameplay-related is free – you don’t need to pay for heroes or wait for them to come into rotation, or anything like that. The only things that cost money are cosmetic items, and they’re randomly dropped at breakneck pace anyway. Of course, with 100 heroes, there’s no guarantee you’ll get one you want. Heroes can be dressed up in a variety of ways, you see; there might be different weapons, or helmets, or gloves, or… whatever. You can buy different announcer packs, or HUD skins, or different shapes of ward. But again: all of these are purely cosmetic, and (almost) all of them have a chance to drop anyway. Hell, the only advantage you get for levelling up your profile is that you’re guaranteed a cosmetic item drop when that number goes up. It doesn’t really mean anything else. The only thing that’s even mildly intrusive is that matches will regularly reward you with locked treasure chests containing a random item from a small selection, and the keys for these cost a couple of quid. That’s it, though. You never have to open them if you don’t want to. Not too much bullshit, then. How many maps are there, anyway? Just one. This game’s shit. Oh piss off. Look: the variety comes from the insane amount of heroes and the insane number of ways they can be built (and the insane number of different ways you’ll need to build them, depending on what you’re facing). The map is there to facilitate this, and it’s got plenty of little tricks to learn anyway. Think of it like a fighting game – the stages don’t matter nearly so much as the characters. Alright, fine. But one map? Is there something special about it? Yeeeeah, I should probably talk about the map. H Which looks fairly simple, but… okay, well. On the bottom-left of the screen you have the Radiant base – that’s one of the two teams – and on the top-right you have the Dire base. Each of these contains, as the furthest red or green spot from the enemy base, that team’s Ancient. Destroy the enemy’s Ancient to win the game. As you can probably see, there are three big paths going',\n",
       " ('Dota 2',\n",
       "  13,\n",
       "  2): 'from one base to the other: one directly above the Radiant base that goes clockwise, one directly to the right of the Radiant base that goes anti-clockwise, and one that’s a straight diagonal run from one base to the other. Each of these paths – or “lanes”, usually differentiated in game as “top”, “middle”, and “bottom” – has two green dots and two red dots between the base. These are towers. We’ll talk about them – and every other element on the map – in detail shortly. There are also sections of the map which can be moved through, but which aren’t on the main lanes. These bits are generally referred to as the jungle, and hanging around in them is more dangerous than sticking to the lanes for two reasons… which we’ll also come to shortly. Also on the map are a pair of shops that sell a few of the items that you can acquire from your base, as well as two “secret” shops which sell powerful items that can only be acquired from there. Finally, there’s Roshan. Do you see the little red mark to the right of the Dire tower in the middle of the map? That’s Roshan’s cave. He just hangs out there unless someone goes and bothers him. That’s a hell of a lot to take in. I know, and I’m sorry, but I need to get you up to speed on the map and give you a reference guide when I start talking about other bits and bobs. Writing “along top lane” is a lot faster than writing out “along the big path that’s directly above the Radiant base, which curves around at the top of the map to move right towards the Dire base,” and you can always refer back to my description of the map anyway, if you need to. PC Invasion is supported by our audience. When you purchase through links on our site, we may earn a small affiliate commission. Learn more about our Affiliate Policy',\n",
       " ('Dota 2',\n",
       "  14,\n",
       "  0): 'This article is over 11 years old and may contain outdated information Recommended Videos Whew. A lot’s happened since last week’s Beginner Guide (in which I went over the absolute basics of Dota 2). For starters, the IncGamers Dota 2 guild has started up, and I’ve spent a fair bit of time playing with our members – who are hopefully also playing amongst themselves a fair bit, too. Sadly, a few of our members are far, far better than me, which somewhat makes me question the wisdom of writing this guide in the first place. I mean, one kind soul gave me a crash course in Bristleback earlier this week. Which is a very long-winded way of saying “I’m suddenly less confident about both my skills and this guide” and “you should join the guild because we’ve got some really great people in there.” Whether you’re new or old, based in America or Australia – we’ve got a place for you as long as you’re not a cock. Anyway! Last time, we talked about the absolute basics so that those who hadn’t even touched the tutorials could get up to speed on how Dota 2 works. This time, we’re going to talk about which heroes are right for you. Unfortunately, before we get to the fun stuff (i.e. me slagging off the heroes) we need to explain a few things – namely, what the hell the basic types of hero are. Dota 2 divides up heroes in terms of whether their primary stat (the one that give them extra damage) is Strength, Agility, or Intelligence, as well as classifying them by giving them star ratings across a dizzying array of types. This hero might be a 2-star nuker, a 1-star disabler, a 1-star escapist, and a 1-star initiator… but, while giving you a rough idea of the hero’s capabilities, it’s not a particularly helpful way of describing heroes early on, particularly if that description made you go cross-eyed. Instead, I’m going to divide them up into a four different categories, some of which will cross over. As with literally everything else in Dota 2 there’s a lot more to it than this, but this is a pretty simple way of giving you a general gist. There’s the Carry, which is a hero that will “carry” your team to victory if they manage to get lots and lots of gold. Carries tend to be weak in the early game, but – if they can get plenty of last hits, kill a few enemy players, and maybe down a few creeps in the jungle – they can absolutely dominate the later stages. The carry will tend to go to a lane with a Support. Support is a fairly nebulous way of describing a hero because this lot have all sorts of wildly varying abilities – healing, silencing, slowing, stunning – but it tends to mean a hero that doesn’t actually require much gold to be useful, and they generally have more functionality than they do damage. Support can sit in lane, keeping the carry safe and harassing the enemy, while said carry focuses on last-hitting all the creeps and hoovering up as much gold as possible. Most supports won’t get many kills, but – unless they’re a powerful disabler and are picked on first in any given fight – they’ll likely have a huge amount of assists by the end of the game. Tanks – who often, but not always, double as carries – are the hard bastards that wade into battle and soak up huge amounts of damage. They’re usually decent',\n",
       " ('Dota 2',\n",
       "  14,\n",
       "  1): 'at starting a teamfight and convincing the enemy to use all of their abilities at the start of the fight, so that squishier (but more damaging) allies can safely engage. Finally, there are Nukers. These are the guys and girls (and horrifying freaks from dimensions of agony) with the firepower; they’re the ones who push out insane amount of damage either in one sudden, hero-assassinating burst, or as sustained attacks over the course of a battle. Some work best wandering the map from about 10-15 minutes in, picking off lone enemy heroes. Others are carries. Others rule the early game. Some lucky few can be effective at all stages. Also, two bits of general advice. First: in a match, look at the top left of the screen. Do you see the little button that looks like an open book? This is the Guides button; if you click that and then the little arrow that expands the window out, you can select a player-created guide. Good ones will give you a rough overview of how to play the hero, which items to get, the order in which to level up your powers, and when (and how) to use them. I don’t think I’ve ever seen one I’ve followed completely – I normally make my own tweaks and adjustments – but they’re a decent guide to how to build and play any given hero that you haven’t touched before. Secondly: do not take a hero online until you’ve tried it in at least one botmatch – preferably two. Playing against the AI might be less interesting, but it’s a completely safe way to figure out how a hero works and whether or not you like them, and this is very important. Okay. Now for the fun stuff. What do you want to play? Hello, Professor Tim! oh no it’s you again I know you don’t mean that. I’d like an overview of the sort of heroes beginners might have fun trying out, so how about I give you a description of how I want to play, and you give me an idea of which hero I should try out? Alright, fine. That can’t go too horribly wrong. It seems like wading into the thick of combat as a beginner might not be the wisest choice, so what would you suggest if I said I wanted to play someone that could sit at long range and dish out damage from there? Two heroes immediately come to mind. The first is Sniper, who – as the name implies – is very good at sitting at long range and dishing out damage. In fact, once he’s levelled up a bit, he’s basically the only hero that can hit towers from outside of their firing range. Better still, Dota 2‘s tutorial forces you to play a few missions as him, so most beginners should have an idea of how he works from the very start. That said… well, Sniper’s very, very squishy and easy to kill, and it takes him a little while to really become at all useful. You can certainly consider him, but I favour the second option. The second option is Drow Ranger, who was – entirely coincidentally – the first hero I really learned how to play, and the first hero I took into an online match. No bias here! Oh fine, I’m biased. I hate Sniper. I hate his smug little face, I hate his smug little voice, I hate the things he says, I hate the fact that he was my much-loathed nemesis when I first started playing the game.',\n",
       " ('Dota 2',\n",
       "  14,\n",
       "  2): 'I hate Sniper. Anyway: Drow’s easy to play for a few reasons. Her primary damage is right-click (that is to say, her basic auto-attack rather than abilities you have to activate) and two of her abilities are passive anyway (that is to say, they’re always active). One gives her a massive boost to agility, which translates directly to a massive boost to her damage, and the other gives bonus damage to every other ranged attacker on her team. Her other two abilities are Frost Arrows and Silence. Silence is a superb ability – you cast it and, for a few seconds, heroes within its area of effect can’t use any abilities. Which is great, obviously. Frost Arrows, on the other hand, is an autocast ability (one that will automatically be used, if turned on) which makes your auto-attack slow the people it hits at the cost of your mana. All of which makes Drow superb at killing single targets, or dishing out huge amounts of damage in a teamfight. She can silence a foe to keep herself safe, then turn on Frost Arrows and completely prevent her target from escaping while she whittles it down. As a helpful tip, do not use Frost Arrows on creeps because it’s a waste of mana. You can easily toggle the ability’s autocast by holding down Alt when you press its key (so by default, Alt-Q); get used to turning it on and off rapidly when you’re switching between fighting creeps and fighting heroes. Both her and Sniper are carries, but Drow’s a lot more effective in the early game. I’ve changed my mind. I thought you might. Well, both of your suggestions there were carries. I’m not ready for that level of responsibility. Instead, I just want to help out my team, and I don’t even care if I’m dishing out damage or not! Sounds like you’re in the market for a good support, this time. There’s a school of thought that most new players should play support in their first few online matches, and it’s one I’m not going to argue with (although mine was as Drow, as I said). There are a lot of supports that are fairly easy and enjoyable to play, and there’s a whole article I could write on how to play support and what your responsibilities are, but at least some of that will have to wait for another week. I really have no idea which to suggest. Oh, just pick one. Tell you what – I’ll pick two. First up is Dazzle. Dazzle’s not the easiest hero to play, but even a bad Dazzle can be helpful to his team, and a Dazzle in the hands of a good player will irritate the shit out of the other team. This is because of his abilities. He’s got one attack ability that poisons and slows (and stuns at higher levels) which is great for dealing with enemies that are running away on the verge of death. His ultimate increases allied armour and decreases enemy armour, which is also pretty great late game when armour matters a hell of a lot. But the two abilities that will massively annoy the other team are Shadow Wave and Shallow Grave. Shadow Wave is a chain healing spell – you cast it, and a bolt of purple light arcs to a bunch of targets in range, healing them all. What makes this a pain in the arse is that it also damages enemies; anyone next to someone healed with Shadow Wave will take damage equal to that heal. If an enemy',\n",
       " ('Dota 2',\n",
       "  14,\n",
       "  3): 'hero is beating up your lane partner, you can fire off a Shadow Wave to heal your ally and hurt your opponent at the same time. Then there’s Shallow Grave which, if abilities were named after the things the other team says when they’re used, would probably be called “Fucking Dazzle.” This creates a protective shield around one ally which prevents them from dropping below 1hp for the duration. In short: while Shallow Grave is up, one of your allies cannot die. Stick this on a Lycanthrope in the middle of a battle, or a raging Ursa, and they’ve suddenly got 5 seconds of immortality with which they can wreck the shit out of the other team. Alternatively, pop it on someone who’s desperately low on health and give them a chance to escape. The difficulty with Dazzle is that Shallow Grave has a long cooldown, and prioritising who to save isn’t necessarily easy. If you’re in the middle of a teamfight and the squishy Crystal Maiden is being picked on, is it worth using what might be the only Shallow Grave you can cast this fight to save her? Or is it better to let her die, and to use it on one of your heavy hitters when the enemy turns their attention elsewhere? Decisions. That sounds a bit tricky. Well, some would say Dazzle’s a poor choice for a newbie compared to other supports because of the hard decisions he has to make, but the advantage is that he’s rather easy to understand and direct healing is always useful. Alright. So who’s the other support? That would be Lich, who doesn’t possess any healing but is also very good at annoying enemies. His only boring ability is Ice Armor, which can be cast on allies so that anyone attacking them is slowed. Happily, you can set this to autocast and then forget about it, which isn’t a bad idea when you’re learning how to use him. So, his other powers. Frost Blast is a single-target attack that does some damage, and slows the movement and attack speed of the target. It also damages and slows anyone around the target, but to a lesser extent. This is boosted up a bit by the ability Sacrifice, which lets Lich “eat” a friendly creep, turning its health into his mana and preventing the enemy from getting experience for that creep. In short: Lich can stop the enemy from getting xp and gold while fueling his own Frost Blasts. He’s kind of a dick. His crowning glory, though, is his ultimate: Chain Frost. This is one of the most devastating ultimates in the game. Here’s how it works: you fire it at a target, and a little ball of blue frost slowly arcs towards them. It hits them really hard, stuns them for a moment, and then bounces off to a nearby target. It hits the new target really hard, then bounces off to a nearby target. Repeat the bouncing and hitting really hard until there’s no-one in range or the spell has bounced 10 times. If you fire it at a single target then you’ve basically wasted it, but you’re still talking a hefty chunk of damage to them. If you fire it at a group of enemies heroes that are tightly packed together – trapped by Enigma, or Dark Seer, or Faceless Void, or anyone else who can control positioning – then it’s just going to wreck the whole lot of them. Casting Chain Frost causes panic in the enemy team, who will normally try to scramble away from each',\n",
       " ('Dota 2',\n",
       "  14,\n",
       "  4): 'other… but if two unlucky teammates go the same way, they’re going to get the spell bounced between them until someone dies, and this also splits people up enough that counterattacks are a lot easier. That seems a bit broken. Just about everyone in Dota 2 is broken in one way or another. Have I talked about the complete bullshit Faceless Void pulls out? No… I’ll save that for another time. Are you done? Read the next part here. PC Invasion is supported by our audience. When you purchase through links on our site, we may earn a small affiliate commission. Learn more about our Affiliate Policy',\n",
       " ('Dota 2',\n",
       "  15,\n",
       "  0): 'Blizzard once made a game called WarCraft III. Then someone made an awesome mod for it called DOTA. Then Valve decided to make a game called DOTA 2. Then Blizzard decided to make something called Blizzard DOTA. Live Forever in the Universe of \\'New World: Aeternum\\' Share Live Forever in the Universe of New World: Aeternum And now Blizzard is fighting a legal battle with Valve over the whole thing. What a mess. Two of the most successful and popular PC developers of all time are squaring off in court over the use of the term DOTA, which stands for Defence of the Ancients. Advertisement In 2010, Valve - who is working on a successor to the original called DOTA 2 - began attempts to trademark the word \"DOTA\", despite the fact it had no historical connection to the property or the genre. At the time, Blizzard said some unkind things publicly about the move, but didn\\'t seem to take things any further. Advertisement Advertisement It has now. Arguing before the US Patent and Trademark Office\\'s Trial and Appeal Board in an attempt to have Valve\\'s trademark application blocked, Blizzard says that, because the term DOTA has been used by the company\\'s games and fans for seven years, \"the DOTA mark has become firmly associated in the mind of consumers with Blizzard\". Advertisement Valve, on the other hand, well...here\\'s what Blizzard has to say about Valve\\'s upcoming DOTA 2: In contrast to Blizzard, Applicant Valve Corporation (\"Valve\") has never used the mark DOTA in connection with any product or service that currently is available to the public. By attempting to register the mark DOTA, Valve seeks to appropriate the more than seven years of goodwill that Blizzard has developed in the mark DOTA and in its Warcraft III computer game and take for itself a name that has come to signify the product of years of time and energy expended by Blizzard and by fans of Warcraft III. Valve has no right to the registration it seeks. If such registration is issued, it not only will damage Blizzard, but also the legions of Blizzard fans that have worked for years with Blizzard and its products, including by causing consumers to falsely believe that Valve\\'s products are affiliated, sponsored or endorsed by Blizzard and are related or connected to Warcraft III. Advertisement Getting into the fine print, Blizzard says that, because the original DOTA required WarCraft III to play - and because it\\'s been using and licensing the term to other companies - that while it doesn\\'t have a trademark on the term, it\\'s got a better case for one than Valve. In a filing dated November 16, 2011, Blizzard wrote that it \"respectfully requests that this Opposition be granted\" to Valve\\'s attempts to trademark DOTA (and \"Defense of the Ancients\", and \"DotA\", and \"Dota\"). Advertisement USPTO Blizzard vs Valve [USPTO, via NeoGAF]',\n",
       " ('Dota 2',\n",
       "  16,\n",
       "  0): '(Valve) On Tuesday, the Dota 2 International 6 prize pool broke last year’s mark of $18,429,613 to become the largest prize pool in the history of esports. It currently sits at roughly $18.7 million, but that number is still rising. Advertisement Advertisement Advertisement After putting up $1,600,000 of their own money, Dota 2 developer Valve boosted the pool by selling an in-game “Battle Pass” that offers players items through a quest-like system of progression. A quarter of all Battle Pass sales go directly towards The International 6 prize pool, though players can also purchase levels to instantly increase their progression. The more you play Dota, the more in-game items you earn. This year features couriers and wards that evolve into magnificent, magical artifacts. The International 6 kicks off on August 2 in Seattle with Wild Card matches, leading into the group stages a few days later. On August 8, the competition moves to Key Arena, where the 16 top teams will play out a double-elimination bracket in front of thousands of cheering fans. Advertisement Advertisement Advertisement Last year, North American squad Evil Geniuses stunned the world by topping their group and making an incredible run through the bracket, beating three of the world’s best teams in LGD, CDEC, and EHOME to bring home the Aegis and a whopping $6.6 million in prize money. One of the most epic moments in esports history occurred in the grand final match between CDEC and EG. Smelling blood in the Rosh pit, Saahil “UNiVeRsE” Arora blinked in and executed what is now referred to as “The Six Million Dollar Echo Slam”: The four frontrunners heading into TI6 are currently Wings Gaming, Team Liquid, Newbee, and OG. How much will the winner take home this year? That remains to be seen, as the prize pool will continue to rise until Valve officially calls it. Dylan Walker is on Twitter @dyluuxx',\n",
       " ('Dota 2',\n",
       "  17,\n",
       "  0): 'Valve\\'s Erik Johnson has told Join Dota that Dota 2 will be getting a LAN mode. \"There are some systems that LAN mode requires that we haven\\'t finished yet, mainly because we\\'ve been focused on matchmaking. We know how important this feature is for the community,\" says Johnson. He also talked a bit about Valve\\'s plans for their next big Dota 2 tournament. The Dota 2 International took place at Gamescom last year, offering Dota pros a shot at a piece of the $1.6 million prize pool. Valve are going to at least match that amount in the next tournament. Johnson said that \"if you look at any major sport around the world that has an audience of similar size to Dota\\'s you\\'ll find that those at the very top in terms of skill tend to make a lot of money.\" \"Frankly, we think the teams represented at The International deserve this kind of money for what they do. We all know how hard it is to master Dota,\" he added. Replays of many of the competition matches are still available on the International site if you want to see the pros in action. The next International will take place in Seattle. When asked whether the Penny Arcade Expo would host the tournament, which is scheduled to run from August 31 to September 2, Johnson said \"good guess, but nothing is finalized just yet.\" \"Like last year, we\\'ll be covering all of the costs for the teams and players to make their way to the event\" said Johnson. If you want to grab an invite for your team, Johnson recommends that you \"play in Dota tournaments and perform well. We\\'ve all been watching every tournament that we find internally, looking for what teams we think should be invited.\"',\n",
       " ('Dota 2',\n",
       "  18,\n",
       "  0): 'Valve has unveiled the Three Spirits update for Dota 2, which brings the hotly-anticipated Diretide event, adds two new heroes to the game, and incorporates a slew of other general changes. The Dota 2 client will automatically download the update later today. Headlining the update are new heroes Earth Spirit and Ember Spirit, cousins of the freshly-redesigned Storm Spirit. New features include an in-game coaching system, an item-crafting system that threatens to disrupt the game\\'s community marketplace, item socketing, and a showcase view. Coaching allows experienced players to join a party and oversee up to three pupils, and multiple coaches can shepherd the same student. Coaches can view the game from the perspective of their students, as well as draw on their screen and ping their minimap. Coaches and pupils are also given a private communication channel. The new crafting system allows players to use recipes in order to either transform multiple unwanted items of one rarity into a new item, or duplicates of the same item into one of a higher rarity. Both types of recipes can be found randomly while playing, or by opening ancient scroll cases. The long-awaited Diretide update will run from November 14 through November 28, Valve adds, but no additional information was given. Another major change is that users who have dropped into low-priority matchmaking must now complete a series of games to return to regular matchmaking, as opposed to waiting an allocated amount of time. Valve is also expecting the game\\'s item economy to change as a result of the new update. \"This update may greatly disrupt market prices,\" the company said. \"In order to prevent items being purchased at pre-update prices for arbitrage, we are removing all item listings and returning them to their owners. While this removal process is taking place, new items will not be able to be listed on the Steam Community Market.\" Full details of the update can be found on the Dota 2 site.',\n",
       " ('Dota 2',\n",
       "  19,\n",
       "  0): 'This article is over 14 years old and may contain outdated information Popular PC developer Valve has registered a trademark for what is apparently popular Warcraft III mod Defense of the Ancients. If you’ve never played Defense of the Ancients, it’s a wildly popular custom game built using the Warcraft III map editor in which players control a single hero (rather than an army) in a team battle to destroy the other team’s base. I also question why you clicked on this news piece in the first place, but that’s beside the point. There has been some intriguing buzz as of late regarding DotA and beloved Steam-powered kingpin Valve. It started back in 2009, when Valve hired DotA developer Icefrog to work on a project that would make DotA fans “as excited as [he was].” It continued just a few days ago, when voice actor Jon St. John – also known as the voice of Duke Nukem – reportedly posted a Tweet that has since been deleted: “Had a great time in Seattle last week recording for DotA. The guys at ValveSoftware are awesome! Going to PAX? Might see you there – Sept3-5″ Now, Valve has filed a trademark for something called “DOTA.” While none of this is absolute concrete evidence that Valve is working on its own DotA clone – to join the ranks of League of Legends, Heroes of Newerth and Demigod – it’s more than enough to make one wonder. Ah, maybe it’ll just be a TF2 mod. While DOTA is immediately recognizable to anyone who’s ever played the original game, might I suggest some other alternate titles: GLeague of GLaDOS? Heroes of Newell? Demigordon, perhaps? (superannuation, via Destructoid)',\n",
       " ('Dota 2',\n",
       "  2,\n",
       "  0): 'You’re not a doofus if you don’t understand Dota 2. I’ve put literally thousands of hours into it and I’m not always sure I understand it. But I do know it’s a lot of fun to watch. With the 2017 International Dota 2 Championships’ main event set to get underway, maybe you’re curious about what all the $20-plus million, 13 million monthly player hubbub is all about. But maybe you’re also frustrated — Dota 2 is an extremely complicated game, and clicking on a stream of the game to watch is like jumping into the deep end of a pool with a half-inflated flotation device. But we’re here to help! We want to help you understand what Dota 2 is, what you might see, and how to watch it as quickly and painlessly as possible. Because this week is likely to see some of the best, most exciting competitive gaming of 2017. I’m going to do everyone a favor, and put the summary cheat sheet at the beginning. Then we’ll get into more detail. Even the most basic information about Dota 2 can seem intimidatingly complex. So let’s summarize. The pregame draft is a chess match. Many games are won or lost in the draft. Casters will give you an idea why. Kills are important, but not everything. Higher-level heroes are worth a lot more as a kill. The team with fewer towers is often at a disadvantage. The team taking objectives is usually winning. But taking an enemy base is hard, and it’s where many games’ momentum can shift — especially this year, because of shrines. Roshan is an important kill, but a bad fight at the Rosh pit can sink a team that previously held the advantage. The team with the economic advantage will usually win the game. What is Dota 2? (Or: How I learned to stop worrying about MOBAs and watch a competitive action-RPG) Dota 2 is, in a nutshell, a competitive action role-playing game. Each of Dota 2’s 100+ characters, referred to as heroes, have different abilities and traits that can help their teammates or harm their opponents in a variety of ways. Each player gets one character, and no one else can use that character. Players receive gold and experience for killing AI-controlled units on the map, and receive even more experience and gold for killing players on the other team. When one side destroys an structure, all players on that offending team receive a gold bounty. And players also receive a slow, steady trickle of gold passively over time. If you’ve played any loot-grinding action game, like Diablo or, hell, even Destiny (kind of), you’ve got the basic idea. There’s more to Dota 2 than that, but this is a good starting point. Kill more stuff, level up, get more abilities, buy better gear. If you’re ever confused, just come back to that. How to watch The International 2017 Twitch As with just about any competitive video game now, the easiest way to watch The International is probably Twitch. However, there are arguably better ways to spectate the most financially lucrative esports tournament ever. Dota2.com Valve is once again streaming every game of TI7 on Dota 2’s website. In addition to multiple versions and languages for each stream, you can also view each match with accompanying real-time information about the game in question, including hero levels, a live minimap, XP and gold graphs, and more. Dota 2 If you’ve purchased The International Battle Pass within the Dota 2 client, not only have you contributed money to TI7’s massive prize pool, you’ve also bought',\n",
       " ('Dota 2',\n",
       "  2,\n",
       "  1): 'a ticket to watch the tournament inside the game. Watching in-game gives you complete control of your view of the action, while also providing the same professional spectator experience and casting you’d get on Twitch or the Dota 2 site. Viewers who watch within Dota 2 can also earn prizes for specific in-game events, make predictions on various aspects of each match, and win battle points and more prizes. VR Valve has created a unique spectator experience just for you, if you’ve got an HTC Vive and have Dota 2 installed. I’ll let my colleague Ben Kuchera tell you about it: Watching battles take place around you is thrilling, even though it can be a bit hard to keep track of everything that’s going on. The interface makes it easy for you to switch views or jump back and forth from the in-person view to the lobby as well; it only took me a few minutes to get used to moving back and forth to get the best view of the action. It’s like being able to watch a football game on TV with the ability to jump onto the field at any time to see what it looks like from the quarterback’s point of view. Dota 2 takes place on the same map every game. It’s a field, kind of like a football or soccer field, except there’s an endlessly reincarnated dragon in a pit and the woods are full of monsters that will attack anyone who gets close. The map is split diagonally down the middle by a river. This is important. When someone refers to “the river,” this is what they’re talking about. The bottom left half of the Dota 2 map is “The Radiant” side, which is colorful and vibrant. The upper right half of the Dota 2 map is referred to as “The Dire,” and looks corrupted and dying. Teams are referred to as the Dire or Radiant depending on which side they spawn on. Dota 2’s map has a time of day as well, which affects things like how far heroes can see. Some heroes even have abilities tied to the time of day. Each “side” of Dota 2 has a central structure called an “ancient.” The Radiant ancient is at the Radiant base in the lower left-hand corner of Dota 2’s map. The Dire ancient is located in the upper-right corner of Dota 2’s map. The ultimate goal of any Dota 2 match is to destroy the other team’s ancient. This is easier said than done. Dota 2 matches do not have a time limit. Games will go on until one side’s ancient is destroyed, or one team surrenders by typing “GG” into Dota 2’s in-game chat (note: this mechanic is only present in Dota 2’s Captains mode). Most professional matches last 30-45 minutes, anecdotally speaking, though hourlong matches — or longer — aren’t uncommon. The map in Dota 2 has three main paths, called “lanes.” The top lane — or just “top” — runs along the left and top sides of Dota 2’s square map. The middle lane — or “mid,” as players call it — runs diagonally from the lower left of the map to the upper right. The bottom lane — “bot” for short — runs along the bottom side of the map and then up the right side. In between each lane is “the jungle,” which contains small camps of neutral monsters that will attack anyone who gets close. The Radiant and Dire bases spawn “creeps.” Inside each base, there are three sets of “barracks” — or “racks/rax” in',\n",
       " ('Dota 2',\n",
       "  2,\n",
       "  2): 'Dota 2 shorthand — that spawn friendly units called creeps. Creeps walk down each lane toward the enemy base, mindlessly attacking any enemy or neutral unit. Radiant creeps attack Dire units and structures, while Dire units attack Radiant creeps and structures. When creeps are killed, they give experience to any enemy hero within a certain range, and they give extra experience and gold to a hero who delivers a killing blow to them. This is called “last-hitting.” However, a player can attack a friendly creep that’s below half health. If a player gets the last hit on a friendly creep, killing it, enemy heroes receive no gold for that creep, and only half the experience they’d otherwise receive. This is called a “deny.” Denying is one of the primary differentiating factor of Dota 2 from similar titles, and it’s only become more important with recent updates. For games played during The International 2017, any hero that denies a friendly creep also earns bonus experience for doing so. In some special circumstances, players can “deny” their teammates, preventing the other team from getting any gold or experience for that kill. Heroes killed by “neutral” units on the map also give no experience or gold. This is a higher-level tactic employed by players in some situations to keep their opponents from gaining an experience or gold advantage from a kill. Each lane is protected by towers. The lower left side of the map is protected by Radiant towers, and the upper right is protected by Dire towers. Radiant towers attack Dire units, and Dire towers attack Radiant units. There are three towers in each lane. The towers closest to the river are called the “Tier 1” towers. Between the entrance to each base and the Tier 1 towers are “Tier 2” towers, and the entrance to each side’s base is protected by a Tier 3 tower. Towers must be destroyed in order — the Tier 1 tower has to fall before the Tier 2 tower can be attacked, and so on. A team’s ancient is protected by a pair of Tier 4 towers. Once a lane’s towers fall, barracks can also be destroyed. If a barracks is destroyed, creeps will still spawn in that lane, though they will be weaker, which allows the other team’s stronger creeps to get closer and damage the enemy ancient. If all of a team’s barracks are destroyed, the other team is rewarded with “mega creeps,” which are much more powerful units that even many heroes will have difficulty dealing with effectively. Mega creeps can easily destroy buildings, given the opportunity. 2017’s big addition: shrines With the close of the 2016 competitive season, Valve made huge changes to Dota 2’s in-game map. Lanes were altered, the spaces between lanes were redesigned, and, perhaps most importantly, a new type of building was added: the Shrine. Shrines in Dota 2 are buildings that, once activated, provide health and mana regeneration for a short period of time to friendly units when triggered. Each team has a total of five shrines: three in their base, and one each between the mid and top lanes and mid and bottom. A used shrine has a five minute cooldown before it can be used again. Shrines are important for a few reasons. They provide a means of “sustain” — meaning players can remain active on the map without having to return all the way home to restore their health and mana. Shrines also provide excellent defensive points on the map in the early game against aggressive enemy lineups — it’s difficult to “fight into”',\n",
       " ('Dota 2',\n",
       "  2,\n",
       "  3): 'an enemy shrine, because of the fast health regeneration they provide to the defending team. Finally, friendly shrines may be teleported to by their respected teams, offering an additional spot for teams to respond to enemy aggression or points from which to stage their own maneuvers. A team’s shrines are invulnerable until that team loses a Tier 3 tower. These are the basics. With that info, you should be able to watch a game of Dota 2 and have a basic idea of what’s going on. Heroes hitting each other dota 2 There’s a lot more to the game than that, obviously. Dota 2 is as much about the way players interact with each other as anything else. Let me try to explain. The Draft Before a competitive game begins, there’s the draft. During the draft, each team takes turns banning some heroes, which prevents either team from selecting them, and picking heroes for their players. The back-and-forth of the draft is a game unto itself. Each team designates one player, usually the team captain, as their “drafter.” It’s the drafter’s job to think steps ahead of the other team, denying them the heroes they want and the strategies they plan to carry out, while securing the tools needed to win. You’ll often hear casters say a game was won or lost in the draft, and this isn’t an exaggeration. Heroes Dota 2 has 113 heroes, each with their own unique sets of abilities that evolve and grow as they gain experience and level up. Generally speaking, a Dota 2 character has three “normal” abilities and one “ultimate” ability, but they can’t pick them all at once. Instead, players receive one point per level to unlock an ability, to level up an already-unlocked ability to make it more powerful, or to increase their basic attributes, or “stats.” Stats determine how much health a hero has, how many spells they can cast (their “mana pool”), how fast they attack, and the degree to which incoming damage is reduced, which is referred to as “armor.” Ultimate abilities, or “ults,” aren’t available for most heroes until they reach level six, which is important. The tempo of a Dota 2 match begins to accelerate and change when more and more heroes unlock their ultimate abilities. Ults are usually very powerful, but take more time to become available again than most other abilities. At the end of 2016, Valve added an entirely new mechanic to Dota 2: talent trees. Talents are available at level 10, 15, 20 and 25, and are presented as either/or choices particular to every hero. Talents can make a big difference in how characters play and what roles they fulfill. Items Heroes in Dota 2 aren’t limited to what they were “born” with. Instead, they can use gold to purchase items from one of Dota 2’s shops. The inventory and the Backpack Every player can hold a maximum of six “active” items at a time, but at the end of 2016, Valve gave every character a new tool: the backpack. The backpack can carry up to three additional items, but there’s a catch — any item moved from a player’s backpack to their active inventory space has a brief cooldown period during which it is unusable and provides no bonuses. In addition, usable items with cooldown timers will see that timer delayed if placed in the backpack. There are three kinds of places for players to purchase items. Basic shops in either base sell consumables, items that can be used a limited number of times for various purposes, like regenerating health',\n",
       " ('Dota 2',\n",
       "  2,\n",
       "  4): 'or mana out in the map; town portal scrolls, which allow the user to teleport to a friendly structure like one of their towers or their base; and the like. These shops also sell more expensive items that provide boosts to a hero’s stats or actually give them new abilities, like instantly teleporting a short distance — or “blinking” — or pushing themselves or another player. More powerful items can’t be bought outright. Instead, they’re built by buying a specific set of other items that then combine into something new. You’ll often hear casters or other players refer to specific heroes as “item-dependent.” This means that character needs specific items to become truly effective. For example, if a character can cast a spell that completely immobilizes any enemy hero caught within it, but lacks an ability to catch those heroes with that ability, they might want to buy a blink dagger, the item providing the aforementioned instant teleport. Without that item, the player’s ability to use their abilities is diminished. Other heroes can do a lot of damage up close, but can be quickly eliminated by spells. These characters might need a BKB, which will render them immune to all but a few extremely powerful spells for a limited amount of time. Items are important, is what I’m saying. Important items in Dota 2 Wards: Wards in Dota 2 come in two varieties: observers and sentries. Observers are invisible objects that last for six minutes and are used to gain vision over places on the map to monitor enemy movement. Defensive observer wards are stationed on the placing team’s side of the map. Offensive observer wards are placed on the enemy team’s side of the map, often behind towers or in the jungle, to secure objectives or kills on unsuspecting heroes. Sentry wards do not provide vision by themselves, but instead reveal invisible units — including observer wards. “Dewarding” means revealing and destroying an enemy team’s observer wards, which robs them of information and awareness of the map. Runes: There are two categories of runes in Dota 2 — power runes, which grant a special bonus to the player who activates them, and bounty runes, which provide gold and experience to the player who picks them up. Bounty runes spawn every two minutes at four spots on Dota 2’s map: two places on Dire’s side of the map, and two places on Radiant’s. Power runes also spawn every two minutes, but only one at a time, and randomly at the top or bottom of the river that divides the map. There are 5 kinds of power rune: Haste — which provides maximum move speed to the hero who collects it; Illusions — which create less powerful duplicates of the hero who grabs them; Double Damage — which should be self explanatory; Regeneration — which refills a heroes health and mana pool quickly over time; and Arcane runes, which reduce the amount of mana required to cast a spell, and reduces the cooldown of any spell cast or item used. Runes collected also refill player bottles, with bounty runes providing two charges and power runes refilling them completely. Runes can be held in a bottle for up to two minutes, allowing them to be saved until needed. Tangos: Tangos come in stacks of four from the main shop in each team’s spawn point. Tangos can be used to consume a tree on Dota 2’s map to provide a healing boost to the player who uses them. Tangos can also eat enemy wards, which provide the healing bonus for twice as long.',\n",
       " ('Dota 2',\n",
       "  2,\n",
       "  5): 'Town portal scrolls: Town portal scrolls, or TPs, are used to relocate to a friendly structure. TP scrolls allow players to escape dangerous situations or respond to enemy aggression elsewhere on Dota 2’s map. However, town portal scrolls take time to cast. If a hero is stunned while casting a town portal scroll, the spell is interrupted, wasting the scroll. Also, each new hero teleporting to a tower or structure takes longer to channel the TP scroll than each previous hero for a short time. Smoke: A smoke is a single-use item that turns all allied heroes within a certain radius invisible for a period of time, and also grants increased move speed. Smoked heroes are not detectable by wards, but are revealed once they get within range of enemy heroes. Smokes are used to sneak into the rosh pit, to find unsuspecting enemy heroes to kill or “gank,” or even for support players to place wards around the map undetected. Each team’s main shop can carry only a few smokes at a time, and when they’re exhausted, it takes quite a while for them to come back in stock. The Gem: The bearer of a gem can see any invisible unit or object, but there’s a catch: If the carrier of a gem is killed, the gem falls to the ground, and any player, friend or foe, can pick it up. Gems take a long time to come back in stock once bought, and a team that loses their gem will often lose all of their wards to the other team. Black King Bar: The Black King Bar, or “BKB,” provides its user with a period of immunity to almost all spells and magic effects in the game. Of course, there’s a catch: The BKB has a long “cooldown” after use. Also, while the BKB is effective for 10 seconds initially, this duration diminishes by one second with each use. The minimum BKB duration is five seconds, though on the bright side, the lower the BKB’s next duration, the sooner it’s available after using it. The Divine Rapier: The Divine Rapier, or simply, rapier, is the “In Case of Emergency, Break Glass” fire ax of Dota 2. The rapier is one of the most expensive items in the game and adds an incredible amount of raw damage. But that comes at a price: If a hero dies while carrying the rapier, they drop it, at which point any other player can pick it up. The rapier cannot be manually dropped by a player, unless they bought it originally and have not yet died with it in their possession. Otherwise, the holder must die for it to change hands. If a rapier is coming out, then shit is very, very real. Timings Dota 2 teams will play around time-based factors for the duration of every match. If a hero that needs a blink dagger to be effective finally has one, it might be time to catch the other team off guard with that. If an ultimate is available, it might be time to secure a kill or destroy a tower. Conversely, if the other team has used a powerful ult unsuccessfully, that provides their enemies with a window to secure an advantage. And if the other team’s item-dependent heroes aren’t doing as well as they need to in order to make those big purchases, smart opponents put more pressure on that team while they have an advantage. You might hear casters refer to “tempo control” — this means heroes and strategies that allow teams to better force the rhythm of',\n",
       " ('Dota 2',\n",
       "  2,\n",
       "  6): 'a game. Player “Positions” While Dota 2 heroes can be somewhat flexible in how they’re played, in part due to items, players tend to fall into a few specific roles. Sometimes these roles are referred to by numbers, from Position 1 to Position 5, which refers to their economic priority — that is, who is given the most opportunity to amass gold and experience through killing, or “farming,” neutral and enemy units. This is in ascending order of the player who is given the most farm. Support players are responsible for buying consumable items for the team, like wards, which give their team vision of an area of the map. Support heroes often have healing or defensive abilities that keep their teammates alive. Some supports also have abilities to hold enemy heroes in place, in order to allow their teammates to attack more or prevent enemies from getting away. This is often referred to as crowd control, or “CC” — teams without CC can have a hard time securing kills on enemies that have a means of escape. Support heroes also often have spells that do a lot of comparative damage early on, before their enemies have time to buy more expensive items providing additional health or spell resistance. This makes supports very important in the early going, though they lose some damage potential in later periods of a match. Supports are either Position 4 or Position 5. Position 5 supports will spend most of a match, well, broke, constantly buying wards and other consumables for their team ahead of their own immediate needs. Position 4 supports are often responsible for starting fights or making sure enemies don’t get away, and are more item- and/or level-dependent to be effective parts of their team. Offlane or Position 3 players are sent to the bottom lane if Dire, and the top lane if Radiant. “Offlanes” are the most dangerous for each team, with the least safe space to sit next to the constant waves of enemy creep units to earn experience and gold. Offlane roles are often “initiators” — characters that start, or “initiate,” a fight with the other team — or even counter-initiators that regain control when the other team attempts to start a fight or can help their team “disengage,” removing them from danger. Offlane heroes are usually “cores” for their team, responsible for much of a team’s damage in the early- to mid-game period of a match. Midlane or Position 2 heroes are characters that benefit from having the most farm quickly. Because the middle lane of the Dota 2 map is the shortest distance between the Radiant and Dire sides, creep waves meet in the middle of the lane much more quickly, resulting in more opportunities to secure last hits and experience for players who lane there. Position 2 heroes often have devastating ultimate abilities that can assert an early advantage over the other team, and are almost always the first to reach level six in a game. These players will often be responsible for much of their team’s damage until the late-game stage of a match. Carry or Position 1 heroes are so called because they “carry” their team. More specifically, carry players select heroes that become very powerful with experience and items, and they usually become the primary damage dealer for their team. Carry heroes are often more vulnerable early in a game, making them a target of the other team’s support heroes, and restricting their progress can be the difference between winning and losing. Carry players tend to be the most exciting to watch, making',\n",
       " ('Dota 2',\n",
       "  2,\n",
       "  7): 'the riskiest, most dynamic plays — their skill can often turn the game in their team’s favor. The kill bounty Generally speaking, the most gold and experience in Dota 2 is awarded for killing an enemy hero. But this number, unlike for every other unit in the game, is not static. Instead, heroes are worth more and more gold and experience the higher level they are and more their “net worth” — that is, the higher the overall value of all their items. In addition, as players secure kills, a bounty is added to their head, and the more kills they score without being killed in return, the higher the bounty gets. Heroes with particularly large killstreaks might be worth thousands of gold if killed. As with enemy creeps, when killed, heroes give experience to enemy players nearby. But unlike with creeps, killed heroes also give gold to all nearby enemies, and the hero who gets the last hit on an enemy player is awarded the kill and extra gold. This system introduces one of Dota 2’s comeback mechanics: If a team is losing badly but can win one or two good fights, or secure just a few high-value kills on their opponent, the “gold/experience swing” — that is, the change in net difference between the two teams, economically and experience-wise — can get the losing side back in the game in a meaningful way. Other things to know Stacking Neutral camps around Dota 2’s maps will spawn new creatures if those camps are empty when the in-game clock reaches the :00 mark every minute. If a player can draw a camp’s creatures out at just the right time, this will “stack” the camp, allowing for multiple camps’ worth of neutrals in one camp. Heroes with abilities that allow them to attack multiple enemies at once can often take advantage of this to farm more efficiently. Ancient Creeps There are special, extra powerful neutral creeps on Dota 2’s map referred to as “ancient creeps.” Ancients are much harder to kill, but yield much more gold and experience than other neutral camps. Supports will often stack ancient camps for carry players to farm once they’ve become powerful enough to do so. Roshan Roshan, or “Rosh” for short, is a unique ancient unit powerful enough that teams may have to work in concert to destroy him. Killing Roshan yields a great deal of gold and experience, but the main prize is the Aegis of the Immortal. The hero that picks up the Aegis will, when killed, respawn again a few seconds later with full life and full mana. Roshan lives in a “pit” that has only one entrance, making it risky for the team attempting to kill him. If their opponents interrupt, they will generally have a very strong positional advantage. Many games turn on a single bad engagement in “the Rosh pit.” High ground There are varying degrees of elevation on Dota 2’s map, referred to as high ground and low ground. High ground provides an absolute tactical advantage — heroes on low ground need an allied unit (or ward) on the high ground to see enemy units and to attack them, and attacks uphill have a chance to miss. The entrances to each base are elevated, making it difficult for the opposing team to attack. Many teams have difficulty taking high ground, and the fights they lose doing so can swing the game in their opponents’ favor, thanks to Dota 2’s comeback mechanics. At this year’s International, high ground is going to be an even more difficult problem to solve',\n",
       " ('Dota 2',\n",
       "  2,\n",
       "  8): 'for teams because of the addition of shrines to Dota 2. Shrines provide a burst of healing and resources to defending teams, and there are three in each base. This forces teams attempting to break high ground to consider whether or not the enemy team has shrines to rely on while they defend, and how many. Fortification Each team has the ability to make its structures invulnerable for a limited amount of time. You’ll know it by a golden glow (it’s identical to the effect present on heroes with a BKB active). Fortification takes five minutes to recharge, though the destruction of any of a team’s Tier 1 towers will reset the cooldown on fortification immediately. It all seems like a lot, I know. It is a lot! Dota 2 is complicated. but regardless of how much you know about the game, it can be a hell of a lot of fun to watch. So pick up what you can as you’re able, and enjoy some of the best esports you’re likely to see in 2017.',\n",
       " ('Dota 2',\n",
       "  20,\n",
       "  0): 'Valve is trying to change the way we watch eSports. The Dota 2 VR Hub is a free download, available now under the game\\'s DLC menu, that allows you to launch the game in virtual reality. You can’t play directly, but you can view \"life-size\" versions of the character models to look at as well as spectate live or pre-recorded matches of Dota 2. And doing so is magical. “Step into Dota VR Theater to watch live matches and replays in SteamVR,” the official page states. “Jump in solo, with friends, or join the community to watch the action unfold on an enormous screen surrounded by full-size avatars of the heroes on the battlefield. Select the minimap at any point to move directly onto the field of battle itself, then use the controllers to teleport around the Dota landscape.” The main view shows you a large floating screen with the directed action you’d normally see when spectating Dota 2, but you’ll notice that you’re flanked by giant versions of the character models complete with indicators for their health, mana and their item build. Directly in front of you is a live map that displays a live, topdown version of the action flanked by displays that show the difference in the teams’ net worth and earned XP. So you can get a bunch of information just by looking around the different screens and displays, and you can have up to 15 friends join in the fun, walking around the environment, pointing to things in the interface and chatting about the match using the Vive’s built-in microphone. It feels like a sort of arena designed exclusively for the consumption of Dota 2. This is already neat stuff, but you can point at any spot on the game’s map using the Vive controller and jump into the battle by clicking the controller’s trigger. This teleports you “physically” onto the game’s map, allowing you to grow or shrink yourself in size to either look down on the action, or to see what the battle would look from your own height, complete with the ability to walk around in your play space. Watching battles take place around you is thrilling, even though it can be a bit hard to keep track of everything that’s going on. The interface makes it easy for you to switch views or jump back and forth from the in-person view to the lobby as well; it only took me a few minutes to get used to moving back and forth to get the best view of the action. It’s like being able to watch a football game on TV with the ability to jump onto the field at any time to see what it looks like from the quarterback’s point of view. The fog of war is a bit thick when you’re watching the game directly — you won’t be able to see that far into the distance — but it’s easy to teleport around the map to change your view if you’d like to look at something else. This is Valve’s second major leap into the creation of VR content, the first is the free Lab experience that is also available now and for free, and the Dota 2 VR Hub shows just how serious the company is about getting VR right.',\n",
       " ('Dota 2',\n",
       "  21,\n",
       "  0): 'This article is over 12 years old and may contain outdated information Valve’s new DotA strategy will connect professional players with their fans. Valve has revealed the “first step” in what’s to be a series of new plans for supporting Dota 2 at tournament level. Soon, players will have access to numerous new features such in-game tournament streaming, team customization options, and making events “more financially stable” by sharing proceeds from virtual ticket sales with event organizers. Players will soon be able to pay a small fee to subscribe to professional tournaments they want to watch within the game client itself. Viewing these matches from within the game’s own engine will remove the need for streaming large game videos while giving watchers extra control options and high-quality visuals currently unavailable in standard video feeds. Valve doesn’t want to alienate those who want to tune in through a browser, however, so will be rolling out various yet-to-be-revealed ideas on how to provide these viewers a rich experience, too. Further, there will be added support within the game for pre-built teams. Players will be now able to provide details about their group, while the game collects long-term performance statistics and adds their logo to special areas of the game. All of this should massively improve the current tournament experience, still nominally in its beta phase. Most of the new features are set to be tested during the upcoming The Defense tournament, and will be rolled out to the community soon after. Source: Dota 2 Blog',\n",
       " ('Dota 2',\n",
       "  22,\n",
       "  0): 'Valve has announced , and released, the first alpha version of its Dota 2 Workshop Tools, which will make it easier for modders to make and share custom maps and game modes for their gargantuan wizard-\\'em-up. This initial release is targeted at developers, so the system requirements might be a tad high: you\\'ll need a 64-bit version of Windows, a Direct3D 11 compatible GPU, and you\\'ll need to opt into the Steam Client Beta. If you have all those things, you can now use the tools to alter Dota 2 to your liking, uploading the results to the Steam Workshop for other players to try. As Valve explains at the above link, the Steam Workshop submission process has been streamlined as of this alpha release to allow players to subscribe to custom game modes, which will tell Steam to automatically update them on your behalf. To play custom game modes and maps you\\'ll need the same specs as above, but Valve are promising support for 32-bit machines sporting Direct 3D9 down the line, so if you can run Dota 2 now, you should be able to run its mods eventually. Seeing how the original Dota started life as a Warcraft 3 mod, it\\'s only fitting that Dota 2 should introduce proper modding tools, and the possibilities are rather exciting. Time will tell just how robust and open to experimentation the new tools are, but many commenters on the Dota 2 subreddit are already hugely impressed, with one existing modder stating that the update is \"like Christmas for all of us\". If you\\'ve been inspired to give the tools a try, you might want to read up on the extensive documentation first. The tools comprise a developer console, asset browser and the Hammer level editor, along with model, material and particle editors. Now go forth, and create the definitive edition of Pudge Wars 2 that the world has been waiting for.',\n",
       " ('Dota 2',\n",
       "  23,\n",
       "  0): 'Компании Blizzard и Valve уладили конфликт, связанный с правами на торговый знак DotA, передает сайт VG24/7. За Valve осталось право на коммерческое использование этого названия (таким образом она сможет выпустить свою условно-бесплатную игру под названием DotA 2), а Blizzard сможет использовать DotA в некоммерческих целях (то есть в названиях карт для Warcraft III and StarCraft II, созданных фанатами). Blizzard также переименовала модификацию Blizzard DotA для Starcraft II, которую сейчас разрабатывает студия. Теперь она будет называться Blizzard All-Stars. Другие условия соглашения между двумя компаниями пока остаются неизвестными. Первоначально Defence of the Ancient была фанатской модификацией к игре Warcraft III, сделанной на базе одной из карт к игре Starcraft. Она стала популярной и позже легла в основу нескольких игр, в том числе League of Legends и Heroes of Newerth. Летом 2010 года в Сети появилась информация о том, что Valve подала заявку на регистрацию торгового знака DotA. Несколько месяцев спустя студия официально анонсировала проект DotA 2. В ноябре 2011 года Blizzard подала жалобу в комитет по рассмотрению споров и апелляций при Патентном ведомстве США и попросила отказать Valve в регистрации торгового знака. Представители студии мотивировали это тем, что оригинальная DotA была модом, созданным к игре Blizzard, а потому название нового проекта Valve может ввести игроков в заблуждение. По мнению Blizzard, геймеры могут счесть, что DotA 2 имеет какое-то отношение к ее продукции. Blizzard All-Stars и DotA 2 в настоящее время находятся в разработке. Точной даты релиза у обоих проектов нет.',\n",
       " ('Dota 2',\n",
       "  24,\n",
       "  0): 'Valve\\'s initial announcement of Dota 2 was a surprise to some. It\\'s a game set in a high fantasy world, following on from a Warcraft III mod, and represents a style of game Valve\\'s never really been involved with before. According to Valve , its development didn\\'t begin solely because the company saw a bright future in the multiplayer online battle arena genre, but also because Valve employees were big Dota fans. Play Play As for the gameplay formula, Valve doesn\\'t want to make any big changes from what players are used to. \"The fundamental things that make Dota such a popular game to so many people, we\\'re not changing those,\" says senior project manager Erik Johnson. \"We\\'ve reinvented the world and built a new place for people to play the game in. We\\'ve solved some of the problems around trying to play a game with your friends. We put a bunch of effort into making sure matchmaking works properly. But all the things we thought were executed so well in Dota 1, we don\\'t see where it makes a lot of sense to jump in and change those things.\"There are still unrevealed playable heroes, but Valve isn\\'t ready to talk about them yet. \"When we release this product to everyone, that\\'s just a moment in time,\" said Johnson. \"One of the defining characteristics of the work IceFrog [former Dota designer, now a Valve employee working on Dota 2] has done for six years now is continually changing and adding content to the game. It\\'s been a pretty huge volume, and you can expect the same thing in Dota 2.\"From the Gamescom show floor Valve is running a Dota 2 tournament with a huge prize, which you can find. As Valve\\'s watched the skilled competitors beat up on each other, it\\'s been a reminder of the work that\\'s left to do before Dota 2 is ready for launch. According to co-founder Gabe Newell, \"We\\'ve already learned, even though this event has only been going on for a couple hours now, a tremendous amount about what we have left to do to take the next step with the game. These types of players are awesome when it comes to refining and testing your decisions. The game that gets released to customers is going to be a whole lot better because we\\'ve taken this step along the way.\"Having the scrutiny of the eSports community bearing down upon a game still in development has, according to Newell, proved to be a challenge. \"It makes everybody really nervous [laughs],\" said Newell. \"The anxiety level around the office the last eight weeks has been incredibly high. Given how good these guys are, we have to make sure to raise our game on the development side so we\\'re giving these guys what they really deserve and ought to have based on how skillful they are.\"So when do we get to play? \"We\\'re going to be ramping up an invite beta coming out of [Gamescom],\" said Erik Johnson. No specifics were available as to whether it would remain invite-only or eventually switch to open testing. \"Whatever\\'s most useful for us.\"\"We put it out to a larger [number of customers] and then once they\\'re satisfied and once you\\'ve addressed all their issues,\" said Newell, \"you keep growing and find new sets of issues. [The beta] will get as big as fast as it needs to help us get the product done.\"The popular pricing model for MOBA games like League of Legends and, more recently, Heroes of Newerth is a free-to-play, microtransaction system. Valve isn\\'t yet set on exactly',\n",
       " ('Dota 2',\n",
       "  24,\n",
       "  1): 'what it will use for Dota 2. \"The big focus is getting the game right,\" said Newell. \"It\\'s much more important to figure out why people are going to like the game and then we\\'ll worry about monetization after. I think the first thing we need to do is built a game that fulfills what IceFrog wanted to do with the sequel to a game being played by tens of millions of people. If we can do that I\\'m sure Valve will end up being ok.\"Valvefor Dota 2\\'s launch, but as most know, Valve tends to be a little slippery with release dates. \"I\\'d be incredibly surprised if we\\'re not out a lot sooner than the end of 2012,\" said Newell. Well that\\'s at least good news.From what you\\'ve seen of Dota 2 so far, are you looking forward to playing?',\n",
       " ('Dota 2',\n",
       "  25,\n",
       "  0): 'Fantasy strategy game Dota 2 won\\'t ship until 2012, Valve boss Gabe Newell has revealed. Valve plans to launch an invitation beta after the Gamescom tournament ends. After that a public beta will launch. \"And then we\\'ll probably start worrying about how we\\'ll monetise it,\" Newell told Eurogamer. \"We\\'ll just go into progressively wider and wider distribution. I don\\'t think it\\'ll be shipped until next year.\" Dota 2 was penned for launch this year. \"But then,\" Newell continued, \"with a game like this, you just keep shipping. You add new heroes. You try out new game modes. You are constantly tweaking item and hero balance. It\\'s very much an ongoing thing.\" Dota 2 is the sequel to Warcraft 3 mod Defense of the Ancients, and is being developed by the reclusive IceFrog, one of a number of of modders who helped make Dota what it is. While Dota 2 will be distributed through Valve\\'s own platform, Steam, the firm is yet to decide on a business model. \"We don\\'t have a plan,\" Newell said. \"IceFrog has a bunch of testers he\\'s worked with as long as he\\'s been doing development. The first thing we\\'ve been working with is addressing their concerns. We\\'ve been through four or five different versions of the user interface, getting it to the point where we\\'ve addressed the feedback we\\'ve got from those guys. \"For us now, this tournament is a really good step. A bunch of the features we\\'re building in the design of Dota 2 related to being able to put on a tournament like this. There\\'s a bunch of stat stuff. There\\'s a bunch of website development, support for simultaneous, four-language broadcasting. \"This was the next step.\" Could Dota 2 end up going free-to-play, like Team Fortress 2? \"We don\\'t know. We don\\'t have plans yet,\" Newell said. \"The problem isn\\'t to figure out what your monetisation strategy is. If you have something with a super careful monetisation strategy and it sucks, it doesn\\'t matter. \"The most important thing is to do something that resonates well with the existing Dota players and creates a vehicle for new players to join into the community. That\\'s the hard problem. That\\'s the interesting one to solve.\"',\n",
       " ('Dota 2',\n",
       "  26,\n",
       "  0): 'How do you improve a game that has millions of active players, spawned an entire genre, and introduced new words into the gamer vernacular while it was still a mod for a decade-old strategy game? Valve chose not to, instead approaching Dota 2 more like chess. The game itself is sacrosanct and not to be changed, but everything else, from the infrastructure behind online matchmaking to its graphical presentation, is fair game for updates and improvements. The result, unsurprisingly, is a world-class service for a game that is just as brilliant and frustrating as it was when I fell in love with it four PCs and nearly a decade ago. Just as in the original, two teams of five heroes apiece vie to turn the tide of battle as constantly spawning NPC armies clash at the river that divides the two halves of a symmetrical map. A thick jungle filled with dangerous monsters and secret vendors occupies the space between the three lanes the armies travel along. Powerful towers mark waypoints along the lanes, quickly smashing all but the largest of invading forces. Heroes level up and develop devastating powers as the match wears on, boosting their powers to godlike levels with composite artifacts that cost thousands of gold to earn. Armies and towers that once controlled the map become speed bumps as heroes hunt each other down while battling for control of strategic resources. Eventually, one team overwhelms their rivals through cleverness, teamwork, and skill. Rankings are adjusted, points awarded, and social rewards unlocked in the postgame analysis. Everything changes in the next match, as 10 players pick 10 different heroes out of the roster of over 100. Friendships form as a strong showing earns you an invite to a recruiting clan. Meta strategies evolve as heroes and team compositions fall in and out of favor from week to week. A popular professional player throws a tournament pool into disarray by choosing an unconventional item progression, and everyone from mid-tier rankings on up scrambles to adjust. If there’s a limit to how far the rabbit hole of skill and strategy in Dota 2 goes, millions of daily players have yet to find it. There is always a way to improve your game. Something as simple as swapping the order in which you purchase two items, or picking up a situational support ability earlier, can have ripple effects across an entire match. The limit at which manual skill can keep improving your results is well beyond human physical abilities; there’s always another creep to last-hit, skillshot to avoid, or area-of-effect to dance out of. Play a single hero in nightly matches for a month straight, and you’ll learn something new as you reflect on the latest game while writing the next rent check. Because of this unmatched skill ceiling and the lengthy 20-45 minute matches, victory and defeat in Dota 2 are some of the biggest peaks and valleys I’ve ever experienced in games. A well-executed plan to follow up a minor victory with killing the big bad monster and using that to snowball into a win is a major high. Pounding your desk in frustration after being ambushed by an enemy you didn’t notice was missing is painful, doubly so when that screws your whole team over by leaving your lane undefended. With few random elements, the outcome of the match rests entirely on the shoulders of the ten players at their keyboards. The impossible heights Dota 2 can rise to also creates its greatest flaw: The game is often arcane, indecipherable, difficult, and actively hostile to new players.',\n",
       " ('Dota 2',\n",
       "  26,\n",
       "  1): \"The wonderful variety in item builds – which potions, weapons, armor, and trinkets you buy in which order and when you combine into what artifacts – comes at the price of a store that takes up half the screen with three tabs’ worth of tiny grids full of unique items. Most of those are useless to your current hero and role (or at least suboptimal, which is practically the same thing in the tightly balanced world of Dota 2). Knowing how to make those decisions requires hundreds of hours of gameplay experience. Reading a dozen or so guides to understand the underlying theory is probably a good idea, while you’re at it. Navigating the intricate hierarchy of item dependencies and counters is the most intimidating part of Dota 2, but it’s only the first foothills of the expansive mountain range of core Dota 2 competencies. Do you know what a support hero is, what kind of lane partner it should be paired with, and when it’s acceptable to last-hit creeps in your lane? How about the appropriate time to summon the courier, what special ability to expect from the boots that the melee carry in your lane is likely to buy during the laning phase, or why pushing past the midpoint of the river without an explicit reason is a terrible idea? These are intentionally jargon-filled questions, but they’re part of the baseline of knowledge that your team will expect you to have in anything beyond training matches. It’s how Dota players think, because their game is intricate and demanding and because a single weak link on a team spells doom more often than not. Do not expect a congenial atmosphere in Dota 2 unless you’re playing strictly with people you know personally. The community is often abusive, racist, and hostile. Prepare to be called horrible things for having the temerity to die when piled on by three enemy heroes. Expect to endure a torrent of profanity for buying items considered inappropriate for your character. There are many, many lovely and mature people who play Dota 2, of course, but the vulgar ones stand out more for obvious reasons. While Riot has at least gotten the majority of the poor sports who play League of Legends to at least keep their ill-tempered thoughts out of chat with community ratings and by following through on ban threats, Dota's system has only mitigated the very worst offenders. Ignoring players is easy enough, but the caustic community remains one of Dota 2’s biggest problems. The entire e-sports package, from spectator mode to tournament integration, is incredible. Extensive support from Valve and other organizations ensures that professional play is here to stay for years. No title makes watching live games, replays, and accessing high-quality commentary and discussion easier than Dota 2. Choosing between Dota 2 and its competition – primarily League of Legends – is a classic chocolate-versus-vanilla argument. Some players love denial (finishing off friendly units to deny enemies the kill bonus) for making Dota 2’s early game more interesting, others find the absence of the mechanic in LoL a necessary refinement. You may love how the native town-portal ability on every LoL hero changes the idea of in-lane sustainability, while someone else can’t imagine playing without Dota 2’s courier. I find the LoL community’s better behavior to be the tipping point myself, but I have friends who have no problem muting abrasive teammates. Valve studiously avoided reinventing the wheel with Dota 2, and given how beloved the gameplay is that is undoubtedly the best thing for the game, the community, and the\",\n",
       " ('Dota 2',\n",
       "  26,\n",
       "  2): 'genre. The infrastructure for matchmaking, spectating, and everything else that surrounds actual matches is executed on a level only the best studios can rival. I’ll still be playing and following League of Legends for my multiplayer online battle arena needs, but I can’t find any fault with another player with different tastes choosing Dota 2.',\n",
       " ('Dota 2',\n",
       "  27,\n",
       "  0): 'There’s an adage that the Dota 2 community often quotes when someone identifies themselves as a new player. “Welcome to Dota 2!” They say, with open arms, before concluding with, “You suck.” They\\'re not wrong: for the first dozen hours or so, you\\'ll be bombarded with too much information and an often unforgiving community of extremely competitive players. But if you persevere, Dota 2 becomes one of the most rewarding and tense team-based multiplayer experiences anywhere in gaming. It\\'s an achievement owed to uncompromising depth, a ridiculously generous free-to-play model, and the great features developer Valve has built up around it. Play Valve\\'s artists deserve praise for a crisp and readable style that, after some practice, makes it possible to tell what\\'s going on even in a massive brawl where both teams of five colorful fantasy characters collide and cast spells at once. However, credit for the intimidatingly complex design of Dota 2 belongs to the original Defense of the Ancients mod (known as DOTA) for Warcraft III, which kicked off the MOBA genre. Valve (after hiring on DOTA\\'s key developers) has copied that formula almost to the letter, and as a result Dota 2 has become notorious even among its MOBA peers for its difficulty – and that’s totally justified. It’s a double-edged sword that leads to both a terrifying introduction and a world-class competitive game at the highest levels. As such, you should not expect to have fun your first day playing... or even your first week. That sounds like a cardinal sin of gaming, but there’s method to this madness. In short, Dota 2 is a deeply layered construct of systems, and to survive you need to understand every single one and how they interact with one another. Everything from learning to work as a member of a coordinated team to the counter-intuitive practice of killing your own AI units to deny the enemy experience points and gold they’d get from doing it themselves, and understanding the effects of hundreds of complex abilities like Bloodseeker’s Rupture (which deals huge damage with every step you take) is a big barrier to entry. Even figuring out which of the 102 heroes (and counting) fits you best is a time-consuming challenge. Initially, you’re thrown into the deep end to flounder, trying out any hero that makes the slightest bit of sense. The selection is bewildering: playing as Riki with his permanent invisibility from level 6 on is an obvious choice, as it\\'s hard to kill what you can\\'t see. Drow Ranger, perhaps, with her obscene damage the instant she unlocks her \"ultimate\" ability at level 6, and her slowing Ice Arrows that enable both escapes and setting up a kill. On the more complex end of the spectrum you have choices like the armour-manipulating Templar Assassin, or the incredibly mobile Storm Spirit, who can dart around the battlefield and avoid damage by simply not being in the wrong place at the wrong time. On top of that there are well over 100 items to choose from within each game, each with their own ways of manipulating and enhancing your stats and suite of active abilities. Your learning has just begun when you\\'ve settled on what roles, heroes, and builds suit you best – you also have to adapt based on what other players choose. If the other team plays a Riki, you need to compensate with an emphasis on detection. Go up against Bloodseeker and his hideously powerful Rupture will force you to carry around a Town Portal Scroll to get home in a hurry. To grasp the subtleties of',\n",
       " ('Dota 2',\n",
       "  27,\n",
       "  1): \"how heroes interact and fight you have to do more homework on the different kinds of damage and how they’re mitigated; how to prevent one type of spell from affecting you, and when you use that countermeasure; how the different kinds of aggro work, and when you need to manipulate them; the timers (which aren't made visible), and how to optimise your play around them. Play Even after all that, to avoid being caught at a disadvantage you must be taught the nuanced techniques that can make or break games, which Dota 2 seems to almost belligerently hide from new players. Tricks like pulling a group of neutral monsters out of their home so that a new group can spawn to effectively double the rewards are never hinted at. This forced me to read and educate my outside of Dota 2, which had the positive effect of introducing me to the player community and making me feel like a part of it. It's almost like an oral tradition that binds together a tribe. This is a balancing system that could only exist in a game where everybody has access to all heroes, and Valve wisely obliges. All of Dota 2, including its growing cast of 102 characters, is available from the moment you complete the all-too-brief tutorial. And that delicate system can only survive if the items for sale have zero effect on gameplay. Again, Valve has come through. Only cosmetic enhancements, almost all of which are created by the community and held to a very high standard, and tournament goodies (such as tickets for viewing live events) are for sale. There’s not a single paid advantage that could have the slightest impact on the in-game balance, and that’s an amazing situation unrivalled among Dota 2’s closest competition. Pretty much everything I've praised Dota 2 for, outside of being totally free, is taken directly from the outstanding original mod. Where Valve has taken initiative to make Dota 2 a significantly better experience is in everything surrounding it, including improving the pre-game matchmaking interface, supporting the community of professional and avid players, and even allowing artists to create and sell cosmetic items on the Dota 2 store. Play Perhaps most important are the steps Valve has taken toward taming the hyper-competitive community. Besides matchmaking, guilds, and a wide variety of different game modes, the things that Valve hasn’t done are just as noticeable than the things it has. For example, there’s no concede button to throw in the towel on a losing match, and though you earn a matchmaking rank to ensure you're placed competitively, it's not visible to other players. If withholding those features seems like a bad idea on the surface, their sacrifice was not in vain – it prevents irritable players from dropping out of a match at the first sign of defeat, or when they're teamed up with people whose stats don't meet their exacting standards – a real frustration in other MOBAs. LIkewise, Valve recognized that less is more when it comes to unlockables. There’s no progression outside of the game that will have the slightest mechanical effect inside of it. Without artificial goals to aim for, the matches are left with a strong and refreshing sense of fairness and purity, where everything that can influence success or failure is right there on the battlefield and in your head. In my personal experience, Valve’s ideas work. I've played for over 1,000 hours, and my encounters with people unwilling to act decently towards their fellow players have become increasingly rare over the course of Dota 2’s development.\",\n",
       " ('Dota 2',\n",
       "  27,\n",
       "  2): \"It has never been more friendly than it is now – though that’s a relative comparison. Even with these enhancements, the best way to play Dota 2 will always be with a team of four friends. Play Valve’s dogged desire to preserve DOTA's design perfectly is a double-edged sword in some ways. There are a few design choices that feel needlessly archaic and slavish to the original, such as the way Blink Dagger will arbitrarily shave 200 units of movement from your blink if you overestimate the distance, or how the towers will occasionally refuse to acknowledge your attempts to turn aggro away from yourself during a siege. They feel like relics of previous era, traditions carried on for the sake of tradition. As for its future prospects, things look bright for Dota 2. Each year of its long beta period is defined by huge balance patches that make widespread changes to keep things fresh and interesting. Given Valve’s excellent ongoing support of Team Fortress 2, its other free-to-play game, it’s a safe bet that there will always be something to learn and something new to master for the foreseeable future. Patches are released on a weekly basis, and on any given day there are multiple professional games to watch. Even the cosmetics are constantly changing, with community chests and themed events occurring regularly throughout the year. Dota 2 isn’t static in any sense of the word, from the wild variety of each game to the overarching sense that it will never be finished being made.\",\n",
       " ('Dota 2',\n",
       "  28,\n",
       "  0): 'У компании Гейба Ньюэлла есть одно неоспоримое достоинство — она умеет ловко доводить до ума чужие идеи, превращая их в бриллианты. Благодаря такому подходу Valve в свое время облагородила много любительских модификаций, в числе которых Team Fortress, Left 4 Dead, Portal и Counter-Strike. Все эти серии до сих пор пользуются заслуженной популярностью, а значит, Valve редко ошибается. Само собой, полноценную поддержку и финансирование получают только тщательно отобранные кандидаты. Одним из недавних «приобретений» компании стал Абдул «IceFrog» Исмаил, известный в узких кругах игровой дизайнер и ключевой автор мода DotA Allstars для Warcraft 3. Его наняли для создания проекта, который должен был за два года стать самой популярной игрой в цифровом сервисе Steam — Dota 2. С задачей Абдул справился даже раньше намеченного срока. Ваша башня под атакой Первая «Дота» стала одной из самых популярных мультиплеерных игр нашего времени. Сиквел закрепил успех и побил его рекорды: количество пользователей, одновременно играющих в Dota 2 через Steam, с недавних пор стабильно превышает отметку в 300 000 человек. Откуда же взялась такая народная любовь? Своей популярностью игра обязана двум факторам: элементарной концепции и хардкорному подходу, принимающему во внимание сотни нюансов, которые каждый раз перемешиваются, словно молекулы в органическом супе. Игра использует стандартную для стратегий в реальном времени камеру и похожий интерфейс, однако сражения приправлены драйвом и элементами ролевых экшенов. Грубо говоря, выглядит и управляется Dota примерно как StarCraft 2 , но вы не строите базу и распоряжаетесь одним-единственным персонажем. Причем всякий раз его приходится развивать с нуля в рамках матча — с первого уровня до максимального двадцать пятого. [[BULLET]] Взрывы, молнии, шальные заклинания и шустро вылетающие цифры урона — неопытный человек рискует спутать происходящее с покорением Diablo 3 на сложности Inferno. На поле боя сталкиваются две команды — воины Света и приспешники Тьмы, в каждой из которых сражается по пять героев, выбираемых из обширной картотеки. У обеих сторон есть по базе, и от одной к другой ведут три дорожки. В свою очередь, вдоль дорожек расположены три ряда защитных башен, в начале матча представляющих серьезную угрозу для героев низкого уровня. Верхняя и нижняя части карты зеркально соответствуют друг другу, а главным словом в лексиконе игроков является «мид» — средняя тропинка, предназначенная для особо кровопролитных сеч. По миду проще всего добраться до негостеприимных дверей чужой базы, поэтому к нему всегда повышенный интерес. Основная идея игры элементарна: необходимо уничтожить башни соперника, а затем сровнять с землей его бараки и здание под названием Древний — сердце базы, по-простому называемое троном. Что больше всего поражает начинающих — в игре всего-навсего одна карта. Это может отпугнуть непосвященных игроков: где это видано, чтобы в проекте, рассчитанном на многочасовые сетевые сражения, не было других мап? Как ни крути, все любят разнообразие. [[BULLET]] Сердце базы воинов Света разрушено. Древний пал, а значит, матч подошел к концу и победившие злодеи без стеснения празднуют. Тут в дело вступает второй фактор бешеной популярности Dota 2. Хоть карта и не меняется, каждый последующий матч все равно не похож на предыдущий. Почему? В игре банально очень много по-настоящему разных, уникальных героев с обширным арсеналом возможностей и уймой артефактов (покупаются во время матча в разбросанных по уровню магазинчиках). На момент написания рецензии в игре было доступно 102 (!) персонажа: зомби, некроманты, роботы, невидимки, древнее божество, создающий двойников лепрекон-геолог, горстка специалистов по призыву мелких юнитов, для управления которыми требуются хорошие навыки микроменеджмента, и др. Можете себе представить, сколько разных комбинаций выстраивается во время матча. Скилл со дна пришел Valve наняла для разработки второй части не только Абдула, но и других участников Dota-сообщества, а потому продолжение осталось верным традициям оригинала: обе стратегии регулярно обновляются с небольшим интервалом, новых героев из первой «Доты» постепенно добавляют во вторую, и даже баланс правят с оглядкой',\n",
       " ('Dota 2',\n",
       "  28,\n",
       "  1): 'на старшего брата. У каждого из ста с лишним персонажей есть три параметра: интеллект, сила и ловкость. В зависимости от их значений происходит деление на специализации — силовиков, ловкачей и магов. Прокачка осуществляется за счет убийства чемпионов вражеской команды и бесчисленных монстров-статистов. Некоторые игроки прямо в начале матча отправляются в «джунгли» (российские игроки по привычке называют их лесом) — место скопления уродцев на экваторе карты — и быстренько качаются, готовясь к битвам формата «команда на команду». [[BULLET]] Окно настройки позволяет перед началом матча экипировать героя или нацепить бонусные предметы. Например, прибавку к получаемому опыту или фирменного курьера команды Na’Vi (всего 299 рублей за штуку!). Многие персонажи оригинальной «Доты» были взяты из сюжетной кампании Warcraft 3. Права на вселенную остаются у Blizzard , а потому разработчики Valve были вынуждены изменить внешность, имена и биографии героев, но сохранили их уникальные способности. Собраны воины на любой вкус: одни способны сохранять невидимость, появляясь на экране только после атаки, другие могут бить молниями с небес, останавливать время или стрелять петардой через всю карту, третьи готовы спасти избитого героя телепортацией на базу и так далее. Однако жестких правил по развитию чемпионов нет, даже заядлые танки, как, например, рыцарь Свен, способны играть и роль киллера (специализируется на атаке), и саппорта (поддержки). Для справки: боец поддержки расставляет на карте маячки, рассеивающие неизведанные области, прокачивает магазинного курьера (дорогостоящий бот, позволяющий не ходить на базу за предметами) и, как правило, не добивает монстров, чтобы опыт с них забирали напарники по команде. В число всеобщих любимцев входят карлик Рики, обожающий атаковать со спины, и полуразложившийся мясник-увалень Пудж с торчащими потрохами, который подтягивает свои жертвы крюком и убивает их трупным запахом собственных нечистот. [[BULLET]] Персонаж Дазл только что подлечил себя, своего напарника и нескольких монстров-крипов. Он умеет выручать в сложных, почти безвыходных ситуациях и очень полезен в качестве саппорта. На сладкое припасен вечно голодный медведь Урса, в одиночку убивающий самого сильного монстра на карте — Рошана. Забавный факт: игроманы дразнят его Равшаном, а свое имя он получил от названия любимого мяча для боулинга одного из создателей первой «Доты». Прикончившая Рошана команда получает весомое преимущество: если героя, забравшего сердце чудовища, убивают, он восстанавливается через пять секунд на месте гибели, без необходимости отправляться в «таверну» (на базу) и ждать воскрешения там. Кроме того, смерть владельца артефакта не приносит его убийцам никакого золота, а сам Рошан автоматически оживает через десять минут после своей кончины — бедняга обречен вечно служить дойной коровой. Поймали под фонтаном В начале матча чемпионы разбиваются на мини-группы и оккупируют все три тропинки, присматриваясь к брешам в обороне врага. Начальная фаза боя, как правило, однообразна и повторяется из игры в игру: бойцы аккуратно истребляют монстров на своей половине карты и пытаются подловить на ошибке кого-либо из вражеских героев. На мид выходит лишь один игрок, которому предстоит стать главным киллером команды, быстрее остальных набрав высокий уровень. Успешные «мидеры» помогают команде набрать вес, навлекая на себя внимание и тем самым позволяя товарищам тоже подкачаться. После этого игра переходит в среднюю фазу, когда чемпионы сплачиваются и охотятся группой, попутно уничтожая башни и заглядывая в гости к Рошану. Скоординированная охота всей командой на мини-группы врага называется «ганком». [[BULLET]] В игру встроена удобная энциклопедия, готовая по первому требованию рассказать все о героях, артефактах и рекомендациях по раскачке персонажей от более опытных игроков. Полносоставные баталии отличаются большим количеством спецэффектов и помпезных заклинаний: на экране творится ураган изо льда, огня и молний, на кого-то набрасывают «сало» (silence), временно лишающее героя способностей, ближайший товарищ превращается в камень, что-то загорается… Но это далеко не все. Зачастую в бой вступает артиллерия. Так, в игре есть гном на вертолете и робот с набором лазеров для прожарки с дистанции. Искалеченный ландшафт пронзается мощнейшим заклинанием',\n",
       " ('Dota 2',\n",
       "  28,\n",
       "  2): 'Древнего Титана, и из трещины бьет разрушительный свет, а неумолимая лучница тем временем пускает в жертв ледяные стрелы. Для успешного выживания в средней и поздней стадии требуется слаженная командная работа, иначе проигравшие, как самые настоящие «раки», окажутся «на дне». Часть героев как раз создана с прицелом на то, что их убийственная мощь проявит себя лишь в лейте (так игроки называют заключительный этап матча). Хорошим примером лейтиста может служить Абаддон, дебютировавший сразу после выхода Dota 2 из бета-теста. Этот герой, быстро завоевавший популярность, был известен в Warcraft 3 как принц Артас — сын короля, выбравший путь некроманта. Помните такого? Абаддон способен исцелять сам себя и калечить врагов, отрывая от себя куски мертвой плоти. Пудж, завидовать! Шапочная ярмарка Dota 2 — условно-бесплатный проект, а зарабатывает Valve на внутриигровом магазине, постоянно обновляя модели героев и выпуская для персонажей предметы одежды. К счастью, обошлось без тотальной монополии: благодаря мастерской Steam сделать костюм, украшение или текстуру интерфейса по своему вкусу может любой игрок. Если она окажется достаточно популярной, ее добавят в магазин и везучий автор, наряду с разработчиками, будет получать отчисления с продаж. Примерно по такой же схеме работает сверхуспешный Team Fortress 2, но если он был для Valve пробой пера, обкаткой схемы, то в Dota 2 «торговля шапками» приобрела поистине пандемический характер и привлекла сотни предприимчивых товарищей, готовых в любой момент обменять какой-нибудь топор на реальные деньги в обход магазина. Тем не менее сейчас большинство контента производится самой Valve. [[BULLET]] Команда британцев пытается разрушить одну из башен на центральной дорожке. Судя по вялому отпору защитников, им это вполне по плечу. Заметили, что экран окрасился в красный цвет? Похоже, нашего героя секунду назад больно ударили. Самая удачная их идея — продавать интерактивную книгу Компендиум, запускаемую прямо из D2. Она привносит в игру кучу новых возможностей и предметов, а за счет прибыли с продаж книги пополняется призовой фонд главного Dota-события года — турнира The International (на момент написания рецензии он составлял $2 684 540, причем больше миллиона долларов — заслуга Компендиума). Книга — настоящее ноу-хау Valve. Это не очередной контент-пак, а уникальным образом организованное подобие Gold-подписки в Xbox Live, за которое, правда, нужно заплатить всего раз. Владельцы Компендиума имеют преимущественное право голосовать за добавление тех или иных героев в игру плюс получают особые коллекционные карточки, которые, представьте себе, буквально вклеиваются на страницы книги. Помните, как в девяностых все дети собирали стикеры для альбомов с какими-нибудь Черепашками-ниндзя? Так и тут, только за сбор полных составов полагаются солидные бонусы. Две твердыни Преимущества клиента Steam, бесплатность игры, ее проработанность и вариативность позволили Dota 2 стать тем, чем когда-то был Counter-Strike. Это настоящее олицетворение растущего на дрожжах культа. Феномен единодушного успеха как среди игроков, так и среди критиков. На сегодняшний день у игры есть лишь два серьезных конкурента: Leauge of Legends и ниваловский Prime World. Но если MOBA от Россиян только-только начинает экспансию на западные рынки, то LoL уже успела завоевать популярность как в Европе, так и в Америке. Надо отдать должное, успех заслуженный: это качественная жанровая игра, которая на порядок дружелюбнее к своему пользователю, чем Dota 2. [[BULLET]] Все, что не уместилось в инвентаре (6 слотов), может подождать владельца в тайнике на базе или в тушке курьера. С курьерами вообще интересно, это ноу-хау серии; в LoL, например, никаких курьеров нету. В магазине разрешают выбрать модель курьера из десятков вариантов. У творения Valve по-прежнему сохраняется целая вереница недостатков. На запуске игра оказалась в числе самых сырых проектов в истории Steam — даже после окончания бета-тестирования ее исправляют на ходу, в режиме реального времени. Сервера часто ведут себя нестабильно, D2 Network иногда отключается, порой приходится подолгу искать соперников. Система матчмейкинга заслуживает отдельного подзатыльника: частенько против слабых игроков выставляют опытных ветеранов, не',\n",
       " ('Dota 2',\n",
       "  28,\n",
       "  3): 'оставляя первым шанса побороться на равных. При этом Dota 2 стала, без обиняков, самой громоздкой работой Valve последних лет, на ее отладку тратится масса времени, труда и денег. Впрочем, мы не сомневаемся, что все ошибки будут исправлены неиссякаемыми патчами. Но главную проблему игры, которая особенно остро видна на фоне официально представленной в России LoL, — недружелюбное сообщество и отсутствие комфортных условий для новичков — перебороть будет отнюдь не просто. Меж тем на фоне популярности Dota 2 и Leauge of Legends многие игровые издательства, включая Warner Bros. Interactive Entertainment , Electronic Arts и Activision Blizzard , поспешили анонсировать свои MOBA. Нравится это кому-то или нет, некогда узкоспециализированный жанр занял одну из крупных ниш в современной индустрии развлечений. Высокий порог вхождения и глубина геймплея выделяют D2 на фоне коллег. Она позволяет бесконечно долго оттачивать свои навыки на ботах или в онлайне против мастеров, пытаясь приблизиться к совершенству. Для многих карусель из бесконечных тренировок и соревнований стала неотъемлемой частью жизни, и это объяснимо: Dota 2 — восхитительный киберспортивный снаряд и просто очень затягивающая игра. Но в этом кроется и один из ее минусов: многие относятся к «Доте» слишком серьезно. Бывает, начнешь игру со случайной компанией, и на тебя тут же начинают кричать командным голосом — сбегай туда, сделай то, что же ты такой нерасторопный и все в таком духе. Если вы играете не с близкими друзьями, то рискуете получить негативный опыт, но мы все же советуем вам попробовать. Не так уж часто в жанре появляются столь увлекательные проекты. Ну а всем фанатикам хочется пожелать быть спокойнее. Игры — это здорово, мы все их любим, но нельзя забывать о простых правилах приличия и взаимоуважении. Реиграбельность: Классный сюжет: Оригинальность: Легко освоить: Геймплей: 9 Графика: 7 Звук и музыка: 9 Интерфейс и управление: 8 Дождались? Один из главных PC-эксклюзивов нашего времени. Вдумчивая и глубокая игра, которая, однако, может отпугнуть новичков своим суровым характером. Впрочем, это не очень критично. Dota 2 явно ждет большое будущее, в ближайшие годы Valve доведет до ума и без того отличную игру, и тогда ее можно будет без зазрения совести рекомендовать всем и каждому. Рейтинг «Мании»: 9,0 «Великолепно» Раки щелкают клешнями Почему русских не любят',\n",
       " ('Dota 2',\n",
       "  29,\n",
       "  0): 'It\\'s the summer of 2010. Typing to a backdrop of Chatroulette and Chilean Miners, it becomes clear that none of us in the Rock, Paper, Shotgun staff chatroom, where I worked at the time, know how to react to the news that Valve, a company famous for giving gamers what they want before they know they want it, is making the sequel to Defense of the Ancients. Today, Valve\\'s characteristic accuracy is intact. Dota 2\\'s beta is the most popular game on Steam, boasting a peak of 329,977 simultaneous players. This falls far short of League of Legends, Dota 2\\'s biggest competitor, which was able to boast five million concurrent players earlier in the year, but this month the real race starts. Valve is rolling out access to Dota 2 in successive waves, and while Dota 2 is arriving late, it\\'s doing so with an inarguably more generous free-to-play business model, which only charges for cosmetic upgrades. Yet for the growing shadow that Dota 2 casts, it remains intimidating, or even bizarre to all of us looking in. Which isn\\'t unfair. Dota 2 is bizarre. It\\'s a game where a cockney porcupine can work together with a god of destruction and a ghost to try to temporarily kill a particularly high-level tree. But Dota 2 represents something far larger than the sum of its endless, mismatched parts. Let me put this as simply as possible: While everyone was trying to make a Multiplayer Online Battle Arena game - a MOBA - Valve went off and purchased a sport. Yes, there\\'s only one map, but it\\'s lush with detail and Valve does seasonal events with gusto. The heroes are all balanced for the map, which is why it doesn\\'t change. You\\'re probably aware of the basics of the MOBA genre at the very least. Two teams of players fight in one large arena, with several lanes connecting their two bases. The game you play is to fight alongside the droves of NPC troops that your base produces, levelling up your hero, knocking down sequential defensive enemy towers, until finally your team smashes their way into the other team\\'s fortress-like base in a dramatic end to the match. \"The second-to-second gameplay is, secretly, as pure and beautiful as the game is convoluted.\" Next, the thing to know about Dota 2 is its comedic scale. It currently offers 102 unique, playable heroes from the original Dota\\'s roster of 112, and with matches frequently lasting 35 minutes (though occasionally stretching past an hour), you\\'re looking at more time than you ever spent in Skyrim just to try them all. Every hero has different stats and four unique skills, but can also be equipped with any one of almost 130 items. Developing a familiarity with all of these different components might take 200 hours. To know how to combine them instinctively, you\\'re looking at 400 hours. Which isn\\'t quite the mortifying challenge it sounds like. Yes, by the end of your first six months of Dota 2 you\\'ll have skimmed an amount of knowledge from the surface of the game comparable to six months at university, but you\\'ll have had fun doing it. This isn\\'t Dwarf Fortress. While you\\'ll want to know everything, it\\'s possible to play knowing nothing, and if you\\'re playing with friends - the biggest factor in successfully trying Dota 2 - you\\'ll have a great time learning. If you\\'re interested, the diary I previously wrote for Eurogamer is the story of five friends learning Dota 2 together. There\\'s magic in those early days. These extremes are what everyone knows about Dota',\n",
       " ('Dota 2',\n",
       "  29,\n",
       "  1): \"2 - how it involves this many hours, this many items, how its millions of players are capable of intense cruelty when you don't know something they take for granted. But it's a huge shame this is the main takeaway, because the second-to-second gameplay is, secretly, as pure and beautiful as the game is convoluted. It's an incredibly tense, precise and uniquely emotional game of positioning that draws easy comparisons to fencing or dancing. At the simplest level, you're trying to glom as much experience and gold from the battlefield and inflict as much damage as possible, without ever overextending yourself. You want to be one step ahead of anyone in your lane, charging them just before they choose to retreat, or falling back the instant they realise the terrain favours them. The temptation will be to pick one hero and learn them back to front, but you'll learn quicker by randoming your hero selection, and receiving a boost in starting gold for your bravery. On a larger scale, you're silently coordinating with your entire team at all times. By far the easiest way to get a kill is to pounce on outnumbered opponents, which means your team has to lock into a pack mentality. This can be as simple as making sure to attack and run away together, or as complex as goading an enemy hero into your territory by being low on health and doing a half-assed job of retreating, coaxing them deeper, deeper, as your friend circles round behind them. This is the beautiful game, the supreme form of the MOBA which everyone else working in the genre is trying to capture like lightning in a bottle. Slipped in among all of Dota 2's thousand lessons about which pairings of heroes make a heartbreakingly tough lane, or where to place Observer Wards (and when they should be Sentry Wards, and whether that's even your job) is a more tender, emotional core than I've ever seen in a multiplayer game. You might have played 500 hours of Dota 2, but you might still suck because you can't resist a kill when it's in front of you. Because you get sloppy when you start losing, or winning. Because you can't predict your friends. This is where comparisons between Dota 2 and organised sport come from. It withstands discussions of tactics, depth and teamwork better than anything I've ever played. The purpose of the game's library of heroes, items and skills isn't simply giddy maximalism. It's what Dota 2 offers as a substitute for physical fitness; instead of a growing mastery your real-life body, Dota 2 offers a growing mastery of a range of powers, combinations and even abbreviations so absurd that a common feature when my friends and I first started Dota 2 was having to stop and reflect on the absolute nonsense we were saying. To stop and catch yourself moving the pub's salt and pepper shakers and squeezy tomato to illustrate tri-laning to your friends. How Dota 2 compares to League of Legends In what has the makings of the fiercest PC community battleground since Quake 3 Arena vs. Unreal Tournament, the question of how League of Legends compares to Dota 2 is as spittle-flecked as it is difficult to answer. The most noticeable difference is the business model. League of Legends offers a rotating cast of 10 free Champions, while additional Champions cost either Infleunce Points (earned through play) or Riot Points (which are bought). Dota 2 offers something much more palatable. All heroes are playable all the time, there is no persistence to reward players\",\n",
       " ('Dota 2',\n",
       "  29,\n",
       "  2): \"who've played or spent more, and everything you buy is cosmetic or about enabling involvement in the professional tournaments. Beyond this, Dota 2 is the more cantankerous, old-fashioned game. It offers one vast map as opposed to League of Legends' varied Fields of Justice, death can happen faster, creep denial is a large part of the game (where you kill your own forces just before they die to deny opponents XP), and Heroes respond to your commands more sluggishly. Something I haven't seen discussed, though, is that Dota 2 feels like a Valve product. From the voice acting, to the as-yet-evolving UI, to the art design, Dota 2 feels... classy. Even if it weren't for the business model, that might be enough to sway me. Once you're in, Dota 2 is so entertaining, and subverts so much of the perceived wisdom of game design as to be troubling. No commercial studio could have made a game this demanding, with matches this long, that fused genres like this, or included such counterintuitive tactics as killing your own soldiers. So what does it say about our industry that it's the most popular game on Steam? The original Dota mod was a fascinating curio. Viewed from this angle, of course Valve had to own it. The only strange part remains, with every publisher under the sun now trying to scratch together their own MOBA, how everyone let them get away with it. Whatever - the series is undoubtedly better off with Valve as the curator of the brand. This is a gorgeous update, with every hero a colourful character, with a thoughtful, powerful, continually evolving UI, and a business model so nice, so kind, so smiling and unselfish as to be properly insidious. Following the Team Fortress 2 model, Dota 2 is entirely free. Better yet, after completing a match people will randomly win loot from the game's bulging catalogue of cosmetic weapons, clothes and hats for specific heroes. The sense of unbridled nausea that comes when you first spend real money on some virtual shoes is to be embraced. This is the future! Maybe! The moment you're OK with the idea of spending money, the second Dota 2's won you over and your eyes begin traveling towards your debit card, you're spoiled for choice as to what to buy first. A £1.59 key for one of your locked chests, the Dota 2 equivalent of scratchcards? Full sets of clothing for your favourite hero? New announcers, from the narrator of Bastion to Half-Life's own Dr. Kleiner? New skins for your wards, couriers, even your HUD? Most of this stuff is made by the community via the Steam Workshop service, meaning a cut of your pay goes straight to the artist, as well as making Dota 2 seem that much more organic and alive. A more recent example of Valve's mystic knack for letting community and commerce spill over is in The International 2013, Dota 2's most prestigious tournament, which takes place next month. Currently advertised front and centre in the game's menu is a £5.99 Interactive Compendium, a bundle offering in-engine access to the matches, live items drops while you're watching, an opportunity to predict winners, one-of-a-kind taunt items, animations and more, with all purchases of The Compendium adding to a Kickstarter-like bar increasing the cash prize of the tournament and unlocking further uses for the Compendium. Valve has shown slightly less interest in the Herculean task of making Dota 2 remotely accessible, but progress is being made. Dota 2's scalable bots have always been genuinely entertaining to fight against (if not with),\",\n",
       " ('Dota 2',\n",
       "  29,\n",
       "  3): 'and they were recently bolstered by a suite of tutorials that Valve is growing into a larger New Player Experience. The game\\'s robust matchmaking was, just a few weeks ago, joined by a new system for banning that Valve say caused a \"35% drop in negative communication interactions\". I think that means fewer players are being pricks. Overall, Dota 2 is a monumental piece of craftsmanship. Valve has managed to transport Dota\\'s house-of-cards design into a new engine, infuse it with life and colour, and attach a business model that people don\\'t simply accept, but enjoy. This is a grand update. But it\\'s still an update rather than a sequel, which means Dota 2\\'s biggest flaw - a dirty stretch of genes it has passed on to almost all other MOBAs - is very much present. Losing a match of Dota 2 is often irredeemably, structurally unpleasant. MOBAs lock players into a panicked race to level up their characters fastest. This brings about a tension which powers the entire game. It\\'s why a kill is a beautiful or stomach-wrenching thing, depending on which side of the ambush you\\'re on. But it also means that when another team is better than you, the game begins handing them advantages. Which is exactly as much fun as it sounds like. Dota 2\\'s metagame is one of choosing powerful heroes and countering your opponent\\'s choices, and awaits you in the distance like a ziggurat built from patch notes. Games are still trying to absorb the success of Dark Souls at the minute, which taught us that having something to lose isn\\'t an intrinsically bad thing. But this is a whole other level. The comparison would only work if dying in Dark Souls transported you to a purgatory where five beefy dudes proceeded to bounce you off the walls for 25 minutes. Price and Availability Price: Free on Steam, supported by micro-transactions. PC version out now. Mac and Linux clients due soon. Valve is managing the influx of new players with a queuing system. More details at Dota2.com. Existing beta players can play on and will be moved over to the launch client in waves. Not that this is something any MOBA community on earth would change. It\\'s part of the culture. Who could ever willingly pave over those stories of legendary comebacks? But I\\'ve played enough Dota 2 to have had my share of bad evenings, where you and your friends go online and just lose. Nights full of possibility compacted into dismal scoreboards and exhausted Skype conversations. In these lost lunch-hours and unlucky weekends, closing the Dota 2 client can feel less like you\\'re playing a game and more like you\\'ve just gotten your fix. \"There\\'s never been a better time to get involved than right now, with the New Player Experience and influx of fresh blood. All of which makes Dota 2 an absurd video game to try to recommend. Being the largest and most immediately open MOBA, with Valve showcasing its talent for rewarding and fostering a community, it demands and offers more than literally any game I can think of. It\\'s almost more comparable to basketball than most commercial games. Something utterly opaque bearing no endgame, but that could happily fill every waking second of your life. Instead, I\\'ll just say that if any of what I\\'ve described has sparked your interest, you owe it to yourself to set the client downloading and take a look. The business model of Dota 2 makes it the best MOBA option out there, and there\\'s never been a better time to get involved',\n",
       " ('Dota 2',\n",
       "  29,\n",
       "  4): \"than right now, with the New Player Experience and influx of fresh blood. Just remember to spend your starting cash, and make sure someone buys the courier. Oh, and when Riki starts showing up in your games, just get some Sentry Wards down and don't run away. Also, you always want a Bottle when in mid-lane, and runes spawn at 0:00 and again every two minutes. Practice last-hitting before you go online. And if you're jungling, memorise where the low-level Creeps are. Actually, you know what? Forget all that. Just have fun.\",\n",
       " ('Dota 2',\n",
       "  3,\n",
       "  0): '\"Being honest, I don\\'t know how DOTA got as big as it did, given how hard it is to sit down and play it with your friends,\" says Erik Johnson, the man charged by Valve boss Gabe Newell with the task of heading up the Dota 2 project. Erik is absolutely right. Defense of the Ancients, the Warcraft 3 mod maintained and developed by the reclusive IceFrog, is virtually impenetrable. (You can bone up on the basics and history in our Story of DOTA.) Millions, possibly tens of millions play it, but for some it remains an incomprehensible curiosity: a game they\\'re aware of, but not playing. Valve hopes to change all that. Valve\\'s Dota 2 matchmaking system is designed to pit players against similarly skilled opponents. A tutorial mode will teach newcomers the basics. There\\'s even a coaching system that allows experienced players to \"see through the eyes\", as Erik puts it, of new players, letting them talk to them and explain the game\\'s mechanics and intricacies. \"We\\'re going to solve all those issues. We want to make it so 10 people who are brand new to the game can have a bunch of fun playing together,\" Erik says, flatly. Valve is showing Dota 2 for the first time via an invitation-only tournament with a million-dollar prize pot at German show Gamescom. (You can follow matches live at the Dota 2 website.) The Half-Life and Portal maker\\'s show-floor booth is a gargantuan affair, packed with rows of seats either side of a giant plastic box. Inside the box stand the players, DOTA specialists flown in from across the globe to show off their micro-management prowess. Overhead, two huge screens hang side by side. It is clear: Dota 2 is a big deal. 1 of 4 Attribution Gamescom and this tournament serve to demystify Dota 2, showing us exactly what it is. It\\'s an action RTS (\"the closest descriptor we have,\" according to Erik). It has an RTS-style camera, but no base-building. 10 players, split into two teams, each control a single hero unit. The teams defend their Ancients while destroying their opponents\\'. One faction begins on the bottom left hand corner of the finely balanced map, the other on the top right. There are items, skills, and distinct abilities for each hero. There are RPG elements, designed to help you better your level one hero up to the 25 cap. Creeps walk the lanes, tempting you to satisfy your experience point hunger. Watching the game played live rekindles memories of sitting gob-smacked in front of my PC monitor, studying grainy DOTA replay videos. These professional players control their heroes like Lionel Messi controls a football, weaving in and out of combat like the Barcelona great darts between bewildered defenders. As the giant screens smash out sword swipes and spellcasting, the whir of unit movement casts its own eerie spell over the audience. They make everything look so easy. All this you can say about DOTA, of course. Indeed, Dota 2 still looks remarkably like a Blizzard game. Everything from the user interface to the cartoony design, the colourful palette to the tooltips is reminiscent of Defense of the Ancients. If Valve hadn\\'t splashed the UI with its trademark grey and orange, you\\'d think it was Defense of the Ancients. Some may baulk at the similarities between the two games, but as boss Gabe Newell recounts the story of how Dota 2 came to be, Valve\\'s vision starts to make perfect sense. \"The reason we got started was because we were fans,\" he explains. In particular: Robin Walker, who heads',\n",
       " ('Dota 2',\n",
       "  3,\n",
       "  1): 'up the Team Fortress 2 team, Adrian Finol, who worked on Half-Life 2, and project manager Erik Johnson. \"They actually entered a league, got crushed and humiliated, and couldn\\'t talk to each other for a couple of weeks because they were so humiliated.\" Robin, Adrian and Erik approached IceFrog and asked him how he\\'d make a sequel. \"We were a little bit star-struck,\" Gabe says. \"It\\'s like where you\\'re a fan of something and you get to meet the person who has built it. We had that to get over.\" Get over it they did. \"That group of people got all fired up and said, hey, we\\'d love to work with you on that. What do you think of coming to Valve?\"',\n",
       " ('Dota 2',\n",
       "  30,\n",
       "  0): 'ФОРМУЛА ИГРЫ Dota 2 60% DotA Allstars 20% удобных штуковин 10% Source 10% доброты Valve Я никогда не играл в DotA Allstars. Долгое время эта карта для Warcraft 3 казалась мне не игрой, а дизайнерским подвигом, о котором будут вспоминать только в игрожурских колонках в духе « откуда пошла Heroes of Newerth , или Что не так сделала Demigod ». Когда Valve вдруг объявила о первом в истории чемпионате по Dota 2 , я тихо-мирно набивал первые ранговые игры в League of Legends. Я и не подозревал, что все настолько серьезно. ► Фанатское видео с красивыми ситуациями из игры. Идеальный дисбаланс ► Тем, кто не играет в Dota 2, происходящее на экране кажется сумасшествием. Но понимание приходит достаточно быстро — дизайнеры Valve сделали все настолько наглядным, насколько возможно. Правила «Доты» уже как только не пересказывались. Есть герои, есть башни, есть две базы и неуправляемые волны войск с обеих сторон. На протяжении длинной (30–50 минут) партии герои из двух команд убивают монстров и друг друга, копят опыт и деньги, развивают навыки и покупают артефакты. Чтобы одна из команд победила, нужно всего ничего — пробиться на базу соперников и разрушить главное здание. Но прежде чем это произойдет, умрут сотни монстров, рухнут ряды турелей, а герои обязательно обо что-нибудь убьются. Не раз, не два и, может быть, даже не три. В Dota играют не из-за того, что это происходит, а из-за того как. Перед началом партии каждый игрок выбирает себе героя, одного из сотни с горкой. Похожих среди нет. По условной классификации одни персонажи сразу наносят много урона, другие преуспевают в поддержке, и так далее, но значит это разделение не так уж много. Героя характеризует некая руководящая черта, за которую его любят или боятся — боятся сильно, потому что всегда есть за что. ► Spirit Breaker несется к цели. Остановить его можно множеством способов. Но успеете ли? ► Рубик владеет телекинезом, умеет пускать молнии, но его коронный трюк — воровство заклинаний. Баратрум — он же Spirit Breaker — это не простой бык с оглушением, а массивная корова, способная нагнать противника с другого конца карты и заставить его вопить. Рубик, великий маг в супергеройской маске, может украсть любое произнесенное заклинание. А Абаддон… вы видели Абаддона? Его называют бойцом поддержки. Черный рыцарь на черном коне защитит своих, изобьет ваших, а когда вы попытаетесь ему отомстить, выяснится, что все ваши удары по нему… лечат. Из таких жутких и вроде бы дисбалансных умений складывается лучший баланс на свете. Герои не размениваются на мелочи (« Зато я больнее бью! — Зато я быстрее! »), а отвечают на любую грандиозную способность своей. На любое действие находится разумное противодействие. Рубик может отобрать только последнее использованное умение — так успейте же подбросить ему какую-нибудь ерунду! Абаддон лечится от урона всего несколько секунд — просто не бейте его в это время! Чтобы Баратрум не докучал, вырубите его первым, а если ваш герой не умеет вырубать, соберите какой-нибудь артефакт — Ghost Scepter, например. Все еще тот ► В Dota почти всех героев можно «заточить» под разные роли. В зависимости от собранных артефактов великан Tiny может быть «танком», инициатором и/или всепобеждающей машиной для ближнего боя. Для победы нужно знать умения героев, знать, как им противодействовать и как противодействия избегать самому. Знать свойства артефактов и представлять себе, какие их сочетания лучше подходят к конкретной ситуации. Помнить все каверзные места на карте (хоть она и одна, но на ее изучение уйдет не один месяц), уметь читать намерения соперников и в то же время угадывать, где находится каждый из них. За годы в DotA скопилось море разливанное деталей и тонкостей. Новичков они пугают, а ветераны будто бы делают все, чтобы поддержать образ механического пугала. Смотрите, дескать, у',\n",
       " ('Dota 2',\n",
       "  30,\n",
       "  1): 'нас тут все настолько сложно, настолько сложно, что нормально играть вы сможете только спустя пятнадцать лет уединения в тибетском храме без еды и воды, занимаясь только «Дотой» и чтением руководств, но поскольку в тибетских храмах обычно нет интернета, разворачивайтесь и идите домой — вы дно и не лечитесь. ► Пользовательские руководства можно открывать прямо в клиенте. На виду все предлагаемые предметы, порядок изучения навыков, а иногда еще и тактические советы, если автор подсуетился. В ремейке воссозданы все особенности оригинала, за исключением совсем уж мелких мелочей. Dota 2 такая же большая и страшная, как и DotA Allstars, но Valve делают все возможное, чтобы она такой не казалась. Обучающий режим трогательно знакомит игроков с самыми базовыми вещами, вроде добивания монстров и покупки вещей, а дальше помогает система подбора команд. Пока вы новичок, играть будете с другими новичками, которые, скорее всего, еще даже обучение не прошли. А вы-то прошли! Если еще и руководства почитали и знаете, что Рикимару контрится вардами и проявляющей пылью, — все совсем прекрасно, и бояться вам нечего. Пока что. Почти. Беда в том, что первые матчи со случайно подобранными командами редко бывают интересными. На одной из сторон почти всегда есть кто-то, кто знает игру намного лучше других, и тогда партия от начала и до конца играется в одни ворота. К более или менее равным игрокам вы попадете игр через пятьдесят-сто, а это стоит кучи времени и нервов. Правила поведения ► Несмотря на все ухищрения Valve, жалобных жетонов на всех пока не хватает. Тратить их стоит только в совсем уж вопиющих случаях. Плохое поведение игроков — проблема и в League of Legends, и в Heroes of Newerth, и даже в SMITE. В какой-нибудь Battlefield парочка глуповатых напарников погоды не испортит: побалуются да выйдут с сервера, в команде и без них достаточно людей. Но в DotA и ее последователях два идиота — это уже полкоманды, и cчитаться с ними приходится весь матч, который может закончиться через полчаса, а может затянуться на час. Новички, которые не умеют играть, — это не самое страшное. Просто расскажите им, что нужно делать, а дальше будет легче. Но, ради Зевса ([этого](Javascript:view(1024,640,‘http://i.imgur.com/QwGeQoo.jpg’);)), не орите на них — в игре и без вас достаточно всезнающих истеричек. Хуже них только провокаторы. Провокаторы в Dota 2 гораздо наглее, чем в League of Legends. Хотя бы потому, что в «Доте» есть умения, с помощью которых можно портить жизнь напарникам: ранить их, погружать в сон, затаскивать в эпицентр схватки, и так далее. Просто убрать эти способности нельзя — у них уйма полезных применений. Да и бессмысленно: в LoL таких умений практически нет, а поганцев ничуть не меньше. ► Не раз бывало, что какой-нибудь самозваный «отец» трижды проклинал своих безмозглых напарников, бросал игру, а потом они брали и выигрывали без него. Все поняли, где тут мораль? Valve бдит. Неблагонадежных игроков здесь не банят, а высылают на отдельный круг ада, где они играют с другими троллями и флеймерами. Это помогает перевоспитаться тем, в ком еще осталась частичка разумного и доброго, а окончательно потерянные души будут вариться в этом котле веки вечные. Только вот всех грешников не отловишь — почти в каждой партии находится находится кто-то, кто портит атмосферу. На пару-тройку дружелюбных игроков приходится один кибергопник, который сочтет своим долгом поведать, что он делал с вашей мамой. Поэтому Dota 2 — игра для сильных духом. Вернее, для тех, кто способен нажать на кнопку «заткнуть». Но лучше всего, конечно, играть с друзьями. ► Коль скоро вас кто-то обматерил, не обижайтесь, не ругайтесь и не спорьте. Плюньте и сосредоточьтесь на игре. Так будет лучше для всех. Play-to-win ► Просматривая турнирные матчи из клиента, можно выбрать любого известного комментатора. Следить при этом получается не только за тем, что',\n",
       " ('Dota 2',\n",
       "  30,\n",
       "  2): 'видит комментатор — есть даже вид «из глаз» игроков. Вы видите все, вплоть до последнего движения мыши. Valve встроили в игру мощнейший инструментарий для любителей киберспорта. Подробные записи игр, возможность наблюдать за турнирами прямо из клиента, детальная статистика игр — следить за профессионалами Dota 2 не только интересно, но и невероятно удобно. А с новой графикой матчи еще и с виду прекрасны. Как раз киберспорт в этот раз и оказался предметом монетизации, вернее, одним из них. Все без исключения игровые возможности доступны забесплатно, а вот, скажем, за виртуальные билеты на турнир, позволяющие разглядывать матчи из клиента, придется заплатить. Трансляции важных чемпионатов можно бесплатно смотреть на twitch.tv, но если хочется условий получше — раскошеливайтесь.',\n",
       " ('Dota 2',\n",
       "  31,\n",
       "  0): \"PC Gamer's got your back Our experienced team dedicates many hours to every review, to really get to the heart of what matters most to you. Find out more about how we evaluate games and hardware. NEED TO KNOW What is it? Valve's lavish successor to Defence of the Ancients, the mod that launched the MOBA genre. Expect to pay Free-to-play; optional progression minigames and guide features available via one-off payment or subscription Developer Valve Publisher Valve Reviewed on GeForce GTX 980, Intel i7-6700K, 16Gb RAM Multiplayer Online, up to 5v5 Link Official site Check Amazon 3 Amazon customer reviews ☆ ☆ ☆ ☆ ☆ We originally reviewed Dota 2 in 2013. It has changed significantly since then, so much so that we decided to review it again. Our original review can still be found here. For more about why we've chosen to re-review certain games, head here. Given that it started life as a faithful recreation of the original Defence of the Ancients mod, you’d be forgiven for thinking of Dota 2 as the archetypical MOBA. Yet this isn’t the case: in practice, Dota 2’s purism sets it apart from the vast majority of games in this genre. What we think of as the MOBA really began with Heroes of Newerth and League of Legends—games that took that roughshod family of WarCraft custom maps and professionalised them, commercialised them, found them a form that would enshrine the MOBA at the top of the gaming world for the better part of a decade. Dota 2 is different. Adopted by Valve, that original mod became a tool for boosting Steam’s popularity in places where the service hadn’t reached the ubiquity that it enjoyed in Europe and North America—such as Russia, Southeast Asia and China, traditional strongholds of the DotA scene. And the best way to do this proved to be to remain steadfastly idiosyncratic. What this resulted in was a free to play MOBA where all of the heroes are free, where there are no account levels to grind, where design compromises imposed by the limitations of a noughties map editor have been embraced as design law. Dota’s leap from mod-scene darling to million-dollar phenomenon was whiplash-inducingly quick, its uncommercial credibility ripped away like a bandaid—so fast that you might not notice it was gone. What does this mean for you as a prospective player? Principally, it means that this is a dizzyingly deep competitive team strategy game whose core design benefits from fifteen years of unbroken refinement. It was in this strategic sandbox that the basic assumptions of the MOBA were established: two teams, three lanes, five heroes per team, towers, creeps, jungles, bases, and Ancients. On paper, your job is to lay siege to the enemy base and blow up the enemy ancient. In practice, your job is to manipulate the strategic, economic and psychological tempo of the match, a challenge whose variables change every time you play. You’ve also got to pick the right wizard, cast the right spells, and make sure they buy the right shoes. Obviously. This is Dota we're talking about. Dota 2’s learning curve is mountainous, but everybody has to start somewhere. You’ll start by picking a character you like and learning how to use their abilities effectively—lining up stuns, dishing out damage, turning foes into frogs, being the best helicopter or bear or fishman that you can be. Then you’ll learn something about how to play that hero as part of a team, which stat-boosting items to buy, and at what stage in the game you’re at your most powerful. You’ll learn some\",\n",
       " ('Dota 2',\n",
       "  31,\n",
       "  1): 'hard lessons about getting too close to enemy towers, about carrying a town portal scroll to get from place to place on time, about vision-granting wards and why everybody’s always yelling for someone else to buy them. Then you’ll improve, maybe learn a few more heroes, learn to look at your minimap, and then you’ll realise that you’re going to have to unlearn about 75% of the things you think you know in order to surmount the next step of Dota 2’s endless staircase. If you enjoy this process of learning, failing, and learning again, then thousands of hours will pass: and before you know it, you’ll be a below-average Dota 2 player like everybody else. Dota 2 is a game you will never finish learning, one that cannot be perfected either by its developers or its players. Although the community has always maintained certain customs about the best way to play, Dota itself has never enforced a particular methodology. This is the key thing that separates it from its peers: while other MOBAs have tended to fold the community metagame into the design of the games themselves—codifying player roles like tanks, supports and damage-dealers as fixed archetypes within their rosters—this doesn’t work quite the same way in Dota 2. This is a game with a simulationist heart, where a character isn’t a good tank because they were always intended to be so, but because of the specific way they interact with Dota 2’s underlying matrix of items, statistics, and map features. This is a game where the addition or subtraction of a tree in a single part of the map might change the viability of a hero—a game of endless interrelated butterfly effects. What this means is that Dota 2 is a game you will never finish learning, one that cannot be perfected either by its developers or its players. It goes without saying that it’s hard to learn: I’ve been playing consistently for the last six years and I’m pretty bad at it. But that journey has been one of the most rewarding and remarkable experiences I’ve ever had with a videogame. The process of learning, sharing knowledge and adapting to continual change brings people together: I have made lifelong friends playing Dota 2, people with whom I now share an extensive vocabulary rooted in this expansive, strange, beautiful game. That inherent flexibility is also the reason Dota 2 makes for such a compelling esport. Its complex sandbox allows for huge divergence in playstyles across teams, players, and regions. While restrictive metagames have emerged from time to time, they have never lasted: and in seven years of high-profile competition, the field has remained open to challengers from all parts of the world, with all sorts of different approaches to that core strategic challenge. Indeed, the creativity that Dota 2’s core simulation supports is something that the best players are ideally positioned to exploit, and watching the metagame get turned on its head by a brilliant bit of lateral thinking—something that happens at least once per International—is a pure thrill. If you’ve never felt a basketball stadium full of people explode with excitement because a teen millionaire has selected an unusual dragon, then, well, you’re missing out. It’d be impractical to recount every way that Dota 2 has changed since I first reviewed the game for PC Gamer back in 2013. It has a better in-game UI and a much improved main menu, including faster load times and a more sophisticated interface for pregame strategising. Most recently, Valve introduced new quality-of-life features like context-sensitive indicators to let you know',\n",
       " ('Dota 2',\n",
       "  31,\n",
       "  2): \"when a hero or item has been altered in a patch. Given that balance passes now take place fortnightly, allowing players ready access to this information is very welcome. The Arcade was a flagship new feature when it launched, a freeform custom game lobby that recreates the conditions of the WarCraft III custom map scene from which the original DotA emerged. As in those days, a few game modes—chiefly tower defence mods and a couple of combat-heavy Dota variants—dominate. In part, the flagging popularity of the Arcade is due to the introduction of Turbo mode last year. Turbo fulfills the same purpose that many of those popular Arcade mods do: it allows you to play Dota—or something like Dota—more quickly and in a more forgiving environment, and its inclusion shows the benefits of relaxing Dota 2’s purist tendencies. This mode features much faster leveling—and therefore much shorter games—and downplays some of Dota 2’s more complex systems, like the item courier. The result is a version of Dota 2 that is both more accessible for new players and offers experienced players the chance to blow off a little steam. It’s easier and sillier, and ultimately less rewarding than a full game, but it’s perfect when you want to check out a new hero or when you don’t have the time or energy to commit to a match that could last more than an hour. Valve has spent years fiddling with ways to make money from Dota without compromising its core. This began with the Compendium—a sort of digital stickerbook released alongside each year’s International esports championship—and grew into Battle Passes, months-long event seasons where players race to complete challenges for points and prizes. This year’s Dota Plus subscription system is as close as Valve has come to putting game features behind a paywall. Your fee grants you access to enhanced tutorial features, including in-game skill and item suggestions based on crowdsourced data. There are also challenges to complete and stat-tracking gems to collect—a further variation on the ‘collect all the hats’ theme that powers Battle Passes. Dota Plus caused controversy when it was announced—this is a community highly sensitive to anything with a whiff of pay-to-win about it. But that hasn’t been my experience with the system. In fact, Dota Plus’ data-driven guides are frequently less useful than the player-made alternatives available in-game for free, and often make skill and item suggestions that aren’t helpful. A bit of extra guidance for new players is always welcome, but there’s nothing here to challenge or replace the value of having a friend show you the ropes. Between Plus and Battle Passes, then, the bulk of Dota 2’s microtransactions take the form of premium systems that let you complete challenges and win hats. There are greater and lesser expressions of this idea—from co-op dungeon minigames to Crystal Maiden’s gambling wheel—but it basically comes down to paying a fee to get better rewards from the matches you’d be playing anyway. Dota 2’s extraordinary generosity in terms of raw game-stuff, which sets it aside from every other game in this genre, means that Valve don’t have much left that they could meaningfully lock behind a paywall. This is a mixed blessing. On one hand, taken on their own merits, Dota 2’s premium options aren’t very compelling. There’s not much that you feel you’ll have to own unless not participating in the latest Battle Pass makes you feel like you're missing out. On the other hand: there’s not much that you feel you’ll have to own. Dota 2’s extraordinary generosity in terms of raw game-stuff, which sets\",\n",
       " ('Dota 2',\n",
       "  31,\n",
       "  3): \"it aside from every other game in this genre, means that Valve don’t have much left that they could meaningfully lock behind a paywall. In that scenario, it’s tempting to forgive them the odd underwhelming hat collection minigame. Every now and then, however, a feature creeps into one of these premium packages that feels like it belongs in the core game. That's happening right now—at the time of writing, owners of the 2018 International Battle Pass gain the ability to queue to play specific roles in their next ranked game. This is a learning from League of Legends—a further relaxation of that signature purism, acknowledging that while Dota 2 allows players to occasionally transcend or redefine team roles, the majority of players naturally sort themselves into positions anyway. And you know what: it's a really good idea to borrow, allowing you to bypass one of the most socially fraught moments in any ranked game—the bit where half your team argues about who has to play support. It's a shame that this feature is, at present, restricted to the International's latest money-spinner. Particularly because player conduct remains an issue for Dota 2. Valve have introduced, extended and tinkered with player reporting systems, matchmaking, and so on. They have taken steps to reduce the anxiety that surrounds ranked play by replacing granular numerical skill ratings with much broader, seasonal rank badges. They've implemented pop-up reports that tell you whether you're doing well or badly in the eyes of your fellow players, and added messages to the start of games telling you to be nice. The success or failure of these methods is, inevitably, invisible: you never know how many internet assholes the game is successfully keeping out of your games. Even so, Dota 2 remains a place where strangers scream at one another for making mistakes, where hostility has been entrenched by parts of the community as the norm and even desirable. It is certainly not the only game that has this problem, but it can feel unusually intense: perhaps because Dota 2 forces strangers together for so long, or makes them depend on one another so much. The same pressures that make this such a remarkable experience with friends can make it hellish, too, and after six years I couldn't assure you that this is going change. Dota 2 is one of my favourite games of all time, but I wouldn't necessarily recommend playing it solo until you know what you're getting yourself into. And yet for me, and for millions of other people, this strange, unlikely, unrepeatable game has become part of the daily fabric of playing games on the PC. It's a shortcut to a particular kind of competitive experience that I click on almost every day, and that has retained its ability to excite, fascinate and frustrate many years and many thousands of hours after other games have run their course. Its present custodian, Valve, has succeeded in improving it—in making it more accessible and adding new ways to play. But most importantly Valve has succeeded in preserving Dota—in protecting the spirit of a phenomenal game that predates this specific iteration and will hopefully outlive it, too.\",\n",
       " ('Dota 2',\n",
       "  32,\n",
       "  0): 'Опубликовано : 20. Dec 2013 От Harriet PC Gamer – знаменитый британский журнал о мире игр – присудил звание «Киберспортивная дисциплина года» (E-sport of the Year) игре Dota 2. Менее года назад еще бывшая бета-версией игра Dota 2, благодаря проведению таких великолепных турниров, как The International 3, превратилась в стандарт качества и образец для подражания всех игр жанра MOBA. Кроме демонстрации мастерства и техники игроков, [...] Dota 2 позволяет показать свою креативность и умение мыслить стратегически. Победить смогут лишь те, кто владеет и техникой игры, и правильным психологическим настроем. Впрочем, игра не создает рок-звезд: она развивает лидеров, стратегов, в ней вы найдете сильных противников и хороших друзей. - Chris, PC Gamer, декабрь 2013 года. Рейтинги Dota 2 Кто-то считает, что появление Dota нужно датировать 2009 годом, хотя фанаты играли в нее еще в 2003 году, когда Eul создал первый мод для игры Warcraft, названный Defence of the Ancients. Несмотря на регулярный выпуск обновлений, IceFrog’у стало ясно, что любимый мод нужно поднять на новый уровень, если он хочет побороться с современными конкурентами жанра MOBA. Неудивительно, что подключение к разработке компании Valve позволило игре достичь немыслимых ранее вершин. На пике популярности в оригинальной игре DotA было зарегистрировано более полутора миллионов игроков, причем каждый месяц игру посещали более миллиона уникальных пользователей. Но официальный релиз Dota 2 побил этот рекорд. Теперь в любое время суток в игре наблюдается в среднем полмиллиона человек со всего мира – и все это при удивительной стабильности серверов, за которую нужно поблагодарить Steam. Редактор веб-ресурса Gamasutra Майкл Уолбридж (Michael Walbridge) упомянул, что Defense of the Ancients был самым популярным модом на нашей планете в 2008 году. Зная потенциал фанатов мода, Valve приняла мудрое решение выпустить сиквел. Пока он был ещё в стадии бета-тестирования, на его базе провели турнир International, в котором приняли участие команды со всего мира. Герои и стиль игры остались прежними, но была обновлена визуализация, и ощущения от игры тоже улучшились. Благодаря этому, люди, фактически не являющиеся геймерами и не склонные к этому, были буквально затянуты в игру и стали реализовывать свои идеи в Мастерской. В последнее время Valve даже начала активно привлекать сообщество при создании исходников для ивентов, как, например, сейчас, при разработке события к Новому Году Лошади – 2014 по восточному календарю. The Aegis of Champions Что касается призовых фондов, то Valve на них не скупится. Принцип, гласящий, что в любом матче игрок может выбрать из более сотни разных героев, делает эту игру по-настоящему бесплатной, давая ей преимущество над главным конкурентом – League of Legends. Одним из достижений Valve стало то, что Dota 2 гораздо проще узнать визуально, чем League of Legends. - Evan, PC Gamer, декабрь 2013 года Численные показатели успехов DOTA 2 доказывают, что если Riot Games оставляет какую-то дверь открытой, то набирающая популярность MOBA от Valve обязательно в нее войдет. - Raptr, август 2013 года Сравнение количества игроков DOTA2 и LoL в Северной Америке Dota 2 действительно позволяет игрокам раскрыть свои способности в игре. Она заслуживает звания «Киберспортивная дисциплина года». Вот, какое заявление PC Gamer: сделал по этому поводу: Высокая комплексность и сложность Dota 2 – это именно то, что постоянно очаровывает людей. Я видел такое, во что вы, люди, ни за что не поверите. Я видел, как при помощи Reverse Polarity-Skewer-Glimpse вся команда отправлялась на фонтан. Я видел, как успешное отступление, используя Wisp Tether-Relocate-Blink, заставило рыдать взрослого мужчину. И я видел, как призрак дерется с медведем в шляпе! Источник: joindota.com',\n",
       " ('Dota 2',\n",
       "  33,\n",
       "  0): '* Enabled Team Matchmaking* Fixed Shared Announcers not working* Fixed dashboard performance impact of the friends list* Added match status and pro player indicators to Watch Live section* The Armory now supports Home, End, PageUp and PageDown to scroll the display.* Automatic region selection will now take into consideration the ping times of the entire party* UI changes to the region select popup to show ping times of all party members.* Alt+clicking items on the courier now reports the correct player* All existing low priority penalties have been cleared* Fixed bug where custom loading screens would render horizontally stretched* Fixed a bug where sometimes animations wouldn\\'t loop in the loadout screens* Fixed ambient effects and textures for Terrorblade* Removed 5% cut from wagering winnings* Added a random bonus to wager winnings for each match that is revealed after wagers have been placed and the match begins* Fixed a bug where effigies would sometimes fail to be successfully created* Hid the Demo button on pages showing information about non-demoable items* Added the ability to equip items or toggle their shuffle state on the owned item details page* Added the dota_export_steam_inventory_layout_flow console command to provide an alternate order for the export* Added dota_sort_steam_inventory which sorts your Steam inventory by rarity, quality or date* Fixed a bug where the corner triangle icon was incorrectly being displayed on the owned item details page when the item wasn\\'t equipped* Techies remote mines are now correctly affected by arcana color gems* Fixed a bug where projectiles affected by color gems would sometimes use the default color* Fixed unit speech overlapping on kills* Fixed Riki\\'s backstab sound* Batrider\\'s Flaming Lasso with Aghanim\\'s now correctly breaks when Batrider dies* Fixed Alchemist\\'s acid spray visibility issues* Fixed Alchemist\\'s acid spray visibility issues* Fixed Alchemist\\'s red wireframe coins when using his immortal* Fixed golden effigy pedestals being improperly lit* Fixed colored greevils having grey noses, tails, ears, etc* Fixed Terrorblade arcana alpha test and colorwarp issues* Fixed Legion Commander arcana set alpha and detail texture issues* Fixed Techies arcana bugs* Fixed Ember Spirit\\'s remnant not having glow applied* Fixed Ember Spirit Run with head tilted too high* Fixed Bristleback Immortal Quill Spray Ability so spikes and pistons line up properly* Fixed issues with arcana effects not being applied in loadout and hero selection* Fixed a bug with particles being too near or too far from the camera* Fixed Chaos Knight\\'s footprints being backwards* Hammer: Fixed bug where ghost tile instances were being left behind when performing certain operations on a tile map.* PET: Remove incorrect \\'obsolete\\' flag from particle blob & screen shake render ops (show up in particle editor now)* Particles: Added fix for case where particle screen shake wouldn\\'t happen unless there were particular other rendering ops in the system* Workshop Importer: Improved optional/default value logic* Workshop Importer: Added templates for Boar, Hawk, Forge Spirit, Wolves, Jugg Ward, Lycan Ult, NP Treant, Spiderling, Tusk Sigil* Workshop Importer: Added \"Contract Only\" template [replaced \"League Ticket\"]* Workshop Importer: Added explicit \\'Custom Skeleton\\' opt-in that disables application of Valve default anims (that wouldn\\'t work on the new skeleton)* Workshop Importer: Animation file browser now allows picking SMD files* Workshop Importer: Fixed bug where \"Import Source1-Style Color\" could auto-fill the normal box with the wrong filename* Workshop Importer: Fixed infinite hang when importing geometry with certain types of morph data* Workshop Importer: Fixed bug where looping animations from FBX files would have their finallooping frame removed (first and last frames should still be identical for asmooth loop)* Workshop Importer: Added information about which animations are looping* We have begun adding Russian voices',\n",
       " ('Dota 2',\n",
       "  33,\n",
       "  1): 'to Dota. Text and voice languages can be mixed to your preference. To select a new voice language, open steam and right-click on Dota 2. From here, select Properties, then the Language tab, and choose your preferred voice language. Steam will then download the new language. This first release of Russian voices includes the following: Default Announcer, Dragon Knight, Invoker, Legion Commander, Ogre Magi, Pudge, Queen of Pain, Shadow Fiend, Shadow Shaman, SniperМы начинаем добавлять русскую озвучку в Dota 2. Язык текста и голосов можно настроить независимо друг от друга. Чтобы сменить язык озвучки, откройте библиотеку Steam, нажмите правой кнопкой мыши на Dota 2 и выберите «Свойства». В разделе «Язык» вы можете выбрать язык озвучки, который вам больше нравится. Затем Steam загрузит необходимые файлы. Русская озвучка начинается с полного перевода голоса стандартного комментатора, а также следующих героев: Dragon Knight, Invoker, Legion Commander, Ogre Magi, Pudge, Queen of Pain, Shadow Fiend, Shadow Shaman, Sniper',\n",
       " ('Dota 2',\n",
       "  34,\n",
       "  0): \"Dota 2 is hard, but there's a huge reward for those who commit. On the surface, the game is a like-for-like reproduction of the genre-creating (and still updated) Defense of the Ancients modification for Warcraft III, now transferred into Valve's Source engine. The game's punishing design is sometimes enough to drive you up the wall, but it's worth sticking the hours in: success in Dota 2 is about learning to effectively juggle both the broad strokes and finer details. If you're not aware of the basics of the burgeoning MOBA genre, two teams of five players spawn on corners of a map. Each team needs to work together with the goal of ultimately destroying a central structure--in Dota 2's case, the Ancient--in the opposing team's base. With most games lasting around the 40-minute mark, and occasionally edging past an hour, watching the enemy fortress dramatically crumble and sink to the ground feels like an exhilarating payoff. Aiding these two teams, named the Radiant and the Dire, are waves of AI assistants, called creeps. Batches of creeps spawn at 30-second intervals and charge merrily up the map's three pathways. In the clumps of remaining land lies a jungle, where numerous AI opponents spawn, offering lucrative benefits to players who take them on successfully. Finally, and in a bid to stop both teams from simply marching into one another's base, each team gets three powerful towers on each lane that easily shred through enemy players at the start of the game. Your individual ability to control and affect the rhythm of the game comes from how well you handle your hero. You mostly control a single unit in Dota 2, though there are exceptions: some heroes can summon controllable allies, such as bears, gargoyle babies, or wolves; one exceptionally versatile hero can split into three; and one item lets you take control of certain creeps. For each rule in Dota 2's impressive house-of-cards design, there's usually at least one character who completely ignores it, or finds a way around it via one of 130-odd items available from the in-match shop. For instance, try negating magic attacks with the black king bar, returning damage with the blade mail, or pounding out two ultimate abilities in quick succession with a refresher orb. Watching the enemy ancient collapse is incredibly satisfying. The aim for most players is to accumulate as much gold and experience as possible, with income being delivered mostly by scoring the killing blow on enemy creeps and players. It's almost always easier to gang up on stray enemies as a group, which is why it's rarely a good idea to run about on your own. Then it's a case of splashing all your hard-earned money on some ultra-powerful items from the shop, while levelling up your base stats and abilities, and then clobbering the enemy team into submission via a few five-versus-five team fights. Rarely does it feel that simple, however. At the time of writing, 102 of the original Dota's 112 heroes have made their way into the sequel. Each hero has a handful of unique abilities and generally works best in a specific role, such as supporting other players as Omniknight, roaming around the map looking for opportunistic kills as Spirit Breaker, or evolving throughout the course of the game into an all-powerful vehicle of carnage and destruction as Phantom Assassin. There's only one map, unlike in many other MOBA titles, although Valve has not ruled out the addition of more over time, and has previously offered game-changing modes with seasonal events at Halloween and Christmas. But Dota 2's single\",\n",
       " ('Dota 2',\n",
       "  34,\n",
       "  1): 'sprawling map sets itself apart from the competition by being larger, more intricate, and packed with greater detail than the rest of the genre. Unlike in League of Legends, the jungle area is riddled with far more tangling pathways, the lanes feature additional shops selling exclusive items, and savvy players are given more opportunities to use the environment to hide, flee, and ambush their opponents. There are multiple layers of additional information that become increasingly relevant as you invest more time in the game. How do you effectively divide your forces? When should your team attempt to vanquish Roshan, the map\\'s most powerful creep? What are runes? What\\'s the significance of the fact that creeps get slightly stronger every seven and a half minutes? Dota 2\\'s client also allows you to watch eSports matches. Often the game\\'s dizzying scale is seen as off-putting or simply too complex, but the truth of Dota is that it can be entertaining as a new player to just sit down and let all those extraneous factors play out around you. Getting down to the brass tacks of the game with a group of like-minded friends is a lot of fun: start by buying your characters\\' recommended items, try your best not to get caught out of position, and get into the habit of buying observer wards. And watch out for Riki. As you\\'d expect from Valve, this is a beautifully presented game, with the Half-Life and Portal maker running victory laps around its competition in terms of UI, voice acting, and showing how to deftly add real personality to its characters. Only recently has the developer turned its attention to gently easing new players into the proceedings, however, and even now, mastering the basics feels like learning to swim by jumping in at the deep end. Efforts are being made to remedy this, though: right now there are a couple of tutorial levels, some well-designed AI bots, and a newbie playlist that restricts hero selection to just 20 of the most frequently picked characters. And with community-created hero guides now built directly into the game itself, Dota 2 is much easier to get started with than it has been in the past. Play a match every evening for a couple of weeks, and you start to see how Dota 2\\'s wealth of disparate systems and mechanics combine into their own harmony, and you begin to understand how there are hundreds of elements that affect the game. Dota 2 is a tense war of accumulation and attrition. The biggest problem, which is coincidentally where the real excitement of the game lies, comes from struggling to process and interpret dozens upon dozens of mitigating circumstances while simultaneously trying to keep your cool. It is a complicated and exhausting game, and for the first few weeks, it\\'s challenging just keeping up with the general rhythm of a match. But invest enough time into Dota 2, and you develop an almost unconscious ability to keep up with the game--performing actions such as sending the slightly fiddly in-game courier over to the faraway \"secret\" shop to get some rare items, for instance. After a couple of hundred hours of Dota 2, what once felt like spinning plates just happens automatically. Late-night Skype calls, drawn-out conversations down at the pub, and lost lunch breaks follow. Very few games can withstand so many emotionally charged discussions. When everything goes south, the psychological toll can be surprisingly intense, and this is very much a game with the power to both start and end close friendships. Dota 2 is an overwhelming, intoxicating, and',\n",
       " ('Dota 2',\n",
       "  34,\n",
       "  2): \"emotionally dangerous game that can quite easily take over your entire gaming life. While Dota 2 has transferred the core of the original Dota into a cleaner, modern engine, the fact remains that losing is uniquely painful. Death in Dota 2 not only gives your opponent money, but robs you of some of your own and leaves you waiting up to a minute to respawn. By the time you've trudged back across the game's massive map--or spent money on a teleportation scroll--your opponent is now stronger and richer. Die two or three times in quick succession, which is easily done, and a match of Dota becomes a painful experience where you spend the next half hour getting bullied by an increasingly superior enemy. Other games in the genre have tried to mitigate this punishment, but Dota 2 positively revels in its complexities. The rich just get richer. Any opportunity to safely accrue gold and experience should be taken. Occasionally there are big, beautiful reversals that turn into plucky underdog stories to be shared on forums and between friends, but for the most part, a team that starves its opposition of money and experience wins the game. Dota 2 ups the ante even further by featuring the concept of denying--one of its most divisive features, and one of the chief distinctions between Dota 2 and Riot's League of Legends--which is when you purposefully kill off your own creeps, allies, and structures so that the enemy team doesn't get the experience or gold. A tense game is always going to be exhilarating, of course, though the game's matchmaking system often feels like a weak link. The gargantuan task of bucketing groups of players into balanced matches in a game that requires both individual and group skills is understandably challenging, but too many matches feel a bit lopsided--either an effortless stomp or a painfully inevitable defeat. Hopefully the influx of new blood over the coming months will help smooth out these bumps. Valve has poured considerable effort into building Dota 2's powerful client, however, and this impressive platform can sometimes help take the sting out of defeat. This is a free-to-play game, but it's one which sets itself apart by being an unquestionably fair one: every hero is immediately available to all players, unlike in League of Legends, and real-money purchases of weapons, hats, and armour are purely cosmetic. Following Team Fortress 2's lead, the game also regularly drops tempting crates that can be unlocked with keys costing a couple of bucks. At the end of each game, players are subjected to a showering of random loot drops, and it's easily possible to notch up hundreds of items just by playing normally for six months. Knowing when to push your advantage is crucial to success. Dota 2's extensive customisation offers new taunts, announcers (Half-Life 2's Dr Kleiner is a particular highlight), and HUD skins, with many of these items created and voted into the game by the community. Passes to watch pro matches live from the in-game client can also be purchased, and Dota 2's suite of options to spectate matches (with incorporated commentary) are undoubtedly the envy of every other MOBA developer on the planet. This is a free-to-play game that feels generous, with profits being dished out to item creators and the eSports teams, and Valve is already in the habit of running seasonal events that award you with heaps of new items. The original Dota was an unexpectedly powerful blend of clashing genres and disparate elements that ended up taking over the world, and Valve's successor retains the original rules\",\n",
       " ('Dota 2',\n",
       "  34,\n",
       "  3): 'and characters while adding in a cheery free-to-play model and slick production values. The experience of playing Dota changes day by day--some evenings will be exhilarating, while others will kick your morale to the curb--but there are few games as worthy of your time investment as this. Those who choose to commit to Dota 2 will find many happy hours within this immaculate update.',\n",
       " ('Dota 2',\n",
       "  35,\n",
       "  0): 'OpenAI, the AI research organization, can claim a world first: its artificial intelligence system trained to play the complex strategy game Dota 2 has bested a world champion e-sports team. The competition was held in San Francisco today and dubbed the OpenAI Five Finals, ending the organization’s public demonstrations of its Dota-playing technology on a high note. The competition on the human side included five top Dota 2 pros from team OG, which won the world’s most coveted e-sports prize last year when it took the No. 1 spot at The International, the premiere annual Dota 2 tournament with prizes now totaling $25 million. OG faced off in a best-of-three contest against the OpenAI Five bots, all trained using the same deep reinforcement learning techniques and controlled independently by different layers of the same system. Reinforcement learning is effectively a trial and error approach to self-improvement, wherein the AI is dropped into the game environment with zero understanding of how the game works and trained extensively using reward systems and other incentivizing mechanisms. Today’s performance is by far the highest-quality demonstration of OpenAI Five’s capabilities to date, with the system having narrowly lost two games to less capable e-sports teams last August. According to OpenAI co-founder and chairman Greg Brockman, who is also the organization’s chief technology officer, OpenAI Five improves by playing itself in an accelerated virtual environment. “OpenAI Five is powered by deep reinforce learning, which means we didn’t code it how to play. We coded it how to learn,” Brockman told the crowd ahead of the competition. “In its 10 months of existence, it’s already played 45,000 years of Dota 2 gameplay. That’s a lot — it hasn’t grown bored yet.” OpenAI’s Dota 2 bots have trained for the equivalent of 45,000 human years Dota 2 is a vastly complex strategy game, involving more than 100 unique characters, deep skill trees and item lists, and a dizzying array of variables playing out onscreen at any given moment in a match. As such, OpenAI imposes certain limits when its AI system plays professional players, most prominently by capping the number of heroes used by both five-player teams. In this case, each squad had 17 heroes to choose from. OpenAI also chose the so-called “Captain’s Draft” game mode, which lets each team strategically ban heroes to prevent the other team from selecting those characters before using a distinct picking order. That lets the captain build off strengths between hero combinations and leverage enemy hero weaknesses through strong counters once the teams do begin filling out the roster one by one. Like prior matches, OpenAI also disabled summoning and illusion features, both of which involve bringing on additional variables in the form of hero copies and unique creatures that OpenAI hasn’t trained its system to account for. Beyond that, the game is played just like a normal Dota 2 match, with the ultimate goal of destroying the enemy team’s “ancient,” or a large tower at the end of each team’s territory that becomes vulnerable only when the enemy team successfully destroy smaller towers throughout the course of the match, in between hero-on-hero team fights. In the first match of the day, OpenAI Five surprised OG and claimed victory through reliance on a number of aggressive tactics, including the peculiar decision to spend earned in-game currency to instantly revive heroes upon death, even early on in the match. As noted by Greg Brockman, OpenAI’s chief technology officer, OpenAI is fond of strategies that favor short-term gain, revealing its deficiencies in mastering the type of long-term planning humans are great at and',\n",
       " ('Dota 2',\n",
       "  35,\n",
       "  1): 'typically rely on to win such strategy contests. However, in this match, the early buy backs paid off and OpenAI Five gained an edge that OG simply could not overcome as the match dragged on into the 30-minute range. In the second match, OpenAI performed even better, gaining an early advantage against OG in the first few minutes and then ruthlessly advancing on the human players until it clinched victory in a little more than half the time it needed to win the first match. Mike Cook, an avid Dota 2 player and viewer who specializes in the blending of AI and game design, noted how unusually aggressive OpenAI Five began playing in the second match, and how little OG was doing to combat its advances across the map. Cook noted specifically how well OpenAI Five was able to take advantage of its specific hero picks. For OpenAI, the victory here is not just a cause of celebration in and of itself, but a testament that its approach to reinforcement learning and its general philosophy about AI is yielding milestones. The research team will no longer hold any public demonstrations of its AI bot, but its now working on software that will let humans collaborate alongside the OpenAI Five software in real time, playing on a team with the bots and learning from their peculiar, unprecedented strategies and behaviors. The organization is also releasing a platform for the public to play against OpenAI Five, a mode it’s calling Arena, that will be open for three days starting April 18th. OpenAI says that the collaboration software may not ever make it to the public, although I was able to try it for myself here at the event. (Despite having world-class Dota 2 AI on my team, I unfortunately was crushed in much less dramatic fashion than OG.) But Sam Altman, co-founder and CEO of OpenAI, says this type of work is evidence that collaboration with AI agents could result in huge benefits in the future. OpenAI wants to take its Dota 2 learnings and apply them to new challenges, like robots “That’s an important lesson for how the world is going to work, training these things and having them work in parallel,” Altman says in an interview with The Verge. “Collaboration is one of the more positive visions we have for the future of the world — AI works alongside humans to make humans better and have more fun and more impact.” Altman says OpenAI will likely continue to dabble with Dota 2 and other video game environments, primarily because they are such good test beds for AI and good benchmarking tools for measuring progress. But he tells me there probably does not exist a video game out there right now that a system like OpenAI Five can’t eventually master at a level beyond human capability. For the broader AI industry, mastering video games may soon become passé, simple table stakes required to prove your system can learn fast and act in a way required to tackle tougher, real-world tasks with more meaningful benefits. Ultimately, OpenAI wants to take its Dota 2 learnings and expand them to new domains outside games and, eventually, into the real world. To that end, the organization is working on using reinforcement learning and other techniques to imbue robotic hands with more deft, dexterous, and humanlike movement. “What OpenAI is trying to do is build general artificial intelligence and to share those benefits with the world and make sure it’s safe,” Altman says, referring to the quest to build a multi-purpose AI system capable of performing',\n",
       " ('Dota 2',\n",
       "  35,\n",
       "  2): 'any task a human can. “Were not here to beat video games, as fun as that is. We’re here to uncover secrets along the path the AGI.” Correction: A previous version of this article said OpenAI co-founder Sam Altman was the organization’s chairman. He is in fact the CEO, while CTO Greg Brockman is its chairman.',\n",
       " ('Dota 2',\n",
       "  4,\n",
       "  0): 'Show full PR text DOTA 2 LAUNCHING NOW Players Being Added In Waves to Maximize Game Performance July 9, 2013 - Valve, creators of best selling game franchises (Counter-Strike, Half-Life, Left 4 Dead, Portal, and Team Fortress) and leading technologies (Source, Steam), today announced the public launch of the highly-anticipated Dota 2. During a two year beta, Dota 2 grew to be the largest active community in Steam\\'s history, with a monthly user base of more than 3 million users, and peak concurrent users of over 300,000. The feedback from these users has put Dota 2 in position to welcome everyone to come and play, as we move from beta to launch. Given the size of the Dota audience, the initial launch of the game will be done in waves. This will ensure that existing Dota 2 users will keep playing without disruption, and new users will be able to join the community seamlessly. \"Thanks to those who participated in the beta and Workshop contributors, you\\'ve helped us build the game and define the infrastructure to support it,\" said Erik Johnson of Valve. \"Our goal over the next few weeks is continue to make the game more enjoyable as more players are brought in. We hope to make it as smooth as possible for existing players and new players alike.\" Those who wish to request their entry to the game just need to visit the Steam page (http://store.steampowered.com/app/570/), sign up, and keep a look out for an email letting them know it\\'s time to play. Available for the PC via Steam, Dota 2 is the massive sequel to one of the most played games of all time, and offers a unique blend of RTS and RPG action. For more information, please visit http://www.dota2.com/thebetaisover',\n",
       " ('Dota 2',\n",
       "  5,\n",
       "  0): \"Guess the earlier accidental release of Dota 2 wasn't quite a false alarm: now the game is officially out of beta. Finally! Here's how the launch will work according to Valve: Like we mentioned before, the launch of Dota 2 is going to take on a different shape than products we've shipped in the past. Our thinking is that we want the existing audience have uninterrupted access during the launch, in addition to bringing new players into Dota 2 in a way that isn't frustrating. Simply put, we want to smooth out the traditional launch spike, but at the same time allow anyone to come in and try out Dota 2. Dota 2's user base is already larger than any game we've ever made, and it continues to grow. Knowing this launch moment was coming, we've spent the past year working on getting both the backend infrastructure and new user experience into a state where we can welcome in anyone that wants to give the game a try. With that work now complete, it is time for us to invite anyone and everyone to come play. If you want to give Dota a try, or you have a friend you want to bring into the community, click the button above and you can get in the launch queue. You'll see your place in line, and when it is your turn we'll send you an email letting you know you're in. We'll begin sending those emails this week. We also have an update from our world-travelling server installation team, who in addition to achieving triple diamond platinum/uranium/aegis level frequent flyer status, also have added significant game server capacity. Most of this trip has been to add capacity to Stockholm and Luxembourg, but we've also recently added servers to US West and our new cluster in Korea. Don't worry if your cluster isn't listed here, we're ready to add as many servers as needed as the user base grows. Here are some photos from the Luxembourg datacenter: These servers represent the ability to host an additional 450,000 players concurrently. Figuring out how much capacity to add, and where, is one important aspect of this launch. For the stats people out there, concurrent numbers are more useful when predicting what capacity we need for specific regions, because Dota players in the same region tend to play during similar hours. Our worldwide active user base is roughly twelve times the peak concurrency. Hopefully the Dota 2 beta has been as fun for you as it has been for us. While it has come to an end, we'll be building the game for a long time, and listening to what direction to take.\",\n",
       " ('Dota 2',\n",
       "  6,\n",
       "  0): 'MOBA games have been around for a long time, but Dota 2 and League of Legends are the first to regularly pull numbers like the 329,977 concurrent users on Dota 2 and the \" over 500,000 peak concurrent players every day on just the EU West\" League of Legends server. You\\'d think that with the sheer popularity of MOBA games, they\\'d be easy to break into, but that\\'s usually not the case. Fortunately, this guide is here to help! This article should help you understand the basic concepts that are common to both games as well as the overarching differences. Already a veteran, but looking to make the switch to LoL or Dota? Find out just what makes the two games so incredibly different. Start Here Both Riot\\'s LoL and Valve\\'s Dota 2 are free-to-play games. League of Legends is available here and Dota 2 is available here . Be warned, both of these games have pretty steep learning curves, but it shouldn\\'t take long to grasp the basics. Glossary The biggest gaming news, reviews and hardware deals Keep up to date with the most important stories and the best deals, as picked by the PC Gamer team. Contact me with news and offers from other Future brands Receive email from us on behalf of our trusted partners or sponsors MOBA : Multiplayer Online Battle Arena, a mix between RTS and action with players controlling a single, main character. : Multiplayer Online Battle Arena, a mix between RTS and action with players controlling a single, main character. Creep or Minion : AI-controlled monsters that are regularly spawned to push down the various lanes. : AI-controlled monsters that are regularly spawned to push down the various lanes. Farm : The act of killing minions to collect gold; also refers to the number of minions you\\'ve killed. : The act of killing minions to collect gold; also refers to the number of minions you\\'ve killed. Lane : The paths that run along the top, middle and bottom of the map; also refers to the minion waves in the lane. : The paths that run along the top, middle and bottom of the map; also refers to the minion waves in the lane. Laning Phase : The part of the game where players stay in their respective lanes to farm. : The part of the game where players stay in their respective lanes to farm. Pushing : Autoattacking and using abilities to kill enemy minions more quickly which causes the lane to literally push towards the enemy turrets. : Autoattacking and using abilities to kill enemy minions more quickly which causes the lane to literally push towards the enemy turrets. Split Push : When one or two players split off from the team to push a lane somewhere else on the map. : When one or two players split off from the team to push a lane somewhere else on the map. b : Back—used to tell someone to be careful, literally move back, or return to base. : Back—used to tell someone to be careful, literally move back, or return to base. Skillshot : An ability that needs to be aimed. : An ability that needs to be aimed. Carry : A hero or champion that is farmed or fed and can carry a team to victory. : A hero or champion that is farmed or fed and can carry a team to victory. Basic Gam eplay If you\\'ve ever played any sort of RTS, then the basic layout of LoL and Dota should be at least somewhat familiar. These are top-down',\n",
       " ('Dota 2',\n",
       "  6,\n",
       "  1): \"games where you control your champion or hero alongside four other players in five-on-five fantasy action. Left-clicking selects units while right-clicking moves your character or attacks. League of Legends uses Q, W, E and R for your main abilities with D and F reserved for summoner spells. Items are assigned to 1-6 by default. Dota 2 does things a little differently with the number keys reserved for control groups—similarly to StarCraft—and Z, X, C, V, B and N bound to your item slots. Some champions with more than four abilities also require the use of other keys like D and F. Last hitting—delivering the killing blow to a minion—is likely the most fundamental skill you'll have to learn to play either game. Last-hitting minions is your primary means of accruing gold. Wait until the minion gets low enough for you to kill it with a single attack before you hit it. You'll still earn a slow trickle of gold over time, but killing a few extra minions can be the difference between buying the item that you need or missing out on XP for nothing. It's raining bloody gold! LoL and Dota 2 do differ in how they reward players for killing players. In both games, killing an enemy player grants gold to everyone who participated in the kill. In League of Legends, the amount of gold a player is worth depends on how many times they've died without getting a kill and whether or not they're on a killing spree. Dota 2 adds to this by punishing the dead player by throwing away some of the unreliable gold that they've earned. Reliable gold is awarded for kills while unreliable gold is gained over time and for killing minions. The distinction between the two types of gold is reason enough to declare that Dota 2 is a far more punishing game. At the same time, getting kills is quite a bit more rewarding than it is in League of Legends because you gain reliable gold while causing an enemy to lose gold. Not only is it easier to make mistakes in Dota 2, but it's also harder to come back from them. Burn, baby, burn! Every single match of Dota 2 or League begins with the laning phase. This generally lasts from the time that minions spawn to anywhere from 15 to 30 minutes into the game. During this time, carry characters spend their time trying to last hit as well as possible. The goal of laning phase is to earn as much gold as possible while harassing your opponent. Battles are more frequent and abrupt in Dota 2. Once a team commits to a fight, enemies will be stunned and spells will be unleashed. It usually only takes a second or two for the first casualty in a fight. During a game, it's not uncommon to see first blood claimed only a few minutes in. Fights in Dota 2 are quite a bit like food fights—you look around to make sure no one's watching, then let loose a few cups of pudding or an Arcane Bolt or two. League of Legends is a little less chaotic. The first kill might take place 10 minutes into a match, but that isn't to say that the game is any slower paced. You'll be casting your spells far more often than you do in Dota 2 because of LoL's emphasis on skillshots and low mana costs. Laning is usually a matter of last hitting while throwing out a spell or two to try and push your opponent out of lane. The later\",\n",
       " ('Dota 2',\n",
       "  6,\n",
       "  2): \"section of both games is reserved for team fighting and coordinated pushes to try and reach the enemy base. As the end of the game approaches, teams usually start to stick together to knock down towers and eventually the base structures—the melee and ranged barracks in Dota 2 and the inhibitors in LoL which strengthens creep waves. Destroying the nexus or ancient is the only way to end the game without forcing a surrender vote. The ancient—eye of Sauron?—doesn't react well to being attacked. Champions/Heroes Although you're given control over a single character in both Dota 2 and LoL, the two games have different ideas of what constitutes a hero or champion. Playing dodge ball with the ground is a lot more fun than it sounds. Champions in League of Legends are more likely to have skillshots and spells that can be spammed. As a result, LoL focuses not only on traditional, attack damage (AD) carries, but also on ability power (AP) carries. Unlike in Dota 2, you can buy items that increase the damage output of your abilities in LoL. The laning phase in League games usually involve quite a bit more ability-based harass. Poking your opponent with a skillshot or target spell is reasonable because of the low mana costs that accompany most spells. Every single champion in this game has four main, character-specific spells along with room for two summoner spells; Flash is one spell that you'll see all the time because it lets you jump a short distance in the direction of your cursor. He's clearly asking for me to push his buttons. The comparatively lesser emphasis on skillshots doesn't mean that Dota 2 isn't a skill-driven game. It makes up for it by having a diverse pool of heroes that are able to build items to satisfy different roles. Dota heroes have much more explosive power with the ability to execute combos that usually leads to battles that last only a few seconds. These powerful spells come at a cost—the mana required to cast these spells is usually high—which prevents them from being used constantly. Another distinguishing factor of Dota 2's hero pool is the Invoker—playable proof of the wide variety of heroes available in the game. With a total of 14 abilities at his disposal, the Invoker is considered by many to be the most complex character in any MOBA game. Mixing and matching reagents to invoke new spells demonstrates just how versatile and varied Dota 2 heroes can be. Next page: A quick peek at the map, metagame and itemization options in both games.\",\n",
       " ('Dota 2',\n",
       "  7,\n",
       "  0): 'Open Extended Reactions It\\'s no secret that esports as a whole has seen a meteoric rise in interest as of late, with games such as League of Legends, Hearthstone and Dota 2 all becoming mainstream. League of Legends is the most popular multiplayer online battle arena (MOBA) and the most popular esport in the world, for that matter, but Dota 2 boasts by far most prize money and has unique qualities that separate itself from other MOBAs. To the casual observer, Dota 2 and League of Legends could seem like fraternal twins. Both games focus on two groups of five players facing off against one another in an attempt to destroy a central location, such as the Ancient in Dota 2 and the Nexus in LoL. Both games allow for each character to use a variety of spells or ultimate abilities to affect the outcome and strategy of the game, like a bizarre chess match. And each game requires the help of creeps, who mindlessly shuffle down specified lanes to destroy enemy objectives and are controlled by the computer. But if you look closely, there are a couple of major differences between Dota 2 and League of Legends, ones that drastically alter the strategy of the game. The first, and arguably most important difference, focuses on those aforementioned creeps and the ability to \"deny\" a kill. Much of the early portion of the game, otherwise known as the \"laning\" phase, is centered on gaining experience and gold. The easiest way to accumulate that wealth and experience is by killing the opposition\\'s creeps. Considering players have the opportunity to accumulate additional gold by landing the final hit on an enemy creep (called last hitting) the timing behind each move becomes increasingly critical. However, Dota 2 provides players the option to deny a kill, attacking their own creep in an effort to reject the opposition\\'s attempt to gain additional gold and experience. While the move might seem barbaric, the strategic elements behind the friendly fire causality cannot be overstated, and it\\'s one of the ways Dota 2 separates itself from League of Legends. Another critical difference between the two games focuses on player deaths. Let\\'s face it, even the best LoL or Dota 2 players will succumb to a death every so often. While LoL tends not to penalize death, other than forcing the player to miss out on potential gold gains while they wait for their hero to respawn, Dota 2 puts a premium on life. So much so that when a player dies, they lose a certain chunk of their acquired gold. Thus killing an opponent\\'s hero in Dota 2 becomes a twofold attack: A player pockets a hefty amount of change by disposing an enemy player while simultaneously ruining their opposition\\'s chance at building up any sort of gold reserves, money which could be used to purchase items that boost the character\\'s attributes. While there are other smaller differences between the two MOBA games, the two highlighted above stand out as particularly important when looking at the finer points of Dota 2. Generally speaking, you, as a fan, can predict the outcome of the game depending on which team does a better job of using those unique aspects to their advantage. There are plenty of opportunities to watch the professionals put together intricate schemes and strategies throughout the year. Dominant organizations like Team Secret and Evil Geniuses display this in spades, and it\\'s part of the reason they are some of the best teams in the world, and likely will continue to be for the foreseeable future. Fighting with',\n",
       " ('Dota 2',\n",
       "  7,\n",
       "  1): \"Team Secret for the right to be named best team in Europe, Team Liquid and the ever-impressive OG will also look to flex their respective gaming prowess. And with the introduction of four annual, seasonal tournaments, dubbed the Dota Major Championship, or majors for short, fans of the game will have more opportunities to watch their favorite teams compete at the highest level beginning this spring. Newcomers to Dota 2 and LoL are unlikely to ever play at such a prestigious level of the game. But what makes them interesting, and altogether more fascinating, is their accessibility. While I love the NFL, my short stature and lack of bulging muscles generally means I will never play the sport at a professional level. The beauty behind esports is that it doesn't require your fitness level to replicate an in-his-prime Arnold Schwarzenegger. It simply requires a bit of ingenuity and a fully charged computer. With a couple of simple clicks and a bit of luck, I could be playing with or, gulp, against one of the many professional Dota 2 players who practice on the game's server at any given time. I can only imagine making a one-handed catch near the back of the end zone against Darrelle Revis. But in Dota 2, I don't have to imagine making some ridiculous play; I can hop on my computer and hone my skills against every-day players. It's this kind of access that originally drew me into the sport, but it's the inner workings of the game and varying strategies that I hope will keep you coming back for more. Information in this report provided by Rotowire\",\n",
       " ('Dota 2',\n",
       "  8,\n",
       "  0): 'Dota 2 is getting a complete overhaul, aiming to provide a more intuitive user experience. Play dota 2 reborn 9 Images Play Valve has revealed numerous updates for Dota 2 Reborn, which includes a new interface, new engine, and all-new custom games. Dota 2 players will get their chance to preview the changes in an upcoming open beta.The official site details a dashboard redesign updating party management, invites, voice chat, and featuring a new party beacon that allows players to set themselves to “open” status and broadcasts to friends that they are looking for more party members.Players can now interact with friends’ customizable miniprofiles and activity feeds. Friends can also compare their performance with heroes and their playstyle with the new interface.Valve has also overhauled the hero browser, giving players the ability to filter heroes and sort sets and items available to heroes.In addition, new information, such as detailed graphs and stats, will be available to viewers on DotaTV. Tournaments will be featured on DotaTV and viewers will have the ability to bookmark matches to watch later.Lastly, Valve recognizes newer players have issues understanding Dota 2, so it has included new Guided Bot Matches and tutorials focusing on Dota mechanics.Next week, Valve intends on discussing the new Custom Games, with details of the new engine and details for the open beta coming shortly after.In related Dota 2 news, The International 2015 has exceeded $13 million, making it the largest prize pool in the history of eSports competition. For more on Dota 2, check out IGN’s MOBA podcast IGN Arena Michael Martin is a freelance writer from Seattle who is hopelessly addicted to pop culture t-shirts. Send help on Twitter',\n",
       " ('Dota 2',\n",
       "  9,\n",
       "  0): 'No developer has a bigger stake in what \"DotA\" (the highly popular Warcraft III mod, Defense of the Ancients) means today than Riot Games, the budding developer of the free-to-play DotA-esque arena game League of Legends. League of Legends has quietly developed into an enormous community, and it\\'s a game all PC gamers should at least try. So when the suprising news came out last week that Valve had submitted an application to trademark \"DotA\", we sat down with two of the top dogs at Riot Games who were major forces in the DotA community before they signed up at Riot--Steve \"Guinsoo\" Feak and Steve \"Pendragon\" Mescon. If anyone has a right to claim the name \"DotA\", it seems like it would be these guys, so we asked them what they thought of the recent announcement and what they plan to do about it. Before teaming up with Riot, Guinsoo and Pendragon made a name for themselves by creating and operating DotA Allstars, by far the most popular version of DotA. Guinsoo, now Game Designer for League of Legends, designed and created the DotA Allstars map, while Pendragon, now Director of Community Relations for LoL, created the website to foster and grow the community around the map. PC Gamer: What was your initial reaction when you heard that Valve was registering a trademark for “DotA”? Steve \"Pendragon\" Mescon: As someone who worked with DotA for years, seeing developers of Valve\\'s caliber take an interest in this genre is always exciting. Hundreds of people have worked on DotA in its many forms over the years, and millions have played the game, and certainly this type of attention demonstrates how far DotA has come. However, the idea that one single company is taking control of the name of something that hundreds of people have contributed to is surprising. I believe DotA should always remain a community-owned product that modders, independent developers and game fans can continue to modify and play as often as they\\'d like. Guinsoo and I had hoped that the DotA name would live on in perpetuity as a community project that is both free to play and free to modify and expand. PCG: Did you think that trademarking the name was even possible? Guinsoo, as the creator of DotA Allstars, you have as much of a right to claim the “DotA” name as anyone else in the world. Why hadn\\'t you or Riot tried to trademark it before? The biggest gaming news, reviews and hardware deals Keep up to date with the most important stories and the best deals, as picked by the PC Gamer team. Contact me with news and offers from other Future brands Receive email from us on behalf of our trusted partners or sponsors Steve \"Guinsoo\" Feak: I was aware that trademarking the name was possible, but originally I had no intention of filing for any DotA-related trademarks because DotA is owned by the community. DotA is a mod that many of people have contributed to, not a single person or development team like most typical games. As soon as you step away and create a new game, like we at Riot Games did with League of Legends, it\\'s no longer DotA. After all, DotA wouldn\\'t be where it is today without the many contributions the community has made over the years. Neither Pendragon, Riot Games nor I have any desire to dictate the future of DotA. PCG: Who has the rights to own properties like “DotA” that started out as a single map, but have evolved into so much more? Do you have insight',\n",
       " ('Dota 2',\n",
       "  9,\n",
       "  1): \"into the legal side of things? Pendragon: I don't know the answer to that question, but certainly the original authors, such as Eul and Guinsoo, and the many contributing authors and companies such as Blizzard, have contributed significantly to the creation of DotA. The situation is not as simple as a single person having total ownership over the name. But now we are exploring options to protect the DotA name. We [Dota-Allstars, LL--the company run by Pendragon] have filed for the “Defense of the Ancients” trademark to protect the work that dozens of authors have invested to create the game and on behalf of the millions of DotA players all over the world. If we were to obtain the trademark, we would keep the game and the DotA name freely available to the mod community. That way the game can continue to be worked on and enjoyed by the independent community. We want to ensure that the DotA name remains in the hands of the community and that it is free for all to use. We have filed for the “Defense of the Ancients” trademark to protect the work that dozens of authors have done to create the game and on behalf of the millions of DotA players all over the world. PCG : Do you feel that Valve's application to trademark DotA affects League of Legends in any way? It is an entirely separate game, but it's legacy is obviously deeply rooted in DotA. Pendragon: The trademark itself doesn't affect League of Legends because it's a standalone game. But as we still are part of the greater DotA community, we hope that the DotA name will remain under the control of the community for the community to continue to play and update. PCG: Valve has a history of snatching up mod teams and having them create their mods as stand-alone Source games under Valve. A lot of modders see this as a beacon of hope—that if they work hard they can get full-time jobs. Do you not feel the same way? Pendragon: We think Valve is a great company that has put out some amazing products--many based on mods. They have done a lot to grow and support the mod community and we are excited to see what they bring to the genre. As far as potentially offering positions for modders and DIY developers, we totally support that movement. After all, Guinsoo was originally a modder that helped create DotA Allstars and he's now one of the lead developers for League of Legends. PCG: Is the DotA situation different from the CS or the Alien Swarm situations? Guinsoo: I don't know the details of those situations, but DotA was created by several different community teams over a long period of time. There were hundreds of people involved in creating and maintaining the product, shaping it into the game you see today. PCG: Is it more devious than people might think on the surface? Pendragon: We give Valve the benefit of the doubt because of their history, but our concern is that by a single organization taking ownership of the name, the community at large would no longer be able to contribute to DotA like they have for years. PCG: Do you think Valve has relied too much on absorbing other people's ideas and refining them in recent years, rather than internally developing games from scratch? Pendragon: I am excited that Valve has taken an interest in the genre and would like to see the innovations they bring to the table. We see this genre of gaming growing and expanding\",\n",
       " ('Dota 2',\n",
       "  9,\n",
       "  2): \"as more gamers discover it. Larger developers like Valve adding their talents, ideas and growing the audience is going to accelerate the popularity of this genre, which is going to be great recognition for all the efforts that the DotA community put into creating this type of game. PCG: What's the best outcome for the average gamer at this point? Pendragon: I think the best-case scenario would be that nobody owns the trademark to the DotA name. But if Valve were to ultimately gain the rights, I hope that they would abandon the trademark and release it to the community to allow them to continue to modify, play and experience DotA for free. That's what DotA is all about.\",\n",
       " ('F-35',\n",
       "  1,\n",
       "  0): '31 июля 2015 года приказом коменданта Корпуса морской пехоты США 121-я ударная эскадрилья «Зеленые рыцари» была объявлена достигшей начальной оперативной готовности. Это первая авиачасть на самолетах F-35, получившая такой статус. После двух десятилетий разработки детище крупнейшей военной программы в истории заступает на службу. Детство. Отрочество. Юность F-35 — детище программы JSF (Joint Strike Fighter — «Единый ударный истребитель»), и это сокращение до сих пор иногда используется как имя собственное для самолета. То, что мы знаем как JSF, имеет свои корни в целом ряде программ ВВС, ВМС и КМП США второй половины 80-х — начала 90-х годов. В августе 1995 года на основе программы JAST (Joint Advanced Strike Technology — «Технология единого продвинутого ударного истребителя»), постепенно вобравшей все «индивидуальные» программы родов войск, была запущена JSF. Цель была крайне амбициозной: впервые в истории военного авиастроения создать на общей платформе с максимально возможной унификацией сразу три самолета разного типа базирования — обычное, аэродромное; палубное, для авианосцев с катапультами; и, наконец, вариант с укороченным взлетом и вертикальной посадкой — для коротких экспедиционных аэродромов и десантных кораблей. Корпус морской пехоты остро нуждается в замене для своих AV-8B «Харриер II» и F/A-18C/D «Хорнет». Если вторые еще можно заменить новыми истребителями палубного базирования, аналогичными флотским «Суперхорнетам», то самолет с укороченным взлетом взять просто неоткуда. Флоту давно необходим малозаметный ударный самолет «первого дня». А в ВВС все еще проще — если к тому моменту, как «начнет сыпаться» флот F-16, основная масса которых построена в конце 70-80-х, в серии не будет массового однодвигательного истребителя, ситуация станет катастрофической. Требовался и экспортный продукт — тяжелый и дорогой F-22 был изначально вещью очень нишевой (даже если бы его допустили на экспорт, чего, как нам сейчас известно, не случилось). Широчайшая международная кооперация предусматривалась с самого начала программы. Еще на ранней стадии, в 1995 году, к ней официально присоединилась Великобритания, тоже нуждавшаяся в замене «Харриеров». Участие Великобритании было во многом предопределено — она участвовала в совместных с КМП США изысканиях по этой теме еще в 80-х годах, страны объединяли общие потребности и понимание, что в одиночку не потянуть. В дальнейшем к программе присоединились Австралия, Дания, Италия, Канада, Нидерланды, Норвегия и Турция. Таким образом сформировался клуб из девяти стран, совместно осуществляющих разработку JSF. При этом серьезную роль в этом процессе играют лишь США и Великобритания, однако и другие страны несут расходы на разработку и получат свой «кусок пирога» в виде участия в производстве, гарантирующего стабильные рабочие места и доход на десятилетия. Так, в Италии организован конвейер для финальной сборки истребителей для части европейских партнеров. Подобный подход доказал свою полезность: за все годы ни одна страна не отказалась от своих планов. Затем, уже по линии экспортных продаж, в число заказчиков вошли Израиль, Япония и Южная Корея. Посадка F-35B на палубу Фото: Department of Defense Процессы слияния в аэрокосмической отрасли США привели к тому, что реально за победу в конкурсе JSF боролись две крупные группы, возглавляемые «Боингом» и «Локхид-Мартином». В 2000 году на летные испытания они представили по два самолета-демонстратора технологий: X-32 и X-35 соответственно. Уже в октябре следующего года выбор был официально сделан в пользу машины «Локхид-Мартин». Первый полет F-35 состоялся через пять лет после победы в конкурсе — 15 декабря 2006 года. Начался долгий период летных испытаний и доводки самолета, продолжающийся до сих пор. Количество связанных с ним скандалов, критики в СМИ, в правительственных, военных кругах и экспертном сообществе не имеет себе равных в военном авиастроении. Простое перечисление тем негативных комментариев заняло бы объем примерно двух таких статей. F-35, несомненно, обладает рядом детских болезней и слабых мест: например, нашлемная система индикации, переносная система диагностики, регулярные задержки с тестированием большого объема программного кода и так далее, — что естественно для подобной программы. При этом в истории',\n",
       " ('F-35',\n",
       "  1,\n",
       "  1): 'испытаний и освоения F-35 есть и положительные моменты. Так, изначальная конструкция не потребовала кардинальных изменений. Весьма впечатляющим для новой машины выглядит и то, что сотни летчиков налетали более 36 тысяч часов, но ни один самолет не был потерян в аварии или катастрофе, а самым серьезным происшествием был пожар двигателя на земле. Наиболее справедливая критика затрагивает вопросы сроков и цены. Причем вопрос со значительным удорожанием по сравнению с ранними обещаниями особенно интересен, ведь на ранней стадии JSF цена «сухопутного» варианта оценивалась в 28 миллионов долларов. Чтобы продемонстрировать читателям, не интересующимся стоимостью современной авиатехники, насколько это фантастически мало для западного истребителя пятого поколения, приведем наглядный пример: сейчас в этом диапазоне находится цена двигателя для F-35 (для F-35B — дороже, для F-35A/C — дешевле). Примерно столько же стоит китайский истребитель JF-17 — вероятно, самый дешевый сегодня истребитель новой постройки. F-35B эскадрильи «Зеленые рыцари» Фото: Department of Defense Что же могло заставить Пентагон и Конгресс двадцать лет назад поверить, что набитый сложнейшим БРЭО малозаметный истребитель пятого поколения, производимый странами с очень недешевой рабочей силой, будет стоить так мало? Отметая варианты с глупостью и наивностью, приходим к своеобразной «хорошей мине при плохой игре». В условиях середины 90-х, когда мощь Америки казалась абсолютно несокрушимой, для того, чтобы у налогоплательщика не возникло лишних вопросов по поводу закупок многих сотен истребителей, авиастроительные корпорации согласились на явно невозможную цену, а государственные чиновники сделали вид, что поверили им. В данный момент (на восьмой партии малосерийного производства) цена F-35A находится в районе 108 миллионов долларов. Для сравнения: цена F/A-18E/F в 2013-м финансовом году составила около 65 миллионов долларов; F-22A на момент прекращения серийного производства — около 148 миллионов долларов. Таким образом, цену F-35 стоит признать адекватной реальному положению вещей. После школы — в армию К концу июля 2015 года заказчикам было передано 142 единицы F-35, в их числе 14 прототипов (System Development and Demonstration) и 128 самолетов, выпущенных в ходе мелкосерийного производства (Low Rate Initial Production). Больше всего выпущено «сухопутных» F-35A — 74 единицы, F-35B с укороченным взлетом — 46 единиц, палубных F-35C — 22 единицы. Подавляющее большинство машин построено для вооруженных сил США, из стран-партнеров первые самолеты получили Великобритания (три F-35B), Австралия (два F-35A) и Нидерланды (два F-35A). Официально текущее производство называется малосерийным, но количество выпущенных F-35 уже приближается к числу произведенных ранее F-22A (195 единиц — 187 серийных и 8 прототипов), а темпы изготовления (более 30 в год) — одни из самых высоких среди выпускаемых в данный момент истребителей. Испытания ведутся в первую очередь на прототипах. Основная часть авиапарка решает задачу массового переобучения многочисленного летного и наземного персонала. Для этой цели активно насыщаются техникой крупные учебные центры — ВВС на авиабазе Люк, КМП на базе Бофорт и объединенный межвидовой учебный центр на авиабазе Эглин. F-35B на палубе десантного корабля Фото: Department of Defense Особняком стоит база КМП в Юме. Авиабаза в Техасе была выбрана для перевооружения первой строевой эскадрильи вооруженных сил США на новый истребитель. Для этой почетной миссии была выбрана 121-я ударная эскадрилья «Зеленые рыцари», до 2012 года летавшая на F/A-18D «Хорнет». Показательно, что первой начальную боеготовность решили объявить в КМП, несмотря на то, что именно F-35B является наиболее сложной модификацией из всех трех и с ней было связано наибольшее число проблем во время разработки. Это служит еще одним свидетельством тяжелой ситуации с авиапарком морской пехоты. Начальная боеготовность недаром называется начальной: пока самолет имеет крайне ограниченные возможности. Достигается боеготовность конкретным подразделением и не отражает готовность всего авиапарка. Для объявления начальной боеготовности 121-я эскадрилья была укомплектована десятью истребителями комплектации Block 2B, авиабазу оснастили тренажерными комплексами, летный и наземный персонал прошел переобучение, а самолеты приняли участие в учениях морской пехоты, в том числе и на десантном корабле. Ввиду специфики авиации',\n",
       " ('F-35',\n",
       "  1,\n",
       "  2): 'КМП первоочередной ее задачей является непосредственная поддержка войск. И F-35B для достижения начальной оперативной готовности требовалось уметь оказывать ее хотя бы на базовом уровне. Для этого на самолетах реализована возможность применять из внутреннего отсека вооружения корректируемых авиабомб GBU-12 (227 килограммов, с лазерным наведением) и GBU-32 (454 килограмма, со спутниковым наведением). Для борьбы с воздушными целями в арсенале присутствует ракета средней дальности AIM-120C, также на внутренней подвеске. То, что на данный момент отсутствует возможность использовать для вооружения подкрыльевые пилоны, значительно ограничивает возможности самолета: боекомплект сводится к двум корректируемым авиабомбам и паре ракет AIM-120С. Впрочем, «пара бомб и пара ракет» — это, пожалуй, наиболее распространенная боевая нагрузка в асимметричных локальных конфликтах современности. Разумеется, возможности БРЭО на данный момент тоже ограничены. Комендант КМП США на фоне F-35B Фото: Department of Defense В целом можно заключить, что F-35B если и обладает сейчас способностью принимать участие в боевых действиях, то исключительно в наиболее простых условиях. Планы на будущее. Достижение нового статуса в первую очередь открывает дорогу к полноценной эксплуатации и освоению в войсках. Для КМП особую важность представляет высокая мобильность и способность к базированию за рубежом и на десантных кораблях. 121-я эскадрилья начала подготовку к первой зарубежной командировке F-35: в 2017 году она будет развернута в Японии, тогда же F-35 впервые войдут в штатный состав авиагруппы универсального десантного корабля. На очереди перевооружение других строевых эскадрилий КМП. В следующем году новые машины начнет получать 211-я ударная эскадрилья, которая достигнет начальной боеготовности в 2018 году. В том же году начнет перевооружение 122-я эскадрилья, а в 2020 — 115-я и 311-я. F-35B в полете Фото: Department of Defense F-35B должны полностью заменить «Харриеры II» к 2026 году. В 2030 году планируется списание «Хорнетов», а в 2031 году КМП получат последние из планируемых к заказу 420 истребителей. Кроме 353 единиц F-35B морская пехота планирует закупить 67 единиц F-35С, которые будут базироваться на авианосцах флота, — подобно нынешним «Хорнетам». Основное внимание в ближайшее время будет приковано к военно-воздушным силам. Осенью этого года 34-я истребительная эскадрилья 338-го истребительного крыла, расположенного на авиабазе Хилл (штат Юта), начнет получать первые машины, с которыми должна будет в августе следующего года достичь начальной боеготовности. Самолеты ВВС будут иметь уровень развития Block 3I, со сходными с Block 2B возможностями, — при несколько усовершенствованной аппаратной части программное обеспечение у этих версий близко. F-35B Фото: Department of Defense В ходе доработки, уже после начала службы, самолеты будут модернизироваться. Кардинальное увеличение возможностей ожидается на версии Block 3F: станет возможно применение вооружения с внешних подвесок, использование пушки как во встроенном (F-35A), так и контейнерном (F-35B/C) исполнении, ракет AIM-9X (используются только на внешней подвеске) и т.д. Начало внедрения Block 3F ожидается с 2017 года. Однако более сложные системы вооружения — например, малогабаритные бомбы семейства SDB и противокорабельные ракеты JSM — станут доступны только после 2020 года на версиях Block 4 и далее. Можно с уверенностью сказать, что боевой «дебют» F-35 вряд ли состоится до 2020 года. Однако в первые годы следующего десятилетия он весьма вероятен, так как части морской пехоты первой линии, в частности, размещаемые на универсальных десантных кораблях (роль которых в условиях нехватки атомных авианосцев только растет) будут по большей части перевооружены с «Харриеров» на F-35B.',\n",
       " ('F-35',\n",
       "  10,\n",
       "  0): 'Canada announced plans Monday to buy 88 US-made F-35 stealth fighter jets to replace its aging fleet, and meet new threats including from Russia. The F-35 “has proven to be a mature, capable and interoperable aircraft and that is why we are moving to the finalization phase of this procurement,” Defense Minister Anita Anand told a joint news conference with Procurement Minister Filomena Tassi. “Canada has one of the greatest air spaces in the world and we have to make sure that our next fleet of fighter jets is flexible, agile, and able to meet a wide spectrum of threats,” she said. Lockheed’s fifth-generation F-35 stealth jets are considered the most modern combat aircraft in the world, and their unique shape and coating make them harder to detect by enemy radar. The new aircraft’s central role will be to patrol North American air space with the US Air Force under NORAD. But it could also be tasked with helping to bolster NATO defenses in Europe, or other overseas missions. Foreign Minister Melanie Joly told reporters in Ottawa that the F-35 decision was “an important step in making sure that we increase our capacity on the military side.” “Why? Because… the world changed on February 24th,” she said in reference to the start of Russia-Ukraine conflict. Top bidder Lockheed Martin beat out Saab’s Gripen, after Boeing’s Superhornet was excluded from the running, and an Airbus-led consortium and France’s Dassault Aviation withdrew their Typhoon and Rafale fighters, respectively, from the competition. Ottawa had earmarked 19 billion Canadian dollars ($15 billion) for the purchase six years ago, and Tassi said negotiations with Lockheed Martin would now proceed to finalize the contract within the next seven months. She said she expects “delivery of the aircraft as early as 2025.” Procurement Politics Canada spent two decades helping to develop the stealth fighter with the United States and its allies. But when Prime Minister Justin Trudeau‘s Liberals swept to power in 2015 he scrapped three previous administrations’ plans to purchase the state-of-the-art F-35 to replace its aging F-18 fleet, calling it too expensive. Prior to Monday, Canada was the only nation in the partnership not yet committed to buying the F-35s. This investment in Canada’s air force, according to a government statement, will be the most significant in more than 30 years. It follows Germany’s announcement mid-March to buy 35 F-35s as part of a multi-billion-euro push to modernize its armed forces in response to Russia’s invasion of Ukraine, and Finland’s order of 64 stealth fighters in December after seeing a spike in incursions into its airspace by Russian jets in recent years. Airbus said when it withdrew from the Canadian competition in 2019 that NORAD security requirements were too expensive, while sources told AFP that Dassault Aviation was unable to meet technical requirements tied to Canada’s membership in the Five Eyes intelligence sharing group of nations. The Five Eyes group is comprised of Canada, the United States, Britain, Australia, and New Zealand. Ottawa had planned to buy 18 new Boeing Super Hornets as a stopgap while it relaunched the procurement competition, but that deal fell apart over a trade dispute. Boeing had filed a trade complaint against Canada’s Bombardier in an effort to keep Bombardier’s new CSeries jetliners out of the US market, resulting in 300 percent duties being slapped on the planes. Bombardier eventually sold a majority stake in the new plane to Airbus. And Canada bought 18 used Australian F-18 jets to fill an air force interim capability gap. These were similar to its own F-18s, which were first deployed in 1983.',\n",
       " ('F-35',\n",
       "  100,\n",
       "  0): \"Компания Lockheed Martin уже вложила средства в снижение цены на истребители F-35 и вложит еще $85 млн. Ранее избранный президент США Дональд Трамп назвал «неконтролируемой» цену на самолеты Истребитель F-35 (Фото: Fiona Hanson/AP) Американская Lockheed Martin Corporation инвестировала большую сумму денег, чтобы уменьшить цену на малозаметные истребители пятого поколения F-35. Об этом заявил куратор программы Lockheed Martin's F-35 Джефф Бабийон в ответ на критику избранного президента США Дональда Трампа по поводу цены истребителя, сообщает Reuters. «С самого начала мы инвестировали сотни миллионов долларов, чтобы уменьшить стоимость самолета на 70%. И мы внесем $85 млн в период с 2019 по 2020 год», — сказал Бабийон. В понедельник, 12 декабря, Трамп написал на своей страничке в Twitter, что цена на F-35 «неконтролируемая». Избранный президент заявил, что миллиарды «могут» и будут сэкономлены на военных и других закупках после 20 января 2017 года. После заявления Трампа акции самой компании снизились на 4,2%. Акции ключевого партнера Lockheed Martin, компании Northrop Grumman Corp упали на 4,5%, акции другого партнера — компании BAE Systems — на 2,4%, уточняет Reuters. Куратор программы F-35 Джефф Бабийон приехал в Израиль с визитом для того, чтобы принять участие в поставках первого F-35 в эту страну. О том, что США поставят Израилю F-35 в 2016 году, стало известно 24 апреля 2015 года. Израильское Министерство обороны заявило, что в конце 2016 года будут поставлены два самолета, завершится поставка истребителей к 2019 году. Как сообщил CNN, F-35 назван самым дорогим военным самолетом в истории. Стоимость одного истребителя составляет $135 млн, стоимость всей линейки оценена в $400 млрд. Пентагон заключил с компанией Lockheed Martin контракт на $1,3 млрд на поставку 13 истребителей F-35, сообщило Defense News 4 мая. Шесть истребителей F-35B будут поставлены для морской пехоты, три F-35A — для военно-воздушных сил и четыре F-35C — для военно-морского флота. Контракт должен быть выполнен к декабрю 2019 года. Ранее, 6 декабря, Трамп написал в своем Twitter, что правительству США нужно разорвать контракт с Boeing на конструирование президентского борта «номер один» (Air Force One) из-за высокой цены. «Boeing строит новый 747 для будущих президентов, но затраты вышли из-под контроля, больше $4 млрд. Отмените заказ!» — призвал избранный президент США на своей странице в социальной сети.\",\n",
       " ('F-35',\n",
       "  101,\n",
       "  0): 'TEL AVIV – Israel\\'s top Air Force officer on Tuesday praised the \"revolutionary\" operational potential of its new fifth-generation fighter – the F-35 Adir – yet warned that growing anti-aircraft threats could mean that part of its fourth-generation force could be downed in combat. Speaking at the annual conference of Israel\\'s Institute for National Security Studies (INSS), Maj. Gen. Amir Eshel, IAF Commander, singled out Russian-deployed S400s in Syria, which he said \"brings critical capability\" that could challenge Israeli operations in the region. \"Clearly we will encounter threats we never encountered before … in the air and from the ground,\" Eshel said of the S400 and a spectrum of other threats posed by regional states and non-state actors. \"From all those threats, yes, there will be an ability to thwart part of the activities of the IAF. I don\\'t delude myself. We are preparing ourselves so this interference is kept to the bare minimum … but part of our activities will be thwarted. That\\'s clear. Part of our planes will fall. That\\'s clear. That\\'s part of war, but [these threats] will never be able to stop us,\" Eshel said. As for the F-35, the first pair of which were delivered into IAF hands last month, Eshel said the US-produced stealth fighter will lift the rest of Israel\\'s fourth-generation frontline force of F-15I and F-16I fighters into the next generation and preserve its air power supremacy for decades to come. \"It\\'s more than just an aircraft. It will transform the entire service into a much more effective, much more lethal force,\" Eshel said. \"We are not adapting the F-35 to the IAF. That would be a mistake. Rather, we\\'re adapting the IAF to the F-35. We\\'ll learn how to do this so that all of the force will rise to the fifth generation,\" he said. Israel\\'s top air force officer said he was undeterred by criticism directed at the F-35 program, and that the return on investment was well worth the cost. \"There\\'s a lot of criticism that this doesn\\'t work and that doesn\\'t work. But whoever has a smart phone knows that software changes all the time. This is a smart plane, and there will be different upgrades and versions. … What\\'s important is that it will know how to operate in places that nothing else can, with a very high level of effectiveness across the spectrum of threats and operational scenarios.\" In an address devoted to the singular attributes of airpower, Eshel said the F-35 embodied flexibility, speed, agility and survivability that has become a central element of Israeli force strength. \"It\\'s a revolution; far better than anything we have and anything that is flying in this region,\" he said. According to the IAF commander, Israeli airpower must be prepared to operate in multiple domains, from anti-terror threats close to home to more advanced threats in neighboring states all the way to strike and intelligence collection operations conducted \"thousands of kilometers away.\" \"The air domain allows us to deal with a spectrum of threats near and very far away,\" he said. Eshel insisted that no other tool of military power, whether it involves cyber, special ops or land and sea forces, is equipped to deal as effectively as airpower, especially when fighting in three theaters simultaneously. \"The Israel Defense Forces demands that we be prepared to fight in three theaters simultaneously …. Our air assets can be in the northern theater in the morning, in places much farther away in the afternoon, and in the evening, operating in Gaza. That\\'s what\\'s demanded and there\\'s no other force that can',\n",
       " ('F-35',\n",
       "  101,\n",
       "  1): 'do this but airpower.\" In his address to the INSS audience, retired US Air Force Gen. Gary North, vice president for customer requirements at Lockheed Martin, also cited threats posed by Russian S400s in Syria and the benefits of operating the F-35 in a high-threat environment. \"The combination of stealth and sensor fusion – from space and other airplanes – gives the individual aviator in the cockpit information and allows him or her to share it with others flying in formation and other airborne platforms and to disseminate it all down to command and control facilities on the ground,\" North said. Israel\\'s F-35 Adir force, said North, provides strategic deterrence as well as the ability to enjoy freedom of movement not provided by the very best of fourth-generation aircraft. \"The Adir uses stealth to get very close and to enable operational decisions as to whether to engage or disengage.\" Opall-Rome is Israel bureau chief for Defense News. She has been covering U.S.-Israel strategic cooperation, Mideast security and missile defense since May 1988. She lives north of Tel Aviv. Visit her website at www.opall-rome.com.',\n",
       " ('F-35',\n",
       "  102,\n",
       "  0): 'Критики утверждают, что новый военно-морской истребитель, разработка которого стала частью самой дорогостоящей военной программы в истории США, уже устарел. Своим заключением законодатели подтвердили, что палубная версия F-35 не сможет эффективно выполнять боевые задачи без дозаправки. По мнению экспертов, проблема возникла из-за того, что авианосцам, на которых будут базироваться F-35C, придется держаться от врага на большом расстоянии, чтобы не стать жертвой ракетной атаки. Комитет не хочет отказываться от закупки F-35C, вместо этого он хочет начать покупать новые модели боевых самолетов. По словам Дэна Грэйзера, представителя некоммерческой организации Project On Government Oversight, осуществляющей надзор за деятельностью правительства, сложившаяся ситуация показывает, насколько плохо была продумана программа по созданию единого ударного истребителя. Грэйзер отметил, что процесс проектирования самолета растянулся на 20 лет, в результате чего не был учтен ряд возникших за это время угроз. Если флот будет вынужден держать авианосцы на расстоянии в 1000 морских миль (1852 километра - примечание \"РГ\") от цели, \"невидимкам\" F-35C понадобятся хорошо заметные на радарах самолеты-заправщики. Боевой радиус F-35C без дополнительных топливных баков и дозаправки в воздухе составляет 670 морских миль (1240 километров). Дозаправка в воздухе раскроет местонахождение истребителей и самолетов-заправщиков, нивелируя все основные преимущества новейшего самолета-невидимки. В пресс-службе ВМС США этот риск называют приемлемым, поскольку дозаправка будет производиться вдали от позиций противника. Бывший офицер ВМС США Брайан Кларк считает, что это не убережет американские самолеты от обнаружения противником. В качестве альтернативы рассматривается возможность размещения авианосцев ближе к вражеской территории. Однако в таком случае в зоне риска окажутся корабли с многотысячными экипажами.. Уже сейчас китайские крылатые ракеты CSS-5 могут поражать цели на расстоянии до 930 миль (1496 километров). Максимальная дальность поражения российских \"Кинжалов\" превышает тысячу миль (более 1600 километров). По мнению экспертов, эти риски стоило предусмотреть при разработке самолета, так как F-35 планируется держать на вооружении в течение 60 лет. Возможным решением указанной проблемы станет разработка заправщика, выполненного по технологии \"стелс\". Также увеличить боевой радиус самолета можно за счет доработки двигателя или систем вооружений, однако все эти возможности пока только обсуждаются.',\n",
       " ('F-35',\n",
       "  103,\n",
       "  0): 'Чиновники Минобороны США намеренно скрывают технические проблемы самолёта пятого поколения F-35. Об этом говорится в расследовании американской организации по надзору за деятельностью правительства США (Project On Government Oversight, POGO). Анализ копий закрытых официальных документов свидетельствует, что Пентагон занижает степень опасности выявленных в ходе испытаний недостатков. Подобный подход создаёт риски для безопасности пилотов, а также может привести к гибели мирного населения во время военных операций. С какой целью американское оборонное ведомство пытается утаить дефекты F-35, разбирался RT. Пентагон последовательно занижает категории недостатков истребителя-бомбардировщика пятого поколения F-35 Lightning II. К такому выводу пришли эксперты некоммерческой организации по надзору за деятельностью правительства США (Project On Government Oversight, POGO), ознакомившись с неопубликованными документами Минобороны США. Системные проблемы По состоянию на январь 2018 года у самолёта было выявлено 966 критических недостатков. 111 дефектов относятся к первой категории сложности (могут привести к гибели, тяжёлой травме, профессиональным заболеваниям), а 855 — ко второй (неисправность отдельных элементов конструкции и бортовых систем). Как выяснила POGO, занимающиеся тестированием F-35 службы добросовестно выполняют свою работу в целях «улучшения окончательного инженерного проектирования». Однако чиновники Пентагона исправляют отчётность, занижая количество недостатков первой и второй категории. Также по теме «Только национальные интересы»: почему Италия отказалась от закупок американских истребителей F-35 Италия решила отказаться от покупки американских истребителей пятого поколения F-35. Такое заявление сделала глава оборонного... «Копия протокола заседания Совета по изучению недостатков F-35 от 4 июня 2018 года, полученного POGO, свидетельствует о том, что Совет перевёл 19 недостатков первой категории в менее серьёзную вторую категорию. При этом категория десяти дефектов была занижена без утверждения плана их исправления», — говорится в расследовании организации. Одним из критических недостатков, которые отказался исправлять Пентагон, является неисправность аварийной системы. При катапультировании пилота комплекс радиолокационного опознавания не отправляет автоматический сигнал на радар наземного контроля, то есть диспетчеры не получают информацию о ЧП. Также военные проигнорировали проблему с одноразовым хвостовым крючком, который выпускается в случае отказа тормозной системы. Но наиболее серьёзный дефект обнаружился в системе управления вооружением. Пилоты F-35 не могут подтвердить координаты наземной цели. Как отмечают эксперты, подобная проблема уменьшает эффективность и точность бомбометания. В реальных боевых условиях это может привести к удару по своим войскам или мирному населению. В июне 2018 года агентство Bloomberg со ссылкой на документы Пентагона сообщило, что 180 недостатков F-35 не будут устранены в краткосрочной перспективе. В доработке нуждаются цифровая аппаратура, помещённая в шлем пилота, бортовые комплексы и множество элементов конструкции, прочность которых вызывает сомнения у специалистов. По информации издания, F-35 оказался крайне уязвим перед ударом молнии. Причина в том, что планер самолёта выполнен в основном из композитных материалов, а не металлических сплавов, как у машин предыдущего поколения. Кроме того, на истребителе с перебоями работает система генерации инертных газов, которая поддерживает низкий уровень кислорода в топливных баках. Полёт в грозоопасных зонах F-35 может привести к взрыву топлива. Истребитель F-35B Lightning II в полёте Reuters © U.S. Air Force / Staff Sgt. Joely Santiago Эксперты POGO полагают, что каждый отдельный недостаток не препятствует эксплуатации самолёта. Однако в совокупности дефекты могут повлиять на безопасность полётов и «значительно увеличивают вероятность того, что воздушное судно не сможет выполнить требуемую миссию». В западных СМИ можно встретить нарекания, связанные с манёвренностью F-35. Несмотря на преимущество по боевой нагрузке и тяговооружённости, машина оказалась слабо приспособлена к воздушной дуэли, уступая по эффективности истребителям F-16. Внеплановый провал F-35 — это второй самолёт пятого поколения, который призван заменить большую часть парка F-16, F-18 и AV-8B. Детище Lockheed Martin выпускается в вариантах для ВВС (F-35А), палубной авиации (F-35С) и морской пехоты (F-35В). Разработка машины началась в середине 1990-х годов. Первый полёт она совершила в 2000 году. В 2003 году Пентагон утвердил план производства самолёта. Предполагалось поставить в Вооружённые силы 2443 самолётов F-35, причём к 2019 году',\n",
       " ('F-35',\n",
       "  103,\n",
       "  1): 'войска должны были получить 1966 единиц. Однако в 2007 году объём поставок к 2019 году был уменьшен до 1035 самолётов, в 2012 году — до 585, а в 2017-м — до 506. По состоянию на июль 2018 года Lockheed Martin произвёл только 305 машин. Также по теме «Акт силового давления»: зачем США модернизируют сеть военных аэродромов в Европе Белый дом может увеличить расходы на укрепление военного присутствия в Европе в 2019 году до $6,5 млрд. В частности, на «сдерживание... Провал плана производства F-35 объясняется не только выявленными дефектами, но и спорами о стоимости самолёта. В апреле 2007 года разработчик оценил своё детище в $221 млн без учёта двигателя Pratt & Whitney. Однако через несколько лет Lockheed Martin начал продавать Пентагону каждый самолёт за $100 млн. В декабре 2016 года президент США Дональд Трамп раскритиковал корпорацию за высокую цену F-35. К июлю 2018 года стоимость истребителя упала до $89 млн. К 2020 году Белый дом рассчитывает добиться снижения цены до $80 млн. Подписанный Трампом законопроект о военном бюджете предполагает закупку 77 F-35. Эксперты POGO обратили внимание на высокие расходы на техническое обслуживание самолётов — каждая машина будет ежегодно обходиться в $5 млн. Это дешевле, чем содержание первого самолёта пятого поколения F-22 Raptor ($8,2 млн), но дороже машин предыдущего поколения. По состоянию на декабрь 2017 года на реализацию проекта F-35 было потрачено $406 млрд. На устранение недостатков потребуется выделение как минимум $10,8 млрд ежегодно. Как подчёркивают эксперты POGO, выделение средств не будет иметь смысла, если Минобороны США продолжит игнорировать проблемы истребителя. Процесс ликвидации дефектов растянется до 2024 года. Однако Lockheed Martin рассчитывает запустить полномасштабное производство самолётов в максимально короткие сроки, и Пентагон, игнорируя проблемы F-35, идёт навстречу корпорации. В противном случае, как отмечают в POGO, программа рискует не окупиться. F-35 Lightning II на взлётно-посадочной полосе AFP © Jeff J Mitchell / Getty Images «Отстали лет на десять» В беседе с RT военный эксперт Владислав Шурыгин заявил, что результаты расследования POGO свидетельствуют о стремлении американских чиновников «продавить» запуск программы производства F-35. По этой причине Минобороны США не желает признавать допущенные в ходе реализации проекта ошибки. «Американцы вложили колоссальное количество денег в рекламу своего самолёта. Но на текущий момент за океаном не смогли создать полноценную боевую машину и уложиться в запланированные сроки. Темпы производства F-35 отстали лет на десять, и дальнейшее промедление грозит обернуться ростом дополнительных расходов и удорожанием самолёта», — отметил Шурыгин. Как пояснил эксперт, Пентагон и американские корпорации закрывают глаза на проблемы истребителя, рассчитывая любыми способами решить вопрос окупаемости проекта при уменьшении цены F-35. С этой целью они собираются как можно скорее запустить масштабное производство. В противном случае программа самолёта пятого поколения окажется убыточной. «F-35 в концептуальном отношении — превосходная машина. Однако нынешняя ситуация с ним свидетельствует о серьёзных просчётах, которые корпорация Lockheed Martin допустила ещё на начальном этапе проектирования. В итоге они вылились в системные недостатки, на решение которых потребуется как минимум несколько лет и десятки миллиардов долларов. Сейчас F-35 — это сырая и достаточно дорогая машина», — подчеркнул Шурыгин.',\n",
       " ('F-35',\n",
       "  104,\n",
       "  0): 'Истребитель F-35 сошел с ума В процессе длительных испытаний американского истребителя пятого поколения F-35 выявлены критические проблемы с надежностью и долговечностью самолета, точностью его оружия, программным обеспечением. Нелестные для создателей Lightning II факты приведены в докладе директора Петагона по испытанию вооружений. Документ опубликовал Bloomberg. Недостатки F-35 можно разделить на несколько категорий. Первая касается надежности и долговечности истребителя F-35B с укороченным взлетом и вертикальной посадкой - такими самолетами планируется оснастить Корпус морской пехоты США. Многие из 60 построенных самолетов подлежат списанию из-за трещин в фюзеляже. Истребители пришли в негодность, не проработав и четверти заявленного производителем срока, констатировали в Пентагоне. К тому же на F-35B установлено устаревшее программное обеспечение, а его пушка так и не научилась попадать в цель, несмотря на многочисленные переработки. Защита бортовой электроники от взлома признана \"ужасающе низкой\". В условиях сетецентрической войны, для которой и предназначен F-35, наличия у противника мощных средств радиоэлектронного перехвата и подавления подобная беззащитность может доставить американской армии много неожиданностей. Например, истребитель может применить оружие против своих, повинуясь командам извне и не обращая внимания на сидящего в кабине пилота. Единственное, что в этой ситуации может хоть немного утешить авиаторов - бортовая система управления оружием самолета тоже работает из рук вон плохо. Насколько электроника F-35 \"живет собственной жизнью\", демонстрирует работа системы логистики ALIS, которой в докладе посвящен отдельный раздел. Планировалось, что эта система будет собирать информацию о находящихся поблизости F-35 и вызывать их на подмогу в случае необходимости. Также программа должна следить за состоянием самолета, рассылать наземным службам напоминания о сервисном обслуживании и заказывать запчасти. В реальности же ALIS воспринимает все находящиеся на земле самолеты как \"небоеспособные\" и рассчитывать на поддержку пилоту F-35 не приходится. Еще опаснее ситуация на авианосцах, где электроника пропускает вылеты и вступает в пререкания с диспетчерами. Наконец, при заказе запчастей ALIS сообщает, что необходимая деталь \"будет доступна через несколько лет\" и персоналу авиабаз приходится связываться с поставщиками по обычному телефону. Тем временем Германия официально отказалась от F-35. Представитель Бундесвера сообщил, что самолет не будет участвовать в конкурсе на замену стареющему флоту немецких истребителей. Пока лидером тендера является модернизированный Eurofighter Typhoon, однако возможна закупка и американских F/A-18 Super Hornet, пишет Defence News. Американские истребители необходимы ФРГ, поскольку Eurofighter не сертифицирован для применения тактических ядерных бомб, которые Германия обязана иметь на вооружении согласно стратегической доктрине НАТО.',\n",
       " ('F-35',\n",
       "  105,\n",
       "  0): 'Путин: Ситуация для Украины будет ухудшаться Tекст: Антон Антонов «Мы, отвечая на просьбы граждан, проживающих на этой территории, провели референдум. Все это теперь неотъемлемая часть Российской Федерации, – приводит слова Путина ТАСС. – И, как я и говорил, ситуация будет ухудшаться. Она и ухудшилась для них (для Украины). Теперь речь идет не о Донецке и Луганске, а еще о двух субъектах теперь Российской Федерации, и Крыме, конечно». Путин отметил, что Украине «предлагали условия договоренностей в Стамбуле в 2022 году», которые «были гораздо более мягкими, чем сейчас», теперь «ситуация поменялась». «Не будут договариваться – ситуация, может быть, еще изменится в худшую для них сторону. Не надо тянуть. Надо садиться и договариваться», – приводит его слова РИА «Новости». Путин указал, что количество дезертиров на Украине сильно растет, укомплектованность военных подразделений Украины составляет 47%, потери Украины на поле боя превышают уровень мобилизации в стране, молодежь бежит с Украины, чтобы не воевать за киевский режим. Россия готова передать Украине еще около 3 тыс. тел украинских военных, заявил Путин. «Мы отдали больше 6 тыс. тел военнослужащих Украины. Взамен получили 57», – сказал Путин. Как подчеркнул глава российского государства, в рамках международного права и Устава ООН Донецк и Луганск «приняли решение отделиться» от Украины. «Часть территории одной страны приняла решение отделиться от основной части», – сказал Путин. Он указал, что Донецк и Луганск не были обязаны «спрашивать разрешение у центральных властей», поскольку есть «решение Международного суда ООН» по «прецеденту, созданному». «Международный суд ООН прямо записал: «Если какая-то часть страны приняла решение отделиться, она не обязана с этим вопросом обращаться к центральным властям», – напомнил он, отметив, что Запад «сам все своими руками сделал», когда давил на суд. Путин подчеркнул, что иной подход к ДНР и ЛНР неприемлем: «Вам можно, а здесь нельзя, что ли? Так не будет. Правила должны быть едиными, только тогда они будут стабильными. А это гарантия безопасности для всех не за счет других – вот ключевое звено». Он отметил, что Москва восемь лет воздерживалась от признания независимости ДНР и ЛНР, «терпела и пыталась договориться» с Киевом. «Восемь лет мы терпели, понимаете. Но людей-то жалко. Восемь лет там над ними издевались», – сказал Путин. Однако после того, как Киев отверг такую возможность, Москва признала ДНР и ЛНР, заключила с ними договор о взаимопомощи. «Они к нам обратились за этой помощью официально, и мы эту помощь оказывали», – сказал он. Он указал, что кризис отношений между Россией и Западной Европой начался не с Крыма, а с госпереворота на Украине, из-за которого в Европе «никто даже не чихнул», более того – западные страны содействовали госперевороту. Путин напомнил. что Франция, Германия и Польша были «гарантами» договоренностей между оппозицией и прошлыми украинскими властями. На Юго-Востоке Украины «люди не признали этот переворот». А Киев не стал договариваться с населением, решив использовать войска, сказал Путин. Напомним, помощник президента России, глава российской делегации на переговорах с Киевом Владимир Мединский заявил, что Россия выполнила обещания, данные в ходе переговоров в Стамбуле, и передала украинской стороне 6060 тел погибших офицеров и солдат Вооруженных сил Украины. При этом некоторое время Киев отказывался принимать трупы солдат ВСУ.',\n",
       " ('F-35',\n",
       "  106,\n",
       "  0): 'https://ria.ru/20210716/f-35-1741468270.html Американские истребители F-35 столкнулись с проблемой деградации Американские истребители F-35 столкнулись с проблемой деградации - РИА Новости, 16.07.2021 Американские истребители F-35 столкнулись с проблемой деградации Десятки истребителей F-35 находятся в нелетном состоянии из-за вышедших из строя двигателей, об этом сообщает американское издание The Drive. РИА Новости, 16.07.2021 2021-07-16T02:06:00+03:00 2021-07-16T02:06:00+03:00 2021-07-16T11:39:00+03:00 в мире сша f-35 министерство обороны сша военно-морские силы сша ввс сша https://cdnn21.img.ria.ru/images/07e4/05/14/1571733345_0:153:2914:1792_1920x0_80_0_0_9fa9131fe28dabda5b3515eca2d7f996.jpg МОСКВА, 16 июл — РИА Новости. Десятки истребителей F-35 находятся в нелетном состоянии из-за вышедших из строя двигателей, об этом сообщает американское издание The Drive.Генерал-лейтенант ВВС США Эрик Фик, руководящий программой F-35, заявил на слушаниях в конгрессе о проблемах с двигателями у 41 F-35, поставленного для Военно-воздушных сил, двух самолетов, поставленных для Корпуса морской пехоты и ВМС США, а также у трех F-35, находящихся в эксплуатации у американских союзников.По состоянию на май этого года на вооружение ВВС США всего поступило 283 самолета F-35.Как сообщил журналист издания Aviation Week Стив Тримбл, причиной неполадок стало быстрое изнашивание теплозащитного покрытия лопаток ротора турбин силовой установки истребителя. Речь, по его словам, идет о \"неожиданной деградации\" сплава силиката кальция, магния и алюминия.В США неоднократно указывали на большое количество недостатков новейшего истребителя F-35 от корпорации Lokheed Martin. В управлении Пентагона по испытаниям насчитали у самолета почти 900 дефектов, многие из которых могут поставить под удар безопасность пилотов и снизить эффективность военных операций.Счетная палата также докладывала конгрессу о проблемах с истребителями пятого поколения: модернизация F-35 до версии Block IV обойдется бюджету страны еще почти в два миллиарда долларов. Стоимость программы по разработке самолета составила на сегодняшний день почти 400 миллиардов долларов. https://ria.ru/20210301/istrebiteli-1599401601.html https://ria.ru/20210422/turtsiya-1729430647.html сша РИА Новости 1 5 4.7 96 internet-group@rian.ru 7 495 645-6601 ФГУП МИА «Россия сегодня» https://xn--c1acbl2abdlkab1og.xn--p1ai/awards/ 353 60 353 60 2021 РИА Новости 1 5 4.7 96 internet-group@rian.ru 7 495 645-6601 ФГУП МИА «Россия сегодня» https://xn--c1acbl2abdlkab1og.xn--p1ai/awards/ 353 60 353 60 Новости ru-RU https://ria.ru/docs/about/copyright.html https://xn--c1acbl2abdlkab1og.xn--p1ai/ РИА Новости 1 5 4.7 96 internet-group@rian.ru 7 495 645-6601 ФГУП МИА «Россия сегодня» https://xn--c1acbl2abdlkab1og.xn--p1ai/awards/ 353 60 353 60 1920 1080 true 1920 1440 true 1920 1920 true РИА Новости 1 5 4.7 96 internet-group@rian.ru 7 495 645-6601 ФГУП МИА «Россия сегодня» https://xn--c1acbl2abdlkab1og.xn--p1ai/awards/ 353 60 353 60 РИА Новости 1 5 4.7 96 internet-group@rian.ru 7 495 645-6601 ФГУП МИА «Россия сегодня» https://xn--c1acbl2abdlkab1og.xn--p1ai/awards/ 353 60 353 60 в мире, сша, f-35, министерство обороны сша, военно-морские силы сша, ввс сша',\n",
       " ('F-35',\n",
       "  107,\n",
       "  0): 'Inauguration Day, it appears, can\\'t come soon enough for Acting Defense Secretary Christopher Miller. He told reporters Thursday that he \"cannot wait to leave this job,\" according to a transcript released by the Pentagon on Friday. \"Believe me,\" Miller said on his 67th day on the job since President Donald Trump fired Defense Secretary Mark Esper after the election. Read Next: Lawmakers Push to Award Congressional Gold Medal to Capitol Police Hero, Army Vet Miller was speaking to reporters en route to Washington, D.C., where tens of thousands of National Guard members are securing the city ahead of troubling threats in the leadup to President-elect Joe Biden\\'s inauguration -- and after a violent mob overtook the U.S. Capitol last week. Though Miller has been in the acting secretary job for just a couple of months, he has faced several challenging tasks. He has overseen the start of the rollout of the COVID-19 vaccines, troop drawdowns in Iraq and Afghanistan, questions about the response to the Capitol riot, and now a massive activation of National Guard members leading up to the end of his boss\\'s presidential term. In the short conversation with reporters, Miller appeared to break ranks with most military leaders who cite China as the top long-term threat to the U.S. When asked about the biggest Defense Department challenge that needs to be fixed, he said: \"What do I think? I think it\\'s changing our mindset that is focused on. ... Everybody says, \\'Oh, all we\\'ve been focusing on is counter violent extremism, and the Chinese stole a march on us.\\' … Historians will figure that one out. ... I think it\\'s not accurate.\" The Navy\\'s top officer released a new 10-year strategy this week that is largely focused on China. \"China,\" the strategy states, is \"our most pressing long-term strategic threat.\" Miller went on to say that if he had been in the job longer, he would have liked to clean up some of the Defense Department\\'s notoriously slow and complicated acquisition processes. \"Talk about [a] wicked problem,\" he said. He zeroed in on the F-35 Joint Strike Fighter, which the Congressional Research Service describes as the Defense Department\\'s largest weapon procurement program. \"I gotta tell you, yesterday we were talking to some guy, some lieutenant colonel, or colonel. [We] said, \\'What are you flying?\\' [He] said, \\'F-35,\\'\" Miller recalled. \"I was like, \\'That\\'s a piece of ...\\' and he laughed, and I was like, \\'No seriously, tell me about it,\\' and he ... said ...\\'Unbelievable aircraft.\\'\" A defense official who was traveling with Miller said the acting defense secretary did not end the sentence about the F-35 being a \"piece of…\" with any particular word. \"The Secretary often uses casual and humorous language with reporters and personnel during travel,\" the official said. \"That characteristic does not convey well in a written transcript but was obvious to participants.\" Miller\\'s not the first person serving in that role to have negative views about the program. Another one of Trump\\'s acting defense secretaries, Patrick Shanahan, called the F-35 Lightning II program \"f---ed up.\" When Shanahan was investigated in 2019 over allegations that he used his position to promote his former employer, Boeing, when he said that the F-35 aircraft itself is \"awesome,\" but that the program is \"f---ed up.\" There are too many expensive retrofits, he said, and the planes are too often on the ground awaiting those fixes. The F-35 is manufactured by Lockheed Martin, a Boeing competitor. Shanahan was ultimately found not to have promoted Boeing while serving as acting defense secretary. Miller was also asked Thursday what',\n",
       " ('F-35',\n",
       "  107,\n",
       "  1): 'he\\'d learned about Russia\\'s capabilities while serving in the job. He responded by saying he has \"professional respect for how they do things,\" citing the country\\'s irregular warfare capabilities. Top military leaders have, in recent years, called a resurgent Russia one of the top threats to the United States. \"I think they\\'ve played a really bad hand of card[s] very, very well,\" Miller said. \"Declining population, single source of economic revenue through natural resources. I kind of, you know, like professionally, I\\'m like, \\'Wow, they\\'re doing pretty well.\\' And they\\'re using a lot of irregular warfare concepts, information, all this stuff, in a way that, you know, like ... good on them.\" Other U.S. military leaders have also expressed professional appreciation for Russian military capabilities. One of the U.S. Navy\\'s top submarine officers was so impressed with Russia\\'s new Project 885 nuclear attack boats that he had a model of K-329 Severodvinsk built for his office, USNI News reported in 2014. -- Gina Harkins can be reached at gina.harkins@military.com. Follow her on Twitter @ginaaharkins. Related: IG Report: Shanahan Called F-35 Program, Not Plane, \\'F-----d Up\\'',\n",
       " ('F-35',\n",
       "  108,\n",
       "  0): 'WASHINGTON — Even after years of updates and improvements, the F-35’s logistics system continues to be beset by data gaps and bugs that make it more difficult for maintainers to keep the joint strike fighter mission-ready, stated the Pentagon’s chief weapons tester in a new report. The Lockheed Martin-made Autonomic Logistics Information System or ALIS was “designed to bring efficiency to maintenance and flight operations, but it does not yet perform as intended,” wrote Robert Behler, director of operational test and evaluation, in his annual report released Thursday. RELATED In effect, these problems cause the military to ground aircraft that are erroneously described as not mission capable, slow down a squadron’s ability to start flying after being deployed, and create a bigger workload for maintainers. DOT&E stated that most ALIS-related deficiencies fall under three categories. The first is a high number of workarounds needed to use the ALIS system to do mission planning, repairs and supply chain management for the F-35. Functions that should be automatic often require manual input by the maintainer. Secondly, the data provided by ALIS is often incomplete or flat-out incorrect. The reasons for this are varied —contractors do not rely on the system for their own use, and thus do not always input information correctly or in a standardized way. Even the system’s own manufacturer, Lockheed Martin, did not start using ALIS on the F-35′s production floor to track new aircraft until March 2018, the report said. The end result is a poor user experience. Fixing more complicated datasets, such as the technical information that follows a complex piece of machinery like the F-35’s ejection seat, eats up a lot of time. But more importantly, these problems result in missed sorties, with the Air Force naming this problem one of its top five drivers of non-mission capable rates. RELATED And during deployments on ships or in austere locations, this complexity makes it difficult to set up ALIS and begin flying. “Often, the timeframe to start flight operation is longer than that with legacy aircraft,” the report notes. This plays into a third problem: a lack of confidence in ALIS that leads those who work with the system to develop other ways of managing data that ALIS was developed to track. Troubles with the ALIS system have been documented extensively by DOT&E and other sources in previous years. During a May 2018 visit to Marine Corps Air Station Beaufort, S.C., which has some of the lowest mission capable rates across the F-35 enterprise, one maintainer told Defense News that ALIS sometimes reports that certain F-35 parts will take several years to arrive. Then, it’s up to maintainers to make the phone calls needed to see whether that can be expedited. RELATED DOT&E notes that the program office has been making progress on fixing certain shortfalls. However, other issues are not being addressed in a timely manner and typically take an “excessive” period of time to resolve. The report points out that ALIS’ Squadron Health Management application and Customer Maintenance Management System application will sometimes show conflicting information as to whether an aircraft is mission capable. This problem has been known since 2012, but persists despite multiple new software patches being developed since then. In a statement, Lockheed Martin said it is making investments to ALIS that will “enhance data integrity, improve user experience and interface, integrate robotic process automation, lower maintenance labor and dramatically improve speed.” For future version of ALIS, the program office wants to move toward fielding smaller increments of software more often and more rapidly — a decision that DOT&E believes is a',\n",
       " ('F-35',\n",
       "  108,\n",
       "  1): \"step in the right direction. However, the office believes that the program doesn’t test the system in a way that mimics how users operate in on a day-to-day basis, and criticizes ALIS testing as not being standard across the different labs that evaluate it. “A single ALIS test venue would increase test efficiency and support more timely fielding of ALIS software to operational unit,” the report says. “The current, non-operationally representative method of testing ALIS releases leads to delays in finding and fixing deficiencies, often after the new software is fielded.” Aside from ALIS’ many problems, the report highlighted a number of concerns about the F-35 program: Durability testing shows that early versions of the Marine Corps’ F-35B short takeoff and vertical landing jet may last as little as 2,100 flight hours — about a quarter of the expected service life of 8,000 hours. This means that certain B models could end up being retired as early as 2026—only about a decade after the jet was declared initially operational. This issue, first reported by Bloomberg, was also detailed at length by The War Zone. In its statement, Lockheed said it remains confident that the F-35B will meet its 8,000 hour service life requirement by having early models undergo “planned modifications and fleet management.” It added: “Aircraft delivering today incorporate these design changes in the build process to ensure they’ll meet 8,000 hours or more.” This means that certain B models could end up being retired as early as 2026—only about a decade after the jet was declared initially operational. This issue, first reported by Bloomberg, was also detailed at length by The War Zone. In its statement, Lockheed said it remains confident that the F-35B will meet its 8,000 hour service life requirement by having early models undergo “planned modifications and fleet management.” It added: “Aircraft delivering today incorporate these design changes in the build process to ensure they’ll meet 8,000 hours or more.” DOT&E considers the accuracy of the F-35A’s internal gun to be unacceptable and not in line with contract specifications . While software upgrades have enhanced the stability of the gun, no hardware or software changes have been implemented that would improve the accuracy of the gun. Furthermore, department investigations have found that guns are misaligned in various ways, so that the true alignment of the gun cannot be assumed. . While software upgrades have enhanced the stability of the gun, no hardware or software changes have been implemented that would improve the accuracy of the gun. Furthermore, department investigations have found that guns are misaligned in various ways, so that the true alignment of the gun cannot be assumed. Although the program validated that it can create mission data files, which act as the jet’s threat library, DOT&E believes it “lacks adequate equipment” to create new data files rapidly “under stressing conditions,” which could hinder its ability to respond to adversaries during a war. DOT&E also continues to be concerned about the F-35’s modernization program, which is using an agile software development plane called Continuous Capability Development and Delivery or C2D2. The testing office believes the JPO’s plan to refresh the aircraft’s software every six months is a “high risk” strategy, and says that the program office should ensure that as much testing as possible is done in a laboratory setting rather than via flight tests. Valerie Insinna is Defense News' air warfare reporter. She previously worked the Navy/congressional beats for Defense Daily, which followed almost three years as a staff writer for National Defense Magazine. Prior to that, she worked as an editorial assistant for\",\n",
       " ('F-35', 108, 2): 'the Tokyo Shimbun’s Washington bureau.',\n",
       " ('F-35',\n",
       "  109,\n",
       "  0): 'WASHINGTON — An issue that risks damage to the F-35’s tail section if the aircraft needs to maintain supersonic speeds is not worth fixing and will instead be addressed by changing the operating parameters, the F-35 Joint Program Office told Defense News in a statement Friday. The deficiency, first reported by Defense News in 2019, means that at extremely high altitudes, the U.S. Navy’s and Marine Corps’ versions of the F-35 jet can only fly at supersonic speeds for short bursts of time before there is a risk of structural damage and loss of stealth capability. The problem may make it impossible for the Navy’s F-35C to conduct supersonic intercepts. “This issue was closed on December 17, 2019 with no further actions and concurrence from the U.S. services,” the F-35 JPO statement read. “The [deficiency report] was closed under the category of ‘no plan to correct,’ which is used by the F-35 team when the operator value provided by a complete fix does not justify the estimated cost of that fix. RELATED “In this case, the solution would require a lengthy development and flight testing of a material coating that can tolerate the flight environment for unlimited time while satisfying the weight and other requirements of a control surface. Instead, the issue is being addressed procedurally by imposing a time limit on high-speed flight.” The carrier-launched \"C\" variant and the short-takeoff-and-vertical-landing \"B\" version will both be able to carry out all their missions without correcting the deficiency, the JPO said. The potential damage from sustained high speeds would influence not only the F-35’s airframe and the low-observable coating that keeps it stealthy, but also the myriad antennas located on the back of the plane that are currently vulnerable to damage, according to documents exclusively obtained by Defense News. The JPO had classified the issues for the \"B\" and \"C\" models as separate category 1 deficiencies, indicating in one document that the problem presents a challenge to accomplishing one of the key missions of the fighter jet. In this scale, category 1 represents the most serious type of deficiency. While it may seem dire that an aircraft procured for flying at supersonic speeds will be unable to do so for extended periods, the F-35 may not need to do it that often. For the F-35, as opposed to the F-22 where supersonic flight is baked into its tactics, the ability to fly supersonic is more of a “break glass in case of emergency” feature, said Bryan Clark, an analyst with the Hudson Institute and a retired naval officer. “Supersonic flight is not a big feature of the F-35,” Clark said. “It’s capable of it, but when you talk to F-35 pilots, they’ll say they’d fly supersonic in such limited times and cases that — while having the ability is nice because you never know when you are going to need to run away from something very fast — it’s just not a main feature for their tactics.” In fact, going supersonic obviates the main advantages of the F-35, Clark said. “It sort of defeats all the main advantages of the F-35,” he explained. “It takes you out of stealthiness, it burns gas like crazy so you lose the range benefits of a single engine and larger fuel tank. When you go into afterburner, you are heating up the outside of your aircraft.” That creates all kinds of signatures that can be detected by an adversary, Clark said. What if? But a retired naval aviator told Defense News last year that the limitations on the afterburner could prove deadly in close-combat scenarios.',\n",
       " ('F-35',\n",
       "  109,\n",
       "  1): 'The concept of operations for the F-35 is to kill an enemy aircraft before it can detect the fighter jet, but relying on long-range kills is a perspective that, for historical and cultural reasons, naval aviation distrusts. In the Vietnam War, when air warfare began heavily relying on missiles and moved away from the forward gun, it caused a spike in air-to-air combat deaths. An F-35A Lightning II taxis during sunset for a night flying operations at Hill Air Force Base, Utah, Aug. 20, 2019. Night flying is required for pilots to sharpen their combat skills and maintainers work around the clock to prepare jets for flight, inspect them after flight and get them ready for the next flying day. The 388th Fighter Wing is the Air Force’s first combat-coded F-35A wing. (U.S. Air Force photo by R. Nial Bradshaw) The lesson naval aviation took away was to prevent the latest and greatest technology from offsetting the learning of fundamentals, and it was the impetus behind the formation of Top Gun 50 years ago, a naval strike fighter course for training and tactics development. “The solution is: ‘Hey, we’ll just limit the afterburner to less than a minute at a time,’ ” a retired naval aviator said when told of the issue. “Which, with what the aircraft is supposed to do and be capable of, that’s a pretty significant limitation.” Primarily it would be an issue if the aircraft had to maneuver at high speeds to avoid a missile or survive a dogfight. The issue is compounded for the Navy, which must operate forward for months at a time, because any significant issues with coatings or the structure of aircraft would require a depot-level repair. And so a damaged aircraft would remain damaged until its host ship returns to home port, reducing the combat effectiveness of the air wing. “We might have to be operating at sea for eight months, so if you damage something on week one, guess what? It’s damaged for the rest of the deployment,” the aviator said. “And it affects your ability to evade detection by the enemy — you just degraded that asset permanently until you can get it somewhere where it can be fixed, at great expense and time.” Other deficiencies Three other category 1 deficiencies have also been officially designated as “closed,\" meaning they have either been fixed or the performance of the aircraft is being accepted as is, the JPO reported. The so-called green glow deficiency has been closed out as of last July. Green glow refers to a green light emitted by the helmet-mounted display’s LED lights. That glow obstructs a pilot’s view of an aircraft carrier’s deck lights during landing operations at sea in very low light, such as that experienced at night. The issue was closed “as a result of incorporating an improved Organic Light-Emitting Diode (OLED) Helmet Mounted Display (HMD),” the JPO told Defense News. “The Generation III F-35 OLED Helmet Display Unit (HDU) significantly reduced the ‘green glow’ experienced by pilots during night operations. The F-35 JPO has taken delivery of the first order of F-35 OLED HDUs to support the U.S. Navy (USN) and U.S. Marine Corps (USMC), and a second order of OLED HDUs has been placed,” the office’s statement read. An issue created when the F-35A and F-35B blow a tire, which can result in a severed hydraulic line, will remain uncorrected, the JPO statement said, but it has not come up again since the program switched tires. “The DR [deficiency report] was closed under the category of ‘no plan to correct’ based on',\n",
       " ('F-35',\n",
       "  109,\n",
       "  2): \"the fact that the landing gear system design meets all F-35 safety standards,” the statement read. “Issues related to premature bursting of tires were resolved by tire design changes during early F-35 development and no instances of dual hydraulic system loss caused by a tire burst have ever been observed on an F-35.” A U.S. Air Force F-35A Lightning II sits on the flight line during pre-Initial Operational Testing and Evaluation on Jan. 23, 2018, at Eielson Air Force Base, Alaska. All three variants of the F-35 were brought to Eielson to test their ability to operate in an extreme cold-weather environment. (U.S. Air Force photo by Airman 1st Class Isaac Johnson) And an issue that forced the F-35 to land in cold weather because of battery trouble has been fixed, the JPO said. The issue was caused by extreme cold entering the plane when the doors to the jet’s nose landing gear were open, setting off alarm bells, according to “for official use only” documents exclusively obtained by Defense News. The cold would enter the plane and overwhelm the battery heater blanket, which is installed to keep a 28-volt battery running at peak condition. The battery would not shut down, but because of the cold, the blanket could not heat the battery as quickly as intended, triggering warning lights in the cockpit that the battery was going to fail. A software upgrade fixed the problem, the JPO said. “This issue was resolved on July 22, 2019 due to improvements in the battery charger’s firmware,” the statement read. “The firmware changes were developed by the battery charger supplier, and integrated and tested by Lockheed Martin and the F-35 Lightning II Joint Program Office.” David B. Larter was the naval warfare reporter for Defense News. Valerie Insinna is Defense News' air warfare reporter. She previously worked the Navy/congressional beats for Defense Daily, which followed almost three years as a staff writer for National Defense Magazine. Prior to that, she worked as an editorial assistant for the Tokyo Shimbun’s Washington bureau. Aaron Mehta was deputy editor and senior Pentagon correspondent for Defense News, covering policy, strategy and acquisition at the highest levels of the Defense Department and its international partners.\",\n",
       " ('F-35',\n",
       "  11,\n",
       "  0): 'Lockheed Martin these days can’t make F-35 stealth fighters fast enough. While there are many reasons for this increase in demand, the most significant two reasons are simple: Russia and China are both creating tensions all over the world. If you follow U.S. military affairs at all, you have probably heard plenty of criticism about the F-35 Lightning II – namely, that the program is overly expensive and has endured multiple delays over the years. What many of these naysayers may not have considered is that the stealth warplane sells extremely well overseas. It is designed to battle China or Russia in aerial combat, and U.S. allies have ordered the fighter in great numbers to stop incursions into their airspace and to deter their adversaries. Let’s examine in more detail how the F-35 has been such a hit on the export market. Germany Is the Latest F-35 Customer At the end of July, the U.S. State Department approved another giant buy of the F-35A. This time the customer is Germany. The deal is for $8.4 billion to purchase 35 F-35As, among other weapons and equipment. The F-35 can deploy with nuclear weapons, and the Germans believe the stealth fighter is the ideal choice for deterrence and response missions. Germany previously depended on the outdated PA-200 Tornado for nuclear delivery. The Germans had intended to purchase the F/A-18 Super Hornet, but earlier this year opted instead for the F-35A. The Lightning II was seen as a better fit because so many other NATO allies fly it, and Berlin also considered the aircraft a necessary answer to counter Russia. The choice also improves Berlin’s relations with Washington. Germany joins a long list of U.S. allies who are buying or plan to buy the F-35. The numbers are staggering, and they will keep the Lockheed Martin plant in Fort Worth, Texas, busy for years. Plenty of Other Euro Customers On June 30, Greece sent an official request to purchase 20 F-35s. If the initial purchase goes well, the Greeks could buy another squadron of 20 Lightning IIs. Greece will not immediately acquire the F-35. The purchase will wait until 2028, as their air force must first invest to train pilots and maintenance crews. They also need to build infrastructure such as hangars and airstrips, and improve their defense industrial base in order to keep the F-35s flying. On July 20, the Czech Republic said it selected the F-35 for acquisition. The Czech military will start negotiations with the Americans to purchase 24 of the fifth-generation jets. The F-35s will eventually replace the Czech air force’s JAS 39 Gripens with two squadrons of Lightning IIs. When the F-35s take over, by 2027, the Czech Republic will become the 16th nation to import the F-35. Finland is another recent customer. In late May, Finland’s Defense Ministry announced it will buy a whopping 64 F-35s to replace the F/A-18. The airplanes will begin to be delivered in 2026, and they will be fully operational by 2030. Some of the Finnish F-35s will comprise a NATO quick-reaction force, as Finland is a prospective member of the alliance. Meanwhile Switzerland, not known for its military, has a provisional agreement to buy 36 F-35s in a deal worth $6.1 billion. This acquisition has become contentious though. Left-wing Swiss groups do not want Switzerland to close the deal, and they have collected signatures to force a referendum on the buy. Poland, on the other hand, has no reservations about the F-35. The Poles signed a $4.6 billion agreement at the beginning of 2020 for 32 F-35s. The deal includes training',\n",
       " ('F-35',\n",
       "  11,\n",
       "  1): 'and maintenance support, and delivery of the stealth fighters will start in 2024. The jets will supplement Poland’s existing fleet of F-16 C/D Block 52+ fighters and will later replace its aging Sukhoi Su-22s and Mikoyan MiG-29s. Belgium chose the F-35 in 2018, purchasing 34 Lightning IIs. The country will have the airplane operational by 2030. Pilots will train on four simulators in Belgium. Weapons are part of a second contract that will be negotiated this year, and Belgium will build the necessary infrastructure to house the F-35 in the coming years. Not Just Europe In Asia, Japan is easily the best customer of the F-35. The Japan Self-Defense Forces plan to acquire 147 of the warbirds, which it operates to deter North Korea and China. Japanese and U.S. pilots trained with the F-35 during joint exercises this year. South Korea also held joint drills with the United States using the F-35, in July. The drills marked the first time the two countries flew Lightning IIs together. South Korea has 40 F-35s that are becoming fully operational this year. An Expert Told Me Why the F-35 Is Such a Hit I asked John Venable, senior fellow in defense policy at the Heritage Foundation, why the F-35 is so popular overseas. Venable, a former F-16 pilot, said that countries are usually willing to rise above politics and focus on self-defense in dangerous neighborhoods such as Europe and the Indo-Pacific that are threatened by Russia and China. The F-35 is the best way to achieve strategic goals and meet requirements for overall usefulness and value. “Other nations are able to more effectively forgo politics and base their decisions on effectiveness and real costs,” Venable said. “Like many others, Switzerland executed an open competition for its next fighter based on weapons system effectiveness, acquisition, and operating costs.” Countries look at different factors when buying an airplane, and the F-35 checks all the boxes, according to Venable. Take the Swiss case: “Effectiveness was a weighted combination of operational capability (55 percent), ease of maintenance (25 percent), the ability to cooperate with regional partners flying the same jet (10 percent), and direct investments in the Swiss economy (10 percent). The F-35A was an absolute standout, receiving a score of 336 points with the next nearest candidate scoring just 241 points,” Venable explained. The Air Force veteran continued. “While the jet’s effectiveness/technological edge was no surprise, the Swiss also determined that 36 F-35As were $2.16 billion less expensive to acquire,” he said. “They can operate and sustain over the life of the weapons system than a similar number of the best of the other three fighters,” Venable said. The F-35 was designed to overwhelm warplanes and air defenses from China and Russia. Many countries agree that it is the best option for their air forces – Lockheed Martin may have to operate three shifts every 24 hours to meet the immense demand for the airplane. Beijing and Moscow probably never thought the F-35 would become such a dominant fixture in their own backyards. Now serving as 1945s New Defense and National Security Editor, Brent M. Eastwood, PhD, is the author of Humans, Machines, and Data: Future Trends in Warfare. He is an Emerging Threats expert and former U.S. Army Infantry officer.',\n",
       " ('F-35',\n",
       "  12,\n",
       "  0): 'ROME — Italy will stretch out the order of F-35 fighter jets, buying six or seven of the aircraft in the next five years instead of the previously planned 10 jets, a government source told Defense News. The decision follows a review of the program by Italy’s populist government, which took office in June and is mulling defense spending cuts to pay for social welfare programs and cover tax cuts. The source said the plan did not envisage a reduction in orders, merely a slowdown of intake, which would leave the decision of the total F-35 purchase to a future government. Previous governments planned to buy 60 F-35As and 30 F-35Bs for a total of 90 aircraft. The new government will focus on spending plans over its five-year mandate and not beyond, the source said, adding that discussions are underway with the U.S. about the change in schedule. The decision on the slowdown keeps with Italian policy on the F-35 set out by Defence Minister Elisabetta Trenta after she took office in June. “What I would like to do is lighten the load, since we have other spending commitments in Europe. We will try to stretch out deliveries instead of cutting the order, which would reduce offsets and mean penalties,” she told Defense News at the time. Italy has taken delivery of 10 F-35As and one F-35B. Two of the \"A\" models as well as the \"B\" model are being used for training in the U.S., while eight \"A\" models are now based at the Italian Air Force’s base in Amendola, southern Italy. Trenta was tapped for office by the Five Star party, one of two political parties in Italy’s current coalition government. Five Star politicians took a hostile line toward the F-35 program before taking office, at one point promising to scrap it. However, a defense spending document released last month suggests the government will maintain spending on the program in the next two years, with €766 million (U.S. $874 million) due to be spent in 2019 and €783 million in 2020. Those figures should be treated as provisional until the overall budget is signed in Parliament in the coming weeks. RELATED Five Star politicians have also shown hostility toward another U.S. defense program — the ground station planned in Sicily to support the Mobile User Objective System, or MUOS, network, a U.S. Navy-run satellite network providing voice and data communications to U.S. military personnel and platforms around the world, even when they are under thick forest canopies. Long held up by legal challenges in Sicily amid health fears, sources have said the MUOS antenna in Sicily could soon see final approval from the Italian government. Tom Kington is the Italy correspondent for Defense News.',\n",
       " ('F-35',\n",
       "  13,\n",
       "  0): 'The Dutch government has ordered nine more Lockheed Martin F-35A Lightning II fighters, lifting the Royal Netherlands Air Force (RNLAF) plan from 37 to 46 aircraft. State Secretary Barbara Visser told Parliament the purchase slots into the Joint Program Office (JPO) production queue and keeps deliveries on track for 2022-2024. Air-force planners argue the extra jets solve a simple math problem. The Netherlands must police national airspace around the clock, send four fighters on sustained NATO duty, and still train crews. Forty-six aircraft give two full squadrons enough airframes to cover each task without running maintenance or pilot schedules to the breaking point. The order also lays the groundwork for a third squadron once personnel, spares, and simulators catch up. Visser’s letter stresses that the new batch follows the same “turn-key” model as the first 37. Every aircraft arrives with its share of support gear so the fleet grows as a single system rather than a patchwork. The package includes spare Pratt & Whitney F135 engines and line-replaceable modules full-mission and desktop simulators for Leeuwarden and Volkel Autonomic Logistics Information System (ALIS) servers, soon to migrate to the ODIN backbone calibrated torque tools, composite-specific fixtures, and stealth-skin repair kits on-board electronic-warfare sets and classified mission-data files Adding airframes means adding concrete. Leeuwarden already fields operational F-35s but still needs hardened shelters, chilled power supplies, and low-observable wash racks sized for the extra tails. Volkel will build blast-proof bays and a deployable flight-line tent set for expeditionary detachments. Defense Estates Service pegs infrastructure at roughly €85 million and expects hand-over before the first of the new lot lands home. Finance officials priced the aircraft package at €1.016 billion and set aside a €143 million risk reserve for currency swings, block-upgrade inserts, or inflation. The sum fits inside the “National Plan” envelope written into the Spring Memorandum. The government’s cost model assumes the euro stays near the current dollar rate and that Lot 16 production hits schedule. If Technical Refresh 3 slips into Lot 17, the order could shift right by six to twelve months but would still meet the Air Force’s force-structure target date of 2024. Fleet size drives operating cost. Budget planners forecast €43 million in 2023, €93 million in 2024, and €97 million a year from 2025 for the extra nine aircraft. The curve covers fuel, munitions, spares, software licenses, depot back-shop hours, and about 220 new uniformed and contract posts. Defense staff note that spreading fixed expenses – base security, tech manuals, data links – across more hulls lowers the average flight-hour bill compared with the aging F-16AM fleet. Dutch industry stands to gain. As a Tier 2 partner, the Netherlands poured close to $800 million into early F-35 development and now supplies global production. GKN Fokker makes flaperon skins and arrestor-hook mountings; Aeroned fashions titanium hydraulic blocks; Thermo Fisher machines composite frames. Lockheed Martin’s latest supplier scorecard lists five Dutch companies in its top “Elite” tier for on-time, on-quality delivery, and sustainment contracts stretch decades. Strategic context drives urgency. Russian Tu-95 and Su-30 flights skirt the Baltic and North Sea air picture almost weekly, putting Dutch fighters on scramble alert. NATO also asks every northern member to field at least eight fifth-generation jets for Baltic Air Policing, Iceland air defense, or the Very High Readiness Joint Task Force. Forty-six aircraft let the Netherlands meet that pledge while retiring F-16s that first flew in 1979. Only 61 Falcons remain in service, and maintenance officers label parts support “increasingly fragile.” Parliament broadly supports the buy. Christian Democrats and Liberals cite alliance credibility and aerospace jobs; Labour voices concern over',\n",
       " ('F-35',\n",
       "  13,\n",
       "  1): 'life-cycle cost but concedes the F-16 fleet can no longer shoulder NATO’s task list. The Party for Animals alone calls for a pause, arguing that climate funds should outrank jet orders. Visser replies that modern engines burn less fuel for more effect and that fighter pilots cannot police the sky with recycling schemes. Training keeps pace. Student pilots now log fifty hours in high-fidelity simulators at home before crossing the Atlantic to Luke AFB, Arizona, for live flights. The Dutch syllabus meshes with U.S. and Danish courses, letting instructors trade cockpit seats and allowing small air forces to share tail numbers in the jet-hungry early phase. Once the nine extra aircraft arrive, the RNLAF will boost its instructor cadre by one-third and aim for ten new mission-ready pilots each year. Capability jump matters. The F-35’s AN/APG-81 AESA radar, Electro-Optical Distributed Aperture System, and sensor-fusion core give Dutch crews a clear picture even over the Baltic’s cluttered sea clutter. Stealth cuts detect-to-engage ranges, and internal fuel tanks triple loiter time compared with the F-16. The jet also carries the new B-61-12 free-fall nuclear bomb under NATO’s dual-capable aircraft program – an assigned task for the Netherlands since the Cold War. Procurement history shows a long road. The Hague first penciled 85 F-35s into its 2002 Defense White Paper, scaled that to 68 in 2011, and dropped to 37 in 2013 to stay within a €4.5 billion capital cap. Better economic growth and sharper security pressure revived expansion talk in 2018, leading to the current 46-jet plan. Defense economists say the nine-aircraft “delta” costs less than half the per-plane price paid in 2013 thanks to higher production volume and a stronger euro. Acceptance milestones come fast. Three Dutch-built wings join final assembly at Fort Worth in April 2021. First flight for the lead jet is slated for December 2021, followed by U.S. government acceptance in February 2022 and ferry flight to Leeuwarden that spring. All nine should reach Dutch soil by late 2024, slotting straight into Squadron 322 while Squadron 312 at Volkel completes its own conversion from F-16s. NATO partners welcome the news. Belgian officers eye Dutch progress as Belgium builds its own 34-jet fleet. Norway’s 332 Squadron shares software labs with the Dutch centre at Woensdrecht. Italian engineers test-fly Dutch jets at Cameri during final checks, and British No. 617 Squadron routinely trains with Dutch pilots on Link-16 and Multifunction Advanced Data Link nodes. Standard kits and joint tactics shrink planning time for combined packages over the High North or Black Sea. Oversight remains tight. Under the Major Projects procedure, the Defense Ministry must file semi-annual progress notes to Parliament. The next brief, due in March 2020, will show the signed Letter of Offer and Acceptance, the production Lot assignment, and any updated cost baseline once contract currency rates lock. A Defense Audit Service team will track spending, and the Court of Audit holds the right to sample purchase orders down to torque wrenches. Visser sums up the deal in one phrase: “More jets mean more safety, more jobs, and more weight inside NATO.” For Dutch crews used to coaxing forty-year-old Falcons through modern missions, the extra nine Lightnings promise margin – margin to train, to deploy, and to come home on schedule. WHAT’S NEW – March 2025 Update The Royal Netherlands Air Force now fields 40 F-35As and passed 18,000 flight hours in February. The last Dutch F-16 flew to the Boneyard in October 2024, letting the Lightning fleet take every alert scramble, nuclear standby, and overseas rotation. Minister of Defense Ruben Brekelmans used that milestone to unveil a',\n",
       " ('F-35',\n",
       "  13,\n",
       "  2): '€2.4 billion add-on package that includes six further F-35s, ground refuellers, and a secure engine-maintenance bay at Volkel. Parliament approved the plan in September 2024, pushing the programme of record to 52 aircraft. Lockheed Martin and the JPO signed the Letter of Offer on 12 February 2025. The six airframes join Lot 20, carry the Block 4 software core, and will reach Dutch soil in 2028-2029. Their arrival triggers the rebirth of 313 Squadron, mothballed since 2012, at Leeuwarden. Command will keep two aircraft on NATO nuclear duty, six available for quick-reaction alert, and eight free for training or deployment – flexibility not seen since the early F-16 era. Dutch F-35s flew Baltic Air Policing out of Šiauliai, Lithuania, from September to December 2024. Crews intercepted Russian Su-30SM fighters three times, sharing track files with Spanish Eurofighters and Lithuanian control sites. In January 2025, two Dutch jets used the Keystone gateway to pass target coordinates to an Israeli-built PULS rocket battery during Exercise Allied Storm in Germany, marking the Netherlands’ first cross-domain live-fire with fifth-generation airborne sensors and ground launchers. Infrastructure keeps pace. Volkel broke ground on a NATO-funded hardened shelter complex and a secure engine test cell in November. The Defense Estates Service says both projects will finish by mid-2026. At Woensdrecht, GKN Fokker opened a wing-panel overhaul line for Dutch, Danish, and Belgian fleets, making the Netherlands the Benelux hub for heavy F-35 maintenance. Industrial wins extend beyond airframes. Dutch suppliers now cut cockpit pressure vessels, machine lift-fan clutch actuators, and cast titanium main-gear lugs. Lockheed Martin’s 2024 supplier-performance list again places five Dutch firms in its top tier for on-time delivery. Aircrews push tactics. During a February media day, pilots showed how passive AESA modes let them guide RAF Typhoons onto targets without lighting their own radars. Air Commodore Stephan de Kraaf called the sensor fusion “a force multiplier that lets a small nation punch above weight while staying inside NATO playbooks.” Looking forward, the Defense White Paper due in June will weigh a fourth squadron once spare-parts flow improves and sustainment costs stabilise. Brekelmans hints the option stays alive if security pressures keep rising. Any move would depend on the 2026 budget cycle and progress on multinational spare-engine pooling. For now, the nine aircraft ordered in 2019 fly front-line missions, the six authorised in 2024 are on order, and every Dutch F-16 sits in a museum, target range, or outbound shipment to Ukraine. The stealth era is no longer Dutch ambition; it is Dutch routine. REFERENCE SOURCES',\n",
       " ('F-35',\n",
       "  14,\n",
       "  0): 'WASHINGTON — South Korea has grounded its fleet of F-35As after one of the aircraft had to conduct an emergency belly landing Tuesday. Yonhap News Agency in Seoul reported that the F-35 was taking part in a training flight when it experienced issues with its avionics system. It was forced to land on its belly at Seosan Air Base south of Seoul when those problems caused the fighter’s landing gear to malfunction, Yonhap reported, citing officials there. The pilot was unharmed, Yonhap reported. A fire engine had sprayed a special foam on the runway to keep the jet from sustaining serious damage during the skid. South Korea’s air force plans to conduct a joint investigation with the U.S. military, Yonhap reported, and grounded its F-35A fighters in the meantime. South Korea plans to buy 40 F-35As in total, and has so far received more than 30 of them. Lockheed Martin, which builds the F-35 Lightning II, said in a statement to Defense News it is “aware of the emergency landing that occurred Tuesday at Seosan Air Base and stand[s] ready to support the Republic of Korea Air Force.” The company referred further questions to South Korea. This is apparently the first time an F-35 has conducted a belly landing, Yonhap reported. Stephen Losey is the air warfare reporter for Defense News. He previously covered leadership and personnel issues at Air Force Times, and the Pentagon, special operations and air warfare at Military.com. He has traveled to the Middle East to cover U.S. Air Force operations.',\n",
       " ('F-35',\n",
       "  15,\n",
       "  0): 'Singapore’s first upgraded Lockheed Martin F-16 fighter has entered service following delivery of the aircraft in June last year, its air force chief has revealed. Chief of the Air Force Major General Kelvin Khong discloses that the fourth-generation F-16C/Ds, which are being upgraded to the V-model standard, are to be operated “for at least another decade”. “Subsequent deliveries will be rolled out progressively to ensure that the RSAF [Republic of Singapore Air Force] continues to have a capable fleet of fighter aircraft to meet our defence requirements,” he said, responding to a series of written questions from journalists. The service continues to eye the fighters’ eventual replacement, Khong adds. Meanwhile, the RSAF is gearing up to receive its first of four Lockheed F-35Bs in 2026. Those aircraft will be based in the USA for training, says Khong, where the service “will test the aircraft’s advanced capabilities, including its short take-off and vertical landing capability, and determine the integration requirements with the rest of the SAF’s warfighting systems. “We have stringent and rigorous evaluation processes in place and have been following the developments of the F-35 closely. We will ensure that the F-35B meets our requirements before inducting them for operations.” Ebbing Air National Guard Base in Arkansas has been selected to host the RSAF’s F-35 and F-16 fighter training detachment – relocating from Luke AFB in Arizona – pending the outcome of an environmental impact assessment. Co-location of the two aircraft types will “maximise opportunities for integrated training between our fourth- and fifth-generation fighter aircraft”, he says. In addition, the RSAF continues to evaluate the potential for an upgrade to its 40-strong Boeing F-15SG fleet. “These fighter jets have served us well since we first took delivery in 2009 and remain a crucial component of our fighter fleet in the next-generation air force,” Khong adds. Having achieved full operating capability with its six Airbus Defence & Space A330 multi-role tanker transport (MRTT) aircraft in April 2021, the air force continues to enhance the platform. It is working with the airframer on the so-called “Smart A330 MRTT” programme to deliver an automatic air-to-air refuelling (AAR) capability, alongside enhanced maintenance solutions for the jet. “The automated refuelling will reduce air refuelling operator workload, improve safety and optimise AAR in operational conditions. Trials are ongoing and progressing well,” says Khong, who describes the twinjet as a “versatile and valuable asset” for the RSAF. With maritime patrol an increasingly pressing issue for all nations in the region, the RSAF is working in tandem with the country’s navy to evaluate the “air capabilities necessary to meet requirements in the maritime domain”. Its fleet of five Fokker 50 maritime patrol aircraft underwent a life-extension programme in 2017 to address obsolescence issues, but a further upgrade could be required, says Khong. “We will continue to operate the Fokker 50 but will upgrade or acquire new systems if required to ensure we remain operationally capable and effective.” Khong, meanwhile, says the service continues to evolve to meet future challenges. “We are faced with a wide spectrum of conventional and unconventional threats and can expect future air combat to evolve. “Looking ahead, we will develop the RSAF in dynamic and multi-faceted ways – continue to invest in conventional air combat capabilities while building capabilities to handle emerging threats.”',\n",
       " ('F-35',\n",
       "  16,\n",
       "  0): 'Министерство обороны Дании после нескольких лет переговоров с Пентагоном решило отказаться от покупки американского перспективного истребителя пятого поколения F-35 Lightning II, сообщает The Copenhagen Post. Поводом для отказа стал рост стоимости истребителя по сравнению с ценой, заявленной в начале реализации проекта. Переговоры о покупке между министерствами обороны Дании и США начались в 1999 году. Тогда заявленная стоимость одного самолета была определена на уровне 275 миллионов датских крон (50,8 миллиона долларов). Сейчас она выросла до 540 миллионов крон. Военное ведомство Дании планировало заменить F-35 устаревшие истребители F-16 Fighting Falcon. Изначально предполагалось, что первые серийные самолеты F-35 будут выпущены в 2012 году, однако позже этот срок был передвинут на 2016 год. Сейчас Министерство обороны Дании рассматривает возможность закупки американских истребителей F/A-18E/F Super Hornet вместо F-35. Как ожидается, окончательное решение о покупке истребителей парламент Дании примет в 2012 году, когда придет срок списания F-16. Если решение о покупке F/A-18E/F будет принято, Дания станет второй страной после Австралии, решившей купить такие самолеты для замены устаревших истребителей. Австралия будет использовать F/A-18E/F в качестве \"переходного звена\" между устаревшими F-111 и новыми F-35. 12 марта 2010 года стало известно, что стоимость F-35 выросла почти вдвое по сравнению с изначальной сметой 2001 года. При этом общая стоимость программы создания истребителя увеличилась по меньшей мере на 50 процентов. Согласно последнему прогнозу Пентагона, стоимость одного F-35 составит 95-113 миллионов долларов. В 2001 году стоимость самолета была определена на уровне 50,2 миллиона долларов.',\n",
       " ('F-35',\n",
       "  17,\n",
       "  0): \"WASHINGTON — Belgium has officially selected the F-35 as its next-generation fighter, becoming the 13th country to join the program, the Belgian government announced Thursday. With that decision, Lockheed Martin has defeated a bid by the governments of Spain, Italy, Germany and the United Kingdom for the Eurofighter Typhoon, as well as an informal offer by France for the Dassault Rafale and an option for Belgium to upgrade its existing F-16s. Belgium plans to buy 34 F-35As to replace F-16 inventory, which numbers about 54 jets. The U.S. State Department has already approved the deal, which has an estimated value of $6.5 billion. RELATED According to Reuters, Belgian Defence Minister Steven Vandeput told reporters on Oct. 25 that the F-35 beat the other contenders in all seven selection criteria. “We are investing heavily in defense,” Vandeput tweeted, citing Belgium’s decision to buy F-35s and new land vehicles. Meanwhile, U.S. stakeholders immediately began celebrating the outcome of the competition. “Lockheed Martin is honored by the Belgian government’s selection of the F-35A Lightning II for their future national security needs,” the company said in a statement. “We look forward to supporting the U.S. government in delivering the F-35 program to meet the requirements of the Belgian government.” Vice Adm. Mat Winter, head of the the F-35 joint program executive office, said the decision to join the program will strengthen the U.S.-Belgian relationship. “We look forward to working closely with our Belgian teammates as they mature plans for purchasing their F-35s,” he said in a statement. The U.S. Embassy in Brussels tweeted a response to Vandeput, stressing how Belgium’s F-35 selection would add to NATO interoperability. “Belgium will fly @thef35 alongside some of its closest @NATO allies & longtime partners in air defense. US is extremely proud of our enduring air partnership w/ Belgium,” it said. U.S. Rep. Mike Turner, R-Ohio, who chairs the House Armed Services Committee’s Tactical Air and Land Forces Subcommittee, said Belgium’s F-35 buy “reaffirms Belgium’s military and strategic partnership with the United States, as well as builds Belgium’s defense capabilities as a strong NATO ally.” Turner had interfaced with Belgian officials over the past year, providing assurances that the U.S. Congress would support an F-35 sale to Brussels, he said in a statement. Valerie Insinna is Defense News' air warfare reporter. She previously worked the Navy/congressional beats for Defense Daily, which followed almost three years as a staff writer for National Defense Magazine. Prior to that, she worked as an editorial assistant for the Tokyo Shimbun’s Washington bureau.\",\n",
       " ('F-35',\n",
       "  18,\n",
       "  0): 'Washington CNN — President Donald Trump says Turkey will be banned from purchasing American F-35 fighter jets after it acquired a Russian air defense system, but made no mention of sanctions that the US is legally required to impose in response, worrying lawmakers on both sides of the aisle. Trump misrepresented the developments that led Turkey to purchase the Russian system, blaming the Obama administration for the situation and sympathizing with President Recep Tayyip Erdogan for the “very tough situation that they’ve been forced in.” “Because they have a system of missiles that’s made in Russia, they’re now prohibited from buying over 100 planes,” Trump said of Turkey during in a Cabinet meeting. “I would say that (F-35 manufacturer) Lockheed isn’t exactly happy. That’s a lot of jobs. And frankly I’ve always had a very good relationship” with Erdogan, Trump added. In the tussle with Turkey over the Russian air defense system, a thorny mix of diplomatic and technological challenges are intersecting with the President’s affinity for strongmen leaders and his tendency to execute international diplomacy based on his personal relationships. Presidential delays The result, said analysts and former officials, is that after months of Trump administration vows that Turkey will face sanctions for the Russian purchase – which creates a threat to US national security and undermines the North Atlantic Treaty Organization – those punitive measures are being put off by the President himself. “The President is the clear cause of the delay,” said John Hannah, a senior counselor at the Foundation for Defense of Democracies. “He doesn’t want to pull the trigger on sanctions and torpedoing Turkey’s purchase of the F-35 fighter jets. In the first place, he’s got an unfortunate affinity for Erdogan.” Hannah noted that at the June G-20 meeting in Japan, Trump undermined US policymakers when asked about the S400 purchase. “Instead of reading Erdogan the riot act in a last-ditch effort to warn him off the S-400 deal, the President accepted hook, line and sinker Erdogan’s ridiculous claim that it was all President Obama’s fault, and that Turkey was somehow justified in alienating NATO and cozying up to (Russian President Vladimir) Putin,” Hannah said. Behind the scenes, administration officials including Secretary of State Michael Pompeo and national security adviser John Bolton were pushing to move forward with sanctions, but Trump has been dragging his feet to preserve some sort of a relationship with Erdogan, according to a source familiar with internal deliberations at the NSC and State Department. On the Hill, where there is solid bipartisan support for action against Turkey, Republican lawmakers quietly phoned the President to push him to sanction Ankara. On Friday, a Pentagon briefing on Turkey’s purchase was scheduled and canceled, the ceremonial podium set up and then taken down. As reporters waited for briefing Monday, congressional aides were told that Trump was meeting with State and Pentagon officials in the Oval Office to discuss options on Turkey. Monday’s briefing was then canceled. “It suggests he sent them back to the drawing board and doesn’t want to sanction them – which is a huge problem for us, all of us,” one Senate aide said. Percolating distrust The tussle over the Russian air defense system reflects a relationship that has frayed over the past few years as Ankara has increasingly come to see Washington as an unreliable, and in some cases, antagonistic actor. The US invasion of Iraq allowed the Turks’ existential rivals the Kurds to establish some autonomy. The US then started training and working with Kurds in an attempt to defeat Syria’s Bashar al-Assad. Washington has subsequently refused to',\n",
       " ('F-35',\n",
       "  18,\n",
       "  1): 'extradite the cleric that Erdogan blames for plotting a 2016 coup against him – one in which he sees the US as complicit. That percolating distrust erupted when the US asked Turkey not to buy the Russian system and Erdogan flatly refused. Instead, the increasingly authoritarian Turkish leader marked the anniversary of the failed coup attempt on Monday by accepting plane loads of S-400 components. Speaking at the White House on Tuesday, Trump laid the blame for that purchase at the feet of the previous administration, saying it had refused to sell Turkey US-made Patriot missiles. That isn’t accurate, analysts and officials involved in that sale said. The US has worked to sell Turkey a Patriot missile system since 2013, but Washington had balked at Turkey’s technology transfer demands. Trump’s pick for secretary of defense Mark Esper said Tuesday that Turkey has “been a long standing and very capable NATO ally, but their decision on the S-400 is the wrong one and it’s disappointing.” The S-400 poses a real threat to US national security, analysts said. The Russian system is built to defeat US stealth technology, leading officials in Washington to worry that if Turkey took delivery of F35s, the Russian system could be used to collect valuable information about the fifth-generation fighter jet. Trump said the decision to ban F-35 sales was one he was making reluctantly. “We are now telling Turkey that because you have really been forced to buy another missile system, we’re not going to sell you the F-35 fighter jets,” the President said. “It’s a very tough situation that they’re in and it’s a very tough situation that we’ve been placed in, the United States. With all of that being said, we’re working through it, we’ll see what happens. But it’s not really fair.” “Because of the fact he bought a Russian missile, we’re not allowed to sell him billions of dollars worth of aircraft. It’s not a fair situation,” Trump continued. ‘Clueless’ or ‘manipulated’ James Townsend, a former deputy assistant secretary of defense for Europe and NATO, now with Center for a New American Security, who was involved in negotiations with Turkey about the Patriot system, said Trump’s comments were “clueless.” “Either his staff doesn’t know or they’re afraid to tell him,” Townsend said, or the President is being “manipulated” by Erdogan. Townsend noted that despite Trump’s regret about the F35s, Lockheed probably would not want to sell the jets if there was a risk it would compromise their technology. Even though Turkey belonged to the international consortium that funded the F-35’s development, lawmakers and administration officials felt the risks were too high to allow the purchase. They warned repeatedly that Turkey would face punitive measures if it went ahead with the S-400s. ‘We will raise hell’ But Trump didn’t raise the prospect of new sanctions on Monday, even though the first shipment of the Russian-made S-400 air defense missile system landed in Ankara last week. The law that requires the administration to sanction Turkey calls for the executive branch to act first and it leaves little to no room for Trump to grant Turkey a waiver, analysts said. One Republican aide said the President could find some wiggle room in the fact that it will take months before the S400 deliveries are complete. But even Republicans say they aren’t sure what the White House is thinking. “We are trying to figure out what is going on,” the aide said. This source said members of Congress, waiting to see some action, are increasingly concerned by the delay. “If they break the law, we will',\n",
       " ('F-35', 18, 2): 'raise hell. The law is the law,” the Republican aide said.',\n",
       " ('F-35',\n",
       "  19,\n",
       "  0): 'Расходы на создание американского истребителя Lockheed Martin F-35 Lightning II за последние девять лет составили 56,1 миллиарда долларов, говорится в отчете Главного контрольного управления (GAO) США. Эта сумма была потрачена как на проведение научно-исследовательских и опытно-конструкторских работ, так и на покупку первых прототипов самолета для испытаний. При этом, по оценке управления, в целом непосредственно разработка самолета обойдется в 56,4 миллиарда долларов, а программа будет завершена в 2018 году с опозданием на пять лет к изначально намеченному графику. При этом программа создания F-35 уже нарушила статут Нанна-Маккерди, обязывающий министерство обороны США закрыть любой военный проект, стоимость разработки которого выросла более чем на 25 процентов по сравнению с изначальной сметой. По оценке GAO, общая стоимость программы создания F-35 подорожала на 26 процентов. Слушания относительно закрытия программы в Конгрессе состоялись в 2010 году, и министру обороны США Роберту Гейтсу удалось отстоять проект. При этом программе F-35B, самолета с укороченным взлетом и вертикальной посадкой, было дано два года на устранение ошибок, иначе проект будет закрыт. Кроме того, по данным GAO, примерно половина поставленных на 2010 год задач относительно создания F-35 не была выполнена. В числе выполненных задач: 400 испытательных полетов, первая вертикальная посадка, первый полет палубной версии F-35, подготовка 125 человек наземного обслуживающего персонала, а также заключение контракта на поставку четвертой партии самолетов мелкосерийного производства (LRIP 4). Некоторые из планов были перевыполнены. В частности, прототипы истребителей совершили в общей сложности 410 испытательных полетов, а Lockheed Martin подготовила 138 человек обслуживающего персонала. В числе невыполненных задач: поставка 11 истребителей испытателям (поставлено восемь), выполнение в среднем 12 полетов в месяц каждым прототипом F-35 (в среднем восемь полетов), поставка трех самолетов на базу ВВС США Эглин (ни одного не поставлено) и заключение контракта на покупку двигателей четвертой партии серийного производства. Наконец, конечная стоимость истребителей для ВВС, ВМС и Морской пехоты США окажется выше изначально запланированной. В частности, в 2016 году стоимость одного F-35A для ВВС США в 2016 году составит 121,4 миллиона долларов за штуку, F-35B для Морской пехоты - 161 миллион долларов, а F-35C для ВМС - 145 миллионов долларов. Стоимость самолетов, по которой военные будут их покупать, превысит изначальную оценку практически вдвое.',\n",
       " ('F-35',\n",
       "  2,\n",
       "  0): 'Story highlights Trials aboard a Navy warship in May did not prove the F-35B is ready for combat, a Pentagon report says The F-35B Lightning II is designed to replace several existing Marine Corps aircraft Marines say the May testing verified several F-35B capabilities CNN — After nearly 15 years of schedule delays and highly criticized cost increases, U.S. military officials and defense contractors confidently proclaimed the much maligned Joint Strike Fighter program back on track when the Marine Corps declared its version of the F-35 fighter jet combat-ready last month. However, the fifth generation stealth fighter jet may still have a number of maintenance and reliability problems that “are likely to present significant near-term challenges for the Marine Corps,” according to a complete copy of a recent memo from the Pentagon’s Director of Operational Test and Evaluation (DOT&E), released in a report by the nonpartisan government watchdog group Project on Government Oversight (POGO). While military officials promoted the F-35’s performance during Marine Corps operational test trials aboard the amphibious assault ship USS Wasp in May as a success and proof that the $400 billion fighter is ready for real-world combat deployment, the POGO report tells a very different story. Sailors and distinguished visitors watch an F-35B Lightning II aircraft conduct vertical takeoff and landing flight operations aboard the amphibious assault ship USS Wasp in May 2015. Click through the gallery to see more images from the testing. Chief Petty Officer William Tonacchio/U.S. Navy Two F-35B Lightning II fighters complete vertical landings aboard the amphibious assault ship USS Wasp during the opening day of the first session of operational testing in May 2015. As the future of Marine Corps aviation, the F-35B is designed to eventually replace all aircraft from three legacy Marine Corps platforms; the AV-8B Harrier, the F/A-18 Hornet, and the EA-6B Prowler. Lance Cpl. Remington Hall/USMC An F-35 B Lightning II fighter lands on the flight deck of the amphibious assault ship USS Wasp during short take-off, vertical landing operations in May. A new Pentagon report says the testing did not adequately reflect conditions the aircraft would face in real operations. Lance Cpl. Remington Hall/USMC Marines and sailors aboard the amphibious assault ship USS Wasp secure and refuel an F-35B Lightning II fighter after its arrival for the first session of operational testing. Lance Cpl. Remington Hall/USMC Vice Adm. William Hilrides, commander of Naval Sea Systems Command, holds up two fingers to indicate to the F-35B Lightning II pilot to power up for takeoff aboard the amphibious assault ship the amphibious assault ship USS Wasp in May. Chief Petty Officer William Tonacchio/U.S. Navy An F-35B Lightning II takes off from the flight deck of the amphibious assault ship USS Wasp during test operations in May. Spc. Rawad Madanat/U.S. Navy Sailors and Marines remove a generator for the F-35B Lightning II aircraft from an MV-22 Osprey assault support aircraft aboard the amphibious assault ship USS Wasp during operational testing in May. A new Pentagon report says the testing highlighted maintenance challenges for the F-35. Spc. Elizabeth Vlahos/U.S. Navy F-35 testing Prev Next Not only did the six F-35Bs used in the demonstration, referred to by the Marines as Operational Test 1, fail to achieve the number of required flight hours necessary to be declared combat-ready, but, in fact, the DOT&E found the trials, “did not – and could not —demonstrate that Block 2B F-35B is operationally effective or suitable for use in any type of limited combat operation, or that it was ready for real-world operational deployments, given the way the event was structured,” the report says. To',\n",
       " ('F-35',\n",
       "  2,\n",
       "  1): 'qualify as a true operational test with results that would allow the Department of Defense to determine whether or not the F-35B is operationally effective and ready to be deployed, testing would have to be conducted under conditions more representative of real-world operations, the report says. Highlighting artificial advantages present during the USS Wasp trials, such as a relatively empty flight-deck, “non-operationally representative (supply system)workarounds” to support the aircraft’s unreliable logistics system and “significant assistance from embarked contractor personnel” to help with maintenance, the report concludes that the flight tests aboard the Navy ship failed to simulate the realistic combat conditions necessary to show whether or not the F-35B is ready for actual deployment. “This report indicates exactly what some of us have been warning about all along,” said Rep. Jackie Speier, D-California, a member of the House Armed Services Committee, and a consistent critic of the F-35 program. “The services are rushing to declare the F-35 ready for combat, ignoring clear readiness issues in order to show that the program is ‘back on track,’ but just saying something doesn’t make it so. The jets currently can’t perform many missions in the real world because of mistakes made throughout the development and procurement process,” she said. While the event aboard the USS Wasp did not qualify as a true operational test in the eyes of the DOT&E, the report says the trials did serve as a useful training opportunity for the Marines assigned to F-35B units and highlighted a number of issues, particularly with the aircraft’s integration with existing ships and maintenance challenges, that were important to identify before its first deployment. Squad of F-35 fighters cleared for combat duty The Marine Corps said it does not agree with all of the conclusions and opinions outlined by the DOT&E in the POGO report, due to what it called a lack of context and qualifying information, according to a statement provided to CNN. “During OT-1, we wanted to prove that non-test F-35B aircraft could be operated and sustained aboard an L-class ship,” the Marine Corps said in a statement. “We successfully did that. The two weeks of operational testing assessed the aircraft’s integration with the U.S. Navy ship and crew, operating a wide array of flight and deck operations.” The Marine Cops also said that the extensive testing done verified expected F-35B capabilities: successful missile shots; successful steel-on-steel, air-to-ground deliveries; and three successful sea-trials. “At IOC, the F-35B targeted in real time, talked to forward air controllers over the radio and data-link, and put weapons on target. The F-35B can provide close air support in threat environments where our current platforms would not survive, and the synthetic aperture radar gives us a through-the-weather targeting capability where the majority of our legacy targeting systems are simply ineffective,” the Marine Corps said. Despite the fact that the observations outlined by the DOT&E within the POGO report contradict those made by defense contractors and military officials last month, the Marine Corps says F-35B’s ability to carry more fuel than the legacy fighters currently in use and weapon payload, coupled with the completion of the installation of Block 3F software on all Marine Corps F-35Bs in the 2017 time frame, means the jet will surpass anything the U.S. has in its arsenal today. “Data collected and lessons learned during OT-1 will lay the groundwork for F-35B deployments aboard U.S. Navy amphibious carriers now that the U.S. Marine Corps’ F-35B Lightning II aircraft reached initial operational capability (IOC) on July 31, 2015,” the Marine Corps said. F-35: Is world’s most expensive weapons program worth the cost?',\n",
       " ('F-35',\n",
       "  20,\n",
       "  0): 'Руководитель проекта перспективного истребителя F-35A Lightning II генерал-лейтенант ВВС США Кристофер Богдан (Christopher Bogdan), выступая в парламенте Нидерландов, назвал стоимость одного летного часа боевого самолета. По его словам, как сообщает Defense News, стоимость часа полета F-35A (версия самолета с обычными взлетом и посадкой) составляет всего 24 тысячи долларов, что лишь на десять процентов больше аналогичного показателя истребителя F-16 Fighting Falcon. По словам Богдана, оценку стоимости летного часа F-35A дали ВВС США совместно с Управлением эксплуатационных испытаний и оценки (DOTE) Пентагона. Стоимость одного часа полета перспективного истребителя является приблизительной; более точные данные будут обнародованы в мае 2013 года в отчете о выборочных закупках F-35A, произведенных в 2012 году. ВВС Нидерландов намерены закупить 85 истребителей Lightning II на замену устаревшим F-16, однако ранее заявили о возможности сократить объем покупки из-за растущей стоимости самолета. США намерены производить истребители F-35 в трех версиях. Помимо обычной F-35A, также будут выпускаться версии B (укороченный взлет и вертикальная посадка) и C (палубная). Стоимость программы разработки и закупки самолетов для ВВС, Морской пехоты и ВМС США (всего 2,4 тысячи F-35) оценивается более чем в 380 миллиардов долларов. С учетом иностранных заказов общее количество запланированных к производству самолетов составляет 3,1 тысячи единиц. Перспективные самолеты намерены купить Великобритания, Италия, Нидерланды, Австралия, Канада, Дания, Норвегия, Турция, Израиль и Сингапур. Самым дорогостоящим в мире серийным истребителем в настоящее время считается F-22 Raptor, производство которого завершилось в 2012 году. По оценке Главного контрольного управления США, стоимость последних серийных экземпляров самолета превысила 400 миллионов долларов за штуку (стоимость одного F-35A сегодня оценивается в 200 миллионов долларов). В 2009 году газета The Washington Post со ссылкой на исследование Пентагона писала, что стоимость летного часа F-22 составляет 44 тысячи долларов. Позднее на слушаниях в Сенате представили военного ведомства объявили, что стоимость часа полета Raptor не превышает 20 тысяч долларов.',\n",
       " ('F-35',\n",
       "  21,\n",
       "  0): 'Италия решила отказаться от покупки американских истребителей пятого поколения F-35. Такое заявление сделала глава оборонного ведомства страны Элизабетта Трента. Рим считается важным партнёром Соединённых Штатов в программе по разработке и производству самолёта. Однако нынешние власти страны эту позицию намерены пересмотреть. Ранее готовность отказаться от этих истребителей выразила и Турция, которая также принимала участие в разработке F-35. Эксперты не исключают, что такие заявления могут говорить об ухудшении отношений между США и их союзниками по НАТО. © Getty Images Рим принял решение отказаться от дальнейших закупок американских истребителей F-35. Такое заявление сделала новый министр обороны Италии Элизабетта Трента, член партии евроскептиков «Движение 5 звёзд». По её словам, власти также намерены более детально разобраться с пунктами контракта 2012 года на поставку 90 американских самолётов. >> Россия проводит испытания \"летающего радара\" По этим договорённостям, предполагается поставка 60 истребителей F-35A и 30 машин F-35B общей стоимостью в 14 млрд евро. «Мы больше не будем закупать F-35», — сказала она в интервью телеканалу La7. Как подчеркнула итальянский министр, отказ от покупки 90 истребителей F-35 может привести к штрафным санкциям со стороны Соединённых Штатов, которые в свою очередь могут негативно сказаться на итальянском бюджете. «Мы (правительство Италии. — RT) проводим тщательную оценку, учитывающую только национальные интересы», — отметила Трента. Отметим, что итальянский завод по производству F-35 в Новаре — единственный за пределами Соединённых Штатов, где выпускают эти истребители. В мае 2017 года в Италии выпустили первый из 119 истребителей, который впоследствии был отправлен в Мэриленд, США, для сертификации и обучения персонала. «Вторая неприятность» Италия — не первое государство, решившее пересмотреть свою позицию касательно новейших американских истребителей. Ранее власти Турции не раз подчёркивали, что Анкара вправе покупать не только американские F-35, но и российские зенитно-ракетные комплексы (ЗРК) С-400, на что Вашингтон пригрозил не только отказом от поставок истребителей, но и экономическими санкциями. Глава МИД Турции Мевлют Чавушоглу в свою очередь подчёркивал, что приобретение Анкарой ЗРК С-400 — «вопрос закрытый». При этом в конце мая 2018 года в конгрессе США был принят законопроект по военному бюджету, согласно которому, в частности, предусматривается ограничение поставок вооружения турецкой стороне. Премьер-министр Турции, Бинали Йылдырым, комментируя принятие документа, заявлял, что в случае, если США откажутся поставлять самолёты F-35, «Турция не останется без альтернативы». В целом, заявление итальянского министра говорит об «очень серьёзной трещине» между странами НАТО по вопросу данного истребителя, считает военный обозреватель «Комсомольской правды», полковник в отставке Виктор Баранец. «Эту трещину нельзя рассматривать в отрыве от другой – турецкой. Анкара некоторое время назад заявила, что она может тоже отказаться от закупок F-35. А Турция намеревалась закупить их аж 100 штук », — сказал он в беседе с RT. Более того, по его мнению, на фоне заявлений о поиске альтернативных вариантов и даже о рассмотрении российского истребителя пятого поколения Су-57, можно говорить об «очень серьёзных проблемах» в вопросе отношений США с союзниками Североатлантическому альянсу. «Это заявление итальянского министра обороны уже наделало немало паники в кабинетах и Белого дома, и Пентагона. Представляю, как дымятся сейчас телефоны, линии связи между Пентагоном и министерством обороны Италии. Это вторая серьёзная неприятность, которая возникла в последнее время в американо-турецких и американо-итальянских отношениях», — считает эксперт. «Трамп давит на страны ЕС с тем, чтобы те из них, кто состоит в НАТО увеличили траты на оборону до 2%. Это связано со стремлением Вашингтона окупить расходы на разработку и производство военной техники», — считает член-корреспондент Академии военных наук политолог Сергей Судаков. «Если Трамп прежде всего заботится о том, чтобы обеспечить свою страну новыми заказами и новыми деньгами, то европейцы и турки не хотят спонсировать американское производство. Если мы говорим, что у США сейчас начинаются отказы от лётной техники — Турция, Италия — то я не исключаю, что многие крупнейшие страны также будут',\n",
       " ('F-35',\n",
       "  21,\n",
       "  1): 'отказываться», — выразил он мнение в беседе с RT. При этом он считает, что данное решение приведёт к замешательству в Белом доме — прежде всего потому что речь идёт о больших объёмах заказов. «Это огромнейшие деньги, миллиарды долларов. И по большому счёту для экономики США в целом будет не сильный удар, но для экономики отрасли это будет означать, что любые другие отказы сильно ударят», — отмечает Судаков. Самый неудачный F-35 — истребитель-бомбардировщик пятого поколения. Ожидается, что он станет основой ВВС США, Великобритании, Канады и других союзников Вашингтона. Его стоимость для Италии составляет 51,3 млн евро за одну боевую машину. Такие данные ранее сообщали в итальянском парламенте. Истребитель считается самым дорогим в истории военным самолётом. Несмотря на позиционирование Соединёнными Штатами F-35 как наиболее современного и эффективного истребителя, периодически становится известно о недоработках. Эксперты связывают это с попыткой внедрить слишком большое количество перспективных разработок, которые пока «сырые» и имеют ряд недостатков. Ранее стало известно о проблемах с программным обеспечением, из-за которой был отложен ввод в эксплуатацию. Данные технические сложности не позволяли осуществлять стрельбу из пушек. Тогда разработчик Пьер Спрей самолёта F-16 сообщил о том, что проект F-35 изначально провальный. Позже CNN стало известно, что изоляционный материал в топливной системе истребителя крошится во время полётов. Дефект был обнаружен на 57 самолётах, 15 из которых были уже приняты на вооружение ВВС США. Из-за этого в сентябре 2016г. истребитель-бомбардировщик загорелся во время запуска двигателя на базе ВВС США Mountain Home в Айдахо. Из-за этих недоработок F-35 ранее был признан самым неудачным самолётом по мнению американского издания The National Interests.',\n",
       " ('F-35',\n",
       "  22,\n",
       "  0): 'An F-35B begins a short takeoff from the deck of the USS Wasp on Aug. 16, 2013. This story is available exclusively to Business Insider subscribers. Become an Insider and start reading now. ARLINGTON, Virginia — On Monday, the F-35 Joint Program Office released the finalized price for the most recent production contract for America\\'s fifth generation stealth fighter. After a little more than 14 months of negotiations between the Department of Defense and Lockheed Martin, the ninth Low Rate Initial Production (LRIP-9) contract for 57 F-35 jets was valued at $6.1 billion. The LRIP-9, which is essentially the ninth batch of jets, includes 34 jets for the US and 23 for five international countries. All three F-35 variants at Edwards Air Force Base. Lockheed Martin The following is a breakdown of the unit price per variant in current year dollars (including aircraft, engine, and fee): 42 F-35A model aircraft: $102.1 million a jet 13 F-35B model aircraft: $131.6 million a jet 2 F-35C model aircraft: $132.2 million a jet By comparison, in the previous contract, LRIP-8, the government paid $108 million for the Air Force\\'s F-35A, $134 million for the Marine Corps\\' F-35B, and $129 million for the Navy\\'s F-35C. While the price for the Air Force and Marine Corps\\' variants saw a reduction of $5.9 million and $2.4 million respectively, the Navy model saw an increase of $3.2 million. \"Why did that happen?\" asked Lt. Gen. Chris Bogdan, head of the F-35 Joint Program Office, during a briefing with reporters. \"That happened because in lot nine the Navy bought two C models and in lot 8 the Navy bought four models.\" \"So they cut their production in half and as a result of that when you do an economies of scale in one direction it hurts you in the other direction. Having said that, I fully anticipate that when we do settle LRIP 10 you\\'ll see all three variants, the A, the B, and the C come down in price significantly,\" Bogdan said. And by \"significantly\" Bogdan added that he believes \"somewhere on the order of 6 to 7 percent per airplane, per variant.\" Meanwhile, the 57 aircraft in LRIP-9 are in various stages of production at Lockheed Martin\\'s facility in Fort Worth, Texas. Deliveries for these aircraft are slated to begin in the first quarter of 2017.',\n",
       " ('F-35',\n",
       "  23,\n",
       "  0): 'Lockheed Martin снизит стоимость истребителей пятого поколения F-35 до $85 млн уже в 2019 году, в 11-й партии, которая должна будет достигнуть 200 единиц. В декабре избранный президент США Дональд Трамп раскритиковал программу создания новейшего боевого самолета из-за ее стоимости, обрушив капитализацию сразу нескольких компаний оборонного сектора. Опрошенные «Газетой.Ru» эксперты констатируют, что по мере удешевления самолет становится недосягаем для перспективных конкурентов из России и Китая. Многофункциональные истребители пятого поколения F-35 десятой партии впервые станут дешевле $100 млн за самолет. Уже в 2019 году Lockheed Martin снизит стоимость машин до $85 млн, заявила генеральный директор компании Мэрилин Хьюсон. При этом и производитель, и министерство обороны США призывают не связывать предполагаемое уменьшение цены F-35 c критикой в адрес программы со стороны нового президента США Дональда Трампа, пишет военно-аналитическое издание Defense News. Трамп не раз нелестно отзывался о F-35 начиная с декабря 2016 года. Глава американского государства неоднократно заявлял, что цена самолета «неконтролируемая», и призывал при этом к альтернативе в виде палубного истребителя-бомбардировщика и штурмовика F/A-18E/F Super Hornet. Заявление президента тогда обрушило стоимость акций Lockheed Martin сразу на 4,2%. В первый же час после высказывания капитализация компании упала на $2 млрд. Снизились также акции еще нескольких подрядчиков оборонного сектора — Northrop Grumman — на 4,5% и BAE Systems — на 2,4%. Генеральный директор Lockheed Мэрилин Хьюсон после этого несколько раз встречалась с Трампом. «Наши встречи были очень продуктивными. Это был очень хороший диалог. Президент задавал превосходные вопросы, и он действительно заинтересован в снижении затрат на программу F-35», — объясняла Хьюсон. В таком же ключе выступал и новый министр обороны США Джеймс Мэттис. Перед своим утверждением на должность главы Пентагона Мэттис сказал сенаторам, что Трамп «никоим образом не показал отсутствие поддержки программы», но хочет, чтобы Lockheed снизил цену. После встречи с президентом Дональдом Трампом, которая состоялась 13 января, Мэрилин Хьюсон заявила, что министерство обороны США и Lockheed «очень близки» к соглашению по цене за десятую партию истребителей F-35. «Цена за самолет в десятой партии будет на 60% меньше, чем в первой», – сказала Хьюсон. По словам генерального директора Lockheed, если в девятой партии было 57 машин, то в десятой их будет около 90. Генерал-лейтенант Кристофер Богдан, курирующий в Пентагоне программу разработки и эксплуатации F-35, заявил в конце 2016 года, что цена за один новейший истребитель по сравнению с девятой партией упадет приблизительно на 6%. Кроме того, Lockheed надеется в 2017 году завершить переговоры по контракту на одиннадцатую партию. Если заказы на истребитель увеличатся до 200 самолетов, как и запланировано, компания в 2019 году предложит F-35A уже по цене $85 млн за штуку. F-35 способен уничтожить перспективные российские и китайские истребители пятого поколения в воздушном бою, уверенно заявляют производители и чиновники Пентагона. «Пока я не видел ничего даже отдаленно похожего на действия F-35 на поле боя, что заставило бы меня предполагать, что где-то есть любой другой самолет, способный на равных бросить вызов «Молнии». Я чувствую себя абсолютно уверенным в успешных действиях F-35 в любой боевой обстановке», – рассказывал в январе изданию Warrior подполковник Мэтт Хайден, руководитель службы безопасности 56-го истребительного авиационного крыла с авиабазы Люк, Аризона. Его мнение разделяют и несколько других американских пилотов F-35. При этом Хайден подчеркнул, что лично не знает в полном объеме летно-технические характеристики российского и китайского самолета. Эксперты не верят в J-20 В России построено около шести прототипов T-50 ПАК ФА. Китай находится в подготовке производства J-20, выполненного по технологии «стелс». Эта машина, названная «Чэнду» в честь китайского города, совершила свой первый полет в 2011 году. Как ожидается, истребитель будет готов к эксплуатации в 2018 году. В доступных источниках утверждается, что J-20 — тяжелый многофункциональный истребитель с малой радиолокационной заметностью, как и в американских F-22 и F-35. Хотя пока очень',\n",
       " ('F-35',\n",
       "  23,\n",
       "  1): 'мало известно о действительном предназначении J-20, самолет может быть использован в качестве истребителя-перехватчика дальнего действия и ударов по наземным объектам высокоточными средствами поражения. С точки зрения размещения авиационных средств поражения на китайском J-20 он имеет некоторое сходство с предыдущим американским истребителем пятого поколения F-22: внутренние отсеки для установки ракет маневренного воздушного боя класса «воздух-воздух», ракет большого радиуса действия и других высокоточных средств поражения. Самолет предполагается оснастить управляемой ракетой с прямоточным воздушно-реактивным двигателем. Это оружие, по некоторым оценкам, находится примерно в том же классе, как управляемая ракета Meteor разработки европейского концерна MBDA. По мнению американского военного обозревателя Криса Осборна, бортовые датчики китайского самолета включают электронно-оптическую систему целеуказания (EOTS) и бортовой радиолокатор типа AESA (активная фазированная антенная решетка, АФАР), разработанный в Нанкинском научно-исследовательском институте электронных технологий (NRIET, 14-й институт). Ромбовидные окна вокруг фюзеляжа истребителя предполагают, что на боевой машине установлена инфракрасная система видения. В кабине J-20 располагаются три больших цветных дисплея плюс другие маленькие экраны и голографический широкоугольный дисплей. Кроме того, здесь же находится модернизированный канал передачи данных. Выдвижная штанга для дозаправки топливом в полете расположена на правом борту передней части фюзеляжа. Большая часть бортового радиоэлектронного оборудования истребителя была проверена CFTE (китайское учреждение летных испытаний) на борту модифицированного Tу-204C почти таким же способом, как системы F-22 были испытаны на борту Boeing 757. Однако опрошенные «Газетой.Ru» специалисты авиационной отрасли скорее согласны с выводами американских пилотов о превосходстве F-35. По словам собеседников, у них есть большие сомнения в наличии на борту J-20 заявленного китайской стороной радиоэлектронного оборудования. К примеру, недавно КНР закупила истребители Су-35, несмотря на то что на них были установлены РЛС с пассивной ФАР. Косвенно это свидетельствует, что работоспособной АФАР у Китая сейчас нет. Сомневаются многие специалисты и в наличии на J-20 электронно-оптической системы целеуказания. «Такие системы далеко не каждая западная страна «поднимет», — выразился один из собеседников «Газеты.Ru», и вряд ли сегодня Китаю это по силам. © Amir Cohen/Reuters «Критика Т-50 — неоправданна» Что касается российского истребителя ПАК ФА T-50, также выполненного по технологии «стелс», в многочисленных докладах и аналитических материалах западных авиаэкспертов отмечается, что самолет имеет многочисленные технологические проблемы. «Российская промышленность последовательно упоминала истребитель ОКБ «Сухой» T-50 ПАК ФА как самолет пятого поколения, но осторожный взгляд на программу показывает, что это «только номинальное» обозначение», — уверяло издание Business Insider. На борту самолета отсутствуют эволюционные технологии по сравнению с машинами предыдущих поколений, которые ранее создавались в России, уверены западные эксперты. Крис Осборн обращает внимание, что двигатели ПАК ФА те же, что и на борту российского истребителя поколения «4 + +» типа Су-35С. Кроме того, ПАК ФА и Су-35С объединяют многие из бортовых систем. И даже в том случае, когда системы ПАК ФА отличаются от Су-35С, Т-50 все еще очень далеко до истинных стандартов пятого поколения, настаивает американский эксперт. Критика российского проекта Т-50 за то, что он использует элементы от Су-35, неоправданна, считает в свою очередь заместитель директора Центра анализа стратегий и технологий Константин Макиенко. По словам отечественного специалиста, на модифицированную платформу пока только интегрируются элементы, разрабатываемые для истребителя пятого поколения. Но сравнивать Т-50 с F-35 на данном этапе все-таки некорректно: ПАК ФА сейчас – это F-35 примерно 15 лет назад. Важно, какое соотношение между этими самолетами будет в 2025 году. Этой же позиции придерживается и главный редактор журнала «Экспорт вооружений» Андрей Фролов. По словам специалиста, F-35 — серийный самолет. J-20 — предсерийный, причем далеко неясно, насколько это реально, а Т-50 на стадии разработки. F-35 станет самым массовым Сторонники F-35 утверждают, что передовые компьютерные технологии и бортовые датчики самолета позволят ему обнаружить и уничтожить вражеские истребители на гораздо больших дальностях, чем все известные самолеты. Уничтожение противника будет происходить прежде, чем он сможет обнаружить F-35. Несколько лет назад теоретик ВВС США полковник Джон',\n",
       " ('F-35',\n",
       "  23,\n",
       "  2): 'Бойд ввел в оборот термин «Петля OODA» («observe» – обнаружение, «orient» – ориентация, «decide» – решение, «act» – действие). Процесс должен завершиться максимально быстро, необходимо проникнуть в цикл решения врага и уничтожить его прежде, чем противник сможет предпринять какие-либо осмысленные действия. Новейшие технологии позволяют F-35 завершить «Петлю OODA» намного быстрее, чем любые потенциальные противники, уверены его разработчики. В помощь F-35 у США есть глобальная информационная поддержка, спутниковая навигация, связь, базирование на всех возможных театрах военных действий, с возможностью заправки топливом, очень мощная поддержка самолетами специального назначения — дальнего радиолокационного обнаружения (ДРЛО) и управления, разведки всех типов и радиоэлектронной борьбы (РЭБ). Но если в локальных конфликтах применение такой сетецентрической боевой системы сулит явные преимущества, то в войне с применением ядерного оружия они не так очевидны. Если будет подавлена инфраструктура, то лучше в подобной ситуации проявят себя самолеты, предназначенные для автономных действий. Тем не менее, по словам Макиенко, основная критика F-35 всегда была связана отнюдь не с технологиями, которые, возможно, лучшие в мире, а как раз со стоимостью проекта. «Ведь изначально амбиции США заключались именно в том, чтобы создать легкий истребитель 5-го поколения: а) дешевый и б) межвидовой», — напоминает эксперт. По мнению специалиста, при цене F-35 более $100 млн за штуку и стоимости летного часа $35 тыс. назвать самолет дешевым не получается. «И его унификация между вариантами для разных видов вооруженных сил тоже не очень удалась», — констатировал собеседник, напомнив о создании в итоге разных модификаций машины. Постепенное же снижение цены F-35 приближает его к изначально заданному образу. «Нравится нам это или нет, но F-35 станет самым массовым в мире истребителем пятого поколения, и коммерческий успех этой боевой машины ни Россия, ни Китай, по всей видимости, повторить не смогут», — констатирует Фролов.',\n",
       " ('F-35',\n",
       "  24,\n",
       "  0): 'Стоимость эксплуатации истребителей F-35 Ligtning II оценивается в триллион долларов, сообщает Bloomberg. Такие данные содержатся в докладе, направленном Пентагоном в Конгресс США. В документе рассчитана стоимость эксплуатации 2443 истребителей на протяжении 30 лет при восьми тысячах часов полета для каждого самолета. В 2009 году министерство обороны США ожидало, что стоимость эксплуатации самолетов не превысит 915 миллиардов долларов. Обнародованная оценка была рассчитана независимой аналитической группой при Пентагоне. Показатели были просчитаны на основе данных по другим боевым самолетам, стоящим на вооружении Армии, ВВС и Корпуса морской пехоты США. Речь идет об истребителях F-16 Fighting Falcon, F/A-18 Hornet и AV-8B Harrier. Озвученная стоимость не включает в себя 382 миллиарда долларов, которые будут потрачены на разработку F-35 и покупку 2443 самолетов для вооружения США. Столь высокая стоимость эксплуатации американских истребителей обусловлена тем, что некоторые детали F-35 будут ломаться чаще, чем у обычных истребителей. О каких именно деталях идет речь, не уточняется. Следует отметить, что Главное контрольное управление США в 2009 году объявило, что стоимость покупки и эксплуатации F-35 превысит триллион долларов: 300 миллиардов будут потрачены на покупку истребителей и 760 миллиардов - на их эксплуатацию. Любопытно, что Flightglobal сообщает, что операционные расходы и траты на ремонт и обслуживание по программе F-35 составят 442 миллиарда долларов в ценах 2002 года (549,04 миллиарда долларов в ценах 2011 года). По данным портала, такую оценку озвучил руководитель проекта F-35 вице-адмирал Дэвид Венлет ( David Venlet). Прогнозная стоимость была подготовлена Командованием морских авиационных систем (NAVAIR) ВМС США. По данным NAVAIR, стоимость одного часа полета F-35 составит 30,7 тысячи долларов. Для сравнения, один час полета F/A-18 стоит 18,9 тысячи долларов. США создают F-35 как более дешевую альтернативу истребителю F-22 Raptor. В июле 2009 года командование ВВС США объявило, что один час полета F-22 стоит 44 тысячи долларов. При этом администрация госсекретаря ВВС США оценила час полета Raptor а 49,8 тысячи долларов.',\n",
       " ('F-35',\n",
       "  25,\n",
       "  0): 'По подсчетам американских экспертов в области аэронавтики и эксплуатации военных самолетов, полная стоимость создания и обслуживания каждого F-35 за все планируемое время его жизни составит 670 млн долларов. А это больше стоимости горы золота с весом самого F-35. По данным Счетной палаты США, на продолжение программы закупки F-35 для ВВС страны на 459 самолетов потребуется больше планируемых сейчас 83,4 млрд долларов. Если же брать в расчет эту сумму, то и тогда официальная стоимость производства одного экземпляра составит $180 млн. Производящая F-35 корпорация Lockheed Martin заявляет, что готова снизить стоимость одного самолета до 85 миллионов, но при условии увеличения числа заказов. Программа закупки F-35 - это объект постоянной критики в США, поскольку мало того, что налицо явная неэффективность использования бюджетных средств, так еще и постоянное малообъяснимое увеличение стоимости самолетов. Кроме того, вся программа F-35 отстает от заложенных сроков исполнения на 7 лет, но и стала дороже уже на 163 млрд долларов. Некоторые эксперты вообще считают, что США было бы выгоднее создавать вместо одного F-35 целые эскадрильи военных беспилотных летательных аппаратов. Так, стоимость дрона MQ-9 Reaper составляет \"всего\" 14,4 млн. Таким образом, если даже противник США собьет 10 дронов, армия США потеряет меньше, чем в случае крушения одного F-35. У многих экспертов вызывает сомнение сам факт того, что самолет можно отнести к категории 5-го поколения, они настаивают, что это скорее самолет поколения 4+. В частности, несмотря на заявления представителей Lockheed Martin, утверждается, что F-35 не способен достигать сверхзвуковой скорости без использования форсажа, имеет низкую маневренность и тяговооруженность. Вопрос его \"малозаметности\" для систем ПВО также остается открытым. В частности, австралийский эксперт, руководитель центра Air Power Australia, проанализировав возможности самолета и российской системы ЗРК С-400 \"Триумф\", пришел к выводу, что \"золотая игрушка\" американских военных станет легкой добычей для C-400.',\n",
       " ('F-35',\n",
       "  26,\n",
       "  0): 'WASHINGTON — The F-35 program is not \"out of control\" as President-elect Donald Trump famously tweeted this month, but more can still be done to tamp costs down, the head of the F-35 program office said Monday. During a Dec. 19 briefing with reporters, Lt. Gen. Christopher Bogdan, the F-35 program executive officer, struck a conciliatory tone when asked about Trump\\'s recent comments about the F-35 joint strike fighter. Last week, the president-elect slammed the F-35\\'s high price tag, warning the Defense Department and industry alike that \"billions of dollars can and will be saved\" on military equipment when he steps into office. Bogdan said Trump\\'s desire to root out waste and efficiency is commendable, but noted that the program has come a long way since 2011, when it hit a Nunn-McCurdy breach. \"I have no doubt that given the controversy on the F-35 program over the years, that there\\'s a perception that this program is out of control,\" he said. \"That\\'s in the past. So, if given the opportunity, I would like to try and explain to the new administration that this is a vastly different program from 2011 on. … I\\'ll just lay the facts out on the table, and I\\'ll let them make their own judgments.\" Trump and his transition team had not been briefed on the joint strike fighter program before he made his fateful tweet, which sent Lockheed Martin stock careening down to $245.70 before rebounding back to more than $250 a share. The team has since asked for a briefing, though nothing has been scheduled yet. For the F-35 program, 2016 has been a year of highs and lows. A recently-announced contract for lot 9 secured the lowest unit prices yet — for the most part. The contract set a price of $102.1 million per A model and $131.6 million per B model, down from about $108 million and $134 million, respectively. However, a smaller Navy order for only two F-35Cs caused unit prices to rise by $3.2 million to $132.2 million per aircraft. At the same time, Bogdan also acknowledged that the schedule for the development phase of the program could slip as much as seven months, with $532 million in additional funds needed for completion. \"I understand the new administration’s position on wanting to get the best value for every dollar that the Department of Defense spends,\" he said. \"The new administration, I believe, is putting everyone on notice. Not just industry, but the department on notice. What it wants is better value for its dollar, and that can happen from both sides of the aisle.\" Because the F-35’s highly technical and cutting-edge capabilities are seen as critical for ensuring the US military’s air dominance, Bogdan advised against changes in requirements that would degrade its performance. \"Are there other things we can do to reduce the cost of this airplane? Absolutely. Are we doing some of those now? Absolutely,\" he said. For instance, in fiscal year 2018, the services plan to ask Congress for permission to buy parts in economic order quantities over multiple years. That, along with a block buy for international customers, is projected to save about $2 billion according to the RAND Corp. He also said more competition could be injected into the program at a system or supplier level. \"If you’ve got a single-source supplier of a particular component of this airplane right now, and you’re not sure if that person can build you 3,000 airplanes worth of that, you might want to open up a second source,\" he said. \"Once you open up a second source, now',\n",
       " ('F-35',\n",
       "  26,\n",
       "  1): 'you’ve got natural competition. We should explore some of that.\" Any incoming leader is going to ask questions about costs, said Air Force Secretary Deborah Lee James at an earlier event at the Atlantic Council on Monday. Once Trump is briefed on the program, he will understand the complexity of programs like the F-35 and realize it is not necessarily easy to reduce the price of the jets. But he should still make the effort, she added. \"Can the costs be driven down more? Perhaps. I know certainly the current leadership, the JPO [F-35 joint program office] itself, they’re focused on this each and every day. I know that industry has made concessions to try to bring down the price,\" she said. \"Can more of this be accomplished? I would say, probably yes, and the pressure should remain on.\" While Bogdan and James were amenable to suggestions that the government has more work to do on lowering the cost of the F-35 program, they bristled against Trump’s criticisms of the \"revolving door\" between industry and the Defense Department, which prompted the president-elect to pitch a lifetime ban on Pentagon contracting officials from ever being employed by a defense contractor. \"I have not seen ethical issues as a source for the problems on this program,\" said Bogdan, who is forbidden by law for ever working on the joint strike fighter program for Lockheed or F-35 engine manufacturer Pratt & Whitney, although he could be employed by the companies in another capacity. \"The problems on this program quite frankly in the past were very simple. We were overly optimistic in the technical risk of building this leading-edge fighter, and so we put unrealistic schedules and budgets together, and then when we ran into problems we did not manage them well.\" James said the restrictions on senior defense officials — which required the former SAIC employee to divest stock — are sometimes stronger than those imposed on the president. Trump himself has been criticized for not maintaining a stronger firewall between his business affairs and emerging duties as president-elect. Valerie Insinna is Defense News\\' air warfare reporter. She previously worked the Navy/congressional beats for Defense Daily, which followed almost three years as a staff writer for National Defense Magazine. Prior to that, she worked as an editorial assistant for the Tokyo Shimbun’s Washington bureau.',\n",
       " ('F-35',\n",
       "  27,\n",
       "  0): 'В процессе длительных испытаний американского истребителя пятого поколения F-35 выявлены критические проблемы с надежностью и долговечностью самолета, точностью его оружия, программным обеспечением. Нелестные для создателей Lightning II факты приведены в докладе директора Петагона по испытанию вооружений. Документ опубликовал Bloomberg. Недостатки F-35 можно разделить на несколько категорий. Первая касается надежности и долговечности истребителя F-35B с укороченным взлетом и вертикальной посадкой - такими самолетами планируется оснастить Корпус морской пехоты США. Многие из 60 построенных самолетов подлежат списанию из-за трещин в фюзеляже. Истребители пришли в негодность, не проработав и четверти заявленного производителем срока, констатировали в Пентагоне. К тому же на F-35B установлено устаревшее программное обеспечение, а его пушка так и не научилась попадать в цель, несмотря на многочисленные переработки. Защита бортовой электроники от взлома признана \"ужасающе низкой\". В условиях сетецентрической войны, для которой и предназначен F-35, наличия у противника мощных средств радиоэлектронного перехвата и подавления подобная беззащитность может доставить американской армии много неожиданностей. Например, истребитель может применить оружие против своих, повинуясь командам извне и не обращая внимания на сидящего в кабине пилота. Единственное, что в этой ситуации может хоть немного утешить авиаторов - бортовая система управления оружием самолета тоже работает из рук вон плохо. Насколько электроника F-35 \"живет собственной жизнью\", демонстрирует работа системы логистики ALIS, которой в докладе посвящен отдельный раздел. Планировалось, что эта система будет собирать информацию о находящихся поблизости F-35 и вызывать их на подмогу в случае необходимости. Также программа должна следить за состоянием самолета, рассылать наземным службам напоминания о сервисном обслуживании и заказывать запчасти. В реальности же ALIS воспринимает все находящиеся на земле самолеты как \"небоеспособные\" и рассчитывать на поддержку пилоту F-35 не приходится. Еще опаснее ситуация на авианосцах, где электроника пропускает вылеты и вступает в пререкания с диспетчерами. Наконец, при заказе запчастей ALIS сообщает, что необходимая деталь \"будет доступна через несколько лет\" и персоналу авиабаз приходится связываться с поставщиками по обычному телефону. Тем временем Германия официально отказалась от F-35. Представитель Бундесвера сообщил, что самолет не будет участвовать в конкурсе на замену стареющему флоту немецких истребителей. Пока лидером тендера является модернизированный Eurofighter Typhoon, однако возможна закупка и американских F/A-18 Super Hornet, пишет Defence News. Американские истребители необходимы ФРГ, поскольку Eurofighter не сертифицирован для применения тактических ядерных бомб, которые Германия обязана иметь на вооружении согласно стратегической доктрине НАТО.',\n",
       " ('F-35',\n",
       "  28,\n",
       "  0): 'Пентагон обнаружил у американского истребителя пятого поколения F-35 проблемы с надежностью, долговечностью, точностью и программным обеспечением. Об этом пишет Defense News, ссылаясь на доклад военного ведомства. Оказалось, что версия самолета F-35B с укороченным взлетом и вертикальной посадкой прослужит всего лишь 2100 летных часов вместо 8 тыс. часов, как предполагалось ранее. Как пояснили военные, из-за этого часть истребителей каждый из которых стоит почти $100 млн, спишут уже в 2026 году. Также критические проблемы обнаружились у самолета F-35A. Встроенный пулемет истребителя не соответствует техстандартам, прописанным в контракте. В то время как обновленное программное обеспечение повысило стабильность оружия, не было реализовано никаких изменений на программном и аппаратном уровнях, которые могли бы улучшить его точность. Более того, выяснилось, что орудия по-разному смещены, поэтому нельзя сделать так, чтобы они приняли верное положение. Имеются у F-35 и серьезные программные ошибки. Так, установленная на истребителе автономная логистическая информационная система (ALIS) от Lockheed Martin, которая предназначена для вызова подмоги и слежкой за состоянием самолета, всё еще не работает должным образом. Предоставляемые ей данные часто являются неполными или вовсе неправильным, что может помешать способности быстро реагировать на противника в экстренных ситуациях. Кроме того, были отмечены неудобства в пользовании системой: автоматизированные функции нередко требуют ручного ввода. Программа создания Lockheed Martin F-35 Lightning II стала самой дорогостоящей в истории производства оружия. США потратили на нее порядка $1,5 трлн. При этом эксперты неоднократно указывали на многочисленные технические проблемы истребителя и отмечали его бесполезность перед системами ПВО России и Китая.',\n",
       " ('F-35',\n",
       "  29,\n",
       "  0): 'Lockheed Martin is projecting annual production of the F-35 Lightning II stealth fighter could rise to as high as 180 examples by 2024. The company sees continued sales to US military services as well as potential wins in international fighter procurement competitions, such as in Finland, Switzerland and Canada, steadily boosting production of the combat aircraft. In 2019, the airframe manufacturer delivered 134 examples of the F-35. “We’re going to deliver 140 aircraft this year,” says Ken Possenriede, executive vice-president of Lockheed Martin on the company’s annual earnings call on 28 January. “Rough number’s 160 next year.” In the years beyond, he sees 165 aircraft delivered in 2020; 170 aircraft delivered in 2023; and 175 to 180 delivered in 2024. The company believes its production will reach peak capacity in 2023 and 2024. Lockheed Martin had delivered 491 aircraft in total to various worldwide military services by the end of 2019. Shortly after Lockheed Martin’s F-35 production reaches peak capacity, in 2025, the company wants to have significantly lowered the operating cost of the aircraft to $25,000 per hour, down from about $35,000 per hour currently. While F-35As purchased as part of production lot 14 have fallen to a historic low price of $77.9 million a copy, the high cost of flying the aircraft is consuming military service budgets and endangering future sales for Lockheed Martin. Lockheed Martin proposed in September 2019 an idea for a performance-based logistics maintenance contract to help lower the cost of flying the F-35. Under similar contracts, suppliers are paid a flat rate to maintain a certain level of performance for an aircraft, such as mission capable rate or cost per flight hour, rather than just supply one-off parts or repair services. The F-35 Joint Program Office said it is considering the idea.',\n",
       " ('F-35',\n",
       "  3,\n",
       "  0): 'The U.S. Air Force declared initial operational capability (IOC) on its F-35A Joint Strike Fighter today. Commander of Air Combat Command Gen. Hawk Carlisle certified that the plane had met all key criteria to be considered “combat ready”: it has enough trained airmen to support an operational deployment of 12 to 24 planes for close air support, interdiction, and limited suppression/destruction of enemy air defenses missions; the ability to deploy and conduct missions using program of record weapons; and the proper logistics in place to sustain a deployed force. “I am proud to announce this powerful new weapons system has achieved initial combat capability,” Carlisle said in a statement. “The F-35A will be the most dominant aircraft in our inventory, because it can go where our legacy aircraft cannot and provide the capabilities our commanders need on the modern battlefield.” The Air Force activated its first operational F-35A squadron – the 34th Fighter Squadron of the 388th Fighter Wing, based at Hill Air Force Base, Utah – on July 17 Ahead of the IOC declaration, that squadron deployed to Mountain Home Air Force Base in Idaho in June and conducted a series of eight-aircraft sorties in mid-July. The first planes delivered last September and have since underdone modifications. “Our Airmen have worked tirelessly to make sure our aircraft are combat ready: meeting challenges head-on and completing all the required milestones,” Col. David Lyons, 388th Fighter Wing commander, said in the statement. “We’re very proud that the Air Force has declared us combat ready and we’re prepared to take this aircraft wherever it’s needed in support of our national defense.” F-35 Program Executive Officer Air Force Lt. Gen. Chris Bogdan said in the statement that “the U.S. Air Force decision to make the 15 F-35As at Hill Air Force Base combat ready sends a simple and powerful message to America’s friends and foes alike – the F-35 can do its mission.” Jeff Babione, Lockheed Martin’s F-35 Executive Vice President and General Manager, congratulated the Air Force, saying in the statement that “the multi-service F-35 Lightning II represents a quantum leap in air power. With the F-35A, the Air Force now has a fighter combining next-generation radar-evading stealth, supersonic speed, fighter agility and advanced logistical support with the most powerful and comprehensive integrated sensor package of any fighter aircraft in history. It will provide Airmen unprecedented lethality and survivability, a capability they will use to defend America and our allies for decades to come.” The Marine Corps declared IOC on its F-35B last July after putting its first operational squadron, Marine Fighter Attack Squadron (VMFA) 121, through an operational readiness inspection – something that was not required by the Department of Defense but instead was borrowed from the British military. In the past year, the service has stood up its second squadron and continues to refine its tactics to make best use of the planes’ capabilities. “The roads leading to IOC for both Services were not easy and these accomplishments are tangible testaments to the positive change happening in the F-35 program,” Bogdan said.',\n",
       " ('F-35',\n",
       "  30,\n",
       "  0): 'Конфликт на Ближнем Востоке переходит в войну США и их союзников против Ирана Фото mil.ru Накануне вылета с кратким визитом в Москву премьер-министр Израиля Биньямин Нетаньяху заявил, что основной темой переговоров с Владимиром Путиным, будет сирийская проблематика. Переговоры прошли в четверг. О важности этой темы для двух стран говорит и тот факт, что в этот же день переговоры в Москве провели секретарь Совета безопасности РФ Николай Патрушев и председатель Совета нацбезопасности Израиля Меир Бен-Шаббат, которые «обменялись мнениями по ряду тем российско-израильского взаимодействия в сфере безопасности, а также обсудили ситуацию в Сирии». Накануне приезда Нетаньяху в Москву ряд израильских СМИ опубликовали подробности последнего ракетно-авиационного удара авиации ЦАХАЛ 27 марта по объектам в сирийском Алеппо. Как сообщается, удары наносились по иранским объектам в районах Шейх-Наджар и Джибрин, а также по авиабазе Найроб с двух разных направлений. И помимо ударов с запада (из воздушного пространства Ливана) авиация ЦАХАЛ впервые за всю сирийскую кампанию действовала из оккупационной зоны, занятой американцами на востоке Сирии. Израильские СМИ утверждают, что наибольший эффект от атаки на иранские объекты был достигнут после того, как «истребители F-35I («Адир» – вариант для Израиля) нанесли удар по объектам в Алеппо, пройдя через воздушное пространство Иордании и Ирака». Арабские СМИ опубликовали видео уничтоженных иранских объектов, на которых видны осколки высокоточной бомбы GBU-39. Их Израиль устанавливает и на самолеты F-35. Максимальная дальность поражения цели этими бомбами – не более 110 км. При этом по направлению осколков видно, что бомбы летели с юго-восточного направления. То есть они применялись по целям в Алеппо с территории Сирии. Как утверждает портал avia.pro, ссылаясь на израильские источники, «средства радиоэлектронной разведки Израиля указывали на тот факт, что сирийские системы ПВО были активированы, но при этом огонь по израильским боевым самолетам не открывался». В публикации anna-news. info утверждается, что «сирийские подразделения ПВО задействовали российские ЗРК С-300ПМУ-2, однако поразить F-35I не смогли». Эксперты avia.pro, в свою очередь, утверждают, что «ЗРК С-300, находящиеся на территории Сирии, действительно могли быть активированы, однако на данный момент подготовка сирийских офицеров, которым и предстоит осуществлять управление комплексами, еще только ведется. С другой стороны, расположенные на авиабазе Хмеймим ЗРК С-400 «Триумф» обладают значительно большим радиусом обнаружения воздушных целей, а с учетом интеграции сирийской системы ПВО с российскими средствами РЛС сирийские военные должны были получать объективные данные о нахождении израильских самолетов». Но российские С-400 по самолетам Израиля, бомбившим территорию Сирии, не применялись. Никаких официальных комментариев со стороны военных ведомств России и Израиля по поводу изложенной выше информации пока не поступало. В то же время информационно-аналитическое израильское издание Debka утверждает, что удар по иранским целям в Алеппо «не будет единичным». По данным издания, штаб-квартира иранского командования Корпуса стражей исламской революции переведена из Дамаска в Алеппо. Поэтому якобы «Израиль покончил с Дамаском как ареной для уничтожения военных объектов Ирана и перенес свою кампанию в Алеппо. Однако география обязывает Израиль разработать новые правила координации с российскими войсками, размещенными на севере Сирии». Этот императив, по утверждению Debka, и стал главным мотивом для «новых контактов Нетаньяху с Путиным». Таким образом, стремление Израиля стать посредником между Москвой и Вашингтоном в диалоге по Сирии, которое, возможно, в очередной раз обозначил Нетаньяху в Москве, направлено против Ирана. Хотя Россия, как и Дамаск, не может согласиться с требованием США и Тель-Авива вывести все иранские шиитские формирования из Сирии. В то же время это совершенно не значит, что визит главы правительства Израиля в РФ в военном плане для Москвы и Тель-Авива оказался малоэффективным. Пока в Сирии присутствует российский воинский контингент, любые контакты двух стран на высшем уровне повышают безопасность военнослужащих и снижают риск их гибели от возможных авиационно-ракетных ударов, которые Израиль и далее будет наносить по иранским объектам в Сирии. При этом для самого Израиля очень важно до конца',\n",
       " ('F-35',\n",
       "  30,\n",
       "  1): 'не испортить отношения с Москвой, уже омраченные гибелью самолета Ил-20 с российскими офицерами-разведчиками в сентябре 2018 года над Средиземным морем.',\n",
       " ('F-35',\n",
       "  31,\n",
       "  0): 'Depending on who you ask, Lockheed Martin’s F-35 Lightning II is either (A) the fighter plane equivalent of the best thing to happen since sliced bread, or (B) the biggest boondoggle ever to bust the budget of the U.S. Department of Defense. For the sake of being “fair and balanced”—to borrow a slogan—let’s take a look at “The Good, The Bad, and The Ugly” of this controversial warbird. F-35 The Good This current iteration of the Lightning certainly has a lethal namesake. The original Lockheed P-38 Lightning, one of the earliest creations of the Kelly Johnson’s famed Skunk Works program that also created the legendary SR-71 Blackbird—still the world’s fastest air-breathing aircraft—was used by American fighter pilots during the Second World war with deadly effect. Most notably, (1) it was flown by Major Richard “Dick” Bong, America’s all-time highest-scoring air ace, who garnered all 40 of his air-to-air kills against Imperial Japanese aircraft whilst flying a P-38, and (2) it was the aircraft to shoot down Admiral Isoroku Yamamoto, dealing a crushing blow to Imperial Japanese Navy morale. Though not quite as successful in the European Theatre of Operations, it nonetheless performed well enough to be given the sobriquet “der Gableschwanz Teufl” (“fork-tailed devil”) by the Germans. So then, how worthy a successor is the new Lightning to its famed predecessor? Alex Hollings of Sandboxx News rates it the #2 best stealth fighter plane in the world, slightly behind the F-22 Raptor but well ahead of China’s Chengdu J-20 and Russia’s Sukhoi Su-57 Felon. Among the superlatives of Mr. Hollings’s assessment: “(T)he F-35’s biggest claim to fame comes in the form of its onboard systems. The F-35’s AN/APG-81 Active Electronically Scanned Array (AESA) Fire Control Radar system is widely considered the best in the world. It’s so powerful that it can actually be leveraged for electronic warfare (EW) operations, making the F-35 the only attack aircraft in the U.S. arsenal that can handle its own EW in a fight.” Alex goes on to add “The powerful computers onboard the F-35 take data fed through both of these systems, as well as from other sensors in space, the air, land, and sea, and fuse it all into a single consumable display presented to the pilot through a combination of a single large screen and a helmet-mounted system. As a result, the F-35 provides better situational awareness than any tactical aircraft in history. And by sharing this data with older aircraft, it makes 4th generation fighters deadlier simply by flying alongside them.” F-35: The Bad As is true of any manmade object, the Lightning II also has its weaknesses. As Alex points out in a separate 1945 article, the F-35 is slower and less maneuverable than many 4th generation fighters: “Cold War speedsters like the F-16 can creep up toward Mach 2 when flying without ordnance, and the legendary air superiority F-15 can do better than Mach 2.5 when it needs to hustle.” In particular, the F-35B and C, specialized for service aboard amphibious assault ships and aircraft carriers, are akin to the cheetah; just as the cheetah can run incredibly fast but then tires out after a relatively short distance and amount of time, the B and C models of the F-35 can hit supersonic speeds but must limit those sound barrier-breaking sprints to a mere 60 seconds or less in order to protect the delicate radar-absorbent coating layered over the airframes. This in turn has led to perceptions that the Lightning II can’t dogfight, a perception that was given a lot of credence by a 2015 report he obtained outlining',\n",
       " ('F-35',\n",
       "  31,\n",
       "  1): 'how the F-35 got its tail kicked over and over again by the F-16. However, as Mr. Hollings points out in the article I linked in the preceding paragraph, that report was missing an awful lot of proper context. Many have called the report a total farse as the F-35 that battle the F-16 was completely ready for combat. F-35 Costs The “Ugly” part of the F-35’s picture stems from the budgetary cost I referred to in the opening paragraph of this piece. How big a boondoggle? We’re talking U.S. taxpayer dollars to the tune of over $1.6 trillion over the program’s lifetime; in other words, a single F-35 costs the United States $36,000 every hour it’s in the sky, which is $14,000 more per hour than the F-16 it was intended to replace…definitely more than Federal minimum wage standards. The F-35: Worth the Money? History Gives Us a Clue But then again, going back to the stated objective of being “fair and balanced,” history is replete with weapons systems that were initially condemned as a waste of money…until they proved their money’s worth in battle: The M-1 Abrams main battle tank, the AH-64 Apache helicopter gunship, the F-117, the B-2, and so forth. While the F-35 has yet to attain the combat-proven credentials of those weapons systems, it has already been “blooded” in combat, as back on 15 March 2021, the Israeli Air Force used the plane to kill Iranian drones that “attempted to infiltrate Israel.” Bottom line: the jury is still out on the F-35. Stay tuned. Christian D. Orr is a former Air Force officer, Federal law enforcement officer, and private military contractor (with assignments worked in Iraq, the United Arab Emirates, Kosovo, Japan, Germany, and the Pentagon). Chris holds a B.A. in International Relations from the University of Southern California (USC) and an M.A. in Intelligence Studies (concentration in Terrorism Studies) from American Military University (AMU). He has also been published in The Daily Torch and The Journal of Intelligence and Cyber Security.',\n",
       " ('F-35',\n",
       "  32,\n",
       "  0): 'https://ria.ru/20190501/1553217728.html США впервые использовали истребители F-35A в бою США впервые использовали истребители F-35A в бою - РИА Новости, 02.05.2019 США впервые использовали истребители F-35A в бою ВВС США впервые использовали истребители F-35A в боевых условиях. Об этом сообщается на сайте Военно-воздушных сил. РИА Новости, 02.05.2019 2019-05-01T16:45:00+03:00 2019-05-01T16:45:00+03:00 2019-05-02T00:17:00+03:00 в мире сша f-35 ввс сша исламское государство* https://cdnn21.img.ria.ru/images/155251/72/1552517287_0:0:3068:1727_1920x0_80_0_0_e13e291484f86e7e6a4d590318e4675a.jpg МОСКВА, 1 мая — РИА Новости. ВВС США впервые использовали истребители F-35A в боевых условиях. Об этом сообщается на сайте Военно-воздушных сил.Военные использовали два истребителя в рамках операции \"Непоколебимая решимость\" (Inherent Resolve) в Ираке. Отмечается, что самолеты нанесли авиаудар по сети туннелей в Хамрине, которые боевики ИГ* используют для хранения и переброски оружия.Истребители F-35A Lightning II прибыли в ОАЭ с военной базы в американском штате Юта транзитом через авиабазу Морон в Испании.В рамках программы Lockheed Martin F-35 Lightning II было создано три варианта самолетов — F-35A (для ВВС), а также F-35B и F-35C (для Военно-морских сил). Эта программа стала самой дорогостоящей в истории производства оружия: США потратили на нее почти полтора триллиона долларов, а сами истребители ввели в строй на семь лет позже, чем предполагалось.*Запрещенная в России террористическая группировка. https://ria.ru/20190410/1552535509.html сша РИА Новости 1 5 4.7 96 internet-group@rian.ru 7 495 645-6601 ФГУП МИА «Россия сегодня» https://xn--c1acbl2abdlkab1og.xn--p1ai/awards/ 353 60 353 60 2019 РИА Новости 1 5 4.7 96 internet-group@rian.ru 7 495 645-6601 ФГУП МИА «Россия сегодня» https://xn--c1acbl2abdlkab1og.xn--p1ai/awards/ 353 60 353 60 Новости ru-RU https://ria.ru/docs/about/copyright.html https://xn--c1acbl2abdlkab1og.xn--p1ai/ РИА Новости 1 5 4.7 96 internet-group@rian.ru 7 495 645-6601 ФГУП МИА «Россия сегодня» https://xn--c1acbl2abdlkab1og.xn--p1ai/awards/ 353 60 353 60 1920 1080 true 1920 1440 true 1920 1920 true РИА Новости 1 5 4.7 96 internet-group@rian.ru 7 495 645-6601 ФГУП МИА «Россия сегодня» https://xn--c1acbl2abdlkab1og.xn--p1ai/awards/ 353 60 353 60 РИА Новости 1 5 4.7 96 internet-group@rian.ru 7 495 645-6601 ФГУП МИА «Россия сегодня» https://xn--c1acbl2abdlkab1og.xn--p1ai/awards/ 353 60 353 60 в мире, сша, f-35, ввс сша, исламское государство*',\n",
       " ('F-35',\n",
       "  33,\n",
       "  0): 'https://ria.ru/20190501/1553217728.html США впервые использовали истребители F-35A в бою США впервые использовали истребители F-35A в бою - РИА Новости, 02.05.2019 США впервые использовали истребители F-35A в бою ВВС США впервые использовали истребители F-35A в боевых условиях. Об этом сообщается на сайте Военно-воздушных сил. РИА Новости, 02.05.2019 2019-05-01T16:45:00+03:00 2019-05-01T16:45:00+03:00 2019-05-02T00:17:00+03:00 в мире сша f-35 ввс сша исламское государство* https://cdnn21.img.ria.ru/images/155251/72/1552517287_0:0:3068:1727_1920x0_80_0_0_e13e291484f86e7e6a4d590318e4675a.jpg МОСКВА, 1 мая — РИА Новости. ВВС США впервые использовали истребители F-35A в боевых условиях. Об этом сообщается на сайте Военно-воздушных сил.Военные использовали два истребителя в рамках операции \"Непоколебимая решимость\" (Inherent Resolve) в Ираке. Отмечается, что самолеты нанесли авиаудар по сети туннелей в Хамрине, которые боевики ИГ* используют для хранения и переброски оружия.Истребители F-35A Lightning II прибыли в ОАЭ с военной базы в американском штате Юта транзитом через авиабазу Морон в Испании.В рамках программы Lockheed Martin F-35 Lightning II было создано три варианта самолетов — F-35A (для ВВС), а также F-35B и F-35C (для Военно-морских сил). Эта программа стала самой дорогостоящей в истории производства оружия: США потратили на нее почти полтора триллиона долларов, а сами истребители ввели в строй на семь лет позже, чем предполагалось.*Запрещенная в России террористическая группировка. https://ria.ru/20190410/1552535509.html сша РИА Новости 1 5 4.7 96 internet-group@rian.ru 7 495 645-6601 ФГУП МИА «Россия сегодня» https://xn--c1acbl2abdlkab1og.xn--p1ai/awards/ 353 60 353 60 2019 РИА Новости 1 5 4.7 96 internet-group@rian.ru 7 495 645-6601 ФГУП МИА «Россия сегодня» https://xn--c1acbl2abdlkab1og.xn--p1ai/awards/ 353 60 353 60 Новости ru-RU https://ria.ru/docs/about/copyright.html https://xn--c1acbl2abdlkab1og.xn--p1ai/ РИА Новости 1 5 4.7 96 internet-group@rian.ru 7 495 645-6601 ФГУП МИА «Россия сегодня» https://xn--c1acbl2abdlkab1og.xn--p1ai/awards/ 353 60 353 60 1920 1080 true 1920 1440 true 1920 1920 true РИА Новости 1 5 4.7 96 internet-group@rian.ru 7 495 645-6601 ФГУП МИА «Россия сегодня» https://xn--c1acbl2abdlkab1og.xn--p1ai/awards/ 353 60 353 60 РИА Новости 1 5 4.7 96 internet-group@rian.ru 7 495 645-6601 ФГУП МИА «Россия сегодня» https://xn--c1acbl2abdlkab1og.xn--p1ai/awards/ 353 60 353 60 в мире, сша, f-35, ввс сша, исламское государство*',\n",
       " ('F-35',\n",
       "  34,\n",
       "  0): 'This story is available exclusively to Business Insider subscribers. Become an Insider and start reading now. The F-35 Lightning II Joint Strike Fighter has been plagued with controversy and growing pains throughout its development and operational fielding. However, the controversial stealth fighter has seen widespread adoption and fielding by the United States and its allies around the world. One of the most enthusiastic adopters of the F-35 is the Israeli Air Force. Israeli F-35s were the first to see combat in 2018. On March 7, 2022, the Israeli Defense Forces declassified a report and footage of the F-35 scoring its first air-to-air kills. \"On March 15, 2021, two Iranian UAVs attempted to infiltrate Israel,\" the previously classified IDF report states. \"The Israeli Air Force successfully intercepted these UAVs using a F-35I \\'Adir\\' fighter jet.\" According to the IDF, the drones were carrying weapons en route to the Gaza Strip. An Israeli Air Force F-35 during an aerial demonstration at the Hatzerim Airbase in southern Israel, December 29, 2016. REUTERS / Amir Cohen The footage released by the IDF is from the F-35\\'s point of view and begins with the pilot making visual contact with the first drone. In contact with a controller, the pilot receives permission to fire on the drone. Cleared to shoot, he launches a missile which connects with the drone and destroys it. The IDF footage continues with a second intercept by a different F-35. It begins with a controller confirming the pilot\\'s identification of the drone and its triangular wing. The pilot, who presumably already received permission to engage, fires a missile which makes impact and the video ends with the destruction of the second drone. While not as glamorous as a dogfight with a piloted aircraft, drone intercepts still require great skill and precision. Smaller UAVs, like the ones shot down by the Israeli F-35s, are more difficult to acquire both visually and with radar and can be just as difficult to secure a lock onto. With its first aerial kills under its belt, the F-35 continues its fight to prove itself on the modern battlefield.',\n",
       " ('F-35',\n",
       "  35,\n",
       "  0): 'In the latest setback for the Pentagon’s nearly $400-billion F-35 Joint Strike Fighter program, the U.S. military has grounded all of the fighter jets from flight operations after one of them caught fire at Eglin Air Force Base in Florida earlier this week. Flights had been expected to resume the day after Monday’s mishap, but the Air Force, Navy and Marine Corps decided to suspend all F-35 operations until it was determined that flights could resume safely. A safety board has begun investigating the incident to determine the cause. Early Monday, one of the Air Force’s radar-evading, supersonic fighter jets caught fire before takeoff. The pilot left the aircraft uninjured, officials said. Advertisement The aircraft was preparing to take off on a training mission but aborted when flames appeared in the rear of the aircraft. Emergency responders extinguished the fire with foam, according to an Air Force statement. The 33rd Fighter Wing at Eglin provides training for F-35 pilots and mechanics for the Marine Corps, Navy and Air Force. The wing commander there stopped flights as a precautionary measure, but flights continued elsewhere around the country. More than 100 F-35s are in service at bases around the nation, including Edwards Air Force Base about 100 miles northeast of Los Angeles. Advertisement The decision to ground all F-35 flights was made Wednesday afternoon as more information became available, according to F-35 spokeswoman Kyra P. Hawn in the military’s Joint Program Office. “We are grateful that Monday’s incident was contained, and that procedures were followed that prevented additional damage or injury,” she said. The Joint Strike Fighter program centered around a plan to develop one basic fighter plane that could — with a few manufacturing tweaks — be used by the Air Force, Navy and Marines. The idea is that it can be configured to take off and land on runways and aircraft carriers, as well as hover like a helicopter. Advertisement No one stealthy fighter aircraft has all these capabilities. From an engineering standpoint, it’s a challenging task for plane maker Lockheed Martin Corp. because the requirements of the different services vary so much. “Follow-on activities are providing us with the opportunity to learn how to efficiently and effectively coordinate the flow of relevant information to a diverse group of F-35 stake holders,” Hawn said. The grounding of the F-35 fleet is a blow to the often-troubled program, which has been in development for more than a decade, is billions of dollars over budget and years behind schedule. Per-plane cost estimates have risen from $78 million in 2001 to $135 million today, according to the Government Accountability Office. Testing is key to the Pentagon’s ultimate plan to build 2,457 of the planes. Problems have repeatedly cropped up. On June 13, test flights were temporarily halted and mandatory inspections were ordered for all versions of the jets after a Marine F-35 suffered an in-flight emergency with its engine. A Lockheed spokesman said that the company was aware of the incident at Eglin and prepared to provide any assistance requested. Interested in things that fly? Follow @wjhenn for aerospace news.',\n",
       " ('F-35',\n",
       "  36,\n",
       "  0): 'This story is available exclusively to Business Insider subscribers. Become an Insider and start reading now. An F-35B from Marine Fighter Attack Training Squadron 501 (VMFAT-501), flies near its base a MCAS Beaufort, South Carolina. Lockheed Martin An F-35B Joint Strike Fighter caught fire while in-flight during a training exercise last month, according to a report from Hope Hodge Seck of Military.com. The incident was listed by the Naval Safety Center as a \"Class A Mishap\" — the most serious mishap class — which means that there was $2 million or more in damage. The Safety Center\\'s report said the fire occurred in the aircraft\\'s weapons bay on Oct. 27, and was followed by an \"uneventful landing.\" The actual amount of damage to the aircraft, which belonged to Marine Fighter Attack Training Squadron 501 out of Beaufort, S.C., is not yet known. A number of calls made by Business Insider to the 2nd Marine Aircraft Wing for comment went unanswered. However, a spokesman reported to Military.com that there were no injuries in the incident. \"The aircraft landed safely and there were no injuries sustained,\" 1st Lt. John Roberts told the site. \"An investigation is ongoing and we will provide updates as they are available.\" This seems to be the first time the Marine F-35B variant of the aircraft — which takes off and lands vertically — has caught on fire. An Air Force F-35A caught on fire soon after its pilot started the engine in September. In 2014, another Air Force F-35 caught on fire during takeoff, according to Popular Mechanics. The 2014 incident led the Pentagon to temporarily ground all F-35s until investigators determined a fix. Besides potentially dangerous incidents of fire, the troubled fifth-generation fighter has been marred by cost overruns and criticized for its excessive cost. Earlier this month, defense officials put in a request for a half-billion more dollars to finish development of the jet, which has already gone 50% over its original budget. Rising costs haven\\'t been the only problem of note for the F-35. The jet has had plenty of other incidents while being built, such as electrical problems, major issues with its software, and problems related to its advanced helmet system. Just four months ago, the Pentagon\\'s chief weapons tester wrote in a memo the F-35 program was \"not on a path toward success but instead on a path toward failing to deliver.\" Still, the Air Force and Marines have both declared the fighter \"combat ready\" and have begun integrating it into their squadrons. The military has only taken delivery of about 180 of the aircraft from Lockheed Martin so far, though it plans to buy more than 2,400. The fighter, which features stealth and advanced electronic attack and communications systems, is a project with roots going back to the late 1990s. Lockheed won the contract for the fighter in 2001.',\n",
       " ('F-35',\n",
       "  37,\n",
       "  0): 'This post was updated to include a statement from Lockheed Martin. A Lockheed Martin F-35 Joint Strike Fighter was severely damaged — possibly destroyed — in a Monday morning fire on the runway at Eglin Air Force Base, Fla., USNI News learned. No injuries were reported and officials have begun an investigation into the incident, defense officials told USNI News on Monday. “The aircraft was preparing to conduct a continuation training mission at the time of the incident, but aborted during takeoff at Eglin Air Force Base due to a fire in the back end of the aircraft,” according to a Monday statement provided to USNI News from the Air Force. “Emergency responders extinguished the fire with foam.” The aircraft was a F-35A — the Air Force variant of the fighter — assigned to the 33rd “Nomads” Fighter Wing. The wing is schoolhouse for all versions of the JSF and trains sailors, airmen and Marines. “We have a robust and extensive training program in which every pilot and aircraft crew member is trained in order to respond quickly and correctly in the event emergencies occur,” said U.S. Navy Capt. Paul Haas, the 33rd Wing vice commander in the statement. “In this case, the pilot followed the appropriate procedures which allowed for the safe abort of the mission, engine shutdown, and egress.” The base had trained for a F-35 ground fire as recently as mid-May, according to a separate release from Eglin. “We are aware of the event at Eglin AFB today involving an F-35A aircraft. The aircraft is in the very capable hands of the 33rd Fighter Wing,” a Lockheed Martin spokeswoman said in a statement to USNI News. “Lockheed Martin informed the wing that we are available for assistance upon request.” This is the first incident this severe for the JSF during the life of the tri-service program. There are currently 104 Joint Strike Fighters in the U.S. inventory — split between U.S. Air Force, U.S. Navy and U.S. Marine Corps variants, according to information from Lockheed. View Eglin Air Force Base in a larger map Eglin — located on the Florida panhandle — is the home the training centers for pilots and maintainers for all three U.S. variants of the JSF as well as international vairants. The 33rd was designated as the F-35 schoolhouse in 2009 and received its first F-35 in 2011. The wing is set to receive an estimated 59 aircraft by 2018. The wing is part of the larger F-35 Integrated Training Center which plans to have annual output of 100 pilots and 2,100 by 2018. The JSF fleet was grounded earlier this month after a Marine variant of the aircraft suffered an engine oil leak in flight.',\n",
       " ('F-35',\n",
       "  38,\n",
       "  0): 'WASHINGTON — An F-35A caught fire during an exercise at Mountain Home Air Force Base, Idaho, the Air Force confirmed to Defense News. The incident took place at around noon and involved an F-35A aircraft from the 61st Fighter Squadron located at Luke Air Force Base, the service said in a statement. No serious injuries seem to have been sustained by the pilot or nearby crew. \"The pilot had to egress the aircraft during engine start due to a fire from the aft section of the aircraft,\" Air Force spokesman Capt. Mark Graff said in an email. \"The fire was extinguished quickly. As a precautionary measure, four 61st Aircraft Maintenance Unit Airmen, three Airmen from the 366th Maintenance Group and the 61st Fighter Squadron pilot were transported to the base medical center for standard evaluation.\" Seven F-35As from Luke AFB, which is one of the bases responsible for joint strike fighter pilot instruction, had deployed to Mountain Home to conduct surface-to-air training from Sept. 10 to 24. The root cause of the event is under investigation, Graff stated. At the time of publication, it is still unknown whether the fire originated from the F-35\\'s F135 engine, manufactured by Pratt & Whitney. \"We are aware of an incident involving an F-35A jet from Luke Air Force Base operating at Mountain Home Air Force Base, but we do not have any further details at this time,\" said Pratt & Whitney spokesman Matthew Bates. \"We are ready to assist the U.S. Air Force and the F-35 Joint Program Office in their investigation.\" It\\'s also unknown if there is a connection to a recent problem with the F-35A\\'s coolant line insulation that caused the flight operations of 15 joint strike fighters to be suspended. During depot maintenance it was discovered that the insulation around the coolant lines was breaking down inside the fuel tank— a situation the joint program office said was due to the supplier using the incorrect materials to manufacture the insulation. The insulation issue also impacts 42 F-35s on manufacturer Lockheed Martin\\'s production line. When the problem was made public last Friday, JPO officials said they were certain no other planes had been affected. Earlier this week, F-35 Joint Program Executive Officer Lt. Gen. Christopher Bogdan said Lockheed planned to test a potential fix next week, and if it works, company teams would roll out the following week to begin repairs. Marine Corps Times Reporter Jeff Schogol and Defense News reporter Aaron Mehta contributed to this report. Valerie Insinna is Defense News\\' air warfare reporter. She previously worked the Navy/congressional beats for Defense Daily, which followed almost three years as a staff writer for National Defense Magazine. Prior to that, she worked as an editorial assistant for the Tokyo Shimbun’s Washington bureau.',\n",
       " ('F-35',\n",
       "  39,\n",
       "  0): 'The Marine Corps is investigating after an F-35B Joint Strike Fighter based out of Beaufort, South Carolina, recently caught fire in mid-air, Military.com has learned. The incident happened Oct. 27 at Marine Fighter Attack Training Squadron 501, a fleet replacement squadron for the Marine Corps consisting of 20 F-35B aircraft. One of the aircraft experienced a fire in the weapons bay while conducting a training mission over Beaufort, 1st Lt. John Roberts, a spokesman for 2nd Marine Aircraft Wing, told Military.com. \"The aircraft landed safely and there were no injuries sustained,\" he said. \"An investigation is ongoing and we will provide updates as they are available.\" No estimate of damage caused by the fire was available. The incident was listed by the Naval Safety Center as a Class A mishap, meaning damage totalled $2 million or more on the $100 million aircraft. The squadron didn\\'t observe any kind of grounding or operational pause as a result of the mishap, Roberts said. The F-35 program has suffered several setbacks due to aircraft catching fire, though previous incidents involved the Air Force\\'s F-35A conventional take-off and landing variant. In June 2014, an F-35A caught fire upon takeoff at Eglin Air Force Base, Florida, prompting the Defense Department to ground the entire F-35 fleet as it investigated the incident. This move forced the Marine Corps to postpone what was to have been the F-35B\\'s international debut at the Farnborough International Airshow that summer. The damage to the aircraft in that incident came to more than $50 million and was determined to have been caused by a rotor arm that detached and came through the aircraft\\'s upper fuselage, cutting fuel and hydraulic lines in its trajectory. More recently, in September, an F-35A from the 61st Fighter Squadron caught fire in the aft section of the aircraft after its engine was started, forcing the pilot to exit the aircraft. In an unrelated issue, the Air Force grounded 15 F-35As the same month due to failing coolant tube insulation. For the Marine Corps, this incident comes at a crucial time for the aircraft, as the first operational F-35B squadron, Marine Fighter Attack Squadron 121, prepares to forward-base from Yuma, Arizona to Japan in January, ahead of a sea deployment in the Pacific early the following year. The aircraft is now completing its third and final round of at-sea developmental tests aboard the amphibious assault ship USS America off the coast of San Diego, and is expected to complete them later this month. -- Hope Hodge Seck can be reached at hope.seck@military.com. Follow her on Twitter at @HopeSeck. Related Video:',\n",
       " ('F-35',\n",
       "  4,\n",
       "  0): 'Lockheed Martin has traced the U.S. Navy F-35C Joint Strike Fighter’s troubles with catching a carrier’s arresting gear wires to the tailhook design. Efforts to fix the problem are well underway, a top company official said. “The good news is that it’s fairly straight forward and isolated to the hook itself,” said Tom Burbage, Lockheed program manager for the F-35 program. “It doesn’t have secondary effects going into the rest of the airplane.” Moreover, the rest of the design of the tailhook system, which include the doors and bay that conceal the device and other ancillary hardware, is sound, Burbage said. “What we are trying to do is make sure that we got the actual design of the hook is optimized so that it in fact repeatedly picks up the wire as long the airplane puts itself in position to do that,” he said. A preliminary review has already been completed and was done in conjunction with the Naval Air Systems Command and F-35 Joint Program Office. Burbage said the hook system is already being modified in accordance with the new test data. “We’re modifying the hook to accommodate what we found so far in test,” Burbage said. “The new parts, we expect to have them back in the next couple of months.” Tests with the newly modified tailhook should start at Lakehurst, N.J, in the second quarter of this year, Burbage said. That will give the F-35 program another set of data to study to make sure the new design works as promised. However, until those tests are done, there is no ironclad guarantee that the redesign of the tailhook will work, but Burbage said he is confident of that the modified design will be successful. “The big test for this airplane is not until the summer of ’13 when we take the Navy jet out to the big deck carrier and do actual traps at sea,” Burbage said. Burbage dismisses claims that the F-35C will be unable to land on a carrier as falsehoods. “That’s patently not true,” he said. Richard Aboulafia, an analyst at the Teal Group, Fairfax, Va., said the claim that the F-35C could never land on a ship was always highly dubious. “They turned the YF-17 into a carrier plane, why couldn’t they correct carrier-hook problems here?” he said. “This does not appear to be a killer problem.” Flight testing is designed to uncover and fix problems with a new aircraft, Aboulafia said. “This is the kind of problem that might come out during the flight testing of a carrier-based plane,” he said. Aboulafia added that the F-35 is an extremely ambitious program with its three variants — technical problems are par for the course. The reason the problem with the hook arose in the first place is because of the inherent constraints of building a stealth fighter, said Burbage. The F-35 is the first naval stealth fighter and as such, Lockheed had the unique challenge of designing the jet with a tail-hook that had to be concealed when it’s not being used. Because the tail-hook has to fit within the outer mold line of the F-35, the device had to be fitted further forward on the jet’s ventral surface than on other naval aircraft, Burbage said. The result is that the hook behaves differently than on previous fighters like the F/A-18. In an ideal world, an arresting-hook will catch a wire 100 percent of the time, however in the real world that doesn’t happen due to various dynamic forces, the veteran former Navy test pilot said. In the case of the F-35, one',\n",
       " ('F-35',\n",
       "  4,\n",
       "  1): 'of those dynamic forces includes the way the wires react when the jet passes over them. The wire reacts in a sine wave pattern, Burbage said. “The time differential between when the main gear rolls over the cable and the time the hook picks up the cable on a more convention airplane, there is more time for that wave to damp out,” he said. “In the case of the F-35, one of our design constraints is that hook just has to be closer to the main landing gear than on a conventional aircraft because of the requirement to hide it inside the airplane.” Another factor that effects landing on a carrier is the sheer force of the impact from a carrier landing. Unlike conventional land-based aircraft, naval aircraft don’t flare on landing. While the landing is on a more precise spot, it causes the tail-hook to oscillate vertically- which increases the chances that it won’t catch a wire, Burbage said. The dampening of that motion has to be tweaked, he said. The shape of the hook itself also has an effect on the probability of catching a wire, he added. All of these are being tweaked to increase the chances that the F-35C will catch a wire on a carrier’s deck. “We’re doing a redesign of the hook to increase the probability the hook will engage the wire a high percentage of the time,” Burbage said.',\n",
       " ('F-35',\n",
       "  40,\n",
       "  0): 'The F-35A experienced an in-flight emergency and returned to base. The aircraft landed safely and parked when the front nose gear collapsed An F-35A Lightning II, assigned to the 58th Fighter Squadron, experienced a ground mishap on Aug. 22, 2018 at approximately 12:50 p.m. today on the flightline at Eglin Air Force Base (AFB). The F-35A experienced an in-flight emergency and returned to base. The aircraft landed safely and parked when the front nose gear collapsed, the U.S. Air Force (USAF) said in a News Release. There was one person on board. Fire crews responded immediately and the pilot suffered no injuries as a result of the incident. An investigation into the circumstances surrounding the mishap is underway. Photos captured by local media show the plane sitting safely on the runway, with its nose down on the ground. Photo credit: Michael Snyder / Daily News What damage may have resulted from the incident, and the costs associated with repairing it, is unclear; the USAF in fact did not share details on the initial incident which required the plane to return to base early. It’s not the first time the F-35 has had an issue with its front landing gear. In 2017, Navy pilots using the F-35C model – a different variation of the fighter jet, designed for operations on a carrier – complained the jet would bob up and down on its nose gear when being launched from a catapult, Defense News reported. The issue was bad enough that pilots said they could not read instruments while trying to take flight. A number of pilots also said they experienced pain from the motion. The department worked with Lockheed Martin on a fix for the issue. F-35A Lighning II 56th OG, 61st FS, LF/12-5050 / 2014 Top image: Senior Airman Stormy Archer / U.S. Air Force Artwork courtesy of AircraftProfilePrints.com',\n",
       " ('F-35',\n",
       "  41,\n",
       "  0): 'WASHINGTON ― After a mid-air emergency forced an F-35A fighter jet to return to Eglin Air Force Base, the plane’s nose landing gear collapsed, leaving the fifth-generation fighter face down on the runway. The incident happened around 12:50 p.m. Wednesday. Fire crews responded immediately, and the pilot suffered no injuries, according to the Air Force. The plane is assigned to the 58th Fighter Squadron, and the service has launched an investigation into the incident. Photos captured by local news outlets show the plane sitting safely on the runway, with its nose down on the ground. What damage may have resulted from the incident, and the costs associated with repairing it, is unclear; the service did not share details on the initial incident which required the plane to return to base early. It’s not the first time the F-35 has had an issue with its front landing gear. In 2017, Navy pilots using the F-35C model — a variation of the fighter jet designed for operations on a carrier ― complained the jet would bob up and down on its nose gear when being launched from a catapult. The issue was bad enough that pilots said they could not read instruments while trying to take flight. A number of pilots also said they experienced pain from the motion. The department worked with Lockheed Martin on a fix for the issue. Aaron Mehta was deputy editor and senior Pentagon correspondent for Defense News, covering policy, strategy and acquisition at the highest levels of the Defense Department and its international partners.',\n",
       " ('F-35',\n",
       "  42,\n",
       "  0): 'A “ground mishap” has just occurred to an F-35A Lightning II at Eglin Air Force Base. Nose gear collapse Just in from 33rd FW: “An F-35A Lightning II, assigned to the 58th Fighter Squadron, experienced a ground mishap at approximately 12:50 p.m. today on the flightline here. The F-35A experienced an in-flight emergency and returned to base. The aircraft landed safely and parked when the front nose gear collapsed. There was one person on board. Fire crews responded immediately and the pilot suffered no injuries as a result of the incident. An investigation into the circumstances surrounding the mishap is underway.” A photograph, taken by a motorist from a road near the incident location, of the aircraft nose down next to the runway was published by local news outlet. The extent of the damage (and the subsequent cost) is unknown (the aircraft’s Electro-Optical Targeting System – EOTS – might be heavily damaged). Nor is it clear the type of emergency that forced the F-35A to return to Eglin AFB where it suffered the gear collapse. Two F-35A Lighting II Joint Strike Fighters were due to depart Eglin AFB in Florida on Thursday morning, August 23, 2018, for the Thunder Over Michigan airshow at Willow Run Airport in Ypsilanti, Michigan. Public Affairs officers at Eglin AFB have verified that the F-35A involved in today’s incident is not one of the two aircraft to be displayed at the airshow this weekend. There have been two other significant incidents with the aircraft including an engine fire on an F-35A on Sept. 23, 2016 at Mountain Home AFB in Idaho and on Oct. 27, 2016 when an F-35B part of Marine Fighter Attack Training Squadron 501 caught fire in the internal weapons bay causing significant damage. The ground incident at Mountain Home AFB was attributed to strong winds blowing into the afterburner outlet of the aircraft. We will provide further updates as soon as they are released. Written with Tom Demerly Top image: File photo of an F-35A Lightning II departs for Exercise Red Flag 17-3 July 6, 2017, at Eglin Air Force Base, Fla. (U.S. Air Force photo by Staff Sgt. Peter Thompson/Released)',\n",
       " ('F-35',\n",
       "  43,\n",
       "  0): 'Both Aircraft Landed Safely, but “Class A” Damage Sustained by F-35C in Accident. A U.S. Navy F-35C Lightning II was damaged during a midair refueling exercise with an F/A-18F Super Hornet over the Atlantic Ocean on Tuesday according to a statement released by the Naval Air Forces Atlantic spokesman Commander Dave Hecht to United States Naval Institute News (USNI). The F-35C, the naval variant of the Joint Strike Fighter, was flying from the aircraft carrier USS Abraham Lincoln (CVN-72). The F-35C involved in the accident returned to the aircraft carrier and landed safely aboard ship following the accident. The F/A-18F Super Hornet landed at Naval Air Station Oceana in Virginia following the accident. The report in USNI indicated the F-35C Lightning II was from Strike Fighter Squadron (VFA) 125, the “Rough Raiders” on board the USS Lincoln. The F/A-18F Super Hornet involved in the accident was from Strike Fighter Squadron (VFA) 103, the “Jolly Rogers”. The F-35C sustained engine damage during the accident when debris from the aerial refueling drogue being trailed by the F/A-18F Super Hornet serving as the tanker aircraft became ingested into the F-35C’s engine. There were no injuries and an official investigation is pending according to U.S. Navy sources. The damage to the F-35C was categorized as a “Class A Mishap”, the most extensive level of damage for a military aircraft. Class A mishaps occur when an aircraft is completely destroyed, involves a serious injury or fatality or the aircraft itself sustains more than $2 million in damage. If the F-35C’s engine, a Pratt & Whitney F135 jet engine, the most powerful and advanced in its class, were destroyed in the accident it could cost as much as $14 million to replace it not including any additional damage to the aircraft’s airframe or avionics. Damage to the F/A-18F Super Hornet was reported to be less severe and categorized as a “Class C” mishap with no injuries and damage reported to be between $50,000 and $500,000 USD according to Commander Dave Hecht. The two aircraft involved in the accident were operating over the Atlantic and from the aircraft carrier USS Abraham Lincoln as part of an integrated air wing test. The series of tests at sea are a realistic simulation, test and training exercise of how the new Lockheed Martin F-35C Lightning II Joint Strike Fighter naval variant will interface with other combat and support aircraft from the USS Abraham Lincoln. U.S. Navy Rear Admiral Dale Horan told reporters on board the USS Abraham Lincoln last week that the operations underway were validating how the F-35C, “Integrates with the ship, how it interoperates with communications, data links, other aircraft, and then how we conduct the mission and tie into the other aircraft that are conducting that mission and how effective they are when they do it.” Rear Admiral Horan is the director of Joint Strike Fighter Fleet Integration for the Navy. Two U.S. Navy units are operating the new F-35C Lightning II from the USS Abraham Lincoln during the exercise, VFA-125, the “Rough Raiders” from Naval Air Station Lemoore, California and VFA-147, the “Argonauts” also from NSA Lemoore. Prior to today’s accident the U.S. Navy forecasted that the F-35C would achieve initial operational capability (IOC) sometime in February of 2019. In order to achieve that level of operational readiness the Navy will have to demonstrate the ability to successfully operate ten F-35Cs at sea, including all support and logistical operations to maintain F-35C operations. Of the three U.S. forces operating the F-35 Joint Strike Fighter; the USAF with the F-35A, the U.S. Marines with the F-35B STOVL',\n",
       " ('F-35',\n",
       "  43,\n",
       "  1): 'variant and the U.S. Navy with the wider-wingspan F-35C model, the U.S. Navy has been the last to enter the IOC phase of operations. Some analysts suggest this is partially because of the demands placed on the Navy’s F-35C by catapult launches and arrested landings on Navy aircraft carriers. Top Image: The accident was the first Class A mishap for a U.S. Navy F-35C Lighting II. (Photo: U.S. Navy)',\n",
       " ('F-35',\n",
       "  44,\n",
       "  0): 'An F-35B that erupted into flames after a faulty bracket issue nearly two years ago has been struck by the Marine Corps, making it the first loss of an F-35 for the Corps. The Corps made the determination that the costs to repair the costly high-tech fighter would not be worth the return on investment. However, the Marines have not put out an official strike message for the F-35B because the Corps has not decided whether the aircraft will be used as a trainer for maintenance or a museum centerpiece. RELATED “With the specific F-35B involved in this discussion, the Marine Corps’ cost-benefit analysis determined the repair costs would not yield a sufficient ROI [return on investment] to justify the expenses,” Capt. Christopher Harrison, a Marine spokesman, told Marine Corps Times. “The decision was made to strike the F-35B; however, there has not yet been a strike message as the disposition decision has not yet been made.” On Oct. 27, 2016, a fire broke out mid-air on F-35B forcing the pilot to land at Marine Corps Air Station Beaufort, South Carolina. The faulty bracket, which was known as a potential hazard by officials overseeing the F-35 program, grazed electrical wiring near hydraulic lines. A fire erupted when an electrical short ignited a small hydraulic leak. Despite the loss of the F-35 the Marine Corps has made some recent historic strides with its F-35 program. Earlier this year, the F-35B made its first deployment aboard the amphibious assault ship Wasp with the 31st Marine Expeditionary Unit, or MEU. And during that deployment, live munitions were loaded onto an F-35 for the first time while underway. The 13th Marine Expeditionary is also slated to deploy with F-35s. That unit is still amid predeployment workups. Shawn Snow is the senior reporter for Marine Corps Times and a Marine Corps veteran.',\n",
       " ('F-35',\n",
       "  45,\n",
       "  0): 'An in-flight fire that erupted on a Marine F-35B last year was caused by a flawed bracket that the Pentagon’s F-35 Joint Strike Fighter program office should have known was a serious hazard, according to a Marine Corps investigation. The weapons bay bracket that caused the fire was a “known and previously identified hazard in the F-35B community,” the commander of Marine Aircraft Group 31 wrote in an endorsement of the investigation. “The Joint Strike Fighter Program Office (JSFPO) should have assessed the risk of the broken bracket as more severe than Marginal, properly assessed the root cause of the broken brackets, and implemented a long-term solution to prevent bracket failures,” according to a redacted copy of the investigation, which Marine Corps Times obtained through a Freedom of Information Act request. On Oct. 27, 2016, a fire broke out while the F-35B was in the air. The plane’s warning system identified the malfunction, allowing the pilot to land safely at Marine Corps Air Station Beaufort, South Carolina, a 2nd Marine Aircraft Wing spokesman said. The broken bracket had chafed against electrical wiring, which is near hydraulic lines, the investigation found. An electrical short ignited fluid from a pinhole-sized leak in the hydraulic line. “The Joint Strike Fighter Program Office should re-evaluate the risk severity of the faulty bracket design in order to prevent re-occurrence of an in-flight fire or the potential loss of an aircraft,” wrote the commander, whose name was redacted. The investigation is the latest criticism for the F-35 program, which is the most expensive weapons program in U.S. military history. A spokesperson for the F-35 program was unable to provide a comment for this story on Friday afternoon. The Marine Corps’ investigation also criticized the aircraft’s pilot warning system, which can “be confusing and task saturating for pilots” during complex emergencies because there is no way of knowing which warning is the most serious, the investigation found. In this case, so many warning lights flashed in such a short period of time that it would be difficult for an experienced F-35 pilot to prioritize them, the investigation found. The pilot did handle the situation in “a safe, efficient and professional manner,” and should not be held responsible for any damage to the aircraft.',\n",
       " ('F-35',\n",
       "  46,\n",
       "  0): 'This post has been updated, and will be updated as more information becomes available. A Marine Corps F-35B Joint Strike Fighter crashed near Marine Corps Air Station Beaufort in South Carolina today, the Marine Corps confirmed. A JSF from training squadron Marine Fighter Attack Training Squadron 501 (VMFAT-501) crashed near the air station around 11:45a.m. today, according to a statement from II Marine Expeditionary Force. “The U.S. Marine pilot safely ejected from the single-seat aircraft and is currently being evaluated by medical personnel. There were no civilian injuries,” according to the statement. The Hilton Head Island Packet newspaper first reported that a military plane crashed five miles from the air station, and the Beaufort County Sheriff’s office stated on Twitter that the pilot of the aircraft ejected safely. The pilot from the military plane crash safely ejected. Being a valuated for injuries. — Beaufort County Sheriff’s Office,SC (@bcsopio) September 28, 2018 Marine Fighter Attack Training Squadron 501 (VMFAT-501), which trains F-35B pilots, operates out of MCAS Beaufort on the South Carolina coast. The following is the full statement from II Marine Expeditionary Force: A 2nd Marine Aircraft Wing F-35B belonging to Marine Fighter Attack Training Squadron 501 (VMFAT-501) stationed at Marine Corps Air Station Beaufort crashed in the vicinity of Beaufort, South Carolina at approximately 11:45 a.m. (EST), today. The U.S. Marine pilot safely ejected from the single-seat aircraft and is currently being evaluated by medical personnel. There were no civilian injuries. Marines from MCAS Beaufort are working with local authorities currently conducting standard mishap operations to secure the crash site and ensure the safety of all personnel in the surrounding area. The cause of the crash is under investigation. For questions outside of this specific incident regarding the F-35, contact [email protected], or call 703-614-4309.',\n",
       " ('F-35',\n",
       "  47,\n",
       "  0): 'A collision between a bird and a F-35 Joint Strike Fighter caused more than two million dollars in damage and grounded the jet until repairs are completed. The pilot of the aircraft, based in Japan, was not injured, but the incident highlights how even the most high tech aircraft can be instantly crippled—sometimes with fatal consequences—by a simple collision with wildlife. The incident took place on May 7th and Marine Corps Air Station Iwakuni. The fighter, assigned to the Japan-based Marine Fighter Attack Squadron 121, collided with a bird on takeoff. According to Military.com the pilot was uninjured and able to safely taxi the aircraft off the runway. Although exact details of the damage were not released the incident was classified “Class A” by military authorities, which means at least $2 million in property damage was sustained by the $120 million F-35B fighter bomber. The Department of Defense’s Partners in Flight program , meant to conserve migratory and resident birds on DoD lands, estimates that the Air Force, Navy, and Marine Corps report up to 3,000 bird strikes a year, what it refers to as Bird/Wildlife Aircraft Strike Hazard (BASH). Most of those strikes do not result in damage to the aircraft or injuries to aircrew, but a handful do very serious damage, resulting in damages in excess of $75 million a year. The DoD takes BASH seriously. Blood, bits of tissue, and feather fragments are sent worldwide to the Smithsonian Institution for species identification, including the use of DNA and microscopic feather analysis. Armed with knowledge of the species involved and their behavior, the military can undertake a variety of measures to mitigate the BASH threat, including habitat clearing, culling with firearms, and the use of propane-powered sonic cannons to scare birds away. U.S. Marine Corps photo by Lance Cpl. Tyler Harmon A Marine Corps MV-22 Osprey tiltrotor and Osprey bird sharing the same airspace over Iwakuni Japan, May 2019. Marine Corps Air Station Iwakuni is home to a variety of wildlife, and surveys conducted in 2017 noted skylarks, ospreys, and peregrine falcons —among other birds—nesting on the base. The base even has a special web page advising Marines and dependents not to feed local wildlife, not only to avoid disrupting the balance of nature but attracting animals that could become a hazard to air operations onto the base. The F-35 Joint Strike fighter, the most expensive military program of all time, involves three versions of the same fighter separately produced for the U.S. Air Force, U.S. Navy, Marine Corps, and foreign customers. The aircraft is relatively safe from an accident perspective, though there have been three ground fires caused by engine exhaust, including one that caused serious injuries to the pilot. Two aircraft have been lost to crashes: a 2018 crash in South Carolina was the result of a manufacturing defect while a Japanese F-35A was lost in April 2019 , the exact cause unknown at this time. The new jet has experienced its share of bird strikes: in 2017 two storks hit an Israeli Air Force F-35 while a F-35A belonging to the U.S. Air Force struck a bird at Eglin Air Force Base in Florida in 2018.',\n",
       " ('F-35',\n",
       "  48,\n",
       "  0): 'WASHINGTON ― After a mid-air emergency forced an F-35A fighter jet to return to Eglin Air Force Base, the plane’s nose landing gear collapsed, leaving the fifth-generation fighter face down on the runway. The incident happened around 12:50 p.m. Wednesday. Fire crews responded immediately, and the pilot suffered no injuries, according to the Air Force. The plane is assigned to the 58th Fighter Squadron, and the service has launched an investigation into the incident. Photos captured by local news outlets show the plane sitting safely on the runway, with its nose down on the ground. What damage may have resulted from the incident, and the costs associated with repairing it, is unclear; the service did not share details on the initial incident which required the plane to return to base early. It’s not the first time the F-35 has had an issue with its front landing gear. In 2017, Navy pilots using the F-35C model — a variation of the fighter jet designed for operations on a carrier ― complained the jet would bob up and down on its nose gear when being launched from a catapult. The issue was bad enough that pilots said they could not read instruments while trying to take flight. A number of pilots also said they experienced pain from the motion. The department worked with Lockheed Martin on a fix for the issue. Aaron Mehta was deputy editor and senior Pentagon correspondent for Defense News, covering policy, strategy and acquisition at the highest levels of the Defense Department and its international partners.',\n",
       " ('F-35',\n",
       "  49,\n",
       "  0): 'Pilots with Marine Fighter Attack Training Squadron 501 (VMFAT-501) fly the F-35B Lightning II during the Marine Corps Air Station Beaufort Air Show, April 27. Pilots with Marine Fighter Attack Training Squadron 501 (VMFAT-501) fly the F-35B Lightning II during the Marine Corps Air Station Beaufort Air Show, April 27. U.S. Marine Corps photo by Warrant Officer Bobby J. Yarbrough lighning bolt icon An icon in the shape of a lightning bolt. lighning bolt icon An icon in the shape of a lightning bolt. Impact Link This story is available exclusively to Business Insider subscribers. Become an Insider and start reading now. A bird reportedly managed to bang up an F-35 stealth fighter to the tune of at least $2 million. A Marine Corps F-35B Joint Strike Fighter was recently forced to abort take-off after a surprise bird strike, Maj. Eric Flanagan, a spokesman for 1st Marine Aircraft Wing, told Marine Corps Times. The fighter never took flight and \"safely taxied off the runway,\" but it didn\\'t escape the situation unscathed. An initial assessment of the incident identified this as a Class A mishap, meaning that the $115 million aircraft suffered more than $2 million in damages. A safety investigation, as well as a more comprehensive damage assessment, are currently underway. Birds sucked into an engine\\'s intake can destroy an engine, forcing the plane to make an emergency landing. It\\'s unclear what exactly happened to the bird, but odds are the end result wasn\\'t pleasant. Birds like Canada Geese, which graze on grass at the edges of air fields, are a constant problem for military aircraft. Four years ago, a US military helicopter crashed in the UK, killing all four crewmembers after the aircraft collided with a flock of geese. Between 1985 and 2016, bird strikes killed 36 American airmen, destroyed 27 US Air Force aircraft and cost the service almost a billion dollars, according to the 28th Bomb Wing Public Affairs Office at Ellsworth Air Force Base. Between 2011 and 2017, the USAF experienced 418 wildlife-related mishaps, resulting in $182 million in damages, according to Military Times. Federal Aviation Administration data, according to USA Today, revealed that in 2018 alone there were 14,661 reported bird strikes involving civilian aircraft in the US. Ellsworth Air Force Base, home to a collection of B-1 bombers, has deployed bird cannons to keep its $400 million bombers safe from birds. Read more: An Air Force base just deployed this new weapon in the fight to save its expensive bombers from nature Last month, a hawk went head-to-head with an Air Force F-16 Fighting Falcon during a routine landing at Holloman Air Force Base in New Mexico, Task and Purpose reported. In that case, the hawk definitely lost. The lastest incident is the third major mishap for an F-35B following last September\\'s crash and a fire back a few years back, according to Military.com.',\n",
       " ('F-35',\n",
       "  5,\n",
       "  0): 'Оборонные компании Израиля начали разрабатывать новое оружие, которое будет использоваться на перспективных истребителях F-35 Lightning II. Как сообщает Flightglobal, Израиль планирует приобрести от 22 до 25 таких самолетов, без вооружения. Израильские ракеты и бомбы будут полностью совместимы с системами взаимодействия с оружием F-35 и смогут размещаться во внутренних отсеках самолета. В настоящее время израильская компания Rafael занимается разработкой небольшой ракеты, которая унаследует часть черт уже существующих Python-5 и Derby. Новая ракета класса \"воздух-воздух\" поместится во внутренних бомбоотсеках F-35 и сможет поражать цели, находящиеся за пределами прямой видимости. Компания Israel Military Industries занимается созданием авиационных бомб для F-35. Пока что фирме удалось разработать корректируемую бомбу MPR-500 массой 226 килограммов. Между тем ВВС Израиля начали подготовку прогноза списания и поступления на вооружение истребителей в ближайшие 30 лет. На основе прогноза ВВС намерены скорректировать объем предполагаемой покупки F-35 у США. Кроме того, ВВС страны ведут переговоры с американской компанией Lockheed Martin, разрабатывающей F-35, об условиях участия Израиля в проекте разработки самолета. Переговорный процесс между Израилем и США об F-35 затрагивает стоимость самолета, количество израильских систем, которые могут быть использованы в истребителе, и объем работы, которую будут выполнять израильские компании в случае покупки F-35 у США. Напомним, Израиль настаивает на самостоятельной разработке некоторых систем для самолетов, которые будут поставлены ВВС страны.',\n",
       " ('F-35',\n",
       "  50,\n",
       "  0): 'An F-35B Lightning II with Marine Fighter Attack Squadron 121 departs Marine Corps Air Station Iwakuni, Japan, Sept. 18, 2017. An F-35B with the same squadron was damaged by a birdstrike at Iwakuni on May 7, 2019. (Aaron Henson/U.S. Marine Corps) A bird strike has caused more than $2 million damage to a Japan-based Marine Corps F-35B Lightning II fighter, according to a U.S. military spokesman. “On May 7, 2019, an F-35B with Marine Aircraft Group 12, 1st Marine Aircraft Wing aborted take-off due to a bird strike at Marine Corps Air Station Iwakuni and safely taxied off the runway,” Capt. Marco Valenzuela, a spokesman for the Iwakuni-based Marine Aircraft Group 12, said in an email Friday. Valenzuela did not state whether the aircraft was in the air or on the ground when the strike happened. He did not state what type of bird struck the F-35B. A safety investigation and a complete damage assessment are ongoing, he said. “An initial assessment estimated the damage to the aircraft as exceeding the two million dollar threshold, classifying it as a Class A mishap,” he said. Iwakuni, in Yamaguchi prefecture on Japan’s largest island, Honshu, has been home to F-35Bs from Marine Fighter Attack Squadron 121 — the Green Knights — since January 2017. The short-takeoff, vertical-landing version of the aircraft was designed to replace the F/A-18 Hornet, AV-8B Harrier and EA-6B Prowler jets. Japan’s military has been searching for a Japan Air Self-Defense Force F-35A stealth fighter and its pilot, based at Misawa Air Base, who crashed off the eastern coast of Japan May 8. In April 2018 an Iwakuni-based F-35B with a maintenance issue made an emergency landing at the Japan Air Self-Defense Force’s Tsuiki Air Base in Fukuoka Prefecture. robson.seth@stripes.com',\n",
       " ('F-35',\n",
       "  51,\n",
       "  0): 'The pilot is being treated for his injuries. Authorities responded to an aircraft emergency involving two planes, a c-130 and an F-35, near the Jacqueline Cochran Regional Airport in Thermal, Calif., Sept. 29, 2020. Authorities responded to an aircraft emergency involving two planes, a c-130 and an F-35, near the Jacqueline Cochran Regional Airport in Thermal, Calif., Sept. 29, 2020. Authorities responded to an aircraft emergency involving two planes, a c-130 and an F-35, near the Jacqueline Cochran Regional Airport in Thermal, Calif., Sept. 29, 2020. Authorities responded to an aircraft emergency involving two planes, a c-130 and an F-35, near the Jacqueline Cochran Regional Airport in Thermal, Calif., Sept. 29, 2020. A Marine Corps F-35 fighter jet crashed in Imperial County, California, after clipping the wing of a Marine KC-130 refueling tanker during a mid-air refueling, according to a Marine Corps statement. The F-35 pilot was able to eject safely and the KC-130 was able to carry out a safe emergency landing. The pilot is now being treated for his injuries. \"At approximately 1600 (4 p.m. Pacific time) it was reported that an F-35B made contact with a KC-130J during an air-to-air refueling evolution, resulting in the crash of the F-35B,\" read a statement from Marine Corps Air Station Yuma in Yuma, Arizona. \"The pilot of the F-35B ejected successfully and is currently being treated.\" Authorities responded to an aircraft emergency involving two planes, a c-130 and an F-35, near the Jacqueline Cochran Regional Airport in Thermal, Calif., Sept. 29, 2020. KESQ \"The KC-130J is on deck in the vicinity of Thermal Airport. All crew members of the KC-130J have been reported safe,\" read the statement. The refueling tanker landed near a field, according to images published on social media. A defense official said the KC-130 was stationed at the Marine Corps Air Station Miramar in San Diego, California, and the F-35 was based in Iwakuni, Japan. The Marines said the incident is under investigation.',\n",
       " ('F-35',\n",
       "  52,\n",
       "  0): 'The aircraft has disappeared at around 19.27LT. The status of the aircraft and its pilot is unknown. According to several Japanese media outlets, an F-35A Lightning II belonging to the Japan Air Self Defense Force is currently reported as missing during a mission over the Pacific Ocean. The F-35 launched from Misawa Air Base, in Aomori Prefecture, in the norther part of the country. Misawa is the home of the 302 Hikotai (Squadron), the unit previously operating the F-4EJ “Kai”, that has officially moved to Misawa air base to operate the JASDF F-35A 5th generation aircraft after retiring its last Phatom on Mar. 26, 2019. According to the JASDF, the aircraft had taken off from about 7 minutes, as part of a 4-ship formation, when it disappered on Apr. 9, at 7:27PM LT on the Pacific Ocean about 135 km east of Misawa. Japan Maritime Self Defense Force search and rescue vessels have been dispatched to the area where the aircraft disappeared. If confirmed, the Japanese loss would be the second involving the Lockheed Martin F-35 Lightning II Joint Strike Fighters. The first one occurred on September 28, 2018 when a U.S. Marine F-35B Lightning II crashed near Beaufort, South Carolina. The pilot ejected safely. As a consequence of that mishap, almost all the F-35s were shortly grounded on Thursday, October 12, 2018 for safety inspections of their fuel flow systems. Japan’s program of record is 147 aircraft says the official Lockheed Martin website. “In December 2018, the Japan Ministry of Defense announced its decision to increase its procurement of F-35s from 42 to 147. They stated the aircraft will be a mix of 105 F-35As and 42 F-35B STOVL (Short Take Off and Vertical Landing) aircraft.” 13 F-35A are currently based at Misawa AB, based on Japanese media reports. We will update the story as new details emerge.',\n",
       " ('F-35',\n",
       "  53,\n",
       "  0): 'Gear-obsessed editors choose every product we review. We may earn commission if you buy from a link. Why Trust Us? An F-35B Joint Strike Fighter accidentally shot itself with one of its own Gatling Gun rounds during an exercise. The high explosive round detonated shortly after leaving the gun barrel. The aircraft managed to land and the pilot was unharmed. A Marine Corps F-35B Joint Strike Fighter accidentally shot itself during a practice mission earlier this month, causing more than $2.5 million in damage. Fortunately, the fighter jet was able to land, and the pilot was unharmed. ✈ You love badass planes. So do we. Let’s nerd out over them together. The incident took place during a nighttime close air support mission at Marine Corps Air Station Yuma in Arizona, according to Military.com. A 25-millimeter PGU-32/U Semi-Armor Piercing High Explosive Incendiary-Tracer (SAPHEI-T) cannon round exploded shortly after leaving the F-35B’s GAU-22 four-barrel, 25-millimeter Gatling gun. The GAU-22 is capable of being used in dogfights against other aircraft and ground targets. It has a rate of fire of 3,000 rounds per minute. The GAU-22 gun pod carries 220 rounds of ammunition, enough for just a few seconds of firing. Here’s a video of an F-35B flying from the amphibious assault ship USS Makin Island firing its GAU-22 at a ground target: The Marine Corps’ F-35B carries the GAU-22 differently differently than the Air Force’s -A version. Unlike the -A aircraft, which mounts the GAU-22 inside the aircraft at the base of the left side wing root, the -B mounts the gun in a separate gun pod mounted to the airplane’s belly. This design change was due to a weight issue caused by the need to make the -B version capable of vertical takeoffs and landings. The Marines can leave the gun off the aircraft to reduce weight when necessary. In the case of this recent incident, the pod-mounted gun might have saved the pilot an injury. The mounting system ensured there was a whole airplane between the pilot and the exploding 25-millimeter high explosive round. Had the round exploded after being fired by an F-35A, it might have exploded mere inches from the cockpit canopy. ➡ The Best RC Planes 🎥 Now Watch This:',\n",
       " ('F-35',\n",
       "  54,\n",
       "  0): 'The F-35A Lightning II joint strike fighter lifts off for its first training sortie March 6, 2020, at Eglin Air Force Base, Fla. (Randy Gon/U.S. Air Force) An F-35A Lightning II crashed Tuesday evening while landing at Eglin Air Force Base, Fla., according to a string of messages posted to the base’s official Twitter account. The accident happened at about 9:30 p.m. during “a routine night training sortie,” one of the messages said. The pilot “successfully ejected” and is in stable condition at the 96th Medical Group. There was “no loss of life or damage to civilian property,” another message said. The accident is under investigation. No information was released about damage to the state-of-the-art joint strike fighter, which is assigned to Eglin’s 58th Fighter Squadron. A single F-35A costs about $90 million. The pilot’s name will not be released at this time, one of the tweets said. The incident happened less than a week after an Eglin-based F-22 Raptor crashed during a training accident Friday at a range 12 miles northeast of the main base. That pilot also ejected safely and was in stable condition, base officials said at the time. Eglin, on the Florida Panhandle, is under the command of the 96th Test Wing, which tests and evaluates Air Force equipment and systems. Tuesday’s accident marks the second time the A variant of the advanced stealth fighter has crashed. On April 9, 2019, one of the Japan Air Self-Defense Force’s F-35As plunged into the Pacific Ocean about 85 miles east of Misawa Air Base, its home field in northeastern Japan. The pilot, whose remains were recovered about two months later, likely experienced “spatial disorientation,” the JASDF said at the time. The first F-35 crash happened on Sept. 28, 2018, when a B variant of the joint strike fighter, which is capable of short takeoffs and vertical landings, went down near Beaufort, S.C. The pilot safely ejected. That accident was caused by a manufacturing defect in a fuel tube that made the part rupture during flight, resulting in a loss of engine power, according to congressional investigators. kidd.aaron@stripes.com @kiddaaron',\n",
       " ('F-35',\n",
       "  55,\n",
       "  0): \"An F-35B has crashed in South Carolina near the Marine Corps Air Station Beaufort, military officials have confirmed. The pilot safely ejected from the aircraft and is currently being looked at by medical personnel, Capt. Christopher Harrison, a Marine spokesman, said in a command release. The aircraft belonged to 2nd Marine Aircraft Wing, Marine Fighter Attack Training Squadron 501, known as the “Warlords.” “Marines from MCAS Beaufort are working with local authorities currently conducting standard mishap operations to secure the crash site and ensure the safety of all personnel in the surrounding area,” Harrison said. Numerous local agencies to include the Beaufort Sheriff’s office, Beaufort County Emergency Medical Services, and Beaufort Water Search and Rescue responded to the crash and assisted the Marines with rescue of the pilot and follow on investigation, according to a press release from Sheriff’s office. The Corps said there were no civilian injuries as a result of the crash. Friday’s crash occurred just one day after the Corps' F-35B flew its first combat mission: a ground clearance airstrike in Afghanistan. According to Defense News, the Marine air base at Beaufort, South Carolina, has been training new pilots for the high-tech stealth fighter, but has faced complications over spare parts and the jet’s logistics system. Some of the F-35s sit for extended periods of time waiting for spare parts ordered through the Autonomic Logistics Information System. Sometimes the ALIS projects delivery of expected spare parts as far as two years out, Defense News has reported. Just 82 miles southwest of the Beaufort airbase is the Townsend Bombing Range in Georgia, which is currently undergoing an expansion and modernization so that F-35B pilots can train with precision-guided munitions. In April, a Marine F-35B was forced to make an emergency landing at Cherry Point, North Carolina, after the aircraft began leaking fuel. The cause of Friday’s F-35B crash is under investigation. This story is breaking and will be updated as new information becomes available. Tara Copp and Valerie Insinna contributed to this report. Shawn Snow is the senior reporter for Marine Corps Times and a Marine Corps veteran.\",\n",
       " ('F-35',\n",
       "  56,\n",
       "  0): 'An F-35B Joint Strike Fighter pilot aborted a takeoff last week after it struck a bird on a Japan runway, leading to at least $2 million in damages. The aircraft, assigned to Marine Fighter Attack Squadron 121, struck the bird on May 7, according to data from the Naval Safety Center. The pilot safely taxied off the runway at Marine Corps Air Station Iwakuni, Maj. Eric Flanagan, a spokesman for 1st Marine Aircraft Wing, said. The aircraft never went airborne, he added. There were no injuries caused by the incident, which was first reported by Marine Corps Times. A safety investigation and damage assessment are ongoing, Flanagan said. “An initial assessment estimated the damage to the aircraft as exceeding the $2 million threshold, classifying it as a Class A mishap,” he said. Bird strikes are not uncommon for military and civilian pilots. An Air Force pilot landed an F-35A safely after striking a bird. Last month, another Air Force jet, an F-16 Fighting Falcon, struck a bird when landing at Holloman Air Force Base in New Mexico. The incident was reported by Task and Purpose after a photo showing the aftermath of the strike emerged on a popular Air Force social media account. An Air Force spokeswoman told the outlet the bird involved in that strike was a Swainson’s Hawk, which can grow to about 2 feet long. \"When a bird strike occurs, the remains are sent to the Smithsonian where they classify the bird and determine how it was struck,\" 2nd Lt. Jasmine Manning told Task and Purpose. This is at least the third mishap for a Marine Corps F-35. In September, a Marine F-35B crashed in South Carolina. The pilot was able to eject and was treated at a local medical facility. And in 2016, another F-35B caught fire midflight due to a flawed bracket. That pilot landed the aircraft safely. -- Gina Harkins can be reached at gina.harkins@military.com. Follow her on Twitter @ginaaharkins.',\n",
       " ('F-35',\n",
       "  57,\n",
       "  0): 'An F-35B joint strike fighter jet attaches to the hose of a KC-130J during aerial refueling training over the Atlantic Ocean, Aug. 13, 2015. (Neysa Huertas Quinones/U.S. Marine Corps) An F-35B Lightning II stealth fighter crashed Tuesday afternoon after colliding with an aerial refueler in California, according to Marine Corps Air Station Yuma, Ariz. The F-35B made contact with a KC-130J Super Hercules during an air-to-air refueling operation, resulting in the fighter jet crashing at about 4 p.m., the air station announced in a news release. The pilot of the F-35B safely ejected from the aircraft, which went down in Imperial County, according to the release. The Desert Sun newspaper said it crashed in Salton City near a state park, igniting fires upon impact. They were put out by local firefighters, the report said. The aerial refueler landed safely in the vicinity of an airport in Thermal, Calif., and all crew members have been reported safe, according to the air station. The Desert Sun report said it landed in a carrot field with eight people onboard and was leaking fuel. The accident’s cause is under investigation. The incident comes nearly two years after a similar but fatal incident involving Marine aviators off the coast of Japan. Five crew members of a KC-130J tanker and the pilot of an F/A-18 Hornet died during the nighttime training mission on Dec. 6, 2018. The Hornet collided with the Super Hercules during a refueling operation. The Hornet’s weapons officer was the sole survivor. Both aircraft were based at Marine Corps Air Station Iwakuni. ditzler.joseph@stripes.com Twitter: @starsandstripes',\n",
       " ('F-35',\n",
       "  58,\n",
       "  0): 'A Marine F-35B aircraft has crashed near Naval Air Facility El Centro, Calif., following an air collision with a KC-130J, defense officials confirmed to USNI News. At approximately 4 p.m. local time, “it was reported that an F-35B made contact with a KC-130J during an air-to-air refueling evolution, resulting in the crash of the F-35B. The pilot of the F-35B ejected successfully and is currently being treated,” read a statement from Marine Corps spokesman Capt. Joseph Butterfield to USNI News. “The KC-130J is on deck in the vicinity of Thermal Airport. All crew members of the KC-130J have been reported safe.” The KC-130, often used as an aerial refueler for Marine aviation, made an emergency landing near the Jacqueline Cochran Regional Airport in Therma, Calif., according to photos published by KESQ Channel 3. In 2018, an F-35B went down outside of Marine Corps Air Station Beaufort in South Carolina. The pilot was recovered safely. In 2019, a Japanese F-35A crashed off the coast of Japan. The following is the complete statement from the Marine Corps. MARINE CORPS AIR STATION YUMA, Ariz. (Sep. 29, 2020) — At approximately 1600 it was reported that an F-35B made contact with a KC-130J during an air-to-air refueling evolution, resulting in the crash of the F-35B. The pilot of the F-35B ejected successfully and is currently being treated. The KC-130J is on deck in the vicinity of Thermal Airport. All crew members of the KC-130J have been reported safe. The official cause of the crash is currently under investigation. Updates will be provided as information becomes available.',\n",
       " ('F-35',\n",
       "  59,\n",
       "  0): 'The footage shows the USMC 5th Generation jet bursting into flames upon impact As you probably already know by now, on Sept. 29, 2020, a U.S. Marine Corps F-35B and a KC-130J belonging to the VMGR-352 “Raiders” based at MCAS Miramar, were involved in a mid-air collision during AAR (Air-to-Air Refueling) operations. The F-35B, callsign VOLT 93 crashed, while the KC-130J, callsign RAIDER 50, performed a safe crash landing on a field near Thermal Airport, California. The single pilot aboard the STOVL (Short Take Off Vertical Landing) variant of the Lightning II stealth jet ejected safely and the Super Hercules crew members survived. The pretty intense audio of the incident was posted by a user at the LiveATC forum. “LA Center LA Center, RAIDER 50 declaring an emergency, midair collision with VOLT 93. We have two engines out, we’re leaking fuel, and likely on fire, and in emergency descent at this time. RAIDER 50.” “We declare an emergency. We still have partial control of the aircraft. Two engines out. We are aiming towards uh…” At a certain point, you can hear a pilot stating that there was a plume of black smoke on the ground in the Kane West MOA. That must have been the smoke caused by the F-35B as it crashed near the Salton Sea. Someone managed to film the last seconds of flight of the stricken jet. A video allegedly showing the impact was filmed by a bystander and posted on Instagram by the popular @aviationdaily account. It shows, from distance, a jet trailing some black smoke, crashing into the ground: H/T Mattia De Carli for the heads up!',\n",
       " ('F-35',\n",
       "  6,\n",
       "  0): 'Израиль приобрел у США 20 истребителей Lockheed Martin F-35 Lightning II, сообщает \"Гаарец\". Соответствующий контракт был подписан 7 октября 2010 года в Нью-Йорке. Сумма сделки составила около 2,75 миллиарда долларов. Заключенное соглашение подразумевает также опцион на поставку Израилю еще 75 американских перспективных истребителей. Как ожидается, новые машины будут переданы заказчику в 2016 году. Генеральный директор Министерства обороны Израиля Эхуд Шани (Ehud Shani) заявил, что покупка самолетов позволит Израилю значительно увеличить военный потенциал. При этом он отметил, что американские малозаметные истребители, в случае необходимости, смогут незамеченными долететь до границы Ирана. Между тем, благодаря приобретению F-35 Израиль станет первой в мире страной, не участвующей в проекте создания самолета, но купившей его. Ранее покупку истребителей у США одобрили министр обороны Израиля Эхуд Барак, премьер-министр Биньямин Нетаниягу и кабинет министров. На покупку самолетов планировалось выделить до трех миллиардов долларов, а первые поставки планировались на период с 2015-2017 год. При этом в Министерстве обороны Израиля заявили, что рассчитывают полностью покрыть расходы на покупку F-35 американской военной помощью - США ежегодно перечисляют стране до трех миллиардов долларов на военные нужды. Между тем, Израиль рассчитывал получить разрешение на установку на американские самолетов нескольких собственных систем. Как сообщалось в конце сентября 2010 года, такое частичное разрешение страна получила. При этом США поставили условие, что в перспективе Министерство обороны Израиля увеличит заказ на F-35, то ему будет позволено установить на самолеты большее число собственных систем и вооружений.',\n",
       " ('F-35',\n",
       "  60,\n",
       "  0): 'This story is available exclusively to Business Insider subscribers. Become an Insider and start reading now. A US Marine Corps F-35B Lighting II Joint Strike Fighter was damaged earlier this month after a round fired from its own cannon exploded, Military.com first reported. On March 12, the fifth-generation fighter was conducting a nighttime close air support mission on a range at Marine Corps Air Station Yuma in Arizona. During a gunnery exercise, a 25mm Semi-Armor Piercing High Explosive Incendiary-Tracer (SAPHEI-T) round fired from its cannon exploded, causing fragmentation damage to the fuselage. The incident was classified as a \"Class A\\' mishap, according to the Naval Safety Center. A Class A mishap, the most severe of the four aircraft mishap classifications, means at least $2.5 million in damages. Despite the damage to the fighter when the round exploded, the aircraft landed safely, according to the Naval Safety Center. Marine Corps spokesman Capt. Andrew Wood said in a statement \"the mishap did not result in any injury to personnel.\" The F-35B is one of three F-35 variants. The F-35B, a short takeoff/vertical landing (STOVL) variant, can fight from airstrips on land and amphibious assault ships at sea. Like the carrier-based F-35C, it is equipped with an externally-mounted gun pod. The Air Force F-35As have an internal gun. All three F-35 variants are equipped, in one configuration or another, with a 25 mm GAU-22/A four-barrel Gatling gun, which is capable of firing over 3,000 rounds a minute. With just 220 rounds, an F-35B pilot can empty the magazine in about 4 seconds. A tracer round leaves a visual trail a pilot can use to track it and potentially adjust fire. It is unclear why the round fired from the gun on March 12 exploded after leaving the barrel, but the incident is currently under investigation. The internally-mounted guns on the F-35A have been more problematic. For instance, the Pentagon\\'s testing and evaluation office reported last January that not only was the cannon inaccurate, but its use caused troubling cracking. The first live-fire test of the externally-mounted podded GAU-22A cannon on an F-35B was conducted in 2016, just one year after the aircraft achieved initial operational capability. A Marine Corps F-35B was the first F-35 to fly into combat, launching from the amphibious assault ship USS Essex to conduct strikes against the Taliban in Afghanistan in 2018. The F-35 Joint Strike Fighter is the most expensive weapon program in US military history, and questions have been raised repeatedly about the value of the program given various developmental setbacks. Earlier this month, Rep. Adam Smith, a Democrat from Washington and the chairman of the House Armed Service Committee, said he wants to \"stop throwing money down that particular rathole,\" referring to the F-35. \"What does the F-35 give us? And is there a way to cut our losses?\" he asked. The estimated lifetime cost of the F-35 is currently around $1.7 trillion. The military has, however, frequently defended the F-35. In 2019, the commanding officer of the 31st Marine Expeditionary Unit stated that \"the F-35B defines shock and awe.\" Praising the fifth-generation aircraft, he said that \"the speed that we can conduct precision strikes with devastating effects while providing close air support to our Marines is nothing shy of awesome.\"',\n",
       " ('F-35',\n",
       "  61,\n",
       "  0): 'Birds can be a hazard for civilian and military aircraft, causing millions in damages every year. On Tuesday an F-35B with Marine Aircraft Group 12, 1st Marine Aircraft Wing, out of Iwakuni, Japan, was forced to abort a take-off because of a bird strike, according to Major Eric Flanagan, a spokesman for 1st Marine Aircraft Wing. The aircraft “safely taxied off the runway,” but initial assessments indicated the high-tech stealth fighter suffered more than $2 million in damages, making it a Class A mishap, Flanagan told Marine Corps Times in an emailed statement. The incident is currently under investigation and a complete damage assessment is underway. On, April 17, an Air Force F-16 with the 49th Wing out of Holloman Air Force Base, New Mexico, struck a hawk during a routine landing. First reported by Task & Purpose, a picture of the incident was posted to the Air Force amn/nco/snco site — a popular Facebook page for airmen and veterans. “When a bird strike occurs, the remains are sent to the Smithsonian where they classify the bird and determine how it was struck,” 2nd Lt. Jasmine Manning told Marine Corps Times in an emailed statement. “The bird pictured is a Swanson’s Hawk.” Manning added that the base “takes measures to prevent as many of these strikes as possible, as well as any obstruction that would affect a safe take-off or landing of our aircraft.” In 2018, USA Today said that there were more than 14,661 reported bird strikes with civilian aircraft in the U.S. — that computes to nearly 40 bird incidents a day. The Associated Press reported that there was a ramped up effort to kill birds around airports following the “miracle” landing of a jetliner piloted by US Airways pilot Chesley “Sully” Sullenberger in 2009 on the Hudson River in New York. A flock of geese were blamed for knocking out two engines of Sullenberger’s US Airways flight 1549. Since that incident, according to a 2017 AP story, more than 70,000 birds have been killed around New York’s three major airports as part of a bird killing program. An Atlanta Journal-Constitution story said the Hartsfield-Jackson Atlanta International Airport was willing to fork over $50,900–$67,800 a year to someone willing to work on helping keep wildlife away from the airport. The F-35B bird strike is the Corps’ second Class A mishap in less than one week. On May 3 a Marine F/A-18 out of Mountain Home Air Force Base, Idaho, made a emergency landing due to an engine bay fire. No one was injured in the F/A-18 incident. The Navy classifies a Class A mishap as an accident resulting in $2 million or more in damages or an incident that results in death or total disability. Shawn Snow is the senior reporter for Marine Corps Times and a Marine Corps veteran.',\n",
       " ('F-35',\n",
       "  62,\n",
       "  0): 'A British F-35 pilot flying from the Queen Elizabeth aircraft carrier had to eject during a routine operation over the Mediterranean, the Ministry of Defence (MoD) has said. The pilot was picked up but the £100m stealth jet crashed into the sea during the incident, which took place at about 10am UK time. No other vessels or aircraft were involved, defence sources said. The accident took place shortly after the F-35 took off, the defence secretary, Ben Wallace, said, but despite the incident other operational and training flights involving the jets were carrying on for the moment. An MoD spokesperson said: “A British F-35 pilot from HMS Queen Elizabeth ejected during routine flying operations in the Mediterranean this morning. The pilot has been safely returned to the ship and an investigation has begun, so it would be inappropriate to comment further at this time.” An immediate priority is recovery of the wreckage, with the UK keen to ensure the lost aircraft does not end up in the hands of a hostile state such as Russia. HMS Queen Elizabeth is returning to the UK after a long deployment that has taken it through the Indian Ocean to the Pacific and back. Eight British and 10 US F-35Bs were deployed onboard before Wednesday. Britain agreed to buy 48 F-35Bs from the US military company Lockheed Martin, at a cost of £6bn by 2025. Of those, 24 have been delivered. It is the first accident involving an RAF F-35B, although there have been a handful of previous accidents involving the fighter jets in the past three years. The most similar crash happened in September 2018, involving an F-35B, when the pilot, a US Marine, had to eject in South Carolina. Faulty engine tubes were blamed. Jets from HMS Queen Elizabeth previously participated in strikes against the remnants of Islamic State in Iraq and Syria. The crash will be investigated by the Defence Accident Investigation Branch, which usually takes several weeks before producing an initial report. A final report typically takes about a year to complete.',\n",
       " ('F-35',\n",
       "  63,\n",
       "  0): 'The TWZ Newsletter Weekly insights and analysis on the latest developments in military technology, strategy, and foreign policy. Email address Sign Up Thank you! Terms of Service and Privacy Policy The underside of a U.S. Marine Corps F-35B Joint Strike Fighter was significantly damaged when a round fired from its underbelly 25mm gun pod exploded shortly after leaving the muzzle of the cannon mounted within. The accident, which occurred over the Yuma Range Complex in Arizona earlier this month, did not injure the pilot of the jet, who was able to bring the aircraft safely back to base. Military.com was first to report on the incident, which took place on March 12, 2021, during a close air support training sortie at night. The Marine Corps did not identify the unit to which the F-35B was assigned, but said it was among those based at Marine Corps Air Station Yuma, which is collocated with Yuma International Airport. This base is home to elements of the 3rd Marine Aircraft Wing, including multiple squadrons equipped with F-35Bs, as well as other aircraft. A gun pod-equipped Marine F-35B comes in to land on the Wasp class amphibious assault ship USS Makin Island during operations off the coast of Somalia in December 2020., USMC “The mishap did not result in any injury to personnel, and an investigation of the incident is currently taking place,” Marine Corps Captain Andrew Wood, a spokesman for the service, told Military.com. Still, the Naval Safety Center, which also handles such matters for the Marines, categorized the accident as a Class A mishap. (Please see the update at the bottom of this piece) Class A is the most severe level in the U.S. military’s mishap scale, which covers incidents in the air and on the ground. For aviation accidents, Class A mishaps are defined as those resulting in at least $2.5 million in property damage, or the total loss of the aircraft, or one or more individuals being killed or permanently disabled. The specifics of how this particular mishap occurred are unclear. The F-35B, as well as the F-35C, can only carry the 25mm GAU-22/A Gatling-type automatic cannon in an underbelly pod, known as the GPU-9/A, while the F-35A has this weapon installed internally. The first live-fire tests of the gun pod took place in 2016. Despite concerns about the accuracy of the weapon in the past, it has since been cleared for at least some level of operational use, notably being fitted to Marine F-35Bs supporting the withdrawal of U.S. forces from Somalia between December 2020 and January 2021. Military.com reported that the particular type of round that blew up underneath the F-35B in this incident was a PGU-32/B SAPHEI-T type. This stands for semi-armor-piercing high-explosive incendiary-tracer. When it functions properly, impacting a target triggers a fuze with a slight delay in the nose of the PGU-32/B’s projectile, which then sets off an incendiary element and a small explosive charge inside its main body. The resulting detonation then also spreads a small amount of zirconium, a compound that spontaneously ignites on contact with the air and burns at a very high temperature, causing additional damage. General Dynamics Ordnance and Tactical Systems (GD-OTS), which, among other contractors, makes PGU-32/B ammunition, says on its website that these rounds have “inherent delay function for improved terminal effectiveness” and “improved graze sensitivity.” What this means is that the fuze in these rounds are designed to give the projectiles time to penetrate through some amount of armor or other “barriers” before detonating, for maximum effect, while the fuzes themselves are constructed in such a way',\n",
       " ('F-35',\n",
       "  63,\n",
       "  1): 'to help ensure they go off even when they only glance a target, rather than hit it directly. A product sheet for the PGU-32/U round, which also provides a basic breakdown of the internal construction of the projectile., GD-OTS While we don’t know, an early detonation of the projectile could certainly point to a malfunction of some kind with the fuze. Of course, the investigation could well turn up other points of failure that led to this mishap, as well. It’s not clear right now if the round that exploded in this incident was even deliberately fired or if there might have been some broader weapons malfunction. Accidental discharges of aircraft guns are certainly not unheard of. In November 2020, the 30mm M230 cannon on a British Army AH-64D Apache went off during ground maintenance following an inflight weapons malfunction. Thankfully, the round in question was a practice type with an inert projectile. Any results of the investigation into that incident have yet to be publicly disclosed. In 2018, a Belgian F-16AM Viper fighter jet’s 20mm M61 Vulcan cannon let loose a string of rounds during an apparent inspection. That weapon was loaded with high-explosive ammunition and the incident left another F-16AM destroyed and a third damaged, as well as two ground crew personnel injured. Brand in Florennes ! pic.twitter.com/Uwu9gS04r3 — Tony Delvita (@ebcrew00) October 11, 2018 While the exact extent of the damage to the F-35B involved in this recent mishap remains to be seen, there may be a silver lining of sorts to this event in that it could provide useful information about the jet’s ability to withstand battle damage. As already noted, the jet was able to return to base after the round blew up. No matter what, thankfully the exploding cannon round did not injure the pilot or anyone else. UPDATE 3/29/21: The U.S. Marine Corps has informed us that this mishap was subsequently downgraded to Class C. This category covers incidents that result in between $60,000 and $599,999, or those that result in a nonfatal injury that leads to “loss of time from work beyond day/shift when injury occurred.” Contact the author: joe@thedrive.com',\n",
       " ('F-35',\n",
       "  64,\n",
       "  0): 'CNN — A British F-35, one of the newest stealth fighter jets in the UK military, crashed into the Mediterranean Sea on Wednesday morning while operating off the aircraft carrier HMS Queen Elizabeth, the UK Defense Ministry said in a tweet. The pilot ejected and was returned safely to the ship, and an investigation of the incident, which occurred during routine flight operations, had begun, the ministry said. Britain operates the F-35B, a single-engine, short-take-off vertical landing variant of the US-developed stealth jet, which cost about $115 million each to build. In June, F-35s operating off the Queen Elizabeth flew combat missions over the Middle East against ISIS, the first combat action for a UK aircraft carrier in more than a decade. “The ability to operate from the sea with the most advanced fighter jets ever created is a significant moment in our history, offering reassurance to our allies and demonstrating the UK’s formidable air power to our adversaries,” British Defense Secretary Ben Wallace said in a statement at the time. British F-35s saw their first combat in 2019, flying strikes against ISIS in Iraq and Syria from a Royal Air Force base on the island of Cyprus. With plans to acquire 138 F-35s, Britain would be the third-largest operator of the Lockheed-Martin produced jets, behind the United States and Japan. Both the US and Japan have lost F-35s to accidents. In September 2018, a US Marine Corps F-35B crashed in South Carolina, the first-ever crash of an F-35. In April 2019, a Japanese F-35A crashed into the Pacific Ocean off northern Japan, killing its pilot. The Japanese Defense Ministry later attributed that crash to spatial disorientation, meaning the pilot couldn’t sense his surroundings adequately and essentially flew the stealth fighter straight into the ocean during the night training mission. In May 2020, a US Air Force F-35A crashed in Florida during routine training, but the pilot ejected safely. After the crash Wednesday, the manufacturer of the F-35’s ejection seat, British company Martin-Baker, touted its hardware. “We’ve saved 7,662 air crew lives from around the world to date,” the company said on its Twitter page. Martin-Baker’s ejection seats are used on a range of aircraft, not just F-35s. The British crash comes on the last leg of a voyage for Queen Elizabeth, leading what the UK calls Carrier Strike Group 21, that saw it go as far as Japan and South Korea to participate in exercises with allies and partners as the Royal Navy tries to increase its global presence. When the strike group departed the UK in the spring, Britain’s Ministry of Defense described it as the largest concentration of maritime and air power to leave British shores in a generation. US and Dutch warships are part of the strike group, and 10 US Marine Corps F-35s have been operating off the Queen Elizabeth along with eight British stealth jets. When a version of this carrier strike group sailed together during military exercises off Scotland last fall, the UK Defense Ministry said it carried “the largest concentration of fighter jets to operate at sea from a Royal Navy carrier since HMS Hermes in 1983.” It also said it was “the largest air group of fifth-generation fighters at sea anywhere in the world.” Fifth-generation fighters are the most advanced warplanes in the air. There was no immediate word on whether the UK would try to recover the wreckage of the F-35 from the Mediterranean. When the Japanese F-35 crashed in 2019, there was speculation the wreckage could be a target for potential adversaries such as Russia and China who could',\n",
       " ('F-35',\n",
       "  64,\n",
       "  1): 'gain access to its advanced technology. But both the US and Japan dismissed that idea.',\n",
       " ('F-35',\n",
       "  65,\n",
       "  0): 'WASHINGTON — South Korea has grounded its fleet of F-35As after one of the aircraft had to conduct an emergency belly landing Tuesday. Yonhap News Agency in Seoul reported that the F-35 was taking part in a training flight when it experienced issues with its avionics system. It was forced to land on its belly at Seosan Air Base south of Seoul when those problems caused the fighter’s landing gear to malfunction, Yonhap reported, citing officials there. The pilot was unharmed, Yonhap reported. A fire engine had sprayed a special foam on the runway to keep the jet from sustaining serious damage during the skid. South Korea’s air force plans to conduct a joint investigation with the U.S. military, Yonhap reported, and grounded its F-35A fighters in the meantime. South Korea plans to buy 40 F-35As in total, and has so far received more than 30 of them. Lockheed Martin, which builds the F-35 Lightning II, said in a statement to Defense News it is “aware of the emergency landing that occurred Tuesday at Seosan Air Base and stand[s] ready to support the Republic of Korea Air Force.” The company referred further questions to South Korea. This is apparently the first time an F-35 has conducted a belly landing, Yonhap reported. Stephen Losey is the air warfare reporter for Defense News. He previously covered leadership and personnel issues at Air Force Times, and the Pentagon, special operations and air warfare at Military.com. He has traveled to the Middle East to cover U.S. Air Force operations.',\n",
       " ('F-35',\n",
       "  66,\n",
       "  0): 'This post has been updated with additional information from the U.K. MoD and a statement from F-35 builder Lockheed Martin. A U.K. F-35B Lightning II Joint Strike Fighter operating from Royal Navy carrier HMS Queen Elizabeth (R08) crashed in the Mediterranean on Wednesday, the U.K. Ministry of Defense announced. “A British F-35 pilot from HMS Queen Elizabeth ejected during routine flying operations in the Mediterranean this morning,” reads a statement from the MoD. “The pilot has been safely returned to the ship and an investigation has begun, so it would be inappropriate to comment further at this time.” The crash occurred at about 10 a.m. London time and no other ships or aircraft were involved, an MoD spokesperson told USNI News. As of Wednesday morning, other type models of U.K. F-35s were still flying without restrictions, the spokesperson said. Queen Elizabeth deployed with a blended air wing that includes the “Wake Island Avengers” of U.S. Marine Fighter Attack Squadron (VMFA) 211 and the Royal Air Force’s 617 Squadron “The Dambusters.” The MoD would not identify the service branch of the pilot of the crashed F-35. RAF and Royal Navy pilots fly the U.K. F-35s. The carrier strike group is on its final leg of its inaugural deployment after departing the U.K. for its deployment on May 22 with eight RAF F-35Bs and 10 Marine F-35Bs. To date, the U.K. has received 21 F-35Bs that will make up the core of the carrier air wings of the Royal Navy’s two new carriers. The crash is the third loss of an F-35B over the history of the program. Last year, a Marine F-35B collided and crashed with a KC-130 during an aerial refueling over California. In 2018, a faulty fuel line resulted in the crash of an F-35B near Marine Corps Air Station Beaufort, S.C. The 2018 incident resulted in an international standdown of all variants of the F-35 while investigators determined the cause. In a Wednesday statement to USNI News, JSF builder Lockheed Martin is, “standing by to support the Ministry of Defence as needed. An investigation is underway and further information on the incident will be released when appropriate.”',\n",
       " ('F-35',\n",
       "  67,\n",
       "  0): 'An ammunition round that exploded following its discharge from a Marine Corps F-35B Joint Strike Fighter at Marine Corps Air Station Yuma, Arizona, earlier this month caused damage to the stealth fighter\\'s fuselage, according to the service. The F-35B, capable of short takeoff and vertical landings, was conducting a nighttime close air support mission on March 12 on the Yuma Range Complex when a PGU-32/U Semi-Armor Piercing High Explosive Incendiary-Tracer (SAPHEI-T) 25mm round exploded after leaving the fighter\\'s cannon, Marine Corps spokesman Capt. Andrew Wood confirmed to Military.com on Tuesday. The jet was attached to VMX-1, the Marines\\' Yuma-based test and evaluation squadron, Wood said. Read Next: Guard Troops Ambushed in Texas, Held at Gunpoint While Transporting COVID-19 Vaccines The aircraft landed safely, according to a Naval Safety Center report, which first noted the incident. \"The mishap did not result in any injury to personnel, and an investigation of the incident is currently taking place,\" Wood said in an email. The mishap was initially labeled Class A, the most severe classification, indicating damage of at least $2.5 million or the loss of an aircraft. Wood later said it was determined to be Class C, meaning the incident caused between $60,000 and $600,000 in damage. It was not immediately clear if the round was fired deliberately. Citing the ongoing investigation, Wood did not provide further details. The F-35 uses a GAU-22 Gatling gun. The GAU-22 is mounted in an external gun pod under the jet\\'s fuselage on the Marines\\' F-35B and Navy\\'s C-variant. The Air Force\\'s A-variant carries the gun internally. The Navy began evaluating its existing PGU-32 semi-armor piercing high explosive incendiary ammunition for the F-35B and F-35C in 2013. Live-fire testing from the gun pod began in 2016, according to The Drive. In 2019, Marines in the Pacific carried out the first-ever at-sea F-35B \"hot reloads\" there, allowing the aircraft to drop back-to-back, 1,000-pound bombs on a target in the middle of the Solomon Sea. Marines from the amphibious assault ship Wasp brought with them the \"killer tomato,\" a big red inflatable target that floated off the coast of Papua New Guinea. The Joint Strike Fighter jets left the ship armed with the 1,000-pound GBU-32 Joint Direct Attack Munition and a 500-pound GBU-12 Paveway II laser-guided bomb. During the same tests -- which marked the first-ever shipboard hot reloads in the Indo-Pacific region -- Marines also tested the SAPHEI-T 25mm round, according to a release. With a capacity of 220 rounds, the 25mm gun pod can fire at a rate of up to 3,300 rounds per minute. Editor\\'s Note: This story has been updated to reflect the change to mishap classification. -- Gina Harkins contributed to this report. -- Oriana Pawlyk can be reached at oriana.pawlyk@military.com. Follow her on Twitter at @Oriana0214. Related: Air Force Cuts Back F-35 Demo Performances Due to Engine Shortage',\n",
       " ('F-35',\n",
       "  68,\n",
       "  0): 'A British F35 stealth jet has crashed shortly after takeoff from the UK\\'s flagship aircraft carrier, forcing the pilot to eject into the Mediterranean. It is the first time HMS Queen Elizabeth, on a maiden voyage, has lost one of its £100 million warplanes. Hostile action is not thought to have been involved in bringing down the F35 jet - one of the UK\\'s most expensive, classified and valued weapons programmes. Efforts are underway to retrieve it. An investigation will likely focus on potential technical or human error. The crash could raise concerns about the safety of all other F35B jets - used by a number of different nations, including the United States. For now, all UK flying operations are continuing as usual. A Ministry of Defence spokesperson said: \"A British F35 pilot from HMS Queen Elizabeth ejected during routine flying operations in the Mediterranean this morning. \"The pilot has been safely returned to the ship and an investigation has begun, so it would be inappropriate to comment further at this time.\" The next-generation RAF F35 ditched into the sea \"shortly after take off\", Defence Secretary Ben Wallace told Sky News. It is loaded with top-secret radars, sensors and other technology so recovering the wreckage will be a priority. Image: A Lockheed Martin F-35 Lightning II. File pic Eight British F35 jets are on the carrier, along with 10 American F35s. They are the B variant of the Lockheed Martin jet, which can take off at a short distance and land on the carrier. As well as being the first crash for the aircraft carrier, it is also the first time any of the UK\\'s fleet of 24 F35 jets have crashed. While very rare, a small number of American F35 jets have come down including one in May 2020 during a routine exercise in Florida. The F35 jets are the most prized part of the UK\\'s new the carrier strike group. The British and American jets have flown to intercept Russian aircraft from HMS Queen Elizabeth in recent months. Please use Chrome browser for a more accessible video player 1:19 June: UK aircraft carrier on first active duty The aircraft carrier is returning to the UK after more than seven months at sea on a maiden voyage to the Far East and back. The jets on board have conducted around 2,000 take-offs and landings during that time. Sky News visited the carrier earlier this month to witness the jets in action. Wednesday\\'s incident occurred at approximately 10am UK time in international waters. No other vessels or aircraft were involved. A comprehensive military air investigation will be conducted urgently.',\n",
       " ('F-35',\n",
       "  69,\n",
       "  0): 'A Republic of Korea Air Force Lockheed Martin F-35A reportedly suffered a belly landing after developing unspecified avionics issues. The incident occurred at midday on 4 January, with the aircraft conducting the belly landing at Seosan air base, 81nm (151km) south of Seoul, according to South Korea’s official Yonhap news agency. The report attributed the belly landing to unspecified “avionic system issues”. The report, citing sources, indicates that the pilot walked away after the fighter landed on a runway that had been coated with foam. The incident appears to be the first belly landing involving an F-35. This the second major safety incident involving an F-35 operator in the Asia-Pacific region. In April 2019, a Japan Air Self-Defense Force F-35A crashed into the northern Pacific Ocean, killing the pilot. The crash resulted in an unsuccesful search to recover the missing jet. Ultimately, it was concluded the pieces of the missing jet would not make their way in to the hands of Beijing or Moscow. The F-35A entered South Korean service in December 2019. Cirium fleets data indicates that its air force has 32 examples in service, with eight on order. In October 2019, Seoul’s Defence Acquisition Program Administration earmarked W4 trillion ($3.3 billion) to obtain 20 additional fighters from 2021, which would bring the fleet to 60. Separately, the US Marine Corps (USMC) celebrated a milestone with the aircraft carrier-capable F-35C, with the service’s first deployment of the type aboard a carrier, the USS Abraham Lincoln. The USMC’s VMFA-314 squadron has already conducted flight operations on the vessel, which is deployed in the Pacific. “Our ability to operate the F-35C in the Pacific greatly increases the Marine Corps’ naval expeditionary force capabilities by providing us the capacity to employ the most advanced electronic warfare capabilities on any aircraft today in support of fleet operations,” says VMFA-314 commanding officer Lieutenant Colonel Brendan Walsh. “In addition, having this asset available greatly increases the Marine Corps’ ability to provide security to our allied nations and preserve a free and open Indo-Pacific.” US Navy F-35Cs commenced carrier operations when Strike Fighter Squadron VFA-147 deployed with the USS Carl Vinson in April 2021, also in the Pacific.',\n",
       " ('F-35',\n",
       "  7,\n",
       "  0): 'Israel’s air superiority over the Middle East can be attributed to its unique F-35I Adir stealth fighter jet – the only nation on Earth with a custom version of the Lockheed Martin F-35 Joint Strike Fighter. F-35I Adir – The History The origin story of the “Mighty One” begins in 2010, when Israel became the first country outside the aircraft’s nine-nation co-development group to buy the jet. By 2018, Israel became the first country to debut its version of the F-35 as combat operational. The Jewish state’s fleet of fifth-generation stealth jets has been an instrumental tool in its shadow war against the Islamic Republic of Iran and overall deterrence in the region. While the American F-35 Lightning II is arguably the most advanced fighter jet in rotation, Israel acquired them with their own unique specifications. In the last decade, custom variants of fourth-generation jets to client states have become a typical practice. For instance, the Su-30MKI is India’s version of the Su-30, and the CF-18 Hornet is Canada’s version of the F-18 Hornet. However, Lockheed-Martin has refused to undergo major client state-specific modifications to the F-35. Israel was able to maneuver around this barrier and involve its local defense contractors in acquiring the jets. This deal allowed sophisticated helmet sets and wings to be manufactured in Israel by its own defense industry, paid for with U.S. military aid. F-35I -A Special Stealth Fighter The F-35I variant can be externally modified by the Israeli Air Force (IAF), which also has access to the jet’s advanced digital architecture, including its communication systems, electronic warfare and surveillance suite, and mission control hardware. Included in the “Mighty One’s” Israeli-made hardware is an electronic warfare system that has a “plug-and-play” function for add-on systems like air-to-air missiles and external electronic warfare pods. Additionally, extending the F-35I’s range has remained a top priority for Israel. Due to distance, Israel’s ability to carry out an airstrike inside Iran while ensuring enough fuel remains for the return trip has been a significant issue. As a result of this challenge, Israel has been the first country to ask for external fuel tanks for the F-35I Adir. According to the Israeli news website Walla, the IAF is developing external drop tanks that would allow the fighter jets to complete long-range missions without having to refuel midair (aerial refueling). Since the external drop tank capability is still in the works, American lawmakers are urging the White House to expedite the process of delivering KC-46 refueling tanker aircraft to Israel. The new Boeing KC-46 tankers would allow a dozen Israeli jets to stay aloft for 12 hours with a range of over 11,000 kilometers. This range would enable Israel to launch airstrikes on Iran. In 2018, Israel became the first country to carry out an operational attack using the F-35 when the IAF used the jets to strike Iranian missile launch sites in Syria. In a public letter, 11 Senators pressured the Biden administration to “take immediate action to provide Israel with the military capabilities it needs to defend itself from Iran,” in part by finalizing the contract for the KC-46 aircraft. According to experts, Iran’s nuclear breakout time is imminent, exasperating Israel’s need to be able to perform long-range missions against its hostile neighbor. Maya Carlin is an analyst with the Center for Security Policy and a former Anna Sobol Levy Fellow at IDC Herzliya in Israel. She has by-lines in many publications, including The National Interest, Jerusalem Post, and Times of Israel.',\n",
       " ('F-35',\n",
       "  70,\n",
       "  0): 'A South Korea air force F-35A Lightning II taxis onto the runway at Luke Air Force Base, Ariz., July 20, 2018. (Louis Vega Jr./U.S. Air Force) CAMP HUMPHREYS, South Korea — An F-35A Lightning II fighter jet crash-landed Tuesday on the runway of a South Korean air force base in Seosan, a city on the western coast, military officials told Stars and Stripes. A South Korean air force official speaking on the customary condition of anonymity said the pilot made the emergency landing at 12:51p.m. Tuesday after the aircraft’s landing gear failed. The pilot was safe and “walked out from the plane,” the official said. “Its landing gear should have been down, but it wasn’t,” the official told Stars and Stripes by phone. “So, it made a belly landing.” The air force suspended all F-35A flights “for a while” as it investigates the incident, the official said. While the incident marks the first-known F-35A crash in the South Korean air force, others have been reported elsewhere. The landing gear collapsed on an F-35A assigned to the 388th Fighter Wing at Hill Air Force Base in Utah during a training flight in June 2020. The pilot exited the aircraft after the incident. The South Korean military operates roughly 40 F-35As. The country’s Defense Acquisition Program Administration agreed in 2014 to purchase the fifth-generation fighter and received its first delivery in 2019. The agreement with U.S.-based defense manufacturer Lockheed Martin was estimated to cost about $7 billion. Production costs for the F-35A have dropped after its initial release in 2006 and are currently priced at around $80 million. The country is expected to introduce additional F-35s into its military, including the F-35B, the short-takeoff and vertical-landing variant, according to local news reports. The Ministry of National Defense approved plans for the construction of an aircraft carrier capable of handling short-takeoff and vertical-landing aircraft by 2033. Stars and Stripes reporter Yoo Kyong Chang contributed to this report.',\n",
       " ('F-35',\n",
       "  71,\n",
       "  0): 'Share Article A South Korean air force F-35 pilot was forced to make an emergency “belly landing” but managed to escape unharmed Jan. 4, according to multiple media reports. The incident was caused by “avionic system issues,” South Korean air force officials told news agency Yonhap, which caused the landing gear to malfunction and resulted in the pilot landing on a runway with the gear up. Before the landing, a fire engine deployed a special foam on the runway, “which prevented the jet’s fuselage from sustaining any serious damage,” officials added. The full extent of the damage has not been reported. The emergency landing occurred around 1 p.m. local time at a South Korean base in Seosan, some 70 kilometersfrom Osan Air Base. According to media reports, it is the first known instance of a belly landing by an F-35 since the U.S. began selling the fifth-generation fighter to partner nations. South Korean officials have reportedly said they are suspending flights for all its air force’s 30-plus F-35 fighters while it investigates the emergency landing. There have been other incidents involving allies and partners in the F-35 program—members of the Japan Air Self-Defense Force have had to make at least seven emergency landings in F-35s, news agency Nikkei reported. There was also a nighttime crash into the ocean in April 2019 that killed a Japanese pilot. More recently, a British F-35B crashed just after takeoff from an aircraft carrier in November 2021, falling into the Mediterranean Sea. U.S. Air Force pilots have also dealt with problems. In May 2020, a pilot at Eglin Air Force Base, Florida, crashed while landing due to excessive speed, as well as issues with faulty flight control logic, the helmet-mounted display, the jet’s oxygen system, and ineffective simulator training. A month later, an F-35A’s landing gear collapsed at Hill Air Force Base, Utah. In addition to South Korea and Japan, U.S. ally Australia also operates F-35As in the Indo-Pacific, and Singapore is slated to receive F-35Bs starting in 2026.',\n",
       " ('F-35',\n",
       "  72,\n",
       "  0): 'It’s the first known gear-up landing of an F-35. An F-35A of the ROKAF (Republic Of Korea Air Force) carried out an emergency landing at 12.51 PM on Jan. 4, 2022, South Korea’s Yonhap news agency reported. According to the report, the 5th generation aircraft was involved in a training mission when an avionic system issues forced the pilot to carry out a gear up landing at Seosan airbase, 151 kilometers southwest of Seoul. The emergency apparently marked the type’s first ever belly landing. “Before the landing, the Air Force mobilized a fire engine to apply special foam on the runway, which prevented the jet’s fuselage from sustaining any serious damage,” Yonhap reported. While the real extent of the damage to the aircraft has not been revealed, the mishap left the pilot unharmed. A joint investigation with Lockheed Martin will determine the root cause of the incident; meanwhile, ROKAF will suspend all of its F-35A fighters pending the probe. The Republic of Korea selected the F-35 at the end of its F-X III fighter acquisition program with the signing of a Letter of Offer and Acceptance (LOA) between the U.S. and Korean governments on Sept. 30, 2014. So far, ROKAF has received more than 30 aircraft out of 40 ordered F-35A Conventional Take Off and Landing (CTOL) variant jets. In December 2017, South Korea’s Defence Acquisition Program Administration established a process for procuring the 20 additional aircraft, the Joongang Ilbo newspaper reported, citing multiple government sources. The first F-35A for the ROKAF, known as aircraft AW-1, took flight in Fort Worth, Texas, in March 2018. In the same year, the first F-35A was delivered to Luke AFB, Arizona, for pilot training while in 2019, the first F-35As were delivered to their permanent base in South Korea. The ROKAF’s 17th Fighter Wing and its two child units, the 151 Fighter Squadron and 152 Fighter Squadron, operate the F-35 out of Cheongju Air Base, southeast of Seoul.',\n",
       " ('F-35',\n",
       "  73,\n",
       "  0): 'Pilot of F-35 that crashed at Hill AFB ejected and taken to a hospital for observation. The pilot of a U.S. Air Force F-35A Lightning II is hospitalized after ejecting from their aircraft before it crashed near Hill AFB in Utah on Oct. 19, 2022. Their condition is unreported. Photos of smoke rising from the area reported as the crash scene were posted on social media following the accident that appears to have occurred in daylight and in clear weather. Reports on the 388th Fighter Wing’s Twitter page said, “The F-35A Lightning II crashed around 6:15 p.m. local time at the north end of the base’s runway.” As with most military aviation accidents, no information about the cause of the crash has been reported and an investigation will begin when the crash scene is safe for investigators to enter. A report published on CNN.com by Raja Razek quoted a nearby resident named Scott Phillips, who witnessed the crash, as saying: “I was at my home …. mowing the lawn and watching the F-35 come in for landing as they do basically every night. We love watching them leave and come home.” Phillips went on to tell CNN.com that, “They land generally towards the south as they did today. On approach, one appeared to lose power and dipped too low below the trees. Next thing I saw was fire”. The 388th Fighter Wing at Hill AFB includes the first operational F-35A fighter squadron in the world, the 34th Fighter Squadron, the “Rude Rams”. The unit became the first Lockheed Martin F-35 Joint Strike Fighter squadron declared operational in August of 2016. Hill AFB is also home to the USAF 4th Fighter Squadron, the “Fighting Fuujins”. The 4th Fighter Squadron was the first unit to be operationally deployed with the USAF F-35A Lightning II in 2019 during operation Inherent Resolve in Iraq, Syria and Libya and operation Freedom’s Sentinel in Afghanistan. As of October 2022, over 840 Lockheed Martin F-35 Joint Strike Fighters have been built across all versions. The aircraft is in service with ten countries, the U.S. (Air Force, Marines and Navy), Australia, Denmark, Israel, Italy, Japan, the Netherlands, Norway, the Republic of Korea, and the U.K. Six more countries have committed to the Joint Strike Fighter program including Belgium, Finland, Germany, Poland, Singapore, and Switzerland, bringing the likely total partner-users to sixteen countries. Since the F-35 Joint Strike Fighter first flew fifteen years ago on December 15, 2006, seven F-35s have crashed. The aircraft involved in crashes include one Japanese F-35A, an RAF F-35B, two USAF F-35As, two U.S. Marine F-35Bs and a U.S. Navy F-35C. The F-35 Joint Strike Fighter has been used in combat by the Israeli Air Force as the F-35I Adir, the U.S. Air Force with their F-35A and the U.S. Marines with the F-35B. While initially panned by popular media as being expensive, the cost per unit of the F-35 Joint Strike Fighter has, according to Lockheed Martin, “dropped 37% between 2015 and 2021” per aircraft and that, “its cost per flying hour dropped 50% over that period”. Lockheed continues to project cost reductions due to economies of scale and increased efficiencies through 2026 according to the company.',\n",
       " ('F-35',\n",
       "  74,\n",
       "  0): 'A Marine Corps F-35B fighter’s landing gear malfunctioned on the runway at Kadena Air Base, Japan, on Thursday, causing its nose to hit the pavement. Nobody was injured in the mishap, but cameras captured video and still images of the unfortunate airplane with its nose in the dirt. Video posted to the popular Facebook page Air Force amn/nco/snco shows the jet being towed before the landing gear fails and the nose falls. The F-35B pilot made a precautionary landing at Kadena at about 1:40 p.m. “due to a suspected electrical issue,” Maj. Roberto Martins, a spokesperson for the 1st Marine Aircraft Wing, said in a statement. The pilot “performed as trained” by landing the aircraft at Kadena safely in line with standard procedures, Martins said. The aircraft is assigned to Marine Fighter Attack Squadron 121 at Marine Corps Air Station Iwakuni, Japan, about 600 miles northeast of Kadena, which is an Air Force base. “There are no injuries as a result of the landing gear malfunction, and a detailed investigation will be conducted,” Martins said. Stars & Stripes reported that Marine Corps officials were not certain yet how much damage was done to the fighter. Subscribe to Task & Purpose Today. Get the latest military news, entertainment, and gear in your inbox daily. The nose is a sensitive spot for many fighter aircraft because it’s where the radar is often stored which allows the jet to spot nearby aircraft or missiles. The F-35 in particular has an electro-optical targeting system that further enhances the pilot’s ability to locate and track targets. The sensors that make up the targeting system are housed in a sapphire window under the jet’s nose. Sapphire windows are “extremely hard and more durable than standard optical glass,” according to the Newport Corporation, a technology company. Hopefully, those windows are strong enough to resist the Kadena mishap. Aircraft mishaps are a part of military aviation, but considering how much the new F-35s cost, accidents pack a punch even when nobody is hurt. The short takeoff and landing variant used by the Marine Corps costs $101.3 million each under a contract with manufacturer Lockheed Martin signed in 2019, Breaking Defense reported in March, though that price may rise due to inflation and supply struggles caused by the COVID-19 pandemic. Aircraft repairs can sometimes take years to complete. In October, the Navy celebrated bringing an EA-18G Growler fighter jet back to life five years after colliding with another aircraft on a training mission. A mid-air collision is more dramatic than a landing-gear failure on the runway, so hopefully it will not take as long to get the F-35B back up to fighting shape. The latest on Task & Purpose Want to write for Task & Purpose? Click here. Or check out the latest stories on our homepage.',\n",
       " ('F-35',\n",
       "  75,\n",
       "  0): 'A Marine Corps F-35B Lightning II stealth fighter prepares for take-off at Kadena Air Base, Okinawa, Feb. 17, 2022. (Justin Marty/U.S. Marine Corps) CAMP FOSTER, Okinawa – A Marine Corps stealth fighter was damaged Thursday following a precautionary landing at an Okinawa air base, a Marine official said Thursday evening. A suspected electrical problem prompted the pilot to land the F-35B Lightning II, assigned to VMFA-121 at Marine Corps Air Station Iwakuni, Japan, at Kadena Air Base without incident at approximately 1:40 p.m., 1st Marine Aircraft Wing spokesman Maj. Rob Martins wrote in a statement to Stars and Stripes. Kadena Air Base is home to the Air Force’s 18th Wing. While the fifth-generation fighter was being towed on the flight line, the front landing gear malfunctioned and the aircraft’s nose dropped onto the ground, Martins said. He said the incident caused no injuries. Video from Japanese public broadcaster NHK shared Thursday on Twitter showed the F-35 stopped on a taxiway with its nose gear collapsed. “The pilot performed as trained and chose the safest option, landing the aircraft safely in accordance with standard procedures,” Martins said in the statement. “Operating our aircraft safely and effectively is a top priority and our aviators take great precautions to ensure the safety of the aircrew and the surrounding areas.” The fighter was conducting “standard training operations” in local ranges at the time of the incident, Martins said in a follow-up email to Stars and Stripes. After the aircraft landed, it was surrounded by fire engines and emergency vehicles, NHK reported Thursday afternoon. It is unclear how much damage was done to the fighter, Martins said in his email. He said a “detailed investigation” will be conducted. “The mishap class will be determined by the investigation,” Martins wrote in the email. The military defines mishaps by class from A to D. Class A mishaps involve repair costs exceeding $2 million or the death or permanent disability of a service member. A Class D mishap involves $25,000 to $59,999 in property damage and injuries ranging requiring first aid up to missing a day from work. The Marine Corps has had three Class A mishaps in manned aircraft in 2022, according to data on the Naval Safety Command’s website. A spokesman for the Okinawa Defense Bureau, a branch of the Japanese Ministry of Defense, said Thursday evening it is aware “the nose of an F35 touched the ground” but is awaiting details. A spokesman for Okinawa prefecture’s Military Base Affairs Division said it was waiting for information from the defense bureau. Gov. Denny Tamaki had not yet made a public comment on the incident. The short-takeoff, vertical-landing fighter has been plagued by high costs and technical issues since its inception. The pilot of an F-35A Lightning II, the Air Force variant, survived a crash at Hill Air Force Base, Utah on Oct. 19. A replacement F-35A costs about $75 million, Reuters reported in July.',\n",
       " ('F-35',\n",
       "  76,\n",
       "  0): 'The TWZ Newsletter Weekly insights and analysis on the latest developments in military technology, strategy, and foreign policy. Email address Sign Up Thank you! Terms of Service and Privacy Policy An F-35 from the 388th Fighter Wing at Hill Air Force Base in Utah crashed at the north end of the runway, according to the wing. The pilot ejected and emergency crews are responding. An F-35 from the 388th crashed at the north end of the runway @HAFB . Pilot ejected. Emergency crews are responding. — 388th Fighter Wing (@388fw) October 20, 2022 Breaking News???? Fire at Hill AFB Coming home from Riverdale and we saw three fighter jets in a line circling to land… kept driving through South Ogden and then a minute or two later saw a giant plume of smoke come up. Followed it here to the Adams Ave parkway entrance. pic.twitter.com/OGZcGVyXr9 — Chappy 🇧🇷 (@itschappy) October 20, 2022 The wing provided no additional details in its tweet. We have reached out to them for further information and will update this story when it comes in. Hill AFB (Google Earth) The northern end of Hill AFB’s runway where the crash occurred. (Google Earth) Hill AFB hosts the largest collection of F-35s and supports a number of weapons evaluation, training, and test activities that include other aircraft. It is also a major logistical depot for refurbishing and upgrading multiple types of aircraft in the Pentagon’s inventory as well as executing a number of other critical functions for the USAF. This is a developing story. We will update it when more information is available. Contact the author: howard@thewarzone.com Update 9:32 PM EST: “As far as we know, the pilot is ok and has been taken to be evaluated,” Micah Garbarino, a spokesman for the 388th Fighter Wing, told The War Zone. Update 9:56 PM EST: The pilot ejected, was recovered and has been taken to local medical center for observation. The cause of the crash is unknown and will be investigated. More information will be provided as it becomes available. — 388th Fighter Wing (@388fw) October 20, 2022 Update 3:10 AM EST: Local CBS affiliate KUTV states that base officials credit the pilot with steering the F-35 towards an unpopulated area before punching out and quoted Colonel Craig Andrle, 388th Fighter Wing Commander as stating the following: “Flying military aircraft is a risky business that we all accept when we go do it… First and foremost, we’re thankful that he’s okay, he got out of the aircraft. We’re thankful that nobody on the ground was injured.” A fire caused by the crash has been extinguished and a hazmat response is underway. Most aircraft are full of toxic materials that can be dangerous when burned, but an F-35 is even more so, with its radar-absorbent skin. Any parts of the aircraft scattered as a result of the crash can also be technologically sensitive in nature and must be recovered if possible.',\n",
       " ('F-35',\n",
       "  77,\n",
       "  0): 'The TWZ Newsletter Weekly insights and analysis on the latest developments in military technology, strategy, and foreign policy. Email address Sign Up Thank you! Terms of Service and Privacy Policy South Korea has grounded its fleet of F-35A stealth fighters, pending a full investigation into an accident yesterday, in which one of the jets was forced to make a belly landing during a training mission. The pilot was uninjured, but initial accounts suggest that the emergency was caused by a “major systems malfunction” that prevented the landing gear from being deployed. Defense ministry sources in Seoul confirmed the grounding order today, an unnamed defense official stating that “with the investigation underway, the entire [F-35] fleet is suspended from flying.” Earlier reports had spoken of “avionics system issues,” although the latest wording sounds, at least superficially, to suggest a more comprehensive problem onboard the jet. The jet is one of at least 30 examples of the type to have been delivered to Korea to date. A Republic of Korea Air Force F-35A pilot prepares for a training mission at Luke Air Force Base, Arizona., U.S. Air Force/Tech. Sgt. Louis Vega Jr. Shin Ok-chul, the vice chief of staff of the Republic of Korea Air Force (ROKAF), meanwhile told a parliamentary hearing that the F-35 had been flying at low altitude when the pilot heard a series of bangs, prompting him to check the aircraft’s systems. “All systems had stopped working except flight controls and the engine,” Shin said, at which point the pilot made the decision to remain with the aircraft and attempt a belly landing at Seosan Air Base in the western province of South Chungcheong, at 12:51 PM local time on Jan. 4. Alerted to the emergency, firefighters at the base doused the runway with foam, to reduce the risk of fire when the jet touched down. So far, however, there is no indication of the extent of the damage sustained, and no photos of the incident have become available. It’s not clear currently if the jet was operating from Seosan Air Base at the time of the incident, or whether it recovered there while flying from its home station of Cheongju, in the central province of North Chungcheong. The locations of Seosan and Cheongju Air Bases., GOOGLE EARTH As far as is known, this is the first time a belly landing has been attempted in a Joint Strike Fighter. Emergency recovery is a challenge for any aircraft, but is not entirely uncommon, especially for high-performance fighters. However, in the case of the F-35, or other stealth designs, a belly landing can be particularly problematic given the sensitive nature of their coatings and the tight tolerances of their construction. On the other hand, even the results of a stealth fighter skidding along a runway can be made good, as evidenced by the recent completion of the effort to return a seriously damaged U.S. Air Force F-22 Raptor to service. However, the process can be long — nearly four years in the F-22 example — and costly. The grounding order is not surprising given the apparent nature of the problems that the pilot faced before the belly landing, and it’s clear that the ROKAF will want to know exactly what was responsible for what sounds like a significant systems anomaly. The ROKAF has invested heavily in modernizing its fleet with the stealth jet. Despite the cost, the ROKAF determined that a fifth-generation type was required to counter China’s stealth developments and have the capability to penetrate North Korean airspace at a time of escalating military tensions with its neighbor. Selected',\n",
       " ('F-35',\n",
       "  77,\n",
       "  1): 'under the third phase of its long-running fighter procurement program, or F-X, Seoul is investing around $7 billion to acquire 40 examples of the conventional takeoff and landing (CTOL) F-35A variant. A Letter of Offer and Acceptance between the South Korean and U.S. governments was signed in September 2014, with plans for another 20 of the jets to be purchased at a later date. The first F-35A for the ROKAF was rolled out at Lockheed Martin’s facility in Fort Worth, Texas, in March 2018, and the first pair of jets arrived at Cheongju Air Base in March 2019. Initial operating capability was declared before the end of the same year. At the same time, the fact that Seoul operates multiple types of fighters means that other fleets are still available to meet routine ROKAF requirements and respond to contingencies. These jets include 60 multirole F-15K Slam Eagles, advanced versions of the F-15E Strike Eagle, and the survivors of 180 F-16C/Ds originally delivered. Seoul is now in the process of upgrading 134 of its Vipers to the F-16V standard, with new avionics including an AESA radar. As well as these more modern jets, the ROKAF still flies smaller numbers of aging F-4E Phantom II and F-5E/F Tiger II fighters, plus tactically roled FA-50 jets derived from the T-50 trainer. Prior to the South Korean incident, the most recent accident involving a Joint Strike Fighter saw a British Royal Air Force F-35B plunging into the Mediterranean during takeoff from the aircraft carrier HMS Queen Elizabeth. The pilot ejected safely, and you can read more about that incident here. Landing incidents involving F-35s are by no means unheard of. The Japan Air Self-Defense Force has reportedly made at least seven emergency landings in F-35As, in addition to a fatal accident in April 2019. In a May 2020 incident at Eglin Air Force Base, an F-35A crashed while landing due to a combination of factors. Other U.S. Air Force F-35As have suffered nose-gear collapses on landing, at Eglin Air Force Base in August 2018 and at Hill Air Force Base in Utah in June 2020. A ROKAF fighter pilot (left) stands near an F-35A during an event marking Armed Forces Day at Daegu Air Base, South Korea, October 2019., Jeon Heon-kyun/Pool Photo via AP The outcome of the investigation into yesterday’s belly-landing incident will be keenly awaited not just by the ROKAF but the wider F-35 operating community, as the delivery total hits the 750-aircraft mark. For South Korea, there remains the option of acquiring another 20 CTOL F-35As, valued at around $3.3 billion, while future plans also envisage orders for short takeoff and vertical landing (STOVL) F-35B variants of the Lightning II, to equip its forthcoming aircraft carriers. With this in mind, officials will be especially eager to determine whether the incident was a one-off or a symptom of a more systemic issue. We will provide updates on this story as soon as further information about the incident becomes available. Contact the author: thomas@thedrive.com',\n",
       " ('F-35',\n",
       "  78,\n",
       "  0): 'The 5th gen aircraft suffered a nose gear down collapse during towing. An F-35B Lightning II, belonging to the Marine Fighter Attack Squadron (VMFA) 121 ‘Green Knights’, was involved in an incident on the ground at Kadena Air Base, Okinawa, Japan, on Dec. 1, 2022. According to a statement released by the 1st Marine Air Wing of the U.S. Marine Corps quoted by the Japanese NHK media outlet, around 1:40PM LT, the F-35B made a precautionary landing at Kadena Air Base due to possible electrical problems. The aircraft was being towed when the nose wheel broke, leaving the 5th generation aircraft with its nose on the taxiway. A camera installed by NHK showed the F-35B nose down on the taxiway of Kadena Air Base just after 3:00PM. While the U.S. Marine Corps is investigating the cause of the incident. The F-35 nose gear has a single wheel that retracts into a NLG wheel well immediately under the cockpit; the extent of the damage (and the subsequent cost) is unknown (the aircraft’s valuable Electro-Optical Targeting System or EOTS – might be heavily damaged). According to the U.S. Air Force, Collins Aerospace is the primary manufacture of all landing gear components. Video of today’s incident with the F-35 fighter jet of the 121st squadron of the #USMC at the Kadena Air Force Base on the #Japanese island of #Okinawa When towing the aircraft, the front landing gear dropped.pic.twitter.com/xIkJZYxXns — Indo-Pacific News – Geo-Politics & Military News (@IndoPac_Info) December 1, 2022 The incident is strikingly similar to another one, that occurred to a USAF F-35A in 2018. In that event, an F-35A Lightning II, assigned to the 58th Fighter Squadron, experienced an in-flight emergency and returned to base. The aircraft landed safely and parked when the front nose gear collapsed. Another gear collapse incident occurred to another F-35A on the runway after landing at Hill AFB on Jun. 8, 2020. The investigation reports on the previous incidents have not been publicly released. VMFA-121 is based at MCAS Iwakuni where it relocated from MCAS Miramar on Jan. 9, 2017.',\n",
       " ('F-35',\n",
       "  79,\n",
       "  0): 'A pilot ejected following the crash of a Lockheed F-35B Lightning II jet on a Texas runway Thursday. Police responded at approximately 10:15 a.m. to emergency calls from both Naval police and Lockheed Martin saying that a fighter jet had crashed at Naval Air Station Joint Reserve Base Fort Worth and that the pilot had ejected, White Settlement, Texas, police chief Chris Cook said in a video shot by a local Fox affiliate. “When we arrived, we were pleased that we didn’t see a big plume of smoke, nothing like that, so we felt like, ‘OK, thoughts and prayers with the pilot, maybe they’re going to be fine,’” Cook said in the video. The crash occurred during a test flight, Fox 4 reported. Footage posted to Twitter by a reporter for a local CBS affiliate shows the jet descend vertically, bounce once on the runway and then go nose-down. In the video, the pilot appears to eject shortly after the landing. “We are aware of the F-35B crash on the shared runway at Naval Air Station Joint Reserve Base in Fort Worth and understand that the pilot ejected successfully,” Lockheed Martin, which has an F-35B assembly plant on the base, said in a statement Thursday, Fox 4 reported. “Safety is our priority, and we will follow appropriate investigation protocol.” Details about the pilot’s condition weren’t immediately available. Cook told Fox 4 that the base sent firefighters and emergency responders to the scene. The plane had not yet been transferred from Lockheed Martin to the U.S. military, but the pilot works for the government, according to Lockheed Martin spokeswoman Jacqueline Lorenzetti. Marine Corps Times has not confirmed if it was an active-duty service member flying the plane. The F-35B is the variant designed for the Marine Corps. It has a short takeoff and vertical landing capability to land on Navy ships. Over the summer, the Marine Corps, along with the Navy and Air Force, conducted investigations into whether the ejection seats in its F-35 fleet contained defective parts. As of August, the Pentagon had found only one F-35 ejection seat with a faulty part, and that was in the plane that prompted the investigations, Air Force Times reported. Irene Loewenson is a staff reporter for Marine Corps Times. She joined Military Times as an editorial fellow in August 2022. She is a graduate of Williams College, where she was the editor-in-chief of the student newspaper.',\n",
       " ('F-35',\n",
       "  8,\n",
       "  0): 'Путин: Ситуация для Украины будет ухудшаться Tекст: Антон Антонов «Мы, отвечая на просьбы граждан, проживающих на этой территории, провели референдум. Все это теперь неотъемлемая часть Российской Федерации, – приводит слова Путина ТАСС. – И, как я и говорил, ситуация будет ухудшаться. Она и ухудшилась для них (для Украины). Теперь речь идет не о Донецке и Луганске, а еще о двух субъектах теперь Российской Федерации, и Крыме, конечно». Путин отметил, что Украине «предлагали условия договоренностей в Стамбуле в 2022 году», которые «были гораздо более мягкими, чем сейчас», теперь «ситуация поменялась». «Не будут договариваться – ситуация, может быть, еще изменится в худшую для них сторону. Не надо тянуть. Надо садиться и договариваться», – приводит его слова РИА «Новости». Путин указал, что количество дезертиров на Украине сильно растет, укомплектованность военных подразделений Украины составляет 47%, потери Украины на поле боя превышают уровень мобилизации в стране, молодежь бежит с Украины, чтобы не воевать за киевский режим. Россия готова передать Украине еще около 3 тыс. тел украинских военных, заявил Путин. «Мы отдали больше 6 тыс. тел военнослужащих Украины. Взамен получили 57», – сказал Путин. Как подчеркнул глава российского государства, в рамках международного права и Устава ООН Донецк и Луганск «приняли решение отделиться» от Украины. «Часть территории одной страны приняла решение отделиться от основной части», – сказал Путин. Он указал, что Донецк и Луганск не были обязаны «спрашивать разрешение у центральных властей», поскольку есть «решение Международного суда ООН» по «прецеденту, созданному». «Международный суд ООН прямо записал: «Если какая-то часть страны приняла решение отделиться, она не обязана с этим вопросом обращаться к центральным властям», – напомнил он, отметив, что Запад «сам все своими руками сделал», когда давил на суд. Путин подчеркнул, что иной подход к ДНР и ЛНР неприемлем: «Вам можно, а здесь нельзя, что ли? Так не будет. Правила должны быть едиными, только тогда они будут стабильными. А это гарантия безопасности для всех не за счет других – вот ключевое звено». Он отметил, что Москва восемь лет воздерживалась от признания независимости ДНР и ЛНР, «терпела и пыталась договориться» с Киевом. «Восемь лет мы терпели, понимаете. Но людей-то жалко. Восемь лет там над ними издевались», – сказал Путин. Однако после того, как Киев отверг такую возможность, Москва признала ДНР и ЛНР, заключила с ними договор о взаимопомощи. «Они к нам обратились за этой помощью официально, и мы эту помощь оказывали», – сказал он. Он указал, что кризис отношений между Россией и Западной Европой начался не с Крыма, а с госпереворота на Украине, из-за которого в Европе «никто даже не чихнул», более того – западные страны содействовали госперевороту. Путин напомнил. что Франция, Германия и Польша были «гарантами» договоренностей между оппозицией и прошлыми украинскими властями. На Юго-Востоке Украины «люди не признали этот переворот». А Киев не стал договариваться с населением, решив использовать войска, сказал Путин. Напомним, помощник президента России, глава российской делегации на переговорах с Киевом Владимир Мединский заявил, что Россия выполнила обещания, данные в ходе переговоров в Стамбуле, и передала украинской стороне 6060 тел погибших офицеров и солдат Вооруженных сил Украины. При этом некоторое время Киев отказывался принимать трупы солдат ВСУ.',\n",
       " ('F-35',\n",
       "  80,\n",
       "  0): 'An F-35A Lightning II crashed at Hill Air Force Base in Utah on Wednesday night, forcing the pilot to eject and causing wildfires on the base. Around 6:15 p.m. local time, the fighter jet crashed on the runway, and on-base and off-base emergency response personnel immediately rushed to the scene. The pilot, who was not identified, was safely recovered and taken to a hospital to be examined. \"The pilot ejected, was recovered and has been taken to [the] local medical center for observation,\" Hill Air Force Base tweeted. \"The cause of the crash is unknown and will be investigated.\" Read Next: Over 41,000 VA Patients Warned of Delayed Care Due to Troubled Electronic Records System Col. Craig Andrle, commander of the 388th Fighter Wing, told news outlets in Utah during a press conference that the pilot was on his way back to the base when the crash occurred. He said he was grateful the F-35 pilot was able to avoid other damage while the aircraft was plummeting. \"Flying military aircraft is a risky business that we all accept when we go do it, and these things happen,\" Andrle said, according to CNN. \"And so tonight, first and foremost, we\\'re thankful that he\\'s OK. He got out of the aircraft. We\\'re thankful that nobody on the ground was injured.\" Residents near the base in Ogden, Utah, began posting photos on social media showing plumes of smoke wafting from the base. \"They land generally toward the south as they did today,\" nearby resident Scott Phillips told CNN. \"On approach, one appeared to lose power and dipped too low below the trees. Next thing I saw was fire.\" The crash caused an estimated 10-acre wildfire, according to a tweet from Utah Fire Info. Andrle told reporters the fire was extinguished in roughly an hour. There have been a total of five Class-A mishaps, the term the Air Force uses for its most expensive or deadly crashes, involving the F-35 since 2014, according to the latest data from the Air Force Safety Center. The previous crash was in fiscal 2020. The price per unit of an F-35, including costs like depot maintenance, ground support equipment and spare parts, is $110.3 million per F-35A; $135.8 million per F-35B, the Marine Corps\\' variant; and $117.3 million per F-35C, the Navy\\'s version of the aircraft, according to data from the Center for Arms Control and Non-Proliferation. In late July, Air Combat Command stood-down its fleet of F-35As after a recall related to the aircraft\\'s ejection seats worried officials. By mid-August, the fighter jets were back in the air. -- Thomas Novelly can be reached at thomas.novelly@military.com. Follow him on Twitter @TomNovelly. Related: Air Force\\'s F-35s Flying Again After Ejection Seat Worries Grounded Fleet',\n",
       " ('F-35',\n",
       "  81,\n",
       "  0): 'A Lockheed Martin F-35B Lightning II fighter jet was involved in a landing mishap during a test flight at Naval Air Station Joint Reserve Base in Fort Worth, Texas. Video footage of the incident shows that the pilot ejected successfully while the aircraft was sliding down the runway following the collapse of the nose gear. Lockheed Martin uses the runway at Naval Air Station Joint Reserve Base for testing, and the aircraft in question was not yet delivered to the US military. #Breaking New much clearer video, courtesy Kitt Wilder, of STOL variant F35 B model landing JRB Fort Worth, and pilot ejects. Condition of pilot still unknown. @CBSDFW pic.twitter.com/BeERIeyhtO — Doug Dunbar (@cbs11doug) December 15, 2022 The video, filmed by a bystander, shows the aircraft descending gently for landing before bouncing off the runway. The aircraft’s nose then pitched down and the nose gear collapsed, sending the jet sliding forward and spinning slowly. The ejection occurred approximately ten seconds after the collapse of the landing gear, indicating that the pilot likely attempted to regain control of the aircraft, but failed to do so. The incident happened at approximately 10:15 AM CST (16:15 GMT) on December 15, 2022, NBC DFW reports. Coincidentally, the date was the 16th anniversary of the maiden flight of the F-35A, the conventional take-off and landing variant of the F-35. The prototype of the jet first took off on December 15, 2006, and was later modified with vertical take-off and landing equipment of the F-35B. “We are aware of the F-35B crash on the shared runway at Naval Air Station Joint Reserve Base in Fort Worth and understand that the pilot ejected successfully. Safety is our priority, and we will follow appropriate investigation protocol,” a statement by Lockheed Martin, quoted by NBC, reads. In a separate statement, the chief of the Arlington Police Department confirmed that the pilot was safe following the ejection. The incident bears comparison to another that occurred on December 2, 2022. The nose gear of a US Marine Corps F-35B collapsed as the aircraft was being towed after an emergency landing at Kadena Air Base on Okinawa Island, Japan.',\n",
       " ('F-35',\n",
       "  82,\n",
       "  0): 'An image published on social media after the crash shows the F-35B Lightning II aircraft resting on its nose. The crash was the result of the aircraft’s failed hovering test. On Dec. 15, 2022 Lockheed Martin said in a statement that an F-35B Lighting II Joint Strike Fighter crashed on the runaway at Naval Air Station Joint Reserve Base in Fort Worth, Texas. The pilot ejected safely, according to the statement. Pentagon Press Secretary Brig. Gen. Patrick Ryder said during a Thursday press conference that the pilot was a US government employee. The plane had not yet been transferred to the US government, Ryder said. Lockheed manufactures the F-35B for the US Marine Corps (USMC). “We are aware of the F-35B crash on the shared runway at Naval Air Station Joint Reserve Base in Fort Worth and understand that the pilot ejected successfully. Safety is our priority, and we will follow appropriate investigation protocol,” reads the statement from Lockheed. An image published on social media after the crash shows the aircraft resting on its nose and, as the video filmed by Kitt Wilder in this post shows, the crash was the result of the aircraft’s failed hovering test. As reported by USNI News, Lockheed Martin’s final assembly plant for the F-35 shares a runway with Naval Air Station Joint Reserve Base in Fort Worth. As part of the test flight for the F-35Bs – which is known for its ability to have a short takeoff and vertical landing – pilots will take the aircraft up to test its ability to hover, Defense News reported. The Marine Corps also had an issue with the F-35B Lightning II aircraft in early December. The nose of the plane touched the ground while being towed due to a malfunction with the landing gear system, Marine Corps Times reported. The pilot had landed at Kadena Air Base in Okinawa, Japan, due to a suspected electrical system problem. The incident is currently under investigation. This print is available in multiple sizes from AircraftProfilePrints.com – CLICK HERE TO GET YOURS. F-35B Lighning II VMFA-121 Green Knights, VK00, 169164 / 2015 Noteworthy, as the following video shows, the F-35B pilot involved in yesterday accident had to do a 0-0 ejection. Actually, ejection seats are optimized to operate at minimum speed and altitude. This is called 0-0 ejection, meaning a seat designed to perform safe ejection and man-seat separation at 0 feet and 0 Knots. So if you are sitting in a parked aircraft, you call pull the handle and theoretically survive. However, there are a couple of other factors that need to be considered as well: 1. Aircraft attitude, specifically pitch and roll – some seats are only zero-zero if the aircraft nose/wings are level. 2. Vertical speed – if the aircraft is in a descent close to the ground, the seat might be out of the safe ejection envelope. Photo and video credit: Kitt Wilder',\n",
       " ('F-35',\n",
       "  83,\n",
       "  0): 'A Lockheed Martin-owned F-35B short take-off and vertical landing (STOVL) fighter jet crashed during an apparent attempted vertical landing in Fort Worth, Texas on 15 December. The defence manufacturer, which is the prime contractor on the F-35 programme, confirms the aircraft is company owned, having not yet been delivered to the US Department of Defense (DoD). Full screen in popup Previous Next A Lockheed Martin-owned F-35B fighter jet crashed in Fort Worth, Texas on 15 December Source: Houston Air Watch A Lockheed Martin-owned F-35B fighter jet crashed in Fort Worth, Texas on 15 December Source: Houston Air Watch 1/2 show caption Lockheed adds that the operator of the aircraft was a “US government pilot” rather than a Lockheed employee. “We are aware of the F-35B crash on the shared runway at Naval Air Station Joint Reserve Base in Fort Worth and understand that the pilot ejected successfully,” Lockheed said on 15 December. “Safety is our priority, and we will follow appropriate investigation protocol.” Twitter Account Houston Air Watch posted a video of the incident. Lockheed conducts final assembly of F-35s at a facility in Fort Worth. The US Marine Corps and US Navy directed about the incident to Lockheed Martin. Video circulating on social media shows the jet approaching a runway in vertical landing mode with landing gear down. The aircraft makes contact with the tarmac, but bounces off the ground – sometimes called “porpoising” or a “kangaroo landing” in pilot parlance. The nose of the F-35 then pitches forward, impacting the runway. The jet briefly disappears in a cloud of smoke, before rotating 180° and dragging the starboard wing across the tarmac. F-35 crash-lands in Fort Worth, TX - pilot ejected 🇺🇸 #aviation pic.twitter.com/Ov7qXf0xad — Houston Air Watch (@houstonairw) December 15, 2022 Editor’s note: This video contains some profanity The pilot ejected when the aircraft settles onto a level plane with both rear landing gear on the runway. Former NASA astronaut and US Navy fighter pilot Scott Kelly described the event on Twitter, saying “Skillful timing on the ejection, right when the wings were level.” The ejected aviator’s condition was not immediately disclosed. An investigation is underway. The US Marine Corps (USMC) is the only branch of the US military that operates the STOVL variant of the multi-service fighter aircraft. The Fort Worth crash caps a year that saw several serious incidents involving F-35s. In October, a US Air Force F-35A crashed in Utah, and in January a US Navy (USN) F-35C was lost in the South China Sea while attempting to land on the USS Carl Vinson aircraft carrier. Pilots in both incidents ejected safely. The F-35C was later recovered by the USN. In November 2021, a UK Royal Navy F-35B assigned to the HMS Queen Elizabeth crashed in the Mediterranean Sea.',\n",
       " ('F-35',\n",
       "  84,\n",
       "  0): 'The TWZ Newsletter Weekly insights and analysis on the latest developments in military technology, strategy, and foreign policy. Email address Sign Up Thank you! Terms of Service and Privacy Policy A U.S. Marine Corps F-35B stealth fighter today suffered damage after a nose-gear collapse at Kadena Air Base, Okinawa, in Japan. The short takeoff and vertical landing (STOVL) jet was under tow when the incident happened, having just returned to the base for a precautionary landing. The jet is home-based at Marine Corps Air Station Iwakuni in Japan. The incident occurred at around 1:40 PM, local time, after the F-35B had touched down and was being towed back to the flight line. In a video, the jet is seen bumping up and down in an unusual way as it’s towed. The nose gear oleo then gives way and the aircraft ends up sitting on its nose on the taxiway. No injuries were reported to any of those involved and the jet was soon surrounded by firefighting and other emergency vehicles. Maj. Rob Martins, a spokesman for the 1st Marine Aircraft Wing, stated in a release that the pilot of the jet, operated by Marine Fighter Attack Squadron 121 (VMFA-121), the “Green Knights,” had been forced to return to base after a suspected electrical problem. “The pilot performed as trained and chose the safest option, landing the aircraft safely in accordance with standard procedures… Operating our aircraft safely and effectively is a top priority and our aviators take great precautions to ensure the safety of the aircrew and the surrounding areas.” At the time of the incident, the F-35B had been flying a routine training mission, making use of local ranges. The “Green Knights” received its first F-35Bs in November 2012 and declared initial operational capability (IOC) in July 2015, before relocating permanently to Iwakuni in January 2017. The squadron has since developed considerable shipborne expertise, becoming the first Lightning II unit to deploy at sea, embarking six F-35Bs aboard the amphibious assault ship USS Wasp (LHD-1) in March 2018. F-35Bs from VMFA-121 go aboard USS Wasp for the first time: F-35s, of all versions, have been involved in a number of mishaps, including several total airframe losses. The most significant incidents to have affected the U.S. Marine Corps F-35B fleet, in particular, include a pair of crashes, which we reported on here and here, while the United Kingdom’s Royal Air Force also lost an F-35B in a dramatic carrier in an accident in November last year that we detailed at the time. There have also been several ground incidents, including engine fires, and it’s notable, too, that there have been previous undercarriage failures. In at least one such incident, the jet in question (a U.S. Air Force F-35A) had an issue in flight and its nose gear collapsed after it touched down and had parked. Separately, the U.S. Navy’s F-35 carrier variant of the stealth jet has historically had issues with its nose gear, a result of nose strut compression right before launch. Since the F-35C model has a different nose gear design for carrier launch, this has not applied to the other models. As to the aircraft involved in today’s mishap, it’s unclear to what degree the aircraft has been damaged, although a “detailed investigation” is now being conducted that will address this, as well as what went wrong in the first place. We will continue to update this story once more information becomes available. Contact the author: thomas@thedrive.com',\n",
       " ('F-35',\n",
       "  85,\n",
       "  0): '28 сентября самолет потерпел крушение в штате Южная Каролина ТАСС-ДОСЬЕ. 28 сентября 2018 года новейший многофункциональный истребитель-бомбардировщик F-35B Корпуса морской пехоты (КМП) США потерпел крушение близ базы морской пехоты Бьюфорт в штате Южная Каролина. По предварительным данным, пилот успешно катапультировался. Это первое крушение самолета данного типа. Lockheed Martin F-35 Lightning II - семейство одноместных однодвигательных сверхзвуковых всепогодных малозаметных многофункциональных истребителей-бомбардировщиков пятого поколения. Разработано американской компанией Lockheed Martin в 2000-х годах для замены устаревающих типов самолетов, состоящих на вооружении военно-воздушных сил (ВВС), военно-морских сил (ВМС) и Корпуса морской пехоты США, а также ряда стран - союзников США. Самолет стал вторым в истории серийным истребителем пятого поколения после Lockheed Martin F-22 Raptor. По состоянию на 2018 год различные модификации F-35 поставляются вооруженным силам США, Великобритании, Австралии, Израиля, Италии, Японии, Нидерландов, Норвегии, Южной Кореи, Турции. Планируется, что самолеты F-35 также закажет и Дания. Истребитель может быть носителем атомного оружия. Ожидается, что к 2024 году F-35 ВВС США получат возможность нести модернизированные ядерные авиабомбы B-61 (мощность до 50 килотонн в тротиловом эквиваленте). История проекта В 1980-х - 1990-х годах американское военное ведомство инициировало целый ряд программ по созданию перспективных самолетов для замены палубного штурмовика Grumman A-6 Intruder, истребителя-бомбардировщика вертикального взлета и посадки Harrier, истребителя F-16 Fighting Falcon, штурмовика Fairchild Republic A-10 Thunderbolt II, истребителя-бомбардировщика и штурмовика McDonnell Douglas F/A-18 Hornet. После распада СССР сокращение оборонных бюджетов США потребовало пересмотра этих программ с целью сокращения расходов. В результате было принято решение создать \"единый ударный истребитель\" (Joint Strike Fighter, JSF), модификации которого были бы унифицированы между собой на 70-90% и позволяли бы заменить названные самолеты. В 1997 году на конкурс по программе JSF компания Lockheed Martin заявила экспериментальный самолет X-35, ее конкурентом стала компания Boeing с самолетом X-32 (третий участник конкурса, компания McDonnell Douglas, отказалась от участия в нем еще в 1996 году). Первый полет X-35A состоялся 24 октября 2000 года в Палмдейле (штат Калифорния, США). 23 июня 2001 года впервые поднялась в воздух модификация X-35B. 26 октября того же года заявка Lockheed Martin победила в конкурсе JSF. Одним из преимуществ X-35 стал метод создания вертикальной тяги с помощью отдельного вентилятора (на Boeing Х-32 применялось изменение направления тяги основных двигателей, приводившее к перегреву силовой установки). В консорциум во главе с Lockheed Martin вошли компании Northrop Grumman, Pratt & Whitney, Rolls-Royce, Allison и British Aerospace. На старте программы предполагалось, что проектирование, испытания и развертывание серийного производства займут пять лет, однако сроки реализации проекта многократно сдвигались. 20 февраля 2006 года состоялась выкатка предсерийного экземпляра самолета для ВВС США - F-35А, 15 декабря он успешно выполнил первый полет. В том же году самолет получил наименование Lightning II (с англ. \"Молния-2\"), в честь американского тяжелого истребителя Второй мировой войны Lockheed P-38 Lightning. В июне 2008 года состоялся первый полет предсерийного самолета для морской пехоты F-35B, а в июне 2010 года - палубного варианта F-35C. Серийное производство было развернуто на заводе в Форт-Уэрте (штат Техас). В июле 2011 года палубный самолет впервые взлетел при помощи катапульты, в октябре того же года F-35B впервые вертикально приземлился на палубу корабля (специально переоборудованного под базирование F-35 универсального десантного корабля ВМС США USS Wasp). С 2012 года F-35B получает Великобритания. В этой стране самолет носит название F-35 Lightning (без цифры II), так как британские ВВС в разное время использовали две разных \"Молнии\" - Lockheed P-38 и English Electric Lightning. В сентябре 2015 года взлетел первый F-35, собранный за пределами США: линия окончательной сборки истребителей заработала на совместном предприятии Lockheed Martin и итальянского министерства обороны в Камери (регион Пьемонт, Италия). С 2015 года сборка F-35 также ведется на заводе корпорации Mitsubishi Heavy Industries в городе Нагоя. С декабря 2016 года специальную версию F-35A получает Израиль, где',\n",
       " ('F-35',\n",
       "  85,\n",
       "  1): 'самолет получил армейское наименование \"Адир\" (с ивр. \"могучий\"). 21 июня 2018 года в Форт-Уэрте состоялась передача турецким вооруженным силам первых F-35A, заказанных этой страной. По словам главы МИД Турции Мевлюта Чавушоглу, в Турцию самолеты будут доставлены в 2020 году, по окончании периода обучения в США пилотов и технического персонала. Передача состоялась несмотря на возражения Конгресса США: американские законодатели требовали отменить поставки Турции современного вооружения, в том числе F-35, из-за покупки этой страной российских зенитных ракетных систем С-400. Промежуточные итоги программы, оценка стоимости В конце февраля 2018 года вице-адмирал Мэт Уинтер, директор отдела минобороны США по реализации программы разработки и закупки F-35, сообщил журналистам, что из поставленных американским ВВС и странам-партнерам 280 самолетов только 51% могут совершать полеты. Уинтер отметил, что на многих машинах выявились проблемы с двигателями, системами жизнеобеспечения пилотов и с программным обеспечением. Напряженной оставалась и ситуация с запасными деталями, которые производитель поставлял с задержками. 11 июня 2018 года Lockheed Martin отчиталась о поставке 300-го экземпляра F-35 (в 2017 году были поставлены 66 единиц - на 40% больше, чем в 2016 году). Из общего числа поставленных самолетов на вариант F-35A пришлось 197 единиц, 75 единиц - на вариант F-35B, 28 единиц - вариант F-35С. По данным производителя, суммарный налет этого флота превысил 140 тыс. летных часов. Всего за 2018 год производитель планирует передать заказчику 91 самолет (таким образом, общее число поставленных машин составит 357). Вооруженные силы США намерены приобрести в общей сложности 2 тыс. 443 экземпляра F-35. Всего на разработку самолета было затрачено свыше $46 млрд, а в целом, согласно прогнозам, реализация программы обойдется США в более чем в $1,5 трлн: $406,5 млрд пойдут на закупку самолетов и еще около $1,1 трлн - на эксплуатацию, техобслуживание, модернизацию и ремонт. Эксперты называют F-35 самой дорогостоящей системой вооружений в истории. Закупочная стоимость единицы F-35A в 2018 году составляет около $100 млн. К 2020 году ее планируется снизить до $80 млн. В 2023 году Lockheed Martin намерена нарастить выпуск до 160 самолетов в год. Ожидается, что истребители-бомбардировщики этого типа будут состоять на вооружении по крайней мере до 2070 года. Конструкция и оснащение Самолет построен по нормальной аэродинамической схеме моноплана с высокорасположенным трапециевидным крылом, двигателем в хвостовой части и хвостовым оперением, включающим два незначительно наклоненных наружу киля. Модификация F-35B имеет за кабиной пилота подъемный вентилятор вертикальной тяги, соединенный валом с двигателем в хвостовой части машины; двигатель этого варианта самолета оснащен поворотным соплом. Место вентилятора на других вариантах истребителя занимают дополнительные топливные баки. Турбореактивный двухконтурный двигатель F-135 разработки Pratt & Whitney имеет бесфорсажную тягу 13 тыс. кгс, в режиме форсажа - 19 тыс. 500 кгс. (в варианте для F-35B - 12 тыс. 250 кгс и 18 тыс. 600 кгс в режиме форсажа). Подъемный вентилятор для F-35B спроектирован и производится компанией Rolls-Royce. Сверхзвуковой режим полета обеспечивается только в режиме форсажа. Выпускающееся шасси трехопорное, с носовым колесом. Истребитель сконструирован в соответствии с критериями технологии stealth, с применением решений, ранее отработанных на F-22 Raptor. Малую радиолокационную заметность обеспечивают малоотражающие формы планера, поверхности которого ориентированы в нескольких строго ограниченных направлениях. Применены радиопоглощающие материалы и покрытия. Вооружение размещается в двух бортовых грузовых отсеках в нижней части центральной секции фюзеляжа (до 2 тыс. 590 кг) и на шести узлах внешней подвески (до 6 тыс. 800 кг). Модификации Боевое применение F-35A - ударный истребитель с обычным взлетом и посадкой, базовый заказчик - ВВС США. F-35B - ударный истребитель с коротким взлетом и вертикальной посадкой, базовый заказчик - КМП США. F-35C - ударный палубный истребитель с катапультным взлетом и посадкой с помощью аэрофинишеров, базовый заказчик - ВМС США. Площадь крыла увеличена по сравнению с другими вариантами. F-35I Adir - модификация F-35A для ВВС Израиля. CF-35 - спроектированная модификация F-35A для ВВС Канады',\n",
       " ('F-35',\n",
       "  85,\n",
       "  2): '(не выпускалась). Первой страной мира, применившей F-35 в боевых миссиях, стал Израиль. 22 мая 2018 года командующий ВВС еврейского государства Амикам Норкин написал в Twitter, что самолеты \"Адир\" уже поставлены на вооружение и \"принимают участие в боевых действиях\". Военачальник не уточнил, в каких именно миссиях были задействованы истребители. 27 сентября 2018 года F-25B КМП США был впервые применен в Афганистане для удара по позициям запрещенного в РФ радикального движения \"Талибан\". В Пентагоне вылет назвали \"успешным\". Летно-технические характеристики F-35B',\n",
       " ('F-35',\n",
       "  86,\n",
       "  0): 'https://ria.ru/20250129/aviakatastrofa-1996029355.html На Аляске потерпел крушение истребитель F-35 На Аляске потерпел крушение истребитель F-35 - РИА Новости, 29.01.2025 На Аляске потерпел крушение истребитель F-35 В американском штате Аляска потерпел крушение истребитель пятого поколения F-35, пилоту удалось спастись, сообщили в американских ВВС. Заявление цитирует... РИА Новости, 29.01.2025 2025-01-29T04:37:00+03:00 2025-01-29T04:37:00+03:00 2025-01-29T08:20:00+03:00 в мире аляска сша f-35 https://cdnn21.img.ria.ru/images/07e9/01/1d/1996039019_0:0:1920:1080_1920x0_80_0_0_81dc8da15f48528f0c195a221db1ae2a.jpg ВАШИНГТОН, 29 янв - РИА Новости. В американском штате Аляска потерпел крушение истребитель пятого поколения F-35, пилоту удалось спастись, сообщили в американских ВВС. Заявление цитирует Ассошиэйтед Пресс.\"Пилот в безопасности и был перевезен в военный госпиталь Бассетт для дальнейшего осмотра\", - говорится в заявлении Военно-воздушных сил США. В ведомстве отметили, что инцидент произошел на базе ВВС Эйлсон во вторник. В результате истребитель получил серьезные повреждения. \"Всё еще ведется расследование\", - добавили в ВВС. https://ria.ru/20241016/ssha-1978301448.html https://ria.ru/20240529/f-35-1949031922.html аляска сша РИА Новости 1 5 4.7 96 internet-group@rian.ru 7 495 645-6601 ФГУП МИА «Россия сегодня» https://xn--c1acbl2abdlkab1og.xn--p1ai/awards/ 353 60 353 60 2025 Дарья Буймова Дарья Буймова Новости ru-RU https://ria.ru/docs/about/copyright.html https://xn--c1acbl2abdlkab1og.xn--p1ai/ РИА Новости 1 5 4.7 96 internet-group@rian.ru 7 495 645-6601 ФГУП МИА «Россия сегодня» https://xn--c1acbl2abdlkab1og.xn--p1ai/awards/ 353 60 353 60 Крушение истребителя ВВС США F-35 на Аляске Крушение истребителя ВВС США F-35 на Аляске 2025-01-29T04:37 true PT0M32S 1920 1080 true 1920 1440 true 1920 1920 true РИА Новости 1 5 4.7 96 internet-group@rian.ru 7 495 645-6601 ФГУП МИА «Россия сегодня» https://xn--c1acbl2abdlkab1og.xn--p1ai/awards/ 353 60 353 60 Дарья Буймова в мире, аляска, сша, f-35',\n",
       " ('F-35',\n",
       "  87,\n",
       "  0): 'An F-35B Lighting II Joint Strike Fighter crashed on the runaway at Naval Air Station Joint Reserve Base in Fort Worth, Texas, Lockheed Martin said in a statement Thursday. The pilot ejected safely, according to the statement. The pilot was a U.S. government employee, Pentagon Press Secretary Brig. Gen. Patrick Ryder said during a Thursday press conference. The plane had not yet been transferred to the U.S. government, Ryder said. Lockheed manufactures the F-35B for the Marine Corps. “We are aware of the F-35B crash on the shared runway at Naval Air Station Joint Reserve Base in Fort Worth and understand that the pilot ejected successfully. Safety is our priority, and we will follow appropriate investigation protocol,” reads the statement from Lockheed. F-35 crash-lands in Fort Worth, TX – pilot ejected 🇺🇸 #aviation pic.twitter.com/Ov7qXf0xad — Houston Air Watch 🚁🛰️ (@houstonairw) December 15, 2022 An image published on social media after the crash shows the aircraft resting on its nose and local reports say the crash was the result of the aircraft’s failed hovering test. Lockheed Martin’s final assembly plant for the F-35 shares a runway with Naval Air Station Joint Reserve Base in Fort Worth. As part of the test flight for the F-35Bs – which is known for its ability to have a short takeoff and vertical landing – pilots will take the aircraft up to test its ability to hover, Defense News reported. The Marine Corps also had an issue with the F-35B Lightning II aircraft in early December. The nose of the plane touched the ground while being towed due to a malfunction with the landing gear system, Marine Corps Times reported. The pilot had landed at Kadena Air Base in Okinawa, Japan, due to a suspected electrical system problem. The incident is currently under investigation. The Navy and the Marine Corps have been testing the idea of the “Lightning Carrier,” USNI News previously reported. Back in April, the Navy loaded 16 F-35Bs onto USS Tripoli (LHA-7), with more expected to be added later. It was the most F-35Bs to be loaded onto a big-deck amphibious ship. Tripoli deployed to the Western Pacific in May and spent the first couple months of the deployment testing the lightning carrier concept. Tripoli returned home in November.',\n",
       " ('F-35',\n",
       "  88,\n",
       "  0): 'Combat aircraft operations in the Asia Pacific is off to a rocky start in 2022 with a spate of high profile aircraft accidents for South Korea and Taiwan in the first two weeks of the year. On 4 January, A Republic of Korea Air Force (RoKAF) Lockheed Martin F-35A Lightning II Joint Strike Fighter made an emergency belly landing at Seosan Air Base during a routine training flight, prompting the service to suspend operations of the aircraft type. A Ministry of National Defense (MND) spokesperson said that the service has launched a formal investigation into the emergency landing and that the fleet will remain grounded until the investigation is complete. RoKAF vice chief of staff Shin Ok-chul testified the next day at a National Assembly hearing that the pilot, who was uninjured, experienced anomalies with the aircraft’s avionics systems while flying at low altitude and excuted an emergency landing at the nearest airbase instead of abandoning the aircraft. However, the RoKAF subsequently lost a Northrop Grumman F-5E Tiger II fighter and its pilot after the aircraft crashed into a mountain in Hwaseong on 11 January, after taking off from Suwon Airbase. The MND said an engine fire warning light had activated a few minutes after take-off but the pilot was unable eject from the aircraft despite two attempts to do so. Meanwhile, the Republic of China Air Force (RoCAF) lost a recently upgraded Lockheed Martin F-16V fighter aircraft after it crashed into the sea on 11 January, also prompting the service to suspend F-16 training operations to conduct investigations. The Taiwanese MND said in a statement that radar and communications contact was lost with the aircraft after it took off from fleet, went missing from radar screens after taking off from the Chiayi Air Base in southern Taiwan for a training mission. The government’s Rescue Command Center said witnesses had seen the aircraft crash into the sea and that wreckage of its fuselage had been found. However, the fate of the pilot is presently unknown despite an overnight involving multiple helicopters and coastguard vessels The RoCAF only recently commissioned its first F-16V squadron, which is assigned to its 4th Tactical Fighter Wing, in November 2021. The crashed aircraft is one of the many F-16A/B aircraft locally upgraded to the latest V-configuration under the Peace Phoenix programme. The service has suffered a spate of crashes that were mainly attributed to pilot error over recent months, including the loss of two F-5E Tiger II fighter aircraft were following a mid-air collision off Taiwan’s south-eastern coast in March 2021. The service also lost another F-5 and an F-16 in separate crashes in October and November 2020, respectively. by Jr Ng',\n",
       " ('F-35',\n",
       "  89,\n",
       "  0): 'The TWZ Newsletter Weekly insights and analysis on the latest developments in military technology, strategy, and foreign policy. Email address Sign Up Thank you! Terms of Service and Privacy Policy Details are still coming in, but a Lockheed Martin-owned F-35B Joint Strike Fighter has ended up nose-down off the side of the runway at Naval Air Station Joint Reserve Base Fort Worth in Texas after a mishap earlier today. Local first responders say the aircraft’s pilot ejected safely during the incident, which comes on the anniversary of the F-35’s first flight in 2006. While the exact circumstances of the mishap remain unclear, video has emerged, seen below, showing the F-35B in hover when it begins to drop vertically. After initially touching down, the jet then bounces back up into the air, and then comes down again nose first hitting the runway hard. The nose gear is seen breaking off entirely before the aircraft spins onto the grass, at which point the pilot ejects. It is worth pointing out that this was a demonstration of the so-called “zero-zero” capabilities of the jet’s Martin-Baker US16E ejection seat, with it safely functioning with aircraft on the ground and essentially stopped. “We are aware of the F-35B crash on the shared runway at Naval Air Station Joint Reserve Base in Fort Worth and understand that the pilot ejected successfully,” according to a statement that Lockheed Martin gave to The War Zone. “Safety is our priority, and we will follow appropriate investigation protocol.” When contacted for additional details, a public affairs officer at Naval Air Station Joint Reserve Base Fort Worth also directed us to contact the company. The mishap involving the F-35 occurred sometime shortly before 10:15 AM local time, which is when the nearby White Settlement Police were called to the scene, according to a report from NBC DFW, a local NBC affiliate in the Dallas-Fort Worth area. White Settlement Police officers along with U.S. Navy and Lockheed Martin personnel secured the scene, White Settlement Police Chief Christoper Cook told that outlet. “According to Cook, a Lockheed-owned jet suffered some sort of malfunction that forced the pilot to eject the aircraft,” NBC DFW reported. “Cook said the pilot safely ejected but had no other information about the pilot’s condition.” At a routine press conference today, Pentagon Press Secretary Air Force Brig. Gen. Pat Ryder further confirmed the crash and that the pilot had ejected safely. He added that a U.S. government pilot was at the controls at the time and that the F-35B in question was to be delivered to the U.S. government, but did not say specifically who the final intended customer might be. Lockheed Martin’s main F-35 production facility in Fort Worth shares the runway with Naval Air Station Joint Reserve Base Fort Worth. While there is no indication that the two incidents are in any way related, this does follow an incident two weeks ago involving a U.S. Marine Corps F-35B, which suffered a nose gear collapse after making an emergency landing at Kadena Air Base on the Japanese island of Okinawa. Today is also the anniversary of the first flight of the F-35A, which occurred on Dec. 15, 2006. The first time an F-35B variant took to the air was on June 11, 2008. We will continue to update this story as more information becomes available. Contact the author: joe@thedrive.com',\n",
       " ('F-35',\n",
       "  9,\n",
       "  0): 'F-35 получит стелс-бомбу, способную пролететь 500 километров Штаты постепенно наращивают возможности новейшего истребителя пятого поколения, предоставляя ему все новые возможности по поражению наземных целей, что, вероятно, станет главной задачей самолета в обозримом будущем. Сейчас Военно-морские силы США заявили, что начнут развертывать новую версию планирующей стелс-бомбы AGM-154, или JSOW, не позднее конца 2023 года. Ее смогут применять как флотские истребители четвертого поколения Boeing F/A-18E/F Super Hornet, так и новейшие F-35C — будущее палубной авиации Соединенных Штатов. Еще 7 февраля Командование авиационных систем ВМС (Naval Air Systems Command, NAVAIR) объявило о намерении заключить контракт с Raytheon на работы, связанные с новой системой вооружения оружием, известным как JSOW-Extended Range, или JSOW-ER. В уведомлении говорится, что боеприпас сделают совместимым с ударным истребителем ВВС США F-35A, но не ясно, намерены ли Военно-воздушные силы закупать эти ракеты для своих новых истребителей. Вообще, в распоряжении ВВС уже есть множество машин, способных нести разные ракеты большой и сверхбольшой дальности. В свою очередь, включение в арсенал F-35C новейшей бомбы даст флоту США принципиально новые возможности. За счет оснащения бомбы турбореактивным двигателем Hamilton-Sundstrand TJ-150 удалось повысить ее дальность полета с примерно 100-130 километров (у базовой версии) до 560 километров. С помощью JSOW-ER можно поражать хорошо защищенные объекты без опасения входа самолета-носителя в зону поражения ПВО. Таким образом, Штатам удалось объединить относительную дешевизну управляемых бомб с возможностями крылатой ракеты. Отметим также, что максимальная масса боевой части JSOW составляет 450 килограммов. JSOW-ER / ©Raytheon Отметим, впрочем, далеко не всегда программе F-35 сопутствует успех. Недавно стало известно, что первые поставленные войскам истребители пятого поколения F-35B Lightning II могут быть списаны уже к середине следующего десятилетия. Причиной этого стали технические недоработки ранних серийных машин. Европа, в свою очередь, решила вообще обойти создание истребителей пятого поколения стороной, сразу приступив к разработке самолетов-истребителей следующего, шестого поколения. Нашли опечатку? Выделите фрагмент и нажмите Ctrl + Enter.',\n",
       " ('F-35',\n",
       "  90,\n",
       "  0): 'Предлагая своим давним стратегическим партнерам истребитель F-35 вместо F-22 Raptor, США уподобляются продавцу мотоциклов, который хочет предложить покупателю скутер с объемом двигателя в 50 кубических сантиметров. Такое мнение высказал австралийский парламентарий и бывший военный исследователь Деннис Дженсен в статье, которую публикует Defense Aerospace. Австралия стала одной из стран, выразивших желание приобрести новые многоцелевые истребители F-22, экспорт которых запрещен американским законодательством. Однако в итоге Канберра предварительно остановила свой выбор на F-35 Lightning II, который, по мнению автора, можно назвать лишь \"младшим братом\" F-22. Как отмечает Дженсен, цитируя мнение экспертов, F-35 никогда не сможет соперничать с российскими самолетами и средствами противовоздушной обороны, которые поступают на вооружение стран азиатско-тихоокеанского региона. Парламентарий выражает недоумение, что США до сих пор отказываются продавать F-22 странам, которые являются давними военными и политическими союзниками Вашингтона и принимают совместное участие с американскими войсками в военных операциях. Такая позиция может негативно отразиться не только на боеготовности армий ближайших партнеров, но и на самих вооруженных силах США, если администрация Белого дома примет решение приостановить покупку F-22 для своей армии. Производство этих самолетов должно продолжаться, констатирует австралийский парламентарий. Напомним, что недавно австралийский аналитический центр Air Power Australia (APA) опубликовал исследование, в котором сравнил возможности российских средств ПВО и американской боевой авиации. По мнению экспертов, российские радиолокационные системы и зенитные ракетные комплексы достигли уровня, который фактически исключает возможность выживания авиации ВВС США в случае военного конфликта. При этом APA также назвал F-22 единственным американским боевым самолетом, способным конкурировать с российской ПВО. В настоящее время дальнейшее производство F-22 Raptor пока под вопросом. По мнению многих экспертов, новое руководство США может принять решение о существенном сокращении их закупок и даже полном прекращении производства. Экспорт этих многоцелевых истребителей также пока под запретом, хотя руководство Пентагона уже высказывало предположение о вероятном разрешении продажи F-22 некоторым странам.',\n",
       " ('F-35',\n",
       "  91,\n",
       "  0): 'DALLAS — A pilot ejected from a military fighter jet, making a crash landing on a runway Thursday morning in Fort Worth. Video shows a pilot in the sky with a parachute after ejecting from an aircraft that had been hovering above the ground moments earlier. “We are aware of the F-35B crash on the shared runway at Naval Air Station Joint Reserve Base in Fort Worth and understand that the pilot ejected successfully,” Lockheed Martin said in a written statement. “Safety is our priority, and we will follow appropriate investigation protocol.” An aircraft can be seen hovering and lowering itself toward the ground in a video obtained by KXAS-TV from Kitt Wilder. The aircraft appears to be landing when the jet’s nose tips forward onto the ground and the front landing gear appears to snap off. The plane slides on the runway, turning as a plume of smoke emerges before the pilot ejects and parachutes back toward the ground. The pilot is “safe and under observation,” White Settlement police Chief Christopher Cook said on Twitter. Lockheed Martin did not provide information about the condition of the pilot or what may have led to the crash in its statement. Police responded at about 10:15 a.m. to the base near the town of White Settlement after receiving multiple calls about a military aircraft crash with a pilot ejecting, Cook told The Dallas Morning News. Cook said the Department of Defense and Lockheed Martin requested the police close off public areas around the runway because they worried people would encroach on federal property. “When we got here, there were people in the middle of the highway,” Cook said. “Certainly we had to clear up all of that, from a safety perspective.” Cook said all roads had been opened Thursday afternoon and authorities would conduct their investigation. He said the plane belonged to Lockheed Martin. The company is an arms, defense, security and aerospace company headquartered in Maryland that employs about 114,000 people worldwide, according to its website. The Tarrant County facility is the primary place where the company manufactures F-35 combat aircraft and employs more than 18,000 people. Lockheed is one of the largest contractors working with the Department of Defense. The F-35B can land like a helicopter and take off in short distances, and it is operated by the United States Marine Corps, the United Kingdom, and the Italian Air Force, according to the company’s website. The base said in a Facebook post Tuesday multiple structures were damaged by strong winds that accompanied a tornado that occurred during storms that day. The group said debris had spread across the runway and the base’s operations department workers were cleaning up the scene that day. At least 14 tornadoes swept through the region Tuesday. The National Weather service said three tornadoes — one with winds up to 110 miles per hour — touched down near the base that day. ——— ©2022 The Dallas Morning News. Visit dallasnews.com. Distributed by Tribune Content Agency, LLC.',\n",
       " ('F-35',\n",
       "  92,\n",
       "  0): 'Во время очередных испытаний инженеры столкнулись с тем, что самолеты \"видят\" не все наземные цели. Это происходит, когда F-35 находятся в воздухе в составе группы. Например, два истребителя, летящие друг за другом, распознают лишь одну из, допустим, четырех находящихся на земле зенитных установок. Как пояснил исполнительный директор программы F-35 генерал-лейтенант Кристофер Богдан, которого цитирует издание Defensetech, из-за разницы углов, под которыми так называемые датчики синтеза двух самолетов \"видят\" объект, в систему взаимодействия пилотов подается разная информация. Электроника как бы путается и не может решить, одна цель присутствует на земле или несколько. Свою роль в этом играют и физические особенности объектов. Следствием этой неразберихи, считают специалисты, вполне может стать поражение истребителей - незамеченные зенитные установки произведут залпы. Генерал поспешил заверить, что проблема не скажется на планах поставки перспективных самолетов военно-морским силам США. По его словам, над решением вопроса уже работают эксперты военно-морского флота и ученые из Лаборатории прикладной физики Джона Хопкинса. Им предстоит усилить чувствительность алгоритмов программного обеспечения для улучшения идентификации. Однако, сколько на это потребуется времени, представитель командования армии США не уточнил. Богдан также заявил, что у F-35 есть много других датчиков, дающих сведения о целеуказании, управлении огнем и надвигающейся угрозе. Вся информация отображается и на панели приборов, и в шлеме пилота с помощью программного обеспечения. Однако армейский чиновник оговорился, что проблемные датчики синтеза являются одной из важнейших составляющих этой системы. Так что в ВМФ пока что планируется поставлять истребители с программным обеспечением, в котором не исправлены ошибки. - Они знают, как обойти обнаруженные недостатки. Имеющегося оснащения им достаточно, чтобы принять F-35B на боевое дежурство, - выразил уверенность Кристофер Богдан. Напомним, самолеты пятого поколения семейства F-35 разработаны американской фирмой Lockheed Martin. Истребитель является самым дорогим в мире оружием за всю историю. По подсчетам экспертов, полная стоимость создания и обслуживания каждого самолета за весь планируемый период эксплуатации составит 670 миллионов долларов, что гораздо больше горы золота массой равной весу самого F-35.',\n",
       " ('F-35',\n",
       "  93,\n",
       "  0): 'A Marine Corps F-35B Lightning II\\'s nose cone was damaged after making a quick landing in Okinawa, Japan, on Thursday, the service said. Maj. Roberto Martins, a spokesman for 1st Marine Aircraft Wing, told Military.com in an emailed statement on Thursday night that the pilot was flying out of Marine Corps Air Station Iwakuni and had to make a \"precautionary landing\" at Kadena Air Base \"due to a suspected electrical issue.\" After touching down at the Air Force base\\'s runway, the stealth fighter\\'s landing gear failed while being towed to the flight line. Read Next: Former Marine Sues VA, Alleging \\'Years\\' of Discrimination Against Black Vets Seeking Benefits \"While being towed the front landing gear malfunctioned causing the nose of the aircraft to touch the ground,\" Martins said. \"There are no injuries as a result of the landing gear malfunction, and a detailed investigation will be conducted.\" Footage from Japanese public broadcaster NHK showed the F-35\\'s nose dipped onto the runway and the front landing gear collapsed. It\\'s not yet clear what the electrical issues were, how much damage was done to the aircraft or what the cost will be to repair it. So far, in 2022, the Marine Corps has reported a total of five Class A aircraft mishaps -- the classification the military uses for its most deadly and most expensive crashes. It\\'s unclear what categorization Thursday\\'s incident will receive. The F-35 Lightning II was first cleared for use in training in 2012 and is flown by the Marine Corps, Air Force and the Navy. It is one of the most advanced aircrafts in the Pentagon\\'s arsenal, possessing stealth technology for reconnaissance, intelligence and electronic warfare that have earned it the nickname \"the flying computer.\" Some variants also have vertical takeoff and landing capabilities. But the program has been criticized over the last decade by many in Washington for its high costs and frequent technical and mechanical issues. A U.S. Government Accountability Office report earlier this year said that the Department of Defense currently has 450 F-35s and plans to have about 2,500 in total. But the F-35\\'s mission-capable rate -- the percentage of time that the aircraft can fly and perform at least one mission -- declined between Fiscal Year 2020 and FY 2021 due to mechanical issues. \"One major reason is that an increasing number of F-35s have not been able to fly, because they don\\'t have a working engine,\" the GAO report from April 28 said. The landing gear mishap marks the most recent issue with an F-35 Lightning II variant this year. In October, an F-35A Lightning II crashed at Hill Air Force Base in Utah, forcing the pilot to eject and causing wildfires on the base. In late July, Air Combat Command stood-down its fleet of F-35As after a recall related to the aircraft\\'s ejection seats worried officials. By mid-August, the fighter jets were back in the air. -- Thomas Novelly can be reached at thomas.novelly@military.com. Follow him on Twitter @TomNovelly. Related: F-35 Crashes in Utah During Training Mission; Pilot Ejects Safely',\n",
       " ('F-35',\n",
       "  94,\n",
       "  0): \"A $100million F-35 stealth fighter jet crashed onto the runway while being towed in Japan after its front wheel collapsed. The US Marine Fighter Attack Squadron plane made an precautionary landing at the Kadena Air Base, Okinawa, Japan, on December 1 for possible electrical problems around 2pm, according to The Aviationist. After landing on the runway, crews began towing the aircraft when the front wheel, which can retract under the cockpit, suddenly collapsed. The plane slowly crashed nose-first into the runway, while the pole attached to the vehicle towing it dragged on the ground, leaving the plane behind. It does not appear there was anyone in the aircraft when it crashed. It is unclear how much damage the crash caused and the US Marine Corps is investigating. A $100million F-35 stealth fighter jet crashed onto the runway while being towed at the Kadena Air Base, Okinawa, Japan, on December 1, 2022, around 2pm While being towed, the front wheel collapsed and the plane was fell nose-first Earlier this summer, the Air Force grounded its fleet of F-35 Joint Strike Fighters to check for a faulty component that could prevent pilots from safely ejecting. A spokesperson for the Air Force confirmed it was a temporary stand-down order in a statement to DailyMail.com, saying the aircrafts are currently being inspected 'to mitigate safety concerns.' 'There is a concern with a component used in the pilot ejection system of several aircraft operated by the US Air Force,' the spokesperson said in July. The explosive cartridges inside the F-35 ejection seats that blows the pilot clear of the aircraft in an emergency had to be inspected. The Air Force has roughly 300 F-35s, which cost around $78million a piece for the latest model. Air Force F-35s use the Martin-Baker ejection seats. In July, the service began an inspection process to determine whether any of them were impacted by the recall. 'Out of an abundance of caution, [Air Combat Command] ACC units will execute a stand-down on July 29 to expedite the inspection process,' an ACC spokesman told DailyMail.com in a statement. The aircraft was seen being towed after landing before it fell. It made a precautionary landing due to possible electrical problems and it was towed after landing 'Based on data gathered from those inspections, ACC will make a determination to resume operations,' the statement added. An Air Force spokesperson insisted that: 'This is a temporary stand down, not a fleet-wide grounding.' The aircrafts reentered service in August.\",\n",
       " ('F-35',\n",
       "  95,\n",
       "  0): 'An F-35B Lightning II crashed during a vertical landing at an air base in North Texas on Thursday, forcing the pilot to eject from the aircraft on the runway. The crash happened at Naval Air Station Joint Reserve Base Fort Worth. Christopher Cook, the chief of police for the nearby White Settlement Police Department, said the pilot was safe. \"We responded to assist Lockheed Martin and Naval Air Station on a military aircraft crash where the pilot ejected,\" Cook tweeted. \"Update on pilot is that they are safe and under observation. Grateful for this news.\" Read Next: Commander of Air Force\\'s` Mississippi Training Wing Removed Video footage of the incident, shared by CBS News\\' Dallas Fort Worth station online, shows the F-35B coming in for a vertical landing on the runway. Shortly after touching down, the aircraft\\'s nose cone smashes into the ground and the jet begins to pivot around the pavement, creating a plume of smoke. The pilot quickly ejected from the F-35B, according to the footage, with their parachute opening feet before the pilot hit the ground. The jet then came to a halt. During a press briefing Thursday, Defense Department spokesman Brig. Gen. Pat Ryder confirmed the incident happened but deferred comment to Lockheed Martin, adding that the F-35B \"had not been transferred to the U.S. government yet,\" an indication that the aircraft was undergoing testing by the manufacturer. Jacqueline M Lorenzetti, a spokeswoman for Lockheed Martin, told Military.com in an emailed statement that there is an investigation into the incident. \"We are aware of the F-35B crash on the shared runway at Naval Air Station Joint Reserve Base in Fort Worth and understand that the pilot ejected successfully,\" Lorenzetti said. \"Safety is our priority, and we will follow appropriate investigation protocol.\" The F-35 Lightning II is used by the Air Force, Marine Corps and Navy. The F-35B variant, which has vertical takeoff and landing capabilities, is used by the Marines. The incident in North Texas is one in a string of several F-35 crashes and mishaps this year. Earlier this month, a Marine Corps F-35B\\'s nose cone was damaged after making a quick landing in Okinawa, Japan. An F-35A crashed at Hill Air Force Base in Utah in October, forcing the pilot to eject and causing wildfires on the base. In March, the U.S. Navy announced it had successfully recovered an F-35C Lightning II fighter that crashed into the deck of the aircraft carrier USS Carl Vinson in January before sliding off and sinking into the South China Sea. -- Thomas Novelly can be reached at thomas.novelly@military.com. Follow him on Twitter @TomNovelly. Related: Marine Corps F-35 Damaged After Landing Gear Failure in Okinawa',\n",
       " ('F-35',\n",
       "  96,\n",
       "  0): 'This story is available exclusively to Business Insider subscribers. Become an Insider and start reading now. Earlier this month, Inside Defense uncovered a Pentagon report that said the US Navy\\'s F-35C had hit a snag that could take years to fix fully, potentially pushing back the already delayed introduction of the revolutionary Joint Strike Fighter naval variant. The Pentagon formed a \"red team\" to investigate the F-35C\\'s carrier takeoffs, where extreme movements in the cockpit during launch risked pilot health. Now, new footage of the F-35Cs taking off from an aircraft carrier may document the issue. Watch below: See the pilot get bucked and hit the top of the cockpit with his helmet? Here\\'s an even better example where the visor actually pops off: A Pentagon deficiency report in 2015 stated that extreme movements in the cockpit, possibly like the ones shown above, during launch risked pilot health. One hundred and five pilots completing catapult launches rated their level of pain or discomfort on a scale of one to five. Of the 105, 74 pilots reported \"moderate\" pain or a 3, 18 pilots reported \"severe\" pain or a 4, and one pilot reported \"severe pain that persists\" after launching from an aircraft carrier. \"The oscillations shake the pilot\\'s head sufficiently to impair their ability to consistently read flight critical data, which poses a safety of flight risk,\" reads the report cited by Inside Defense. This pain, more than a mere inconvenience, threatens the ability of pilots to read flight-critical data as they perform the complicated task of launching from a moving platform at sea. Exacerbating the problem, some pilots locked down their harnesses to avoid jostling around during the launch, but this makes it more difficult for the pilot to eject, should they need to. Watch an F-18 launch for comparison: The F-18 has been a mainstay of carrier air wings for decades, with thousands and thousands of successful launches to their credit — and even they rock a little bit when the aircraft carrier\\'s catapult engages. However, in the case of the F-18, the pilot isn\\'t wearing a $400,000 helmet displaying flight-critical information. When Business Insider contacted Lockheed about this story earlier this month, they said that all their carrier launches had been successful. But as this footage shows, it\\'s still rough on the pilot.',\n",
       " ('F-35',\n",
       "  97,\n",
       "  0): 'One week after the U.S. Air Force declared the F-35A Joint Strike Fighter ready for combat, the Pentagon\\'s top weapons tester warned that the aircraft is still fraught with problems and that fully-capable planes might not be available before the deadline that marks the end of development and the beginning of realistic combat testing. The Pentagon\\'s director of operational testing, Michael Gilmore, stated in a memo obtained by Bloombergthat the F-35 is \"actually not on a path toward success but instead on a path toward failing to deliver\" the plane\\'s full combat capabilities on time. Gilmore also said the plane is \"running out of time and money\" to address deficiencies The U.S. Air Force declared the F-35A—the Joint Strike Fighter\\'s land-based variant—Initial Operational Capability (IOC) on August 2nd. That means that the stealthy fighter is cleared for deployments—including combat—although the plane is not fully functional. Gilmore\\'s memo was dated August 9th. The F-35A was originally set to achieve IOC in 2011 . Gilmore warned that the plane \"is at substantial risk\" of not being fully combat capable—that is, at risk of not being able to use its full range of promised weapons, sensors, and other advanced systems—before late summer or early fall 2017 , when realistic combat testing is set to commence. The problem seems to be due to delays in getting the Block 3F software package, which controls much of the F-35\\'s most important features, ready for the entire F-35 fleet. Block 3F is known as the \"full warfighting package\" and having it operational is one of the key requirements of ending F-35 development. Testing now appears likely to be pushed back to later in 2017 or even 2018. At least 15 capabilities in the 3F software package—including the ability to process enemy radar signals, track moving targets on the ground, share imagery between aircraft, use the GPS-guided GBU-39 Small Diameter Bomb , and operate the plane\\'s 25-millimeter gun—are all still under development and at risk of not being ready for combat testing. For its part, the F-35 program office told Bloomberg that the report contained \"absolutely no surprises\" and that all of the issues mentioned were well-known and in the process of being resolved. Exactly when they would be resolved was not mentioned. The F-35 program office would like to get successful testing behind the troubled fighter as soon as possible, as that would open the door for large \"block buys\" of F-35s for the United States and its allies. Such buys take advantage of economies of scale and result in lower per-plane prices. In addition to the U.S., the United Kingdom, Denmark, the Netherlands, Norway, Turkey, South Korea, Italy, Australia, Japan and Israel are all committed to buying the F-35, with other countries including Canada and Singapore potential customers. Source: Bloomberg',\n",
       " ('F-35',\n",
       "  98,\n",
       "  0): 'В воскресенье, 24 сентября, на американской авиабазе Mountain Home в штате Айдахо во время учений загорелся новейший истребитель F-35A. По предварительным данным, возгорание произошло в хвосте самолета. Пожарным удалось оперативно ликвидировать возгорание. В результате никто не пострадал. Пилот и три авиаинженера, находившиеся на борту, доставлены в больницу для осмотра. Напомним, что неделю назад военно-воздушные силы США временно приостановили эксплуатацию десяти истребителей пятого поколения F-35. Причиной стали механические дефекты в изоляции системы охлаждения топливных баков. Недостатки были выявлены в 57 истребителях, 15 из них уже были сняты с конвейера и поставлены на вооружение. F-35 отозвали спустя месяц после того как было объявлено об их боеготовности. Lockheed Martin F-35 Lightning II («Локхид-Мартин» Ф-35 «Молния II») — малозаметный истребитель-бомбардировщик, обладающий характерными признаками самолётов пятого поколения: пониженной радиолокационной заметностью, сверхзвуковой крейсерской скоростью, многофункциональностью, полным набором бортовых сенсоров, работающих на разных физических принципах. Первый F-35 Lightning II поднялся в воздух в октябре 2010 года. Разработан американской фирмой «Lockheed Martin». Финансированием проекта занимаются не только США, но и Великобритания, Италия, Нидерланды, Австралия, Канада, Турция, Норвегия и Дания. В разработке самолета также принимали участие российские авиаконструкторы, ранее работавшие над ЯК-141. Вариации При разработке ставилась цель создать тактическую машину, которая смогла бы одинаково успешно вести бой в воздухе и наносить удары по наземным целям. Однако вместо одного самолета спроектировали три варианта истребителя. F-35A Lightning II — наземный истребитель с обычными взлётом и посадкой для нужд ВВС США. F-35B Lightning II — машина с укороченным взлётом и вертикальной посадкой, для Корпуса морской пехоты США и ВМС Великобритании. Самолёт предназначен для действий с небольших авианесущих кораблей и с полевых площадок непосредственно у линии фронта. F-35C Lightning II — палубный вариант с катапультным взлетом и посадкой на аэрофинишер, разработанный для нужд ВВС США. Конструктивные особенности Истребитель F-35 оснащен двигателем «Pratt & Whitney F135», разработанным при участии «Rolls-Royce Defence». Эта установка позволяет производить манёвры при полном вооружении с заполненными топливными баками с перегрузкой в 9 единиц. На истребителе установлены шесть инфракрасных датчиков, расположенных на фюзеляже. Эта электронно-оптическая система (ЭОС) позволяет выявлять групповые пуски баллистических ракет на дальности до 1300 км, обнаруживать точки пуска ракеты, предупреждать о ракетной атаке самолёта, осуществлять навигацию при полёте. Для широкого обзора и целеуказания используется всенаправленная инфракрасная CCD-TV камера высокого разрешения. Она обеспечивает захват и сопровождение любых наземных, надводных и воздушных целей. Руководство компании Lockheed Martin заявляют, что истребитель способен совершать полёт со скоростью в 1,2 раза превышающей скорость звука на протяжении 240 км без включения системы форсажа. Для F-35 Lightning II был специально разработан шлем пилота. Изображение передается непосредственно на визоры, снабжая его также подсказками, необходимыми для полета, навигации и ведения боя. Он позволяет видеть ночью, автоматически переключаться между видеорежимами. F-35А ВВС США. Фото: Public Domain Вооружение На F-35 установлена авиационная четырёхствольная пушка GAU-22/A калибра 25 мм, боекомплект составляет от 180 до 220 снарядов в зависимости от модификации. В основу вооружения F-35 входят ракеты класса воздух-воздух, крылатые ракеты, корректируемые бомбы весом до 910 кг, управляемые авиационные бомбы и противотанковые ракеты. Истребитель может запускать ракеты и бомбы из внутренних отсеков на своих максимальных сверхзвуковых скоростях. К 2017 году производители планируют дополнить вооружение самолета тактической ядерной бомбой. Тактико-технические характеристики Lockheed F-35 Lightning II Экипаж: 1 человек Длина: F-35A: 15,7 м F-35B: 15,7 м F-35C: 15,6 м Размах крыла: F-35A: 10,7 м F-35B: 10,7 м F-35C: 13,1 м Высота: F-35A: 4,33 м F-35B: 4,33 м F-35C: 4,54 м Площадь крыла: F-35A: 42,7 м F-35B: 42,7 м F-35C: 62,1 м Масса: пустого: F-35A: 14200 кг F-35B: 15800 кг F-35C: 17200 кг нормальная взлётная масса: F-35A: 24350 кг F-35B: 22240 кг F-35C: 25896 кг максимальная взлетная масса: F-35A: 31800 кг F-35B: 27000 кг F-35C: 31800 кг масса топлива: F-35A: 8382 кг F-35B:',\n",
       " ('F-35',\n",
       "  98,\n",
       "  1): '6352 кг F-35C: 9110 кг Двигатель: тип двигателя: турбореактивный двухконтурный с форсажной камерой модель: «Pratt & Whitney F135-100/400/600» (для F-35A, F-35B и F-35C соответственно) тяга: максимальная: 1 x 12460 кгс на форсаже: 1 x 18100 кгс (демонстрировалась работа двигателя с тягой до 22700 кгс) Максимальная скорость: 1700 км/ч (1,6 М) Крейсерская скорость: 850 км/ч (0,8 М) Дальность полета: F-35A: 2200 км F-35B: 1670 км F-35C: 2520 км Продолжительность полёта: 2,6 ч Практический потолок: 18200 м Скороподъемность 12000 м/мин Максимальная эксплуатационная перегрузка: F-35A: +9 G F-35B: +7,5 G F-35C: +7,5 G Вооружение Пушечное: F-35A: 1 x 20-мм авиационная пушка M61 Vulcan F-35B: 1 x 25-мм авиационная пушка GAU-22 в подвесном контейнере Боевая нагрузка: 8100 кг Точки подвески: внутренних: 4 внешних: 6 Ракетное вооружение: УРВВ: AIM-120 AMRAAM, AIM-132 ASRAAM, AIM-9X Sidewinder, IRIS-T УРВП: AGM-154 JSW, AGM-158 JASSM.',\n",
       " ('F-35',\n",
       "  99,\n",
       "  0): 'For free real time breaking news alerts sent straight to your inbox sign up to our breaking news emails Sign up to our free breaking news emails Sign up to our free breaking news emails Email * SIGN UP I would like to be emailed about offers, events and updates from The Independent. Read our Privacy notice US President-elect Donald Trump has sent another stock reeling into the red. Barely a week after taking shots at Boeing, Donald Trump took aim at Lockheed Martin\\'s F-35 fighter jet programme, saying the cost was \"out of control\". Donald Trump \\'will violate US Constitution on first day of presidency\\' due to business interests \"The F-35 program and cost is out of control. Billions of dollars can and will be saved on military (and other) purchases after January 20th,\" Mr Trump said. Following the tweet on Monday morning, shares of the aerospace company plunged by more than 4 per cent in early trade. Based on the number of shares outstanding, the tweet has shaved just over $3.5bn from Lockheed\\'s market value. Shares of the New York-listed company fell by more than 5 per cent by midday on Monday, and had not fully recovered by market close. By 4pm Eastern Time, the share price had only bounced back half way by about 2.5 per cent. The President-elect\\'s comment has also had a knock-on for other companies involved in the project, which is worth up to $400bn over the contract\\'s duration. Shares in Northrop Gumman were down 4 per cent, while Britain\\'s BAE Systems saw its stock slip 1.3 per cent after Mr Trump\\'s tweet. Neither of those companies\\' share prices have recovered throughout Monday. open image in gallery Mr Trump\\'s latest twitter firestorm comes just one week after he used the same social media platform to take aim at Boeing over costs for the replacement Air Force One. Boeing fell by 1.5 per cent after the tweet but ended the trading day positive. Although Lockheed\\'s dip is temporary, it is a reminder of investors\\' knee-jerk reaction when the President-elect expresses his views on a company. His tweet is also a cause for concern in the longer term, as the anticipated increase in defence spending in 2017 may not be as lucrative to contractors as they had hoped. A Lockheed Martin executive responded to Mr Trump’s attack, insisting that the company has taken steps to cut costs. \"Since the beginning, we have invested hundreds of millions of dollars to reduce the price of the airplane by about 70 per cent since its original costing, and we project it to be about £85m in the 2019 or 2020 time frame”, said Jeff Babione, Lockheed Martin’s F-35 programme leader. A week before Mr Trump won the presidential election, the US Defence Department and Lockheed Martin concluded their 14-month negotiations on their ninth contract for F-35 fighter jets. The F-35 Lightining II is meant to become the next leading-edge platform for the US Air Force, Navy and Marines, as well for the armed forces of nearly 10 US allies, including the UK, Netherlands and Australia. Last week, the President-elect critcised Boeing by claiming the total cost of Boeing\\'s 747 Air Force One programme would be more than $4bn. On Twitter, he said: \"Boeing is building a brand new 747 Air Force One for future presidents, but costs are out of control, more than $4 billion. Cancel order!\" The aircraft manufacturer took a $1.4bn hit to its market value. In response to Mr Trump\\'s tweet, Boeing said that its current contract with the Air Force is actually for $170m. Additional',\n",
       " ('F-35', 99, 1): 'reporting by Reuters',\n",
       " ('Google (компания)',\n",
       "  1,\n",
       "  0): '«ГУГЛ» («Google Inc.»), круп\\xadней\\xadшая ком\\xadпа\\xadния, ока\\xadзы\\xadваю\\xadщая ус\\xadлу\\xadги по по\\xadис\\xadку разл. ти\\xadпа ин\\xadфор\\xadма\\xadции в Ин\\xadтер\\xadне\\xadте. Штаб-квар\\xadти\\xadра ком\\xadпа\\xadнии – в г. Ма\\xadун\\xadтин-Вью (штат Ка\\xadли\\xadфор\\xadния, США). Ком\\xadпа\\xadния ос\\xadно\\xadва\\xadна в сент. 1998 Лар\\xadри Пей\\xadджем и Сер\\xadге\\xadем Бри\\xadном, ро\\xadдив\\xadшим\\xadся в Мо\\xadск\\xadве и по\\xadлу\\xadчив\\xadшим выс\\xadшее об\\xadра\\xadзо\\xadва\\xadние в ун-те шта\\xadта Мэ\\xadри\\xadленд в США. На\\xadзва\\xadние ком\\xadпа\\xadнии про\\xadис\\xadхо\\xadдит от англ. googol, оз\\xadна\\xadчаю\\xadще\\xadго чис\\xadло 10 в со\\xadтой сте\\xadпе\\xadни, т. е. 1 со ста ну\\xadля\\xadми. Пейдж и Брин на\\xadча\\xadли со\\xadвме\\xadст\\xadную ра\\xadбо\\xadту по соз\\xadда\\xadнию сис\\xadте\\xadмы по\\xadис\\xadка ин\\xadфор\\xadма\\xadции в Ин\\xadтер\\xadне\\xadте (1996). В те\\xadче\\xadние 2 лет им уда\\xadлось раз\\xadра\\xadбо\\xadтать уни\\xadкаль\\xadную тех\\xadно\\xadло\\xadгию, ос\\xadно\\xadван\\xadную на ана\\xadли\\xadзе зна\\xadчи\\xadмо\\xadсти веб-стра\\xadниц. По\\xadсле об\\xadра\\xadзо\\xadва\\xadния ком\\xadпа\\xadнии, ко\\xadгда сис\\xadте\\xadма ра\\xadбо\\xadта\\xadла в тес\\xadто\\xadвом ре\\xadжи\\xadме, об\\xadра\\xadба\\xadты\\xadва\\xadлось 10 тыс. за\\xadпро\\xadсов в день, а че\\xadрез 5 мес, в февр. 1999, чис\\xadло за\\xadпро\\xadсов со\\xadстав\\xadля\\xadло 500 тыс. в день. 21.9.1999 за\\xadвер\\xadше\\xadно тес\\xadти\\xadро\\xadва\\xadние по\\xadис\\xadко\\xadвой сис\\xadте\\xadмы «Г.». В по\\xadсле\\xadдую\\xadщие го\\xadды ком\\xadпа\\xadния уве\\xadли\\xadчи\\xadла чис\\xadло спе\\xadциа\\xadли\\xadзир. сер\\xadви\\xadсов и ус\\xadлуг, ко\\xadто\\xadрые при\\xadоб\\xadре\\xadли боль\\xadшую по\\xadпу\\xadляр\\xadность сре\\xadди ин\\xadтер\\xadнет-поль\\xadзо\\xadва\\xadте\\xadлей. В 2004 ак\\xadции «Г.» бы\\xadли раз\\xadме\\xadще\\xadны на Нью-Йорк\\xadской фон\\xadдо\\xadвой бир\\xadже. Ны\\xadне по\\xadис\\xadко\\xadвая сис\\xadте\\xadма «Г.» – об\\xadще\\xadпри\\xadзнан\\xadный ли\\xadдер и за\\xadни\\xadма\\xadет бо\\xadлее 70% ми\\xadро\\xadво\\xadго рын\\xadка в сво\\xadём сек\\xadто\\xadре. Еже\\xadднев\\xadно ре\\xadги\\xadст\\xadри\\xadру\\xadют\\xadся ок. 50 млн. по\\xadис\\xadко\\xadвых за\\xadпро\\xadсов. Чис\\xadло за\\xadня\\xadтых в ком\\xadпа\\xadнии (на сер. 2006) бо\\xadлее 7 тыс. чел., её ры\\xadноч\\xadная стои\\xadмость 125 млрд. долл.',\n",
       " ('Google (компания)',\n",
       "  10,\n",
       "  0): 'Google закрыл футуристический Project Loon, планировавшийся как альтернативный – при помощи летающих на больших высотах воздушных шаров – способ обеспечить интернетом труднодоступные районы Земли. Google закрыл футуристический Project Loon. Это была попытка обеспечить труднодоступные районы планеты интернетом с помощью воздушных шаров. Он просуществовал восемь лет, не раз оказывался на первых полосах технологической (и не только) прессы, принес некоторое количество открытий, но в итоге компания признала: экономика не сходится. Сам Loon появился в 2013 году в знаменитом подразделении Google X, на так называемой фабрике \"муншотов\" — сложных, но перспективных проектов. Идея была действительно амбициозная: поднять в воздух множество аэростатов, с которых можно было бы раздавать интернет для владельцев смартфонов и ноутбуков, то есть пользователю не пришлось бы тратиться на какое-то дорогостоящее оборудование. Еще одна часть идеи заключалась в том, что эти самые воздушные шары должны были перемещаться в стратосфере, на высоте примерно 18 км, ловя воздушные потоки нужного направления. Еще одно интересное техническое решение – канал передачи данных от самого аэростата до наземной станции реализовали с помощью лазерного луча. Как говорили авторы проекта, этакое оптоволокно без самого оптоволокна. В целом Loon прожил сравнительно долго для \"муншота\". В 2018 году проект выделили в самостоятельное подразделение Google Loon, что означало увеличение финансирования, но даже это не помогло. Как в итоге признал гендиректор проекта, команда так и не смогла сделать коммерчески успешное решение. С одной стороны, за годы развития проекта проникновение интернета в мире выросло с 73 до 95%, а с другой в тех регионах, где компания все же начала пилотный проект, например в Кении, у части населения просто не было смартфонов с поддержкой 4G, которая была необходима для работы. Кроме того, не все были готовы платить за доступ в интернет. Но несмотря на общую неудачу, компания дважды доказала, что эта технология может сыграть важную роль в случае катастрофы, когда традиционная сотовая связь не работает. Так, Loon обеспечивал связью жителей Перу после землетрясения и пуэрториканцев – после урагана и наводнения, так что, возможно, воздушные шары еще пригодятся – просто они не станут массовыми. Стоит сказать, что раньше от похожего проекта отказался Facebook (запрещена в РФ). Компания тоже решала проблему обеспечения интернетом труднодоступных районов, но с помощью беспилотников на солнечных батареях; называлось начинание Facebook Aquila и его закрыли два с половиной года назад. Таким образом, из идей глобального интернета остались только космические, в первую очередь — проект Илона Маска. Цель ровно та же: обеспечить покрытие чуть ли не всей Земли с низкой орбитой. Для этого Маску нужно свыше 10 000 небольших спутников, и, что показательно, он запустил более 1000 всего за три года. Уже идет полноценное тестирование проекта, а скоро обещают подключать и всех желающих. Как пишут американские деловые издания, у проекта лучше сходится как раз экономика: он предлагает не мобильный интернет, а стационарный, но зато сравнительно быстрый, необходимый для работы и исследований. И хотя комплект оборудования недешевый, 500 долларов, и абонентская плата $100 в месяц, технология доступна и заметно надежнее, чем привычный спутниковый интернет. Секрет — в большом количестве спутников в сети Маска и их низкой орбите, за счет этого задержка сигнала при передаче меньше. Кстати, как раз накануне вечером Space X, космическая компания Маска, запустила еще 10 новых спутников для Starlink, и это, возможно, главный секрет успеха: собственные технологии вывода на орбиту с относительно невысокой стоимостью, то есть Маску строить спутниковый интернет дешевле, чем кому-либо.',\n",
       " ('Google (компания)',\n",
       "  11,\n",
       "  0): 'Google подписала чек на $2,7 млрд, чтобы вернуть Ноама Шазира, который в 2021 году уволился из компании и запустил собственный стартап Character.AI, сообщила The Wall Street Journal со ссылкой на информированные источники. Они рассказали, что официально Google заплатила средства за лицензии на технологии Character.AI. Но сделка включала положение, что IT-гений возвращается в компанию. Сегодня 48-летний Шазир является вице-президентом Google, которая работает над созданием своей самой мощной технологии ИИ — Gemini. И в Google распространено мнение, что возвращение Шазира было основной причиной, по которой компания согласилась выплатить многомиллиардный лицензионный сбор, отмечает издание. Один из собеседников WSJ сообщил, что в рамках сделки Шазир заработал сотни миллионов долларов на своей доле в Character.AI. Эта выплата необычно велика для основателя, который не продал свою компанию и не вывел ее на биржу, отмечает издание. Шазир присоединился к Google в 2000 году. В 2017-м он в соавторстве с семью другими исследователями Google опубликовал статью «Внимание — это все, что вам нужно», которая стала основой для технологии генеративного ИИ. Вскоре вместе с коллегой из Google Даниэлем де Фрейтасом он создал чат-бот Meena. Тогда в записке «Meena съедает мир» Шазир предсказал, что чат-бот может заменить поисковую систему Google и принести триллионы долларов дохода, рассказали WSJ люди, знакомые с документом. Руководство Google отказалось представить чат-бота публике. И в 2021 году Шазир и де Фрейтас ушли из компании, обвинив ее в бюрократической волоките при интеграции технологии в продукты для обычного пользователя. Они создали Character.AI, который через пару лет привлек $150 млн инвестиций и был оценен в $1 млрд. На фоне конкуренции с OpenAI и Microsoft Шазир пытался привлечь больше средств для стартапа. И в конце концов договорился с Alphabet (материнская компания Google). Character.AI объявила о сделке в августе, отметив, что в бизнесе ИИ «ландшафт изменился». В результате сделки Шазир, де Фрейтас и около 30 сотрудников Character.AI перешли в Google. «Ноам вернулся в Google, и это здорово», — заявил по этому поводу соучредитель Google Сергей Брин, сыгравший ключевую роль в сделке по возвращению Шазира. Миллиардер на пресс-конференции признал, что компания раньше была слишком робкой в \\u200b\\u200bразвертывании приложений ИИ. Но теперь, пообещал он, Google будет разрабатывать и запускать технологии ИИ так быстро, как только может.',\n",
       " ('Google (компания)',\n",
       "  12,\n",
       "  0): 'NEW YORK (CNN/Money) - Google, the world\\'s No. 1 Internet search engine, finally filed for its initial public stock offering Thursday and promised to maintain its long-term focus even though it will soon face the intense scrutiny of Wall Street. Google files for its IPO, the most highly anticipated stock sale in the post-dot.com era. CNNfn\\'s Allan Chernoff reports. Google files for its IPO, the most highly anticipated stock sale in the post-dot.com era. CNNfn\\'s Allan Chernoff reports. Play video (Real or Windows Media) The company said in a filing with the Securities and Exchange Commission that it expects to raise as much as $2.7 billion from the offering, which it will conduct in the unusual format of an online auction in a bid to make its shares more widely available. Morgan Stanley and Credit Suisse First Boston were named as the lead underwriters for the deal. The company\\'s IPO filing has been rumored for the better part of a year and recent speculation has created a buzz about Internet stocks not seen since online auctioneer eBay went public in September 1998. Wall Street has been eagerly anticipating a filing from Google so investors could finally get a glimpse into the company\\'s finances. Gaga for Google\\'s numbers In the filing, Google said that it generated revenues of $961.9 million in 2003 and reported a net profit of $106.5 million. Sales rose 177 percent from a year ago although earnings increased by just 6 percent. Google also revealed that has been profitable since 2001. For the first quarter of 2004, Google reported sales of $389.6 million, an increase of 118 percent from a year ago. Net income was $64 million, up 148 percent from the first quarter of 2003. (For more of the financial details revealed in the filing, click here.) Mark Mahaney, an Internet analyst with American Technology Research, said Google\\'s numbers were incredibly strong, noting that its sales grew in the first quarter at a higher rate than Yahoo! (YHOO: Research, Estimates) and eBay (EBAY: Research, Estimates). Google\\'s core business of selling search-based advertising, which allows companies to purchase ads tied to specific keyword searches, is one of the most lucrative and rapidly growing markets in the tech sector. Google, founded in 1998 by former Stanford University students Sergey Brin and Larry Page, has quickly become one of the most successful Internet companies, thanks to search technology that many experts say is superior to offerings from rivals. (For more on the founders\\' stakes in Google and their pay, click here). Eric Schmidt, the former CEO of Novell and chief technology officer at Sun Microsystems, joined Google as its chairman in March 2001 and was named CEO later that year. The company has become not just a tech juggernaut but a popular culture phenomenon as well, with people using the verb \"Googled\" to describe searching for information on the site. IPO should increase competition in search And during the past few months, Google has stepped up its efforts to compete against large Internet companies such as Yahoo!, Microsoft\\'s MSN, Time Warner\\'s AOL and Amazon.com. (Time Warner is the parent company of CNN/Money.) Google recently launched a comparison shopping Web site called Froogle and a test version of a local search engine. The company also is testing a controversial free e-mail service called Gmail, which provides far more storage space than most other Web-based e-mail offerings. Google has said it intends to sell ads that will be tied to keywords in e-mails, which has raised some privacy concerns. Now that Google has filed to go public, the search business could become',\n",
       " ('Google (компания)',\n",
       "  12,\n",
       "  1): 'even more intense, said Safa Rashtchy, an analyst with Piper Jaffray. \"The competition between Google and Yahoo! and MSN will certainly intensify,\" Rashtchy, \"They are already heavily competing to make sure that each gets their share of the search business.\" According to research firm comScore Networks, Google sites had nearly 35 percent of Web searches conducted in the United States in February, making it the market share leader. Yahoo! was second with 30 percent of searches. Worldwide, Google had an even bigger lead over Yahoo!, with 43 percent of searches, compared to 31 percent for Yahoo! Many tech investors have been hoping that an IPO filing from Google will lead to another tech boom period. But one hedge fund manager said he does not think Google\\'s filing will cause a flood of new Internet and technology companies. \"There\\'s always a tremendous amount of buzz with Internet IPOs but I don\\'t think we\\'ll go back to people getting excited about all Internet stocks like in the late \\'90s,\" said Peter Thiel, managing member with hedge fund firm Clarium Capital. \"Google is going public because it\\'s profitable. This is not a publicity stunt.\" Thiel was the co-founder of PayPal, which went public in 2001 and was sold to eBay a year later. What\\'s it going to be worth? Demand for Google\\'s shares is expected to be extremely high. As such, Brin and Page said in a letter included in the filing that the company intends to use the auction process to price its shares. Larry Page, left, and Sergey Brin founded Google in 1998. \"It is important to us to have a fair process for our IPO that is inclusive of both small and large investors. It is also crucial that we achieve a good outcome for Google and its current shareholders,\" the co-founders wrote. \"Our goal is to have a share price that reflects a fair market valuation of Google and that moves rationally based on changes in our business and the stock market.\" During the late \\'90s, many tech IPOs rose sharply on their first day of trading because a small amount of shares were available to the public. \"Many companies have suffered from unreasonable speculation, small initial share float, and boom-bust cycles that hurt them and their investors in the long run. We believe that an auction-based IPO will minimize these problems,\" Brin and Page said. As part of the auction process, interested investors will need to get a unique bidder ID from a Web site, the company said in the filing. Qualified investors would then be able to submit a bid detailing how many shares they wanted and at what price. Once the underwriters have determined the stock\\'s opening price, shares will be allocated, the company said. Google and the market Will a Google IPO hurt other tech stocks? Google won\\'t usher in new gold rush You, the next Google millionaire? The auction process is fairly unique, particularly for a company of Google\\'s stature. But Google has a reputation of doing things differently, which should make for some interesting times once the company starts trading. Brin and Page pledged in their letter that they will not play the game of managing expectations, trying to meet quarterly earnings estimates just to appease Wall Street. The two even quoted legendary value investor Warren Buffett. \"In Warren Buffett\\'s words, \\'We won\\'t \"smooth\" quarterly or annual results: If earnings figures are lumpy when they reach headquarters, they will be lumpy when they reach you\\',\" the two wrote. In addition, the offering is structured in a way so that Brin and Page will',\n",
       " ('Google (компания)',\n",
       "  12,\n",
       "  2): \"continue to have strong control of the company's fate. Brin and Page own nearly a third of the company's Class B stock, which has 10 times the voting power of the Class A shares to be sold in the public offering. YOUR E-MAIL ALERTS Google IPOs Securities and Exchange Commission (SEC) or or Create your own Manage alerts | What is this? Google did not say in its filing whether it intends to list on the New York Stock Exchange or the Nasdaq. Most of its competitors list on the Nasdaq. Since Google did not say how many shares it intends to sell or what the price would be, investors can still only speculate about how much Google will be worth when it goes public. It probably makes the most sense to compare Google with Yahoo! since it is Google's main rival. Yahoo! reported net income of about $238 million last year and has a market value of about $36 billion. So it is valued at 151 times trailing net income. Based on that multiple, Google's stock market value would be about $16 billion. But Google would be worth more if you looked at a price to sales ratio. Yahoo! is valued at about 24.5 times 2003 revenues of about $1.47 billion. Using that multiple, Google could have a market worth of about $24 billion.\",\n",
       " ('Google (компания)',\n",
       "  13,\n",
       "  0): 'Google to buy YouTube for $1.65 billion Search engine leader looks to bulk up in the burgeoning online video market. NEW YORK (CNNMoney.com) -- Google, the Internet\\'s leading search engine, announced Monday that it is buying popular online video site YouTube for $1.65 billion in stock. YouTube, which was founded in February 2005, has quickly become the most well-known of several online video sites. More than 100 million videos, many of which are short videos created by the site\\'s users, are downloaded a day on the site. According to Internet research firm Hitwise, YouTube has about a 46 percent share of the online video market. For Google (Charts), the purchase of YouTube gives the company the ability to tap into the potentially lucrative online video and social networking markets. Some analysts have criticized Google for relying too much on advertising tied to keyword searches. The combination of Google and YouTube could further strengthen Google\\'s dominance in online advertising, giving it an edge over rivals such as Yahoo! (Charts), Microsoft\\'s (Charts) MSN and News Corp (Charts)., which owns the social networking site MySpace. Some analysts said Monday that Yahoo, Microsoft and News Corp. also had probably expressed interest in buying YouTube. Bill Tancer, general manger of global research of Hitwise, said after the deal was announced that MySpace would now probably need to promote its own video service more aggressively on its site in order to compete with a combined Google-YouTube. And Martin Pyykkonen, an analyst with Global Crown Capital, said that Google\\'s purchase of YouTube could be viewed as a preemptive strike against Yahoo, which has been rumored to be in talks to purchase social networking site Facebook. In a statement, Google said YouTube will operate as an independent unit of Google once the deal closes and will retain the YouTube brand name. The companies added that no YouTube workers will lose their jobs as a result of the acquisition and that Google will maintain its own online video business. Clayton Moran, an analyst with Stanford Group, said after the deal was announced that Google was paying a rich price for YouTube since it has yet to generate a sizable amount of sales. But he said Google needed to do something to become more competitive with MySpace, which currently ranks in second place in online video market share. \"My sense is that Google is paying a full price considering that YouTube is still unproven in regards to its revenue potential. But considering the success of MySpace it was clearly worthwhile for Google to take this step,\" Moran said. In addition to giving Google a stronger foothold in the burgeoning social networking market, YouTube could also help Google extend its highly successful text-based search platform into video, which could wind up being even more profitable. Pyykkonen said that for this reason, Google may be able to justify paying such a high price for YouTube. \"Google has talked a lot about video and video search without really having anything particularly going on there. I would think that a lot of advertisers would be willing to pay a premium for a video search ad opposed to paid search text,\" he said. First step? During a conference call, Google chief executive officer Eric Schmidt said the YouTube deal would be one of \"many investments\" that Google planned to make in online video. He added that the combination of Google and YouTube would make Google more desirable to advertisers. \"This is just the beginning of an Internet video revolution,\" he said. There is some debate about whether or not YouTube or other user-generated video sites',\n",
       " ('Google (компания)',\n",
       "  13,\n",
       "  1): 'will be able to attract the interest of top advertisers. But Tancer said that big corporations may be forced to start spending on ads tied to such clips. \"I don\\'t know if advertisers will have the choice going forward. They\\'ll have to start taking risks. People more and more are going to use brands in user generated content,\" Tancer said. He mentioned the popularity of the so-called Diet Coke-Mentos Experiment video, a clip that featured two men creating elaborate gushers of Diet Coke by dropping Mentos candies into bottles of the soft drink. Mentos eventually wound up becoming the exclusive sponsor of the video on Revver, a privately held online video site that sells ads tied to user-generated videos. Reports of a Google-YouTube deal first began to circulate on Friday. Shares of Google rose about 2 percent on the Nasdaq Monday after posting a similar gain on Friday. The stock edged slightly higher in after hours trading. Before the deal was announced, some analysts expressed concerns about the litigation risks involved with YouTube since some videos posted on the site infringe on copyrighted material owned by major traditional media firms. To that end, YouTube truly became a part of the pop culture lexicon earlier this year after people started posting pirated versions of \"Lazy Sunday,\" a skit on NBC\\'s sketch comedy show \"Saturday Night Live\" on the site. NBC eventually forced YouTube to take down links to this clip. But Chad Hurley, co-founder and CEO of YouTube, said the Google deal will allow YouTube to focus even more on copyright protection since Google has more financial and technological resources to dedicate to the issue. However, more and more media companies have recently begun to partner with YouTube. In fact, NBC announced a partnership with YouTube earlier this summer to promote shows from its new fall schedule on the site. And on Monday, YouTube announced separate agreements with broadcast firm CBS (Charts) and music companies Sony BMG Entertainment and Universal Music Group to show video from these companies libraries. CBS and Sony BMG will share advertising revenue with YouTube. Terms of the Universal deal were not disclosed. Google also announced an online video deal with Sony BMG Monday as well as one with Warner Music Group. Quigo: The next Google? Social networks: Bait for cybercrime Is Facebook worth a billion bucks? Analysts quoted in this story do not own shares of Google and their firms have no investment banking ties to the company.',\n",
       " ('Google (компания)',\n",
       "  14,\n",
       "  0): 'In a filing with the Securities and Exchange Commission on Thursday, Google outlined how prospective investors can participate in the IPO process and offered tips to avoid disqualification. Given the expected strong demand for the shares, investors are likely to heed such advice. Download the S-1 Google\\'s registration statement Click here to download Google\\'s S-1 filing. Caution: Large file. Among other things, Google issued a firm warning to speculators hoping to make a buck by quickly flipping their shares, a hallmark of many hot technology IPOs in the past. Instead, Google hopes to place its shares in a way that avoids the typical investment banking strategy of intentional underpricing--and the volatility that frequently follows. \"Our goal is to have an efficient market price--a rational price set by informed buyers and sellers--for our shares at the IPO and afterward,\" the filing states. \"Our goal is to achieve a relatively stable price in the days following the IPO and that buyers and sellers receive a fair price at the IPO.\" So, how does one get from point A to B? First, interested investors need to have an account with one of the underwriters, Morgan Stanley or Credit Suisse First Boston, where they must submit a bid with the number of shares desired and price they are willing to pay. Complete coverage Google\\'s IPO Web search king plans to raise $2.7 billion Google\\'s investment bankers will gather up the bids and enter them into a master order book, which will be reviewed by the company\\'s founders and underwriters. If a bid appears unusually large or the share price listed far exceeds the top range, then investors may be disqualified for creating a speculative bidding environment, according to the filing. \"As part of this auction process, we are attempting to assess the market demand for our Class A common stock and to set the size of the offering and the initial offering price to meet that demand,\" the founders state in the SEC filing. \"Buyers hoping to capture profits shortly after our Class A common stock begins trading may be disappointed.\" After Morgan Stanley and Credit Suisse notify bidders of the auction\\'s close, the bids will be reviewed by the company and its bankers. The highest bids that clear the number of shares being offered in total will receive an allotment of IPO shares. Let\\'s say Google wanted to sell 100 million shares at between $26 and $28 per share. The highest bids totaling 100 million shares would get in on the offering, sold to everyone at the lowest qualifying price, also known as the \"clearing price.\" For example, if three investors offered to buy 50 million shares apiece at $26, $27 and $28 a share, the last two investors might be invited to purchase shares at the clearing price of $27, while the first would be shut out. Google\\'s auction is likely to draw in thousands of bidders, and the lowest qualifying price could easily bring in well over the 100 million shares used in the above example. To address that problem, Google\\'s underwriters can choose between one of two allocation methods to determine how the shares would be doled out to the successful bidders. One method would be prorated, ensuring each investor received a certain percentage of their requested allotment. The other method would simply give each successful investor the opportunity to buy the same number of shares, no matter how many they had originally requested.',\n",
       " ('Google (компания)',\n",
       "  15,\n",
       "  0): 'Shares of the top search engine are getting close to $300 and analysts still see more room to run. $300 and beyond? Google\\'s stock has been on an incredible ride since last year\\'s IPO. Google chairman and CEO Eric Schmidt has said that despite its triple-digit share price, the company has no plans for a stock split in the near future. More news about Google \\x95 \\x95 \\x95 \\x95 \\x95 \\x95 \\x95 NEW YORK (CNN/Money) - Is Google on its way to hitting a perfect bowling score, a $300 stock price, in the near future? At Tuesday\\'s closing price of $256, it\\'s less than 20 percent away. Shares of the leading search engine have been on a tear, shooting up 25 percent since the company reported much better than expected sales and earnings for the first quarter, thanks to a booming market for online advertising. During the past month, Google (Research) has also released several new features -- including a desktop search function for businesses and a test version of a personalized home page tool -- that should help the company remain competitive against rivals Yahoo! (Research) and Microsoft (Research). Most recently, speculation that Google will soon be added to the S&P 500 index has helped propel the stock higher. So is it possible that Google could continue climbing? Is $300 in the bag and should we be talking about Google hitting $350 or higher? Investors still feel lucky Crazy as it may sound, Google could still have a lot more upside. Sure, the stock price looks frothy on an absolute basis. Few companies have prices in the triple digits, let alone, approaching $300. But Google has maintained that it would not split its stock to make the shares more affordable for the average investor. Clearly, that hasn\\'t hindered the stock\\'s performance. In fact, data from Vickers Stock Research suggests that Google\\'s surge has been fueled by retail investors, not big mutual funds. According to Vickers, only 35 percent of Google\\'s shares are held by institutional investors while 73 percent of Yahoo!\\'s shares are owned by mutual funds and other money managers. So what\\'s more important for investors to look at is not the dollar amount of Google\\'s stock price but what Google\\'s valuation is relative to its peers. And on that basis, Google still looks reasonably attractive, if not exactly cheap. Shares trade at 50 times 2005 earnings estimates and 39 times 2006 projections. Yahoo!, on the other hand, trades at 64 times 2005 profit forecasts and has a P/E of 50 times 2006 estimates. Steve Weinstein, an analyst with Pacific Crest Securities, said that Google\\'s fundamentals could justify a $330 stock price. At that level, Google would trade at a multiple in line with Yahoo! If anything, Google looks to be the company that deserves the premium right now. It has reported stronger gains in sales and earnings than Yahoo! lately since Google has more exposure to the online advertising market, specifically ads tied to key word search results, than Yahoo! \"In the short-term, Google could grow faster than Yahoo!, as it has over the past few quarters,\" said Marianne Wolk, an analyst with Susquehanna Financial Group. To that end, earnings estimates for Google have risen at a meteoric pace. Three months ago, analysts expected Google\\'s earnings to come in at $3.94 a share this year. Now the consensus estimate is $5.14 a share, an increase of 30 percent. Likewise, estimates for 2006 have surged nearly 30 percent in the past three months, from $5.14 a share to current projections of $6.56 a share. By way of comparison,',\n",
       " ('Google (компания)',\n",
       "  15,\n",
       "  1): 'estimates for Yahoo! have increased by about 10 percent for 2005 and 2006 during the past three months. Searching for the S&P 500 The S&P 500 speculation is also worth keeping an eye on. (I wrote last year about why I thought Google probably would be added to the index sometime in 2005. Click here for that column.) At the time, the only major knock against Google was that less than half of its outstanding shares were available to the public. One of Standard & Poor\\'s criteria for adding a stock to the index is that a company\\'s float, or available shares, must be at least 50 percent of the total shares. That\\'s no longer an issue. According to Vickers, the float now accounts for nearly two-thirds of shares outstanding. And if Google does get added to the S&P, many institutions that run index funds would have to buy the stock. \"We view the possible inclusion of Google in the S&P as a potential positive catalyst due to the relatively low institutional ownership as compared to Yahoo! and eBay,\" wrote David Edwards, an analyst with American Technology Research in a recent report. Since going public last August, Google has faced a lot of skepticism (from me included) and has defied all the critics. Fears about how the stock could take a hit following a deluge of new shares hitting the market after IPO lock-up periods expired were for naught. Worries about a slowdown in Internet ad spending proved temporary. And the valuation, while rich, never seems to have gotten ahead of itself because the stock has simply moved higher as earnings estimates for Google have increased. So as long as online ad spending doesn\\'t take a sudden sharp turn downward, it\\'s hard to imagine Google\\'s stock losing serious ground. \"Internet advertising is in its infancy. The long-term prospects for Google are quite strong,\" said Wolk. For a look at Google and other Internet stocks, click here. Some Google customers don\\'t love the company. Click here for more. Analysts quoted in this story do not own shares of the companies mentioned and their firms have no investment banking relationships with the companies. Sign up to receive the Tech Investor column by e-mail. Plus, see more tech commentary and get the latest tech news.',\n",
       " ('Google (компания)',\n",
       "  16,\n",
       "  0): 'There are different ways to filter your Google searches to be more precise or to expand in new directions. Advanced search Google offers pages designed to help you perform specialized web and image searches: Filters & topics After you perform a search, filter and topic buttons appear near the search bar. They may also appear in other places on the page. Filters Filters allow you to narrow results to a particular type, such as: Video News Images Web The \"Web\" filter contains text-based links to websites. The exact filters and the order in which they appear is dynamic. It\\'s based on what our systems might think are most helpful to your query. If you don\\'t find a particular filter that you want, use the \"All\" option to check others that are available. Topics Topics allow you to add terms to your query that can help you get more specific information or explore related information. Relevant topics for a query are automatically generated and displayed. They\\'re based on what our systems understand about how people search and how content is analyzed across the web. Topics are available on computers for most countries or regions, and they\\'ll expand to more countries or regions and languages on mobile. Operators To narrow your results in specific ways, you can use special operators in your search. Do not put spaces between the operator and your search term. A search for [ site:nytimes.com ] will work, but [ site: nytimes.com ] won\\'t. Here are some popular operators: Search for an exact match: Enter a word or phrase inside quotes. For example, [ tallest building ]. Go to our blogpost for more information about how to search using quotes. Search for a specific site: Enter site: in front of a site or domain. For example, [ site:youtube.com cat videos] . Exclude words from your search: Enter - in front of a word that you want to leave out. For example, [ jaguar speed -car ]. Related results After you click a web result and return back to the search results, you may find more related results added to what was originally generated. These added results are related to the web result that you clicked on. Related searches After a search, you find related searches to what you originally searched for. Related searches are automatically generated based on what our systems understand about how people search. Settings In Google Search, you can use settings that allow you to match or remove certain types of content: You can filter Google Search results to different languages with the Language results filter. You can filter explicit content from your results with SafeSearch. Related resources',\n",
       " ('Google (компания)',\n",
       "  17,\n",
       "  0): 'Over the past few years, we’ve seen massive improvements in digital marketing sophistication and capabilities. Today there’s a rich suite of tools allowing marketers to gain better insights, reach audiences in new ways, and develop improved marketing campaigns so users have better web experiences. Yet many modern marketing tools—like web analytics, conversion tracking, remarketing, and more—depend on adding \"tags\" to your website. Website tags help enable today’s sophisticated digital marketing technologies Tags are tiny bits of website code that can help provide useful insights, but they can also cause challenges. Too many tags can make sites slow and clunky; incorrectly applied tags can distort your measurement; and it can be time-consuming for the IT department or webmaster team to add new tags—leading to lost time, lost data, and lost conversions. We’ve been hard at work to help take the pain out of tagging for everyone. That’s why today, we’re announcing our first release of Google Tag Manager help take the pain out of tagging for everyone.. We’re launching globally in English, and the product will soon be available in many other languages. Google Tag Manager is a free tool that consolidates your website tags with a single snippet of code and lets you manage everything from a web interface. You can add and update your own tags, with just a few clicks, whenever you want, without bugging the IT folks or rewriting site code. It gives marketers greater flexibility, and lets webmasters focus on other important tasks. Take a quick look at how easy it is to set up an account and manage your tags: Google Tag Manager is built to handle your tagging needs, and it works with Google and non-Google website tags. We’ve packed in lots of great features , including: Asynchronous tag loading Easy-to-use tag templates , so marketers can quickly add tags with our web interface, as well as support for custom tags , so marketers can quickly add tags with our web interface, as well as support for Error-prevention tools like Preview mode (so you can see proposed changes before implementing them), the Debug Console , and Version History to ensure that new tags won’t break your site (so you can see proposed changes before implementing them), the , and to ensure that new tags won’t break your site User permissions multi-account functionality to make it easy for large teams and agencies and clients to work together with appropriate levels of access functionality to make it easy for large teams and agencies and clients to work together with appropriate levels of access Plus we have exciting plans to add great new features over the next several months We’re also happy to announce our tag vendor program: If your company provides tag technology and you’d like Google Tag Manager to include a template for your tag, please contact us here to become a tag vendor.',\n",
       " ('Google (компания)',\n",
       "  18,\n",
       "  0): 'Так, мессенджер Allo сможет автоматически подбирать нужные ответы при общении с собеседником НЬЮ-ЙОРК, 19 мая. /Корр. ТАСС Кирилл Волков/. Платформа виртуальной реальности, \"умный\" мессенджер, а также домашний голосовой помощник - такие новинки в области высокотехнологичной продукции представила корпорация Google. Презентация гаджетов состоялась в среду в ходе ежегодной пресс-конференции разработчиков в городе Маунтин-Вью (штат Калифорния). Самообучаемый мессенджер Одним из центральных приложений, представленных на мероприятии, стала новая программа по обмену сообщениями под названием Allo. Как считают в Google, этот \"умный\" мессенджер позволит \"вывести общение на новый уровень\". В приложение встроен самообучаемый помощник Google Assistant, который, в частности, сможет автоматически подбирать нужные ответы при общении с собеседником. Программа также снабжена специальным методом шифрования с целью исключить вероятность хакерского взлома. Вдобавок к Allo калифорнийская корпорация презентовала видеомессенджер под названием Duo, самой инновационной возможностью которого станет функция \"превью разговора\", когда адресат сможет видеть звонящего еще до того, как снимет трубку. Оба приложения будут доступны летом текущего года как на платформе от Google - Andriod, так и на операционной системе iOS от конкурента Apple. Виртуальная реальность Одной из самых заметных новинок на пресс-конференции стала платформа для создания на ее основе приложений виртуальной реальности, которую в Google назвали Daydream. Благодаря Daydream разработчики смогут создавать программы и игры с элементами виртуальной реальности для специальных \"шлемов\", а также мобильных устройств на новой версии операционной системы Android N, сообщили в корпорации. Специально для Daydream Google создала контроллер, работающий по принципу лазерной указки и четко реагирующий на движения пользователя. В Google указали, что корпорация заручилась поддержкой таких компаний, как Samsung, HTC и LG, которые намерены выпустить первые смартфоны с поддержкой Daydream уже ближайшей осенью. \"Умный\" дом от Google Еще одной новинкой, анонсированной Google, стал голосовой помощник для дома под названием Google Home. Устройство, которое похоже на небольшой динамик с микрофонами, способно подключаться к домашней сети и удаленно управлять бытовыми приборами - телевизорами, лампами, будильниками, а также по голосовым запросам пользователей включать и выключать свет или музыку. Кроме того, Google Home сможет самостоятельно выходить в интернет и делать покупки в электронных магазинах. Устройство, которое поступит в продажу уже в этом году, станет конкурентом аналогичного девайса от компании Amazon под названием Echo, уже как год продающегося на рынке. Другие новинки Помимо прочего, корпорация представила обновленную платформу Android Wear для \"умных\" часов. По словам представителей Google, это \"самое масштабное обновление за двухлетнюю историю данной платформы\". Главными ее нововведениями станут отказ от обязательной привязки к смартфону, наличие виртуальной клавиатуры для дисплея часов, а также возможность отвечать на сообщения с помощи рукописного ввода. Как ожидается, новая версия Android Wear выйдет осенью. Google также показала уже анонсированную ранее новую версию своей ОС под рабочим названием Android N. Ее особенностями станут более низкий расход заряда батареи, улучшенная графика и возможность шифрования отдельных файлов, а не всего устройства целиком. Кроме того, корпорация представила функцию Instant Apps. С ее помощью пользователи Android получат возможность запускать приложения из онлайн-магазина Google Play без необходимости их установки на устройство.',\n",
       " ('Google (компания)',\n",
       "  19,\n",
       "  0): 'Москва, 6 декабря, 2018, 13:33 — ИА Регнум. Руководство корпорации Google намерено отказаться от мессенджера Allo, запущенного в 2016 году. Проект признан неудачным. Как сообщается в блоге компании, окончательное прекращение работы Allo произойдёт в марте 2019 года. Читайте также: Google показала новый мессенджер Allo и приложение для видеозвонков Duo До этого времени история переписок ещё будет доступна. Пользователям Allo рекомендовано сохранить истории сообщений, в противном случае после указанного срока будут удалены с серверов корпорации. «Мы решили прекратить поддержку мессенджера Allo, чтобы полностью сосредоточиться на приложении «Сообщения», — говорится в официальном пресс-релизе компании. Также создатели чата заявили, что благодаря работе над мессенджером смогли многому научиться. Так, возможности машинного обучения, впервые использованные именно в Allo, теперь применяются и в «Сообщениях». Ранее по теме: Назван лидер среди мессенджеров в России Напомним, ранее корпорация Google сообщила о закрытии социальной сети Google+. Вслед за ней «поисковой гигант» объявил о закрытии интегрированного во всю экосистему Google мессенджера Hangouts. Полностью поддержку работы мессенджера планируется прекратить к 2020 году. Как сообщало ИА REGNUM, самым популярным в России оказался мессенджер WhatsApp— его установили на свои смартфоны 71% москвичей и 59% жителей других регионов. На втором месте по популярности — Viber. Этим приложением пользуются 37% жителей Москвы и 36% обладателей смартфонов по всей России. Такие данные содержатся отчёте института современных медиа MomriInstitute, опубликованном в начале 1018 года.',\n",
       " ('Google (компания)',\n",
       "  2,\n",
       "  0): '%PDF-1.4 %öäüß 1 0 obj << /Type /Catalog /Version /1.4 /Pages 2 0 R /Outlines 3 0 R >> endobj 4 0 obj << /Producer (Wdesk Fidelity Content Translations Version 004.068.050) /Creator (Workiva) /ModDate (D:20210427194906+00\\'00\\') /Title (GOOG Exhibit 99.1 Q1 2021) /Author (anonymous) /CreationDate (D:20210427194906+00\\'00\\') >> endobj 2 0 obj << /Type /Pages /Kids [5 0 R 6 0 R 7 0 R 8 0 R 9 0 R 10 0 R 11 0 R 12 0 R 13 0 R 14 0 R] /Count 10 >> endobj 3 0 obj << /Type /Outlines /First 15 0 R /Last 16 0 R /Count 9 >> endobj 5 0 obj << /Type /Page /MediaBox [0.0 0.0 612.0 792.0] /Parent 2 0 R /Contents 17 0 R /Resources 18 0 R >> endobj 6 0 obj << /Type /Page /MediaBox [0.0 0.0 612.0 792.0] /Parent 2 0 R /Contents 19 0 R /Resources 20 0 R >> endobj 7 0 obj << /Type /Page /MediaBox [0.0 0.0 612.0 792.0] /Parent 2 0 R /Contents 21 0 R /Resources 22 0 R >> endobj 8 0 obj << /Type /Page /MediaBox [0.0 0.0 612.0 792.0] /Parent 2 0 R /Contents 23 0 R /Resources 24 0 R >> endobj 9 0 obj << /Type /Page /MediaBox [0.0 0.0 612.0 792.0] /Parent 2 0 R /Contents 25 0 R /Resources 26 0 R >> endobj 10 0 obj << /Type /Page /MediaBox [0.0 0.0 612.0 792.0] /Parent 2 0 R /Contents 27 0 R /Resources 28 0 R >> endobj 11 0 obj << /Type /Page /MediaBox [0.0 0.0 612.0 792.0] /Parent 2 0 R /Contents 29 0 R /Resources 30 0 R >> endobj 12 0 obj << /Type /Page /MediaBox [0.0 0.0 612.0 792.0] /Parent 2 0 R /Contents 31 0 R /Resources 32 0 R >> endobj 13 0 obj << /Type /Page /MediaBox [0.0 0.0 612.0 792.0] /Parent 2 0 R /Contents 33 0 R /Resources 34 0 R >> endobj 14 0 obj << /Type /Page /MediaBox [0.0 0.0 612.0 792.0] /Parent 2 0 R /Contents 35 0 R /Resources 36 0 R >> endobj 15 0 obj << /Title (Overview) /Dest [5 0 R /XYZ null 753 null] /Parent 3 0 R /C [0.0 0.0 0.0] /F 2 /Count 0 /Next 37 0 R >> endobj 16 0 obj << /Title (Segment Results) /Dest [14 0 R /XYZ null 751 null] /Parent 3 0 R /Prev 38 0 R /C [0.0 0.0 0.0] /F 2 /Count 0 >> endobj 17 0 obj << /Length 2522 /Filter /FlateDecode >> stream xœÕ[ëoÜD¯!Ğ©D}Q Èd¸^¯½¶ªDu½¤IDšKrI_ßª!ø |àßg_³;³k_BÏ.B•sw³cïo�;;ë>XğŒËìôÍ¬ÈKQ—]¦>ë¢kõ§,›:[îıùvöètVuy�5¢ÉeÑu]vúzöbçÚWlçÚ‘ºNÔu ®¹º«kO]çêÚbu�Y¶cw-Õuá¾/ëÊ°¾ÊN÷g�Og6[E.ËîK¦&:T×™›ÔbÜ¹V9Ps7vî€�� ª+r!Š\"Å5®ì]•7Mß4·•D7™ı¼5æ”Jª\\\\”z¢T²�k5²ò…s˜só›@(FpO.�èvöBÍR2®<°Uß¸ºÖX‡ÔÄïÌ_n|àû®Tß;D\\x7f¹c>~`µT7ÌàûÚùÊ‘ó§\\'ftñüX´óò¡ù%šlDAySæB&¢Z‰Nœÿ:l€W[ü3K±Æ6Ã¨Æò¶M0öi�gŒØZRÇ6»îLlŸ\\'ÍßoüïÊü½OîøÖü*Ñ_K¹q%®êÙ#[¤:½í:^¾DÃóKrà.âµîtè8æˆó9Ş–â=‚ŠŠ˜ì¬7v5º•C h—Îõ,Íò¸»GFÊy™· ÔÓ$‡k{Ö�Så®Wú¨‘YçEU<�6¶üM“·é,~áBÉŠ}Çxpl>iğW�¢›Å ¸=�ÃÊ–æ÷ÈÎsïß7:ß\\\\ ¤¹,÷†Oçx·”d`é>P¾õ ¯}\\'{hÒ9¤heyÅÄG!\\xadXı¤ûhT§ÕŸÖg»¾½;�IK=rÏ\\\\ádkFLúÚó4•Åsâ–N†Xj�éYD?÷F:szAq,Ù¿Ñ±ô!�FAŸ&pÆ†:üS”½a1�ã˜…úá8ˆbÆWÈ|ÏXğÖP,[>¢&\\x7f§¥ÎãIa\"š¯Ÿ\"í{ëş@à‚$Ö]ôôÈÃ Ò-MÅ]ß·Mæÿ�qûíÚÍCâF Às²d^° ,ºgˆT±p£+–Z ~ÃªVÃA3ï\\'Ö9CO�U7�Ê’¸à<‰‹:v%K:@ò�à�5qo q¡³›Îvß÷œÇ<Š�Â²”$wxò×î˜‘Ìve% n*VCdjËôY»õŠ…éW8ÄÂm‡ñ³¢P 2@>9rWô°¹k� ƒØsâ}“x^]Ï£&†]·->v‘Ø‡§„#Ï¢ô¡U�&¯ Ù!1»ò�óÁ² eµ³~�Y¥\\xad|µ±L¬àMg¸L\\xadÁh\\xadaH\\xada(k×AÃ×İ¿\\xad5ÌSk 5 µFÃ84± íS ˜ Uâä¼bëäüPQ>u×¶¯baâ\"›x£ßIÎ1Ô°× M!Œã²m•ó‰×3]-�‡å³$,\\'[Jšxá„�ÔNª²,PF ñéÓR ¾°Ükªšğ8RÎ”°VÌû¡:İ‹÷Ñ�Ïãè³,È„]F×î ^(ü-ë|Ø/N–5)YĞbb9ğ¼T{x!ù9Q?5qoj”}§(ºzMàkE›ÔÀKä_¡X¯SP¥¤¶2¿×f:ÃÑ·èû,f8zõeF®�™ÉL†¢3Ó]oû›ˆ÷’¬Ô+eb6C½4ë†²NT©˜{B†ƒ»�#ÕQ¯^\\'îZtPè¥é¡WğÇ/Ğ¬Ûë�ö¬SiÇ6V·üº…w†>”AÄŸ�[œ°�!è`\\x7fô0 /ÇAŞĞ@²LÜªÙxµWhE25Ãæ“Ô¹Læê>m<[Ûäj¡íI‡‰öBÛAF×ß~Ä0¡Mvà‰›õ&P�èÓlÔuCäiâ¤QÕ®�!ÁÊ%‚*lÁ <Š�…Ë¨²aŸûŠ¦IÃí® -.3 ””}Å–äò¸å¾¬IkcLÒ¯¡®O¿ø©iGÆÆô�JæÒt–cGèïùZhq××RqäİÓQkŞäï SGËÉ¸:ª«\"çµ�4�~²Nw\\xadò§èú%�`%«j2Çu†×Tmâ§l¸üÀ½ğåh;aa«Â{¢…g¡í(+6“¡ÔÅ±{ÕıúĞ2Œç¬¡„œ»œÑÿ%’ Ê‘9Åa(M Võ >—øCı+òÎÚ ã�¬õgÙU\\\\Ûb`DğÁÛ¿xöö¯Y‘ı={ñ*+²×êë¯êÚwÖ+š\\\\Ÿ�wÙïÆo0å7G©ºÒSÌM˜ğËì��¤4“¼@±`ÕÄ Å”1@™ ¬6 X¯¨ÿV §x€¢ò{\"8€r€ÍZ€<È€…*G‰Ál7 Ø\\xad(:îæ€� EÄPe³wGÈ×†‰� D™@¬bˆU ÑÄÉ³ãÿÕ¥ÿ�±}(›¼kµ>êRä²�÷>wÒw� sºSÏc×ª é2$×´îc¸î€´:–d¢ÉE›Õ¼ÈÛ®ÿÅ¦PÓŒ4gÍ«\\\\ŠµsŞŠæÜ¼²(s.Tú¯É”ğ\"U\\x7fËbd•[©:Æğ¡\\xadİ¸¢e¶ JLıM·k¿°<]UecƒRùJ¦Š¡ k|ƒxãİÉ@9cµÔ?è«JPáÆ-”¶HOf¸+åû*ø {ËWYôà¿‡yl‹¨ôÌe\"ı+›Ö¹„ëÛ›÷>=RD›WE×5ƒîãOÁÚ_Ö#Ø?Ş2Ÿ“²èp`}Æh\\'OÓ]ßíı:”Ö¤RA½áË«B�k-V²Ë»F4x»sËìypd?ìÁŸ¾\\'€pÇ-3S{°Â«0}™lÀèÖ Ÿ\" x°í÷O´(EH]ş/+£�ğ¢«^ˆ>s×´R? · iºçAİu)q:PÎœªö{wsâ�œÒOzRz_¼§Ğ€ usúĞª ]l+Ú› ¸?Ô`ô:İ°6,\\'{Ìv šı\"hN]¢à mo¿É—ß0Î™n;÷±€n³Á ªnÀŒRÅÚ®”Z\\\\D)1XÀê¹º O Œø¢R£á°…Wæ�/ÎÂ^â¦�¾íÿÄÓ—r�Ö •²ËÂûØYØ#nÄ(qué �ØsºhnĞ;Ğ£ üÒ‹b†—Í û�·Hp\"§ó�Çù9Ÿ°ğºĞS<°N1WxM$ˆ»Ä„cvuõ§Û>¼é‹/Ùõ�ç]jï¥8¯j}ÄEÿ?P¿:ì‹„Õv8> ï…c¢ph â‚)WŞë°@Ğ%ı\"‚*á endstream endobj 18 0 obj << /Font 39 0 R /ExtGState 40 0 R >> endobj 19 0 obj << /Length 4160 /Filter /FlateDecode >> stream xœÕ][o·6à‡ ÇTÛ²-_RœÇ1Ûf½äŞ‹ �î>‰¬#ëH¶“· . ûÁÍCş~yr†ä®$Ÿ]5Epä]’K~œ‡3ÜÍ‹]>çùüõ¯³<E%º¹ü·Ê»Vı[‹¦š/÷z«şó~öıëYÙeÕ¼)yÖÕ]×Ì_ÿ2{÷üFÉøüù�MöóüõálçõìÅúãÔ\"k‹h ›r 1©²:ã{~ã.3ÿ�:¥¶ÉÚ29¥ç7Vr°s}u‚şé¿û²î3ÿë’3yµÍ Şô°Ğ\\x7fMı�¬[ê«Sû¬j\\xad�2\\xad–®\\xadŸ�Xwz‚‹¬=ó»¥ÇVcBÉ+[rd\\x7f�Ù´PÔØ@sS3\\x7f\\'\\x7f»– \\'z6¾şÀÎÊÌ÷¦��¢¨gÇ>çkUÛƒ`„W¶ç#‹ä§ŸìcûÒ_Ğçê¶fÏNáÌu§J¾DòSŒ£z\"\\'ä\\xad,¾7D@ÎŠ�”�‹mfåÀ‰Å®#ÏSKì×¨·…Ô…ÂPœàùgN WVğV‹BãFy¦©uÛn{¨7<\\'ÃN˜f(~ÈP¯H¦MÀV`Ğ\\'ùŸ$\\xad!{Ç›ºRÿŠ®äŠü=5’g/ŞÿÆçï\\x7f›åóßgï~�çó_äå¿åïĞ0¬nkÉÍùÇY%Mš»ı ·Rc>Ø†úò_³_U—BwùypŠA8U“5�¹upÊ\"« {c!•k@ª!‰�PÈÜ:HÜâN½œfN� ™[€SIş9@pc!µk@ê† U�À²·RÕ:@úÒÂ‘ææóñğA¡®¤h Ù[HtˆFö@\\xad#Ù|P´+^*™[*ç’¾@Z®?Í�ÿ0?õww£�¬ïºnŞä¥ô<:Ù»kçÎâ�ZM-êOÏ‘ñİCËš7Ì9ó¨åâ%ª»¯İ\\'³ø€�kf…¶¡uÛ‘iaÇí.yÌŠ—�¹Œ¹¶GU—™”øº©²ªóCşÕ90êwh–}Ç·Ú±Š²êÿ„˜´tËKÇÿ‘\\'QJ·°m£Y|¡ñ|+Úº˜ò=p�Ê\"ªlSUó±1uùÅ˜° ?¿ñX^=’¿\\'Sa²Ì®yV ùú�uÂòé\\\\ûMEk�ÏÂômëp®¦b_€K’ èd#Ì6Å2E´ÇS³\\xadËC‚Eı¶&fWÙdùt“Û;£so™ß´ü8ã„�X[�X÷¬®İŸšq½X<ã3Ï¼I°4µf\\\\!ˆ¿ˆq _°Í:uL\\\\0Ø™ ááTŒ+â•¼³†ê¾# 2R¯ƒ™½xcşĞZ„k\"o¯´J^ãÊ K™Î–a“™+`Z/–‡Ë“)V Í0é”WĞ@ïÖœZ=\\\\0òá…³€½&N6kƒ9P�|ìHºiI:ùÊØ‹g‹83›Ö™™�aq%Q]eu|Æ|ğÍÄÔ¦a[ˆËkÁ=bFá7%Ëú±PÇêÁ”X,»¤;Œ-º@úä�$0ëk§�g6Ğ7³T’ e›·VŠ¯Ãh#˜T¯-c¤Ã‹\\xadöß˜�0×˜£®¶Q �¾‚�\\xadìè—S±0À¯HUÔ%Zk&e_ ÿ}–ÏÕ\\x7f6Ä¯SEaxŸç:øªRge[¢ôÔ÷ú1�Š:kR�µ-îŒ&¾Lgm²³n G¸¸ëHä©�@Å&Ô‘HvTô#R™ @d²B¦£2ÙQ’è‘égšLGI‚‹$Á-¢²49#ÊÜ~ğÕ‚VSmFKrD$9baÃh�¡‚Ñ ZĞj',\n",
       " ('Google (компания)',\n",
       "  20,\n",
       "  0): 'Earlier this year, as part of the Google Analytics 360 Suite announcement , we unveiled a new data visualization and reporting platform for large enterprises — Data Studio 360 Yesterday, at the Google Performance Summit, we announced a free version of Data Studio for individuals and smaller teams. Data Studio lets you connect to all your marketing data and turn that data into beautiful, informative reports that are easy to understand, share, and fully customizable. We wanted to take a moment to give you some of the details about Data Studio.One of the fundamental ideas behind Data Studio is that data should be easily accessible to anyone in an organization. We believe that as more people have access to data, better decisions will be made.With multiple data connectors, you can now easily create dashboards from many different types of data and share with everyone in your organization - and you can mix and match data sources within a single report. For example, you can combine Google Analytics data and Google AdWords data into a single report.Today, we’re offering multiple data connectors, so you can connect to Google Analytics, Google AdWords, Google Sheets and many other Google services. But Data Studio offers integration with a wide variety of data sources. There’s also a connector for BigQuery and we will soon have connectors to SQL databases that will let you access first party data.Data Studio is more that just sharing reports with other people — it’s true collaboration. We used the same infrastructure as Google Docs, so you can edit reports together, in real time. This is useful as you combine data from multiple teams and need others to add analysis and context to the report.In addition to new sharing and collaboration tools, Data Studio gives you many flexible ways to present your data. Sure, there’s the usual assortment of bar charts, pie charts, and time series. But we’ve also included some new visualizations — like bullet charts that help you communicate your progress towards a business goal.Another advanced feature is the ability to create a heatmap using tabular data. This visualization makes it easy to instantly identify outliers within a table of data.Data Studio also has an array of other features to help you customize how you present your data. There are a number stylistic tools that enable you to design your reports to represent your specific brand. There are also interactive data controls, like a date picker and dynamic filters, that enable report editors to make reports interactive for viewers.For example, let’s say you want to let users segment a report by country. Just add a control element to the top of your report and the user can dynamically segment the data. In the image below the check boxes will change the data in the map and data table based on what a user selects.These are just a few of the tools that you can use to help others in your organization understand data.The primary difference between Data Studio 360 and the free version, Data Studio, is the the number of reports you can create, which is five per account. Both versions support connecting to unlimited data sources and offer unlimited report viewing, editing and collaboration. For more information, check out our Help Center If you’re ready to get started, watch this brief overview that will help you build your first reports.Then check out the interactive walkthrough - it’s built with Data Studio. Just choose “Welcome to Data Studio (Start Here)” from the list of reports in your account.Data Studio is currently available to users in the United States and',\n",
       " ('Google (компания)',\n",
       "  20,\n",
       "  1): 'we’ll be rolling it out to other geographic regions throughout the year. We hope it helps you share more data and make better business decisions.Happy Dashboarding,',\n",
       " ('Google (компания)',\n",
       "  21,\n",
       "  0): \"An enterprise-class solution for a multi-screen world Our lives are filled with micro-moments: intent-rich moments when we turn to the nearest device to find a store, buy a product or look for answers to all kinds of wants and needs. In these moments, today's consumers decide what to do, where to go, and what to buy. If you're in marketing or analytics, you know this consumer behavior brings new opportunities to reach your customer in the right moment with the right message. At the same time, it's harder than ever to get a complete view of the consumer journey and then make sense of it all. That’s why we’re introducing the Google Analytics 360 suite, a set of integrated data and marketing analytics products, designed specifically for the needs of enterprise-class marketers. It all starts with understanding consumer behavior in the moment—getting the right insights, and then making your brand useful to consumers. “The Google Analytics 360 suite gave us the really big ah-\\xadha moment. When we launched our mobile app, it provided insurance quotes. But after looking at the data, we saw people were attempting to buy insurance. So, we shifted our mobile strategy to offer ecommerce. Google gave us that insight.” -Pawan Divakarla, Analytics Leader, Progressive Modern measurement tools that are simple to use Sophisticated marketers who use analytics platforms are three times more likely to outperform their peersin achieving revenue goals. It’s no wonder enterprise-class marketers have been telling us they need more from their marketing analytics tools. Many toolsets can't cope: They're too hard to use, lack sufficient collaboration capabilities, are poorly integrated, and require hard-to-find expertise. Several years ago, Google engineers set out to simplify marketing analytics in the same way we simplified web search with Google.com. With infrastructure that allows us to handle billions and billions of daily search queries—generating answers before users even finish typing—we set out to give enterprise marketers the same utility. As we built the system, enterprise marketers shared what they needed with us: See the complete customer journey: Marketers require full visibility and context to see what’s really happening across all customer touchpoints, devices, and channels. Marketers require full visibility and context to see what’s really happening across all customer touchpoints, devices, and channels. Useful insights, not just more data: Marketers need enormous computing power, data science and smart algorithms, all working together to quickly make sense of data for them. In other words, built-in intelligence to do the heavy lifting for marketers and make insights easy to see. Marketers need enormous computing power, data science and smart algorithms, all working together to quickly make sense of data for them. In other words, built-in intelligence to do the heavy lifting for marketers and make insights easy to see. Enable better sharing within your organization: Marketers seek to put insights into everyone’s hands and get the whole company on the same page—resulting in stronger cross-functional goals and smarter decision-making. Marketers seek to put insights into everyone’s hands and get the whole company on the same page—resulting in stronger cross-functional goals and smarter decision-making. Deliver engaging experiences to the right people: Marketers want to make their brand immediately useful to consumers. With integrations across multiple Google technologies, the suite products not only work well together, but also with other products, including DoubleClick Ad Exchange, DoubleClick, and third-party platforms—enabling marketers to take immediate action and drive business impact. The Google Analytics 360 suite is built to address these needs. Its powerful set products are unified, providing a consistent user experience and cross product data integrations, plus services. Simply put: it’s a complete\",\n",
       " ('Google (компания)', 21, 1): 'measurement platform.',\n",
       " ('Google (компания)',\n",
       "  22,\n",
       "  0): 'Google анонсировала закрытую предварительную версию Veo — модели генерации видео на базе искусственного интеллекта. Она позволяет создавать ролики с разрешением 1080p в широком диапазоне кинематографических и визуальных стилей. Предварительная версия Veo стала доступной для клиентов Vertex AI. Теперь они могут генерировать видео, используя простые текстовые или графические подсказки. Вместе с этим Google также объявила о выпуске в открытый доступ Imagen 3, своей последней модели преобразования текста в изображение. Компания утверждает, что Imagen 3 может генерировать изображения с высокой детализацией, которые являются фотореалистичными и содержат меньше отвлекающих визуальных артефактов по сравнению с Imagen 2. Модель будет доступна на следующей неделе на Vertex AI для клиентов Google Cloud. Google также рассказала о новых функциях, которые позволят клиентам Imagen 3 изменять изображения, созданные с помощью ИИ: редактирование с помощью текстовых подсказок, которое может затрагивать только части изображения, например, обновлять фон; настройка управления моделью для создания изображений на основе определённых характеристик. Клиенты могут попросить Imagen 3 использовать собственный бренд, стиль, логотип, тему или характеристики продукта. Google отмечает, что Veo и Imagen 3 поставляются с функциями безопасности. Обе модели предотвращают создание вредоносного контента и соответствуют принципам ответственного ИИ. Кроме того, невидимые водяные знаки SynthID встроены в каждое изображение и кадр, созданные Imagen 3 и Veo. Генератор видео Veo впервые показали на Google I/O 2024 в мае этого года. В августе исследователи Google анонсировали модель машинного обучения Imagen 3, которая заменит собой прошлую версию и будет доступна в сервисе ImageFX. Она по умолчанию создаёт изображения с разрешением 1024×1024 пикселей. При этом есть возможность увеличить разрешение в 2, 4 и 8 раз.',\n",
       " ('Google (компания)',\n",
       "  23,\n",
       "  0): 'OpenAPI | gRPC After your API is deployed, users of your API need to access it through a domain name rather than an IP address. You can either: Configure .endpoints. PROJECT_ID .cloud.goog as the domain name (where PROJECT_ID is your Google Cloud project ID). as the domain name (where is your Google Cloud project ID). Or register your own domain name, such as example.com , which entails: Configuring DNS name servers (or using Cloud DNS). Updating registry addresses. Creating and maintaining DNS records. If you already have a DNS infrastructure, or you want to register your own domain name, see Serving an API from your domain name for more information. , which entails: This page describes how to configure Cloud Endpoints APIs to use .endpoints. PROJECT_ID .cloud.goog as the domain name. The configuration steps on this page are applicable for APIs using OpenAPI running on Compute Engine, Google Kubernetes Engine, or Kubernetes. The .endpoints. PROJECT_ID .cloud.goog domain name isn\\'t supported for APIs running on App Engine. For APIs on App Engine, we recommend that you use PROJECT_ID .appspot.com as the Endpoints service name. When you deploy the API to App Engine, a DNS entry with a name in the format PROJECT_ID .appspot.com is created automatically. The .cloud.goog domain is managed by Google and shared by Google Cloud customers. Because Google Cloud projects are guaranteed to have a globally unique project ID, a domain name in the format .endpoints. PROJECT_ID .cloud.goog is unique and can be used as the domain name for your API. Configuring the .endpoints. PROJECT_ID .cloud.goog domain name is optional. If you prefer, you can register your own domain name. Prerequisites As a starting point, this page assumes that you have already created your Cloud Endpoints API and deployed it to Compute Engine, Google Kubernetes Engine, or Kubernetes. If you need an API for testing, you can use one of the tutorials that walk you through configuring and deploying a sample API. Configuring DNS The following procedure describes how to configure DNS for Cloud Endpoints APIs that use .endpoints.[PROJECT_ID].cloud.goog as the Endpoints service name where [PROJECT_ID] represents your Google Cloud project ID. For convenience, the procedure refers to your OpenAPI configuration file as openapi.yaml . To configure DNS: Open openapi.yaml , and add the x-google-endpoints field to the file as shown in the following snippet: swagger : \"2.0\" host : \"[API_NAME].endpoints.[PROJECT_ID].cloud.goog\" x - google - endpoints : - name : \"[API_NAME].endpoints.[PROJECT_ID].cloud.goog\" target : \"[IP_ADDRESS]\" Typically, you configure the host field and the x-google-endpoints.name field to be the same. When you deploy your OpenAPI specification, the text specified in the host field is used as the name of your Endpoints service. Replace [API_NAME] with the name of your API (for example, bookstore or my-cool-api ). Replace [PROJECT_ID] with your Google Cloud project ID. Replace [IP_ADDRESS] with an IPv4 address. For example, if you deploy your Endpoints API service to a Compute Engine virtual machine instance, you can use the external IP of that virtual machine. Alternatively, if you run your code on a group of virtual machine instances (or GKE pods) behind a load balancer, you can use the IP address of the load balancer. Deploy your new OpenAPI specification to Service Management using the following command: gcloud endpoints services deploy openapi.yaml For example, if the following is specified in an openapi.yaml file: swagger: \"2.0\" host: \"my-cool-api.endpoints.my-project-id.cloud.goog\" x-google-endpoints: - name: \"my-cool-api.endpoints.my-project-id.cloud.goog\" target: \"192.0.2.1\" When you deploy the openapi.yaml using the previous gcloud command, Service Management creates a DNS A-record, my-cool-api.endpoints.my-project- id.cloud.goog , which resolves to the target IP address, 192.0.2.1 . You might need to wait a few minutes',\n",
       " ('Google (компания)',\n",
       "  23,\n",
       "  1): \"for the new DNS configuration to propagate. What's next\",\n",
       " ('Google (компания)',\n",
       "  24,\n",
       "  0): 'Google удалила из принципов разработки ИИ абзац под названием «Приложения ИИ, которые мы не будем развивать». В нем перечислялись и «технологии, которые наносят или могут нанести общий вред». Речь шла и об оружии, пишет Bloomberg Фото: yuriyt / Shutterstock Американская корпорация Google удалила из своих принципов разработки искусственного интеллекта формулировку, предписывающую избегать применения этой технологии в потенциально опасных для человека целях, в том числе в оружии. Внимание на это обратило Bloomberg. На странице, где изложены принципы разработки ИИ, ранее был абзац под названием «Приложения ИИ, которые мы не будем развивать». Сейчас он отсутствует, а сама статья обновлена 19 часов назад, убедился корреспондент РБК. Среди таких приложений перечислялись и «технологии, которые наносят или могут нанести общий вред», отмечает Bloomberg со ссылкой на скриншоты из веб-архивов. Указаний на это теперь в статье нет. В ответ на просьбу прокомментировать изменения политики представитель Google прислал агентству ссылку на заявление из блога компании, опубликованное 4 февраля. «Мы считаем, что демократии должны лидировать в разработке ИИ, руководствуясь основными ценностями, такими как свобода, равенство и уважение прав человека», — говорится в заявлении старшего вице-президента Google Джеймса Манийки и главы лаборатории Google по разработке ИИ DeepMind. «Мы считаем, что компании, правительства и организации, разделяющие эти ценности, должны работать вместе, чтобы создать ИИ, который защищает людей, способствует глобальному росту и поддерживает национальную безопасность», — подчеркнули топ-менеджеры. По словам одного из бывших руководителей команды Google по этике при разработке ИИ, Маргарет Митчелл, удаление пункта о технологиях, способных нанести вред, может повлиять на типы работы, которую будет вести корпорация. «Google теперь, вероятно, будет работать над прямым внедрением технологий, которые могут убивать людей», — сказала она. Один из главных спонсоров нового президента США Дональда Трампа, член его администрации и основатель компаний Tesla и SpaceX Илон Маск, еще в 2015 году подписал открытое письмо с предупреждением о гонке вооружений с искусственным интеллектом. Под ним подписались более 1 тыс. известных ученых, бизнесменов и экспертов в области искусственного интеллекта, в том числе профессор физики Стивен Хокинг. Авторы письма утверждали, что искусственный интеллект может быть использован на поле боя, чтобы сделать его более безопасным для военнослужащих, но наступательное вооружение с применением искусственного разума приведет к росту потерь человеческих жизней. Чат-боты с искусственным интеллектом уже способны помогать пользователям создавать биологическое оружие, писал Bloomberg. Биохимик Рокко Касагранде предупреждал Белый дом о способности ИИ идентифицировать биологические агенты. К таким выводам он пришел после тестирования чат-бота Claude, который предложил использовать патогены в ракетах.',\n",
       " ('Google (компания)',\n",
       "  25,\n",
       "  0): \"Updating AI Principles Since we first published our AI Principles in 2018, the technology has evolved rapidly. Billions of people are using AI in their everyday lives. AI has become a general-purpose technology, and a platform which countless organizations and individuals use to build applications. It has moved from a niche research topic in the lab to a technology that is becoming as pervasive as mobile phones and the internet itself; one with numerous beneficial uses for society and people around the world, supported by a vibrant AI ecosystem of developers. Common baseline principles are an important part of this evolution. In addition to AI companies and academic institutions, we're encouraged by the progress we’ve seen on AI principles globally. The G7 and the International Organization for Standardization, as well as individual democratic nations, have all published frameworks to guide the safe development and use of AI. Increasingly, organizations and governments are able to look to these common standards as they consider how best to build, regulate, and deploy this evolving technology — our Responsible AI Progress Report, for example, is now based on the United States’ NIST Risk Management Framework. Our experience and research over recent years, along with threat intelligence, expertise, and best practices we’ve shared with other AI companies, have deepened our understanding of AI's potential and risks. There’s a global competition taking place for AI leadership within an increasingly complex geopolitical landscape. We believe democracies should lead in AI development, guided by core values like freedom, equality, and respect for human rights. And we believe that companies, governments, and organizations sharing these values should work together to create AI that protects people, promotes global growth, and supports national security. With that backdrop, we’re updating our own AI Principles to focus on three core tenets: Bold Innovation: We develop AI to assist, empower, and inspire people in almost every field of human endeavor, drive economic progress and improve lives, enable scientific breakthroughs, and help address humanity's biggest challenges. We develop AI to assist, empower, and inspire people in almost every field of human endeavor, drive economic progress and improve lives, enable scientific breakthroughs, and help address humanity's biggest challenges. Responsible Development and Deployment: Because we understand that AI, as a still-emerging transformative technology, poses new complexities and risks, we consider it an imperative to pursue AI responsibly throughout the development and deployment lifecycle — from design to testing to deployment to iteration — learning as AI advances and uses evolve. Because we understand that AI, as a still-emerging transformative technology, poses new complexities and risks, we consider it an imperative to pursue AI responsibly throughout the development and deployment lifecycle — from design to testing to deployment to iteration — learning as AI advances and uses evolve. Collaborative Progress, Together: We learn from others, and build technology that empowers others to harness AI positively. You can read our full AI Principles on AI.google. Guided by our AI Principles, we will continue to focus on AI research and applications that align with our mission, our scientific focus, and our areas of expertise, and stay consistent with widely accepted principles of international law and human rights — always evaluating specific work by carefully assessing whether the benefits substantially outweigh potential risks. We’ll also take into account whether our engagements require bespoke research and development or rely on general purpose, widely-available technology. These assessments are particularly important as AI is increasingly being developed by numerous organizations and governments for uses in fields like healthcare, science, robotics, cybersecurity, transportation, national security, energy, climate, and more. Of course, in addition to the\",\n",
       " ('Google (компания)',\n",
       "  25,\n",
       "  1): 'Principles, we continue to have specific product policies and clear terms of use that contain prohibitions like illegal use of our services.',\n",
       " ('Google (компания)',\n",
       "  26,\n",
       "  0): 'Google выдал полиции пользователя с детским порно в электронной почте Сотрудники Gmail обнаружили в переписке жителя Техаса непристойные фото девочки, после чего сообщили об этом в службу по защите детей Фото: Reuters Москва. 4 августа. INTERFAX.RU - Компания Google раскрыла личность пользователя электронной почты Gmail, в ящике которого обнаружились детские фото порнографического характера, сообщает KHOU 11 News. Инцидент произошел в Хьюстоне, штат Техас. Сотрудники Google заметили, что в электронном сообщении 41-летнего пользователя Gmail Джона Генри Скиллерна (John Henry Skillern), которое тот послал своему другу, содержатся непристойные фото девочки. Вначале Google сообщил о находке службе по защите детей, а те, в свою очередь, известили полицию. Полицейские получили ордер на обыск и арестовали Скиллерна. На его компьютере и в телефоне обнаружили детское порно, а также переписку, содержимое которой свидетельствовало о сексуальном интересе мужчины к детям. Выяснилось, что ранее Скиллерн уже был осужден за преступления сексуального характера по отношению к ребенку. На этот раз его обвинили в хранении и распространении детской порнографии. BBC News сообщает, что в Google им отказались давать комментарии относительно частных случаев. В компании также не сообщили о том, проверяют ли они электронные ящики пользователей на предмет хранения других запрещенных данных, например, информации, нарушающей авторское право, или материалов экстремистского характера. Ранее главный юрист Google Дэвид Драммонд сообщил, что компания сотрудничает с британской организацией Internet Watch Foundation, которая борется с детской порнографией в Сети, и с американской организацией National Center for Missing and Exploited Children, которая занимается поиском пропавших детей и предоставляет помощь детям, подвергшимся насилию. Кроме того, известно, что Google автоматически сканирует содержимое ящиков Gmail, чтобы \"подобрать\" каждому пользователю релевантную рекламу. Инцидент с Джоном Генри Скиллерном вновь поднял вопросы о тайне электронной переписки и о роли Google по поддержанию порядка в интернете, отмечает BBC News.',\n",
       " ('Google (компания)',\n",
       "  27,\n",
       "  0): 'Интернет-компания Google при помощи технологий распознавания контента на сервисе Gmail помогла выявить распространителя детской порнографии в США. Об этом сообщает издание Mashable. По данным издания, Google перехватила момент, когда 41-летний Джон Генри Скиллерн пересылал по Gmail откровенную фотографию несовершеннолетней девочки. Компания проанализировала содержание его аккаунта и выявила три снимка, относящихся к категории детской порнографии, о чем Google оповестила Национальный центр США по делам пропавших и эксплуатируемых детей. «Закон требует от интернет-компаний сообщать о детской порнографии, если они ее выявляют. Еженедельно мы получаем около 10 — 15 тысяч подобных оповещений», — отметила представитель центра Мишель Коллинз. Как именно Google смогла выявить нелегальный контент в аккаунте Скиллерна, не уточняется. Возможно, содержание его электронных коммуникаций было под более пристальным вниманием, поскольку он около 20 лет назад уже привлекался к ответственности за совращение несовершеннолетних. Исходя из информации полиции, при нынешнем аресте у Скиллерна была обнаружена детская порнография на смартфоне и планшете, а также текстовые сообщения и электронные письма, в которых он проявлял интерес к такого рода контенту. В настоящий момент ему предъявлены обвинения в хранении и продвижении материалов, относящихся к детской порнографии. Google не скрывает от пользователей, что автоматически анализирует содержание почтовых ящиков в Gmail для лучшего таргетинга рекламы, а также для выявления спама и вредоносного контента. Однако такая практика регулярно вызывает критику со стороны пользователей, обвиняющих Google в нарушении приватности частной жизни.',\n",
       " ('Google (компания)',\n",
       "  28,\n",
       "  0): 'Wael Ghonim, the Google executive and Egyptian activist who played a key role in the popular uprising that toppled Hosni Mubarak, was on Wednesday lauded as \"a hero\" by his boss, Eric Schmidt. However, the young marketing manager described himself as \"just another guy in the movement\" that brought down the long-serving Egyptian president in January. Ghonim became a hero of the Egyptian anti-government uprising after setting up a highly influential Facebook page which quickly became the focus for protests in the country. The father-of-two, who is now on an \"extended sabbatical\" from Google, was arrested by Mubarak\\'s forces and later broke down on national TV when shown pictures of dead protesters. \"I don\\'t claim to be a leader. I don\\'t think I am a leader anyway. I was just another guy in the movement,\" he told Google\\'s Big Tent conference in London on Wednesday. Ghonim also played down talk that the Egyptian uprising was a \"Facebook revolution\". \"No one argues that this is an internet-sparked revolution,\" he said, adding that the internet was just a tool for \"mobilising\" protesters. \"The internet\\'s role was very critical on the 25th, maybe the 27th, but got less and less important because it\\'s role was to expose what was happening.\" Egypt implemented a countrywide internet blackout in the dying days of the Mubarak regime aimed at curbing communication between protesters. Ghonim said it actually had the opposite effect. \"The blackout was a regime mistake, because people just went to the streets to find out what was happening,\" he said. \"If you try and hide something it\\'s going to get harder and harder and harder.\" He added: \"I will do my best to help my country. I\\'ll always be optimistic, even when I\\'m frustrated. The new democracy is not built on being pessimistic. \"We just got rid of a nightmare, there are more we have to deal with, but the challenge is to drive the country towards a wave of optimism and keep fighting for the same reasons that brought us to 25 January.\"',\n",
       " ('Google (компания)',\n",
       "  29,\n",
       "  0): 'Ассоциация менеджеров и ИД «Коммерсантъ» представляют ежегодный, 22-й рейтинг «Топ-1000 российских менеджеров». Число новых имен в «Топ-1000» достигло исторического минимума — вполне возможно, на фоне продолжающихся карантинных ограничений. Исключением стала номинация ИТ-директоров. Заметное событие в списке бизнес-лидеров: его покинул один из основателей рыночной экономики современной России. Выйти из полноэкранного режима Развернуть на весь экран Общее количество новых имен в рейтинге «Топ-1000 российских менеджеров» в 2021 году составило 37,7% от общего списка, что близко к минимуму за всю более чем двадцатилетнюю историю наблюдений Фото: Александр Подгорчук, Коммерсантъ / купить фото Общее количество новых имен в рейтинге «Топ-1000 российских менеджеров» в 2021 году составило 37,7% от общего списка, что близко к минимуму за всю более чем двадцатилетнюю историю наблюдений Фото: Александр Подгорчук, Коммерсантъ / купить фото Тихий омут Как всегда при анализе результатов исследования Ассоциации менеджеров «Топ-1000 российских менеджеров», мы обращаем внимание на количество новых имен в соответствующем рейтинге, точнее, на проценты их ротации — это позволяет сделать вывод, в каких отраслях наибольшие перспективы у менеджеров, делающих ставку на карьерный рост, а в каких — у предпочитающих «синицу в руке». Высшие руководители при этом не учитываются — в России они зачастую являются владельцами бизнеса, поэтому на основании данной статистики не слишком корректно делать выводы об авторитете и частоте ротации специалистов в отдельных отраслях и профессиональных сферах. Общее количество новых имен в рейтинге «Топ-1000 российских менеджеров» в текущем году составило 37,7% от общего списка, что близко к минимуму за всю 20-летнюю историю наблюдений, меньше (37,0%) было лишь по итогам 2018 года, в среднем же новичков в разные годы бывало около 45%. Возможно, нынешний показатель связан с коронакризисом (напомним, рейтинг составляется по итогам предыдущего года, в данном случае — 2020-го), а также с соображениями вроде «коней на переправе не меняют». Вместе с тем по отдельным позициям наблюдаются довольно существенные изменения, вероятно хорошо объяснимые в свете «новой реальности», которая настигла экономику в прошлом году. Из более «массовых» сегментов наивысший показатель ротации лучших менеджеров обнаружился в «Профессиональных услугах» (48,7%). На втором месте «Финансовый сектор» (47,9%), на третьем — «Сервис и производство потребительских товаров» (45,4%). В категории «Онлайн-платформы» результат также заметно выше среднего (45,2%), равно как и в «Фармацевтике» (44,4%). Логично предположить, что в первых четырех отраслях существенная ротация произошла в связи со сменой потребительских предпочтений и моделей поведения в период пандемии, а также с существенным ускорением процесса цифровизации, перестройка в сфере фармацевтики в нынешней ситуации и вовсе не нуждается в комментариях. С этой же точки зрения логичной выглядит низкая ротация в списках «Топ-1000» в отраслях «Связь и телекоммуникации» ((24,4%) и «Медиабизнес» (25,0%) — они и до пандемии жили в цифровом формате «на удаленке». А также в металлургии и сельском хозяйстве (25,4% и 27,8% соответственно) — пандемия на них повлиять не могла: плавильный цех и посевные работы на удаленку не переведешь. При рассмотрении профессиональных компетенций наблюдается примерно такая же картина. Если не учитывать ротацию в рейтинге директоров по логистике (64,0%, но это относительно новый рейтинг — там очень мало участников, и статистические выводы едва ли уместны), на первое место по доле новых имен (58%) вышла категория «ИТ-директор». Отметим, что аналогичная картина наблюдалась в прошлом году (56%), но кризис был и тогда и ускорение цифровизации тоже. На втором месте директора по маркетингу и общественным связям (49,5% и 45,0% соответственно), что также объяснимо: в период смены потребительских предпочтений возникает необходимость в резком изменении бизнес-моделей: реклама, как известно, двигатель торговли. Среди специальностей с самым низким «коэффициентом обновляемости» — директора по корпоративной социальной ответственности (32% — впрочем, там выборка тоже не особенно репрезентативная), такой же результат показали директора по корпоративному управлению, далее плотной группой идут финансовые директора (36,7%), директора по правовым вопросам (38,0%) и GR-директора (38,8%). Как видно, разброс не очень',\n",
       " ('Google (компания)',\n",
       "  29,\n",
       "  1): 'велик. Среди высших руководителей «коэффициенты обновления» в этот раз немного выше, чем среди остальных директоров (39,6% против 37,7%), что не очень характерно (обычно они ниже), но не выходит за рамки статистической погрешности. Больше всего топ-менеджеров в рейтинге «Топ-1000» сменилось в сегменте «Онлайн-платформы» (71,4%), что также укладывается в концепцию «цифровой трансформации», и в машиностроении (62,5% — нетипично высокий показатель для отрасли; не исключено, что это связано со сменой кабинета министров в 2020 году). Среди наиболее «консервативных» в данном плане отраслей — показавшие в прошлом и текущем годах очень неплохие результаты металлургия (11,1% новых имен) и фармацевтика (22,2%), а также традиционно консервативное сельское хозяйство (16,7%). Смотрите, кто ушел В списке бизнес-лидеров, подготовленном Ассоциацией менеджеров, общее количество капитанов отечественной экономики по сравнению с прошлым годом почти не изменилось. Их стало 47 вместо 46: появились 2 новых лидера, один покинул список. В этом плане ситуация напоминает пандемийную стагнацию, характерную в текущем году для «Топ-1000» в целом. Другое дело, что существенные изменения в списке бизнес-лидеров наблюдались лишь однажды — по итогам 2017 года, когда за счет изменения методики их число резко увеличилось: с 28 до 42 (в частности, в список были включены люди, оказывающие влияние на общественные настроения, такие как, например, руководители СМИ). Потом эта тенденция стала сходить на нет: по итогам 2018-го было пять новых имен (при одном выбывшем), по итогам 2019-го — три новых имени, столько же руководителей компаний покинули список. По итогам 2020 года, в нынешнем рейтинге, в список бизнес-лидеров вошли председатель правления «Фосагро» Андрей Гурьев и гендиректор ДОМ.РФ Виталий Мутко. Появление в числе бизнес-лидеров Андрея Гурьева, видимо, является признанием успехов отечественной химической промышленности со стороны формировавших рейтинг АМР экспертов, а также их желанием подобрать достойную компанию присутствующему в данном списке уже не первый год совладельцу «Еврохима» Андрею Мельниченко. Что касается экс-министра спорта и экс-вице-премьера правительства России Виталия Мутко, назначенного гендиректором ДОМ.РФ в начале 2020-го, то нельзя не признать, что одним из ключевых проектов господдержки экономики пандемийного прошлого года стала программа льготной ипотеки, в которой ДОМ.РФ играл ключевую роль. И символическим можно считать исключение из данного списка Анатолия Чубайса, входившего в него все годы существования рейтинга бизнес-лидеров. Формальная причина очевидна: в конце 2020-го он покинул пост главы «Роснано» и был назначен спецпредставителем президента России по связям с международными организациями для достижения целей устойчивого развития, то есть перестал быть бизнесменом. Нельзя не отметить, что именно благодаря Анатолию Чубайсу, который считается «отцом» российской приватизации, и появилась возможность формирования подобных списков бизнес-лидеров, не говоря уже о том, что многие члены данного списка попали в него именно потому, что сформировали капитал именно в эпоху той самой приватизации. Петр Рушайло, Марина Кочетова Бизнес-лидеры (в алфавитном порядке) Фамилия ИО Должность Компания Абрамович Роман Аркадьевич Предприниматель Авен Петр Олегович Председатель совета директоров банка, председатель совета директоров ABH Holdings S.A. Альфа-банк Алекперов Вагит Юсуфович Президент, исполнительный член совета директоров, председатель правления ЛУКОЙЛ Белозеров Олег Валентинович Генеральный директор—председатель правления «Российские железные дороги» Богданов Владимир Леонидович Генеральный директор и совладелец «Сургутнефтегаз» Вексельберг Виктор Феликсович Председатель совета директоров Группа компаний «Ренова» Венедиктов Алексей Алексеевич Главный редактор Радиостанция «Эхо Москвы» Волож Аркадий Юрьевич Сооснователь и генеральный директор Группа компаний «Яндекс» Греф Герман Оскарович Президент, председатель правления Сбербанк России Гурьев Андрей Андреевич Председатель правления, генеральный директор, член совета директоров «Фосагро» Дерипаска Олег Владимирович Владелец, председатель наблюдательного совета «Базовый элемент» Дуров Павел Валерьевич Основатель Telegram Евтушенков Владимир Петрович Председатель совета директоров, неисполнительный директор, председатель комитета по стратегии АФК «Система» Задорнов Михаил Михайлович Президент—председатель правления банка Банк «Открытие» Иванов Сергей Сергеевич Президент АК АЛРОСА Ивлев Александр Владимирович Управляющий партнер EY по странам СНГ, заместитель руководителя по работе с клиентами по странам Центральной, Восточной, Юго-Восточной Европы и Центральной Азии EY Касперский Евгений Валентинович Генеральный директор «Лаборатория Касперского» Конов',\n",
       " ('Google (компания)',\n",
       "  29,\n",
       "  2): 'Дмитрий Владимирович Председатель правления «СИБУР Холдинг» Костин Андрей Леонидович Президент—председатель правления, член наблюдательного совета, председатель комитета по стратегии и корпоративному управлению Банк ВТБ Линник Виктор Вячеславович Президент агрохолдинга «Мираторг» Лисин Владимир Сергеевич Председатель совета директоров Новолипецкий металлургический комбинат Лихачев Алексей Евгеньевич Генеральный директор Государственная корпорация по атомной энергии «Росатом» Мазепин Дмитрий Аркадьевич Председатель совета директоров Объединенная химическая компания «Уралхим» Махмудов Искандар Кахрамонович Президент Уральская горно-металлургическая компания Мельниченко Андрей Игоревич Совладелец «Еврохим», Сибирская угольная энергетическая компания Миллер Алексей Борисович Председатель правления, заместитель председателя совета директоров «Газпром» Михайлов Сергей Владимирович Генеральный директор Информационное агентство России ТАСС Михельсон Леонид Викторович Председатель правления НОВАТЭК Мордашов Алексей Александрович Председатель совета директоров «Северсталь» Мутко Виталий Леонтьевич Генеральный директор ДОМ.РФ Пономаренко Александр Анатольевич Председатель совета директоров Международный аэропорт Шереметьево Потанин Владимир Олегович Президент—председатель правления компании «Норникель»; основатель и президент ХК «Интеррос» «Норникель», ХК «Интеррос» Рашников Виктор Филиппович Председатель совета директоров, председатель комитета по стратегическому планированию ММК Ротенберг Аркадий Романович Частный инвестор Сечин Игорь Иванович Главный исполнительный директор, председатель правления, заместитель председателя совета директоров НК «Роснефть» Симоньян Маргарита Симоновна Главный редактор Медиагруппа «Россия сегодня» Слюсарь Юрий Борисович Генеральный директор Объединенная авиастроительная корпорация Стрешинский Иван Яковлевич Генеральный директор «ЮэСэМ Телеком» Тимченко Геннадий Николаевич Основатель и акционер Volga Group Тиньков Олег Юрьевич Председатель совета директоров Тинькофф-банк Тынкован Александр Анатольевич Председатель правления и президент Группа «М.Видео—Эльдорадо» Усманов Алишер Бурханович Основатель Холдинговая компания ЮэСэМ Фридман Михаил Маратович Председатель наблюдательного совета консорциума «Альфа-групп» Фролов Александр Владимирович Член совета директоров ЕВРАЗ Хан Герман Борисович Совладелец LetterOne Holdings и «Альфа-групп» LetterOne Holdings Чемезов Сергей Викторович Генеральный директор Государственная корпорация «Ростехнологии» Шувалов Игорь Иванович Председатель Государственная корпорация развития ВЭБ.РФ Высшие руководители. Топ-250 Место ФИО Должность Компания Информационные технологии 1 Добродеев Борис Олегович Генеральный директор Mail.ru Group 2 Соловьева Юлия Дмитриевна Управляющий директор «Google Россия» 3 Касперская Наталья Ивановна Президент ГК InfoWatch 4 Бобровников Борис Леонидович Генеральный директор ИТ-компания КРОК 5 Щербаков Борис Иванович Вице-президент и генеральный директор Dell Technologies 6 Генс Филипп Георгиевич Президент ЛАНИТ 7 Сорокина Татьяна Борисовна Генеральный директор IBM в России 8 Филатов Андрей Викторович Генеральный директор SAP CIS 9 Рыжиков Сергей Владимирович Генеральный директор «1С-Битрикс» 10 Романенко Андрей Николаевич Генеральный директор «Эвотор» Белинский Алексей Анатольевич Генеральный директор CTRL2GO Калин Сергей Владимирович Президент «Открытые технологии» Митюков Андрей Алексеевич Генеральный директор, управляющий партнер IT-холдинг TalentTech Оселедько Сергей Леонидович Управляющий партнер «Нотамедиа» Соловьев Сергей Владимирович Генеральный директор Т1 Спиридонов Дмитрий Юрьевич Генеральный директор CloudPayments Хасьянова Гульнара Шамильевна Генеральный директор «Микрон» Коммерческие банки 1 Верхошинский Владимир Вячеславович Главный управляющий директор Альфа-банк 2 Руденко Дмитрий Васильевич Президент—председатель правления Почта-банк 3 Близнюк Станислав Викторович Председатель правления Тинькофф-банк 4 Зауэрс Дмитрий Владимирович Заместитель председателя правления Газпромбанк 5 Монин Сергей Александрович Председатель правления Райффайзенбанк 6 Поляков Илья Андреевич Председатель правления Росбанк 7 Пешнев-Подольский Дмитрий Игоревич Председатель правления Банк «Хоум Кредит» 8 Федорко Артем Николаевич Председатель правления БАНК ДОМ.РФ 9 Чижевский Илья Петрович Президент ОТП-банк 10 Филатов Илья Валентинович Председатель правления МТС-банк Гусев Дмитрий Владимирович Председатель правления Совкомбанк Лесная и лесоперерабатывающая промышленность 1 Шамолин Михаил Валерьевич Президент Segezha Group 2 Фришман Анатолий Семенович Генеральный директор «Свеза-Лес» Машиностроение 1 Хряпов Тимофей Владимирович Генеральный директор НПК «Объединенная вагонная компания» 2 Никипелов Андрей Владимирович Генеральный директор «Атомэнергомаш» 3 Сорокин Вадим Николаевич Президент Группа ГАЗ 4 Богатырев Борис Юрьевич Генеральный директор «Локотех» 5 Горбунов Андрей Валериевич Президент—генеральный директор «Автотор Холдинг Менеджмент» 6 Зайцев Олег Евгеньевич Генеральный директор «СТМ-Сервис» 7 Вандерплаетсе Йохан Президент Schneider Electric в России и СНГ 8 Кравченко Сергей Владимирович Президент The Boeing Company Медиабизнес 1 Молибог Николай Петрович Генеральный директор РБК 2 Муругов Вячеслав Александрович Генеральный директор «СТС Медиа» 3 Баланова Светлана Евгеньевна Генеральный директор Национальная Медиа Группа 4 Вайнштейн Тимур Леонидович Заместитель генерального директора—генеральный продюсер Телекомпания НТВ 5 Доронов Илья Алексеевич',\n",
       " ('Google (компания)',\n",
       "  29,\n",
       "  3): 'Исполнительный директор Телеканал РБК 6 Бергер Михаил Львович Генеральный директор ГК «Румедиа» (BusinessFM—BFM—«Радио Шоколад») 7 Герасимов Владимир Владимирович Первый заместитель генерального директора—исполнительный директор «Интерфакс» 8 Цыпер Андрей Сергеевич Исполнительный директор по медиа Rambler & Co 9 Яременко Николай Николаевич Генеральный директор—главный редактор Редакция газеты «Советский спорт» 10 Абашидзе Кахабер Генеральный директор The Walt Disney Company CIS LLC Благодыренко Андрей Александрович Директор Sputnik в странах ближнего зарубежья и Балтии Болтянский Борис Александрович Генеральный директор «Правовые новости» (Право.ru) Веснина Наталья Вячеславовна Генеральный директор Медиахолдинг Independent Media Геворкян Марина Александровна Генеральный директор «Сноб Медиа» Костин Юрий Алексеевич Генеральный директор «ГПМ Радио» Кухальский Ян Иванович Генеральный директор «Медиа-1» Малькевич Александр Александрович Генеральный директор Городское агентство по телевидению и радиовещанию Молодов Борис Викторович Управляющий партнер «Главный советник. Регион» Новиков Руслан Юрьевич Генеральный директор «Аргументы и факты» Слащева Юлиана Юрьевна Генеральный директор «Союзмультфильм» Сычев Максим Владимирович Директор Плеймейкер Толстоган Алексей Владимирович Генеральный директор Национальный рекламный альянс Металлургия и горнодобывающая промышленность 1 Никитин Евгений Викторович Генеральный директор «Русал» 2 Шевелев Александр Анатольевич Генеральный директор «Северсталь Менеджмент» 3 Сафин Денис Галялхакович Генеральный директор Загорский трубный завод 4 Несис Виталий Натанович Главный исполнительный директор «Полиметалл» 5 Шиляев Павел Владимирович Генеральный директор Магнитогорский металлургический комбинат 6 Грачев Павел Сергеевич Генеральный директор УК «Полюс» 7 Корытько Игорь Валерьевич Генеральный директор Трубная металлургическая компания 8 Коржов Олег Викторович Генеральный директор «Мечел» Многопрофильные холдинги 1 Зингман Вадим Яковлевич Президент «Альфа-групп» 2 Чирахов Владимир Санасарович Президент АФК «Система» 3 Шелопутов Вячеслав Александрович Генеральный директор Концерн «Россиум» 4 Судариков Сергей Николаевич Председатель совета директоров Группа компаний «Регион» 5 Илиопуло Андрей Андреевич Президент Группа компаний «Новард» Онлайн-платформы 1 Жуков Михаил Александрович Генеральный директор HeadHunter 2 Шульгин Александр Александрович Генеральный директор Ozon 3 Колесников Алексей Сергеевич Генеральный директор «Кухня на районе» 4 Алексеев Илья Петрович Генеральный директор «Спотифай» 5 Донмез Гюванч Генеральный директор «Деливери Клаб» 6 Крайнов Максим Юрьевич CEO «Авиасейлс» 7 Сморгонский Анатолий Валерьевич Генеральный директор Gett в России Gett 8 Курмангужин Асан Жасуланович СЕО «Сбермаркет» 9 Шаповалов Вадим Генеральный директор «Работа.ру» 10 Миндубаева Юлия Халиловна Генеральный директор Start Бедарев Виталий Евгеньевич Генеральный директор «Ситимобил» Крутов Дмитрий Валерьевич Генеральный директор Skillbox Снигирева Марианна Владимировна Генеральный директор «Нетология» Юнусова Динара Абдульберовна Генеральный директор Финансовый супермаркет «Банки.ру» Производство потребительских товаров 1 Кузьмина Регина Юрьевна Президент в России, Украине и Беларуси Unilever 2 Ружевич Александар Генеральный директор «Coca-Cola HBC Россия» 3 Рам Мохан Ашок Президент Аффилированные компании «Филип Моррис Интернэшнл» в России 4 Маринидис Сотириос Старший вице-президент, глава в Восточной Европе Procter & Gamble 5 Щапов Валерий Владимирович Президент Mars 6 Ершов Роман Владимирович Генеральный директор Торговый дом «Аскона» 7 Соколов Артем Алексеевич CEO SOKOLOV jewelry 8 Капьев Евгений Викторович Генеральный директор Издательство «Эксмо» 9 Шпаков Дмитрий Александрович Президент AB InBev Efes 10 Марсий Андрей Жакович Генеральный директор Вологодский текстильный комбинат Родионов Александр Анатольевич Генеральный директор «Мон`дэлис Русь» Профессиональные услуги 1 Соломон Николай Иосифович Генеральный директор Федеральный центр компетенций 2 Федоров Валерий Валерьевич Генеральный директор Всероссийский центр изучения общественного мнения 3 Веселкова Екатерина Александровна Генеральный директор Сейлз-хаус «Газпром-медиа» 4 Максимовская Марианна Александровна Президент ГК «Михайлов и партнеры» 5 Фадеева Елена Николаевна Генеральный директор FleishmanHillard Vanguard 6 Баранников Андрей Петрович Генеральный директор SPN Communications 7 Шапигузов Сергей Михайлович Президент, управляющий партнер ФБК Grant Thornton 8 Виноградов Владимир Геннадьевич Генеральный директор Pro-Vision Communications 9 Козлова Нина Андреевна Генеральный директор «Финэкспертиза» 10 Терехов Денис Эдуардович Генеральный директор Агентство «Социальные сети» Андреев Станислав Владимирович Генеральный директор «Сбермаркетинг» Балахнин Илья Александрович Управляющий партнер Paper Planes Борисов Константин Андреевич Генеральный директор Support Partners Глазова Лилия Ильдаровна Генеральный директор PR News Горохова Екатерина Юрьевна Генеральный директор Kelly Services Дашевская Ольга Аркадьевна Старший партнер Коммуникационное агентство PR Inc. Дмитриева* Наталья Викторовна Генеральный директор GPMD Долякова Татьяна Владимировна',\n",
       " ('Google (компания)',\n",
       "  29,\n",
       "  4): 'Генеральный директор ProPersonnel Донских Мария Евгеньевна CEO dentsu Russia Змеющенко Владимир Анатольевич Генеральный директор «ЛюдиPEOPLE» Карабанова Екатерина Владимировна Управляющий партнер Ventra Кицура Анатолий Анатольевич Генеральный директор «Бизнес Диалог» Комарова Мария Александровна Генеральный директор «Гэллэри Сервис» Коулберн Иан Главный исполнительный директор «Делойт», СНГ Кремер Алена Игоревна Управляющий партнер DPG Russia Лащевский Вячеслав Викторович Председатель совета директоров Коммуникационная группа АГТ Литинецкая Мария Александровна Управляющий партнер «Метриум» Маслов Михаил Александрович Генеральный директор Ketchum Мельников Вадим Вячеславович Генеральный директор Коммуникационное агентство ДБО Минченко Евгений Николаевич Президент «Минченко Консалтинг» Никитин Максим Юрьевич Управляющий партнер Агентство специальных поручений Писарский Игорь Владимирович Председатель совета директоров Коммуникационное агентство Р.И.М. Рудакова Лариса Анатольевна Президент Коммуникационная группа «Медиалайн» Рябокобылко Сергей Юрьевич Управляющий партнер, генеральный директор Cushman & Wakefield Сафронов Алексей Владимирович Председатель совета директоров Elefante Porter Novelli Сидоренко Валерий Геннадьевич Генеральный директор Digital-агентство «Интериум» Слагода Сергей Константинович Старший партнер Адвокатское бюро «S&K Вертикаль» Стюарт Элла Владимировна Главный управляющий директор BBDO Group Топильская Дарья Александровна Генеральный директор Национальный центр промышленного дизайна и инноваций 2050.ЛАБ Тышковский Роман Александрович Управляющий партнер Odgers Berndtcon Шнайдер Ульф Президент Schneider Group Связь и телекоммуникации 1 Корня Алексей Валерьевич Председатель правления—gрезидент МТС 2 Торбахов Александр Юрьевич Генеральный директор «Вымпелком» («Билайн») 3 Кузяев Андрей Равелевич Президент «ЭР-Телеком» 4 Кравцов Роман Васильевич Генеральный директор Компания «Транстелеком» 5 Чуб Александр Витальевич Президент «Русские башни» Сельское хозяйство 1 Басов Максим Дмитриевич Генеральный директор Группа компаний «Русагро» 2 Михайлов Сергей Игоревич Генеральный директор Группа «Черкизово» 3 Недужко Андрей Михайлович Генеральный директор Агрохолдинг «Степь» 4 Мак Фарлан Стефан Генеральный директор Группа компаний «РЗ Агро» 5 Гидирим Патрик Джордж Управляющий директор «Агротерра» 6 Мерзляков Сергей Владимирович Генеральный директор Русская торфяная компания Сервис 1 Брусилова Елена Анатольевна Президент Группа компаний «Медси» 2 Полякова Раиса Тельмановна Генеральный директор в России и СНГ Yum! Brands (KFC) 3 Демура Тарас Александрович Генеральный директор «TUI Россия» 4 Карена Марк Генеральный директор «Макдоналдс Россия» 5 Прянишников Николай Николаевич Генеральный директор World Class 6 Круковский Андрей Алексеевич Генеральный директор «Красная поляна» 7 Кожевников Михаил Юрьевич Президент Группа компаний «Просвещение» 8 Швецов Денис Евгеньевич Генеральный директор МК «Доктор рядом» 9 Курцер Марк Аркадьевич Генеральный директор ГК «Мать и дитя» 10 Зингер Анатолий Сергеевич Генеральный директор «Сберздоровье» Бекренев Сергей Сергеевич Президент Европейская юридическая служба Левин Юрий Генрихович Ректор Московская школа управления «Сколково» Ордовский-Танаевский Бланко Ростислав Вадимович Президент «Ростик Групп» Пехова Инна Николаевна Генеральный директор Venedi Hotel Group Страхование 1 Скворцов Владимир Юрьевич Генеральный директор «АльфаСтрахование» 2 Гадлиба Юлия Олеговна генеральный директор Группа «Ренессанс страхование» 3 Гальперин Геннадий Аронович Генеральный директор «Росгосстрах» 4 Волков Михаил Юрьевич Генеральный директор «Сбербанк страхование» 5 Руденко Алексей Викторович Генеральный директор Страховая компания «Росгосстрах Жизнь» 6 Тарновский Александр Яковлевич Генеральный директор Страховой дом ВСК 7 Тихонова Майя Александровна Генеральный директор Страховая компания «Согласие» Строительство и девелопмент 1 Молчанов Андрей Юрьевич Генеральный директор Группа ЛСР 2 Гордеев Сергей Эдуардович Генеральный директор ПИК 3 Голубицкий Вениамин Максович Президент «Кортрос» 4 Адамов Виктор Евгеньевич Генеральный директор ГК «Галс» 5 Щербина Геннадий Филиппович Президент Группа «Эталон» 6 Елистратов Антон Николаевич Генеральный директор ГК «Самолет» 7 Николаев Александр Леонидович Президент «Интеко» 8 Борисенко Антон Владимирович Генеральный директор «Сити-XXI век» 9 Лунтовский Андрей Георгиевич Генеральный директор Управляющая компания «Динамо» 10 Гейзер Максим Георгиевич Генеральный директор Stone Hedge Мутлу Али Ихсан Генеральный директор Renaissance Development Становова Валентина Степановна Генеральный директор Capital Group Торговля 1 Изосимов Александр Вадимович Генеральный директор Группа «М.Видео—Эльдорадо» 2 Шехтерман Игорь Владимирович Главный исполнительный директор X5 Group 3 Дюннинг Ян Гезинюс Президент, генеральный директор «Магнит» 4 Дефассье Лоран Луи Клод Генеральный директор «Леруа Мерлен Восток» 5 Соколова Алла Вадимовна Генеральный директор «Мэри Кэй» 6 Гончаров Сергей Владимирович Главный директор Торговая сеть «Пятерочка» 7 Шумахер Мартин Арнольд Бенедикт Генеральный директор Metro 8 Курбатов Владислав',\n",
       " ('Google (компания)',\n",
       "  29,\n",
       "  5): 'Александрович Генеральный директор Торговая сеть «Перекресток» 9 Буздалин Антон Романович Генеральный директор «еАптека» 10 Егорова Тамара Николаевна Исполнительный директор «Никамед» Давыдова Мария Сергеевна Генеральный директор ГК «Детский мир» Калмис Джери Кристофер Генеральный директор Lamoda Карпова Анастасия Геннадьевна Генеральный директор «Эркафарм» Кузин Александр Владимирович Генеральный директор Аптечная сеть 36,6 Сологуб Денис Николаевич Президент «Азбука вкуса» Филиппов Александр Павлович Генеральный директор Аптечная сеть «Ригла» Транспорт 1 Василенко Михаил Михайлович Генеральный директор Международный аэропорт Шереметьево 2 Гончаров Константин Анатольевич Президент Группа компаний «Новотранс» 3 Каратаев Сергей Михайлович Генеральный директор Первая грузовая компания 4 Гольдорт Леонид Яковлевич Генеральный директор «СДЭК-Глобал» 5 Воронович Виктор Казимирович Генеральный директор Федеральная грузовая компания 6 Бисембаева Алина Маратовна Генеральный директор «Аэроэкспресс» 7 Барбариуш Алексей Алексеевич Генеральный директор «Транслес» 8 Мурев Дмитрий Иовчович Генеральный директор «РЖД Логистика» 9 Коростелев Аркадий Николаевич Президент Транспортная группа Fesco 10 Сергеев Леонид Владимирович Генеральный директор «Воздушные ворота северной столицы» Калетин Сергей Владимирович Генеральный директор «СГ-транс» Шпаков Валерий Васильевич Генеральный директор Новая перевозочная компания Фармацевтика 1 Морозов Дмитрий Валентинович Генеральный директор Biocad 2 Музяев Вадим Геннадиевич Президент «Протек» 3 Штефан Эдер Исполнительный вице-президент в России и СНГ Stada 4 Родионов Петр Петрович Генеральный директор «Герофарм» 5 Литвинова Елена Юрьевна Генеральный директор «Новамедика» 6 Бучнева Валентина Николаевна Глава бизнес-подразделения «Евразия» «Босналек» 7 Патруйярд Эрик Жан Франсуа Генеральный директор Pfizer 8 Погодина Екатерина Борисовна Генеральный директор «Джонсон & Джонсон» 9 Монж Оксана Анатольевна Генеральный директор «Санофи» УК в финансовом секторе 1 Елинсон Андрей Михайлович Управляющий партнер А1 2 Кривошеева Ирина Владимировна Генеральный директор УК «Альфа-Капитал» 3 Зайцева Екатерина Александровна Генеральный директор УК «Регион Эссет Менеджмент» 4 Зайцев Евгений Юрьевич Генеральный директор «Сбер Управление Активами» 5 Бусаров Игорь Геннадьевич Генеральный директор УК «Система Капитал» 6 Бирман Александр Петрович Генеральный директор Управляющая компания «Финам Менеджмент» 7 Филатов Дмитрий Александрович Президент Sistema Venture Capital Финансовый сектор 1 Потапов Владимир Михайлович Главный исполнительный директор «ВТБ Капитал Инвестиции» 2 Малиновский Алексей Владимирович Старший вице-президент, глава MasterCard в России MasterCard 3 Денисов Юрий Олегович Председатель правления Московская биржа 4 Сагдиев Асхат Жансерикович Генеральный директор «Универ Капитал» 5 Бугаенко Дмитрий Витальевич Управляющий партнер ИК «Велес Капитал» 6 Менжинский Сергей Юрьевич Председатель совета директоров Инвестиционная компания «Регион» 7 Соколов Александр Константинович Президент—председатель правления Банк непрофильных активов «Траст» 8 Спиров Вячеслав Юрьевич Генеральный директор «Сбербанк Лизинг» 9 Ильин Денис Вячеславович Заместитель председателя правления Евразийский банк развития 10 Морозова Галина Владимировна Председатель совета директоров НПФ «Будущее» Бычков Александр Петрович Президент—генеральный директор ИК «Русс-Инвест» Горчаковская Лариса Алексеевна Генеральный директор НПФ «ВТБ Пенсионный фонд» Зарецкий Александр Михайлович Генеральный директор НПФ Сбербанка Ивантер Дмитрий Евгеньевич Генеральный директор «ВТБ Лизинг» Кочетков Владислав Вячеславович Президент—председатель правления «Финам» Химическая промышленность 1 Рашевский Владимир Валерьевич Генеральный директор МХК «Еврохим» 2 Куницкий Владимир Яковлевич Президент, генеральный директор «Акрон» 3 Лаук Виталий Викторович Генеральный директор «Уралкалий» 4 Рериг Кристоф Дитер Глава BASF в России и СНГ BASF Энергетика и топливный комплекс 1 Ковальчук Борис Юрьевич Генеральный директор «Интер РАО» 2 Вагнер Андрей Александрович Генеральный директор «Т Плюс» 3 Хардиков Михаил Юрьевич Генеральный директор «Евросибэнерго» 4 Назаралиев Ислам Замирович Генеральный директор «Нафтагаз» Финансовые директора. Топ-100 Место ФИО Должность Компания Информационные технологии 1 Милинова Елена Михайловна Финансовый директор «Лаборатория Касперского» 2 Рубцов Федор Евгеньевич Финансовый директор Mail.ru Group 3 Михайлов Александр Георгиевич Финансовый директор «Ланит» 4 Хюберт Алексей Андреевич Финансовый директор SAP CIS 5 Салахов Ильдар Ринатович Вице-президент по финансам и инвестициям «Элемент» Садовникова Галина Михайловна Директор по экономическим вопросам развития бизнеса ИТ-компания КРОК Коммерческие банки 1 Чухлов Алексей Евгеньевич Главный финансовый директор, заместитель председателя правления Альфа-банк 2 Пьянов Дмитрий Васильевич Член правления Банк ВТБ 3 Левин Дмитрий Олегович Первый заместитель председателя правления Банк «ФК Открытие» 4 Бурико Александра Юрьевна Старший вице-президент, руководитель блока «Финансы» Сбербанк 5 Строкун',\n",
       " ('Google (компания)',\n",
       "  29,\n",
       "  6): 'Наталия Николаевна Финансовый директор Почта-банк Коликова Ирина Валерьевна Финансовый директор Банк «Хоум Кредит» Стырин Константин Юрьевич Заместитель председателя правления Российский сельскохозяйственный банк Лесная и лесоперерабатывающая промышленность 1 Алиев Ровшан Бейлярович Вице-президент по финансам и инвестициям Segezha Group Машиностроение 1 Палунин Дмитрий Николаевич Заместитель генерального директора по экономике и финансам Концерн «Калашников» 2 Малыгина Ольга Сергеевна Старший вице-президент—директор по экономике и финансам «Автотор Холдинг» 3 Бринза Александр Валентинович Заместитель генерального директора по экономике и финансам НПК «Объединенная вагонная компания» Медиабизнес 1 Маляревская Любовь Аркадьевна Заместитель генерального директора по экономике и финансам Русская Медиагруппа 2 Руденко Елена Кирилловна Заместитель генерального директора Информационное агентство России ТАСС 3 Киселев Кирилл Александрович Директор по экономике и финансам Медиагруппа «Россия сегодня» 4 Бойцов Никита Михайлович Заместитель генерального директора по финансам РБК 5 Кононов Илья Борисович Заместитель генерального директора по финансам ГК «Румедиа» (BusinessFM—BFM—«Радио Шоколад») Бегишев Равиль Эрикович Финансовый директор медиахолдинга Медиахолдинг Independent Media Протасов Денис Сергеевич Вице-президент, руководитель департамента стратегии и финансов The Walt Disney Company CIS LLC Металлургия и горнодобывающая промышленность 1 Куличенко Алексей Геннадьевич Заместитель генерального директора по финансам и экономике «Северсталь» 2 Малышев Сергей Геннадьевич Старший вице-президент—финансовый директор «Норникель» 3 Иванов Николай Владимирович Вице-президент по финансам ЕВРАЗ 4 Шхиянц Юлия Игоревна Финансовый директор Объединенная металлургическая компания 5 Воронов Алексей Борисович Заместитель генерального директора по финансам и экономике УК «Металлоинвест» Еремин Андрей Анатольевич Директор по экономике Магнитогорский металлургический комбинат Курмашов Шамиль Равильевич Вице-президент по финансам НЛМК Назимок Максим Анатольевич Заместитель генерального директора по финансам «Полиметалл» Стискин Михаил Борисович Старший вице-президент по финансам и стратегии УК «Полюс» Многопрофильные холдинги 1 Зиновьева Ольга Николаевна Первый заместитель генерального директора, заместитель председателя правления Холдинговая компания «Интеррос» 2 Травков Владимир Сергеевич Вице-президент по финансам АФК «Система» Онлайн-платформы 1 Федоров Даниил Александрович Финансовый директор Ozon 2 Моисеев Григорий Юрьевич Финансовый директор HeadHunter Профессиональные услуги 1 Горшкова Наталья Викторовна Финансовый директор Kelly Services 2 Кусембаева Асель Бекетовна Руководитель финансовой службы EY 3 Чесных Александр Владимирович Заместитель генерального директора по экономике и финансам «Финэкспертиза» 4 Ломизе Сергей Львович Финансовый директор ФБК Grant Thornton 5 Сурикова Людмила Ивановна Финансовый директор GPMD Алексеев Тимофей Викторович Директор по инвестициям и экономическому развитию Ventra Связь и телекоммуникации 1 Суриков Николай Анатольевич Заместитель генерального директора по экономике и финансам Tele2 2 Каменский Андрей Михайлович Вице-президент по финансам МТС 3 Михайлов Дмитрий Валерьевич Финансовый директор «Русские башни» 4 Калмыков Константин Сергеевич Заместитель генерального директора по экономике и финансам Компания «Транстелеком» Сельское хозяйство 1 Михайлова Людмила Ильинична Финансовый директор Группа «Черкизово» 2 Платошин Василий Васильевич Директор по экономике и финансам Агрохолдинг «Степь» 3 Щащаев Алексей Орджоникидзевич Финансовый директор Группа компаний «РЗ Агро» 4 Черничер Борис Александрович Финансовый директор Группа компаний «Русагро» Сервис и производство потребительских товаров 1 Ковалышко Александр Александрович Заместитель генерального директора по финансам и стратегии ФК «Динамо-Москва» 2 Шакирова Ольга Владимировна Директор по финансам и инвестициям Группа компаний «Медси» 3 Васильев Юрий Михайлович Вице-президент по финансам Unilever 4 Федосов Илья Валентинович Финансовый директор в России, СНГ, Центральной и Восточной Европе Yum! Brands (KFC) 5 Силкина Елена Владимировна Финансовый директор МК «Доктор рядом» Блинов Алексей Вячеславович Старший финансовый директор, Восточная Европа «Мон`дэлис Русь» Горская Татьяна Владимировна Финансовый директор Издательство АСТ Кирюхин Алексей Иванович Директор отдела сервиса и финансов Mars Petcare в России Mars Лашков Иван Николаевич Финансовый директор Торговый дом «Аскона» Яночкина Екатерина Сергеевна Главный финансовый директор Московская школа управления «Сколково» Страхование 1 Ковтун Сергей Геннадиевич Заместитель генерального директора по финансово-экономической деятельности «Ингосстрах» 2 Маммадова Вера Александровна Финансовый директор «АльфаСтрахование» 3 Абрамова Надежда Сергеевна Заместитель генерального директора по экономике и финансам Страховой дом ВСК 4 Решетин Евгений Андреевич Заместитель генерального директора по финансам «Росгосстрах» Строительство и девелопмент 1 Ильин Юрий Юрьевич Вице-президент по рынкам капитала и корпоративным финансам',\n",
       " ('Google (компания)',\n",
       "  29,\n",
       "  7): 'ПИК 2 Косолапов Илья Викторович Вице-президент по экономике и финансам Группа «Эталон» 3 Заболотнева Марина Викторовна Заместитель генерального директора, финансовый и административный директор Группа компаний МИЦ Торговля 1 Соколова Екатерина Феликсовна Финансовый директор Группа «М.Видео—Эльдорадо» 2 Ярина Екатерина Михайловна Финансовый директор Simple Group 3 Саверо Фредерик Ален Ив Финансовый директор «Леруа Мерлен Восток» 4 Иванов Дмитрий Анатольевич Финансовый директор «Магнит» 5 Ланцева Евгения Валентиновна Управляющий финансовый директор Lamoda Борисов Роман Валерьевич Финансовый директор «реСтор» Гарманова* Анна Сергеевна Финансовый директор ГК «Детский мир» Лубнина Виктория Казимировна Старший вице-президент по финансам «Азбука вкуса» Транспорт 1 Михайлов Вадим Валерьевич Первый заместитель генерального директора «Российские железные дороги» 2 Скачков Павел Алексеевич Вице-президент по экономике и финансам «Трансконтейнер» 3 Шиповская Наталья Ивановна Заместитель генерального директора по экономике и финансам Федеральная грузовая компания 4 Чиханчин Андрей Юрьевич Заместитель генерального директора по финансам и коммерции «Аэрофлот — российские авиалинии» 5 Митяева Елена Аркадьевна Директор по экономике и финансам Группа компаний «Новотранс» Фармацевтика 1 Каганова Светлана Юрьевна Руководитель финансового отдела Pfizer 2 Макарова Мария Владимировна Заместитель генерального директора, CFO «Новамедика» Финансовый сектор 1 Лапин Максим Вячеславович Финансовый директор Московская биржа 2 Горшков Алексей Владимирович Заместитель генерального директора—директор казначейства «Универ Капитал» 3 Лерман Филипп Александрович Член правления Банк непрофильных активов «Траст» 4 Шлепов Виктор Игоревич Финансовый директор ДОМ.РФ 5 Астахов Алексей Владимирович Финансовый директор ИК «Велес Капитал» Будаков Василий Васильевич Финансовый директор «Сбер Управление активами» Гришина Елена Владимировна Финансовый директор «Ренессанс Капитал — Финансовый консультант» Киркоров Алексей Николаевич Заместитель генерального директора, финансовый директор Сбербанк Лизинг Лазарева Ольга Андреевна CFO Sistema Venture Capital Судец Евгения Леонидовна Советник генерального директора «ВТБ Лизинг» Тухтаева Джаннат Рахматуллаевна Финансовый директор Инвестиционная компания «Регион» Химическая промышленность 1 Петров Александр Анатольевич Управляющий директор по экономике и финансам** «СИБУР Холдинг» 2 Буланцев Игорь Владимирович Заместитель генерального директора—директор по экономике и финансам ОХК «Уралхим» 3 Вищаненко Антон Владимирович Директор по экономике и финансам «Уралкалий» Энергетика и топливный комплекс 1 Янкевич Алексей Викторович Заместитель генерального директора по экономике и финансам «Газпром нефть» 2 Мирошниченко Евгений Николаевич Руководитель Финансово-экономического центра «Интер РАО» 3 Матыцын Александр Кузьмич Первый вице-президент ЛУКОЙЛ Коммерческие директора. Топ-100 Место ФИО Должность Компания Информационные технологии 1 Алексеева Ирина Георгиевна Коммерческий директор Mail.ru Group 2 Никулин Игорь Викторович Директор департамента продаж и менеджмента проектов ИТ-компания КРОК 3 Дмитриев Александр Сергеевич Операционный директор CTRL2GO Коммерческие банки 1 Тач Майкл Борис Директор по розничному бизнесу, заместитель председателя правления Альфа-банк 2 Ведяхин Александр Александрович Первый заместитель председателя правления Сбербанк 3 Тулубьев Павел Андреевич Заместитель президента—председателя правления Почта-банк 4 Антоненко Александр Владимирович Заместитель председателя правления банка Банк «Хоум Кредит» 5 Литвинов Данила Владимирович Заместитель председателя правления БАНК ДОМ.РФ Лесная и лесоперерабатывающая промышленность 1 Харитонов Александр Владимирович Вице-президент по коммерческой деятельности Segezha Group Машиностроение 1 Амоскин Игорь Вячеславович Вице-президент по рынку «Промышленность» Schneider Electric в России и СНГ 2 Ранцев Александр Юрьевич Первый заместитель генерального директора по атомной энергетике и новым бизнесам «Атомэнергомаш» 3 Кузнецова Мария Викторовна Вице- президент по организации внешнеэкономической деятельности—коммерческий директор «Автотор Холдинг» Медиабизнес 1 Груздев Дмитрий Николаевич Заместитель главного редактора Медиагруппа «Россия сегодня» 2 Гурей Людмила Анатольевна Коммерческий директор РБК 3 Ланюгова Светлана Николаевна Коммерческий директор Информационное агентство России ТАСС 4 Гемст Владислав Александрович Первый заместитель генерального директора Медиагруппа «Комсомольская правда» 5 Гайдебурова Дана Григорьевна Коммерческий директор ГК «Румедиа (BusinessFM—BFM—«Радио Шоколад») Гандрабура Мария Михайловна Директор департамента партнерских проектов МИЦ «Известия» Зубкова Виолетта Валерьевна Коммерческий директор «Медиа-1» Лобачева Елена Сергеевна Заместитель генерального директора по продажам Национальный рекламный альянс Ломтев Виталий Витальевич Вице-президент, руководитель департамента медиадистрибуции и интерактивных проектов The Walt Disney Company CIS LLC Мишункина Марина Николаевна Первый заместитель генерального директора «Аргументы и факты» Пинчук Артем Андреевич Директор Объединенной службы продаж и маркетинга «Интерфакс» Филимонова Ирина Викторовна Коммерческий директор группы',\n",
       " ('Google (компания)',\n",
       "  29,\n",
       "  8): 'проектов Cosmopolitan Медиахолдинг Independent Media Чибисов Владимир Геннадьевич Коммерческий директор «Союзмультфильм» Металлургия и горнодобывающая промышленность 1 Широкоброд Илья Олегович Вице-президент по продажам и логистике ЕВРАЗ 2 Ненашев Сергей Александрович Коммерческий директор Магнитогорский металлургический комбинат 3 Ицков Феликс Юрьевич Вице-президент по коммерции и логистике УК «Полюс» 4 Овчинников Юрий Борисович Управляющий директор торгового дома «Полиметалл» 5 Селезнева Елена Юрьевна Заместитель генерального директора по коммерческой деятельности «Мечел» Онлайн-платформы 1 Пантелеев Андрей Дмитриевич Директор департамента коммерческих операций HeadHunter 2 Посредников Михаил Игоревич Коммерческий директор ЦИАН 3 Корицкий Владимир Александрович Коммерческий директор «Работа.ру» 4 Бегус Татьяна Петровна Коммерческий директор Финансовый супермаркет «Банки.ру» 5 Казаков Артем Юрьевич Коммерческий директор Skillbox Профессиональные услуги 1 Ефимова Алина Ивановна Заместитель генерального директора по продажам Сейлз-хаус «Газпром-медиа» 2 Щербакова Наталья Сергеевна Директор по продажам и маркетингу Ancor 3 Кинд* Екатерина Юрьевна Коммерческий директор GPMD Связь и телекоммуникации 1 Галактионова Инесса Васильевна Первый вице-президент по телекоммуникационному бизнесу МТС 2 Вольфсон Влад Коммерческий директор «МегаФон» 3 Майстренко Игорь Николаевич Заместитель генерального директора по продажам и развитию массового рынка Tele2 4 Волков* Михаил Юрьевич Заместитель генерального директора по операционному управлению и розничной торговле «Почта России» 5 Хелд Джордж Исполнительный вице-президент по развитию цифрового и нового бизнеса «Вымпелком» («Билайн») Нелюбов Дмитрий Валентинович Заместитель генерального директора, коммерческий директор «Русские башни» Сельское хозяйство 1 Заков Олег Леонидович Директор торгового дома Группа «Черкизово» Сервис и производство потребительских товаров 1 Косьер Владимир Директор по продажам «Coca-Cola HBC Россия» 2 Васильев Андрей Николаевич Вице-президент по продажам Unilever 3 Канунникова Алла Владимировна Директор по коммерческой деятельности и маркетингу Группа компаний «Медси» 4 Палий Валерия Вадимовна Директор рынка сегмента «Продукты питания» Mars 5 Рубцов Владимир Игоревич Коммерческий директор «TUI Россия» Доттер Александр Александрович Директор департамента оптово-розничных продаж Группа компаний «Просвещение» Каманина Наталья Львовна Коммерческий директор Swissotel Krasnye Holmy Moscow Ким Александр Анатольевич Проректор по финансам и развитию бизнеса Московская школа управления «Сколково» Корчагов Владимир Викторович Исполнительный директор Торговый дом «Аскона» Ориновский Александр Михайлович Управляющий директор «Сберздоровье» Пичугин Сергей Юрьевич Директор департамента по лицензированию и работе с розницей The Walt Disney Company EMEA Широян Арсен Сумбатович Директор по продажам МК «Доктор рядом» Страхование 1 Сорокина Ольга Николаевна Заместитель генерального директора по развитию бизнеса Страховой дом ВСК 2 Пушкарев Максим Сергеевич Первый заместитель генерального директора, директор партнерских продаж Страховая компания «Росгосстрах Жизнь» 3 Мартьянов Андрей Александрович Исполнительный директор МАКС 4 Кривошеев Виктор Алексеевич Первый заместитель генерального директора «Абсолют Страхование» Строительство и девелопмент 1 Волков Дмитрий Валерьевич Управляющий директор ГК «Самолет» 2 Семенов Евгений Андреевич Первый вице-президент, исполнительный директор «Интеко» 3 Исаев Петр Викторович Коммерческий директор Capital Group 4 Тумайкина Ольга Витальевна Коммерческий директор ГК ФСК 5 Соловьева Ирина Игоревна Коммерческий директор Группа «Эталон» Голышева Елизавета Сергеевна Директор по управлению активами и аренде Metrika Investments Торговля 1 Артюшкина Александра Андреевна Управляющий коммерческий директор Lamoda 2 Муравьев Олег Васильевич Коммерческий директор Группа «М.Видео—Эльдорадо» 3 Вальков Виталий Анатольевич Коммерческий директор Торговая сеть «Пятерочка» 4 Володина Мария Валериевна Коммерческий директор по направлению «Одежда и обувь» ГК «Детский мир» 5 Медведев Дмитрий Владимирович Коммерческий директор Торговая сеть «Перекресток» Даниелян Армине Самвеловна Коммерческий директор «Эркафарм» Транспорт 1 Шило Алексей Николаевич Заместитель генерального директора—начальник Центра фирменного транспортного обслуживания «Российские железные дороги» 2 Толстобров Максим Владимирович Коммерческий директор «СДЭК-Глобал» 3 Воронин Леонид Анатольевич Первый заместитель генерального директора Федеральная грузовая компания 4 Станиславский Вячеслав Леонидович Первый заместитель генерального директора Новая перевозочная компания 5 Брагин Алексей Игоревич Заместитель генерального директора по коммерции Ремонтная компания «Новотранс» Фармацевтика 1 Бахметьев Игорь Владимирович Коммерческий директор Stada 2 Верещагина Ольга Николаевна Директор департамента по развитию розничного, оптового и тендерного сегментов бизнеса «Сандоз» 3 Соколов Андрей Валерьевич Директор по операционной деятельности и стратегическому планированию «Босналек» 4 Свищенко Ярослав Юрьевич Руководитель коммерческих продаж «Берлин-Хеми/А.Менарини» Финансовый сектор 1 Марич',\n",
       " ('Google (компания)',\n",
       "  29,\n",
       "  9): 'Игорь Леонидович Управляющий директор по продажам и развитию бизнеса Московская биржа 2 Иванов Алексей Алексеевич Коммерческий директор «Универ Капитал» 3 Кириллова Ольга Игоревна Директор департамента корпоративного бизнеса «Сбербанк Лизинг» 4 Шиленков Евгений Викторович Заместитель генерального директора по активным операциям ИК «ВЕЛЕС Капитал» 5 Обухов Алексей Алексеевич Руководитель блока «Розничный бизнес» УК «Альфа-Капитал» Арутюнян Александр Тельманович Первый вице-президент—заместитель генерального директора ИК «Русс-Инвест» Бувин Дмитрий Александрович Коммерческий директор Национальная система платежных карт Люкманов Тимур Алиевич Директор ДОМ.РФ Татаринов Евгений Сергеевич Коммерческий директор «ВТБ Лизинг» Шкерин Егор Андреевич Коммерческий директор НПФ «Открытие» Элик Максим Эдуардович Первый заместитель генерального директора НПФ «Благосостояние» Химическая промышленность 1 Воронин Юрий Павлович Коммерческий директор ОХК «Уралхим» Энергетика и топливный комплекс 1 Орлов Дмитрий Станиславович Заместитель генерального директора, руководитель Блока розничного бизнеса «Интер РАО» 2 Пашаев Олег Давидович Старший вице-президент по поставкам и продажам ЛУКОЙЛ 3 Кадагидзе Леван Давидович Директор коммерческой дирекции, Блока логистики переработки и сбыта «Газпром нефть» 4 Грибановский Игорь Владимирович Коммерческий директор АО СУЭК Сибирская угольная энергетическая компания 5 Вилесов Александр Игоревич Заместитель генерального директора по коммерции и развитию «Т Плюс» Мольский Алексей Валерьевич Заместитель генерального директора по инвестициям, капитальному строительству и реализации услуг «Россети» Директора по маркетингу. Топ-100 Место ФИО Должность Компания Информационные технологии 1 Шедова Елена Леонидовна Global CMO Softline 2 Вербицкая Юлия Владимировна Директор по маркетингу Naumen 3 Волковская Елена Викторовна Директор по стратегическому маркетингу ИТ-компания КРОК 4 Сивенкова Елена Александровна Руководитель отдела маркетинга IBM в России 5 Одинцова Виктория Николаевна Директор по маркетингу Calltouch Андрияшкин Сергей Викторович Директор по маркетингу АТОЛ Коммерческие банки 1 Гиязов Алексей Валерьевич Директор по маркетингу и коммуникациям Альфа-банк 2 Сидоров Евгений Вячеславович Руководитель блока маркетинга и коммуникаций Банк «ФК Открытие» 3 Крейнин Владислав Геннадьевич Старший вице-президент-директор департамента маркетинга и коммуникаций Сбербанк 4 Пономарева Лариса Анатольевна Руководитель департамента маркетинга и рекламы Банк ВТБ 5 Стерлигов Петр Андреевич Руководитель службы маркетинга Почта-банк Алешкин Артем Геннадьевич Заместитель председателя правления банка Банк «Хоум Кредит» Баташева Яна Андреевна Директор по маркетингу и связям с общественностью ОТП-банк Курочкин Иван Николаевич Руководитель управления роста клиентской базы Райффайзенбанк Пойгина* Виктория Владимировна Вице-президент, директор дирекции по маркетингу и PR Московский кредитный банк Смирнова Анастасия Андреевна Вице-президент—начальник департамента коммуникаций и маркетинга Газпромбанк Лесная и лесоперерабатывающая промышленность 1 Милешин Михаил Александрович Вице-президент по маркетингу и инновациям Segezha Group Машиностроение 1 Дубинина Кристина Олексиивна Директор по стратегическому маркетингу «Трансмашхолдинг» Медиабизнес 1 Миронов Павел Владимирович Директор по маркетингу и PR ГК «Румедиа» (BusinessFM—BFM—«Радио Шоколад») 2 Сикорский Андрей Анатольевич Директор по маркетингу РБК 3 Лисова Анастасия Владимировна Директор по маркетингу Телекомпания НТВ 4 Боброва Ольга Вячеславовна Корпоративный директор по маркетингу Медиахолдинг Independent Media 5 Гладченко Артемий Юрьевич Заместитель генерального директора по маркетингу и диджитал—маркетинг-директор канала Телекомпания «Пятница» Абрамочкина Наталия Владимировна Директор по маркетингу СТС Белова Марина Владимировна Заместитель генерального директора—директор программ и маркетинга «Пятый канал» Бродская Елена Юрьевна Вице-президент по маркетингу фильмов и интегрированному маркетингу The Walt Disney Company CIS LLC Ласкари Кирилл Кириллович Директор по управлению брендами Национальная Медиа Группа Мельникова Татьяна Владиславовна Руководитель департамента маркетинга «Союзмультфильм» Михайлова Мария Александровна Руководитель службы маркетинга, рекламы и PR «Москва Медиа» Рябова Ольга Анатольевна Заместитель директора Дирекции развития бизнеса—начальник управления анализа рынков и развития продуктов Медиагруппа «Россия сегодня» Металлургия и горнодобывающая промышленность 1 Шалина Мария Владимировна Директор по маркетингу и улучшению клиентского опыта «Северсталь Менеджмент» 2 Берлин Антон Витальевич Вице-президент руководитель блока сбыта и коммерции «Норникель» 3 Ушаков Сергей Николаевич Заместитель генерального директора по продажам Магнитогорский металлургический комбинат 4 Алексеев Сергей Александрович Директор Дирекции по маркетингу Трубная металлургическая компания 5 Плотникова Анастасия Владимировна Директор дирекции по бренд-менеджменту ЕВРАЗ Андрюшин Роман Евгеньевич Директор по сбыту и маркетингу «Русал» Онлайн-платформы 1 Родин Кирилл Павлович Директор по маркетингу «Кухня на районе» 2 Мец Ольга Александровна Директор',\n",
       " ('Google (компания)',\n",
       "  29,\n",
       "  10): 'по маркетингу и PR HeadHunter 3 Дорожок Олег Евгеньевич Директор по маркетингу и монетизации Ozon 4 Золотухина Дарья Александровна Директор по маркетингу бизнес-группы E-com & Ridetech «Яндекс.Такси» 5 Доброхотова Елена Валентиновна Директор по маркетингу и развитию «Ситимобил» Анжело Дарья Евгеньевна Медиадиректор Storytel Бацуева Анастасия Николаевна Директор по маркетингу Start Иванова Елена Эмилевна Вице-президент по маркетингу и продажам «Сбермаркет» Нелюбина Александра Васильевна Директор по производству и продвижению контента Amediateka Патютько Дарья Ивановна CMO «Авиасейлс» Симонов Павел Игоревич Директор по маркетингу Skillbox Хаустов Олег Олегович Директор по маркетингу «Деливери Клаб» Профессиональные услуги 1 Папаева Светлана Юрьевна Директор группы бренда, маркетинга и коммуникаций по странам СНГ EY 2 Матвеева Татьяна Андреевна Медиадиректор GPMD 3 Реут Андрей Леонидович Первый заместитель директора «Росконгресс» 4 Тимофеева Ольга Алексеевна Руководитель управления маркетинга и исследований Сейлз-хаус «Газпром-медиа» 5 Сухова Ирина Алексеевна Вице-президент ФБК Grant Thornton Ермакова Александра Игоревна Директор по маркетингу и связям с общественностью SPN Communications Миневич Яков Владимирович Старший партнер Коммуникационное агентство Р.И.М. Толкаченко Яна Александровна Вице-президент FleishmanHillard Vanguard Связь и телекоммуникации 1 Походня Инна Александровна Директор по маркетингу Tele2 2 Николаев Вячеслав Константинович Первый вице-президент по клиентскому опыту, маркетингу и экосистемному развитию** МТС 3 Спиридонов Тимур Викторович Директор по маркетингу «НТВ-Плюс» 4 Шиков Тимур Кошмазукович Директор по маркетингу и стратегии «Русские башни» Сервис и производство потребительских товаров 1 Кострова Ольга Владимировна Директор отдела маркетинга Mars Petcare в России Mars 2 Огородов Максим Геннадиевич Директор департамента маркетинга Группа компаний «Медси» 3 Галивонджян Татьяна Валерьевна Вице-президент по маркетингу Аффилированные компании «Филип Моррис Интернэшнл» в России 4 Кнорре Анастасия Георгиевна Директор по маркетингу бытовой химии Unilever 5 Пономарева Ольга Сергеевна Директор по маркетингу Группа компаний «Просвещение» Басанович Варвара Андреевна Операционный директор по маркетингу «Столото» Берегулина* Светлана Евгеньевна Директор по маркетингу Московская школа управления «Сколково» Карев Алексей Константинович Директор по маркетингу SOKOLOV jewelry Копытов Александр Александрович Директор по маркетингу** Paulig Group Костина Евгения Сергеевна Директор по стратегии и маркетингу World Class Потокина Екатерина Владимировна Вице-президент по маркетингу Пивоваренная компания «Балтика» Ширшов Дмитрий Александрович Директор по маркетингу в России, СНГ, Центральной и Восточной Европе Yum! Brands (KFC) Страхование 1 Пучкова Татьяна Анатольевна Заместитель генерального директора - директор по маркетингу и развитию «АльфаСтрахование» 2 Рожнов Александр Евгеньевич Руководитель Блока маркетинга «Росгосстрах» 3 Никифорова Елена Владимировна Директор по маркетингу «Абсолют Страхование» Строительство и девелопмент 1 Соколова Анна Валериевна Директор по маркетингу «Инград» 2 Фетисов Василий Юрьевич Вице-президент по маркетингу и продвижению Группа «Эталон» 3 Коршунова Ирина Григорьевна Директор по маркетингу «Интеко» 4 Мудрицкая Юлия Александровна Директор департамента маркетинга ГК «Галс» 5 Могилевцева-Головина Мария Борисовна Директор по продукту «Сити-XXI век» Торговля 1 Степанова Татьяна Леонидовна Директор по маркетингу Торговая сеть «Перекресток» 2 Никитина Юлия Николаевна Управляющий директор по цифровому маркетингу—заместитель генерального директора Lamoda 3 Зуева Ирина Сереевна Директор по маркетингу Сеть «Эконика» 4 Вершинская Юлия Владимировна Директор по маркетингу Simple Group 5 Ярцев Михаил Михайлович Директор по маркетингу Торговая сеть «Пятерочка» Панарин Виталий Игоревич Corporate Marketing and Digital Director Estee Lauder Companies Паршикова Наталья Геннадьевна Директор по маркетингу «еАптека» Федосов Александр Геннадьевич Директор по маркетингу и электронной коммерции Metro Ящук Галина Николаевна Директор по маркетингу «Ашан» Транспорт 1 Сгибнева Ольга Ивановна Директор по маркетингу «СДЭК-Глобал» 2 Мягков Антон Павлович Директор по маркетингу «Аэрофлот — российские авиалинии» Финансовый сектор 1 Шахурин Виктор Вячеславович Директор по маркетингу «Универ Капитал» 2 Артемова Кристина Борисовна Начальник Управления по реализации партнерских и имиджевых мероприятий Московская биржа 3 Крохина Ксения Сергеевна Руководитель управления маркетинга и PR УК «Альфа-Капитал» 4 Пейсахович Наталья Валерьевна Директор департамента маркетинга и коммуникаций Национальная система платежных карт 5 Смирнова Ольга Сергеевна Директор по маркетингу «Сбербанк Лизинг» Химическая промышленность 1 Стеркин Михаил Владимирович Директор по маркетингу и развитию «Фосагро» 2 Комышан Сергей Валентинович Исполнительный директор «СИБУР',\n",
       " ('Google (компания)',\n",
       "  29,\n",
       "  11): 'Холдинг» Энергетика и топливный комплекс 1 Белякова Яна Сергеевна Начальник департамента маркетинговых коммуникаций «Газпром нефть» 2 Ртищева Евгения Владимировна Руководитель направления маркетинга и брендинга «Интер РАО» Директора по персоналу. Топ-100 Место ФИО Должность Компания Информационные технологии 1 Смыслов Дмитрий Анатольевич Вице-президент по персоналу и образовательным проектам Mail.ru Group 2 Алексеева Марина Михайловна Директор по работе с персоналом «Лаборатория Касперского» 3 Хабарова Полина Михайловна HR-директор, директор по трансформации бизнесa ИТ-компания КРОК 4 Кухарчук Оксана Викторовна Вице-президент по управлению персоналом «Элемент» 5 Шалашилина Надежда Владимировна Директор по персоналу «Ланит» Бажанова Наталия Викторовна Директор по персоналу «Микрон» Коммерческие банки 1 Ермаков Глеб Валентинович Руководитель департамента по работе с персоналом Банк ВТБ 2 Исмагулов Марат Равильевич Директор по персоналу Альфа-банк 3 Бородай Юлия Анатольевна Вице-президент, директор по персоналу Почта-банк 4 Салихова Елена Искандеровна Старший вице-президент, руководитель блока по работе с персоналом Банк «ФК Открытие» 5 Литвинова Елена Михайловна Директор департамента персонала Промсвязьбанк Вайсбанд Галина Михайловна Вице-президент по управлению персоналом Банк «Хоум Кредит» Ефремова Алена Андреевна Директор по персоналу Московский кредитный банк Капранова Дарья Николаевна Вице-президент, руководитель Департамента по работе с персоналом МТС-банк Логинова Елена Владимировна Старший вице-президент, директор Департамента по работе с персоналом КБ «Ренессанс Кредит» Мосина Мария Валентиновна Директор по персоналу Росбанк Рощина Наталья Евгеньевна Директор дирекции по персоналу ОТП-банк Химаныч Владимир Олегович Управляющий директор по работе с персоналом Райффайзенбанк Машиностроение 1 Плетенецкая Наталья Александровна Заместитель генерального директора по корпоративному развитию «Локотех» 2 Николаева Юлия Михайловна Заместитель генерального директора по управлению персоналом «Атомэнергомаш» Медиабизнес 1 Волхонская Светлана Вячеславовна Заместитель генерального директора по работе с персоналом Национальная Медиа Группа 2 Гаврилина Наталья Викторовна Директор по персоналу The Walt Disney Company CIS LLC 3 Солодова Евгения Александровна Директор Дирекции по персоналу Медиагруппа «Россия сегодня» 4 Федосеева Варвара Юрьевна Директор по управлению персоналом и корпоративному развитию «Медиа-1» 5 Сухарева Юлия Сергеевна Директор по персоналу и организационному развитию Медиахолдинг Independent Media Металлургия и горнодобывающая промышленность 1 Ионова* Наталья Леонидовна Вице-президент по персоналу ЕВРАЗ 2 Львова* Анна Анатольевна Директор по работе с персоналом «Северсталь» 3 Крячкова Дарья Алексеевна Вице-президент по кадровой политике «Норникель» 4 Альбрехт Наталья Александровна Заместитель генерального директора по управлению персоналом «Русал» 5 Николашина Светлана Леонидовна Директор по управлению персоналом Объединенная металлургическая компания Кийков Олег Вячеславович Директор по персоналу Магнитогорский металлургический комбинат Многопрофильные холдинги 1 Матвеева Светлана Сергеевна Вице-президент по управлению персоналом АФК «Система» 2 Сыс Наталия Александровна Директор по персоналу и организационному развитию Группа компаний «Новард» Онлайн-платформы 1 Львова Марина Алексеевна Директор по организационному развитию HeadHunter 2 Кабурова Ирина Михайловна Директор по персоналу Ozon 3 Санина Юлия Владимировна Директор по персоналу и организационному развитию «Работа.ру» 4 Астафурова Марина Анатольевна Директор по персоналу Skillbox 5 Тарабрин Антон Юрьевич Директор по персоналу «Яндекс.Маркет» Болкунова Мария Викторовна Директор по управлению персоналом «МОНОПОЛИЯ.Онлайн» Гавра Полина Георгиевна HR-директор «Авиасейлс» Профессиональные услуги 1 Савенкова Татьяна Павловна Директор отдела по работе с персоналом EY 2 Абгарян Лусине Рубиковна Директор по персоналу Kelly Services 3 Ваньчкова Татьяна Олеговна Заместитель генерального директора по корпоративному обучению Ancor 4 Флоренцева Ольга Станиславовна HR-директор dentsu Russia 5 Алехина Анастасия Андреевна Директор по работе с персоналом BBDO Group Климова Наталья Сергеевна HR-директор Ventra Связь и телекоммуникации 1 Иванова Елена Викторовна Заместитель генерального директора по организационному развитию и управлению персоналом Tele2 2 Чернышева* Татьяна Сергеевна Вице-президент по управлению персоналом МТС 3 Филатова Ольга Юрьевна Исполнительный вице-президент по управлению персоналом, организационному развитию и поддержке «Вымпелrом» («Билайн») 4 Новикова Екатерина Юрьевна Директор по организационному развитию «Русские башни» Сельское хозяйство 1 Федорова Ольга Викторовна Директор по персоналу и организационному развитию Группа компаний «Русагро» 2 Мишечко Оксана Викторовна Директор по управлению персоналом Агрохолдинг «Степь» Сервис и производство потребительских товаров 1 Петрова Ирина Анатольевна Директор по персоналу «Coca-Cola HBC Россия» 2 Розаренова Анна Валерьевна',\n",
       " ('Google (компания)',\n",
       "  29,\n",
       "  12): 'Директор по организационному развитию и работе с персоналом Группа компаний «Медси» 3 Орлов Петр Сергеевич Вице-президент по персоналу, организационному развитию и стратегическим инициативам Mars Petcare в России Mars 4 Кислова Людмила Викторовна Директор по персоналу в России, СНГ, Центральной и Восточной Европе Yum! Brands (KFC) 5 Рябова Надежда Николаевна Вице-президент по управлению персоналом Unilever Бояркина Наталия Владимировна Директор по персоналу World Class Котюкова Ольга Александровна Директор по персоналу Вологодский текстильный комбинат Орел Ольга Борисовна Директор по работе с персоналом AB InBev Efes Серебреникова Екатерина Владимировна Вице-президент по развитию людских ресурсов и обучению «Макдоналдс Россия» Сидякина Виктория Васильевна Корпоративный директор по персоналу, Россия и Евразия «Нестле Россия» Спасов Сергей Александрович Директор по работе с персоналом Московская школа управления «Сколково» Федорова Евгения Федоровна Старший директор по персоналу Procter & Gamble Филатова Татьяна Валентиновна Директор по персоналу Группа компаний «Просвещение» Фокина Надежда Владимировна Директор по персоналу «Мон`дэлис Русь» Страхование 1 Ефремова Анна Мансуровна Директор департамента по работе с персоналом «АльфаСтрахование» 2 Невская Виктория Николаевна Директор по персоналу «Ингосстрах» 3 Лаврентьев Дмитрий Александрович Директор по персоналу «Росгосстрах» Строительство и девелопмент 1 Чернуха Андрей Викторович Директор административного департамента ГК «Галс» 2 Танаева Наталья Александровна Директор по персоналу Группа «Эталон» Торговля 1 Бояркова Вера Евгеньевна Директор по персоналу «Леруа Мерлен Восток» 2 Боброва Анна Николаевна Директор по персоналу «Магнит» 3 Красноперова Татьяна Владимировна Директор по персоналу и организационному развитию X5 Group 4 Дерябина Лилия Васильевна Директор по персоналу Торговая сеть «Перекресток» 5 Демченко Юлия Александровна Управляющий директор по персоналу Lamoda Бедненко Алла Викторовна Директор по персоналу Сеть «Эконика» Ярошевская Анастасия Владимировна Директор департамента по управлению персоналом ГК «Детский мир» Транспорт 1 Шаханов Дмитрий Сергеевич Заместитель генерального директора по вопросам управления персоналом, социального развития и здравоохранения «Российские железные дороги» 2 Стешина Светлана Александровна Директор по персоналу Международный аэропорт Внуково 3 Селянина Ольга Викторовна Директор по персоналу «Аэроэкспресс» Фармацевтика 1 Арендарь Александра Сергеевна Директор по персоналу «Герофарм» 2 Латышева Екатерина Вячеславовна Директор по управлению персоналом «Новамедика» Финансовый сектор 1 Григорьян Юрий Сергеевич Управляющий директор УК «Альфа-Капитал» 2 Мешковская Елена Анатольевна Директор департамента по работе с персоналом Банк непрофильных активов «Траст» 3 Миронова Марина Андреевна Директор по персоналу ИК «Велес Капитал» 4 Трофимова Ольга Николаевна Директор по персоналу Московская биржа 5 Первенцев Алексей Валерьевич Директор по персоналу и операционной эффективности ДОМ.РФ Говорина Анаит Георгиевна Директор департамента по работе с персоналом Лизинговая компания «Европлан» Зырянова Анна Владимировна Директор по персоналу А1 Комиссарова Елена Николаевна Директор по персоналу «Сбербанк Факторинг» Крылов Роман Николаевич Директор по персоналу—директор департамента работы с персоналом НПФ «Открытие» Родина Анастасия Витальевна Директор по работе с персоналом УК «Система Капитал» Химическая промышленность 1 Лабашова Альбина Рахимовна Директор, управление персоналом «СИБУР Холдинг» 2 Бородич Дмитрий Сергеевич Директор по персоналу и социальной политике «Фосагро» 3 Глазкова Александра Сергеевна Директор по организационному развитию и персоналу ОХК «Уралхим» Энергетика и топливный комплекс 1 Терентьева Татьяна Анатольевна Заместитель генерального директора по персоналу Госкорпорация «Росатом» 2 Кузьминых Светлана Александровна Директор по управлению персоналом и организационному развитию «Т Плюс» 3 Москаленко Анатолий Алексеевич Вице-президент по управлению персоналом и социальной политике ЛУКОЙЛ 4 Логвин Максим Михайлович Руководитель блока управления персоналом и организационного развития «Интер РАО» ИТ-директора. Топ-50 Место ФИО Должность Компания Информационные технологии 1 Шахаб Максим Бассамович Директор по информационным технологиям «Лаборатория Касперского» 2 Филатов Александр Михайлович Директор по ИТ «Ланит» 3 Конова Марина Валерьевна ИТ-директор ИТ-компания КРОК 4 Киселев Андрей Николаевич Директор по информационным технологиям «Гринатом» Коммерческие банки 1 Поляков Сергей Олегович Директор по информационным технологиям Альфа-банк 2 Батурова Елена Анатольевна Директор Центра развития финансовых технологий Российский сельскохозяйственный банк 3 Пегасов Сергей Викторович Старший вице-президент - руководитель блока информационных технологий ПСБ Промсвязьбанк 4 Русанов Сергей Георгиевич Руководитель IT-блока Банк «ФК Открытие» 5 Фролов Андрей Петрович',\n",
       " ('Google (компания)',\n",
       "  29,\n",
       "  13): 'Вице-президент, директор по информационным технологиям Почта-банк Тараторин Александр Викторович Директор по информационным технологиям Росбанк Цыганов Вячеслав Владимирович Директор по информационным технологиям, вице-президент Тинькофф-банк Лесная и лесоперерабатывающая промышленность 1 Вахнин Павел Анатольевич Вице-президент по информационным технологиям и автоматизации процессов Segezha Group Медиабизнес 1 Якунин Александр Анатольевич Руководитель департамента информационных технологий Информационное агентство России ТАСС Металлургия и горнодобывающая промышленность 1 Дунаев Сергей Вадимович Директор по ИТ «Северсталь Менеджмент» 2 Шуткина Юлия Яновна Директор по цифровой трансформации УК «Металлоинвест» 3 Ермишина Лиана Рагиновна Директор IT-департамента «Норникель» 4 Бондаренко Лев Генрихович Вице-президент по трансформации бизнеса и информатизации УК «Полюс» 5 Натрусов Артем Владимирович Вице-президент по информационным технологиям ЕВРАЗ Якоб Дмитрий Александрович Директор по информационным технологиям Трубная металлургическая компания Многопрофильные холдинги 1 Козлов Игорь Люсьенович Вице-президент по информационным технологиям АФК «Система» Онлайн-платформы 1 Степаненко Антон Валерьевич Технический директор Ozon 2 Береговский Геннадий Аркадьевич Директор по информационным технологиям HeadHunter Профессиональные услуги 1 Андреев Дмитрий Александрович Руководитель ИТ-отдела в России и странах СНГ EY Связь и телекоммуникации 1 Белов Виктор Леонидович Вице-президент по технике МТС 2 Савенок Григорий Вадимович Директор по диджитал-решениям «МегаФон» 3 Берзин Алексей Александрович Руководитель Департамента информационных технологий Компания «Транстелеком» 4 Рубенчик Антон Владимирович Вице-президент по информационным технологиям «Вымпелком» («Билайн») Сельское хозяйство 1 Беляев Владислав Михайлович Директор по информационным технологиям Группа «Черкизово» 2 Ткаченко Сергей Петрович Директор департамента НИОКР и информационных технологий Агрохолдинг «Степь» Сервис и производство потребительских товаров 1 Валчев Стоян Менеджер по информационным системам и бизнес решениям «Coca-Cola HBC Россия» 2 Пасынков Владимир Анатольевич Директор по информационным технологиям Группа компаний «Медси» Страхование 1 Аверин Максим Олегович Управляющий директор—директор дирекции информационных технологий «Сбербанк страхование» 2 Муравьев Владимир Сергеевич Директор департамента информационных технологий «АльфаСтрахование» Торговля 1 Соколовский Александр Михалович Директор по информационным технологиям Группа «М.Видео—Эльдорадо» 2 Мироненков Антон Сергеевич Управляющий директор БЕ Технологии X5 Group 3 Бахин Евгений Владимирович Директор по информационным технологиям «Рестор» Транспорт 1 Чаркин Евгений Игоревич Заместитель генерального директора по цифровой трансформации и информационным технологиям «Российские железные дороги» Фармацевтика 1 Мартынов Михаил Владимирович Заместитель генерального директора по информационным технологиям Biocad Финансовый сектор 1 Громов Михаил Владимирович Директор ИТ-группы ДОМ.РФ, Заместитель председателя банка ДОМ.РФ ДОМ.РФ 2 Бурилов Андрей Анатольевич Управляющий директор по информационным технологиям Московская биржа 3 Беляев Алексей Викторович Технический директор—директор департамента информационных технологий НПФ «Открытие» 4 Зотов Сергей Иванович Директор департамента информационных технологий Инвестиционная компания «Регион» 5 Можаитин Роман Викторович Руководитель департамента информационных технологий и защиты Евразийский банк развития Хапаев Андрей Александрович Начальник Департамента информационных технологий ИК «Велес Капитал» Химическая промышленность 1 Мельникова Алиса Валериевна Директор, цифровые и информационные технологии «СИБУР Холдинг» Энергетика и топливный комплекс 1 Абакумов Евгений Михайлович Директор по информационным технологиям Госкорпорация «Росатом» 2 Думин Антон Сергеевич Директор Дирекции информационных технологий, автоматизации и телекоммуникаций «Газпром нефть» 3 Парфентьев Николай Александрович Директор по цифровизации и информационным технологиям—начальник Департамента цифровизации и эксплуатации информационных технологий «Россети» 4 Алтухов Дмитрий Юрьевич Руководитель Блока информационных технологий «Интер РАО» 5 Подольский Александр Ефимович Начальник Департамента информационно-технологического обеспечения ЛУКОЙЛ Директора по логистике и цепям поставок. Топ-25 Место ФИО Должность Компания Машиностроение 1 Долгов Виктор Иванович Заместитель генерального директора по производству и снабжению НПК «Объединенная вагонная компания» Медиабизнес 1 Яковлев Вадим Николаевич Директор Административно-хозяйственной дирекции Медиагруппа «Россия сегодня» Металлургия и горнодобывающая промышленность 1 Коваленко Мария Анатольевна Директор по снабжению УК «Металлоинвест» 2 Насыбуллов Равиль Фидаевич Директор департамента логистики «Норникель» 3 Лихарев Сергей Константинович Вице-президент по логистике НЛМК Связь и телекоммуникации 1 Петров Алексей Владимирович Директор по снабжению «Вымпелком» («Билайн») Сельское хозяйство 1 Субботин Евгений Викторович Директор по логистике и поставкам Группа «Черкизово» Сервис и производство потребительских товаров 1 Челнокова Ламара Евгеньевна Директор по закупке и логистике в России и СНГ Yum! Brands (KFC) 2 Елецких Илья Владимирович Директор по логистике по стране «Coca-Cola HBC Россия»',\n",
       " ('Google (компания)',\n",
       "  29,\n",
       "  14): '3 Леклерк Бертран Вице-президент по снабжению и логистике в Восточной Европе Procter & Gamble 4 Войтиков Константин Николаевич Вице-президент по производству и поставкам Unilever Торговля 1 Дементьева Ирина Петровна Директор по управлению поставками, дистрибуцией и логистикой Группа «М.Видео—Эльдорадо» 2 Дей* Марья Викторовна Директор по цепочкам поставок «Магнит» 3 Стародубцев Илья Леонидович Директор департамента доставки Lamoda 4 Образцова Елена Александровна Директор по операциям «Утконос Онлайн» 5 Булычев Максим Александрович Операционный директор «Максима Групп» (Familia) Транспорт 1 Бриль Роман Витальевич Директор по производству—начальник департамента по логистике и тарифной политике Федеральная грузовая компания 2 Воронов Александр Владимирович Руководитель направления «Внутригородская логистика» «СДЭК-Глобал» 3 Лебедев Алексей Викторович Генеральный директор «УК Мечел-Транс» 4 Петров Михаил Юрьевич Директор по логистике Первая грузовая компания Фармацевтика 1 Бовтун Виктор Григорьевич Заместитель генерального директора по операциям ЦВ «Протек» Химическая промышленность 1 Агаркова Ирина Сергеевна Руководитель функции «Логистика» «СИБУР Холдинг» 2 Шепель Андрей Владимирович Директор по логистике «Апатит» 3 Ковшов Всеволод Владимирович Директор по логистике ОХК «Уралхим» Энергетика и топливный комплекс 1 Симдякин Вадим Михайлович Директор дирекции логистики и операций с нефтью, Блока логистики переработки и сбыта «Газпром нефть» Директора по отношениям с органами власти. Топ-50 Место ФИО Должность Компания Информационные технологии 1 Жунич Марина Алексеевна Директор по взаимодействию с органами государственной власти «Google Россия» 2 Алексеев Игорь Юрьевич Директор по взаимодействию с государственными органами и корпоративным отношениям «Яндекс» 3 Голуб Константин Юрьевич Директор по связям с государственными органами Mail.ru Group 4 Гудым Денис Анатольевич Директор по связям с правительственными организациями в России «Интел» 5 Певнев Сергей Викторович Директор по корпоративным проектам и взаимодействию с государственными органами Samsung Electronics Коммерческие банки 1 Попова Анна Владиславовна Вице-президент Сбербанк 2 Сенин Владимир Борисович Заместитель председателя правления Альфа-банк 3 Зорин Андрей Викторович Директор Центра по взаимодействию с органами государственной власти Банк «ФК Открытие» 4 Тынчеров Артем Агитович Начальник управления по работе с органами государственной власти и общественными организациями Банк ВТБ Лесная и лесоперерабатывающая промышленность 1 Шерлыгин Алексей Игоревич Вице-президент по работе с государственными органами Segezha Group Машиностроение 1 Матвеева Елена Викторовна Вице-президент по корпоративной политике Группа ГАЗ 2 Гаранина Юлия Владимировна GR-директор «Автотор Холдинг» 3 Матасов Михаил Владимирович Заместитель генерального директора КамАЗ Медиабизнес 1 Карманов* Роман Владимирович Первый заместитель генерального директора Медиагруппа «Комсомольская правда» Металлургия и горнодобывающая промышленность 1 Грачев Андрей Михайлович Вице-президент по федеральным и региональным программам «Норникель» 2 Шибалкин Александр Степанович Советник по внешним коммуникациям дирекции Магнитогорский металлургический комбинат 3 Шабала Юлия Игоревна Заместитель генерального директора по взаимодействию с органами государственной власти УК «Металлоинвест» 4 Журавлев Сергей Игоревич Вице-президент по работе с государственными органами УК «Полюс» 5 Дронова Мария Михайловна Директор по связям с органами государственной власти и благотворительной деятельности ЕВРАЗ Многопрофильные холдинги 1 Семкин Сергей Викторович Исполнительный вице-президент по региональной политике АФК «Система» Онлайн-платформы 1 Петраков Антон Анатольевич Директор по корпоративным отношениям и работе с органами государственной власти «Яндекс Go« («Такси», «Еда», «Лавка») 2 Глущенко Артем Николаевич Директор по связям с органами власти «Яндекс.Маркет» 3 Терентьев Виталий Анатольевич GR-директор HeadHunter Профессиональные услуги 1 Амелина Марина Вячеславовна Директор по связям с государственными органами «Бэринг Восток» 2 Бородюк Светлана Владимировна Руководитель группы стратегических проектов, СНГ EY Связь и телекоммуникации 1 Ибрагимов Руслан Султанович Вице-президент по взаимодействию с органами государственной власти и связям с общественностью МТС 2 Гошко Юлия Викторовна Директор по взаимодействию с государственными органами Tele2 Сельское хозяйство 1 Клепикова Наталья Александровна Руководитель управления по работе с государственными органами Группа «Черкизово» 2 Журавский Денис Владимирович GR-директор «Сингента» Сервис и производство потребительских товаров 1 Максимов Александр Юрьевич Директор по работе с государственными органами Mars 2 Дурдыев Ораз Алиевич Директор по правовым вопросам и корпоративным отношениям AB InBev Efes 3 Зырянов Андрей Федорович Старший директор по связям с органами власти «Макдоналдс Россия» 4 Сирченко',\n",
       " ('Google (компания)',\n",
       "  29,\n",
       "  15): 'Александр Александрович Заместитель генерального директора по взаимодействию с органами власти и коммуникациям «TUI Россия» 5 Башкиров Андрей Николаевич Старший директор по взаимодействию с органами государственной власти в Восточной Европе Procter & Gamble Брижицкий Артем Анатольевич Руководитель отдела по взаимодействию с органами государственной власти Unilever Толмачева Татьяна Александровна Коммерческий директор Группа компаний «Просвещение» Страхование 1 Соломатин Илья Петрович Заместитель генерального директора по внешним связям «Ингосстрах» 2 Артамонов Алексей Игоревич Вице-президент—директор департамента по взаимодействию с органами государственной власти «АльфаСтрахование» 3 Чуб Алексей Васильевич Старший вице-президент—руководитель Департамента по связям с государственными органами и страховым сообществом Страховой дом ВСК Торговля 1 Калимуллин Тагир Равилович Директор по взаимодействию с государственными органами власти Группа «М.Видео—Эльдорадо» 2 Лурье Наталья Леонидовна Директор по взаимодействию с органами власти «Леруа Мерлен Восток» 3 Мелешина Анна Юрьевна Директор департамента по корпоративным отношениям и устойчивому развитию бизнеса «Магнит» 4 Богданов Станислав Алексеевич Директор по развитию отношений с органами государственной власти X5 Group Транспорт 1 Петренко Вячеслав Александрович Заместитель генерального директора по взаимодействию с федеральными и региональными органами власти Группа компаний «Новотранс» Фармацевтика 1 Торгов Алексей Владимирович Директор Департамента по взаимодействию с органами государственной власти Biocad Финансовый сектор 1 Погорелова Ирина Владимировна Директор по GR «Сбербанк Лизинг» Химическая промышленность 1 Шахов Алексей Алексеевич Директор, cвязи с государственными органами «СИБУР Холдинг» 2 Мозгунов Олег Николаевич Заместитель директора по взаимодействию с государственными органами АО «МХК Еврохим» Энергетика и топливный комплекс 1 Григорьев Сергей Александрович Заместитель генерального директора, директор по связям и коммуникациям Сибирская угольная энергетическая компания 2 Овсянников Глеб Львович Начальник Департамента общественных связей ЛУКОЙЛ Директора по корпоративной социальной ответственности. Топ-25 Место ФИО Должность Компания Информационные технологии 1 Трофимова Инга Владимировна Менеджер по КСО и внутренним коммуникациям SAP CIS 2 Ефремова-Гарт Ирина Юрьевна Директор КСО IBM в России 3 Бабкина Александра Юрьевна Директор социальных проектов Mail.ru Group Коммерческие банки 1 Плужник Екатерина Владимировна Руководитель направления КСО Росбанк Металлургия и горнодобывающая промышленность 1 Мазанова Юлия Борисовна Заместитель генерального директора по устойчивому развитию и корпоративным коммуникациям УК «Металлоинвест» 2 Поппель Наталья Анатольевна Советник генерального директора по вопросам устойчивого развития «Северсталь Менеджмент» 3 Закиев Рустам Гулюсович Директор департамента социальной политики «Русал» 4 Бугров Андрей Евгеньевич Старший вице-президент по устойчивому развитию «Норникель» 5 Миронова Ольга Ивановна Руководитель направления КСО Объединенная металлургическая компания Гончарова Дарья Николаевна Директор по устойчивому развитию «Полиметалл» Григорьева Дарья Константиновна Директор по устойчивому развитию УК «Полюс» Клименко Андрей Владимирович Руководитель направления по корпоративной социальной ответственности ЕВРАЗ Связь и телекоммуникации 1 Чистова Евгения Михайловна Руководитель по устойчивому развитию «Вымпелком» («Билайн») 2 Филатова* Екатерина Валерьевна Руководитель благотворительных программ МТС Сервис и производство потребительских товаров 1 Жукова Ирина Семеновна Директор по устойчивому развитию и корпоративным программам Аффилированные компании «Филип Моррис Интернэшнл» в России 2 Антюшина Ирина Валериевна Директор по устойчивому развитию бизнеса и корпоративным отношениям Unilever 3 Владимирская Наталья Викторовна Руководитель социальных проектов Группа компаний «Медси» 4 Cемерикова Анна Борисовна Генеральный директор корпоративного благотворительного фонда Yum! Brands (KFC) 5 Коршунова Ирина Анатольевна Старший директор по обеспечению и гарантии качества и устойчивому развитию «Макдоналдс Россия» Ноздряков Руслан Анатольевич Старший директор по корпоративной социальной и экологической ответственности Procter & Gamble Фокин Василий Юрьевич Руководитель направления устойчивого развития «Данон Россия» Торговля 1 Бенеславская Наталья Викторовна Руководитель отдела по устойчивому развитию ИКЕА 2 Галактионова Надежда Александровна Руководитель управления по устойчивому развитию «Магнит» Химическая промышленность 1 Каспаров Станислав Сергеевич Руководитель функции, Обеспечение поддержки бизнеса в регионах присутствия «СИБУР Холдинг» Энергетика и топливный комплекс 1 Гончар Наталья Владимировна Начальник департамента корпоративных отношений «Сахалин Энерджи Инвестмент Компани Лтд.» Директора по корпоративному управлению. Топ-50 Место ФИО Должность Компания Информационные технологии 1 Зайцева Анна Викторовна Корпоративный секретарь РТИ 2 Грибов Владимир Юрьевич Управляющий директор «Ланит» 3 Афонина Юлия Сергеевна Ведущий корпоративный юрист, секретарь совета директоров «Микрон» 4 Котляков',\n",
       " ('Google (компания)',\n",
       "  29,\n",
       "  16): 'Михаил Владимирович Вице-президент по корпоративному управлению, имущественным и правовым вопросам «Элемент» Коммерческие банки 1 Цветков Олег Юрьевич Управляющий директор—руководитель Службы корпоративного секретаря Сбербанк 2 Масленников Александр Игоревич Начальник управления корпоративного развития— вице-президент Банк ВТБ 3 Короткова Екатерина Александровна Корпоративный секретарь МТС-банк 4 Воронов Вадим Анатольевич Руководитель аппарата председателя банка Промсвязьбанк 5 Гольдман Леонид Михайлович Директор департамента правового обеспечения общебанковской деятельности Росбанк Машиностроение 1 Халиуллина Жанна Евгеньевна Заместитель генерального директора—корпоративный директор, корпоративный секретарь КамАЗ 2 Бреева Елена Леонидовна Директор по корпоративному управлению и комплаенс Группа ГАЗ 3 Вощинина Юлия Анатольевна Руководитель службы правового обеспечения, корпоративного и имущественного управления, корпоративный секретарь Научно-производственное объединение им. С. А. Лавочкина 4 Полутин Кирилл Владимирович Начальник отдела корпоративного управления, корпоративный секретарь НПО Энергомаш имени академика В. П. Глушко 5 Ворновский Андрей Николаевич Директор по корпоративному и организационному развитию «Автотор Холдинг Менеджмент» Медиабизнес 1 Кожина Галина Ивановна Первый заместитель генерального директора Медиагруппа «Россия сегодня» Металлургия и горнодобывающая промышленность 1 Чедаева Татьяна Алексеевна Директор по корпоративному управлению «Полиметалл» 2 Лоскутов Валерий Александрович Корпоративный секретарь НЛМК 3 Платов Павел Евгеньевич Корпоративный секретарь «Норникель» 4 Якунина Ольга Анатольевна Директор департамента корпоративного управления и собственности «Мечел» 5 Николаева Ольга Сергеевна Директор Дирекции по корпоративным и имущественным отношениям Трубная металлургическая компания Многопрофильные холдинги 1 Кулакова Екатерина Алексеевна Корпоративный секретарь АФК «Система» 2 Трофимов Евгений Валерьевич Директор по стратегическому развитию Группа компаний «Новард» Онлайн-платформы 1 Сергиенков Дмитрий Сергеевич Директор по стратегии HeadHunter 2 Герасимов Игорь Владиславович Директор по корпоративному развитию и финансам Ozon Связь и телекоммуникации 1 Калинин* Максим Александрович Директор по корпоративному управлению МТС 2 Московская Елена Сергеевна Директор по корпоративному управлению «Вымпелком» («Билайн») Сельское хозяйство 1 Шивидов Борис Викторович Заместитель генерального директора по корпоративному управлению Агрохолдинг «Степь» Сервис и производство потребительских товаров 1 Сергиевская Арина Андреевна Руководитель отдела по соблюдению деловой этики Unilever 2 Якушева Елена Алексеевна Директор по корпоративному управлению Splat Строительство и девелопмент 1 Пожидаева Анна Вячеславовна Первый вице-президент—главный операционный директор Группа «Эталон» 2 Петров Максим Валерьевич Заместитель генерального директора по корпоративному управлению, правовым и имущественным вопросам «Мосинжпроект» Торговля 1 Павликов Петр Сергеевич Директор по корпоративному праву и комплаенсу X5 Group 2 Литвиненко Юлия Олеговна Директор департамента по корпоративным отношениям Группа «М.Видео—Эльдорадо» Транспорт 1 Плутник Александр Альбертович Заместитель генерального директора по вопросам корпоративного управления дочерними и зависимыми обществами, управления и распоряжения имуществом «Российские железные дороги» 2 Мелехин Алексей Владимирович Директор департамента корпоративного управления, исполнительный секретарь совета директоров «Аэрофлот — Российские авиалинии» 3 Кошкин Андрей Николаевич Директор по корпоративному управлению и юридическим вопросам «Аэроэкспресс» 4 Арабова Наталья Владимировна Заместитель генерального директора по корпоративному управлению Федеральная грузовая компания Финансовый сектор 1 Каменский Александр Михайлович Директор департамента корпоративного управления Московская биржа 2 Ильина Ольга Николаевна Корпоративный секретарь ИК «Русс-Инвест» 3 Антипов Николай Николаевич Директор корпоративного центра УК «Альфа-Капитал» Химическая промышленность 1 Медведева Марина Владимировна Управляющий директор, бизнес-процессы. Общекорпоративные сервисы. Корпоративное управление «СИБУР Холдинг» 2 Самосюк Сергей Алексеевич Корпоративный секретарь «Фосагро» 3 Попов Александр Валериевич Председатель совета директоров «Акрон» Энергетика и топливный комплекс 1 Меребашвили Тамара Александровна Заместитель генерального директора, руководитель Блока корпоративных и имущественных отношений, корпоративный секретарь «Интер РАО» 2 Коптяков Станислав Сергеевич Директор Департамента корпоративного управления и управления имуществом «РусГидро» 3 Хавкин Евгений Леонидович Вице-президент-руководитель аппарата ЛУКОЙЛ 4 Тихонова Мария Геннадьевна Заместитель генерального директора по корпоративному управлению «Россети» 5 Роганова Светлана Юрьевна Руководитель Управления корпоративной работы Концерн «Росэнергоатом» Бикмурзин Альберт Фяритович Заместитель генерального директора по правовым и имущественным вопросам «Газпром энергохолдинг» Даньшина Ольга Александровна Заместитель генерального директора по корпоративной и правовой деятельности МРСК Центра Директора по общественным и корпоративным связям. Топ-100 Место ФИО Должность Компания Информационные технологии 1 Зверева Татьяна Валерьевна Директор по связям с общественностью SAP CIS 2 Зенкин Денис Владимирович Руководитель департамента корпоративных коммуникаций «Лаборатория Касперского» 3 Кондратьева Екатерина',\n",
       " ('Google (компания)',\n",
       "  29,\n",
       "  17): 'Алексеевна Глава отдела коммуникаций «Google Россия» 4 Керценбаум Дарья Алексеевна Вице-президент по развитию бренда и корпоративных коммуникаций Группа компаний ABBYY 5 Лучин Сергей Валерьевич Руководитель по внешним и внутренним корпоративным коммуникациям Mail.ru Group Левченко Валерий Юрьевич Руководитель пресс-службы IBM в России Феоктистова Анна Геннадьевна PRD IT-холдинг TalentTech Юсупов Реваз Александрович Заместитель генерального директора по связям с общественностью и маркетингу Центр развития перспективных технологий Коммерческие банки 1 Кантер Анна Викторовна Старший вице-президент, директор департамента коммуникаций, пресс-секретарь президента—председателя правления Банк «ФК Открытие» 2 Согрин Андрей Владимирович Начальник управления информационной политики Альфа-банк 3 Очеретина Ольга Викторовна Руководитель Дирекции по связям с общественностью Почта-банк 4 Шкаровская Ирэн Владимировна Начальник управления стратегических коммуникаций Банк «Хоум Кредит» 5 Корягина Инна Сергеевна Директор Департамента общественных связей и маркетинговых коммуникаций Российский сельскохозяйственный банк Запольский Антон Эдуардович PR-директор Совкомбанк Трифонов Антон Евгеньевич Начальник Центра внешних коммуникаций — пресс-службы Газпромбанк Лесная и лесоперерабатывающая промышленность 1 Полетаева Анастасия Анатольевна Директор по связям с общественностью Segezha Group Машиностроение 1 Александрова Елена Владимировна Региональный директор по связям с общественностью, Россия и СНГ The Boeing Company 2 Пашинкина Ирина Викторовна Директор по коммуникациям, заместитель директора филиала УК по коммуникациям Группа ГАЗ Медиабизнес 1 Комарова Любовь Викторовна Заместитель главного редактора по коммуникациям «Эхо Москвы» 2 Айбашева Анна Борисовна Директор по коммуникациям Национальная Медиа Группа 3 Литовченко Елена Григорьевна Директор по связям с общественностью The Walt Disney Company CIS LLC 4 Белов Ким Николаевич Директор по стратегическим коммуникациям «СТС Медиа» 5 Колева Ольга Николаевна Исполнительный директор—руководитель Международного мультимедийного пресс-центра Медиагруппа «Россия сегодня» Ямольдинова Яна Владимировна PR-директор «Аргументы и факты» Металлургия и горнодобывающая промышленность 1 Зелькова Лариса Геннадьевна Старший-вице президент «Норникель» 2 Залужский Владимир Владимирович Начальник управления по коммуникациям и работе с инвесторами «Северсталь Менеджмент» 3 Старовойт Мария Владимировна Директор по внутренним и внешним коммуникациям ЕВРАЗ 4 Руга Владимир Эдуардович Заместитель генерального директора по внешним коммуникациям Магнитогорский металлургический комбинат 5 Курносова Мария Викторовна Директор по корпоративным коммуникациям Объединенная металлургическая компания Многопрофильные холдинги 1 Захаренкова Анна Викторовна Директор по связям с общественностью Группа компаний «Международный аэропорт Шереметьево» 2 Копытов Сергей Юрьевич Пресс-секретарь—управляющий директор АФК «Система» 3 Житомирский Илья Михайлович Директор по общественным связям и коммуникациям Группа «Синара» 4 Ходоровский Анатолий Матвеевич Директор по внешним коммуникациям Концерн «Россиум» 5 Байбарович Ирина Васильевна Директор по стратегическим коммуникациям «РАТМ Холдинг» Онлайн-платформы 1 Упитис Полина Владимировна PR-директор «Яндекс.Маркет» 2 Перцева Александра Сергеевна Директор по PR «Работа.ру» 3 Гущина Ирина Петровна PR-директор по региону Россия, Восточная Европа и Центральная Азия DiDi 4 Белоусов Алексей Александрович Руководитель по внешним коммуникациям «Деливери Клаб» 5 Прокопьев Валерий Радикович Руководитель пресс-службы Wildberries Профессиональные услуги 1 Хутько Анастасия Александровна Руководитель группы по внешним коммуникациям и развитию бренда в странах Центральной, Восточной, Юго-Восточной Европы и Центральной Азии EY 2 Гельтищев Петр Дмитриевич Директор Департамента по связям с общественностью ФБК Grant Thornton 3 Алексеева Татьяна Игоревна PR-директор Национальный центр промышленного дизайна и инноваций 2050.ЛАБ 4 Груздева Светлана Андреевна Партнер Агентство специальных поручений 5 Паутова Лариса Александровна Управляющий директор ФОМ Гладкова Каролина Геннадьевна PR-директор BBDO Group Связь и телекоммуникации 1 Мартынова Елена Андреевна Директор по стратегическим коммуникациям и продвижению бренда «МегаФон» 2 Алявдин Кирилл Григорьевич Директор по корпоративным коммуникациям Tele2 3 Меркутов Алексей Анатольевич Директор департамента корпоративных коммуникаций—пресс-секретарь МТС 4 Смиркин Дмитрий Анатольевич Пресс-секретарь «ЭР-Телеком» 5 Ким Иван Валерьевич Руководитель Департамента по связям с общественностью и коммуникациям Компания «Транстелеком» Сельское хозяйство 1 Воронина Анна Владимировна Советник по коммуникациям ГК РТК Сервис и производство потребительских товаров 1 Архипова Ирина Петровна Директор по внешним связям и коммуникациям «Coca-Cola HBC Россия» 2 Вишнякова Елена Геннадьевна Заместитель генерального директора «Эколайн» 3 Бадер Андрей Николаевич Директор по делам корпорации «Нестле Россия» 4 Плетюхин Владимир Васильевич Директор по коммуникациям и связям с общественностью Аффилированные компании «Филип Моррис',\n",
       " ('Google (компания)',\n",
       "  29,\n",
       "  18): 'Интернэшнл» в России 5 Костиков Александр Михайлович Директор по коммуникациям PepsiCo Александрова Елизавета Юрьевна Директор по корпоративным отношениям «Mars Wrigley Россия» Mars Кожанова Екатерина Сергеевна Директор по стратегическим коммуникациям Издательство «Эксмо» Новикова Елизавета Азеровна Старший директор по связям с общественностью «Макдоналдс Россия» Орешкина Нина Евгеньевна Руководитель отдела по связям с общественностью «Инвитро» Трифонова Ксения Владимировна Директор по коммуникациям Московская школа управления «Сколково» Страхование 1 Асоян Карен Тадевосович Директор по связям с общественностью «Ингосстрах» Строительство и девелопмент 1 Зильберт Александр Борисович Директор по информационной политике и корпоративным коммуникациям Группа ЛСР 2 Самородова Екатерина Юрьевна PR-директор ГК ФСК 3 Опимах Ирина Михайловна Директор Службы пресс-атташе «Кортрос» 4 Бурдельная Ирина Анатольевна Директор по внешним коммуникациям ГК «Галс» 5 Яушев Алексей Васильевич Директор по коммуникациям и управлению рисками «Инград» Торговля 1 Селиванова Елена Александровна Директор по связям с общественностью Simple Group 2 Андреева Валерия Сергеевна Руководитель департамента по связям с общественностью Группа «М.Видео—Эльдорадо» 3 Коннова Елена Александровна Директор по корпоративным коммуникациям X5 Group 4 Лебедь Юлия Владимировна PR-директор «Азбука вкуса» 5 Сатторова Лола Абдулвосихоновна Директор по внешним коммуникациям и корпоративному имиджу «Леруа Мерлен Восток» Поликарпова Юлия Александровна Начальник управления по внешним коммуникациям ГК «Детский мир» Транспорт 1 Лунев Максим Михайлович Начальник департамента корпоративных коммуникаций «Российские железные дороги» 2 Саксонина Наталья Сергеевна Руководитель пресс-службы «Аэроэкспресс» 3 Михайличенко Владислав Владимирович Начальник Управления корпоративных коммуникаций Московского представительства Федеральная грузовая компания Фармацевтика 1 Албаут Татьяна Викторовна Директор по связям с общественностью «НоваМедика» 2 Саяпина Галина Евгеньевна Лидер направления внутрикорпоративных коммуникаций в кластере Восточная Европа Pfizer 3 Кенюхова Ирина Геннадьевна Директор департамента по внешним коммуникациям Biocad 4 Козловская Анна Александровна Вице-президент по коммуникациям Stada Финансовый сектор 1 Брагинский Андрей Александрович Управляющий директор по коммуникациям Московская биржа 2 Жог Мария Валерьевна Директор по маркетингу и связям с общественностью «Ренессанс Капитал — Финансовый консультант» 3 Бабаев Кирилл Владимирович Партнер—управляющий директор А1 4 Балалуева Ирина Александровна PR-директор УК «Альфа-Капитал» 5 Панасюк Татьяна Михайловна Начальник Управления маркетинга и коммуникаций ИК «Велес Капитал» Бакаева Виктория Сергеевна Пресс-секретарь «Сбербанк Лизинг» Борцов Артур Валентинович Управляющий директор—руководитель Департамента коммуникаций и международного сотрудничества Евразийский банк развития Волкова Оксана Олеговна Директор пресс-службы ДОМ.РФ Журавлева Анастасия Вадимовна Глава PR Qiwi Ле Дарья Виневна Руководитель пресс-службы НПФ Сбербанка Могильная Татьяна Александровна PR-директор Инвестиционная компания «Регион» Молева Екатерина Владимировна Начальник Управления коммуникаций и маркетинга Банк непрофильных активов «Траст» Химическая промышленность 1 Торин Владимир Александрович Директор по коммуникациям АО «МХК Еврохим» 2 Черников Дмитрий Юрьевич Руководитель функции, «Корпоративные коммуникации и брендинг» «СИБУР Холдинг» Энергетика и топливный комплекс 1 Санарова Ольга Викторовна Директор департамента по внешним связям En+Group 2 Дыбаль Александр Михайлович Заместитель генерального директора по корпоративным коммуникациям «Газпром нефть» 3 Нагога Маргарита Георгиевна Директор департамента корпоративных коммуникаций «РусГидро» 4 Князев Владимир Александрович Директор по связям с общественностью—руководитель блока информационной политики «Интер РАО» 5 Решетников Георгий Олегович Директор по внешним коммуникациям «Россети» Рукина Надежда Валерьевна Директор по стратегическим коммуникациям «Т Плюс» Директора по правовым вопросам. Топ-50 Место ФИО Должность Компания Информационные технологии 1 Журба Евгений Васильевич Директор юридического департамента «Ланит» 2 Сырчиков Александр Васильевич Заместитель генерального директора по правовым вопросам «Микрон» 3 Тот Игорь Валериевич Директор по правовой поддержке Dell Technologies 4 Хаустов Илья Андреевич Директор по правовым вопросам IT-холдинг TalentTech Коммерческие банки 1 Кондрашов Игорь Валерьевич Вице-президент—директор правового департамента Сбербанк 2 Полуянов Александр Ильич Вице-президент, директор юридического департамента Банк «ФК Открытие» 3 Дорофеев Михаил Викторович Руководитель юридического блока Промсвязьбанк 4 Гришин Михаил Олегович Директор по правовым вопросам и управлению проблемными активами Альфа-банк 5 Лебедева Полина Константиновна Директор по правовым вопросам Росбанк Ухов Константин Викторович Директор Правового департамента Российский сельскохозяйственный банк Лесная и лесоперерабатывающая промышленность 1 Мирсаев Салават Асгатович Вице-президент по правовым вопросам и корпоративному управлению Segezha Group Машиностроение 1 Черник Ирина Дмитриевна Вице-президент—директор',\n",
       " ('Google (компания)',\n",
       "  29,\n",
       "  19): 'по правовым вопросам «Автотор Холдинг» Медиабизнес 1 Кулагина Екатерина Михайловна Руководитель юридического департамента Информационное агентство России ТАСС 2 Корнеева Ольга Николаевна Вице-президент по юридическим вопросам The Walt Disney Company CIS LLC 3 Кожевникова Татьяна Олеговна Руководитель Юридического департамента ГК «Румедиа» (BusinessFM—BFM—«Радио Шоколад») 4 Клименко Андрей Александрович Заместитель Генерального директора -Директор Правового управления Интерфакс 5 Щербаков Тимофей Викторович Заместитель генерального директора по юридическим вопросам РБК Металлургия и горнодобывающая промышленность 1 Захарова Марианна Александровна Первый вице-президент—руководитель Блока корпоративных, акционерных и правовых вопросов «Норникель» 2 Станюленайте Янина Эдуардовна Вице-президент по правовым вопросам ЕВРАЗ 3 Донов Дмитрий Всеволодович Директор по правовым вопросам НЛМК 4 Федотов Дмитрий Николаевич Директор по правовым вопросам «Северсталь Менеджмент» Многопрофильные холдинги 1 Войтович Ольга Валерьевна Заместитель генерального директора по правовым вопросам Холдинговая компания ИНТЕРРОС 2 Шишкин Сергей Анатольевич Вице-президент по корпоративному управлению и правовым вопросам АФК Система Онлайн-платформы 1 Афанасьев Артем Игоревич Вице-президент по правовым вопросам Ozon 2 Донников Юрий Евгеньевич Директор юридического департамента и комплаенс HeadHunter Профессиональные услуги 1 Маренкова Наталия Максимовна Руководитель отдела правового сопровождения спонсорской рекламы и спецпроектов Сейлз-хаус «Газпром-медиа» Связь и телекоммуникации 1 Переверзев Сергей Андреевич Директор по правовым вопросам «МегаФон» 2 Барсегян Алексей Визскопбович Вице-президент по корпоративным и правовым вопросам МТС 3 Бирюков Виктор Алексеевич Исполнительный вице-президент по юридической поддержке, взаимодействию с органами государственной власти и комплаенсу «Вымпелком» («Билайн») Сервис и производство потребительских товаров 1 Носов Тимофей Сергеевич Директор по правовым вопросам и связям с госорганами Azimut Hotels 2 Конорев Дмитрий Васильевич Вице-президент по корпоративным и правовым вопросам Группа компаний «Медси» 3 Каширина Елена Александровна Директор юридического департамента «Макдоналдс Россия» 4 Мищенко Виктория Владимировна Директор юридического отдела Аффилированные компании «Филип Моррис Интернэшнл» в России 5 Паняева* Татьяна Николаевна Директор по юридическим вопросам «Coca-Cola HBC Россия» Антипов Иван Викторович Директор по юридическим вопросам Unilever Шеварденидзе Ольга Владимировна Старший директор по правовым вопросам и комплаенсу Procter & Gamble Страхование 1 Щукин Макар Дмитриевич Руководитель Центра юридического обеспечения Страховой дом ВСК 2 Полина-Сташевская Анна Леонидовна Директор судебно-правового департамента',\n",
       " ('Google (компания)',\n",
       "  3,\n",
       "  0): 'В ходе торгов на Nasdaq во вторник акции Google поднимались до исторического рекорда в 1191,87 доллара. Исходя из этого показателя, капитализация Google оценивалась в 400 миллиардов долларов. На закрытии торгов акции Google стоили 1190,18 доллара, а капитализация составляла 399,7 миллиарда долларов. Напомним, что отметку в 1000 долларов акции компании впервые пробили в октябре 2013 года. По показателю рыночной капитализации Google уступает Apple примерно 80 миллиардов долларов. Акции Apple во вторник на Nasdaq доходили до максимума в 537,75 доллара, прежде чем закрыться на уровне 535,96 доллара. Таким образом, капитализация компании во вторник доходила до отметки в 479,9 миллиарда долларов. Верхняя граница, до которой доходила рыночная капитализация Exxon Mobil на нью-йоркской фондовой бирже в понедельник, составляет около 397,7 миллиарда долларов. Чем известна компания Google Google Inc. — американская компания, владеющая первой по популярности в мире поисковой системой Google. По данным компании ComScore, в 2012 году рыночная доля Google в мире составила 65,2% (114,7 миллиарда поисковых запросов). Читайте подробнее >> Как выросла чистая прибыль Google по итогам 2013 года Чистая прибыль интернет-компании Google в 2013 году выросла по US GAAP на 20% — до 12,92 миллиарда долларов по сравнению с 10,74 миллиарда долларов за 2012 год. В пересчете на одну акцию прибыль составила 38,13 доллара против 32,3 доллара в 2012 году. Годовая выручка Google увеличилась на 19% — до 59,83 миллиарда долларов, из них 4,3 миллиарда пришлось на подразделение Motorola Mobility. Читайте подробнее >>',\n",
       " ('Google (компания)',\n",
       "  30,\n",
       "  0): 'Last month, we noted that \"google\" had entered Merriam-Webster\\'s Collegiate Dictionary. It was a landmark for the search engine -- going from nonentity to common usage in only eight years. One would think that a company that existed only in the minds of two college dudes a few years ago would be happy that a major publication such as The Washington Post prominently marked the occasion. One would, that is, until one got a letter from Google\\'s trademark lawyer. Google, evidently, took offense to this passage in last month\\'s article: \"Google, the word, now takes its place alongside the handful of proper nouns that have moved beyond a particular product to become descriptors of an entire sector -- generic trademarks.\" This characterization of Google, the letter warned, is \"genericide\" and should be avoided. Such letters are cranked out every day by companies keen on protecting their trademarks. Wham-O Inc. wants writers to eschew \"Frisbee\" for \"plastic flying disc,\" for instance. I\\'ll note that in my Palm. Excuse me -- my \"personal digital assistant.\" Google, however, goes the extra mile and provides a helpful list of appropriate and inappropriate uses of its name. To show how hip and down with the kids Google is, the company gets a little wacky with its examples. Here\\'s one: \" Appropriate: He ego-surfs on the Google search engine to see if he\\'s listed in the results. Inappropriate: He googles himself.\" But this one\\'s our favorite: \" Appr opriate: I ran a Google search to check out that guy from the party. Inappropriate: I googled that hottie.\" It\\'s a matter of debate whether it\\'s appropriate or inappropriate for a market-leading company worth $113 billion to use the word \"hottie\" in official correspondence. What is beyond debate is the eye-popping fact that Google\\'s trademark complaint arrived via a hand-addressed letter in the actual mail. Wonder if they Google(TM)-d me to get the address. -- Frank Ahrens',\n",
       " ('Google (компания)',\n",
       "  31,\n",
       "  0): 'Уточняется, что совсем запрещать сайты российских СМИ поисковик не планирует НЬЮ-ЙОРК, 21 ноября. /ТАСС/. Председатель совета директоров холдинга Alphabet Эрик Шмидт заявил, что входящая в холдинг компания Google работает над тем, чтобы понизить ранжирование сайтов RT и Sputnik в подборке новостей. Об этом сообщил в понедельник интернет-портал Motherboard, ссылаясь на высказывания Шмидта на Форуме Галифакса по международной безопасности, завершившемся в воскресенье в городе Галифаксе (провинция Новая Шотландия). \"Нам хорошо об этом известно, и мы работаем над тем, чтобы выявить такого рода сценарии, о которых вы говорите и понизить ранжирование такого рода сайты\", - приводит портал слова Шмидта, отвечавшего на вопрос о том, рассматривает ли Google эти российские компании как новостные. \"Это в основном RT и Sputnik, - продолжал он. - Нам это хорошо известно, и мы пытаемся разработать систему, которая предотвращала бы это\". При этом он утверждал, что \"не хочет запрещать сайты\". \"Это не тот метод, каким мы действуем, - указал он. - Я решительно не одобряю цензуры. Я весьма решительно поддерживаю ранжирование. Именно это мы и делаем\". Ранжирование и цензура Высказывания Эрика Шмидта о намерении понизить ранжирование сайтов RT и Sputnik вызвали оживленные комментарии в Twitter. \"Google манипулирует системой поисков новостей таким образом, чтобы новости RT было труднее обнаружить, - пишет один из пользователей микроблога Даниэль Райан. - Есть ли для этого законные основания? Есть ли доказательства того, что RT размещает ложную информацию? Нет\". \"Найдутся ли представители журналистского мейнстрима, выступающие за свободу слова, достаточно смелые для того, чтобы защитить RT? Сомнительно\", - добавил он. Другой пользователь Макс Блюменталь отметил: \"Эрик Шмидт говорит, что Google разработал специальный алгоритм по снижению рейтинга RT и Sputnik, а затем настаивал на том, что он \"очень решительно настроен против цензуры\". Пользователь Линдон Олсен отметил, что Шмидт, \"давний друг\" Хиллари Клинтон, \"не привел конкретных примеров того, что RT или Sputnik размещают лживые статьи и не сказал, что понижение рейтинга будет касаться только \"плохих статьей\". Автор сообщения назвал эти высказывания Шмидта \"попыткой заискивания перед антироссийски настроенными парнями из Вашингтона и чиновниками, пытающимися тайно влиять на политику\".',\n",
       " ('Google (компания)',\n",
       "  32,\n",
       "  0): 'Поисковик Google намерен понизить публикации телеканала RT и агентства Sputnik в своей новостной выдаче. Об этом заявил Эрик Шмидт, председатель совета директоров холдинга Alphabet, в который входит Google. В Госдуме назвали планы компании продолжением травли российских СМИ в Америке. Как отмечают депутаты, это нанесёт серьёзный удар по посещаемости ресурсов. Политологи и журналисты, опрошенные RT, сходятся во мнении, что такая мера негативно отразится на свободе слова в США. О новых способах давления на российские медиа — в материале RT. Поисковик Google намерен понизить телеканал RT и агентство Sputnik в новостной выдаче в Google.News. Об этом заявил Эрик Шмидт, председатель совета директоров холдинга Alphabet, в который входит Google. В ходе выступления на Форуме Галифакса по международной безопасности он заявил: «Мы работаем над обнаружением подобных вещей и понижением таких сайтов в новостной выдаче». Таким образом представитель компании ответил на вопрос, почему новости российских СМИ отображаются в поиске Google.News. «В основном речь идёт о сайтах RT и Sputnik», — подчеркнул он. В то же время Шмидт отметил, что компания «не хочет запрещать сайты», поскольку Google не использует подобные методы. Глава компании Alphabet заявил, что он выступает против цензуры, однако прошлый год показал, что аудитория не может самостоятельно распознать фейки. «Поначалу в США чем-то очевидным считали, что «плохой» контент заменит собой «хороший», но в прошлом году мы столкнулись с тем, что в некоторых случаях это может быть и не так, в особенности когда ваш оппонент получает хорошее финансирование и активно пытается распространять такую информацию», — заявил Шмидт. Главный редактор RT Маргарита Симоньян прокомментировала заявление Шмидта: «Господину Шмидту стоит погуглить, как три недели назад его коллеги по Google признали, что RT не нарушал никаких правил их платформы». Во время президентской кампании 2012 года Эрик Шмидт консультировал Барака Обаму по вопросам цифровых технологий. В 2015 году он предложил Хиллари Клинтон, которая ранее называла его «давним другом», аналогичное сотрудничество. Об этом говорится в письмах из почтового ящика Джона Подесты, опубликованных WikiLeaks в прошлом году. В день выборов в 2016 году Шмидт, по данным американского ресурса Politico, присутствовал в избирательном штабе Клинтон, и у него был бейдж с надписью «сотрудник». «Открытая форма войны» Если компания реализует свои планы, это станет мощнейшим ударом по RT и Sputnik, так как ссылки на них фактически исчезнут из новостей Google. Об этом заявил заместитель председателя комитета Госдумы по информационной политике, информационным технологиям и связи Андрей Свинцов. © RT «То, что они решили таким образом фактически изолировать сайты RT и Sputnik из поисковой выдачи именно в категории СМИ, говорит о том, что они нашли тот самый формат давления на наши каналы и агентства, который позволит при введении поискового запроса по той или иной тематике не видеть наши средства массовой информации. Это мощнейший удар по Sputnik и RT. Это фактически полностью уберёт из поисковой выдачи любые ссылки на эти СМИ. Это ещё более серьёзный удар, чем запрет на коммерциализацию. Это снизит посещаемость в десятки раз», — сказал депутат в разговоре с RT. В Госдуме, по его мнению, должны подумать о зеркальных мерах в отношении американских СМИ в российских поисковых системах. «Мы, как депутаты, должны подумать над тем, что, вполне возможно, придётся ограничить поисковые системы Google и определённые социальные сети, принадлежащие этому холдингу, на территории России. Это открытая форма информационной войны, которая сейчас развязалась, — это бомбардировка, прямая агрессия», — отмечает Свинцов. В Америке продолжается кампания против RT и Sputnik, считает депутат комитета Госдумы по международным делам Антон Морозов. «Это двойные стандарты. Вроде в Америке свобода СМИ, а когда RT и Sputnik начали формировать свой мейнстрим, который не совпадает с американским, уже началась травля. Точнее, её продолжение после того, как их объявили иноагентами. Западный мир всё больше становится несвободным», — полагает Морозов. Ведущий аналитик Регионального общественного',\n",
       " ('Google (компания)',\n",
       "  32,\n",
       "  1): 'центра интернет-технологий, координатор Центра безопасного интернета Урван Парфентьев, в свою очередь, заявил о безосновательности в правовом плане подобных действий Google. «Практически независимо от национальных юрисдикций принципы недопустимости ограничения конкуренции, ограничения оборота информации являются едиными. В связи с этим правовая основа для подобных действий становится не очень понятной. По сути, определённые СМИ по воле агрегатора ограничиваются в своих возможностях присутствия в этом агрегаторе и таким образом ограничиваются в донесении информации до своей целевой аудитории. На практике такие действия чётко регулируются действующим законодательством», — отметил специалист. Профессор Питтсбургского университета Дэн Ковалик считает, что инициатива Google отразится на «свободе слова и мысли» в США. «Это форма цензуры. Цель здесь — увести читателей от контента RT. Это отразится на общественном дискурсе в США. Когда кто-то начинает подвергаться цензуре, в конечном итоге ей подвергнутся все. Я считаю, что в Америке все должны быть этим возмущены и крайне обеспокоены», — сказал Ковалик. Также по теме «RT удалось напугать американское руководство» RT публикует авторскую статью журналиста Владимира Познера. Google исполняет волю американских властей, которые ведут кампанию против Москвы. Такое мнение выразил в комментарии RT американский политический обозреватель, журналист Стив Малзберг. «На данный момент Россия является врагом. В таком свете её выставляют левые, демократы и, по сути, СМИ, которые на протяжении года непрестанно называют Россию «воплощением зла». Всё, что связано с этим «злом», неизменно влечёт за собой гнев правительства, — заявляет Малзберг. — Всё потому, что их вызывали на слушания в конгресс, а также из-за охоты на ведьм, которая сейчас ведётся. <...> Они не хотят навлечь на себя гнев конгресса, и в этом заключается проблема», — подчеркнул журналист. Против кампании США по дискредитации телеканала RT выступил также российский журналист Владимир Познер. «Для меня очевидно, что уважаемые сенаторы и члены палаты представителей конгресса США просто боятся той информации, которую сообщает канал RT», — отметил Познер. «Не выявили доказательств» Ранее в Google заявили об отсутствии свидетельств нарушения политики YouTube телеканалом RT. Напомним, в американском конгрессе проходили слушания о «российском следе» в президентских выборах в США 2016 года. Одна из главных докладчиков по данному делу, компания Google, предоставила доклад с результатами внутреннего расследования, в котором говорится об отсутствии манипуляций со стороны RT и других российских государственных СМИ платформой YouTube. «К нам поступали запросы относительно использования YouTube телеканалом RT, который финансируется российскими властями. В ходе расследования мы не выявили доказательств манипуляции нашей платформой или нарушения политики сервиса, RT и другие финансируемые государством СМИ по-прежнему работают в соответствии с нашими стандартными правилами», — сообщалось в заявлении американской компании. Кроме того, директор по связям с правоохранительными органами и информационной безопасности компании Google Ричард Сальгадо признал, что RT популярен на YouTube и может получать средства благодаря рекламе. Тем не менее Минюст США потребовал, чтобы телеканал зарегистрировался в качестве иностранного агента. 13 ноября RT America выполнил требование американских властей.',\n",
       " ('Google (компания)',\n",
       "  33,\n",
       "  0): 'Google уволила 28 сотрудников за протест против контракта с властями Израиля Google уволила 28 сотрудников за бунт против сотрудничества с Израилем Фото: Spencer Platt / Getty Images Корпорация Google уволила 28 сотрудников, которые устроили протест против контракта корпорации с правительством Израиля. Об этом сообщает The Wall Street Journal со ссылкой на распространенное внутри компании электронное письмо вице-президента Google по глобальной безопасности Криса Рэкоу. Протесты проходили в офисах корпорации в Нью-Йорке и городе Саннивейл в штате Калифорния. Работники выступили против контракта Google с израильскими властями на облачные вычисления. Рэкоу в письме назвал протесты «неприемлемыми и крайне разрушительными». По его словам, протестующие заставили других сотрудников «почувствовать угрозу». «Подавляющее большинство наших сотрудников поступают правильно. <...> Если вы один из немногих, кто склонен думать, что мы собираемся игнорировать поведение, нарушающее нашу политику, подумайте еще раз», — говорится в письме вице-президента. Организаторы протестов назвали увольнение 28 сотрудников компании «явным свидетельством того, что Google ценит свой контракт на сумму $1,2 млрд с израильским правительством и военными, проводящими геноцид, больше, чем своих собственных работников». Протесты работников корпорации прошли 16 апреля. The Wall Street Journal пишет, что в Нью-Йорке была организована десятичасовая сидячая забастовка. Протестующие держали баннер с надписью «Нет технологиям для геноцида». Полицейские арестовали девять человек. В Саннивейле сотрудники компании захватили офис генерального директора Google Cloud Томаса Куриана. По информации WSJ, протестующие заявили, что планируют занимать офисные помещения Google до тех пор, пока их не арестуют или пока корпорация не расторгнет свой контракт с Израилем. Протесты вызваны израильским проектом Nibmus, в рамках которого правительство и военные структуры Израиля в 2021 году заключили с Google и Amazon контракт на предоставление услуг облачных вычислений, в том числе технологий искусственного интеллекта и машинного обучения.',\n",
       " ('Google (компания)',\n",
       "  34,\n",
       "  0): 'Google оштрафовали на 4,3 млрд евро по делу ОС Android Это рекордная сумма штрафа, эквивалентная ежегодному взносу Нидерландов в бюджет ЕС Фото: Reuters Москва. 18 июля. INTERFAX.RU - Европейская комиссия (ЕК) в среду оштрафовала Google на 4,35 млрд евро в рамках самого важного из трех антимонопольных расследований в отношении компании в Евросоюзе - по обвинениям в злоупотреблении доминирующим положением на рынке операционных систем для мобильных устройств Android. \"С 2011 года Google незаконным образом ограничивала работу производителей устройств на ОС Android и операторов мобильных сетей, чтобы закрепить доминирующее положение на рынке интернет-поиска\", - говорится в сообщении ЕК. Сумма штрафа является новым мировым рекордом для антимонопольных разбирательств, пишет агентство Bloomberg. Она вдвое меньше возможного максимума - $11 млрд, или 10% от мирового оборота Alphabet Inc., холдинговой компании Google, но существенно больше, чем прогнозировали аналитики еще весной. Для Евросоюза 4,34 млрд евро - эквивалент ежегодного взноса Нидерландов в бюджет блока. Еврокомиссия обязала Google в течение 90 дней прекратить такую \"незаконную практику\", отказавшись от ограничений для производителей смартфонов и разработчиков приложений на Android. В случае несоблюдения требований могут последовать новые штрафы и санкции в ЕС. Google объявила о намерении обжаловать решения ЕК. \"Android расширила возможности выбора для всех, а не сократила их число\", - говорится в сообщении компании. \"Наше расследование касалось трех видов ограничений Google в отношении производителей устройств Android и сетевых операторов, чтобы направить трафик с таких устройств в поисковик Google\", - заявила член Еврокомиссии по вопросам конкуренции Маргрете Вестагер. Такой подход вредит конкуренции и сокращает потребительский выбор, считают в ЕК. Операционная система Android установлена на более чем 80% используемых по всему миру смартфонов. Во-первых, Google в качестве условия лицензии на доступ к магазину приложений Play Store требовала от производителей предустанавливать поисковик Google Search и браузер Chrome на все устройства на Android. Во-вторых, компания предлагала финансовые стимулы и осуществляла незаконные выплаты некоторым крупным производителям устройств и мобильным операторам, чтобы Google Search и Chrome были единственными предустановленными приложениями в своих категориях. В-третьих, производителям, предустанавливающим приложения Google, запрещалось использовать альтернативные версии Android (forks или ответвления). В частности, компания не допускала разработку и продажу устройства на основе Fire OS - ответвления Android, созданного Amazon. Вместе с тем Еврокомиссия пришла к выводу, что Apple или Blackberry не были прямыми конкурентами Google, Android - лицензируемая операционная система, то есть устройства на ней могут разрабатывать и продавать сторонние компании. Соответственно, как отмечают аналитики, Apple вряд ли когда-либо будут предъявлены аналогичные обвинения в ЕС. О предварительных выводах расследования было объявлено еще в 2016 году. Все это время Google отрицала обвинения в нарушении антимонопольных норм ЕС, утверждая, что ЕК не понимает рынок. Дело Android является наиболее чувствительным и дорогостоящим из трех расследований Еврокомиссии в отношении Google. Оно затрагивает огромный сегмент, позволивший компании создать себе прочные позиции на рынке поиска и рекламы с помощью мобильных устройств В 2017 году регулятор оштрафовал компанию на 2,4 млрд евро в рамках дела о злоупотреблении доминирующим положением на рынке при продвижении сервиса Google Shopping. Компания подала апелляцию, однако за прошедшие почти 13 месяцев не было ни одного слушания по делу. Кроме того, ЕК продолжает расследование возможного злоупотребления Google своим положением на рынке поисковых сервисов.',\n",
       " ('Google (компания)',\n",
       "  35,\n",
       "  0): 'Google’s practice of scanning Gmail messages recently led to the arrest of a 41-year-old man who was allegedly using the service to send child pornography. Google’s controversial practice of scanning emails and analyzing users’ emails for targeted ads reportedly led to the arrest of a 41-year-old Houston man who has been charged with possessing and promoting child pornography. According to a local TV station news report, Google detected a Houston man using Gmail allegedly to send explicit images of a “young girl” to his friend. The Mountain View, Calif., tech giant reportedly alerted the authorities, who then allegedly found more child pornography on the suspect’s phone and tablet after obtaining a search warrant, KHOU reported. Advertisement The suspect, identified as John Henry Skillern, is being held on a $200,000 bond, according to the TV report, which said Skillern is a registered sex offender. The practice of Google scanning Gmail messages has been controversial and has led to lawsuits that have accused Google of illegally opening and reading emails in violation of federal wiretapping statutes. Google has argued that users agree to let Google read emails by accepting the service’s terms and privacy policy. Google says it automatically scans emails to target advertising based on words that appear in Gmail messages but says that machines, not people, do the scanning. Advertisement Late last year, Google Executive Chairman Eric Schmidt wrote a piece outlining several changes Google had made to remove child pornography from its search results, and last summer, Google announced that it was committing $5 million “to eradicate child abuse imagery online.” “We’re in the business of making information widely available, but there’s certain ‘information’ that should never be created or found,” said Google Giving Director Jacquelline Fuller in a blog. “We can do a lot to ensure it’s not available online -- and that when people try to share this disgusting content they are caught and prosecuted.” Follow me on Twitter at: @sal19',\n",
       " ('Google (компания)',\n",
       "  36,\n",
       "  0): 'В решении Еврокомиссии отмечается, что компания злоупотребляла доминирующим положением на рынке поисковых систем, искажая результаты поиска товаров, чтобы предоставить преимущество сервису Google Shopping Фото: Baz Ratner / Reuters Европейская комиссия оштрафовала компанию Google на рекордную сумму в €2,42 млрд за злоупотребление доминирующим положением на рынке поисковых систем Евросоюза. Ранее газета Financial Times сообщала, что размер наложенного Еврокомиссией штрафа может превысить €1 млрд, что уже могло установить новый рекорд. Однако итоговый размер штрафа оказался существенно выше. В сообщении Еврокомиссии отмечается, что результаты поиска товаров через поисковик Google искажались в пользу собственного сервиса компании Google Shopping. Чтобы повысить число клиентов собственного сервиса, рейтинги конкурирующих проектов существенно занижались, в результате чего их предложения не выдавались на первой странице поиска. В отчете Еврокомиссии говорится, что проведенные ею опыты показали, что предложения основного конкурента Google Shopping выдавались в среднем на четвертой странице, а предложения остальных конкурентов и того дальше. Такой подход позволял Google существенно повысить популярность собственного сервиса. Эксперты Еврокомиссии отмечают, что потребители тем чаще кликают на предложения, чем они заметнее, то есть чем выше они стоят в результатах поиска Google, и даже на настольных компьютерах (на мобильных устройствах с маленьким экраном разница еще заметнее) десять первых результатов на первой странице получают в общей сложности примерно 95% всех кликов (в том числе первый примерно 35%). Для сравнения, на долю первого результата на второй странице приходится в среднем лишь 1% кликов. «Это означает, что, предоставляя лучшее место собственному сервису сравнения покупок и понижая рейтинги конкурентов, Google предоставлял собственному сервису значительное преимущество по сравнению с конкурентами», — говорится в отчете Еврокомиссии. Отказаться от использования нечестной практики Google должен не позднее чем через 90 дней. В противном случае на компанию может быть наложен новый штраф в размере до 5% от общемировой дневной выручки ее «материнской» компании Alphabet. «То, что делал Google, по антимонопольным нормам Евросоюза является незаконным. И, что самое важное, европейские потребители лишались подлинной возможности выбора услуг», — пояснила еврокомиссар по вопросам конкуренции Маргрет Вестагер.',\n",
       " ('Google (компания)',\n",
       "  37,\n",
       "  0): 'Вы смотрите GamesBlender, еженедельный видеодайджест новостей игровой индустрии от 3DNews.ru. В этом выпуске: продажа Ubisoft, выход Nintendo Switch 2 и ворох игровых анонсов под новую консоль, русский дубляж для Alan Wake 2 и кое-что еще Игра предлагает отправиться в зону отчуждения после ядерной катастрофы… нет, это не S.T.A.L.K.E.R., это Atomfall. Впрочем, на затравке параллели с похождениями ловцов маслин и заканчиваются. Рассказываем, чем удивляет новое творение студии Rebellion, широко известной в узких кругах любителей снайперской стрельбы Принадлежащий Xiaomi технологический бренд Poco, ориентированный на молодёжную аудиторию, предлагает вниманию пользователей смартфоны среднего ценового сегмента Poco X7 Pro, Poco X7 и Poco F6. Смартфоны обладают всеми основными качествами серии Poco, включая оригинальный дизайн, мощные чипы и ёмкие батареи в сочетании с высокой надёжностью и доступной ценой Южнокорейский производитель автомобилей Hyundai Motor Group и американский разработчик роботов Boston Dynamics объявили о планах по углублению партнёрства, в рамках которого Hyundai купит у Boston Dynamics в ближайшие годы «десятки тысяч» роботов для использования в своём производстве. Сотрудничество будет способствовать росту Boston Dynamics благодаря интеграции с производственными возможностями автопроизводителя Новое в обзорах Игры Wreckfest 2 — праздник будет, но потом. Предварительный обзор На трек раннего доступа выбралась примечательная «ласточка» — сиквел аркадной гонки Wreckfest. И пусть эту тачку ещё предстоит изрядно прокачать, но почувствовать кураж контактных заездов и безудержного автобезумия можно уже сейчас. На сколько кругов хватит бензина проекту в его текущем состоянии, расскажем в нашем предварительном обзоре Программное обеспечение Обзор системы резервного копирования и восстановления данных «Кибер Бэкап Малый Бизнес» В деле обеспечения непрерывности рабочих процессов и защиты важной информации не бывает мелочей. Грамотно и — самое главное — максимально эффективно подойти к решению этого вопроса позволяет новый продукт российской компании «Киберпротект», в полной мере отвечающий потребностям индивидуальных предпринимателей и малых предприятий Корпуса, БП и охлаждение Выбираем кулер для процессора Intel LGA1700 до 2 000 рублей Какой из недорогих башенных кулеров сможет охладить процессор при минимальном уровне шума? Моделей стоимостью до двух тысяч рублей на самом деле несколько десятков, поэтому, чтобы выбрать из них наиболее удачный, приходится перелопатить не один обзор, но и это зачастую не помогает определиться. А вот мы поможем! Смартфоны Обзор смартфона HONOR Magic 7: зачем платить больше? В этом году HONOR, несмотря на задранные цены, делает на флагманскую серию Magic 7 большую ставку. И да, здесь нет ошибки — именно серию. Если год назад на российский рынок выходил одинокий HONOR Magic6 Pro, то сейчас наряду с «прошкой» анонсирован и HONOR Magic 7 – упрощенная версия флагмана. Но «на бумаге» она кажется во многом даже более интересной! Игры Assassin’s Creed Shadows — мы ждали этого почти двадцать лет. Рецензия В 2027 году серии Assassin’s Creed исполнится двадцать лет, и на протяжении всего этого времени аудитория постоянно просила Ubisoft сделать «ассасина» в японском антураже. Желание исполнено — теперь пробуем понять, не опоздала ли студия с этим Игры Selaco — неоновый кураж. Предварительный обзор Когда-то шутер F.E.A.R. произвёл революцию комбинацией взрывной зрелищности и необычайной хитрости врагов. Недавно студия-разработчик Monolith была закрыта, так что продолжение серии мы уже вряд ли когда-нибудь увидим. Но её духовная наследница подаёт большие надежды — насколько Selaco верна идеям F.E.A.R., рассказываем в нашем предварительном обзоре Мониторы и проекторы Обзор 4K IPS-монитора Digma Pro Art S: чёткий стиляга Ищете стильный 4К-монитор в пару к вашему современному ноутбуку или просто предпочитаете минимализм и порядок на рабочем столе? Удивительно, но таких моделей в продаже не так много, а одна из них представлена в ассортименте бренда Digma Pro ServerNews Rikor — это база: обзор российской серверной платформы Rikor 7212 Rikor 7212 — это российская двухсокетная 2U-платформа на базе Intel Xeon Ice Lake-SP с хорошими возможностями расширения. Она основана на востребованном, пусть и не самом новом, поколении',\n",
       " ('Google (компания)',\n",
       "  37,\n",
       "  1): 'процессоров, произведена в РФ и создана с учётом особенностей локального рынка Смартфоны Обзор смартфона OnePlus 13: дитя унификации — и это даже к лучшему C некоторым опозданием, но все же рассказываем об очередном флагмане бренда OnePlus (никак не привыкну, что у него бывают «не флагманы»), почти завершая тем самым серию разговоров о «зимних» топ-смартфонах (почти — потому что мы еще поговорим о некоторых младших версиях уже знакомых нам аппаратов) Искусственный интеллект Мастерская локальных ИИ: беседы с компьютером о прекрасном Мощность нейросети, что лежит в основе генеративной T2I-модели FLUX.1, — 12 млрд параметров, тогда как у чат-бота DeepSeek R1 — 671 млрд параметров. Неудивительно, что генерировать картинки даже на слабеньком игровом ПК ещё выходит за разумное время, а вот поболтать по душам с запущенным локально ИИ навряд ли удастся. Так что же, одни лишь облачные универсальные модели по-настоящему полезны? Смартфоны Обзор realme 14 Pro+: смартфон-хамелеон, который любит мороз Компания realme обновляет свою номерную серию раз в полгода — и пришла пора очередной итерации. Причем прошлое обновление не добралось до официальной российской розницы, а вот на realme 14 Pro+ бренд делает очень серьезную ставку Видеокарты Radeon RX 9070 XT против GeForce RTX 5070 Ti Новые «Радеоны» вышли на рынок без особой помпы и не претендуют на лидирующее быстродействие, но AMD сделала главное — повысила скорость рейтрейсинга и внедрила масштабирование кадров с помощью ИИ. Тестирование выполнено на примере устройств GIGABYTE GAMING OC и Palit GamingPro Мониторы и проекторы Обзор игрового 4K IPS-монитора Bloody MN272U: кровавые игры На рынке настольных мониторов в РФ появляется все больше новых брендов, а цены на актуальные решения становятся всё ниже – конкуренция играет на руку потребителям. Очередным новичком, представившим фирменную серию мониторов и пожелавшим присоединиться к борьбе за долю рынка, стал бренд Bloody',\n",
       " ('Google (компания)',\n",
       "  38,\n",
       "  0): 'Причиной является якобы нарушение европейских норм БРЮССЕЛЬ, 18 сентября. /ТАСС/. Европейский суд юстиции аннулировал наложенный Еврокомиссией (ЕК) в 2019 году штраф на американскую компанию Google в размере почти €1,5 млрд из-за якобы нарушения европейских норм. Об этом говорится в решении, обнародованном судом ЕС. \"Суд общей юрисдикции поддерживает большинство выводов Еврокомиссии, но отменяет решение, которым Еврокомиссия наложила штраф в размере почти €1,5 млрд на Google, на том основании, в частности, что она не приняла во внимание все соответствующие обстоятельства при оценке срока действия положений договора, которые Еврокомиссия сочла злоупотребляющими\", - отмечается в документе. По мнению суда ЕС, \"Еврокомиссия не установила, что три положения, которые она определила, представляли собой злоупотребление доминирующим положением и вместе составляли единое и непрерывное нарушение статьи 102 договора ЕС\". \"Суд общей юрисдикции отменяет решение Еврокомиссии в полном объеме\", - говорится в нем. На прошлой неделе Европейский суд в Люксембурге постановил, что американская корпорация Google должна заплатить €2,4 млрд в качестве штрафа, наложенного Еврокомиссией в 2017 году за нарушения правил конкуренции Евросоюза. В решении суда говорилось, что штраф был наложен \"на Google за злоупотребление своим доминирующим положением путем поддержки собственного шоппинг-сервиса\". Еврокомиссия за последние годы санкционировала многомиллиардные штрафы ведущим американским цифровым корпорациям, включая Microsoft, Google и Amazon, за нарушение правил ЕС в сфере конкуренции на цифровом рынке. В феврале более 30 медийных организаций Европы предъявили американской корпорации Google иск, потребовав от нее возмещения ущерба на сумму около €2,1 млрд. Они настаивали на том, что Google злоупотребляла своим доминирующим положением на рекламном рынке.',\n",
       " ('Google (компания)',\n",
       "  39,\n",
       "  0): 'https://ria.ru/20240918/google-1973340881.html Суд Евросоюза отменил решение ЕК по штрафу в отношении Google Суд Евросоюза отменил решение ЕК по штрафу в отношении Google - РИА Новости, 18.09.2024 Суд Евросоюза отменил решение ЕК по штрафу в отношении Google Суд Евросоюза общей юрисдикции отменил решение Европейской комиссии о штрафе в размере 1,5 миллиарда евро в отношении Google за злоупотребление доминирующим... РИА Новости, 18.09.2024 2024-09-18T10:56:00+03:00 2024-09-18T10:56:00+03:00 2024-09-18T11:10:00+03:00 экономика еврокомиссия google россия брюссель технологии евросоюз https://cdnn21.img.ria.ru/images/155858/31/1558583174_0:113:3076:1843_1920x0_80_0_0_3e51ece616a55899cc276214783d8608.jpg БРЮССЕЛЬ, 18 сен - РИА Новости. Суд Евросоюза общей юрисдикции отменил решение Европейской комиссии о штрафе в размере 1,5 миллиарда евро в отношении Google за злоупотребление доминирующим положением на рынке интернет-рекламы, говорится в заявлении суда.\"Суд подтверждает большинство оценок Еврокомиссии, но отменяет решение, в соответствии с которым ЕК оштрафовала Google на 1,5 миллиарда евро\", - говорится в документе.По мнению суда, Еврокомиссия не учла все обстоятельства, связанные с нарушениями, в частности, сроки действия положений контрактов, которые в Брюсселе сочли нарушающими правила конкуренции.Речь идет о решении суда первой инстанции, которое еще может быть опротестовано.Еврокомиссия в 2019 году решила оштрафовать Google почти на полтора миллиарда евро за то, что компания якобы навязывала сайтам положения в контрактах, запрещавшие размещение рекламы у конкурентов. Такие нарушения фиксировались с 2006 до 2016 года. Предварительное расследование было открыто еще в 2010 году.СМИ сообщали, что антимонопольные регуляторы Евросоюза изучают возможность потребовать от Google разделения рекламно-технологического подразделения в рамках новой антимонопольной жалобы. Чиновники ЕС, по данным СМИ, рассматривают возможность предписать Google продать некоторые части своего рекламно-технологического бизнеса.В последние годы Еврокомиссия ужесточила меры контроля в отношении крупных международных интернет-платформ.В 2022 году был утвержден Закон о цифровых рынках (Digital Markets Act, DMA). Этот закон, по замыслу авторов, нацелен \"сделать рынки цифрового сектора более справедливыми и конкурентными\", предоставить больше выбора и свободы конечным пользователям. К примеру, он обязывает компании разрешать установку сторонних приложений и позволять пользователям более легко изменять настройки. В ЕС указывали, что DMA - один из первых инструментов эффективного регулирования деятельности крупнейших цифровых компаний. Он призван дополнить, но не изменить правила конкуренции в ЕС.Позже Европейская комиссия определила шесть крупных цифровых компаний, которые обязаны привести деятельность принадлежащих им социальных сетей, цифровых торговых площадок и поисковых систем в соответствие с новым европейским законом о цифровых рынках. Распоряжение Еврокомиссии касается таких компаний, как Alphabet, Amazon, Apple, ByteDance, Meta* и Microsoft.На прошлой неделе Суд ЕС окончательно утвердил штраф в размере 2,4 миллиарда евро, наложенный решением Еврокомиссии еще в 2017 году за злоупотребление доминирующей позицией на рынке положением и продвижение своей услуги сравнения товаров Google Shopping. Компания Google и владеющий ей холдинг Alphabet пытались оспорить это решение в европейских судах. *Деятельность Meta (соцсети Facebook и Instagram) запрещена в России как экстремистская https://ria.ru/20240828/smi-1969026655.html https://ria.ru/20240918/mask-1973326057.html https://ria.ru/20240825/durov-1968352551.html россия брюссель РИА Новости 1 5 4.7 96 internet-group@rian.ru 7 495 645-6601 ФГУП МИА «Россия сегодня» https://xn--c1acbl2abdlkab1og.xn--p1ai/awards/ 353 60 353 60 2024 РИА Новости 1 5 4.7 96 internet-group@rian.ru 7 495 645-6601 ФГУП МИА «Россия сегодня» https://xn--c1acbl2abdlkab1og.xn--p1ai/awards/ 353 60 353 60 Новости ru-RU https://ria.ru/docs/about/copyright.html https://xn--c1acbl2abdlkab1og.xn--p1ai/ РИА Новости 1 5 4.7 96 internet-group@rian.ru 7 495 645-6601 ФГУП МИА «Россия сегодня» https://xn--c1acbl2abdlkab1og.xn--p1ai/awards/ 353 60 353 60 1920 1080 true 1920 1440 true 1920 1920 true РИА Новости 1 5 4.7 96 internet-group@rian.ru 7 495 645-6601 ФГУП МИА «Россия сегодня» https://xn--c1acbl2abdlkab1og.xn--p1ai/awards/ 353 60 353 60 РИА Новости 1 5 4.7 96 internet-group@rian.ru 7 495 645-6601 ФГУП МИА «Россия сегодня» https://xn--c1acbl2abdlkab1og.xn--p1ai/awards/ 353 60 353 60 экономика, еврокомиссия, google, россия, брюссель, технологии, евросоюз',\n",
       " ('Google (компания)',\n",
       "  4,\n",
       "  0): 'Google Workspace (formerly known as \"G Suite\") is a brand of cloud computing, productivity and collaboration tools, software and products developed by Google. University IT (UIT) makes these tools available for use at the university. Features Google Drive Google Drive is also the home of Google Docs. Access files, folders and Google Docs from a web browser or any device on which Google Drive is installed. Google Drive Google Shared drives Google Docs Collaboration Google collaboration tools allow you to easily interact with others and share information. Google Groups Google Sites Google Chat Email & Calendar Since 2015, student email accounts are provisioned in Microsoft 365. Students who have Google email accounts, plus some schools and departments, can continue to use Gmail to access their @stanford.edu email and calendar. Google Workspace Email and Calendar Following are additional Google Workspace applications that are available for use: Google Sheets Google Slides Google Forms Google Keep Google Photos Google Contacts Google Meet Google ClassRoom The following Google Workspace applications are available upon request and might have a per user, per month fee associated with their use: Google Vault Designed for Faculty, staff, and students. Requirements A full-service SUNet ID. Data security Google Workspace applications are approved for the following Risk Classifications as defined by the Information Security Office. Risk Classification Applications All classifications - High Risk & PHI only if Secure: is used in the subject line. Google Mail All classifications except Protected Health Information (PHI) Cardinal Key is required to store PHI data in Stanford’s Google Drive. Review applicable requirements. Google Docs Google Drive Google Forms Google Sheets Google Slides Google Shared drives Low and Moderate Risk Only Google Calendar Google ClassRoom Google Contacts Google Groups Google Chat Google JamBoard Google Keep Google Meet Google Photos Google Sites Google Vault Get started To start using any of the Google Workspace applications, access the application and login. How to Login to Google Workspace contains detailed instructions for the various ways you can login to and use Google Workspace applications. Get help Google carefully documents how to use the applications that are part of Google Workspace. Refer to their documentation for help. Google Help If you still need help, please submit a Help ticket.',\n",
       " ('Google (компания)',\n",
       "  40,\n",
       "  0): 'Штраф выписан за то, что \"корпорация не вела должным образом переговоры с издателями прессы о применении смежных прав, о вознаграждении редакторов за использование их контента\" ПАРИЖ, 13 июля. /ТАСС/. Антимонопольный регулятор Франции выписал штраф в отношении корпорации Google в размере €500 млн. Об этом говорится в сообщении регулятора, обнародованном во вторник на его сайте. В нем отмечается, что \"регулятор оштрафовал компанию за невыполнение нескольких судебных постановлений, вынесенных в апреле 2020 года\". Как отмечает Agence France-Presse, штраф выписан за то, что \"корпорация не вела должным образом переговоры с издателями прессы о применении смежных прав, о вознаграждении редакторов за использование их контента\". \"Когда регулятор делает предписания в отношении компаний, то они должны скрупулезно выполняться. В данном случае этого не произошло\", - сказала глава антимонопольного ведомства Франции Изабель де Сильва, комментируя решение о наложении штрафа на Google. В апреле прошлого года Евросоюз одобрил директиву, усиливающую контроль за соблюдением законодательства об авторском праве при размещении работ в интернете. Помимо прочего, она расширяет права издателей СМИ, позволяя им получать вознаграждение при использовании их материалов интернет-платформами. Документ при этом разрешает сайтам свободно размещать адресные ссылки на статьи и другие материалы СМИ. В конце июля 2019 года на основе этой директивы во Франции был принят закон о \"создании смежного права в интересах информационных агентств и редакторов СМИ\". Согласно этому документу, новостные агрегаторы, соцсети и иные интернет-платформы должны платить вознаграждение СМИ за публикацию их материалов в рамках специального соглашения. Размер выплат зависит не только от вложений издания в создание конкретного материала, но и от того, какую выгоду агрегатор получает от размещения соответствующих материалов.',\n",
       " ('Google (компания)',\n",
       "  41,\n",
       "  0): 'ИТ-компании впервые получили многомиллиардные оборотные штрафы за неудаление запрещенного контента. Google и Facebook, скорее всего, оспорят их, но им придется удалить ссылки, иначе они рискуют лишиться рекламных доходов в России Фото: Sean Gallup / Getty Images В пятницу, 24 декабря, судебный участок мирового судьи № 422 Таганского района назначил оборотный штраф Google LLC (входит в холдинг Alphabet) в размере 7,221 млрд руб. и Meta Platforms Inc. (до недавнего времени — Facebook Inc., владеет одноименной соцсетью, Instagram, WhatsApp и Oculus) в размере 1,99 млрд руб. Обе компании обвинялись в том, что не удалили размещенную на их ресурсах информацию, признанную запрещенной в России. Как заявляли ранее представители Роскомнадзора, принадлежащий Google видеохостинг YouTube, а также Facebook и Instagram не удаляли материалы экстремистских и террористических организаций, разжигающие религиозную рознь, оскорбляющие чувства верующих или направленные на раскол государства, пропагандирующие употребление наркотических средств, демонстрирующие места реализации самодельного оружия и др. В отношении Google в этом году российский суд рассмотрел 16 административных протоколов за неудаление противоправной информации в установленный срок. По состоянию на октябрь сервис не удалил около 2,6 тыс. материалов и был привлечен к административной ответственности на 37,5 млн руб., говорили ранее в Роскомнадзоре. В отношении Meta Platforms с начала года суд рассмотрел 19 административных протоколов, сумма штрафов составила 70 млн руб. Ранее глава комитета Госдумы по безопасности и противодействию коррупции Василий Пискарев заявлял, что Google выплатила 32,5 млн руб. Как считали штраф Наказание в виде оборотных штрафов за неудаление запрещенного контента применяется в России впервые. Согласно ч. 5 ст. 13.41 КоАП, при повторном нарушении суд имеет право применить оборотный штраф в размере от 1/20 до 1/10 выручки за год, предшествующий году, в котором было выявлено правонарушение, но не менее 4 млн руб. Исходя из этого, можно предположить, что выручка Google в России может составлять от 72 млрд до 144 млрд руб., а Facebook — от 19 млрд до 38 млрд руб. По данным СПАРК, выручка российской «дочки» Google ООО «Гугл» в 2020 году составляла 85 млрд руб., а чистая прибыль — 1,73 млрд руб. У Facebook нет юрлица в России. Представитель Роскомнадзора не пояснил, как рассчитывались суммы штрафов. По словам ведущего юриста проекта «Роскомсвобода» Саркиса Дарбиняна, методика подсчета оборотных штрафов для иностранных компаний — это для него и многих других экспертов «темный лес». «Ни Facebook, ни Google не имеют филиалов в России, а значит, нет никаких документов, по которым можно судить, сколько они зарабатывают. Все, что есть, — отчетность юрлица ООО «Гугл», состоящего из двух человек и агрегирующего платежи за рекламу, но это далеко не все платежи, у Google в России есть еще платежи, которые идут через партнерские сети и т.д. Предполагаю, что взяли общую глобальную выручку, посмотрели, какое количество аудитории относится к России, и поделили эту выручку на аудиторию из России, прикинув, что она может представлять какой-то объем», — рассуждает Дарбинян. По итогам 2020 года выручка сервисов Google составляла $168,635 млрд (12,2 трлн руб. по среднему курсу за тот год). У Google было около 1 млрд активных пользователей в месяц, у YouTube — 2,1 млрд. Выручка Meta Platforms составляла $85,965 млрд (6,2 трлн руб.). На конец прошлого года у Facebook было 2,8 млрд пользователей в месяц, а у семейства продуктов корпорации (Facebook, Instagram и мессенджер) — 3,3 млрд. Как эти показатели распределялись по странам, компании не раскрывают. Будут ли платить Google и Facebook Представитель Google в ответ на вопросы РБК лишь заявил, что компания «изучит решение суда и после этого определит дальнейшие шаги». Представитель Meta Platforms не ответил на вопросы РБК. Административный штраф должен быть уплачен в течение 60 дней со дня вступления в силу постановления, отметил адвокат BMS Law Firm Александр Иноядов. Суд может отсрочить исполнение постановления на срок до одного месяца при',\n",
       " ('Google (компания)',\n",
       "  41,\n",
       "  1): 'наличии определенных обстоятельств. В случае уклонения от исполнения такого вида наказания административный штраф накладывается в двойном размере, что следует из ч. 1 ст. 20.25 КоАП, подчеркнул Иноядов. В то же время он считает наиболее вероятным, что постановление мирового судьи будет обжаловано и не вступит в законную силу. Для Google это не первый крупный штраф в России. В сентябре 2015 года Федеральная антимонопольная служба признала Google виновной в злоупотреблении доминирующим положением: являясь владельцем операционной системы Android, компания запрещала производителям мобильных устройств предустанавливать на них конкурирующие приложения, в частности поиск от «Яндекса». ФАС назначила штраф Google и выдала предписание об устранении нарушений. Компания оспорила штраф и уплатила его в размере 450 млн руб. только после 2,5-летнего разбирательства. По мнению главного аналитика Российской ассоциации электронных коммуникаций (РАЭК) Карена Казаряна, Google, скорее всего, будет действовать в рамках закона, но сделать такой же прогноз для Facebook нельзя, потому что прецедентов не было. В то же время он считает, что обе компании постараются затянуть процесс оспаривания штрафа в суде. Есть ли угроза блокировки Google и Facebook По словам Иноядова, неуплата административного штрафа не является основанием для блокировки ресурса в России. Эксперты напоминают, что летом в России был принят так называемый закон о приземлении, по которому с 1 января 2022 года международные ИТ-компании с суточной аудиторией более 500 тыс. пользователей должны открыть в России филиал, представительство или уполномоченное юридическое лицо. В числе мер понуждения к исполнению требований российского законодательства в документе перечислялись: информирование пользователей ресурса иностранной компании о том, что она нарушает законодательство; запрет на распространение рекламы на этом ресурсе, а также на рекламирование его самого; ограничение на территории России денежных переводов в пользу владельца ресурса от физических и юридических лиц; запрет на поисковую выдачу, трансграничную передачу данных; замедление скорости доступа к ресурсу, а также его блокировка. Ранее Роскомнадзор составил реестр ИТ-компаний, которые подпадают под действие этого закона и должны открыть в России представительство, Google и Meta Platforms оказались в нем. «С 1 января начинается другая форма взаимодействия с иностранными компаниями, и как она будет реализована на деле, пока неизвестно», — отметил Казарян. Представитель Роскомнадзора заявил, что если Google и Meta и после назначения оборотных штрафов не удалят запрещенные материалы, то их снова привлекут к административной ответственности и назначат новые оборотные штрафы. Ранее замглавы Роскомнадзора Вадим Субботин говорил, что они рассматривают замедление и блокировку зарубежных интернет-ресурсов как «последнюю меру, когда другие аргументы уже не работают». Он также говорил, что власти не намерены вводить немедленные санкции, если зарубежные ИТ-компании не успеют открыть представительства в России до 1 января 2022 года. «Закон [о «приземлении»] содержит в себе несколько новых и интересных механизмов, позволяющих принудить компанию к исполнению решения суда. При наихудшем раскладе Google может потерять сумму, которая значительно превосходит сумму назначенного штрафа», — говорит зампредседателя комиссии Ассоциации юристов России по новым технологиям и правовому обеспечению цифровизации общества Дмитрий Липин. Он считает, что при выборе мер власти будут исходить из интересов российских пользователей и что Google и Facebook стоит в первую очередь опасаться сокращения поступления средств от российских рекламодателей. В марте этого года Роскомнадзор замедлил скорость доступа к Twitter из-за того, что эта платформа также не удаляла запрещенный в России контент. В мае доступ к соцсети был восстановлен, после того как она удалила более 90% запрещенных материалов.',\n",
       " ('Google (компания)',\n",
       "  42,\n",
       "  0): '885 российских компаний подали заявления о включении их требований в иск о банкротстве ООО «Гугл» (российское юрлицо Google), сообщают «Ведомости» со ссылкой на судебную картотеку. В числе подавших заявления — «Российская газета», АО «Росбизнесконсалтинг», АО «Коммерсантъ», IТ-компании ООО «1С-Битрикс» и ООО «Нетология». Выйти из полноэкранного режима Развернуть на весь экран Фото: Andrew Kelly/File Photo, Reuters Фото: Andrew Kelly/File Photo, Reuters По данным газеты, только в реестр требований кредиторов третьей очереди к «Гугл» вошло 66 компаний, сумма их требований составляет 105 млн руб. Крупнейшие кредиторы — ООО «Шкулев медиа» (с требованиями на 31,2 млн руб.) и АО «ВТБ лизинг» (24,3 млн руб.). Большинство исков связано с неоказанием услуг по размещению рекламы. В Роскомнадзоре заявили, что Google до сих пор не уплатил 19,6 млрд руб. штрафа. «Общая сумма назначенных судом штрафов — 28,3 млрд руб., из которых только 62 млн компания оплатила добровольно, а более 8,7 млрд принудительно взыскано приставами»,— добавил представитель ведомства. В декабре 2021 года суд по заявлению Роскомнадзора наложил на компанию оборотный штраф в 7,2 млрд руб. за неудаление запрещенной информации. Менее чем за полгода штраф вырос на 0,5 млрд руб. за счет исполнительского сбора. В мае 2022 года приставы заявили, что взыщут с компании еще 4 млн руб., а спустя неделю на счетах Google арестовали 500 млн руб. по иску ВГТРК. В июне российская «дочка» Google подала заявление о банкротстве. Лаура Кеффер',\n",
       " ('Google (компания)',\n",
       "  43,\n",
       "  0): 'Арбитражный суд Москвы признал банкротом ООО «Гугл» — российскую дочернюю компанию американской корпорации Google, после чего в компании было открыто конкурсное производство. Об этом говорится 18 октября в решении суда. Известно, что начальную процедуру банкротства — наблюдение — в ООО «Гугл» инициировали в ноябре 2022 года решением Девятого арбитражного апелляционного суда по собственному заявлению компании. По данным на конец августа, когда состоялось первое собрание кредиторов «Гугла», в реестр их требований были включены голосующие требования на сумму около 20,2 млрд рублей. Основным кредитором в реестре выступает Федеральная налоговая служба РФ, предъявившая требования в размере около 19,6 млрд рублей. До этого, 17 августа, мировой суд в Москве оштрафовал американскую компанию Google на 3 млн рублей за неудаление информации, запрещенной в РФ. Как сообщил корреспондент «Известий» из зала суда, сервис распространял данные о способах нелегального проникновения на охраняемые объекты, представляющие собой опасность для жизни и здоровья. Кроме того, удалению подлежали видео, содержащие недостоверные данные о спецоперации на Украине. Позже, 16 сентября, сообщалось, что в США началось разбирательство по иску властей к Google. Компанию обвиняют в создании искусственных барьеров для конкурентов на рынке интернет-поиска. Государственный обвинитель от минюста США отметил, что Google платит более $10 млрд за удержание своих позиций. Так, в смартфонах Apple поиск Google установлен по умолчанию, что ограничивает пользователей от сервисов конкурентов. Прокуроры заявили, что компания использует эту нездоровую практику более 15 лет.',\n",
       " ('Google (компания)',\n",
       "  44,\n",
       "  0): '(Fortune Magazine) -- Google co-founders Larry Page and Sergey Brin and CEO Eric Schmidt take Google\\'s reputation seriously. When informed that Google would be named the best company to work for, for the second year running, they agreed to sit for a rare three-way interview with Fortune\\'s Adam Lashinsky. Here are snippets of the hourlong chat. How do you maintain Google\\'s culture as the company gets bigger and bigger? Page: I think as we get bigger, the way we\\'re going to try to maintain our culture is to make sure we have the right-sized groups. I just visited our new office in the Seattle area. It really felt like Google (GOOG, Fortune 500) felt when we were a couple hundred people. There is sort of a natural size for human organizations, and I think to the extent we\\'re able to create groups that are those sizes, we can retain a lot of that culture. Brin: I actually don\\'t think keeping the culture is a goal. I think improving the culture is. We shouldn\\'t be, like, looking back to our golden years and saying, \"Oh, I wish it was the same.\" So as you grow, how do you Google-ize the companies you acquire? Page: We don\\'t. For example, YouTube has remained largely a division. They\\'re in San Bruno [north of the main campus in Mountain View, Calif.] and have their own culture, which is different and cool. Your perks are famous, but they\\'re not permanent. You recently killed the $5,000 hybrid-car subsidy, for example, and replaced it with a three-tiered incentive that promotes fuel efficiency. Why? Brin: The goal behind the original policy was that we wanted to encourage cleaner technologies. But by encourage, I don\\'t mean we wanted to subsidize them forever. By any measure, Google treats employees incredibly well. Is it possible to treat them too well? Page: My grandfather worked in the auto plants in Flint, Mich. He was an assembly-line worker. During the sit-down strikes he used to carry this long iron pipe with a big chunk of lead on the end when he walked to work. Schmidt: For what reason? Page: To protect himself from the company. I still have the hammer. That\\'s two generations ago, and we\\'ve come a long way. I don\\'t think any of our employees have to carry such weapons to work. At least I hope they don\\'t. But that\\'s a big change in two generations. It\\'s common sense: Happy people are more productive. Will you all work at Google for the rest of your careers? Schmidt: We agreed to work together for how long, gentlemen? Brin: Twenty years. Really? When did you make that agreement? Schmidt: Two years, seven months, and four days ago. But who\\'s counting? Actually, we agreed the month before we went public that we would work together for 20 years. I will be 69, and according to Google I\\'m going to live to 84, so I should be fine. Is it possible for a successful company like Google to adequately prepare for the moment when it could suffer a major hiccup? Post your thoughts on the Go West blog.',\n",
       " ('Google (компания)',\n",
       "  45,\n",
       "  0): 'Согласно решению суда, RT, \"Царьград\" и \"Спас\" теперь не могут начинать новые или продолжать текущие судебные разбирательства против компании в любых юрисдикциях, кроме США и Великобритании ЛОНДОН, 22 января. /ТАСС/. Высокий суд Англии и Уэльса удовлетворил ходатайство компании Google о защите от исков со стороны российских телеканалов RT, \"Царьград\" и \"Спас\". Как говорится в распространенном решении судьи Эндрю Хеншоу, выданный им запрет ограничивает право трех ответчиков начинать новые или продолжать текущие судебные разбирательства против Google в любых юрисдикциях, кроме Великобритании и США. \"В [вынесенных в РФ] судебных решениях, исполнения которых ответчики пытаются добиться за границей, указываются неслыханные, поистине запредельные суммы штрафов, которые (по крайней мере сейчас) никак не соотносятся с каким-либо компенсируемым ущербом\", - полагает судья. Он отметил, что суммы, о которых идет речь, делают рассматриваемый им случай уникальным. Ранее российский суд назначил штраф Google в размере 2 ундециллионов рублей в связи с тем, что компания не восстановила аккаунты российских медиа в YouTube (видеохостинг принадлежит Google). Речь идет о телеканалах \"Звезда\", Первый канал, ВГТРК (телеканалы \"Россия-1\", \"Россия-24\" и др.), \"Парламентское телевидение\", \"Москва медиа\", \"ТВ Центр\", НТВ, \"ГПМ Развлекательное телевидение\", \"Общественное телевидение России\", \"360\", \"ТРК Петербург\", \"Фонд православного телевидения\", \"Национальный спортивный телеканал\", ТК \"Центр\", а также YouTube-канал главного редактора RT Маргариты Симоньян. За неисполнение решения суда в течение девяти месяцев с момента его вступления в силу начисляется ежедневная неустойка 100 тыс. рублей, которая удваивается каждую неделю без ограничения общей суммы. Согласно оценкам компании, занимавшейся ликвидацией российского представительства Google, по состоянию на май 2024 года общая сумма штрафа превышала суммарный ВВП всех стран мира в 20 трлн раз. С целью взыскать часть этой суммы с американской компании российские телеканалы подали иски против Google в суды нескольких государств. В марте 2022 года в Google было принято решение приостановить работу российских каналов на YouTube. Среди них оказались Первый канал, \"Россия-1\", \"Россия-24\", ТНТ, НТВ, RT, \"Москва-24\", РБК и \"Пятый канал\". Причиной в компании назвали государственное финансирование этих медиа и публикацию ими материалов о специальной военной операции на Украине.',\n",
       " ('Google (компания)',\n",
       "  46,\n",
       "  0): 'Сумма требований российских телеканалов к Google из-за блокировки аккаунтов на YouTube возросла до ₽2 ундециллионов. Суд обязал компанию восстановить доступ, и пока она это не сделает, неустойка ежедневно растет Фото: Justin Sullivan / Getty Images Общая сумма требований 17 российских телеканалов к Google достигла 2 ундециллионов рублей, рассказал источник РБК, знакомый с ходом спора. Ундециллион — это единица с 36 нулями. В ходе очередного заседания суда, которое состоялось в понедельник, 28 октября судья упомянул, что рассматривает «дело, в котором много-много нулей». Указанный штраф российский суд назначил Google из-за того, что компания не выполнила требование восстановить аккаунты российских медиа на YouTube (видеохостинг принадлежит Google). Пострадавшими в качестве третьих лиц в деле проходят телеканалы «Звезда», «Первый канал», ВГТРК (телеканалы «Россия 1», «Россия 24» и др.), «Парламентское телевидение», «Москва Медиа», «ТВ-Центр», НТВ, «ГПМ Развлекательное телевидение», «Общественное телевидение России», «Телеканал 360», «ТРК Петербург», «Фонд православного телевидения», «Национальный спортивный телеканал», «Технологическая компания Центр», а также ИП Симоньян М.С., представляющий YouTube-канал телеведущей Маргариты Симоньян. По вышеуказанным искам суд ранее обязал Google восстановить их аккаунты на YouTube, а в случае неисполнения требований — взыскать неустойку. Если решение суда не будет выполнено в течение девяти месяцев с момента его вступления в силу, за каждый день неисполнения начисляется штраф в размере 100 тыс. руб. Сумма удваивается каждую неделю, пока решение не будет выполнено, без ограничения общей суммы штрафа. Другой участник процесса рассказал, что в сентябре общий размер штрафа составлял почти 13 дециллионов (единица с 33 нулями). Как российские телеканалы судятся с Google Суды российских медийных компаний с Google начались в 2020 году после того, как YouTube заблокировал аккаунты телеканала «Царьград» и РИА ФАН «в связи с нарушениями законодательства о санкциях и правил торговли» (владельцы этих ресурсов находятся под санкциями США с конца 2014-го). В августе 2020 года «Царьград» обратился в Арбитражный суд Москвы с требованием отменить решение о блокировке. Ответчиками выступали американская Google LLC, ирландская Google Ireland, а также представитель российского ООО «Гугл». Весной 2021 года столичный суд обязал Google вернуть «Царьграду» доступ к заблокированным аккаунтам под угрозой начисления прогрессивного штрафа при неисполнении этого решения. После начала специальной военной операции на Украине в феврале 2022 года YouTube заблокировал аккаунты Sputnik, НТВ и «Россия 24», чуть позже — RT, все российские госканалы, каналы «Гостелерадиофонда», «Спас», каналы информационного агентства «Аврора», «Дума ТВ», региональные филиалы ВГТРК и др. В феврале 2022 года Федеральная антимонопольная служба (ФАС) признала Google LLC нарушившей статью закона «О защите конкуренции» из-за злоупотребления доминирующим положением, поскольку YouTube произвольно блокировал аккаунты и каналы российских вещателей. ФАС потребовала с компании штраф в размере 2 млрд руб., а позже увеличила сумму до 4 млрд руб. в связи с неуплатой. Через месяц ООО «Гугл» частично удовлетворило требования «Царьграда» и, по словам представителя этого канала, им выплатили 1 млрд руб. Что происходит с Google в России В июне 2022 года российское юрлицо Google — ООО «Гугл» — подало заявление о банкротстве. Представитель компании объяснял это тем, что к тому моменту долги превышали 19 млрд руб., а активов было всего на 3,5 млрд руб. В ноябре 2023 года суд признал «Гугл» банкротом. Среди прочих в реестр кредиторов были включены требования от телеканала «Царьград», которому в августе 2024-го Верховный суд подтвердил задолженность в размере 32,7 млрд руб. «Царьград» был первым телеканалом, который подал в суд на Google, поэтому его требование было включено в общий реестр кредиторов, а неустойка перестала начисляться, — пояснил РБК источник, знакомый с ходом дела. — Все остальные телеканалы управляющий квалифицировал как текущих кредиторов, требования которых погашаются раньше реестра, а неустойки продолжают начисляться». Выручка ООО «Гугл» в 2022 году составила 24,17 млрд руб., чистый убыток — 10,2 млрд руб. Сейчас конкурсный управляющий ООО «Гугл» Валерий Таляровский пытается привлечь к ответственности зарубежное юрлицо',\n",
       " ('Google (компания)',\n",
       "  46,\n",
       "  1): 'компании — Google Ireland Limited, требуя через суд признать недействительными платежи в его пользу от российского юрлица. Среди требований в том числе есть начисление процентов до момента фактического возврата средств. Кроме того, управляющий просит привлечь к ответственности бывших топ-менеджеров ООО «Гугл»: гендиректора Дэвида Снэддона, управляющего директора Юлию Соловьеву и финансового директора Юлию Рамазанову. Он считает, что они должны отвечать за обязательства компании вместе с Google International LLC, Google LLC и Карло Бьондо, который руководил компанией с апреля 2016 по февраль 2020 года. Российские медиа, в свою очередь, обратились в суды Турции, Венгрии, Испании, ЮАР и других стран с просьбой признать и исполнить судебные решения, вынесенные против Google в России. В июне Высокий суд Южно-Африканской Республики удовлетворил ходатайство о наложении ареста на активы Google в этой стране. Это произошло после того, как корпорация не исполнила судебный приказ московского суда о восстановлении аккаунта российского телеканала «Спас» на YouTube. Сама Google в августе подала иски в суды США и Великобритании против владельцев российских телеканалов RT, «Царьград» и «Спас». Компания пытается получить решение, которое запретит телеканалам инициировать судебные разбирательства за пределами России. Первое заседание по этому делу прошло в конце сентября в окружном суде Калифорнии. Аналогичные иски Google также направила в Высокий суд Англии и Уэльса. Материнская компания Google — Alphabet — в своем отчете за второй квартал 2024 года сообщила, что «у Google есть текущие юридические вопросы, касающиеся России». «Например, часть споров связана с закрытием счетов, в том числе лиц, подвергшихся санкциям. Также на компанию были наложены прогрессирующие штрафы в связи со спорами о блокировке аккаунтов, включая аккаунты подсанкционных лиц. Мы не считаем, что эти юридические дела окажут существенное негативное влияние на деятельность Google», — указывалось в отчете.',\n",
       " ('Google (компания)',\n",
       "  47,\n",
       "  0): 'Юрист российской дочки компании попросил суд прекратить производство по делу МОСКВА, 20 марта. /ТАСС/. Компания Google в конце 2024 года не смогла подготовиться к процессу в московском суде, по итогам которого ей был назначен административный штраф в размере более 8 млрд рублей за уклонение от уплаты ранее вынесенных штрафов, из-за католического Рождества. Об этом говорится в материалах административного дела, с текстом которого ознакомился корреспондент ТАСС. \"Извещения были направлены в канун католического Рождества, и Гугл ЛЛС (Google LLC) 25 декабря 2024 года и 26 декабря 2024 года не работали\", - следует из текста апелляционной жалобы, которую в суде поддержал представитель компании и попросил производство по делу прекратить. Так, юрист российской дочки заявил, что суд первой инстанции лишил Google права на защиту и квалифицированную помощь. Вместе с тем протокол об административном правонарушении в отношении компании был составлен 27 декабря 2024 года, а католическое Рождество отмечается 25 декабря, его канун - 24 декабря. Ни в РФ, ни в США указанные защитником даты привлеченной к ответственности Google выходными днями не являлись, следует из ответа российского суда в апелляции. Кроме того, по мнению представителя оштрафованной компании, мировой судья якобы не применил срока давности и не создал ей равные с другими процессуальными сторонами условия при рассмотрении административного протокола. В ходе заседания юрист Google заявляла ходатайство об отложении процесса, но ей в этом было отказано. Также в докумантах утверждается, что американская Google International LLC не давала полномочий на представление ее интересов в российском суде юристу ООО \"Гугл\". Как следует из материалов, представленные в деле скриншоты якобы не подтверждают, что американская компания была надлежащим образом извещена о дате судебного заседания, а пристав не присутствовал при извещении Google Роскомнадзором. В опровержение данных утверждений апелляционная инстанция напомнила, что для ознакомления с материалами дела и подготовки позиции представителю административного ответчика 14 января (когда был назначен штраф) предлагалось объявить перерыв на 2 часа. Однако позиция Google по вменяемому ей правонарушению не была представлена также и в жалобе. Довод компании о том, что в суде не было оглашено соответствующее постановление, является несостоятельным, так как ее представитель не участвовала в судебном заседании и \"ушла по собственной инициативе\". \"Это является недобросовестным поведением, - следует из судебных документов. - Штраф в установленный срок не оплачен\".',\n",
       " ('Google (компания)',\n",
       "  48,\n",
       "  0): 'Российская «дочка» американской IT-корпорации Google — ООО «Гугл» — подала иск о собственном банкротстве в Арбитражный суд Москвы, следует из данных картотеки арбитражных дел. Forbes направил запрос компании. 18 мая стало известно, что ООО «Гугл» начало процесс банкротства. Арест банковского счета «Google Россия» сделал невозможным работу офиса в России, в том числе сохранение сотрудников и оплату труда в России, оплату поставщиков и подрядчиков, выполнение других финансовых обязательств, заявляла тогда компания. Ранее арбитражный суд уже арестовал активы и имущество российского юрлица Google на 1,5 млрд рублей по нескольким искам от телеканалов. 19 мая 2022 года он заблокировал 500 млн рублей в качестве обеспечительной меры по иску телеканала RT, который требует восстановить доступ к своему аккаунту на YouTube и взыскать судебную неустойку. 26 апреля суд арестовал еще 500 млн по аналогичному иску от «ГПМ Развлекательное Телевидение» (дочерняя структура «Газпром Медиа»). Предметом иска стал односторонний отказ в размещении контента на YouTube от 2015 года, «дочка» ГПМ просит суд признать его недействительным. Компания также требует от Google восстановить полный доступ к аккаунту на YouTube, обеспечить показ контента и выплатить судебную неустойку. Четвертого мая арбитражный суд заблокировал активы Google еще на 500 млн рублей в рамках аналогичного иска от НТВ. Однако за несколько дней до этого суд отказал НТВ в аресте активов, так как это может нанести ущерб интересам ООО «Гугл» и третьим лицам, поскольку эти средства могут понадобиться компании на текущие траты. В марте 2022 года YouTube заявил, что заблокирует аккаунты российских телеканалов, связанных с государственными СМИ. В мае к ООО «Гугл» подали иски ВГТРК, «ТВ Центр», RT, «Звезда», «Общественное телевидение России», «Телеканал 360» и холдинг «Москва Медиа». Скорее всего, в исках содержатся те же требования к Google, что и у «Газпром Медиа», предположил ранее в беседе с Forbes управляющий партнер юридической компании ЭБР Александр Журавлев. «В Google считают, что банкротство снижает риски привлечения материнской компании к субсидиарной ответственности. На время процедуры банкротства в компании будет назначен временный управляющий. При этом она может продолжать вести свою деятельность и использовать счета: фактически арест средств снимается», — отметил он. По данным Forbes, у российского юрлица Google есть долги перед рекламными агентствами. Google уже вывезла большинство персонала из Москвы в офис в Дубае, писало издание The Wall Street Journal (WSJ) со ссылкой на источники. Всего в «Балчуг-Плаза» работали около 250 человек: часть из них решили остаться в России, однако им придется уволиться из компании. По данным издания, в ближайшее время компания прекратит коммерческое присутствие в стране. О том, что Google приостановит монетизацию YouTube, ограничит работу магазина приложений Google Play и больше не будет показывать рекламу в России, стало известно в начале марта. Официально компания неоднократно заявляла, что ее российское юрлицо ООО «Гугл» — не представительство и не филиал материнской Google LLC, а «занимается исключительно вопросом рекламы и маркетинга продукции и сервисов Google» на территории России без какой-либо «иной деятельности».',\n",
       " ('Google (компания)',\n",
       "  49,\n",
       "  0): 'Компания приняла решение убрать ролик из эфира Google убрал из эфира рекламу, которую подготовил к Олимпийским играм, после того, как ролик вызвал негативную реакцию у телезрителей, сообщил AdAge. Креатив до сих пор можно посмотреть на YouTube, однако комментарии к публикации отключены. Рекламная кампания под названием Dear Sydney («Дорогая Сидни») должна была продвигать ИИ-платформу Gemini AI от Google. В ролике главный герой рассказывает историю своей дочери, которая стала фанаткой американской легкоатлетки Сидни Маклафлин. В июле спортсменка побила мировой рекорд в беге на 400 метров с барьерами. Девочка хочет «показать Сидни немного любви» и написать для нее письмо. Для этого отец обращается к искусственному интеллекту: «Gemini AI, помоги моей дочери написать письмо, в котором она расскажет, как Сидни ее вдохновляет. И обязательно упомяни, что моя дочь планирует однажды побить ее мировой рекорд». После этого нейросеть генерирует текст. Зрители обвинили главного героя рекламы в том, что он обратился к ИИ в таком «личном моменте» и не дал дочери самостоятельно составить письмо. Кроме того, комментаторы заявили, что «Google, очевидно, не видит проблемы в том, что ИИ заимствует формирующий акт детства». Другие пользователи посчитали, что из-за этой рекламы у них усилился «экзистенциальный страх», что нейросети полностью заменят некоторые профессии. «Хотя реклама прошла длительное тестирование перед выходом в эфир, учитывая отзывы, мы решили постепенно исключить ее из ротации на Олимпиаде», — сообщил представитель Google изданию. Ролик транслировался на канале NBC в прайм-тайм, а также на E!, CNBC и USA. В последний раз его показывали около полуночи 30 июля. Компания также выступила в защиту рекламы, сделав такое заявление: «Мы считаем, что ИИ может быть отличным инструментом для повышения креативности человека, но никогда не сможет заменить его. Нашей целью было создать подлинную историю, восхваляющую сборную США. Она показывает реальную энтузиастку легкой атлетики и ее отца и стремится рассказать, как приложение Gemini может стать отправной точкой, источником вдохновения или черновиком для тех, кто ищет идеи для своего произведения». Ранее с негативной реакцией из-за рекламы с участием Беллы Хадид столкнулся adidas. Компания решила перезапустить модель кроссовок SL Super Light 72, которая изначально была разработана для печально известных Олимпийских игр в Мюнхене в 1972 г. После того как adidas удалил креатив, Хадид заявила, что подаст в суд на обувной бренд.',\n",
       " ('Google (компания)',\n",
       "  5,\n",
       "  0): 'Google Acquires Keyhole Corp MOUNTAIN VIEW, Calif. – October 27, 2004 – Google Inc. (Nasdaq: GOOG) today announced it acquired Keyhole Corp., a Mountain View, Calif.-based digital mapping company. Financial terms of the deal were not disclosed. \"With Keyhole, you can fly like a superhero from your computer at home to a street corner somewhere else in the world – or find a local hospital, map a road trip or measure the distance between two points,\" said Jonathan Rosenberg, vice president, Product Management. \"This acquisition gives Google users a powerful new search tool, enabling users to view 3D images of any place on earth as well as tap a rich database of roads, businesses and many other points of interest. Keyhole is a valuable addition to Google’s efforts to organize the world’s information and make it universally accessible and useful.\" With an Internet connection, users enter an address or other location information and Keyhole’s software accesses the database and takes them to a digital image of that location on their computer screen. The interactive software then gives users many options, including the ability to zoom in from space-level to street-level, tilt and rotate the view or search for other information such as hotels, parks, ATMs or subways. Unlike traditional mapping technologies, Keyhole creates a dynamic 3D interface for geographic information. Keyhole’s technology combines a multi-terabyte database of mapping information and images collected from satellites and airplanes with easy-to-use software. Google also announced, effective immediately, a price reduction for Keyhole 2 LT from $69.95 to $29.95. Keyhole was founded in 2001. Keyhole customers include consumers, large and small businesses and public agencies. Current Keyhole users will benefit from the expanded resources and operational scale made possible by the integration into Google. Their service will continue uninterrupted. For a free, seven-day trial of Keyhole, please go to www.keyhole.com. About Google Inc. Google’s innovative search technologies connect millions of people around the world with information every day. Founded in 1998 by Stanford Ph.D. students Larry Page and Sergey Brin, Google today is a top web property in all major global markets. Google’s targeted advertising program, which is the largest and fastest growing in the industry, provides businesses of all sizes with measurable results, while enhancing the overall web experience for users. Google is headquartered in Silicon Valley with offices throughout North America, Europe, and Asia. For more information, visit www.google.com. Labels: English, Press Center Blog',\n",
       " ('Google (компания)',\n",
       "  50,\n",
       "  0): 'Компания Google объявила о расширении функции «Обзоры ИИ» (AI Overviews), которая теперь будет доступна пользователям по всему миру, даже тем, кто не авторизован в системе. Также появится новый режим поисковика AI Mode, который трансформирует привычный поиск в интерактивный диалог с искусственным интеллектом. Google продолжает расширять использование AI Overviews в своей поисковой системе, показывая сгенерированные ИИ сводки для всё большего числа запросов и делая их доступными для всех пользователей. Но гораздо интереснее другая новая функция — отдельный ИИ-режим поиска AI Mode. AI Mode представляет собой поисковый чат-бот, интегрированный прямо в основную систему поиска. Инструмент напоминает Perplexity или ChatGPT Search, но адаптирован для Google. Как пишет TheVerge, пока AI Mode доступен только подписчикам Google One AI Premium, но даже они должны вручную включить его в разделе Labs. Основная идея AI Mode заключается в том, что многим пользователям нравится сразу получать сгенерированный ответ, а не просматривать ссылки. В этом режиме запрос обрабатывается поисковой ИИ-моделью, которая использует данные из индекса Google, а также добавляет ссылки на источники. Визуально AI Mode напоминает чат-бот Gemini, но в отличие от него может анализировать информацию в реальном режиме времени, а также взаимодействовать с веб-страницами. Некоторые эксперты отмечают, что Google всё больше отходит от традиционной схемы поиска, при которой пользователи переходят на сайты из списка ссылок. Однако вице-президент по продуктам поисковой команды Робби Стайн (Robby Stein) с этим не согласен. «AI Overviews дают пользователям необходимый контекст, после чего они, наоборот, охотнее кликают по ссылкам и проводят больше времени на сайтах», — пояснил он. По мнению компании, новые технологии не заменяют старые механизмы поиска, а улучшают его. Google утверждает, что AI Mode не является попыткой полностью заменить традиционный поиск. Тем не менее, очевидно, что ИИ-технологии уже заметно меняют работу поисковой системы, будущее которой всё сильнее связано с искусственным интеллектом. Что касается функции AI Overviews, то в ней будет использоваться обновлённая модель Gemini 2.0, что, по словам Стайна, улучшит ответы на запросы, связанные с математикой, программированием и логическим анализом.',\n",
       " ('Google (компания)',\n",
       "  51,\n",
       "  0): 'Компания Google объявила о запуске экспериментальной версии нейросети Gemini 2.5 Pro для всех пользователей приложения Gemini, включая бесплатных. Это довольно неожиданный шаг, поскольку данный алгоритм был анонсирован всего несколько дней назад как «самая интеллектуальная модель искусственного интеллекта» от Google, которая способна рассуждать, а не только выдавать ответы на задаваемые пользователями вопросы. В настоящее время нейросеть Gemini 2.5 Pro продолжает оставаться в статусе экспериментальной, но поддерживает ряд функций, включая приложения/расширения, загрузку файлов и Canvas. На момент запуска алгоритм был доступен только платным подписчикам Gemini Advanced. Однако на выходных Google объявила о намерении сделать алгоритм доступным для всех пользователей Gemini. Уже сейчас взаимодействовать с Gemini 2.5 Pro можно на странице gemini.google.com, а в скором времени алгоритм станет доступен в приложениях Gemini для Android и iOS. Google заявила о желании как можно скорее передать свою самую интеллектуальную модель ИИ в руки большего количества людей. Отметим, что на сегодняшний день Gemini 2.5 Pro возглавляет рейтинг LMArena, оценивающего модели на основе пользовательских предпочтений. Алгоритм также лидирует в математических (AIME 2025) и научных (GPQA diamond) тестах. В дополнение к этому Google работает над улучшением возможностей нейросети в сфере написания программного кода. Пока неясно, сделает ли Google стабильную версию Gemini 2.5 Pro бесплатной для всех пользователей или же расширение доступа является одним из шагов на пути тестирования ИИ-модели. Официальные представители компании пока не делали каких-либо заявлений по данному вопросу.',\n",
       " ('Google (компания)',\n",
       "  52,\n",
       "  0): 'Сумма требований российских ТВ-каналов к Google из-за блокировки YouTube-аккаунтов к середине января достигла ₽1,8 дуодециллиона. Сумма давно превышает весь ВВП мира, поэтому сторонам придется искать другой способ решения спора Фото: Михаил Гребенщиков / РБК Общая сумма требований 17 российских телеканалов к Google достигла 1,81 дуодециллиона руб., рассказали РБК два источника, знакомых с ходом дела. Дуодециллион — это единица с 39 нулями. По словам одного из собеседников, указанная сумма — это долг, накопившийся у Google к 15 января за неисполнение требования восстановить аккаунты российских медиа на YouTube. Разбирательство началось еще в 2020 году, когда «Царьград» и РИА ФАН подали к американской Google LLC, ирландской Google Ireland, а также к российскому ООО «Гугл» иски с требованием восстановить заблокированные на YouTube аккаунты каналов. В 2021 году суд согласился с доводами телеканалов и обязал Google восстановить доступ. Корпорация не исполнила это решение в течение отведенных девяти месяцев, после чего за каждый день неисполнения начал начисляться штраф в размере 100 тыс. руб. Сумма штрафа удваивается каждую неделю, пока решение не будет выполнено, без ограничения общей суммы штрафа. В процессе разбирательств «Царьграда» и РИА ФАН с Google к процессу в качестве третьих лиц подключились другие телеканалы, аккаунты которых YouTube заблокировал после начала конфликта на Украине в 2022 году. Среди них «Звезда», «Первый канал», ВГТРК (телеканалы «Россия 1», «Россия 24» и др.), «Парламентское телевидение», «Москва Медиа», «ТВ Центр», НТВ, «ГПМ Развлекательное телевидение» (принадлежит «Газпром-Медиа»), «Общественное телевидение России», «Телеканал 360», «ТРК Петербург», «Фонд православного телевидения», «Национальный спортивный телеканал», «Технологическая компания Центр», а также ИП Симоньян М.С., представляющий YouTube-канал телеведущей Маргариты Симоньян. На конец октября 2024 года сумма долга составляла 2 ундециллиона руб. (единица с 36 нулями). Можно ли заставить Google заплатить По состоянию на 28 января 2025 года капитализация Alphabet на бирже NASDAQ составляла $2,4 трлн. Еще в прошлом году в отчете за второй квартал компания сообщала о текущих юридических вопросах в России, включая закрытие счетов подсанкционных лиц и штрафы за блокировку аккаунтов. Alphabet указывала, что считает, что эти дела не повлияют существенно на ее деятельность. После начала специальной военной операции Google приостановила деятельность в России и перевела основную часть сотрудников местного офиса в другие страны. В апреле 2022-го Арбитражный суд Москвы арестовал имущество и счета ООО «Гугл» на сумму 500 млн руб. в качестве обеспечительной меры по иску «ГПМ Развлекательное телевидение» о восстановлении аккаунта на YouTube. В июне того же года «Гугл» обратилась в суд с заявлением о собственном банкротстве, в октябре 2023-го компания была признана банкротом. Среди прочих в реестр кредиторов тогда были включены требования «Царьграда», которому в августе 2024-го Верховный суд подтвердил задолженность в размере 32,7 млрд руб. «Царьград» был первым телеканалом, который подал в суд на Google, «поэтому его требование было включено в общий реестр кредиторов, а неустойка перестала начисляться», пояснял РБК источник, знакомый с ходом дела. «Все остальные телеканалы управляющий квалифицировал как текущих кредиторов, требования которых погашаются раньше реестра, а неустойки продолжают начисляться». В 2024 году «Фонд православного телевидения», действуя от имени ряда российских телеканалов, подал в суды более десяти стран, в том числе Турции, Испании, ЮАР, Сербии и Алжира, иски с требованием арестовать местные активы Google по решению российского суда. Во всех этих странах разбирательства продолжаются, за исключением ЮАР — там активы Google были арестованы летом 2024 года. Google, в свою очередь, обратилась в суд Англии с требованием запретить российским ТВ-компаниям предъявлять претензии за пределами США и Британии. 22 января суд Англии поддержал это требование. Параллельно «Фонд православного телевидения» ищет другие способы оказать влияние на компанию. В декабре 2024 года он подал заявление в Комиссию по ценным бумагам и биржам США (SEC), в котором обвинил Alphabet в неисполнении обязательств по раскрытию информации о своих финансовых обязательствах перед российскими телеканалами, несмотря на то',\n",
       " ('Google (компания)',\n",
       "  52,\n",
       "  1): 'что эта информация является важной для акционеров Alphabet. Исполнение судебных решений зависит от национального законодательства каждой конкретной страны и международных соглашений, говорит руководитель практики «Цифровое и IT-право» компании «Лемчик, Крупский и партнеры» Екатерина Соколова. Во многих случаях, по ее словам, страны признают и исполняют решения иностранных судов в рамках международных договоров или на основе принципов взаимности, но это может требовать отдельного судебного разбирательства или признания решения в соответствующих юрисдикциях. Соколова уточняет, что между Россией и Великобританией нет двусторонних договоров, касающихся признания и исполнения судебных решений, то есть признание решения потребует отдельной судебной процедуры в России, что «сложно представить с учетом текущего развития событий». Но запрет английского суда может привести к тому, что ранее инициированные судебные процессы в различных странах по исполнению решения российского суда могут быть приостановлены. Советник коллегии адвокатов Pen & Paper Роман Кузьмин также считает, что российские суды не связаны решением Высокого суда Англии о запрете предъявлять претензии за пределами США и Британии. «Во-первых, российское законодательство не предусматривает автоматического признания или исполнения решений иностранных судов, включая английские, без соответствующей процедуры признания в России. Во-вторых, такой запрет налагает обязанности на стороны спора, а не на сам иностранный суд», — рассуждает он, отмечая, что сам по себе запрет может стать препятствием к приведению в исполнение решения российских судов в иностранных юрисдикциях. Разбирательство в России продолжается, поскольку российские суды не связаны решениями иностранных юрисдикций, тем более недружественных, соглашается руководитель практики «Цифровая экономика» юридической компании GMT Legal Денис Поляков. Сам по себе процесс, по его словам, «с обеих сторон политизирован». «Как и по многим другим категориям дел, связанным с применением санкций и их последствиями, отечественные суды «отстаивают» интересы наших лиц, тогда как суды недружественных государств создают защитные механизмы для компаний, которые прямо или косвенно соблюдают введенные недружественными государствами санкции», — отметил юрист. По его оценке, судебные процессы будут идти «вплоть до снятия санкций и попыток Google вернуться на российский рынок». «Скорее всего, будут достигнуты мировые соглашения, по которым Google выплатит незначительные компенсации российским судам в обмен на отказ от текущих исков», — считает Поляков. РБК направил запрос в Google.',\n",
       " ('Google (компания)',\n",
       "  53,\n",
       "  0): 'Суд вынес решение об аресте имущества экс управляющего директора ООО «Гугл» Юлии Соловьевой в рамках заявления конкурсного управляющего Валерия Таляровского Юлия Соловьева (Фото: Кирилл Кухмарь / ТАСС) Арбитражный суд Москвы арестовал имущество бывшего управляющего директора ООО «Гугл» (российская «дочка» Google) Юлии Соловьевой на 232,7 млн руб., сообщает РАПСИ. Решение было вынесено в рамках заявления конкурсного управляющего «Гугл» Валерия Таляровского о привлечении к ответственности по обязательствам российского юрлица Google International LLC, Google LLC, Google Ireland Limited, бывшего генерального директора «Гугл» Дэвида Мунро Снэддона, Соловьевой и других топ-менеджеров. Таляровский пояснил, что принятие обеспечительных мер позволит сохранить возможность, что кредиторы удовлетворят свои требования, пишет агентство. По его словам, уполномоченные органы на период проведения процедуры банкротства наложили арест на земельный участок, жилой дом в Подмосковье и мотоцикл BMW, принадлежащие Соловьевой. «Гугл» сообщил о намерении обратиться в суд для признания банкротства в мае 2022 года. В сентябре суд признал заявление обоснованным и ввел наблюдение на полгода, после апелляции в ноябре было вновь назначено наблюдение с утверждением нового временного управляющего — им стал Таляровский из СРО арбитражных управляющих «Межрегиональный центр экспертов и профессиональных управляющих». В октябре 2023-го суд признал ООО «Гугл» банкротом. Таляровский тогда сообщил, что размер требований кредиторов компании, включенных в реестр, составляет почти 54 млрд руб. Выручка ООО «Гугл» в 2022 году составила 24,17 млрд руб., чистый убыток — 10,2 млрд руб. В 2023-м выручка была нулевой. С 2020 года в России продолжаются суды медийных компаний с Google, которая является частью холдинговой компании Alphabet. Они начались в 2020 году после того, как YouTube (принадлежит Google с 2006 года) заблокировал аккаунты российских СМИ «в связи с нарушениями законодательства о санкциях и правил торговли». К январю 2025-го общая сумма требований 17 российских телеканалов к Google достигла 1,81 дуодециллиона руб., рассказывали источники РБК (дуодециллион — это единица с 39 нулями).',\n",
       " ('Google (компания)',\n",
       "  54,\n",
       "  0): 'Суд ограничил начисление неустойки Google октябрем 2023-го, когда российская «дочка» компании была признана банкротом. Начисленный до этого момента штраф подлежит взысканию, так как у Google была возможность разблокировать каналы Фото: Michael M. Santiago / Getty Images Арбитражный суд Москвы 7 марта ограничил начисление судебной неустойки (астрент) в пользу российских телеканалов в рамках разбирательства с Google, сообщил «РИА Новости» конкурсный управляющий российской «дочки» Google ООО «Гугл» Валерий Таляровский. Как пояснил РБК Таляровский, суд в начале марта ограничил период начисления астрента моментом признания ООО «Гугл» банкротом (это произошло 18 октября 2023 года). После этой даты, по мнению суда, компания не имела возможности исполнять судебные акты, по которым начисляется астрент. К 18 октября сумма неустойки по искам телеканалов составляла 91,5 квинтиллиона руб. (единица с 18 нулями). До введения ограничения сумма астрента по состоянию на 15 января 2025-го составляла 1,81 дуодециллиона руб. (единица с 39 нулями). Из решения суда (копия есть у РБК) следует, что все судебные акты о восстановлении доступа к заблокированным YouTube-каналам были приняты после подачи заявления о банкротстве российской «дочки» Google. Таким образом, обязанность по уплате штрафа появилась только после истечения сроков для добровольного выполнения решений, то есть тоже после начала процедуры банкротства. Суд пришел к выводу, что после признания ООО «Гугл» банкротом компания не могла выполнить судебные решения о восстановлении доступа к YouTube-каналам, поэтому требования телеканалов могут быть удовлетворены только до этого момента. Начисленный к 18 октября 2023-го астрент в размере 91,5 квинтиллиона руб. подлежит выплате, поскольку у Google была возможность разблокировать каналы, но она не предприняла никаких действий для этого, следует из решения. При этом суд отклонил требование Google исключить из реестра кредиторов все телеканалы, а соответственно, и их взыскания. Как пояснил «РИА Новости» Таляровский, в деле о банкротстве текущие кредиторы могут рассчитывать в основном на конвертацию астрентного обязательства в требование из субсидиарной ответственности. В этом случае все указанные кредиторы совместно даже при исполнении судебных актов по субсидиарной ответственности в иностранных юрисдикциях смогут претендовать только на совокупную величину активов Google в юрисдикции по месту признания (а в конечном счете на величину капитализации Alphabet). Текущая капитализация Alphabet на американской бирже NASDAQ — $3,2 трлн (около 270 трлн руб.). РБК направил запрос в Google. Откуда взялась неустойка Google В 2020 году «Царьград» и РИА ФАН подали к американской Google LLC, ирландской Google Ireland, а также к российскому ООО «Гугл» иски с требованием восстановить заблокированные на YouTube аккаунты каналов. В 2021 году суд согласился с доводами телеканалов и обязал Google восстановить доступ. Корпорация не исполнила это решение в течение отведенных девяти месяцев, после чего за каждый день неисполнения начал начисляться штраф в размере 100 тыс. руб. Сумма штрафа удваивается каждую неделю, пока решение не будет выполнено, без ограничения общей суммы штрафа. Пострадавшими в качестве третьих лиц в деле проходят телеканалы «Звезда», «Первый канал», ВГТРК (телеканалы «Россия 1», «Россия 24» и др.), «Парламентское телевидение», «Москва Медиа», «ТВ-Центр», НТВ, «ГПМ Развлекательное телевидение», «Общественное телевидение России», «Телеканал 360», «ТРК Петербург», «Фонд православного телевидения», «Национальный спортивный телеканал», «Технологическая компания Центр», а также ИП Симоньян М.С., представляющий YouTube-канал телеведущей Маргариты Симоньян. После начала специальной военной операции Google приостановила свою деятельность в России и перевела большинство сотрудников в другие страны. В апреле 2022 года Арбитражный суд Москвы арестовал активы и счета ООО «Гугл» на сумму 500 млн руб. по иску «ГПМ Развлекательное телевидение» о восстановлении аккаунта на YouTube. В июне компания подала заявление о банкротстве, и в октябре 2023 года была признана банкротом. Среди прочих в реестр кредиторов была включена задолженность «Царьграда» в размере 32,7 млрд руб., подтвержденная Верховным судом в августе 2024 года. «Царьград» стал первым телеканалом, подавшим иск против Google, что позволило его требованию попасть в реестр кредиторов без начисления неустойки. Остальные телеканалы были квалифицированы как',\n",
       " ('Google (компания)',\n",
       "  54,\n",
       "  1): 'текущие кредиторы с продолжающимися неустойками. В 2024 году «Фонд православного телевидения», представляя ряд российских телеканалов, подал иски в десяти странах, включая Турцию и Испанию, с требованием арестовать активы Google по решению российского суда. Разбирательства продолжаются, кроме ЮАР, где активы Google были арестованы летом 2024 года. Google, в свою очередь, обратилась в суд Англии с требованием запретить российским ТВ-компаниям предъявлять претензии за пределами США и Британии, и 22 января суд поддержал это требование. Нынешнее решение суда о начислении неустойки адвокат, руководитель практики «Антикризис и банкротство» компании «Лемчик, Крупский и Партнеры» Давид Кононов назвал ожидаемым, поскольку непрекращающееся начисление делает процедуру еще более затруднительной и зачастую бессмысленной. Он пояснил, что с момента признания банкротства руководство компании теряет полномочия по управлению своим имуществом и операционной деятельностью: все ключевые решения переходят к конкурсному управляющему. «Учитывая, что российская «дочка» Google, вероятно, не контролирует техническую инфраструктуру глобального YouTube, а само ООО «Гугл» не имеет прямой возможности управлять видеохостингом на уровне глобальной компании, «восстановить доступ» оказывается юридически или практически невозможно», — говорит Кононов. При этом «астрономический» долг ООО «Гугл» суд признал «текущим», то есть подлежащим приоритетному удовлетворению, продолжает он. На практике, по словам юриста, взыскать подобные суммы невозможно: их величина превышает весь объем мирового богатства. По мнению Кононова, развязка этого спора будет связана либо с мировым соглашением, где кредиторы согласятся снизить требования, либо с фактическим списанием большей части штрафов после расчетов с другими кредиторами и работниками. «В противном случае «дуодециллионы» и «гуголы» так и останутся на бумаге: в реестре требований они значатся формально, но ресурсов для их погашения даже в масштабах планеты не существует», — заключил юрист.',\n",
       " ('Google (компания)',\n",
       "  55,\n",
       "  0): 'https://ria.ru/20250113/google--1993515365.html Суд признал незаконной передачу Google ее \"дочкой\" дивидендов и налогов Суд признал незаконной передачу Google ее \"дочкой\" дивидендов и налогов - РИА Новости, 13.01.2025 Суд признал незаконной передачу Google ее \"дочкой\" дивидендов и налогов Арбитражный суд Московского округа вслед за двумя нижестоящими инстанциями признал незаконным перечисление ООО \"Гугл\" в 2021 году около 9,5 миллиарда рублей... РИА Новости, 13.01.2025 2025-01-13T17:28:00+03:00 2025-01-13T17:28:00+03:00 2025-01-13T17:28:00+03:00 москва девятый арбитражный апелляционный суд google https://cdnn21.img.ria.ru/images/100940/56/1009405685_0:178:2500:1584_1920x0_80_0_0_8926262de469ffee5c794ec8e115cb95.jpg МОСКВА, 13 янв – РИА Новости. Арбитражный суд Московского округа вслед за двумя нижестоящими инстанциями признал незаконным перечисление ООО \"Гугл\" в 2021 году около 9,5 миллиарда рублей дивидендов в адрес своей материнской американской Google International LLC и выплату 500 миллионов рублей налогов на эту сумму, следует из сообщения в картотеке арбитражных дел. Окружной суд в понедельник отклонил кассационную жалобу Google International на вынесенное в июле определение арбитражного суда Москвы и последующее постановление Девятого арбитражного апелляционного суда. \"Оставить определение суда первой инстанции и постановление суда апелляционной инстанции без изменения, кассационную жалобу без удовлетворения\", - приводится в карточке дела результат заседания. Суды по заявлению Валерия Таляровского, конкурсного управляющего \"Гугла\", признали незаконными перечисление российским подразделением Google почти 9,5 миллиарда рублей дивидендов в адрес Google International и перечисление в бюджет налогов на эти дивиденды в размере 500 миллионов рублей. Суды применили последствия недействительности сделок, взыскав с Google International около 10 миллиардов рублей в конкурсную массу \"Гугла\". Таляровский сообщил в суде первой инстанции, что Google International, единственный участник \"Гугла\", в декабре 2020 года приняла решение о распределении до 10 миллиардов рублей прибыли \"дочки\" за 2015-2017 годы. Дивиденды в размере около 128,7 миллиона долларов (около 9,5 миллиарда рублей на тот момент) были выплачены в декабре 2021 года. Еще 500 миллионов рублей \"Гугл\" выплатил в бюджет в качестве налога на прибыль организаций с доходов, полученных в виде дивидендов иностранным организациям. В заявлении Таляровского отмечалось, что решения и сделки происходили на фоне разбирательства в судах с телеканалом \"Царьград\", закончившегося присуждением структурам Google многомиллиардной прогрессивной судебной неустойки. В суде юристы назвали дело \"Царьграда\" \"спусковым крючком дела о банкротстве\". Управляющий считает, что оспариваемые действия в преддверии банкротства были направлены на причинение вреда кредиторам. Представители Google International заявили, что на момент решения о выплате дивидендов на счетах \"Гугла\" было 19 миллиардов рублей, а после выплаты осталось еще 14 миллиардов. Деятельность \"Гугла\" приносила большой доход - за четвертый квартал 2021 года стоимость реализованных услуг составила 47,5 миллиарда рублей. Поэтому, по мнению ответчика, нельзя было говорить ни о неплатежеспособности \"Гугла\", ни о противоправности действий его участника. Долг перед \"Царьградом\", составлявший до сентября 2022 года 1 миллиард рублей, был погашен в марте того же года, добавили юристы. Арбитражный суд Москвы в октябре признал ООО \"Гугл\" банкротом и открыл в компании конкурсное производство. Начальную процедуру банкротства – наблюдение – в ООО \"Гугл\" ввел в ноябре 2022 года Девятый арбитражный апелляционный суд по собственному заявлению компании. https://ria.ru/20241101/google-1981440916.html https://ria.ru/20240411/google-1939475267.html https://ria.ru/20241028/sud-1980512075.html москва РИА Новости 1 5 4.7 96 internet-group@rian.ru 7 495 645-6601 ФГУП МИА «Россия сегодня» https://xn--c1acbl2abdlkab1og.xn--p1ai/awards/ 353 60 353 60 2025 Ольга Фомченкова Ольга Фомченкова Новости ru-RU https://ria.ru/docs/about/copyright.html https://xn--c1acbl2abdlkab1og.xn--p1ai/ РИА Новости 1 5 4.7 96 internet-group@rian.ru 7 495 645-6601 ФГУП МИА «Россия сегодня» https://xn--c1acbl2abdlkab1og.xn--p1ai/awards/ 353 60 353 60 1920 1080 true 1920 1440 true 1920 1920 true РИА Новости 1 5 4.7 96 internet-group@rian.ru 7 495 645-6601 ФГУП МИА «Россия сегодня» https://xn--c1acbl2abdlkab1og.xn--p1ai/awards/ 353 60 353 60 Ольга Фомченкова москва, девятый арбитражный апелляционный суд, google',\n",
       " ('Google (компания)',\n",
       "  56,\n",
       "  0): 'washingtonpost.com Staff Writer Thursday, August 19, 2004; 9:43 AM Google plans to raise as much as $1.67 billion in its public stock offering today, but even that impressive estimate doesn\\'t hide the fact that the hype surrounding the search engine\\'s IPO is only half as hot as yesterday. With its initial pricing of $85 a share, Google\\'s market value is pegged at $23 billion. That\\'s \"less than originally expected, but still impressive for a 6-year-old dot-com dreamed up in a garage,\" the Associated Press reported. The New York Times noted that just \"three weeks ago, the company and its bankers had valued the company as high as $36 billion and said they hoped to raise as much $3.6 billion.\" The reason the air\\'s out of the balloon? According to the Wall Street Journal, it\\'s payback for all that sassy behavior on Google\\'s part. \"A combination of Google\\'s own hubris, stubborn investors and a deteriorated technology market transformed what was billed as the hottest IPO of this short century into a rather messy affair,\" the Journal wrote. \\x95 The Associated Press via washingtonpost.com: Google\\'s IPO Price Set At $85 Before Debut (Registration required) \\x95 The New York Times: Google Lowers Its Sights As Demand Proves Weak (Registration required) \\x95 The Wall Street Journal: Engine Trouble: How Miscalculations and Hubris Hobbled Celebrated Google IPO (Subscription required) Bob Clarkson, a securities attorney at the law firm Jones Day, told the AP: \"With all the negative publicity in the last few weeks,\" Clarkson said, \"it\\'s still a phenomenal success story and that\\'s still a phenomenal valuation for a company as young as Google.\" Matthew Fordahl wrote in another AP story that despite the lowe pricing, \"the offering remains one of the biggest and most highly anticipated for an Internet business, surpassing most of the hot tech issues of the 1990s. It will make billionaires -- at least on paper -- of founders Sergey Brin and Larry Page, who started Google six years ago.\" The San Jose Mercury News offered some more perspective: \"\\'This still gives them the third-biggest market cap in the Internet space,\\' behind eBay and Yahoo, said Mark Mahaney, Internet analyst with American Technology Research.\" \\x95 The Associated Press via San Francisco Chronicle: Google Price Set At $85, At Low End of Company\\'s Expectations \\x95 San Jose Mercury News: Google Shares Start At $85 (Registration required) Google insiders are not the only ones getting rich. Stanford University, where Brin and Page started the company in 1998 as graduate students, is going to make a mint in the deal. USA Today reported Stanford is selling nearly $16 million of its stock in the IPO. \"Stanford\\'s stake in Google -- a total of about 1.8 million shares -- is worth about $156 million at $85 a share, the price set by the search engine giant Wednesday,\" the paper said. \\x95 USA Today: Founders Alma Mater To Rake In Nearly $16M Take it Back to 85 Because that\\'s all you\\'re worth! That\\'s the message Google\\'s getting without a whole lot of sugar-coating. \"This is kind of like what happens when you list your house for too much, and no one shows up for the open house,\" Kevin Landis, portfolio manager of Firsthand Funds, told USA Today. \"The buyers step back and watch you mark it down.\" And this caustic assessment from a technology analyst: \"Google is damaged goods,\" David M. Garrity of New York\\'s Caris & Co. told the Boston Globe. \"For all intents and purposes, this is a failed IPO. In the process of mismanaging the IPO, the company will raise less money than',\n",
       " ('Google (компания)',\n",
       "  56,\n",
       "  1): 'it would have otherwise.\" Garrity also told the paper: \"They wanted to manage it themselves, but their process was so cumbersome that they ended up alienating the very investors they were trying to attract. I don\\'t think you\\'ll see anyone try this experiment again until the next century.\" Garrity also spoke to the New York Post, saying, \"Google has been doing a very successful job on their own of doing a face plant on every step of Wall Street.\" Tom Wyman, portfolio manager of Husic Capital Management, told the Los Angeles Times that Google \"broke all 10 commandments of a successful IPO.\" \\x95 USA Today: Whiz Kids\\' Blunders Blacken IPO\\'s Eye \\x95 The Boston Globe: Small Investors Scared Off By Exercise In Stock Democracy \\x95 New York Post: A Frugal Google \\x95 Los Angeles Times: At $1.7 Billion, Google\\'s IPO Comes Up Short (Registration required) The Washington Post wrote that Google\\'s price cut came \"after weaker-than-expected demand from investors forced it to drastically slash the price and size of its initial public offering. After several months of hype and warnings surrounding the IPO, the Internet\\'s leading search engine and its two founders were humbled by market forces, missteps of their own making and opposition from the Wall Street establishment, which stridently opposed their novel method for distributing shares because it cut fees and reduced the clout of the major brokerage houses.\" More from the article: \"While Google\\'s roughly $1.7 billion IPO will still rank among the biggest technology offerings ever, the difficulty the online giant is experiencing is a sign of the troubled times for technology companies that want to go public and attract capital. Investors who once bid up the price of anything that had the dot-com label have been cautious since the high-tech bubble burst several years ago.\" \"The thing that hurt them the most was the spurning of Wall Street,\" Danny Sullivan, editor of online publication Search Engine Watch, told the Post. \"If this had been a traditionally run IPO where investment banks were going to cash in, they would have been supportive of the higher price, and you would have seen less criticism. They felt locked out of the process, so there was no incentive for them to move things along.\" \\x95 The Washington Post: Google Ends Auction of IPO Shares (Registration required) The Wall Street Journal said that Google \"may have needed Wall Street after all. The Web-search giant\\'s quest to reform the Street through an unconventional initial public offering backfired\" with the lower pricing. Matthew Rhodes-Kropf, a Columbia University auction theorist (a title that proves there\\'s a job for everything), told the Journal that the price \"says that a type of auction going out to the public like this is a failure because it raised uncertainties to such a level that people backed away.\"',\n",
       " ('Google (компания)',\n",
       "  6,\n",
       "  0): 'Google to Acquire On2 Technologies CLIFTON PARK, NY and MOUNTAIN VIEW, Calif. (August 5, 2009) – On2 Technologies, Inc. (NYSE Amex: ONT) and Google Inc. (NASDAQ: GOOG) jointly announced today that they have entered into a definitive agreement under which Google will acquire On2, a leading developer of video compression technology. Under the terms of the agreement, each outstanding share of On2 common stock will be converted into $0.60 worth of Google class A common stock in a stock-for-stock transaction. The transaction is valued at approximately $106.5 million. \"Today video is an essential part of the web experience, and we believe high-quality video compression technology should be a part of the web platform,\" said Sundar Pichai, Vice President, Product Management, Google. \"We are committed to innovation in video quality on the web, and we believe that On2’s team and technology will help us further that goal.\" \"We’re thrilled that On2 is joining one of the world’s most innovative companies,\" said Matt Frost, interim CEO of On2. \"After intensive review of On2 products, Google confirmed our long-held beliefs as to the quality of our video technologies. This transaction is a testament to the hard work of every On2 employee and the strongest possible endorsement of our products and people. On2 will continue to improve, support and sell our products throughout the transition. We believe that Google shares our ambitions and know that our products and expertise, combined with Google’s globally recognized brand, ingenuity and resources, will create an incredible team.\" The number of shares of Google class A common stock to be received by On2 stockholders will be determined by dividing $0.60 per share by the volume weighted average trading price of a share of Google class A common stock based on the sales price of every share of Google class A common stock traded during the twenty trading-day period ending on and including the second trading day prior to the date of the meeting of On2’s stockholders to consider and vote on the merger agreement. $0.60 per share represents a premium of approximately 57% over the closing price of On2’s common stock on the last trading day immediately prior to the announcement of the transaction, and a premium of approximately 62% over the average closing price of On2’s common stock for the six month period immediately prior to the announcement of the transaction. The transaction, which is subject to On2 stockholder approval, regulatory clearances and other closing conditions, is expected to close in the fourth quarter of 2009. Wilson Sonsini Goodrich & Rosati and Potter Anderson & Corroon served as legal counsel to Google, and Credit Suisse provided M&A advisory services to Google. Covington Associates, LLC served as financial advisor to On2 and its board of directors and Duff & Phelps, LLC served as an independent financial advisor to On2’s board of directors, and each of them provided an opinion as to the fairness, from a financial point of view, to the public stockholders of On2 of the exchange ratio in the proposed transaction. Hogan & Hartson LLP and Richards, Layton & Finger served as legal counsel to On2. About On2 Technologies, Inc. On2 (NYSE Amex: ONT) creates advanced video compression technologies that power the video in today’s leading desktop and mobile applications and devices. On2 customers include Adobe, Skype, Nokia, Infineon, Sun Microsystems, Mediatek, Sony, Brightcove, and Move Networks. On2 Technologies is headquartered in Clifton Park, NY USA. For more information, visit www.on2.com. About Google Inc. Google’s innovative search technologies connect millions of people around the world with information every day. Founded in 1998 by Stanford Ph.D. students Larry',\n",
       " ('Google (компания)',\n",
       "  6,\n",
       "  1): 'Page and Sergey Brin, Google today is a top web property in all major global markets. Google’s targeted advertising program provides businesses of all sizes with measurable results, while enhancing the overall web experience for users. Google is headquartered in Silicon Valley with offices throughout the Americas, Europe and Asia. For more information, visit www.google.com. Caution Concerning Forward-Looking Statements This document includes certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements regarding the expected timing of the acquisition, Google’s and On2’s ability to close the acquisition, Google’s ability to integrate On2’s technology and employees, and the expected benefits of the acquisition, including that the acquisition will further Google’s goal to enhance the web experience with video. These statements are based on the current expectations or beliefs of managements of Google Inc. and On2 Technologies, Inc., and are subject to uncertainty and changes in circumstances. Actual results may vary materially from those expressed or implied by the statements herein due to (1) changes in economic, business, competitive, technological and/or regulatory factors, (2) failure to receive the required stockholder and regulatory approval for the acquisition, (3) failure to compete successfully in this highly competitive and rapidly changing marketplace, (4) failure to retain key employees, and (5) other factors affecting the operation of the respective businesses of Google and On2. More detailed information about these and other factors that may affect current expectations may be found in filings by Google or On2, as applicable, with the Securities and Exchange Commission, including their respective most recent Annual Report on Form 10-K and Quarterly Report on Form 10-Q. Google and On2 are under no obligation to, and expressly disclaim any such obligation to, update or alter their respective forward-looking statements, whether as a result of new information, future events, or otherwise. Additional Information and Where to Find It Google plans to file with the Securities and Exchange Commission (the \"SEC\") a Registration Statement on Form S-4 in connection with the transaction, which will include a Proxy Statement of On2 that also constitutes a Prospectus of Google. On2 will mail the Proxy Statement/Prospectus to its stockholders in connection with the transaction. The Registration Statement and the Proxy Statement/Prospectus will contain important information about Google, On2, the transaction and related matters. Investors and security holders are urged to read the Registration Statement and the Proxy Statement/Prospectus carefully when they are available. Investors and security holders will be able to obtain free copies of the Registration Statement and the Proxy Statement/Prospectus and other documents filed with the SEC by Google and On2 through the web site maintained by the SEC at www.sec.gov and by contacting Google Investor Relations at +1-650-253-7663 or On2 Investor Relations at +1-518-881-4299. In addition, investors and security holders will be able to obtain free copies of the documents filed with the SEC on Google’s website at investor.google.com and on On2’s website at www.on2.com. Participants in the Solicitation Google, On2 and their respective directors and executive officers may be deemed to be participants in the solicitation of proxies in respect of the proposed transaction. Information regarding Google’s executive officers and directors is included in Google’s definitive proxy statement, which was filed with the SEC on March 24, 2009, and information regarding On2’s executive officers and directors is included in On2’s definitive proxy statement, which was filed with the SEC on April 7, 2009. The Proxy Statement / Prospectus for the proposed transaction will provide more information about participants in the solicitation of proxies from On2 stockholders, which participants may have interests different from On2 stockholders generally. You',\n",
       " ('Google (компания)',\n",
       "  6,\n",
       "  2): 'can obtain free copies of these documents from Google or On2 using the contact information above. Contacts: Investor Contact, Google: Maria Shim 650.253.7663 marias@google.com Media Contact, Google: Andrew Pederson 650.450.3896 andrewpederson@google.com Contact, On2: Garo Toomajanian 518.881.4299 invest@on2.com ### Google is a registered trademark of Google Inc. All other company and product names may be trademarks of the respective companies with which they are associated. Labels: English, Press Center Blog',\n",
       " ('Google (компания)',\n",
       "  7,\n",
       "  0): 'Yahoo and Google buried the hatchet, settling two long-running disputes with high-priced shares of Google common stock. The leaders — and bitter rivals — in search engine marketing services have decided against civil actions. Google gave Yahoo 2.7 million shares of Class A common stock, which could be worth more than $280 million if Google’s impending IPO garners at least the bottom of its suggested price. In return, Google got out from under a two-year-old patent infringement suit and a dispute over stock warrants owed Yahoo for a 2000 services agreement. A Yahoo spokesperson said the agreement grants Google a license to the ‘361 and several other patents owned by Yahoo. “There is no ongoing licensing fee. It’s netting out at a one-time share receipt for the life of the patents covered under the suit,” she said. The agreement also puts to rest the dispute over how much stock Google owed Yahoo. Yahoo had a warrant to purchase 3.7 million shares, but Google claimed the 1.2 million shares it issued to Yahoo followed a conversion provision in the agreement. Yahoo protested the lowered amount. The companies didn’t disclose what proportion of the shares Google parted with covered the patent licenses. A Google spokesperson would say only, “We are pleased to have resolved these issues and pleased with the terms of the agreement.” Yahoo now holds around 8.2 million shares in Google. The Yahoo spokesperson declined to say when settlement talks began or whether the judge handling the patent infringement suit directed them to talk turkey. But after simmering along on the back burner, the case was about to get hot. Overture Services, Yahoo’s subsidiary, sued Google in April 2002, claiming the latter’s lucrative AdWords search marketing service infringed Overture’s U.S. Patent No. 6,269,361. The discovery in the case was getting ugly: Google claimed that an Overture executive lied in his deposition. Also, despite Overture’s success in keeping parts of its testimony out of the public record, the discovery process was bringing to light plenty of information about its business. In the long term, the patent dispute could have had serious consequences: If its patents were upheld, Yahoo could have refused to license them to Google, bringing AdWords to a screeching halt. However, that day was at least a couple years down the road, according to Randy Lipsitz, an intellectual property specialist with the New York City law firm of Kramer Levin Naftalis & Frankel. However, that might have changed. Both sides were awaiting one critical ruling: The Markman Order, which defines the terms at issue before the case can go to trial. The Markman hearing took place in March and the decision was expected any day — perhaps before bidding on Google’s IPO shares closed. While these rulings don’t necessarily give much indication of how the case may be decided, anything that appeared negative to the public could have dinged the price. “The big companies really don’t like to bet the farm unless they are going up against a much smaller company, one they feel they can over-lawyer or overwhelm,” said Konrad Trope, a patent and intellectual property specialist based in Los Angeles. In this case, he said, “You have two giants who in a sense could be doing more damage to themselves by beating up on each other than by settling.” “Most of these cases do settle,” Lipsitz agreed. “At some point it may sound good to go after [a rival] and corner a piece of the market. But usually after a couple of years, clients see how much they’ve spent, how much time, the disruption to the business',\n",
       " ('Google (компания)',\n",
       "  7,\n",
       "  1): 'and its executives, and they realize a settlement wouldn’t be so bad.” In the short term, the dispute seemed to have little impact on the market. “There were so many other nuances in the whole situation that no one really focused on the consequences [of the suit] — anyone relevant at least,” Lipsitz said. Google set the extraordinarily high price of $108 to $135 for IPO shares, although the Dutch auction system being used is designed to determine the price the market is willing to pay. The Mountain View, Calif.-based company’s revised S-1 filing that included details of the previously disclosed plan to offer a buy-back program for shares and stock options it failed to register with the SEC gave rise to concerns about its internal governance. “They were more interesting to read about than an arcane patent infringement lawsuit,” Lipsitz said. In its most recent filing, Google also slightly upped the number of shares in the float, to 25.7 million. Ironically, Google’s stock is putatively worth as much as nine times more than Yahoo’s. In the last year, YHOO has traded between $14.05 and $36.51. The stock was selling at $25.70 at close of today’s trading. Pamela Parker contributed to this story.',\n",
       " ('Google (компания)',\n",
       "  8,\n",
       "  0): 'Google AdSense for Mobile unlocks the potential of the mobile advertising market Announcement September 17, 2007 The mobile device is fast becoming the world’s most popular gateway to information. In fact, there are currently more mobile devices worldwide than personal computers and televisions combined. As part of our ongoing efforts to develop new ways for users to find the information they need anytime and anywhere, Google announced today the availability of AdSense™ for Mobile, a program that contextually targets ads to mobile website content. AdSense for Mobile also allows AdSense publishing partners the ability to earn revenue from their mobile websites through the targeted placement of mobile text ads. With this program, advertisers can connect with the growing number of mobile publishers, ultimately providing users with an enhanced mobile experience that helps them find what they are looking for more quickly and efficiently on the go. AdSense for Mobile is intended for AdSense partners who have created websites specifically for mobile browsers, and who want to monetize their mobile content via contextual advertising. Like Google’s other AdSense products, mobile text ads run on an auction model. The system automatically reviews the content of publishers’ mobile websites and delivers text ads that are relevant to the websites’ audience and content. Publishers earn money whenever mobile users click on the ads. With this new program, the unmatched reach of the Google content network is extended to the mobile platform. AdSense for Mobile provides a valuable way to connect mobile users with the right ad at the right time as they seek information on the go. AdSense for Mobile is now available to all mobile publishers in 13 countries worldwide. For more information, please see: adsense.blogspot.com. AdSense for Mobile will be available in the following countries: US, England, France, Italy, Germany, Spain, Ireland, Russia, Netherlands, Australia, India, China, and Japan (available in the coming weeks). Google and AdSense are trademarks of Google Inc. All other company and product names may be trademarks of the respective companies with which they are associated. Labels: English, Press Center Blog',\n",
       " ('Google (компания)',\n",
       "  9,\n",
       "  0): 'По данным агентства, представители прокуратуры также попросили судебные органы в рамках антимонопольных мер запретить корпорации выходить на рынок браузеров в течение пяти лет НЬЮ-ЙОРК, 21 ноября. /ТАСС/. Министерство юстиции США обратилось в суд с целью потребовать от корпорации Alphabet, владеющей технологическим гигантом Google, отказаться от браузера Chrome. Об этом сообщило агентство Reuters. По его данным, представители прокуратуры, помимо продажи Chrome, также попросили судебные органы в рамках антимонопольных мер запретить корпорации выходить на рынок браузеров в течение пяти лет. Кроме того, Минюст стремится к тому, чтобы запретить Google заключать контракты с Apple и другими компаниями насчет установки на смартфонах и в браузерах поисковой системы. Корпорацию хотят также обязать делиться данными с конкурентами в течение 10 лет. \"Правила игры не равны из-за действий Google\", получающей выгоду от незаконно полученного преимущества, отмечается в судебных документах юристов истца. Ответчик собирается представить собственные предложения по исправлению ситуации к 20 декабря. Ожидается, что вердикт может быть вынесен к концу лета 2025 года. Как считают представители Google, подобные предложения нанесут ущерб потребителям и разработчикам. По данным службы анализа веб-трафика StatCounter, доля Chrome на рынке США составляет 61%. 5 августа Федеральный суд округа Колумбия постановил, что Google злоупотреблял своим положением на рынке, чтобы сохранить монополию в сфере поисковых систем и размещения рекламы в интернете. Суд постановил, что Google заблокировала для конкурентов порядка 90% рынка интернет-поиска, заключив соглашение с производителем электроники Apple, который сделал поисковую систему Google поисковиком по умолчанию в своем браузере Safari. Похожие соглашения корпорация заключила с производителем техники Samsung и оператором мобильной связи Verizon.',\n",
       " ('Linkin Park',\n",
       "  1,\n",
       "  0): \"Вокалист Честер Беннингтон умер в 2017 году, после чего легендарная рок-группа прекратила выступления. На замену Беннингтону придет Эмили Армстронг, соосновательница группы Dead Sara Майк Шинода (Фото: Timothy Norris / Getty Images) Рок-группа Linkin Park объявила о возвращении на сцену в обновленном составе. Об этом один из основателей коллектива, гитарист и вокалист Майк Шинода заявил во время стрима на YouTube-канале. Место вокалиста Честера Беннингтона, умершего в 2017 году, заняла Эмили Армстронг, также у группы сменился барабанщик — теперь им стал Колин Бриттейн. 15 ноября выйдет новый альбом коллектива From Zero («С нуля»), в него войдет композиция The Emptiness Machine («Машина пустоты»). Беннингтон покончил с собой в 2017 году. После этого группа прекратила концертную и музыкальную деятельность. В феврале 2024 года коллектив анонсировал выход трека Friendly Fire («Огонь по своим»), записанного еще при участии Беннингтона. Linkin Park основали в 1996 году. Коллектив неоднократно номинировали на музыкальную премию «Грэмми», дважды он ее получил. При Беннингтоне группа выпустила семь студийных альбомов, которые разошлись тиражом свыше 70 млн экземпляров. Эмили Армстронг — американская певица из Лос-Анджелеса. Музыкальной деятельностью она начала заниматься с 11 лет, петь — с 15 лет. В 2002 году она стала одной из основательниц хард-рок-группы Dead Sara, коллектив издал дебютный альбом в 2012 году. 5 сентября 2024 года Армстронг впервые вышла на сцену в составе Linkin Park, исполнив наиболее известные хиты группы — What I've Done, In The End и Numb.\",\n",
       " ('Linkin Park',\n",
       "  10,\n",
       "  0): 'LINKIN PARK has released a video update from the studio in which the members of the band discuss the lyrical themes covered on their upcoming seventh album. The yet-to-be-titled new LINKIN PARK effort does not yet have a release date, but will follow up 2014\\'s \"The Hunting Party\". LINKIN PARK singer Chester Bennington said: \"There are songs that don\\'t specifically talk about situations, they talk about a frame of thinking. Like, \\'This is shit that\\'s going on inside my head,\\' or, \\'This is something that I\\'m dealing with.\\' To me, also, it tells a story, but it\\'s also revealing as well in another way, and that feels honest to me. \"People ask me, \\'You guys are in the studio, right?\\' \\'Yeah.\\' \\'Well, what\\'s it like?\\' I\\'m, like, \\'Well, we\\'re just focused on writing really great songs that mean something to people.\\' He continued: \"We\\'re trying to connect with people. We\\'re trying to make a record that has fucking stellar songs that people wanna listen to all the time.\" LINKIN PARK singer Mike Shinoda recently hinted that there might be some \"featured artists\" on the new CD, adding that the band also worked with \"other people\" during the writing process. But he added, \"It\\'s still us. It\\'s self-produced . It\\'s all us, curated by us at the very least. It\\'s a LINKIN PARK record.\" Shinoda also said that the biggest challenge of recording this new disc was that \"we approached the process differently.\" LINKIN PARK guitarist Brad Delson added: \"There\\'s a certain amount of experimentation and failure, essentially trial and error that\\'s baked into this process. We\\'ve made so many records and we clearly know how to make a record and we definitely didn\\'t take the easy way out this time.\" Delson continued: \"The songs are shaping up so well, we just want them to be as phenomenal when we share them with you… as we imagine them in our heads.\"',\n",
       " ('Linkin Park',\n",
       "  11,\n",
       "  0): 'LINKIN PARK has revealed the cover artwork of its seventh studio album. The image was unveiled via a digital puzzle sourced through various \"ambassadors\" of the band across social media. LINKIN PARK has also announced that the first single from the upcoming disc is titled \"Heavy\" and it features guest vocals from Kiara Saulters, who is best known for recording stop-motion, hip-hop-inspired electro-R&B under the name Kiiara. The \"Heavy\" lyrics can be found at Genius.com. LINKIN PARK recently released new video update from the studio in which members of the band discussed their approach to the upcoming album\\'s lyrical themes. Singer Chester Bennington said: \"There are songs that don\\'t specifically talk about situations, they talk about a frame of thinking. Like, \\'This is shit that\\'s going on inside my head,\\' or, \\'This is something that I\\'m dealing with.\\' To me, also, it tells a story, but it\\'s also revealing as well in another way, and that feels honest to me.\" Bennington added in the new video update: \"We\\'re trying to connect with people. We\\'re trying to make a record that has fucking stellar songs that people wanna listen to all the time.\" Co-vocalist Mike Shinoda appeared on a YouTube question-and-answer session recently and told fans about the new album: \"I can\\'t tell you what it sounds like. I can tell you you\\'re going to be surprised. You gotta expect the unexpected. Don\\'t expect what you\\'ve heard before.\" No release date has been confirmed yet for the new disc, which will follow up 2014\\'s \"The Hunting Party\".',\n",
       " ('Linkin Park',\n",
       "  12,\n",
       "  0): 'Linkin Park continue to make progress toward the completion of their seventh studio album, with Chester Bennington taping a brief video update for fans. The singer says in the clip above, \"I\\'ve been working really hard on some vocals for the last couple of months. And we\\'ve done some really great stuff in here. The songs are amazing. I\\'m really proud of what we\\'ve accomplished in the studio so far. We\\'ve got a lot of great material that I hope challenges our fanbase as well as inspires them as much as it has us. And so I\\'m really looking forward to you guys hearing the stuff. It\\'s, like, super, super exciting.\" Linkin Park have been delivering plenty of updates as they continue to work on the album. Earlier this year, Mike Shinoda put a challenge to the band that he shared in an open letter. “I had an epiphany today about the album. Right now, in the studio, the foundations of the songs are there … I think it’s time to shift into the next gear. Let’s discover the voice of this album … I want to get into experimentation mode, get weirder, and record more live instruments … I said at the beginning, I want this album to be our best. Let’s do this! Feel free to give me a call to discuss, or we can talk on Monday. I’m AMPED,” said the excited vocalist. In a podcast in early August, Shinoda and Brad Delson discussed their recording process. \"There’s a certain discomfort in doing things the right way…for our band, we’ve talked to folks here a lot about our typical process and we really turned it on its head this time,\" explained Delson. \"We took on a new challenge by flipping our script. There’s a certain amount of experimentation and failure, essentially trial and error that’s baked into this process. We’ve made so many records and we clearly know how to make a record and we definitely didn’t take the easy way out this time. I think that we just dove straight into the fray of inspiration and its yielded really interesting substance, finding the destination is definitely a journey. We kind of have a sense of the path and we’re finding our way there. We were just talking about the kind of stamina that goes along with that because the songs are shaping up so well, we just want them to be as phenomenal when we share them with you oh listeners out there in the podcast world as we imagine them in our heads.\" Shinoda also revealed that they\\'ve worked with different songwriters this time around. \"The people that we’re collaborating with aren’t artists that you know, whose albums that you bought-they’re songwriters, often times they write songs for people like that. The idea, that at any point in any career, you can never know everything, so the idea of picking the brain of somebody whose done it for many years, whose done music that I personally like, and we get together and neither one of us takes the reigns and runs off with it.\" To hear more of the podcast, check it out in the player below. Linkin Park\\'s Mike Shinoda + Brad Delson Discuss the Recording of Their New Album Linkin Park\\'s Joe Hahn Plays \\'Wikipedia: Fact or Fiction?\\' Linkin Park Albums Ranked',\n",
       " ('Linkin Park',\n",
       "  13,\n",
       "  0): 'Linkin Park will host a public event in Los Angeles to honor late singer Chester Bennington. The band announced their plans in a short but poignant note on Facebook, saying they would share specific details soon. Bennington died by suicide on July 20th. Linkin Park also addressed their fans, writing, “Just wanted to say thank you to all our fans around the world for the tremendous outpouring of love, which has strengthened our spirit during this incredibly difficult time. The five of us are so grateful for all of your support as we heal and build the future of Linkin Park.” Linkin Park has not performed or made many public appearances since Bennington’s death. However, the band did issue a statement in which they discussed their “grief and denial” while reminiscing about their time with the singer. “Your absence leaves a void that can never be filled — a boisterous, funny, ambitious, creative, kind, generous voice in the room is missing,” the band wrote. “We’re trying to remind ourselves that the demons who took you away from us were always part of the deal. After all, it was the way you sang about those demons that made everyone fall in love with you in the first place. You fearlessly put them on display, and in doing so, brought us together and taught us to be more human.” Bennington was laid to rest at a private service July 29th at the South Coast Botanical Garden in Palos Verdes Estates, California. During the ceremony, Linkin Park’s Mike Shinoda and Joe Hahn delivered eulogies, as did Bennington’s Dead by Sunrise bandmate, Ryan Shuck. Fans around the world have also organized their own public memorials, while the countless musicians have also honored the late singer. Recently Coldplay’s Chris Martin covered Linkin Park’s “Crawling” at a show in New Jersey, while Jay-Z performed “Numb/Encore” – from his collaborative LP with Linkin Park, Collision Course – at V Festival.',\n",
       " ('Linkin Park',\n",
       "  14,\n",
       "  0): 'Linkin Park‘s Mike Shinoda says the band will continue after the death of Chester Bennington. Bennington passed away at the age of 41 after he was tragically found dead at his California home on July 20. Advertisement During a twitter Q&A, one fan asked Shinoda, “Mike what will happen with Linkin Park in the future?” Shinoda replied, “I have every intention on continuing with LP, and the guys feel the same. We have a lot of rebuilding to do, and questions to answer, so it’ll take time.” You can see the exchange below. I have every intention on continuing with LP, and the guys feel the same. We have a lot of rebuilding to do, and questions to answer, so it’ll take time. https://t.co/nXLxTSd40J — Mike Shinoda (@mikeshinoda) January 25, 2018 Last month, Shinoda ruled out the prospect of ever touring with a holographic Chester Bennington. Responding to a fan during a recent Instagram live, Shinoda said: “I’ve actually heard other people outside the band suggest that and there’s absolutely no way… I can’t do a hologram Chester you guys, that would be the worst. Recommended “For any of you guys who have lost a loved one, best friend, family member, can you imagine having a hologram of them? Awful. I can’t do it. I don’t know what we’re going to do, but we’ll figure it out eventually.” Meanwhile, Shinoda recently opened up on the release of Linkin Park’s new live album – and discussed how the record was a “beautiful” way of reflecting on the band’s time with Bennington. “It’s a really nice way to showcase what a special experience each night was,” he said. Advertisement And while I don’t know what comes next for us together or individually, this album is certainly a beautiful way of looking back at the body of work we created with Chester.”',\n",
       " ('Linkin Park',\n",
       "  15,\n",
       "  0): 'UPDATE: Members of Korn, System of a Down and Avenged Sevenfold have all tweeted that they will be performing at the benefit concert. Korn’s Jonathan Davis, Avenged Sevenfold’s M. Shadows and Synyster Gates, System of a Down’s Daron Malakian, Shavo Odadjian and John Dolmayan, Blink-182, Bring Me the Horizon’s Oliver Sykes, Yellowcard’s William Key, Machine Gun Kelly and singer-songwriter Kiiara have all announced that they will be performing with Linkin Park at the concert. Linkin Park will pay tribute to their late singer Chester Bennington with a tribute concert in Los Angeles. The”one-night-only” event will feature the five surviving members performing together for the first time since Bennington’s July 20th death. The concert, set for the Hollywood Bowl on October 27th, will raise money for Music for Relief’s One More Light Fund in memory of Bennington. Check out Linkin Park’s website for full ticket information. Linkin Park also released a video for “One More Light,” the title track of the band’s latest LP. The Joe Hahn-directed video focuses on Bennington both onstage, where he’s surrounded by his legions of fans, as well as the singer backstage with his band mates. “‘One More Light’ was written with the intention of sending love to those who lost someone. We now find ourselves on the receiving end,” Mike Shinoda said in a statement. “In memorial events, art, videos, and images, fans all over the world have gravitated towards this song as their declaration of love and support for the band and the memory of our dear friend, Chester. We are so very grateful and can’t wait to see you again.” Hahn added, “It has been incredibly emotional to work on this, and especially to watch it. I feel that by doing it, we not only faced some of our biggest fears, but it enabled us to use our talents to bring some light to people that need it. As we move forward to the Hollywood Bowl show and beyond, I think about the people that connect with the band, outside and inside our circle. This video is a gesture of good will to the people that want that connection.” Revisit 12 great Linkin Park songs that showcase the talents of the band’s late singer Chester Bennington. Watch here.',\n",
       " ('Linkin Park',\n",
       "  16,\n",
       "  0): 'Linkin Park officially canceled their upcoming tour in the wake of the death of their singer Chester Bennington. “We are incredibly saddened to hear about the passing of Chester Bennington,” Live Nation, the tour’s promoter, said in a statement Friday. “The Linkin Park One More Light North American Tour has been canceled and refunds are available at point of purchase. Our thoughts go out to all those affected.” The band has not released an official statement following Bennington’s death by suicide Thursday. Linkin Park, who recently wrapped a European tour, were scheduled to begin a North American leg in support of their chart-topping new LP One More Light starting June 27th in Mansfield, Massachusetts. The North American trek was scheduled to conclude October 22nd with a concert at Los Angeles’ Staples Center. Along the way, Linkin Park were set to perform two more dates on their co-headlining tour with Blink-182, the “Welcome to Blinkin Park” tour, on July 28th in Flushing, New York and July 30th in Hershey, Pennsylvania. Those two shows appear to remain on schedule but without Linkin Park. On Twitter, Blink-182 drummer Travis Barker paid tribute to Bennington in a pair of tweets. Trending Stories Sabrina Carpenter Is Under Fire for a Spicy Album Cover. Tell It to Carly Simon Carol Kaye Declines Rock & Roll Hall of Fame Induction Fox News Is Demanding War With Iran. Donald Trump Is Listening ‘007 First Light’ Ditches Franchise Lore for a Whole New James Bond “Absolutely heartbroken. I’ll cherish every time we hung out or rocked a stage together. Condolences & prayers to all. So sad,” Barker wrote.',\n",
       " ('Linkin Park',\n",
       "  17,\n",
       "  0): 'Last night (Oct. 27), Linkin Park hit the stage at the Hollywood Bowl in Los Angeles with a wealth of guest artists as they paid tribute to the late Chester Bennington with a special 31 song set that spanned over three hours. Among the most impactful moments of the night was a new song, \"Looking for an Answer,\" a somber ballad performed solely by Mike Shinoda, which can be viewed above. With a shaky voice, the vocalist addressed the crowd, speaking about how music typically gets him through tough times. While he couldn\\'t bring himself to listen to his own band\\'s music in the days after Bennington\\'s death, it was actually about eight days following that he started a song inspired by what he was feeling. Shinoda introduced the song\\'s title and brought the crowd to a hush with its barren piano melody, filling the space between chords with pensive and emotional lyrics, other times letting the light sustain of the keys disappear into the ether as silence overtook the room and had just as profound of an effect. During his intro, Shinoda said that it has not been decided yet what Linkin Park\\'s future will be, but he envisions the song, which is a work in progress, as being something that he would allow fans to follow through to its completion via social media to see how a song comes together, with the Hollywood Bowl performance being the infancy. However, that may be contingent on Linkin Park\\'s plans as a group moving forward. The Linkin Park and Friends Celebrate Life in Honor of Chester Bennington memorial concert marked the first time the members of the band had stepped onstage together since the tragic passing of Bennington on July 20 when he took his own life. Since his death, tributes have been held around the world as fans came together to remember the singer, who was one of the most influential rock musicians of the 21st century. Bennington was voted Best Vocalist in the 2017 Loudwire Music Awards where Halestorm\\'s Lzzy Hale accepted the award on the singer\\'s behalf. Addressing the crowd, she became a harsh critic of cyber bullying and admitted that none of us are alone and all battle demons and vices every day. She implored everyone to come together to lift each other up instead of spreading messages of hate. You can watch the full Linkin Park & Friends - Celebrate Life in Honor of Chester Bennington show below. Rockers We\\'ve Lost in 2017',\n",
       " ('Linkin Park',\n",
       "  18,\n",
       "  0): 'Linkin Park have announced the release of a new song titled ‘Lost’ – listen to a clip below. The band shared the news on social media earlier today (February 6), writing: ““Lost,” a new, never-before-heard song from the Meteora archives. Out Friday, February 10th.” Advertisement The track will arrive ahead of the 20th anniversary of ‘Meteora’, which was the band’s second studio album, featuring hits like ‘Numb’ and ‘Somewhere I Belong’. Fans have been speculating Linkin Park could be gearing up to release an expanded version of ‘Meteora’ in honour of the album’s 20th anniversary. Last month, Linkin Park posted a countdown on their website, which expired on February 1. This was then replaced by an interactive puzzle which fans have been scouring for clues. Back in 2020, the band reissued debut album ‘Hybrid Theory’ across multiple formats. The anniversary edition of that record featured unreleased tracks. Recommended Last May, they unveiled a new, deluxe edition of their 2007 album ‘Minutes To Midnight’. Linkin Park have been on hiatus since the 2017 death of frontman Chester Bennington, but last year said they planned to communicate with their fans “a little more regularly” moving forward. It comes after Shinoda told fans that the band’s survivng members were still in regular contact. “The only Linkin Park news I have for you is that… Yeah, we talk every few weeks – I talk to the guys, or some of the guys,” Shinoda said on a Twitch stream last Spring. “And there’s no tours, there’s no music, there’s no albums in the pipeline. Okay, so let me just tell you that. So just keep in your minds that that is not happening.” “I’m just gonna say that much for now,” he continued. “I say that because anytime the band says anything or does anything, everyone tries to start up the hype train, and we’re, like, ‘No, no, no, no. Don’t start up the hype train.’ You’re gonna disappoint yourself. Don’t do that.”',\n",
       " ('Linkin Park',\n",
       "  19,\n",
       "  0): \"“Lost” is a song from the Meteora recording sessions that was officially released on February 10th, 2023 as the first pre-release song from the 20th Anniversary Edition of Meteora. “Lost” is a song that became popular in the Linkin Park fan community when the DVD of their second album Meteora was released in 2003. On The Making Of Meteora DVD that was released with Meteora, fans immediately noticed a demo that wasn’t on the album which had vocals recorded for it. In this case, a five second clip of Chester singing “thoughts that take away my pride, trapped in places deep inside” over an instrumental has almost become legendary in the Linkin Park community and has appeared on fans' Linkin Park Underground CD wishlists for years. A lyric sheet of the song with the demo bridge can also be seen on the DVD. The words were scribbled on the Meteora art wall at one point when Linkin Park, Delta, and Frank Maddocks were making it in the summer of 2002. The song continued to make small appearances over time, but was never released in full until 2023. In 2007, the second LPTV series was released and the episode about the Summer Sanitarium 2003 Tour features an instrumental clip of the song: LPTV: Summer Sanataruim Additionally, another instrumental clip was shown in an episode of LPUTV for the Linkin Park Underground titled “Mike’s Shirt” from 2007: LPUTV: Mike’s Shirt In the same year of 2003, in the second LPTV series, the episode about Episode 4: The Studio 2, again, features an instrumental clip of the song: LPTV Season 1, Episode 4: The Studio 2 Again, in the same year of 2003, in the second LPTV series, Episode 5: The Vocals features a small snippet/clip of the song LPTV Season 1, Episode 5: The Vocals. The same exact clip is also featured in The Making Of Meteora: The Making Of Meteora The snippet itself: Thoughts That Take Away My Pride (“Lost” Demo) Linkin Park put up a TikTok on Febuary 5th, 2023. The video features a tape recorder that Brad found. He played a few messages from it, including a snippet of “Lost”. It was eventually uploaded to YouTube by Nicholas Pierson: Does Anybody Know What This Is? – Linkin Park Linkin Park put up a tweet with a snippet of the song and a pre-save link for the song on February, 6th, 2023: They put the same snippet on Instagram Facebook , and YouTube Linkin Park also put up a teaser of the song on SoundCloud on February 6th, 2023 that’s longer than the snippet on Twitter: Lost (Teaser) Linkin Park Coalition posted a different snippet from the ones on Twitter and SoundCloud: It would eventually be uploaded to YouTube by Nicholas Pierson: Lost (Bridge Snippet) – Linkin Park On Febuary 14th, 2023, Linkin Park put up a reward for figuring out their puzzle: The Warehouse. In it you can see the Meteora art wall and all sorts of unreleased photo, proofs, ect. When you click the robot looking thing up on the far left side of the wall up at the top, it will send you to a video called “Linkin Park – BBB Soundbites”. In that video, you can hear a longer version of the video that was posted on TikTok. There’s recordings of both “Lost” and “Resolution”. Here’s the video: Linkin Park – BBB Soundbites With only around fifteen songs recorded for Meteora and a growing list of Meteora-era demos appearing on the LPU CDs, it was a surprise that this song hadn’t been released in some form\",\n",
       " ('Linkin Park',\n",
       "  19,\n",
       "  1): 'until 2023. Until the release, its true title remained unknown and fans called it “Thoughts That Take Away My Pride” for twenty years due to the small clip of Chester in the DVD. There have been quite a few interpretations of this demo from Linkin Park fans. Here’s a small snippet of the song comprised of the song and instrumental snippets by xzpureskillzxz on YouTube: Here’s an instrumental cover of Thoughts That Take Away My Pride by Darkenius Storm: Here’s an instrumental remake of the song that was originally made and uploaded by ScribbZzzz on YouTube (who then eventually removed it) but was then re-uploaded by Nicholas Pierson on YouTube: Unreleased Meteroa Instrumental Remake (Lost) Here’s another instrumental concept of the song that was made and uploaded by ScribbZzzz: Lost Instrumental Concept Here’s another instrumental of the song reimagined that was made and uploaded by ScribbZzzz: Lost Instrumental Reimagined',\n",
       " ('Linkin Park',\n",
       "  2,\n",
       "  0): \"Award Artist Title Certification Date Label Format SHARE CLAIRO SEXY TO SOMEONE June 17, 2025 CLAIRO RECORDS SINGLE MORE DETAILS CLAIRO Title: SEXY TO SOMEONE Certification Date: June 17, 2025 Label: CLAIRO RECORDS Format: SINGLE SHARE MORE DETAILS SHARE KANII I KNOW June 17, 2025 MASKED RECORDS / WARNER RECORDS SINGLE MORE DETAILS KANII Title: I KNOW Certification Date: June 17, 2025 Label: MASKED RECORDS / WARNER RECORDS Format: SINGLE SHARE MORE DETAILS SHARE KRIS R., HADES66, YAMA MAKE THEM BOUNCE TREMENDA HP June 17, 2025 LA K COMPANY SAS SINGLE MORE DETAILS KRIS R., HADES66, YAMA MAKE THEM BOUNCE Title: TREMENDA HP Certification Date: June 17, 2025 Label: LA K COMPANY SAS Format: SINGLE SHARE MORE DETAILS SHARE TOMMY RICHMAN MILLION DOLLAR BABY June 17, 2025 ISO SUPREMACY / PULSE RECORDS SINGLE MORE DETAILS TOMMY RICHMAN Title: MILLION DOLLAR BABY Certification Date: June 17, 2025 Label: ISO SUPREMACY / PULSE RECORDS Format: SINGLE SHARE MORE DETAILS SHARE VOILÀ FIGURE YOU OUT June 17, 2025 VOILÀ LLC SINGLE MORE DETAILS VOILÀ Title: FIGURE YOU OUT Certification Date: June 17, 2025 Label: VOILÀ LLC Format: SINGLE SHARE MORE DETAILS SHARE ALEX ISLEY AND MASEGO & JACK DINE GOOD & PLENTY June 16, 2025 ISLEY & DINE RECORDS SINGLE MORE DETAILS ALEX ISLEY AND MASEGO & JACK DINE Title: GOOD & PLENTY Certification Date: June 16, 2025 Label: ISLEY & DINE RECORDS Format: SINGLE SHARE MORE DETAILS SHARE BABY SMOOVE OVERTIME June 16, 2025 FRANCHISE SINGLE MORE DETAILS BABY SMOOVE Title: OVERTIME Certification Date: June 16, 2025 Label: FRANCHISE Format: SINGLE SHARE MORE DETAILS SHARE COCTEAU TWINS CHERRY-COLOURED FUNK June 16, 2025 4AD SINGLE MORE DETAILS COCTEAU TWINS Title: CHERRY-COLOURED FUNK Certification Date: June 16, 2025 Label: 4AD Format: SINGLE SHARE MORE DETAILS SHARE FKA TWIGS TWO WEEKS June 16, 2025 YOUNG SINGLE MORE DETAILS FKA TWIGS Title: TWO WEEKS Certification Date: June 16, 2025 Label: YOUNG Format: SINGLE SHARE MORE DETAILS SHARE FRANK REYES DEVUÉLVEME MI LIBERTAD June 16, 2025 FRANK REYES ASOCIADO ALBUM MORE DETAILS FRANK REYES Title: DEVUÉLVEME MI LIBERTAD Certification Date: June 16, 2025 Label: FRANK REYES ASOCIADO Format: ALBUM SHARE MORE DETAILS SHARE JUNGLE CASIO June 16, 2025 XL RECORDINGS SINGLE MORE DETAILS JUNGLE Title: CASIO Certification Date: June 16, 2025 Label: XL RECORDINGS Format: SINGLE SHARE MORE DETAILS SHARE Q TAKE ME WHERE YOUR HEART IS June 16, 2025 COLUMBIA SINGLE MORE DETAILS Q Title: TAKE ME WHERE YOUR HEART IS Certification Date: June 16, 2025 Label: COLUMBIA Format: SINGLE SHARE MORE DETAILS SHARE RILEY GREEN WORST WAY June 16, 2025 NASHVILLE HARBOR RECORDS & ENTERTAINMENT SINGLE MORE DETAILS RILEY GREEN Title: WORST WAY Certification Date: June 16, 2025 Label: NASHVILLE HARBOR RECORDS & ENTERTAINMENT Format: SINGLE SHARE MORE DETAILS SHARE THE HEAD AND THE HEART LET'S BE STILL June 16, 2025 SUB POP RECORDS ALBUM MORE DETAILS THE HEAD AND THE HEART Title: LET'S BE STILL Certification Date: June 16, 2025 Label: SUB POP RECORDS Format: ALBUM SHARE MORE DETAILS SHARE TINASHE 2 ON June 16, 2025 RCA SINGLE MORE DETAILS TINASHE Title: 2 ON Certification Date: June 16, 2025 Label: RCA Format: SINGLE SHARE MORE DETAILS SHARE VAMPIRE WEEKEND CAPE COD KWASSA KWASSA June 16, 2025 XL RECORDINGS SINGLE MORE DETAILS VAMPIRE WEEKEND Title: CAPE COD KWASSA KWASSA Certification Date: June 16, 2025 Label: XL RECORDINGS Format: SINGLE SHARE MORE DETAILS SHARE LUKE COMBS SHE GOT THE BEST OF ME June 13, 2025 COLUMBIA NASHVILLE / RIVER HOUSE ARTISTS SINGLE MORE DETAILS LUKE COMBS Title: SHE GOT THE BEST OF ME Certification Date: June 13, 2025 Label: COLUMBIA NASHVILLE / RIVER HOUSE ARTISTS Format:\",\n",
       " ('Linkin Park',\n",
       "  2,\n",
       "  1): \"SINGLE SHARE MORE DETAILS SHARE LUKE COMBS GROWIN' UP AND GETTIN' OLD June 13, 2025 COLUMBIA NASHVILLE / RIVER HOUSE ARTISTS SINGLE MORE DETAILS LUKE COMBS Title: GROWIN' UP AND GETTIN' OLD Certification Date: June 13, 2025 Label: COLUMBIA NASHVILLE / RIVER HOUSE ARTISTS Format: SINGLE SHARE MORE DETAILS SHARE LUKE COMBS NOTHING LIKE YOU June 13, 2025 COLUMBIA NASHVILLE / RIVER HOUSE ARTISTS SINGLE MORE DETAILS LUKE COMBS Title: NOTHING LIKE YOU Certification Date: June 13, 2025 Label: COLUMBIA NASHVILLE / RIVER HOUSE ARTISTS Format: SINGLE SHARE MORE DETAILS SHARE LUKE COMBS BEAUTIFUL CRAZY June 13, 2025 COLUMBIA NASHVILLE / RIVER HOUSE ARTISTS SINGLE MORE DETAILS LUKE COMBS Title: BEAUTIFUL CRAZY Certification Date: June 13, 2025 Label: COLUMBIA NASHVILLE / RIVER HOUSE ARTISTS Format: SINGLE SHARE MORE DETAILS SHARE LUKE COMBS WHEN IT RAINS IT POURS June 13, 2025 COLUMBIA NASHVILLE / RIVER HOUSE ARTISTS SINGLE MORE DETAILS LUKE COMBS Title: WHEN IT RAINS IT POURS Certification Date: June 13, 2025 Label: COLUMBIA NASHVILLE / RIVER HOUSE ARTISTS Format: SINGLE SHARE MORE DETAILS SHARE LUKE COMBS FOREVER AFTER ALL June 13, 2025 COLUMBIA NASHVILLE / RIVER HOUSE ARTISTS SINGLE MORE DETAILS LUKE COMBS Title: FOREVER AFTER ALL Certification Date: June 13, 2025 Label: COLUMBIA NASHVILLE / RIVER HOUSE ARTISTS Format: SINGLE SHARE MORE DETAILS SHARE LUKE COMBS FAST CAR June 13, 2025 COLUMBIA NASHVILLE / RIVER HOUSE ARTISTS SINGLE MORE DETAILS LUKE COMBS Title: FAST CAR Certification Date: June 13, 2025 Label: COLUMBIA NASHVILLE / RIVER HOUSE ARTISTS Format: SINGLE SHARE MORE DETAILS SHARE LUKE COMBS THE KIND OF LOVE WE MAKE June 13, 2025 COLUMBIA NASHVILLE / RIVER HOUSE ARTISTS SINGLE MORE DETAILS LUKE COMBS Title: THE KIND OF LOVE WE MAKE Certification Date: June 13, 2025 Label: COLUMBIA NASHVILLE / RIVER HOUSE ARTISTS Format: SINGLE SHARE MORE DETAILS SHARE LUKE COMBS WHERE THE WILD THINGS ARE June 13, 2025 COLUMBIA NASHVILLE / RIVER HOUSE ARTISTS SINGLE MORE DETAILS LUKE COMBS Title: WHERE THE WILD THINGS ARE Certification Date: June 13, 2025 Label: COLUMBIA NASHVILLE / RIVER HOUSE ARTISTS Format: SINGLE SHARE MORE DETAILS SHARE LUKE COMBS GOING, GOING, GONE June 13, 2025 COLUMBIA NASHVILLE / RIVER HOUSE ARTISTS SINGLE MORE DETAILS LUKE COMBS Title: GOING, GOING, GONE Certification Date: June 13, 2025 Label: COLUMBIA NASHVILLE / RIVER HOUSE ARTISTS Format: SINGLE SHARE MORE DETAILS SHARE LUKE COMBS LOVE YOU ANYWAY June 13, 2025 COLUMBIA NASHVILLE / RIVER HOUSE ARTISTS SINGLE MORE DETAILS LUKE COMBS Title: LOVE YOU ANYWAY Certification Date: June 13, 2025 Label: COLUMBIA NASHVILLE / RIVER HOUSE ARTISTS Format: SINGLE SHARE MORE DETAILS SHARE LUKE COMBS MUST'VE NEVER MET YOU June 13, 2025 COLUMBIA NASHVILLE / RIVER HOUSE ARTISTS SINGLE MORE DETAILS LUKE COMBS Title: MUST'VE NEVER MET YOU Certification Date: June 13, 2025 Label: COLUMBIA NASHVILLE / RIVER HOUSE ARTISTS Format: SINGLE SHARE MORE DETAILS SHARE LUKE COMBS REMEMBER HIM THAT WAY June 13, 2025 COLUMBIA NASHVILLE / RIVER HOUSE ARTISTS SINGLE MORE DETAILS LUKE COMBS Title: REMEMBER HIM THAT WAY Certification Date: June 13, 2025 Label: COLUMBIA NASHVILLE / RIVER HOUSE ARTISTS Format: SINGLE SHARE MORE DETAILS\",\n",
       " ('Linkin Park',\n",
       "  20,\n",
       "  0): '\"Meteora\", LINKIN PARK\\'s groundbreaking second album, was released in March 2003 and included the global hit singles \"Somewhere I Belong\", \"Faint\", \"Numb\", \"Breaking The Habit\" and \"From The Inside\". It has sold over eight million copies in the U.S. and has been certified multi-platinum, platinum, or gold in 15 countries. To mark the 20th anniversary of this landmark release, it is being reissued on April 7 in multiple formats: Limited Edition Super Deluxe Box Set, 4 LP Deluxe Vinyl Box Set, 3-disc Deluxe CD and digital: all containing a wealth of previously unreleased or rare tracks. Among the unreleased tracks are several gems previously unknown to LINKIN PARK fans, including \"Lost\" — a fully realized track from the 2002 album recording sessions featuring stunning vocals from late frontman Chester Bennington. LINKIN PARK\\'s Mike Shinoda said: \"Finding \\'Lost\\' was like finding a favorite photo you had forgotten you\\'d taken, like it was waiting for the right moment to reveal itself.\" LINKIN PARK has been on hiatus since the death of Bennington in 2017. Last April, Shinoda said that there are no plans for new music, albums or live shows from the band. The 45-year-old musician, who was appointed Community Innovation Advisor of Warner Recorded Music (WRM),addressed LINKIN PARK\\'s future during a Twitch livestream. \"The only LINKIN PARK news I have for you is that… Yeah, we talk every few weeks — I talk to the guys, or some of the guys,\" he said. \"And there\\'s no tours, there\\'s no music, there\\'s no albums in the pipeline. Okay, so let me just tell you that. So just keep in your minds that that is not happening. \"I\\'m just gonna say that much for now,\" he continued. \"I say that because anytime the band says anything or does anything, everyone tries to start up the hype train, and we\\'re, like, \\'No, no, no, no. Don\\'t start up the hype train.\\' You\\'re gonna disappoint yourself. Don\\'t do that.\" LINKIN PARK has not performed together in public since October 2017, when the surviving members staged a tribute concert in Los Angeles to singer Chester Bennington. The band has not officially announced whether it intends to carry on following the death of Bennington, who committed suicide in July 2017 at the age of 41. Four years ago, Shinoda shot down reports that LINKIN PARK was actively searching for a replacement for Bennington. In February 2019, Shinoda took to his Twitter account to write: \"Lemme clarify a rumor: we are not looking for a new singer, and if it were to happen organically, I\\'d be open. Seems pretty clear, yet I guess some folks have a hard time understanding. \"I\\'m not into predicting the future. The future will happen.\" Shinoda made his comments in an apparent response to how the media covered an interview he gave to Rock Antenne. When asked about the possibility of finding a new singer, Shinoda said: \"That\\'s not my goal right now. I think it has to happen naturally. And if we find somebody that\\'s a great person that we think is a good personality fit and a good stylistic fit, then I could see trying to do some stuff with somebody... I wouldn\\'t wanna ever feel like we were replacing Chester.\" Shinoda added: \"I know the other guys, they love to get onstage, they love to be in the studio, and so to not do that would be — I don\\'t know — almost unhealthy. If doing that means that we need to have some other people in the mix in order to do it and do it well, then we',\n",
       " ('Linkin Park',\n",
       "  20,\n",
       "  1): 'would do that... But, like I said before, it has to happen naturally. I\\'m not running out and putting up \\'vocalist wanted\\' posters.\"',\n",
       " ('Linkin Park',\n",
       "  21,\n",
       "  0): 'Mike Shinoda says that there are no plans for new music, albums or live shows from LINKIN PARK. The 45-year-old musician, who was recently appointed Community Innovation Advisor of Warner Recorded Music (WRM),addressed LINKIN PARK\\'s future during a Twitch livestream on Friday (April 22). \"The only LINKIN PARK news I have for you is that… Yeah, we talk every few weeks — I talk to the guys, or some of the guys,\" he said. \"And there\\'s no tours, there\\'s no music, there\\'s no albums in the pipeline. Okay, so let me just tell you that. So just keep in your minds that that is not happening. \"I\\'m just gonna say that much for now,\" he continued. \"I say that because anytime the band says anything or does anything, everyone tries to start up the hype train, and we\\'re, like, \\'No, no, no, no. Don\\'t start up the hype train.\\' You\\'re gonna disappoint yourself. Don\\'t do that.\" LINKIN PARK has not performed together in public since October 2017, when the surviving members staged a tribute concert in Los Angeles to singer Chester Bennington. The band has not officially announced whether it intends to carry on following the death of Bennington, who committed suicide in July 2017 at the age of 41. Three years ago, Shinoda shot down reports that LINKIN PARK was actively searching for a replacement for Bennington. In February 2019, Shinoda took to his Twitter account to write: \"Lemme clarify a rumor: we are not looking for a new singer, and if it were to happen organically, I\\'d be open. Seems pretty clear, yet I guess some folks have a hard time understanding. \"I\\'m not into predicting the future. The future will happen.\" Shinoda made his comments in an apparent response to how the media covered an interview he gave to Rock Antenne. When asked about the possibility of finding a new singer, Shinoda said: \"That\\'s not my goal right now. I think it has to happen naturally. And if we find somebody that\\'s a great person that we think is a good personality fit and a good stylistic fit, then I could see trying to do some stuff with somebody... I wouldn\\'t wanna ever feel like we were replacing Chester.\" Shinoda added: \"I know the other guys, they love to get onstage, they love to be in the studio, and so to not do that would be — I don\\'t know — almost unhealthy. If doing that means that we need to have some other people in the mix in order to do it and do it well, then we would do that... But, like I said before, it has to happen naturally. I\\'m not running out and putting up \\'vocalist wanted\\' posters.\"',\n",
       " ('Linkin Park',\n",
       "  22,\n",
       "  0): 'Linkin Park is getting ready to bring fans back to the early 2000s with its upcoming single “Lost”. For those who haven’t heard, the band announced the track was coming this week in light of the 20th anniversary of Meteora, one of the group’s most beloved albums. It turns out a track titled “Lost” was discovered in the album’s backlogs, and Linkin Park agreed it was only right to release the unheard single which features late frontman Chester Bennington. And now, we have been given a look at the band’s anime music video for “Lost”. Videos by ComicBook.com As you can see, the band brought in directors pplpleasr1 and Maciej Kuciara to oversee the animated MV. The team oversees the company Shibuya which produces anime and anime-inspired projects all about decentralized storytelling. Linkin Park approached the group with “Lost” when looking for music video pitches, and it seems the directors are taking the single in a haunting direction. https://twitter.com/linkinpark/status/1623561791447117824?ref_src=twsrc^tfw Of course, fans are eager to hear the song in full as “Lost” has only been shown in snippets so far. The track is incredibly reminiscent of Linkin Park’s greatest tracks from Meteora, and that is quite the compliment. After all, the award-winning album features hits like “Numb” and “Breaking the Habit”. Of course, this anime-centric music video is not the first one done by Linkin Park. The group has released several such videos for tracks like “Breaking the Habit” and “Points of Authority” before now. The former was animated by Studio Gonzo under director Joe Hahn and supervisor Kazuto Nakazawa. Upon their release, the animated videos were met with universal love, and now Linkin Park will recreate that magic with “Lost” this week. So if you are eager to check out the video, Linkin Park plans to drop “Lost” on Friday, February 10th. What do you think about this sneak peek at Linkin Park’s next MV? Share your thoughts with us in the comments section below or hit me up on Twitter @MeganPetersCB.',\n",
       " ('Linkin Park',\n",
       "  23,\n",
       "  0): 'The nominees for the 2018 Billboard Music Awards have been announced, and while there\\'s not a lot of hard rock and metal representation, those who have made the cut are getting a fair shake. The primary acts in contention this year are Guns N\\' Roses and Linkin Park. Guns N\\' Roses have been nominated largely off their touring, with nods for Top Touring Artist, where they face competition from Coldplay, Bruno Mars, Ed Sheeran and U2, and Top Rock Tour, where Coldplay and U2 are the competition. Linkin Park, meanwhile, have been nominated for Top Rock Artist, Top Rock Album for One More Light, and Top Rock Song for \"Heavy,\" the track they recorded with pop singer Kiiara. In the Top Rock Artist category, they face off against Imagine Dragons, Portugal. The Man, Tom Petty and the Heartbreakers and Twenty One Pilots. Their Top Rock Album competition includes Imagine Dragons\\' Evolve, Panic! at the Disco\\'s Death of a Bachelor, Portugal. The Man\\'s Woodstock and U2\\'s Songs of Experience. For Top Rock Song, they square off against Imagine Dragons twice for \"Believer\" and \"Thunder,\" Portugal. The Man\\'s \"Feel It Still\" and The Revivalists\\' \"Wish I Knew You.\" With the Billboard Music Awards, the various chart performance of the acts is of primary importance. You can see the full list of nominees over at Billboard. This year, the Billboard Music Awards will air live from the MGM Grand Garden Arena in Las Vegas on May 20. NBC will have the broadcast at 8PM ET / 5PM PT. Slash - Wikipedia: Fact or Fiction?',\n",
       " ('Linkin Park',\n",
       "  24,\n",
       "  0): 'Twenty years after the release of Meteora, Linkin Park is revisiting their mega-selling sophomore album: Meteora 20th Anniversary Edition will be released through Warner Records on Apr. 7, the band announced on Friday (Feb. 10), and will include multiple previously unreleased songs in addition to several other fan-friendly collectibles. Explore Explore Linkin Park See latest videos, charts and news See latest videos, charts and news One of those unreleased songs, “Lost,” arrives today as a fleshed-out, fully realized showcase for the band’s Chester Bennington, who passed away in 2017. Linkin Park recorded “Lost” for Meteora but the track didn’t make the final track list; while scavenging through hard drives for the 20th anniversary of the album, the group rediscovered the song and Bennington’s intensely riveting vocals that serve as its highlight. “Finding this track was like finding a favorite photo you had forgotten you’d taken, like it was waiting for the right moment to reveal itself,” the band’s Mike Shinoda says in a press statement. “For years, fans have been asking us to release something with Chester’s voice, and I’m thrilled we’ve been able to make that happen in such a special way. I think they’re going to be floored when they hear and see all the incredible unreleased songs and video footage in Meteora 20.” Trending on Billboard “Lost” will be among six unreleased songs on Meteora 20, in addition to demos, live shows, B-sides and previously unaired footage with the band. The project will be available in multiple variations, including a limited edition super deluxe box set, deluxe vinyl box set, deluxe 3-CD and digital download. The 20th anniversary reissue of Meteora follows the 2020 release of Hybrid Theory: 20th Anniversary Edition, which toasted Linkin Park’s diamond-selling 2000 debut. “It’s a nice time to pause and think and focus on what it took to make that record, the impact it had, and the opportunity it allowed us to continue with our careers,” the band’s Joe Hahn told Billboard at the time. “For me, it’s a testament to the camaraderie between all the guys in the band, to our friendship, to our work ethic, to the values in how we approached not just making music, but the business of making music, and the way we interact with our fans.” Released in March 2003, Meteora includes some of Linkin Park’s most enduring hits, from “Numb” to “Breaking the Habit” to “Faint” to “Somewhere I Belong” to “Lying From You” — all of which topped Billboard’s Alternative Songs chart — as well as essential fan favorites like “Nobody’s Listening” and “Easier to Run.” Meteora has earned 8.5 million equivalent album units to date, of which 6.5 million are in traditional album sales, according to Luminate. To celebrate the Meteora 20 announcement and the release of “Lost,” Linkin Park will relaunch their official Discord on Friday, with a Q&A on the Discord Stage. The band is also teasing “more surprises” leading up to the April release. Watch the official video for “Lost” — which was produced and animated by by pplpleasr and Maciej Kuciara’s Web3 studio, Shibuya — below:',\n",
       " ('Linkin Park',\n",
       "  25,\n",
       "  0): 'For free real time breaking news alerts sent straight to your inbox sign up to our breaking news emails Sign up to our free breaking news emails Sign up to our free breaking news emails Email * SIGN UP I would like to be emailed about offers, events and updates from The Independent. Read our Privacy notice A lyricist to the last, Chester Bennington conjured a neat line to encapsulate the maelstrom of depression and addiction which swirled around him for much of his life and career as lead singer with American nu-metal band Linkin Park. Pointing to his head, he told an interviewer: “I like to say, ‘This is like a bad neighbourhood and I should not go walking alone.’” Bennington, whose death at the age of 41 has been confirmed as “suicide by hanging” by the Los Angeles Coroner’s office, was seen by disaffected young people around the world as someone who could articulate their problems in song. In Linkin Park, he sang about mental illness and substance abuse; his powerful, urgent, soaring vocals dovetailing with Mike Shinoda’s rapping. One reason Bennington empathised so strongly with his audience was that he had endured much of what many of them were going through. Born in Phoenix, Arizona, to parents who divorced when he was 11, he was barely into his teens before he slipped into alcohol and drug abuse. He later listed LSD, methamphetamine, crack and opium among the drugs he used to cope with feelings of self-loathing created by being sexually violated by an older “friend” from the age of seven to 13. Music gave him a fresh sense of purpose and escape. Bennington recorded three albums with the post-grunge band Grey Daze, formed in his hometown, but left in 1998. He nearly quit his musical career before he was finally offered an audition in California with the band that would become Linkin Park, then called Xero, to which he was recruited in 1999. The six-piece’s fusion of hard rock and hip-hop, characterised by Bennington and Shinoda’s respective styles, prompted the name-change from Xero to Hybrid Theory. The band was well received online, circulating the new sound through chat rooms and forums, giving way to another name change to Linkin Park. There were still numerous rejections before they were finally signed to Warner Bros. Records in 1999, releasing their debut album Hybrid Theory in 2000. To date they have sold 70 million albums worldwide, as well as 30 million singles, and in 2014 Kerrang! magazine branded them “The Biggest Rock Band in the World Right Now”. open image in gallery Linkin Park poses with the Grammy Award for Best Rap Song (‘Numb’) in 2006 (Getty) ( Getty Images ) Hybrid Theory remains the best-selling debut album of the 21st century. It was followed by the remix album Reanimation (2002), and six more studio albums: Meteora (2003), Minutes To Midnight (2007), A Thousand Suns (2010), Living Things (2012), The Hunting Party (2014) and this year’s One More Light, which topped the US chart. Bennington also undertook side projects. In 2005 he co-founded Dead By Sunrise, whose album Out Of Ashes (2009) he considered “darker” than Linkin Park’s material, while in 2013 he began a two-year stint fronting Stone Temple Pilots, the grunge band which he said – along with Depeche Mode – had sparked his adolescent interest in music, and which he had once dreamed of singing with. Linkin Park collaborated with numerous artists, including Jay-Z and British grime artist Stormzy. His first marriage, to Samantha Olit, was dissolved after nine years in 2005, after which he lapsed back',\n",
       " ('Linkin Park',\n",
       "  25,\n",
       "  1): 'into drink and drug abuse. A year later, when he married teacher and former model Talinda Bentley, he declared himself clean again. He was father to six children with three partners. Bennington said this year that he had shrugged off his demons. But the May suicide by hanging of his close friend Chris Cornell, the Soundgarden singer, hit him hard; he gave an emotional rendition of Leonard Cohen’s Hallelujah at the funeral and could not finish One More Light when performed with Linkin Park in tribute to Cornell. He took own life at the family home in LA on what would have been Cornell’s 53rd birthday. Chester Charles Bennington: singer, songwriter, musician, actor; born 20 March 1976, died 20 July 2017',\n",
       " ('Linkin Park',\n",
       "  26,\n",
       "  0): 'Linkin Park are in the unenviable position of deciding if or how to continue without one of rock\\'s most identifiable voices, the late Chester Bennington. But in a new interview with Rock Antenne, co-vocalist Mike Shinoda says the band is open to the idea of continuing, though what form that takes has yet to be decided. \"We all thrive making and performing music,\" says Shinoda. \"I know the other guys, they love to be onstage, they love to be in a studio, and so to not do that would be like ... I don’t know, almost like unhealthy.\" He added that the band\\'s large fanbase also is something they take into consideration. \"As long as that connection and interest is there, I think that is our driving force to figure out Linkin Park,\" he explained. When asked about the band\\'s future minus Chester, Shinoda states, \"It’s not my goal to look for a new singer. If it does happen, it has to happen naturally. If we find someone that is a great person and good stylistic fit, I could see trying to do some stuff with somebody. I would never want to feel like we are replacing Chester.\" Shinoda has been revisiting some of Linkin Park\\'s material while on his solo tour, stating that in doing so his primary goal was to have fans celebrate his late bandmate. That said, it\\'s not a stretch for Shinoda to sing parts that might be more familiar with Chester\\'s voice. He explains, \"In the demo stages of our songs, I would always sing my demos. So I would sing the original versions of the songs, and then I would play them for the guys and I would play them for Chester, and then he would re-sing stuff. So getting onstage today and singing one of those songs, it just goes back to the first version of the song.\" Hear more of Shinoda\\'s chat with Rock Antenne in the player below, and look for the singer continuing his solo tour next month in Europe. All dates can be found here.',\n",
       " ('Linkin Park',\n",
       "  27,\n",
       "  0): 'Hybrid theories “Any long-time fan of this band knows that we tend to make violent course changes from album to album,” Linkin Park guitarist Brad Delson says as we discuss the band’s new record, One More Light. He’s not kidding. Since the release of their monumentally successful debut, Hybrid Theory, 17 years ago, the band has lurched from rap metal to straight up rock to electronica and back again. With more than 70 million records sold and two Grammys on their mantle, it would appear that their eclecticism has been rewarded. So, for album seven did they decide to stick or twist? “The change between the last album and this one is no exception,” Brad assures MusicRadar. “That’s fun for us as musicians.” Judging from lead single Heavy, Delson is once again right on the money. The song\\'s stripped-back pop is in stark contrast to the raw, rough-and-ready rock of 2014’s The Hunting Party. Ahead of the album’s 19 May release, we spoke to the guitarist all about One More Light, the influence of Rick Rubin and confounding fan expectations at every turn. You’re seven albums in now; how does the studio-seasoned 2017 Linkin Park approach making a new record? “This was a really fun album to create. We created it in a way that was totally upside-down. We had this idea; we wanted to write songs. That might sound ridiculous, because everything we write are songs, but I really mean songs. “We’ve made a lot of music throughout our career where the music takes the steering wheel. In that case, the sounds lead us through the journey. On this album we wanted to write songs that had something to say. “Another idea we had was to be totally open in terms of our style of working and everything from guest artists to co-producers to co-composers. Anyone interesting that we wanted to meet, we wanted to give an open invitation to coming through, and in that regard it was a very fun record to make.” We had a finished song that we loved and then we had to figure out what style it is. Is it a heavy rock song, is it minimalist, is it country, is it electronic-driven, or is it all of the above? Judging by Heavy, this is a very different sounding record to The Hunting Party… “The Hunting Party was driven by a ferocity and a desire to make a stylistic statement. It was definitely intended to be aggressive and really instrument-driven in terms of guitar and drums. “On One More Light, we wrote all of the songs before they had any notion of style or context. We would go into the studio and really ask each other what was on our minds and what was in our hearts, what did we have to say and what did we want to express. It almost always started from conversations about things going on in our lives that were very personal. \"We worked with vocals, lyrics and melodies first. We almost completed a full song every single day. We wrote about 70 songs and they were all very naked and stripped, barebones. “We normally have a lot of music cooked up and then work on vocals later. This was the opposite challenge. We had a finished song that we loved and then we had to figure out what style it is. Is it a heavy rock song, is it minimalist, is it country, is it electronic-driven, or is it all of the above? I think my favourite results were when you couldn’t quite tell what style it was;',\n",
       " ('Linkin Park',\n",
       "  27,\n",
       "  1): 'it was just a hybrid of all of the styles that we loved.”',\n",
       " ('Linkin Park',\n",
       "  28,\n",
       "  0): 'Emily Armstrong and Linkin Park perform during a global livestream at Warner Bros. Studios in Burbank on Sept. 5 ahead of the launch of their new tour at Kia Forum on Wednesday. Seven years after tragedy silenced the raging platinum-selling rock band Linkin Park, the group took a major step toward its resurrection at the Kia Forum on Wednesday night, launching a tour with new singer Emily Armstrong. Following 17 years of radio hits and major touring success, the band’s original run ended abruptly with the 2017 suicide of singer Chester Bennington, who had long been the roaring counterpoint to Mike Shinoda’s rapped vocals. In his lyrics and performances, he was an artist adept at the extremes of fury and tenderness, and had connected deeply around the world. A new singer who sounded too much like Bennington would only make fans miss him more. For his replacement, casting against type was the braver and more intriguing path, rebirthing Linkin Park as something more than a sad echo of its past. Armstrong, who previously sang for Los Angeles-based rock band Dead Sara, showed that potential at the Forum. Advertisement The band played in the round, on a mostly empty, high-tech stage shaped like an aircraft carrier. That meant great sight lines for more people in the arena, but muddier sound as a result. Regardless, for two hours the band powered through 27 songs as tight as ever, beginning with two of their most popular early anthems, “Somewhere I Belong” and “Crawling.” Like most of the Linkin Park songbook, Bennington’s voice was central on the original recordings, but Armstrong dived in with confidence and appropriate angst, frequently bent over her mic, wailing at the edge of the stage. On “Crawling,” she roared the signature anguished lyric, headbanging her blond locks: “I’ve felt this way before/So insecure!” as the crowd shouted along. Advertisement Emily Armstrong and Linkin Park perform at Warner Bros. Studios on Sept. 5. (Timothy Norris/Getty Images for Warner Music) Genders aside, there are similarities between the current and former singers. Like Bennington, Armstrong is as capable with rich melodies as throat-ripping vocals, a natural fit with the established Linkin Park sound, which collides metal riffs with hip-hop, electronics and pop hooks. “Have you met our friend Emily yet?” said a grinning Shinoda, bearded and wearing a leopard-print jacket, who did most of the talking between songs. He also noted the spontaneous, high-octane singalongs that were already filling the arena, with an affectionate nod to their late vocalist. “You already know that you guys are singing for Chester tonight, right?” Advertisement Later, he added, “We are thrilled to be back out here. It is not about erasing the past. It is about starting a new chapter into the future.” That new chapter arrived with little warning less than a week ago, when Linkin Park announced its return, and introduced their new singer, via livestream performance from Warner Bros.’ Burbank studio and included a new song, “The Emptiness Machine.” A new album, “From Zero,” will land this November from the band’s longtime label, Warner Records. Losing a talented, charismatic frontman is a devastating blow to any rock group, and few survive. If most Linkin Park fans were resigned to the band being over, the impulse to find a way back is in character for Shinoda, long its most driven creative force in the studio. But keeping the reunion a secret even as the group rehearsed with Armstrong, recorded an entire album and planned an arena tour was a startling feat. “I’m sorry we had to keep this big secret from you for',\n",
       " ('Linkin Park',\n",
       "  28,\n",
       "  1): 'so long. It was very difficult for us,” Shinoda said from the Forum stage, then nodded toward Armstrong. “She had to not even hang out with her friends or tell anybody anything.” There are other changes too. Drummer Rob Bourdon chose not to participate in the reunion and was replaced by Colin Brittain. While guitarist Brad Delson remains a full member, he will no longer tour with Linkin Park; filling in on the road is Alex Feder. Fans were primed for this moment and roared with approval. There were many spontaneous chants of: “Linkin Park! Linkin Park! Linkin Park!” Bennington’s singular presence was irreplaceable, but Armstrong showed she had chops of her own to help the veteran act work toward something new. Advertisement Until “From Zero” is released, the band’s set list will remain almost entirely songs from the past. But Armstrong seemed up to the challenge, even on 2007’s agitated “Given Up,” originally featuring one of Bennington’s most superhuman vocals, as she paced the large stage, pumping her fist, reshaping the vocal to her voice. At a different volume was “Lost,” as Shinoda tapped a delicate piano melody, and Armstrong added an understated vocal of regret (“I’m lost in these memories/Living behind my own illusion”). Originally recorded during sessions for 2003’s “Meteora,” the song remained unreleased until a 20th anniversary reissue of the album, but at the Forum it was rearranged to its most austere and vulnerable. Late in the evening, Linkin Park delivered three of the band’s most popular and explosive songs of frustration and defiance — “Numb,” “In the End” and “Faint” — as Armstrong was nearly drowned out by a crowd passionately singing every word. In those moments, it hardly mattered who held the microphone, as thousands of the band’s most devoted followers took on the lyrics as their own, and maybe saw something of themselves in this new singer. The Forum concert was the first night of a short international tour that continues Monday in New York, followed by stops in Hamburg, Germany; London; Seoul; and Bogota, Colombia. A longer tour is promised for 2025. After years of silence, Linkin Park once again sounds like a band with a future.',\n",
       " ('Linkin Park',\n",
       "  29,\n",
       "  0): 'As the concert business rebounded in 2011, touring remained the biggest source of income for the top earners in the U.S. music business. Billboard’s sixth annual Money Makers ranking includes veteran road warriors U2, Kenny Chesney and Bon Jovi, as well as other artists emerging in recent years as A-list arena headliners, from Taylor Swift to Lady Gaga. But not all of the 40 artists on the Money Makers list relied heavily, if at all, on touring income. Thanks to the breathtaking sales of sophomore album “21,” Adele made a top 10 showing despite vocal cord problems limiting her ability to perform publicly before she was forced to cancel 10 sold-out U.S. dates in the fall. Sales of the Beatles’ classic catalog-powered by impressive digital album sales at iTunes-enabled the Fab Four to make their Money Makers debut. And who says kids don’t buy music these days? Justin Bieber enjoyed such robust album and digital track sales that even his absence from the U.S. touring market didn’t keep him from making the cut. Country artists had another banner year, occupying 11 of the 40 slots on the list, with Swift surpassing all with U.S. earnings of $35.7 million, 17% more than the take-home pay of last year’s top-earner, Lady Gaga. Conspicuously absent are dance artists, despite the genre’s recent commercial resurgence. That’s due, in part, to the fact that even the most prominent dance acts can’t match the recorded-music sales of mainstream pop, rock and country artists. Moreover, touring itineraries of most star DJs not named Tiësto include multiple club dates, and venue capacities are simply too small to generate the financial returns of an arena tour. Trending on Billboard Music’s Top Money Makers 2011 40. Linkin Park $5,190,655 Linkin Park spent the majority of last year touring the globe to promote its 2010 album, A Thousand Suns, which was also the group’s best-selling 2011 title with U.S. sales of 208,000. The set debuted at No. 1 in September 2010 with 241,000 first-week copies sold. Linkin Park sold a total of 657,000 albums and 3.7 million digital tracks in 2011. Live, the group performed throughout Australia, Europe and Asia, grossing $7 million alone from 10 U.S. arena shows. Overall, Linkin Park’s take in 2011 came out to $5.2 million. 39. Kanye West $5,363,661 The rapper’s November 2010 release, My Beautiful Dark Twisted Fantasy, rocked through all of 2011 as he leveraged its success by releasing collaborative album Watch the Throne with Jay-Z. West reaped the multiplying power from both projects, as well as earlier hits, by moving 1.1 million albums (physical and digital) and 3.4 million digital tracks. Right after releasing Throne, the two rappers ventured out on a U.S. tour that grossed $29.3 million. Now working on a G.O.O.D. Music compilation and prepping a new album, West is sitting pretty on last year’s net earnings of $5.4 million. 38. Mötley Crüe $5,376,272 Three decades after forming, Los Angeles hard rock icon Mötley Crüe is still blazing a trail. On the road is where the Crüe did the majority of its business in 2011, grossing nearly $14.2 million from 28 dates and playing for 255,182 headbangers during its June-August arena/amphitheater run with supporting acts Poison and the New York Dolls. Famed for its outrageous concert production, on this tour drummer Tommy Lee’s kit was outfitted with a roller-coaster loop he actually rode on while playing-and one lucky fan also got strapped in for the ride almost every night. During the year, Mötley Crüe sold more than 700,000 digital tracks and 183,000-plus copies of its various albums. 37. Steely Dan $5,389,509',\n",
       " ('Linkin Park',\n",
       "  29,\n",
       "  1): 'Steely Dan hasn’t released a new studio album since Everything Must Go in 2003, but it’s remained active in the touring space during the past decade despite the slow drip of studio recordings. In 2011, the act’s album and digital track sales earnings were nominal compared with its touring revenue. The group sold 141,000 albums and 438,000 tracks last year. With plenty of catalog material from the ’70s to fill up set lists, Steely Dan grossed $14.7 million from 50 U.S. theater and amphitheater dates. Highlights from that trek included a seven-night run at New York’s Beacon Theatre in September. 36. New Kids On The Block $5,519,805 Like tour mates Backstreet Boys (No. 33), the re-formed New Kids on the Block earned quite a bit in 2011 thanks to the co-headlining NKOTBSB tour. The bill was the 17th-most successful tour last year. Traveling across North America, Europe and Australia, the New Kids performed their hits onstage with BSB (and vice versa), and this year the tour is playing overseas. While the group hasn’t recorded an album of new material since 2008, a compilation of both groups’ greatest hits, a pair of joint recordings and a mashup pushed NKOTB’s album sales to nearly 83,000 units in 2011. 35. Justin Bieber $5,523,459 A break from touring the United States pushed Justin Bieber lower in the rankings, but don’t feel bad for him-he still closed out 2011 at No. 9 on Billboard’s year-end Top Artists chart, thanks to what appears to be an unending appetite for his music. Under the Mistletoe (his first Christmas collection) and dance mix compilation Never Say Never: The Remixes both debuted at No. 1 on the Billboard 200. Mistletoe sold 1.3 million copies while Remixes sold 824,000. In total, Bieber sold 3.4 million albums and 6.9 million digital tracks in 2011, despite the fact that he didn’t tour domestically. 34. Sugarland $5,632,406 For star country duo Sugarland, last year was marred by a stage collapse at the Indiana State Fair in August, a tragedy that resulted in seven deaths. (A lawsuit brought by fair-goers and their families cites the group’s negligence in preparing to go on, despite the high winds.) But the ongoing support of Jennifer Nettles and Kristian Bush by loyal fans can be measured by sales in 2011 of 2010’s The Incredible Machine (324,000) and total album sales of more than 550,000 units. Enthusiasm for the pair’s live shows never waned, either-Sugarland earned more than $4 million from an extensive 2011 tour that continued through the end of the year. 33. Backstreet Boys $5,712,050 Ranking a few notches above tour mates New Kids on the Block (No. 36), Backstreet Boys grossed $15.8 million last year, mostly from the combination NKOTBSB tour. The show, which features BSB and New Kids performing their hits together, kicked off in May with more than 50 North American dates, and continues with overseas dates through this spring. The Boys came off their own tour just a few months before hitting the road with NKOTB, which could explain their higher rank on the Money Makers list. In 2011 the two groups released a compilation of their combined greatest hits, two new joint recordings and a mashup. Total album sales for BSB came in at 120,000 units for the year. 32. Rush $5,819,304 The Canadian prog-rock power trio remains a mighty draw on the road, thanks to the band’s deep catalog of anthems like “Tom Sawyer,” “Closer to the Heart” and “The Spirit of Radio,” and the chops of bassist/vocalist Geddy Lee, guitarist Alex Lifeson and drummer Neil Peart. The band’s Time Machine',\n",
       " ('Linkin Park',\n",
       "  29,\n",
       "  2): 'tour continued through the first half of 2011, grossing $14.1 million in the United States and netting $4.8 million. Rush also made noise at retail, generating U.S. album sales of 431,000 units. Adding to the revenue mix: a concert recording titled “Time Machine: Live in Cleveland 2011” debuted and peaked at No. 54 on the Billboard 200 in November, with the live show kicking off a new deal with Roadrunner Records. 31.Foo Fighters $6,013,257 Last April, Foo Fighters scored their first No. 1 on the Billboard 200 with the aggressive Wasting Light, the band’s seventh full-length set. The Dave Grohl-led Foos solidified their credibility among rock fans by tapping producer Butch Vig, who helmed Nirvana’s Nevermind, to record the set on analog tape in Grohl’s home garage. Wasting Light debuted with 235,000 copies sold in its first week, helping push the group’s overall album sales to 986,000 in 2011, along with 1.6 million digital tracks last year. A stellar live act, the Foos’ primary source of revenue in 2011 came from touring arenas. The five-piece grossed $10.6 million from just 18 U.S. concerts that drew close to 219,000 people. 30. Usher $6,292,586 With his OMG tour spending nearly the entire first half of 2011 on the road, Usher visited Europe, Asia and Australia, then returned in April for a second North America run. His 73-show trek finished seventh on Billboard’s annual Top 25 Tours tally last year, with Boxscore tallying OMG’s domestic revenue at $14 million, and Usher’s personal take at $4.7 million. The tour, which kicked off in November 2010, was mounted in support of Usher’s sixth studio album, Raymond v. Raymond. Last year’s other highlights included the October release of the “OMG Tour: Live From London” DVD and his performance saluting late R&B songwriting legends Jerry Leiber and Nick Ashford on CBS’ “Grammy Nominations Concert.” 29. Rod Stewart $6,388,756 A 13-city tour with Stevie Nicks and a Las Vegas residency were the primary earners for Rod Stewart in 2011, even as he pursued other projects including a new album deal with Universal and induction into the Rock and Roll Hall of Fame as lead singer of the Faces. His Heart & Soul tour (paired with Nicks) and 18 greatest-hits shows at the Colosseum at Caesars Palace pushed Stewart’s U.S. concert grosses to $16.6 million, with his take coming in at $5.6 million. Album sales, driven by 2010 release Fly Me to the Moon (72,000) and last year’s The Best Of . . . The Great American Songbook (69,000), reached 350,000, while digital track sales reached 825,000. 28. Zac Brown Band $6,481,564 From its namesake singer’s distinctive beanie cap to the group’s emphasis on providing great gourmet eats for fans at live shows, Zac Brown Band has always approached country music from a decidedly different angle. The result: a loyal and growing fan base that trusts the group’s ability to deliver quality goods, ranging from tasty pulled pork sandwiches to digital tracks (5.3 million of them in 2011) or a couple of deep albums (1.3 million, including 360,000 digital copies), and top-notch performances as a bona fide amphitheater (and sometimes even stadium-level) headliner. Zac Brown Band has proved an excellent brand-builder, bringing a Dave Matthews Band-style fan-centric ethos to country music-and the act is just getting started. 27. Keith Urban $6,579,695 Get Closer wasn’t just the name of Keith Urban’s November 2010 album and subsequent summer tour. It was also a promotional tag line that played out in real life, thanks to Samsung’s sponsorship/endorsement deal that gave hundreds of fans personal time with the country singer at meet-and-greets. The',\n",
       " ('Linkin Park',\n",
       "  29,\n",
       "  3): 'full tour yielded $15.7 million in grosses, with Urban taking home $5.3 million. Album sales totaled 330,000 copies, while digital track sales topped out at more than 2 million. As a result, Urban pocketed $6.6 million in 2011. 26. Lady Antebellum $6,676,450 Lady Antebellum’s success continued to transcend the country genre in 2011. The group began last year by collecting five Grammy Awards, including record of the year for multiformat smash Need You Now. The hits kept coming with “Just a Kiss,” the debut single from third album Own the Night. The group sold nearly 2.2 million albums last year, and digital track sales exceeded 5.3 million. The Own the Night tour was among the year’s top country treks, raking in more than $3,209,000. Thus far, 2012 is shaping up to be another banner year for Lady A, with Own the Night earning a Grammy for best country album and the trio already selling a half-million tickets for this year’s trek. 25. Paul McCartney $6,726,519 Paul McCartney lands on the Money Makers tally the same way he appeared on the 2010 list: on the strength of just a few U.S. concerts. The stateside leg of his On the Run tour lasted all of six shows in four cities-New York, Detroit, Chicago and Cincinnati. Promoted by AEG Live, the concerts played to sellout crowds in major-league ballparks, grossing $18.6 million in ticket sales and netting McCartney an estimated $6.2 million. The $10.9 million combined gross from the two shows at Chicago’s Wrigley Field were the highest concert gross by a single artist at that point in the year. McCartney’s catalog sold a modest 144,000 albums and 422,000 tracks. Of course, this tally doesn’t take into account his healthy percentage (plus publishing) from his recorded work with the Beatles. 24. The Beatles $6,743,863 On Nov. 16, 2010, seven years after iTunes opened its virtual doors, the Beatles’ catalog finally became available on the digital music service, offering all 13 remastered studio albums at $12.99 each for individual releases and $19.99 for each double-album or anthology. Also up for sale: a $150 downloadable digital boxed set of the entire catalog, a mini-documentary on each set and a bonus video of the complete 1964 Washington Coliseum concert. The Beatles sold 1.2 million albums during the year, with their best seller being 2000 hits set 1 (280,000). Overall, the group sold 4.7 million individual tracks in 2011; “Here Comes the Sun” moved the most downloads (270,000). 23. Enrique Iglesias $7,448,670 Iglesias enters the list thanks to his most successful year in nearly a decade. It began with the mid-2010 release of his bilingual breakthrough album, Euphoria. The set generated hit after hit, including 2011’s “Tonight (I’m Loving You),” which topped Billboard’s Mainstream Top 40 chart in March, and “Dirty Dancer,” which debuted in the top 10 on the digital singles chart with 125,000 copies sold. Ultimately, the album helped propel digital downloads of Iglesias’ singles past the 4 million mark. Euphoria also became the top Latin title of 2010 with 225,000 copies sold, and bolstered Iglesias’ catalog by moving nearly 200,000 units of his other albums in 2011. As part of his world tour, Iglesias played 20 U.S. arena dates in 2011-some featuring Pitbull and Prince Royce-that grossed nearly $18 million and made a net profit of $6 million. After playing 65 shows around the world, he’s preparing an even broader global trek in 2012 that’ll include U.S. dates. 22. Rihanna $7,660,833 Though Rihanna’s sixth studio album, Talk That Talk, lagged in its first week compared with previous release Loud, which bowed at No. 2',\n",
       " ('Linkin Park',\n",
       "  29,\n",
       "  4): 'on the Billboard 200 with 207,000 units sold in December 2010 (Talk That Talk came in at No. 3 on the Nov. 30, 2011, chart with 197,000), together the two projects gave Rihanna a strong 2011. Thanks to a slate of hits-including Billboard Hot 100 No. 1s “What’s My Name?,” “S&M” and “We Found Love”-she sold 14 million digital tracks and 1.5 million albums. On the road, Rihanna’s exposure to the domestic market was limited: Of the shows reported to Boxscore (11), she grossed $7.1 million and sold 111,704 tickets. 21. Brad Paisley $8,602,374 Buoyed by a hot new album, a successful tour and a book, 2011 was a productive year for Brad Paisley. This Is Country Music, an ambitious 15-song set that featured guests including Don Henley and Clint Eastwood, debuted atop Billboard’s Top Country Albums chart. The project spawned four hit singles, including the chart-topping “Old Alabama.” Selling more than 1 million albums last year (more than 181,000 of them downloads), his digital tracks tally tops 4 million. In 2011, Paisley played to 1 million-plus fans in 52 markets, including five stadium shows and eight European dates. His H20 II: Wetter & Wilder tour raked in more than $16.9 million, and his current Virtual Reality tour has sold out its first 12 dates. 20. Michael Bublé $9,027,177 It was a very merry holiday season for Michael Bublé, whose Christmas album quickly became the No. 2 best-selling album of 2011, moving 2.4 million copies in its first five weeks. That hot streak, coupled with continued strong action with his catalog (particularly 2009’s Crazy Love), helped him sell nearly 3 million albums total and an additional 1.3 million tracks during the entire year. A June swing through North America made up the bulk of his 2011 touring, with grosses of $11.1 million, of which Bublé netted $3.7 million. Endorsement deals with Beringer Vineyards and Target, a prime-time NBC Christmas special and high-profile appearances on “Saturday Night Live,” “Today” and “60 Minutes” all helped further promote the Canadian artist. 19. Tim McGraw $9,335,258 It’s highly unlikely Tim McGraw will release new music through longtime label home Curb Music, since he recently won a court decision that effectively closed any obligations to the label. But he sure moved a lot of music on his way out the door. The delayed release of Emotional Traffic, out in January, was offset by a wealth of compilations in the marketplace, and McGraw sold more than 770,000 albums (mostly physical units) in 2011. His touring clout has also been trending upward, which helps direct interest to his catalog of hits, the result being 2.5 million digital track downloads last year. These days, McGraw is a branding/merchandising powerhouse and, lest we forget, a multifaceted artist who also has a healthy film career. 18. Rascal Flatts $9,639,270 Rascal Flatts switched labels and management companies but continued to post stellar numbers in 2011. Nothing Like This, the band’s first album for Big Machine Records after a decade with now-defunct Lyric Street Records, was released Nov. 16, 2010, and sold 499,000 units and 1.8 million tracks in the following year. The album’s second single, “I Won’t Let Go,” spent 22 weeks on Billboard’s Hot Country Songs chart and peaked at No. 2. “Easy,” featuring Natasha Bedingfield, peaked at No. 3 on Hot Country Songs after a 25-week stay. The Nothing Like This tour continued into 2011 and was followed in the summer by the Flatts Fest trek, with the back-to-back outings helping Rascal Flatts gross $21.8 million in ticket sales. 17. Bob Seger & The Silver Bullet Band $10,017,031 Recent',\n",
       " ('Linkin Park',\n",
       "  29,\n",
       "  5): 'Songwriters Hall of Fame inductee Bob Seger earned the majority of his revenue in 2011 on the road, but the legendary artist made a significant leap into the digital music space by allowing some of the band’s live and greatest-hits albums to be sold on iTunes. The September announcement of Bob Seger & the Silver Bullet Band’s iTunes debut coincided with the group announcing dates for the second leg of its 2011 tour, which no doubt helped raise awareness of the trek. Grossing $25.4 million from 32 U.S. arena concerts and attracting more than 354,000 fans, Seger sold 70,000 albums digitally and 630,000 overall in 2011. His Ultimate Hits: Rock and Roll Never Forgets, released last November, sold 185,000 copies, but his biggest seller last year was a 1994 greatest-hits album (191,000). The latter is one of the top-selling hits sets of the Nielsen SoundScan era. 16. Britney Spears $10,090,973 While Britney Spears’ seventh album, the chart-topping Femme Fatale, was released in March 2011, she spent the latter half of the year earning most of her millions. The Live Nation-sponsored Femme Fatale tour, her first concert endeavor in nearly two years, kicked off stateside in June, with Nicki Minaj in tow for North American dates. The elaborately staged trek wrapped six months later, after visiting four continents for nearly 80 shows and culminating with revenue of $21.7 million. While Spears earned $7.3 million for her half-year on the road, her 2011 album sales of 883,000 were fueled by three Femme Fatale singles, including the No. 1 “Hold It Against Me.” 15. Toby Keith $10,413,127 Country music mega-star Toby Keith secured a spot on the Money Makers list with his Locked & Loaded tour that grossed more than $24 million. Sponsored by Ford, it included dates in 40-plus U.S. cities and a European leg that wrapped in Berlin last November. During a year that saw the singer lauded as both artist of the decade by the American Country Music Awards and the highest-paid country star by Forbes, Keith released Clancy’s Tavern, which topped Billboard’s country albums chart. Tavern has sold more than 336,000 copies, with the album’s singles including country chart-topper “Made in America” and “Red Solo Cup,” the latter crossing over and reaching No. 17 on the pop chart-Keith’s biggest hit to date on the Billboard Hot 100. 14. Katy Perry $11,969,426 In 2011, Katy Perry tied Michael Jackson’s record by scoring five No. 1 singles from one album, 2010’s Teenage Dream, with such songs as “E.T.” and “Firework.” Not surprisingly, the radio ruler’s digital track sales soared above her fellow pop phenoms: With 15.2 million units moved, Perry bested Lady Gaga, Taylor Swift and Rihanna in the category. Meanwhile, the singer’s California Dreams world tour kept Perry on the road for most of 2011, grossing $19.5 million domestically and netting her $6.6 million. Perry also raised her visibility at the multiplex (with a voice spot in “The Smurfs”), on the small screen (with appearances on “How I Met Your Mother” and “American Idol”) and at awards ceremonies (with a performance at the 2011 Grammy Awards and a video of the year win at MTV’s Video Music Awards). Perry has already started off strong in 2012: “Part of Me,” the lead single to her Teenage Dream reissue (due March 27), became the 20th song to debut atop the Hot 100 in the chart’s history. 13. Elton John $11,973,990 Elton John returned to Las Vegas in 2011 and performed 16 of his “Million Dollar Piano” shows before heading to Russia and Australia. His Colosseum at Caesars Palace residency accounted for a',\n",
       " ('Linkin Park',\n",
       "  29,\n",
       "  6): \"third of his concert grosses, which hit $32.5 million and a personal take of $11 million. A summer tour of Europe, scattered U.S. dates and the soundtrack to his animated “Gnomeo & Juliet” dominated John’s activity prior to setting up shop in Vegas, while “The Union,” Cameron Crowe’s documentary about John’s collaboration with Leon Russell, debuted in April at the Tribeca Film Festival. Concert income was significant for John in 2011 as sales of his recordings dipped: Physical album sales were 254,000 units, while digital album and single track sales were 148,000 each. John also contributed music to “Billy Elliot: The Musical,” and though the Broadway stand ended in January 2012, road versions continued in other territories around the world. 12. Journey $12,313,822 Through the revival of 1981 anthem “Don’t Stop Believin'” on “Glee” and “Big Brother,” combined with the arrival of vocalist Arnel Pineda, 2011 proved another stellar year as Journey toured Latin and South America and played 50 shows in the United States. The latter concerts represented a step up in venue size to include arenas and the Hollywood Bowl along with the traditional amphitheaters, fairgrounds and casinos. Touring in support of Eclipse, the band netted $9.9 million from domestic dates while continuing to be a significant player at retail with sales of 703,000 physical albums. Recognizing the group’s longevity on the concert stage, band founder Neal Schon and longtime members Jonathan Cain, Ross Valory and Deen Castronovo were honored with the Legend of Live Award at the Billboard Touring Awards in November. 11. “Glee” Cast $12,587,771 The cast of Fox’s “Glee” won’t tour this year, but the TV musical troupe made a splash in 2011, grossing nearly $22 million from 23 U.S. arena concerts that attracted nearly 266,000 fans. That number helped the Glee Live! In Concert! outing rank 16th on Billboard’s top 25 highest-grossing tours of 2011. The “Glee” cast also scored at retail, selling 2.1 million albums during the year. The cast released six albums in 2011; the biggest of them all (Glee: The Music, Volume 5) sold 318,000 copies. In February 2011, the show’s cast reached another milestone by beating the record set by Elvis Presley for the most singles simultaneously appearing on the Billboard Hot 100. Online, the “Glee” cast sold 13.6 million downloads in 2011. 10. Adele $13,081,909 Even an extreme medical emergency couldn’t interfere with Adele’s success in 2011. From the moment sophomore album 21 stormed in atop the Billboard 200 in March 2011, the singer/songwriter has been setting-and demolishing-a seemingly endless array of retail and radio feats. Before her latest achievement-spending 23 weeks atop the chart to notch the longest-running No. 1 album in Nielsen SoundScan’s history-Adele racked up numerous other milestones. Her single “Rolling in the Deep” became the most widely crossed-over song of the past 25 years, topping rock, pop, AC, R&B/hip-hop, dance and Latin charts. In addition, she became one of only four female artists to spend at least 13 weeks at the peak of the Billboard 200, joining Judy Garland, Carole King and Whitney Houston. Adele then capped the year by winning six Grammy Awards, including album of the year. Although throat surgery sidelined her touring schedule last October, her album sales continued to soar to the tune of 6.7 million in 2011. 9. Jason Aldean $13,409,011 Contrary to the third-time-lucky rule, it was Jason Aldean’s fourth album for Broken Bow Records, My Kinda Party, that turned him into a legitimate country superstar. Released in November 2010, Party sold 1.6 million units and 5 million tracks last year, moving 2.4 million albums and 6.6 million tracks\",\n",
       " ('Linkin Park',\n",
       "  29,\n",
       "  7): 'through mid-February of this year. “Don’t You Wanna Stay,” a duet with Kelly Clarkson, peaked atop Billboard’s Hot Country Songs chart in March 2011 and sold 1.5 million tracks last year. “Stay” was quickly followed by the country-rap hybrid “Dirt Road Anthem,” which reached No. 1 in July. Aldean also matured into one of country’s most successful live acts. The My Kinda Party tour sold out arenas and amphitheaters across the country, grossed $27 million in 2011 and netted Aldean an estimated $9.1 million. His rapid ascent to the concert industry’s upper echelon helped him win the Breakthrough honor at the 2011 Billboard Touring Awards. 8. Celine Dion $14,261,515 Celine Dion sure knows how to make a comeback. After her historic five-year residency at Las Vegas’ Colosseum at Caesars Palace ended in late 2007, the Canadian singer took a well-deserved break, then returned to the 4,000-seat venue in March 2011 for yet another stand. She grossed $40.1 million from 57 performances last year that drew nearly a quarter-million fans and booked additional Vegas dates through this August. Though Dion’s last studio album was 2007’s Taking Chances, she sold 331,000 albums in 2011, the biggest catalog item being 1997’s Let’s Talk About Love (75,000 copies). The singer also sold 956,000 digital tracks last year, with the top seller still being “My Heart Will Go On,” from 1997’s blockbuster film “Titanic” (167,000 downloads). 7. Bon Jovi $15,835,856 Guided by the business acumen and savvy musical instincts of charismatic frontman Jon Bon Jovi, the New Jersey rock phenom has been a brand and a band on fire for much of the past decade. The Circle tour, marking the most ambitious trek in the band’s 30-year history, wrapped last summer with a final tally of $265 million, the sixth-largest-grossing tour of all time. Aside from its prized catalog of hits, the band releases chart-topping new material as well: During the most recent round of live gigs, Bon Jovi put out its first greatest-hits package and new studio album The Circle, each cross-marketed on the AEG Live-produced tour directed by BJM’s Paul Korzilius. Bon Jovi moved more than 320,000 physical CDs last year, 1.6 million digital tracks and two new DVD titles in addition to tons of branded merch, maximizing its highly familiar image and sound decades after its humble beginnings. 6. Sade $16,382,809 Just as fans clamored for a return to the recording studio in 2010-causing her Soldier of Love to debut at No. 1 on the Billboard 200 with 502,000 units sold-followers of the sultry singer and her smooth jazz band also lined up last year for Sade’s first North American tour since 2001. The 59-date, Live Nation-produced arena trek claimed 10th place on Billboard’s Top 25 Tours listing. With John Legend opening all U.S. dates, the tour ultimately posted $45.7 million in revenue that resulted in a cool $15.4 million take for the group. Longtime collaborator Sophie Muller served as creative director and Baz Halpin (Pink!, Tina Turner) handled production and lighting design for the critically acclaimed live shows, which featured a massive LED screen showing videos and dazzling images behind the band. While an official release date hasn’t yet been announced, Muller stayed busy last year editing a film version of the tour that may appear on cable and DVD soon. 5. Lil Wayne $23,178,722 Lil Wayne’s first full year back in the market after serving eight months for attempted gun possession in New York proved a lucrative stretch. For the week ending Sept. 6, ninth studio set Tha Carter IV debuted atop the Billboard 200, racking up the year’s second-biggest',\n",
       " ('Linkin Park',\n",
       "  29,\n",
       "  8): 'sales week with 964,000 units sold. The tally also gave Wayne the best sales week by a male artist since his own Carter III topped the charts with 1 million units in June 2008 and accounted for nearly a third of his total 2.7 million sales for that year. (Only Lady Gaga’s Born This Way, offered at a special 99 cent price for two days at AmazonMP3 during its first week, had a better debut than IV in 2011.) Wayne also moved 12.3 million digital tracks, driven by Hot 100 top 10s like “6 Foot, 7 Foot” and “She Will,” and continued to prove himself on the road. His I Am Still Music tour grossed $44.7 million from 67 shows and 695,291 tickets sold. Then there’s the fortune he earned as founder of Young Money Entertainment, label home of Nicki Minaj, Drake, Tyga and others, but that’s a different list. 4. Lady Gaga $25,353,039 Topping the Money Makers list in 2011, the theatrical chanteuse enjoyed a near-repeat of her previous stellar year. Defined by the May launch of yet another full-length opus, Born This Way, the album sold 1.1 million units during its first week, marking the biggest single sales frame for an album release in 2011. Combined with her previous sets The Fame and The Fame Monster, Gaga moved 2.8 million albums last year. Meanwhile, Born This Way spawned four singles that all reached the top 10 of the Billboard Hot 100 and helped the singer move 12.7 million digital tracks. Despite holding off on another traditional tour when her 19-month Monster Ball trek wrapped last May, Gaga’s Boxscore revenue equaled $51.4 million in 2011, after reaping $70.4 million the year before. Expect Born This Way to keep delivering in 2012, with the Born This Way Ball ready to roll overseas in April. 3. Kenny Chesney $29,837,103 Kenny Chesney rejuvenated himself by taking time off from touring in 2010, and fans responded by turning out in record numbers to see him last year. Promoted nationally by TMG/AEG Live, Chesney captured his sixth top package honor at the 2011 Billboard Touring Awards for his Goin’ Coastal concert swing, his eighth consecutive tour to sell more than 1 million tickets. As with most leading country live acts, Chesney also sells a healthy amount of recordings while touring: more than 650,000 physical album units (buoyed by hit-laden 2010 album Hemingway’s Whiskey) and 4.3 million-plus digital tracks. Chesney’s fans worship his romantic, hard-drinking lifestyle, so he derives additional revenue streams from various merchandise, a laid-back clothing line, ringtones, DVDs and even a sponsorship deal with the beverage firm that makes Corona. (No surprise, given that Chesney wrote the No. 1 country hit “Beer in Mexico.”) 2. U2 $32,116,315 U2’s monumental 360° tour finally wrapped in 2011 with a $91.5 million Boxscore for the year, including a return trek through North America originally scheduled for 2010 but postponed due to Bono’s back surgery. Fewer than 10% of the tickets had to be refunded, and those returns were quickly scooped up. The total Boxscore tally of $736 million stands as an amazing record, and the attendance of 7.3 million concert-goers (another record) led to merchandise sales approaching $50 million, according to Billboard estimates (but not included in calculating the Money Makers tally). Merch sales and fan club revenue were maximized under synergies created through the band’s long-term, multirights deal with Live Nation, and the 360° tour marked an impressive testament to the ability of both sides to deliver. U2 also sold a significant amount of recorded content, including 1.4 million digital tracks, since the tour',\n",
       " ('Linkin Park',\n",
       "  29,\n",
       "  9): 'drew fans’ attention to catalog favorites. Combining digital and physical units, however, U2 moved the least number of albums among the top 10 Money Makers. Today’s music business is all about the live thing, and U2 stands high on the mountaintop in that regard. 1. Taylor Swift $35,719,902 After wrapping the final leg of her Fearless tour, Taylor Swift’s blockbuster success two years ago left music industry observers wondering what she could possibly do for an encore. The pop-country superstar answered them with her smash Speak Now album and accompanying tour, which jetted through Asia and Europe in addition to making its way across North America. Grossing $88.5 million in the U.S. alone, the tour netted Swift a remarkable $29.8 million. Honored as Billboard’s Woman of the Year in December, she racked up U.S. album sales of 1.8 million units last year-led by booming business for late 2010’s Speak Now, which sold 967,000 units and digital single track sales of 7.8 million. Songwriting royalties were another highly beneficial source of income, given that Swift wrote all 14 Speak Now tunes herself.',\n",
       " ('Linkin Park',\n",
       "  3,\n",
       "  0): 'My problem with Linkin Park has always been their sound. It leans toward being dry and unemotional; delivering stoically detached resonance that leaves me feeling empty and unsatisfied. I\\'ve always wished they\\'d flesh out their sound a bit more, delve just a little deeper into the low-end and groove to give some added sonic depth to their proceedings. They may very well have been reading my thought transmissions this time around, which would be cool and a wee bit scary at the same time. The first thing you notice from the opening instrumental \"Wake\" is that not only does it seem fitting in relation to the album\\'s title—yes, it\\'s atmospherically indicative of the minutes leading up to the proverbial Witching Hour—is that it\\'s richly nuanced and not at all like the flat sounding excursions of their past. Ditto for the blitzkrieg that is \"Given Up,\" the first bona fide song featuring a resurrected Chester B. on vocal chord wrenching utterances. Okay, so this track kind of falls victim to the post-Nu Metal fall-out combined with screamo backlash and aggressive emo tendencies, but still despite the routine nature of much of the song it still packs a wallop and offers up some intriguing shifts in musicality, specifically the wonderfully turgid bass blast.The LP boys continue to wrestle with their past sound while making a few inroads towards a new entity on \"Leave Out All The Rest,\" a veritable ballad, at least in LP molting out of their old Nu Metal skin formulaicy. Bennington reveals that he has a lovely voice when he\\'s not busy concealing the fact underneath feedback and acid drenched intensity. The cool harmonic introduction to the track again hints at a sonic makeover, as do the side shifting elements of ambiance. The click track rhythms and bubbly bass also echo with minimalistic electronic bliss, which is a nice, warm shift in tone for the band. Yet underneath the rippling elements of a new sound it is revealed that the band is still very much tethered to their past, the song conforming to a number of LP blueprints. But hey, you can\\'t expect a band to change that drastically overnight. That would be unrealistic. With \"Bleed It Out\" the band kicks out an almost U2 sounding guitar skirmish while Mike Shinoda kicks the verbal ballistics. The addition of handclaps helps propel the track into one of the better raps that MH has lit to tape. Even when Chester drops in with his scratchy voice of pain and anguish chorus it still sounds fresh and mile ahead of their past rap-meet-aggro rock machinations. Yeah, it still follows the LP style book in that it flips from rap to screaming mimi theatrics in measured aplomb, but it sounds better than any of their previously like-minded efforts of this nature. A lot of this has to do with the overall sound, which feels richer and warmer, albeit in LP terms (meaning it\\'s still not all that rich and warm, but its head and tails more fleshed out than they have every sounded before).\"Shadow Of The Day\" starts out not quite unlike a vintage Nine Inch Nails number as a shuffling syncopation drift echoes with ebb and flow in-between minimalist electro washes. Then Chester enters the mix and the track takes a decidedly U2 turn, both vocally and spiritually as he croons (yes, croons) in lilting harmony \"and the sun will set for you/the sun will set for you/and the shadow of the day/will embrace the world in grey/and the sun will set for you…\" It\\'s an unusually uplifting moment for the band',\n",
       " ('Linkin Park',\n",
       "  3,\n",
       "  1): 'even though it showcases them still searching for a new voice that transcends their obvious influences (think Bono).Piano, clanking ambiance, and reverb rhythms set the tone for \"What I\\'ve Done,\" which quickly dives into guitar driven crunch that parts its skirling waters enough to let Bennington\\'s clean vocals sift through the mix that is given added scratchmatic enhancement. This track essentially takes all the elements of past LP tunes and turns them into a gentler, more mature endeavor that comes off like aggressive balladeering aimed at the older set (i.e. your mom might find this an appealing number).Church like organ fills waft over the opening of \"Hands Held High\" which then introduces militaristic march inclined snares over which Mike Shinoda pumps his fists in a strangely aggressive quietude, showing that his rhyme scheme has risen several levels since their last effort. Chester\\'s ecclesiastical \"amen\" chorus only adds to the strange, ethereal vibe. \"No More Sorrow\" begins with searing crystalline guitar, then the shattergun bass and drums burst in with riot squad intensity turning the number into a shifting Metallicaesque rampage that burns with liquid metal. Yeah you\\'ve heard it before, but you\\'ll still snap your neck to the churning cadence.\"Valentine\\'s Day\" returns to the harmonic styled guitar filters over which Bennington delivers a raspy whisper. The melancholy is deep, even despite the treacley nature of the subject matter (being alone on Valentine\\'s Day). The somber tone is carried over into \"In Between,\" in which Mike Shinoda sings with a crisply soft baritone over a simple clacking rhythm and stripped down electronic burble and ripple. The wurble and glide continues into \"In Pieces,\" which goes for stripped down electronic repose which compliments Bennington\\'s quietly aggressive whisper delivery. It has tinges of some of their contemporary pop/punk/emo brethren, at least in terms of melodic interface and harmonious delivery, which makes it strange and enticing and confusing all at once. Of course that is all thrown violently out the window with the very \\'80s guitar solo tacked on at the 2:35 mark. The album\\'s last official track is \"The Little Things Give You Away,\" which returns to the minimalistic clanking and stutter electronics that point to Mr. Reznor as an obvious influence. The gently strummed acoustic guitar that filters underneath is a nice touch and helps augment Bennington\\'s casually emotional whisper. It\\'s a nice stripped down combination that makes one yearn to hear LP go fully acoustic. They might just surprise the skeptics lurking out there if they did. This track definitely hints at future greatness to come in terms of an even more mature sound. Bennington\\'s lyrics are equally impressive as he comments on the band\\'s visit to New Orleans in the wake of Katrina\\'s destruction. It\\'s hauntingly poetic and easily the strongest number on the entire album.The album concludes with a live version of \"What I\\'ve Done,\" which really doesn\\'t sound all that much different than the studio version. Sure there\\'s a little more noticeable chop and grind in the guitars, but otherwise it sounds slick, clean, and fully furnished. Minutes To Midnight showcases a band in transition, a group of musicians caught in a molting holding pattern as they valiantly claw at their previous musical skin, shedding little chunks here and there and making way for a new glisten to grow in. I\\'m still not 100% sold on Linkin Park but of their three official studio albums this one is the one that really shows off the band and their willingness to stretch their musical boundaries and a growing desire to shift with the times. Granted they still rely a',\n",
       " ('Linkin Park',\n",
       "  3,\n",
       "  2): \"little too heavily on obvious influences (Metallica, U2, Nine Inch Nails), but they have improved in many respects, capturing a much richer and fuller sound overall. Mike Shinoda displays much improved verbal chops on the microphone, Bennington further reveals that he's in possession of a voice capable of delivering heart-wrenching melancholy and introspective desire. And the rest of the band—Phoenix, Joe Hahn, Rob Bourdon, and Brad Delson—are equally up to the task at hand. Oh yeah, having Rick Rubin behind the boards certainly didn't hinder any forward movement, either. This is definitely a step in the right direction and a stepping stone for things to come. I hope.\",\n",
       " ('Linkin Park',\n",
       "  30,\n",
       "  0): 'Stone Temple Pilots singer Scott Weiland, Dec. 3, 2015. Soundgarden, Audioslave and Temple of the Dog frontman and solo artist Chris Cornell, May 18, 2017. And now Chester Bennington, singer of Linkin Park, on July 20, 2017 – found dead at 41 on his late friend Cornell’s birthday. In just over 18 months, three singers who helped define a generation of the hard rock sound, who were tied together artistically and personally, have succumbed to the very emotional pain that fueled their music and sold millions of albums over a 30-year-long period. Explore Explore Linkin Park See latest videos, charts and news See latest videos, charts and news The ties that bind were many. Bennington, like Cornell, was found dead by hanging just two months after the Soundgarden frontman’s death. Linkin Park and Cornell met in 2007 on tour and teamed up in 2008 on the Projekt Revolution tour; Bennington would often join Cornell to sing the Temple of the Dog classic “Hunger Strike” and even led the crowd in singing “Happy Birthday” to celebrate Cornell’s 44th birthday in 2008. “I’m such a fan. I think that’s the most important aspect of why I do what I do and how I do it,” Bennington told Rolling Stone in 2008. ”I’ve got to play with a lot of guys that I’ve grown up loving; I get to sing on stage with Chris Cornell. … I’m just like, ‘What world do I live in, ‘cause this can’t be real?’” Bennington later became the godfather to Cornell’s son and sang Leonard Cohen’s “Hallelujah” at the grunge rocker’s funeral in May. “You have inspired me in many ways you could never have known,” Bennington wrote to Cornell in an open letter after his death. This morning, in response to Bennington’s death, Cornell’s wife Vicky tweeted, “Just when I thought my heart couldn’t break any more…” Trending on Billboard Bennington’s relationship to Weiland was different—the Linkin Park co-founder replaced him as the singer in Stone Temple Pilots in 2013. STP and LP met on the 2001 Family Values Tour, but Bennington had absolutely idolized STP and Weiland as a kid. In multiple interviews, Bennington had said that being a member of the Stone Temple Pilots was his lifelong dream. That came true when the members of STP fired Weiland and teamed with Bennington for a tour and five-track EP, High Rise, credited to ”Stone Temple Pilots with Chester Bennington.” ”I grew up listening to these guys,” Bennington told L.A. radio station KROQ. “When this opportunity came up, it was just like a no-brainer.” His relationship with Weiland never flagged, though, and Weiland knew Bennington didn’t join the group to spite him. Two years later Bennington would bow out of STP to spend more time with his wife and six children, and focus on new music with Linkin Park. As children, both Bennington and Weiland were sexually abused by older men. In his book Not Dead & Not For Sale, Weiland wrote that when he was 12 years old “a high school senior … [who] rode the bus with me every day to school … invited me to his house. The dude raped me. It was quick, not pleasant. I was too scared to tell anyone.” He continued, “This is a memory I suppressed until only a few years ago when, in rehab, it came flooding back.” Bennington had said that he was also abused by an older male friend from the time he was just seven years old. “It escalated from a touchy, curious, ‘what does this thing do’ into full-on, crazy violations,” he told',\n",
       " ('Linkin Park',\n",
       "  30,\n",
       "  1): 'Kerrang! magazine in 2014. “I was getting beaten up and being forced to do things I didn’t want to do. It destroyed my self-confidence. Like most people, I was too afraid to say anything. I didn’t want people to think I was gay or that I was lying.” All three were also joined in their struggle with drugs and alcohol and depression, a struggle they channeled into their music. Soundgarden arrived first in the mid-’80s, making a name for themselves in the burgeoning Seattle scene before the band—and their contemporaries—blew up the outside world. They had an arty, heavy, but vulnerable sound, peaking with 1994’s Grammy-winning, Billboard 200-topping Superunknown—the album that brought Cornell’s pained wailing to the masses. He would also memorialize his late friend Andrew Wood, who died of a heroin overdose, with the Temple of the Dog project with members of Pearl Jam. Related The 15 Greatest Linkin Park Songs Next came Stone Temple Pilots out of San Diego, CA, with Weiland slithering in pink feather boas, singing about his struggles over the band’s modern, colorful twist on classic rock. Bennington, weaned on both, joined Linkin Park in 1999, soon releasing a string of albums that reached monumental success with their heavy, but modern, electronic and hip hop-influenced sound. The band was often unfairly roped into the nu-metal genre alongside bands like Korn, Limp Bizkit, and Disturbed, but were far more willing to experiment, releasing a pair of remix albums featuring underground rappers, collaborating with JAY-Z, and working electronics into their sound over seven studio albums. All three singers served a similar role to their fans, too; Soundgarden and STP appealed to the rockers and outcasts of Generation X, while Linkin Park did the same for disaffected Millennials and Gen Zers with monster hits like “Numb,” “Crawling,” “In the End” and “One Step Closer.” Many fans reacted to the loss of Bennington on social media, recalling how his voice ushered them through high school, and posted their favorite lyrics. A meme with the lyrics to “Leave Out all the Rest,” from 2007’s Minutes to Midnight, was a favorite: “I’m strong on the surface / Not all the way through / I’ve never been perfect / But neither have you.”',\n",
       " ('Linkin Park',\n",
       "  31,\n",
       "  0): 'What was so startling about Chester Bennington’s left-field rant this past May toward fans who weren’t down with Linkin Park’s EDM-influenced 2017 single “Heavy” (a duet with newcomer Kiiara, of scrambled-sample “Gold” fame) was that he cared about the idea of “selling out” at all. The tenor was disturbing (“I will punch you in your f—ing mouth”), and we now know with today’s tragic news that the singer died by suicide at age 41 that he likely wasn’t of sound mind. But inflammatory language aside, he was right — they’ve always taken “musical risks” in an extremely high-fidelity pop echelon that few other rock bands ever reach. I mean, when your first album sells 30 million copies worldwide, besting any other album’s numbers in 2001, how exactly do you “sell out”? If nothing else, Linkin Park became rich enough so quickly that we have to believe they only did whatever they wanted after. Explore Explore Chester Bennington See latest videos, charts and news See latest videos, charts and news Related Watch Linkin Park Perform With Chester Bennington for the Last Time Trending on Billboard But money doesn’t buy happiness, and today’s horrific news of Bennington’s death, leaving behind his wife and six children, follows the grim trajectory that befell his good friend Chris Cornell, whose funeral he famously sang Leonard Cohen’s “Hallelujah” at, and Scott Weiland, whom Bennington briefly replaced in Stone Temple Pilots during one of that band’s many tumultuous eras. Somehow we’ve become vastly desensitized to the real pain behind the angst-ridden lyrics and brickwalled guitars of angry hard rock to the point that these deaths were all fairly shocking. It’s possible that we miscalculated the true decibel of the pain Bennington was suffering just because we couldn’t believe yet another nü-metal frontman had emerged to scream “Shut up when I’m talking to you.” It doesn’t make it any less real. “His music spoke to my soul,” went a typical Facebook comment today, though it wouldn’t be off-base to say that our souls were amplified through Bennington’s music. Of course, part of the shock is because that Kiiara collaboration is actually more consistent with the Linkin Park we know than that beatdown threat was. They were ultimately not a raw band; that landmark 2000 debut Hybrid Theory was and probably remains the most expensive-sounding nü-metal album of all time, which is probably what got the always-enterprising JAY-Z’s attention to share co-billing on 2004’s endearingly wacky Collision Course mash-up experiment. Not only did it sweep the compressed-riff-chunk world, but it rivaled the biggest Nine Inch Nails productions for gadgets and gewgaws whirring around subtle piano figures, boasted frenetic drum programming to match Stankonia’s, combined all sorts of glitch digital trickery with Mike Shinoda’s love of dusty indie-rap beats and Bennington’s unmistakably Depeche Mode-like melodies on, say, the verses of “Crawling.” Hybrid Theory was the correct name for this thing; they hit the sweet spots of several different genres they loved and they did them all pretty well, in part because they had a genuine interest in the styles they combined. But also, Linkin Park’s sound-factory makeup and broad lyrics may have reached the masses in part because they understood that their individual egos as players in the ensemble weren’t as great as the sum they could be combined. Bennington wasn’t a frontman, really — he was a foil for Shinoda and the squeals and booms of Pro Tooled tech-metal bricolage as part of this big sound-tsunami that young, frustrated audiences could hear their own thoughts in, as well as their spin cycle of musical tastes forming. The singer was',\n",
       " ('Linkin Park',\n",
       "  31,\n",
       "  1): 'very nearly a megaphone for his fans, emoting for them in broad strokes like “I had to fall/ To lose it all/ In the end/ It doesn’t even matter” from their signature hit “In The End,” easily the most pensive rap-rock song the genre had spawned to date. That song was purely hip-hop, with Bennington augmenting Shinoda’s rhymes by accenting each line like a hypeman and storming in to carry the load of the hook. It wasn’t a fun song, but it was also heavy in a light way, something a festival crowd could sing along to together without discomfort. It beat Drake to calcifying arena-emo-rap by almost a decade. That’s a big sticking point for these guys: They had good taste in rap, and rap liked them, too. Pusha T and Stormzy are on “Good Goodbye” from this year’s One More Light, and in crisp form. Busta Rhymes featured the band on his own underrated and surprisingly melodic “We Made It” in 2008. And besides the proto-Watch The Throne splendor of hearing the glitchy, No Age-worthy squall of “Faint” (arguably the LP’s best moment) with JAY-Z’s “Jigga What, Jigga Who” skittering across it on Collision Course, Pharoahe?Monch and Black Thoughtwere among the rappers they handpicked for their unusually sincere remix album Reanimation in 2002. In 2015, Aesop Rock and Homeboy Sandman, arguably the best last two backpack-rappers standing, cut up Linkin Park’s sparks-flying “One Step Closer” riff for their excellent, pseudo-treacherous “Get A Dog.” Bennington’s band worked exceedingly well with others, and for multi-millionaire rockers appropriating hip-hop, they gave back whenever they could. For nü-metal, you could say Linkin Park were ideal as far as PG-rated stuff goes: productions that seemed to have legitimate fun with their skyward budget, lyrics that focused on introspection rather than demonizing women, and pop gifts they took seriously. The dancehall-inflected “Waiting For The End,” from 2010’s open-source experimental A Thousand Suns, is as indelible a pretty melody as anything in the Coldplay oeuvre (another influence Bennington would incorporate pretty well on 2007’s “Shadow Of The Day“). They made a point of not cursing on Hybrid Theory (again, what could this band possibly be selling out from?), a bold move in an aggro band that paid off. Linkin Park were ultimately kind of a class act relative to many of their contemporaries, which contributes to the analogy that they may have been nü-metal’s Def Leppard: unabashed hook-chasers and polished studio rats who are nonetheless beloved for their tidiness and mass appeal rather than chastised for it, and ultimately too professional for us to really buy the authenticity of their misspelled name. Chester Bennington made a load of pop-metal hits that all sound big and heartfelt and completely realized in their vision. He was clearly an important conduit for his far-ranging audience, and it’s hard to imagine many other hard-rock vocalists reaching so many souls. But here’s hoping that mental health care is drastically more accessible by the time the next one does. This article was originally published by Stereogum.',\n",
       " ('Linkin Park',\n",
       "  32,\n",
       "  0): 'Beginning in 2000, Linkin Park brought the collision of hard rock and hip-hop to its commercial and aesthetic peak, with its lead singer, Chester Bennington, delivering intense, almost physically palpable emotion alongside the grounded rapping of Mike Shinoda. But how Mr. Bennington — who was found dead Thursday morning in his California home — truly set himself apart was with his flexibility, taking on different vocal personas, depending on the demands of the song. That made him an anomaly for his era: a 2000s progressive who rooted his singing in the tenets of 1980s and 1990s rock, and someone who knew how to extract feeling both from careful whispers and gnarled yelps. [ Read Chester Bennington’s obituary ] He had many guises. On “Numb,” from Linkin Park’s second album, he started out plaintive and became gutturally desperate at the hook: “All I want to do/is be more like me/and be less like you.” On “Walking Dead,” a collaboration with the D.J.-producer Z-Trip, he was languorous and mildly sleazy. On “New Divide,” a midcareer hit from, of all places, the soundtrack to the film “Transformers: Revenge of the Fallen,” he was dreamlike and practically sweet. On “Crawling,” from Linkin Park’s debut, he brought gale-force anguish, vivid and baptismal. Mr. Bennington’s ability to pair serrate rawness with sleek melody separated him from the other singers of his era, and also from the ones he grew up on. He was an emo sympathizer in a time when heavy metal was still setting the agenda for mainstream hard rock, and a hip-hop enthusiast who found ways to make hip-hop-informed music that benefited from his very un-hip-hop skill set.',\n",
       " ('Linkin Park',\n",
       "  33,\n",
       "  0): 'Vocalist Austin Carlile of the California-based rock quintet OF MICE & MEN spoke to Revolver magazine about being asked to open for LINKIN PARK on the latter act\\'s European tour last November — a huge honor for Carlile, who counts the Chester Bennington-fronted group as one of his formative musical influences. \"I bought \\'Hybrid Theory\\' when I was a sophomore in high school,\" Carlile remembers. \"It was the angriest thing I\\'d ever heard at the time, other than PANTERA — but PANTERA was my dad\\'s music, and this was the first record I really got into that I didn\\'t learn about through him. LINKIN PARK has been my band for such a long time.\" Speaking to The Rockpit last year, Carlile said about OF MICE & MEN\\'s musical influences: \"I think all of us love all kinds of stuff from hardcore to just about anything. I like we can appreciate all kinds of music from all kinds of musicians.\" OF MICE & MEN has set a February 24 release date for \"Restoring Force: Full Circle\", a deluxe double-disc, foil-stamped digipack that includes three brand-new songs and an acoustic version of the band\\'s hit single \"Feels Like Forever\". The new songs — \"Broken Generation\", \"Something To Hide\", \"Never Giving Up\" and the acoustic version of \"Feels Like Forever\" — were recorded this past fall with producer David Bendeth (PARAMORE, BRING ME THE HORIZON) in Southern California. The two-CD set is a special reissue of the album \"Restoring Force\", which hit No. 4 on The Billboard 200 chart and No. 1 on both the Billboard Top Independent and Top Rock Albums charts. In a recent interview with UMusicians, OF MICE & MEN guitarist Phil Manansala stated about \"Restoring Force\": \"The whole album is about restoring the equilibrium of rock music. We have developed our sound to a new level and want to display it. We have heavy influences from \\'90s bands such as LINKIN PARK and KORN and there hasn\\'t exactly been music like that around lately, so the album is really about restoring rock music and the force that it has.\"',\n",
       " ('Linkin Park',\n",
       "  34,\n",
       "  0): 'Linkin Park’s “Minutes to Midnight” crashes in at No. 1 on The Billboard 200 in a big way this week, its 623,000 copies the highest first-week total of 2007, according to Nielsen SoundScan. It’s the biggest debut week number since Jay-Z’s “Kingdome Come” moved 680,000 last December; only five other titles have moved more than 600,000 in a week in the past two years. Linkin Park’s last album, 2003’s “Meteora,” began at No. 1 on The Billboard 200 with 810,000. R&B singer Tank rolls in at No. 2 with his third Good Game/Blackground album “Sex, Love & Pain,” selling 103,000 units, a sales and charting best for the artist. His last album, “One Man,” debuted and peaked at No. 20 in 2002 with 58,000, while his 2001 debut “Force of Nature,” opened at No. 7 with 98,000. His current single, “Please Don’t Go,” is a top-three hit on the Hot R&B/Hip-Hop Songs chart and is still rising on the Hot 100. After topping the chart last week, Michael Buble‘s 143/Reprise set “Call Me Irresponsible” slips to No. 3 with 88,000, a 39% sales slide. Wilco earns its biggest charting and sales week yet, as “Sky Blue Sky” (Nonesuch) bows at No. 4 with 87,000 copies. It’s the Chicago-based rock group’s second top 10 album and surpasses the No. 8 entry that greeted 2004’s “A Ghost Is Born,” which sold 81,000. Nearly a quarter of its sales this week were snapped up via digital retailers. Country singer Gretchen Wilson is three for three in the top five on the char,t as her third effort “One of the Boys” jumps on at No. 5. The Columbia set moved 73,000 copies, short of the 227,000 that greeted 2004’s “Here for the Party” and the 264,000 for 2005’s “All Jacked Up.” “One of the Boys” also tops the Hot Country Albums tally, her third No. 1 on that chart. Avril Lavigne’s “The Best Damn Thing” (RCA) falls 5-6 after a 21% decrease to 56,000, while Ne-Yo’s Def Jam album “Because of You” descends 4-7 with 55,000, a 39% drop. Veteran metal troupe Megadeth scores its first top 10 album in 13 years, as “United Abominations” (Roadrunner) debuts at No. 8 with 54,000. The group’s 1994 set “Youthanasia” debuted and peaked at No. 4. This week is also tge best sales week for the band since “The World Needs a Hero” began with 61,000 at No. 16 in 2001. Elsewhere, Bone Thugs-N-Harmony’s “Strength & Loyalty” (Full Surface/Interscope) slides 2-9 with 53,000 copies (-56%), while Daughtry’s self-titled RCA debut falls 6-10 with 51,000 (-24%). Other big debuts this week include Rufus Wainwright’s Geffen set “Release the Stars,” which earns him his best charting and sales week ever with 24,000 at No. 23, and Pink Martini’s Heinz effort “Hey Eugene!,” which scores the same accolades on its way to 19,000 and a No. 30 debut. Album sales are up 1% from last week’s total at 8.59 million units and down 7% compared to the same week last year. Overall sales are down 16.6% compared to last year at 177.1 million units.',\n",
       " ('Linkin Park',\n",
       "  35,\n",
       "  0): 'It’s no secret that Linkin Park were a band that truly came to define a musical movement in the early 2000s and would go on to influence many musicians on the rock scene today, as well as introduce a generation to a new and truly revolutionary sound. Their impact is often overlooked, as it’s difficult to comprehend just how huge they are. However, in a new interview with Heavy Consequence, I Prevail’s guitarist, Steve Menoian, spoke about how Chester’s passing affected not just him, but other artists who were performing on Warped Tour when the news broke. “We were out on Warped Tour when we got the news about Chester, and it hit everybody on the scene. We almost couldn’t believe it. Anytime stuff like that happens within the heavy music community, it’s something that hits close to home and makes you question and rethink a lot of things. It influences you in a weird way. When we were on the Warped Tour and the news came out that he passed away, every single band was pouring their hearts out onstage, talking about how influential Linkin Park and Chester Bennington were to their music. It’s one of those things that just gives you some perspective.” Menoian goes on to talk about how this impacted their own music as well, “I’m sure that there’s some way that it impacted our headspace for writing the new record. It’s almost like you become numb to how influential they were, just because they were so big. With Linkin Park, it was so mainstream, but then you have that moment when you realise how ground-breaking they were.” Of course, only a few years prior was Linkin Park’s surprise performance at Warped Tour to celebrate the festival’s 20th anniversary, where they played with Warped Tour veterans like A Day To Remember’s Jeremy McKinnon, Finch’s Nate Barcalow and Yellowcard’s Ryan Key that had been specially chosen by the band. The set was only seven songs, but left an unforgettable impact on the event that would be hard to beat and still boasts the title of earning the stage that was specially constructed for their short set one of the biggest crowds in Warped history. It seems likely that the musicians that were first inspired by Linkin Park will always acknowledge and want to pay tribute or homage to the band, whether it be covering their songs at live shows or just speaking on how they were influenced by them. Linkin Park’s influence has undoubtedly touched many musicians and fans alike and seems as though the outpouring of appreciation and thanks will continue with every new interview and performance.',\n",
       " ('Linkin Park',\n",
       "  36,\n",
       "  0): 'At just 18 years old, Bishop Nehru has accumulated a good amount of accolades. The rapper/producer, born Markel Scott, signed to Turnfirst/Noizy Cricket in 2013, then Nas’ Mass Appeal Records in 2014. He was one of the first three signees to Mass Appeal Records, alongside Boldy James and Fashawn. Within two to three years, he’s dropped a handful of projects, including a collaborative album with the legendary MF DOOM, NehruvianDOOM. Explore Explore See latest videos, charts and news See latest videos, charts and news Nehru has been simultaneously working on his major label full-length, produced by MF DOOM and to feature Nas, and his 8-song EP, Nehruvia: The Nehruvian EP. Today (May 11), Bishop Nehru premieres his first project off of Mass Appeal Records, Nehruvia: The Nehruvian EP, exclusively on Billboard’s The Juice and talks the making of the EP, working alongside Nas and his upcoming Mass Appeal debut album. Trending on Billboard You spent some time touring in Tokyo. How was that experience? It was cool. It felt like New York to me. Osaka was more calm, I could live out there. I’d have to get used to the food. What’s wrong with the food? It’s just not my preference. I tried the ramen, I like a little bit of that. That was the coolest thing I tried out there. I don’t eat meat. I haven’t ate meat in ten months. I’m trying to go a year straight without eating it, and everything out there is pretty much beef and pork. So you’re not going full vegan? Nah, nah, I’m not vegan. I’m vegetarian. I definitely eat eggs and stuff like that. I could never go vegan, that’s too much. You grew up in New York, so was it different to listen to things that weren’t primarily from the East Coast? For sure, a lot of people when I was growing up weren’t listening to what I was listening to. People my age were really big on Jeezy, Soulja Boy, Lil Wayne — everybody loves Wayne. I had different types of friends — some of them listened to Jonas Brothers or Avril Lavigne. I would go to my grandma’s house and listen to Al Green or Luther Vandross, and then my cousin’s would listen to Eminem or 50 [Cent]. I was exposed to different stuff. What were some of your influences growing up? I didn’t really listen to rap, I had certain artists I listened to. Pretty much the stuff my mom or my dad played. 50, Eminem, Pharrell [Williams], Nas, MF DOOM. In middle school I got into DOOM. I was into stuff like Red Hot Chili Peppers, Linkin Park and Paramore. You mentioned that you were influenced by DOOM and Nas, and you’ve worked with both of them already. What advice has Nas given? Nas and DOOM pretty much told me the same thing: just do what I want to do and don’t let anybody stop me. I already know what I’m doing so I just have to do it and never compromise. Is Nas going to be on your upcoming debut album? Yeah, we been in the studio. Who are some artists that you want to work with in the future? I really want to work with Herbie Hancock, I’m saying this so he can hear it. A$AP Rocky, I definitely got fire for him. Wiz Khalifa, I got beats for him. Ab-Soul. Oh, and Willow and Jaden Smith! You said on Twitter that your new EP is “too raw for the album.” Were you just trying to warm up the fans beforehand? By raw, I',\n",
       " ('Linkin Park',\n",
       "  36,\n",
       "  1): 'meant sonically. It’s not mixed to sound great or sound amazing. While the mix isn’t terrible, I had my own ideas for it. An album has it’s own quality and texture. An album also has experimentation. [This EP] is me doing me normally. Making what I would make but getting really, really comfortable with it. I had an idea when I was in LA working on the album, and some of these songs I had already finished but you can’t keep dropping song after song. So I had to compile it. How old would you say some of the songs are? Not old, like a year old. Some are like four months old. One standout song on the EP is called “Users.” Do you feel like that it’s important to take control of everything in your career at such a young age? Yeah, because people try and take advantage of you. People want to use you as a pawn to do what they want to do. Some things people are going to try and throw at me and I have to say “no.” It sounds like you’ve been dealing with that already. Yeah, plenty of times. People get mad when you say “no.” It’s crazy (laughs). On “Harmony In A Glass” you say that “the future is the past.” Is that a comment on new artists like yourself who are quickly rising up next to the older artists? Not really. It’s kind of a play on words on “future is passed.” What you see already you can manifest it, if you do the work. It’s kind of deeper than that line. Everything you see yourself doing, just go and do it. What’s your craziest tour experience so far? After shows I usually go to my room to be honest. Wait, I can’t say that no more –– this girl started crying when she met me. It was weird, like “What the hell?” It was awkward. It’s going to get crazier. What are you going to do then? I don’t know, I just think that was a rare occasion. You don’t think you’re going to meet a fan who is going to go that crazy for you? Crying like that? I don’t know. Maybe. That was wild though. Usually I just leave the show and go work on music or watch The Boondocks on my laptop. You’re a big fan of Stephen Curry of the Golden State Warriors. Do you think they’re going to go all the way this year? Yes! You already know, I been a fan of Steph Curry since he [attended Davidson College]. My friends was on Brandon Jennings and Tyreke Evans all crazy but I was like “watch, Steph Curry is gonna be the one.” It’s crazy. Shout out to him for winning MVP. How much of an inspiration has he been to you, being another young person reaching their potential? It’s crazy! I always notice the people who are gonna be big and I become a fan of them. I always been like that. Attracted to people who are gonna be great. Steph Curry is gonna be great. You could say the same about yourself, and your development. Of course. That’s another instance of, “the future is passed.” It’s like you’re watching someone at your home become great. You don’t feel like you could do that yourself? I watched him do this, he’s doing it. There’s no way that I can’t. I wanna go further than that. Reporting by Justin Davis',\n",
       " ('Linkin Park',\n",
       "  37,\n",
       "  0): 'Crossfaith has been hitting a massive amount of location for the European tour Synchronicity Tour 2020 and for the first time, they decided to make a stop in Sweden where we were honored to spend a lovely time with the band during the day and experienced a mad show at night. We spoke with vocalist Ken and programmer Teru in order to find out all the little bits of details we’ve been craving to know, such as their current and future work, philosophy, the unique sound of Crossfaith, and even crazy stories from the past. Can you tell us what you’re expecting from the Swedish fans as it’s your first time here? Ken: I know Sweden is famous for metal music, such as black metal and death metal. For example, Soilwork and similar bands, industrial kind of bands. So yeah, I’m super excited to play for the black metalheads! Has there been one country that you’ve been taken aback by the crazy response? Ken: When we play in Germany, they always do this “rowing the boat” thing. There are so many people who would sit on the floor and— [Ken does a rowboat movement]. It’s super famous in Germany. It has happened so many times now, especially at festivals. During which song did they do this? Ken: I don’t know, it’s very random. The first time I saw that I was like “Hey guys, stop that”, telling them to circle pit instead. But they started rowing the boat and didn’t stop, so after that I just let it go. But you know, I think that’s the best way to express respect to the band so I love it. That was awesome. How about you Teru, any crazy moments on stage? Teru: I really like stage diving! What’s your philosophy or approach when it comes to performing live? Ken: My role on the stage is to connect to the audience, I need to be their commander to enable that. The person I look up to for that is Corey Taylor from Slipknot. He’s the best commander and I want to be like him. It’s not really a philosophy per se, but I would think that should be my role on stage. Teru: The vision I have in my head whenever I compose a song. I want to bring that out into the wild, to the stage. Tell us about a crazy experience that happened during your past tours! Ken: At the Thailand show, some guy lit his hand on fire. He wrapped his hand in bandage before soaking it in lighter fluid and set it on fire. Later, he put it out by throwing it on the floor. This all happened in the middle of a show, in the middle of the crowd. That was crazy [laughs]! At the beginning of the EU-tour, you released the incredibly heavy single Endorphin. Was this song specifically written to be performed live? Ken: For the most part, that’s just the type of music we’ve been listening to while growing up, heavy music that is. And of course, we’ve listened to a big variety of genres too such as electronic, hip-hop, and pop. But at the end of the day, heavy music is in my blood, you know? That’s why we play heavy music. They make us feel alive. Teru: That’s right, they make us feel high! I’ve tried to compose so many bright and upbeat songs, I really have, lots of times. However, before I knew it, they have all turned into heavy songs [laughs]. It’s like starting from major chords, but they end',\n",
       " ('Linkin Park',\n",
       "  37,\n",
       "  1): 'up turning into minor chords. [Everyone laughs] Crossfaith - Endorphin [Official Music Video] Watch this video on YouTube Would you consider Endorphin a new direction of Crossfaith? Ken: Yeah it’s a new direction. We got inspiration from genres and sounds like acid bass, acid techno, those kinds of stuff. The tempo of the song is intentionally set to 143 BPM in order to fit the sound. With the influence of hard techno and acid techno, we decided to start the song at the very beginning with the acid bass. We took inspiration from the 90’s rave culture too, which is the generation we were born into. I feel around that time, there was a lot more excitement compared to now, which is why we wanted to incorporate that into our new song. We remember you saying Japan is dominated by about 80% pop music in a previous interview. Ken: Yes, it’s true! Techno music and similar types have a small market in Japan. Regardless, we still have great techno musicians like Takkyu Ishino and this type of music is interesting for us, which is also why we decided to pick up this sound. That’s the guy who composed the “Ghost In The Shell” song! But we guess a lot of Crossfaith’s electronic influences come from you Teru? How do you decide on what sound to incorporate? Teru: Yes, that’s right. I always want to create something that is unique that no one has heard before. Ken: Yeah, that’s our role! Always trying out new things, because we don’t want to be like the others. Playing the same old stuff. We like to explore new music and mix it in with ours. It’s also interesting that you have a programmer on stage because not a lot of bands have that. On the top of our heads, Linkin Park comes to mind. Ken: Yes indeed. There are also bands like Enter Shikari, or in the more electronic kind of field, The Prodigy. They mix rock and rave music. How did you end up going for this setup with a programmer on stage? Ken: Before we started Crossfaith we were in the same band, Teru did DJing and played samplers as well. That was the early beginnings—the very start of it—but after that, Crossfaith took shape and he joined our band. Teru: There are so many bands with a DJ, but some of them simply stand on the stage without much interaction. I wanted to be a more iconic person that stands out among those DJs. And with Crossfaith, I can do that, so I wanted to become a part of it. That’s cool, it’s very unique and makes it a lot more special. Ken: Yes, it allows us to expand for a wider approach. About the electronic sound, it’s usually themed around space and sci-fi. Why is that? Ken: Because we love sci-fi and Teru especially loves cyberpunk and steampunk. Teru, what inspires you? Teru: I’m inspired by the movie “The Matrix”. So with a synthesizer, I’m able to create futuristic sounds with it. It’s as if the synthesizer is alive because every time you play it, something will be slightly different and in that sense, there are essentially infinite ways for me to play it and make music. Tell us about the Linkin Park song you covered, Faint. Ken: We brought in Masato from coldrain to do the clean vocals on this one. When we lost Chester Bennington of Linkin Park, we spoke with Masato and decided that we should do a tribute song. Why did you specifically choose Faint? Ken:',\n",
       " ('Linkin Park',\n",
       "  37,\n",
       "  2): 'It was a really natural choice for us. I would do the rap part and Masato could do the clean parts, so that’s how we decided on this song. There weren’t any other that fit us this perfectly. About the scream vocals which is an essential part of Crossfaith. Over the years, we’ve noticed that you included a bigger variety of scream techniques, whereas before it was more monotone and flat. Is that also a way for Crossfaith to expand the way you express yourself? Ken: Yeah, definitely! Screaming is very interesting because you have a high-note pitch, high-note scream, and low screaming as well. We can choose different styles of screams like Bert McCracken from the band The Used, who uses a more emotional type of scream. The lower screams are when I want to go for a more death metal style. However, I prefer the emotional style, but I can do both. It reminds us of Ryo from Crystal Lake who said: “When I scream, I do it as if I’m singing”. Ken: Yeah, I agree. Scream vocals can express a lot of things, express emotions and whatnot. But at some point, I needed to include clean vocals to expand that range of emotions which is why we decided to incorporate it. It was really tough and I’m still struggling with it to this day, however, we needed it to be able to fully express Crossfaith, you know? With that said, would you consider the album XENO to be an experimental phase? Because that was essentially the first album that included clean vocals. Ken: We always like to experiment. Some songs have only screaming vocals and some other songs have a lot more clean vocals. But in the end, everything we do is Crossfaith. Before the interview, you guys mentioned your upcoming EP which hasn’t yet been announced. Is it okay if we talk about it? Ken: Yeah, a little bit! It will have five songs and it will be released this spring. We have a guest vocalist for one of the songs in the EP, you might be surprised by who it is. Previously we’ve collaborated with many artists like Benji from Skindred, Caleb from Beartooth, and Rou Reynolds from Enter Shikari. These artists are from the rock music scene, but in our new release, we collaborated with someone from a different music scene which is going to surprise you. That’s all I can say [laughs]. When you create your albums and EPs, how do you usually approach it? Ken: It depends. For example, when we wrote EX_MACHINA, our latest album, we decided on a concept for it. As for XENO, while we still had a concept it was still very experimental for us. We wanted to try to add clean vocals, different styles like industrial rock and a lot more genres. It really depends. With the new upcoming EP, it’s similar to how we approached XENO or Zion. We just wanted to create stronger songs so I cannot wait to share the new music from the upcoming EP with you all. You also recorded the song Soul Seeker in 2018 for the anime “Souten no Ken”. It took us by surprise as we never expected such a heavy song to be included in an anime. How did you guys end up with this opportunity? Ken: We got an offer from them to write a song. At the time we were in a studio in Los Angeles, we had written a couple of songs that were going to be included in the EP Wipe Out. But since',\n",
       " ('Linkin Park',\n",
       "  37,\n",
       "  3): 'we received the offer, we could no longer put Soul Seeker in the EP and had it in a separate release. I rewrote the lyrics, but the music itself was already 80% finished. I was actually also surprised when we got the offer from the anime team because that anime is a really famous one in Japan. It’s also about Asia, like Japan or China. Soul Seeker Watch this video on YouTube You also didn’t care about accommodating your music style for the anime? Ken: They did request us to sing the song in Japanese… but fuck it! You know, that’s not our thing. Speaking about your music style. We feel your past music had a lot more electronic influences, as in the electronic sound being a lot more prominent in the songs. The recent music, however, seems to be more balanced overall? Teru: Yeah that might be the case because I always think of the balance when composing music. Whether it is the electronic sound or the band sound, we try to achieve a “double punch”, meaning both types of sound get their own equal presence while still being prominent. But it depends on which song it is, as each song has a different theme. How do you generally decide on how much electronic sound to include in that case? Ken: It really depends. We have two songwriters, one is Teru and one is Kazu. Kazu always brings guitar riffs and compose for example the beginning of the song until the chorus. Teru also works with him so it’s hard to say. Sometimes Teru would put the electronic parts on top of what Kazu has composed. In those cases, we don’t want the sound to clash. As with the song Monolith, Teru built up the song starting from the intro which is played on a synthesizer. But for other songs, he might approach it differently. Teru: Hm… Well, I don’t want the electronic sound to stand out too much. I’ve started to become more attentive and tend to use it more as a way to articulate songs. Lastly, please give your best advice on how we can learn to scream as you do! Ken: Feel the emotions, yeah… just feel it. Because it’s hard to teach how to do it, it comes naturally for me. But you know, try not to think about your throat too much when you start out. Just feel the emotions. Your throat will get used to it but it’s important to make use of the power of the diaphragm. Do you want to demonstrate it? Ken: I only scream on stage [laughs]! Please leave a message for your fans! Ken: Thanks for reading this! If you missed our set tonight, we might come back to Sweden this summer, so see you guys in a bit. Teru: Cheers! It was really fun to hang out with the band and learn more about the thought process that goes on behind the scenes. If you like this content, make sure to stick around because we have more exclusive coverage of their other shows in Europe! Keep yourself updated on Facebook, Twitter, or Instagram. Endorphin More info: Official Website YouTube Facebook Twitter Twitter (Kenta Koie) Twitter (Terufumi Tamano) Twitter (Kazuki Takemura) Twitter (Hiroki Ikegawa) Twitter (Amano Tatsuya) Instagram Instagram (Kenta Koie) Instagram (Terufumi Tamano) Instagram (Kazuki Takemura) Instagram (Hiroki Ikegawa) Instagram (Amano Tatsuya)',\n",
       " ('Linkin Park',\n",
       "  38,\n",
       "  0): 'This interview took place on: 6/3/03 Jesus freak Hideout: Why the name Kutless? Jon Micah Sumrall: The idea behind the name is; when Christ died on the cross for us he bore all of the cuts and bruises that we deserved, leaving us without those cuts and therefore, kut-less. JFH: How did you guys get started as a band? When did you know you wanted to make a ministry out of it? Jon Micah: We started in college about 3.5 years ago. We were originally a worship band and we led an alternative worship service at our college on Thursday nights. During practice one night, Stu mentioned that it had been on his heart to be in a rock band and do original music. We all looked at him and saying, \\x93No way, that has totally been on my heart too.\\x94 Looking around, we realized we already had a band, so we decided to go for it. Over the next several months, our calling became more evident and specific and we knew that God had great plans for our life and our music. JFH: What artists have influenced your sound? Jon Micah: Unfortunately, there are very few Christian bands that have a good \\x93nu-metal\\x94/\\x94popmetal\\x94 sound. Because of this we had to pull musical influences from some secular sources such as Linkin Park, Incubus, Nickleback, and Staind. These groups, while musically very talented, unfortunately do not always have the most positive messages. We have had to be very careful as we try to pull musical ideas from their music, without taking in too much of their negative messages. JFH: It is reported that later this year your self-titled debut will be released to the mainstream audience. How did this come about and how will the band handle the wider audience? Jon Micah: Our record is scheduled to be re-released to the mainstream market late this summer. It was a decision that our distributor, EMI and our label, Tooth and Nail/BEC made. We are excited about the opportunity to reach more people. Particularly people who do not yet know Christ. We do not plan to change our message in any way and we hope that we can share God\\x92s love to this broader audience. JFH: Already you guys have had some chances to play to secular crowds and to minister to some kids there. Any particular stories, testimonies or experiences that have really impacted you guys? Jon Micah: We hear daily of lives being changed and how our music has affected their lives. It has been incredible to see people accept Christ and turn their lives around. To be a part of what God is doing in many lives is an incredible privilege. JFH: You guys just got off the GO Show tour with Audio Adrenaline and MercyMe. What was that experience like for the band? Any standout moments? Jon Micah: We had a great time on the GO Show. We really enjoyed hanging out with Audio, Mercy Me and the Swift. All the bands were really cool and we had a great time on the entire tour. As far as memories, all I can say is on the last night of the tour, traditionally \\x93prank night\\x94, Audio got WORKED! JFH: We heard you guys are working on a new record. When is the projected release date and what can fans expect in your sophomore record? Jon Micah: The release date is not yet set, but we will be in the studio for all of August and part of September and November. I think our second record will be a little more',\n",
       " ('Linkin Park',\n",
       "  38,\n",
       "  1): 'refined as we have grown a lot as musicians in the last year. JFH: Who are some of your favorite Christian artists?',\n",
       " ('Linkin Park',\n",
       "  39,\n",
       "  0): 'In a warehouse in an industrial stretch of Long Beach, a man dressed in black slunk up to Amber Liu and tried to grab her. The wiry, wary Liu was ready, though, and kicked his legs out from under him. She pinned him to the ground, their shouts echoing through the hangar-sized building as a small crowd circled to watch. The two tangled for a bit, and Liu finally got the upper hand. Confident the guy was subdued, Liu let him up. They smiled and separated, ready to go in for Round 2. Advertisement Liu, the K-pop star and member of the foundational girl group f(x), wasn’t smacking the guy around entirely for fun. She was shooting some mixed-martial-arts moves for a workout video to raise money for the Special Olympics. Behind her, Long Beach Mayor Robert Garcia watched them tussle, then joined her on-screen for a quick PSA about the charity. Liu, one of the most recognizable stars in one of the world’s most popular genres of music, has never been afraid to take some hits. The 26-year-old Chinese American singer was born and raised in L.A., before a a South Korean label discovered her at a Koreatown festival and shot her to stardom halfway around the world in a third, new culture. But as Liu transitions into a solo artist with an eye on U.S. pop fame (she headlines the Belasco Theatre on Dec. 13), she’ll have to take up a whole different fight. “I was terrified to go solo. It’s lonely doing it by myself,” Liu said, sitting on a weight bench after her combat session. “But I wanted to challenge myself. Sitting on my butt waiting on opportunities won’t do me any good.” Advertisement The last two years were transitional for K-pop and “hallyu,” the umbrella term for the glossy, fan-delirious pop culture originating from South Korea. On one hand, the genre finally had its U.S. pop breakthrough when the group BTS topped the Billboard album charts in May (2012’s “Gangnam Style” was arguably its first crossover hit, but Psy’s follow-ups haven’t had the same impact). The KCON festival in downtown L.A., the largest K-pop event in America, now draws well over 100,000 fans every year for concerts, dance workshops and panels on cultural issues. Liu comes from a generation of K-pop singers who have risen to the pinnacle of genre fame, yet now find themselves at a crossroads. Many of the first-wave K-pop groups initially tipped for U.S. success in the 2010s have recently stumbled or broken up . 2NE1, Wonder Girls and BigBang all disbanded permanently or temporarily in 2017, and Girls Generation, AOA and T-ara all had members depart the same year. Advertisement And while many new acts have risen in their place, Liu, rather than wait for the Korean major-label machine to decide her fate, is striking out on her own in America. As a solo act in South Korea, she’s still signed to SM, the Seoul-based label conglomerate that’s shepherded some of the genre’s biggest acts. But this year, she’s testing a notably new sound, a new U.S.-focused management firm and a creative autonomy that few K-pop acts have ever enjoyed (or risked). “Being on a K-pop label and agency, everything’s taken care of for you. The music is set up for you. Your food, manager, practice room, recording studios, all these things are in the palm of your hand. However, you know the compromise of what you can actually do or say,” Liu said. K-pop labels have a reputation for controlling nearly every minute of their artists’ lives, from their',\n",
       " ('Linkin Park',\n",
       "  39,\n",
       "  1): 'music and tour schedules to their fashion choices, and have been reported to include clauses that regulate an artist’s romantic life. But now, Liu said, “I’m driving the artistry. I get more freedom, but my head’s going crazy. I have no idea what I’m doing half the time now.” Liu always stood out in f(x) because of her tomboyish aesthetic and her nimble, assertive rapping. The group was fairly experimental in its generation of K-pop, with head-spinning productions and melodies that dropped the genre’s sweetness for stranger hooks. In 2013, it was the first K-pop act to perform at the South by Southwest music festival in Texas, and its album “Pink Tape” topped many year-end lists of the best Asian pop (or any other kind). Advertisement Liu released her first solo material in 2015 and in April dropped “Rogue Rouge,” a six-song EP on Soundcloud that felt like a departure from that work. Her rhymes were edgier, the styles brasher, the music less polished but perhaps more ambitious. It set the tone for a pair of new September solo singles, “Lost at Sea” and “White Noise,” both sung in English and much more akin to the bloodletting electro-pop of Halsey, Lorde or Tove Lo than any K-pop peer. “Lost at Sea” is, by K-pop standards, an uncommonly despairing take on a failing relationship: “There’s no help for us in sight / Nothing, no possibilities / ’Cause no matter what I do / It don’t get through to you.” It fits right in with the depressed yet steely sounds of much mainstream U.S. pop at the moment, like Billie Eilish or Maggie Rogers. “I’m an adult, I can talk about more mature things that you don’t expect in what the group might do,” Liu said. “There’s a finesse to f(x) that I can’t do without those girls. [But] every song I had written was on the darker side, and looking back, maybe it’s because that’s who I was then.” BTS’ success proved that K-pop acts can succeed in America without pandering to what tastemakers see as a “mainstream” (read: white) U.S. audience. But Liu’s turn toward English-language, Western-ready pop isn’t cynical either. Liu graduated from El Camino Real high school in the San Fernando Valley, and SM scouted her at a local festival in 2008. American pop, rock and hip-hop come just as naturally to her as K-pop, and she cites hometown heroes Linkin Park as a formative influence. Her multilingual background (English, Korean and Chinese ) gives her a unique vantage to speak to different crowds. Advertisement For John Kim, an artist manager in Liu’s new U.S. management firm Steel Wool Entertainment (and a K-pop veteran who managed Girls Generation and BoA), Liu’s shift is part of the next wave of edgy Asian pop music, which may come out of K-pop but is also restless with its confines. “She’s a global artist who can sing, rap, write and produce. She still has those roots, and the ‘K’ will always be there. But she’s her own person and artist,” Kim said. (Kim is an artist manager at the firm founded by Kevin Morrow, a former Live Nation executive.) K-pop-reared acts like G-Dragon and Kris Wu have made inroads in U.S. hip-hop and club music. But post-BTS, such transitions face a very different pop landscape now, one arguably more hospitable but also perhaps more wide-open and confusing. BTS “definitely helped with Asian acts coming to the U.S. It brings more awareness to the scene,” Kim said. “BoA, Rain and Wonder Girls all tried to break 10 years ago, but the timing wasn’t',\n",
       " ('Linkin Park',\n",
       "  39,\n",
       "  2): 'right. But once BTS did its thing, it’s helped open doors to give new opportunities.” Amber Liu of K-pop group f(x) is already a global superstar. Liu is trying to cross over and reach U.S. audiences with her solo career with Steel Wool Entertainment. (Ana Venegas / For The Times) For me to do what I’m doing, Jackie Chan had to be there, Lucy Liu had to be there. Now it’s Awkwafina. We just need to keep popping up. — Amber Liu Advertisement Liu is at an in-between place, both musically and personally. She’s a Chinese American whose entire adult life was spent pursuing stardom in another Asian country. She accomplished everything she set out to then, but she’s excited and nervous about the next steps her generation of K-pop stars need to take to stay relevant. “I was talking with Dumbfoundead [the Korean American rapper] about this, and he said that when something becomes ‘popular,’ it’s when white people accept it,” she said. But maybe it’s also more nuanced than that. “I think when something becomes a trend it’s, like, ‘What is this shiny new rock?’ But then that rock becomes part of the collection. With K-pop, you had Girls Generation, 2NE1 and BigBang, and now people just know about us. K-pop’s not up and down [anymore], it just stays,” she said. Just a few months after the expectation-shattering success of “Crazy Rich Asians,” it’s clear that the U.S. (and the rest of the world) is ready to meet new kinds of Asian narratives on their own terms, with all the complicated humanity and culture that drives them. Liu made her career in one ascendant Asian pop-art form that helped drive that change. Now she’s hoping there’s yet another new round for her. “For me to do what I’m doing, Jackie Chan had to be there, Lucy Liu had to be there. Now it’s Awkwafina. We just need to keep popping up,” Liu said. “Society tells you home is where you grew up or where you settled, but nah. I have friends all over the world. Maybe I have a billion homes.” Advertisement [For The Record: 10:30 A.M. Nov. 30] A profile of the singer Amber Liu incorrectly described John Kim’s title at Steel Wool Entertainment. He is an artist manager, not a co-founder. For breaking music news, follow @augustbrown on Twitter.',\n",
       " ('Linkin Park',\n",
       "  4,\n",
       "  0): 'I gotta give it up to whoever designed the packaging for Linkin Park\\'s official sophomore release (let\\'s face it, Reanimated was a remix album, not a new album). The liner note booklet is fresh, thanks to some deft photography and a cool graff theme (I\\'m not even gonna get into the whole appropriation thing, LP jacking hip-hop culture for their liner notes--as it would take up the bulk of this review, let\\'s just say that regardless of the subject matter, it looks sweet). I also like how there\\'s a sidebar next to the printed lyrics of each song called \"Notes\" and wherein the band gives some background info on the recording of that specific track. The only bummer is that my booklet was misprinted, containing extra pages for songs 10-13. So I think while I got extra pages I also got shortchanged on the pages that should have been part of the booklet.Eye catching liner notes/booklet aside, the real thrust of the CD is the music, no? So exactly how does LP\\'s second album of new, original material hold up? For starters I should probably come clean and admit that I never got caught up in the wave of praise and hype surrounding LP when they emerged in 2000. I found their debut album to be rather stiff and flat sounding. When I caught them live I found that each and every song began to blur into one another and by the end of their set it was as if I\\'d been subjected to one long, continuous angst ridden, down-tuned, nu-metal melee.So, it was with great trepidation that I plucked the Meteora disc from the case, popped it into the computer and jacked up the volume on my Creative speaker system. The album commences with a rather pointless \"Intro\"; a meager 13 seconds of clanking and breaking glass. Why it warranted it\\'s own title is beyond me. From here we are sucked into the Linkin Park vacuum of dark emptiness and bitter angst flow. All of it rendered by Chester Bennington\\'s monochromatic wail/scream/croon. \"Don\\'t Stay\" runs familiar terrain, sounding rather similar to their previous album\\'s worth of material--spiky guitars, scream therapy vocals, chirping scratch embellishment, the works.\"Somewhere I Belong\" begins promisingly enough with shimmering, crystalline guitar, but then the familiar chirping scratches drop in while Mike Shinoda raps stiffly and Bennington\\'s wail floats as a whisper in the background before bursting out on the chorus. The track sounds a lot like their previous hits \"One Step Closer\" and \"Crawling\".\"Lying From You\" is the first track on the album that hit me as something different, at least for the first 45-seconds. Cool faux violin sounds flit from channel to channel before careening buzz saw guitars cut through the mix and for once the all-too-familiar chirping from the turntables adds a welcome sonic boost to the proceedings. The eerie ambiance actually enhances Shinoda\\'s routine verbal volley. But then the track slips and falters back into familiar LP territory with Chester yelping on the chorus \"The very worst part of you is me...\" proving that even artistic self-effacement can be pushed over the edge.\"Hit The Floor\" follows suit, again beginning with a promising aural crush as chugging bass and jigsaw guitar rip and curl and Shinoda actually shows some microphone finesse (now before you think that I totally abhor his microphone technique, lemme point out that I thought he came off competently enough on the X-Ecutioner\\'s fist-waving jammy \"It\\'s Goin\\' Down\"). His lickety split delivery rolls over mutated clanking and intermittent chug thrusts to solid effect. Without a doubt this is easily the',\n",
       " ...}"
      ]
     },
     "execution_count": 5,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "wiki_bench.wiki_utility.load_corpus(window_size=600)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "id": "8bbd508e-1e28-4938-90cc-74ab0e0010e0",
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Default prompt name is set to 'Classification'. This prompt will be applied to all `encode()` calls, except if `encode()` is called with `prompt` or `prompt_name` parameters.\n"
     ]
    }
   ],
   "source": [
    "wiki_bench.wiki_agent = WikiAgent(wiki_bench.wiki_writer, True)\n",
    "wiki_bench.wiki_evaluater = WikiEvaluater(wiki_bench.wiki_agent.device, wiki_bench.wiki_agent.encoder)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "id": "6ec37652-f472-4cd6-92b2-0dad1b06dc19",
   "metadata": {},
   "outputs": [],
   "source": [
    "article_name = 'Python'\n",
    "snippets_count = sum([1 if snippet[0] == article_name else 0 for snippet in wiki_bench.wiki_evaluater.snippets.keys()])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "id": "167274ad-cedc-477b-98ac-05ebaab7efa0",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "100\n"
     ]
    }
   ],
   "source": [
    "print(len(set(wiki_bench.article_names)))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "id": "ab071734-d05c-40d5-ae49-123ff6723b40",
   "metadata": {},
   "outputs": [],
   "source": [
    "for article_name in wiki_bench.article_names:\n",
    "    wiki_bench.wiki_agent.get_embeddings(article_name, force_download=True)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 110,
   "id": "acafabb0-00aa-401e-bbac-2f642c1dd731",
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Default prompt name is set to 'Classification'. This prompt will be applied to all `encode()` calls, except if `encode()` is called with `prompt` or `prompt_name` parameters.\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "228.75\n",
      "(0.5570 | 0.5808 | 0.5573)\n"
     ]
    }
   ],
   "source": [
    "import time\n",
    "import numpy as np\n",
    "from scipy.stats import bootstrap\n",
    "\n",
    "def calc(data):\n",
    "  data = np.array(data)\n",
    "  data1 = (data,)\n",
    "  bootstrap_ci = bootstrap(data1, np.mean, confidence_level=0.95, n_resamples=len(data)-1)\n",
    "\n",
    "  dist = bootstrap_ci.bootstrap_distribution\n",
    "  mean = np.quantile(dist, q=0.5)\n",
    "  min = np.quantile(dist, q=0.025)\n",
    "  max = np.quantile(dist, q=0.975)\n",
    "  return mean\n",
    "\n",
    "    \n",
    "page = wiki_bench.get_article(article_name, False, True)\n",
    "start = time.perf_counter()\n",
    "pr, rec, f1 = await wiki_bench.wiki_evaluater.rank_sections(page, 'RefalMachine/RuadaptQwen2.5-32B-Pro-Beta')\n",
    "end = time.perf_counter()\n",
    "count = end - start\n",
    "print(f'{count:2.2f}')\n",
    "a = calc(pr)\n",
    "b = calc(rec)\n",
    "c = calc(f1)\n",
    "print(f'({a:.4f} | {b:.4f} | {c:.4f})')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 111,
   "id": "2d52df05-ef6f-4554-8f50-90d91b8a5632",
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Default prompt name is set to 'Classification'. This prompt will be applied to all `encode()` calls, except if `encode()` is called with `prompt` or `prompt_name` parameters.\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "222.45\n",
      "(0.5554 | 0.5804 | 0.5773)\n"
     ]
    }
   ],
   "source": [
    "import time\n",
    "import numpy as np\n",
    "from scipy.stats import bootstrap\n",
    "\n",
    "def calc(data):\n",
    "  data = np.array(data)\n",
    "  data1 = (data,)\n",
    "  bootstrap_ci = bootstrap(data1, np.mean, confidence_level=0.95, n_resamples=len(data)-1)\n",
    "\n",
    "  dist = bootstrap_ci.bootstrap_distribution\n",
    "  mean = np.quantile(dist, q=0.5)\n",
    "  min = np.quantile(dist, q=0.025)\n",
    "  max = np.quantile(dist, q=0.975)\n",
    "  return mean\n",
    "\n",
    "    \n",
    "page = wiki_bench.get_article(article_name, False, True)\n",
    "start = time.perf_counter()\n",
    "pr, rec, f1 = await wiki_bench.wiki_evaluater.rank_sections(page, 'RefalMachine/RuadaptQwen2.5-32B-Pro-Beta')\n",
    "end = time.perf_counter()\n",
    "count = end - start\n",
    "print(f'{count:2.2f}')\n",
    "a = calc(pr)\n",
    "b = calc(rec)\n",
    "c = calc(f1)\n",
    "print(f'({a:.4f} | {b:.4f} | {c:.4f})')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "id": "1cbd3a89-2bba-4ae5-b331-ab2bf4e6ec8e",
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Default prompt name is set to 'Classification'. This prompt will be applied to all `encode()` calls, except if `encode()` is called with `prompt` or `prompt_name` parameters.\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "80.72\n",
      "(0.5667 | 0.5657 | 0.5640)\n"
     ]
    }
   ],
   "source": [
    "import time\n",
    "import numpy as np\n",
    "from scipy.stats import bootstrap\n",
    "\n",
    "def calc(data):\n",
    "  data = np.array(data)\n",
    "  data1 = (data,)\n",
    "  bootstrap_ci = bootstrap(data1, np.mean, confidence_level=0.95, n_resamples=len(data)-1)\n",
    "\n",
    "  dist = bootstrap_ci.bootstrap_distribution\n",
    "  mean = np.quantile(dist, q=0.5)\n",
    "  min = np.quantile(dist, q=0.025)\n",
    "  max = np.quantile(dist, q=0.975)\n",
    "  return mean\n",
    "\n",
    "article_name = 'Python'\n",
    "page = wiki_bench.get_article(article_name, False, True)\n",
    "start = time.perf_counter()\n",
    "pr, rec, f1 = await wiki_bench.wiki_evaluater.rank_sections(page, 'lol')\n",
    "end = time.perf_counter()\n",
    "count = end - start\n",
    "print(f'{count:2.2f}')\n",
    "a = calc(pr)\n",
    "b = calc(rec)\n",
    "c = calc(f1)\n",
    "print(f'({a:.4f} | {b:.4f} | {c:.4f})')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "id": "ad789d74-88f6-4554-939b-aac3ec7f96cc",
   "metadata": {},
   "outputs": [],
   "source": [
    "mode = 1\n",
    "page = wiki_bench.get_article(article_name, is_downloaded=True)\n",
    "neighbor_count = 0\n",
    "description_mode = 0"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "id": "4b483e35-2e69-48e3-a2cb-c4f37991dc58",
   "metadata": {
    "scrolled": true
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Python\n",
      "1\n",
      "0\n",
      "0\n",
      "17.50\n",
      "(0.6723 | 0.7072 | 0.6893)\n"
     ]
    }
   ],
   "source": [
    "import time\n",
    "print(article_name)\n",
    "print(mode)\n",
    "print(neighbor_count)\n",
    "print(description_mode)\n",
    "start = time.perf_counter()\n",
    "p, r, f = await wiki_bench.wiki_evaluater.rank_outline(article_name, mode=mode, page=page, neighbor_count=neighbor_count, description_mode=description_mode)\n",
    "end = time.perf_counter()\n",
    "count = end - start\n",
    "print(f'{count:2.2f}')\n",
    "print(f'({p:.4f} | {r:.4f} | {f:.4f})')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 14,
   "id": "d370fcb0-a98c-461f-9291-a645605c3890",
   "metadata": {
    "collapsed": true,
    "jupyter": {
     "outputs_hidden": true
    },
    "scrolled": true
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\"Python: Всеобъемлющее руководство для начинающих и продвинутых разработчиков\"\n",
      "\n",
      "В статье \"Python: Всеобъемлющее руководство для начинающих и продвинутых разработчиков\" подробно рассматриваются основы языка программирования Python, начиная с установки и первой программы, и заканчивая сложными темами, такими как многопоточность, асинхронное программирование и машинное обучение. Особое внимание уделено лучшим практикам написания кода, оптимизации производительности и актуальным библиотекам, включая NumPy, Pandas, TensorFlow и Django, что делает материал полезным как для новичков, так и для опытных разработчиков, стремящихся расширить свои навыки в работе с Python. Также рассматриваются кейс-стади из реальной жизни, демонстрирующие эффективность применения Python в различных индустриях, что позволяет читателям глубже понять его потенциал и возможности.\n",
      "The article provides an in-depth overview of Python, covering its latest updates, key features, applications in various industries such as data science, machine learning, and web development, best practices for beginners, and future trends in the programming language. It also highlights popular libraries and frameworks that enhance Python's capabilities for modern software development.\n",
      "Python\n",
      "413\n"
     ]
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "ee5df34684e34c4db495979be3cc36a7",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Split strings:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "407e4325b2a54517b4eeacca20e426c0",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Stem Tokens:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "905ff144439d4fa4b0388b05fc012a8c",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "BM25S Retrieve:   0%|          | 0/1 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "137.32003480000003\n",
      "0.9239447734030481 0.6346749226006192\n"
     ]
    }
   ],
   "source": [
    "import time\n",
    "\n",
    "annotations = AsyncList()\n",
    "annotations.append(wiki_bench.wiki_writer.get_ref_subqueries(None, 0, 0, article_name))\n",
    "annotations.append(wiki_bench.wiki_writer.get_ref_subqueries(None, 1, 0, article_name))\n",
    "await annotations.complete_couroutines(batch_size=2)\n",
    "annotations = await annotations.to_list()\n",
    "new_texts = annotations\n",
    "new_text = new_texts[0] + '\\n' + new_texts[1]\n",
    "print(new_text)\n",
    "print(article_name)\n",
    "print(snippets_count)\n",
    "start = time.perf_counter()\n",
    "ndcg, pr_r_score = await wiki_bench.wiki_evaluater.rank_one_query(new_text, 3*snippets_count, article_name)\n",
    "end = time.perf_counter()\n",
    "print(end - start)\n",
    "print(ndcg, pr_r_score)"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3 (ipykernel)",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.12.9"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
